PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Eid, N; Ito, Y; Otsuki, Y				Eid, Nabil; Ito, Yuko; Otsuki, Yoshinori			The topographic relationships between thoracic duct and bronchial arteries and surgical relevance	ESOPHAGUS			English	Letter									[Eid, Nabil; Ito, Yuko; Otsuki, Yoshinori] Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, Takatsuki, Osaka 5698686, Japan	Eid, N (reprint author), Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	nabil@art.osaka-med.ac.jp					Eid N, 2013, SURG RADIOL ANAT, V35, P969, DOI 10.1007/s00276-013-1111-7; Eid N, 2010, CLIN ANAT, V23, P897, DOI 10.1002/ca.20932; Eid N, 2011, JAPANESE J LYMPHOLOG, V34, P53; Kajiyama Y, 2015, ESOPHAGUS-TOKYO, V12, P398, DOI 10.1007/s10388-014-0450-8	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					401	401		10.1007/s10388-014-0464-2		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800011		
J	Kajiyama, Y				Kajiyama, Yoshiaki			The topographic relationships between thoracic duct and bronchial arteries and surgical relevance Reply	ESOPHAGUS			English	Letter									Juntendo Univ, Dept Esophageal & Gastroenterol Surg, Tokyo 1138421, Japan	Kajiyama, Y (reprint author), Juntendo Univ, Dept Esophageal & Gastroenterol Surg, Tokyo 1138421, Japan.	kaji@juntendo.ac.jp					Eid N, 2013, SURG RADIOL ANAT, V35, P969, DOI 10.1007/s00276-013-1111-7; Eid N, 2010, CLIN ANAT, V23, P897, DOI 10.1002/ca.20932; Kajiyama Y, 2015, ESOPHAGUS-TOKYO, V12, P398, DOI 10.1007/s10388-014-0450-8	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					402	402		10.1007/s10388-014-0474-0		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800012		
J	Matsumoto, Y; Endo, M; Harimaya, K; Hayashida, M; Doi, T; Iwamoto, Y				Matsumoto, Yoshihiro; Endo, Makoto; Harimaya, Katsumi; Hayashida, Mitsumasa; Doi, Toshio; Iwamoto, Yukihide			Malignant peripheral nerve sheath tumors presenting as spinal dumbbell tumors: clinical outcomes and characteristic imaging features	EUROPEAN SPINE JOURNAL			English	Article						Malignant peripheral nerve sheath tumor (MPNST); Spinal tumor; Dumbbell tumor; Imaging characteristics	INTRAOSSEOUS SCHWANNOMA; SARCOMA; SYSTEM	Purpose To investigate the clinical outcomes and imaging features of malignant peripheral nerve sheath tumors (MPNSTs) presenting as spinal dumbbell tumors. Methods We retrospectively reviewed the clinical outcomes and imaging features of consecutive cases of spinal dumbbell MPNSTs (n = 8) and schwannomas (n = 15). Results A maximal diameter > 5 cm was more frequently seen in MPNSTs (88 %) than in schwannomas (14 %). Irregularly lobulated margins occurred frequently in MPNSTs (75 %), but not in schwannomas (21 %). Indistinguishable boundaries were observed in 63 % of MPNSTs, but only 7 % of schwannomas. Osteolytic bone destruction was found exclusively in MPNSTs (50 % of MPNSTs vs. 0 % of schwannomas). Conclusions There is little clinical information relating to spinal dumbbell MPNSTs. We propose that the following imaging features are suggestive of spinal dumbbell MPNSTs: maximal diameter > 5 cm, irregularly lobulated shape, boundary indistinguishable from surrounding tissues, and osteolytic bone destruction.	[Matsumoto, Yoshihiro; Endo, Makoto; Harimaya, Katsumi; Hayashida, Mitsumasa; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Doi, Toshio] Kyushu Univ, Beppu Hosp, Dept Orthopaed Surg, Beppu, Oita, Japan	Matsumoto, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ymatsu@ortho.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23592192]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#23592192).	Lang N, 2012, CLIN IMAG, V36, P209, DOI 10.1016/j.clinimag.2011.08.015; Eden K, 1941, BRIT J SURG, V28, P549, DOI 10.1002/bjs.18002811205; Baehring JM, 2003, NEUROLOGY, V61, P696; WANEBO JE, 1993, CANCER, V71, P1247, DOI 10.1002/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S; Kojima M, 2011, EUR SPINE J, V20, pS153, DOI 10.1007/s00586-010-1456-0; Chamoun RB, 2009, PEDIATR NEUROSURG, V45, P230, DOI 10.1159/000224621; MCCORMICK PC, 1990, J NEUROSURG, V72, P523, DOI 10.3171/jns.1990.72.4.0523; Catton C, 1996, RADIOTHER ONCOL, V41, P67, DOI 10.1016/S0167-8140(96)91805-8; Matsumoto K, 2013, CANCER-AM CANCER SOC, V119, P3496, DOI 10.1002/cncr.28177; Jiang L, 2009, SPINE, V34, P1307, DOI 10.1097/BRS.0b013e3181a27a32; Palocaren T, 2008, J BONE JOINT SURG BR, V90B, P803, DOI 10.1302/0301-620X.90B6.19901; Wong WW, 1998, INT J RADIAT ONCOL, V42, P351, DOI 10.1016/S0360-3016(98)00223-5; Mounasamy V, 2006, SKELETAL RADIOL, V35, P117, DOI 10.1007/s00256-005-0028-6; Ichikawa T, 1996, BRIT J RADIOL, V69, P114; Ren XH, 2013, J NEUROSURG, V119, P695, DOI 10.3171/2013.5.JNS122119; Nooraie H, 1997, ARCH ORTHOP TRAUM SU, V116, P440; LOVE JG, 1952, SURG GYNECOL OBSTET, V94, P161; Ozawa H, 2007, J NEUROSURG-SPINE, V7, P587, DOI 10.3171/SPI-07/12/587; Endo M, 2011, CLIN CANCER RES, V17, P3771, DOI 10.1158/1078-0432.CCR-10-2393; DUCATMAN BS, 1986, CANCER, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Goldblum JJ, 2008, ENZINGER WEISSS SOFT; Heuer GJ, 1929, ARCH SURG-CHICAGO, V18, P935; Singh Tarvinder, 2007, Neurosurg Focus, V22, pE6	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	OCT	2015	24	10					2119	2125		10.1007/s00586-014-3467-8		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS8FC	WOS:000362320200004		
J	Sugita, S; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Yokogawa, N; Tanaka, S; Tsuchiya, H				Sugita, Shurei; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Yokogawa, Noriaki; Tanaka, Sakae; Tsuchiya, Hiroyuki			Repeated total en bloc spondylectomy for spinal metastases at different sites in one patient	EUROPEAN SPINE JOURNAL			English	Article						Spinal metastases; Total en bloc spondylectomy; Preoperative artery embolization; Nerve root ligation and cut; Repeated times	BILATERAL SEGMENTAL ARTERIES; PREOPERATIVE EMBOLIZATION; CORD COMPRESSION; DOG-MODEL; TUMORS; SURGERY	Purpose Total en bloc spondylectomy (TES) is accompanied by preoperative embolization of segmental arteries, which is limited to three consecutive levels to avoid the risk of spinal cord ischemia. We retrospectively examined the efficacy and safety of repeated TES with embolization of more than three levels of segmental arteries. Methods Seven patients underwent TES twice for spinal metastases at different levels. Every patient underwent embolization of the bilateral segmental arteries before each surgery. We assessed the total number of segmental arteries embolized, the existence of Adamkiewicz arteries during the embolization procedure, intraoperative blood loss, and the motor function of the lower limbs, using the American Spinal Injury Association (ASIA) motor score. Results No patient experienced any motor deficit after embolization. During the embolization procedure, an Adamkiewicz artery was depicted in five patients, which precluded embolization at that level. The median number of segmental arteries embolized in total was 9 (9-11). Intraoperative blood loss (median, IQR) was 480 (420-630) ml during the first surgery and 520 (280-600) ml during the second surgery. The ASIA motor scores (median, IQR) were as follows; 100 (98-100) (first admission), 100 (100-100) (first discharge), 100 (98-100) (second admission), and 97 (94-100) (second discharge). No patients had developed statistically significant neurological deterioration, and there had been no local recurrence after a median follow-up of 17.8 months (range 1-51 months). Conclusion Repeated TES procedures can be performed safely even if more than three levels of segmental arteries are embolized.	[Sugita, Shurei; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Yokogawa, Noriaki; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan	Sugita, S (reprint author), Kanazawa Univ, Dept Orthopaed Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	ssugita-tky@umin.ac.jp					Etz CD, 2011, J THORAC CARDIOV SUR, V141, P1029, DOI 10.1016/j.jtcvs.2010.06.017; Pikis S, 2014, NEUROL RES, V36, P502, DOI 10.1179/1743132814Y.0000000361; Murakami H, 2010, J NEUROSURG-SPINE, V12, P253, DOI 10.3171/2009.9.SPINE09506; Guzman R, 2005, EUR SPINE J, V14, P263, DOI 10.1007/s00586-004-0757-6; Fujimaki Y, 2006, SPINE, V31, pE781, DOI 10.1097/01.brs.0000238717.51102.79; GOMEZ JAO, 1995, INT ORTHOP, V19, P309; Kato S, 2013, SPINE, V38, P1964, DOI 10.1097/BRS.0b013e3182a46576; Rades D, 1999, STRAHLENTHER ONKOL, V175, P378, DOI 10.1007/s000660050024; Geisbusch S, 2012, J THORAC CARDIOV SUR, V144, P1471, DOI 10.1016/j.jtcvs.2012.08.062; BLACK P, 1979, NEUROSURGERY, V5, P726; Kato S, 2008, SPINE, V33, P1533, DOI 10.1097/BRS.0b013e318178e5af; TOMITA K, 1994, INT ORTHOP, V18, P291; Boriani S, 2010, EUR SPINE J, V19, P231, DOI 10.1007/s00586-009-1137-z; Kato S, 2012, ORTHOPEDICS, V35, pE1389, DOI 10.3928/01477447-20120822-27; BACH F, 1990, ACTA NEUROCHIR, V107, P37, DOI 10.1007/BF01402610; CONSTANS JP, 1983, J NEUROSURG, V59, P111, DOI 10.3171/jns.1983.59.1.0111; Kato S, 2014, ANN SURG ONCOL, V21, P1330, DOI 10.1245/s10434-013-3333-7; Etz D C, 2014, J Cardiovasc Surg (Torino), V55, P159; Luehr Maximilian, 2014, Innovations (Phila), V9, P60, DOI 10.1097/IMI.0000000000000038	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	OCT	2015	24	10					2196	2200		10.1007/s00586-015-4091-y		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS8FC	WOS:000362320200014		
J	Ohba, T; Ebata, S; Fujita, K; Sato, H; Devin, CJ; Haro, H				Ohba, Tetsuro; Ebata, Shigeto; Fujita, Koji; Sato, Hironao; Devin, Clinton J.; Haro, Hirotaka			Characterization of symptomatic lumbar foraminal stenosis by conventional imaging	EUROPEAN SPINE JOURNAL			English	Article						Foraminal stenosis; Computed tomography (CT); Magnetic resonance imaging (MRI); Modic changes; Intervertebral vacuum phenomenon	LOW-BACK-PAIN; SCREW PLACEMENT; MRI; CLASSIFICATION; ASSOCIATION; SURGERY; DISEASE	Purpose The preoperative identification of lumbar foraminal stenosis (LSFS) is important because a lack of recognition of this clinical entity is often associated with failed back surgery syndrome. Although magnetic resonance imaging (MRI) is widely used, and is considered by many as an appropriate tool for studying spine pathologies, there is limited data to suggest that MRI examinations are sufficiently sensitive or specific for the diagnosis of LSFS. There is a paucity of literature on the diagnostic performance of the combination of conventional diagnostic imaging methods. The purpose of this study is to determine the characteristics of conventional diagnostic imaging for symptomatic lumbar foraminal stenosis. Methods The characteristics of conventional diagnostic imaging of LSFS (X-ray, computed tomography (CT) and MRI) were assessed in 68 patients in whom the site of the stenosis was confirmed by means of selective decompression surgeries. Results Measurement of the foraminal width and height on CT imaging of the diseased side was significantly less than that on the intact side in the LSFS group. The grading scale for facet joint arthritis on the diseased side was significantly higher than that on the intact side in the LSFS group. The prevalence of the vacuum phenomenon and stage of intervertebral disk (IVD) pathology were higher in the L5-S1 spine of the LSFS group (95.2 %) compared with the lumbar spinal canal stenosis (LCS) group (21.1 %). MRI study revealed that the prevalence of Type 3 Modic changes was significantly higher in the LSFS group (39.3 %) compared with the LCS group (7.7 %). Conclusions Our study demonstrates combination of conventional imaging techniques, to improve the detection of symptomatic foraminal stenosis.	[Ohba, Tetsuro; Ebata, Shigeto; Fujita, Koji; Sato, Hironao; Haro, Hirotaka] Univ Yamanashi, Dept Orthopaed Surg, Chuo Ku, Yamanashi 4093898, Japan; [Devin, Clinton J.] Vanderbilt Univ, Dept Orthopaed, Nashville, TN 37235 USA	Ohba, T (reprint author), Univ Yamanashi, Dept Orthopaed Surg, Chuo Ku, Yamanashi 4093898, Japan.	tooba@yamanashi.ac.jp					Xu RM, 1998, SPINE, V23, P1065, DOI 10.1097/00007632-199805010-00021; Iguchi T, 2011, EUR SPINE J, V20, P1349, DOI 10.1007/s00586-011-1793-7; Albert HB, 2011, EUR SPINE J, V20, P1355, DOI 10.1007/s00586-011-1794-6; MODIC MT, 1988, RADIOLOGY, V168, P177; Inufusa A, 1996, SPINE, V21, P2412, DOI 10.1097/00007632-199611010-00002; Attias N, 2006, J SPINAL DISORD TECH, V19, P249, DOI 10.1097/01.bsd.0000203942.81050.c8; Nowicki BH, 1996, AM J NEURORADIOL, V17, P1605; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Yamada K, 2014, EUR SPINE J, V23, P504, DOI 10.1007/s00586-013-3055-3; TOYONE T, 1994, J BONE JOINT SURG BR, V76B, P757; Sokolowski MJ, 2008, SPINE, V33, P108, DOI 10.1097/BRS.0b013e31815e39af; Cramer GD, 2003, J MANIP PHYSIOL THER, V26, P160, DOI 10.1016/S0161-4754(02)54109-9; Hasegawa K, 2011, J BONE JOINT SURG BR, V93B, P650, DOI 10.1302/0301-620X.93B5.25520; FAGER CA, 1980, SPINE, V5, P87, DOI 10.1097/00007632-198001000-00015; Upendra BN, 2008, SPINE, V33, P384, DOI 10.1097/BRS.0b013e3181646ba1; Braithwaite I, 1998, Eur Spine J, V7, P363, DOI 10.1007/s005860050091; PHEASANT HC, 1982, CLIN ORTHOP RELAT R, P93; Nemoto Osamu, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS209, DOI 10.1007/s00590-013-1377-9; Splendiani A, 2014, RADIOL MED, V119, P164, DOI 10.1007/s11547-013-0330-7; Yamada K, 2015, EUR SPINE J, V24, P333, DOI 10.1007/s00586-014-3683-2	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	OCT	2015	24	10					2269	2275		10.1007/s00586-015-3859-4		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS8FC	WOS:000362320200023		
J	Takeuchi, M; Wakao, N; Kamiya, M; Gosho, M; Osuka, K; Hirasawa, A; Niwa, A; Aoyama, M; Kawaguchi, R; Shima, H; Takayasu, M				Takeuchi, Mikinobu; Wakao, Norimitsu; Kamiya, Mitsuhiro; Gosho, Masahiko; Osuka, Koji; Hirasawa, Atsuhiko; Niwa, Aichi; Aoyama, Masahiro; Kawaguchi, Reo; Shima, Hiroshi; Takayasu, Masakazu			Diagnostic accuracy of multifidus muscle spontaneous activity by needle electromyography for the detection of lumbar foraminal and lateral exit-zone stenosis	EUROPEAN SPINE JOURNAL			English	Article						Lumbar foraminal stenosis; Lumbar lateral exit-zone stenosis; Needle electromyography; Multifidus muscle; Denervation	SPINAL-NERVE; PARASPINAL ELECTROMYOGRAPHY; EXTRAFORAMINAL STENOSIS; ASYMPTOMATIC SUBJECTS; LUMBOSACRAL JUNCTION; DECOMPRESSION; ENTRAPMENT; PAIN	Purpose The medial branch of the posterior ramus of the lumbar spinal nerve is well known to be innervated independently and to end in the multifidus muscle without anastomosis. This prospective cohort study aimed to determine the diagnostic specificity and sensitivity of multifidus muscle denervation (MMD) by needle electromyography (N-EMG) for lumbar foraminal and lateral exit-zone stenosis (LF/LEZS). Methods We enrolled 61 consecutive patients experiencing unilateral dysesthesia and/or leg pain in the L4 or L5 regions with suspicious LF/LEZS. The Japanese Orthopedic Association (JOA) score, Visual Analog Scale (VAS) for leg pain, and N-EMG were examined. In this study protocol, all patients received at least 3 months of conservative therapy. Surgery was performed on patients who experienced less than 50 % VAS pain relief compared with their initial score after confirming the responsible level by lumbar nerve root block. The specificity of N-EMG was the proportion of patients who improved with conservative therapies (non-surgery) after 3 months. The sensitivity of N-EMG was the proportion of patients who improved with surgical therapies (surgery) after more than 12 months. Results Twenty-three patients underwent surgery. The initial lower JOA, positive Kemp test and motor weakness were significantly higher in the surgery group. The MMD by N-EMG indicated that 34 of 38 patients were negative in the non-surgery group. In the surgery group, 21 of 23 patients were positive. The diagnostic sensitivity and specificity were 91.3 and 92.1 %, respectively. Conclusions Needle electromyography is a simple and available additional method for the diagnosis of LF/LEZS.	[Takeuchi, Mikinobu; Wakao, Norimitsu; Kamiya, Mitsuhiro; Takayasu, Masakazu] Aichi Med Univ, Dept Spine Ctr, Nagakute, Aichi 4801195, Japan; [Takeuchi, Mikinobu; Osuka, Koji; Niwa, Aichi; Aoyama, Masahiro; Kawaguchi, Reo; Shima, Hiroshi; Takayasu, Masakazu] Aichi Med Univ Hosp, Neurol Surg, Nagakute, Aichi, Japan; [Wakao, Norimitsu; Kamiya, Mitsuhiro; Hirasawa, Atsuhiko] Aichi Med Univ Hosp, Orthoped Surg, Nagakute, Aichi, Japan; [Gosho, Masahiko] Aichi Med Univ Hosp, Adv Med Res Ctr, Nagakute, Aichi, Japan	Takeuchi, M (reprint author), Aichi Med Univ, Dept Spine Ctr, Nagakute, Aichi 4801195, Japan.	micky911@goo.jp			AO Spine Japan	The authors wish to thank the following special technicians for their assistance with the study: Aichi Medical University (Mrs. Taeko Kamiya, Mrs. Yuka Shibata, Mr. Hiroshi Moriya). This work was partially supported by the Grant. Research Funding; AO Spine Japan. Consultant; none. Royalty/IP Payments; none. Other compensation; none. This research received the Grant from AO Spine Japan.	Yeom JS, 2008, AM J NEURORADIOL, V29, P1017, DOI 10.3174/ajnr.A0955; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; KUNOGI J, 1991, SPINE, V16, P1312, DOI 10.1097/00007632-199111000-00012; Taguchi T, 2002, J NEURORADIOLOGY, V29, P122; Aota Y, 2007, SPINE, V32, P896, DOI 10.1097/01.brs.0000259809.75760.d5; Chang HS, 2011, J SPINAL DISORD TECH, V24, P302, DOI 10.1097/BSD.0b013e3181f7cc9f; Nakao S, 2010, J SPINAL DISORD TECH, V23, pE47, DOI 10.1097/BSD.0b013e3181cdd262; Maher CO, 1999, J NEUROSURG, V90, P52, DOI 10.3171/spi.1999.90.1.0052; LEE CK, 1988, SPINE, V13, P313, DOI 10.1097/00007632-198803000-00015; BOGDUK N, 1982, J ANAT, V134, P383; Park YK, 2003, J NEUROSURG, V98, P264, DOI 10.3171/spi.2003.98.3.0264; Tong HC, 2005, SPINE, V30, pE499, DOI 10.1097/01.brs.0000176318.95523.12; Matsumoto M, 2010, J NEUROSURG-SPINE, V12, P72, DOI 10.3171/2009.7.SPINE09344; Date ES, 1996, MUSCLE NERVE, V19, P350, DOI 10.1002/(SICI)1097-4598(199603)19:3<350::AID-MUS11>3.0.CO;2-W; Haig AJ, 1997, ARCH PHYS MED REHAB, V78, P1185, DOI 10.1016/S0003-9993(97)90329-4; Morimoto D, 2013, J NEUROSURG-SPINE, V19, P71, DOI 10.3171/2013.3.SPINE12420; WILTSE LL, 1984, SPINE, V9, P31, DOI 10.1097/00007632-198401000-00008; BUCHTHAL F, 1966, ELECTROEN CLIN NEURO, V20, P321, DOI 10.1016/0013-4694(66)90001-0; Tong HC, 2003, AM J PHYS MED REHAB, V82, P917, DOI 10.1097/01.PHM.0000091983.14237.00; Saito T, 2013, ANESTHESIOLOGY, V118, P88, DOI 10.1097/ALN.0b013e318272f40a; HUSKISSO.EC, 1974, LANCET, V2, P1127; Izumida S, 1986, J JPN ORTHOP ASSOC, V60, P391; Jacoby GW, 1895, NY MED J, V28, P813; Kimura J, 2001, ELECTRODIAGNOSIS DIS; JOHNSON E W, 1971, Archives of Physical Medicine and Rehabilitation, V52, P239	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	OCT	2015	24	10					2281	2287		10.1007/s00586-015-3846-9		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS8FC	WOS:000362320200025		
J	Sekiguchi, M; Yonemoto, K; Kakuma, T; Nikaido, T; Watanabe, K; Kato, K; Otani, K; Yabuki, S; Kikuchi, S; Konno, S				Sekiguchi, Miho; Yonemoto, Koji; Kakuma, Tatsuyuki; Nikaido, Takuya; Watanabe, Kazuyuki; Kato, Kinshi; Otani, Koji; Yabuki, Shoji; Kikuchi, Shin-ichi; Konno, Shin-ichi			Relationship between lumbar spinal stenosis and psychosocial factors: a multicenter cross-sectional study (DISTO project)	EUROPEAN SPINE JOURNAL			English	Article						Lumbar spinal stenosis; Psychosocial factors; Job satisfaction; LSS diagnostic support tool	LOW-BACK-PAIN; SUPPORT TOOL; LIFE; ATHEROSCLEROSIS; SEVERITY; JAPAN	Lumbar spinal stenosis (LSS) is a lumbar spinal disorder that causes leg symptoms and intermittent claudication. It is reported that the risk factors for low back pain include age, family history, smoking, obesity, work-related physical load, exercise, and depression. This was a multicenter, cross-sectional survey, and the aim of this study was to investigate the prevalence of LSS by age and the relationships between LSS and psychosocial factors and job satisfaction. This study enrolled subjects aged 50 years and over from a survey of LSS in 2177 hospitals and general practices nationwide. The clinical characteristics of the LSS and non-LSS groups were compared using the chi (2) test, and the multivariate logistic regression analysis was performed to examine associations between exercise, perceived stress, strenuous use of the low back or legs, job satisfaction, and LSS. In total, 18,642 patients (8338 males, 10,267 females) were analyzed. The rate of LSS was 38.3 % and it increased with age. Regular exercise was less common among those in the LSS group than those in the non-LSS group (p < 0.001). Satisfaction in all job-related items was less in the LSS group than in the non-LSS group (p < 0.001). The odds for having LSS were higher in subjects having perceived stress and strenuous use of the low back or legs (p = 0.001). The odds ratios of heart diseases and hypertension (p < 0.001) were higher in the LSS group. This study investigated factors associated with LSS. The prevalence of LSS increased with age. Perceived stress and strenuous use of the low back or legs might be associated with LSS, and job satisfaction was lower with LSS.	[Sekiguchi, Miho; Nikaido, Takuya; Watanabe, Kazuyuki; Kato, Kinshi; Otani, Koji; Yabuki, Shoji; Kikuchi, Shin-ichi; Konno, Shin-ichi] Fukushima Med Univ, Dept Orthopaed Surg, Sch Med, Fukushima, Fukushima 9601295, Japan; [Yonemoto, Koji; Kakuma, Tatsuyuki] Kurume Univ, Ctr Biostat, Fukuoka, Japan	Sekiguchi, M (reprint author), Fukushima Med Univ, Dept Orthopaed Surg, Sch Med, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	miho-s@fmu.ac.jp					Konno S, 2007, EUR SPINE J, V16, P1951, DOI 10.1007/s00586-007-0402-2; Yabuki S, 2013, J ORTHOP SCI, V18, P893, DOI 10.1007/s00776-013-0455-5; Ono R, 2012, SPINE, V37, P1130, DOI 10.1097/BRS.0b013e31824231b8; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P647, DOI 10.1016/j.apmr.2011.09.023; Abbas J, 2013, SPINE, V38, pE554, DOI 10.1097/BRS.0b013e31828a2846; KAUPPILA LI, 1994, SPINE, V19, P923, DOI 10.1097/00007632-199404150-00010; Battie MC, 2012, SPINE J, V12, P189, DOI 10.1016/j.spinee.2011.11.009; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Kim HJ, 2013, PAIN PHYSICIAN, V16, P135; Papageorgiou AC, 1997, SPINE, V22, P1137, DOI 10.1097/00007632-199705150-00014; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; Ohtori S, 2014, J ORTHOP SCI, V19, P412, DOI 10.1007/s00776-014-0551-1; Takahashi N, 2006, SPINE, V31, P931, DOI 10.1097/01.brs.0000209319.94256.89; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Kato K, 2014, RINSYOSEIKEI, V49, P123; Konno S, 2007, BMC MUSCLOSKELET DIS, V102, P1; Lotan R, 2008, J SPINE DISORD TECH, V21, P245; Otani K, 2008, RINSYOSEIKEI, V43, P883; Otani K, 2013, SCI WORD J, V2013, P1; Otani K, 2008, RINSYOSEIKEI, V43, P789; Uesugi K, 2013, SPINE, V38, pE540, DOI 10.1097/BRS.0b013e31828a2517; Zeifang F, 2008, BMC MUSCLOSKELET DIS, V20, P1	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	OCT	2015	24	10					2288	2294		10.1007/s00586-015-4002-2		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS8FC	WOS:000362320200026		
J	Attur, M; Yang, Q; Shimada, K; Tachida, Y; Nagase, H; Mignatti, P; Statman, L; Palmer, G; Kirsch, T; Beier, F; Abramson, SB				Attur, Mukundan; Yang, Qing; Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Kirsch, Thorsten; Beier, Frank; Abramson, Steven B.			Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13	FASEB JOURNAL			English	Article						posttraumatic osteoarthritis; chondrocytes; Wnt signaling; ADAMTS	ARTICULAR-CARTILAGE; GENE-EXPRESSION; INFLAMMATORY MEDIATORS; NITRIC-OXIDE; BONE; CHONDROCYTES; REVEALS; DISEASE; GROWTH; MICE	We investigated the role of periostin, an extracellular matrix protein, in the pathophysiology of osteoarthritis (OA). In OA, dysregulated gene expression and phenotypic changes in articular chondrocytes culminate in progressive loss of cartilage fromthe joint surface. The molecular mechanisms underlying this process are poorly understood. We examined periostin expression by immunohistochemical analysis of lesional and nonlesional cartilage from human and rodent OA knee cartilage. In addition, we used small interfering (si) RNA and adenovirus transduction of chondrocytes to knock down and up-regulate periostin levels, respectively, and analyzed its effect on matrix metalloproteinase (MMP)-13, a disintegrin and MMP with thrombospondin motifs (ADAMTS)-4, and type II collagen expression. We found high periostin levels in human and rodent OA cartilage. Periostin increased MMP-13 expression dose [1-10 mu g/ml (EC50 0.5-1 mu g/ml)] and time (24-72 h) dependently, significantly enhanced expression of ADAMTS4 mRNA, and promoted cartilage degeneration through collagen and proteoglycan degradation. Periostin induction of MMP-13 expression was inhibited by CCT031374 hydrobromide, an inhibitor of the canonical Wnt/beta-catenin signaling pathway. In addition, siRNA-mediated knockdown of endogenous periostin blocked constitutive MMP-13 expression. These findings implicate periostin as a catabolic protein that promotes cartilage degeneration in OA by up-regulating MMP-13 through canonical Wnt signaling.	[Attur, Mukundan; Yang, Qing; Mignatti, Paolo; Statman, Lauren; Palmer, Glyn; Abramson, Steven B.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Sch Med, Dept Orthopaed Surg, New York, NY 10016 USA; [Kirsch, Thorsten] NYU, Langone Med Ctr, New York, NY USA; [Shimada, Kohei; Tachida, Yuki; Nagase, Hiroyuki] Daiichi Sankyo Co Ltd, Frontier Res Labs, Tokyo, Japan; [Palmer, Glyn] Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL USA; [Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Attur, M (reprint author), NYU, Hosp Joint Dis, Div Rheumatol, 301 East 17th St,Suite 1410, New York, NY 10003 USA.	mukundan.attur@nyumc.org			U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR054817]; U.S. NIH National Cancer Institute [R01-CA136715]; Daiichi Sankyo Co., Ltd. (Tokyo, Japan)	This work was supported in part by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR054817 (to S.B.A.) and U.S. NIH National Cancer Institute Grant R01-CA136715 (to P.M.); and by a research grant from Daiichi Sankyo Co., Ltd. (Tokyo, Japan). K.S., Y.T., and H.N. are employees of Daiichi Sankyo Co., Ltd. The authors declare no conflicts of interests.	Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Kikuchi Y, 2014, AM J PATHOL, V184, P859, DOI 10.1016/j.ajpath.2013.11.012; Attur M, 2012, ARTHRITIS RHEUM-US, V64, P1940, DOI 10.1002/art.34360; Fosang AJ, 2011, BEST PRACT RES CL RH, V25, P751, DOI 10.1016/j.berh.2011.11.010; Chou CH, 2013, OSTEOARTHR CARTILAGE, V21, P450, DOI 10.1016/j.joca.2012.11.016; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Abramson SB, 2006, NAT CLIN PRACT RHEUM, V2, P304, DOI 10.1038/ncprheum0193; Nagase H, 2013, OSTEOARTHR CARTILAGE, V21, P514, DOI 10.1016/j.joca.2012.12.013; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Maldonado M, 2013, BIOMED RES INT, DOI 10.1155/2013/284873; Sandell LJ, 2007, ARTHRITIS RHEUM, V56, P2474, DOI 10.1002/art.22760; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; McCann JC, 2009, AM J CLIN NUTR, V90, P889, DOI 10.3945/ajcn.2009.27930; Lourido L, 2014, J PROTEOME RES, V13, P6096, DOI 10.1021/pr501024p; HANDLEY CJ, 1995, METHOD ENZYMOL, V248, P47; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Mariani E, 2014, INT J MOL SCI, V15, P8667, DOI 10.3390/ijms15058667; Attur MG, 2001, ARTHRITIS RHEUM, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.0.CO;2-7; Appleton CTG, 2007, ARTHRITIS RHEUM, V56, P1854, DOI 10.1002/art.22711; Lotz M, 2012, OSTEOARTHR CARTILAGE, V20, P192, DOI 10.1016/j.joca.2011.11.015; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Attur M, 2011, OSTEOARTHR CARTILAGE, V19, P1158, DOI 10.1016/j.joca.2011.06.006; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Li YP, 2013, BIOMED RES INT, DOI 10.1155/2013/916530; Loeser RF, 2006, ARTHRITIS RHEUM, V54, P1357, DOI 10.1002/art.21813; Olex AL, 2014, GENE, V542, P38, DOI 10.1016/j.gene.2014.03.022; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; AMIN AR, 1995, J EXP MED, V182, P2097, DOI 10.1084/jem.182.6.2097; Attur M. G., 2002, Current Issues in Molecular Biology, V4, P129; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Gardiner MD, 2015, OSTEOARTHR CARTILAGE, V23, P616, DOI 10.1016/j.joca.2014.12.014; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; Loeser RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054633; Marie PJ, 2014, TRENDS ENDOCRIN MET, V25, P567, DOI 10.1016/j.tem.2014.06.009; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994; Zhang RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032356	59	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4107	4121		10.1096/fj.15-272427		15	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	WOS:000361367300003		
J	Nomura, T; Cox, CD; Bavi, N; Sokabe, M; Martinac, B				Nomura, Takeshi; Cox, Charles D.; Bavi, Navid; Sokabe, Masahiro; Martinac, Boris			Unidirectional incorporation of a bacterial mechanosensitive channel into liposomal membranes	FASEB JOURNAL			English	Article						MscS; reconstitution; patch clamp fluorometry; electrophysiology; finite element simulation	ESCHERICHIA-COLI MSCS; ION-CHANNEL; SMALL-CONDUCTANCE; RECONSTITUTION METHOD; CYTOPLASMIC DOMAIN; LIGAND-BINDING; PATCH-CLAMP; ACTIVATION; MECHANISM; PURIFICATION	The bacterial mechanosensitive channel of small conductance (MscS) plays a crucial role in the protection of bacterial cells against hypo-osmotic shock. The functional characteristics of MscS have been extensively studied using liposomal reconstitution. This is a widely used experimental paradigm and is particularly important for mechanosensitive channels as channel activity can be probed free from cytoskeletal influence. A perpetual issue encountered using this paradigm is unknown channel orientation. Here we examine the orientation of MscS in liposomes formed using 2 ion channel reconstitution methods employing the powerful combination of patch clamp electrophysiology, confocal microscopy, and continuum mechanics simulation. Using the previously determined electrophysiological and pharmacological properties of MscS, we were able to determine that in liposomes, independent of lipid composition, MscS adopts the same orientation seen in native membranes. These results strongly support the idea that these specific methods result in uniform incorporation of membrane ion channels and caution against making assumptions about mechanosensitive channel orientation using the stimulus type alone.	[Nomura, Takeshi; Cox, Charles D.; Bavi, Navid; Martinac, Boris] Victor Chang Cardiac Res Inst, Mechanosensory Biophys Lab, Mol Cardiol & Biophys Div, Darlinghurst, NSW 2010, Australia; [Nomura, Takeshi] Kyushu Nutr Welf Univ, Grad Sch Hlth Sci, Dept Phys Therapy, Fac Rehabil, Kitakyushu, Fukuoka, Japan; [Bavi, Navid; Martinac, Boris] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Aichi 4648601, Japan	Martinac, B (reprint author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	b.martinac@victorchang.edu.au			National Health & Medical Research Council of Australia [APP1047980]; Yamada Science Foundation; Office of Health and Medical Research, NSW State Government, Australia; University of New South Wales for the International Postgraduate Award (UIPA); Australian Government	The authors thank Paul R. Rohde and Maryrose Constantine (Victor Chang Cardiac Research Institute, Sydney, Australia) for technical assistance. The authors also thank Prof. I. R. Booth (University of Aberdeen, Aberdeen, UK) for his generous donation of the MJF465 strain. This study was supported by the National Health & Medical Research Council of Australia (APP1047980) and Yamada Science Foundation. This work was also supported in part by funds from the Office of Health and Medical Research, NSW State Government, Australia. The authors also thank the University of New South Wales for the International Postgraduate Award (UIPA) (to N.B.). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The authors declare no competing financial interests.	Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Akitake B, 2007, BIOPHYS J, V92, P2771, DOI 10.1529/biophysj.106.098715; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; SOKABE M, 1991, BIOPHYS J, V59, P722; KELLER BU, 1988, PFLUG ARCH EUR J PHY, V411, P94, DOI 10.1007/BF00581652; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Petrov E, 2013, BIOPHYS J, V104, P1426, DOI 10.1016/j.bpj.2013.01.055; Cox CD, 2014, CHANNELS, V8, P5, DOI 10.4161/chan.27107; DELCOUR AH, 1989, BIOPHYS J, V56, P631; Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109; Gamini R, 2011, BIOPHYS J, V101, P80, DOI 10.1016/j.bpj.2011.05.042; Boer M, 2011, BIOCHEMISTRY-US, V50, P4087, DOI 10.1021/bi1019435; Martinac B, 2010, METHODS MOL BIOL, V606, P31, DOI 10.1007/978-1-60761-447-0_4; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maksaev G, 2011, J GEN PHYSIOL, V138, P641, DOI 10.1085/jgp.201110723; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Slavchov RI, 2014, J PHYS CHEM B, V118, P12660, DOI [10.1021/jp506965v, 10.1021/jp506965v1J]; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Berrier C, 2013, J BIOL CHEM, V288, P27307, DOI 10.1074/jbc.M113.478321; Das N, 2013, NAT PROTOC, V8, P2256, DOI 10.1038/nprot.2013.129; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Hamill OP, 2001, PHYSIOL REV, V81, P685; DEAMER DW, 1982, J MOL EVOL, V18, P203, DOI 10.1007/BF01733047; HASE CC, 1995, J BIOL CHEM, V270, P18329; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Sukharev S, 2002, BIOPHYS J, V83, P290; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Bavi N, 2014, P NATL ACAD SCI USA, V111, P13864, DOI 10.1073/pnas.1409011111; Bavi O, 2014, CHANNELS, V8, P344, DOI 10.4161/chan.29572; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Cox CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3137; Cox CD, 2015, PFLUG ARCH EUR J PHY, V467, P3, DOI 10.1007/s00424-014-1522-2; Teng J., 2014, PFLUGERS AR IN PRESS; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k	53	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4334	4345		10.1096/fj.15-275198		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	WOS:000361367300022		
J	Rafi, M; Wulansari, L; Heryanto, R; Darusman, LK; Lim, LW; Takeuchi, T				Rafi, Mohamad; Wulansari, Laela; Heryanto, Rudi; Darusman, Latifah Kosim; Lim, Lee Wah; Takeuchi, Toyohide			Curcuminoid's Content and Fingerprint Analysis for Authentication and Discrimination of Curcuma xanthorrhiza from Curcuma longa by High-Performance Liquid Chromatography-Diode Array Detector	FOOD ANALYTICAL METHODS			English	Article						Curcuma xanthorrhiza; Curcuma longa; Curcuminoids; High-performance liquid chromatography; Discriminant analysis	CAPILLARY-ELECTROPHORESIS; QUANTITATIVE-ANALYSIS; HPLC METHOD; RHIZOME; MS; VALIDATION; PRINCIPLES; COMPONENTS; SEPARATION; EXTRACTS	An accurate and reliable method for authentication and discrimination of Curcuma xanthorrhiza (CX) from Curcuma longa (CL) by determining the curcuminoid's content and analyzing the HPLC fingerprint combined with discriminant analysis (DA) was developed. By using the proposed method, it was found that CL had higher amount of all curcuminoid compounds compared to CX. Therefore, these two closely related species could be authenticated and discriminated by the amount of curcuminoids present in the samples. Authentication and discrimination of the two species were also achieved by comparing their HPLC fingerprint chromatograms using their typical marker peaks. To be more convincing, an aid from DA was also used. Combination of HPLC fingerprint analysis and DA gave excellent result that the two species were separated clearly, including CX samples adulterated with CL. The developed method was successfully used for quality control of the two plants.	[Rafi, Mohamad; Wulansari, Laela; Heryanto, Rudi; Darusman, Latifah Kosim] Bogor Agr Univ, Fac Math & Nat Sci, Dept Chem, Bogor 16680, Indonesia; [Rafi, Mohamad; Heryanto, Rudi; Darusman, Latifah Kosim] Bogor Agr Univ, Biopharmaca Res Ctr, Res & Community Empowerment Inst, Bogor 16128, Indonesia; [Lim, Lee Wah; Takeuchi, Toyohide] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Rafi, M (reprint author), Bogor Agr Univ, Fac Math & Nat Sci, Dept Chem, Jalan Agatis Kampus IPB Dramaga, Bogor 16680, Indonesia.	mra@ipb.ac.id					Anggakusuma Y., 2009, Biological & Pharmaceutical Bulletin, V32, P1892, DOI 10.1248/bpb.32.1892; Pothitirat W, 2006, CURR SCI INDIA, V91, P1397; OZAKI Y, 1990, CHEM PHARM BULL, V38, P1045; Govindaraghavan S, 2012, FITOTERAPIA, V83, P979, DOI 10.1016/j.fitote.2012.05.001; ITOKAWA H, 1985, CHEM PHARM BULL, V33, P3488; Lee J, 2014, MOLECULES, V19, P9535, DOI 10.3390/molecules19079535; ARORA RB, 1971, INDIAN J MED RES, V59, P1289; Tanaka K, 2008, J AGR FOOD CHEM, V56, P8787, DOI 10.1021/jf801338e; Liang XR, 2014, FOOD ANAL METHOD, V7, P197, DOI 10.1007/s12161-013-9618-4; Liu XS, 2013, J PHARMACEUT BIOMED, V76, P70, DOI 10.1016/j.jpba.2012.12.013; Watanabe T, 2000, J JPN SOC FOOD SCI, V47, P780; MASUDA T, 1992, PHYTOCHEMISTRY, V31, P3645, DOI 10.1016/0031-9422(92)83748-N; KISO Y, 1983, PLANTA MED, V49, P185, DOI 10.1055/s-2007-969845; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Peng QH, 2015, FOOD ANAL METHOD, V8, P103, DOI 10.1007/s12161-014-9874-y; Anubala S, 2014, TALANTA, V123, P10, DOI 10.1016/j.talanta.2014.01.017; Sotanaphun U, 2009, PHYTOCHEM ANALYSIS, V20, P19, DOI 10.1002/pca.1086; Wichitnithad W, 2009, PHYTOCHEM ANALYSIS, V20, P314, DOI 10.1002/pca.1129; Lechtenberg M, 2004, PHYTOCHEM ANALYSIS, V15, P152, DOI 10.1002/pca.759; Jadhav BK, 2007, CHROMATOGRAPHIA, V65, P483, DOI 10.1365/s10337-006-0164-8; Devaraj S, 2010, MOLECULES, V15, P2925, DOI 10.3390/molecules15042925; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Inoue K, 2001, ANAL LETT, V34, P1711, DOI 10.1081/AL-100105354; Li R, 2011, FOOD CHEM, V126, P1890, DOI 10.1016/j.foodchem.2010.12.014; Brereton R. G., 2003, CHEMOMETRICS DATA AN; Parthasarathy VA, 2008, CHEMISTRY OF SPICES, P1, DOI 10.1079/9781845934057.0000; Cheng Jin, 2010, J Pharm Biomed Anal, V53, P43, DOI 10.1016/j.jpba.2010.03.021; Hwang J. K., 2000, Fitoterapia, V71, P321, DOI 10.1016/S0367-326X(99)00170-7; International Conference on Harmonization, 2005, VAL AN PROC METH Q2; Itokawa Hideji, 2008, Chin Med, V3, P11, DOI 10.1186/1749-8546-3-11; Lin SC, 1996, PHYTOTHER RES, V10, P131, DOI 10.1002/(SICI)1099-1573(199603)10:2<131::AID-PTR786>3.0.CO;2-0; Lv SD, 2015, FOOD ANAL METHOD, V8, P321, DOI 10.1007/s12161-014-9900-0; Ministry of Health Republic of Indonesia, 2008, IND HERB PHARM, V1; Singh R, 2002, CURR SCI INDIA, V83, P737; Verma MK, 2013, DARU, V21, DOI 10.1186/2008-2231-21-11; Wang P, 2012, J PHARM ANA, V2, P422, DOI DOI 10.1016/j.jpha.2012.05.006; Zeng Zhongda, 2008, Chin Med, V3, P9, DOI 10.1186/1749-8546-3-9	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1936-9751	1936-976X		FOOD ANAL METHOD	Food Anal. Meth.	OCT	2015	8	9					2185	2193		10.1007/s12161-015-0110-1		9	Food Science & Technology	Food Science & Technology	CS3OX	WOS:000361985100004		
J	Otsubo, S; Cossu, D; Eda, S; Otsubo, Y; Sechi, LA; Suzuki, T; Iwao, Y; Yamamoto, S; Kuribayashi, T; Momotani, E				Otsubo, Shigeru; Cossu, Davide; Eda, Shigetoshi; Otsubo, Yuriko; Sechi, Leonardo Antonio; Suzuki, Tsuyoshi; Iwao, Yumiko; Yamamoto, Shizuo; Kuribayashi, Takashi; Momotani, Eiichi			Seroprevalence of IgG1 and IgG4 Class Antibodies Against Mycobacterium avium subsp paratuberculosis in Japanese Population	FOODBORNE PATHOGENS AND DISEASE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; JOHNES-DISEASE; AUTOIMMUNE PANCREATITIS; BOVINE PARATUBERCULOSIS; NORTH-AMERICA; MILK; PREVALENCE; DIAGNOSIS; CATTLE; PRODUCTS	Mycobacterium avium subsp. paratuberculosis (MAP) is the established causative agent of Johne's disease in cattle and other ruminants, and it has also been speculated to be a putative etiological agent of several human autoimmune diseases. It is acknowledged that dairy products deriving from infected animals play a role (could be vehicles) in exposing humans to MAP. MAP could stimulate the human immune system by means of their complex antigen (in the case of lipids, multivalent antigens) and may modulate it, acting as adjuvant molecules such as Freund's complete adjuvant. The immune system might be abnormally stimulated by the constant presence of MAP antigens (for example, in the dairy products), and this might be particularly relevant in genetically predisposed individuals. However, there is limited understanding about the current human exposure to MAP. The present study analyzed the antibody recognition profile of MAP lipophilic antigens in a cohort of 126 healthy Japanese. We measured the serum levels of total immunoglobulin G (IgG) and subclasses targeting MAP surface antigens through ethanol vortex indirect enzyme-linked immunosorbent assay (EVELISA) by using serum absorbed with Mycobacterium phlei. Elevated IgG (especially IgG1 and IgG4) responses were observed in 14% of the sera. To assess the specificity of EVELISA, the same samples were analyzed by means of a commercially available Johnelisa II kit. It was noteworthy that a high degree of correlation was observed when comparing the two methodologies (r(s)=0.7, p<0.0001). Moreover, in order to investigate the specificity of the binding, inhibition assay experiments were carried out also searching for antibodies against Bacillus Calmette-Guerin antigens, but no cross-reaction was observed. The result obtained represents the first evidence implying that the Japanese population is exposed to MAP, and additionally the existence of a foodborne chain of exposure that transmits MAP antigens to humans.	[Otsubo, Shigeru; Otsubo, Yuriko] Sangenjaya Hosp, Tokyo, Japan; [Cossu, Davide; Sechi, Leonardo Antonio] Univ Sassari, Div Microbiol & Virol, Dept Biomed Sci, I-07100 Sassari, Italy; [Cossu, Davide; Suzuki, Tsuyoshi; Iwao, Yumiko; Momotani, Eiichi] Tohto Coll Hlth Sci, Dept Human Care, Fukaya, Saitama 3660052, Japan; [Eda, Shigetoshi] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Ctr Wildlife Hlth, Knoxville, TN USA; [Yamamoto, Shizuo; Kuribayashi, Takashi] Azabu Univ, Sch Life & Environm Sci, Labs Immunol, Saitama, Kanagawa, Japan	Momotani, E (reprint author), Tohto Coll Hlth Sci, Dept Human Care, Nishi Ku, 4-2-11 Kamishiba Machi, Fukaya, Saitama 3660052, Japan.	eiichi@momotani.com			Japan Society for the Promotion of Science KAKENHI [23240061]	We gratefully acknowledge Dr. Y. Mori and Y. Shimoji of National Institute of Animal Health for providing heat-killed mycobacterial antigens. This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23240061.	Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Frau J, 2013, MULT SCLER J, V19, P1437, DOI 10.1177/1352458513477926; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Grant IR, 2003, ACTA VET SCAND, V44, P261; Carter MA, 2012, JPN J VET RES, V60, pS9; Patel A, 2011, J MICROBIOL IMMUNOL, V44, P473, DOI 10.1016/j.jmii.2011.04.009; YOKOMIZO Y, 1985, JPN J VET SCI, V47, P111; Momotani E, 2012, JPN J VET RES, V60, pS19; Favila-Humara LC, 2010, FOODBORNE PATHOG DIS, V7, P351, DOI 10.1089/fpd.2009.0374; Bannantine JP, 2008, INFECT IMMUN, V76, P739, DOI 10.1128/IAI.00915-07; Ridge SE, 2010, PREV VET MED, V95, P186, DOI 10.1016/j.prevetmed.2010.05.001; Buddle BM, 2003, VET REC, V153, P615; Momotani E, 2012, VET IMMUNOL IMMUNOP, V148, P55, DOI 10.1016/j.vetimm.2012.03.005; Scott MC, 2010, FOODBORNE PATHOG DIS, V7, P1291, DOI 10.1089/fpd.2010.0541; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; YOKOMIZO Y, 1983, AM J VET RES, V44, P2205; Eda S, 2006, CLIN VACCINE IMMUNOL, V13, P837, DOI 10.1128/CVI.00148-06; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Cossu D, 2014, MULT SCLER, V21, P984; Fernandez-Silva JA, 2014, TROP ANIM HEALTH PRO, V46, P1321, DOI 10.1007/s11250-014-0656-8; Kohl J, 2012, JPN J VET RES, V60, pS1; Masala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097621; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; SHARP JCM, 1987, B WORLD HEALTH ORGAN, V65, P397; Stabel JR, 2014, J DAIRY SCI, V97, P6296, DOI 10.3168/jds.2014-8204; USDA-APHIS, 2008, JOHN DIS US DAIR 199; Wolf R, 2014, J DAIRY SCI, V97, P6250, DOI 10.3168/jds.2014-8101	28	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1535-3141	1556-7125		FOODBORNE PATHOG DIS	Foodborne Pathog. Dis.	OCT 1	2015	12	10					851	856		10.1089/fpd.2015.1956		6	Food Science & Technology	Food Science & Technology	CS7NT	WOS:000362271000006		
J	Miyamoto, W; Takao, M; Miki, S; Giza, E				Miyamoto, Wataru; Takao, Masato; Miki, Shinya; Giza, Eric			Tendoscopic Repair of the Superior Peroneal Retinaculum via 2 Portals for Peroneal Tendon Instability	FOOT & ANKLE INTERNATIONAL			English	Article						tendoscopy; peroneal tendon; dislocation; ankle; repair	RECURRENT DISLOCATION; SUBLUXATION; ANKLE; FOOT; DISORDERS; OPERATION		[Miyamoto, Wataru; Takao, Masato; Miki, Shinya] Teikyo Univ, Sch Med, Tokyo 1738605, Japan; [Giza, Eric] Univ Calif Davis, Davis, CA 95616 USA	Takao, M (reprint author), Teikyo Univ, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	mtakao@med.teikyo-u.ac.jp					Ogawa BK, 2007, FOOT ANKLE INT, V28, P1034, DOI 10.3113/FAI.2007.1034; Lui TH, 2006, KNEE SURG SPORT TR A, V14, P478, DOI 10.1007/s00167-005-0691-0; Adachi N, 2006, FOOT ANKLE INT, V27, P1074; Tomihara T, 2010, ARCH ORTHOP TRAUM SU, V130, P1059, DOI 10.1007/s00402-010-1136-x; DeOrio MJ, 2008, FOOT ANKLE INT, V29, P542, DOI 10.3113/FAI.2008.0542; Maffulli N, 2006, AM J SPORT MED, V34, P986, DOI 10.1177/0363546505283275; Mason RB, 1996, AM J SPORT MED, V24, P652, DOI 10.1177/036354659602400515; Hui JHP, 1998, J BONE JOINT SURG BR, V80B, P325, DOI 10.1302/0301-620X.80B2.8293; Heckman DS, 2009, AM J SPORT MED, V37, P614, DOI 10.1177/0363546508331206; DASDE S, 1985, J BONE JOINT SURG BR, V67, P585; Ogawa BK, 2007, FOOT ANKLE INT, V28, P1194, DOI 10.3113/FAI.2007.1194; ECKERT WR, 1976, J BONE JOINT SURG AM, V58, P670; Scholten PE, 2013, KNEE SURG SPORT TR A, V21, P1304, DOI 10.1007/s00167-012-2121-4; Guillo S, 2013, FOOT ANKLE CLIN, V18, P293, DOI 10.1016/j.fcl.2013.02.007; Jerosch J, 2007, KNEE SURG SPORT TR A, V15, P806, DOI 10.1007/s00167-006-0227-2; Cychosz CC, 2014, ARTHROSCOPY, V30, P755, DOI 10.1016/j.arthro.2014.02.022; Vega J, 2013, FOOT ANKLE INT, V34, P832, DOI 10.1177/1071100713483098; Cho J, 2014, FOOT ANKLE INT, V35, P683, DOI 10.1177/1071100714531233; Hsu AR, 2014, J AM ACAD ORTHOP SUR, V22, P10, DOI 10.5435/JAAOS-22-01-10; Marti R, 1977, Am J Sports Med, V5, P19, DOI 10.1177/036354657700500104	20	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	OCT	2015	36	10					1243	1250		10.1177/1071100715604735		8	Orthopedics	Orthopedics	CS8OZ	WOS:000362348800019		
J	Watanabe, N				Watanabe, Noboru			On Entropy of Quantum Compound Systems	FOUNDATIONS OF PHYSICS			English	Article						General quantum entropy; Quantum dynamical entropy; Quantum information theory	DYNAMICAL ENTROPY; TOPOLOGICAL-ENTROPY; ALGEBRAS	We review some notions for general quantum entropies. The entropy of the compound systems is discussed and a numerical computation of the quantum dynamical systems is carried for the noisy optical channel.	Tokyo Univ Sci, Dept Informat Sci, Noda, Chiba 2788510, Japan	Watanabe, N (reprint author), Tokyo Univ Sci, Dept Informat Sci, Noda, Chiba 2788510, Japan.	watanabe@is.noda.tus.ac.jp					Accardi L., 1996, Reports on Mathematical Physics, V38, DOI 10.1016/S0034-4877(97)84895-1; Accardi L., 1997, Open Systems & Information Dynamics, V4, DOI 10.1023/A:1009609602126; Watanabe N, 2011, FOUND PHYS, V41, P549, DOI 10.1007/s10701-010-9455-x; CONNES A, 1975, ACTA MATH-DJURSHOLM, V134, P289, DOI 10.1007/BF02392105; EMCH GG, 1974, Z WAHRSCHEINLICHKEIT, V29, P241, DOI 10.1007/BF00536283; Kossakowski A, 1999, INFIN DIMENS ANAL QU, V2, P267, DOI 10.1142/S021902579900014X; Choda M, 1996, ERGOD THEOR DYN SYST, V16, P1197; VOICULESCU D, 1995, COMMUN MATH PHYS, V170, P249, DOI 10.1007/BF02108329; HUDETZ T, 1994, J MATH PHYS, V35, P4303, DOI 10.1063/1.530855; ALICKI R, 1994, LETT MATH PHYS, V32, P75, DOI 10.1007/BF00761125; CONNES A, 1987, COMMUN MATH PHYS, V112, P691, DOI 10.1007/BF01225381; Accardi L, 1999, APPL MATH OPT, V39, P33, DOI 10.1007/s002459900097; UHLMANN A, 1977, COMMUN MATH PHYS, V54, P21, DOI 10.1007/BF01609834; Araki H, 1976, PUBL RES I MATH SCI, V11, P809, DOI DOI 10.2977/PRIMS/1195191148; Benatti F., 1993, DETERMINISTIC CHAOS; Fichtner K.H., 1996, MATHINF9639 FAK MATH, P105; Ingarden R. S., 1997, INFORM DYNAMICS OPEN; Jamio lkowski A., 1972, REP MATH PHYS, V3, P275, DOI DOI 10.1016/0034-4877(72)90011-0; Khrennikov A, 2011, PHYS SCRIPTA, VT143, DOI 10.1088/0031-8949/2011/T143/014013; Khrennikov A., 2009, SERIES FUNDAMENTALS; KOLMOGOROV A. N., 1963, AM MATH SOC TRANSL 2, V33, P291; Ohya M., 1983, NUOVO CIMENTO, V38, P402; Ohya M., 1998, FDN QUANTUM COMMUNIC; OHYA M, 1983, IEEE T INFORM THEORY, V29, P770, DOI 10.1109/TIT.1983.1056719; Ohya M., 1995, QUANTUM COMMUNICATIO, V2, P309; Ohya M., 1993, QUANTUM ENTROPY ITS; Ohya M, 2011, THEOR MATH PHYS SER, P1, DOI 10.1007/978-94-007-0171-7; Ohya M., 1989, Reports on Mathematical Physics, V27, DOI 10.1016/0034-4877(89)90034-7; Ohya M., 1985, Electronics and Communications in Japan, Part 1 (Communications), V68, DOI 10.1002/ecja.4410680204; PARK YM, 1994, LETT MATH PHYS, V32, P63, DOI 10.1007/BF00761124; Schatten R., 1970, NORM IDEALS COMPLETE; Tuyls P, 1998, BANACH CTR PUBLICATI, V43, P411; Umegaki H, 1962, KODAI MATH SEM REP, V14, P59, DOI DOI 10.2996/KMJ/1138844604; von Neumann J., 1932, MATH GRUNDLAGEN QUAN	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0015-9018	1572-9516		FOUND PHYS	Found. Phys.	OCT	2015	45	10			SI		1311	1329		10.1007/s10701-015-9925-2		19	Physics, Multidisciplinary	Physics	CS2KD	WOS:000361898600010		
J	Asano, M; Basieva, I; Khrennikov, A; Ohya, M; Tanaka, Y; Yamato, I				Asano, Masanari; Basieva, Irina; Khrennikov, Andrei; Ohya, Masanori; Tanaka, Yoshiharu; Yamato, Ichiro			Quantum Information Biology: From Information Interpretation of Quantum Mechanics to Applications in Molecular Biology and Cognitive Psychology	FOUNDATIONS OF PHYSICS			English	Article						Quantum biological information; Quantum adaptive dynamics; Open quantum systems; Information interpretation; QBism; Molecular biology; Genetics; Cognition	DECISION-MAKING; INEQUALITY; MODEL; VIOLATION; INTERFERENCE; NONLOCALITY; DYNAMICS; PHYSICS; BRAIN	We discuss foundational issues of quantum information biology (QIB)-one of the most successful applications of the quantum formalism outside of physics. QIB provides a multi-scale model of information processing in bio-systems: from proteins and cells to cognitive and social systems. This theory has to be sharply distinguished from "traditional quantum biophysics". The latter is about quantum bio-physical processes, e.g., in cells or brains. QIB models the dynamics of information states of bio-systems. We argue that the information interpretation of quantum mechanics (its various forms were elaborated by Zeilinger and Brukner, Fuchs and Mermin, and D' Ariano) is the most natural interpretation of QIB. Biologically QIB is based on two principles: (a) adaptivity; (b) openness (bio-systems are fundamentally open). These principles are mathematically represented in the framework of a novel formalism- quantum adaptive dynamics which, in particular, contains the standard theory of open quantum systems.	[Asano, Masanari] Tokuyama Coll Technol, Liberal Arts Div, Shunan, Japan; [Basieva, Irina; Khrennikov, Andrei] Linnaeus Univ, Int Ctr Math Modeling Phys & Cognit Sci, Vaxjo, Sweden; [Ohya, Masanori; Tanaka, Yoshiharu] Tokyo Univ Sci, Dept Informat Sci, Tokyo 162, Japan; [Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 162, Japan	Khrennikov, A (reprint author), Linnaeus Univ, Int Ctr Math Modeling Phys & Cognit Sci, Vaxjo, Sweden.	andrei.khrennikov@lnu.se					Acacio de Barros J, 2012, QUANTUM THEORY RECON, V1508, P98; de Barros JA, 2014, PHYS SCRIPTA, VT163, DOI 10.1088/0031-8949/2014/T163/014008; Acacio de Barros J, 2015, ADV COGNITIVE NEUROD, VIV, P401; Zeilinger A, 1999, FOUND PHYS, V29, P631, DOI 10.1023/A:1018820410908; Cheon T, 2006, PHYS LETT A, V348, P147, DOI 10.1016/j.physleta.2005.08.066; Khrennikov A, 2006, BIOSYSTEMS, V84, P225, DOI 10.1016/j.biosystems.2005.11.005; Atmanspacher H, 2012, AIP CONF PROC, V1508, P79, DOI 10.1063/1.4773119; Busemeyer JR, 2011, PSYCHOL REV, V118, P193, DOI 10.1037/a0022542; Atmanspacher H, 2009, RECASTING REALITY, P135, DOI 10.1007/978-3-540-85198-1_7; Brukner C, 1999, PHYS REV LETT, V83, P3354, DOI 10.1103/PhysRevLett.83.3354; de Barros JA, 2012, BIOSYSTEMS, V110, P171, DOI 10.1016/j.biosystems.2012.10.002; Khrennikova P, 2012, AIP CONF PROC, V1508, P108, DOI 10.1063/1.4773122; Brukner C, 1999, ACTA PHYS SLOVACA, V49, P647; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; Dzhafarov EN, 2012, J MATH PSYCHOL, V56, P54, DOI 10.1016/j.jmp.2011.12.003; Fuchs CA, 2011, FOUND PHYS, V41, P345, DOI 10.1007/s10701-009-9404-8; Khrennikov A, 2011, BIOSYSTEMS, V105, P250, DOI 10.1016/j.biosystems.2011.05.014; Chiribella G, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062348; Khrennikov A, 2008, ENTROPY, V10, P19, DOI 10.3390/entropy-e10020019; Khrennikova P, 2014, INT J THEOR PHYS, V53, P1346, DOI 10.1007/s10773-013-1931-6; Khrennikov A, 2004, OPEN SYST INF DYN, V11, P267, DOI 10.1023/B:OPSY.0000047570.68941.9d; Giustina M, 2013, NATURE, V497, P227, DOI 10.1038/nature12012; D'Ariano GM, 2011, AIP CONF PROC, V1327, P7, DOI [10.1063/1.3578749, 10.1063/1.3567424]; Caves CM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.022305; Asano M, 2012, J MATH PSYCHOL, V56, P166, DOI 10.1016/j.jmp.2012.02.003; D'Ariano GM, 2007, AIP CONF PROC, V889, P79; Conte E, 2008, NEUROQUANTOLOGY, V6, P214; Cheon T, 2010, PHYS LETT A, V375, P100, DOI 10.1016/j.physleta.2010.10.063; Busemeyer JR, 2006, J MATH PSYCHOL, V50, P220, DOI 10.1016/j.jmp.2006.01.003; Brukner C, 2009, FOUND PHYS, V39, P677, DOI 10.1007/s10701-009-9316-7; Asano M, 2011, J THEOR BIOL, V281, P56, DOI 10.1016/j.jtbi.2011.04.022; 't Hooft G, 2011, HER RUSS ACAD SCI, V81, P907; 't Hooft G., 2006, ARXIVARXIVQUANTPH060; 't Hooft G., 1999, ARXIVARXIVGRQC990308; Arndt M., 2009, HFSP J, V3; Asano M, 2010, OPEN SYST INF DYN, V17, P1, DOI DOI 10.1142/S1230161211000042; Asano M, 2014, PHYS SCRIPTA, VT163, DOI 10.1088/0031-8949/2014/T163/014006; Asano Masanari, 2013, Syst Synth Biol, V7, P161, DOI 10.1007/s11693-013-9109-3; Asano M., 2010, FOUND PHYS, V41, P538; Asano M., 2015, QUANTUM ADAPTIVITY B; Asano M., 2013, FOUND PHYS, V43, P2083; Asano Masanari, 2012, Syst Synth Biol, V6, P1, DOI 10.1007/s11693-012-9091-1; Basieva I., 2010, SYST SYNTH BIOL, V5, P1; Busemeyer J. R., 2012, QUANTUM MODELS COGNI; ChA Fuchs, ARXIV10035209; Chiribella G, 2012, AIP CONF PROC, V1424, DOI 10.1063/1.3688980; Christensen B.G., 2013, PHYS REV LETT, V111, P1304; Conte E, 2006, CHAOS SOLITON FRACT, V31, P1076; de Barros JA, 2014, LECT NOTES COMPUT SC, V8369, P257, DOI 10.1007/978-3-642-54943-4_23; Dragovich B., 2009, ANAL APPL, V1, P1, DOI 10.1134/S2070046609010014; Fichtner K.-H., 2008, QP PQ QUANTUM PROB W, V21, P64; Fuchs C. A., 2002, MATH MODELLING, V2, P463; Fuchs C. A., 2002, SER MATH MODEL, V2, P99; Hameroff S. R., 1994, J CONSCIOUSNESS STUD, V1, P91; Hasegawa Y., 2006, ACATA PHYS HUNG A, V26, P157; Haven E., 2012, QUANTUM SOCIAL SCI; Khrennikov A, I QUANT OPT QUANT IN; Khrennikov A, 2009, INTERPRETATIONS OF PROBABILITY, 2ND REVISED AND EXTENDED EDITION, P1, DOI 10.1515/9783110213195.fm; Khrennikov A, 2010, P ADIC NUMBERS ULTRA, P2, DOI [10.1134/S2070046610010012, DOI 10.1134/S2070046610010012]; Khrennikov A. Yu., 2004, FUNDAMENTAL THEORIES; Khrennikov A, 2010, UBIQUITOUS QUANTUM STRUCTURE: FROM PSYCHOLOGY TO FINANCE, P1, DOI 10.1007/978-3-642-05101-2; Khrennikov A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110909; Khrennikov Y.A., 2002, SER MATH MODELLING P, V5, P325; Kolmogoroff A.N., 1933, FDN THEORY PROBABILI; Ohya M, 2011, THEOR MATH PHYS SER, P1, DOI 10.1007/978-94-007-0171-7; Penrose R., 1989, EMPERORS NEW MIND; Plotnitsky A., 2006, READING BOHR PHYS PH; Plotnitsky A., 2009, EPISTEMOLOGY PROBABI; Suppes P., 2009, J MATH PSYCHOL, V53, P306; Tegmark M, 2000, PHYS REV E, V61; Von Neuman J., 1955, MATH FDN QUANTUM MEC; Zeilinger A., 2010, DANCE PHOTONS EINSTE	72	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0015-9018	1572-9516		FOUND PHYS	Found. Phys.	OCT	2015	45	10			SI		1362	1378		10.1007/s10701-015-9929-y		17	Physics, Multidisciplinary	Physics	CS2KD	WOS:000361898600014		
J	Matsushita, M; Takata, K; Hitsuma, G; Yagihashi, T; Noguchi, M; Shibata, M; Masaki, T				Matsushita, Michinari; Takata, Katsuhiko; Hitsuma, Gaku; Yagihashi, Tsutomu; Noguchi, Mahoko; Shibata, Mitsue; Masaki, Takashi			A novel growth model evaluating age-size effect on long-term trends in tree growth	FUNCTIONAL ECOLOGY			English	Article						age-related physiological constraints; climate; competition; conifer; genetic variation; hierarchical Bayes; metabolic theory; neighbourhood analysis	METABOLIC SCALING THEORY; NEW-ENGLAND FORESTS; ENVIRONMENTAL GRADIENTS; NEIGHBORHOOD ANALYSIS; EUCALYPTUS TREES; TROPICAL FOREST; LIFE-HISTORY; COMPETITION; ECOLOGY; ACCUMULATION	1. One of the major problems in understanding growth trends in long-lived trees is the difficulty of separately quantifying the effects of tree size and age. Careful statistical control of the axiomatic agexsize covariation is therefore required to identify long-term trends in tree growth and their drivers, and to predict forests' responses to environmental changes reliably. 2. To address this issue, we present a novel tree growth model: a two-dimensional log-normal growth model'. This is an extension of the one-dimensional log-normal growth model, in which tree growth is modelled primarily as a function of size. Our model assesses the trend in tree growth over time by explicitly partitioning the effects of age and size, controlling the covariation. The model is then extended to incorporate the effects of neighbourhood crowding and individual tree variation. 3. To demonstrate our model, we apply it to long-term monitoring data from a mature (104-year-old) plantation of Japanese cedar. Thinning operations of various intensities have been applied to this plantation, and the diameter of each individual tree has been measured repeatedly. 4. We observed a pronounced age-related decline in diameter growth. However, at each age, greater tree size was associated with a higher growth rate. The growth-size curve predicted from the model became flatter with tree age, and the curve's peak shifted rightwards as tree age increased. The model reveals that the sensitivity of a target tree to neighbourhood crowding depends strongly on neighbours' size and also provides an estimate of among-tree variation in growth performance. 5. Although the relationships between growth, size and age in long-lived trees are very complex, our growth model supports the conclusion that it is possible to predict long-term trends in tree growth reliably with respect to both age and size. In addition, the model's flexibility will facilitate more robust testing of species-specific responses to long-term environmental changes.	[Matsushita, Michinari] Akita Prefectural Univ, Dept Environm Biol, Shimoshinjo Nakano, Akita 0100195, Japan; [Takata, Katsuhiko] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Hitsuma, Gaku; Yagihashi, Tsutomu; Noguchi, Mahoko; Shibata, Mitsue] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate 0200123, Japan; [Masaki, Takashi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Matsushita, M (reprint author), Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, 3809-1 Ishi, Hitachi, Ibaraki 3191301, Japan.	mats.m.michi@gmail.com			FFPRI Research Project [A1P02]	We thank Yoneshiro-Seibu Forest Office for permitting us to conduct our study and for maintaining the sites. We are very grateful to Kousei Terasaki and Wataru Terasaki, who initially set up the plots. We thank Takuya Kajimoto, Kazuki Miyamoto, Masuo Mori, Shigeta Mori, Takuo Nagaike, Katuhiro Osumi, Katsuro Saito, Atsushi Sakai, Shobu Sakurai, Shoubin Sato, Satoshi Sawata, Takeshi Seki, Wajirou Suzuki and Mitsuru Ueno for field assistance. We thank Akifumi Makita, Kazuhiko Hoshizaki, Mizuki Inoue, So Hanaoka, Ichiro Tamaki and Takeshi Torimaru for helpful discussions. This study was financially supported by FFPRI Research Project (A1P02).	Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Binkley D, 2004, FOREST ECOL MANAG, V190, P265, DOI 10.1016/j.foreco.2003.10.018; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Vesk PA, 2006, J ECOL, V94, P1027, DOI 10.1111/j.1365-2745.2006.01154.x; Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI 10.1139/X03-232; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Coulson T, 2011, SCIENCE, V334, P1275, DOI 10.1126/science.1209441; Clark JS, 2011, ECOL LETT, V14, P1273, DOI 10.1111/j.1461-0248.2011.01685.x; Masaki T, 2006, J FOREST RES-JPN, V11, P217, DOI 10.1007/s10310-005-0175-6; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Das A, 2012, CAN J FOREST RES, V42, P1983, DOI 10.1139/x2012-142; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Kunstler G, 2011, J ECOL, V99, P300, DOI 10.1111/j.1365-2745.2010.01751.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Papaik MJ, 2006, ECOL APPL, V16, P1880, DOI 10.1890/1051-0761(2006)016[1880:MAOTCA]2.0.CO;2; Boyden S, 2008, ECOLOGY, V89, P2850, DOI 10.1890/07-1733.1; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Russo SE, 2007, ECOL LETT, V10, P889, DOI 10.1111/j.1461-0248.2007.01079.x; Lee WK, 2004, ECOL MODEL, V176, P187, DOI 10.1016/j.ecolmodel.2003.11.012; Smallegange IM, 2013, TRENDS ECOL EVOL, V28, P143, DOI 10.1016/j.tree.2012.07.021; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Xu CY, 2012, J ECOL, V100, P428, DOI 10.1111/j.1365-2745.2011.01933.x; Luu TC, 2013, FOREST ECOL MANAG, V289, P90, DOI 10.1016/j.foreco.2012.09.033; Gelman A., 2003, BAYESIAN DATA ANAL; Long J. N., 2001, FOREST ECOL MANAG, V86, P3048; Masaki T., B FFPRI IN PRESS; Masaki T., 2013, Journal of the Japanese Forest Society, V95, P227, DOI 10.4005/jjfs.95.227; Matsushita M., 2015, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.7qc3s, DOI 10.5061/DRYAD.7QC3S]; R Development Core Team, 2012, R LANG ENV STAT COMP; Spiegelhalter D. J., 2003, WINBUGS VERSION 1 4; Stape J. L., 2010, FOREST ECOL MANAG, V259, P1674	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	OCT	2015	29	10					1250	1259		10.1111/1365-2435.12416		10	Ecology	Environmental Sciences & Ecology	CS9FN	WOS:000362395400002		
J	Garmaroodi, HS; Taga, M				Garmaroodi, Hamid S.; Taga, Masatoki			Meiotic inheritance of a fungal supernumerary chromosome and its effect on sexual fertility in Nectria haematococca	FUNGAL BIOLOGY			English	Article						Conditionally dispensable chromosome (CDC); FISH; Nondisjunction	CONDITIONALLY DISPENSABLE CHROMOSOME; ELECTROPHORETIC KARYOTYPES; ALTERNARIA-ALTERNATA; SORDARIA-MACROSPORA; LENGTH-POLYMORPHISM; B-CHROMOSOMES; PATHOGENICITY; PEA; MEIOSIS; GENES	PDA1-conditionally dispensable chromosome (CDC) of Nectria haematococca MP VI has long served as a model of supernumerary chromosomes in plant pathogenic fungi because of pathogenicity-related genes located on it. In our previous study, we showed the dosage effects of PDA1-CDC on pathogenicity and homoserine utilization by exploiting tagged PDA1-CDC with a marker gene. CDC content of mating partners and progenies analyzed by PCR, PFGE combined with Southern analysis and chromosome painting via FISH. In this study, we analyzed mode of meiotic inheritance of PDA1-CDC in several mating patterns with regard to CDC content and found a correlation between CDC content of parental strains with fertility of crosses. The results showed non-Mendelian inheritance of this chromosome followed by duplication or loss of the CDC in haploid genome through meiosis that probably were due to premature centromere division, not by nondisjunction as reported for the supernumerary chromosomes in other species. Correlation of CDC with fertility is the first time to be examined in fungi in this study. (C) 2015 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.	[Garmaroodi, Hamid S.; Taga, Masatoki] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Garmaroodi, HS (reprint author), Seed & Plant Improvement Inst, Karaj 3135933181, Iran.	hsgarmaroodi@spii.ir; mtaga@okayama-u.ac.jp			Japan Student Services Organization (JASSO)	We would like to thank Profs. H.D. VanEtten for providing the strains and J.P.M. Camacho for fruitful discussions. This work was supported in part by Japan Student Services Organization (JASSO) as a fellowship to HSG.	Kerenyi Z, 2004, APPL ENVIRON MICROB, V70, P4419, DOI 10.1128/AEM.70.8.4419-4423.2004; Orbach MJ, 1996, MOL PLANT MICROBE IN, V9, P261, DOI 10.1094/MPMI-9-0261; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Saitoh Ken-ichiro, 2006, Journal of General Plant Pathology, V72, P348, DOI 10.1007/s10327-006-0300-1; Ahn JH, 1996, PLANT CELL, V8, P887; Funnell DL, 2001, PHYTOPATHOLOGY, V91, P92, DOI 10.1094/PHYTO.2001.91.1.92; KISTLER HC, 1984, J GEN MICROBIOL, V130, P2595; Johnson LJ, 2001, CURR GENET, V40, P65, DOI 10.1007/s002940100233; Leclair S, 1996, CURR GENET, V30, P541, DOI 10.1007/s002940050167; TEGTMEIER KJ, 1982, PHYTOPATHOLOGY, V72, P604, DOI 10.1094/Phyto-77-604; MASEL AM, 1993, MOL GEN GENET, V237, P73; MILLS D, 1990, MOL PLANT MICROBE IN, V3, P351, DOI 10.1094/MPMI-3-351; FULTON AM, 1983, GENET RES, V41, P165; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; ARNAISE S, 1984, MUTAT RES, V125, P33, DOI 10.1016/0027-5107(84)90029-0; Covert SF, 1998, CURR GENET, V33, P311, DOI 10.1007/s002940050342; Geiser DM, 1996, CURR GENET, V29, P293; Taga M, 1998, MYCOL RES, V102, P1355, DOI 10.1017/S0953756298006455; Wang CS, 2003, FEMS MICROBIOL LETT, V226, P373, DOI 10.1016/S0378-1097(03)00640-2; DYER PS, 1993, MYCOL RES, V97, P485; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; TZENG TH, 1992, GENETICS, V130, P81; Camacho JPM, 2000, PHILOS T ROY SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; KIM DH, 1993, PHYTOPATHOLOGY, V83, P1209, DOI 10.1094/Phyto-83-1209; Banaszek A, 2006, FOLIA ZOOL, V55, P113; NAUTA MJ, 1993, GENETICS, V135, P923; Martin RH, 2008, REPROD BIOMED ONLINE, V16, P523; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Garmaroodi HS, 2007, MOL PLANT MICROBE IN, V20, P1495, DOI 10.1094/MPMI-20-12-1495; Poggeler S, 2000, J EVOLUTION BIOL, V13, P281; Taga M, 1999, FUNGAL GENET BIOL, V26, P169, DOI 10.1006/fgbi.1999.1123; PERKINS DD, 1974, GENETICS, V77, P459; XU JR, 1995, MOL PLANT MICROBE IN, V8, P74, DOI 10.1094/MPMI-8-0074; Hatta R, 2002, GENETICS, V161, P59; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Funnell DL, 2002, FUNGAL GENET BIOL, V37, P121, DOI 10.1016/S1087-1845(02)00503-0; Dias AL, 1998, CARYOLOGIA, V51, P105; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Coleman JJ, 2009, PLOS GENETICS, P5; Jones RN, 1982, B CHROMOSOMES; Pukkila PJ, 1992, CULTURE COLLECTION B, P249; Rodriguez-Carres M, 2008, Appl Environ Microbiol, V74, P3849, DOI 10.1128/AEM.00351-08; Salamiah, 2001, J GEN PLANT PATHOL, V67, P97; THRELKEL.SF, 1970, GENET RES, V16, P29; Turner BC, 1987, FUNGAL GENET NEWSL, V34, P59; VanEtten HD, 2001, NELSON MEMORIAL S, P97; Wassman CC, 1996, MOL PLANT MICROBE IN, V9, P793; Wittenberg AHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005863; Zickler D., 2006, THE MYCOTA, V1, P415; ZOLAN ME, 1995, MICROBIOL REV, V59, P686	50	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1878-6146	1878-6162		FUNGAL BIOL-UK	Fungal Biol.	OCT	2015	119	10					929	939		10.1016/j.funbio.2015.07.004		11	Mycology	Mycology	CS5RQ	WOS:000362136100006		
J	Xu, MJ; Cai, Y; Wang, H; Altamirano, J; Chang, BX; Bertola, A; Odena, G; Lu, J; Tanaka, N; Matsusue, K; Matsubara, T; Mukhopadhyay, P; Kimura, S; Pacher, P; Gonzalez, FJ; Bataller, R; Gao, B				Xu, Ming-Jiang; Cai, Yan; Wang, Hua; Altamirano, Jose; Chang, Binxia; Bertola, Adeline; Odena, Gemma; Lu, Jim; Tanaka, Naoki; Matsusue, Kimihiko; Matsubara, Tsutomu; Mukhopadhyay, Partha; Kimura, Shioko; Pacher, Pal; Gonzalez, Frank J.; Bataller, Ramon; Gao, Bin			Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans	GASTROENTEROLOGY			English	Article						Lipid Metabolism; Endoplasmic Reticulum; Inflammation; Translational Research	LIVER-DISEASE PATHOGENESIS; LEPTIN-DEFICIENT MICE; THERAPEUTIC TARGETS; HEPATIC STEATOSIS; PPAR-GAMMA; CIDE PROTEINS; HEPATOSTEATOSIS; INJURY; FSP27; MODEL	BACKGROUND & AIMS: Alcoholic steatohepatitis (ASH) is the progressive form of alcoholic liver disease and may lead to cirrhosis and hepatocellular carcinoma. We studied mouse models and human tissues to identify molecules associated with ASH progression and focused on the mouse fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) protein, which is expressed in white adipose tissues and promotes formation of fat droplets. METHODS: C57BL/6N mice or mice with hepatocyte-specific disruption of Fsp27 (Fsp27(Hep-/-) mice) were fed the Lieber-Decarli ethanol liquid diet (5% ethanol) for 10 days to 12 weeks, followed by 1 or multiple binges of ethanol (5 or 6 g/kg) during the chronic feeding. Some mice were given an inhibitor (GW9662) of peroxisome proliferator-activated receptor gamma (PPARG). Adenoviral vectors were used to express transgenes or small hairpin (sh) RNAs in cultured hepatocytes and in mice. Liver tissue samples were collected from ethanolfed mice or from 31 patients with alcoholic hepatitis (AH) with biopsy-proved ASH and analyzed histologically and immunohistochemically and by transcriptome, immunoblotting, and real-time PCR analyses. RESULTS: Chronic-plus-binge ethanol feeding of mice, which mimics the drinking pattern of patients with AH, produced severe ASH and mild fibrosis. Microarray analyses revealed similar alterations in expression of many hepatic genes in ethanol-fed mice and humans with ASH, including up-regulation of mouse Fsp27 (also called Cidec) and human CIDEC. Fsp27(Hep-/-) mice and mice given injections of adenovirus-Fsp27shRNA had markedly reduced ASH following chronic-plus-binge ethanol feeding. Inhibition of PPARG and cyclic AMP-responsive element binding protein H (CREBH) prevented the increases in Fsp27 alpha and FSP27 beta mRNAs, respectively, and reduced liver injury in this chronic-plusbinge ethanol feeding model. Overexpression of FSP27 and ethanol exposure had synergistic effects in inducing production of mitochondrial reactive oxygen species and damage to hepatocytes in mice. Hepatic CIDEC mRNA expression was increased in patients with AH and correlated with the degree of hepatic steatosis and disease severity including mortality. CONCLUSIONS: In mice, chronic-plus-binge ethanol feeding induces ASH that mimics some histological and molecular features observed in patients with AH. Hepatic expression of FSP27/CIDEC is highly up-regulated in mice following chronic-plus-binge ethanol feeding and in patients with AH; this up-regulation contributes to alcohol-induced liver damage.	[Xu, Ming-Jiang; Cai, Yan; Wang, Hua; Chang, Binxia; Bertola, Adeline; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA; [Xu, Ming-Jiang] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Cai, Yan; Tanaka, Naoki; Matsubara, Tsutomu; Kimura, Shioko; Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Wang, Hua] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China; [Altamirano, Jose; Bataller, Ramon] Vall dHebron Hosp, Vali dHebron Inst Recerca, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Altamirano, Jose; Bataller, Ramon] Vall dHebron Hosp, Vali dHebron Inst Recerca, Internal Med Dept, Liver Unit, Barcelona, Spain; [Odena, Gemma; Bataller, Ramon] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC USA; [Lu, Jim] GoPath Diagnost LLC, Chicago, IL USA; [Matsusue, Kimihiko] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 81401, Japan; [Mukhopadhyay, Partha; Pacher, Pal] NIAAA, Sect Oxidat Stress & Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA; [Bataller, Ramon] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	Gao, B (reprint author), NIAAA, Lab Liver Dis, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	bgao@mail.nih.gov	Cai, Yan/P-4383-2015				Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377; Lazaro R, 2015, HEPATOLOGY, V61, P129, DOI 10.1002/hep.27383; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Aibara D, 2013, BIOL PHARM BULL, V36, P1766; Lee JS, 2012, AM J TRANSL RES, V4, P102; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Hall AM, 2010, OBESITY, V18, P417, DOI 10.1038/oby.2009.236; Williams JA, 2014, WORLD J GASTROENTERO, V20, P12908, DOI 10.3748/wjg.v20.i36.12908; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Bertola Adeline, 2013, Hepatology, V58, P1814, DOI 10.1002/hep.26419; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Dominguez M, 2008, AM J GASTROENTEROL, V103, P2747, DOI 10.1111/j.1572-0241.2008.02104.x; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980; Chayanupatkul M, 2014, WORLD J GASTROENTERO, V20, P6279, DOI 10.3748/wjg.v20.i20.6279; Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Singal AK, 2014, CLIN GASTROENTEROL H, V12, P555, DOI 10.1016/j.cgh.2013.06.013; Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270; Yu FX, 2012, MOL CELL BIOCHEM, V369, P35, DOI 10.1007/s11010-012-1366-z; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Sun R, 2006, HEPATOLOGY, V44, P955, DOI 10.1002/hep.21344; Ueno A, 2012, NAT PROTOC, V7, P771, DOI 10.1038/nprot.2012.014; Iimuro Y, 1997, AM J PHYSIOL-GASTR L, V272, pG1186; Mathurin P, 2012, J HEPATOL, V56, pS39, DOI 10.1016/S0168-8278(12)60005-1	42	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	OCT	2015	149	4					1030	U367		10.1053/j.gastro.2015.06.009		18	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS3LX	WOS:000361976900038		
J	Sawano, M; Umeno, J; Esaki, M				Sawano, Miyuki; Umeno, Junji; Esaki, Motohiro			An Unusual Cause of Small Intestinal Ulcers	GASTROENTEROLOGY			English	Editorial Material							CHURG-STRAUSS-SYNDROME; DIAGNOSIS		[Sawano, Miyuki; Umeno, Junji; Esaki, Motohiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan	Sawano, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.						Mouthon L, 2014, J AUTOIMMUN, V48-49, P99, DOI 10.1016/j.jaut.2014.01.018; Sanchez R, 2006, GASTROINTEST ENDOSC, V63, P1082, DOI 10.1016/j.gie.2006.01.003; Suzuki Takayoshi, 2012, World J Gastrointest Endosc, V4, P194, DOI 10.4253/wjge.v4.i5.194	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	OCT	2015	149	4					E10	E11		10.1053/j.gastro.2015.02.018		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS3LX	WOS:000361976900005		
J	Young, RS; Hayashizaki, Y; Andersson, R; Sandelin, A; Kawaji, H; Itoh, M; Lassmann, T; Carninci, P; Bickmore, WA; Forrest, AR; Taylor, MS				Young, Robert S.; Hayashizaki, Yoshihide; Andersson, Robin; Sandelin, Albin; Kawaji, Hideya; Itoh, Masayoshi; Lassmann, Timo; Carninci, Piero; Bickmore, Wendy A.; Forrest, Alistair R.; Taylor, Martin S.		The FANTOM Consortium	The frequent evolutionary birth and death of functional promoters in mouse and human	GENOME RESEARCH			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; HUMAN GENOME; NONCODING RNAS; DNA ELEMENTS; CONSERVATION; SELECTION; ENHANCER; SITES; ENCYCLOPEDIA	Promoters are central to the regulation of gene expression. Changes in gene regulation are thought to underlie much of the adaptive diversification between species and phenotypic variation within populations. In contrast to earlier work emphasizing the importance of enhancer evolution and subtle sequence changes at promoters, we show that dramatic changes such as the complete gain and loss (collectively, turnover) of functional promoters are common. Using quantitative measures of transcription initiation in both humans and mice across 52 matched tissues, we discriminate promoter sequence gains from losses and resolve the lineage of changes. We also identify expression divergence and functional turnover between orthologous promoters, finding only the latter is associated with local sequence changes. Promoter turnover has occurred at the majority (>56%) of protein-coding genes since humans and mice diverged. Tissue-restricted promoters are the most evolutionarily volatile where retrotransposition is an important, but not the sole, source of innovation. There is considerable heterogeneity of turnover rates between promoters in different tissues, but the consistency of these in both lineages suggests that the same biological systems are similarly inclined to transcriptional rewiring. The genes affected by promoter turnover show evidence of adaptive evolution. In mice, promoters are primarily lost through deletion of the promoter containing sequence, whereas in humans, many promoters appear to be gradually decaying with weak transcriptional output and relaxed selective constraint. Our results suggest that promoter gain and loss is an important process in the evolutionary rewiring of gene regulation and may be a significant source of phenotypic diversification.	[Young, Robert S.; Bickmore, Wendy A.; Taylor, Martin S.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hayashizaki, Yoshihide; Kawaji, Hideya; Itoh, Masayoshi] RIKEN, Prevent Med & Diag Innovat Program, Wako, Saitama 3510198, Japan; [Andersson, Robin; Sandelin, Albin] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Andersson, Robin; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Kawaji, Hideya; Itoh, Masayoshi; Lassmann, Timo; Carninci, Piero; Forrest, Alistair R.] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Forrest, Alistair R.] QEII Med Ctr, Harry Perkins Inst Med Res, Syst Biol & Genom, Nedlands, WA 6009, Australia	Young, RS (reprint author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	robert.young@igmm.ed.ac.uk; martin.taylor@igmm.ed.ac.uk	Andersson, Robin/B-5311-2009; 	Andersson, Robin/0000-0003-1516-879X; Forrest, Alistair/0000-0003-4543-1675	UK Medical Research Council [U127597124]; Medical Research Foundation; European Research Council (ERC) under European Union [638273]; Novo Nordisk Foundation; Lundbeck Foundation; MEXT; MEXT, Japan; research grants for the RIKEN Preventive Medicine and Diagnosis Innovation Program (RIKEN PMI); RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST [DGT]) from the MEXT, Japan	M.S.T. and R.S.Y. acknowledge the support of the UK Medical Research Council (U127597124) and the Medical Research Foundation. R.A. was supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme (grant agreement No. 638273). A.S. was supported by the Novo Nordisk Foundation and the Lundbeck Foundation. FANTOM5 was made possible by a Research Grant to the RIKEN Omics Science Center from MEXT to Y.H. and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to Y.H. This work was also supported by research grants for the RIKEN Preventive Medicine and Diagnosis Innovation Program (RIKEN PMI) to Y.H. and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST [DGT]) from the MEXT, Japan. We thank all members of the FANTOM5 Consortium for contributing to generation of samples and analysis of the data set, and we thank GeNAS for data production.	Laurie S, 2012, GENOME RES, V22, P478, DOI 10.1101/gr.121897.111; He ZS, 2014, RNA, V20, P1103, DOI 10.1261/rna.043075.113; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Munafo MR, 2003, MOL PSYCHIATR, V8, P471, DOI 10.1038/sj.mp.4001326; Taylor MS, 2008, NAT GENET, V40, P1262, DOI 10.1038/ng1108-1262; Fay JC, 2001, GENETICS, V158, P1227; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Anderson E, 2014, CURR OPIN GENET DEV, V27, P54, DOI 10.1016/j.gde.2014.03.011; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Mustonen V, 2008, P NATL ACAD SCI USA, V105, P12376, DOI 10.1073/pnas.0805909105; Sandelin A, 2007, NAT REV GENET, V8, P424, DOI 10.1038/nrg2026; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; De S, 2009, GENOME RES, V19, P785, DOI 10.1101/gr.086165.108; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Ballester B, 2014, ELIFE, V3, DOI 10.7554/eLife.02626; Bozek K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001871; Brown RP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-110; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Johnson KR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-247; Kindt ASD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-108; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lowe CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043128; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; R Core Team, 2015, R LANG ENV STAT COMP; Stolfi A, 2014, ELIFE, V3, DOI 10.7554/eLife.03728; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006	61	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2015	25	10					1546	1557		10.1101/gr.190546.115		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CS5ZS	WOS:000362157400018		
J	Setoyama, T; Miyamoto, S; Nikaido, M; Muto, M; Chiba, T				Setoyama, Takeshi; Miyamoto, Shin'ichi; Nikaido, Mitsuhiro; Muto, Manabu; Chiba, Tsutomu			Instability of IGF-IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse	GROWTH HORMONE & IGF RESEARCH			English	Article						Insulin-like growth factor (IGF); IGF-binding protein (IGFBP); Bioactive IGF; Free IGF; Kinase receptor activation (KIRA) assay; IGF-IGFBP complex	GROWTH-FACTOR-I; COMBINED IMMUNODEFICIENT MICE; LIGAND-SPECIFIC ANTIBODY; POSTMENOPAUSAL WOMEN; BINDING-PROTEINS; BREAST-CANCER; INSULIN; INHIBITION; SUPPRESSES; NEOPLASIA	Objective: The insulin-like growth factor (IGF) signaling pathway is recognized as a potential target for treating several cancers, and strategies targeting the IGF type 1 receptor (IGF-1R) have been evaluated in many clinical trials. These suggested that the pretreatment level of circulating free IGF gives an estimate of IGF bioactivity and might be a predictive biomarker of the response to anti-IGF-1R antibodies. However, there is no defined protocol for measuring free and bioactive IGF concentrations, partly because the measurement procedures, including sample collection and handling, have not been standardized. We investigated the effects of sample collection methods and storage conditions on bioactive IGF measurement using a modified kinase receptor activation (KIRA) assay in human and mouse samples. Design: Blood samples were obtained from healthy men and women, and from healthy male and female wildtype BALB/c mice. Serum and ethylenediaminetetraacetic acid (EDTA)-plasma samples were collected and used immediately or stored in small quantities at 4 degrees C or -80 degrees C for 3, 7, or 14 days. A bioassay directed against the phosphorylated IGF-1R using western blot analysis was developed as a modification of the KIRA assay, in which the level of phosphorylation of IGF-1R represented the IGF bioactivity in blood samples. Results: The levels of bioactive IGFs in mouse serum stored at 4 degrees C increased markedly in a time-dependent manner; the increase was slightly reduced in samples stored at -80 degrees C. Analysis of mouse EDTA-plasma stored at 4 degrees C showed a similar pattern, but the rime-dependent increase was less than in the serum samples. By contrast, the levels of bioactive IGFs in EDTA-plasma stored at -80 degrees C were stable over 14 days. The levels of human bioactive IGFs in both serum and EDTA-plasma stored at 4 degrees C increased slightly with time, but the increases were much smaller than in mouse samples. The levels of human bioactive IGF in both serum and EDTA-plasma stored at -80 degrees C were stable over 14 days. Conclusions: The use of EDTA-plasma avoids the problems with long-term storage. Therefore, EDTA-plasma should be used when measuring circulating IGF bioactivity, especially in mouse samples. All samples should be stored at -80 degrees C when long-term storage is unavoidable. Because of the large difference in the stability of the IGF-IGF-binding protein complex between the human and mouse in vitro, all samples should be handled carefully to ensure the accurate evaluation of IGF bioactivity, especially in mouse samples. (C) 2015 Elsevier Ltd. All rights reserved.	[Setoyama, Takeshi; Miyamoto, Shin'ichi; Nikaido, Mitsuhiro; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kyoto 6068507, Japan	Miyamoto, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	shmiyamo@kuhp.kyoto-u.ac.jp					GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753; Harris TG, 2006, GROWTH HORM IGF RES, V16, P86, DOI 10.1016/j.ghir.2006.01.002; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; Goya M, 2004, CANCER RES, V64, P6252, DOI 10.1158/0008-5472.CAN-04-0919; Araki K, 2006, INT J CANCER, V118, P2602, DOI 10.1002/ijc.21653; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Elis S, 2011, DIS MODEL MECH, V4, P649, DOI 10.1242/dmm.006775; Bang P, 2001, HORM RES, V55, P84, DOI 10.1159/000063482; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Hjortebjerg R, 2013, BEST PRACT RES CL EN, V27, P771, DOI 10.1016/j.beem.2013.08.010; Gunter MJ, 2008, CANCER RES, V68, P329, DOI 10.1158/0008-5472.CAN-07-2946; Weickhardt A, 2012, J THORAC ONCOL, V7, P419, DOI 10.1097/JTO.0b013e31823c5b11; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Sangai T, 2008, CLIN EXP METASTAS, V25, P401, DOI 10.1007/s10585-008-9144-8; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X; Janssen JAMJL, 2011, HORM RES PAEDIAT, V76, P106, DOI 10.1159/000329191; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gunter MJ, 2009, J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Frystyk J, 2001, GROWTH HORM IGF RES, V11, P117, DOI 10.1054/ghir.2001.0197; Frystyk J, 2007, PITUITARY, V10, P181, DOI 10.1007/s11102-007-0025-y; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Miyamoto S, 2005, CLIN CANCER RES, V11, P3494, DOI 10.1158/1078-0432.CCR-04-1701; Chen J.W., 2003, AM J PHYSIOL-ENDOC M, V284, P1149	24	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1096-6374	1532-2238		GROWTH HORM IGF RES	Growth Horm. IGF Res.	OCT	2015	25	5					227	231		10.1016/j.ghir.2015.06.009		5	Cell Biology; Endocrinology & Metabolism	Cell Biology; Endocrinology & Metabolism	CS5SS	WOS:000362139000004		
J	Lee, CC; Yanagawa, Y; Imaizumi, K				Lee, Charles C.; Yanagawa, Yuchio; Imaizumi, Kazuo			Commissural functional topography of the inferior colliculus assessed in vitro	HEARING RESEARCH			English	Article						Inferior colliculus (IC); Commissural; GABA; Inhibition; Auditory; Disinhibition	PHYSIOLOGICALLY CHARACTERIZED REGION; FREQUENCY-RESPONSE AREAS; ADULT CBA MOUSE; FLAVOPROTEIN AUTOFLUORESCENCE; CENTRAL NUCLEUS; GUINEA-PIG; LASER PHOTOSTIMULATION; SYNAPTIC PROPERTIES; AUDITORY-SYSTEM; RAT	The inferior colliculus (IC) receives ascending and descending information from several convergent neural sources. As such, exploring the neural pathways that converge in the IC is crucial to uncovering their. multi-varied roles in the integration of auditory and other sensory information. Among these convergent pathways, the IC commissural connections represent an important route for the integration of bilateral information in the auditory system. Here, we describe the preparation and validation of a novel in vitro slice preparation for examining the functional topography and synaptic properties of the commissural and intrinsic projections in the IC of the mouse. This preparation, in combination with modern genetic approaches in the mouse, enables the specific examination of these pathways, which potentially can reveal cell-type specific processing channels in the auditory midbrain. (C) 2015 Elsevier B.V. All rights reserved.	[Lee, Charles C.; Imaizumi, Kazuo] Louisiana State Univ, Dept Comparat Biomed Sci, Sch Vet Med, Baton Rouge, LA 70803 USA; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; [Imaizumi, Kazuo] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Lee, CC (reprint author), Louisiana State Univ, Dept Comparat Biomed Sci, Sch Vet Med, Skip Bertman Dr, Baton Rouge, LA 70803 USA.	cclee@lsu.edu			NIH/NIDCD [R03 DC 11361]; SVM USDA CORP [LAV3300, 3487]; Louisiana Board of Regents RCS [RD-A-09]; Action on Hearing Loss Grant [F42]; American Hearing Research Foundation	We thank X. Wu for assistance with confocal microscopy and Sherry Ring for histology assistance. pCS2-Venus was developed by Dr. Atsushi Miyawaki at Brain Science Institute, Riken, Wako, Japan. This work was supported by NIH/NIDCD grant R03 DC 11361, SVM USDA CORP grant LAV3300 and 3487, Louisiana Board of Regents RCS grant RD-A-09, Action on Hearing Loss Grant (F42), and the American Hearing Research Foundation.	ROSS LS, 1988, J COMP NEUROL, V270, P488, DOI 10.1002/cne.902700403; OLIVER DL, 1984, J COMP NEUROL, V224, P155, DOI 10.1002/cne.902240202; Lee CC, 2010, P NATL ACAD SCI USA, V107, P372, DOI 10.1073/pnas.0907873107; Theyel BB, 2011, NAT PROTOC, V6, P502, DOI 10.1038/nprot.2011.315; Li Y, 1999, HEARING RES, V137, P15, DOI 10.1016/S0378-5955(99)00129-X; Winer JA, 1998, J COMP NEUROL, V400, P147; SALDANA E, 1992, J COMP NEUROL, V319, P417, DOI 10.1002/cne.903190308; Broicher T, 2010, NEUROSCIENCE, V165, P371, DOI 10.1016/j.neuroscience.2009.10.025; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361; SaintMarie RL, 1996, J COMP NEUROL, V373, P255, DOI 10.1002/(SICI)1096-9861(19960916)373:2<255::AID-CNE8>3.0.CO;2-2; Reetz G, 1999, BRAIN RES, V816, P527, DOI 10.1016/S0006-8993(98)01230-X; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Chakravarty DN, 1997, BRAIN RES, V761, P263, DOI 10.1016/S0006-8993(97)00331-4; Casseday JH, 2002, SPR HDB AUD, V15, P238; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ono M, 2005, NEUROSCI RES, V51, P475, DOI 10.1016/j.neures.2004.12.019; MALMIERCA MS, 1995, J COMP NEUROL, V357, P124, DOI 10.1002/cne.903570112; LeBeau FEN, 2001, J NEUROSCI, V21, P7303; Lee CC, 2013, NEUROPHYSIOLOGY+, V45, P396, DOI 10.1007/s11062-013-9385-2; Frisina RD, 1998, HEARING RES, V115, P61, DOI 10.1016/S0378-5955(97)00176-7; Covic EN, 2011, CEREB CORTEX, V21, P2425, DOI 10.1093/cercor/bhr029; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; SCHWEIZER H, 1981, J COMP NEUROL, V201, P25, DOI 10.1002/cne.902010104; HERNANDEZ THG, 1986, BRAIN RES, V368, P268; Llano DA, 2009, CEREB CORTEX, V19, P2810, DOI 10.1093/cercor/bhp050; SMITH PH, 1992, J NEUROSCI, V12, P3700; Papageorgiou G, 1999, J AM CHEM SOC, V121, P6503, DOI 10.1021/ja990931e; Theyel BB, 2010, NEUROREPORT, V21, P861, DOI 10.1097/WNR.0b013e32833d7cec; Torterolo P, 1998, NEUROSCI LETT, V249, P172, DOI 10.1016/S0304-3940(98)00367-X; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Frisina RD, 1997, J ACOUST SOC AM, V101, P2741, DOI 10.1121/1.418562; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; Sturm J, 2014, J NEUROSCI, V34, P15032, DOI 10.1523/JNEUROSCI.2276-14.2014; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; Llano DA, 2009, J NEUROPHYSIOL, V101, P3325, DOI 10.1152/jn.91291.2008; Bajo Victoria M, 2012, Front Neural Circuits, V6, P114, DOI 10.3389/fncir.2012.00114; Cant NB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00029; Choy Buentello D., 2015, J COMP NEUROL; de Lahunta A., 2014, VET NEUROANATOMY CLI; Franklin KB, 2001, MOUSE BRAIN STEREOTA; GonzalezHernandez T, 1996, J COMP NEUROL, V372, P309, DOI 10.1002/(SICI)1096-9861(19960819)372:2<309::AID-CNE11>3.0.CO;2-E; Husson TR, 2009, FRONT NEUROSCI, P221; Imaizumi K, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00075; Lee C. C., 2013, J VIS EXP, V82, P50915, DOI 10.3791/50915; Llano DA, 2014, J NEUROPHYSIOL, V111, P197, DOI 10.1152/jn.00605.2013; Saldana E, 2005, INFERIOR COLLICULUS, P155, DOI 10.1007/0-387-27083-3_5; Shepherd Gordon M G, 2012, Cold Spring Harb Protoc, V2012, P998, DOI 10.1101/pdb.prot070664; Sivaramakrishnan S, 2001, J NEUROSCI, V21, P2861; Suter Benjamin A, 2010, Front Neural Circuits, V4, P100, DOI 10.3389/fncir.2010.00100; Winer J. A., 2005, INFERIOR COLLICULUS	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	OCT	2015	328						94	101		10.1016/j.heares.2015.08.011		8	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	CS5XQ	WOS:000362152000010		
J	Sato, N				Sato, Naoki			Epidemiology of Heart Failure in Asia	HEART FAILURE CLINICS			English	Article						Hospitalized heart failure; Site selection; Time frame; Ethnicity; Guideline-directed medical therapy; Mortality	INITIATE LIFESAVING TREATMENT; NATIONAL REGISTRY ADHERE; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; MULTICENTER COHORT; ORGANIZED PROGRAM; OPTIMIZE-HF; RATIONALE; DESIGN; OUTCOMES	Epidemiologic study is essential to improve management and outcomes in patients hospitalized for heart failure (HF). The academic and socioeconomic status can be clarified by epidemiologic study, and the unsolved issues can be realized. Based on results from epidemiologic studies, strategies to improve the present status could be considered. This article describes several key issues to conduct and interpret an epidemiologic study, for example, definition of HF, time frame, ethnicity, and site selection. Furthermore, assessments and evaluations that are based on comparisons with Western or other Asian data can give a clue to solve the present issues regarding HF management.	Musashi Kosugi Hosp, Nippon Med Sch, Cardiol & Intens Care Unit, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Sato, N (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Cardiol & Intens Care Unit, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	nms-nd@nms.ac.jp					Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Ariely R, 2013, DRUGS, V73, P689, DOI 10.1007/s40265-013-0057-8; Kajimoto K, 2013, INT J CARDIOL, V168, P554, DOI 10.1016/j.ijcard.2013.01.187; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Liu XY, 2014, HEART LUNG CIRC, V23, P818, DOI [10.1016/j.hlc.2014.02.022, 10.1016/j.h1c.2014.02.022]; Kajimoto K, 2015, INT J CARDIOL, V191, P100, DOI 10.1016/j.ijcard.2015.04.258; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Chong AY, 2003, EUR J HEART FAIL, V5, P569, DOI 10.1016/S1388-9842(03)00013-8; Ng TP, 2003, ANN ALLERG ASTHMA IM, V90, P51; Atherton JJ, 2012, J CARD FAIL, V18, P82, DOI 10.1016/j.cardfail.2011.09.003; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489; Central Intelligence Agency, WORLD FACTBOOK; Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI 10.1016/j.ahj.2007.03.012; Guo Yutao, 2013, Curr Cardiol Rev, V9, P112; Society of Cardiology Chinese Medical Association, 1980, CHIN J CARDIOL, V30, P450; Yang Yi-ning, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P460; Zhang J, 2014, CHIN MED J S2, V127, P79	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7136			HEART FAIL CLIN	Heart Fail. Clin.	OCT	2015	11	4					573	+		10.1016/j.hfc.2015.07.009		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS2IY	WOS:000361895100009		
J	Takamatsu, Y; Tanaka, Y; Kohgo, S; Murakami, S; Singh, K; Das, D; Venzon, DJ; Amano, M; Higashi-Kuwata, N; Aoki, M; Delino, NS; Hayashi, S; Takahashi, S; Sukenaga, Y; Haraguchi, K; Sarafianos, SG; Maeda, K; Mitsuya, H				Takamatsu, Yuki; Tanaka, Yasuhito; Kohgo, Satoru; Murakami, Shuko; Singh, Kamalendra; Das, Debananda; Venzon, David J.; Amano, Masayuki; Higashi-Kuwata, Nobuyo; Aoki, Manabu; Delino, Nicole S.; Hayashi, Sanae; Takahashi, Satoru; Sukenaga, Yoshikazu; Haraguchi, Kazuhiro; Sarafianos, Stefan G.; Maeda, Kenji; Mitsuya, Hiroaki			4-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus	HEPATOLOGY			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; ANTI-HIV ACTIVITY; IMMUNODEFICIENCY-VIRUS; IN-VITRO; UNITED-STATES; 4'-ETHYNYL-2-FLUORO-2'-DEOXYADENOSINE; LAMIVUDINE; INFECTION; THERAPY; TYPE-1	Certain nucleoside/nucleotide reverse transcriptase (RT) inhibitors (NRTIs) are effective against human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV). However, both viruses often acquire NRTI resistance, making it crucial to develop more-potent agents that offer profound viral suppression. Here, we report that 4-C-cyano-2-amino-2-deoxyadenosine (CAdA) is a novel, highly potent inhibitor of both HBV (half maximal inhibitory concentration [IC50]=0.4 nM) and HIV-1 (IC50=0.4 nM). In contrast, the approved anti-HBV NRTI, entecavir (ETV), potently inhibits HBV (IC50=0.7 nM), but is much less active against HIV-1 (IC50=1,000 nM). Similarly, the highly potent HIV-1 inhibitor, 4-ethynyl-2-fluoro-2-deoxyadenosine (EFdA; IC50=0.3 nM) is less active against HBV (IC50=160 nM). Southern analysis using Huh-7 cells transfected with HBV-containing plasmids demonstrated that CAdA was potent against both wild-type (IC50=7.2 nM) and ETV-resistant HBV (IC50=69.6 nM for HBVETV-RL180M/S202G/M204V), whereas ETV failed to reduce (HBVETV-RV)-V-L180M/S202G/M204 DNA even at 1 mu M. Once-daily peroral administration of CAdA reduced HBVETV-RL180M/S202G/M204V viremia (P=0.0005) in human-liver-chimeric/HBVETV-RL180M/S202G/M204V-infected mice, whereas ETV completely failed to reduce HBVETV-RL80M/S202G/M204V viremia. None of the mice had significant drug-related body-weight or serum human-albumin concentration changes. Molecular modeling suggests that a shallower HBV-RT hydrophobic pocket at the polymerase active site can better accommodate the slightly shorter 4-cyano of CAdA-triphosphate (TP), but not the longer 4-ethynyl of EFdA-TP. In contrast, the deeper HIV-1-RT pocket can efficiently accommodate the 4-substitutions of both NRTIs. The ETV-TP's cyclopentyl ring can bind more efficiently at the shallow HBV-RT binding pocket. Conclusion: These data provide insights on the structural and functional associations of HBV- and HIV-1-RTs and show that CAdA may offer new therapeutic options for HBV patients. (Hepatology 2015;62:1024-1036)	[Takamatsu, Yuki; Das, Debananda; Aoki, Manabu; Delino, Nicole S.; Maeda, Kenji; Mitsuya, Hiroaki] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA; [Tanaka, Yasuhito; Murakami, Shuko; Hayashi, Sanae] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Tanaka, Yasuhito; Hayashi, Sanae] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Kohgo, Satoru; Higashi-Kuwata, Nobuyo; Sukenaga, Yoshikazu; Maeda, Kenji; Mitsuya, Hiroaki] Natl Ctr Global Hlth & Med, Res Inst, Tokyo 1628655, Japan; [Kohgo, Satoru; Higashi-Kuwata, Nobuyo; Sukenaga, Yoshikazu; Maeda, Kenji; Mitsuya, Hiroaki] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Tokyo 1628655, Japan; [Kohgo, Satoru] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, Saitama, Japan; [Singh, Kamalendra] Univ Missouri, Sch Med, Mol Microbiol & Immunol Biochem, Columbia, MO USA; [Singh, Kamalendra] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA; [Venzon, David J.] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA; [Amano, Masayuki; Higashi-Kuwata, Nobuyo; Aoki, Manabu; Mitsuya, Hiroaki] Kumamoto Univ, Grad Sch Med Sci, Dept Hematol, Dept Rheumatol & Clin Immunol, Kumamoto, Japan; [Amano, Masayuki; Higashi-Kuwata, Nobuyo; Aoki, Manabu; Mitsuya, Hiroaki] Kumamoto Univ, Grad Sch Med Sci, Dept Infect Dis, Kumamoto, Japan; [Aoki, Manabu] Kumamoto Hlth Sci Univ, Dept Med Technol, Kumamoto, Japan; [Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi, Japan	Maeda, K (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kmaeda@ri.ncgm.go.jp			Center for Cancer Research, National Cancer Institute, National Institutes of Health; Health and Labor Sciences Research Grant (Practical Research on Hepatitis [Research on the innovative development and the practical application of new drugs for hepatitis B; International Research Center Aiming at the Control of AIDS, Kumamoto University;  [R01AI112417];  [R01AI076119]	This work was supported, in part, by the Intramural Research Program of Center for Cancer Research, National Cancer Institute, National Institutes of Health (H.M.), in part by a Health and Labor Sciences Research Grant (Practical Research on Hepatitis [Research on the innovative development and the practical application of new drugs for hepatitis B [H.M., Ya.T., K.H.]), and in part by a Grant from International Research Center Aiming at the Control of AIDS, Kumamoto University (H.M.). S.G.S. was supported by R01AI112417 and R01AI076119.	Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MITSUYA H, 1987, NATURE, V325, P773, DOI 10.1038/325773a0; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200; Kohgo S, 2004, NUCLEOS NUCLEOT NUCL, V23, P671, DOI 10.1081/NCN-120037508; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959; Hayashi S, 2015, J HEPATOL, V63, P546, DOI 10.1016/j.jhep.2015.03.020; Birkus G, 2002, ANTIMICROB AGENTS CH, V46, P716, DOI 10.1128/AAC.46.3.716-723.2002; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; [Anonymous], MERCK SIGNS 2 DEALS; Bartholomeusz A, 2004, ANTIVIR THER, V9, P149; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; OYANG C, 1992, TETRAHEDRON LETT, V33, P37, DOI 10.1016/S0040-4039(00)77667-2; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Fisher EJ, 2001, AIDS, V15, P1695, DOI 10.1097/00002030-200109070-00013; Levy V, 2006, CLIN INFECT DIS, V43, P904, DOI 10.1086/507532; WECKBECKER G, 1987, CANCER RES, V47, P2218; SRINIVAS RV, 1993, ANTIMICROB AGENTS CH, V37, P2247; Murphey-Corb M, 2012, ANTIMICROB AGENTS CH, V56, P4707, DOI 10.1128/AAC.00723-12; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; MAAG H, 1992, J MED CHEM, V35, P1440, DOI 10.1021/jm00086a013; Michailidis E, 2014, J BIOL CHEM, V289, P24533, DOI 10.1074/jbc.M114.562694; Karras A, 2003, CLIN INFECT DIS, V36, P1070, DOI 10.1086/368314; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Kohgo S, 1999, NUCL ACIDS S SER, V42, P127; Maeda K, 2014, ANTIVIR THER, V19, P179, DOI 10.3851/IMP2697; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	OCT	2015	62	4					1024	1036		10.1002/hep.27962		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS6TJ	WOS:000362214800009		
J	Kumada, H; Chayama, K; Rodrigues, L; Suzuki, F; Ikeda, K; Toyoda, H; Sato, K; Karino, Y; Matsuzaki, Y; Kioka, K; Setze, C; Pilot-Matias, T; Patwardhan, M; Vilchez, RA; Burroughs, M; Redman, R				Kumada, Hiromitsu; Chayama, Kazuaki; Rodrigues, Lino, Jr.; Suzuki, Fumitaka; Ikeda, Kenji; Toyoda, Hidenori; Sato, Ken; Karino, Yoshiyasu; Matsuzaki, Yasushi; Kioka, Kiyohide; Setze, Carolyn; Pilot-Matias, Tami; Patwardhan, Meenal; Vilchez, Regis A.; Burroughs, Margaret; Redman, Rebecca			Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis	HEPATOLOGY			English	Article							TREATMENT-NAIVE PATIENTS; VIVO ANTIVIRAL ACTIVITY; FIXED-DOSE COMBINATION; 1 INFECTION; RESISTANCE PROFILE; IN-VITRO; OPEN-LABEL; RIBAVIRIN; HCV; DASABUVIR	GIFT-I is a phase 3 trial evaluating the efficacy and safety of a 12-week regimen of coformulated ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) for treatment of Japanese hepatitis C virus genotype 1b-infected patients. It consists of a double-blind, placebo-controlled substudy of patients without cirrhosis and an open-label substudy of patients with compensated cirrhosis. Patients without cirrhosis were randomized 2:1 to once-daily OBV/PTV/r (25 mg/150 mg/100 mg; group A) or placebo (group B). Patients with cirrhosis received open-label OBV/PTV/r (group C). The primary efficacy endpoint was the rate of sustained virological response 12 weeks posttreatment in interferon-eligible, treatment-naive patients without cirrhosis and hepatitis C virus RNA 100,000 IU/mL in group A. A total of 321 patients without cirrhosis were randomized and dosed with double-blind study drug (106 received double-blind placebo and later received open-label OBV/PTV/r), and 42 patients with cirrhosis were enrolled and dosed with open-label OBV/PTV/r. In the primary efficacy population, the rate of sustained virological response 12 weeks posttreatment was 94.6% (106/112, 95% confidence interval 90.5-98.8). Sustained virological response 12 weeks posttreatment rates were 94.9% (204/215) in group A, 98.1% (104/106) in group B (open-label), and 90.5% (38/42) in group C. Overall, virological failure occurred in 3.0% (11/363) of patients who received OBV/PTV/r. The rate of discontinuation due to adverse events was 0%-2.4% in the three patient groups receiving OBV/PTV/r. The most frequent adverse event in patients in any group was nasopharyngitis. Conclusion: In this broad hepatitis C virus genotype 1b-infected Japanese patient population with or without cirrhosis, treatment with OBV/PTV/r for 12 weeks was highly effective and demonstrated a favorable safety profile. (Hepatology 2015;62:1037-1046)	[Kumada, Hiromitsu; Suzuki, Fumitaka; Ikeda, Kenji] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Rodrigues, Lino, Jr.; Setze, Carolyn; Pilot-Matias, Tami; Patwardhan, Meenal; Vilchez, Regis A.; Burroughs, Margaret; Redman, Rebecca] AbbVie Inc, N Chicago, IL USA; [Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu, Japan; [Sato, Ken] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 371, Japan; [Karino, Yoshiyasu] Sapporo Kosei Gen Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Matsuzaki, Yasushi] Tokyo Med Univ, Ibaraki Med Ctr, Dept Gastroenterol, Ibaraki, Japan; [Kioka, Kiyohide] Osaka City Gen Hosp, Dept Hepatol, Osaka, Japan	Kumada, H (reprint author), Toranomon Gen Hosp, Dept Hepatol, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	kumahiro@toranomon.gr.jp			AbbVie Inc.	Supported by AbbVie Inc., which contributed to the design and conduct of the study, data management, data analysis, interpretation of data, and the review and approval of the manuscript.	Kumada H, 2015, HEPATOL RES, V45, P501, DOI 10.1111/hepr.12375; [Anonymous], 2013, NORV RIT TABL 100 MG; Ronzoni L, 2014, J VIRAL HEPATITIS, V21, P416, DOI 10.1111/jvh.12158; [Anonymous], 2014, DAKL DACL TABL PRESC; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2014, AML; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Behrends M, 2010, J GASTROINTEST SURG, V14, P528, DOI 10.1007/s11605-009-1112-3; Chayama K, 2015, HEPATOLOGY, V61, P1523, DOI 10.1002/hep.27705; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Miyake Y, 2003, J HEPATOL, V38, P18, DOI 10.1016/S0168-8278(02)00323-9; Takada A, 1996, J GASTROEN HEPATOL, V11, P201, DOI 10.1111/j.1440-1746.1996.tb00063.x; Menon RM, 2015, J HEPATOL, V63, P20, DOI 10.1016/j.jhep.2015.01.026; [Anonymous], 2014, SUNV AS CAPS PRESCR; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; [Anonymous], 2015, HARV LED SOF TABL PR; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Drafting Committee for Hepatitis Management Guidelines Japan Society of Hepatology, 2014, HEPATOL RES SS1, P59; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Kan T, 2015, J GASTROENTEROL, DOI [10.1007/s00535-015-1080-1, DOI 10.1007/S00535-015-1080-1]; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Menon R, 2013, P 23 C AS PAC ASS ST; Muir A, 2014, HEPATOLOGY, V60, p1267A, DOI 10.1002/hep.27589; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	OCT	2015	62	4					1037	1046		10.1002/hep.27972		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS6TJ	WOS:000362214800010		
J	Yamazaki, Y; Yasui, K; Hashizume, T; Suto, A; Mori, A; Murata, Y; Yamaguchi, M; Ikari, A; Sugatani, J				Yamazaki, Yasuhiro; Yasui, Kenta; Hashizume, Takahiro; Suto, Arisa; Mori, Ayaka; Murata, Yuzuki; Yamaguchi, Masahiko; Ikari, Akira; Sugatani, Junko			Involvement of a cyclic adenosine monophosphate-dependent signal in the diet-induced canalicular trafficking of adenosine triphosphate-binding cassette transporter g5/g8	HEPATOLOGY			English	Article							BILIARY CHOLESTEROL SECRETION; RAT-LIVER; MEMBRANE-VESICLES; ABC TRANSPORTERS; PHOSPHOINOSITIDE 3-KINASE; P-GLYCOPROTEIN; APICAL DOMAIN; PLASMID DNA; PROTEINS; HEPATOCYTE	The adenosine triphosphate-binding cassette (ABC) half-transporters Abcg5 and Abcg8 promote the secretion of neutral sterol into bile. Studies have demonstrated the diet-induced gene expression of these transporters, but the regulation of their trafficking when the nutritional status changes in the liver remains to be elucidated. Here, we generated a novel in vivo kinetic analysis that can monitor the intracellular trafficking of Abcg5/Abcg8 in living mouse liver by in vivo transfection of the genes of fluorescent protein-tagged transporters and investigated how hypernutrition affects the canalicular trafficking of these transporters. The kinetic analysis showed that lithogenic diet consumption accelerated the translocation of newly synthesized fluorescent-tagged transporters to intracellular pools in an endosomal compartment and enhanced the recruitment of these pooled gene products into the bile canalicular membrane in mouse liver. Because some ABC transporters are reported to be recruited from intracellular pools to the bile canaliculi by cyclic adenosine monophosphate (cAMP) signaling, we next evaluated the involvement of this machinery in a diet-induced event. Administration of a protein kinase A inhibitor, N-(2-{[3-(4-bromophenyl)-2-propenyl]amino}ethyl)-5-isoquinolinesulfonamide, decreased the canalicular expression of native Abcg5/Abcg8 in lithogenic diet-fed mice, and injection of a cAMP analog, dibutyryl cAMP, transiently increased their levels in standard diet-fed mice, indicating the involvement of cAMP signaling. Indeed, canalicular trafficking of the fluorescent-tagged Abcg5/Abcg8 was enhanced by dibutyryl cAMP administration. Conclusion: These observations suggest that diet-induced lipid loading into liver accelerates the trafficking of Abcg5/Abcg8 to the bile canalicular membrane through cAMP signaling machinery. (Hepatology 2015;62:1215-1226)	[Yamazaki, Yasuhiro; Yasui, Kenta; Hashizume, Takahiro; Suto, Arisa; Mori, Ayaka; Murata, Yuzuki; Yamaguchi, Masahiko; Sugatani, Junko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, Shizuoka 4228526, Japan; [Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, Gifu, Japan	Sugatani, J (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	sugatani@u-shizuoka-ken.ac.jp			JSPS KAKENHI [25504008]	Supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) (25504008).	Roelofsen H, 1998, J CELL SCI, V111, P1137; Kagawa T, 2002, AM J PHYSIOL-CELL PH, V283, pC1655, DOI 10.1152/ajpcell.00041.2002; Yamazaki Y, 2011, DRUG METAB PHARMACOK, V26, P442, DOI 10.2133/dmpk.DMPK-11-RG-025; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Wang DQH, 1999, J LIPID RES, V40, P2066; Kipp H, 2003, AM J PHYSIOL-CELL PH, V285, pC737, DOI 10.1152/ajpcell.00041.2003; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Misra S, 1998, J BIOL CHEM, V273, P26638, DOI 10.1074/jbc.273.41.26638; Dombrowski F, 2000, BIOCHEM J, V348, P183, DOI 10.1042/0264-6021:3480183; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; Wu JE, 2004, J BIOL CHEM, V279, P22913, DOI 10.1074/jbc.M402838200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI 10.1172/JCI200216001; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gatmaitan ZC, 1997, AM J PHYSIOL-GASTR L, V272, pG1041; Ji HF, 2012, LIVER TRANSPLANT, V18, P659, DOI 10.1002/lt.23399; Wittenburg H, 2002, J CLIN INVEST, V110, P605, DOI 10.1172/JCI200216548; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; TSUKADA N, 1995, HEPATOLOGY, V21, P1106, DOI 10.1016/0270-9139(95)90262-7; NUNEZ L, 1995, GUT, V37, P422, DOI 10.1136/gut.37.3.422; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; GATMAITAN ZC, 1995, PHYSIOL REV, V75, P261; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Klett EL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-5; NISHIDA T, 1992, AM J PHYSIOL, V262, pG629; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; STIEGER B, 1992, BIOCHEM J, V284, P67; Wan G, 2011, CELL SIGNAL, V23, P1127; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	OCT	2015	62	4					1215	1226		10.1002/hep.27914		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS6TJ	WOS:000362214800024		
J	Schrumpf, E; Tan, C; Karlsen, TH; Sponheim, J; Bjorkstrom, NK; Sundnes, O; Alfsnes, K; Kaser, A; Jefferson, DM; Ueno, Y; Eide, TJ; Haraldsen, G; Zeissig, S; Exley, MA; Blumberg, RS; Melum, E				Schrumpf, Elisabeth; Tan, Corey; Karlsen, Tom H.; Sponheim, Jon; Bjorkstrom, Niklas K.; Sundnes, Olav; Alfsnes, Kristian; Kaser, Arthur; Jefferson, Douglas M.; Ueno, Yoshiyuki; Eide, Tor J.; Haraldsen, Guttorm; Zeissig, Sebastian; Exley, Mark A.; Blumberg, Richard S.; Melum, Espen			The biliary epithelium presents antigens to and activates natural killer T cells	HEPATOLOGY			English	Article							PRIMARY SCLEROSING CHOLANGITIS; BILE-DUCT EPITHELIUM; ULCERATIVE-COLITIS; CD1D EXPRESSION; LIVER-DISEASE; NKT CELLS; HLA-DR; CHOLANGIOCYTES; ESTABLISHMENT; CIRRHOSIS	Cholangiocytes express antigen-presenting molecules, but it has been unclear whether they can present antigens. Natural killer T (NKT) cells respond to lipid antigens presented by the major histocompatibility complex class I-like molecule CD1d and are abundant in the liver. We investigated whether cholangiocytes express CD1d and present lipid antigens to NKT cells and how CD1d expression varies in healthy and diseased bile ducts. Murine and human cholangiocyte cell lines as well as human primary cholangiocytes expressed CD1d as determined by flow cytometry and western blotting. Murine cholangiocyte cell lines were able to present both exogenous and endogenous lipid antigens to invariant and noninvariant NKT cell hybridomas and primary NKT cells in a CD1d-dependent manner. A human cholangiocyte cell line, cholangiocarcinoma cell lines, and human primary cholangiocytes also presented exogenous CD1d-restricted antigens to invariant NKT cell clones. CD1d expression was down-regulated in the biliary epithelium of patients with late primary sclerosing cholangitis, primary biliary cirrhosis, and alcoholic cirrhosis compared to healthy controls. Conclusions: Cholangiocytes express CD1d and present antigens to NKT cells and CD1d expression is down-regulated in diseased biliary epithelium, findings which show that the biliary epithelium can activate an important lymphocyte subset of the liver. This is a potentially important immune pathway in the biliary system, which may be capable of regulating inflammation in the context of biliary disease. (Hepatology 2015;62:1249-1259)	[Schrumpf, Elisabeth; Tan, Corey; Karlsen, Tom H.; Alfsnes, Kristian; Melum, Espen] Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Div Canc Surg & Transplantat, N-0424 Oslo, Norway; [Schrumpf, Elisabeth; Tan, Corey; Karlsen, Tom H.; Alfsnes, Kristian; Melum, Espen] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, KG Jebsen Inflammat Res Ctr, N-0424 Oslo, Norway; [Schrumpf, Elisabeth; Karlsen, Tom H.; Eide, Tor J.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sponheim, Jon] Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Div Canc Med Surg & Transplantat,Sect Gastroenter, N-0424 Oslo, Norway; [Sponheim, Jon; Sundnes, Olav; Haraldsen, Guttorm] Oslo Univ Hosp, Rikshosp, KG Jebsen Inflammat Res Ctr, Dept Pathol,Lab Immunohistochem & Immunopathol, N-0424 Oslo, Norway; [Bjorkstrom, Niklas K.] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Bjorkstrom, Niklas K.] Karolinska Inst, Dept Med, Liver Immunol Lab, Stockholm, Sweden; [Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Jefferson, Douglas M.] Tufts Univ, Sch Med, Sackler Sch, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Div Gastroenterol, Yamagata 990, Japan; [Eide, Tor J.] Oslo Univ Hosp, Rikshosp, Dept Pathol, N-0424 Oslo, Norway; [Zeissig, Sebastian] Univ Hosp Schleswig Holstein, Dept Internal Med, Kiel, Germany; [Exley, Mark A.] Univ Manchester, Fac Med & Human Sci, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England; [Exley, Mark A.; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	Melum, E (reprint author), Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Div Canc Surg & Transplantat, Postboks 4950 Nydalen, N-0424 Oslo, Norway.	espen.melum@medisin.uio.no		Bjorkstrom, Niklas/0000-0002-0967-076X	South Eastern Norway Regional Health Authority [2012024]; PSC; Norwegian PSC Research Center; Kristian Gerhard Jebsen Foundation; National Institutes of Health [CA170194]; Manchester Collaborative Centre for Inflammation Research	Supported by South Eastern Norway Regional Health Authority (project 2012024), PSC partners (www.pscpartners.org), the Norwegian PSC Research Center, the Kristian Gerhard Jebsen Foundation, National Institutes of Health (CA170194), and the Manchester Collaborative Centre for Inflammation Research.	Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Feng JX, 2004, J PEDIATR SURG, V39, P1658, DOI 10.1016/j.jpedsurg.2004.07.010; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; YANO H, 1992, CANCER, V69, P1664, DOI 10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P; SAIJYO S, 1995, TOHOKU J EXP MED, V177, P61, DOI 10.1620/tjem.177.61; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Behar SM, 1999, J IMMUNOL, V162, P161; Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; JOPLIN R, 1990, J PATHOL, V162, P255, DOI 10.1002/path.1711620312; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Leon MP, 1996, HEPATOLOGY, V24, P561; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Tsuneyama K, 1998, HEPATOLOGY, V28, P620, DOI 10.1002/hep.510280303; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060; CHAPMAN RW, 1988, GUT, V29, P422, DOI 10.1136/gut.29.4.422; Heydtmann M, 2005, J IMMUNOL, V174, P1055; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; DEMETRIS AJ, 1985, TRANSPLANTATION, V40, P504, DOI 10.1097/00007890-198511000-00007; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; SCHRUMPF E, 1980, SCAND J GASTROENTERO, V15, P689; Liao CM, 2013, INFLAMM BOWEL DIS, V19, P1330, DOI 10.1097/MIB.0b013e318280b1e3; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; BARBATIS C, 1981, GUT, V22, P985, DOI 10.1136/gut.22.12.985; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Zeissig Sebastian, 2013, Methods Mol Biol, V960, P557, DOI 10.1007/978-1-62703-218-6_41	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	OCT	2015	62	4					1249	1259		10.1002/hep.27840		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS6TJ	WOS:000362214800027		
J	Nakamura, M; Kanda, T; Nakamoto, S; Haga, Y; Sasaki, R; Jiang, X; Yasui, S; Arai, M; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Nakamoto, Shingo; Haga, Yuki; Sasaki, Reina; Jiang, Xia; Yasui, Shin; Arai, Makoto; Yokosuka, Osamu			Reappearance of Serum Hepatitis B Viral DNA in Patients With Hepatitis B Surface Antigen Seroclearance	HEPATOLOGY			English	Letter							REACTIVATION		[Nakamura, Masato; Kanda, Tatsuo; Nakamoto, Shingo; Haga, Yuki; Sasaki, Reina; Jiang, Xia; Yasui, Shin; Arai, Makoto; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan	Nakamura, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.						Nakamoto S, 2014, INT J MOL SCI, V15, P21455, DOI 10.3390/ijms151121455; Kanda T, 2004, J GASTROEN HEPATOL, V19, P238, DOI 10.1111/j.1440-1746.2004.03269.x; Di Bisceglie AM, 2015, HEPATOLOGY, V61, P703, DOI 10.1002/hep.27609	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	OCT	2015	62	4					1329	1329		10.1002/hep.27693		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS6TJ	WOS:000362214800046		
J	Akizuki, K; Ohashi, Y				Akizuki, Kazunori; Ohashi, Yukari			Measurement of functional task difficulty during motor learning: What level of difficulty corresponds to the optimal challenge point?	HUMAN MOVEMENT SCIENCE			English	Article						Challenge point framework; Optimal challenge point; Task difficulty; Salivary alpha-amylase; NASA-TIX; Motor learning	SALIVARY ALPHA-AMYLASE; ANAEROBIC THRESHOLD; MENTAL WORKLOAD; CARDIOVASCULAR ASSESSMENT; ATTENTIONAL DEMANDS; SUBJECTIVE WORKLOAD; DETERMINANTS; PERFORMANCE; MOVEMENTS; EXERCISE	The relationship between task difficulty and learning benefit was examined, as was the measurability of task difficulty. Participants were required to learn a postural control task on an unstable surface at one of four different task difficulty levels. Results from the retention test showed an inverted-U relationship between task difficulty during acquisition and motor learning. The second-highest level of task difficulty was the most effective for motor learning, while learning was delayed at the most and least difficult levels. Additionally, the results indicate that salivary a-amylase and the performance dimension of the National Aeronautics and Space Administration-Task Load Index (NASA-TLX) are useful indices of task difficulty. Our findings suggested that instructors may be able to adjust task difficulty based on salivary alpha-amylase and the performance dimension of the NASA-TLX to enhance learning. (C) 2015 Elsevier B.V. All rights reserved.	[Akizuki, Kazunori] Mejiro Univ, Fac Hlth Sci, Dept Phys Therapy, Iwatsuki Ku, Saitama, Saitama 3398501, Japan; [Ohashi, Yukari] Ibaraki Prefectural Univ Hlth Sci, Dept Phys Therapy, Ami, Ibaraki 3000394, Japan	Akizuki, K (reprint author), Mejiro Univ, Fac Hlth Sci, Dept Phys Therapy, Iwatsuki Ku, 320 Ukiya, Saitama, Saitama 3398501, Japan.	akiduki@mejiro.ac.jp; Ohashi@ipu.ac.jp					LEE TD, 1994, QUEST, V46, P328; Rendell MA, 2011, J MOTOR BEHAV, V43, P1, DOI 10.1080/00222895.2010.530304; Rubio S, 2004, APPL PSYCHOL-INT REV, V53, P61, DOI 10.1111/j.1464-0597.2004.00161.x; SALMONI AW, 1976, J MOTOR BEHAV, V8, P161, DOI 10.1080/00222895.1976.10735068; Richter M, 2008, PSYCHOPHYSIOLOGY, V45, P869, DOI 10.1111/j.1469-8986.2008.00688.x; Li YH, 2000, Q J EXP PSYCHOL-A, V53, P591, DOI 10.1080/027249800390628; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; BACKS RW, 1994, HUM FACTORS, V36, P514; Chiviacowsky S, 2013, J INTELL DISABIL RES, V57, P627, DOI 10.1111/j.1365-2788.2012.01569.x; GUTTENTAG RE, 1989, DEV REV, V9, P146, DOI 10.1016/0273-2297(89)90027-0; Backs RW, 1999, INT J AVIAT PSYCHOL, V9, P33, DOI 10.1207/s15327108ijap0901_3; Arnold BL, 1998, J ATHL TRAINING, V33, P323; GLENCROSS DJ, 1979, J MOTOR BEHAV, V11, P1; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; HENDY KC, 1993, HUM FACTORS, V35, P579; HILL SG, 1992, HUM FACTORS, V34, P429; Goh HT, 2014, J MOTOR BEHAV, V46, P95, DOI 10.1080/00222895.2013.868337; SCHMIDT RA, 1990, HUM MOVEMENT SCI, V9, P325, DOI 10.1016/0167-9457(90)90007-Z; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Calvo F, 1997, CAN J APPL PHYSIOL, V22, P553; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Shetty V, 2011, PSYCHONEUROENDOCRINO, V36, P193, DOI 10.1016/j.psyneuen.2010.07.008; Akizuki K, 2014, J PHYS THER SCI, V26, P1059, DOI 10.1589/jpts.26.1059; KERR B, 1975, J MOTOR BEHAV, V7, P15, DOI 10.1080/00222895.1975.10735009; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; ELLS JG, 1973, J EXP PSYCHOL, V99, P10, DOI 10.1037/h0034740; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Backs RW, 1995, INT J AVIAT PSYCHOL, V5, P25, DOI 10.1207/s15327108ijap0501_3; Battiste V., 1988, P HUM FACT SOC 32 AN, P150; Byers J. C., 1989, ADV IND ERGONOMICS S, VI, P481; Cooper G.E., 1969, TND5153 NASA AM RES; Eggemeier T. F., 1988, HUMAN MENTAL WORKLOA, P41; Hart S. G., 2006, P HUM FACT ERG SOC A, V50, P904, DOI DOI 10.1177/154193120605000909; Hart S. G., 1988, HUMAN MENTAL WORKLOA, V1, P139, DOI DOI 10.1016/S0166-4115(08)62386-9; Kantowitz B. H., 2000, P HUM FACT ERG SOC A, V44, P3; Kantowitz B. H., 1988, MENTAL STATE ESTIMAT, P179; Marteniuk R. G., 1976, INFORM PROCESSING MO; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037//0033-295X.101.2.343; Akizuki K, 2014, RES Q EXERCISE SPORT, V85, P502, DOI 10.1080/02701367.2014.961052; Reid G.B., 1988, ADV PSYCHOL, V52, P185, DOI DOI 10.1016/S0166-4115(08)62387-0; ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; WASSERMA.K, 1973, J APPL PHYSIOL, V35, P236; Wickens C. D., 1992, ENG PSYCHOL HUMAN PE; Wickens C.D., 1984, VARIETIES ATTENTION, P63	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	OCT	2015	43						107	117		10.1016/j.humov.2015.07.007		11	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CS5PW	WOS:000362131400012		
J	Kondo, T; Saeki, M; Hayashi, Y; Nakayashiki, K; Takata, Y				Kondo, Toshiyuki; Saeki, Midori; Hayashi, Yoshikatsu; Nakayashiki, Kosei; Takata, Yohei			Effect of instructive visual stimuli on neurofeedback training for motor imagery-based brain-computer interface	HUMAN MOVEMENT SCIENCE			English	Article						Brain-computer interface; Motor imagery; Event-related desynchronization; Neurofeedback training	EVENT-RELATED DESYNCHRONIZATION; FUNCTIONAL ELECTRICAL-STIMULATION; VIRTUAL-REALITY; EEG; MOVEMENTS; STROKE; REHABILITATION; COMMUNICATION	Event-related desynchronization (ERD) of the electroencephalogram (EEG) from the motor cortex is associated with execution, observation, and mental imagery of motor tasks. Generation of ERD by motor imagery (MI) has been widely used for brain-computer interfaces (BCIs) linked to neuroprosthetics and other motor assistance devices. Control of MI-based BCIs can be acquired by neurofeedback training to reliably induce MI-associated ERD. To develop more effective training conditions, we investigated the effect of static and dynamic visual representations of target movements (a picture of forearms or a video clip of hand grasping movements) during the BCI neurofeedback training. After 4 consecutive training days, the group that performed MI while viewing the video showed significant improvement in generating MI-associated ERD compared with the group that viewed the static image. This result suggests that passively observing the target movement during MI would improve the associated mental imagery and enhance MI-based BCIs skills. (C) 2014 Elsevier B.V. All rights reserved.	[Kondo, Toshiyuki; Saeki, Midori; Nakayashiki, Kosei] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Koganei, Tokyo 1848588, Japan; [Hayashi, Yoshikatsu] Univ Reading, Sch Syst Engn, Brain Embodiment Lab, Reading RG6 6AY, Berks, England; [Takata, Yohei] Hamamatsu Photon KK, Branch 5000, Hamamatsu, Shizuoka 4348601, Japan	Kondo, T (reprint author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	t_kondo@cc.tuat.ac.jp	Kondo, Toshiyuki/B-9972-2013	Kondo, Toshiyuki/0000-0001-8200-9276	JSPS KAKENHI [23300216, 26120005]; MEXT Fund for Smart Space Technology toward Sustainable Society	The research was partially supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (B) (Grant No. 23300216) and for Scientific Research on Innovative Areas (Grant No. 26120005), and MEXT Fund for Smart Space Technology toward Sustainable Society.	Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Alegre M, 2002, NEUROSCI LETT, V331, P29, DOI 10.1016/S0304-3940(02)00825-X; Crow JL, 2008, PHYS THER, V88, P1554, DOI 10.2522/ptj.20070186; Daly I, 2012, PATTERN RECOGN, V45, P2123, DOI 10.1016/j.patcog.2011.04.034; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Pfurtscheller G, 2007, PRESENCE-TELEOP VIRT, V16, P111, DOI 10.1162/pres.16.1.111; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Zhao QB, 2009, CHINESE SCI BULL, V54, P78, DOI 10.1007/s11434-008-0547-3; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Leeb R, 2007, IEEE T NEUR SYS REH, V15, P473, DOI 10.1109/TNSRE.2007.906956; Takata Y, 2012, IEEE ENG MED BIO, P4619, DOI 10.1109/EMBC.2012.6346996; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Pfurtscheller G, 2008, COMPUTER, V41, P58, DOI 10.1109/MC.2008.432; Nakayashiki K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-90; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Ono T, 2013, CLIN NEUROPHYSIOL, V124, P1779, DOI 10.1016/j.clinph.2013.03.006; Formaggio E, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-24; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00060; Leeb R., 2007, COMPUT INTEL NEUROSC, V2007, P1, DOI DOI 10.1155/2007/79642; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Lotte F, 2013, FRONT HUM NEUROSCI, V7, P1, DOI DOI 10.3389/FNHUM.2013.00568; Takahashi M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-56	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	OCT	2015	43						239	249		10.1016/j.humov.2014.08.014		11	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CS5PW	WOS:000362131400025		
J	Imamura, H; Ohishi, Y; Aman, M; Shida, K; Shinozaki, T; Yasutake, N; Sonoda, K; Kato, K; Oda, Y				Imamura, Hiroko; Ohishi, Yoshihiro; Aman, Murasaki; Shida, Kaai; Shinozaki, Tomoko; Yasutake, Nobuko; Sonoda, Keno; Kato, Kiyoko; Oda, Yoshinao			Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor	HUMAN PATHOLOGY			English	Article						Ovarian high-grade serous carcinoma; Ovarian serous borderline tumor; Noninvasive growth pattern; Nuclear grade; TP53 mutation	MOLECULAR-GENETIC-ANALYSIS; INTRAEPITHELIAL CARCINOMA; TP53 MUTATIONS; P53; EXPRESSION; NEOPLASMS; MARKER; ABNORMALITIES; FIMBRIA; LESIONS	Ovarian serous borderline tumors (SBTs) being a precursor of low-grade serous carcinomas are morphologically characterized by noninvasive growth and low-grade cytology. On the other hand, many pathologists regard cytologically high-grade, noninvasive (HG-noninv) ovarian serous tumors resembling SBTs in low magnification as conventional high-grade serous carcinomas (HGSCs) by personal experiences. Nonetheless, there are no established molecular characteristic of such tumors. In this study, therefore, we attempted to provide the molecular evidence. We selected 37 ovarian serous tumors that exhibited a cytologically HG-noninv growth pattern, including 36 tumors that coexisted with conventional invasive HGSC components (HG-inv) and a single tumor exclusively composed of pure HG-noninv. Histologically, all HG-noninv showed many mitotic figures, and serous tubal intraepithelial carcinomas were identified in 3 tumors with HG-noninv. Immunohistochemically, most HG-noninv showed aberrant p53 expression, frequent IMP3 positivity, p16 overexpression, a high MIB-1 labeling index, and infrequent PAX2. By molecular analysis, the pure HG-noninv and 13 HGSCs with HG-noninv showed TP53 mutations, but KRASIBRAF mutations were not detected in any of them. In 1 tumor, we detected an identical TP53 mutation in both HG-noninv and HG-inv components by using laser capture microdissection. These immunohistochemical and molecular features of HG-noninv were similar to those of conventional invasive HGSCs but different from those of SBTs. In conclusion, our results showed that a cytologically HG-noninv growth pattern simulating an SBT is a morphological spectrum of HGSC, but not a true SBT. (C) 2015 Elsevier Inc. All rights reserved.	[Imamura, Hiroko; Ohishi, Yoshihiro; Aman, Murasaki; Shida, Kaai; Shinozaki, Tomoko; Yasutake, Nobuko; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Sonoda, Keno; Kato, Kiyoko] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka 8128582, Japan	Oda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [26460419]	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (26460419), Tokyo, Japan.	Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Gurung A, 2013, HISTOPATHOLOGY, V62, P59, DOI 10.1111/his.12033; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Kuhn E, 2010, AM J SURG PATHOL, V34, P829, DOI 10.1097/PAS.0b013e3181dcede7; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8; Altman AD, 2013, MODERN PATHOL, V26, P1255, DOI 10.1038/modpathol.2013.55; Laury AR, 2011, AM J SURG PATHOL, V35, P1759, DOI 10.1097/PAS.0b013e318233b0f7; Tung CS, 2009, MODERN PATHOL, V22, P1243, DOI 10.1038/modpathol.2009.92; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; Allred DC, 1998, MODERN PATHOL, V11, P155; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Fujita K, 2011, AM J SURG PATHOL, V35, P295, DOI 10.1097/PAS.0b013e318205df36; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Medeiros F, 2006, AM J SURG PATHOL, V30, P230, DOI 10.1097/01.pas.0000180854.28831.77; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Chene G, 2013, CLIN CANCER RES, V19, P2873, DOI 10.1158/1078-0432.CCR-12-3947; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Dehari R, 2007, AM J SURG PATHOL, V31, P1007, DOI 10.1097/PAS.0b013e31802cbbe9; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Seidman JD, 2004, HUM PATHOL, V35, P918, DOI 10.1016/j.humpath.2004.03.004; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Morimatsu K, 2013, HUM PATHOL, V44, P1714, DOI 10.1016/j.humpath.2012.12.020; Boyd C, 2012, AM J SURG PATHOL, V36, P368, DOI 10.1097/PAS.0b013e31823732a9; Kobel M, 2010, J PATHOL, V222, P191, DOI 10.1002/path.2744; Oda Y, 2000, MODERN PATHOL, V13, P994, DOI 10.1038/modpathol.3880180; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Kurman RJ, 2014, WHO CLASSIFICATION T; Scully RE, 1999, COLLABORATION SOBIN; Scully RE, 1999, ATLAS TUMOR PATHOLOG, V23; Serov SF, 1973, COLLABORATION SOBIN; Tavassoli F.A., 2003, WHO CLASSIFICATION T	34	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	OCT	2015	46	10					1455	1463		10.1016/j.humpath.2015.06.002		9	Pathology	Pathology	CS4QQ	WOS:000362061400006		
J	Inukai, M; Flara, A; Yasui, Y; Kumabe, T; Matsumoto, T; Saegusa, M				Inukai, Madoka; Flara, Atsuko; Yasui, Yoshie; Kumabe, Toshihiro; Matsumoto, Toshihide; Saegusa, Makoto			Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1 alpha/Akt axis in glioblastoma	HUMAN PATHOLOGY			English	Article						Cancer stem cell; Pseudopalisade; HIF-1 alpha; Akt; Glioblastoma	ENDOTHELIAL GROWTH-FACTOR; BRAIN; ANGIOGENESIS; EXPRESSION; APOPTOSIS; PATHWAY; GLIOMAS; DIFFERENTIATION; ASTROCYTOMAS; DISCRIMINATE	Pseudopalisades (Ps) around necrotic foci are severely hypoxic and overexpress hypoxia-inducible factor (HIF) in glioblastoma (GBM). Hypoxic regions have been proposed as one of several distinct niches for cancer stem cells (CSCs) in GBM, but little is known about the association between Ps features and CSC properties. Herein, we focused on the biological role of Ps lesions. In clinical cases of GBM, expression of hypoxia-related molecules including HIF-1 alpha, Glut-1, p271(Kip1), and pAkt was significantly increased in perinecrotic Ps lesions compared with nonnecrotic areas and perinecrolic lesions lacking Ps features. Significantly higher expression levels of several CSC-related markers, including CD133, Sox2, CD44s, and aldehyde dehydrogenase (ALDH) 1, were also observed in Ps lesions, which were positively correlated with expression of hypoxia-related molecules and pAkt. Ps lesions also showed increased number of apoptotic cells and decreased bc1-2 and survivin expression compared with the surrounding tissue. Short-term exposure of astrocytoma cell lines to cobalt chloride, which is known to mimic the effect of hypoxia, caused an increase in expression of both hypoxia- and CSC-related markers, in line with increases in the ALDH(high) cell population and number of spheroids. Inhibition of endogenous Akt by LY294002 resulted in decreased expression of Sox2, ALDH1, and CD133, leading to enhancement of cobalt chloride mediated apoptotic events due to altered ratio of bcl-2 to bax expression. These findings suggest that Ps lesions within GBM may serve as a specialized hypoxic niche, in which the HIF-1 alpha/pAkt axis is activated, in response to severe hypoxia. (C) 2015 Elsevier Inc. All rights reserved.	[Inukai, Madoka; Flara, Atsuko; Matsumoto, Toshihide; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2520374, Japan; [Inukai, Madoka; Yasui, Yoshie; Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 2520374, Japan	Saegusa, M (reprint author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	msaegusa@med.kitasato-u.ac.jp			JSPS KAKENHI [25670179]	This study was supported by a grant from JSPS KAKENHI (Grant No. 25670179).	Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; DAUMASDUPORT C, 1988, CANCER, V62, P2152, DOI 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Peoc'h M, 2002, ANTICANCER RES, V22, P2147; McCarthy BJ, 2002, NEURO-ONCOLOGY, V4, P134, DOI 10.1215/15228517-4-2-134; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Mao XG, 2009, CELL MOL NEUROBIOL, V29, P141, DOI 10.1007/s10571-008-9310-1; Tazo Y, 2014, J CANCER RES CLIN, V140, P2027, DOI 10.1007/s00432-014-1762-8; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Gupta M, 2005, AM J CLIN PATHOL, V124, P755, DOI 10.1309/6JNX4PA0TQ5U5VG; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Studer L, 2000, J NEUROSCI, V20, P7377; Sathornsumetee S, 2006, EXPERT REV ANTICANC, V6, P1087, DOI 10.1586/14737140.6.7.1087; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(04)94002-X; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Yoshida T, 2013, LAB INVEST, V93, P1184, DOI 10.1038/labinvest.2013.111; Ling X, 2007, J BIOL CHEM, V282, P27204, DOI 10.1074/jbc.M705161200; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Eavans SM, 2004, CLIN CANCER RES, V10, P8177; Kerr RJ, 1994, CANCER, V73, P2013; Scheithauer BW, 2007, WHO CLASSIFICATION T, P13; Tsugeno Y, 2014, BIOMED REP, V2, P644	38	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	OCT	2015	46	10					1496	1505		10.1016/j.humpath.2015.06.008		10	Pathology	Pathology	CS4QQ	WOS:000362061400011		
J	Kamoda, H; Kitazawa, S; Kukutsu, N; Kobayashi, K				Kamoda, Hirokazu; Kitazawa, Shoichi; Kukutsu, Naoya; Kobayashi, Kiyoshi			Loop Antenna Over Artificial Magnetic Conductor Surface and Its Application to Dual-Band RF Energy Harvesting	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Energy harvesting; impedance matching; periodic structures; rectennas; UHF antennas	EBG REFLECTION PHASE; DIPOLE ANTENNA; IMPEDANCE; ARRAYS	This paper studies loop antennas over artificial magnetic conductor (AMC) surfaces with the objective of designing a dual-band RF energy harvesting antenna. The AMC surface is well known to achieve low-profile and higher gain wire antennas. From a practical point of view, impedance matching is of paramount importance to achieve highly efficient reception of weak ambient RF energy. First, the driving-point impedance of a loop antenna over an AMC surface was studied, where a conventional method using image theory to estimate the impedance was found to be not always useful for loop antennas. As the AMC surface is within the reactive near field, mutual coupling between the antenna and the AMC unit cells is significant, which the conventional method does not take into account. Then, we proposed a novel use of a polarization-dependent AMC surface for dual-band RF energy harvesting. An AMC surface with a rectangular unit cell was adopted for two orthogonal polarizations with different frequencies. Finally, the AMC surface and the loop antennas were successfully implemented as a dual-band energy harvesting panel together with RF-to-dc conversion circuits and a power management circuit.	[Kamoda, Hirokazu] Adv Telecommun Res Inst Int ATR, Wave Engn Labs, Kyoto 6190288, Japan; [Kitazawa, Shoichi; Kukutsu, Naoya; Kobayashi, Kiyoshi] ATR, Wave Engn Labs, Kyoto 6190288, Japan	Kamoda, H (reprint author), NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578510, Japan.	kamoda@ieee.org			Japan Ministry of Internal Affairs and Communications; fund of "Research and Development of Radio Wave Energy Harvesting"	This work was supported by Japan Ministry of Internal Affairs and Communications with the fund of "Research and Development of Radio Wave Energy Harvesting."	Yang F, 2005, IEEE T ANTENN PROPAG, V53, P3083, DOI 10.1109/TAP.2005.854536; Mikeka C, 2009, EURO WIREL TECHNOL C, P73; Sievenpiper D, 1999, IEEE T MICROW THEORY, V47, P2059, DOI 10.1109/22.798001; Pinuela M, 2013, IEEE T MICROW THEORY, V61, P2715, DOI 10.1109/TMTT.2013.2262687; Sample A, 2009, IEEE RADIO WIRELESS, P16; Abedin MF, 2005, IEEE T ANTENN PROPAG, V53, P3664, DOI 10.1109/TAP.2005.858584; Hagerty JA, 2004, IEEE T MICROW THEORY, V52, P1014, DOI 10.1109/TMTT.2004.823585; Azad MZ, 2008, IEEE T ANTENN PROPAG, V56, P1242, DOI 10.1109/TAP.2008.922673; Sakaki H, 2013, 2013 IEEE WIRELESS POWER TRANSFER (WPT), P187; Collado A, 2014, IEEE MICROW WIREL CO, V24, P354, DOI 10.1109/LMWC.2014.2309074; Yang F, 2003, IEEE T ANTENN PROPAG, V51, P2691, DOI 10.1109/TAP.2003.817559; McMichael IT, 2013, IEEE T ANTENN PROPAG, V61, P2411, DOI 10.1109/TAP.2013.2244552; Kim S, 2014, P IEEE, V102, P1649, DOI 10.1109/JPROC.2014.2357031; Zhang Y, 2003, IEEE T ANTENN PROPAG, V51, P2704, DOI 10.1109/TAP.2003.817550; Goussetis G, 2006, IEEE T ANTENN PROPAG, V54, P82, DOI 10.1109/TAP.2005.861575; Alavikia B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873587; Arai H., 2012, P IEEE INT WORKSH AN, P169; Arrawatia M, 2015, IEEE T ANTENN PROPAG, V63, P1581, DOI 10.1109/TAP.2015.2399939; Kitazawa S., 2014, P MICR WORKSH EXH YO; Kitazawa S., 2012, P IEEE MTT S INT MIC, P39; Mavaddat A, 2015, IEEE ANTENN WIREL PR, V14, P515, DOI 10.1109/LAWP.2014.2370103; Ullah S., 2009, P LOUGHB ANT PROP C, P637; Yang F., 2003, IEEE AP S INT S, V3, P339; Yoshida Y., 2015, P IEICE GEN C KUS JA; Zhan S., 2007, P IEEE MTT S INT MIC, P1659	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	OCT	2015	63	10					4408	4417		10.1109/TAP.2015.2459132		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CS8TU	WOS:000362362200017		
J	Drozdik, M; Akimoto, Y; Aguirre, H; Tanaka, K				Drozdik, Martin; Akimoto, Youhei; Aguirre, Hernan; Tanaka, Kiyoshi			Computational Cost Reduction of Nondominated Sorting Using the M-Front	IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTATION			English	Article						Computational cost reduction; data structures; evolutionary computation; K-d tree; many-objective optimization; multiobjective optimization; nearest neighbor searches; nondominated sorting; Pareto optimization	MULTIOBJECTIVE OPTIMIZATION; DIFFERENTIAL EVOLUTION; NSGA-II	Many multiobjective evolutionary algorithms rely on the nondominated sorting procedure to determine the relative quality of individuals with respect to the population. In this paper, we propose a new method to decrease the cost of this procedure. Our approach is to determine the nondominated individuals at the start of the evolutionary algorithm run and to update this knowledge as the population changes. In order to do this efficiently, we propose a special data structure called the M-front, to hold the nondominated part of the population. The M-front uses the geometric and algebraic properties of the Pareto dominance relation to convert orthogonal range queries into interval queries using a mechanism based on the nearest neighbor search. These interval queries are answered using dynamically sorted linked lists. Experimental results show that our method can perform significantly faster than the state-of-the-art Jensen-Fortin's algorithm, especially in many-objective scenarios. A significant advantage of our approach is that, if we change a single individual in the population we still know which individuals are dominated and which are not.	[Drozdik, Martin] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Nagano 3808553, Japan; [Akimoto, Youhei; Aguirre, Hernan; Tanaka, Kiyoshi] Shinshu Univ, Fac Engn, Nagano 3808553, Japan	Drozdik, M (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Nagano 3808553, Japan.	martin@iplab.shinshu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Manuscript received April 9, 2014; revised August 11, 2014; accepted October 1, 2014. Date of publication October 31, 2014; date of current version September 29, 2015. The work of M. Drozdik was supported by the Monbukagakusho Scholarship of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This paper is an expansion and revision of our earlier work [1].	While L, 2012, IEEE T EVOLUT COMPUT, V16, P86, DOI 10.1109/TEVC.2010.2077298; Wagner M, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P687; Drozdik M, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P599; Kukkonen S, 2005, IEEE C EVOL COMPUTAT, P443; Aguirre HE, 2007, EUR J OPER RES, V181, P1670, DOI 10.1016/j.ejor.2006.08.004; Fortin FA, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P615; Kukkonen S, 2006, LECT NOTES COMPUT SC, V4193, P553; Jensen MT, 2003, IEEE T EVOLUT COMPUT, V7, P503, DOI 10.1109/TEVC.2003.817234; KUNG HT, 1975, J ACM, V22, P469, DOI 10.1145/321906.321910; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Tagawa K, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P657; Huband S, 2006, IEEE T EVOLUT COMPUT, V10, P477, DOI 10.1109/TEVC.2005.861417; Schutze O, 2003, LECT NOTES COMPUT SC, V2632, P509; Fieldsend JE, 2003, IEEE T EVOLUT COMPUT, V7, P305, DOI 10.1109/TEVC.2003.810733; Hadka D, 2013, EVOL COMPUT, V21, P231, DOI 10.1162/EVCO_a_00075; McClymont K, 2012, EVOL COMPUT, V20, P1, DOI 10.1162/EVCO_a_00041; David H. A., 2005, BASIC DISTRIBUTION T, P9; de Berg M., 2000, COMPUTATIONAL GEOMET; Deb K., 2005, EVOLUTIONARY MULTIOB, P105, DOI 10.1007/1-84628-137-7_6; Drozdik M., 2014, DATA STRUCTURES; Farina M., 2002, P NAFIPS FLINT INT C, P233; Kukkonen S., 2012, THESIS LAPPEENRANTA; Price K., 2005, DIFFERENTIAL EVOLUTI; Robic T, 2005, LECT NOTES COMPUT SC, V3410, P520; Samet H., 2005, MORGAN KAUFMANN SERI; Toth C., 2004, DISCRETE COMBINATORI; Zitzler E., 1999, THESIS ETH ZURICH SW	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-778X	1941-0026		IEEE T EVOLUT COMPUT	IEEE Trans. Evol. Comput.	OCT	2015	19	5					659	678		10.1109/TEVC.2014.2366498		20	Computer Science, Artificial Intelligence; Computer Science, Theory & Methods	Computer Science	CS8SK	WOS:000362358600004		
J	Cheng, JJ; Cheng, JL; Zhou, MC; Liu, FQ; Gao, SC; Liu, C				Cheng, JiuJun; Cheng, JunLu; Zhou, MengChu; Liu, FuQiang; Gao, ShangCe; Liu, Cong			Routing in Internet of Vehicles: A Review	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Internet of Vehicles; routing; VANET; LTE; WAVE; DSRC; WiMAX; heterogeneous network	AD-HOC NETWORKS; DELAY-TOLERANT NETWORKS; VEHICULAR-NETWORKS; DATA DELIVERY; MAC PROTOCOL; MOBILITY; ENVIRONMENTS; GEOCAST; VANET	This work aims to provide a review of the routing protocols in the Internet of Vehicles (IoV) from routing algorithms to their evaluation approaches. We provide five different taxonomies of routing protocols. First, we classify them based on their transmission strategy into three categories: unicast, geocast, and broadcast ones. Second, we classify them into four categories based on information required to perform routing: topology-, position-, map-, and path-based ones. Third, we identify them in delay-sensitive and delay-tolerant ones. Fourth, we discuss them according to their applicability in different dimensions, i.e., 1-D, 2-D, and 3-D. Finally, we discuss their target networks, i.e., homogeneous and heterogeneous ones. As the evaluation is also a vital part in IoV routing protocol studies, we examine the evaluation approaches, i.e., simulation and real-world experiments. IoV includes not only the traditional vehicular ad hoc networks, which usually involve a small-scale and homogeneous network, but also a much larger scale and heterogeneous one. The composition of classical routing protocols and latest heterogeneous network approaches is a promising topic in the future. This work should motivate IoV researchers, practitioners, and new comers to develop IoV routing protocols and technologies.	[Cheng, JiuJun; Cheng, JunLu] Tongji Univ, Key Lab Embedded Syst & Serv Comp, Minist Educ, Shanghai 200092, Peoples R China; [Zhou, MengChu] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA; [Zhou, MengChu] Tongji Univ, Key Lab Embedded Syst & Serv Comp, Minist Educ, Shanghai 200092, Peoples R China; [Liu, FuQiang] Tongji Univ, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China; [Gao, ShangCe] Toyama Univ, Fac Engn, Toyama 9308555, Japan; [Liu, Cong] Shandong Univ Sci & Technol, Qingdao 266590, Peoples R China	Cheng, JJ (reprint author), Tongji Univ, Key Lab Embedded Syst & Serv Comp, Minist Educ, Shanghai 200092, Peoples R China.	chengjj@tongji.edu.cn; 1233777@tongji.edu.cn; mencghu@ieee.org; fuqiangliu@163.com; gaosc@eng.u-toyama.ac.jp; liucongchina@163.com			ISTCP [2013DFM10100]; U.S. NSF [CMMI-1162482]; National Natural Science Foundation of China [61331009]; NSFC [61472284, 61203325]; Natural Science Foundation Programs of Shanghai [13ZR1443100]	This work was supported in part by ISTCP under Grant 2013DFM10100, by the U.S. NSF under Grant CMMI-1162482, by the National Natural Science Foundation of China (Key Program) under Grant 61331009, by NSFC under Grants 61472284 and 61203325, and by the Natural Science Foundation Programs of Shanghai under Grant 13ZR1443100. The Associate Editor for this paper was J. E. Naranjo. (Corresponding authors: JiuJun Cheng and MengChu Zhou.)	Al-Sultan S., 2014, J NETW COMPUT APPL, V37, P360; Harri J, 2009, IEEE COMMUN SURV TUT, V11, P19, DOI 10.1109/SURV.2009.090403; Nzouonta J, 2009, IEEE T VEH TECHNOL, V58, P3609, DOI 10.1109/TVT.2009.2014455; [Anonymous], 2013, P 2013 6 INT C CONT; Shafiee K, 2011, IEEE J SEL AREA COMM, V29, P534, DOI 10.1109/JSAC.2011.110304; Khanna B, 2013, 2013 IEEE MILITARY COMMUNICATIONS CONFERENCE (MILCOM 2013), P1099, DOI 10.1109/MILCOM.2013.190; Banda L, 2012, IEEE VEH TECHNOL MAG, V7, P77, DOI 10.1109/MVT.2012.2203881; Zhao J, 2008, IEEE T VEH TECHNOL, V57, P1910, DOI 10.1109/TVT.2007.901869; Maihofer C, 2004, IEEE COMMUN SURV TUT, V6, P32, DOI 10.1109/COMST.2004.5342238; Wang ZG, 2007, IEEE T WIREL COMMUN, V6, P478, DOI 10.1109/TWC.2007.04822; Zhu K, 2011, WIREL COMMUN MOB COM, V11, P459, DOI 10.1002/wcm.853; Jerbi M, 2007, IEEE ICC, P3972, DOI 10.1109/ICC.2007.654; Jiang ZH, 2007, INT J COMMUN SYST, V20, P477, DOI 10.1002/dac.837; Jiang ZH, 2007, IEEE T VEH TECHNOL, V56, P3149, DOI 10.1109/TVT.2007.900384; Wang SY, 2007, IEEE VTS VEH TECHNOL, P2081, DOI 10.1109/VETECF.2007.437; Xiang Y, 2013, AD HOC NETW, V11, P2125, DOI 10.1016/j.adhoc.2012.02.015; Chang JJ, 2012, IEEE WIREL COMMUN, V19, P82, DOI 10.1109/MWC.2012.6155880; Akhtar N, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P1774; Lin YW, 2010, J INF SCI ENG, V26, P913; Wisitpongphan N, 2007, IEEE WIREL COMMUN, V14, P84, DOI 10.1109/MWC.2007.4407231; Saleet H, 2011, IEEE T VEH TECHNOL, V60, P4560, DOI 10.1109/TVT.2011.2173510; Amoroso A, 2012, CONSUM COMM NETWORK, P477, DOI 10.1109/CCNC.2012.6181007; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Naja R, 2012, WIRELESS PERS COMMUN, V67, P387, DOI 10.1007/s11277-011-0389-1; Tseng KL, 2013, INT C PAR DISTRIB SY, P582, DOI 10.1109/ICPADS.2013.104; Lee U, 2008, I C NETWORK PROTOCOL, P218; Zhao QW, 2013, IEEE SENS J, V13, P3575, DOI 10.1109/JSEN.2013.2265304; Hung CC, 2008, IEEE WCNC, P2200; Imadali S, 2013, UEEE INT SYM PERS IN, P2940, DOI 10.1109/PIMRC.2013.6666650; Dorge PD, 2012, 2012 INTERNATIONAL CONFERENCE ON RADAR, COMMUNICATION AND COMPUTING (ICRCC), P206, DOI 10.1109/ICRCC.2012.6450578; Bachir A, 2003, IEEE VTS VEH TECHNOL, P2456; Mojela LS, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P1353, DOI 10.1109/ICIT.2013.6505869; Sommer C, 2011, IEEE T MOBILE COMPUT, V10, P3, DOI 10.1109/TMC.2010.133; Karagiannis G, 2011, IEEE COMMUN SURV TUT, V13, P584, DOI 10.1109/SURV.2011.061411.00019; Sommer C, 2012, IEEE VEHIC NETW CONF, P64, DOI 10.1109/VNC.2012.6407446; Chen W, 2005, IEEE COMMUN MAG, V43, P100; Tonguz O, 2007, 2007 MOBILE NETWORKING FOR VEHICULAR ENVIRONMENTS, P7, DOI 10.1109/MOVE.2007.4300825; Fernandes R, 2012, IEEE VEHIC NETW CONF, P195, DOI 10.1109/VNC.2012.6407431; Zhang CZ, 2007, INT J COMMUN SYST, V20, P909, DOI 10.1002/dac.840; Bana S., 2001, P IEEE INT TRANSP SY, P962; Barr R., 2004, JIST SWANS; Bononi L., 2006, P ACM MSWIM 2006 OCT, P28, DOI 10.1145/1164717.1164725; Celes C., 2013, P IEEE FALL VEH TECH, P1; Choffnes D., 2005, P 2 ACM INT WORKSH V, P69, DOI 10.1145/1080754.1080765; Dannheim C., 2013, P AFRICON, P1; Durresi M, 2005, P 11 INT C PAR DISTR, V2, P402; el mouna Zhioua G., 2012, P ACM MSWIM, P353; Enkelmann W., 2003, P IEEE INT VEH S 200, P162; Fang S., 2013, P IEEE ITHINGS CPSCO, P1518; Gorgorin C., 2006, P 20 EUR SIM MOD C, V59, P1; Harri J., 2006, P 3 INT WORKSH VEH A, P96, DOI DOI 10.1145/1161064.1161084; Ho K Y, 2010, COMP COMM CONTR AUT, V2, P522; Hou J., 2005, J SIM OFFICIAL; Huang HY, 2007, IEEE T VEH TECHNOL, V56, P3381, DOI 10.1109/TVT.2007.907273; Ibrahim K., 2008, P IEEE INFOCOM WORKS, P1; Imadali S., 2014, P IEEE 39 LCN WORKSH, P722; Johnson D., 1996, MOBILE COMPUTING, V353, P153, DOI [DOI 10.1007/978-0-585-29603-6_5, DOI 10.1007/978-0-585-29603-6_]; Johnson D., 2011, 6275 RFC; Karp B., 2000, P 6 ANN INT C MOB CO, P243, DOI DOI 10.1145/345910.345953; Kihl M., 2008, J INT ENG, V2, P1; Korkmaz G., 2004, P 1 ACM INT WORKSH V, P76, DOI DOI 10.1145/1023875.1023887; Kumar V, 2010, PHIL MAG LETT, V90, P493, DOI 10.1080/09500831003767005; Lee H., 2007, P IEEE WIR COMM NETW, P4405; Lee S.-J., 1999, WIR COMM NETW C 1999, V3, P1298; Li G, 2013, PROCEEDINGS OF THE 9TH EURO-ASIA CONFERENCE ON ENVIRONMENT AND CSR: TOURISM, SOCIETY AND EDUCATION SESSION (PT II), P49; Li Y. H., 2012, INT J FLOW CONTROL, V4, P1; Lin Q., 2013, P IEEE SENSORS, P1; Lindgren A, 2003, MOBILE COMPUTING COM, V7, P19, DOI DOI 10.1145/961268.961272; Liu J., 2012, P IEEE 12 INT C COMP, P828; Lochert C., 2003, P IEEE INT VEH S, P156, DOI DOI 10.1109/IVS.2003.1212901; Lochert C., 2005, VANET 2005, P87; Lochert C., 2005, ACM SIGMOBILE MOBILE, V9, P69, DOI DOI 10.1145/1055959.1055970; Lynch R. L., 2007, ROADNAV; Maihofer C., 2004, P IEEE INT VEH S PAR, P951; Mangharam R., 2005, P 2 ACM INT WORKSH V, P59, DOI 10.1145/1080754.1080764; Mangharam R., 2006, P 3 ANN INT C MOB UB, P1; Marfia G., 2011, P 4 INT C COGN RAD A, P29; Mehar S., 2012, P IFIP WD, P1; Nagel R., 2008, P 1 ICST BRUSS BELG; Naumov V., 2006, P 7 ACM INT S MOB AD, P108, DOI DOI 10.1145/1132905.1132918; Neves F., 2011, P 8 ACM INT WORKSH V, P89; O'Driscoll A., 2013, P IEEE VNC, P63; Olariu S, 2009, CH CRC COMP INFO SCI, P1, DOI 10.1201/9781420085891; Perkins C.E., 1999, P 2 IEEE WORKSH MOB, V2, P90, DOI DOI 10.1109/MCSA.1999.749281]; Perkins C.E., 1994, COMPUT COMMUN REV, V24, P234, DOI DOI 10.1145/190314.190336; Petrescu A., 2005, 3963 RFC; Pinol P., 2012, P 7 ACM WORKSH PERF, P7; Rahbar H., 2010, P 9 IFIP ANN MED AD, P1; Riverbed Technology, 2013, NETW PLANN SIM OPNET; Shafiee K., 2011, PATTERN ANAL APPL, P1; Simulcraft Inc, 2013, OMNEST; Soares VNGJ, 2014, INFORM FUSION, V15, P102, DOI 10.1016/j.inffus.2011.11.003; Sommer C., 2011, P ACM MOBICOM, P1; Sommer C., 2011, P 8 INT C WIR ON DEM, P84; Sommer C., 2008, P IEEE INFOCOM WORKS, P1; Spyropoulos T., 2005, P ACM SIGCOMM WORKSH, P252, DOI DOI 10.1145/1080139.1080143; Tonguz O. K., 2006, P 3 INT C BROADB COM, P1; Torok A., 2011, P IEEE 73 VTC SPRING, P1; Uppoor S., 2011, P IEEE VNC NOV, P62, DOI 10. 1109/VNC. 2011. 6117125; Uppoor S., 2012, TAPASCOLOGNE SCENARI; Vahdat A., 2000, CS200006 DUK U; Van E. M. Eenennaam, 2008, SURVEY PROPAGATION M; Viriyasitavat W., 2010, P IEEE VNC JERS CIT, V49, P25, DOI DOI 10.1109/VNC.2010.5698266; Vuyyuru R., 2007, P 4 IEEE IFIP WIR DE, P100; Wang Z., 2005, INT J INTELL CONTROL, V10, P86; Wegener A., 2008, P 11 COMM NETW SIM S, P155, DOI 10.1145/1400713.1400740; Yin J., 2004, P 1 ACM INT WORKSH V, P1, DOI 10.1145/1023875.1023877; Yu M, 2009, IEEE T VEH TECHNOL, V58, P449, DOI 10.1109/TVT.2008.923683; Zhang C., 2003, INT J INTELL CONTROL, V8, P8; Zhang H., 2004, IEEE COMMUNICATIONS, V8, P718, DOI 10.1109/LCOMM.2004.837658	110	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	OCT	2015	16	5					2339	2352		10.1109/TITS.2015.2423667		14	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CS4ZI	WOS:000362084600002		
J	Kosaka, N; Ohashi, G				Kosaka, Naoya; Ohashi, Gosuke			Vision-Based Nighttime Vehicle Detection Using CenSurE and SVM	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Intelligent transport systems; nighttime driving scenes; vehicle detection; Center Surround Extremas	TRAFFIC SCENES; TRACKING; ASSISTANCE; ALGORITHM	In this paper, we propose a method for detecting vehicles from a nighttime driving scene taken by an in-vehicle monocular camera. Since it is difficult to recognize the shape of the vehicles during nighttime, vehicle detection is based on the headlights and the taillights, which are bright areas of pixels called blobs. Many research studies using automatic multilevel thresholding are being conducted, but these methods are prone to get affected by the ambient light because it uses the luminance of the whole image to derive the thresholds. Owing to such reasons, we focused on the Laplacian of Gaussian operator, which derives the response of luminance difference between the blob and its surroundings. Compared with automatic multilevel thresholding, Laplacian of Gaussian operator is more robust to the ambient light. However, the computational cost to derive the response of this operator is large. Therefore, we used a method called Center Surround Extremas to detect the blobs in high speed. Since the detected blobs include nuisance lights, we had to determine whether the blob is a light of a vehicle or not. Thus, we classified them according to the features of the blob using support vector machines. Then, we detected vehicle traffic lane and specified the region where the vehicle may exist. Finally, we classified the blobs based on the movements across the frames. We applied the proposed method to nighttime driving sequences and confirmed the effectiveness of the classification process used in this method and that it could process within frame rate.	[Kosaka, Naoya; Ohashi, Gosuke] Shizuoka Univ, Dept Elect & Elect Engn, Hamamatsu, Shizuoka 4328561, Japan	Kosaka, N (reprint author), Shizuoka Univ, Dept Elect & Elect Engn, Hamamatsu, Shizuoka 4328561, Japan.	tegooha@ipc.shizuoka.ac.jp					Alcantarilla P., 2008, P IEEE INT VEH S EIN, P291; Alonso D., 2007, P IEEE INT C IM PROC, V4, P321; Sun ZH, 2006, IEEE T PATTERN ANAL, V28, P694; Yuan QA, 2011, IEEE T PATTERN ANAL, V33, P514, DOI 10.1109/TPAMI.2010.117; [Anonymous], 2013, P IEEE INT VEH S 4 J; Chen YL, 2012, SENSORS-BASEL, V12, P2373, DOI 10.3390/s120302373; Alcantarilla PF, 2011, MACH VISION APPL, V22, P819, DOI 10.1007/s00138-011-0327-y; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Sun ZH, 2006, IEEE T IMAGE PROCESS, V15, P2019, DOI 10.1109/TIP.2006.877062; Arrospide J, 2013, IEEE T IMAGE PROCESS, V22, P2286, DOI 10.1109/TIP.2013.2249080; O'Malley R, 2010, IEEE T INTELL TRANSP, V11, P453, DOI 10.1109/TITS.2010.2045375; Rebut J, 2009, ISIE: 2009 IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS, P311; Wang JQ, 2013, SENSORS-BASEL, V13, P16474; Betke M, 2000, MACH VISION APPL, V12, P69, DOI 10.1007/s001380050126; Wang Y, 2004, IMAGE VISION COMPUT, V22, P269, DOI 10.1016/j.imavis.2003.10.003; Guo JB, 2014, SENSORS-BASEL, V14, P15325, DOI 10.3390/s140815325; Liao PS, 2001, J INF SCI ENG, V17, P713; Agrawal M, 2008, LECT NOTES COMPUT SC, V5305, P102, DOI 10.1007/978-3-540-88693-8_8; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Chang C., 2001, ACM T INTEL SYST TEC, V27, P27; Chen Y.L., 2009, WSEAS T COMPUT, V8, P506; Choi J., 2006, REALTIME ON ROAD VEH; Kang DJ, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P189; Kim H., 2010, P INT C COMP EL SYST, P54; Korogi N., 2004, IEICE TECHNICAL REPO, V104, P7; Lpez A., 2008, P 2 WORKSH PLANN PER, P59; Niwattanakul S, 2013, P INT MULT ENG COMP, VI, P380; Ogura R., 2012, P 1 IEEE GLOB C CONS, P690; Sivaraman S, 2010, IEEE T INTELL TRANSP, V11, P267, DOI 10.1109/TITS.2010.2040177	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	OCT	2015	16	5					2599	2608		10.1109/TITS.2015.2413971		10	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CS4ZI	WOS:000362084600025		
J	Rezaei, M; Terauchi, M; Klette, R				Rezaei, Mahdi; Terauchi, Mutsuhiro; Klette, Reinhard			Robust Vehicle Detection and Distance Estimation Under Challenging Lighting Conditions	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Advanced driver assistance systems; vehicle detection; distance estimation; tail-light segmentation; symmetry detection; challenging lighting condition; global Haar-like features; horizontal edge detection; rear-end crashes; collision avoidance; Dempster-Shafer fusion	PROBABILISTIC HOUGH TRANSFORM; OBJECT DETECTION; LANE DETECTION; FEATURES; TRACKING; SYSTEM; LINES	Avoiding high computational costs and calibration issues involved in stereo-vision-based algorithms, this paper proposes real-time monocular-vision-based techniques for simultaneous vehicle detection and inter-vehicle distance estimation, in which the performance and robustness of the system remain competitive, even for highly challenging benchmark datasets. This paper develops a collision warning system by detecting vehicles ahead and, by identifying safety distances to assist a distracted driver, prior to occurrence of an imminent crash. We introduce adaptive global Haar-like features for vehicle detection, tail-light segmentation, virtual symmetry detection, inter-vehicle distance estimation, as well as an efficient single-sensor multifeature fusion technique to enhance the accuracy and robustness of our algorithm. The proposed algorithm is able to detect vehicles ahead at both day or night and also for short-and long-range distances. Experimental results under various weather and lighting conditions (including sunny, rainy, foggy, or snowy) show that the proposed algorithm outperforms state-of-the-art algorithms.	[Rezaei, Mahdi] Islamic Azad Univ, Qazvin Branch, Fac Comp & Informat Technol Engn, Qazvin 341851416, Iran; [Terauchi, Mutsuhiro] Hiroshima Int Univ, Dept Psychol, Hiroshima 7300016, Japan; [Klette, Reinhard] Auckland Univ Technol, Dept Elect & Comp Engn, Sch Engn, Auckland 1010, New Zealand	Rezaei, M (reprint author), Islamic Azad Univ, Qazvin Branch, Fac Comp & Informat Technol Engn, Qazvin 341851416, Iran.	m.rezaei@auckland.ac.nz; mucha@he.hirokoku-u.ac.jp; r.klette@auckland.ac.nz					Ali A., 2005, P IEEE INT C INF COM, P346; Sun ZH, 2006, IEEE T PATTERN ANAL, V28, P694; Geiger A, 2012, PROC CVPR IEEE, P3354, DOI 10.1109/CVPR.2012.6248074; [Anonymous], 2012, P IEEE INT VEH S; Papageorgiou C, 2000, INT J COMPUT VISION, V38, P15, DOI 10.1023/A:1008162616689; [Anonymous], 2013, DISTRONIC PLUS STEER; Santos D, 2009, 2009 10TH INTERNATIONAL WORKSHOP ON IMAGE ANALYSIS FOR MULTIMEDIA INTERACTIVE SERVICES, P137, DOI 10.1109/WIAMIS.2009.5031451; Viola P, 2001, PROC CVPR IEEE, P511; Vargas M, 2010, IEEE T VEH TECHNOL, V59, P3694, DOI 10.1109/TVT.2010.2058134; Rublee E, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P2564, DOI 10.1109/ICCV.2011.6126544; Yao W, 2011, IEEE GEOSCI REMOTE S, V8, P607, DOI 10.1109/LGRS.2010.2097239; Garcia F, 2012, 2012 IEEE INTELLIGENT VEHICLES SYMPOSIUM (IV), P494, DOI 10.1109/IVS.2012.6232199; Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; Haselhoff A, 2009, IEEE INT VEH SYM, P261, DOI 10.1109/IVS.2009.5164288; Matas J, 2000, COMPUT VIS IMAGE UND, V78, P119, DOI 10.1006/cviu.1999.0831; Gu HZ, 2013, MACH VISION APPL, V24, P255, DOI 10.1007/s00138-012-0414-8; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; O'Malley R, 2010, IEEE T INTELL TRANSP, V11, P453, DOI 10.1109/TITS.2010.2045375; Haar A, 1910, MATH ANN, V69, P331, DOI 10.1007/BF01456326; Jiang RY, 2009, LECT NOTES COMPUT SC, V5702, P1044; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Briechle K, 2001, P SOC PHOTO-OPT INS, V4387, P95, DOI 10.1117/12.421129; Felzenszwalb PF, 2010, PROC CVPR IEEE, P2241, DOI 10.1109/CVPR.2010.5539906; Huang LL, 2009, IEEE INT VEH SYM, P604, DOI 10.1109/IVS.2009.5164346; Dalal N, 2005, PROC CVPR IEEE, P886; Toulminet G, 2006, IEEE T IMAGE PROCESS, V15, P2364, DOI 10.1109/TIP.2006.875174; KIRYATI N, 1991, PATTERN RECOGN, V24, P303, DOI 10.1016/0031-3203(91)90073-E; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Klette R, 2011, IEEE T VEH TECHNOL, V60, P2012, DOI 10.1109/TVT.2011.2148134; Qian ZM, 2011, ADV MATER RES-SWITZ, V186, P56, DOI 10.4028/www.scientific.net/AMR.186.56; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430; Liu YK, 2005, PATTERN RECOGN, V38, P553, DOI 10.1016/j.patcog.2004.08.017; Bai H., 2006, P INT C MULT MOD BEI, P356; Choi J., 2006, REALTIME ON ROAD VEH; Crow F. C., 1984, SIGGRAPH COMPUT GRAP, V18, P207, DOI DOI 10.1145/800031.808600; EPFL University Computer Vision Laboratory, 2012, EPFL MULT CAR DAT; Freeman H., 1961, Institute of Radio Engineers Transactions on Electronic Computers, VEC-10; Han S., 2009, P WORLD ACAD SCI ENG, P455; Haselhoff A., 2007, P EUR ASS SIGN PROC, P2070; Hermann S., 2012, LNCS, V7726, P465; Jazayeri A., 2012, IEEE T INTELL TRANSP, V12, P583; Kim Z, 2008, IEEE T INTELL TRANSP, V9, P16, DOI 10.1109/TITS.2007.908582; Klette R., 2014, CONCISE COMPUTER VIS; Koks D., 2005, DSTOTR1436 SYST SCI; Moutarde F., 2008, P WORKSH PLANN PERC, P70; National Highway Traffic Safety Administration, 2012, TRAFF SAF FACTS; Nguyen T. T., 2007, P IEEE INT C RES INN, P87; Nguyen V. D., 2012, P IEEE VEH TECH C, P1; O'Malley R., 2008, P INT S VEH COMP SYS, P128; Philip B., 2001, CALTECH VEHICLE DATA; Premebida C., 2007, P IEEE INT C INT TRA, P1044; Rezaei M., 2012, LNCS, V7729, P427; Rezaei M., 2014, IROADS DATASET INTER; Rezaei M., 2014, P IEEE CVPR, P129; Rezaei M, 2014, LECT NOTES COMPUT SC, V8333, P302, DOI 10.1007/978-3-642-53842-1_26; Rezaei M., 2011, INT J IMAGE DATA FUS, V2, P217; Shafer G., 1976, MATH THEORY EVIDENCE; Tuohy S., 2010, P IET IR SIGN SYST C, P100; Wen X., 2007, P IEEE C INT TRANSP, P1050; Xu Z., 2013, LNCS, V8333, P111; Zoratti P. K., 2011, WP399 XILINX XA SPAR	62	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	OCT	2015	16	5					2723	2743		10.1109/TITS.2015.2421482		21	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	CS4ZI	WOS:000362084600035		
J	Minh, HL; Ghassemlooy, Z; Pham, AT				Hoa Le Minh; Ghassemlooy, Zabih; Pham, Anh T.			Guest Editorial: Special Issue on Optical-Wireless Communications	IET OPTOELECTRONICS			English	Editorial Material						laser beams; optical design techniques; optical links; optical transceivers; visible spectra; optical modulation; wireless channels; optical-wireless communications; visible light communcation; modulation bandwidth; colour spectrum; high speed data communications; optical integration; body area networks; optical fibre communication system; IEEE 802; 15; 7r1; link-performance analysis; free space optic systems; channel turbulence; optical system design; optical intensity distribution; radiated laser beam; photonic-based multiband RF transceiver; reconfigurable multiband RF transceiver; OWC networks			[Hoa Le Minh; Ghassemlooy, Zabih] Northumbria Univ, Fac Engn & Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Pham, Anh T.] Univ Aizu, Comp Commun Lab, Aizu Wakamatsu, Fukushima, Japan	Minh, HL (reprint author), Northumbria Univ, Fac Engn & Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.							0	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8768	1751-8776		IET OPTOELECTRON	IET Optoelectron.	OCT	2015	9	5			SI		169	171		10.1049/iet-opt.2015.0094		3	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CS3CS	WOS:000361949600001		
J	Pham, HTT; Trinh, PV; Dang, NT; Pham, AT				Pham, Hien T. T.; Trinh, Phuc V.; Dang, Ngoc T.; Pham, Anh T.			Secured relay-assisted atmospheric optical code-division multiple-access systems over turbulence channels	IET OPTOELECTRONICS			English	Article						code division multiplexing; atmospheric turbulence; error statistics; optical communication; atmospheric optics; secured relay-assisted atmospheric optical code-division multiple-access systems; secured multiuser optical communications; chip detect-and-forward scheme; bit-error rate; transmission confidentiality; atmospheric turbulence channel; atmospheric attenuation; beam divergence; multiple-access interference; background noise; relay transmission	CDMA COMMUNICATION-SYSTEMS; PERFORMANCE ANALYSIS; FSO/CDMA SYSTEMS; BER PERFORMANCE; DIVERSITY; WIRELESS; NETWORKS	The authors propose a relay-assisted atmospheric optical code-division multiple-access (AO/CDMA) system for secured, multiuser optical communications. Chip detect-and-forward (CDF) scheme is used at relay nodes so that the complex multiuser decoding process can be avoided. The proposed system performance, in terms of bit-error rate (BER) and transmission confidentiality, is analysed over atmospheric turbulence channel taking into account channel loss due to atmospheric attenuation and beam divergence. Multiple-access interference and background noise are also included in the analysis. In addition, a quantitative analysis of data confidentiality is further examined in the study. The numerical results show that the relay transmission is an efficient solution to improve the system performance. Thanks to this solution, AO/CDMA systems can achieve low BER, long distance, and a large number of users. Moreover, high confidentiality can be attained by properly configuring system parameters, such as limiting the transmitted power and/or reducing the signal beam width.	[Pham, Hien T. T.] Posts & Telecommun Inst Technol, Dept Opt Commun, Hanoi 100000, Vietnam; [Trinh, Phuc V.] Univ Aizu, Comp & Informat Syst, Aizu Wakamatsu, Fukushima 9658580, Japan; [Dang, Ngoc T.] Posts & Telecommun Inst Technol, Dept Opt Commun, Hanoi 150000, Vietnam; [Pham, Anh T.] Univ Aizu, Comp Engn, Aizu Wakamatsu, Fukushima 9658580, Japan	Pham, HTT (reprint author), Posts & Telecommun Inst Technol, Dept Opt Commun, Km 10,Nguyen Trai Rd, Hanoi 100000, Vietnam.	hienptt@ptit.edu.vn			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [102.02-2013.02]	This research was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant no. 102.02-2013.02.	Miyazawa T, 2007, J LIGHTWAVE TECHNOL, V25, P2992, DOI 10.1109/JLT.2007.905219; Ohtsuki T, 2003, J LIGHTWAVE TECHNOL, V21, P406, DOI [10.1109/JLT.2003.808791, 10.1106/JLT.2003.808791]; Navidpour SM, 2007, IEEE T WIREL COMMUN, V6, P2813, DOI 10.1109/TWC.2007.06109; Liu QC, 2005, J OPT NETW, V4, P807, DOI 10.1364/JON.4.000807; Pham AT, 2010, IEICE T FUND ELECTR, VE93A, P2696, DOI 10.1587/transfun.E93.A.2696; Datsikas CK, 2010, J OPT COMMUN NETW, V2, P576, DOI 10.1364/JOCN.2.000576; Farid AA, 2007, J LIGHTWAVE TECHNOL, V25, P1702, DOI 10.1109/JLT.2007.899174; Shake TH, 2005, J LIGHTWAVE TECHNOL, V23, P655, DOI 10.1109/JLT.2004.838844; Chatzidiamantis ND, 2013, J OPT COMMUN NETW, V5, P92, DOI 10.1364/JOCN.5.000092; Dang NT, 2012, OPT EXPRESS, V20, P26786, DOI 10.1364/OE.20.026786; Ricklin JC, 2002, J OPT SOC AM A, V19, P1794, DOI 10.1364/JOSAA.19.001794; Heatley DJT, 1998, IEEE COMMUN MAG, V36, P72, DOI 10.1109/35.735881; Tancevski L, 1996, J LIGHTWAVE TECHNOL, V14, P2636, DOI 10.1109/50.545782; Kashani MA, 2013, J OPT COMMUN NETW, V5, P37, DOI 10.1364/JOCN.5.000037; Meenakshi M, 2005, IEEE PHOTONIC TECH L, V17, P1112, DOI 10.1109/LPT.2005.843935; Zhu XM, 2002, IEEE T COMMUN, V50, P1293, DOI 10.1109/TCOMM.2002.800829; Safari M, 2008, IEEE T WIREL COMMUN, V7, P5441, DOI 10.1109/T-WC.2008.071352; Jazayerifar M, 2006, IEEE T COMMUN, V54, P1614, DOI 10.1109/TCOMM.2006.881245; Simon M. K., 2000, DIGITAL COMMUNICATIO	19	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8768	1751-8776		IET OPTOELECTRON	IET Optoelectron.	OCT	2015	9	5			SI		241	248		10.1049/iet-opt.2014.0148		8	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CS3CS	WOS:000361949600011		
J	Akashi, M; Shibuya, Y; Wanifuchi, S; Kusumoto, J; Sakakibara, A; Kimoto, A; Hasegawa, T; Suzuki, H; Hashikawa, K; Komori, T				Akashi, Masaya; Shibuya, Yasuyuki; Wanifuchi, Satoshi; Kusumoto, Junya; Sakakibara, Akiko; Kimoto, Akira; Hasegawa, Takumi; Suzuki, Hiroaki; Hashikawa, Kazunobu; Komori, Takahide			CT Evaluation of Morphology of Transferred Fibula for Implant Placement in Reconstructed Mandible	IMPLANT DENTISTRY			English	Article						free fibula osteocutaneous flap; dental implant; computed tomography	FREE FLAPS; GRAFTS; EXPERIENCE; SITES; JAW	Background:Dental rehabilitation with osseointegrated implants in reconstructed mandibles remains one of the most challenging procedures for oral and maxillofacial surgeons. Satisfactory outcome requires appropriate assessment of graft morphology. There are few analyses of the morphology of fibulae in reconstructed mandibles, although cadaver studies on fibular shape have been performed.Materials and Methods:In this study, we used postoperative computed tomography to retrospectively evaluate the shape, height, and orientation of fibulae transferred after mandibulectomy in 19 patients.Results:The average height of transferred fibulae was 14.3 mm (range, 10.8-20.5 mm). The cross-sectional morphology of transferred fibulae could be classified into 2 types: apex and nonapex. The former type included knife-edged and triangular shapes; the latter included square and circular shapes.Conclusion:When implant insertion is planned in a reconstructed mandible, the orientation of the apex of transferred fibula should be evaluated preoperatively to allow for adjustments in implant procedure because the ridge at the apex of the fibula is narrow.	[Akashi, Masaya; Wanifuchi, Satoshi; Kusumoto, Junya; Sakakibara, Akiko; Kimoto, Akira; Hasegawa, Takumi; Suzuki, Hiroaki; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo 6500017, Japan; [Shibuya, Yasuyuki] Nagoya City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan; [Hashikawa, Kazunobu] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo 6500017, Japan	Akashi, M (reprint author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo Ku, Kusunoki Cho 7-5-1, Kobe, Hyogo 6500017, Japan.	akashim@med.kobe-u.ac.jp					Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P220, DOI 10.1111/j.1600-0501.2005.01212.x; Nocini PF, 2000, J CRANIO MAXILL SURG, V28, P20, DOI 10.1054/jcms.2000.0106; Anne-Gaelle B, 2011, ORAL ONCOL, V47, P1099, DOI 10.1016/j.oraloncology.2011.07.016; Foster RD, 1999, HEAD NECK-J SCI SPEC, V21, P66, DOI 10.1002/(SICI)1097-0347(199901)21:1<66::AID-HED9>3.0.CO;2-Z; Raoul G, 2009, J CRANIOFAC SURG, V20, P2105, DOI 10.1097/SCS.0b013e3181bec611; [Anonymous], 2013, JPN J HEAD NECK CANC; Tsuchiya S, 2011, HEAD NECK-J SCI SPEC, V33, P383, DOI 10.1002/hed.21460; Hakim SG, 2012, CLIN ORAL INVEST, V16, P673, DOI 10.1007/s00784-011-0582-3; Shen Y, 2013, J PLAST RECONSTR AES, V66, P364, DOI 10.1016/j.bjps.2012.10.005; Urken ML, 1998, ARCH OTOLARYNGOL, V124, P46; Klesper B, 2000, J CRANIO MAXILL SURG, V28, P110, DOI 10.1054/jcms.2000.0122; Choi SW, 2001, INT J ORAL MAX SURG, V30, P329, DOI 10.1054/ijom.2001.0055; Kramer FJ, 2005, CLIN ORAL IMPLAN RES, V16, P80, DOI 10.1111/j.1600-0501.2004.01040.x; Shibuya Y, 2013, J ORAL REHABIL, V40, P484, DOI 10.1111/joor.12066; [Anonymous], 2008, JPN J HEAD NECK CANC; TAYLOR GI, 1975, PLAST RECONSTR SURG, V55, P533, DOI 10.1097/00006534-197505000-00002; Sieg P, 2002, BRIT J ORAL MAX SURG, V40, P322, DOI 10.1016/S0266-4356(02)00134-1; Blus C, 2006, CLIN ORAL IMPLAN RES, V17, P700, DOI 10.1111/j.1600-0501.2006.01206.x; Sonmez TT, 2013, BRIT J ORAL MAX SURG, V51, P736, DOI 10.1016/j.bjoms.2013.07.010; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Bak M, 2010, ORAL ONCOL, V46, P71, DOI 10.1016/j.oraloncology.2009.11.006; Fujisawa M, 1998, ODONTOLOGY, V86, P150; Hakim SG, 2015, CLIN ORAL INVEST, V19, P525, DOI 10.1007/s00784-014-1247-9; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; Levin Lawrence, 2003, Facial Plast Surg, V19, P87, DOI 10.1055/s-2003-39138; Roumanas ED, 2006, J CALIF DENT ASSOC, V9, P711	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	OCT	2015	24	5					541	546		10.1097/ID.0000000000000290		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS5LN	WOS:000362119700007		
J	Nishijo, J; Enomoto, M				Nishijo, Junichi; Enomoto, Masaya			Synthesis, structure and magnetic properties of [CrCyclam (C equivalent to C-6-methoxynaphthalene)(2)](TCNQ)(n)(1,2-dichloroethane) (n=1, 2)	INORGANICA CHIMICA ACTA			English	Article						Acetylide; Magnetism; pi-pi stacking; Chromium complex	NEGATIVE MAGNETORESISTANCE; CHROMIUM(III) COMPLEXES; CHARGE-TRANSFER; CONDUCTOR; LIGANDS	New chromium-acetylide-based magnetic materials, [CrCyclam(C equivalent to C-NaphOMe)(2)](TCNQ)(n)(1,2-dichloroethane) (Cyclam = 1,4,8,11-tetraaza cyclotetradecane, TCNQ = 7,7,8,8-tetracyanoquinodimethane, NaphOMe = 6-methoxynaphthalene, n = 1, 2) were prepared. The crystal structures are characterized by uniform ferrimagnetic chains of [CrCyclam(C equivalent to C-NaphOMe)(2)](+) (S = 3/2) and (TCNQ)(n) (S = 1/2), where pi-pi-stacking between NaphOMe ligands and (TCNQ)(n) units mediates intermolecular exchange interactions. The strengths of the intrachain exchange interactions were estimated to be 2J/kB = -19.5 and -4.6 K for n = 1 and 2, respectively. The observed strengths of the interactions, especially in the case of n = 1, suggest that pi-conjugated acetylide ligands can play an important role in constructing molecule-based magnetic materials. (C) 2015 Elsevier B.V. All rights reserved.	[Nishijo, Junichi] Meisei Univ, Sch Sci & Engn, Hino, Tokyo 1918506, Japan; [Enomoto, Masaya] Tokyo Univ Sci, Dept Chem, Fac Sci, Div 1,Shinjyuku Ku, Tokyo 1628601, Japan	Nishijo, J (reprint author), Meisei Univ, Sch Sci & Engn, 2-1-1 Hodokubo, Hino, Tokyo 1918506, Japan.	jun-ichi.nishijo@meisei-u.ac.jp		Nishijo, Junichi/0000-0002-9779-5481			Uji S, 2001, NATURE, V410, P908, DOI 10.1038/35073531; Nishijo J, 2011, INORG CHEM, V50, P3464, DOI 10.1021/ic102384s; Fan YP, 2015, ACS APPL MATER INTER, V7, P6162, DOI 10.1021/am509074m; FLANDROIS S, 1978, CHEM PHYS LETT, V58, P596, DOI 10.1016/0009-2614(78)80027-X; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Sugawara T, 2011, CHEM SOC REV, V40, P3105, DOI 10.1039/c0cs00157k; Nishijo J, 2005, INORG CHEM, V44, P2493, DOI 10.1021/ic048548k; Caneschi A, 2001, ANGEW CHEM INT EDIT, V40, P1760, DOI 10.1002/1521-3773(20010504)40:9<1760::AID-ANIE17600>3.0.CO;2-U; Nakatsuji S, 1997, J MATER CHEM, V7, P2161, DOI 10.1039/a702177a; Sun HL, 2010, COORDIN CHEM REV, V254, P1081, DOI 10.1016/j.ccr.2010.02.010; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; CHAPPELL JS, 1981, J AM CHEM SOC, V103, P2442, DOI 10.1021/ja00399a066; BAKAC A, 1992, INORG CHEM, V31, P1108, DOI 10.1021/ic00032a038; Hanasaki N, 2000, PHYS REV B, V62, P5839, DOI 10.1103/PhysRevB.62.5839; Grisenti DL, 2008, INORG CHEM, V47, P11452, DOI 10.1021/ic801376p; Vacher A, 2011, ORGANOMETALLICS, V30, P3570, DOI 10.1021/om200266q; Train C, 2011, CHEM SOC REV, V40, P3297, DOI 10.1039/c1cs15012j; Nishijo J, 2009, INORG CHEM, V48, P9402, DOI 10.1021/ic901295d; Kumagai H, 1999, ANGEW CHEM INT EDIT, V38, P1601, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1601::AID-ANIE1601>3.0.CO;2-#; Wright-Garcia K, 2003, INORG CHEM, V42, P4885, DOI 10.1021/ic030037v; Nishijo J, 2013, INORG CHEM, V52, P13263, DOI 10.1021/ic402217c; Cai XM, 2012, ORGANOMETALLICS, V31, P8591, DOI 10.1021/om300985z; Nishijo J, 2013, POLYHEDRON, V66, P43, DOI 10.1016/j.poly.2013.01.035; Faltham H.L.C., 2014, COORDIN CHEM REV, V276, P1; KINOSHITA M, 1991, CHEM LETT, P1225, DOI 10.1246/cl.1991.1225; Makhoul R, 2014, EUR J INORG CHEM, P3899, DOI 10.1002/ejic.201402022; Miller J. S., 2001, MAGNETISM MOL MAT, V1-5; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Vacher A., 2009, CHEM COMMUN, V2009, P7200; Vibkers E.B., 2005, CHEM MATER, V17, P1667	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693	1873-3255		INORG CHIM ACTA	Inorg. Chim. Acta	OCT 1	2015	437						59	63		10.1016/j.ica.2015.08.007		5	Chemistry, Inorganic & Nuclear	Chemistry	CS2YT	WOS:000361938600009		
J	Surendar, M; Bhattacharya, A; Singh, G; Yamaguchi, Y; Venkataraman, G				Surendar, M.; Bhattacharya, A.; Singh, G.; Yamaguchi, Y.; Venkataraman, G.			Development of a snow wetness inversion algorithm using polarimetric scattering power decomposition model	INTERNATIONAL JOURNAL OF APPLIED EARTH OBSERVATION AND GEOINFORMATION			English	Article						SAR; Polarimetry; Decomposition; Dielectric; Snow wetness	SAR DATA; GLACIATED TERRAIN; COHERENCY MATRIX; WET SNOW; RADAR; CLASSIFICATION; COMPENSATION; BACKSCATTER; PARAMETERS; RETRIEVAL	In this paper, a new snow wetness estimation model is proposed for full-polarimetric Synthetic Aperture Radar (SAR) data. Surface and volume are the dominant scattering components in wet-snow conditions. The generalized four component polarimetric decomposition with unitary transformation (G4U) based generalized surface and volume parameters are utilized to invert snow surface and volume dielectric constants using the Bragg coefficients and Fresnel transmission coefficients respectively. The snow surface and volume wetness are then estimated using an empirical relationship. The effective snow wetness is derived from the weighted averaged surface and volume snow wetness. The weights are derived from the normalized surface and volume scattering powers obtained from the generalized full-polarimetric SAR decomposition method. Six Radarsat-2 fine resolution full-polarimetric datasets acquired over Himachal Pradesh, India along with the near-real time in situ measurements were used to validate the proposed model. The snow wetness derived from the SAR data by the proposed model with in situ measurements indicated that the absolute error at 95% confidence interval is 1.3% by volume. (C) 2015 Elsevier B.V. All rights reserved.	[Surendar, M.; Bhattacharya, A.; Singh, G.; Venkataraman, G.] Indian Inst Technol, Ctr Studies Resources Engn, Powai 400076, Maharashtra, India; [Yamaguchi, Y.] Niigata Univ, Fac Engn, Niigata 9502181, Japan	Surendar, M (reprint author), Indian Inst Technol, Ctr Studies Resources Engn, Powai 400076, Maharashtra, India.	surendarmtech@gmail.com			Japan Society for the Promotion of Science (JSPS)	The authors would like to thank the Snow and Avalanche Study Establishment (SASE) under the Ministry of Defense, Government of India for providing the logistics for us to conduct the in situ measurements and the observatory data. The authors would also like to thank the Canadian Space Agency (CSA) and MacDonald, Dettwiler and Associates Ltd (MDA) to provide us the Radarsat-2 data in 2014 under the SOAR Education International Proposal, SOAR-EI 5176. Dr. Singh is thankful to the Japan Society for the Promotion of Science (JSPS) for providing research grant.	Yamaguchi Y, 2005, IEEE T GEOSCI REMOTE, V43, P1699, DOI 10.1109/TGRS.2005.852084; Chen SW, 2014, IEEE T GEOSCI REMOTE, V52, P1843, DOI 10.1109/TGRS.2013.2255615; Koskinen JT, 1997, IEEE T GEOSCI REMOTE, V35, P601, DOI 10.1109/36.581975; BERNIER PY, 1987, NORD HYDROL, V18, P1; Lee JS, 2002, IEEE T GEOSCI REMOTE, V40, P30; STILES WH, 1980, J GEOPHYS RES-OC ATM, V85, P1037, DOI 10.1029/JC085iC02p01037; Freeman A, 1998, IEEE T GEOSCI REMOTE, V36, P963, DOI 10.1109/36.673687; Lee JS, 2011, IEEE T GEOSCI REMOTE, V49, P53, DOI 10.1109/TGRS.2010.2048333; Shi JC, 2000, IEEE T GEOSCI REMOTE, V38, P2465, DOI 10.1109/36.885195; SHI JC, 1995, IEEE T GEOSCI REMOTE, V33, P905; Lee JS, 2000, IEEE T GEOSCI REMOTE, V38, P2153, DOI 10.1109/36.868874; TIURI ME, 1984, IEEE J OCEANIC ENG, V9, P377, DOI 10.1109/JOE.1984.1145645; Cloude SR, 1997, IEEE T GEOSCI REMOTE, V35, P68, DOI 10.1109/36.551935; Koskinen J, 2000, INT GEOSCI REMOTE SE, P1754, DOI 10.1109/IGARSS.2000.857335; Nagler T, 2000, IEEE T GEOSCI REMOTE, V38, P754, DOI 10.1109/36.842004; Singh G, 2014, IEEE J-STARS, V7, P872, DOI 10.1109/JSTARS.2013.2266354; An WT, 2010, IEEE T GEOSCI REMOTE, V48, P2732, DOI 10.1109/TGRS.2010.2041242; Small D, 2011, IEEE T GEOSCI REMOTE, V49, P3081, DOI 10.1109/TGRS.2011.2120616; Arii M, 2011, IEEE T GEOSCI REMOTE, V49, P1104, DOI 10.1109/TGRS.2010.2076285; Singh G, 2010, GEOCARTO INT, V25, P187, DOI 10.1080/10106040903486130; Singh G, 2011, GEOCARTO INT, V26, P377, DOI 10.1080/10106049.2011.584978; Surendar M, 2013, INT GEOSCI REMOTE SE, P3199, DOI 10.1109/IGARSS.2013.6723507; FUNG AK, 1992, IEEE T GEOSCI REMOTE, V30, P356, DOI 10.1109/36.134085; Touzi R, 2007, IEEE T GEOSCI REMOTE, V45, P73, DOI 10.1109/TGRS.2006.886176; Guneriussen T, 2001, CAN J REMOTE SENS, V27, P109; ULABY FT, 1995, INT GEOSCI REMOTE SE, P1499, DOI 10.1109/IGARSS.1995.521791; Kendra JR, 1998, IEEE T GEOSCI REMOTE, V36, P864, DOI 10.1109/36.673679; Singh G, 2014, IEEE T GEOSCI REMOTE, V52, P1177, DOI 10.1109/TGRS.2013.2248369; Singh G, 2012, GEOCARTO INT, V27, P139, DOI 10.1080/10106049.2011.626082; HALLIKAINEN MT, 1986, IEEE T ANTENN PROPAG, V34, P1329, DOI 10.1109/TAP.1986.1143757; Singh G, 2012, INT J REMOTE SENS, V33, P4161, DOI 10.1080/01431161.2011.639402; SHI JC, 1993, INT GEOSCI REMOTE SE, P1038; Cloude S. R., 2009, POLARISATION APPL RE; DENOTH A, 1994, ANN GLACIOL-SER, V19, P104; FSI, 2011, FOR COV TECH REP; Fung A K, 1994, MICROWAVE SCATTERING; Hallikainen M., 1987, IEEE T GE 25 GEOSCI, V6, P737; Niang M., 2007, P 2007 ENVISAT S; Rott H., 1985, TECH REP; Shi J., 1992, P INT GEOSC REM SENS, V2, P927; SIHVOLA A, 1986, IEEE T GEOSCI REMOTE, V24, P717, DOI 10.1109/TGRS.1986.289619; Singh G, 2013, IEEE T GEOSCI REMOTE, V51, P3014, DOI 10.1109/TGRS.2012.2212446; Singh G., 2013, THESIS NIIGATA U; Stiles W., 1980, DIELECTRIC PROPERTIE; Ulaby F. T., 1986, MICROWAVE REMOTE SEN; von Hippel A. R., 1954, DIELECTRIC MAT APPL; Yamaguchi Y, 2011, IEEE T GEOSCI REMOTE, V49, P2251, DOI 10.1109/TGRS.2010.2099124	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-2434			INT J APPL EARTH OBS	Int. J. Appl. Earth Obs. Geoinf.	OCT	2015	42						65	75		10.1016/j.jag.2015.05.010		11	Remote Sensing	Remote Sensing	CS4QO	WOS:000362061200007		
J	Sasai, K; Oguchi, M				Sasai, Keisuke; Oguchi, Masahiko			ISRT: a new radiation therapy for malignant lymphomas	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material							STAGE HODGKIN LYMPHOMA; ONCOLOGY GROUP; DOSE GUIDELINES; RESPONSE ASSESSMENT; FIELD		[Sasai, Keisuke] Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, Tokyo 1138421, Japan; [Oguchi, Masahiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan	Sasai, K (reprint author), Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ksasai@juntendo.ac.jp					Specht L, 2014, INT J RADIAT ONCOL, V89, P854, DOI 10.1016/j.ijrobp.2013.05.005; Hoppe RT, 2013, INT J CLIN ONCOL, V18, P359, DOI 10.1007/s10147-013-0556-3; Specht L, 2015, INT J RADIAT ONCOL, V92, P32, DOI 10.1016/j.ijrobp.2015.01.008; Maraldo MV, 2013, INT J RADIAT ONCOL, V85, P1057, DOI 10.1016/j.ijrobp.2012.08.041; Maraldo MV, 2015, INT J RADIAT ONCOL, V92, P144, DOI 10.1016/j.ijrobp.2014.12.009; Yahalom J, 2015, INT J RADIAT ONCOL, V92, P11, DOI 10.1016/j.ijrobp.2015.01.009; Eich HT, 2008, STRAHLENTHER ONKOL, V184, P406, DOI 10.1007/s00066-008-1882-7; Illidge T, 2014, INT J RADIAT ONCOL, V89, P49, DOI 10.1016/j.ijrobp.2014.01.006; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Specht L, 2015, INT J CLIN ONCOL, V20, P849, DOI 10.1007/s10147-015-0863-y	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					847	848		10.1007/s10147-015-0874-8		2	Oncology	Oncology	CS3VC	WOS:000362002200001		
J	Tamura, K; Aiba, K; Saeki, T; Nakanishi, Y; Kamura, T; Baba, H; Yoshida, K; Yamamoto, N; Kitagawa, Y; Maehara, Y; Shimokawa, M; Hirata, K; Kitajima, M				Tamura, Kazuo; Aiba, Keisuke; Saeki, Toshiaki; Nakanishi, Yoichi; Kamura, Toshiharu; Baba, Hideo; Yoshida, Kazuhiro; Yamamoto, Nobuyuki; Kitagawa, Yuko; Maehara, Yoshihiko; Shimokawa, Mototsugu; Hirata, Koichi; Kitajima, Masaki		CINV Study Grp Japan	Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Cancer chemotherapy; Antiemetics; Guidelines; Nausea; Vomiting	CHEMOTHERAPY-INDUCED NAUSEA; EMESIS; CYCLOPHOSPHAMIDE; APREPITANT; PREDICTOR; THERAPY; TRIALS; UPDATE	Many cancer patients suffer from the common side effect of chemotherapy-induced nausea and vomiting (CINV). Guidelines recommend a combination of two prophylactic antiemetics for moderately emetogenic chemotherapy (MEC) and three for highly emetogenic chemotherapy (HEC) and certain MEC regimens. This multicenter, prospective, observational study analyzed data for 1,910 patients in Japan scheduled for MEC or HEC. Use of antiemetic prophylaxis in relation to type of chemotherapy, incidences of and risk factors for nausea, vomiting, and acute versus delayed CINV, and estimated incidence of CINV by staff were analyzed using Fisher's exact test and multivariate logistic regression. The patients recorded the incidence of CINV and severity of nausea by visual analogue scales daily for 7 days after receiving chemotherapy. A total of 240 (20.1 %) HEC and 476 MEC patients (66.6 %) received 2 antiemetics, compared with 883 (73.9 %) and 200 (28.0 %), respectively, who received 3 antiemetics. Approximately 74 % of HEC and 95 % of MEC patients received antiemetic therapy in compliance with guidelines. Acute nausea and vomiting were well controlled, but high incidences of delayed nausea occurred in both HEC and MEC patients. Delayed vomiting (p < 0.0001) was significantly less frequent in patients receiving three compared with 2 antiemetics. Female sex was a major risk factor for CINV. Medical staff tended to overestimate the incidence of CINV. Among HEC regimens, the incidence of CINV and the degree of nausea on day 1 of anthracycline-cyclophosphamide combination therapy were higher than with a cisplatin-based regimen. Adherence to antiemetic guidelines effectively controls vomiting but is less effective against delayed nausea in HEC and MEC patients. Identification of individual risk factors, such as female sex, will assist in the development of personalized treatments for CINV. More intensive antiemetic therapy or a different modality of prophylaxis should be considered for the control of acute CINV in an anthracycline-cyclophosphamide regimen.	[Tamura, Kazuo] Fukuoka Univ, Sch Med, Div Med Oncol Hematol & Infect Dis, Dept Med,Jonan Ku, Fukuoka, Fukuoka 8140180, Japan; [Aiba, Keisuke] Jikei Univ, Div Clin Oncol Hematol, Dept Internal Med, Sch Med,Minato Ku, Tokyo 1058461, Japan; [Saeki, Toshiaki] Saitama Med Univ, Int Med Ctr, Breast Oncol Serv, Hidaka, Saitama 3501298, Japan; [Nakanishi, Yoichi] Kyushu Univ, Res Inst Dis Chest, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Kamura, Toshiharu] Kurume Univ, Dept Obstet & Gynecol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Baba, Hideo] Kumamoto Univ, Dept Surg Gastroenterol, Chuo Ku, Kumamoto, Kumamoto 8600811, Japan; [Yoshida, Kazuhiro] Gifu Univ, Dept Surg Oncol, Gifu, Gifu 5011194, Japan; [Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka 4110934, Japan; [Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1600016, Japan; [Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Shimokawa, Mototsugu] Natl Hosp Org, Kyushu Canc Ctr, Dept Canc Informat Res, Minami Ku, Fukuoka, Fukuoka 8111395, Japan; [Hirata, Koichi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kitajima, Masaki] Int Univ Hlth & Welf, Ohtawara, Tochigi 3248501, Japan	Tamura, K (reprint author), Fukuoka Univ, Sch Med, Div Med Oncol Hematol & Infect Dis, Dept Med,Jonan Ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	ktamura@fukuoka-u.ac.jp			Public Health Research Foundation	We appreciate a research grant from the Public Health Research Foundation, and the support from Ms. Etsuko Kumakawa, Yukimi Itoh, Noriko Ikoma, Noriko Gushima, and Kazuko Nakata for the registration and analysis of the collected data. We also thank all the patients and investigators who participated in this study.	Roscoe JA, 2004, CANCER, V101, P2701, DOI 10.1002/cncr.20718; Shih V, 2009, ANN PHARMACOTHER, V43, P444, DOI 10.1345/aph.1L437; Majem M, 2011, SUPPORT CARE CANCER, V19, P1983, DOI 10.1007/s00520-010-1042-3; Roscoe JA, 2010, SUPPORT CARE CANCER, V18, P869, DOI 10.1007/s00520-009-0723-2; Warr D, 2014, EUR J PHARMACOL, V722, P192, DOI 10.1016/j.ejphar.2013.10.015; Fraunholz I, 2011, STRAHLENTHER ONKOL, V187, P1, DOI 10.1007/s00066-010-2196-0; Warr DG, 2011, SUPPORT CARE CANCER, V19, P807, DOI 10.1007/s00520-010-0899-5; Roila F, 2010, ANN ONCOL, V21, pv232, DOI 10.1093/annonc/mdq194; Roscoe JA, 2000, ANN BEHAV MED, V22, P121, DOI 10.1007/BF02895775; Pirri C, 2011, SUPPORT CARE CANCER, V19, P1549, DOI 10.1007/s00520-010-0982-y; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Aapro M, 2012, ANN ONCOL, V23, P1986, DOI 10.1093/annonc/mds021; Neymark N, 2005, SUPPORT CARE CANCER, V13, P812, DOI 10.1007/s00520-005-0803-x; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Grunberg SM, 2004, CANCER, V100, P2261, DOI 10.1002/cncr.20230; Gilmore James W, 2014, J Oncol Pract, V10, P68, DOI 10.1200/JOP.2012.000816; Japan Society of Clinical Oncology, 2010, GUID APPR US ANT DRU; Navari Rudolph M, 2011, J Support Oncol, V9, P188, DOI 10.1016/j.suponc.2011.05.002; NCCN, 2014, NCCN CLIN PRACT GUID; Ricarte C, 2013, EUR CANC C AMST	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					855	865		10.1007/s10147-015-0786-7		11	Oncology	Oncology	CS3VC	WOS:000362002200003		
J	Hirayama, Y; Ishitani, K; Sato, Y; Iyama, S; Takada, K; Murase, K; Kuroda, H; Nagamachi, Y; Konuma, Y; Fujimi, A; Sagawa, T; Ono, K; Horiguchi, H; Terui, T; Koike, K; Kusakabe, T; Sato, T; Takimoto, R; Kobune, M; Kato, J				Hirayama, Yasuo; Ishitani, Kunihiko; Sato, Yasushi; Iyama, Satoshi; Takada, Kohichi; Murase, Kazuyuki; Kuroda, Hiroyuki; Nagamachi, Yasuhiro; Konuma, Yuichi; Fujimi, Akihito; Sagawa, Tamotsu; Ono, Kaoru; Horiguchi, Hiroto; Terui, Takeshi; Koike, Kazuhiko; Kusakabe, Toshiro; Sato, Tsutomu; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji			Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Duloxetine; Neuropathy; Chemotherapy; Supportive care; CIPN	CANCER PATIENTS; DOUBLE-BLIND; MANAGEMENT; EFFICACY; PLACEBO; PACLITAXEL; PREVENTION; SYMPTOMS; PAIN	Chemotherapy-induced peripheral neuropathy (CIPN) is difficult to manage. A phase III trial conducted in the United States demonstrated that duloxetine was effective for CIPN caused by taxane and platinum-based chemotherapy. No randomized trial of duloxetine for CIPN has been conducted in Japan. In this open-label, randomized, crossover study, eligible patients were randomized to Group A or Group B. Group A received duloxetine 20 mg/day orally for the first week and 40 mg/day for the next 3 weeks. Group B received vitamin B12 (VB12) 1.5 mg/day orally for 4 weeks. After a 2- to 4-week washout period, treatment was crossed over for another 4 weeks. The severity of numbness and pain was assessed using a visual analog scale (VAS). Thirty-four patients were enrolled. Obvious decreases in the mean VAS scores for numbness and pain were observed for the periods of duloxetine administration. Significant differences were observed between the duloxetine-first (Group A) and the VB12-first (Group B) groups with respect to numbness (p = 0.03) and pain (p = 0.04) at 4 weeks after administration. Fatigue was observed in six of the 34 participants (17.6 %). Our data suggests that duloxetine has a beneficial effect on CIPN caused by oxaliplatin, paclitaxel, vincristine, or bortezomib in Japanese patients.	[Hirayama, Yasuo; Terui, Takeshi; Kusakabe, Toshiro] Higashi Sapporo Hosp, Dept Hematol Oncol, Shiroishi Ku, Sapporo, Hokkaido 0038585, Japan; [Ishitani, Kunihiko; Koike, Kazuhiko] Higashi Sapporo Hosp, Div Palliat Care, Sapporo, Hokkaido 0038585, Japan; [Sato, Yasushi; Iyama, Satoshi; Takada, Kohichi; Murase, Kazuyuki; Ono, Kaoru; Horiguchi, Hiroto; Sato, Tsutomu; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol Hematol, Sapporo, Hokkaido, Japan; [Kuroda, Hiroyuki] Seitetsu Mem Hosp, Dept Hematol Oncol, Muroran, Hokkaido, Japan; [Nagamachi, Yasuhiro] Kiyota Hosp, Dept Hematol Oncol, Sapporo, Hokkaido, Japan; [Konuma, Yuichi] Asahikawa Red Cross Hosp, Dept Hematol Oncol, Asahikawa, Hokkaido, Japan; [Fujimi, Akihito] Oji Gen Hosp, Dept Hematol Oncol, Tomakomai, Japan; [Sagawa, Tamotsu] Hokkaido Canc Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan	Hirayama, Y (reprint author), Higashi Sapporo Hosp, Dept Hematol Oncol, Shiroishi Ku, Sapporo, Hokkaido 0038585, Japan.	hirayama@hsh.or.jp					Albers JW, 2011, COCHRANE DB SYST REV, V2, pCD005; Cavaletti G, 2010, EUR J CANCER, V46, P479, DOI 10.1016/j.ejca.2009.12.008; Hammack JE, 2002, PAIN, V98, P195, DOI 10.1016/S0304-3959(02)00047-7; Barton DL, 2011, SUPPORT CARE CANCER, V19, P833, DOI 10.1007/s00520-010-0911-0; Cavaletti G, 2013, ANN ONCOL, V24, P454, DOI 10.1093/annonc/mds329; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Rao RD, 2007, CANCER, V110, P2110, DOI 10.1002/cncr.23008; Berk M, 1997, INT CLIN PSYCHOPHARM, V12, P137, DOI 10.1097/00004850-199705000-00003; Kautio AL, 2008, J PAIN SYMPTOM MANAG, V35, P31, DOI 10.1016/j.jpainsymman.2007.02.043; Takenaka M, 2013, AM J HOSP PALLIAT ME, V30, P734, DOI 10.1177/1049909112463416; Rao RD, 2008, CANCER, V112, P2802, DOI 10.1002/cncr.23482; Nagashima M, 2014, SUPPORT CARE CANCER, V22, P1579, DOI 10.1007/s00520-014-2132-4; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Hertz DL, 2013, ANN ONCOL, V24, P1472, DOI 10.1093/annonc/mdt018; Baldwin RM, 2012, CLIN CANCER RES, V15, P18	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					866	871		10.1007/s10147-015-0810-y		6	Oncology	Oncology	CS3VC	WOS:000362002200004		
J	Takayama, T; Okura, Y; Okada, Y; Honma, K; Nashimoto, A; Sato, N; Yokoyama, A; Minamino, T				Takayama, Tsugumi; Okura, Yuji; Okada, Yoshinobu; Honma, Keiichi; Nashimoto, Atsushi; Sato, Nobuaki; Yokoyama, Akira; Minamino, Tohru			Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Neoplastic cardiac tamponade; Pericardiocentesis; Prognosis	MALIGNANT PERICARDIAL-EFFUSION; LUNG-CANCER; PALLIATIVE-CARE; MUTATIONS; GEFITINIB	Neoplastic cardiac tamponade (NCT) is a life-threatening complication of cancer. The interval between cancer diagnosis and NCT onset and the prognosis after pericardiocentesis may differ according to cancer type. We performed a retrospective study of 113 patients (54 % male) with NCT who underwent pericardiocentesis at Niigata Cancer Center Hospital between 1992 and 2013. Mean age at NCT was 61.2 years (range 15.9-94.8 years). The most common underlying cancers were lung cancer (59.2 %), breast cancer (21.2 %), lymphoma/leukemia (5.3 %), and gastric/esophageal cancer (5.3 %). The median time from cancer diagnosis to NCT onset was 9.0, 60.4, 5.6, and 8.0 months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively. Kaplan-Meier survival estimates were worse for breast cancer patients with NCT than for matched breast cancer patients without NCT (P < 0.0001). Median survival time after pericardiocentesis was 2.9, 4.2, 2.3, and 0.6 months for lung cancer, breast cancer, lymphoma/leukemia, and gastric/esophageal cancer, respectively; one-year survival after pericardiocentesis was 6.0, 16.7, 33.3, and 0 %, respectively. The interval between cancer diagnosis and NCT onset, the impact of NCT on prognosis, and the prognosis after pericardiocentesis differed according to cancer type. Healthcare practitioners caring for patients with NCT should recognize the differences between cancer types and customize their care accordingly.	[Takayama, Tsugumi; Okura, Yuji] Niigata Canc Ctr Hosp, Dept Cardiol, Chuo Ku, Niigata 9518560, Japan; [Okada, Yoshinobu] Kamo Hosp, Dept Internal Med, Niigata, Japan; [Honma, Keiichi] Niigata Canc Ctr Hosp, Dept Pathol, Niigata 9518560, Japan; [Nashimoto, Atsushi] Niigata Canc Ctr Hosp, Dept Digest Surg, Niigata 9518560, Japan; [Sato, Nobuaki] Niigata Canc Ctr Hosp, Dept Breast Surg, Niigata 9518560, Japan; [Yokoyama, Akira] Niigata Canc Ctr Hosp, Dept Resp Med, Niigata 9518560, Japan; [Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan	Okura, Y (reprint author), Niigata Canc Ctr Hosp, Dept Cardiol, Chuo Ku, Kawagishicho 2-15-3, Niigata 9518560, Japan.	okuray@niigata-cc.jp					Ikematsu Y, 2012, HEART LUNG, V41, P264, DOI 10.1016/j.hrtlng.2011.08.005; VAITKUS PT, 1994, JAMA-J AM MED ASSOC, V272, P59, DOI 10.1001/jama.272.1.59; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364; De Lima L, 2007, ANN ONCOL, V18, P395, DOI 10.1093/annonc/mdl373; SINGH S, 1986, AM J CARDIOL, V57, P652, DOI 10.1016/0002-9149(86)90853-2; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Kunitoh H, 2009, BRIT J CANCER, V100, P464, DOI 10.1038/sj.bjc.6604866; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; KLATT EC, 1990, CANCER, V65, P1456, DOI 10.1002/1097-0142(19900315)65:6<1456::AID-CNCR2820650634>3.0.CO;2-5; Lestuzzi Chiara, 2010, World J Cardiol, V2, P270, DOI 10.4330/wjc.v2.i9.270	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					872	877		10.1007/s10147-015-0794-7		6	Oncology	Oncology	CS3VC	WOS:000362002200005		
J	Kawaguchi, Y; Nishiyama, K; Hirata, T; Konishi, K; Otozai, S; Suzuki, M; Yoshii, T; Fujii, T; Teshima, T				Kawaguchi, Yoshifumi; Nishiyama, Kinji; Hirata, Takerou; Konishi, Kouji; Otozai, Shinji; Suzuki, Motoyuki; Yoshii, Tadashi; Fujii, Takashi; Teshima, Teruki			Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Base of tongue cancer; External-beam radiotherapy; Intra-arterial chemotherapy; Organ preservation	STAGE-IV HEAD; RANDOMIZED-TRIAL; INTRAARTERIAL CISPLATIN; RADIATION-THERAPY; NECK; CHEMOTHERAPY; CANCER; OROPHARYNX; ONCOLOGY; SURGERY	To evaluate definitive external-beam radiotherapy (EBRT) for patients with base of the tongue (BOT) cancers. We reviewed results for 26 patients with BOT cancers who were treated with EBRT. Clinical stages T1, T2, T3, and T4a were observed for 10, 7, 4, and 5 patients, respectively, and stages N0, N1, N2a, N2b, N2c, and N3 were observed for 4, 2, 5, 6, 8, and 1 patients, respectively. More than half of the patients (n = 19) were stage IVA. Standard total delivered doses were 70 Gy to primary tumors and cervical lymph node (CLN) metastases and 40-46 Gy to elective nodal regions. Eleven patients with advanced loco-regional disease received concurrent or neoadjuvant chemotherapy. Four T3 patients and one T2 patient received 2 or 3 cycles of concurrent intra-arterial cisplatin with EBRT (RADPLAT). Three-year overall survival was 69 % (95 % CI 47-83 %), with a median follow-up period of 33 months. Three-year local control was 100, 86, 100, and 20 % for T1, T2, T3, and T4 patients, respectively. Three-year regional control was 100 % for N0, N1, and N2a, 83 % for N2b, 75 % for N2c, and 0 % for N3 patients. Treatment failed for 7 patients. All 5 patients undergoing RADPLAT achieved complete responses and did not develop local recurrence. We achieved favorable outcomes for patients with T1-T3 BOT cancers by use of definitive EBRT with or without chemotherapy.	[Kawaguchi, Yoshifumi; Hirata, Takerou; Konishi, Kouji; Teshima, Teruki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Higashinari Ku, Osaka 5378511, Japan; [Nishiyama, Kinji] Yao Municipal Hosp, Dept Radiol, Osaka, Japan; [Otozai, Shinji; Suzuki, Motoyuki; Yoshii, Tadashi; Fujii, Takashi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Head & Neck Surg, Osaka 5378511, Japan	Kawaguchi, Y (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Higashinari Ku, 3-3 Nakamichi 1 Chome, Osaka 5378511, Japan.	kawaguti-yo@mc.pref.osaka.jp					Oikawa H, 2009, INT J RADIAT ONCOL, V75, P338, DOI 10.1016/j.ijrobp.2009.02.084; Pederson AW, 2010, HEAD NECK-J SCI SPEC, V32, P1519, DOI 10.1002/hed.21360; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Robbins KT, 2005, J CLIN ONCOL, V23, P1447, DOI 10.1200/JCO.2005.03.168; Olmi P, 2003, INT J RADIAT ONCOL, V55, P78, DOI 10.1016/S0360-3016(02)03792-6; Rasch CRN, 2010, CANCER-AM CANCER SOC, V116, P2159, DOI 10.1002/cncr.24916; Nabil S, 2012, OR SURG OR MED OR PA, V113, P54, DOI 10.1016/j.tripleo.2011.07.042; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P32, DOI 10.1097/01.coc.0000189680.60262.eb; Brunin F, 1999, HEAD NECK-J SCI SPEC, V21, P751, DOI 10.1002/(SICI)1097-0347(199912)21:8<751::AID-HED11>3.3.CO;2-W; ALSARRAF M, 1987, CANCER, V59, P259, DOI 10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO;2-1; HINERMAN RW, 1994, LARYNGOSCOPE, V104, P1466; Machtay M, 1997, HEAD NECK-J SCI SPEC, V19, P494, DOI 10.1002/(SICI)1097-0347(199709)19:6<494::AID-HED6>3.0.CO;2-U; Rabbani A, 2007, AM J CLIN ONCOL-CANC, V30, P283, DOI 10.1097/01.coc.0000258118.38177.74; Kano S, 2011, ORAL ONCOL, V47, P665, DOI 10.1016/j.oraloncology.2011.04.015; Merlano M, 1996, J NATL CANCER I, V88, P583, DOI 10.1093/jnci/88.9.583; Osaka Prefectural Department of Public Health and Welfare Osaka medical Association, 2008, ANN REP OS CANC REG	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					891	896		10.1007/s10147-015-0805-8		6	Oncology	Oncology	CS3VC	WOS:000362002200007		
J	Murakami, Y; Takahashi, I; Nishibuchi, I; Doi, Y; Okabe, T; Kenjo, M; Kimura, T; Nagata, Y				Murakami, Yuji; Takahashi, Ippei; Nishibuchi, Ikuno; Doi, Yoshiko; Okabe, Tomoyuki; Kenjo, Masahiro; Kimura, Tomoki; Nagata, Yasushi			Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Esophageal cancer; Submucosal cancer; Chemoradiotherapy	SQUAMOUS-CELL CARCINOMA; ENDOSCOPIC MUCOSAL RESECTION; EXTERNAL-BEAM RADIATION; DOSE-RATE BRACHYTHERAPY; LYMPH-NODE METASTASIS; SUPERFICIAL CANCER; THORACIC ESOPHAGUS; INTRALUMINAL BRACHYTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP	The long-term outcomes of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer without regional and distant metastasis were retrospectively analyzed. Patients with histologically confirmed esophageal submucosal cancers without regional and distant metastasis who received definitive concurrent chemoradiotherapy from 2001 to 2011 were included. Radiation therapy of a median total dose of 60 Gy/30 fractions (range, 54-66 Gy) with elective nodal irradiation of 40 Gy was combined concurrently with 5-furuorouracil-based chemotherapy. Thirty-six patients (33 men and 3 women) aged from 45 to 80 years (median, 67 years) were assessed. All patients had squamous cell carcinoma. With a median follow-up time of 61 months, the 5-year overall survival, disease-free survival, and locoregional failure-free survival rates were 86 % [95 % confidence interval (CI), 74-99 %], 59 % (95 % CI, 42-77 %), and 90 % (95 % CI, 79-100 %), respectively. Late toxicities of grade 3 pleural effusion in 2 patients, grade 4 pericardial effusion in 1 patient, and grade 5 pneumonitis in 1 patient were observed. Metachronous esophageal cancer was observed in 8 patients (22 %). Among them, 6 patients with mucosal legions were salvaged by endoscopic resection. Our long-term results of concurrent chemoradiotherapy (CCRT) for patients with esophageal submucosal cancer showed acceptable toxicities and favorable locoregional control and survivals while maintaining organ preservation.	[Murakami, Yuji; Doi, Yoshiko; Okabe, Tomoyuki; Kenjo, Masahiro; Kimura, Tomoki; Nagata, Yasushi] Hiroshima Univ, Dept Radiat Oncol, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan; [Takahashi, Ippei] Hiroshima Red Cross Hosp, Dept Radiat Oncol, Naka Ku, Hiroshima 7308619, Japan; [Takahashi, Ippei] Atom Bomb Survivors Hosp, Naka Ku, Hiroshima 7308619, Japan; [Nishibuchi, Ikuno] Hiroshima Prefectural Hosp, Dept Radiat Oncol, Ujinakanda Minami Ku, Hiroshima 7348530, Japan	Murakami, Y (reprint author), Hiroshima Univ, Dept Radiat Oncol, Grad Sch Biomed Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yujimura@hiroshima-u.ac.jp; ippei@hiroshima-u.ac.jp; ikuno@hiroshima-u.ac.jp; yoshikod@hiroshima-u.ac.jp; t-okabe1115@hiroshima-u.ac.jp; kenjom@hiroshima-u.ac.jp; tkimura@hiroshima-u.ac.jp; nagat@hiroshima-u.ac.jp					Okawa T, 1999, INT J RADIAT ONCOL, V45, P623, DOI 10.1016/S0360-3016(99)00253-9; [Anonymous], 2010, GASTROINTEST ENDOSC, DOI [DOI 10.1016/J.GIE.2010.02.040, DOI 10.1016/J.GIE.2010.02.040]]; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Ishikawa H, 2010, INT J RADIAT ONCOL, V76, P452, DOI 10.1016/j.ijrobp.2009.02.029; Murakami Y, 2007, JPN J CLIN ONCOL, V37, P493, DOI 10.1093/jjco/hym055; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Endo M, 2000, DIS ESOPHAGUS, V13, P125; Tachibana M, 1997, AM J SURG, V174, P49, DOI 10.1016/S0002-9610(97)00046-9; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Yorozu A, 1999, INT J RADIAT ONCOL, V45, P271, DOI 10.1016/S0360-3016(99)00184-4; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Murakami Y, 2012, INT J CLIN ONCOL, V17, P263, DOI 10.1007/s10147-011-0285-4; Nemoto K, 2006, ANTICANCER RES, V26, P1507; AlSarraf M, 1997, J CLIN ONCOL, V15, P277; Shimizu Y, 2001, GASTROINTEST ENDOSC, V54, P190, DOI 10.1067/mge.2001.116877; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Altorki NK, 2008, ANN SURG, V247, P434, DOI 10.1097/SLA.0b013e318163a2ff; HAREYAMA M, 1992, INT J RADIAT ONCOL, V24, P235; Ozawa S, 2012, ESOPHAGUS-TOKYO, V9, P75, DOI 10.1007/s10388-012-0327-7; Gaspar LE, 2000, CANCER, V88, P988, DOI 10.1002/(SICI)1097-0142(20000301)88:5<988::AID-CNCR7>3.0.CO;2-U; Bollschweiler E, 2006, ENDOSCOPY, V38, P149, DOI 10.1055/s-2006-924993; Yamada K, 2006, INT J RADIAT ONCOL, V64, P1106, DOI 10.1016/j.ijrobp.2005.10.015; Maingon P, 2000, INT J RADIAT ONCOL, V46, P71, DOI 10.1016/S0360-3016(99)00377-6; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Makuuchi H, 1997, Diagn Ther Endosc, V3, P211, DOI 10.1155/DTE.3.211; NISHIMAKI T, 1993, WORLD J SURG, V17, P766; Tachibana T, 2012, ANN SURG ONCOL, V19, P750	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					897	904		10.1007/s10147-015-0819-2		8	Oncology	Oncology	CS3VC	WOS:000362002200008		
J	Komatsu, Y; Doi, T; Sawaki, A; Kanda, T; Yamada, Y; Kuss, I; Demetri, GD; Nishida, T				Komatsu, Yoshito; Doi, Toshihiko; Sawaki, Akira; Kanda, Tatsuo; Yamada, Yasuhide; Kuss, Iris; Demetri, George D.; Nishida, Toshirou			Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Regorafenib; Japanese; Gastrointestinal stromal tumor; Hand-foot syndrome; Hypertension	RENAL-CELL CARCINOMA; EFFICACY; SAFETY; GIST; THERAPY	The randomized, double-blind, placebo-controlled GRID trial tested the oral multikinase inhibitor regorafenib in 199 patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib, and showed a significant improvement in progression-free survival (PFS) versus placebo [hazard ratio (HR) 0.27; 95 % confidence interval (CI) 0.19-0.39; p < 0.0001]. A subgroup analysis of Japanese patients in the GRID study was performed to compare the efficacy and safety of oral regorafenib 160 mg once daily with matching placebo, in combination with best supportive care. The primary study endpoint was progression-free survival (PFS); safety was evaluated through the incidence of adverse events (AEs). Seventeen Japanese patients were randomized to regorafenib (n = 12) or placebo (n = 5). Patient demographics were consistent with those of the overall study population. PFS was significantly longer with regorafenib than placebo (HR 0.08; 95 % CI 0.02-0.45; p = 0.000164). Centrally assessed disease control rates were 58 % and 20 % in the regorafenib and placebo groups, respectively (p = 0.080796). Treatment-related adverse events (AEs) were reported in all regorafenib-treated patients and 60 % of placebo recipients; the most frequent AE was hand-foot skin reaction (HFSR) (92 % versus 20 %, respectively). Regorafenib showed efficacy and a manageable safety profile in Japanese patients with advanced GIST, consistent with the overall GRID study population. AEs, such as HFSR and maculopapular rash, were observed more frequently in Japanese patients. Although dose modification was frequently reported, only one patient with hepatic failure discontinued regorafenib because of AEs.	[Komatsu, Yoshito] Hokkaido Univ Hosp, Ctr Canc, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Doi, Toshihiko] Natl Canc Ctr, Hosp East, Kashiwa, Chiba, Japan; [Sawaki, Akira] Nagoya Second Red Cross Hosp, Dept Oncol & Gastroenterol, Nagoya, Aichi, Japan; [Kanda, Tatsuo] Niigata Univ, Div Digest & Gen Surg, Sch Med & Dent Sci, Niigata, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Kuss, Iris] Bayer Pharma AG, Global Clin Dev Oncol Ophthalmol & Neurol, Berlin, Germany; [Demetri, George D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ludwig Canc Ctr, Boston, MA 02115 USA; [Nishida, Toshirou] Natl Canc Ctr, Hosp East, Dept Surg, Kashiwa, Chiba, Japan	Komatsu, Y (reprint author), Hokkaido Univ Hosp, Ctr Canc, Kita Ku, Kita 14 Nishi 5, Sapporo, Hokkaido 0608648, Japan.	ykomatsu@ac.cyberhome.ne.jp			Bayer Health Care Pharmaceuticals	We thank the participating patients and staff at each of the study centers. Editorial assistance in the preparation of this manuscript was provided by Succinct Medical Communications, with financial support from Bayer Health Care Pharmaceuticals; the authors retained editorial control over the content.	Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Blay JY, 2011, CANCER TREAT REV, V37, P373, DOI 10.1016/j.ctrv.2010.11.003; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Agaram NP, 2007, CLIN CANCER RES, V13, P170, DOI 10.1158/1078-0432.CCR-06-1508; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Nilsson B, 2005, CANCER, V103, P821, DOI 10.1002/cncr.20862; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Kim HS, 2011, ONCOLOGY-BASEL, V80, P395, DOI 10.1159/000330361; Tryggvason G, 2005, INT J CANCER, V117, P289, DOI 10.1002/ijc.21167; Blay JY, 2012, DISCOV MED, V72, P357; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Nishida T, 2009, GASTRIC CANCER, V12, P175, DOI 10.1007/s10120-009-0525-8; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Bayer HealthCare, 2013, BAYERS STIV APPR TRE; Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1; Demetri GD, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-LB-295; Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1; Li J, 2014, ANN ONCOL         S2, V25, pii114; Yoshino T, 2014, INVEST NEW DRUGS	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					905	912		10.1007/s10147-015-0790-y		8	Oncology	Oncology	CS3VC	WOS:000362002200009		
J	Kajiwara, T; Miura, K; Ohnuma, S; Shimada, M; Komura, T; Toshima, M; Kohyama, A; Kudoh, K; Haneda, S; Musha, H; Naitoh, T; Shirasaka, T; Unno, M				Kajiwara, Taiki; Miura, Koh; Ohnuma, Shinobu; Shimada, Miki; Komura, Toshihiro; Toshima, Masahide; Kohyama, Atsushi; Kudoh, Katsuyoshi; Haneda, Sho; Musha, Hiroaki; Naitoh, Takeshi; Shirasaka, Tetsuhiko; Unno, Michiaki			Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						5-FU; Gastrointestinal toxicity; Regulatory T cell; S-1; Alternate-day administration	PERIPHERAL-BLOOD LYMPHOCYTES; COLORECTAL-CANCER; GASTRIC-CANCER; ADJUVANT CHEMOTHERAPY; ANTITUMOR IMMUNITY; POTASSIUM OXONATE; TUMOR-IMMUNITY; LYMPH-NODES; TH17 CELLS; IMMUNOTHERAPY	5-Fluorouracil (5-FU), a core anticancer agent for malignancies, induces gastrointestinal (GI) toxicities. Despite recent advances in tumor immunology, it still remains unknown how GI toxicities affect antitumor immunity. S-1 is a tegafur-based oral 5-FU prodrug which has been widely introduced in Japan and other countries. The alternate-day S-1 administration has been proposed to minimize its GI and other toxicities without reducing its anticancer efficacy. In this study, two S-1 administration regimens were compared in mice to evaluate their impact of GI toxicities on immunity. In the daily group as a standard administration model, S-1 was administered for 14 days on and 14 days off, and in the alternate-day group as a non-GI toxicity model, S-1 was administered every other day for 28 days. As well as physical findings, regulatory T cells, Th1 cells and other cells in murine lymphoid tissues were analyzed with flow cytometry. Only the daily group exhibited body weight loss and GI toxicities. In the daily group, a proportion of regulatory T cells in the intestinal lymphoid tissue were demonstrated to be six-fold higher than in the control without S-1, and the proportion of Th1 cells showed a decreasing trend. However, the alternate-day group exhibited almost no change in T-cell subsets. GI toxicities of 5-FU may have a negative influence on antitumor immunity due to increased proportions of regulatory T cells and decreased proportions of Th1 cells. The alternate-day S-1 administration may be a useful regimen with its minimal influence on T-cell subsets.	[Kajiwara, Taiki; Ohnuma, Shinobu; Komura, Toshihiro; Toshima, Masahide; Kohyama, Atsushi; Kudoh, Katsuyoshi; Haneda, Sho; Musha, Hiroaki; Naitoh, Takeshi; Unno, Michiaki] Tohoku Univ, Dept Surg, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Miura, Koh] Miyagi Canc Ctr, Dept Surg, Natori, Miyagi 9811293, Japan; [Shimada, Miki] Tottori Univ Hosp, Dept Pharmaceut, Yonago, Tottori 6838504, Japan; [Shirasaka, Tetsuhiko] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan	Miura, K (reprint author), Miyagi Canc Ctr, Dept Surg, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	kou-miura@miyagi-pho.jp			Setsuro Fujii Memorial Osaka Basic Medical Research Foundation (Osaka, Japan); HIROMI Medical Research Foundation (Sendai, Japan); KAKENHI [26461967, 24591895]	We are grateful to Prof. Naoto Ishii and Dr. Takeshi Kawabe (Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine) for their helpful discussions and technical advice. We also thank Prof. Hiroki Yamaue and Dr. Masaji Tani (Second Department of Surgery, Wakayama Medical University) for their thoughtful comments toward the improvement of the manuscript. The present study was financially supported by the Setsuro Fujii Memorial Osaka Basic Medical Research Foundation (Osaka, Japan), the HIROMI Medical Research Foundation (Sendai, Japan) and the Grant-in-Aid for Scientific Research (KAKENHI) (26461967 and 24591895).	Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Lee JS, 2009, BIOSCI BIOTECH BIOCH, V73, P1732, DOI 10.1271/bbb.90035; Arai W, 2008, INT J CLIN ONCOL, V13, P515, DOI 10.1007/s10147-008-0780-4; Tsuji E, 2003, INT J CANCER, V107, P303, DOI 10.1002/ijc.11196; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Miura K, 2012, EXPERT OPIN DRUG DEL, V9, P273, DOI 10.1517/17425247.2012.652945; Yoshimatsu K, 2008, ANTICANCER RES, V28, P373; Kawabe T, 2013, J IMMUNOL, V190, P5788, DOI 10.4049/jimmunol.1203111; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Nagayoshi H, 2005, JPEN-PARENTER ENTER, V29, P395, DOI 10.1177/0148607105029006395; Soares PMG, 2011, CANCER CHEMOTH PHARM, V68, P713, DOI 10.1007/s00280-010-1540-5; Tatebe S, 2014, GASTRIC CANCER, V17, P508, DOI 10.1007/s10120-013-0289-z; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Kim SJ, 2013, CANCER SCI, V104, P116, DOI 10.1111/cas.12044; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Roozendaal R, 2001, INT IMMUNOL, V13, P519, DOI 10.1093/intimm/13.4.519; Yamashita T, 2006, CANCER CHEMOTH PHARM, V58, P183, DOI 10.1007/s00280-005-0150-0; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Shirasaka T, 2009, JPN J CLIN ONCOL, V39, P2, DOI 10.1093/jjco/hyn127; Sakuma K, 2010, INT J CLIN ONCOL, V15, P166, DOI 10.1007/s10147-010-0036-y; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Kinouchi M, 2011, HEPATO-GASTROENTEROL, V58, P352; Cui GL, 2012, SCAND J GASTROENTERO, V47, P367, DOI 10.3109/00365521.2011.648950; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Eisenthal A, 2008, ANTICANCER RES, V28, P3785; Shirasaka T, 1996, CANCER RES, V56, P2602; Arai Wataru, 2004, Int J Clin Oncol, V9, P143; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Yamaue H, 2014, CANCER CHEMOTH PHARM, V73, P97, DOI 10.1007/s00280-013-2323-6; Komura T, 2015, INT J CLIN ONCOL, V20, P117, DOI 10.1007/s10147-014-0699-x; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					913	921		10.1007/s10147-015-0791-x		9	Oncology	Oncology	CS3VC	WOS:000362002200010		
J	Furuhata, T; Okita, K; Nishidate, T; Hirata, K; Ohnishi, H; Kobayashi, H; Kotake, K; Sugihara, K				Furuhata, Tomohisa; Okita, Kenji; Nishidate, Toshihiko; Hirata, Koichi; Ohnishi, Hirofumi; Kobayashi, Hirotoshi; Kotake, Kenjiro; Sugihara, Kenichi		Japanese Soc Canc Colon Rectum; Study Grp Peritoneal Metastasis Co	Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colorectal cancer; Peritoneal metastasis; Lymph node dissection; Propensity score analysis	COMPLETE MESOCOLIC EXCISION; SURGERY; CARCINOMATOSIS; CHEMOTHERAPY; LIGATION	Peritoneal metastasis is recognized as a predictor of poor prognosis in patients with colorectal cancer, and whether surgical intervention for peritoneal metastasis has any clinical benefit has remained controversial. The purposes of this study were to identify prognostic factors in cases of unresectable colorectal cancer with synchronous peritoneal metastasis and to clarify the impacts of primary tumor resection with high tie lymph node dissection. A multi-institutional retrospective analysis was conducted of 579 patients who underwent resection of the primary tumor for unresectable colorectal cancer with peritoneal metastasis between 1991 and 2007. For these 579 patients, clinicopathological variables were analyzed for prognostic significance using Cox proportional hazards model and propensity score analysis to mitigate the selection bias. Multivariate analysis revealed hematogenous metastasis (p < 0.001), histology of the tumor (p = 0.006), postoperative chemotherapy (p < 0.001), and lymph node dissection (p = 0.001) as independent prognostic factors. In the propensity-matched cohort, patients treated with high tie lymph node dissection showed a significantly better overall survival than those with low tie lymph node dissection (median overall survival 13.0 vs. 11.5 months; p = 0.041). It is suggested that primary tumor resection with high tie lymph node dissection favorably affects survival, even in unresectable colorectal cancer with peritoneal metastasis.	[Furuhata, Tomohisa] Sapporo Med Univ, Dept Nursing, Chuo Ku, Sapporo, Hokkaido, Japan; [Okita, Kenji; Nishidate, Toshihiko; Hirata, Koichi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Kobayashi, Hirotoshi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan; [Kotake, Kenjiro] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan	Furuhata, T (reprint author), Sapporo Med Univ, Dept Nursing, Chuo Ku, South 1,West 17, Sapporo, Hokkaido, Japan.	furuhata@sapmed.ac.jp					Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; Kotake K, 2003, DIS COLON RECTUM, V46, pS32, DOI 10.1097/01.DCR.0000083389.92214.AA; West NP, 2012, J CLIN ONCOL, V30, P1763, DOI 10.1200/JCO.2011.38.3992; Deng LF, 2010, CLIN CANCER RES, V16, P4105, DOI 10.1158/1078-0432.CCR-10-1073; Kobayashi H, 2014, J GASTROENTEROL, V49, P646, DOI 10.1007/s00535-013-0820-3; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Kobayashi H, 2010, DIGEST SURG, V27, P473, DOI 10.1159/000320460; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Clancy C, 2014, ANN SURG ONCOL, V21, P3900, DOI 10.1245/s10434-014-3805-4; Ishihara S, 2014, ANN SURG ONCOL, V21, P2949, DOI 10.1245/s10434-014-3719-1; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Muto Tetsuichiro, 2001, International Journal of Clinical Oncology, V6, P171, DOI 10.1007/PL00012102; Nitzkorski JR, 2011, ANN SURG ONCOL, V19, P379	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					922	927		10.1007/s10147-015-0815-6		6	Oncology	Oncology	CS3VC	WOS:000362002200011		
J	Arimoto, A; Uehara, K; Tsuzuki, T; Aiba, T; Ebata, T; Nagino, M				Arimoto, Atsuki; Uehara, Keisuke; Tsuzuki, Toyonori; Aiba, Toshisada; Ebata, Tomoki; Nagino, Masato			Role of bevacizumab in neoadjuvant chemotherapy and its influence on microvessel density in rectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Bevacizumab; Neoadjuvant chemotherapy; Microvessel density; Rectal cancer	METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; OXALIPLATIN-BASED CHEMOTHERAPY; SQUAMOUS-CELL CARCINOMA; PLUS BEVACIZUMAB; LUNG-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; CAPECITABINE; ANGIOGENESIS	The role of bevacizumab (Bev) in neoadjuvant chemotherapy (NAC) without radiotherapy for rectal cancer has not been fully discussed. The purpose of this study is to assess the clinicopathological benefit of Bev in NAC for rectal cancer and to investigate its influence on microvessel status in cancerous tissue. Data on 47 patients with rectal cancer, who received NAC with or without Bev between August 2008 and November 2012, were analyzed retrospectively. The objective response was evaluated using the maximum tumor diameter. Tumor regression grade 3/4 was classified as a pathological response. Thirty-one patients (66 %) received NAC that included Bev and the other 16 patients were treated without Bev. The objective response rate was significantly higher in the Bev group than in the non-Bev group (64.5 vs. 25.0 %, p = 0.015). The rate of pathological response was much higher in the Bev group (41.9 %) than in the non-Bev group (12.5 %), but did not reach significant difference (p = 0.052). Microvessel density (MVD) in the resected cancerous tissue was significantly lower in the Bev group than in the non-Bev group. We have confirmed that objective and pathological responses were better in patients treated with NAC that included Bev than in those who received NAC without Bev. Additionally, MVD in tumor tissues was inhibited in the patients treated with Bev. To investigate the impact of Bev in NAC on long-term survival, further follow-up is required.	[Arimoto, Atsuki; Uehara, Keisuke; Aiba, Toshisada; Ebata, Tomoki; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan; [Tsuzuki, Toyonori] Nagoya Daini Red Cross Hosp, Dept Pathol, Showa Ku, Nagoya, Aichi 4668650, Japan	Uehara, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kuehara@med.nagoya-u.ac.jp					Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Yanagisawa M, 2009, ONCOL REP, V22, P241, DOI 10.3892/or_00000430; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Zhao YY, 2012, J THORAC ONCOL, V7, P71, DOI 10.1097/JTO.0b013e31823085f4; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Uehara K, 2013, JPN J CLIN ONCOL, V43, P964, DOI 10.1093/jjco/hyt115; de Oliveira MVM, 2013, APPL IMMUNOHISTO M M, V21, P444, DOI 10.1097/PAI.0b013e3182773125; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Lee YC, 2013, DIS COLON RECTUM, V56, P1093, DOI 10.1097/DCR.0b013e318298e36b; Uehara K, 2011, JPN J CLIN ONCOL, V41, P1041, DOI 10.1093/jjco/hyr084; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Uehara M, 2004, ORAL ONCOL, V40, P321, DOI 10.1016/j.oraloncology.2003.08.020; Yeo SG, 2010, ANN SURG, V252, P998, DOI 10.1097/SLA.0b013e3181f3f1b1; Nasti G, 2013, BRIT J CANCER, V108, P1566, DOI 10.1038/bjc.2013.140; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Risau W, 1997, NATURE, V386, P671; Folkman J, 1995, NEW ENGL J MED, V333, P1757; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Longatto Filho A, 2010, J ONCOL, DOI [10.1155/2010/576384, DOI 10.1155/2010/576384]; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Murri A M Al, 2008, Br J Cancer, V99, P1013, DOI 10.1038/sj.bjc.6604667; Watanabe T, 2010, INT J CLIN ONCOL, V17, P1, DOI DOI 10.1007/S10147-011-0315-2	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					935	942		10.1007/s10147-015-0818-3		8	Oncology	Oncology	CS3VC	WOS:000362002200013		
J	Yokoyama, T; Takehara, K; Yamamoto, Y; Okame, S; Shiroyama, Y; Yokoyama, T; Nogawa, T; Sugawara, Y				Yokoyama, Takanori; Takehara, Kazuhiro; Yamamoto, Yasuko; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi; Nogawa, Takayoshi; Sugawara, Yosifumi			The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						FDG-PET/CT; SUVmax; Teratoma; Malignant transformation; Immature teratoma	POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; MATURE CYSTIC TERATOMA; DIAGNOSTIC-ACCURACY; F-18-FDG PET/CT; FDG-PET/CT; CANCER; WOMEN; CT	The present study investigates the usefulness of 18F-FDG-PET/CT (PET/CT) in distinguishing between benign and malignant ovarian teratomas. This study includes 4 mature teratomas (MTs) with malignant transformation, 8 immature teratomas (ITs), and 16 MTs that were diagnosed after surgical resection. Preoperative tumor marker values, MRI findings, PET/CT SUVmax values, and other clinical parameters were retrospectively compared with those of 14 patients who had MTs. The median CA125 was significantly higher for ITs than for MTs (P = 0.04). The median AFP was significantly higher for ITs than for MTs (P = 0.0034). The median SUVmax values for MTs with malignant transformation, ITs, and MTs were 18.3 (5.3-23.3), 6.0 (3.6-22.6), and 1.1 (1.0-15.5), respectively. SUVmax was significantly higher in MTs with malignant transformation and ITs than in MTs (P = 0.004, P = 0.0007). With a cut-off SUVmax of 3.6 to distinguish between benign and malignant MTs, sensitivity was 100 %, specificity was 81 %, positive predictive value was 80 %, negative predictive value was 100 %, and diagnostic accuracy was 89 % (AUC 0.94). However, one patient with an MT had a high SUVmax corresponding to values in the central nervous system (CNS). 18F-FDG-PET/CT has a high diagnostic accuracy in distinguishing between benign and malignant ovarian teratomas. Thus, PET/CT may be useful in cases where the diagnosis is unclear on MRI and other clinical findings. However, some MTs with abundant CNS tissue may have a high SUVmax. Therefore, the diagnosis of a benign or malignant lesion should be made carefully in conjunction with other clinical findings.	[Yokoyama, Takanori; Takehara, Kazuhiro; Yamamoto, Yasuko; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi; Nogawa, Takayoshi] Natl Hosp Org, Shikoku Canc Ctr, Dept Gynecol Oncol, Matsuyama, Ehime 7910280, Japan; [Sugawara, Yosifumi] Natl Hosp Org, Shikoku Canc Ctr, Dept Diagnost Radiol, Matsuyama, Ehime 7910280, Japan	Takehara, K (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Dept Gynecol Oncol, Ko-160 Minamiumemoto, Matsuyama, Ehime 7910280, Japan.	katakehara@shikoku-cc.go.jp			Health and Labour Sciences Research Expenses for Commision	This study is supported by Health and Labour Sciences Research Expenses for Commision.	Kitajima K, 2011, NUCL MED COMMUN, V32, P549, DOI 10.1097/MNM.0b013e328345b339; Kikkawa F, 1997, OBSTET GYNECOL, V89, P1017, DOI 10.1016/S0029-7844(97)00117-8; Kawahara K, 2004, J COMPUT ASSIST TOMO, V28, P505, DOI 10.1097/00004728-200407000-00011; KAWAI M, 1991, GYNECOL ONCOL, V40, P133, DOI 10.1016/0090-8258(91)90104-D; Moore RG, 2011, OBSTET GYNECOL, V118, P280, DOI 10.1097/AOG.0b013e318224fce2; Hackethal A, 2008, LANCET ONCOL, V9, P1173, DOI 10.1016/S1470-2045(08)70306-1; Koyama K, 2003, J NUCL MED, V44, P353; Miyasaka N, 2011, J OBSTET GYNAECOL RE, V37, P623, DOI 10.1111/j.1447-0756.2010.01393.x; Tanizaki Y, 2014, INT J GYNECOL CANCER, V24, P454, DOI 10.1097/IGC.0000000000000074; Konishi H, 2014, INT J GYNECOL CANCER, V24, P1190, DOI 10.1097/IGC.0000000000000180; Kitajima K, 2008, EUR J NUCL MED MOL I, V35, P1912, DOI 10.1007/s00259-008-0890-2; Fenchel S, 2002, RADIOLOGY, V223, P780, DOI 10.1148/radiol.2233001850; Cho A, 2014, CLIN NUCL MED, V39, pE193, DOI 10.1097/RLU.0b013e3182a20d5c; Balink H, 2012, CLIN NUCL MED, V37, P804, DOI 10.1097/RLU.0b013e3182485361; Kajihara M, 2014, JAP J CLIN RADIOL, V59, P1769; Konishi H, 2014, OBSTET GYNECOL, V63, P9; Suzuki M, 1995, ONCOLOGY, V52, P2872	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					960	966		10.1007/s10147-015-0800-0		7	Oncology	Oncology	CS3VC	WOS:000362002200016		
J	Itamochi, H; Oumi, N; Oishi, T; Shoji, T; Fujiwara, H; Sugiyama, T; Suzuki, M; Kigawa, J; Harada, T				Itamochi, Hiroaki; Oumi, Nao; Oishi, Tetsuro; Shoji, Tadahiro; Fujiwara, Hiroyuki; Sugiyama, Toru; Suzuki, Mitsuaki; Kigawa, Junzo; Harada, Tasuku			Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Ovarian carcinoma; Clear cell; ARID1A; Biomarker	REMODELING GENE ARID1A; PI3K-AKT PATHWAY ALTERATIONS; ENDOMETRIOID CARCINOMA; PROTEIN EXPRESSION; TUMOR PROGRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; ARID1A/BAF250A EXPRESSION; SOMATIC MUTATIONS; CANCER; CHEMORESISTANCE	Recent studies have shown that somatic mutations in the AT-rich interactive domain 1A (SWI-like) gene (ARID1A) are the most common genetic changes in clear cell carcinoma of the ovary (CCC). A gene mutation of ARID1A was found in approximately half of CCC cases, and led to absence of the encoded protein and inactivation of the putative tumor suppressor. Here, we investigated whether ARID1A could be a prognostic biomarker for this disease. We analyzed the protein expression of ARID1A in CCC from 112 patients by immunohistochemical staining, and evaluated the association of these molecular parameters with clinical outcome. The loss of ARID1A expression was found in 39 % (44/112) of CCC, and was not associated with patient age, FIGO stage, and status of residual tumor. The 5-year survival rate for FIGO stage I or II patients with negative tumor expression of ARID1A was lower than those with positive tumor expression of ARID1A (74 % vs 91 %), but this difference was not observed in FIGO stage III or IV patients. Multivariable analysis revealed that ARID1A expression was an independent prognostic factor in FIGO stage I or II CCC patients. ARID1A may be a biomarker that is predictive of the outcome of FIGO stage I and II CCC.	[Itamochi, Hiroaki; Oumi, Nao; Oishi, Tetsuro; Harada, Tasuku] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Shoji, Tadahiro; Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate 0208505, Japan; [Fujiwara, Hiroyuki; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Kigawa, Junzo] Matsue City Hosp, Matsue, Shimane 6908509, Japan	Itamochi, H (reprint author), Tottori Univ, Sch Med, Dept Obstet & Gynecol, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	itamochi@hotmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [17244120]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17244120 to H. Itamochi).	Cho H, 2013, HUM PATHOL, V44, P1365, DOI 10.1016/j.humpath.2012.11.007; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Huang HN, 2014, MODERN PATHOL, V27, P983, DOI 10.1038/modpathol.2013.216; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Lichner Z, 2013, AM J PATHOL, V182, P1163, DOI 10.1016/j.ajpath.2013.01.007; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Xiao WB, 2012, INT J CLIN EXP PATHO, V5, P642; Yokoyama Y, 2014, J GYNECOL ONCOL, V25, P58, DOI 10.3802/jgo.2014.25.1.58; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Samartzis EP, 2012, MODERN PATHOL, V25, P885, DOI 10.1038/modpathol.2011.217; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Yan HB, 2014, CARCINOGENESIS, V35, P867, DOI 10.1093/carcin/bgt398; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Lai CR, 2013, J CHIN MED ASSOC, V76, P629, DOI 10.1016/j.jcma.2013.07.008; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Lowery WJ, 2012, INT J GYNECOL CANCER, V22, P9, DOI 10.1097/IGC.0b013e318231f140; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Fadare O, 2012, J CANCER, V3, P129, DOI 10.7150/jca.4140; Maeda D, 2010, INT J MOL SCI, V11, P5121, DOI 10.3390/ijms11125120; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; McConechy MK, 2014, MODERN PATHOL, V27, P128, DOI 10.1038/modpathol.2013.107; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Samartzis EP, 2014, ONCOTARGET, V5, P5295; Scully R E, 1975, Natl Cancer Inst Monogr, V42, P5; Wang DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040364; Wiegand KC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-120	35	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					967	973		10.1007/s10147-015-0811-x		7	Oncology	Oncology	CS3VC	WOS:000362002200017		
J	Nakamura, Y; Matsumoto, K; Satoh, T; Nishide, K; Nozue, A; Shimabukuro, K; Endo, S; Nagai, K; Oki, A; Ochi, H; Morishita, Y; Noguchi, M; Yoshikawa, H				Nakamura, Yuko; Matsumoto, Koji; Satoh, Toyomi; Nishide, Ken; Nozue, Akiko; Shimabukuro, Koji; Endo, Seiichi; Nagai, Kimihiro; Oki, Akinori; Ochi, Hiroyuki; Morishita, Yukio; Noguchi, Masayuki; Yoshikawa, Hiroyuki			HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Human papillomavirus; Genotyping; Colposcopy; Cervical intraepithelial neoplasia; Cervical cancer; Low-grade squamous intraepithelial lesion	CARCINOGENIC HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL LESION CYTOLOGY; VACCINATION PROGRAM; PREVALENCE; REDUCTION; RISK	In cervical cancer screening programs, women with abnormal cytology are referred for colposcopy for histological evaluation. We examined whether a human papillomavirus (HPV) genotyping assay could be used to identify women who do not need immediate colposcopy and biopsy because of low risk of cervical intraepithelial neoplasia grade 3 or worse (CIN3+). We prospectively evaluated test performance for 2 carcinogenic HPV genotypes (HPV16/18), for 8 types (HPV16/18/31/33/35/45/52/58), and for 13 types (HPV16/18/31/33/35/45/51/52/56/58/59/68) for prediction of histological CIN3+ results among 427 screen-positive women referred for colposcopy. The study subjects consisted of 214 women with low-grade squamous intraepithelial lesion (LSIL), 184 with high-grade squamous intraepithelial lesion (HSIL), and 29 with atypical squamous cells, cannot exclude HSIL (ASC-H). Among women with LSIL cytology, HPV16/18 positivity was 29.4 % and increased to 58.9 % for 8 types and to 74.8 % for 13 types (P < 0.001). The risk of CIN3+ biopsy results was still 7.9 % for women testing negative for HPV16/18, but decreased to 0.0 % for those testing negative for at least eight types of HPV (HPV16/18/31/33/35/45/52/58). Although HPV genotyping results enabled additional risk stratification among women with HSIL/ASC-H cytology, the risk of histological CIN3+ diagnosis among women testing negative for eight types or more was still sufficiently high (> 35 %) to warrant immediate colposcopy referral. Of women with LSIL cytology, those testing negative for at least eight of the highest-risk types of HPV (HPV16/18/31/33/35/45/52/58) may not need immediate colposcopy and biopsy. This would reduce the number of colposcopy referrals by approximately 40 %. However, the HPV genotyping assay is not likely to alter the clinical management of women with HSIL/ASC-H.	[Nakamura, Yuko; Matsumoto, Koji; Satoh, Toyomi; Oki, Akinori; Ochi, Hiroyuki; Yoshikawa, Hiroyuki] Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan; [Nakamura, Yuko; Morishita, Yukio; Noguchi, Masayuki] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nishide, Ken; Nozue, Akiko] Tsukuba Med Ctr Hosp, Dept Gynecol, Tsukuba, Ibaraki 3058558, Japan; [Shimabukuro, Koji; Endo, Seiichi] Tsuchiura Kyodo Gen Hosp, Dept Obstet & Gynecol, Tsuchiura, Ibaraki 3000053, Japan; [Nagai, Kimihiro; Oki, Akinori] Ibaraki Cent Hosp, Dept Gynecol, Kasama, Ibaraki 3091793, Japan	Matsumoto, K (reprint author), Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan.	matsumok@mui.biglobe.ne.jp			Ministry of Education, Science, Sports and Culture of Japan [25462585, 24791682]; Ibaraki Clinical and Epidemiological Cancer Research Project	The authors thank Chizuko Fukui and Yoko Kuno, for technical assistance, Kokoro Hirai and Chieko Abe, for assistance with data collection, many other researchers who facilitated this study, and all the women who participated as study subjects. This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (grants #25462585 and #24791682) and the Ibaraki Clinical and Epidemiological Cancer Research Project. The supporting organizations were not involved in the design and implementation of the study, in collection, management, analysis, and interpretation of the data, or in preparation, review, or approval of the manuscript.	Matsumoto K, 2011, INT J CANCER, V128, P2898, DOI 10.1002/ijc.25630; Onuki M, 2009, CANCER SCI, V100, P1312, DOI 10.1111/j.1349-7006.2009.01161.x; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Takeda T, 2012, J OBSTET GYNAECOL RE, V38, P615, DOI 10.1111/j.1447-0756.2012.01858.x; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Castle PE, 2008, OBSTET GYNECOL, V112, P637, DOI 10.1097/AOG.0b013e3181834637; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Cuzick J, 2013, INT J CANCER, V132, P959, DOI 10.1002/ijc.27723; Sherman ME, 2006, CANCER CYTOPATHOL, V108, P298, DOI 10.1002/cncr.21844; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Castle PE, 2008, OBSTET GYNECOL, V111, P847, DOI 10.1097/AOG.0b013e318168460b; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Massad LS, 2012, OBSTET GYNECOL, V121, P829; Matsumoto K, 2014, JPN J CLIN ONCOL, V44, P1000, DOI 10.1093/jjco/hyu097; Muoz N, 2003, NEW ENGL J MED, V348, P518; Nakamura Y, 2014, INT J CLIN IN PRESS; NHS, 2010, NHSCSP PUBL, V20; Satoh T, 2013, J VIROL METHODS, V188, P83, DOI 10.1016/j.jviromet.2012.10.014	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					974	981		10.1007/s10147-015-0789-4		8	Oncology	Oncology	CS3VC	WOS:000362002200018		
J	Mizunuma, M; Yokoyama, Y; Futagami, M; Aoki, M; Takai, Y; Mizunuma, H				Mizunuma, Makito; Yokoyama, Yoshihito; Futagami, Masayuki; Aoki, Masahiko; Takai, Yoshihiro; Mizunuma, Hideki			The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						NLR; Uterine cervical cancer; Radiation therapy; Concurrent chemoradiation therapy; Therapeutic outcome	NEUTROPHIL/LYMPHOCYTE RATIO; HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; PROGNOSTIC-FACTOR; LUNG-CANCER; SURVIVAL; CHEMOTHERAPY; RADIOTHERAPY; INFLAMMATION; RESECTION	The aim of this study was to investigate the prognostic role of the pretreatment neutrophil-to-lymphocyte ratio (NLR) as a predictive marker prior to treatment ofcervical cancer with radiation therapy (RT) alone or concurrent chemoradiation therapy (CCRT). Fifty-six patients with squamous cell carcinoma (SCC) of the uterine cervix who underwent RT or CCRT from 2005-2013 at the Hirosaki University Hospital were retrospectively identified using electronic databases. Patients were divided into a high NLR group (a parts per thousand yen2.5) and a low NLR group (< 2.5). The efficacy of RT and CCRT in the two groups was compared. Of the 56 patients, 35 were in the high NLR group and 21 were in the low NLR group. In comparison to a high NLR, a low NLR was significantly associated with a complete response (P < 0.001). When cancer was divided into stages I/II and III/IV, patients with a low NLR had a significantly better therapeutic outcome than those with a high NLR (P < 0.05). Multivariate analysis showed that only the NLR was a significant prognostic factor for progression-free survival (PFS) and overall survival (OS). Patients with a high NLR had significantly shorter PFS and OS than those with a low NLR. Results showed that a low NLR before treatment could predict a good response to RT or CCRT at all stages of uterine cervical cancer. The NLR may be a promising parameter on which to base the choice of a therapeutic strategy to treat SCC of the uterine cervix.	[Mizunuma, Makito; Yokoyama, Yoshihito; Futagami, Masayuki; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 0368562, Japan; [Aoki, Masahiko; Takai, Yoshihiro] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori 0368562, Japan	Yokoyama, Y (reprint author), Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yokoyama@hirosaki-u.ac.jp		Aoki, Masahiko/0000-0002-3760-919X	Ministry of Education, Science and Culture of Japan [20591935]	This study was supported by a Grant-in Aid for Cancer Research (No. 20591935) from the Ministry of Education, Science and Culture of Japan.	Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Santin AD, 2000, INT J RADIAT ONCOL, V48, P997, DOI 10.1016/S0360-3016(00)00769-0; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Zhang Y, 2014, INT J GYNECOL CANCER, V24, P1319, DOI 10.1097/IGC.0000000000000219; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Mabuchi S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju147; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Lee YY, 2012, ANTICANCER RES, V32, P1555; Yokoyama Y, 2008, ONCOL REP, V19, P1551; Romano F, 2004, J EXP CLIN CANC RES, V23, P195; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Kono K, 2008, ONCOLOGY-BASEL, V74, P143, DOI 10.1159/000151361; Matsumoto Y, 2010, INT J GYNECOL CANCER, V20, P417, DOI 10.1111/IGC.0b013e3181d15a11; Wang D, 2013, CHINESE MED J-PEKING, V126, P1464, DOI 10.3760/cma.j.issn.0366-6999.20122672; Wang T, 2014, MOL BIOL REP, V41, P4069, DOI 10.1007/s11033-014-3276-5; Noh JM, 2014, GYNECOL ONCOL, V132, P618, DOI 10.1016/j.ygyno.2014.01.043; Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891; Gabay C, 1999, NEW ENGL J MED, V340, P448; Grigiene R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-234; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Najjar Yana G, 2013, Front Oncol, V3, P49, DOI 10.3389/fonc.2013.00049; Siegel R, 2013, CA-CANCER J CLIN, V2013, P11, DOI DOI 10.3322/CAAC.21166; Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079; Yoshioka S, 2013, JPN J CANC CHEMOTHER, V40, P2086; Young Caroline A, 2014, Clin Med Insights Oncol, V8, P81, DOI 10.4137/CMO.S15476; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					989	996		10.1007/s10147-015-0807-6		8	Oncology	Oncology	CS3VC	WOS:000362002200020		
J	Yokoyama, Y; Ito, K; Takamatsu, K; Takehara, K; Nakanishi, T; Harano, K; Watari, H; Susumu, N; Aoki, D; Saito, T				Yokoyama, Yoshihito; Ito, Kiyoshi; Takamatsu, Kiyoshi; Takehara, Kazuhiro; Nakanishi, Toru; Harano, Kenichi; Watari, Hidemichi; Susumu, Nobuyuki; Aoki, Daisuke; Saito, Toshiaki		Dis Comm Uterine Canc; Japanese Gynecologic Oncology Grp	How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Endometrial cancer; Hormone replacement therapy; Japanese gynecologists attitude; Anonymous questionnaire	ESTROGEN REPLACEMENT; STAGE-I; ADENOCARCINOMA CELLS; WOMEN; ESTRADIOL; MENOPAUSE; TRIAL	This survey sought to determine Japanese gynecologists' attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Responses from 363 individuals (response rate 40.9 %) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46 % of physicians in Germany (P < 0.0002). Forty-nine percent of Japanese physicians approved of prescribing HRT for patients with high risk of recurrence vs. 25 % of physicians in Germany (P < 0.0001). Many Japanese gynecologists have a favorable attitude toward prescribing HRT after treatment of EC.	[Yokoyama, Yoshihito] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Ito, Kiyoshi] Tohoku Univ, Grad Sch Med, Dept Disaster Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808573, Japan; [Takamatsu, Kiyoshi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Obstet & Gynecol, Ichikawa, Chiba, Japan; [Takehara, Kazuhiro] Natl Hosp Org, Shikoku Canc Ctr, Dept Gynecol Oncol, Matsuyama, Ehime, Japan; [Nakanishi, Toru] Aichi Canc Ctr Hosp, Dept Gynecol, Nagoya, Aichi 464, Japan; [Harano, Kenichi] Nippon Med Sch, Musashikosugi Hosp, Dept Med Oncol, Kawasaki, Kanagawa, Japan; [Watari, Hidemichi] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Susumu, Nobuyuki; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 160, Japan; [Saito, Toshiaki] Natl Hosp Org, Kyushu Canc Ctr, Gynecol Serv, Fukuoka, Fukuoka, Japan	Ito, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Disaster Obstet & Gynecol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808573, Japan.	kito@med.tohoku.ac.jp					[Anonymous], 2002, JAMA-J AM MED ASSOC, DOI DOI 10.1001/JAMA.288.3.321); Chapman JA, 1996, AM J OBSTET GYNECOL, V175, P1195, DOI 10.1016/S0002-9378(96)70027-3; Farnell YZ, 2003, J STEROID BIOCHEM, V84, P453, DOI 10.1016/S0960-0760(03)00066-9; Suriano KA, 2001, OBSTET GYNECOL, V97, P555, DOI 10.1016/S0029-7844(00)01221-7; Rozenberg S, 2000, MATURITAS, V35, P125, DOI 10.1016/S0378-5122(00)00109-2; CREASMAN WT, 1986, OBSTET GYNECOL, V67, P326; Ayhan A, 2006, INT J GYNECOL CANCER, V16, P805, DOI 10.1111/j.1525-1438.2006.00526.x; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Vavilis D, 2011, EUR J GYNAECOL ONCOL, V32, P81; Querleu D, 2011, INT J GYNECOL CANCER, V21, P945, DOI 10.1097/IGC.0b013e31821bd473; LEE RB, 1990, GYNECOL ONCOL, V36, P189, DOI 10.1016/0090-8258(90)90171-G; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Kilic S, 2010, CLIMACTERIC, V13, P55, DOI 10.3109/13697130902914650; Decruze SB, 2007, INT J GYNECOL CANCER, V17, P964, DOI 10.1111/j.1525-1438.2007.00897.x; Yoshida T, 2011, CLIMACTERIC, V14, P445, DOI 10.3109/13697137.2011.562994; HOLINKA CF, 1986, J STEROID BIOCHEM, V25, P781, DOI 10.1016/0022-4731(86)90308-0; Lee SJ, 2013, EUR J GYNAECOL ONCOL, V34, P513; Hancke K, 2010, CLIMACTERIC, V13, P271, DOI 10.3109/13697130903131338; Barakat RR, 2006, J CLIN ONCOL, V24, P587, DOI 10.1200/JCO.2005.02.8464; Aoki D, 2014, J OBSTET GYNAECOL RE, V40, P338, DOI 10.1111/jog.12360; Committee on Gynecologic Practice The American College of Obstetricians and Gynecologists, 2001, INT J GYNECOL OBSTET, V73, P77; Japan Society of Gynecologic Oncology, 2013, END CANC TREATM GUID	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					997	1004		10.1007/s10147-015-0808-5		8	Oncology	Oncology	CS3VC	WOS:000362002200021		
J	Futagami, M; Yokoyama, Y; Iino, K; Aoki, M; Shoji, T; Sugiyama, T; Ariga, H; Tokunaga, H; Takano, T; Watanabe, Y; Yaegashi, N; Jingu, K; Sato, N; Terada, Y; Anbai, A; Ohta, T; Kurachi, H; Kuroda, Y; Nishiyama, H; Fujimori, K; Watanabe, T; Sato, H; Tase, T; Wada, H; Mizunuma, H				Futagami, Masayuki; Yokoyama, Yoshihito; Iino, Kaori; Aoki, Masahiko; Shoji, Tadahiro; Sugiyama, Toru; Ariga, Hisanori; Tokunaga, Hideki; Takano, Tadao; Watanabe, Yoh; Yaegashi, Nobuo; Jingu, Keiichi; Sato, Naoki; Terada, Yukihiro; Anbai, Akira; Ohta, Tsuyoshi; Kurachi, Hirohisa; Kuroda, Yuuki; Nishiyama, Hiroshi; Fujimori, Keiya; Watanabe, Takafumi; Sato, Hisashi; Tase, Toru; Wada, Hitoshi; Mizunuma, Hideki			Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Squamous cell carcinoma of the vulva; Surgery; CCRT; Prognosis	FIGO STAGING SYSTEM; RADIATION-THERAPY; PROGNOSTIC-FACTORS; CERVICAL-CANCER; ONCOLOGY-GROUP; LYMPH-NODES; CHEMOTHERAPY; CISPLATIN; RADIOTHERAPY; RECURRENCE	This multi-institutional study was conducted to clarify the clinicopathological features of squamous cell carcinomas of the vulva. The medical records of vulvar cancer patients treated between 2002 and 2012 were retrospectively reviewed following approval by the Institutional Review Board of each institution. One hundred and eleven patients with vulvar malignancies were included. Of these, 63 patients had squamous cell carcinoma (57 %). Initial treatment was surgery, radiation therapy (RT), and concurrent chemoradiotherapy (CCRT) in 34 (54 %), 15 (24 %), and 11 (17 %) patients, respectively. Nineteen, 11, 26, and 7 patients had stage I, II, III, and IV disease, respectively. Of the 34 patients who had surgical treatment, 50 % had stage I disease, while 74 % of those who received CCRT had stage III or IV disease. Complete response (CR) rates for the surgery, RT, and CCRT groups were 73, 60, and 64 %, respectively. The 5-year survival rates for stage I/II and III/IV disease were 64 and 39 %, respectively (P = 0.019). The 5-year survival rates for the surgery, RT, and CCRT groups were 53, 38, and 50 %, respectively, and the prognosis of patients treated with surgery or CCRT was significantly better than that of patients who received RT (P < 0.05). In multivariate analysis, clinical response to initial treatment was an independent prognostic factor (P < 0.001). Although many patients had advanced-stage disease in the CCRT group, the therapeutic outcome for the surgery and CCRT groups was similar. Thus, CCRT may be a promising treatment for squamous cell carcinoma of the vulva.	[Futagami, Masayuki; Yokoyama, Yoshihito; Iino, Kaori; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 0368562, Japan; [Aoki, Masahiko] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori 0368562, Japan; [Shoji, Tadahiro; Sugiyama, Toru] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan; [Ariga, Hisanori] Iwate Med Univ, Sch Med, Dept Radiat Oncol, Morioka, Iwate 020, Japan; [Tokunaga, Hideki; Takano, Tadao; Watanabe, Yoh; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Jingu, Keiichi] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, Sendai, Miyagi 980, Japan; [Sato, Naoki; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Anbai, Akira] Akita Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Akita 010, Japan; [Ohta, Tsuyoshi; Kurachi, Hirohisa] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan; [Kuroda, Yuuki] Yamagata Univ, Fac Med, Dept Radiat Oncol, Yamagata 990, Japan; [Nishiyama, Hiroshi; Fujimori, Keiya; Watanabe, Takafumi] Fukushima Med Univ, Sch Med, Dept Obstet & Gynecol, Fukushima, Japan; [Sato, Hisashi] Fukushima Med Univ, Sch Med, Dept Radiat Oncol, Fukushima, Japan; [Tase, Toru] Miyagi Canc Ctr, Dept Gynecol, Natori, Miyagi 9811293, Japan; [Wada, Hitoshi] Miyagi Canc Ctr, Dept Radiat Oncol, Natori, Miyagi 9811293, Japan	Yokoyama, Y (reprint author), Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, 5-Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yokoyama@cc.hirosaki-u.ac.jp		Aoki, Masahiko/0000-0002-3760-919X			Tabbaa ZM, 2012, GYNECOL ONCOL, V127, P147, DOI 10.1016/j.ygyno.2012.06.005; Tans L, 2011, AM J CLIN ONCOL-CANC, V34, P22, DOI 10.1097/COC.0b013e3181cae6a1; Reade CJ, 2014, GYNECOL ONCOL, V132, P780, DOI 10.1016/j.ygyno.2013.11.025; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Xu LQ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-20; Hacker NF, 2009, INT J GYNECOL OBSTET, V105, P105, DOI 10.1016/j.ijgo.2009.02.011; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; HOPKINS MP, 1993, CANCER, V72, P799, DOI 10.1002/1097-0142(19930801)72:3<799::AID-CNCR2820720327>3.0.CO;2-5; Woelber L, 2009, ANTICANCER RES, V29, P545; Moore DH, 2009, GYNECOL ONCOL, V113, P379, DOI 10.1016/j.ygyno.2009.01.004; Yokoyama Y, 2008, ONCOL REP, V19, P1551; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Mak RH, 2011, GYNECOL ONCOL, V120, P101, DOI 10.1016/j.ygyno.2010.09.004; Beriwal S, 2013, INT J RADIAT ONCOL, V85, P1269, DOI 10.1016/j.ijrobp.2012.11.012; Baiocchi G, 2013, EJSO-EUR J SURG ONC, V39, P780, DOI 10.1016/j.ejso.2013.03.004; Sznurkowski JJ, 2013, ARCH GYNECOL OBSTET, V287, P1211, DOI 10.1007/s00404-012-2683-x; Beller U, 2006, INT J GYNECOL OBSTET, V95, pS7, DOI 10.1016/S0020-7292(06)60028-3; Aragona AM, 2014, GYNECOL ONCOL, V132, P643, DOI 10.1016/j.ygyno.2013.12.022; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Moore DH, 2012, GYNECOL ONCOL, V124, P529, DOI 10.1016/j.ygyno.2011.11.003; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Iacoponi S, 2013, J GYNECOL ONCOL, V24, P242, DOI [10.3802/jgo.2013.24.3.242, 10.3802/jgo.2013.243.242]; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Obermair A, 2009, GYNECOL ONCOL, V131, P467; Shylasree TS, 2011, COCHRANE DB SYST REV, V13, P4	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1005	1011		10.1007/s10147-015-0803-x		7	Oncology	Oncology	CS3VC	WOS:000362002200022		
J	Nishiyama, N; Takahashi, S; Mizuno, T; Uehara, T; Hashimoto, J; Kurimura, Y; Masumori, N				Nishiyama, Naotaka; Takahashi, Satoshi; Mizuno, Takahiro; Uehara, Teruhisa; Hashimoto, Jiro; Kurimura, Yuichirou; Masumori, Naoya			Clinical analysis of febrile neutropenia in urological anticancer chemotherapy: retrospective single center study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Febrile neutropenia; Urology; Anticancer chemotherapy; MASCC score	COLONY-STIMULATING FACTOR; UROTHELIAL CANCER; PHASE-III; RISK; VINBLASTINE; MULTICENTER; MANAGEMENT; CISPLATIN; THERAPY; FIELD	The aims of this study were to clarify the frequency and prognosis of febrile neutropenia (FN) in patients who received urological anticancer chemotherapy. Between May 2005 and January 2010, 141 patients underwent urological anticancer chemotherapy at the Sapporo Medical University Hospital, Sapporo, Japan. They consisted of 124 men and 17 women aged 62 (range 16-80) years. The patients underwent a total of 626 treatment courses of urological anticancer chemotherapy. Of the 626 urological anticancer chemotherapy courses, grades 3 and 4 neutropenia occurred in 451 (72.0 %) courses. FN developed in 57 (9.1 %) courses in which 7 (12.3 %) and 50 (87.7 %) patients were classified as high risk and low risk, respectively, according to the Multinational Association for Supportive Care in Cancer (MASCC) risk index scoring system. There was no anticancer chemotherapy-related death in either the high- or low-risk group. The frequencies of bacteria isolated from courses with FN were 0 and 10.0 % for the high- and low-risk groups, respectively. According to the MASCC scoring system, there were fewer patients in the high-risk group than in the low-risk group in this study. There were no cases of anticancer chemotherapy-related death in either group. Therefore, urological anticancer chemotherapy can be conducted safely with the proper management of neutropenia and FN.	[Nishiyama, Naotaka; Takahashi, Satoshi; Mizuno, Takahiro; Uehara, Teruhisa; Hashimoto, Jiro; Kurimura, Yuichirou; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Nishiyama, N (reprint author), Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	nishiyan@sapmed.ac.jp; stakahas@sapmed.ac.jp; koukai100@yahoo.co.jp; teruhisa5963@yahoo.co.jp; jirooh519@yahoo.co.jp; kurimura@sapmed.ac.jp; masumori@sapmed.ac.jp					Aapro MS, 2010, EUR J CANCER, V47, P8, DOI DOI 10.1016/J.EJCA.2010.10.013; Culine S, 2008, J CLIN ONCOL, V26, P421, DOI 10.1200/JCO.2007.13.8461; Matsumoto T, 2007, INT J UROL, V14, P890, DOI 10.1111/j.1442-2042.2007.01869.x; Yasufuku T, 2013, J INFECT CHEMOTHER, V19, P211, DOI 10.1007/s10156-012-0478-4; Kotake T, 1999, INT J UROL, V6, P61, DOI 10.1046/j.1442-2042.1999.00624.x; Klastersky J, 2004, CLIN INFECT DIS, V39, pS32, DOI 10.1086/383050; Farhat F, 1996, CANCER, V77, P1193, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1193::AID-CNCR28>3.0.CO;2-W; Klastersky J, 2000, J CLIN ONCOL, V18, P3038; Kitamura H, 2011, CANCER SCI, V102, P1171, DOI 10.1111/j.1349-7006.2011.01909.x; Bellmunt J, 2012, J CLIN ONCOL, V30, P1107, DOI 10.1200/JCO.2011.38.6979; von der Maase H, 2000, J CLIN ONCOL, V18, P3068; [Anonymous], 2014, JPN J CHEMOTHER; Clark OAC, 2005, J CLIN ONCOL, V23, P4198, DOI 10.1200/JCO.2005.05.645; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Counsell R, 1994, Clin Oncol (R Coll Radiol), V6, P232, DOI 10.1016/S0936-6555(05)80292-4; Freifeld AG, 2010, CLIN INFECT DIS, V52, P56, DOI DOI 10.1093/CID/CIR073; Matsumoto T., 1999, International Urology and Nephrology, V31, P7, DOI 10.1023/A:1007107403610; Takamatsu Y, 2013, JPN J CANC CHEMOTHER, V406, P697	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1012	1017		10.1007/s10147-015-0787-6		6	Oncology	Oncology	CS3VC	WOS:000362002200023		
J	Koie, T; Mitsuzuka, K; Yoneyama, T; Narita, S; Kawamura, S; Kaiho, Y; Tsuchiya, N; Tochigi, T; Habuchi, T; Arai, Y; Ohyama, C; Yoneyama, T; Tobisawa, Y				Koie, Takuya; Mitsuzuka, Koji; Yoneyama, Takahiro; Narita, Shintaro; Kawamura, Sadafumi; Kaiho, Yasuhiro; Tsuchiya, Norihiko; Tochigi, Tatsuo; Habuchi, Tomonori; Arai, Yoichi; Ohyama, Chikara; Yoneyama, Tohru; Tobisawa, Yuki			Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						High-risk prostate cancer; Prostatectomy; Neoadjuvant therapy; LHRH plus estramustine; Propensity score analysis	BEAM RADIATION-THERAPY; TERM-FOLLOW-UP; RADICAL PROSTATECTOMY; PHASE-II; MORTALITY OUTCOMES; RADIOTHERAPY; DOCETAXEL; CHEMOTHERAPY; CARCINOMA; CELLS	The optimal treatment for high-risk prostate cancer (Pca) remains to be established. We previously reported favorable biochemical recurrence-free survival (BRFS) in high-risk Pca patients treated with a neoadjuvant therapy comprising a luteinizing-hormone-releasing hormone (LHRH) agonist plus low dose estramustine phosphate (EMP) (LHRH+EMP) followed by radical prostatectomy (RP). In the present study, we used a retrospective design via propensity score matching to elucidate the clinical benefit of neoadjuvant LHRH+EMP for high-risk Pca. The Michinoku Urological Cancer Study Group database contained data for 1,268 consecutive Pca patients treated with RP alone at 4 institutions between April 2000 and March 2011 (RP alone group). In the RP alone group, we identified 386 high-risk Pca patients. The neoadjuvant LHRH+EMP group included 274 patients with high-risk Pca treated between September 2005 and November 2013 at Hirosaki University. Neoadjuvant LHRH+EMP therapy included LHRH and EMP administration at a dose of 280 mg/day for 6 months before RP. The outcome measures were overall survival (OS) and BRFS. The propensity score-matched analysis indicated 210 matched pairs from both groups. The 5-year BRFS rates were 90.4 and 65.8 % for the neoadjuvant LHRH+EMP and RP alone groups, respectively (P < 0.0001). The 5-year OS rates were 100 and 96.1 % for the neoadjuvant LHRH+EMP and RP alone groups, respectively (P = 0.110). Although the present study was not randomized, neoadjuvant LHRH+EMP therapy followed by RP appeared to reduce the risk of biochemical recurrence. A prospective randomized study is warranted to determine the clinical implications of the neoadjuvant therapy described here.	[Koie, Takuya; Yoneyama, Takahiro; Ohyama, Chikara; Yoneyama, Tohru; Tobisawa, Yuki] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Mitsuzuka, Koji; Kaiho, Yasuhiro; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan; [Narita, Shintaro; Tsuchiya, Norihiko; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Kawamura, Sadafumi; Tochigi, Tatsuo] Miyagi Canc Ctr, Dept Urol, Natori, Miyagi 9811293, Japan	Koie, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	goodwin@cc.hirosaki-u.ac.jp					Nepple KG, 2013, EUR UROL, V64, P372, DOI 10.1016/j.eururo.2013.03.005; Prayer-Galetti T, 2007, BJU INT, V100, P274, DOI 10.1111/j.1464-410X.2007.06760.x; Meng MV, 2005, J UROLOGY, V173, P1557, DOI 10.1097/01.ju.0000154610.81916.81; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Koie T, 2012, PROSTATE CANCER P D, V15, P397, DOI 10.1038/pcan.2012.29; Lester-Coll NH, 2013, CANCER-AM CANCER SOC, V119, P1808, DOI 10.1002/cncr.27980; Gleave M, 2005, J CLIN ONCOL, V23, P8186, DOI 10.1200/JCO.2005.03.3068; Womble PR, 2011, J UROLOGY, V186, P882, DOI 10.1016/j.juro.2011.04.087; Lawrentschuk N, 2011, J UROLOGY, V185, P848, DOI 10.1016/j.juro.2010.10.055; Yossepowitch O, 2008, EUR UROL, V53, P950, DOI 10.1016/j.eururo.2007.10.008; Koie T, 2011, EJSO-EUR J SURG ONC, V37, P805, DOI 10.1016/j.ejso.2011.06.009; Magi-Galluzzi C, 2007, CANCER, V110, P1248, DOI 10.1002/cncr.22897; Ward JF, 2005, BJU INT, V95, P751, DOI 10.1111/j.1464-410X.2005.05394.x; Cooperberg MR, 2010, CANCER-AM CANCER SOC, V116, P5226, DOI 10.1002/cncr.25456; Kraus S, 2006, CANCER LETT, V234, P109, DOI 10.1016/j.canlet.2005.02.038; SPEICHER LA, 1994, MOL PHARMACOL, V46, P866; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Loeb S, 2010, UROLOGY, V76, P710, DOI 10.1016/j.urology.2009.09.014; Chi KN, 2008, J UROLOGY, V180, P565, DOI 10.1016/j.juro.2008.04.012; Edge SB, 2010, AJCC CANC STAGING MA, P457; Fong L, 2014, UROL ONCOL IN PRESS, DOI [10.1016/j.urolonc.2013.12.001., DOI 10.1016/J.UR0L0NC.2013.12.001.(IN]; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Heidenreich A, 2013, EUR ASS UROL, V65, P124, DOI DOI 10.1016/J.EURUR0.2013.09.046; Hoshi Senji, 2006, Int J Clin Oncol, V11, P303, DOI 10.1007/s10147-006-0563-8; Merino T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-530; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; Taplin ME, 2012, J CLIN ONCOL, V30; Van Poppel H, 1990, Acta Urol Belg, V58, P89; Vuky Jacqueline, 2009, Cancer, V115, P784, DOI 10.1002/cncr.24092; Yuh B, 2013, EUR UROL, V65, P918	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1018	1025		10.1007/s10147-015-0802-y		8	Oncology	Oncology	CS3VC	WOS:000362002200024		
J	Nozawa, M; Mukai, H; Takahashi, S; Uemura, H; Kosaka, T; Onozawa, Y; Miyazaki, J; Suzuki, K; Okihara, K; Arai, Y; Kamba, T; Kato, M; Nakai, Y; Furuse, H; Kume, H; Ide, H; Kitamura, H; Yokomizo, A; Kimura, T; Tomita, Y; Ohno, K; Kakehi, Y				Nozawa, Masahiro; Mukai, Hirofumi; Takahashi, Shunji; Uemura, Hiroji; Kosaka, Takeo; Onozawa, Yusuke; Miyazaki, Jun; Suzuki, Kazuhiro; Okihara, Koji; Arai, Yoichi; Kamba, Tomomi; Kato, Masashi; Nakai, Yasutomo; Furuse, Hiroshi; Kume, Haruki; Ide, Hisamitsu; Kitamura, Hiroshi; Yokomizo, Akira; Kimura, Takahiro; Tomita, Yoshihiko; Ohno, Keiji; Kakehi, Yoshiyuki			Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Adverse event; Cabazitaxel; Japan; Neutropenia; Phase I; Prostate cancer	ADVANCED SOLID TUMORS; DOCETAXEL; TAXANE	We previously reported the pharmacokinetic profile and preliminary tolerability of cabazitaxel in a phase I study in Japanese patients with metastatic castration-resistant prostate cancer (mCRPC). Here we report the final safety profile and anti-tumor activity of cabazitaxel in a larger population, including all patients enrolled in the expansion cohort of the study. Japanese patients with mCRPC previously treated with docetaxel received cabazitaxel intravenously every 3 weeks plus daily prednisolone. In patients treated with the maximum tolerated dose of 25 mg/m(2) we evaluated adverse events including treatment-related neutropenia, prostate-specific antigen (PSA) response and objective response. In total, 44 patients were treated with the maximum tolerated dose. The most frequent adverse events (any grade) were neutropenia (100 %), febrile neutropenia (54.5 %), fatigue (54.5 %), nausea (52.3 %) and diarrhea (50.0 %). There were no deaths due to treatment-related adverse events. Neutropenia with prior docetaxel did not appear to influence the probability of febrile neutropenia with cabazitaxel. Most patients received therapeutic granulocyte colony-stimulating factor (G-CSF; cycle 1: 86.4 %; cycle 2 or later: 81.8 %). In the efficacy population, two of 12 patients with measurable disease had partial response (objective response rate: 16.7 %), while 10 had stable disease. PSA response rate was 29.3 % (12/41 patients). Median time to PSA progression was 3.68 months (95 % confidence interval 1.35-4.63). In this heavily pretreated Japanese population, the occurrence of neutropenia and febrile neutropenia was high, suggesting G-CSF prophylaxis may be required as part of toxicity management. However, the efficacy of cabazitaxel was consistent with global studies. ClinicalTrials.gov identifier: NCT01324583.	[Nozawa, Masahiro] Kinki Univ, Fac Med, Dept Urol, Osaka, Osaka 5898511, Japan; [Mukai, Hirofumi] Natl Canc Ctr, Hosp East, Kashiwa, Chiba, Japan; [Takahashi, Shunji] Hosp JFCR, Inst Canc, Dept Med Oncol, Koto Ku, Tokyo, Japan; [Uemura, Hiroji] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Kosaka, Takeo] Keio Univ, Sch Med, Dept Urol, Minato Ku, Tokyo, Japan; [Onozawa, Yusuke] Shizuoka Canc Ctr, Div Clin Oncol, Shizuoka, Japan; [Miyazaki, Jun] Univ Tsukuba, Inst Clin Med, Dept Urol, Tsukuba, Ibaraki 305, Japan; [Suzuki, Kazuhiro] Gunma Univ, Grad Sch Med, Dept Urol, Maebashi, Gunma, Japan; [Okihara, Koji] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan; [Arai, Yoichi] Tohoku Univ Hosp, Aoba Ku, Sendai, Miyagi, Japan; [Kamba, Tomomi] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan; [Nakai, Yasutomo] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Furuse, Hiroshi] Hamamatsu Univ Sch Med, Dept Urol, Hamamatsu, Shizuoka 4313192, Japan; [Kume, Haruki] Tokyo Univ Hosp, Tokyo 113, Japan; [Ide, Hisamitsu] Teikyo Univ Hosp, Itabashi Ku, Tokyo, Japan; [Kitamura, Hiroshi] Sapporo Med Univ Hosp, Sapporo, Hokkaido, Japan; [Yokomizo, Akira] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; [Kimura, Takahiro] Jikei Univ Hosp, Tokyo, Japan; [Tomita, Yoshihiko] Yamagata Univ Hosp, Yamagata, Japan; [Ohno, Keiji] Sanofi KK, Tokyo, Japan; [Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Kagawa, Japan	Nozawa, M (reprint author), Kinki Univ, Fac Med, Dept Urol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	nozawa06@med.kindai.ac.jp			Sanofi	The authors would like to thank all patients who participated in the study, and Efficacy and Safety Evaluation Committee members Dr Koichiro Akakura and Dr Toshihiko Doi for their support. Dr Paul Scutt of MediTech Media provided editorial support in the form of medical writing services. This study was funded by Sanofi.	Mukai H, 2014, CANCER CHEMOTH PHARM, V73, P703, DOI 10.1007/s00280-014-2394-z; Vrignaud P, 2013, CLIN CANCER RES, V19, P2973, DOI 10.1158/1078-0432.CCR-12-3146; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; [Anonymous], 2012, SAN JEVTANA INJ PRES; Mukherji D, 2014, CANCER METAST REV, V33, P555, DOI 10.1007/s10555-013-9473-1; [Anonymous], 2011, SUMMARY PRODUCT CHAR; Mita AC, 2009, CLIN CANCER RES, V15, P723, DOI 10.1158/1078-0432.CCR-08-0596; Dieras V, 2013, EUR J CANCER, V49, P25, DOI 10.1016/j.ejca.2012.07.008; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Kuramoto T, 2013, INT J CLIN ONCOL, V18, P890, DOI 10.1007/s10147-012-0463-z; Yano R, 2013, INT J CLIN ONCOL, V18, P96, DOI 10.1007/s10147-011-0349-5; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Berthold Pond GR, 2008, J CLIN ONCOL, V26, P242; Ferlay J, 2013, GLOBOCAN 2012 V1 0, V11; Fumoleau P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-460; Malik Z, 2012, ANN ONCOL, V23, P931; [National Cancer Center Center for Cancer Control and Information Services], 2013, CANC STAT JAP 13, P13; National Comprehensive Cancer Network (NCCN), 2014, NAT COMPR CANC NETW; The National Cancer Institute, 2010, COMM TERM CRIT ADV E	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1026	1034		10.1007/s10147-015-0820-9		9	Oncology	Oncology	CS3VC	WOS:000362002200025		
J	Hashimoto, Y; Takagi, T; Kondo, T; Iizuka, J; Kobayashi, H; Omae, K; Yoshida, K; Tanabe, K				Hashimoto, Yasunobu; Takagi, Toshio; Kondo, Tsunenori; Iizuka, Junpei; Kobayashi, Hirohito; Omae, Kenji; Yoshida, Kazuhiko; Tanabe, Kazunari			Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Kidney neoplasm; Prognosis; Nephrectomy; Hemodialysis	LINDAU-DISEASE GENE; DIALYSIS PATIENTS; KIDNEY; CANCER; SURVIVAL; JAPAN	We compared the clinical features and prognosis of renal cell carcinoma (RCC) between patients on hemodialysis (RCC-HD) and those in the general population (RCC-general). We included a total of 1,794 patients who underwent surgery (RCC-HD, 408; RCC-general, 1,386) and analyzed the clinical characteristics and oncological outcomes using a stage-for-stage analysis between the two groups. In the RCC-HD group, the mean duration of dialysis before surgery was 120 months. Compared to the RCC-general group, the RCC-HD group tended to be younger (55 vs. 60 years, p < 0.0001) and more predominately male (84 % vs. 70 %, p < 0.0001), and the tumor size was smaller in this group (39 vs. 49 mm, p < 0.0001). The pathological characteristics of the RCC-HD group included a higher frequency of papillary tumors (22 % vs. 5 %, p < 0.0001) and stage I tumors (82 % vs. 68 %, p < 0.0001). During the follow-up period, 39 of patients (10 %) in the RCC-HD group and 193 patients (14 %) in the RCC-general group died of cancer. The patients on hemodialysis had better cancer-specific survival (CSS) than their counterparts (p = 0.0292) in the univariable analysis, but no significance was found in the multivariable analysis. In the stage-for-stage analysis, the 5-year CSS was similar between the two groups for each stage. CSS appeared to be better in the RCC-HD group than in the RCC-general group, which may be associated with the higher incidence of stage I disease in the RCC-HD group. The comparable CSS between the groups in the stage-for-stage analysis supports this finding.	[Hashimoto, Yasunobu; Takagi, Toshio; Kondo, Tsunenori; Iizuka, Junpei; Kobayashi, Hirohito; Omae, Kenji; Yoshida, Kazuhiko; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, Tokyo 1628666, Japan	Takagi, T (reprint author), Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	t.takagi1192@gmail.com					Ishikawa I, 2004, THER APHER DIAL, V8, P468, DOI 10.1111/j.1774-9987.2004.00192.x; Takagi T, 2011, INT J UROL, V18, P806, DOI 10.1111/j.1442-2042.2011.02852.x; Hughson MD, 1996, J AM SOC NEPHROL, V7, P2461; Inoue H, 2007, NEPHROL DIAL TRANSPL, V22, P2052, DOI 10.1093/ndt/gfm184; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Neuzillet Y, 2011, EUR UROL, V60, P366, DOI 10.1016/j.eururo.2011.02.035; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Ishikawa I, 2004, NEPHRON CLIN PRACT, V97, pC11, DOI 10.1159/000077590; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Breda A, 2015, WORLD J UROL, V33, P1, DOI 10.1007/s00345-014-1248-y; MARPLE JT, 1994, J AM SOC NEPHROL, V4, P1951; Yoshida M, 2002, GENE CHROMOSOME CANC, V35, P359, DOI 10.1002/gcc.10123; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Sassa N, 2011, NEPHROL DIAL TRANSPL, V26, P1677, DOI 10.1093/ndt/gfq529; Shrewsberry AB, 2014, CLIN TRANSPLANT, V28, P211, DOI 10.1111/ctr.12299; Hughson MD, 1999, MODERN PATHOL, V12, P301	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1035	1041		10.1007/s10147-015-0812-9		7	Oncology	Oncology	CS3VC	WOS:000362002200026		
J	Asai, S; Fukumoto, T; Tanji, N; Miura, N; Miyagawa, M; Nishimura, K; Yanagihara, Y; Shirato, A; Miyauchi, Y; Kikugawa, T; Yokoyama, M				Asai, Seiji; Fukumoto, Tetsuya; Tanji, Nozomu; Miura, Noriyoshi; Miyagawa, Masao; Nishimura, Kenichi; Yanagihara, Yutaka; Shirato, Akitomi; Miyauchi, Yuki; Kikugawa, Tadahiko; Yokoyama, Masayoshi			Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						FDG-PET/CT; Upper urinary tract urothelial carcinoma; Urine cytology; Ureteroscopy	BLOOD-GLUCOSE; F-18-FDG PET/CT; BLADDER-CANCER; CELL-CARCINOMA; FDG UPTAKE; TUMORS	The purpose of this study was to assess the ability of fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to detect upper urinary tract urothelial carcinomas (UTUC) compared with pathological examination of tissues obtained by ureteroscopic biopsy and split cytologic analysis of urine obtained after retrograde pyelography. Clinicopathological records of patients at our institution were retrospectively reviewed. Fifty patients with clinically suspected UTUC, who were histologically diagnosed by nephroureterectomy, partial ureterectomy, or endoscopic biopsy, were included. The patient cohort included 42 men and 8 women, with a median age of 73 (range 54-92) years. Only 27 % of 49 patients with UTUC had positive voided urine cytology, and 33 % of 40 patients had positive split urine cytology. In addition, 40 % of 10 patients had a positive endoscopic biopsy. However, 83 % of 48 patients with UTUC had positive results from FDG-PET/CT examination. The positive predictive value of FDG-PET/CT was 95 %. There were no correlations between sensitivity and tumor stage or tumor grade. Sensitivity of FDG-PET/CT for patients with and without diabetes mellitus was 60 and 89 %, respectively. These preliminary results from a small number of patients revealed that FDG-PET/CT enabled effective detection of UTUC.	[Asai, Seiji; Fukumoto, Tetsuya; Tanji, Nozomu; Miura, Noriyoshi; Nishimura, Kenichi; Yanagihara, Yutaka; Shirato, Akitomi; Miyauchi, Yuki; Kikugawa, Tadahiko; Yokoyama, Masayoshi] Ehime Univ, Grad Sch Med, Dept Urol, Toon, Ehime 7910295, Japan; [Miyagawa, Masao] Ehime Univ, Grad Sch Med, Dept Diagnost & Therapeut Radiol, Toon, Ehime 7910295, Japan	Asai, S (reprint author), Ehime Univ, Grad Sch Med, Dept Urol, Toon, Ehime 7910295, Japan.	archann02092000@yahoo.co.jp; siawase110bann@yahoo.co.jp; tanji@m.ehime-u.ac.jp; norimiurajp@yahoo.co.jp; miyagawa@m.ehime-u.ac.jp; i401063@hotmail.co.jp; yyanagi@m.ehime-u.ac.jp; ashirato@m.ehime-u.ac.jp; uroyuukictb12@yahoo.co.jp; takikuga@m.ehime-u.ac.jp; myoko@m.ehime-u.ac.jp					Potts SA, 1997, MODERN PATHOL, V10, P657; Messer J, 2011, BJU INT, V108, P701, DOI 10.1111/j.1464-410X.2010.09899.x; Kosuda S, 1997, EUR J NUCL MED, V24, P615, DOI 10.1007/BF00841398; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Skolarikos A, 2003, UROLOGY, V61, P1146, DOI 10.1016/S0090-4295(03)00026-8; Koyama K, 2003, J NUCL MED, V44, P353; Takao A, 2010, JPN J CLIN ONCOL, V40, P1087, DOI 10.1093/jjco/hyq096; Anjos DA, 2007, J NUCL MED, V48, P764, DOI 10.2967/jnumed.106.036350; Hara T, 2009, ANN NUCL MED, V23, P657, DOI 10.1007/s12149-009-0288-7; Smith AK, 2011, UROLOGY, V78, P82, DOI 10.1016/j.urology.2011.02.038; Tavora F, 2009, AM J SURG PATHOL, V33, P1540, DOI 10.1097/PAS.0b013e3181aec42a; Crippa F, 1997, TUMORI, V83, P748; Yeh CL, 2009, CLIN NUCL MED, V34, P829, DOI 10.1097/RLU.0b013e3181b81df4; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Busing KA, 2013, NUCL MED BIOL, V40, P206, DOI 10.1016/j.nucmedbio.2012.10.014; Delbeke D, 2006, J NUCL MED, V47, P1227; Ceriani Luca, 2011, J Nucl Med Technol, V39, P77, DOI 10.2967/jnmt.110.081265; Japanese Urological Association and the Japanese Pathological Society, 2002, GEN RUL CLIN PATH ST, P38; LINDHOLM P, 1993, J NUCL MED, V34, P1	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1042	1047		10.1007/s10147-015-0817-4		6	Oncology	Oncology	CS3VC	WOS:000362002200027		
J	Moriyama, S; Takeshita, H				Moriyama, Shingo; Takeshita, Hideki			Patterns of metastasis from the primary site to the testes indicate the potential pathway of metastasis	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Letter									[Moriyama, Shingo; Takeshita, Hideki] Saitama Red Cross Hosp, Dept Urol, Saitama, Saitama 3388553, Japan	Moriyama, S (reprint author), Saitama Red Cross Hosp, Dept Urol, 8-3-33 Kamiochiai, Saitama, Saitama 3388553, Japan.	zodiac_507@hotmail.com					Hatoum HA, 2011, INT J CLIN ONCOL, V16, P203, DOI 10.1007/s10147-010-0140-z; HAUPT HM, 1984, CANCER, V54, P709, DOI 10.1002/1097-0142(1984)54:4<709::AID-CNCR2820540419>3.0.CO;2-6; Moriyama S, 2014, ONCOL LETT, V7, P1273, DOI 10.3892/ol.2014.1830; Gat Y, 2008, ANDROLOGIA, V40, P273, DOI 10.1111/j.1439-0272.2008.00883.x	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	OCT	2015	20	5					1048	1049		10.1007/s10147-015-0792-9		2	Oncology	Oncology	CS3VC	WOS:000362002200028		
J	Miki, K; Masamune, K				Miki, Kohei; Masamune, Ken			High-resolution small field-of-view magnetic resonance image acquisition system using a small planar coil and a pneumatic manipulator in an open MRI scanner	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						MR-compatible robotics; Pneumatic stepping actuator; Planar coil; High-resolution MR images	SURGERY; ROBOT	Low-field open magnetic resonance imaging (MRI) is frequently used for performing image-guided neurosurgical procedures. Intraoperative magnetic resonance (MR) images are useful for tracking brain shifts and verifying residual tumors. However, it is difficult to precisely determine the boundary of the brain tumors and normal brain tissues because the MR image resolution is low, especially when using a low-field open MRI scanner. To overcome this problem, a high-resolution MR image acquisition system was developed and tested. An MR-compatible manipulator with pneumatic actuators containing an MR signal receiver with a small radiofrequency (RF) coil was developed. The manipulator had five degrees of freedom for position and orientation control of the RF coil. An 8-mm planar RF coil with resistance and inductance of 2.04 and 1.00 was attached to the MR signal receiver at the distal end of the probe. MR images of phantom test devices were acquired using the MR signal receiver and normal head coil for signal-to-noise ratio (SNR) testing. The SNR of MR images acquired using the MR signal receiver was 8.0 times greater than that of MR images acquired using the normal head coil. The RF coil was moved by the manipulator, and local MR images of a phantom with a 2-mm grid were acquired using the MR signal receiver. A wide field-of-view MR image was generated from a montage of local MR images. A small field-of-view RF system with a pneumatic manipulator was integrated in a low-field MRI scanner to allow acquisition of both wide field-of-view and high-resolution MR images. This system is promising for image-guided neurosurgery as it may allow brain tumors to be observed more clearly and removed precisely.	[Miki, Kohei] Univ Tokyo, Bunkyo Ku, Grad Sch Informat Sci & Technol, Tokyo 113, Japan; [Masamune, Ken] Tokyo Womens Med Univ, Inst Adv BioMed Engn & Sci, Shinjuku Ku, Tokyo, Japan	Miki, K (reprint author), Univ Tokyo, Bunkyo Ku, Grad Sch Informat Sci & Technol, 7-3-1 Hongo, Tokyo 113, Japan.	k_miki@atre.t.u-tokyo.ac.jp; masamune.ken@twmu.ac.jp					American Society for Testing and Materials (ASTM)International Designation, 2005, STAND PRACT MARK MED; Wheeler HA, 1928, P IRE, V16, P1398, DOI 10.1109/JRPROC.1928.221309; Fischer GS, 2008, IEEE-ASME T MECH, V13, P295, DOI 10.1109/TMECH.2008.924044; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; Stoianovici D, 2007, MINIM INVASIV THER, V16, P241, DOI 10.1080/13645700701520735; Seifabadi R, 2012, INT J COMPUT ASS RAD, V7, P181, DOI 10.1007/s11548-011-0598-9; Dave UR, 2004, RADIOLOGY, V230, P281, DOI 10.1148/radiol.2301021047; Hashizume M, 2007, INT J CLIN ONCOL, V12, P94, DOI 10.1007/s10147-007-0664-z; Badilita V, 2010, LAB CHIP, V10, P1387, DOI 10.1039/c000840k; Stoianovici D, 2007, IEEE-ASME T MECH, V12, P98, DOI 10.1109/TMECH.2006.886258; Damianou C, 2013, INT J MED ROBOT COMP, V10, P1; Inamura T, 2013, PROC IEEE MICR ELECT, P335, DOI 10.1109/MEMSYS.2013.6474246; Iseki H, 2001, STEREOT FUNCT NEUROS, V76, P159, DOI 10.1159/000066714; Koseki Y, 2008, 20 INT C SOC MED INN, P28; Masamune K, 1995, J Image Guid Surg, V1, P242, DOI 10.1002/(SICI)1522-712X(1995)1:4<242::AID-IGS7>3.3.CO;2-R; Massin C, 2003, 12 INT C SOL STAT SE, V2, P967; Sajima H., 2012, J ROBOT MECHATRON, V24, P820; Su H, 2012, IEEE INT C ROB AUT, P1939; Sutherland GR, 2008, IEEE ENG MED BIOL, V27, P59, DOI 10.1109/EMB.2007.910272; Takahashi H, 2007, IEEE MEMS 07 C KOB J, P549; Yang B, 2011, IEEE INT C ROB AUT, P674	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	OCT	2015	10	10					1687	1697		10.1007/s11548-014-1136-3		11	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CS8LM	WOS:000362339100017		
J	Nomura, H; Maeda, T; Usami, T; Abe, A; Yamamoto, A; Matoda, M; Okamoto, S; Kondo, E; Omatsu, K; Kato, K; Umayahara, K; Utsugi, K; Takeshima, N; Sawaizumi, M				Nomura, Hidetaka; Maeda, Takuma; Usami, Tomoka; Abe, Akiko; Yamamoto, Akiko; Matoda, Maki; Okamoto, Sanshiro; Kondo, Eiji; Omatsu, Kohei; Kato, Kazuyoshi; Umayahara, Kenji; Utsugi, Kuniko; Takeshima, Nobuhiro; Sawaizumi, Masayuki			Vulvar Reconstruction Following Surgery for Vulvar Cancer Using a Stepladder V-Y Advancement Medial Thigh Flap	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Hospital stay; Reconstruction; V-Y advancement flap; Vulvar cancer		Objective The aim of this study was to identify the risks and benefits of the stepladder V-Y advancement medial thigh flap for vulvovaginal reconstruction in comparison to direct skin closure. Methods Fifty-four patients with vulvar cancer treated in our hospital between 1992 and 2013 were enrolled in this study. The cohort group (group A) consisted of 25 patients who underwent surgery from August 2006 until April 2013. During this period, we changed our surgical paradigm to incorporate reconstructive plastic surgery immediately following surgery for vulvar cancer performed by gynecologic oncologists. The control group (group B) consisted of 29 patients treated between 1992 and August 2006. During this period, our surgical approach was limited to direct skin closure with no reconstructive plastic surgery. Perioperative findings and clinical outcomes were compared retrospectively. Results Patient characteristics and surgical procedures, other than the reconstructive surgery, were the same for the 2 groups. The mean blood loss and operative times were similar, and there were no major complications in either group; however, the average length of hospital stay was significantly shorter in group A (P = 0.04). Conclusions Stepladder V-Y advancement medial thigh flap lowers posttreatment morbidity and improves quality of life for patients with vulvar cancer. Rapid recovery from surgery is reflected in the short hospital stay, and it enables immediate induction of adjuvant therapy. It may possibly contribute to improved treatment outcome.	[Nomura, Hidetaka; Usami, Tomoka; Abe, Akiko; Yamamoto, Akiko; Matoda, Maki; Okamoto, Sanshiro; Kondo, Eiji; Omatsu, Kohei; Kato, Kazuyoshi; Umayahara, Kenji; Utsugi, Kuniko; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo 1358550, Japan; [Maeda, Takuma; Sawaizumi, Masayuki] Canc Inst Hosp, Dept Plast & Reconstruct Surg, Tokyo 1358550, Japan	Nomura, H (reprint author), Canc Inst Hosp, Koto Ku, Ariake 3-8-31, Tokyo 1358550, Japan.	hidetaka.nomura@jfcr.or.jp					Panici PB, 2014, GYNECOL ONCOL, V132, P125, DOI 10.1016/j.ygyno.2013.10.037; Carramaschi F, 1999, INT J GYNECOL OBSTET, V65, P157, DOI 10.1016/S0020-7292(99)00016-8; Lee JH, 2013, ANN PLAS SURG, V71, P571, DOI 10.1097/SAP.0b013e31824f23e4; Saito Akira, 2009, J Plast Reconstr Aesthet Surg, V62, pe196, DOI 10.1016/j.bjps.2009.01.090; Weikel W, 2005, GYNECOL ONCOL, V99, P92, DOI 10.1016/j.ygyno.2005.05.031	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	OCT	2015	25	8					1484	1487		10.1097/IGC.0000000000000518		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CS6GZ	WOS:000362177800021		
J	Yata, K; Beder, LB; Tamagawa, S; Hotomi, M; Hirohashi, Y; Grenman, R; Yamanaka, N				Yata, Kazuya; Beder, Levent Bekir; Tamagawa, Shunji; Hotomi, Muneki; Hirohashi, Yoshihiko; Grenman, Reidar; Yamanaka, Noboru			MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						head and neck cancer; microRNA; microarray; cancer stem cells; cell line	EPITHELIAL-MESENCHYMAL TRANSITION; ALDEHYDE DEHYDROGENASE; MARKER; IDENTIFICATION; SUBPOPULATION; PROGRESSION	Increasing evidence indicates that cancer stem cells have essential roles in tumor initiation, progression, metastasis and resistance to chemo-radiation. Recent research has pointed out biological importance of microRNAs in cancer stem cell dysregulation. Total number of mature microRNAs in human genome increased to more than 2,500 with the recent up-date of the database. However, currently no information is available regarding microRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma (HNSCC). Increased ALDH1 activity has been demonstrated as a reliable marker for isolation of cancer stem cells. Therefore, we evaluated the microRNA expression profile of ALDH1-high subpopulations in the HNSCC cell lines UTSCC-9 and UTSCC-90. Initially, we examined cancer stem cell properties of ALDH1-high subpopulations in both cell lines. We analyzed expression of stemness markers, sphere formation capacity and xenograft transplantation into NOD/SCID mice. Our findings validated that ALDH1-high subpopulations showed significantly increased tumor-initiating ability. Furthermore, we investigated the microRNA expression profile of HNSCC stem cells using microRNA array and confirmed the results by quantitative real-time PCR. We found that expressions of miR-424, let-7a, miR-6836, miR-6873 and miR-7152 were downregulated, whereas miR-147b was upregulated with statistical significance in the ALDH1-high subpopulation. In conclusion, we identified a subset of microRNAs that were differentially expressed in ALDH1-high subpopulation, providing new microRNA targets to study dysregulation of HNSCC-initiating cells and develop therapeutic strategies aimed at eradicating the tumorigenic stem cells in HNSCC.	[Yata, Kazuya; Beder, Levent Bekir; Tamagawa, Shunji; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama 6418509, Japan; [Hirohashi, Yoshihiko] Sapporo Med Univ, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Grenman, Reidar] Univ Turku, Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Turku, Finland; [Grenman, Reidar] Univ Turku, Turku Univ Hosp, Dept Med Biochem, Turku, Finland	Yamanaka, N (reprint author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Kimiidera 811-1, Wakayama 6410012, Japan.	ynobi@wakayama-med.ac.jp			Wakayama Medical University	This study was supported in part by Doctorate Program Research Grant of Wakayama Medical University.	O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; MINN H, 1995, J NUCL MED, V36, P252; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Tamagawa S, 2014, INT J MOL MED, V33, P879, DOI 10.3892/ijmm.2014.1625; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Pouliot LM, 2012, CANCER RES, V72, P5945, DOI 10.1158/0008-5472.CAN-12-1400; Huang CX, 2013, ASIAN PAC J CANCER P, V14, P4533, DOI 10.7314/APJCP.2013.14.8.4533; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; [Anonymous], 1999, HUMAN CELL CULTURE; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dufour X, 2012, Eur Ann Otorhinolaryngol Head Neck Dis, V129, P26, DOI 10.1016/j.anorl.2011.05.004; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Major AG, 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013/319489; Nam EJ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-18; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Sun JG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-174; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06248	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	OCT	2015	47	4					1249	1256		10.3892/ijo.2015.3145		8	Oncology	Oncology	CS4PN	WOS:000362058300008		
J	Yamada, A; Osada, S; Tanahashi, T; Matsui, S; Sasaki, Y; Tanaka, Y; Okumura, N; Matsuhashi, N; Takahashi, T; Yamaguchi, K; Yoshida, K				Yamada, Atsuko; Osada, Shinji; Tanahashi, Toshiyuki; Matsui, Satoshi; Sasaki, Yoshiyuki; Tanaka, Yoshihiro; Okumura, Naoki; Matsuhashi, Nobuhisa; Takahashi, Takao; Yamaguchi, Kazuya; Yoshida, Kazuhiro			Novel therapy for locally advanced triple-negative breast cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						vitamin K3 (menadione); triple-negative breast cancer; ablation therapy; minimally invasive therapy	REGULATED KINASE PHOSPHORYLATION; INDUCED GROWTH-INHIBITION; PHASE-II TRIAL; MITOMYCIN-C; VITAMIN-K3 MENADIONE; PANCREATIC-CANCER; CELL-DEATH; T-CELLS; APOPTOSIS; MECHANISMS	To evaluate a novel therapy for triple-negative breast cancer (TNBC), the biological responses to vitamin K3 (VK3) should be considered with the understanding of the features of breast cancer. In human breast cancer cell lines, the effects of VK3 on cell growth inhibition and the cellular signaling pathway were determined by MTT assay and western blotting. In the in vivo study, a subcutaneous tumor model of breast cancer was created, VK3 was injected into the subcutaneous tumors, and tumor size was measured. The IC50 of VK3 for breast cancer cells was calculated to be 11.3-25.1 mu M. VK3 induced phosphorylation of whole tyrosine and epidermal growth factor receptor. VK3 mediated phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) for 30 min. ERK but not JNK phosphorylation was maintained for at least 6 h. In contrast, another antioxidant agent, catalase, showed no effect on either ERK phosphorylation or growth inhibition. On built-up tumors under the skin of mice, local treatment with VK3 was effective in a time- and dose-dependent manner, and the experiments for total tumor volume also showed a dose-dependent effect of VK3. The expression of phosphorylated ERK was clearly detected at 10.9 times the control in tumor tissue, whereas ethanol itself showed no effect. In conclusion, ERK plays a critical role in VK3-induced growth inhibition, and it will be the focus of next steps in the development of molecular therapy for TNBC.	[Yamada, Atsuko; Tanahashi, Toshiyuki; Sasaki, Yoshiyuki; Tanaka, Yoshihiro; Okumura, Naoki; Matsuhashi, Nobuhisa; Takahashi, Takao; Yamaguchi, Kazuya; Yoshida, Kazuhiro] Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu 5011194, Japan; [Osada, Shinji; Matsui, Satoshi] Gifu Univ, Multidisciplinary Therapy Hepatobiliary Pancreat, Grad Sch Med, Gifu 5011194, Japan	Osada, S (reprint author), Gifu Univ, Multidisciplinary Therapy Hepatobiliary Pancreat, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	sting@gifu-u.ac.jp					Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; Imai H, 2007, CANCER SCI, V98, P416, DOI 10.1111/j.1349-7006.2006.00385.x; Wu J, 2011, CHEM-BIOL INTERACT, V193, P3, DOI 10.1016/j.cbi.2011.03.008; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; MARGOLIN KA, 1995, CANCER CHEMOTH PHARM, V36, P293, DOI 10.1007/BF00689046; Zagar TM, 2014, INT J HYPERTHER, V30, P285, DOI 10.3109/02656736.2014.936049; Osada S, 2001, J HEPATOL, V34, P676, DOI 10.1016/S0168-8278(00)00102-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Chen FH, 2010, CANCER LETT, V296, P96, DOI 10.1016/j.canlet.2010.04.004; Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Yang CR, 2013, TOXICOL APPL PHARM, V273, P611, DOI 10.1016/j.taap.2013.10.007; Manenti G, 2013, BREAST CARE, V8, P356, DOI 10.1159/000355707; Osada S, 2001, CANCER, V91, P1156, DOI 10.1002/1097-0142(20010315)91:6<1156::AID-CNCR1112>3.0.CO;2-1; Suresh S, 2013, ASIAN PAC J CANCER P, V14, P5461, DOI 10.7314/APJCP.2013.14.9.5461; Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599; Gelmon K, 2012, ANN ONCOL, V23, P2223, DOI 10.1093/annonc/mds067; TETEF M, 1995, J CANCER RES CLIN, V121, P103, DOI 10.1007/BF01202221; TETEF M, 1995, INVEST NEW DRUG, V13, P157, DOI 10.1007/BF00872865; Osada S, 2001, J MOL BIOL, V314, P765, DOI 10.1006/jmbi.2001.5171; Li X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.321; Osada S, 2005, J AM COLL SURGEONS, V201, P405, DOI 10.1016/j.jamcollsurg.2005.05.015; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Osada S, 2008, CANCER CHEMOTH PHARM, V62, P315, DOI 10.1007/s00280-007-0610-9; Osada S, 2008, ANTICANCER RES, V28, P45; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Kovacic P, 2001, CURR MED CHEM, V8, P773; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Akiyoshi T, 2009, CANCER CHEMOTH PHARM, V65, P143, DOI 10.1007/s00280-009-1016-7; Baran I, 2014, LEUKEMIA RES, V38, P836, DOI 10.1016/j.leukres.2014.04.010; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Scott GK, 2005, MOL PHARMACOL, V68, P606, DOI 10.1124/mol.105.013474; Dong-Yun Shi, 2003, FEBS Lett, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Esakky P, 2015, J MOL CELL BIOL, V7, P73, DOI 10.1093/jmcb/mju049; Hamza Alaa, 2014, Gland Surg, V3, P149, DOI 10.3978/j.issn.2227-684X.2013.10.09; Nguyen Tiffany, 2014, Gland Surg, V3, P128, DOI 10.3978/j.issn.2227-684X.2014.03.05; Oostra Drew R, 2014, Breast Cancer (Dove Med Press), V6, P103, DOI 10.2147/BCTT.S67297; Osada Shinji, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P119, DOI 10.2174/1568011033353461; Osada S, 2009, ANTI-CANCER AGENT ME, V9, P877; Williams Cecilia, 2013, Ecancermedicalscience, V7, P370, DOI 10.3332/ecancer.2013.370; Zelnak AB, 2015, CANCER-AM CANCER SOC, V121, P17, DOI 10.1002/cncr.28815	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	OCT	2015	47	4					1266	1272		10.3892/ijo.2015.3113		7	Oncology	Oncology	CS4PN	WOS:000362058300010		
J	Nakashiro, K; Tanaka, H; Goda, H; Iwamoto, K; Tokuzen, N; Hara, S; Onodera, J; Fujimoto, I; Hino, S; Hamakawa, H				Nakashiro, Koh-Ichi; Tanaka, Hiroshi; Goda, Hiroyuki; Iwamoto, Kazuki; Tokuzen, Norihiko; Hara, Shingo; Onodera, Jun; Fujimoto, Ichiro; Hino, Satoshi; Hamakawa, Hiroyuki			Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						oral squamous cell carcinoma; Akt1; molecular target therapy	SMALL INTERFERING RNA; IN-VIVO; PROTEIN EXPRESSION; PLUS CETUXIMAB; HUMAN CANCER; NECK-CANCER; PATHWAY; ATELOCOLLAGEN; DELIVERY; HEAD	Oncogene addiction can provide therapeutic opportunities in human malignancies. In this study, we aimed to identify critical oncogenes for oral squamous cell carcinoma (OSCC) development and progression. We determined gene expression profiles in 10 primary OSCCs and 10 human OSCC cell lines using Applied Biosystems Human Genome Survey Arrays. Akt1 was the only gene identified that was expressed in all OSCC tissues and cultured cells, but not in non-neoplastic tissues and cells. Subsequently, western blot analysis showed that Aka protein was overexpressed in OSCC tissues and cell lines. Immunohistochemistry also showed Akt1 protein expression in 59 of 63 (94%) primary OSCCs. To clarify the oncogenic function of Akt1 in human OSCC cells, we used RNA interference. We designed and synthesized 5 small interfering RNAs specific for Akt1 (siAkt1). Transfecting human OSCC cells with siAkt1 in vitro markedly suppressed their expression of Akt1 protein and significantly reduced their growth rate. Furthermore, the growth of human OSCC tumors which had been subcutaneously xenografted in athymic nude mice lacking interferon responses was markedly inhibited by atelocollagen-mediated systemic siAkt1 administration. We also found that synthetic siAkt1 had an inhibitory effect on the growth of primary cultured OSCC cells. Finally, we investigated the molecular mechanisms involved in the growth inhibitory effect of Akt1 suppression using microarray analysis of human OSCC cells transfected with siAkt1. Knockdown of Aka induced the expression of CDKN2B, a tumor suppressor gene, and reduced the expression of TGFBR1, which supports malignant phenotypes. These results suggest that Aka functions as a critical oncogene in human OSCC cells and may therefore be an appropriate target for novel OSCC therapies.	[Nakashiro, Koh-Ichi; Tanaka, Hiroshi; Goda, Hiroyuki; Iwamoto, Kazuki; Tokuzen, Norihiko; Hino, Satoshi; Hamakawa, Hiroyuki] Ehime Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Toon, Ehime 7910295, Japan; [Hara, Shingo] Kochi Hlth Sci Ctr, Dept Oral & Maxillofacial Surg, Kochi, Kochi, Japan; [Onodera, Jun; Fujimoto, Ichiro] Koken Co Ltd, Koken Res Inst, Tokyo, Japan	Nakashiro, K (reprint author), Ehime Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, 454 Shitsukawa, Toon, Ehime 7910295, Japan.	nakako@m.ehime-u.ac.jp		Hara, Shingo/0000-0002-4390-7820	Japan Society for the Promotion of Science [21592557, 17689057]	This study was supported by Grant-in-Aid for Young Scientists (A) 17689057 and Scientific Research (C) 21592557 in Japan Society for the Promotion of Science.	Beck JT, 2014, CANCER TREAT REV, V40, P980, DOI 10.1016/j.ctrv.2014.06.006; Huang SF, 2012, ORAL ONCOL, V48, P67, DOI 10.1016/j.oraloncology.2011.06.511; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Naruse T, 2015, PATHOL ONCOL RES, V21, P765, DOI 10.1007/s12253-014-9888-1; Cohen Y, 2011, ORAL ONCOL, V47, P946, DOI 10.1016/j.oraloncology.2011.07.013; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Lim J, 2005, J CLIN PATHOL, V58, P1199, DOI 10.1136/jcp.2004.024786; Ochiya T, 1999, NAT MED, V5, P707; Shintani S, 2002, ORAL ONCOL, V38, P664, DOI 10.1016/S1368-8375(01)00131-2; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI [10.1158/0008-5472.CAN-07-3293, 10.1158/0008-5472.CA,N-07-3293]; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Azuma K, 2010, BIOCHEM BIOPH RES CO, V391, P1075, DOI 10.1016/j.bbrc.2009.12.024; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Klosek SK, 2008, ONCOL REP, V20, P873, DOI 10.3892/or_00000085; Shintani S, 2010, INT J ORAL MAX SURG, V39, P1115, DOI 10.1016/j.ijom.2010.02.027; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	OCT	2015	47	4					1273	1281		10.3892/ijo.2015.3134		9	Oncology	Oncology	CS4PN	WOS:000362058300011		
J	Toyota, Y; Iwama, H; Kato, K; Tani, J; Katsura, A; Miyata, M; Fujiwara, S; Fujita, K; Sakamoto, T; Fujimori, T; Okura, R; Kobayashi, K; Tadokoro, T; Mimura, S; Nomura, T; Miyoshi, H; Morishita, A; Kamada, H; Yoneyama, H; Okano, K; Suzuki, Y; Masaki, T				Toyota, Yuka; Iwama, Hisakazu; Kato, Kiyohito; Tani, Joji; Katsura, Akiko; Miyata, Miwa; Fujiwara, Shintaro; Fujita, Koji; Sakamoto, Teppei; Fujimori, Taicayuki; Okura, Ryoichi; Kobayashi, Kiyoyuki; Tadokoro, Tomoko; Mimura, Shima; Nomura, Takako; Miyoshi, Hisaaki; Morishita, Asahiro; Kamada, Hideki; Yoneyama, Hirohito; Okano, Keiichi; Suzuki, Yasuyuki; Masaki, Tsutomu			Mechanism of gemcitabine-induced suppression of human cholangiocellular carcinoma cell growth	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						gemcitabine; cholangiocellular carcinoma; microRNA; angiogenesis; cell cycle	HUMAN HEPATOCELLULAR-CARCINOMA; ANTIDIABETIC DRUG METFORMIN; BILIARY-TRACT CANCER; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; IN-VITRO; INTRAHEPATIC CHOLANGIOCARCINOMA; REDUCED EXPRESSION; LUNG-CANCER; LET-7	Although gemcitabine (2',2'-difluorocytidine monohydrochloride) is a common anticancer agent of cholangiocellular carcinoma (CCC), its growth inhibitory effects and gemcitabine resistance in CCC cells are poorly understood. Our aims were to uncover the mechanism underlying the antitumor effect of gemcitabine and to analyze the mechanism regulating in vitro CCC cell gemcitabine resistance. In addition, we sought to identify miRNAs associated with the antitumor effects of gemcitabine in CCCs. Using a cell proliferation assay and flow cytometry, we examined the ability of gemcitabine to inhibit cell proliferation in three types of human CCC cell lines (HuCCT-1, Huh28,TKKK). We also employed western blotting to investigate the effects of gemcitabine on cell cycle-related molecules in CCC cells. In addition, we used array chips to assess gemcitabine-mediated changes in angiogenic molecules and activated tyrosine kinase receptors in CCC cells. We used miRNA array chips to comprehensively analyze gemcitabine-induced miRNAs and examined clusters of differentially expressed miRNAs in cells with and without gemcitabine treatment. Gemcitabine inhibited cell proliferation in a dose- and time-dependent manner in HuCCT-1 cells, whereas cell proliferation was unchanged in Huh28 and TKKK cells. Gemcitabine inhibited cell cycle progression in HuCCT-1 cells from G0/G1 to S phase, resulting in G1 cell cycle arrest due to the reduction of cyclin D1 expression. In addition, gemcitabine upregulated the angiogenic molecules IL-6, IL-8, ENA-78 and MCP-1. In TKKK cells, by contrast, gemcitabine did not arrest the cell cycle or modify angiogenic molecules. Furthermore, in gemcitabine-sensitive HuCCT-1 cells, gemcitabine markedly altered miRNA expression. The miRNAs and angiogenic molecules altered by gemcitabine contribute to the inhibition of tumor growth in vitro.	[Toyota, Yuka; Kato, Kiyohito; Tani, Joji; Katsura, Akiko; Miyata, Miwa; Fujiwara, Shintaro; Fujita, Koji; Sakamoto, Teppei; Fujimori, Taicayuki; Okura, Ryoichi; Kobayashi, Kiyoyuki; Tadokoro, Tomoko; Mimura, Shima; Nomura, Takako; Miyoshi, Hisaaki; Morishita, Asahiro; Kamada, Hideki; Yoneyama, Hirohito; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan; [Okano, Keiichi; Suzuki, Yasuyuki] Kagawa Univ, Dept Surg Gastroenterol, Miki, Kagawa 7610793, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan	Masaki, T (reprint author), Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tmasaki@med.kagawa-u.ac.jp					Morishita A, 2004, HEPATOLOGY, V40, P677, DOI 10.1002/hep.20337; Haga H, 2014, GENE EXPRESSION, V16, P93, DOI 10.3727/105221614X13919976902174; Wang XJ, 2012, BIOCHEM BIOPH RES CO, V428, P525, DOI 10.1016/j.bbrc.2012.10.039; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Zhu XM, 2011, J INT MED RES, V39, P2323; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Masaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705; Sugimachi K, 2001, J HEPATOL, V35, P74, DOI 10.1016/S0168-8278(01)00079-4; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Osada H, 2011, CANCER SCI, V102, P9, DOI 10.1111/j.1349-7006.2010.01707.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Yang YF, 2014, INT J CLIN EXP MED, V7, P893; Guo YJ, 2011, MOL CELL BIOCHEM, V354, P275, DOI 10.1007/s11010-011-0827-0; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Hong DS, 2007, CANCER, V110, P1911, DOI 10.1002/cncr.22999; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Anderson CD, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-1-43; Miyoshi H, 2014, INT J ONCOL, V45, P322, DOI 10.3892/ijo.2014.2419; Matsumoto K, 2008, ONCOL REP, V20, P863, DOI 10.3892/or_00000084; Nakajima Y, 2012, ANTICANCER RES, V32, P5251; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Jarnagin WR, 2003, CANCER, V98, P1689, DOI 10.1002/cncr.11699; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Sun CY, 2013, ONCOL LETT, V6, P507, DOI 10.3892/ol.2013.1393; Chun-Zhi Zhang, 2010, BMC Cancer, V10, P367, DOI 10.1186/1471-2407-10-367; Hirata H, 2013, BRIT J CANCER, V108, P2070, DOI 10.1038/bjc.2013.173; Iwaki J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069496; Katsura A, 2015, INT J MOL MED, V35, P877, DOI 10.3892/ijmm.2015.2092; Patel T, 2014, J GASTROENTEROL, V49, P165, DOI 10.1007/s00535-013-0894-y; Saito Yoshimasa, 2011, Frontiers in Genetics, V2, P66, DOI 10.3389/fgene.2011.00066; Salcedo R, BLOOD, V96, P34; Wang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043826; Xiao ZG, 2014, CANCER RES, V74, P6236, DOI 10.1158/0008-5472.CAN-14-0855	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	OCT	2015	47	4					1293	1302		10.3892/ijo.2015.3118		10	Oncology	Oncology	CS4PN	WOS:000362058300013		
J	Yamaguchi, M; Murata, T; Shoji, M; Weitzmann, MN				Yamaguchi, Masayoshi; Murata, Tomiyasu; Shoji, Mamoru; Weitzmann, M. Neale			The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						p-hydroxycinnamic acid; human breast cancer; MDA-MB-231 cell; cell proliferation; apoptosis; mineralization; osteoclastogenesis; bone marrow	NF-KAPPA-B; HEPATOMA H4-II-E CELLS; OSTEOCLASTOGENESIS; PROLIFERATION; REGUCALCIN; OSTEOBLASTOGENESIS; DIFFERENTIATION; MINERALIZATION; ACTIVATION; MECHANISMS	Tumor invasion into bone tissues is associated with osteoclast and osteoblast recruitment, resulting in the liberation of growth factors from the bone matrix, which can feed back to enhance tumor growth resulting in the vicious cycle of bone metastasis. Activated nuclear factor-kappa B (NF-kappa B) in breast cancer cells has been shown to play a crucial role in the osteolytic bone metastasis of breast cancer in stimulating osteoclastogenesis. The flavonoid p-hydroxycinnamic acid (HCA) mediates bone anabolic and anti-catabolic effects by stimulating osteoblastic bone formation and suppressing osteoclastic bone resorption. However, the capacity of HCA to ameliorate the negative effects of breast cancer on bone cells has not been investigated. The present study was undertaken to determine the anticancer effects of HCA on MDA-MB-231 human breast cancer bone metastatic cells in vitro models. Proliferation of MDA-MB-231 cells was suppressed by culture with HCA (10-1000 nM) due to G1 and G2/M phase cell cycle arrest. The suppressive effects of HCA were mediated through signaling pathways that are related to NF-kappa B, extracellular signal-regulated kinase (ERK), protein kinase C, calcium signaling, phosphatidylinositol 3-kinase (PI3K) and nuclear transcription activity. HCA was also found to induce death of confluent cancer cells. Furthermore, co-culture with MDA-MB-231 cells suppressed mineralization and stimulated osteoclastogenesis in bone marrow cells. These alterations were prevented by HCA (10-250 nM). The present study demonstrates that HCA possesses anticancer properties in MDA-MB-231 human breast cancer cells and alleviates the negative effects on osteoblastogenesis and osteoclastogenesis in vitro. HCA may have important applications in the treatment of breast cancer bone metastasis.	[Yamaguchi, Masayoshi; Shoji, Mamoru] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Murata, Tomiyasu] Meijo Univ, Fac Pharm, Lab Analyt Neurobiol, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Weitzmann, M. Neale] Vet Affairs Med Ctr, Atlanta Dept, Decatur, GA 30033 USA; [Weitzmann, M. Neale] Emory Univ, Sch Med, Dept Med, Div Endocrinol & Metab & Lipids, Atlanta, GA 30322 USA	Yamaguchi, M (reprint author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365 C Clifton Rd NE, Atlanta, GA 30322 USA.	yamamasa1155@yahoo.co.jp					Yamaguchi M, 2013, APOPTOSIS, V18, P1145, DOI 10.1007/s10495-013-0859-x; Zaidi M, 2003, J BONE MINER RES, V18, P599, DOI 10.1359/jbmr.2003.18.4.599; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Palangat M, 2011, MOL CELL BIOL, V31, P3312, DOI 10.1128/MCB.05318-11; Lai YL, 2007, INT J MOL MED, V19, P123; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yamaguchi M, 2008, MOL CELL BIOCHEM, V311, P31, DOI 10.1007/s11010-007-9689-x; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Akhtari M, 2008, CANCER BIOL THER, V7, P3; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Boyce BF, 1999, ENDOCR-RELAT CANCER, V6, P333, DOI 10.1677/erc.0.0060333; Yamaguchi M, 2007, INT J MOL MED, V19, P803; Tang SC, 2014, WORLD J GASTROENTERO, V20, P10825, DOI 10.3748/wjg.v20.i31.10825; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2001.0210; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490; Yamaguchi M, 2013, CELL TISSUE RES, V354, P743, DOI 10.1007/s00441-013-1707-6; Yamaguchi M, 2012, INT J MOL MED, V30, P708, DOI 10.3892/ijmm.2012.1043; Yamaguchi M, 2008, INT J MOL MED, V22, P287, DOI 10.3892/ijmm_00000021; Lai YL, 2006, MOL CELL BIOCHEM, V292, P45, DOI 10.1007/s11010-006-9175-x; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Chen SY, 2014, ONCOL LETT, V8, P2333, DOI 10.3892/ol.2014.2521; Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Roodman CD, 2004, NEW ENGL J MED, V350, P1655; Serrano-Nascimento C, 2014, ENDOCRINOLOGY, V155, P1145, DOI 10.1210/en.2013-1665; Yamaguchi M, 2015, MOL CELL BIOCHEM, V401, P1, DOI 10.1007/s11010-014-2286-x	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	OCT	2015	47	4					1563	1571		10.3892/ijo.2015.3106		9	Oncology	Oncology	CS4PN	WOS:000362058300041		
J	Masaki, H; Xu, L; Taima, N; Murphy, TI				Masaki, Hiroaki; Xu, Lu; Taima, Naoya; Murphy, Timothy I.			The functional significance of the skilled performance positivity: An update	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Skilled performance positivity; Feedback-related negativity; P300; Performance monitoring; Error-related negativity	MEDIAL-FRONTAL-CORTEX; EVENT-RELATED FMRI; ERROR-DETECTION; NEURAL SYSTEM; HUMAN BRAIN; FEEDBACK; INFORMATION; TOPOGRAPHY; COMPONENTS; ATTENTION	The skilled performance positivity (SPP) emerges approximately 450 ms after button presses in a skilled performance task (SPT) where the participant is required to initiate a visual sweep with a left-hand button press and then stop it with a right-hand button press within a predetermined time frame (ranging from 40 to 60 ms). The SPP has been thought to represent appraisal of performance results independent of the reafferent activity, and reported to reduce in amplitude following inaccurate timing performance. We hypothesized that reduced SPP on incorrect trials merely indicates superimposition of the feedback-related negativity (FRN) that is elicited by negative outcomes, because the right-hand button press not only stops the visual sweep but also presents visual feedback. Further, we assumed that the SPP essentially represents a P300 elicited by the visual feedback. To address these questions, we compared the SPT condition and a delayed-feedback (DFB) condition where feedback was presented approximately 1 s after the left-hand button press. We observed the SPP only in the SPT condition, and found feedback-elicited P300s in the DFB condition. Both of these positivities shared a similar scalp distribution. We also replicated the reduced SPP on incorrect trials that shared a similar topography with the FRN elicited by the negative feedback. According to these findings, it is reasonable to conclude that the SPP represents the feedback-elicited P300, and after incorrect performance an FRN is superimposed on it. (C) 2015 Elsevier B.V. All rights reserved.	[Masaki, Hiroaki; Xu, Lu; Taima, Naoya] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Xu, Lu] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Murphy, Timothy I.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada	Masaki, H (reprint author), Waseda Univ, Fac Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	masaki@waseda.jp			JSPS [24530925]	We would like to thank Eriko Tanaka and Toni Karouji for their help with the data collection. We also thank Dr. Rolf Verleger and an anonymous reviewer for their helpful comments on earlier versions of this manuscript. This study was supported by a Grant-in-Aid for Scientific Research (C) 24530925 from JSPS.	Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Masaki H, 2006, BRAIN RES, V1105, P110, DOI 10.1016/j.brainres.2006.01.022; Krigolson OE, 2006, NEUROSCIENCE, V137, P13, DOI 10.1016/j.neuroscience.2005.10.064; Fattapposta F, 2002, CLIN NEUROPHYSIOL, V113, P243, DOI 10.1016/S1388-2457(01)00723-4; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Fontani G, 2007, PERCEPT MOTOR SKILL, V105, P803, DOI 10.2466/PMS.105.3.803-826; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1017/S0048577200990231; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Krigolson OE, 2007, BRAIN RES, V1155, P70, DOI 10.1016/j.brainres.2007.04.024; MCADAM DW, 1971, ELECTROEN CLIN NEURO, V30, P511, DOI 10.1016/0013-4694(71)90148-9; CHIARENZA GA, 1990, J LEARN DISABIL, V23, P375; Satow T, 2004, AM J PHYSIOL-GASTR L, V287, pG459, DOI 10.1152/ajpgi.00323.2003; Luu P, 2000, J NEUROSCI, V20, P464; Krigolson OE, 2012, BRAIN RES, V1430, P62, DOI 10.1016/j.brainres.2011.10.028; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; CHIARENZA GA, 1990, INT J PSYCHOPHYSIOL, V10, P105, DOI 10.1016/0167-8760(90)90025-9; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KLEIN RM, 1977, J EXP PSYCHOL HUMAN, V3, P365, DOI 10.1037//0096-1523.3.3.365; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Chiarenza GA, 2014, INT J PSYCHOPHYSIOL, V94, P111, DOI 10.1016/j.ijpsycho.2014.09.002; Coles M.G.H., 1995, ELECTROPHYSIOLOGY MI, P8; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; Kornhuber H.H., 1965, PFLUGERS ARCH GES PH, V248, P1; Krigolson O. E., 2008, EXP BRAIN RES, V190, P401; Papakostopoulos D, 1978, MULTIDISCIPLINARY PE, P134; PAPAKOSTOPOULOS D, 1980, ELECTROEN CLIN NEURO, V48, P622, DOI 10.1016/0013-4694(80)90420-4; SWINNEN SP, 1990, J EXP PSYCHOL LEARN, V16, P706, DOI 10.1037/0278-7393.16.4.706; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2015	98	1					44	53		10.1016/j.ijpsycho.2015.06.007		10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CS5QT	WOS:000362133700006		
J	Niina, M; Okamura, J; Wang, G				Niina, Megumi; Okamura, Jun-ya; Wang, Gang			Electrophysiological evidence for separation between human face and non-face object processing only in the right hemisphere	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						ERP; Face recognition; Object recognition; Right hemispheric dominance; Dipole source	MONKEY INFEROTEMPORAL CORTEX; HUMAN NEURAL SYSTEM; TEMPORAL CORTEX; FUNCTIONAL ARCHITECTURE; VISUAL-CORTEX; FACIAL EXPRESSION; FUSIFORM GYRUS; PERCEPTION; RECOGNITION; BRAIN	Scalp event-related potential (ERP) studies have demonstrated larger N170 amplitudes when subjects view faces compared to items from object categories. Extensive attempts have been made to clarify face selectivity and hemispheric dominance for face processing. The purpose of this study was to investigate hemispheric differences in NI 70s activated by human faces and non-face objects, as well as the extent of overlap of their sources. ERP was recorded from 20 subjects while they viewed human face and non-face images. N170s obtained during the presentation of human faces appeared earlier and with larger amplitude than for other category images. Further source analysis with a two-dipole model revealed that the locations of face and object processing largely overlapped in the left hemisphere. Conversely, the source for face processing in the right hemisphere located more anterior than the source for object processing. The results suggest that the neuronal circuits for face and object processing are largely shared in the left hemisphere, with more distinct circuits in the right hemisphere. (C) 2015 Elsevier B.V. All rights reserved.	[Niina, Megumi; Okamura, Jun-ya; Wang, Gang] Kagoshima Univ, Grad Sch Sci & Engn, Dept Informat Sci & Biomed Engn, Kagoshima 8900065, Japan; [Wang, Gang] Weifang Med Univ, Lab Cognit Neurosci, Weifang, Peoples R China	Wang, G (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Informat Sci & Biomed Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	gwang@ibe.kagoshima-u.ac.jp			 [26350506]	This research was supported in part by a Grant-in-Aid for Scientific Research (26350506) to G.W.	Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.3576.d8; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; LEVY J, 1983, BRAIN COGNITION, V2, P404, DOI 10.1016/0278-2626(83)90021-0; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Jemel B, 2005, NEUROPSYCHOLOGIA, V43, P2024, DOI 10.1016/j.neuropsychologia.2005.03.016; Puce A, 1996, J NEUROSCI, V16, P5205; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; SERGENT J, 1981, PSYCHOL BULL, V89, P541, DOI 10.1037/0033-2909.89.3.541; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; RHODES G, 1985, BRIT J PSYCHOL, V76, P249; Nguyen VT, 2014, NEUROIMAGE, V86, P492, DOI 10.1016/j.neuroimage.2013.10.047; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Willems RM, 2010, CEREB CORTEX, V20, P1719, DOI 10.1093/cercor/bhp234; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; LEVINE SC, 1988, BRAIN COGNITION, V8, P303, DOI 10.1016/0278-2626(88)90057-7; Eger E, 2005, NEUROIMAGE, V26, P1128, DOI 10.1016/j.neuroimage.2005.03.010; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Gauthier I, 2005, COGN AFFECT BEHAV NE, V5, P222, DOI 10.3758/CABN.5.2.222; Puce A, 1998, J NEUROSCI, V18, P2188; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Rotshtein P, 2007, CEREB CORTEX, V17, P2713, DOI 10.1093/ccrcor/bhl180; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Godard O, 2010, BRAIN COGNITION, V73, P167, DOI 10.1016/j.bandc.2010.04.008; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; De Renzi E., 1997, BEHAV NEUROLOGY NEUR, P245; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Jeffreys D. A., 1996, VIS COGN, V6, P1, DOI DOI 10.1080/713756729; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Rossion B., 2000, NEUROREPORT, V11, P1; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; Tiedt HO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069107; Valkonen-Korhonen Minna, 2005, Brain Res Cogn Brain Res, V23, P277; Yue X., 2011, CEREB CORTEX, V17, P2713	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2015	98	1					119	127		10.1016/j.ijpsycho.2015.07.008		9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CS5QT	WOS:000362133700014		
J	Ando, M; Ohsato, H; Igimi, D; Higashida, Y; Kan, A; Suzuki, S; Yasufuku, Y; Kagomiya, I				Ando, Minato; Ohsato, Hitoshi; Igimi, Daisuke; Higashida, Yutaka; Kan, Akinori; Suzuki, Sadahiko; Yasufuku, Yoshitoyo; Kagomiya, Isao			Low-temperature sintering of silica-boric acid-doped willemite and microwave dielectric properties	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLID-SOLUTIONS; FORSTERITE; CERAMICS; FREQUENCY	Millimeter-wave wireless communications in a high-level information society have been expanding in terms of high-density data transfer and radar for pre-crash safety systems. For these communications, millimeter-wave dielectrics have been expected for the development of substrates with high quality factor (Qf), low dielectric constant (epsilon(r)), and near-zero temperature coefficient of resonance frequency (TCf). We have been studying several silicates such as forsterite, willemite, diopside, wollastonite, and cordierite/indialite glass ceramics. In this study, the synthesis of willemite and low-temperature-sintered willemite for low temperature co-fired ceramics (LTCC) is examined. The raw materials used for preparing slurries in doctor blade tape casting are also analyzed. (C) 2015 The Japan Society of Applied Physics	[Ando, Minato; Ohsato, Hitoshi] Nagoya Inst Technol, Funct Mat Lab, Nagoya, Aichi 4668555, Japan; [Kagomiya, Isao] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan; [Ohsato, Hitoshi] Nagoya Ind Sci Res Inst, Dept Res, Nagoya, Aichi 4640819, Japan; [Igimi, Daisuke; Higashida, Yutaka] Japan Fine Ceram Ctr, Mat Res & Dev Lab, Nagoya, Aichi 4568587, Japan; [Kan, Akinori] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan; [Suzuki, Sadahiko] Marusu Glaze Co Ltd, Seto, Aichi 4890032, Japan; [Yasufuku, Yoshitoyo] Yasufuku Ceram Co Ltd, Okazaki, Aichi 4440838, Japan	Ando, M (reprint author), Nagoya Inst Technol, Funct Mat Lab, Nagoya, Aichi 4668555, Japan.	ohsato.hitoshi@nitech.ac.jp			Supporting Industry Project of Japan by the Ministry of Economy, Trade and Industry of Japan (METI); MEXT/JSPS KAKENHI by the Ministry of Education, Culture, Science and Technology of Japan (MEXT) [25420721]; Adaptable and Seamless Technology Transfer Program (A-step) Japan by MEXT	The authors would like to express their thanks to Professor Ken'ichi Kakimoto of NIT and Dr. Kenji Nakahira of JFCC for support in experiments and helpful discussions. Part of this work was supported by the following projects: (1) the Supporting Industry Project of Japan by the Ministry of Economy, Trade and Industry of Japan (METI), (2) MEXT/JSPS KAKENHI (Grant Number 25420721) by the Ministry of Education, Culture, Science and Technology of Japan (MEXT), (3) Adaptable and Seamless Technology Transfer Program (A-step) Japan by MEXT.	Ohsato H, 2010, J EUR CERAM SOC, V30, P315, DOI 10.1016/j.jeurceramsoc.2009.05.024; [Anonymous], 2013, NIKKEI ELECT    1209; Ando M, 2008, JPN J APPL PHYS, V47, P7729, DOI 10.1143/JJAP.47.7729; Ohsato H, 2013, J CERAM SOC JPN, V121, P649, DOI 10.2109/jcersj2.121.649; Guo YP, 2006, J EUR CERAM SOC, V26, P1827, DOI 10.1016/j.jeurceramsoc.2005.09.008; OHSATO H, 1995, JPN J APPL PHYS 1, V34, P187, DOI 10.1143/JJAP.34.187; Tsunooka T, 2003, J EUR CERAM SOC, V23, P2573, DOI 10.1016/S0955-2219(03)00177-8; Tohdo Y, 2006, J EUR CERAM SOC, V26, P2039, DOI 10.1016/j.jeurceramsoc.2005.09.098; [Anonymous], 2006, NIKKEI ELECT    0130; Sebastian MT, 2008, INT MATER REV, V53, P57, DOI 10.1179/174328008X277524; OHSATO H, 1993, JPN J APPL PHYS 1, V32, P4323, DOI 10.1143/JJAP.32.4323; Koga E, 2006, JPN J APPL PHYS 1, V45, P7484, DOI [10.1143/JJAP.45.7484, 10.1143/JJAP.45.74841]; Ando M, 2007, JPN J APPL PHYS 1, V46, P7112, DOI 10.1143/JJAP.46.7112; Fujimoto M., 2015, 150 EL CER PROC M; Guo Y., 2006, WO, Patent No. [2006= 041093 A1, 2006041093A1]; Hakki B.W., 1960, Institute of Radio Engineers Transactions on Microwave Theory and Techniques, VMTT-8, DOI 10.1109/TMTT.1960.1124749; Imanaka Y., 2005, MULTILAYERED LOW TEM; Japan Fine Ceramics Center, 2014, REP SUPP IND PROJ 20; Kagomiya I, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KE02; KOBAYASHI Y, 1985, IEEE T MICROW THEORY, V33, P586, DOI 10.1109/TMTT.1985.1133033; Kolar D., 1978, Berichte der Deutschen Keramischen Gesellschaft, V55; Ohasto H., 2003, J KOREAN CERAM SOC, V40, P350; Ohsato H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NF01; Ohsato H., 2009, KEY ENG MATER, p[421, 77]; Ohsato H, 2005, MATER RES SOC SYMP P, V833, P55; Ohsato H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LF02; Sebastian MT, 2008, DIELECTRIC MATERIALS FOR WIRELESS COMMUNICATION, P1, DOI 10.1016/B978-0-08-045330-9.00001-7; Tsunooka T., 2004, J CERAM SOC JPN, V112, pS1637; Yamamoto T., 2005, EXPLOITATION TECHNOL, P169	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NE03	10.7567/JJAP.54.10NE03		6	Physics, Applied	Physics	CS7SO	WOS:000362286000047		
J	Aoyagi, S; Osawa, H; Sugimoto, K; Iwata, M; Takeda, S; Moriyoshi, C; Kuroiwa, Y				Aoyagi, Shinobu; Osawa, Hitoshi; Sugimoto, Kunihisa; Iwata, Makoto; Takeda, Shoichi; Moriyoshi, Chikako; Kuroiwa, Yoshihiro			Crystal structure analysis of LiTaO3 under electric field	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							X-RAY-DIFFRACTION; 24 DEGREES C; SINGLE-CRYSTAL; LINBO3; SUPERLATTICE; CONSTANTS; DYNAMICS; KINETICS; DOMAINS	Structural changes of a stoichiometric LiTaO3 single crystal accompanied by polarization switching are investigated using high-energy X-ray diffraction under static electric fields. The electric field dependence of the c-axis lattice constant depicts a small hysteresis and shows a butterfly curve. Inversion of the crystal structure accompanied by polarization switching is clearly detected with changes in the diffraction intensities of Friedel pairs. The electric field dependences of the atomic positions and volume ratio of the ferroelectric domains are obtained by crystal structure analyses. The results are fully consistent with the bulk properties and ensure that the present experimental techniques are applicable to detecting the transient atomic motions in the nucleation and growth of the ferroelectric domains during polarization switching. (C) 2015 The Japan Society of Applied Physics	[Aoyagi, Shinobu] Nagoya City Univ, Dept Informat & Basic Sci, Nagoya, Aichi 4678501, Japan; [Osawa, Hitoshi; Sugimoto, Kunihisa] JASRI, SPring 8, Sayo, Hyogo 6795198, Japan; [Iwata, Makoto] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan; [Takeda, Shoichi; Moriyoshi, Chikako; Kuroiwa, Yoshihiro] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan	Aoyagi, S (reprint author), Nagoya City Univ, Dept Informat & Basic Sci, Nagoya, Aichi 4678501, Japan.				Ministry of Education, Culture, Sports, Science and Technology of Japan [26870491]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 26870491). The synchrotron radiation experiments were performed at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2013A0100, 2013B0100, 2014A0100, and 2014B0100). S.A. thanks Mr. M. Ohmoto and Ms. Y. Nakahira for their help in the experiments.	Gahagan KT, 1999, APPL OPTICS, V38, P1186, DOI 10.1364/AO.38.001186; Zhu S, 1997, SCIENCE, V278, P843, DOI 10.1126/science.278.5339.843; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Hsu R, 1997, ACTA CRYSTALLOGR B, V53, P420, DOI 10.1107/S010876819600777X; ABRAHAMS SC, 1967, J PHYS CHEM SOLIDS, V28, P1685, DOI 10.1016/0022-3697(67)90142-4; FUJIMOTO I, 1978, PHYS REV LETT, V40, P941, DOI 10.1103/PhysRevLett.40.941; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; ABRAHAMS SC, 1967, J PHYS CHEM SOLIDS, V28, P1693, DOI 10.1016/0022-3697(67)90143-6; Gopalan V, 1999, APPL PHYS LETT, V75, P2482, DOI 10.1063/1.125055; YAMADA T, 1969, JPN J APPL PHYS, V8, P1127, DOI 10.1143/JJAP.8.1127; Nelson CT, 2011, SCIENCE, V334, P968, DOI 10.1126/science.1206980; WARNER AW, 1967, J ACOUST SOC AM, V42, P1223, DOI 10.1121/1.1910709; Kitamura K, 1998, APPL PHYS LETT, V73, P3073, DOI 10.1063/1.122676; Bargheer M, 2004, SCIENCE, V306, P1771, DOI 10.1126/science.1104739; Gopalan V, 1998, J APPL PHYS, V83, P941, DOI 10.1063/1.366782; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Gruverman A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.097601; Shur VY, 2006, J MATER SCI, V41, P199, DOI 10.1007/s10853-005-6065-7; Sugimoto K, 2010, AIP CONF PROC, V1234, P887, DOI 10.1063/1.3463359; Schroer CG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090801; Lange K, 2008, ANAL BIOANAL CHEM, V391, P1509, DOI 10.1007/s00216-008-1911-5; Gopalan V, 1999, J APPL PHYS, V86, P1638, DOI 10.1063/1.370940; Chen YF, 1997, APPL PHYS LETT, V70, P592, DOI 10.1063/1.118284; Friedel G, 1913, CR HEBD ACAD SCI, V157, P1533; Gorfman S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.097601; Moriyoshi C, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE05; Parsons S., 2004, ACTA CRYSTALLOGR A, V60, ps61; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH RT, 1971, J APPL PHYS, V42, P2219, DOI 10.1063/1.1660528	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB03	10.7567/JJAP.54.10NB03		5	Physics, Applied	Physics	CS7SO	WOS:000362286000021		
J	Choi, JH; Yoshimura, T; Fujimura, N				Choi, Jin Hong; Yoshimura, Takeshi; Fujimura, Norifumi			Growth and characterization of (1-x)BiFeO3-x(Bi-0.5,K-0.5)TiO3 thin films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PIEZOELECTRIC PROPERTIES; ENHANCED POLARIZATION; ELECTRICAL-PROPERTIES; CERAMICS; MEMS; ACTUATORS; SENSORS	Growth of 0.6BiFeO(3)-0.4(Bi-0.5,K-0.5)TiO3 thin films by rf-magnetron sputtering deposition was investigated. The (100)-oriented films with perovskite were grown on (100)-oriented LaNiO3 bottom electrodes at substrate temperatures of 475-575 degrees C. It was found that the lattice constant of the films decreases with increasing growth temperature. Moreover, the films deposited below 505 degrees C show a dielectric permittivity of similar to 600 and a loss tangent of 0.02 at 1 kHz, whereas the films deposited above 540 degrees C show large frequency dispersion. It appears that these results are caused by A-site deficiency. Although ferroelectricity was observed at the growth temperatures of 475 and 505 degrees C, the piezoelectric response was obtained only at 505 degrees C. (C) 2015 The Japan Society of Applied Physics	[Choi, Jin Hong; Yoshimura, Takeshi; Fujimura, Norifumi] Osaka Prefecture Univ, Dept Phys & Elect, Grad Sch Engn, Sakai, Osaka 5998531, Japan	Choi, JH (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Grad Sch Engn, Sakai, Osaka 5998531, Japan.	tyoshi@pe.osakafu-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was supported by the Industrial Technology Research Grant Program 2011 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Bai FM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1851612; OBRIEN RW, 1986, J COLLOID INTERF SCI, V113, P81, DOI 10.1016/0021-9797(86)90208-0; Murakami S, 2013, J PHYS CONF SER, V476, DOI 10.1088/1742-6596/476/1/012007; Kim SG, 2012, MRS BULL, V37, P1039, DOI 10.1557/mrs.2012.275; Gonzalez AHM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2433027; Baek SH, 2011, SCIENCE, V334, P958, DOI 10.1126/science.1207186; Cheng CJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3520642; Yun KY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2385859; Morozov MI, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772588; Li JF, 2004, APPL PHYS LETT, V84, P5261, DOI 10.1063/1.1764944; Kanno I, 2012, SENSOR ACTUAT A-PHYS, V179, P132, DOI 10.1016/j.sna.2012.03.003; Hagiwara M, 2015, J AM CERAM SOC, V98, P469, DOI 10.1111/jace.13287; Izyumskaya N, 2007, CRIT REV SOLID STATE, V32, P111, DOI 10.1080/10408430701707347; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Muralt P, 1996, SENSOR ACTUAT A-PHYS, V53, P398, DOI 10.1016/0924-4247(96)01139-9; Aksel E, 2010, SENSORS-BASEL, V10, P1935, DOI 10.3390/s100301935; Matsuo H, 2010, J APPL PHYS, V108, DOI 10.1063/1.3506717; Jo W, 2012, J ELECTROCERAM, V29, P71, DOI 10.1007/s10832-012-9742-3; Yang YW, 2008, SENSORS-BASEL, V8, P271, DOI 10.3390/s8010271; Shrout TR, 2007, J ELECTROCERAM, V19, P185, DOI 10.1007/s10832-007-9095-5; Ujimoto K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3692579; Ivan IA, 2010, REV ADV MATER SCI, V24, P1; MOAZZAMI R, 1992, IEEE T ELECTRON DEV, V39, P2044, DOI 10.1109/16.155876; Leontsev SO, 2009, J AM CERAM SOC, V92, P2957, DOI 10.1111/j.1551-2916.2009.03313.x; Hiruma Y, 2007, JPN J APPL PHYS 1, V46, P1081, DOI 10.1143/JJAP.46.1081; Yoshimura T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.051501; Choi JH, 2012, J KOREAN PHYS SOC, V61, P956, DOI 10.3938/jkps.61.956; MURALT P, 1995, SENSOR ACTUAT A-PHYS, V48, P157, DOI 10.1016/0924-4247(95)00994-9; Choi JH, 2014, J KOREAN PHYS SOC, V65, P382, DOI 10.3938/jkps.65.382; Hiruma Y, 2004, J CERAMIC SOC JPN S, V112, pS1125; Kariya K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.08NB02; Rojac T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3490249; Trolier-McKinstry S, 2004, J ELECTROCERAM, V12, P7, DOI 10.1023/B:JECR.0000033998.72845.51; Yun KY, 2004, JPN J APPL PHYS 2, V43, pL647, DOI 10.1143/JJAP.43.L647	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA14	10.7567/JJAP.54.10NA14		4	Physics, Applied	Physics	CS7SO	WOS:000362286000015		
J	Choi, YJ; Naoi, Y; Tomita, T				Choi, Yun Jeong; Naoi, Yoshiki; Tomita, Takuro			Self-organization of highly ordered honeycomb buckling patterns in crystalline thin films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRONICS	Highly ordered honeycomb buckling patterns were self-organized by a simple annealing process. The patterns were formed by thin, layered crystalline films of Al4C3 and carbon synthesized on a sapphire c-plane substrate by chemical vapor deposition. While annealing at 1000 degrees C, the thin bilayer film wrinkled and began to develop a two-dimensionally periodic pattern. Two patterns, with periodicities of 34 and 20 mu m, were observed by two-dimensional fast Fourier transform (2D-FFT) analysis. Both patterns showed clear and sharp peaks at six orientations, corresponding to the vertices of a regular hexagon, similarly to the crystallinity of sapphire. Additionally, a shift of the Raman peak to a lower frequency was observed after annealing. These results reveal that the self-organization of a periodic buckling pattern is possible without complicated conventional lithography through the use of crystalline materials. Thus, the highly periodic hexagonal patterns obtained with thin crystal materials have a high symmetry, as characterized from 2D-FFT, and can be applied as an optical grating. (c) 2015 The Japan Society of Applied Physics	[Choi, Yun Jeong; Naoi, Yoshiki; Tomita, Takuro] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima 7708506, Japan; [Naoi, Yoshiki; Tomita, Takuro] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Choi, YJ (reprint author), Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima 7708506, Japan.	choi@ee.tokushima-u.ac.jp; naoi@ee.tokushima-u.ac.jp			Japan Science and Technology Agency (JST)	This work was supported in part by the Japan Science and Technology Agency (JST).	Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018; Annabattula RK, 2011, J APPL PHYS, V109, DOI 10.1063/1.3544467; ALJISHI R, 1982, PHYS REV B, V26, P4514, DOI 10.1103/PhysRevB.26.4514; Pundt A, 2004, ACTA MATER, V52, P1579, DOI 10.1016/j.actamat.2003.12.003; Malachias A, 2008, ACS NANO, V2, P1715, DOI 10.1021/nn800308p; Edmondson S, 2004, ADV MATER, V16, P1327, DOI 10.1002/adma.200400761; Baca AJ, 2008, ANGEW CHEM INT EDIT, V47, P5524, DOI 10.1002/anie.200703238; Colin J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.046101; Harrison C, 2004, APPL PHYS LETT, V85, P4016, DOI 10.1063/1.1809281; Jiang HQ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719027; del Corro E, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033407; Coupeau C, 2008, MAT SCI ENG A-STRUCT, V483-84, P617, DOI 10.1016/j.msea.2006.09.181; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Horie F., 2010, 16 INT C CRYST GROWT, pPA135; Moon MW, 2002, J MECH PHYS SOLIDS, V50, P2355, DOI 10.1016/S0022-5096(02)00034-0; Yu SJ, 2013, MAT SCI ENG A-STRUCT, V583, P123, DOI 10.1016/j.msea.2013.06.084	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							105502	10.7567/JJAP.54.105502		5	Physics, Applied	Physics	CS7SG	WOS:000362285100026		
J	Eltanany, AM; Yoshimura, T; Fujimura, N; Elsayed, NZ; Ebied, MR; Ali, MGS				Eltanany, Ali M.; Yoshimura, Takeshi; Fujimura, Norifumi; Elsayed, Nour Z.; Ebied, Mohamed R.; Ali, Mohamed G. S.			Theoretical analysis of linear and nonlinear piezoelectric vibrational energy harvesters for human walking	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DUFFING OSCILLATOR; JUMP FREQUENCIES; MICROSYSTEMS; BEHAVIOR	The role of nonlinear stiffness in the performance of the piezoelectric vibrational energy harvester (pVEH) was discussed. Harmonic balance and numerical methods are applied to characterize the electromechanical response of pVEHs based on Duffing oscillator at a deterministic harmonic excitation of fundamental vibration characteristics (2 Hz, 1m.s(-2)), which corresponds to human walking. Then, the response to a vibration with two harmonic waves, which has a fixed fundamental frequency (2 Hz, 1m.s(-2)) and a frequency varied from 1.5 to 2.5 Hz. The numerical results obtained in this study indicate that nonlinearity does not have a significant advantage on the energy harvesting from human walking. (C) 2015 The Japan Society of Applied Physics	[Eltanany, Ali M.; Yoshimura, Takeshi; Fujimura, Norifumi] Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Sakai, Osaka 5998531, Japan; [Eltanany, Ali M.; Elsayed, Nour Z.; Ebied, Mohamed R.; Ali, Mohamed G. S.] Menia Univ, Fac Sci, Dept Phys, Al Minya 61519, Egypt	Eltanany, AM (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	tyoshi@pe.osakafu-u.ac.jp			Mission Department, Ministry of Higher Education (MoHE) of the Government of Egypt	Ali M. Eltanany appreciates his joint scholarship funded by the Mission Department, Ministry of Higher Education (MoHE) of the Government of Egypt.	Williams CB, 1996, SENSOR ACTUAT A-PHYS, V52, P8, DOI 10.1016/0924-4247(96)80118-X; Ando B, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/12/125020; Roundy S, 2003, COMPUT COMMUN, V26, P1131; Triplett A, 2009, J INTEL MAT SYST STR, V20, P1959, DOI 10.1177/1045389X09343218; FRISWELL MI, 1994, J SOUND VIB, V169, P261, DOI 10.1006/jsvi.1994.1018; Kim SG, 2012, MRS BULL, V37, P1039, DOI 10.1557/mrs.2012.275; Zhu DB, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/2/022001; Anton SR, 2007, SMART MATER STRUCT, V16, pR1, DOI 10.1088/0964-1726/16/3/R01; Dutoit NE, 2007, AIAA J, V45, P1126, DOI 10.2514/1.25047; Neiss S, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/10/105031; Cook-Chennault KA, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/4/043001; Sebald G, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/102001; Daqaq MF, 2014, APPL MECH REV, V66, DOI 10.1115/1.4026278; Stanton SC, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486519; Erturk A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3159815; Mann BP, 2009, J SOUND VIB, V319, P515, DOI 10.1016/j.jsv.2008.06.011; Stanton SC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3253710; Brennan MJ, 2008, J SOUND VIB, V318, P1250, DOI 10.1016/j.jsv.2008.04.032; Hu YT, 2006, IEEE T ULTRASON FERR, V53, P1387, DOI 10.1109/TUFFC.2006.1665088; Daqaq MF, 2010, J SOUND VIB, V329, P3621, DOI 10.1016/j.jsv.2010.04.002; Ramlan R, 2010, NONLINEAR DYNAM, V59, P545, DOI 10.1007/s11071-009-9561-5; Ujimoto K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3692579; Worden K, 1996, J SOUND VIB, V198, P522; Daqaq MF, 2012, NONLINEAR DYNAM, V69, P1063, DOI 10.1007/s11071-012-0327-0; Stanton SC, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3530449; Beeby SP, 2006, MEAS SCI TECHNOL, V17, pR175, DOI 10.1088/0957-0233/17/12/R01; Hajati A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3629551; Yoshimura T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.051501; Cottone F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.080601; Daqaq MF, 2011, J SOUND VIB, V330, P2554, DOI 10.1016/j.jsv.2010.12.005; Beeby SP, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/7/075022; Kariya K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.08NB02; Kariya K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA14; Kawahara Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091804, 10.1143/JJAP.51.09LB04]; Stanton SC, 2012, J INTEL MAT SYST STR, V23, P183, DOI 10.1177/1045389X11432656; Sebald G, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/7/075022; Suhaimi K, 2014, APPL MECH MATER, V471, P349, DOI 10.4028/www.scientific.net/AMM.471.349; Yoshimura T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA03	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND02	10.7567/JJAP.54.10ND02		5	Physics, Applied	Physics	CS7SO	WOS:000362286000033		
J	Fujii, I; Tagata, S; Nakao, T; Koyama, N; Adachi, H; Wada, T				Fujii, Ichiro; Tagata, Saori; Nakao, Tomohiro; Koyama, Natsuki; Adachi, Hideaki; Wada, Takahiro			Fabrication of (K,Na)NbO3 films on SrRuO3/(001)SrTiO3 substrates by pulsed laser deposition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; PIEZOELECTRIC PROPERTIES	1-3-mu m-thick (K,Na)NbO3 films were epitaxially grown on SrRuO3/(001)SrTiO3 substrates by the pulsed laser deposition using (KxNa1-x)NbO3 targets. Energy dispersive X-ray spectroscopy analysis showed that the film K content was about 10% lower than the target K content x at x = 0.1-0.8, and the (K + Na)/Nb atomic ratio was 0.8-1.0. Reciprocal space mapping of the films revealed that the films were epitaxially grown at x = 0-0.7, and the crystal system was altered with increasing K content. Ferroelectric polarization-electric field loops were observed at x = 0-0.9, with the maximum remanent polarization of similar to 40 mu C/cm(2) at x = 0.5. The remanent polarization vs K content profile was discussed with crystal structure analyses. (C) 2015 The Japan Society of Applied Physics	[Fujii, Ichiro; Tagata, Saori; Nakao, Tomohiro; Koyama, Natsuki; Wada, Takahiro] Ryukoku Univ, Mat Chem, Otsu, Shiga 5202194, Japan; [Adachi, Hideaki] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Adachi, Hideaki] Panasonic Corp, Adv Res Div, Kyoto 6190237, Japan	Fujii, I (reprint author), Ryukoku Univ, Mat Chem, Otsu, Shiga 5202194, Japan.		Fujii, Ichiro/O-6257-2015		MEXT; Green Network of Excellence (GRENE) project of MEXT	This work was, in part, supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, and the Green Network of Excellence (GRENE) project of MEXT.	Shibata K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.075502; Yamazoe S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4746079; Wakasa Y, 2011, SENSOR ACTUAT A-PHYS, V171, P223, DOI 10.1016/j.sna.2011.06.018; AHTEE M, 1976, ACTA CRYSTALLOGR A, V32, P434, DOI 10.1107/S0567739476000983; Tian H, 2015, CRYST GROWTH DES, V15, P1180, DOI 10.1021/cg501554v; Shibata K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011501; Horikiri F, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.076202; Shiraishi T, 2013, J CERAM SOC JPN, V121, P627, DOI 10.2109/jcersj2.121.627; Shibata K, 2008, JPN J APPL PHYS, V47, P8909, DOI [10.1143/JJAP.47.89091, 10.1143/JJAP.47.8909]; Yamazoe S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3330963; Saito T, 2004, JPN J APPL PHYS 1, V43, P6627, DOI 10.1143/JJAP.43.6627; Wu L, 2008, J APPL PHYS, V103, DOI 10.1063/1.2907866; Yamazoe S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3205103; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Saito T, 2005, JPN J APPL PHYS 2, V44, pL573, DOI 10.1143/JJAP.44.L573; Eom CB, 2012, MRS BULL, V37, P1007, DOI 10.1557/mrs.2012.273; Kurokawa F, 2012, MICRO NANO LETT, V7, P1223, DOI 10.1049/mnl.2012.0570; Shibata K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.121408; Baker DW, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3212861; Wada T, 2003, JPN J APPL PHYS 1, V42, P6110, DOI 10.1143/JJAP.42.6110; Kawada S, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111401; Shibata K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.041503; Fujii I, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA09; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Nakao T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LA06; Shibata K., 2014, 4 INT WORKSH PIEZ ME, pI; Shiraishi T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND11; Smith D. L., 1995, THIN FILM DEPOSITION; Suenaga K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MA05; Yamazoe S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA07; Yamazoe S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KA13; Zushi J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HB02	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA13	10.7567/JJAP.54.10NA13		6	Physics, Applied	Physics	CS7SO	WOS:000362286000014		
J	Fujisawa, H; Seto, S; Nakashima, S; Shimizu, M				Fujisawa, Hironori; Seto, Shota; Nakashima, Seiji; Shimizu, Masaru			Introduction of an artificial domain wall into BiFeO3 thin film using SrTiO3 bicrystal substrate	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTIFERROICS; DEVICES	For the future realization of nanoelectronic devices using domain walls (DWs) in ferroelectric thin films as a functional element, the artificial introduction and position control of DWs in BiFeO3 (BFO) thin films using SrTiO3 bicrystal substrates are demonstrated. The BFO thin film follows the bicrystal nature of SrTiO3, and consequently the boundary with an out-of-plane misorientation angle of 8 degrees is formed immediately above that of the substrate. The boundary shows a charged nature induced by a head-to-head polarization configuration. The BFO bicrystal film exhibits a well-saturated polarization hysteresis loop equivalent to those of single-crystalline films. The piezoresponse scanning force microscopy of polarization switching suggests ferroelastic relaxation-mediated 180 degrees switching through 71 degrees switching. Although the boundary corresponds to a low-angle symmetry boundary with misfit dislocations, experimental results show that it behaves just like normal DWs by crystallographic twinning. Therefore, it is concluded that the artificially introduced boundary can be considered as a charged 101 degrees DW. (C) 2015 The Japan Society of Applied Physics	[Fujisawa, Hironori; Seto, Shota; Nakashima, Seiji; Shimizu, Masaru] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Fujisawa, Hironori; Nakashima, Seiji; Shimizu, Masaru] Univ Hyogo, Grad Sch Engn, Res Ctr Nanomicro Struct Sci & Engn, Himeji, Hyogo 6712280, Japan	Fujisawa, H (reprint author), Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan.	fujisawa@eng.u-hyogo.ac.jp; nakashima@eng.u-hyogo.ac.jp			Japan Society for the Promotion of Science [26820115]; CASIO Science Foundation; University of Hyogo; JKA and its promotion funds from KEIRIN RACE	This work was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) 26820115, research grants from the CASIO Science Foundation and University of Hyogo, and JKA and its promotion funds from KEIRIN RACE.	Kim TH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3535981; Chen ZH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875801; Chu YH, 2007, MATER TODAY, V10, P16, DOI 10.1016/S1369-7021(07)70241-9; Seidel J, 2013, PHASE TRANSIT, V86, P53, DOI 10.1080/01411594.2012.695371; Baek SH, 2010, NAT MATER, V9, P309, DOI [10.1038/nmat2703, 10.1038/NMAT2703]; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Lee D, 2014, ADV MATER, V26, P5005, DOI 10.1002/adma.201400654; Zavaliche F, 2006, PHASE TRANSIT, V79, P991, DOI 10.1080/01411590601067144; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Jang HW, 2009, ADV MATER, V21, P817, DOI 10.1002/adma.200800823; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; Maksymovych P, 2012, NANO LETT, V12, P209, DOI 10.1021/nl203349b; DIMOS D, 1990, PHYS REV B, V41, P4038, DOI 10.1103/PhysRevB.41.4038; Cruz MP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217601; KAWASAKI M, 1994, SCIENCE, V266, P1540, DOI 10.1126/science.266.5190.1540; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/nmat2373, 10.1038/NMAT2373]; Koster G, 1998, APPL PHYS LETT, V73, P2920, DOI 10.1063/1.122630; Eliseev EA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085416; Eliseev EA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045312; Farokhipoor S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.127601; Fujisawa H, 2014, JPN J APPL PHYS, V53, DOI [10.7567/JJAP.53.09PA13, 10.7567/JJAP.53..09PA13]; Nakashima S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LB02; Nakashima S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NB01; Nakashima S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KB03; Nakashima S., 2011, IEEE P ISAF PFM, P168; Nakashima S., 2012, 5 INT C EM TRENDS EN, P128; Zavaliche F, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149180	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA06	10.7567/JJAP.54.10NA06		5	Physics, Applied	Physics	CS7SO	WOS:000362286000007		
J	Hagiwara, M; Fujihara, S				Hagiwara, Manabu; Fujihara, Shinobu			Grain size effect on phase transition behavior and electrical properties of (Bi1/2K1/2)TiO3 piezoelectric ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TITANATE CERAMICS; RELAXOR	Dense and phase-pure (Bi1/2K1/2)TiO3 (BKT) ceramics with various grain sizes from 0.18 to 1.01 mu m were prepared by conventional sintering of a hydrothermally synthesized fine powder. The decrease in grain size resulted in the reductions in tetragonality, remanent polarization, and the piezoelectric d(33) coefficient, whereas the room-temperature dielectric permittivity slightly increased with decreasing grain size. The measurement of the temperature dependence of permittivity revealed that BKT exhibited the spontaneous relaxor-to-normal ferroelectric (R-nFE) phase transition. It was also found that the maximum permittivity was decreased and the R-nFE transition was inhibited by the reduction in grain size. In this paper, on the basis of the observed grain-size-dependent phase transition behaviors, microstructural models are proposed for both coarse- and fine-grained BKT ceramics, and the mechanism underlying the grain size effect on the electrical properties is discussed. (C) 2015 The Japan Society of Applied Physics	[Hagiwara, Manabu; Fujihara, Shinobu] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan	Hagiwara, M (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan.				Japan Society for the Promotion of Science (JSPS) [25889049]	This work was supported by a Grant-in-Aid for Research Activity Start-up (No. 25889049) from the Japan Society for the Promotion of Science (JSPS).	ARLT G, 1990, J MATER SCI, V25, P2655, DOI 10.1007/BF00584864; Zou TT, 2008, J AM CERAM SOC, V91, P121, DOI 10.1111/j.1551-2916.2007.01903.x; Yang JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2754366; PAPET P, 1990, J MATER RES, V5, P2902, DOI 10.1557/JMR.1990.2902; Randall CA, 1998, J AM CERAM SOC, V81, P677; CHU F, 1993, J APPL PHYS, V74, P5129, DOI 10.1063/1.354300; Carreaud J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945884; Otonicar M, 2010, J AM CERAM SOC, V93, P4168, DOI 10.1111/j.1551-2916.2010.04013.x; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; Li ZF, 2003, J APPL PHYS, V94, P2548, DOI 10.1063/1.1592290; Zhao Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024107; Konig J, 2009, J EUR CERAM SOC, V29, P1695, DOI 10.1016/j.jeurceramsoc.2008.10.002; Hagiwara M, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4926496; Hiruma Y, 2005, JPN J APPL PHYS 1, V44, P5040, DOI 10.1143/JJAP.44.5040; RANDALL CA, 1993, J MATER RES, V8, P880, DOI 10.1557/JMR.1993.0880; Hoshina T, 2013, J CERAM SOC JPN, V121, P156, DOI 10.2109/jcersj2.121.156; CHU F, 1995, J APPL PHYS, V77, P1671, DOI 10.1063/1.358856; Hiruma Y, 2007, JPN J APPL PHYS 1, V46, P1081, DOI 10.1143/JJAP.46.1081; Hagiwara M, 2015, J MATER SCI, V50, P5970, DOI 10.1007/s10853-015-9144-4; Hoshina T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC02; Ivanova V.V., 1962, Izvestiya Akademii Nauk SSSR, Seriya Fizicheskaya, V26; Kakimoto K, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091-006, 10.1143/JJAP.51.09LD06]; Nagata H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD05	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND10	10.7567/JJAP.54.10ND10		4	Physics, Applied	Physics	CS7SO	WOS:000362286000041		
J	Hara, A; Awano, T				Hara, Akito; Awano, Teruyoshi			Mechanism of formation of ultrashallow thermal donors in carbon-doped oxygen-rich monocrystalline silicon preannealed to introduce hydrogen	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PARAMAGNETIC-RESONANCE; COMPLEXES; NITROGEN; ABSORPTION; CRYSTALS; AL	We previously reported on ultrashallow thermal donors (USTDs) in carbon-doped oxygen-containing monocrystalline silicon (Czochralski-grown, CZ-Si) crystals that were preannealed to introduce hydrogen at 1300 degrees C, and then annealed at 480 degrees C. In this study, the formation mechanism of the USTDs was evaluated. It was observed that an increase in the intensity of UTSDs leads to a reduction in that of hydrogen-related shallow thermal donors [STD(H)s], and the sum of the area intensities of the lines in the transmission spectra of USTDs and STD(H) s is nearly constant when the silicon crystals are annealed for longer than 10 h at 480 degrees C. We also found some thermally activated processes linked to the formation of USTDs. We thus conclude that the mechanism is composed of the high-speed formation of STD(H) s in the first stage and carbon modulation of the electronic structure of STD(H)s in the second stage. (c) 2015 The Japan Society of Applied Physics	[Hara, Akito; Awano, Teruyoshi] Tohoku Gakuin Univ, Fac Engn, Tagajo, Miyagi 9858537, Japan	Hara, A (reprint author), Tohoku Gakuin Univ, Fac Engn, Tagajo, Miyagi 9858537, Japan.	akito@mail.tohoku-gakuin.ac.jp			Japan Society for the Promotion of Science [25420339]	This study was partly conducted under the Joint Studies Program of the Institute for Molecular Science and the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C), No. 25420339].	Newman RC, 1998, PHYS STATUS SOLIDI B, V210, P519, DOI 10.1002/(SICI)1521-3951(199812)210:2<519::AID-PSSB519>3.0.CO;2-H; Hara A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.050203; NEWMAN RC, 1969, J PHYS CHEM SOLIDS, V30, P1493, DOI 10.1016/0022-3697(69)90211-X; Peng C, 2011, J APPL PHYS, V109, DOI 10.1063/1.3561367; HARA A, 1995, JPN J APPL PHYS 1, V34, P3418, DOI 10.1143/JJAP.34.3418; MARTYNOV YV, 1995, PHYS REV LETT, V74, P2030, DOI 10.1103/PhysRevLett.74.2030; HARA A, 1989, JPN J APPL PHYS 1, V28, P142, DOI 10.1143/JJAP.28.142; SONG LW, 1990, PHYS REV B, V42, P5765, DOI 10.1103/PhysRevB.42.5765; SUEZAWA M, 1988, JPN J APPL PHYS 1, V27, P62, DOI 10.1143/JJAP.27.62; SUEZAWA M, 1986, JPN J APPL PHYS 2, V25, pL859, DOI 10.1143/JJAP.25.L859; ZHAN XD, 1993, PHYS REV B, V47, P6363, DOI 10.1103/PhysRevB.47.6363; Aberg D, 1999, J APPL PHYS, V85, P8054, DOI 10.1063/1.370642; HARA A, 1989, APPL PHYS LETT, V54, P626, DOI 10.1063/1.100899; Newman RC, 1996, PHYS REV B, V54, pR6803; Pritchard RE, 1997, SEMICOND SCI TECH, V12, P1404, DOI 10.1088/0268-1242/12/11/012; Zhang HX, 2013, J APPL PHYS, V114, DOI 10.1063/1.4820516; Hara A., 2014, 6 WORLD C PHOT EN CO, P659; Hara A., 2014, UVSOR ACTIVITY REP, V2013, P88; Hara A., 2013, UVSOR ACTIVITY REP, V2012, P103; KOHN W, 1957, SOLID STATE PHYS, V5, P257, DOI 10.1016/S0081-1947(08)60104-6; Shimura F., 1988, SEMICONDUCTOR SILICO	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							101302	10.7567/JJAP.54.101302		5	Physics, Applied	Physics	CS7SG	WOS:000362285100010		
J	Hara, T; Nojiri, Y; Hanada, K; Yoshitake, T				Hara, Takeshi; Nojiri, Yoshihiro; Hanada, Kenji; Yoshitake, Tsuyoshi			Detection methods of diamond diffraction peaks in ultrananocrystalline diamond/amorphous carbon composite films by X-ray diffraction measurement with semiconductor counter detector	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PULSED-LASER DEPOSITION; NANOCRYSTALLINE DIAMOND; THIN-FILMS; GROWTH; CVD	Ultrananocrystalline diamond (UNCD)/amorphous carbon (a-C) composite films were fabricated by a coaxial arc plasma deposition (CAPD) method. Hereafter, UNCD with crystallite diameters of less than 10nm in an a-C matrix could only be unambiguously detected by powder X-ray diffraction measurement using a synchrotron radiation source (SR-XRD) or transmission electron microscopy (TEM) observation. In this study, we succeeded in detecting diffraction peaks due to diamond-111 in the film by X-ray diffraction (XRD) using a Cu-K alpha radiation source with a semiconductor counter detector. The obtained data were in agreement with the powder SR-XRD measurements of the deposited films. (c) 2015 The Japan Society of Applied Physics	[Hara, Takeshi] Ariake Coll, Natl Inst Technol, Elect & Informat Engn Dept, Omuta, Fukuoka 8368585, Japan; [Nojiri, Yoshihiro] Sasebo Coll, Natl Inst Technol, Dept Chem & Biol Engn, Nagasaki 8571193, Japan; [Hanada, Kenji] Saga Univ, Dept Elect & Elect Engn, Saga 8408502, Japan; [Yoshitake, Tsuyoshi] Kyushu Univ, Dept Appl Sci Elect & Mat, Kasuga, Fukuoka 8168580, Japan	Hara, T (reprint author), Ariake Coll, Natl Inst Technol, Elect & Informat Engn Dept, Omuta, Fukuoka 8368585, Japan.	hara@ariake-nct.ac.jp			A-STEP of JST [AS251Z01588M]	This study was partially supported by A-STEP of JST (AS251Z01588M). SR-XRD measurements were performed at Kyushu Synchrotron Light Research Center (SAGA-LS/BL15). XRD measurements were performed at Department of Chemical and Biological Engineering, National Institute of Technology, Sasebo College. The author would like to thank Yuzuru Maki, Hisashi Yashiro, and Akihiro Maeda (Rigaku Corporation) for their technical advice concerning the detector of the XRD measurement system.	Al-Riyami S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GG06; Hanada K, 2009, J NANOMATER, DOI 10.1155/2009/901241; Su QF, 2012, APPL SURF SCI, V258, P4645, DOI 10.1016/j.apsusc.2012.01.047; Szczygiel R, 2009, IEEE T NUCL SCI, V56, P487, DOI 10.1109/TNS.2008.2012345; Williams OA, 2006, PHYS STATUS SOLIDI A, V203, P3375, DOI 10.1002/pssa.200671406; Ohmagari S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.031302; Yao Y, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035402; Gupta A, 2004, B MATER SCI, V27, P445; Yoshitake T, 2007, JPN J APPL PHYS 2, V46, pL936, DOI 10.1143/JJAP.46.L936; Hara T, 2006, DIAM RELAT MATER, V15, P649, DOI 10.1016/j.diamond.2005.12.015; Yoshitake T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.015503; Hara T, 2004, DIAM RELAT MATER, V13, P679, DOI 10.1016/j.diamond.2003.10.055; Popov C, 2004, DIAM RELAT MATER, V13, P2071, DOI 10.1016/j.diamond.2004.04.001; Williams OA, 2006, DIAM RELAT MATER, V15, P654, DOI 10.1016/j.diamond.2005.12.009; KUZNETSOV VL, 1994, CHEM PHYS LETT, V222, P343, DOI 10.1016/0009-2614(94)87072-1; Katamune Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.078003; Yang TS, 2002, J APPL PHYS, V92, P4912, DOI 10.1063/1.1512320; Yang TS, 2001, DIAM RELAT MATER, V10, P2161, DOI 10.1016/S0925-9635(01)00495-2; Hanada K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.125503; Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211; Katamune Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.068002; Vlasov II, 2007, DIAM RELAT MATER, V16, P2074, DOI 10.1016/j.diamond.2007.07.007; Xiao X, 2006, DIAM RELAT MATER, V15, P244, DOI 10.1016/j.diamond.2005.07.013; Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405; Hanada K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08JF09	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							108002	10.7567/JJAP.54.108002		3	Physics, Applied	Physics	CS7SG	WOS:000362285100035		
J	Hashimoto, S; Sugie, T; Zhang, ZY; Yamashita, K; Noda, M				Hashimoto, Shuhei; Sugie, Toshiyuki; Zhang, Ziyang; Yamashita, Kaoru; Noda, Minoru			Effects of final annealing in oxygen on characteristics of BaTiO3 thin films for resistance random access memory	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL SOLUTION DEPOSITION; ELECTRICAL-PROPERTIES	We have prepared BaTiO3 thin films by metal-organic decomposition, focusing on the effects of a final annealing in oxygen. In particular, we investigated the relation between the resistive switching and ferroelectric properties and the behaviors of the resultant resistive hysteresis and switching in the films. The films annealed in oxygen showed the hysteresis of bipolar-type switching with a current on/off ratio from 100 to 1000 for both bias polarities. It was particularly noted that abrupt peaks of the leakage current density occurred in the hysteretic resistivity curve. We consider that the abrupt increase in current density is related to the polarization reversal due to ferroelectricity in the BaTiO3 film. However, the main resistive switching mode was not affected by this behavior, thus suggesting that polarization reversal is insufficient to control the hysteresis in the total resistivity. (C) 2015 The Japan Society of Applied Physics	[Hashimoto, Shuhei; Sugie, Toshiyuki; Zhang, Ziyang; Yamashita, Kaoru; Noda, Minoru] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 6068585, Japan	Hashimoto, S (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 6068585, Japan.				Mazda Foundation	This research was partly supported by The Mazda Foundation (2013-2014).	Kinoshita K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959065; Voora VM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3116122; Wu D, 2000, J APPL PHYS, V88, P5941, DOI 10.1063/1.1322387; Sawa A, 2004, APPL PHYS LETT, V85, P4073, DOI 10.1063/1.1812580; Chen C, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672811; Kamiya K, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685222; Peterson RB, 2004, LANGMUIR, V20, P5114, DOI 10.1021/la049683c; El Kamel F, 2010, IOP CONF SER-MAT SCI, V8, DOI 10.1088/1757-899X/8/1/012030; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; Sekhar KC, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809531; Liu H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3527962; Chang WY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834852; KUWABARA M, 1993, APPL PHYS LETT, V62, P3372, DOI 10.1063/1.109050; Shibuya K, 2010, ADV MATER, V22, P411, DOI 10.1002/adma.200901493; Au K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812219; Song ZT, 2001, J MATER SCI, V36, P4285, DOI 10.1023/A:1017999223329; Bogle KA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3263713; Lee CB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2967194; Zhong L, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867198; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; Pan RK, 2012, THIN SOLID FILMS, V520, P4016, DOI 10.1016/j.tsf.2012.01.013; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Li AD, 1997, APPL PHYS LETT, V70, P1616, DOI 10.1063/1.118633; Schwartz RW, 1997, CHEM MATER, V9, P2325, DOI 10.1021/cm970286f; Iakovlev S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1881776; Shen W, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3039809; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Liu Q, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2832660; Son JY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2931087; Wang LH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681366; Yang G, 2014, J APPL PHYS, V115, DOI 10.1063/1.4878236	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA12	10.7567/JJAP.54.10NA12		5	Physics, Applied	Physics	CS7SO	WOS:000362286000013		
J	Hayashi, S; Kamimura, Y; Tsukamoto, N; Imoto, K; Sugitani, H; Kondo, T; Imada, Y; Nakiri, T; Tajitsu, Y				Hayashi, Syota; Kamimura, Yuki; Tsukamoto, Nobuyuki; Imoto, Kenji; Sugitani, Hideki; Kondo, Takashi; Imada, Yuya; Nakiri, Takuo; Tajitsu, Yoshiro			Piezoelectric characteristics of three-dimensional solid object of poly(L-lactide) fabricated by three-dimensional printing	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHIRAL POLYMERIC FIBER	Through three-dimensional (3D) printing, we attempted to fabricate 3D solid objects with piezoelectricity. By optimizing the conditions of 3D printing, we realized the fabrication of a piezoelectric object by 3D printing. In fact, we could produce a poly(L-lactide) (PLLA) object similar to a smart phone case fabricated by 3D printing, the molded body of which has button sensors at the desired sites by exploiting the piezoelectric properties of PLLA. Finally, we confirmed that the PLLA object behaved as a fully functional sensor. (C) 2015 The Japan Society of Applied Physics	[Hayashi, Syota; Kamimura, Yuki; Tsukamoto, Nobuyuki; Imoto, Kenji] Imoto Mech Engn Co Ltd, Kyoto 6028315, Japan; [Sugitani, Hideki; Kondo, Takashi; Imada, Yuya; Nakiri, Takuo; Tajitsu, Yoshiro] Kansai Univ, Grad Sch Sci & Engn, Dept Elect Engn, Suita, Osaka 5648680, Japan	Hayashi, S (reprint author), Imoto Mech Engn Co Ltd, Kyoto 6028315, Japan.				Ministry of Education, Culture, Sports, Science and Technology of Japan [2528059, 15K13714]	The experimental measurement system for this work was supported in part by Grants-in-Aid for Scientific Research (Nos. 2528059 and 15K13714) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ando M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD17; Ando M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD14; Tajitsu Y, 2008, IEEE T ULTRASON FERR, V55, P1000, DOI 10.1109/TUFFC.2008.746; Tajitsu Y, 2010, IEEE T DIELECT EL IN, V17, P1050, DOI 10.1109/TDEI.2010.5539674; Tajitsu Y, 2013, IEEE T ULTRASON FERR, V60, P1625, DOI 10.1109/TUFFC.2013.2744; Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516; Sawano M, 2010, POLYM INT, V59, P365, DOI 10.1002/pi.2758; Sessler GM, 2001, J ELECTROSTAT, V51, P137, DOI 10.1016/S0304-3886(01)00091-2; Aleman C, 2001, MACROMOLECULES, V34, P4795, DOI 10.1021/ma001630o; Tajitsu Y, 2006, POLYM ADVAN TECHNOL, V17, P907, DOI 10.1002/pat.817; Bower D., 2002, POLYM PHYS; Galetti P., 1988, MED APPL PIEZOELECTR; Gerhard-Multhaupt R, 2002, IEEE T DIELECT EL IN, V9, P850, DOI 10.1109/TDEI.2002.1038668; Gibson I., 2015, ADDITIVE MANUFACTURI; Greener J., 2006, PRECISION INJECTION; Inuzuka Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091D15, 10.1143/JJAP.51.09LD15]; Kaimori S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC04; Lines M. E., 1979, PRINCIPLES APPL FERR; Nakayama M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KE05; Nalwa Hari Singh, 1995, FERROELECTRIC POLYM; Powers J., 2006, SCATTERING DIFFRACTI; Pribble W., 1987, PLASTICS MOLD ENG HD; Rees H., 1995, MOLD ENG; Schut J., 2009, BIORESINS TACKLE DUR; Shiomi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KE02; Smela E., 2009, BIOMEDICAL APPL ELEC; Tadmor Z., 2006, PRINCIPLES POLYM PRO; Tajitsu Y., 2010, P C ACTUATOR, P473; Takarada J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KE01; Tanimoto K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC01; Uchino K., 2000, FERROELECTRIC DEVICE; Uehara Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND02; Wang T. T., 1988, APPL FERROELECTRIC P; Yoshida M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC02; Yoshida T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC11	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NF01	10.7567/JJAP.54.10NF01		5	Physics, Applied	Physics	CS7SO	WOS:000362286000048		
J	Honda, A; Higai, S; Kageyama, K; Higuchi, Y; Shiratsuyu, K				Honda, Atsushi; Higai, Shin'ichi; Kageyama, Keisuke; Higuchi, Yukio; Shiratsuyu, Kosuke			y Theoretical study on low dielectric loss perovskites Ba(Zn1/3Ta2/3)O-3 by first-principles calculations	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							AUGMENTED-WAVE METHOD; LOW MICROWAVE LOSS; RESONATOR MATERIALS; CERAMICS; FREQUENCIES; CRYSTAL; BATIO3; POLARIZATION; OXIDES; ORDER	We performed first-principles theoretical calculations on microwave dielectric compounds Ba(Zn1/3Ta2/3)O-3, to clarify the origin of high Q characteristics in the Zn/Ta ordered structure. It was found that Zn atoms suppress the intrinsic ferroelectric nature of Slater mode vibration in TaO6 octahedra. This results in the improvement of harmonicity in lattice vibration. There are two important mechanisms. One is the compression of TaO6 octahedra by adjacent ZnO6, and then the double-well potential that TaO6 originally has is narrowed to be single-well with higher harmonicity. The other is the weakening of the covalent character of Ta-O bonds by adjacent Zn atoms, which is the origin of the double-well potential. In the fully ordered Ba(Zn1/3Ta2/3)O-3, all Ta atoms are adjacent to Zn atoms, where Zn atoms have the maximum effect on improving harmonicity. Thus, highly ordered Ba(Zn1/3Ta2/3)O-3 with prolonged heat treatment exhibits a high Q value. (C) 2015 The Japan Society of Applied Physics	[Honda, Atsushi; Higai, Shin'ichi; Kageyama, Keisuke; Higuchi, Yukio; Shiratsuyu, Kosuke] Murata Mfg Co Ltd, Kyoto 6178555, Japan	Honda, A (reprint author), Murata Mfg Co Ltd, Kyoto 6178555, Japan.	hnd@murata.com					COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; NOMURA S, 1983, FERROELECTRICS, V49, P61, DOI 10.1080/00150198308244666; KAWASHIMA S, 1983, J AM CERAM SOC, V66, P421, DOI 10.1111/j.1151-2916.1983.tb10074.x; KATO J, 1991, JPN J APPL PHYS 1, V30, P2343, DOI 10.1143/JJAP.30.2343; ZHONG W, 1995, PHYS REV B, V52, P6301, DOI 10.1103/PhysRevB.52.6301; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Togo A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134106; OHSATO H, 1992, JPN J APPL PHYS 1, V31, P3136, DOI 10.1143/JJAP.31.3136; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; GANGULI AK, 1995, SOLID STATE COMMUN, V94, P13, DOI 10.1016/0038-1098(95)00016-X; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SAGALA DA, 1992, J AM CERAM SOC, V75, P2573, DOI 10.1111/j.1151-2916.1992.tb05613.x; TAMURA H, 1984, J AM CERAM SOC, V67, pC59; Ghosez P, 1998, PHYS REV B, V58, P6224, DOI 10.1103/PhysRevB.58.6224; OBRYAN HM, 1974, J AM CERAM SOC, V57, P450, DOI 10.1111/j.1151-2916.1974.tb11380.x; WAKINO K, 1984, J AM CERAM SOC, V67, P278; POSTERNAK M, 1994, PHYS REV B, V50, P8911, DOI 10.1103/PhysRevB.50.8911; DESU SB, 1985, J AM CERAM SOC, V68, P546, DOI 10.1111/j.1151-2916.1985.tb11521.x; KAGEYAMA K, 1992, J AM CERAM SOC, V75, P1767, DOI 10.1111/j.1151-2916.1992.tb07195.x; Ishidate T, 1997, PHYS REV LETT, V78, P2397, DOI 10.1103/PhysRevLett.78.2397; GONZE X, 1995, PHYS REV A, V52, P1086, DOI 10.1103/PhysRevA.52.1086; SLATER JC, 1950, PHYS REV, V78, P748, DOI 10.1103/PhysRev.78.748; Wu X, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035105; Reaney IM, 2000, J APPL PHYS, V88, P6708, DOI 10.1063/1.1290737; TAMURA H, 1989, JPN J APPL PHYS 1, V28, P21; Higuchi Y, 2003, J EUR CERAM SOC, V23, P2683, DOI 10.1016/S0955-2219(03)00193-6; WAKINO K, 1989, FERROELECTRICS, V91, P69, DOI 10.1080/00150198908015730; TAKATA M, 1989, J AM CERAM SOC, V72, P1955, DOI 10.1111/j.1151-2916.1989.tb06006.x; TAMURA H, 1986, JPN J APPL PHYS 1, V25, P787, DOI 10.1143/JJAP.25.787; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; DECKER DL, 1989, PHYS REV B, V39, P2432, DOI 10.1103/PhysRevB.39.2432; TAKAHASHI H, 1991, JPN J APPL PHYS 1, V30, P2339, DOI 10.1143/JJAP.30.2339; Ghosez P, 1999, PHYS REV B, V60, P836, DOI 10.1103/PhysRevB.60.836; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; NOMURA S, 1982, JPN J APPL PHYS 2, V21, pL624, DOI 10.1143/JJAP.21.L624; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Moriwake H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE02; NISHIGAKI S, 1988, J AM CERAM SOC, V71, pC11; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NE01	10.7567/JJAP.54.10NE01		5	Physics, Applied	Physics	CS7SO	WOS:000362286000045		
J	Honmi, H; Hashizume, Y; Nakajima, T; Okamura, S				Honmi, Hitoshi; Hashizume, Yoichiro; Nakajima, Takashi; Okamura, Soichiro			Theoretical analysis on polarization-induced resistance switching effects of polymer thin films including dead layers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC TUNNEL-JUNCTIONS; ELECTRORESISTANCE; ORIGIN	Polarization-induced resistance switching effects are analytically investigated. The electrostatic potential profile in metal is expressed by the Thomas-Fermi screening theory at the metal/ferroelectric interface. We estimate the current density using an assumed effective potential in metal/ferroelectric/metal junctions. Furthermore, we focus on the existence of a lower permittivity region such as a "dead layer" located at the boundary between the metal electrode and the ferroelectric material. In order to explain the ON/OFF ratio obtained in the experiment, we suggest that the dead layer near the smaller-work-function electrode side should be thicker by 2-3 angstrom than another electrode. Consequently, we propose a new hypothesis, that is, the thickness of the dead layer controls the ratio of resistance switching. (C) 2015 The Japan Society of Applied Physics	[Honmi, Hitoshi; Hashizume, Yoichiro; Nakajima, Takashi; Okamura, Soichiro] Tokyo Univ Sci, Dept Appl Phys, Tokyo 1258585, Japan	Honmi, H (reprint author), Tokyo Univ Sci, Dept Appl Phys, Tokyo 1258585, Japan.	1515632@ed.tus.ac.jp			JSAS KAKENHI [15K04653]	This work was partly supported by JSAS KAKENHI Grant Number 15K04653.	Wen Z, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823580; Gysel R, 2008, J APPL PHYS, V103, DOI 10.1063/1.2907990; Sun P, 2013, J APPL PHYS, V113, DOI 10.1063/1.4803151; Chanthbouala A, 2012, NAT NANOTECHNOL, V7, P101, DOI [10.1038/nnano.2011.213, 10.1038/NNANO.2011.213]; Zhuravlev MY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3195075; Takahashi Y, 2004, IEEE T DIELECT EL IN, V11, P227, DOI 10.1109/TDEI.2004.1285891; Li JQ, 2014, PHYS STATUS SOLIDI B, V251, P469, DOI 10.1002/pssb.201349222; Wen Z, 2013, NAT MATER, V12, P617, DOI [10.1038/nmat3649, 10.1038/NMAT3649]; Stengel M, 2009, NAT MATER, V8, P392, DOI [10.1038/nmat2429, 10.1038/NMAT2429]; Usui S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900490; Streiffer SK, 1999, J APPL PHYS, V86, P4565, DOI 10.1063/1.371404; Gruverman A, 2009, NANO LETT, V9, P3539, DOI 10.1021/nl901754t; Tsymbal EY, 2006, SCIENCE, V313, P181, DOI 10.1126/science.1126230; Stengel M, 2006, NATURE, V443, P679, DOI 10.1038/nature05148; Maksymovych P, 2009, SCIENCE, V324, P1421, DOI 10.1126/science.1171200; Kohlstedt H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125341; Grossmann M, 2002, J APPL PHYS, V92, P2680, DOI 10.1063/1.1498966; Yamada H, 2013, ACS NANO, V7, P5385, DOI 10.1021/nn401378t; Yamada H, 2015, ADV FUNCT MATER, V25, P2708, DOI 10.1002/adfm.201500371; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246802; Sun P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619841; Nakajima T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC05; Pantel D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134105; Lu H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6518; Ashcroft N. W., 1976, SOLID STATE PHYS, P340; Brennan C. J., 1992, Integrated Ferroelectrics, V2, DOI 10.1080/10584589208215733; Garcia V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5289; Li ZP, 2014, ADV MATER, V26, P7185, DOI 10.1002/adma.201402527; Mabuchi Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA05; Vendik OG, 2009, J APPL PHYS, V105, DOI 10.1063/1.3021303	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA08	10.7567/JJAP.54.10NA08		4	Physics, Applied	Physics	CS7SO	WOS:000362286000009		
J	Hoshina, T; Sahashi, A; Takeda, H; Tsurumi, T				Hoshina, Takuya; Sahashi, Akira; Takeda, Hiroaki; Tsurumi, Takaaki			Fabrication and characterization of dielectric strontium titanium oxynitride single crystal	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; FERROELECTRIC BEHAVIOR; PEROVSKITE OXIDES; SRTAO2N; CERAMICS; NITROGEN; LANTHANUM; BATIO3; ORIGIN	In this paper, we show a fabrication method and the dielectric properties of strontium titanium oxynitride (SrTiO3:N) single crystals. Oxynitride single crystals were prepared by annealing SrTiO3 single crystals in gaseous ammonia. SrTiO3:N was assumed to have the chemical composition SrTiO3-3xN2x, which contained oxygen vacancies. To reduce the number of oxygen vacancies, SrTiO3 crystals co-doped with nitrogen and niobium (SrTiO3:N,Nb) were fabricated. The semiconducting Nb-doped SrTiO3 crystals changed to dielectric N,Nb-codoped SrTiO3 crystals with a resistivity of 6 x 10(12)Omega.cm with annealing in gaseous ammonia. XPS measurement indicated that niobium doping was effective for increasing the amount of dopant nitrogen. The dielectric permittivity increased with the amount of dopant nitrogen, indicating the effectivity of nitrogen doping for increasing the dielectric permittivity of perovskite oxides. (C) 2015 The Japan Society of Applied Physics	[Hoshina, Takuya; Sahashi, Akira; Takeda, Hiroaki; Tsurumi, Takaaki] Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, Tokyo 1528552, Japan	Hoshina, T (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Nanophonon Lab, Meguro Ku, Tokyo 1528552, Japan.	thoshina@ceram.titech.ac.jp			JSPS KAKENHI [26420676]	This work was supported by JSPS KAKENHI Grant Number 26420676.	Akishige Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC03; COHEN RE, 1992, NATURE, V358, P136, DOI 10.1038/358136a0; Sun SK, 2014, J AM CERAM SOC, V97, P1023, DOI 10.1111/jace.12806; Tsurumi T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2804570; Fu HX, 2000, NATURE, V403, P281; Hinuma Y, 2012, CHEM MATER, V24, P4343, DOI 10.1021/cm302335q; Wang JS, 2005, J EUR CERAM SOC, V25, P3207, DOI 10.1016/j.jeurceramsoc.2004.07.027; Masubuchi Y, 2015, J EUR CERAM SOC, V35, P1191, DOI 10.1016/j.jeurceramsoc.2014.10.028; David A, 2014, CRYST GROWTH DES, V14, P523, DOI 10.1021/cg401259r; Kishi H, 2003, JPN J APPL PHYS 1, V42, P1, DOI 10.1143/JJAP.42.11; Mi YY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2403181; Shvartsman VV, 2012, J AM CERAM SOC, V95, P1, DOI 10.1111/j.1551-2916.2011.04952.x; Shkabko A, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145202; Kuroiwa Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.217601; Bhalla AS, 2000, MATER RES INNOV, V4, P3, DOI 10.1007/s100190000062; COHEN RE, 1992, FERROELECTRICS, V136, P65, DOI 10.1080/00150199208016067; Matsumoto N, 2011, OPT LETT, V36, P265, DOI 10.1364/OL.36.000265; Takenaka T, 2005, J EUR CERAM SOC, V25, P2693, DOI 10.1016/j.jeurceramsoc.2005.03.125; Miyauchi M, 2004, LANGMUIR, V20, P232, DOI 10.1021/la0353125; Kanehara K, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891767; Akishige Y, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.073704; Hoshina T, 2013, J CERAM SOC JPN, V121, P156, DOI 10.2109/jcersj2.121.156; COHEN RE, 1990, PHYS REV B, V42, P6416, DOI 10.1103/PhysRevB.42.6416; Marozau I, 2009, MATERIALS, V2, P1388, DOI 10.3390/ma2031388; Zhang YR, 2012, J EUR CERAM SOC, V32, P1269, DOI 10.1016/j.jeurceramsoc.2011.12.001; Whangbo MH, 2015, Z ANORG ALLG CHEM, V641, P1043, DOI 10.1002/zaac.201500058; Terakura K, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.195120; Zhu WL, 2014, J APPL PHYS, V116, DOI 10.1063/1.4891981; Cross L. E., 1994, Ferroelectrics, V151, DOI 10.1080/00150199408244755; Akishige Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KD01; Hoshina T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC05; Hoshina T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC04; Hoshina T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD03; Matsumoto N, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC11; Moriyoshi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD02; Oka D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04987; Sakabe Y., 1981, JPN J APPL PHYS S, V20, P147; Tsukada S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD04	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB05	10.7567/JJAP.54.10NB05		4	Physics, Applied	Physics	CS7SO	WOS:000362286000023		
J	Tu, HTC; Inoue, S; Nishioka, K; Fujimoto, N; Karashima, S; Shimoda, T				Huynh Thi Cam Tu; Inoue, Satoshi; Nishioka, Kiyoshi; Fujimoto, Nobutaka; Karashima, Shuichi; Shimoda, Tatsuya			Fabrication of source and drain regions of self-aligned ZrInZnO thin-film transistors using a solution of tin and poly(propylene carbonate)	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							AMORPHOUS OXIDE SEMICONDUCTORS; GA-ZN-O; HIGH-PERFORMANCE; TEMPERATURE FABRICATION; TFTS; DRIVEN; ROUTE; PAPER	In this paper, we report a novel doping method based on a solution process to fabricate source and drain regions of a self-aligned ZrInZnO thin-film transistor (TFT). A solution of Sn compound mixed with poly(propylene carbonate) (PPC) was used to allow Sn to be diffused into ZrInZnO source and drain regions. The resistivity of the obtained Sn-doped ZrInZnO was reduced dramatically from 4 x 10(3) to 1.8 x 10(-2) Omega cm. The self-aligned ZrInZnO TFT exhibited a mobility of 20cm(2)V(-1)s(-1), a threshold voltage of 1V, a subthreshold swing of 0.2V/decade, and an ON/OFF ratio of 7. These results indicate that the solution-based doping could provide an alternative way to substitute the ion implantation or plasma treatment which are conducted under vacuum for fabrication of the self-aligned oxide semiconductor TFT. (c) 2015 The Japan Society of Applied Physics	[Huynh Thi Cam Tu; Inoue, Satoshi; Shimoda, Tatsuya] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Inoue, Satoshi; Shimoda, Tatsuya] Japan Adv Inst Sci & Technol, Green Devices Res Ctr, Nomi, Ishikawa 9231211, Japan; [Nishioka, Kiyoshi; Fujimoto, Nobutaka; Karashima, Shuichi] Sumitomo Seika Chem Co Ltd, Osaka 5410041, Japan; [Shimoda, Tatsuya] Japan Sci & Technol Agcy, Shimoda Nanoliquid Proc Project, ERATO, Nomi, Ishikawa 9231211, Japan	Tu, HTC (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.	tu-huynh@jaist.ac.jp			ERATO Shimoda Nano-Liquid Process Project of the Japan Science and Technology Agency	This research was supported by the ERATO Shimoda Nano-Liquid Process Project of the Japan Science and Technology Agency. The authors would like to thank the researchers of the ERATO Shimoda Nano-Liquid Process Project for their kind support and discussions.	Ahn B.D., 2008, APPL PHYS LETT, V93; Wu CH, 2009, J DISP TECHNOL, V5, P515, DOI 10.1109/JDT.2009.2026189; Geng D, 2012, IEEE ELECTR DEVICE L, V33, P1012, DOI 10.1109/LED.2012.2194133; Kim YH, 2012, NATURE, V489, P128, DOI 10.1038/nature11434; Kamiya T, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044305; Lee JH, 2008, SID INT SYMP DIG TEC, V39, P625; Ye Z, 2012, IEEE T ELECTRON DEV, V59, P393, DOI 10.1109/TED.2011.2175398; Yabuta H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2353811; Jeon S, 2011, ACS APPL MATER INTER, V3, P1, DOI 10.1021/am1009088; Fan CL, 2014, MATERIALS, V7, P5761, DOI 10.3390/ma7085761; Mei P, 1999, MATER RES SOC SYMP P, V557, P677; Kim HD, 2008, SID INT SYMP DIG TEC, V39, P291; Suresh A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2824758; Kim S, 2009, IEEE ELECTR DEVICE L, V30, P374, DOI 10.1109/LED.2009.2014181; Chern J. G. J., 1980, IEEE Electron Device Letters, VEDL-1, DOI 10.1109/EDL.1980.25276; Kim MG, 2011, NAT MATER, V10, P382, DOI [10.1038/nmat3011, 10.1038/NMAT3011]; Kim YH, 2012, IEEE ELECTR DEVICE L, V33, P50, DOI 10.1109/LED.2011.2171913; Chen RS, 2013, IEEE ELECTR DEVICE L, V34, P60, DOI 10.1109/LED.2012.2223192; Hayashi R, 2007, J SOC INF DISPLAY, V15, P915, DOI 10.1889/1.2812992; Kim GH, 2009, J ELECTROCHEM SOC, V156, pH7, DOI 10.1149/1.2976027; Chen RS, 2012, IEEE ELECTR DEVICE L, V33, P1150, DOI 10.1109/LED.2012.2201444; Park JS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2753107; Park J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2966145; Chang YJ, 2007, ELECTROCHEM SOLID ST, V10, pH135, DOI 10.1149/1.2666588; Lee CG, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3454241; Tue PT, 2013, IEEE T ELECTRON DEV, V60, P320, DOI 10.1109/TED.2012.2227483; Kang DH, 2011, IEEE ELECTR DEVICE L, V32, P1385, DOI 10.1109/LED.2011.2161568; Park WJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976309; Lee DH, 2007, ADV MATER, V19, P843, DOI 10.1002/adma.200600961; Son KS, 2008, SID INT SYMP DIG TEC, V39, P633; Kim H, 2011, IEEE T ELECTRON DEV, V58, P3820, DOI 10.1109/TED.2011.2165286; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Gorrn P, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2458457; Hwang YH, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.11; Ito M., 2006, P 13 IDW, P585; Kim DN, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3506503; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Tu H. T. C., 2014, SID S, V45, P945	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							106501	10.7567/JJAP.54.106501		6	Physics, Applied	Physics	CS7SG	WOS:000362285100029		
J	Iida, D; Ogawa, H; Kan, A; Takahashi, S; Moriyama, T				Iida, Daiki; Ogawa, Hirotaka; Kan, Akinori; Takahashi, Susumu; Moriyama, Tohru			Effects of SrZrO3 addition on piezoelectric properties of Bi-0.5(Na0.8K0.2)(0.5)TiO3 ceramic	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC PROPERTIES; ELECTRICAL-PROPERTIES; CRYSTAL-STRUCTURE; SYSTEM	(1-x)Bi-0.5(Na0.8K0.2)(0.5)TiO3-xSrZrO(3)[(1-x)BNKT-xSZ] ceramics were synthesized by conventional solid-state reaction methods, and their ferroelectric and piezoelectric properties were investigated in this study. The X-ray powder diffraction profiles of the ceramics showed a single phase in the composition range of 0-0.07; the formation of morphotropic phase boundary between rhombohedral and tetragonal phases was suggested at compositions lower than x = 0.01. From the temperature dependence of dielectric properties, both the depolarization temperature and transition temperature from a rhombohedral phase to a tetragonal phase decreased, depending on the composition x. A pinched polarization-electric field (P-E) hysteresis loop was obtained for x = 0.005, suggesting the coexistence of ferroelectric and antiferroelectric phases. The remanent polarization and coercive field of the ceramics decreased with increasing composition x, whereas d(33) improved from 116 to 191 pC/N in the composition range of 0-0.005. (C) 2015 The Japan Society of Applied Physics	[Iida, Daiki; Ogawa, Hirotaka; Kan, Akinori; Takahashi, Susumu] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan; [Moriyama, Tohru] Toba Coll, Natl Inst Technol, Dept Elect & Mech Engn, Toba, Mie 5178501, Japan	Iida, D (reprint author), Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan.	akan@meijo-u.ac.jp					Kobayashi K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.011501; Lee DS, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.021801; Palei PK, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.011503; Wang XX, 2003, J AM CERAM SOC, V86, P1809; Sasaki A, 1999, JPN J APPL PHYS 1, V38, P5564, DOI 10.1143/JJAP.38.5564; Schmitt LA, 2011, J MATER SCI, V46, P4368, DOI 10.1007/s10853-011-5427-6; Jaita P, 2014, FERROELECTRICS, V458, P49, DOI 10.1080/00150193.2013.849982; Hao JG, 2014, J AM CERAM SOC, V97, P1776, DOI 10.1111/jace.12820; Anton EM, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.055802; Jaita P, 2013, J APPL PHYS, V114, DOI 10.1063/1.4811813; Liao YW, 2009, J MATER SCI TECHNOL, V25, P777; Hiruma Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.3043588; Hiruma Y, 2006, JPN J APPL PHYS 1, V45, P7409, DOI 10.1143/JJAP.45.7409; Matsubara M, 2005, JPN J APPL PHYS 1, V44, P258, DOI 10.1143/JJAP.44.258; Wu JG, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3127519; Patterson EA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4738770; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; Rahman JU, 2014, IOP CONF SER-MAT SCI, V60, DOI 10.1088/1757-899X/60/1/012043; Yao YG, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/3/035008; Moriyama T, 2013, J CERAM SOC JPN, V121, P679, DOI 10.2109/jcersj2.121.679; Harigai T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.111501; Moriyama T, 2013, J CERAM SOC JPN, V121, P644, DOI 10.2109/jcersj2.121.644; Wu CC, 2013, CRYSTENGCOMM, V15, P9097, DOI 10.1039/c3ce41484a; Zhou CR, 2009, J MATER SCI, V44, P3833, DOI 10.1007/s10853-009-3519-3; Do Nam-Binh, 2011, Transactions on Electrical and Electronic Materials, V12, P64; Hiruma Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC08; Lin D., 2009, J PHYS C SER, V152; Parija B, 2013, J MATER SCI-MATER EL, V24, P402, DOI 10.1007/s10854-012-0764-z; Sundari S. S., 2013, MATER SCI ENG, V43	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND12	10.7567/JJAP.54.10ND12		5	Physics, Applied	Physics	CS7SO	WOS:000362286000043		
J	Imai, S; Nakajima, A; Kobata, T				Imai, Shigeru; Nakajima, Atsushi; Kobata, Teppei			Single-electron pumping in single-common-gate triple-dot devices with asymmetric gate capacitances	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TURNSTILE DEVICE	Single-common-gate triple-dot single-electron devices with homogeneous junction capacitances and asymmetric gate capacitances can transfer a single electron to a negative-biased electrode, that is, single-electron pumping can be achieved by alternating only one gate voltage. The device can work as a pump if the gate capacitances have a large-small-small, large-large-small, or large-medium-small distribution with an appropriate large-small difference. The third distribution is preferable because it can take the maximum large-small difference and single-electron pumping is possible with the largest negative-biasing voltage. (c) 2015 The Japan Society of Applied Physics	[Imai, Shigeru; Nakajima, Atsushi; Kobata, Teppei] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan	Imai, S (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan.	imai@se.ritsumei.ac.jp					POTHIER H, 1992, EUROPHYS LETT, V17, P249, DOI 10.1209/0295-5075/17/3/011; Imai S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.034302; Imai S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.124301; Moraru D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075332; GEERLIGS LJ, 1990, PHYS REV LETT, V64, P2691, DOI 10.1103/PhysRevLett.64.2691; Waugh FR, 1996, PHYS REV B, V53, P1413, DOI 10.1103/PhysRevB.53.1413; Fujiwara A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837544; Kang YB, 1996, J APPL PHYS, V80, P1526, DOI 10.1063/1.362947; Fujiwara A, 2004, APPL PHYS LETT, V84, P1323, DOI 10.1063/1.1650036; Nuryadi R, 2003, IEEE T NANOTECHNOL, V2, P231, DOI 10.1109/TNANO.2003.820788; Imai S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.064001; TAKAHASHI Y, 1995, ELECTRON LETT, V31, P136, DOI 10.1049/el:19950082; Mizuta A, 2007, JPN J APPL PHYS 1, V46, P3144, DOI [10.1143/JJAP.46.3144, 10.1143/JJAP.46.31441]; Imai S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.124502; Nuryadi R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883705; Imai S, 2008, JPN J APPL PHYS, V47, P9003, DOI 10.1143/JJAP.47.9003; KOUWENHOVEN LP, 1991, PHYS REV LETT, V67, P1626, DOI 10.1103/PhysRevLett.67.1626; Yokoi K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.024503; Ikeda H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2189214; NAKAZATO K, 1994, J APPL PHYS, V75, P5123, DOI 10.1063/1.355758; Ono Y, 2003, APPL PHYS LETT, V82, P1221, DOI 10.1063/1.1556558; Jalil MBA, 1998, J APPL PHYS, V84, P4617, DOI 10.1063/1.368688; Weiss DN, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189012; DEVORET MH, 1992, NATO ADV SCI I B-PHY, V294, P1; Imai S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.094002; Tanaka T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GE07	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							104001	10.7567/JJAP.54.104001		11	Physics, Applied	Physics	CS7SG	WOS:000362285100020		
J	Ishii, K; Tashiro, S				Ishii, Keisuke; Tashiro, Shinjiro			Nonlinear piezoelectricity in Li-modified (K,Na)NbO3 system ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ZIRCONATE-TITANATE CERAMICS; 3RD-HIGHER TERM; COEFFICIENT; BEHAVIOR; TRANSDUCER; DEPENDENCE; MNO	The effects of Li substitution on the nonlinear piezoelectricity in lead-free (K,Na)NbO3 (KNN) system ceramics were studied. The nonlinear piezoelectricity causes nonlinear phenomena such as the generation of nonlinear voltages, a change in the resonance frequency, and current jumping under high-power vibration. The magnitude of the nonlinear piezoelectricity was estimated by measuring the third-harmonic voltage generated in samples during constant-current driving. With the increase in the amount of substituted Li, the nonlinear piezoelectricity decreased and became a minimum at the phase boundary composition. The nonlinear piezoelectric coefficient at the phase boundary composition was less than one-tenth of the value in the nonsubstituted KNN ceramic. (C) 2015 The Japan Society of Applied Physics	[Ishii, Keisuke; Tashiro, Shinjiro] Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan	Ishii, K (reprint author), Natl Def Acad, Dept Mat Sci & Engn, Yokosuka, Kanagawa 2398686, Japan.				Ministry of Education, Culture, Sports, Science and Technology of Japan [15K06451]	This work was supported by a Grant-in-Aid for Scientific Research C (No. 15K06451) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Kobayashi K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.031501; Aurelle N, 1996, ULTRASONICS, V34, P187, DOI 10.1016/0041-624X(95)00077-G; Hagiwara M, 2011, IEEE T ULTRASON FERR, V58, P1721, DOI 10.1109/TUFFC.2011.2009; Ishii K, 2008, J CERAM SOC JPN, V116, P1214, DOI 10.2109/jcersj2.116.1214; Bomlai P, 2008, J AM CERAM SOC, V91, P624, DOI 10.1111/j.1551-2916.2007.02130.x; Tashiro S, 2001, JPN J APPL PHYS 1, V40, P5679, DOI 10.1143/JJAP.40.5679; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Tashiro S, 2005, JPN J APPL PHYS 1, V44, P7032, DOI 10.1143/JJAP.44.7032; Ishii K, 2011, J CERAM SOC JPN, V119, P29, DOI 10.2109/jcersj2.119.29; Mgbemere HE, 2009, J EUR CERAM SOC, V29, P1729, DOI 10.1016/j.jeurceramsoc.2008.10.012; Ishii K, 1999, J EUR CERAM SOC, V19, P1157, DOI 10.1016/S0955-2219(98)00397-5; Du HL, 2007, MATER RES BULL, V42, P1594, DOI 10.1016/j.materresbull.2006.11.043; Ishii K, 2015, J CERAM SOC JPN, V123, P114, DOI 10.2109/jcersj2.123.114; Ishii K, 2007, JPN J APPL PHYS 1, V46, P7048, DOI 10.1143/JJAP.46.7048; Ishii K, 2000, JPN J APPL PHYS 1, V39, P5597, DOI 10.1143/JJAP.39.5597; Cheng LQ, 2013, J AM CERAM SOC, V96, P2693, DOI 10.1111/jace.12497; Ishii K, 2003, J CERAM SOC JPN, V111, P401, DOI 10.2109/jcersj.111.401; Tashiro S, 2002, J CERAM SOC JPN, V110, P649, DOI 10.2109/jcersj.110.649; Guyomar D, 1997, J PHYS III, V7, P1197, DOI 10.1051/jp3:1997183; Tashiro S, 2003, JPN J APPL PHYS 1, V42, P6068, DOI 10.1143/JJAP.42.6068; Ishii K, 2002, JPN J APPL PHYS 1, V41, P7095, DOI 10.1143/JJAP.41.7095; Tashiro S, 2006, JPN J APPL PHYS 1, V45, P7449, DOI 10.1143/JJAP.45.7449; Tashiro S, 2005, J CERAM SOC JPN, V113, P642, DOI 10.2109/jcersj.113.642; Hatano K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD11; Ishii K., 2001, Ferroelectrics, V262, DOI 10.1080/00150190108225134; Ishii K., 2002, T MAT RES SOC JPN, V27, P265; Ishii K., 1999, T MAT RES SOC JPN, V24, P3; Kakimoto K., 2010, SERAMIKKUSU, V45, P469; Kobayashi K, 2013, JPN J APPL PHYS, V52; Shimizu H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD02; Ishii K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD01; Wang K, 2012, J ADV CERAM, V1, P24, DOI DOI 10.1007/S40145-012-0003-3	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND11	10.7567/JJAP.54.10ND11		5	Physics, Applied	Physics	CS7SO	WOS:000362286000042		
J	Ito, A; Akiyama, T; Nakamura, K; Ito, T; Kageshima, H; Uematsu, M; Shiraishi, K				Ito, Ayako; Akiyama, Toru; Nakamura, Kohji; Ito, Tomonori; Kageshima, Hiroyuki; Uematsu, Masashi; Shiraishi, Kenji			First-principles calculations for initial oxidation processes of SiC surfaces: Effect of crystalline surface orientations	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							GROWTH-RATE ENHANCEMENT; THIN OXIDE REGIME; SILICON-CARBIDE; THERMAL-OXIDATION; ELECTRICAL-PROPERTIES; DYNAMICAL SIMULATION; INTERFACE; MODEL; PSEUDOPOTENTIALS; MECHANISMS	The initial oxidation processes on both the C-face and Si-face SiC surfaces are investigated by performing electronic-structure calculations within the density functional theory. We find the characteristic features of stable structures and adsorption-desorption behavior depending on the surface orientation of SiC. The desorption of C atoms as CO molecules on the C-face occasionally occurs in addition to the adsorption of O atoms even for the surfaces with low oxygen coverage, whereas the adsorption of O atoms preferentially occurs on the Si-face. These calculated results indicate that the incorporation of O atoms along with the desorption of C atoms is predominant even during the initial oxidation processes on the C-face of SiC. Moreover, on the C-face, three-coordinated O atoms can be formed at the topmost layer of the SiC surface, resulting in the formation of SiO2-like layers whose characteristics are different from those on the Si-face. These findings suggest that the differences in carbon-desorption behavior and resultant structural difference of SiO2 layers between the C-face and the Si-face are possible origins of the orientation dependence of oxidation rate observed in SiC oxidation. (c) 2015 The Japan Society of Applied Physics	[Ito, Ayako; Akiyama, Toru; Nakamura, Kohji; Ito, Tomonori] Mie Univ, Dept Engn Phys, Tsu, Mie 5148507, Japan; [Kageshima, Hiroyuki] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Uematsu, Masashi] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Shiraishi, Kenji] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Ito, A (reprint author), Mie Univ, Dept Engn Phys, Tsu, Mie 5148507, Japan.	akiyama@phen.mie-u.ac.jp	Kageshima, Hiroyuki/C-8899-2012		Japan Society for the Promotion of Science [24560025]	This work was supported in part by Grant-in-Aid for Scientific Research (No. 24560025) from the Japan Society for the Promotion of Science. Computations were performed at the Research Center for Computational Science (National Institutes of Natural Sciences) and the Research Institute for Information Technology (Kyushu University).	Afanas'ev VV, 1997, PHYS STATUS SOLIDI A, V162, P321, DOI 10.1002/1521-396X(199707)162:1<321::AID-PSSA321>3.0.CO;2-F; SUZUKI A, 1982, JPN J APPL PHYS 1, V21, P579, DOI 10.1143/JJAP.21.579; Ohnuma T, 2007, MATER SCI FORUM, V556-557, P615; Soon JM, 2008, J PHYS CHEM C, V112, P16864, DOI 10.1021/jp802306e; Xie XN, 2003, J CHEM PHYS, V119, P4905, DOI 10.1063/1.1594716; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Neuefeind J, 1996, BER BUNSEN PHYS CHEM, V100, P1341; MOZZI RL, 1969, J APPL CRYSTALLOGR, V2, P164, DOI 10.1107/S0021889869006868; Raynaud C, 2001, J NON-CRYST SOLIDS, V280, P1, DOI 10.1016/S0022-3093(00)00350-1; MUEHLHOFF L, 1986, J APPL PHYS, V60, P2558, DOI 10.1063/1.337121; Kurth S, 1999, INT J QUANTUM CHEM, V75, P889, DOI 10.1002/(SICI)1097-461X(1999)75:4/5<889::AID-QUA54>3.0.CO;2-8; Song Y, 2004, J APPL PHYS, V95, P4953, DOI 10.1063/1.1690097; Di Ventra M, 1999, PHYS REV LETT, V83, P1624, DOI 10.1103/PhysRevLett.83.1624; Seubert A, 2000, SURF SCI, V454, P45, DOI 10.1016/S0039-6028(00)00091-1; Ohnuma T, 2009, MATER SCI FORUM, V600-603, P591, DOI 10.4028/www.scientific.net/MSF.600-603.591; Hirai H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823468; BILLON T, 1995, MICROELECTRON ENG, V28, P193, DOI 10.1016/0167-9317(95)00041-6; OWMAN F, 1995, SURF SCI, V330, pL639, DOI 10.1016/0039-6028(95)00427-0; Wang JJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125304; Kageshima H, 1997, PHYS REV B, V56, P14985, DOI 10.1103/PhysRevB.56.14985; Sabisch M, 1997, PHYS REV B, V55, P10561, DOI 10.1103/PhysRevB.55.10561; Li WB, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085320; Christiansen K, 1996, J APPL PHYS, V79, P3276, DOI 10.1063/1.361225; ZHENG Z, 1990, J ELECTROCHEM SOC, V137, P854, DOI 10.1149/1.2086568; PANDEY KC, 1981, PHYS REV LETT, V47, P1913, DOI 10.1103/PhysRevLett.47.1913; Northrup JE, 1995, PHYS REV B, V52, P17001; NARUSHIMA T, 1989, J AM CERAM SOC, V72, P1386, DOI 10.1111/j.1151-2916.1989.tb07658.x; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Gavrikov A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3006004; Chokawa K, 2013, MATER SCI FORUM, V740-742, P469, DOI 10.4028/www.scientific.net/MSF.740-742.469; Knaup JM, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235321; Devynck F, 2005, MICROELECTRON ENG, V80, P38, DOI 10.1016/j.mee.2005.04.021; Vickridge I, 2007, J PHYS D APPL PHYS, V40, P6254, DOI 10.1088/0022-3727/40/20/S10; Kita K, 2014, ECS TRANSACTIONS, V61, P135, DOI 10.1149/06102.0135ecst; Shenoy JN, 1996, J APPL PHYS, V79, P3042, DOI 10.1063/1.361244; Akiyama T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4804665; Yamamoto T, 2008, JPN J APPL PHYS, V47, P7803, DOI 10.1143/JJAP.47.7803; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Yamauchi J, 1996, PHYS REV B, V54, P5586, DOI 10.1103/PhysRevB.54.5586; Devynck F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075351; Shen X, 2013, J APPL PHYS, V114, DOI 10.1063/1.4815962; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Hijikata Y, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.021203; Bongiorno A, 2004, APPL SURF SCI, V234, P190, DOI 10.1016/j.apsusc.2004.05.020; DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945; Wang SW, 2001, PHYS REV LETT, V86, P5946, DOI 10.1103/PhysRevLett.86.5946; Kageshima H, 1998, PHYS REV LETT, V81, P5936, DOI 10.1103/PhysRevLett.81.5936; Kikuchi RH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864284; Kageshima H, 1999, JPN J APPL PHYS 2, V38, pL971, DOI 10.1143/JJAP.38.L971; Okamoto M., 2006, Applied Physics Letters, V89, DOI 10.1063/1.2221400; Ray EA, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832408; von Munch W., 1975, Journal of the Electrochemical Society, V122; Yamamoto T, 2007, JPN J APPL PHYS 2, V46, pL770, DOI 10.1143/JJAP.46.L770	53	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							101301	10.7567/JJAP.54.101301		8	Physics, Applied	Physics	CS7SG	WOS:000362285100009		
J	Jin, XG				Jin, Xiuguang			Analysis of electron emission from GaAs(Cs,O) by low energy electron microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							WORK-FUNCTION; LARGE ENHANCEMENT; GAAS; PHOTOELECTRONS; AFFINITY	Low-energy electron microscopy was carried out to study the electron emission process from a GaAs photocathode with a negative electron affinity (NEA) surface. The relationship between emission current and electron affinity was investigated in detail to obtain information regarding the electron tunneling in the vacuum barrier and the electron distribution in the interior of GaAs, especially with respect to photoelectron capture in the band bending region. A comparison of the calculated quantized sub-band energies in the band bending region confirmed that the majority of photoelectrons fell within sub-bands, from where a large portion of the photoelectrons escape into the vacuum. (c) 2015 The Japan Society of Applied Physics	High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan	Jin, XG (reprint author), High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki 3050801, Japan.				Japan Society for the Promotion of Science (JSPS) [25390066]	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 25390066) from the Japan Society for the Promotion of Science (JSPS). I am also thankful to Dr. Yosuke Honda (KEK) for fruitful discussion and Professor Masao Tabuchi (Nagoya Industrial Science Research Institute) for helpful comments.	More S, 2003, SURF SCI, V527, P41, DOI 10.1016/S0039-6028(02)02568-2; Jin XG, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902337; Unal B, 2009, J VAC SCI TECHNOL A, V27, P1249, DOI 10.1116/1.3168561; DUDEN T, 1995, REV SCI INSTRUM, V66, P2861, DOI 10.1063/1.1145569; NAKANISHI T, 1991, PHYS LETT A, V158, P345, DOI 10.1016/0375-9601(91)90995-K; Kuwahara M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737177; Suzuki M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.026601; Jin X, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.045002; BABOUT M, 1980, J PHYS D APPL PHYS, V13, P1161, DOI 10.1088/0022-3727/13/7/011; SU CY, 1983, J APPL PHYS, V54, P1413, DOI 10.1063/1.332166; OMORI T, 1991, PHYS REV LETT, V67, P3294, DOI 10.1103/PhysRevLett.67.3294; TEREKHOV AS, 1994, JETP LETT+, V59, P864; Jin XG, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.015801; Davies J. H., 2004, PHYS LOW DIMENSIONAL; FREEOUF JL, 1981, APPL PHYS LETT, V39, P727, DOI 10.1063/1.92863; Gasiorowicz S., 2003, QUANTUM PHYS; Hernandez-Garcia C., 2005, P 2005 PART ACC C, P3117, DOI 10.1109/PAC.2005.1591383; Nakanishi T., 2002, P 21 LIN ACC C, P813; Pastuszka S, 2000, J APPL PHYS, V88, P6788, DOI 10.1063/1.1311307; SINCLAIR CK, 1992, NUCL INSTRUM METH A, V318, P410, DOI 10.1016/0168-9002(92)91090-V; Sze S. M., 2002, SEMICONDUCTOR DEVICE	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							101201	10.7567/JJAP.54.101201		4	Physics, Applied	Physics	CS7SG	WOS:000362285100008		
J	Kanematsu, D; Yata, S; Terakawa, A; Tanaka, M; Konagai, M				Kanematsu, Daiji; Yata, Shigeo; Terakawa, Akira; Tanaka, Makoto; Konagai, Makoto			Effective light trapping by modulated quantum structures for Si nanowire/wall solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON NANOWIRES; OPTICAL-ABSORPTION; PHOTOVOLTAIC APPLICATIONS; CONTROLLED GROWTH; ARRAYS; DEVICES; LITHOGRAPHY; ENHANCEMENT; CONFINEMENT; SURFACES	The quantum size effect allows the use of silicon nanowires and nanowalls for the top cell of all-Si tandem solar cells by tuning the band gap. However, these Si nanostructures are far thinner than the wavelength of visible light in the direction of amplitude, so the incoming light cannot concentrate in the Si nanostructures, resulting in low absorption. Our calculations using the finite-difference time-domain (FDTD) method show that the absorption of Si nanowires and nanowalls with a diameter of 10nm depends on their arrangement. We have found an effective optical confinement structure for Si nanowalls that is compatible with the quantum size effect. (c) 2015 The Japan Society of Applied Physics	[Kanematsu, Daiji; Yata, Shigeo; Terakawa, Akira; Tanaka, Makoto] Panasonic Corp, Kadoma, Osaka 5708501, Japan; [Kanematsu, Daiji; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Kanematsu, D (reprint author), Panasonic Corp, Kadoma, Osaka 5708501, Japan.				MEXT FUTURE-PV Innovation	Part of this work was performed under the management of JST, supported by MEXT FUTURE-PV Innovation.	Kempa TJ, 2008, NANO LETT, V8, P3456, DOI 10.1021/nl8023438; Ma DDD, 2003, SCIENCE, V299, P1874, DOI 10.1126/science.1080313; Weisse JM, 2011, NANO LETT, V11, P1300, DOI 10.1021/nl104362e; Garnett E, 2010, NANO LETT, V10, P1082, DOI 10.1021/nl100161z; Sturmberg BCP, 2011, OPT EXPRESS, V19, pA1067, DOI 10.1364/OE.19.0A1067; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Lin CX, 2009, OPT EXPRESS, V17, P19371, DOI 10.1364/OE.17.019371; Tanaka Y, 2013, OPT EXPRESS, V21, P20111, DOI 10.1364/OE.21.020111; Cho EC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245201; Cao LY, 2009, NAT MATER, V8, P643, DOI [10.1038/nmat2477, 10.1038/NMAT2477]; Wu Y, 2004, NANO LETT, V4, P433, DOI 10.1021/nl035162i; Chutinan A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023825; Tsujino K, 2005, ADV MATER, V17, P1045, DOI 10.1002/adma.200401681; Chang SW, 2009, ADV FUNCT MATER, V19, P2495, DOI 10.1002/adfm.200900181; Weisse JM, 2012, NANO LETT, V12, P3339, DOI 10.1021/nl301659m; Sivakov V, 2009, NANO LETT, V9, P1549, DOI 10.1021/nl803641f; Conibeer G, 2008, THIN SOLID FILMS, V516, P6748, DOI 10.1016/j.tsf.2007.12.096; Zhang X, 2013, J PHYS CHEM LETT, V4, P2002, DOI 10.1021/jz400533v; Feng SQ, 2000, J CRYST GROWTH, V209, P513, DOI 10.1016/S0022-0248(99)00608-9; Dossou KB, 2012, J OPT SOC AM A, V29, P817, DOI 10.1364/JOSAA.29.000817; Doscher H, 2012, CHEMPHYSCHEM, V13, P2899, DOI 10.1002/cphc.201200390; Kurokawa Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PE12; Tsakalakos L, 2007, J NANOPHOTONICS, V1, DOI 10.1117/1.2768999; Wang J, 2011, OPT EXPRESS, V19, P23078, DOI 10.1364/OE.19.023078; Choi WK, 2008, NANO LETT, V8, P3799, DOI 10.1021/nl802129f; Chang SW, 2010, ADV FUNCT MATER, V20, P4364, DOI 10.1002/adfm.201000437; Musin RN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165308; Hu L, 2007, NANO LETT, V7, P3249, DOI 10.1021/nl071018b; Li JS, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186046; Shigeta H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4759149; Stelzner T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295203; Wang JJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358813; Zhang ML, 2008, J PHYS CHEM C, V112, P4444, DOI 10.1021/jp077053o	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							102301	10.7567/JJAP.54.102301		4	Physics, Applied	Physics	CS7SG	WOS:000362285100017		
J	Karaki, T; Kobayashi, M; Song, SJ; Fujii, T; Adachi, M; Ohashi, Y; Kushibiki, J				Karaki, Tomoaki; Kobayashi, Masakazu; Song, Shengjie; Fujii, Tadashi; Adachi, Masatoshi; Ohashi, Yuji; Kushibiki, Jun-ichi			Growth and high-temperature characterization of langasite-family Ca3NbGa3-xAlxSi2O14 single crystals	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ACOUSTIC-WAVE PROPERTIES; PIEZOELECTRIC PROPERTIES; ELECTROMECHANICAL PROPERTIES; LA3TA0.5GA5.5O14; ALUMINUM	Langasite-family single crystals Ca3NbGa3-xAlxSi2O14 (CNGAS) (x = 0.1-0.8) were grown by a Czochralski technique along the x-axis. With increasing amount of Al substituent, the lattice constants decreased and the electric resistivity in a high temperature range was improved. The CNGAS (x = 0.8) specimen had an electric resistivity of 10(10)Omega cm at 350 degrees C. From the dependence of the resistivity on temperature, an activation energy of about 1.19 eV was obtained. Thermal treatment in oxygen atmosphere was also considered effective for the improvement in electric resistivity. However, the dielectric features associated with loss tangent jump at about 400 degrees C were not improved by the Al substituent and thermal treatment. Spectroscopic ellipsometry was applied to determine the pseudodielectric function epsilon = epsilon(1) + i epsilon(2) spectrum of the Ca3NbGa3Si2O14 crystal from 2 to 6 eV at 27 to 450 degrees C. No crystal structure change was observed from room temperature to 450 degrees C. The mechanism of the loss tangent change above 400 degrees C needs further investigation. (C) 2015 The Japan Society of Applied Physics	[Karaki, Tomoaki; Kobayashi, Masakazu; Song, Shengjie; Fujii, Tadashi; Adachi, Masatoshi] Toyama Prefectural Univ, Fac Engn, Dept Intelligent Syst Design Engn, Toyama 9390398, Japan; [Ohashi, Yuji; Kushibiki, Jun-ichi] Tohoku Univ, Fac Engn, Sendai, Miyagi 9808579, Japan	Karaki, T (reprint author), Toyama Prefectural Univ, Fac Engn, Dept Intelligent Syst Design Engn, Toyama 9390398, Japan.	chen@pu-toyama.ac.jp			Japan Society for the Promotion of Science [25420399]	The authors would like to thank Professor Z. G. Hu and Dr. L. P. Xu of East China Normal University for their help in spectroscopic ellipsometry measurement and fruitful discussions. Part of this study was financially supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 25420399).	Takeda H, 2006, KEY ENG MAT, V320, P239; Adachi M, 1999, JPN J APPL PHYS 1, V38, P3283, DOI 10.1143/JJAP.38.3283; Kitaura M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115120; Zhang SJ, 2008, SOLID STATE COMMUN, V148, P213, DOI 10.1016/j.ssc.2008.08.013; Takeda H, 1997, JPN J APPL PHYS 2, V36, pL919, DOI 10.1143/JJAP.36.L919; Adachi M, 1998, J KOREAN PHYS SOC, V32, pS1274; Dejneka A, 2009, OPT EXPRESS, V17, P14322, DOI 10.1364/OE.17.014322; Takeda H, 2010, J CERAM SOC JPN, V118, P706, DOI 10.2109/jcersj2.118.706; Inoue K, 1998, JPN J APPL PHYS 1, V37, P2909, DOI 10.1143/JJAP.37.2909; Choi SG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235210; Onozato N, 2000, JPN J APPL PHYS 1, V39, P3028, DOI 10.1143/JJAP.39.3028; Choi SG, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115207; ILYAEV AB, 1986, PHYS STATUS SOLIDI A, V98, pK109, DOI 10.1002/pssa.2210980243; Kushibiki J, 2002, IEEE T ULTRASON FERR, V49, P99, DOI 10.1109/58.981388; KUSHIBIKI J, 1985, IEEE T SON ULTRASON, V32, P189; KAMINSKII AA, 1983, PHYS STATUS SOLIDI A, V80, P607, DOI 10.1002/pssa.2210800225; Takeda H, 2006, T MRS JAP, V31, P11; Kushibiki J, 2000, J ACOUST SOC AM, V108, P564, DOI 10.1121/1.429587; Kadota M, 1999, JPN J APPL PHYS 1, V38, P3288, DOI 10.1143/JJAP.38.3288; Karaki T, 2004, JPN J APPL PHYS 1, V43, P6721, DOI 10.1143/JJAP.43.6721; Bashara N. M., 1987, ELLIPSOMETRY POLARIZ, P1; Fritze H., 1999, MRS P, V604, P65; Fujiwara H., 2007, SPECTROSCOPIC ELLIPS; Huang WQ, 2010, PROCEEDINGS OF THE 7TH NATIONAL CONFERENCE ON CHINESE FUNCTIONAL MATERIALS AND APPLICATIONS (2010), VOLS 1-3, P1085; Jung IH, 2004, J ELECTROCERAM, V13, P471, DOI 10.1007/s10832-004-5144-5; Karaki T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD09; McGahan W. A., 1999, SPECTROSCOPIC ELLIPS; Ohashi Y., 2010, P S ULTR EL, P425; Pisarevsky Y. V., 1995, P 49 IEEE INT FREQ C, P653; Sakharov S, 1995, PROCEEDINGS OF THE 1995 IEEE INTERNATIONAL FREQUENCY CONTROL SYMPOSIUM, P647, DOI 10.1109/FREQ.1995.484067; SSAKHAROV SA, 1992, PROCEEDINGS OF THE 1992 IEEE FREQUENCY CONTROL SYMPOSIUM, P713, DOI 10.1109/FREQ.1992.269965; Takeda H., 2005, P 2005 IEEE ULTR S, P560	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND07	10.7567/JJAP.54.10ND07		3	Physics, Applied	Physics	CS7SO	WOS:000362286000038		
J	Katayama, T; Sakamoto, W; Yuitoo, I; Takeuchi, T; Hayashi, K; Yogo, T				Katayama, Takeshi; Sakamoto, Wataru; Yuitoo, Isamu; Takeuchi, Teruaki; Hayashi, Koichiro; Yogo, Toshinobu			Enhancement of photoinduced electrical properties of Al-doped ZnO/BiFeO3 layered thin films prepared by chemical solution deposition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BISMUTH FERRITE; PHOTOVOLTAIC DEVICES; BIFEO3; NANOPARTICLES; PHOTOCURRENT; BEHAVIOR; TITANATE; PHYSICS; DIODE	Polycrystalline BiFeO3 and Al-doped ZnO/BiFeO3 bilayered thin films were prepared on Pt/TiOx/SiO2/Si substrates by chemical solution deposition. Their photoinduced electrical properties under blue light irradiation were characterized. The rapid on/off response of the photocurrent to light in unpoled BiFeO3 (BFO) and Al-doped ZnO/BiFeO3 (AZO/BFO) thin films was demonstrated. The AZO/BFO layered film exhibited an approximately triple-digit larger photocurrent in comparison with a BFO single-layer film. This is attributable to the photoexcited carrier generation effect at the interface between AZO (n-type) and BFO (p-type) films. Furthermore, in the AZO/BFO layered structure, the direction of the internal bias electric field caused by the space charge distribution in the unpoled BFO film is the same as that of the built-in electric field by forming a p-n junction of AZO and BFO layers. Photovoltaic properties were also improved by fabricating such a layered film. On the other hand, when the placement of BFO to AZO was reversed, the photoelectric current decreased to approximately one-tenth of that of the BFO single-layer film. In the BFO/AZO film, the internal electric field at the p-n junction between BFO and AZO is considered to have an orientation opposite to the self-bias field formed in the BFO film. (C) 2015 The Japan Society of Applied Physics	[Katayama, Takeshi; Sakamoto, Wataru; Hayashi, Koichiro; Yogo, Toshinobu] Nagoya Univ, EcoTopia Sci Inst, Div Green Mat, Nagoya, Aichi 4648603, Japan; [Yuitoo, Isamu; Takeuchi, Teruaki] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo 1620041, Japan	Katayama, T (reprint author), Nagoya Univ, EcoTopia Sci Inst, Div Green Mat, Nagoya, Aichi 4648603, Japan.	sakamoto@esi.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24656381]	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (No. 24656381) and a collaboration research project on Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials (Inter-University Collaboration of 6 Research Institutes) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alexe M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1261; Heron JT, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4870957; Itoh N, 2009, J CERAM SOC JPN, V117, P939, DOI 10.2109/jcersj2.117.939; Choi T, 2009, SCIENCE, V324, P63, DOI 10.1126/science.1168636; Yuan YB, 2014, J MATER CHEM A, V2, P6027, DOI 10.1039/c3ta14188h; Catalan G, 2009, ADV MATER, V21, P2463, DOI 10.1002/adma.200802849; Yang XL, 2012, ADV MATER, V24, P1202, DOI 10.1002/adma.201104078; Sakamoto W, 2006, JPN J APPL PHYS 1, V45, P7315, DOI 10.1143/JJAP.45.7315; Chen B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195201; CHYNOWETH AG, 1956, PHYS REV, V102, P705, DOI 10.1103/PhysRev.102.705; Dong W, 2013, MATER LETT, V91, P359, DOI 10.1016/j.matlet.2012.10.031; Yang SY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204695; FISCHER P, 1980, J PHYS C SOLID STATE, V13, P1931, DOI 10.1088/0022-3719/13/10/012; Tuboltsev V, 2011, J NANOPART RES, V13, P5603, DOI 10.1007/s11051-010-0134-9; Spaldin NA, 2010, PHYS TODAY, V63, P38, DOI 10.1063/1.3502547; Ihlefeld JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901160; Tuboltsev V, 2011, J MATER CHEM, V21, P781, DOI 10.1039/c0jm02273j; Makino N, 2013, FERROELECTRICS, V453, P20, DOI 10.1080/00150193.2013.842086; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Wu JG, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500498; Gao F, 2007, ADV MATER, V19, P2889, DOI 10.1002/adma.200602377; Ito Y, 2013, CERAM INT, V39, pS451, DOI 10.1016/j.ceramint.2012.10.112; Fan Z, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4899146; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Khan GG, 2012, PHYS STATUS SOLIDI-R, V6, P312, DOI 10.1002/pssr.201206211; Vullers RJM, 2009, SOLID STATE ELECTRON, V53, P684, DOI 10.1016/j.sse.2008.12.011; Wu JG, 2010, ELECTROCHEM SOLID ST, V13, pG9, DOI 10.1149/1.3264093; Sakamoto W, 2009, MATER CHEM PHYS, V116, P536, DOI 10.1016/j.matchemphys.2009.04.029; Gao RL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862793; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Puli VS, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/7/075502; Gao F, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345825; Kumar A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901168; Ji W, 2010, ADV MATER, V22, P1763, DOI 10.1002/adma.200902985; Hieno A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NB04; Kiselev S. V., 1963, SOV PHYS DOKL, V7, P742; Lee D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125305; Nakashima S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA16; Ukai Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LE10; Yoshida K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA17	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA05	10.7567/JJAP.54.10NA05		6	Physics, Applied	Physics	CS7SO	WOS:000362286000006		
J	Kawakami, S; Nakajima, N; Nakatake, M; Kawamura, N; Mizumaki, M; Maruyama, H				Kawakami, Shuhei; Nakajima, Nobuo; Nakatake, Masashi; Kawamura, Naomi; Mizumaki, Masaichiro; Maruyama, Hiroshi			Mechanism of intrinsic dipole moment induction in quantum paraelectric SrTiO3	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OXYGEN-ISOTOPE EXCHANGE; ELECTRIC-FIELD; FERROELECTRICITY; PEROVSKITE; SURFACE; TIO2; GAS	We measure the Ti K beta resonant X-ray emission spectra of SrTiO3 in the quantum paraelectric phase. We find that charge transfer (CT) excitation is affected by temperature decrease and UV irradiation, which provides direct evidence of the fact that the induced electric dipole moment is derived from the Ti off-center displacement. The UV-assisted dipole moments are aligned parallel to the applied DC electric field, as inferred from the additional change in the CT peak. We conclude that the local polar region formed by UV irradiation evolves under DC field application at low temperature. (C) 2015 The Japan Society of Applied Physics	[Kawakami, Shuhei; Nakajima, Nobuo; Maruyama, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Phys Sci, Hiroshima 7398526, Japan; [Nakatake, Masashi] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Hiroshima 7390046, Japan; [Kawamura, Naomi; Mizumaki, Masaichiro] Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan	Kawakami, S (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Phys Sci, Hiroshima 7398526, Japan.	s-kawakami@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [24540325]; Murata Scientific Foundation	We are grateful to H. Toyokawa and T. Uruga of the Japan Synchrotron Radiation Research Institute (JASRI/SPring-8) for their technical assistance with the PILATUS detector. We also thank S. Tsutsui of JASRI/SPring-8 for his technical assistance with the cryostat. This work was performed under the approval of the SPring-8 Program Advisory Committee (2012A1408, 2012B1202, and 2013A1419), and was financially supported by a Grant-in-Aid for Scientific Research (C) of the Japan Society for the Promotion of Science (No. 24540325), and the Murata Scientific Foundation in 2012.	Itoh M, 1999, PHYS REV LETT, V82, P3540, DOI 10.1103/PhysRevLett.82.3540; Isohama Y, 2011, J ELECTRON SPECTROSC, V184, P207, DOI 10.1016/j.elspec.2010.12.023; Santander-Syro AF, 2011, NATURE, V469, P189, DOI 10.1038/nature09720; Hasegawa T, 2003, J PHYS SOC JPN, V72, P41, DOI 10.1143/JPSJ.72.41; Ohta S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847723; Kawakami S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.053701; Toyokawa H, 2010, NUCL INSTRUM METH A, V623, P204, DOI 10.1016/j.nima.2010.02.196; Tenne DA, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499273; Meevasana W, 2011, NAT MATER, V10, P114, DOI 10.1038/nmat2943; Harada Y, 2000, PHYS REV B, V61, P12854, DOI 10.1103/PhysRevB.61.12854; Nozawa S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.061501; Kan D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202750; Nakajima N, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.224114; Nishimatsu T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.134106; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Uozumi T, 2004, J ELECTRON SPECTROSC, V137, P623, DOI 10.1016/j.elspec.2004.02.045; Danger J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.243001; Hemberger J, 1996, J PHYS-CONDENS MAT, V8, P4673, DOI 10.1088/0953-8984/8/25/021; Nozawa S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.121101; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; Kan DS, 2005, NAT MATER, V4, P816, DOI 10.1038/nmat1498; Takesada M, 2003, J PHYS SOC JPN, V72, P37, DOI 10.1143/JPSJ.72.37; Itoh M, 2000, APPL PHYS LETT, V76, P221, DOI 10.1063/1.125708; Isohama Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE04; Mandic L, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042519; Nakajima N, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KF05; OKADA K, 1993, J ELECTRON SPECTROSC, V62, P131, DOI 10.1016/0368-2048(93)80010-J	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NC03	10.7567/JJAP.54.10NC03		5	Physics, Applied	Physics	CS7SO	WOS:000362286000029		
J	Kishimoto, K; Lee, DH; Kang, I; Jeong, CO; Ishikawa, Y; Kong, HS				Kishimoto, Katsushi; Lee, Dong-Hee; Kang, Iljoon; Jeong, Chang-Oh; Ishikawa, Yasuaki; Kong, Hyang-Shik			High-mobility material research for thin-film transistor with amorphous thallium-zinc-tin oxide semiconductor	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LASER	The applicability of thallium-zinc-tin oxide (TlZnSnO) as a channel material for a thin-film transistor (TFT) was investigated by first-principles simulation and cosputtering experiment with XZnSnO (X = Al, Ga or In). The electron effective mass (m*) of Tl0.4ZnSnO was simulated to be similar to 0.153, which is much smaller than that of In0.4ZnSnO (0.246). An In0.4ZnSnO TFT exhibited a mobility (mu) of 32.0cm(2)V(-1) s(-1) in the experiment; therefore, the Tl0.4ZnSnO TFT was expected to have a higher mobility of approximately 50cm(2)V(-1) s(-1) following the relation (mu proportional to 1/m*). Moreover, the Tl-related oxide semiconductor would provide better TFT stability because its oxide vacancy is more stable than that of an In-related oxide semiconductor. (c) 2015 The Japan Society of Applied Physics	[Kishimoto, Katsushi; Ishikawa, Yasuaki] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Lee, Dong-Hee; Kang, Iljoon; Jeong, Chang-Oh; Kong, Hyang-Shik] Samsung Display Co Ltd, Display Res Ctr, Yongin 446711, Gyeonggi, South Korea	Kishimoto, K (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan.	yishikawa@ms.naist.jp					Benwadih M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4880163; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Jeong JK, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3236694; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Ogo Y, 2008, PHYS STATUS SOLIDI A, V205, P1920, DOI 10.1002/pssa.200778908; EHRLICH DJ, 1978, APPL PHYS LETT, V33, P931, DOI 10.1063/1.90222; Scanlon DO, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4860986; Kamiya T, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/4/044305; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Myong SY, 2003, APPL PHYS LETT, V82, P3026, DOI 10.1063/1.1571651; ANISIMOV VI, 1991, PHYS REV B, V44, P943, DOI 10.1103/PhysRevB.44.943; Kehoe AB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.233202; Fortunato EMC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2937473; Cho DH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2998612; BURKHARD P, 1980, OPT LETT, V5, P522, DOI 10.1364/OL.5.000522; Park JS, 2012, THIN SOLID FILMS, V520, P1679, DOI 10.1016/j.tsf.2011.07.018; KAMEDA K, 1983, J JPN I MET, V47, P406; Fukumoto E., 2010, P IDW 10, P631; Hosono H., 1996, J NONCRYST SOLIDS, V198-200, P165, DOI 10.1016/0022-3093(96)80019-6; Jung HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03765; Limpijumnong S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.193202; Matsueda Y., 2010, P 6 INT THIN FILM TR, P314; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Tomai S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.03CB01; Wang D., 2012, P 19 INT WORKSH ACT, P159	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							104101	10.7567/JJAP.54.104101		5	Physics, Applied	Physics	CS7SG	WOS:000362285100021		
J	Kitanaka, Y; Makisumi, K; Oshima, Y; Noguchi, Y; Miyayama, M; Torii, S; Kamiyama, T				Kitanaka, Yuuki; Makisumi, Kohei; Oshima, Yumiko; Noguchi, Yuji; Miyayama, Masaru; Torii, Shuki; Kamiyama, Takashi			Ferrielectric phase in the (Bi1/2Na1/2)TiO3-Ba(Mg1/3Nb2/3)O-3 system	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE-CRYSTAL PIEZOELECTRICS; POLARIZATION ROTATION; ELECTRIC-FIELDS; CERAMICS; STRAIN; NA0.5BI0.5TIO3	We have investigated the crystal structure of (1 - x)(Bi1/2Na1/2)TiO3-xBa(Mg1/3Nb2/3)O-3 (BNT-BMN) by high-resolution neutron powder diffraction (NPD) analysis. Our NPD study combined with polarization hysteresis measurements for ceramics reveals that a boundary between rhombohedral R3c and tetragonal P4bm phases exists at x = 4-5%. The Rietveld analysis of the NPD data shows that the crystal structure with x = 10% has a single-phase tetragonal structure in space group P4bm, as has been reported for BNT-7%BaTiO3. The P4bm structure exhibits antiparallel displacements of A- and B-site cations, which results in a small spontaneous polarization (P-s) of 13.3 mu C/cm(2) (estimated from the refined structural parameters). The results obtained for BNT-10%BMN ceramics strongly suggest ferrielectric features; the application of electric fields induces a transition from the P4bm phase with a small P-s to other ferroelectric phases with a large P-s. (C) 2015 The Japan Society of Applied Physics	[Kitanaka, Yuuki; Makisumi, Kohei; Oshima, Yumiko; Noguchi, Yuji; Miyayama, Masaru] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Torii, Shuki; Kamiyama, Takashi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan	Kitanaka, Y (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.						Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Moreira RL, 2005, CRYST GROWTH DES, V5, P1457, DOI 10.1021/cg049565n; Park SEE, 2002, CURR OPIN SOLID ST M, V6, P11, DOI 10.1016/S1359-0286(02)00023-2; Kitanaka Y, 2013, J CERAM SOC JPN, V121, P632, DOI 10.2109/jcersj2.121.632; Fu HX, 2000, NATURE, V403, P281; Daniels JE, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602316; Jo W, 2011, J APPL PHYS, V109, DOI 10.1063/1.3530737; Luo L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3587236; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; [Anonymous], 1960, SOV PHYS-SOLID STATE; Ogawa T, 2002, JPN J APPL PHYS 2, V41, pL55, DOI 10.1143/JJAP.41.L55; Nagata H, 1999, FERROELECTRICS, V229, P273, DOI 10.1080/00150199908224350; Ohshima Y, 2012, ECS TRANSACTIONS, V45, P195, DOI 10.1149/1.3700885; Ma C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.107602; Yao JJ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3488879; Oishi-Tomiyasu R, 2012, J APPL CRYSTALLOGR, V45, P299, DOI 10.1107/S0021889812003998; Chen PY, 2014, J EUR CERAM SOC, V34, P4223, DOI 10.1016/j.jeurceramsoc.2014.05.044; Kitanaka Y, 2011, FERROELECTRICS, V414, P24, DOI 10.1080/00150193.2011.577291; Ogino M, 2014, CRYSTALS, V4, P273, DOI 10.3390/cryst4030273; Ma C, 2013, ADV FUNCT MATER, V23, P5261, DOI 10.1002/adfm.201300640; Gorfman S, 2010, J APPL CRYSTALLOGR, V43, P1409, DOI 10.1107/S002188981003342X; Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140; Jones GO, 2002, ACTA CRYSTALLOGR B, V58, P168, DOI 10.1107/S0108768101020845; GLAZER AM, 1975, ACTA CRYSTALLOGR A, V31, P756, DOI 10.1107/S0567739475001635; Kitanaka Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.104104; Arai T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA07; Ehara Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA02; Iwata M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD05; Kitanaka Yuuki, 2015, Journal of Asian Ceramic Societies, V3, DOI 10.1016/j.jascer.2014.12.005; Kitanaka Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD01; Kurokawa F., JPN J APPL PHYS, V53; Luo CT, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757877; Moriyoshi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD02; Noheda B, 2002, CURR OPIN SOLID ST M, V6, P27, DOI 10.1016/S1359-0286(02)00015-3; Onozuka H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE07; Li FX, 2007, J APPL PHYS, V101, DOI 10.1063/1.2645889; Suzuki M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD09; Takenaka T., 1999, Ferroelectrics, V230, DOI 10.1080/00150199908214902; Torii S, 2014, J PHYS CONF SER, V502, DOI 10.1088/1742-6596/502/1/012052; Torii S., 2011, J PHYS SOC JPN, V80, pSB020	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NC05	10.7567/JJAP.54.10NC05		5	Physics, Applied	Physics	CS7SO	WOS:000362286000031		
J	Kobune, M; Kuriyama, T; Furotani, R; Kugimiya, T; Ueshima, S; Kikuchi, T; Fujisawa, H; Nakashima, S; Shimizu, M; Fukumuro, N				Kobune, Masafumi; Kuriyama, Tomoyuki; Furotani, Ryosuke; Kugimiya, Takuya; Ueshima, Satoshi; Kikuchi, Takeyuki; Fujisawa, Hironori; Nakashima, Seiji; Shimizu, Masaru; Fukumuro, Naoki			Effects of sputtering gas pressure on physical properties of ferroelectric (Bi3.25Nd0.65Eu0.10)Ti3O12 nanoplate films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NEUTRON POWDER DIFFRACTION; CRYSTAL-STRUCTURE; THIN-FILMS; POLARIZATION; CERAMICS	(Bi3.25Nd0.65Eu0.10)Ti3O12 (BNEuT-0.1) films with a-and b-axis orientations and thicknesses of 1.8-2.3 mu m were sputter-deposited on conductive Nb:TiO2(101) substrates containing 0.79 mass% Nb. The deposition temperature was fixed at 650 degrees C, and the sputtering gas pressure was varied from 0.4 to 5.0Pa in order to examine its effect on the structural, ferroelectric and piezoelectric properties of the films. The films were found to have a mostly single-phase orthorhombic structure, with a high degree of a- and b-axis orientations (93-98%). The films had a nanoplate microstructure, with the plates being aligned along the [100]/[010] direction, and porosities of 15-25%. A maximum room-temperature remanent polarization (2P(r)) of 93 mu C/cm(2) was obtained for a sputtering gas pressure of 5.0 Pa. All the films were strongly a-axis oriented, according to the results of X-ray diffraction measurements and vertical amplitude images in piezoresponse force microscopy. The optimal sputtering gas pressure for heteroepitaxial growth of BNEuT-0.1 nanoplates with a high degree of a-axis orientation of 96.5%, a maximum orthorhombicity of 0.0017, a comparatively large remanent polarization of 2P(r) = 66 mu C/cm(2), and a high porosity of 24% was found to be 0.4 Pa. (C) 2015 The Japan Society of Applied Physics	[Kobune, Masafumi; Kuriyama, Tomoyuki; Furotani, Ryosuke; Kugimiya, Takuya; Ueshima, Satoshi; Kikuchi, Takeyuki; Fukumuro, Naoki] Univ Hyogo, Grad Sch Engn, Dept Chem Engn, Himeji, Hyogo 6712201, Japan; [Fujisawa, Hironori; Nakashima, Seiji; Shimizu, Masaru] Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan	Kobune, M (reprint author), Univ Hyogo, Grad Sch Engn, Dept Chem Engn, Himeji, Hyogo 6712201, Japan.	kobune@eng.u-hyogo.ac.jp			Japan Society for the Promotion of Science (JSPS) [26289275]	This work was supported in part by a Grant-in-Aid for Scientific Research B (No. 26289275) from the Japan Society for the Promotion of Science (JSPS).	Hervoches CH, 1999, CHEM MATER, V11, P3359, DOI 10.1021/cm991090d; Cong CJ, 2005, NANOTECHNOLOGY, V16, P981, DOI 10.1088/0957-4484/16/6/060; Lu CJ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135386; Hase T, 1998, JPN J APPL PHYS 1, V37, P5198, DOI 10.1143/JJAP.37.5198; Kawada S, 2006, JPN J APPL PHYS 1, V45, P7455, DOI 10.1143/JJAP.45.7455; Yamauchi K, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/10/103201; Jeon MK, 2004, J PHYS D APPL PHYS, V37, P2588, DOI 10.1088/0022-3727/37/18/015; Masud MG, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/29/295902; Noda Y, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434206; Chen W, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/7/075421; SHIMIZU M, 1994, JPN J APPL PHYS 1, V33, P5135, DOI 10.1143/JJAP.33.5135; Jeon MK, 2007, J PHYS D APPL PHYS, V40, P4647, DOI 10.1088/0022-3727/40/15/044; Tsukada M, 2003, APPL PHYS LETT, V83, P4393, DOI 10.1063/1.1630371; Franke I, 2005, J PHYS D APPL PHYS, V38, P749, DOI [10.1088/0022-3727/38/5/013, 10.1088/002-3727/38/5/013]; Picozzi S, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/30/303201; Sawamura S, 2008, JPN J APPL PHYS, V47, P7603, DOI 10.1143/JJAP.47.7603; McFarland EW, 2003, NATURE, V421, P616, DOI 10.1038/nature01316; Nechache R, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/14/142202; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Ahn CW, 2006, FERROELECTRICS, V331, P129, DOI 10.1080/00150190600737677; Fujisawa H., 2014, JPN J APPL PHYS; Kobune M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.02BC07; Kobune M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MA03; Kobune M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA02; Kobune M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA10; Moriyoshi C., 2007, 24 M APPL FERR, P69; Patel Satyanarayan, 2014, Materials Research Express, V1, DOI 10.1088/2053-1591/1/4/045502; Rhun G L, 2006, NANOTECHNOLOGY, V17, P3154, DOI 10.1088/0957-4484/17/13/013; Sadhana K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795820; Sawada S., 1967, JISEITAI YUUDENTAI N, P247; Smith D.L., 1995, THIN FILM DEPOSITION, P476; Yao YG, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/17004	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA01	10.7567/JJAP.54.10NA01		6	Physics, Applied	Physics	CS7SO	WOS:000362286000002		
J	Koshimizu, M; Bertrand, GHV; Hamel, M; Kishimoto, S; Haruki, R; Nishikido, F; Yanagida, T; Fujimoto, Y; Asai, K				Koshimizu, Masanori; Bertrand, Guillaume H. V.; Hamel, Matthieu; Kishimoto, Shunji; Haruki, Rie; Nishikido, Fumihiko; Yanagida, Takayuki; Fujimoto, Yutaka; Asai, Keisuke			X-ray detection capability of bismuth-loaded plastic scintillators	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							AVALANCHE PHOTODIODE DETECTOR	We evaluated the high-energy X-ray detection capabilities of Bi-loaded plastic scintillators. The detection efficiency for 67.4 keV X-rays was successfully increased by increasing the Bi concentration. The detection efficiency of a plastic scintillator loaded with 10 wt% Bi was comparable to that of a commercially available plastic scintillator loaded with 5wt% Pb, NE-142. A subnanosecond time resolution was achieved, and no long scintillation component appeared with Bi loading. These results indicate that Bi loading is an effective method of enhancing the detection efficiency for high-energy X-rays while preserving the timing properties of plastic scintillators. (c) 2015 The Japan Society of Applied Physics	[Koshimizu, Masanori; Fujimoto, Yutaka; Asai, Keisuke] Tohoku Univ, Grad Sch Engn, Dept Appl Chem, Sendai, Miyagi 9808579, Japan; [Bertrand, Guillaume H. V.; Hamel, Matthieu] CEA, LIST, Lab Capteurs & Architectures Elect, F-91191 Gif Sur Yvette, France; [Kishimoto, Shunji; Haruki, Rie] High Energy Accelerator Res Org, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Nishikido, Fumihiko] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; [Yanagida, Takayuki] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Koshimizu, M (reprint author), Tohoku Univ, Grad Sch Engn, Dept Appl Chem, Sendai, Miyagi 9808579, Japan.	koshi@qpc.che.tohoku.ac.jp	Koshimizu, Masanori/B-9491-2008	Koshimizu, Masanori/0000-0002-0905-2144	Ministry of Education, Culture, Sports, Science and Technology, Japan [25709088]; SPRITS program, Kyoto University; Cooperative Research Project of Research Institute of Electronics, Shizuoka University; French "Direction Generale de l'Armement"; Secretariat General de la Defense et de la Securite Nationale	This research was partially supported by a Grant-in-Aid for Young Scientists (A) (No. 25709088, 2013-2015) from Ministry of Education, Culture, Sports, Science and Technology, Japan. It was performed with the approval of the Photon Factory Advisory Committee (Proposal Nos. 2008G104, 2010G179, 2012G062, and 2014G085). This work was partially supported by the SPRITS program, Kyoto University and the Cooperative Research Project of Research Institute of Electronics, Shizuoka University. This research was also partially supported by the French "Direction Generale de l'Armement" and "Secretariat General de la Defense et de la Securite Nationale" for the grant to GHVB.	Bertrand GHV, 2014, CHEM-EUR J, V20, P15660, DOI 10.1002/chem.201404093; Bertrand GHV, 2015, J MATER CHEM C, V3, P6006, DOI 10.1039/c5tc00387c; Koshimizu M, 2012, J APPL PHYS, V111, DOI 10.1063/1.3677986; Bertrand GHV, 2014, J MATER CHEM C, V2, P7304, DOI 10.1039/c4tc00815d; Yahaba N, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062602; Koshimizu M, 2014, OPT MATER, V36, P1930, DOI 10.1016/j.optmat.2014.04.004; Hamel M, 2011, NUCL INSTRUM METH A, V660, P57, DOI 10.1016/j.nima.2011.08.062; Kishimoto S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3059562; Yanagida T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062401; [Anonymous], DAT SHEET BC 452; Baron AQR, 2006, J SYNCHROTRON RADIAT, V13, P131, DOI 10.1107/S090904950503431X; Araya Y, 2015, SENSOR MATER, V27, P255; KISHIMOTO S, 1991, NUCL INSTRUM METH A, V309, P603, DOI 10.1016/0168-9002(91)90272-R; KISHIMOTO S, 1992, REV SCI INSTRUM, V63, P824, DOI 10.1063/1.1142619; Sun Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875025; Turk G, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3475788	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							102202	10.7567/JJAP.54.102202		4	Physics, Applied	Physics	CS7SG	WOS:000362285100016		
J	Lei, BL; Eze, VO; Mori, T				Lei, Binglong; Eze, Vincent Obiozo; Mori, Tatsuo			High-performance CH3NH3PbI3 perovskite solar cells fabricated under ambient conditions with high relative humidity	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VAPOR-DEPOSITION; LEAD IODIDE; FILMS	Hygroscopic perovskite solar cells are commonly fabricated under conditions of inert atmosphere or low relative humidity (RH). To generate high-performance perovskite light-absorbing layers for super power conversion efficiency (PCE), we fabricated CH3NH3PbI3 solar cells under ambient conditions (RH = 42-48%) by a flowing gas directly from high-RH air. The primary advantage of this technique, together with the casting of a hot solution and quick conduction, enabled us to achieve the highest and average PCEs of 16.32 and 14.27% respectively, with an extremely small deviation of 0.49%. Our research will be of significance for fabricating highly efficient and reproducible perovskite photovoltaics. (c) 2015 The Japan Society of Applied Physics	[Lei, Binglong; Eze, Vincent Obiozo; Mori, Tatsuo] Aichi Inst Technol, Dept Elect & Elect Engn, Toyota, Aichi 4700392, Japan	Lei, BL (reprint author), Aichi Inst Technol, Dept Elect & Elect Engn, Toyota, Aichi 4700392, Japan.	t2mori@aitech.ac.jp			MEXT [S1001033]; AIT special grant for Education, and Research; Hibi Science Foundation	This research is financially supported by the MEXT-Supported Program for Strategic Research Foundation at private universities (S1001033, 2010-2014), an AIT special grant for Education, and Research and Hibi Science Foundation. We thank Professor Wakamiya and Dr. Endo at Kyoto University for assistance in the fabrication of perovskite solar cells and Professor Kobayashi for the measurement of XRD at the Research Institute of Industrial Technology, AIT.	Ahuja R, 2002, J APPL PHYS, V92, P7219, DOI 10.1063/1.1523145; Ito S, 2015, CHEM LETT, V44, P849, DOI 10.1246/cl.150238; Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Chueh CC, 2015, ENERG ENVIRON SCI, V8, P1160, DOI 10.1039/c4ee03824j; Jeng JY, 2014, ADV MATER, V26, P4107, DOI 10.1002/adma.201306217; Norrman K, 2005, ANN RP CH C, V101, P174, DOI 10.1039/b408857n; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Ito S, 2014, CHEMPHYSCHEM, V15, P1194, DOI 10.1002/cphc.201301047; Zhang W, 2015, NANO LETT, V15, P1698, DOI 10.1021/nl504349z; Luo PF, 2015, ACS APPL MATER INTER, V7, P2708, DOI 10.1021/am5077588; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Sfyri G, 2015, SOL ENERG MAT SOL C, V134, P60, DOI 10.1016/j.solmat.2014.11.034; Ko HS, 2015, J MATER CHEM A, V3, P8808, DOI 10.1039/c5ta00658a; Raga SR, 2015, CHEM MATER, V27, P1597, DOI 10.1021/cm5041997; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Huang FZ, 2014, NANO ENERGY, V10, P10, DOI 10.1016/j.nanoen.2014.08.015; Cao DYH, 2014, APL MATER, V2, DOI [10.1063/1.4895038, 10.1063/14895038]; Chen Y., 2014, ADV MATER, V2, P1; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Wu KL, 2015, CHEM LETT, V44, P321, DOI 10.1246/cl.140919; You JB, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4901510	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							100305	10.7567/JJAP.54.100305		4	Physics, Applied	Physics	CS7SG	WOS:000362285100005		
J	Liu, YY; Morita, T				Liu, Yaoyang; Morita, Takeshi			Simplified determination of nonlinear coefficients in piezoelectric transducers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC CERAMICS; BEHAVIOR; SENSOR	Hard-type piezoelectric materials usually need to be driven under high power operation. However, in this occasion the piezoelectrics show significant nonlinear behavior, which affects various properties and should be taken as one extra criterion. In previous studies, the nonlinear phenomena in piezoelectric transducers were investigated and a nonlinear model was proposed to describe the nonlinear phenomena. Curve fitting of admittance curves yielded the nonlinear level of the piezoelectric transducers. In this study, on the basis of the nonlinear model a simplified method was proposed to replace the curve fitting; for hard-type piezoelectric transducers the results obtained from two methods show consistence with each other. With the determined nonlinear coefficients, we analyzed the high power properties of hard-type piezoelectric transducers. The conventional method for calculating quality factor was improved and demonstrated to be efficient. The energy density of high power piezoelectrics was also discussed. (C) 2015 The Japan Society of Applied Physics	[Liu, Yaoyang; Morita, Takeshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan	Liu, YY (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan.	yaoyang@ems.k.u-tokyo.ac.jp	MORITA, Takeshi/E-8484-2010				Albareda A, 2000, IEEE T ULTRASON FERR, V47, P844, DOI 10.1109/58.852066; Aurelle N, 1996, ULTRASONICS, V34, P187, DOI 10.1016/0041-624X(95)00077-G; Umeda M, 2000, JPN J APPL PHYS 1, V39, P5623, DOI 10.1143/JJAP.39.5623; Liu YY, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.015503; Birol H, 2006, J EUR CERAM SOC, V26, P861, DOI 10.1016/j.jeurceramsoc.2004.11.022; Sebald G, 2005, IEEE T ULTRASON FERR, V52, P596, DOI 10.1109/TUFFC.2005.1428042; Zhuang Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.041401; Ogawa H, 2007, IEEE T ULTRASON FERR, V54, P2500, DOI 10.1109/TUFFC.2007.567; Kawada S, 2006, JPN J APPL PHYS 1, V45, P7455, DOI 10.1143/JJAP.45.7455; Blackburn JF, 2006, J APPL PHYS, V100, DOI 10.1063/1.2365385; Ishikawa M, 2008, JPN J APPL PHYS, V47, P7673, DOI 10.1143/JJAP.47.7673; Meeker TR, 1996, IEEE T ULTRASON FERR, V43, P717; Liu YY, 2015, SENSOR ACTUAT A-PHYS, V227, P31, DOI 10.1016/j.sna.2015.03.036; Umeda M, 2001, JPN J APPL PHYS 1, V40, P5735, DOI 10.1143/JJAP.40.5735; Zhang SJ, 2007, J ELECTROCERAM, V19, P251, DOI 10.1007/s10832-007-9056-z; Mahmoodi SN, 2008, IEEE-ASME T MECH, V13, P58, DOI 10.1109/TMECH.2008.915823; Ishii K, 1999, J EUR CERAM SOC, V19, P1157, DOI 10.1016/S0955-2219(98)00397-5; Maeder MD, 2004, J ELECTROCERAM, V13, P385, DOI 10.1007/s10832-004-5130-y; Tressler JF, 1998, J ELECTROCERAM, V2, P257, DOI 10.1023/A:1009926623551; Hiruma Y, 2008, JPN J APPL PHYS, V47, P7659, DOI [10.1143/JJAP.47.7659, 10.1143/JJAP.47.7059]; Lim JB, 2010, J AM CERAM SOC, V93, P1218, DOI 10.1111/j.1551-2916.2009.03528.x; Morita T, 2003, SENSOR ACTUAT A-PHYS, V103, P291, DOI 10.1016/S0924-4247(02)00405-3; Nagata H, 2010, INTEGR FERROELECTR, V115, P63, DOI 10.1080/10584587.2010.488548; Albareda A, 2007, IEEE T ULTRASON FERR, V54, P2175, DOI 10.1109/TUFFC.2007.514; Jung H, 2000, REV SCI INSTRUM, V71, P1896, DOI 10.1063/1.1150559; Morita T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HE05; Liu YY, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.07HC01; Nagata H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND05; Noumura Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HB06; Shimizu H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD02; Tanaka D, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD03; Watanabe T, 2009, FERROELECTRICS, V385, P135, DOI 10.1080/00150190902889036	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND01	10.7567/JJAP.54.10ND01		7	Physics, Applied	Physics	CS7SO	WOS:000362286000032		
J	Magome, E; Kuroiwa, Y; Moriyoshi, C; Hirose, Y; Ueno, S; Nakashima, K; Wada, S				Magome, Eisuke; Kuroiwa, Yoshihiro; Moriyoshi, Chikako; Hirose, Yoshinobu; Ueno, Shintaro; Nakashima, Kouichi; Wada, Satoshi			Role of structure gradient region on dielectric properties in Ba(Zr,Ti)O-3-KNbO3 nanocomposite ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL BATIO3/SRTIO3 SUPERLATTICES; RADIATION POWDER DIFFRACTION; TITANATE NANOPARTICLES; POTASSIUM NIOBATE; PHASE-TRANSITION; POLARIZATION; ENHANCEMENT; KNBO3	Crystal structures of KNbO3 (KN)/BaZrxTi1-xO3 [BZT, (0.1 <= x <= 1)] nanocomposite ceramics have been investigated using synchrotron radiation X-ray powder diffraction, where BZT nanoparticles thinly coated with KN crystals through the heteroepitaxial interface are sintered. The Rietveld analysis based on the multicomponent model reveals that the ceramic grain has the core/multishell structure consisting of a BZT core, distorted BZT and KN multishells. The variations of the volume ratio of the distorted BZT shell region corresponding to the structure gradient interface region and the dielectric property of the ceramics show similar trends as a function of x. From these results, we propose that the structure gradient region is electrically soft, and provides a crucial contribution to the dielectric properties of the nanocomposite ceramics. (C) 2015 The Japan Society of Applied Physics	[Magome, Eisuke; Kuroiwa, Yoshihiro; Moriyoshi, Chikako] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan; [Hirose, Yoshinobu; Ueno, Shintaro; Nakashima, Kouichi; Wada, Satoshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan	Magome, E (reprint author), Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan.	magome@sci.hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Dr. E. Nishibori, Dr. M. Takata, and Professor M. Sakata for their help in Rietveld analysis. The SR experiments were carried out with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal Nos. 2014B1559 and 2015A0078). This study was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Harigai T, 2003, J APPL PHYS, V94, P7923, DOI 10.1063/1.1625780; Qi JQ, 2006, J NANOPART RES, V8, P959, DOI 10.1007/s11051-006-9069-6; Zeches RJ, 2009, SCIENCE, V326, P977, DOI 10.1126/science.1177046; Fu HX, 2000, NATURE, V403, P281; Kuroiwa Y, 2002, J THERM ANAL CALORIM, V69, P933, DOI 10.1023/A:1020676510622; Tian W, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335367; RHODES RG, 1951, ACTA CRYSTALLOGR, V4, P105, DOI 10.1107/S0365110X51000374; Yamanaka S, 2003, J ALLOY COMPD, V359, P109, DOI 10.1016/S0925-8388(03)00214-7; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Neaton JB, 2003, APPL PHYS LETT, V82, P1586, DOI 10.1063/1.1559651; Shimuta T, 2002, J APPL PHYS, V91, P2290, DOI 10.1063/1.1434547; Hoshina T, 2006, J APPL PHYS, V99, DOI 10.1063/1.2179971; Johnston K, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.100103; Ueno S, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818960; Goh GKL, 2006, J CRYST GROWTH, V286, P457, DOI 10.1016/j.jcrysgro.2005.10.021; Magome E, 2013, J CERAM SOC JPN, V121, P602, DOI 10.2109/jcersj2.121.602; NAZERIESHGHI A, 1990, J MATER SCI, V25, P3333, DOI 10.1007/BF00587695; HEWAT AW, 1973, J PHYS C SOLID STATE, V6, P2559, DOI 10.1088/0022-3719/6/16/010; Schonau KA, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184117; Aoyagi S, 2002, J PHYS SOC JPN, V71, P1218, DOI 10.1143/JPSJ.71.1218; Nishibori E, 2001, NUCL INSTRUM METH A, V467, P1045, DOI 10.1016/S0168-9002(01)00639-8; Tsunekawa S, 2000, PHYS REV LETT, V85, P3440, DOI 10.1103/PhysRevLett.85.3440; Garbarz-Glos B, 2011, INTEGR FERROELECTR, V123, P130, DOI 10.1080/10584587.2011.570666; Hoshina T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3027067; Jiang AQ, 2003, J APPL PHYS, V93, P1180, DOI 10.1063/1.1533094; Chen HY, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-530; Fujii I, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662397; Kell R.C., 1956, Acustica, V6; Hoshina T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC04; Jaffe B., 1971, PIEZOELECTRIC CERAMI, P135; Magome E, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091E05, 10.1143/JJAP.51.09LE05]; Wada S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC05; Wada S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NC08	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB04	10.7567/JJAP.54.10NB04		5	Physics, Applied	Physics	CS7SO	WOS:000362286000022		
J	Maiwa, H				Maiwa, Hiroshi			Characterization of electrocaloric properties by indirect estimation and direct measurement of temperature-electric field hysteresis loops	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CERAMICS; CRYSTALS	The electrocaloric properties of Pb(Zr,Ti)O-3(PZT)-based and Ba(Zr,Ti)O-3 ceramics and Pb(Mg,Nb)O-3-PbTiO3 (PMN-PT) crystals were investigated by the indirect estimation and direct measurement of temperature-electric field (T-E) hysteresis loops. The measured T-E loops showed a similar shape to strain-electric field (s-E) loops. The adiabatic temperature change Delta T due to electrocaloric effects was estimated from the polarization change of these samples. Delta Ts of 0.48 and 0.66K were estimated for the (Pb,La)(Zr,Ti)O-3 (PLZT)(9.1/65/35) ceramics and PMN-PT crystals under a field of 30 kV/cm, respectively. The measured temperature changes Delta Ts in these samples upon the release of the electric field from 30 kV/cm to zero were 0.39 and 0.36 K, respectively. (C) 2015 The Japan Society of Applied Physics	Shonan Inst Technol, Dept Mat & Human Environm Sci, Fujisawa, Kanagawa 2518511, Japan	Maiwa, H (reprint author), Shonan Inst Technol, Dept Mat & Human Environm Sci, Fujisawa, Kanagawa 2518511, Japan.	maiwa@mate.shonan-it.ac.jp			JSAP KAKENHI [26420684]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Kato Science Foundation	This study was supported in part by a grant from JSAP KAKENHI (Grant Number 26420684), a Green Network of Excellence (GRENE) project grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant from the Kato Science Foundation.	Maiwa H, 1999, JPN J APPL PHYS 1, V38, P5402, DOI 10.1143/JJAP.38.5402; Ozgul M, 2008, J ELECTROCERAM, V20, P133, DOI 10.1007/s10832-007-9120-8; Kar-Narayan S, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/3/032002; Maiwa H, 2008, J MATER SCI, V43, P6385, DOI 10.1007/s10853-008-2700-4; TUTTLE BA, 1981, FERROELECTRICS, V37, P603, DOI 10.1080/00150198108223496; Dunne LJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2991443; Neese B, 2008, SCIENCE, V321, P821, DOI 10.1126/science.1159655; Mischenko AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405889; Wang JF, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801997; Valant M, 2012, PROG MATER SCI, V57, P980, DOI 10.1016/j.pmatsci.2012.02.001; Lin GC, 2005, J THERM ANAL CALORIM, V81, P41, DOI 10.1007/s10973-005-0742-2; Moya X, 2014, NAT MATER, V13, P439, DOI [10.1038/nmat3951, 10.1038/NMAT3951]; Perantie J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4829012; Kobeko P, 1930, Z PHYS, V66, P192, DOI 10.1007/BF01392900; Zhang R, 1998, CRYST RES TECHNOL, V33, P827, DOI 10.1002/(SICI)1521-4079(1998)33:5<827::AID-CRAT827>3.0.CO;2-H; Lu SG, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3569953; Maiwa H, 2013, FERROELECTRICS, V446, P67, DOI 10.1080/00150193.2013.821011; Correia T, 2014, ENG MATER, V34, P1, DOI 10.1007/978-3-642-40264-7_1; Glass A. M., 1977, PRINCIPLES APPL FERR, P148; Maiwa H., 2012, P 2012 21 IEEE INT S; Maiwa H, 2015, FERROELECTRICS, V475, P71, DOI 10.1080/00150193.2015.995518; Matsushita M., 2009, J MIN MAT PROCESS I, V125, P259; Shebanovs L., 2002, Ferroelectrics, V273; Thomson W., 1878, PHILOS MAG, V5, P4; Uchino K., 1996, PIEZOELECTRIC ACTUAT, P52; WISEMAN GG, 1969, IEEE T ELECTRON DEV, VED16, P588, DOI 10.1109/T-ED.1969.16804	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB08	10.7567/JJAP.54.10NB08		5	Physics, Applied	Physics	CS7SO	WOS:000362286000026		
J	Martin, A; Kakimoto, K				Martin, Alexander; Kakimoto, Ken-ichi			Electric fatigue process in lead-free alkali niobate ceramics at various pressures and temperatures	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ZIRCONATE-TITANATE CERAMICS; FREE PIEZOELECTRIC CERAMICS; FREE PIEZOCERAMICS; FERROELECTRIC CERAMICS; UNIPOLAR FATIGUE; BENDING STRENGTH; BEHAVIOR; BIPOLAR; PZT	Electric fatigue tests are important for evaluating the reliability of piezoceramics. However, these tests have not been the focus of studies of lead-free alkali niobate (NKN) ceramics so far. For this purpose, two different materials, Li0.06Na0.47K0.47NbO3 (LNKN6) and Na0.55K0.45NbO3 + 0.25% MnO (Mn-NKN), have been examined at various uniaxial pressures ranging from 0.1 to 100MPa and various temperatures ranging from room temperature to 150 degrees C. It was shown that the harder ferroelectric Mn-NKN could maintain its piezoelectric properties at pressures up to 25MPa. When bipolar fatigue occurred under pressures over the coercive stress of similar to 30MPa, the sample depolarized and formed microcracks. In contrast, the softer LNKN6 did not show fatigue at higher pressures between 25 and 50 MPa. However, in both materials, higher temperatures enhanced domain wall and charge carrier movements and conclusively domain wall pinning. (C) 2015 The Japan Society of Applied Physics	[Martin, Alexander; Kakimoto, Ken-ichi] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Martin, A (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.				JSPS [25289227]	This research was supported by a JSPS Grant-in-Aid for Scientific Research B (25289227).	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Matsubara M, 2005, JPN J APPL PHYS 1, V44, P6136, DOI 10.1143/JJAP.44.6136; Rodel J, 2015, J EUR CERAM SOC, V35, P1659, DOI 10.1016/j.jeurceramsoc.2014.12.013; Glaum J, 2014, J AM CERAM SOC, V97, P665, DOI 10.1111/jace.12811; Fu R, 2000, ACTA MATER, V48, P1729, DOI 10.1016/S1359-6454(00)00010-0; Donnelly NJ, 2007, J AM CERAM SOC, V90, P490, DOI 10.1111/j.1551-2916.2006.01450.x; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Luo Z, 2011, J AM CERAM SOC, V94, P529, DOI 10.1111/j.1551-2916.2010.04101.x; Lucato SLDE, 2001, ACTA MATER, V49, P2751; Yao FZ, 2015, J AM CERAM SOC, V98, P448, DOI 10.1111/jace.13265; Mgbemere HE, 2009, J EUR CERAM SOC, V29, P1729, DOI 10.1016/j.jeurceramsoc.2008.10.012; Yao FZ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829150; Patterson EA, 2011, IEEE T ULTRASON FERR, V58, P1835, DOI 10.1109/TUFFC.2011.2021; Hill MD, 1996, J AM CERAM SOC, V79, P1915, DOI 10.1111/j.1151-2916.1996.tb08013.x; Zhukov S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014109; Haertling GH, 1999, J AM CERAM SOC, V82, P797; Hao JG, 2015, MATER RES BULL, V65, P94, DOI 10.1016/j.materresbull.2015.01.044; Hall DA, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812326; Shvartsman VV, 2005, J APPL PHYS, V98, DOI 10.1063/1.2126782; Fett T, 2003, J EUR CERAM SOC, V23, P195, DOI 10.1016/S0955-2219(02)00174-7; Nuffer J, 2002, J EUR CERAM SOC, V22, P2133, DOI 10.1016/S0955-2219(02)00017-1; Zhang SJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908960; Calderon-Moreno JM, 2001, MAT SCI ENG A-STRUCT, V315, P227, DOI 10.1016/S0921-5093(01)01154-6; Egerton L., 1962, J AM CERAM SOC, V45, P209; Genenko YA, 2015, MATER SCI ENG B-ADV, V192, P52, DOI 10.1016/j.mseb.2014.10.003; HAERTLIN.GH, 1967, J AM CERAM SOC, V50, P329, DOI 10.1111/j.1151-2916.1967.tb15121.x; Martin A, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB09; Lines M. E., 2001, PRINCIPLES APPL FERR; Priya S, 2012, LEAD FREE PIEZOELECT; Tsurekawa S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NC02; Weitzing H, 1999, J EUR CERAM SOC, V19, P1333, DOI 10.1016/S0955-2219(98)00429-4	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB06	10.7567/JJAP.54.10NB06		6	Physics, Applied	Physics	CS7SO	WOS:000362286000024		
J	Matsumae, T; Fujino, M; Suga, T				Matsumae, Takashi; Fujino, Masahisa; Suga, Tadatomo			Room-temperature bonding method for polymer substrate of flexible electronics by surface activation using nano-adhesion layers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; BARRIER COATINGS; WAFERS; FILMS	A sealing method for polymer substrates to be used in flexible electronics is studied. For this application, a low-temperature sealing method that achieves flexible bonding of inorganic bonding material is required, but no conventional technique satisfies these requirements simultaneously. In this study, a new polymer bonding method using thin Si and Fe layers and the surface activated bonding (SAB) method are applied to bond poly(ethylene naphthalate) (PEN) films to each other. PEN films can be bonded via the proposed method without voids at room temperature, and the bonded samples are bendable. The adhesion strength of the bonded samples is so strong that fracture occurs in the polymer bulk rather than at the bond interface. Investigations of the bonded samples by transmission electron microscopy (TEM) and Fourier-transform infrared spectroscopy (FTIR) reveal that bonding is achieved by chemical interactions between the polymer surface and deposited atoms. (c) 2015 The Japan Society of Applied Physics	[Matsumae, Takashi; Fujino, Masahisa; Suga, Tadatomo] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 113, Japan	Matsumae, T (reprint author), Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 113, Japan.		Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326			LAU SS, 1975, THIN SOLID FILMS, V25, P415, DOI 10.1016/0040-6090(75)90059-0; Leterrier Y, 2003, PROG MATER SCI, V48, P1, DOI 10.1016/S0079-6425(02)00002-6; Kondou R, 2011, SCRIPTA MATER, V65, P320, DOI 10.1016/j.scriptamat.2011.04.040; Howlader MMR, 2007, IEEE T ADV PACKAGING, V30, P598, DOI 10.1109/TADVP.2007.906394; Wang Q, 2003, MICROELECTRON RELIAB, V43, P751, DOI 10.1016/S0026-2714(03)00039-8; MacDonald WA, 2004, J MATER CHEM, V14, P4, DOI 10.1039/b310846p; GUSTAFSSON G, 1993, SYNTHETIC MET, V57, P4123, DOI 10.1016/0379-6779(93)90568-H; Erlat AG, 1999, J PHYS CHEM B, V103, P6047, DOI 10.1021/jp990737e; Shigetou A, 2006, IEEE T ADV PACKAGING, V29, P218, DOI 10.1109/TADVP.2006.873138; Jing SY, 2002, J KOREAN PHYS SOC, V41, P769; Gu G, 1997, OPT LETT, V22, P172, DOI 10.1364/OL.22.000172; MacDonald WA, 2007, J SOC INF DISPLAY, V15, P1075, DOI 10.1889/1.2825093; Brabec CJ, 2001, ADV FUNCT MATER, V11, P15, DOI 10.1002/1616-3028(200102)11:1<15::AID-ADFM15>3.0.CO;2-A; Sobrinho ASD, 1998, J VAC SCI TECHNOL A, V16, P3190; Kondou R, 2012, MICROELECTRON RELIAB, V52, P342, DOI 10.1016/j.microrel.2010.12.006; Akatsu T, 1999, J MATER SCI, V34, P4133, DOI 10.1023/A:1004661610307; Okada H, 2008, SENSOR ACTUAT A-PHYS, V144, P124, DOI 10.1016/j.sna.2007.12.023; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; JEAN YC, 1995, J POLYM SCI POL PHYS, V33, P2365, DOI 10.1002/polb.1995.090331708; Itoh T., 2003, 12 INT C SOL STAL SE, V2, P1828; Kondou R, 2011, ELEC COMP C, P2165, DOI 10.1109/ECTC.2011.5898819; Matsuzawa Y., 2001, P 51 EL COMP TECHN C, P384; Teresa O. H., 2010, J KOREAN PHYS SOC, V56, P1150	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							101602	10.7567/JJAP.54.101602		7	Physics, Applied	Physics	CS7SG	WOS:000362285100013		
J	Matsumoto, K; Kojima, S				Matsumoto, Kazuya; Kojima, Seiji			Effect of electric field on uniaxial relaxor ferroelectric strontium barium niobate	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE-CRYSTALS	The effects of an electric field and the temperature dependence on the elastic properties of Sr0.61Ba0.39Nb2O6 were studied by micro-Brillouin scattering. In the ferroelectric phase, a dramatic increase in the longitudinal acoustic (LA) velocity, which is related to the elastic constant c(33), was observed upon the application of a static electric field along the ferroelectric c-axis. A marked thermal hysteresis was observed below the Curie temperature, T-C = 72 degrees C, between field heating (FH) and zero field (ZFC) cooling. The effect of an electric field on the static polar nanoregions (PNRs) was examined by the temporal application of a static electric field at 140 degrees C between T-C and the intermediate temperature T-* = 190 degrees C. After turning off the applied field at 140 degrees C, the LA velocity during ZFC was measured, and it is found that, below T-C, the temperature dependence is similar to that during FH. This fact indicates that the alignment of local polarization in static PNRs between T-C and T* is possible using an external electric field. (C) 2015 The Japan Society of Applied Physics	[Matsumoto, Kazuya; Kojima, Seiji] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan	Matsumoto, K (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.	kojima@bk.tsukuba.ac.jp					Bokov AA, 2006, J MATER SCI, V41, P31, DOI 10.1007/s10853-005-5915-7; Kim MS, 2002, JPN J APPL PHYS 1, V41, P7042, DOI 10.1143/JJAP.41.7042; Kim TH, 2014, CURR APPL PHYS, V14, P1643, DOI 10.1016/j.cap.2014.09.014; Dul'kin E, 2011, J APPL PHYS, V110, DOI 10.1063/1.3622670; BURNS G, 1983, SOLID STATE COMMUN, V48, P853, DOI 10.1016/0038-1098(83)90132-1; Kleemann W, 2002, EUROPHYS LETT, V57, P14, DOI 10.1209/epl/i2002-00534-y; CROSS LE, 1987, FERROELECTRICS, V76, P241; MEGUMI K, 1976, J MATER SCI, V11, P1583, DOI 10.1007/BF00737513; GLASS AM, 1969, J APPL PHYS, V40, P4699, DOI 10.1063/1.1657277; Roth M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.265701; Sivasubramanian V, 2008, JPN J APPL PHYS, V47, P7740, DOI 10.1143/JJAP.47.7740; Dec J, 2001, EUROPHYS LETT, V55, P781, DOI 10.1209/epl/i2001-00348-5; FRANCOMBE MH, 1960, ACTA CRYSTALLOGR, V13, P131, DOI 10.1107/S0365110X60000285; Suzuki K, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064110; OLIVER JR, 1988, J APPL PHYS, V64, P37, DOI 10.1063/1.341438; KAHMANN F, 1994, PHYS REV B, V50, P2474, DOI 10.1103/PhysRevB.50.2474; Iwata M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.038004; Ko JH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3663622; Granzow T, 2002, EUROPHYS LETT, V57, P597, DOI 10.1209/epl/i2002-00503-6; Jiang FM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.184301; Blinc R., 2011, INT SERIES MONOGRAPH, V151; David C., 2004, Physica Status Solidi A, V201, DOI 10.1002/pssa.200409044; Imai T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB02; Kim TH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC01; Kojima Seiji, 2012, Journal of Advanced Dielectrics, V2, DOI 10.1142/S2010135X12410044; Tsukada S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09ME03; Kojima S., 2010, JPN J APPL PHYS, V49; Pirc R, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020101; Shvartsman VV, 2008, FERROELECTRICS, V376, P197, DOI 10.1080/00150190802440658; Tsukada S, 2013, APL MATER, V1, DOI 10.1063/1.4821624	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NC04	10.7567/JJAP.54.10NC04		4	Physics, Applied	Physics	CS7SO	WOS:000362286000030		
J	Matsuo, H; Kitanaka, Y; Inoue, R; Noguchi, Y; Miyayama, M				Matsuo, Hiroki; Kitanaka, Yuuki; Inoue, Ryotaro; Noguchi, Yuji; Miyayama, Masaru			Heavy Mn-doping effect on spontaneous polarization in ferroelectric BiFeO3 thin films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ROOM-TEMPERATURE; APPROXIMATION; DENSITY; PHASE	Mn doping effect on the crystal structure and spontaneous polarization (P-s) in ferroelectric BiFeO3 (BFO) thin films are experimentally and theoretically investigated. Polarization hysteresis measurements for BiFe1-xMnxO3 (BFMO) films grown on (100) SrTiO3 substrates with SrRuO3 electrodes indicate that remanent polarization (P-r) remains unchanged in the range of 0 <= x <= 0.1. As a result of the density-functional theory (DFT) calculations for the rhombohedral, tetragonal, and monoclinic phases of BFO and BFMO (x = 0.5), we find that the monoclinic phase with compressive strain from the substrates yields the most reasonable P-s. The DFT calculations also indicate that heavy doping of up to 50% Mn does not lead to a considerable deterioration in P-s, which is consistent with the experiments. Our investigations demonstrate that the ferroelectric polarization in the BFMO system can be retained for a wide range of Mn content either in bulk or thin-film form. (C) 2015 The Japan Society of Applied Physics	[Matsuo, Hiroki] Univ Tokyo, Sch Engn, Dept Adv Interdisciplinary Studies, Bunkyo Ku, Tokyo 1138656, Japan; [Kitanaka, Yuuki; Noguchi, Yuji; Miyayama, Masaru] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Inoue, Ryotaro] Nihon Univ, Sch Med, Inst Liberal Educ, Div Phys, Tokyo 1738610, Japan	Matsuo, H (reprint author), Univ Tokyo, Sch Engn, Dept Adv Interdisciplinary Studies, Bunkyo Ku, Tokyo 1138656, Japan.	hmatsuo@fmat.t.u-tokyo.ac.jp			JSPS [26-4693]; Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP)	This research is supported by JSPS through a Grant-in-Aid for JSPS Fellows (26-4693) and partly through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP).	Abe K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MB01; Armiento R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085108; MICHEL C, 1969, SOLID STATE COMMUN, V7, P701, DOI 10.1016/0038-1098(69)90597-3; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Hu GD, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822826; Xu GY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1924891; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Yang SY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3204695; Christen HM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144107; Reyes A, 2007, J EUR CERAM SOC, V27, P3709, DOI 10.1016/j.jeurceramsoc.2007.02.034; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Naganuma H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965799; Chen ZH, 2011, ADV FUNCT MATER, V21, P133, DOI 10.1002/adfm.201001867; Gruning M, 2011, COMP MATER SCI, V50, P2148, DOI 10.1016/j.commatsci.2011.02.021; Yun KY, 2004, J APPL PHYS, V96, P3399, DOI 10.1063/1.1775045; Singh SK, 2007, J PHYS D APPL PHYS, V40, P2705, DOI 10.1088/0022-3727/40/9/004; Neaton JB, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014113; Singh SK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2218819; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Singh SK, 2007, J APPL PHYS, V102, DOI 10.1063/1.2812594; Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413; Ederer C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060401; Kawae T, 2008, JPN J APPL PHYS, V47, P7586, DOI [10.1143/JJAP.47.7586, 10.1143/JJAP.47.75861]; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Chu YH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750524; Kawae T, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.09IA08, 10.1143/JJAP.51.09LA08]; Kawahara Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091804, 10.1143/JJAP.51.09LB04]; Kim Jong Kuk, 2006, Journal of the Korean Physical Society, V49, P566; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lee D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125305; Martin LW, 2010, MAT SCI ENG R, V68, pIII, DOI 10.1016/j.mser.2010.03.001; Nakashima S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KB03; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Siemons W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/3/034011; Yun KY, 2004, JPN J APPL PHYS 2, V43, pL647, DOI 10.1143/JJAP.43.L647	37	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA03	10.7567/JJAP.54.10NA03		7	Physics, Applied	Physics	CS7SO	WOS:000362286000004		
J	Mimura, K; Kato, K				Mimura, Ken-ichi; Kato, Kazumi			Dielectric properties of micropatterns consisting of barium titanate single-crystalline nanocubes	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BATIO3 THIN-FILMS; CHEMICAL-VAPOR-DEPOSITION; PIEZORESPONSE PROPERTIES; THICKNESS DEPENDENCE; NANOCRYSTALS; FABRICATION; GROWTH	Micropatterns of barium titanate nanocube (BT NC) assemblies were fabricated by dip-coating self-assembly using a micropatterned mold made of Si or polyimide (PI). The microstructure of the BT NC assembly in the micropatterned mold made of PI showed the closest packing structure. This result indicated that the polymer wall in the micropatterns is swollen by the organic solvent used in the dip-coating self-assembly process. As a result, this swelling might work effectively for the self-assembly of the NCs with high ordering assisted by capillary force. Moreover, it is clarified that the line-and-space-molds with a taper angle and a large width were more useful for the self-assembly of BT NCs in microtrenches selectively. The micropatterned mold made of PI could be removed by immersing in N-methyl-2-pyrrolidone at 65 degrees C. The ordered structure was not destroyed during the removal process. Micropatterned BT NC capacitor structures were obtained by this method after sintering at 850 degrees C. The interfaces of BT NCs were conjugated face-to-face, as shown by the obtained high-resolution transmission electron microscopy (HR-TEM) cross-sectional profiles. This process has a great potential for fabricating patterned assemblies directly on substrates. The dielectric properties of BT NC micropatterned assemblies in micropatterned molds made of Si were also characterized and compared with those of BT NC assemblies on Pt/Si substrates without micropatterning. (C) 2015 The Japan Society of Applied Physics	[Mimura, Ken-ichi; Kato, Kazumi] Natl Inst Adv Ind Sci & Technol, Nagoya, Aichi 4638560, Japan	Mimura, K (reprint author), Natl Inst Adv Ind Sci & Technol, Nagoya, Aichi 4638560, Japan.	k.mimura@aist.go.jp; kato@aist.go.jp			Advanced Low Carbon Technology Research and Development Program (ALCA)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA). The authors would like to thank Dr. Kenta Suzuki (AIST) for the preparation of micropatterned substrates and useful discussions.	Adireddy S, 2010, CHEM MATER, V22, P1946, DOI 10.1021/cm9038768; Mimura KI, 2012, J NANOSCI NANOTECHNO, V12, P3853, DOI 10.1166/jnn.2012.6153; KIM IT, 1994, JPN J APPL PHYS 1, V33, P5125, DOI 10.1143/JJAP.33.5125; Dang F, 2011, CRYSTENGCOMM, V13, P3878, DOI 10.1039/c1ce05296a; Fujinami K, 2010, NANOSCALE, V2, P2080, DOI 10.1039/c0nr00543f; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Shevchenko EV, 2002, J AM CHEM SOC, V124, P11480, DOI 10.1021/ja025976l; Mimura KI, 2008, THIN SOLID FILMS, V516, P8408, DOI 10.1016/j.tsf.2008.04.068; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Mimura K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4731198; Mimura K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.061501; Tang XG, 2005, J CRYST GROWTH, V285, P613, DOI 10.1016/j.jcrysgro.2005.09.024; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Tanaka K, 2008, JPN J APPL PHYS, V47, P7480, DOI 10.1143/JJAP.47.7480; Sato K, 2013, CRYST GROWTH DES, V13, P1685, DOI 10.1021/cg400013q; McAlpine MC, 2007, NAT MATER, V6, P379, DOI 10.1038/nmat1891; Bigioni TP, 2006, NAT MATER, V5, P265, DOI 10.1038/nmat1611; HAYASHI T, 1994, JPN J APPL PHYS 1, V33, P5277, DOI 10.1143/JJAP.33.5277; Polking MJ, 2012, NAT MATER, V11, P700, DOI [10.1038/nmat3371, 10.1038/NMAT3371]; FUNAKUBO H, 1993, JPN J APPL PHYS 1, V32, P4175, DOI 10.1143/JJAP.32.4175; Li M, 1999, NATURE, V402, P393; Dang F, 2012, NANOSCALE, V4, P1344, DOI 10.1039/c2nr11594h; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Hoshina T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC02; Hoshina T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC01; Imanaka Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DA02; Kaneko K, 2007, NANO LETT, V7, P421, DOI 10.1021/nl062677b; Mimura K, 2015, J CERAM SOC JPN, V123, P579, DOI 10.2109/jcersj2.123.579; Mimura K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA03; Mimura K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NC09; Mimura K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC06; Mimura K, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1995-5; Mimura K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC03; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA11	10.7567/JJAP.54.10NA11		6	Physics, Applied	Physics	CS7SO	WOS:000362286000012		
J	Mori, S; Ishii, Y; Tanaka, E; Tsukasaki, H; Kawaguchi, S				Mori, Shigeo; Ishii, Yui; Tanaka, Eri; Tsukasaki, Hirofumi; Kawaguchi, Shogo			Suppression of structural phase transition by Sr substitution in the improper ferroelectric BaAl2O4	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NEGATIVE THERMAL-EXPANSION; FE-PD ALLOY; THERMOELECTRIC-MATERIALS; PREMARTENSITIC PHASE; PRECURSOR PHENOMENA; DIFFUSE-SCATTERING; FLUCTUATIONS; MODES	To clarify lattice fluctuations and precursor phenomena accompanied by structural phase transition in stuffed tridymite compounds, changes in diffuse scattering as a function of temperature in Ba0.6Sr0.4Al2O4 have been carefully investigated by powder X-ray diffraction using synchrotron radiation, electron diffraction and transmission electron microscopy (TEM) experiments. In situ electron diffraction experiments revealed that Ba0.6Sr0.4Al2O4 exhibits lattice fluctuation manifested as a unique honeycomb-shaped diffuse scattering in the wide temperature range between 298 and 100 K. Unlike in the case of BaAl2O4, Ba0.6Sr0.4Al2O4 shows no structural phase transition to the ferroelectric structure with the hexagonal P6(3) space group in the temperature range. In contrast, it is revealed that the electron beam irradiation to the Ba0.6Sr0.4Al2O4 sample inside the transmission electron microscope induced structural change from the hexagonal P6(3)22 structure to the modulated structure with double periodicity in the three equivalent < 110 > directions in the low-temperature region. This implies that the total energy difference between these two structures is small. The hexagonal P6(3)22 structure transforms into the modulated one with short correlation length owing to some small external perturbations. (C) 2015 The Japan Society of Applied Physics	[Mori, Shigeo; Ishii, Yui; Tanaka, Eri; Tsukasaki, Hirofumi] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Kawaguchi, Shogo] Japan Synchrotron Radiat Res Inst JASRI, SPring8, Sayo, Hyogo 6795198, Japan	Mori, S (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	mori@mtr.osakafu-u.ac.jp; ishii@mtr.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	The authors thank Drs. H. Taniguchi (Nagoya University), Y. Kubota (Osaka Prefecture University), C. Moriyoshi (Hiroshima University), and Y. Kuroiwa (Hiroshima University) for fruitful discussions. The work performed at Osaka Prefecture University was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). The synchrotron diffraction experiments were performed at BL02B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2015A1510 and 2014A1323).	Abakumov AM, 2000, PHASE TRANSIT, V71, P143, DOI 10.1080/01411590008224545; Lind C, 2012, MATERIALS, V5, P1125, DOI 10.3390/ma5061125; YAMADA Y, 1985, J PHYS SOC JPN, V54, P2940, DOI 10.1143/JPSJ.54.2940; Hu L, 2014, J AM CHEM SOC, V136, P13566, DOI 10.1021/ja5077487; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Mori S, 2014, FERROELECTRICS, V464, P116, DOI 10.1080/00150193.2014.893160; Mary TA, 1996, SCIENCE, V272, P90, DOI 10.1126/science.272.5258.90; CHEN CH, 1995, PHYS REV B, V51, P6777, DOI 10.1103/PhysRevB.51.6777; Larsson AK, 2008, J SOLID STATE CHEM, V181, P1816, DOI 10.1016/j.jssc.2008.03.043; Xie CW, 2014, PHYS LETT A, V378, P1867, DOI 10.1016/j.physleta.2014.04.047; SHAPIRO SM, 1984, PHYS REV B, V30, P4314, DOI 10.1103/PhysRevB.30.4314; Fukuda K, 2005, J SOLID STATE CHEM, V178, P3662, DOI 10.1016/j.jssc.2005.09.015; HUANG SY, 1994, J PHYS CHEM SOLIDS, V55, P119, DOI 10.1016/0022-3697(94)90192-9; Mittal R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174303; SETO H, 1990, J PHYS SOC JPN, V59, P978, DOI 10.1143/JPSJ.59.978; Li JF, 2010, NPG ASIA MATER, V2, P152, DOI 10.1038/asiamat.2010.138; Bieniok A, 1998, MICROPOR MESOPOR MAT, V25, P193, DOI 10.1016/S1387-1811(98)00207-8; Bridges F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.045505; YAMADA Y, 1974, FERROELECTRICS, V7, P37, DOI 10.1080/00150197408237947; MORI M, 1975, SOLID STATE COMMUN, V17, P127, DOI 10.1016/0038-1098(75)90025-3; Perez-Mato JM, 2010, ACTA CRYSTALLOGR A, V66, P558, DOI 10.1107/S0108767310016247; SETO H, 1990, J PHYS SOC JPN, V59, P965, DOI 10.1143/JPSJ.59.965; Horibe Y, 2005, EUROPHYS LETT, V70, P383, DOI 10.1209/epl/i2005-10007-5; Dove MT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/27/275209; BINDER K, 1987, REP PROG PHYS, V50, P783, DOI 10.1088/0034-4885/50/7/001; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Christensen M, 2008, NAT MATER, V7, P811, DOI 10.1038/nmat2273; Ishii Y., UNPUB; Perez-Mato JM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.064111; Sui-Yang H., 1994, FERROELECTRICS, V159, P127, DOI 10.1080/00150199408007560; Tanaka E, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB01; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Yamamoto N., 1994, P ICEM 13, P553	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NC02	10.7567/JJAP.54.10NC02		4	Physics, Applied	Physics	CS7SO	WOS:000362286000028		
J	Murakami, S; Watanabe, T; Suzuki, T; Matsuda, T; Miura, K				Murakami, Shunsuke; Watanabe, Takayuki; Suzuki, Tatsuya; Matsuda, Takanori; Miura, Kaoru			Effects of poling termination and aging process on piezoelectric properties of Mn-doped BaTi0.96Zr0.04O3 ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CRYSTALS; BEHAVIOR; TITANATE; STRAIN	The effects of poling termination and aging process on the piezoelectric properties at room temperature of 1 mol% Mn-doped Ba(Ti0.96Zr0.04)O-3 ceramics with orthorhombic structure have been investigated. It is expected that the substitution of accepter Mn into the Ti0.96Zr0.04 site will result in a defect dipole with an oxygen vacancy and generate an internal field (E-d) in 1 mol% Mn-doped Ba(Ti0.96Zr0.04)O-3 ceramics. In order to investigate the effect of the rearrangement of defect dipoles on the piezoelectric properties, the following two investigations have been performed. One is on the relationship between the piezoelectric properties and the change in the poling-termination temperature (T-P) around the orthorhombic-tetragonal temperature (T-OT). The result shows that piezoelectric properties are related to spontaneous polarizations, and that the rearrangement of defect dipoles is small. The other is on the influence of aging treatment at 70 degrees C for 24 h on the piezoelectric properties. Above T-OT, the piezoelectric properties are almost the same, independent of the T-P of the specimen. This result suggests that the change in piezoelectric properties is due to a change in the domain in spontaneous polarizations and that the rearrangement of defect dipoles is also small. The result of domain observation reflection electron microscopy supports the rearrangement of spontaneous polarizations during the aging process. (C) 2015 The Japan Society of Applied Physics	[Murakami, Shunsuke; Watanabe, Takayuki; Suzuki, Tatsuya; Matsuda, Takanori; Miura, Kaoru] Canon Inc, Corp R&D, Ota, Tokyo 1468501, Japan	Murakami, S (reprint author), Canon Inc, Corp R&D, Ota, Tokyo 1468501, Japan.	murakami.shunsuke@canon.co.jp					Liu WF, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257602; Yu Z, 2000, J APPL PHYS, V88, P410, DOI 10.1063/1.373674; Zheng P, 2013, CURR APPL PHYS, V13, P1064, DOI 10.1016/j.cap.2013.02.020; BERLINCOURT D, 1958, PHYS REV, V111, P143, DOI 10.1103/PhysRev.111.143; Kalyani AK, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812472; Morozov MI, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573790; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Li BZ, 2013, J EUR CERAM SOC, V33, P3037, DOI 10.1016/j.jeurceramsoc.2013.05.032; Kalyani AK, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4885516; Sehirlioglu A, 2006, J APPL PHYS, V99, DOI 10.1063/1.2179972; Jarupoom P, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812227; Dobal PS, 2001, J APPL PHYS, V89, P8085, DOI 10.1063/1.1369399; Ren XB, 2004, NAT MATER, V3, P91, DOI 10.1038/nmat1051; Rubio-Marcos F, 2010, J AM CERAM SOC, V93, P318, DOI [10.1111/j.1551-2916.2009.03404.X, 10.1111/j.1551-2916.2009.03404.x]; Wu JG, 2012, J EUR CERAM SOC, V32, P891, DOI 10.1016/j.jeurceramsoc.2011.11.003; Yao FZ, 2014, J APPL PHYS, V116, DOI 10.1063/1.4895774; Yu Z, 2002, J APPL PHYS, V92, P1489, DOI 10.1063/1.1487435; Hoshina T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC04; Inoue R, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KF03; Jaffe B, 1971, PIEZOELECTRIC CERAMI; Tsuchida K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD02; Kim J.W., 2012, JPN J APPL PHYS, V51, P1; Kubota M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE08; Ogawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD03; Ogawa T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KD07; Limboeck T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4897361; Uchino K., 2000, FERROELECTRIC DEVICE; Kaneshiro J, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NE11; Umeda Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LE01; Watanabe T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KF02; Watanabe T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD12; Watanabe T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC02; Watanabe T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB08; Watanabe T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND01; Woong KJ, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB04; Yabuta H, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091D04, 10.1143/JJAP.51.09LD04]	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND05	10.7567/JJAP.54.10ND05		5	Physics, Applied	Physics	CS7SO	WOS:000362286000036		
J	Naka, N; Kashiwagi, S; Nagai, Y; Namazu, T				Naka, Nobuyuki; Kashiwagi, Shinsuke; Nagai, Yuji; Namazu, Takahiro			Micro-Raman spectroscopic analysis of single crystal silicon microstructures for surface stress mapping	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TENSILE TEST; STRAIN; DIFFRACTION; FILMS	In this paper, an experimental analysis using a micro-Raman spectroscope for surface stress distribution in single crystal silicon (SCS) microstructures is described. Specially developed tensile test equipment applies a uniaxial tensile stress on SCS specimens with a 270 nm-high, 4 mu m(2) convex structures in the gauge section. Raman spectra around the convex region are measured using an ultraviolet laser with an excitation line of 363.8 nm. The shape of the Raman spectrum on the flat surface is symmetrical, whereas that around the edge of the convex is asymmetrical due to the multi-stress condition. Two-curve fitting is adopted for the asymmetric spectrum obtained at the edge, and the stress distribution estimated by the two peak positions is much closer to finite element analysis (FEA) results than that obtained by the one peak position. In partial least squares (PLS) analysis that is performed at the edge of the convex section only, explanatory variables are Raman spectral parameters, such as peak position, peak intensity, and full width at half maximum, and the response variable is the FEA stress distribution. The plane stress distributions derived from PLS analyses on each component are in good agreement with that from FEA. The combination of micro-Raman spectroscopy and tensile testing enables us to directly determine the stress components as well as stress magnitudes on SCS microstructures. (c) 2015 The Japan Society of Applied Physics	[Naka, Nobuyuki; Kashiwagi, Shinsuke] HORIBA Ltd, Sci & Semicond Instruments R&D Dept, Kyoto 6018510, Japan; [Nagai, Yuji; Namazu, Takahiro] Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712201, Japan	Naka, N (reprint author), HORIBA Ltd, Sci & Semicond Instruments R&D Dept, Kyoto 6018510, Japan.	namazu@eng.u-hyogo.ac.jp					ANASTASS.E, 1970, SOLID STATE COMMUN, V8, P133, DOI 10.1016/0038-1098(70)90588-0; Kodera M, 2008, JPN J APPL PHYS, V47, P2506, DOI 10.1143/JJAP.47.2506; ITO T, 1994, JPN J APPL PHYS 1, V33, P171, DOI 10.1143/JJAP.33.171; Takagi SI, 1996, J APPL PHYS, V80, P1567, DOI 10.1063/1.362953; Kosemura D, 2008, JPN J APPL PHYS, V47, P2538, DOI 10.1143/JJAP.47.2538; DEWOLF I, 1992, J APPL PHYS, V71, P898, DOI 10.1063/1.351311; Senez V, 2003, J APPL PHYS, V94, P5574, DOI 10.1063/1.1611287; YAMAZAKI K, 1984, JPN J APPL PHYS 1, V23, P681, DOI 10.1143/JJAP.23.681; Ishibashi M, 2005, JPN J APPL PHYS 1, V44, P2152, DOI 10.1143/JJAP.44.2152; Namazu T, 2007, FATIGUE FRACT ENG M, V30, P13, DOI 10.1111/j.1460-2695.2006.01043.x; LOECHELT GH, 1995, APPL PHYS LETT, V66, P3639, DOI 10.1063/1.114125; Koseski RP, 2011, J APPL PHYS, V110, DOI 10.1063/1.3644971; Popov E, 2005, APPL OPTICS, V44, P2332, DOI 10.1364/AO.44.002332; Siakavellas M, 1998, MICROELECTRON ENG, V42, P469; Mehtani D, 2005, J RAMAN SPECTROSC, V36, P1068, DOI 10.1002/jrs.1409; Srikar VI, 2003, J MICROELECTROMECH S, V12, P779, DOI 10.1109/JMEMS.2003.820280; Urena F, 2013, J APPL PHYS, V114, DOI 10.1063/1.4824291; Poborchii V, 2006, APPL PHYS LETT, V89, DOI [10.1063/1.2400057, 10.1063/1.2300057]; CERDEIRA F, 1972, PHYS REV B, V5, P580, DOI 10.1103/PhysRevB.5.580; Chan V., 2005, Proceedings of the IEEE 2005 Custom Integrated Circuits Conference (IEEE Cat. No. 05CH37658); Komatsubara M., 2009, PMC MEMS, P659; Komatsubara M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C021; MA Q, 1995, J APPL PHYS, V78, P1614, DOI 10.1063/1.360255; Massart D. L., 1997, HDB CHEMOMETRICS QUA, P307; Namazu T, 2004, PROC IEEE MICR ELECT, P157; Namazu T., 2011, J ENG MATER-T ASME, V134; Namazu T., 2005, IEEJ T SENS MICROMAC, V125, P374, DOI 10.1541/ieejsmas.125.374; Nouri F, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P1055; Thean A. V.-Y., 2006, P VLSI S, P130; Thean A. V.-Y., 2005, IEDM, P509, DOI 10.1109/IEDM.2005.1609393; Wolf I.D., 1996, SEMICOND SCI TECH, V11, P139, DOI DOI 10.1088/0268-1242/11/2/001; Yoshikawa M., 2002, HDB VIBRATIONAL SPEC, P2593	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							106601	10.7567/JJAP.54.106601		8	Physics, Applied	Physics	CS7SG	WOS:000362285100032		
J	Nakagawa, Y; Hashizume, Y; Nakajima, T; Okamura, S				Nakagawa, Yuuta; Hashizume, Yoichiro; Nakajima, Takashi; Okamura, Soichiro			Polarization switching characteristics of vinylidene fluoride/tefrafluoroethylene copolymer thin films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC PROPERTIES; FLUORIDE	The polarization switching characteristics of vinylidene fluoride/tetrafluoroethylene (VDF/TeFE) copolymer thin film obtained from a melt-crystallization process were investigated over a wide electric field range from 80 to 180MV/m. It was found that full polarization reversal occurred in 210-, 270-, and 320-nm-thick films; such reversal is independent of film thickness. The analysis of the switching kinetics based on the Avrami equation indicated a one-or two-dimensional domain growth process. The switching time obeyed the exponential law as evidence of the linear relationship between log t(s) and 1/E, which is consistent with the results for the vinylidene fluoride/trifluoroethylene (VDF/TrFE) copolymer. The switching time for VDF/TeFE was shorter than that for VDF/TrFE. For instance, switching times at 120MV/m were 1.8 and 3.3 mu s for VDF/TeFE and VDF/TrFE, respectively. It was revealed that the polarization switching of the VDF/TeFE can be achieved in a shorter time than that of the VDF/TrFE. (C) 2015 The Japan Society of Applied Physics	[Nakagawa, Yuuta; Hashizume, Yoichiro; Nakajima, Takashi; Okamura, Soichiro] Tokyo Univ Sci, Dept Appl Phys, Fac Sci, Tokyo 1258585, Japan	Nakagawa, Y (reprint author), Tokyo Univ Sci, Dept Appl Phys, Fac Sci, Tokyo 1258585, Japan.	sokamura@rs.kagu.tus.ac.jp					Tamura R, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.021501; Li J, 2004, APPL PHYS LETT, V84, P1174, DOI 10.1063/1.1644917; TAJITSU Y, 1987, JPN J APPL PHYS 1, V26, P554, DOI 10.1143/JJAP.26.554; Furukawa T, 2006, IEEE T DIELECT EL IN, V13, P1120, DOI 10.1109/TDEI.2006.1714938; Zirkl M, 2011, ADV MATER, V23, P2069, DOI 10.1002/adma.201100054; Yang Y, 2013, ACS NANO, V7, P785, DOI 10.1021/nn305247x; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Sharma P, 2011, NANO LETT, V11, P1970, DOI 10.1021/nl200221z; Liu YM, 2010, ACS NANO, V4, P83, DOI 10.1021/nn901397r; FURUKAWA T, 1983, J APPL PHYS, V54, P1540, DOI 10.1063/1.332182; Rodriguez BJ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715102; Liu Q, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826323; Nakhmanson SM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115210; Ishii H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.031501; Yoshita S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3176487; Yoon SM, 2010, ADV FUNCT MATER, V20, P921, DOI 10.1002/adfm.200902095; Wang ZY, 2009, SOFT MATER, V7, P296, DOI 10.1080/15394450903344751; Rodriguez BJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2942390; Soin N, 2014, ENERG ENVIRON SCI, V7, P1670, DOI 10.1039/c3ee43987a; Tamura R, 2008, JPN J APPL PHYS, V47, P476, DOI 10.1143/JJAP.47.476; FURUKAWA T, 1989, PHASE TRANSIT, V18, P143, DOI 10.1080/01411598908206863; Kanashima T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BK06; Kanashima T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ED11; Kano K., 1999, MATER RES SOC S P, V600, P89; Persano L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2639; Takahashi Y, 2015, POLYM J, V47, P249, DOI 10.1038/pj.2014.109; TASAKA S, 1985, J APPL PHYS, V57, P906, DOI 10.1063/1.334691; Watanabe T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DD14; Yamada H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PB01; Yamada H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA06	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA09	10.7567/JJAP.54.10NA09		3	Physics, Applied	Physics	CS7SO	WOS:000362286000010		
J	Nakajima, A; Shoji, A; Nagano, K; Kajihara, J				Nakajima, Anri; Shoji, Atsushi; Nagano, Kohei; Kajihara, Jun			Dependence of memory characteristics of fullerene-containing polymer on the kind of gate metal	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIELD-EFFECT TRANSISTORS; SINGLE-ELECTRON MEMORY; DEVICES; THIN; SI; FABRICATION; OPERATION; CIRCUITS; LAYER	The memory operation of [6,6]-phenyl-C-61-butyric-acid-methyl-ester-containing polystyrene nanocomposites was investigated while varying the kind of gate metal used. Moderate magnitudes of flatband voltage shift were observed both after negative and positive programming voltages were applied to the Au gate. Excellent retention characteristics were obtained for electrons, whereas the retention time of holes was much shorter than that of electrons for the gate. An analysis of the band diagram indicated that carriers are injected and stored in the lowest unoccupied molecular orbital or highest occupied molecular orbital levels of fullerene. Au gates are promising from the practical viewpoint because they make the magnitudes of both the writing and erasing voltages small. (c) 2015 The Japan Society of Applied Physics	[Nakajima, Anri; Shoji, Atsushi; Nagano, Kohei; Kajihara, Jun] Hiroshima Univ, Res Inst Nanodevice & Bio Syst, Higashihiroshima, Hiroshima 7398527, Japan	Nakajima, A (reprint author), Hiroshima Univ, Res Inst Nanodevice & Bio Syst, Higashihiroshima, Hiroshima 7398527, Japan.	anakajima@hiroshima-u.ac.jp					Nakajima A, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4914881; Kim HJ, 2008, JPN J APPL PHYS, V47, P5083, DOI 10.1143/JJAP.47.5083; Lee DI, 2009, J KOREAN PHYS SOC, V55, P42; Jabbour GE, 1997, APPL PHYS LETT, V71, P1762, DOI 10.1063/1.119392; Nakajima A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4812840; NAKAJIMA A, 1992, APPL PHYS LETT, V61, P46, DOI 10.1063/1.107663; Nakajima A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767132; Nishikawa T, 2005, J APPL PHYS, V97, DOI 10.1063/1.1903109; Gelinck GH, 2000, APPL PHYS LETT, V77, P1487, DOI 10.1063/1.1290728; Yasuda T, 2004, APPL PHYS LETT, V85, P2098, DOI 10.1063/1.1794375; Nakajima A, 1998, J APPL PHYS, V84, P1316, DOI 10.1063/1.368199; Akaike K, 2008, J APPL PHYS, V104, DOI 10.1063/1.2957588; YANO K, 1994, IEEE T ELECTRON DEV, V41, P1628, DOI 10.1109/16.310117; FULTON TA, 1989, PHYS REV LETT, V63, P1307, DOI 10.1103/PhysRevLett.63.1307; Nakajima A, 1997, APPL PHYS LETT, V71, P353, DOI 10.1063/1.119535; Peumans P, 2003, J APPL PHYS, V93, P3693, DOI 10.1063/1.1534621; Ham JH, 2008, JPN J APPL PHYS, V47, P4988, DOI 10.1143/JJAP.47.4988; Guo LJ, 1997, APPL PHYS LETT, V70, P850, DOI 10.1063/1.118236; Nakajima A, 1997, APPL PHYS LETT, V70, P1742, DOI 10.1063/1.118653; Shibata K, 2004, APPL PHYS LETT, V84, P2572, DOI 10.1063/1.1695193; Kobayashi S, 2003, APPL PHYS LETT, V82, P4581, DOI 10.1063/1.1577383; Tiwari S, 1996, APPL PHYS LETT, V69, P1232, DOI 10.1063/1.117421; Baeg KJ, 2012, ADV FUNCT MATER, V22, P2915, DOI 10.1002/adfm.201200290; Baeg KJ, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.05EB01	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							100303	10.7567/JJAP.54.100303		4	Physics, Applied	Physics	CS7SG	WOS:000362285100003		
J	Nakamura, T; Sameshima, T; Hasumi, M; Mizuno, T				Nakamura, Tomohiko; Sameshima, Toshiyuki; Hasumi, Masahiko; Mizuno, Tomohisa			Passivation of silicon surfaces by heat treatment in liquid water at 110 degrees C	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PRESSURE H2O VAPOR; MINORITY-CARRIER LIFETIME; SOLAR-CELLS; INVERSION-LAYER; LOW-TEMPERATURE; BULK LIFETIME; THIN-FILMS; WAFERS; REDUCTION	We report the effective passivation of silicon surfaces by heating single-crystalline silicon substrates in liquid water at 110 degrees C for 1 h. High photoinduced effective minority carrier lifetimes t(eff) were obtained ranging from 8.3 x 10(-4) to 3.1 x 10(-3) s and from 1.2 x 10(-4) to 6.0 x 10(-4) s for the n- and p-type samples, respectively, under 635nm light illumination, while the t(eff) values of the initial bare samples were lower than 1.2 x 10(-5) s. The heat treatment in liquid water at 110 degrees C for 1 h resulted in low surface recombination velocities ranging from 7 to 34 cm/s and from 49 to 250cm/s for the n- and p-type samples, respectively. The photo-conductivity of the n-type sample was increased from 3.8 x 10(-3) (initial) to 1.4 x 10(-1)S/cm by the present heat treatment under air-mass (AM) 1.5 light illumination at 100mW/cm(2). The thickness of the passivation layer was estimated to be only approximately 0.7 nm. Metal-insulator-semiconductor-type solar cells were demonstrated with Al and Au metal formation on the passivated surface. Rectified current voltage and solar cell characteristics were observed. The open circuit voltages were obtained to be 0.52 and 0.49V under AM 1.5 light illumination at 100mW/cm(2) for the n- and p-type samples, respectively. (c) 2015 The Japan Society of Applied Physics	[Nakamura, Tomohiko; Sameshima, Toshiyuki; Hasumi, Masahiko] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan; [Mizuno, Tomohisa] Kanagawa Univ, Hiratsuka, Kanagawa 2591293, Japan	Nakamura, T (reprint author), Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan.	tsamesim@cc.tuat.ac.jp	Sameshima, Toshiyuki/G-1078-2013	Sameshima, Toshiyuki/0000-0003-2915-2385	Ministry of Education, Culture, Sports, Science and Technology of Japan [25420282]; Naito Science and Engineering Foundation; Sameken Co., Ltd	This work was partly supported by Grants-in-Aid for Scientific Research C (No. 25420282) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, The Naito Science and Engineering Foundation, and Sameken Co., Ltd.	Takenezawa J, 2012, J NON-CRYST SOLIDS, V358, P2285, DOI 10.1016/j.jnoncrysol.2012.01.057; Sritharathikhun J, 2007, JPN J APPL PHYS 1, V46, P3296, DOI 10.1143/JJAP.46.3296; Asada K, 2000, JPN J APPL PHYS 1, V39, P3883, DOI 10.1143/JJAP.39.3883; Ogita YI, 1996, J APPL PHYS, V79, P6954, DOI 10.1063/1.361459; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P183, DOI 10.1002/pip.892; Sameshima T, 1997, JPN J APPL PHYS 2, V36, pL687, DOI 10.1143/JJAP.36.L687; Takahashi Y, 2008, JPN J APPL PHYS, V47, P5320, DOI 10.1143/JJAP.47.5320; Sameshima T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.011801; KOUSIK GS, 1992, J APPL PHYS, V72, P141, DOI 10.1063/1.352174; Schmidt J, 2001, SEMICOND SCI TECH, V16, P164, DOI 10.1088/0268-1242/16/3/308; Schmidt J, 2008, PROG PHOTOVOLTAICS, V16, P461, DOI 10.1002/pip.823; WU IW, 1989, IEEE ELECTR DEVICE L, V10, P123, DOI 10.1109/55.31689; Sakamoto K, 2000, JPN J APPL PHYS 1, V39, P2492, DOI 10.1143/JJAP.39.2492; BORREGO JM, 1987, SOLID STATE ELECTRON, V30, P195, DOI 10.1016/0038-1101(87)90149-3; Munakata C, 2004, JPN J APPL PHYS 2, V43, pL1394, DOI 10.1143/JJAP.43.L1394; THOOFT GW, 1981, J CRYST GROWTH, V55, P173, DOI 10.1016/0022-0248(81)90285-2; Bohndiek SE, 2007, OPT ENG, V46, DOI 10.1117/1.2818224; Har-Lavan R, 2013, IEEE J PHOTOVOLT, V3, P1443, DOI 10.1109/JPHOTOV.2013.2270347; Sopori BL, 1996, SOL ENERG MAT SOL C, V41-2, P159, DOI 10.1016/0927-0248(95)00098-4; CORBETT JW, 1988, SOL CELLS, V24, P127, DOI 10.1016/0379-6787(88)90042-7; Webster EAG, 2013, IEEE T ELECTRON DEV, V60, P1188, DOI 10.1109/TED.2013.2243152; Sameshima T, 1998, JPN J APPL PHYS 1, V37, P4254, DOI 10.1143/JJAP.37.4254; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Arvanitis CD, 2007, MED PHYS, V34, P4612, DOI 10.1118/1.2804744; Sameshima T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.110205; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Lo SH, 1997, IEEE ELECTR DEVICE L, V18, P209, DOI 10.1109/55.568766; Sameshima T, 2007, JPN J APPL PHYS 1, V46, P1286, DOI 10.1143/JJAP.46.1286; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Sameshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.021204; BOULOU M, 1977, J APPL PHYS, V48, P4713, DOI 10.1063/1.323537; Webster EAG, 2012, IEEE ELECTR DEVICE L, V33, P1589, DOI 10.1109/LED.2012.2214760; DAIO H, 1993, JPN J APPL PHYS 2, V32, pL1792; Kuhlmann B, 2000, IEEE T ELECTRON DEV, V47, P2167, DOI 10.1109/16.877180; Feldmann F, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4875904; Groove A. S., 1967, PHYS TECHNOLOGY SEMI; Larionova Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291681; Orton J. W., 1990, ELECT CHARACTERIZATI; Palk E. D., 1985, HDB OPTICAL CONSTANT, P547; Rohatgi A, 2003, PROCEEDINGS OF 3RD WORLD CONFERENCE ON PHOTOVOLTAIC ENERGY CONVERSION, VOLS A-C, pA29; Sameshima T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.03CA02; Sze S. M., 1985, SEMICONDUCTOR DEVICE	42	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							106503	10.7567/JJAP.54.106503		7	Physics, Applied	Physics	CS7SG	WOS:000362285100031		
J	Nakashima, S; Takayama, K; Uchida, T; Fujisawa, H; Shimizu, M				Nakashima, Seiji; Takayama, Kouta; Uchida, Tomohisa; Fujisawa, Hironori; Shimizu, Masaru			Anomalous photovoltaic effects in Pt/single-domain-structured BiFeO3/Pt coplanar capacitors on SrTiO3 substrates	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; DEVICES	Recently, anomalous photovoltaic effects in BiFeO3 (BFO) thin films have attracted much attention. To investigate anomalous photovoltaic effects in BFO thin films, the photovoltaic properties of single-domain structured BFO should be determined. In this study, Pt/single-domain-structured BFO/Pt coplanar capacitors have been fabricated on SrTiO3 substrates, and the illuminated laser power density, BFO film thickness, measurement direction, polarization direction of light, and sample rotation angle dependences of short-circuit current and open-circuit voltage have been investigated. It is found that such anomalous photovoltaic effects are due to second-order nonlinear optical effects including carrier excitation. Moreover, the values of independent elements in the bulk photovoltaic tensor (beta), namely, beta(33), beta(31), beta(15), and beta(22) have been evaluated. (C) 2015 The Japan Society of Applied Physics	[Nakashima, Seiji; Takayama, Kouta; Uchida, Tomohisa; Fujisawa, Hironori; Shimizu, Masaru] Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan	Nakashima, S (reprint author), Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan.	nakashima@eng.u-hyogo.ac.jp			Japan Society of Promotion of Science [26820115]; University of Hyogo, Japan; JKA and its promotion funds from KEIRIN RACE; CASIO Science Promotion Foundation	The authors would like to thank Associate Professor A. Yamaguchi of the Laboratory of Advanced Science and Technology for Industry, University of Hyogo, Japan, for his assistance in the optical reflectance and transmittance measurements of our BFO thin films. This work was supported in part by the Japan Society of Promotion of Science through a Grant-in-Aid for Young Scientists (B) 26820115, a research grant from the University of Hyogo, Japan, JKA and its promotion funds from KEIRIN RACE, and a grant from the CASIO Science Promotion Foundation.	Choi T, 2009, SCIENCE, V324, P63, DOI 10.1126/science.1168636; Yuan YB, 2014, J MATER CHEM A, V2, P6027, DOI 10.1039/c3ta14188h; CHYNOWETH AG, 1956, PHYS REV, V102, P705, DOI 10.1103/PhysRev.102.705; Kohli KK, 2011, J OPT SOC AM B, V28, P470, DOI 10.1364/JOSAB.28.000470; Guo R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3641905; Young SM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116601; Nakashima S, 2015, J KOREAN PHYS SOC, V66, P1389, DOI 10.3938/jkps.66.1389; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; KOCH WTH, 1975, SOLID STATE COMMUN, V17, P847, DOI 10.1016/0038-1098(75)90735-8; Fan Z, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4899146; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Jang HW, 2009, ADV MATER, V21, P817, DOI 10.1002/adma.200800823; Takahashi K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.117402; Tarun MC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.187403; Bieler M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2360380; GLASS AM, 1974, APPL PHYS LETT, V25, P233, DOI 10.1063/1.1655453; Nastos F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035201; Seidel J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.126805; ROBERTSON J, 1995, J APPL PHYS, V77, P3975, DOI 10.1063/1.358580; Ji W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.094115; Qu TL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3584031; Basu SR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887908; Bhatnagar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3835; Lee D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125305; Nakashima S., 2012, JPN J APPL PHYS, V51; Nakashima S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KB03; Nakashima S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA16; Nechache R, 2015, NAT PHOTONICS, V9, P61, DOI 10.1038/NPHOTON.2014.255; Popov B. N., 1078, SOV PHYS USP, V21, P891; Ukai Y., 2012, JPN J APPL PHYS, V51; Yoshida K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA17; Zhou Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4905000	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA16	10.7567/JJAP.54.10NA16		6	Physics, Applied	Physics	CS7SO	WOS:000362286000017		
J	Oka, T; Suhara, T				Oka, Toshiharu; Suhara, Toshiaki			Annealed proton-exchanged waveguide quasi-phase-matched second-harmonic generation devices in 8 mol% MgO-doped congruent LiTaO3 crystal	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LITHIUM TANTALATE; FREQUENCY; VOLTAGE	Heavily (8 mol %) MgO-doped congruent LiTaO3 (MgO:cLT) crystal has wider transparency range and higher photorefractive damage resistance than LiNbO3 or non-doped LiTaO3 crystal. We examined the possibility of forming annealed proton-exchanged (APE) waveguides with various conditions. We obtained good quality APE waveguides with the propagation loss 0.7 dB/cm for 1.064 mu m wavelength and demonstrated a prototype waveguide quasi-phase-matched second-harmonic generation device of 56%/W normalized efficiency for the first time in MgO:cLT crystal. (c) 2015 The Japan Society of Applied Physics	[Oka, Toshiharu; Suhara, Toshiaki] Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Oka, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	toka@ioe.eei.eng.osaka-u.ac.jp					Ishizuki H, 2008, OPT EXPRESS, V16, P16963, DOI 10.1364/OE.16.016963; Nosaka T, 2006, IEEE PHOTONIC TECH L, V18, P124, DOI [10.1109/LPT.2005.860048, 10.1109/LPT2005.860048]; Inoue T, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.062601; Oka T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.070310; Ishizuki H, 2010, OPT EXPRESS, V18, P253, DOI 10.1364/OE.18.000253; Moutzouris K, 2011, OPT MATER EXPRESS, V1, P458; SUCHOSKI PG, 1988, OPT LETT, V13, P1050, DOI 10.1364/OL.13.001050; Suhara T, 2009, IEEE PHOTONIC TECH L, V21, P1096, DOI 10.1109/LPT.2009.2023799; Kitamura K, 1998, APPL PHYS LETT, V73, P3073, DOI 10.1063/1.122676; Horikawa N, 2007, JPN J APPL PHYS 1, V46, P5178, DOI [10.1143/JJAP.46.5178, 10.1143/JJAP.46.51778]; NITANDA F, 1995, JPN J APPL PHYS 1, V34, P1546, DOI 10.1143/JJAP.34.1546; Samanta GK, 2009, OPT LETT, V34, P1561, DOI 10.1364/OL.34.001561; Fujimura M, 2004, JPN J APPL PHYS 2, V43, pL1543, DOI 10.1143/JJAP.43.L1543; Kintaka K, 1996, J LIGHTWAVE TECHNOL, V14, P462, DOI 10.1109/50.485608; MATTHEWS PJ, 1992, J APPL PHYS, V72, P2562, DOI 10.1063/1.351555; Suhara T, 2009, LASER PHOTONICS REV, V3, P370, DOI 10.1002/lpor.200810054; Shoji I, 1997, J OPT SOC AM B, V14, P2268, DOI 10.1364/JOSAB.14.002268; Yokoyama T, 2008, JPN J APPL PHYS, V47, P6787, DOI 10.1143/JJAP.47.6787; Inoue K., 2013, ANN M LAS SOC JAP; Inoue T., 2015, IEICE TECH REP, V114, P17; Ishizuki H., 2013, JOINT S JAP SOC APPL, p18a; REGENER R, 1985, APPL PHYS B-PHOTO, V36, P143, DOI 10.1007/BF00691779; Suhara T., 2003, WAVEGUIDE NONLINEAR; Yi SY, 1996, APPL PHYS LETT, V68, P2493, DOI 10.1063/1.115832	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							100304	10.7567/JJAP.54.100304		3	Physics, Applied	Physics	CS7SG	WOS:000362285100004		
J	Oshima, N; Uchiyama, K; Ehara, Y; Oikawa, T; Tanaka, H; Sato, T; Uchida, H; Yamada, T; Funakubo, H				Oshima, Naoya; Uchiyama, Kiyoshi; Ehara, Yoshitaka; Oikawa, Takahiro; Tanaka, Hiroki; Sato, Tomoya; Uchida, Hiroshi; Yamada, Tomoaki; Funakubo, Hiroshi			Fabrication and characterization of (110)-oriented (Ba-0.5,Sr-0.5)TiO3 thin films using PdO//Pd buffer layer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; ELECTRICAL-PROPERTIES; ORIENTATION DEPENDENCE; FERROELECTRIC MEMORIES; CRYSTAL ORIENTATION; GROWTH; OXIDES	A new orientation control method for depositing (110)-oriented perovskite thin films was demonstrated using a (101)PdO//(111)Pd buffer layer on (100) Si substrates, which is widely used in integrated ferroelectric and dielectric applications. The (101)-oriented PdO was obtained by oxidizing (111) Pd films deposited on a (111)Pt/TiOx/SiO2/(100)Si substrate and (110)-oriented perovskites including SrRuO3 and (Ba-0.5,Sr-0.5)TiO3 (BST) were obtained on (101)PdO by the RF magnetron sputtering method. Although the BST films deposited at 500 degrees C were not crystallized, the BST films deposited above 600 degrees C are fully crystallized and the (110)-orientation is dominant. The (110)-oriented BST thin film showed good dielectric property with high dielectric constant (>600) at 0 kV/cm and high tunability (>50% at +/- 200 kV/cm). Comparing this dielectric property with those of other oriented BST films, both the dielectric constant and the tunability tend to decrease in the order of (111)-, (100)-, and (110)-preferred orientations. (C) 2015 The Japan Society of Applied Physics	[Oshima, Naoya; Ehara, Yoshitaka; Oikawa, Takahiro; Tanaka, Hiroki; Funakubo, Hiroshi] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan; [Uchiyama, Kiyoshi; Sato, Tomoya] Tsuruoka Coll, Natl Inst Technol, Dept Creat Engn, Tsuruoka, Yamagata 9978511, Japan; [Uchida, Hiroshi] Sophia Univ, Dept Mat, Tokyo 1028554, Japan; [Uchida, Hiroshi] Sophia Univ, Life Sci Coll, Tokyo 1028554, Japan; [Yamada, Tomoaki] Nagoya Univ, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan	Oshima, N (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan.	uchiyama@tsuruoka-nct.ac.jp; funakubo.h.aa@m.titech.ac.jp			ALCA from Japan Science and Technology Agency (JST); A-STEP from Japan Science and Technology Agency (JST); JSPS KAKENHI [26220907]	This research is partially supported by ALCA and A-STEP from Japan Science and Technology Agency (JST) and by JSPS KAKENHI Grant Number 26220907.	EOM CB, 1992, SCIENCE, V258, P1766, DOI 10.1126/science.258.5089.1766; Prellier W, 2005, J PHYS-CONDENS MAT, V17, pR803, DOI 10.1088/0953-8984/17/30/R01; Shiraishi T, 2013, J KOREAN PHYS SOC, V62, P1055, DOI 10.3938/jkps.62.1055; Weaver JF, 2009, J PHYS CHEM C, V113, P9773, DOI 10.1021/jp9013114; Spearing SM, 2000, ACTA MATER, V48, P179, DOI 10.1016/S1359-6454(99)00294-3; Kan HH, 2008, SURF SCI, V602, pL53, DOI 10.1016/j.susc.2008.03.007; Nakajima M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3581190; Miyazaki H, 2004, J EUR CERAM SOC, V24, P1005, DOI 10.1016/S0955-2219(03)00382-0; Schmid U, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838229; Ito S, 2005, JPN J APPL PHYS 1, V44, P6881, DOI 10.1143/JJAP.44.6881; Oikawa T, 2004, J APPL PHYS, V95, P3111, DOI 10.1063/1.1645646; FOX GR, 1995, J MATER RES, V10, P1508, DOI 10.1557/JMR.1995.1508; Ito S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2719621; Izyumskaya N, 2007, CRIT REV SOLID STATE, V32, P111, DOI 10.1080/10408430701707347; Okamoto S, 2004, JPN J APPL PHYS 1, V43, P6567, DOI 10.1143/JJAP.43.6567; Ouyang J, 2007, ADV FUNCT MATER, V17, P2094, DOI 10.1002/adfm.200600823; Kamo T, 2007, JPN J APPL PHYS 1, V46, P6987, DOI 10.1143/JJAP.46.6987; TAKEMURA K, 1994, APPL PHYS LETT, V64, P2967, DOI 10.1063/1.111396; Yokoyama S, 2005, J APPL PHYS, V98, DOI 10.1063/1.2126156; JIA QX, 1995, APPL PHYS LETT, V66, P2197, DOI 10.1063/1.113945; Auciello O, 1998, PHYS TODAY, V51, P22, DOI 10.1063/1.882324; Ito S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3058998; Ehara Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3575565; TUTTLE BA, 1993, J AM CERAM SOC, V76, P1537, DOI 10.1111/j.1151-2916.1993.tb03936.x; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; YANG CC, 1995, APPL PHYS LETT, V66, P2643, DOI 10.1063/1.113111; Funakubo H., 2014, Japan Patent Application, Patent No. [2014-052545, 2014052545]; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Setter N., 2002, PIEZOELECTRIC MAT DE, P1; Tanaka H., UNPUB; Tanaka Y., 2014, 52 S BAS SCI CER	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA15	10.7567/JJAP.54.10NA15		4	Physics, Applied	Physics	CS7SO	WOS:000362286000016		
J	Rahaman, MM; Imai, T; Kobayashi, J; Kojima, S				Rahaman, Md. Mijanur; Imai, Tadayuki; Kobayashi, Junya; Kojima, Seiji			Effect of Li-doping on polar-nanoregions in K(Ta1-xNbx)O-3 single crystals	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FERROELECTRIC PHASE-TRANSITION; MICRO-BRILLOUIN SCATTERING; RELAXOR FERROELECTRICS; PEROVSKITE STRUCTURE; KTA1-XNBXO3; SPECTROSCOPY; GROWTH; CONSTANTS	The anomalous changes of the elastic properties in the vicinity of the Curie temperature, T-C = 304 K, of a 5%Li-doped KTa1-xNbxO3 (KTN) single crystal were investigated by micro-Brillouin scattering. By the Li-doping, the temperature region of the elastic anomaly was extended in comparison with a non-doped KTN crystal. This fact indicates that the Li-doping enhances the growth of polar nanoregions (PNRs), while the remarkable elastic anomaly just above T-C is suppressed. The growth of PNRs was also evident from the change in the behavior of the central peak (CP) in comparison with the non-doped KTN. The broadening of the elastic anomaly can be the evidence of the enhanced diffusive nature of the ferroelectric phase transition, which is induced by Li ions. (C) 2015 The Japan Society of Applied Physics	[Rahaman, Md. Mijanur; Kojima, Seiji] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Imai, Tadayuki; Kobayashi, Junya] NTT Corp, NTT Corp Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan	Rahaman, MM (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	mijanmse@gmail.com; kojima@ims.tsukuba.ac.jp			Marubun research promotion foundation; JSPS KAKENHI [90134204]	The research was supported in part by the Marubun research promotion foundation and the JSPS KAKENHI Grant Number 90134204. The authors thank to Dr. T. Mori and Mr. M. A. Helal for fruitful discussion.	Zhou ZX, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/12/125405; Bokov AA, 2006, J MATER SCI, V41, P31, DOI 10.1007/s10853-005-5915-7; CHEN FS, 1966, J APPL PHYS, V37, P388, DOI 10.1063/1.1707846; BONNER WA, 1965, AM CERAM SOC BULL, V44, P9; SAMARA GA, 1991, FERROELECTRICS, V117, P347, DOI 10.1080/00150199108222427; TOULOUSE J, 1992, PHYS REV LETT, V68, P232, DOI 10.1103/PhysRevLett.68.232; BELL RO, 1963, PHYS REV, V129, P90, DOI 10.1103/PhysRev.129.90; Tsukada S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144106; COURDILLE JM, 1977, J PHYS-PARIS, V38, P1519, DOI 10.1051/jphys:0197700380120151900; KLEEMANN W, 1985, PHYS REV LETT, V54, P2038, DOI 10.1103/PhysRevLett.54.2038; Ohta R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560345; Kojima S, 2011, CURR APPL PHYS, V11, pS22, DOI 10.1016/j.cap.2011.04.038; Imai T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.022501; FOSSUM JO, 1985, J PHYS C SOLID STATE, V18, P5549, DOI 10.1088/0022-3719/18/29/007; Yagi S, 2012, PROC SPIE, V8213, DOI 10.1117/12.908210; HOFMEISTER R, 1993, J CRYST GROWTH, V131, P486, DOI 10.1016/0022-0248(93)90201-7; RYTZ D, 1982, J CRYST GROWTH, V59, P468, DOI 10.1016/0022-0248(82)90368-2; CROSS LE, 1987, FERROELECTRICS, V76, P241; KNAUSS LA, 1995, PHYS REV B, V52, P13261, DOI 10.1103/PhysRevB.52.13261; VIEHLAND D, 1990, J APPL PHYS, V68, P2916, DOI 10.1063/1.346425; FOX AJ, 1975, APPL OPTICS, V14, P343, DOI 10.1364/AO.14.000343; Kojima S, 2010, FERROELECTRICS, V405, P32, DOI 10.1080/00150193.2010.482885; BURNS G, 1983, PHYS REV B, V28, P2527, DOI 10.1103/PhysRevB.28.2527; SOKOLOFF JP, 1990, PHYS REV B, V41, P2398, DOI 10.1103/PhysRevB.41.2398; Svitelskiy O, 2003, J PHYS CHEM SOLIDS, V64, P665, DOI 10.1016/S0022-3697(02)00369-4; GEUSIC JE, 1964, APPL PHYS LETT, V4, P141, DOI 10.1063/1.1754003; REISMAN A, 1958, J AM CHEM SOC, V80, P1877, DOI 10.1021/ja01541a024; KASHIDA S, 1973, J PHYS SOC JPN, V34, P997, DOI 10.1143/JPSJ.34.997; Cai L, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.134106; Dul'kin E, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/57004; HANSKEPETITPIERRE O, 1991, PHYS REV B, V44, P6700, DOI 10.1103/PhysRevB.44.6700; Kim TH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC01; Kojima S, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HA01; Li J., 2011, J URBAN TRANSP CHINA, V9, P9; Pashkin A, 2005, J PHYS-CONDENS MAT, V17, pL265, DOI 10.1088/0953-8984/17/25/L04; Phelan D, 2014, P NATL ACAD SCI USA, V111, P1754, DOI 10.1073/pnas.1314780111; VACHER R, 1972, PHYS REV B, V6, P639, DOI 10.1103/PhysRevB.6.639	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB01	10.7567/JJAP.54.10NB01		5	Physics, Applied	Physics	CS7SO	WOS:000362286000019		
J	Saitoh, A; Oba, Y; Takebe, H				Saitoh, Akira; Oba, Yuya; Takebe, Hiromichi			Fabrication of optical fiber of zinc tin borophosphate glass with zero photoelastic constant	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VISCOSITY	An optical fiber made of zinc tin boro-phosphate glass having a zero photoelastic constant, good water durability, and excluding hazardous elements was drawn from a prepared preform for use in a fiber-type current sensor device. The proposed cladding compositions enable single-mode propagation for a wavelength of 1550 nm, which is estimated from the difference in the refractive index between the core and cladding compositions. The drawing conditions should be controlled since the multiple-component glass is very sensitive to changes in viscosity and crystal precipitation during the heat-treated stretching of the preform. The temperature dependence of viscosity in the core and cladding reveals the feasibility of drawing. (c) 2015 The Japan Society of Applied Physics	[Saitoh, Akira; Oba, Yuya; Takebe, Hiromichi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan	Saitoh, A (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan.	asaito@ehime-u.ac.jp			JSPS KAKENHI [25820333]	This work was partially supported by JSPS KAKENHI Grant Number 25820333.	GHOSH G, 1994, J LIGHTWAVE TECHNOL, V12, P1338, DOI 10.1109/50.317500; Chernaya VV, 2005, CHEM MATER, V17, P284, DOI 10.1021/cm048463h; Takebe H, 1999, J NON-CRYST SOLIDS, V258, P239, DOI 10.1016/S0022-3093(99)00540-2; Fujino S, 1998, J JPN I MET, V62, P106; CARDOSO AV, 1991, GLASS TECHNOL, V32, P174; Saitoh A, 2015, APL MATER, V3, DOI 10.1063/1.4917347; Feng X, 2003, OPT EXPRESS, V11, P2225, DOI 10.1364/OE.11.002225; Kumar VVRK, 2002, OPT EXPRESS, V10, P1520, DOI 10.1364/OE.10.001520; Karabulut M, 2001, J NON-CRYST SOLIDS, V288, P8, DOI 10.1016/S0022-3093(01)00615-9; Kurosawa K., 2014, PHOTONIC SENSORS, V4, P12; Kurosawa K., 2000, IEICE T ELECTRON, VE83-C, P326; NAPOLITA.A, 1974, J RES NBS A PHYS CH, VA 78, P323, DOI 10.6028/jres.078A.017; Robertson B. E., 1970, J SOLID STATE CHEM, V1, P120, DOI 10.1016/0022-4596(70)90002-2; Shelby JE, 2005, INTRODUCTION TO GLASS SCIENCE AND TECHNOLOGY, P1	14	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							100307	10.7567/JJAP.54.100307		3	Physics, Applied	Physics	CS7SG	WOS:000362285100007		
J	Sakai, Y; Adachi, M				Sakai, Yuichi; Adachi, Masatoshi			Preparation of BaTiO3-based thick films with c-axis-preferred orientation using screen printing	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TITANATE SINGLE-CRYSTALS; FREE PIEZOELECTRIC CERAMICS; TEMPLATED GRAIN-GROWTH; FABRICATION; STRAIN	Pb(Zr,Ti)O-3 and related materials have been lauded for their piezoelectric properties, but their toxicity has driven the search for alternative materials with the same high performance in electronic devices. Among these, BaTiO3-based materials are regarded as excellent substitutes. Using a screen printing method, in this study, we prepare BaTiO3 thick films on ZrO2 stabilized with 3 mol% Y2O3 (YSZ) or MgO ceramics with Pt bottom electrodes. BaTiO3 thick films prepared on YSZ and MgO substrates preferentially oriented along the a-and c-axes, respectively. The remanent polarization P-r of the MgO-based films was higher than that of the YSZ-based films (10.8 mu C/cm(2) vs 6.5 mu C/cm(2)) and comparable to that of BaTiO3 bulk ceramics. Thermal expansion measurements of BaTiO3, YSZ, and MgO ceramics suggested that compressive stress was exerted on the BaTiO3 thick films, causing them to orient along the c-axis. (Ba0.92Ca0.08)(Ti0.975Zr0.025)O-3 thick films were also prepared on the YSZ and MgO substrates and showed similar preference for the c-axis on MgO. However, the remanent polarization of (Ba0.92Ca0.08)(Ti0.975Zr0.025)O-3 thick films prepared on MgO was greater than that of bulk ceramics (14.9 mu C/cm(2) vs 11.0 mu C/cm(2)). (C) 2015 The Japan Society of Applied Physics	[Sakai, Yuichi] Toyama Ind Technol Ctr, Toyama 9300866, Japan; [Adachi, Masatoshi] Toyama Prefectural Univ, Fac Engn, Dept Intelligent Syst Design Engn, Imizu, Toyama 9390398, Japan	Sakai, Y (reprint author), Toyama Ind Technol Ctr, 383 Takada, Toyama 9300866, Japan.	sakai@itc.pref.toyama.jp			Japan Society for the Promotion of Science [25820130]	This work was partially supported by a Grant-in-Aid for Young Scientists (B) (No. 25820130) from the Japan Society for the Promotion of Science.	Guo YP, 2004, APPL PHYS LETT, V85, P4121, DOI 10.1063/1.1813636; Liu WF, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257602; Fujii S, 1997, JPN J APPL PHYS 1, V36, P6065, DOI 10.1143/JJAP.36.6065; Karaki T, 2007, JPN J APPL PHYS 2, V46, pL97, DOI 10.1143/JJAP.46.L97; Utsugi S, 2010, J CERAM SOC JPN, V118, P627, DOI 10.2109/jcersj2.118.627; NAGATA K, 1989, JPN J APPL PHYS 1, V28, P98; Kobayashi T, 2005, JPN J APPL PHYS 1, V44, P7078, DOI 10.1143/JJAP.44.7078; Rehrig PW, 2000, IEEE T ULTRASON FERR, V47, P895, DOI 10.1109/58.852072; Takahashi H, 2006, JPN J APPL PHYS 2, V45, pL30, DOI 10.1143/JJAP.45.L30; Wang Z, 2014, J AM CERAM SOC, V97, P688, DOI 10.1111/jace.12836; YAMAMOTO T, 1994, J AM CERAM SOC, V77, P1107, DOI 10.1111/j.1151-2916.1994.tb07281.x; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Rehrig PW, 2000, J AM CERAM SOC, V83, P2654; Kishi H, 2000, JPN J APPL PHYS 1, V39, P5533, DOI 10.1143/JJAP.39.5533; Harrington SA, 2011, NAT NANOTECHNOL, V6, P491, DOI [10.1038/nnano.2011.98, 10.1038/NNANO.2011.98]; LOTGERING FK, 1959, J INORG NUCL CHEM, V9, P113, DOI 10.1016/0022-1902(59)80070-1; MITSUI T, 1961, PHYS REV, V124, P1354, DOI 10.1103/PhysRev.124.1354; Takao H, 2006, J AM CERAM SOC, V89, P1951, DOI 10.1111/j.1551-2916.2006.01042.x; Futakuchi T, 2002, JPN J APPL PHYS 1, V41, P6948, DOI 10.1143/JJAP.41.6948; Yu Z, 2002, J APPL PHYS, V92, P1489, DOI 10.1063/1.1487435; Shindo Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3656445; Ehara Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA02; Sakai Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091A02, 10.1143/JJAP.51.09LA02]; Sakai Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA12; Ichikawa H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD08; Karaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD11; Kitanaka Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD01; Moriyoshi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD02; Ogawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD14; Sakai Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB07; Sakai Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09NA02; Tanaka Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA01; Tomioka S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND16	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA02	10.7567/JJAP.54.10NA02		6	Physics, Applied	Physics	CS7SO	WOS:000362286000003		
J	Sano, R; Inoue, J; Kanda, K; Fujita, T; Maenaka, K				Sano, Ryo; Inoue, Jun-ichi; Kanda, Kensuke; Fujita, Takayuki; Maenaka, Kazusuke			Fabrication of multilayer Pb(Zr,Ti)O-3 thin film by sputtering deposition for MEMS actuator applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PIEZOELECTRIC CANTILEVER; BENDING ACTUATORS; INTEGRATION; DEVICES; DRIVEN; SENSOR; AFM	Multimorph structures composed of multiple thin-film piezoelectric layers and electrode layers were realized by sputtering deposition. Cantilevers with four layers of Pb(Zr,Ti)O-3 (PZT) thin film are fabricated and evaluated. The electrical and piezoelectric characteristics of each PZT layer are very similar and are comparable to those of conventional single-layer PZT thin film. The piezoelectric constant d(31) is estimated to be -38.3pm/V from the relationship between tip displacement and applied voltage under the condition of driving four all piezoelectric layers. The generative force is also estimated from the tip displacement. It is confirmed that multimorph cantilevers have larger generative force than those of conventional unimorph and bimorph cantilevers for identical driving voltage. (C) 2015 The Japan Society of Applied Physics	[Sano, Ryo; Inoue, Jun-ichi; Kanda, Kensuke; Fujita, Takayuki; Maenaka, Kazusuke] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan	Sano, R (reprint author), Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan.				Ministry of Education, Science, Sports and Culture [26420204]	This study was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C) 26420204.	Ambika D., 2012, ADV MAT LETT, V3, P102; Jeon Y, 2000, JPN J APPL PHYS 1, V39, P2705, DOI 10.1143/JJAP.39.2705; Kim YS, 2003, SENSOR ACTUAT A-PHYS, V103, P122, DOI 10.1016/S0924-4247(02)00311-4; Jiang YG, 2013, MICROSYST TECHNOL, V19, P137, DOI 10.1007/s00542-012-1532-y; Kobayashi T, 2005, JPN J APPL PHYS 1, V44, P7078, DOI 10.1143/JJAP.44.7078; Muralt P, 2009, PROCEDIA CHEM, V1, P1191, DOI 10.1016/j.proche.2009.07.297; Lin G, 2001, IEEE T BIO-MED ENG, V48, P996; Balma D, 2014, J AM CERAM SOC, V97, P2069, DOI 10.1111/jace.12894; Wang QM, 1998, FERROELECTRICS, V215, P187, DOI 10.1080/00150199808229562; Wang QM, 1999, IEEE T ULTRASON FERR, V46, P638, DOI 10.1109/58.764850; Xu R, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/9/094007; Inoue J, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/5/055001; Lee HC, 2007, SENSOR ACTUAT A-PHYS, V136, P282, DOI 10.1016/j.sna.2006.10.050; DeVoe DL, 1997, J MICROELECTROMECH S, V6, P266, DOI 10.1109/84.623116; Kanda K, 2009, J MICROELECTROMECH S, V18, P610, DOI 10.1109/JMEMS.2009.2015478; Harris NR, 2006, SENSOR ACTUAT A-PHYS, V132, P311, DOI 10.1016/j.sna.2006.06.006; Shibata T, 2004, SENSOR ACTUAT A-PHYS, V114, P398, DOI 10.1016/j.sna.2003.11.025; Kim H, 2005, SENSOR ACTUAT A-PHYS, V121, P162, DOI 10.1016/j.sna.2004.12.005; Sanchez LM, 2014, IEEE T ULTRASON FERR, V61, P654, DOI 10.1109/TUFFC.2014.2953; Muralt P, 2000, IEEE T ULTRASON FERR, V47, P903, DOI 10.1109/58.852073; Ledermann N, 2003, SENSOR ACTUAT A-PHYS, V105, P162, DOI 10.1016/S0924-4247(03)00090-6; Beeby SP, 2006, MEAS SCI TECHNOL, V17, pR175, DOI 10.1088/0957-0233/17/12/R01; Yu JC, 2009, FERROELECTRICS, V383, P127, DOI 10.1080/00150190902888681; Kanda K, 2012, SENSORS-BASEL, V12, P16673, DOI 10.3390/s121216673; Ballas R.G., 2006, SENSOR ACTUAT A-PHYS, P130; Cui Y, 2007, PHYS SCRIPTA, VT129, P209, DOI 10.1088/0031-8949/2007/T129/047; Ishii T., 2005, KYOYUDENTAI DEVICE, P143; Kanda K., 2014, IEEJ T SENS MICROMAC, V134, P18; Kanda K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD12; Koh H. K., 2009, PROCEDIA CHEM, V1, P1303; McKinstry, 2003, SENSOR ACTUAT A-PHYS, V107, P26; Sakakibara T., 1994, P IEEE 5 INT S MICR, P71; Uchino K, 2010, ADVANCED PIEZOELECTRIC MATERIALS: SCIENCE AND TECHNOLOGY, P1, DOI 10.1533/9781845699758	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND03	10.7567/JJAP.54.10ND03		7	Physics, Applied	Physics	CS7SO	WOS:000362286000034		
J	Sato, T; Nakamura, K; Imanishi, M; Murakami, K; Imabayashi, H; Takazawa, H; Todoroki, Y; Matsuo, D; Imade, M; Maruyama, M; Yoshimura, M; Mori, Y				Sato, Taro; Nakamura, Koshi; Imanishi, Masayuki; Murakami, Kosuke; Imabayashi, Hiroki; Takazawa, Hideo; Todoroki, Yuma; Matsuo, Daisuke; Imade, Mamoru; Maruyama, Mihoko; Yoshimura, Masashi; Mori, Yusuke			Homoepitaxial growth of GaN crystals by Na-flux dipping method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LIGHT-EMITTING-DIODES; AMMONOTHERMAL GAN; SINGLE-CRYSTALS; HVPE; NITRIDE	The realization of low-dislocation-density bulk GaN crystals is necessary for use in the fabrication of future high-power devices with low power consumption. In this study, we attempted the regrowth of low-dislocation-density (10(4) - 10(5)cm(-2)) GaN substrates to fabricate thick and low-dislocation-density GaN crystals using the dipping technique with the Na-flux method. In the growth using this dipping technique, the generation of dislocations at the interface between the GaN substrate and the regrowth layer was prevented, and we succeeded in fabricating thick and low-dislocation-density GaN crystals. In the growth without the dipping technique, the surface of the GaN substrate demonstrated meltback immediately before the growth, and dislocations were newly generated. These results indicate that the Na-flux dipping technique has potential use for the fabrication of low-dislocation-density bulk GaN crystals. (c) 2015 The Japan Society of Applied Physics	[Sato, Taro; Nakamura, Koshi; Imanishi, Masayuki; Murakami, Kosuke; Imabayashi, Hiroki; Takazawa, Hideo; Todoroki, Yuma; Matsuo, Daisuke; Imade, Mamoru; Maruyama, Mihoko; Yoshimura, Masashi; Mori, Yusuke] Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Sato, T (reprint author), Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	imade@eei.eng.osaka-u.ac.jp	Yoshimura, Masashi/N-7222-2013		New Energy and Industrial Technology Development Organization; Japan Science and Technology Agency	We gratefully acknowledge the funding from the New Energy and Industrial Technology Development Organization and the Japan Science and Technology Agency.	Imade M, 2012, CRYST GROWTH DES, V12, P3799, DOI 10.1021/cg300643r; Iwaya M, 2006, THIN SOLID FILMS, V515, P768, DOI 10.1016/j.tsf.2005.12.188; Cruz SC, 2009, J CRYST GROWTH, V311, P3817, DOI 10.1016/j.jcrysgro.2009.02.051; Storm DF, 2005, J CRYST GROWTH, V281, P32, DOI 10.1016/j.jcrysgro.2005.03.009; Imade M, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.035503; GUHA S, 1992, APPL PHYS LETT, V60, P3220, DOI 10.1063/1.107465; Dwilinski R, 2011, PHYS STATUS SOLIDI A, V208, P1489, DOI 10.1002/pssa.201001196; Dwilinski R, 2008, J CRYST GROWTH, V310, P3911, DOI 10.1016/j.jcrysgro.2008.06.036; Imade M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.075501; Geng HY, 2012, J CRYST GROWTH, V350, P44, DOI 10.1016/j.jcrysgro.2011.12.020; Imade M, 2011, CRYST GROWTH DES, V11, P2346, DOI 10.1021/cg2000443; LilientalWeber Z, 1996, J ELECTRON MATER, V25, P1545, DOI 10.1007/BF02655397; Kawamura F, 2008, J CRYST GROWTH, V310, P3946, DOI 10.1016/j.jcrysgro.2008.06.008; NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1998; Lee SW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357930; Saito W, 2006, IEEE ELECTR DEVICE L, V27, P326, DOI 10.1109/LED.2006.873756; Zhang L, 2010, J ALLOY COMPD, V504, P186, DOI 10.1016/j.jallcom.2010.05.085; Imanishi M, 2013, PHYS STATUS SOLIDI C, V10, P400, DOI 10.1002/pssc.201200705; Rosner SJ, 1997, APPL PHYS LETT, V70, P420, DOI 10.1063/1.118322	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							105501	10.7567/JJAP.54.105501		5	Physics, Applied	Physics	CS7SG	WOS:000362285100025		
J	Shinoda, R; Iwase, A; Matsui, T				Shinoda, Ryoichi; Iwase, Akihiro; Matsui, Toshiyuki			Measuring the effect of oxygen deficiency on magnetic coupling in Ba(Co1-xMnx)O3-delta by synchrotron X-ray spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							K-EDGE; PEROVSKITE; ABSORPTION; MANGANITES; DICHROISM; BEHAVIOR; SYSTEM	We report on the effect of oxygen deficiency on the structural and magnetic properties of Ba(Co1-xMnx)O-3 (x = 0.10-0.20) ceramics, as characterized by synchrotron X-ray spectroscopy. Different amounts of oxygen deficiency were introduced by an annealing process under vacuum. The stoichiometry of the oxygen ions in the ceramic samples gradually decreased from an ABO(3)-perovskite type to an ABO(2) type with increasing annealing temperature. Saturation magnetization decreased with increasing annealing temperature irrespective of the amount of Mn substitution, and the magnetic properties for the x = 0.10-0.20 samples changed from ferromagnetic to paramagnetic. According to the X-ray photoelectron spectroscopy (XPS) using synchrotron X-ray radiation and X-ray absorption near-edge structure (XANES) spectroscopy measurements for the x = 0.10 samples, the valence states of the Co and Mn ions gradually changed from tetravalent to trivalent to divalent with increasing annealing temperatures. The transient states of the structural and magnetic properties owing to the induced oxygen deficiency could be observed by synchrotron X-ray spectroscopy. (c) 2015 The Japan Society of Applied Physics	[Shinoda, Ryoichi; Iwase, Akihiro; Matsui, Toshiyuki] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Matsui, Toshiyuki] Osaka Prefecture Univ, Res Org 21st Century, Sakai, Osaka 5998531, Japan	Shinoda, R (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	t-matsui@21c.osakafu-u.ac.jp			Japan Society for the Promotion of Science [21560725]	The synchrotron XPS and XANES measurements were carried out under the approval of KEK-PF BL27A, B proposals 2013G616 and 2013G617. We are grateful to Dr. Yuji Baba and Dr. Yoshihiro Okamoto for technical discussions on the XPS and XANES measurements and analysis. Financial support through a Grant-in-Aid for Scientific Research (C) No. 21560725 from the Japan Society for the Promotion of Science is gratefully acknowledged.	Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; GOODENOUGH JB, 1955, PHYS REV, V98, P391, DOI 10.1103/PhysRev.98.391; TAWFIK A, 1987, J MATER SCI LETT, V6, P1224, DOI 10.1007/BF01729192; Nazir S, 2011, PHYS LETT A, V375, P1481, DOI 10.1016/j.physleta.2011.02.041; Fujimura N, 1996, APPL PHYS LETT, V69, P1011, DOI 10.1063/1.117969; Yoshimura T, 2000, J APPL PHYS, V87, P3444, DOI 10.1063/1.372364; Inoue T, 2005, IEEE T MAGN, V41, P3496, DOI [10.1109/TMAG.2005.854766, 10.1109/TMAG.2005.0854766]; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; Nan CW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2836410; Subias G, 1997, PHYS REV B, V56, P8183, DOI 10.1103/PhysRevB.56.8183; Cherepanov VA, 2000, J SOLID STATE CHEM, V153, P205, DOI 10.1006/jssc.2000.8743; Yi JX, 2012, J MEMBRANE SCI, V387, P17, DOI 10.1016/j.memsci.2011.08.053; Hanashima T, 2004, JPN J APPL PHYS 1, V43, P4171, DOI 10.1143/JJAP.43.4171; KANAMORI J, 1959, J PHYS CHEM SOLIDS, V10, P87, DOI 10.1016/0022-3697(59)90061-7; Shinoda R, 2014, J APPL PHYS, V116, DOI 10.1063/1.4904851; Matsui T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868887; GONZALEZCALBET JM, 1994, J SOLID STATE CHEM, V111, P202, DOI 10.1006/jssc.1994.1218; Haas O, 2004, J SOLID STATE CHEM, V177, P1000, DOI 10.1016/j.jssc.2003.10.004; Shinoda R, 2014, MATER TRANS, V55, P637, DOI 10.2320/matertrans.M2013429; Seyama H, 2008, APPL SURF SCI, V255, P1509, DOI 10.1016/j.apsusc.2008.11.004; Ohno H, 2008, NUCL INSTRUM METH B, V266, P3013, DOI 10.1016/j.nimb.2008.03.155; Soldati AL, 2013, J SOLID STATE CHEM, V198, P253, DOI 10.1016/j.jssc.2012.10.019; Monesi C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174104; Sikolenko VV, 2006, CRYSTALLOGR REP+, V51, pS67, DOI 10.1134/S106377450607011X; Kanatani H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3360208; Kanatani H, 2009, J APPL PHYS, V105, DOI 10.1063/1.3059407; Katsube K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3062950; Kishino T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FC07; Matsui T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2836709; Matsui T, 2005, J APPL PHYS, V97, DOI 10.1063/1.1850860; Sanchez MC, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144409; Shinoda R, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799476	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							103001	10.7567/JJAP.54.103001		5	Physics, Applied	Physics	CS7SG	WOS:000362285100019		
J	Shiraishi, T; Kaneko, N; Kurosawa, M; Uchida, H; Suzuki, Y; Kobayashi, T; Funakubo, H				Shiraishi, Takahisa; Kaneko, Noriyuki; Kurosawa, Minoru; Uchida, Hiroshi; Suzuki, Yasuhiro; Kobayashi, Takeshi; Funakubo, Hiroshi			Vibration-energy-harvesting properties of hydrothermally synthesized (K,Na)NbO3 films deposited on flexible metal foil substrates	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; PIEZOELECTRIC PROPERTIES; ELECTRICAL-PROPERTIES; HIGH-TEMPERATURE; MEMS; NANOGENERATOR; CANTILEVERS; FABRICATION; TECHNOLOGY; THICKNESS	Energy-harvesting properties were investigated for the flexible piezoelectric devices, Pt/hydrothermally synthesized (K0.88Na0.12)NbO3/SrRuO3/metal foil, fabricated at low process temperatures below 300 degrees C. Fabricated devices had high flexibility, and cracking and peeling were not observed under the bending condition with the maximum curvature of 5.2mm. The estimated Young's modulus of the fabricated flexible devices was 37GPa. The pulse poling treatment with AC voltage above 150 V enhanced the energy-harvesting properties. Although the dielectric constant was almost unchanged (epsilon(r) = 120 at 200 Hz), the maximum output voltage measured at an acceleration of 10m/s(2) was observed at a resonance frequency of 126 Hz, and this voltage increased from 7.2 to 11 V after pulse poling treatment at 200V. The maximum output power was 7.7 mu W at a load resistance of 560 k Omega. The calculated Q and K-2 values were 30 and 0.0014, respectively. The power density was 1.8 mu W/(G(2).mm(3)), which is higher than the previous reports for films and sintered bodies of (KxNa1-x) fabricated above 500 degrees C. (C) 2015 The Japan Society of Applied Physics	[Shiraishi, Takahisa; Kaneko, Noriyuki; Funakubo, Hiroshi] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan; [Kurosawa, Minoru] Tokyo Inst Technol, Dept Informat Proc, Yokohama, Kanagawa 2268502, Japan; [Uchida, Hiroshi] Sophia Univ, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan; [Suzuki, Yasuhiro; Kobayashi, Takeshi] Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Engn, Tsukuba, Ibaraki 3058564, Japan	Shiraishi, T (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan.				Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	This research was partially supported by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy (CSTP).	Kok SL, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/12/124010; Lee JH, 2014, ADV MATER, V26, P765, DOI 10.1002/adma.201303570; Kanno I, 2003, SENSOR ACTUAT A-PHYS, V107, P68, DOI 10.1016/S0924-4247(03)00234-6; Shibata K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.075502; Wang LY, 2012, CERAM INT, V38, pS291, DOI 10.1016/j.ceramint.2011.04.104; Gavan KB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152772; Zhu H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595325; Priya S, 2007, J ELECTROCERAM, V19, P167, DOI 10.1007/s10832-007-9043-4; Shiraishi T, 2013, J KOREAN PHYS SOC, V62, P1055, DOI 10.3938/jkps.62.1055; Roundy S, 2003, COMPUT COMMUN, V26, P1131; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Wiegand S, 2012, B MATER SCI, V35, P745, DOI 10.1007/s12034-012-0367-6; Shibata K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011501; Mane P, 2011, IEEE T ULTRASON FERR, V58, P10, DOI 10.1109/TUFFC.2011.1769; Kim SG, 2012, MRS BULL, V37, P1039, DOI 10.1557/mrs.2012.275; Anton SR, 2007, SMART MATER STRUCT, V16, pR1, DOI 10.1088/0964-1726/16/3/R01; Choi WJ, 2006, J ELECTROCERAM, V17, P543, DOI 10.1007/s10832-006-6287-3; Rho J, 2010, IEEE ELECTR DEVICE L, V31, P1017, DOI 10.1109/LED.2010.2053344; Liao Y, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/6/065026; Shiraishi T, 2013, J CERAM SOC JPN, V121, P627, DOI 10.2109/jcersj2.121.627; Yeo HG, 2014, J APPL PHYS, V116, DOI 10.1063/1.4886597; Kanno I, 2012, SENSOR ACTUAT A-PHYS, V179, P132, DOI 10.1016/j.sna.2012.03.003; Cook-Chennault KA, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/4/043001; Qi Y, 2010, NANO LETT, V10, P524, DOI 10.1021/nl903377u; Mei Z, 2000, INT J ADHES ADHES, V20, P273, DOI 10.1016/S0143-7496(99)00056-1; Qi Y, 2010, ENERG ENVIRON SCI, V3, P1275, DOI 10.1039/c0ee00137f; Isarakorn D, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/2/025015; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; BACSA R, 1992, J MATER RES, V7, P423, DOI 10.1557/JMR.1992.0423; Seguchi T, 2002, RADIAT PHYS CHEM, V63, P35, DOI 10.1016/S0969-806X(01)00478-9; Hudak NS, 2008, J APPL PHYS, V103, DOI 10.1063/1.2918987; Goh GKL, 2006, J CRYST GROWTH, V286, P457, DOI 10.1016/j.jcrysgro.2005.10.021; Tian AF, 2012, APPL SURF SCI, V258, P2674, DOI 10.1016/j.apsusc.2011.10.116; Okada H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.070222; Li XX, 2003, APPL PHYS LETT, V83, P3081, DOI 10.1063/1.1618369; Morita T, 1998, IEEE T ULTRASON FERR, V45, P1178, DOI 10.1109/58.726441; Chun DM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789347; Shu YC, 2006, SMART MATER STRUCT, V15, P1499, DOI 10.1088/0964-1726/15/6/001; CHAVEZ SA, 1994, NUCL ENG DES, V148, P351, DOI 10.1016/0029-5493(94)90120-1; Itoh M, 1997, MACROMOLECULES, V30, P694, DOI 10.1021/ma961081f; Park KI, 2014, ADV MATER, V26, P2514, DOI 10.1002/adma.201305659; Singh KB, 2012, MECHATRONICS, V22, P970, DOI 10.1016/j.mechatronics.2012.06.006; Beeby SP, 2006, MEAS SCI TECHNOL, V17, pR175, DOI 10.1088/0957-0233/17/12/R01; Lin YH, 2009, APPL THERM ENG, V29, P573, DOI 10.1016/j.applthermaleng.2008.03.028; Yoshimura T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.051501; Yi JW, 2002, J APPL PHYS, V91, P1680, DOI 10.1063/1.1427403; Xu JB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2409365; Erturk A, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/2/025009; Kobayashi T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA01; Shiraishi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FE02; Shiraishi T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA10; Trolier-McKinstry S, 2004, J ELECTROCERAM, V12, P7, DOI 10.1023/B:JECR.0000033998.72845.51; Tsujiura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD13; Wang L., 2012, J ADV DIELECTR, V2	54	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND06	10.7567/JJAP.54.10ND06		6	Physics, Applied	Physics	CS7SO	WOS:000362286000037		
J	Takahashi, S; Imai, Y; Kan, A; Hotta, Y; Ogawa, H				Takahashi, Susumu; Imai, Yusuke; Kan, Akinori; Hotta, Yuji; Ogawa, Hirotaka			Microwave dielectric properties of composites consisting of MgAl2O4 filler synthesized by molten-salt method and isotactic polypropylene polymer matrix	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SUBSTRATE APPLICATIONS; CERAMIC COMPOSITES; THERMAL-PROPERTIES; PTFE COMPOSITES; SPINEL MGAL2O4; COEFFICIENT; WHISKERS; ALUMINA; SYSTEM; NMR	MgAl2O4 particles were synthesized through the solid-state reaction method (MAO-S) or molten-salt method (MAO-M). The crystallinity, particle size, and crystal structure of spinel-structured MAO-S and MAO-M particles were characterized and these particles used as dielectric fillers were filled into an isotactic polypropylene matrix, up to 30 vol% filler concentration. Significant differences in the degree of inversion (lambda), which represents the cation distribution in tetrahedral and octahedral sites, were obtained for MAO-S and MAO-M by solid-state NMR measurements and the lambda value of MAO-S fired for 10 h was 0.39, while that of MAO-M fired for 10 h was 0.64. The dielectric constant of MAO-S-or MAO-M-filled composites increased from 2.4 to 3.7 with increasing filler concentration and was consistent with the Bruggeman model. The dielectric loss and thermal conductivity of the composites were remarkably improved by the addition of the MAO-M filler, depending on the increase in the duration of firing, and were 1.74 x 10(-4) and 0.62W/(m.K), respectively. The coefficient of thermal expansion and the temperature coefficient of the dielectric constant of composites also depended on the filler concentration. (C) 2015 The Japan Society of Applied Physics	[Takahashi, Susumu; Kan, Akinori; Ogawa, Hirotaka] Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan; [Imai, Yusuke; Hotta, Yuji] Natl Inst Adv Ind Sci & Technol, Nagoya, Aichi 4638560, Japan	Takahashi, S (reprint author), Meijo Univ, Grad Sch Sci & Technol, Nagoya, Aichi 4688502, Japan.	akan@meijo-u.ac.jp					Hosseini SM, 2008, PHYS STATUS SOLIDI B, V245, P2800, DOI 10.1002/pssb.200844142; Surendran KP, 2005, APPL PHYS A-MATER, V81, P823, DOI 10.1007/s00339-005-3282-5; Rajesh S, 2011, PHYSICA B, V406, P4312, DOI 10.1016/j.physb.2011.08.080; Takahashi S, 2013, J CERAM SOC JPN, V121, P606, DOI 10.2109/jcersj2.121.606; Anjana PS, 2008, INT J APPL CERAM TEC, V5, P325, DOI 10.1111/j.1744-7402.2008.02228.x; Gao YW, 2012, POLYM ADVAN TECHNOL, V23, P919, DOI 10.1002/pat.1992; Maekawa H, 1997, AM MINERAL, V82, P1125; Takahashi S, 2014, J ALLOY COMPD, V615, P141, DOI 10.1016/j.jallcom.2014.06.138; Takahashi S, 2015, POLYM BULL, V72, P1595, DOI 10.1007/s00289-015-1358-8; Im DH, 2012, CERAM INT, V38, pS191, DOI 10.1016/j.ceramint.2011.04.081; Thomas S, 2009, MATER SCI ENG B-ADV, V163, P67, DOI 10.1016/j.mseb.2009.05.007; Zheng CW, 2007, J AM CERAM SOC, V90, P1483, DOI 10.1111/j.1551-2916.2007.01550.x; Rajesh S, 2009, MATER SCI ENG B-ADV, V163, P1, DOI 10.1016/j.mseb.2009.04.011; Murali KP, 2009, MATER CHEM PHYS, V113, P290, DOI 10.1016/j.matchemphys.2008.07.089; Subodh G, 2007, J AM CERAM SOC, V90, P3507, DOI 10.1111/j.1551-2916.2007.01914.x; Wu SP, 2014, J ALLOY COMPD, V585, P542, DOI 10.1016/j.jallcom.2013.09.176; Takahashi S, 2015, J ALLOY COMPD, V640, P428, DOI 10.1016/j.jallcom.2015.03.087; Sepelak V, 2006, SOLID STATE IONICS, V177, P2487, DOI 10.1016/j.ssi.2006.04.014; [Anonymous], 2007, R1641 JIS; Wilkerson KR, 2013, J AM CERAM SOC, V96, P859, DOI 10.1111/jace.12125; Jayaseelan DD, 2007, J EUR CERAM SOC, V27, P4745, DOI 10.1016/j.jeurceramsoc.2007.03.027; Wang WZ, 2002, ADV MATER, V14, P837, DOI 10.1002/1521-4095(20020605)14:11<837::AID-ADMA837>3.0.CO;2-4; Surendran KP, 2004, EUR PHYS J B, V41, P301, DOI 10.1140/epjb/e2004-00321-8; Xue JJ, 2013, J AM CERAM SOC, V96, P2481, DOI 10.1111/jace.12331; Chen YJ, 2001, J CRYST GROWTH, V224, P244, DOI 10.1016/S0022-0248(01)00673-X; Hashimoto S, 2013, CERAM INT, V39, P2077, DOI 10.1016/j.ceramint.2012.08.062; ASPNES DE, 1982, AM J PHYS, V50, P704, DOI 10.1119/1.12734; Kobayashi Y., 1989, IEICE TECH REP, V88, P43; Sebastian M. T., 2008, DIELECTRIC MAT WIREL, P21	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NE02	10.7567/JJAP.54.10NE02		5	Physics, Applied	Physics	CS7SO	WOS:000362286000046		
J	Takarada, J; Sato, H; Furukawa, A				Takarada, Jun; Sato, Hiroki; Furukawa, Akio			Domain switching of ferroelectric polymer film using piezoelectric force microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VAPOR-DEPOSITION POLYMERIZATION; THIN-FILMS; VINYLIDENE FLUORIDE; COPOLYMER FILMS; LITHIUM-NIOBATE; TRIFLUOROETHYLENE; POLARIZATION; RESOLUTION; DYNAMICS	We attempted to clarify the domain switching dynamics in a microscale region of the ferroelectric copolymer poly(vinylidene fluoride-trifluoroethylene) using piezoelectric response force microscopy (PFM). Spatial nonuniformity of the electric field occurred in the polarization operation using PFM owing to the application of a voltage to the cantilever tip. From the nonuniformity in the thickness direction, we found that the nucleation of domain switching occurred unless an electric field exceeding the coercive electric field was applied from the front surface to the back surface of the film. From this finding, it is assumed that a region with a switching domain cannot spread in the film face direction unless the region is penetrated in the thickness direction. Also, we found that the nonuniformity in the film face direction affects the configuration of domain switching and that the domain area can be divided into regions where the polarization is switched rapidly, domain walls move slowly, and both these phenomena occur. These phenomena can be applied to not only the polarization reversal process of ferroelectric polymers but also general polarizations using scanning probe microscopy. (C) 2015 The Japan Society of Applied Physics	[Takarada, Jun; Sato, Hiroki; Furukawa, Akio] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Takarada, J (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan.	takarada@rs.tus.ac.jp					Ando M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD17; Paruch P, 2001, APPL PHYS LETT, V79, P530, DOI 10.1063/1.1388024; Xue DF, 2003, CHEM PHYS LETT, V377, P475, DOI 10.1016/S0009-2614(03)01190-4; TAJITSU Y, 1987, JPN J APPL PHYS 1, V26, P554, DOI 10.1143/JJAP.26.554; OHIGASHI H, 1995, APPL PHYS LETT, V66, P3281, DOI 10.1063/1.113730; Furukawa T, 2006, IEEE T DIELECT EL IN, V13, P1120, DOI 10.1109/TDEI.2006.1714938; Zhang LX, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.174108; Tajitsu Y, 2013, IEEE T ULTRASON FERR, V60, P1625, DOI 10.1109/TUFFC.2013.2744; Lohse O, 2001, J APPL PHYS, V89, P2332, DOI 10.1063/1.1331341; Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516; Kim Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3290247; KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975; Lim YT, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876605; Hodoyama K, 2007, JPN J APPL PHYS 1, V46, P1549, DOI 10.1143/JJAP.46.1549; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Sharma P, 2011, NANO LETT, V11, P1970, DOI 10.1021/nl200221z; TAKAHASHI Y, 1991, J APPL PHYS, V70, P6983, DOI 10.1063/1.349827; Cho Y, 1999, APPL PHYS LETT, V75, P2833, DOI 10.1063/1.125165; Gruverman A, 1997, APPL PHYS LETT, V71, P3492, DOI 10.1063/1.120369; Hong S, 2001, J APPL PHYS, V89, P1377, DOI 10.1063/1.1331654; Kundu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08494; Gopalan V, 1999, J APPL PHYS, V85, P2304, DOI 10.1063/1.369542; Fujisawa H, 2002, FERROELECTRICS, V269, P21, DOI 10.1080/00150190211173; Nakajima T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC05; Kubono A, 2008, JPN J APPL PHYS, V47, P5553, DOI 10.1143/JJAP.47.5553; Hiranaga Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA05; Fujisawa H., 2014, JPN J APPL PHYS, V53; Griffiths D. J., 1999, INTRO ELECTRODYNAMIC, P121; Hu WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04772; ISHIBASH.Y, 1971, J PHYS SOC JPN, V31, P506; Kariya K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA14; Lines M. E., 1977, PRINCIPLES APPL FERR; Morimoto M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DK13; Nakashima S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KB03; Shvartsman VV, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014102; Takarada J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KE01; Yoshida M., 2014, JPN J APPL PHYS, V53	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA17	10.7567/JJAP.54.10NA17		6	Physics, Applied	Physics	CS7SO	WOS:000362286000018		
J	Tanaka, K; Hiraoka, N; Nakano, S; Kameda, T; Fujimoto, M; Fukagawa, R				Tanaka, Katsuhiko; Hiraoka, Nobutaka; Nakano, Shunya; Kameda, Takuma; Fujimoto, Masamitsu; Fukagawa, Ryoichi			Improved measurement of soil moisture using an ultrasonic waveguide to predict rainfall-induced slope failure	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SENSORS; SUCTION	Field monitoring of soil moisture and groundwater level is important to predict shallow slope failure stemming from heavy rainfall. We previously proposed a monitoring technique using ultrasonic waveguides in which soil moisture and groundwater levels are monitored on the basis of the intensity and propagation time of ultrasonic waves reflected from the underground soil surface, respectively. In field monitoring, the reflective intensity depends on the depth of monitoring points and the inhomogeneity of grains, so it has been difficult to examine the reflective intensity change quantitatively. In the present work, we propose improvements that will allow us to measure the intensity change quantitatively. Specifically, we utilize an ultrasonic waveguide of a constant length by using casing pipes with different lengths depending on the monitoring depth and cover the surface of coarse-grained soil with a homogeneous fine soil to obtain repeatable data for wetting and drying cycles. The positive effects of these improvements were confirmed by a field monitoring test. (C) 2015 The Japan Society of Applied Physics	[Tanaka, Katsuhiko; Hiraoka, Nobutaka; Nakano, Shunya; Kameda, Takuma; Fujimoto, Masamitsu; Fukagawa, Ryoichi] Ritsumeikan Univ, Kusatsu, Shiga 5258577, Japan	Tanaka, K (reprint author), Ritsumeikan Univ, Kusatsu, Shiga 5258577, Japan.	tanaka-k@fc.ritsumei.ac.jp			JSPS KAKENHI [23510230, 15K01265]; Ritsumeikan University	This work was partially supported by JSPS KAKENHI Grant Numbers 23510230 and 15K01265 and Advanced Research Programs from Ritsumeikan University (2014). The authors thank Mrs. A. Togari of the East Japan Railway Company and Mr. N. Iwasa of Nippon Steel and Sumikin Material Products Co., Ltd. for their fruitful discussions.	Egeli I, 2011, SCI IRAN, V18, P1179, DOI 10.1016/j.scient.2011.09.010; Huang CC, 2008, ENG GEOL, V101, P134, DOI 10.1016/j.enggeo.2008.04.009; KASAP SO, 1994, ULTRASONICS, V32, P379, DOI 10.1016/0041-624X(94)90108-2; Greco R, 2010, PHYS CHEM EARTH, V35, P127, DOI 10.1016/j.pce.2009.12.003; Tohari A, 2007, J GEOTECH GEOENVIRON, V133, P575, DOI 10.1061/(ASCE)1090-0241(2007)133:5(575); Chanzy A, 2012, SENSORS-BASEL, V12, P9773, DOI 10.3390/s120709773; Kitamura R, 2010, SOILS FOUND, V50, P955, DOI 10.3208/sandf.50.955; Takano N, 2000, JPN J APPL PHYS 1, V39, P3112, DOI 10.1143/JJAP.39.3112; MINKIN MB, 1988, SOV SOIL SCI+, V20, P104; Stacheder M, 2009, SENSORS-BASEL, V9, P2951, DOI 10.3390/s90402951; Sasahara K, 2014, ENG GEOL, V170, P43, DOI 10.1016/j.enggeo.2013.12.005; Lekshmi SUS, 2014, MEASUREMENT, V54, P92, DOI 10.1016/j.measurement.2014.04.007; Toll DG, 2011, Q J ENG GEOL HYDROGE, V44, P23, DOI 10.1144/1470-9236/09-010; Huang CC, 2010, GEOMORPHOLOGY, V120, P326, DOI 10.1016/j.geomorph.2010.04.006; Li AG, 2005, CAN GEOTECH J, V42, P13, DOI 10.1139/T04-069; Hiraoka N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HC19; Huang ChingChuan, 2009, Journal of Hydrology (Amsterdam), V370, P39, DOI 10.1016/j.jhydrol.2009.02.051; Reder A, 2014, PROCED EARTH PLAN SC, V9, P171, DOI 10.1016/j.proeps.2014.06.016; Sako K., 2011, J DISASTER RES, V6, P70; Suzuki T., 2008, PROC 43RD JAPAN NATL, P1943; Tanaka K., 2009, IEEE SENS 2009 C, P617; Tanaka K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KD12; Tanaka K, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.092; Taneda Y., 1973, NOGYO DOBOKU GAKKAI, V1973, P1	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND04	10.7567/JJAP.54.10ND04		5	Physics, Applied	Physics	CS7SO	WOS:000362286000035		
J	Taniguchi, Y; Kakimoto, K				Taniguchi, Yuya; Kakimoto, Ken-ichi			Microscopic Raman spectroscopy in the vicinity of domain wall of (Na,K)NbO3 piezoelectrics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TITANATE SINGLE-CRYSTALS; LEAD-FREE PIEZOCERAMICS; FERROELECTRIC DOMAINS; DIELECTRIC-PROPERTIES; PHASE-TRANSITIONS; LITHIUM TANTALATE; FORCE MICROSCOPY; CERAMICS; NIOBATE; KNBO3	The domain walls of Mn-doped (Na,K)NbO3 (NKN) crystals and ceramics have been measured by spectroscopy methods. Microscopy-Raman and infrared (IR) spectroscopies were performed vertically to lamellar domain structures by line mapping. Regarding the crystals, large changes were confirmed in the vicinity of domain walls. Both the Raman shift and the peak intensity at approximately 600 cm(-1), which include the symmetric stretching modes of the oxygen octahedron, were observed. Similar changes were also characterized for electrically polarized NKN ceramics. In addition, the permittivity of NKN crystals increased in the vicinity of the domain wall, which was measured by IR spectroscopy. These results were attributed to the changes in the oxygen octahedron structures due to local changes in spontaneous polarization directions in the vicinity of the domain walls. (C) 2015 The Japan Society of Applied Physics	[Taniguchi, Yuya; Kakimoto, Ken-ichi] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Taniguchi, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.				JSPS [25289227]	This work was supported by JSPS Grant-in-Aid for Scientific Research B (25289227).	Wada S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957130; Tsuji T, 2004, JPN J APPL PHYS 1, V43, P2907, DOI 10.1143/JJAP.43.2907; Pezzotti G, 2010, J EUR CERAM SOC, V30, P199, DOI 10.1016/j.jeurceramsoc.2009.04.016; Capek P, 2007, PHYS STATUS SOLIDI C, V4, P830, DOI 10.1002/pssc.200673720; Inagaki Y, 2010, J EUR CERAM SOC, V30, P301, DOI 10.1016/j.jeurceramsoc.2009.05.050; Guo YP, 2004, JPN J APPL PHYS 1, V43, P6662, DOI 10.1143/JJAP.43.6662; Deluca M, 2006, J EUR CERAM SOC, V26, P2337, DOI 10.1016/j.jeurceramsoc.2005.04.016; Wada S, 1999, JPN J APPL PHYS 1, V38, P5505, DOI 10.1143/JJAP.38.5505; Herber RP, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2750395; Yamazoe S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3330963; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Buixaderas E, 2009, IEEE T ULTRASON FERR, V56, P1843, DOI 10.1109/TUFFC.2009.1259; Rubio-Marcos F, 2011, J RAMAN SPECTROSC, V42, P639, DOI 10.1002/jrs.2753; DUNGAN RH, 1965, J AM CERAM SOC, V48, P601, DOI 10.1111/j.1151-2916.1965.tb14682.x; Wada S, 2006, FERROELECTRICS, V334, P17, DOI 10.1080/00150190600689647; Kling J, 2010, J AM CERAM SOC, V93, P2452, DOI 10.1111/j.1551-2916.2010.03778.x; Jungk T, 2006, FERROELECTRICS, V334, P29, DOI 10.1080/00150190600689654; EGERTON L, 1959, J AM CERAM SOC, V42, P438, DOI 10.1111/j.1151-2916.1959.tb12971.x; Rubio-Marcos F, 2012, J MATER CHEM, V22, P9714, DOI 10.1039/c2jm30483j; KATZ L, 1967, ACTA CRYSTALLOGR, V22, P639, DOI 10.1107/S0365110X6700129X; Lingwal V, 2003, B MATER SCI, V26, P619, DOI 10.1007/BF02704326; FONTANA MD, 1984, J PHYS C SOLID STATE, V17, P483, DOI 10.1088/0022-3719/17/3/020; JAEGER RE, 1962, J AM CERAM SOC, V45, P209, DOI 10.1111/j.1151-2916.1962.tb11127.x; Stone G, 2012, OPT LETT, V37, P1032, DOI 10.1364/OL.37.001032; Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140; PORTO SPS, 1967, J CHEM PHYS, V47, P1009, DOI 10.1063/1.1711980; Wada S, 2004, BRIT CERAM T, V103, P93, DOI 10.1179/096797804225012747; Inagaki Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC09; Tsuchida K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD02; Karaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD11; LOUDON R, 1963, PROC R SOC LON SER-A, V275, P218, DOI 10.1098/rspa.1963.0166	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND09	10.7567/JJAP.54.10ND09		6	Physics, Applied	Physics	CS7SO	WOS:000362286000040		
J	Tanimoto, K; Saihara, S; Adachi, Y; Harada, Y; Shiomi, Y; Tajitsu, Y				Tanimoto, Kazuhiro; Saihara, Shota; Adachi, Yu; Harada, Yuhei; Shiomi, Yuki; Tajitsu, Yoshiro			Shear piezoelectricity of optically active polysuccinimides	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							STRONG MAGNETIC-FIELD; L-ASPARTIC ACID; THERMAL POLYCONDENSATION; POLYVINYLIDENE FLUORIDE; NMR CHARACTERIZATION; CROSS-LINKING; POLYMER; PYROELECTRICITY; NYLON-11; BLENDS	Optically active crystalline polymers have shear piezoelectricity owing to their asymmetric crystal structure. In this study, to explore a novel shear piezoelectric polymer, we have focused on an imide ring structure and synthesized optically active polysuccinimides (PSIs), the minimum structure of optically active polyimides. As a result, optically active PSIs were obtained, and we observed that oriented optically active PSI films show shear piezoelectricity. Furthermore, both optical purity and molecular weight are significant factors in piezoelectric performance. This is the first report of the shear piezoelectricity of optically active polyimides, and we identify herein a novel category of a shear piezoelectric polymer. (C) 2015 The Japan Society of Applied Physics	[Tanimoto, Kazuhiro; Saihara, Shota; Adachi, Yu; Harada, Yuhei; Shiomi, Yuki; Tajitsu, Yoshiro] Kansai Univ, Grad Sch Sci & Engn, Dept Elect Engn, Suita, Osaka 5648680, Japan; [Tanimoto, Kazuhiro] Mitsui Chem Inc, Minato Ku, Tokyo 1057117, Japan	Tanimoto, K (reprint author), Kansai Univ, Grad Sch Sci & Engn, Dept Elect Engn, Suita, Osaka 5648680, Japan.						Ando M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD17; Fukada E, 1984, FERROELECTRICS, V60, P285, DOI 10.1080/00150198408017529; Jiang JQ, 2007, MACROMOLECULES, V40, P790, DOI 10.1021/ma062493j; BROADHURST MG, 1978, J APPL PHYS, V49, P4992, DOI 10.1063/1.324445; KOVACS J, 1961, J ORG CHEM, V26, P1084, DOI 10.1021/jo01063a026; Lee KM, 2013, MACROMOL CHEM PHYS, V214, P1189, DOI 10.1002/macp.201200340; VEGOTSKY A, 1958, J AM CHEM SOC, V80, P3361, DOI 10.1021/ja01546a042; KEPLER RG, 1978, J APPL PHYS, V49, P4490, DOI 10.1063/1.325454; Tajitsu Y, 2013, IEEE T ULTRASON FERR, V60, P1625, DOI 10.1109/TUFFC.2013.2744; Fukada E, 2000, IEEE T ULTRASON FERR, V47, P1277, DOI 10.1109/58.883516; KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975; Nakiri T, 2005, JPN J APPL PHYS 1, V44, P7119, DOI 10.1143/JJAP.44.7119; Ghosh S, 1998, ADV MATER, V10, P1097, DOI 10.1002/(SICI)1521-4095(199810)10:14<1097::AID-ADMA1097>3.0.CO;2-M; Hirai N, 1998, J WOOD SCI, V44, P35, DOI 10.1007/BF00521872; Sun L, 2010, SOFT MATTER, V6, P4403, DOI 10.1039/c0sm00236d; Wang SQ, 2013, ANGEW CHEM INT EDIT, V52, P11143, DOI 10.1002/anie.201305647; NEWMAN BA, 1980, J APPL PHYS, V51, P5161, DOI 10.1063/1.327283; IWATA K, 1984, J POLYM SCI POL LETT, V22, P215, DOI 10.1002/pol.1984.130220405; SASAKI S, 1976, J POLYM SCI POL PHYS, V14, P565, DOI 10.1002/pol.1976.180140317; FURUKAWA T, 1976, J POLYM SCI POL PHYS, V14, P1979, DOI 10.1002/pol.1976.180141106; Matsubara K, 1997, MACROMOLECULES, V30, P2305, DOI 10.1021/ma961579h; Nakiri T, 2004, JPN J APPL PHYS 1, V43, P6769, DOI 10.1143/JJAP.43.6769; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Tsuji H, 1996, MACROMOL CHEM PHYSIC, V197, P3483, DOI 10.1002/macp.1996.021971033; FUKADA E, 1971, JPN J APPL PHYS, V10, P722, DOI 10.1143/JJAP.10.722; KOKUFUTA E, 1978, B CHEM SOC JPN, V51, P1555, DOI 10.1246/bcsj.51.1555; FUKADA E, 1973, J MACROMOL SCI PHYS, VB  8, P475, DOI 10.1080/00222347308201633; COHEN J, 1971, J APPL PHYS, V42, P3072, DOI 10.1063/1.1660687; WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016; TAKASE Y, 1991, MACROMOLECULES, V24, P6644, DOI 10.1021/ma00025a014; Bharti V, 1995, IEEE T DIELECT EL IN, V2, P1106, DOI 10.1109/94.484313; DATE M, 1970, J POLYM SCI A2, V8, P61, DOI 10.1002/pol.1970.160080105; Freeman M. B., 1995, U. S. Patent, Patent No. 5393868; FUKADA E, 1955, J PHYS SOC JPN, V10, P149, DOI 10.1143/JPSJ.10.149; Fukada E., 1991, REPT PROG POLYM PHYS, V34, P269; Fukada E., 1964, Japanese Journal of Applied Physics, V3, DOI 10.1143/JJAP.3.117; Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y; NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006; Nye J F, 1985, PHYS PROPERTIES CRYS; Schrader L., 1991, SYNTHETIC MET, V41, P831; Shiomi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KE02; Takarada J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KE01; Tanimoto K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PC01; Uchino K., 2000, FERROELECTRIC DEVICE; Yoshida T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND13	45	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NF02	10.7567/JJAP.54.10NF02		6	Physics, Applied	Physics	CS7SO	WOS:000362286000049		
J	Teranishi, T; Yoshikawa, Y; Sakuma, R; Okamura, H; Hayashi, H; Kishimoto, A; Takeda, Y				Teranishi, Takashi; Yoshikawa, Yumi; Sakuma, Ryo; Okamura, Hirokazu; Hayashi, Hidetaka; Kishimoto, Akira; Takeda, Yasuo			In situ impedance analysis on BaTiO3-LiCoO2 composite cathodes for lithium ion batteries	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLYMER SECONDARY BATTERIES; DIELECTRIC-PROPERTIES; LICOO2 CATHODES; BATIO3 CERAMICS; POTENTIAL STEP; SPECTROSCOPY; ELECTRODES; DEPOSITION; PARTICLES; DEGRADATION	In situ electrochemical impedance spectroscopy (EIS) was undertaken to investigate the contribution of a ferroelectric artificial solid electrolyte interface (SEI) to the enhancement of the rate capability of lithium ion batteries. Resistance elements, consisting of the cell reactions, the resistance of the electrolyte, R-sol, that of the Li metal anode reaction, R-Li, and the charge transfer resistance, R-ct, were measured. A small ferroelectric BaTiO3 (BT) load, similar to 1 mol %, notably reduced R-ct and R-sol compared with bare LiCoO2 (LC), indicating that loaded ferroelectric BT SEIs effectively promote Li inter/deintercalation into and from the active material, LC, and restrict cobalt ion dissolution into the electrolyte liquid. Lower R-ct and R-sol resulted in a significantly higher capacity retention ratio at a 10C rate compared with the initial cycle for small BT load, similar to 1 mol %. The capacity retention dropped rapidly, accompanied by a slight increase in R-ct for larger BT loads, 5 and 15 mol %, which may be attributed to the thicker BT layer and the existence of the impurity phase, BaCO3. These results imply that the ferroelectric SEI affected the kinetics of mobile Li ions at the cathode-electrolyte interface, significantly enhancing the rate capability. (C) 2015 The Japan Society of Applied Physics	[Teranishi, Takashi; Yoshikawa, Yumi; Sakuma, Ryo; Hayashi, Hidetaka; Kishimoto, Akira] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Okamura, Hirokazu; Takeda, Yasuo] Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan	Teranishi, T (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	terani-t@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [15H04126]	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 15H04126) from the Japan Society for the Promotion of Science.	Miyashiro H, 2006, J ELECTROCHEM SOC, V153, pA348, DOI 10.1149/1.2149306; Kim Y, 2011, ELECTROCHIM ACTA, V56, P6573, DOI 10.1016/j.electacta.2011.03.070; Seki S, 2005, J POWER SOURCES, V146, P741, DOI 10.1016/j.jpowsour.2005.03.072; Tsurumi T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2804570; Tu J, 2006, MATER LETT, V60, P3251, DOI 10.1016/j.matlet.2006.02.089; Dokko K, 2003, J ELECTROCHEM SOC, V150, pA425, DOI 10.1149/1.1556596; Liu N, 2006, ELECTROCHEM SOLID ST, V9, pA328, DOI 10.1149/1.2200138; Alcantara R, 2004, J ELECTROANAL CHEM, V566, P187, DOI 10.1016/j.jelechem.2003.11.025; Seki S, 2006, CHEM COMMUN, P544, DOI 10.1039/b514681j; Teranishi T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.041506; Cho J, 2001, ANGEW CHEM INT EDIT, V40, P3367, DOI 10.1002/1521-3773(20010917)40:18<3367::AID-ANIE3367>3.0.CO;2-A; Oh Y, 2010, J SOLID STATE ELECTR, V14, P1235, DOI 10.1007/s10008-009-0946-7; Jung YS, 2010, J ELECTROCHEM SOC, V157, pA75, DOI 10.1149/1.3258274; Lee JK, 2001, J AM CERAM SOC, V84, P2001; Takanashi Y, 2011, J POWER SOURCES, V196, P10679, DOI 10.1016/j.jpowsour.2011.08.097; MATTHIAS B, 1948, PHYS REV, V73, P1378, DOI 10.1103/PhysRev.73.1378; Teranishi T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898006; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; Yoon WS, 2001, J POWER SOURCES, V97-8, P282, DOI 10.1016/S0378-7753(01)00514-6; Zhao Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024107; Miyashiro H, 2006, KOBUNSHI RONBUNSHU, V63, P139, DOI 10.1295/koron.63.139; Scott ID, 2011, NANO LETT, V11, P414, DOI 10.1021/nl1030198; Guan DS, 2011, NANOSCALE, V3, P1465, DOI 10.1039/c0nr00939c; Myung ST, 2005, CHEM MATER, V17, P3695, DOI 10.1021/cm050566s; Kim Y, 2006, ELECTROCHIM ACTA, V52, P1316, DOI 10.1016/j.electacta.2006.07.033; Hoshina T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3027067; Yoon WS, 2002, J PHYS CHEM B, V106, P2526, DOI 10.1021/jp013735e; Dokko K, 2001, J ELECTROCHEM SOC, V148, pA422, DOI 10.1149/1.1359197; Kim YJ, 2003, J ELECTROCHEM SOC, V150, pA1723, DOI 10.1149/1.1627347; Nishizawa M, 1998, CHEM COMMUN, P1631, DOI 10.1039/a802962h; Teranishi T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.011502; Teranishi T., ECS ELECTROCHE UNPUB; Teranishi T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KF06; Xia H, 2007, PHYS SCRIPTA, VT129, P43, DOI 10.1088/0031-8949/2007/T129/010	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB02	10.7567/JJAP.54.10NB02		5	Physics, Applied	Physics	CS7SO	WOS:000362286000020		
J	Tsujiura, Y; Kawabe, S; Kurokawa, F; Hida, H; Kanno, I				Tsujiura, Yuichi; Kawabe, Saneyuki; Kurokawa, Fumiya; Hida, Hirotaka; Kanno, Isaku			Comparison of effective transverse piezoelectric coefficients e(31,f) of Pb(Zr,Ti)O-3 thin films between direct and converse piezoelectric effects	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLYCRYSTALLINE FERROELECTRICS; FABRICATION; CONSTANT; DESIGN; DOMAIN; D(33)	We evaluated the effective transverse piezoelectric coefficients (e(31,f)) of Pb(Zr,Ti)O-3 (PZT) thin films from both the direct and converse piezoelectric effects of unimorph cantilevers. (001) preferentially oriented polycrystalline PZT thin films and (001)/(100) epitaxial PZT thin films were deposited on (111)Pt/Ti/Si and (001)Pt/MgO substrates, respectively, by rf-magnetron sputtering, and their piezoelectric responses owing to intrinsic and extrinsic effects were examined. The direct and converse vertical bar e(31,f)vertical bar values of the polycrystalline PZT thin films were calculated as 6.4 and 11.5-15.0C/m(2), respectively, whereas those of the epitaxial PZT thin films were calculated as 3.4 and 4.6-4.8C/m(2), respectively. The large vertical bar e(31,f)vertical bar of the converse piezoelectric property of the polycrystalline PZT thin films is attributed to extrinsic piezoelectric effects. Furthermore, the polycrystalline PZT thin films show a clear nonlinear piezoelectric contribution, which is the same as the Rayleigh-like behavior reported in bulk PZT. In contrast, the epitaxial PZT thin films on the MgO substrate show a piezoelectric response owing to the intrinsic and linear extrinsic effects, and no nonlinear contribution was observed. (C) 2015 The Japan Society of Applied Physics	[Tsujiura, Yuichi; Kawabe, Saneyuki; Kurokawa, Fumiya; Hida, Hirotaka; Kanno, Isaku] Kobe Univ, Mech Engn, Kobe, Hyogo 6578501, Japan	Tsujiura, Y (reprint author), Kobe Univ, Mech Engn, Kobe, Hyogo 6578501, Japan.		Kanno, Isaku/B-3959-2010; Hida, Hirotaka/J-2100-2014	Hida, Hirotaka/0000-0002-4749-1893			Bintachitt P, 2010, P NATL ACAD SCI USA, V107, P7219, DOI 10.1073/pnas.0913172107; LI SP, 1993, MATER LETT, V17, P21, DOI 10.1016/0167-577X(93)90141-J; Cattan E, 1999, J APPL PHYS, V86, P7017, DOI 10.1063/1.371788; Zhu W, 2000, SENSOR ACTUAT A-PHYS, V86, P149, DOI 10.1016/S0924-4247(00)00356-3; Hiboux S, 1999, J MATER RES, V14, P4307, DOI 10.1557/JMR.1999.0584; Aridogan U, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/4/045039; Wolf RA, 2004, J APPL PHYS, V95, P1397, DOI 10.1063/1.1636530; Zhou QF, 2003, APPL PHYS LETT, V82, P4767, DOI 10.1063/1.1581366; Schroth A, 1999, SENSOR ACTUAT A-PHYS, V73, P144, DOI 10.1016/S0924-4247(98)00265-9; Dow ABA, 2014, MICROSYST TECHNOL, V20, P1035, DOI 10.1007/s00542-014-2116-9; ISAAK DG, 1989, PHYS CHEM MINER, V16, P704; Iijima T, 2004, MATER TRANS, V45, P233, DOI 10.2320/matertrans.45.233; Gross SJ, 2003, APPL PHYS LETT, V83, P174, DOI 10.1063/1.1589192; Pramanick A, 2011, J AM CERAM SOC, V94, P293, DOI 10.1111/j.1551-2916.2010.04240.x; Ledermann N, 1999, INTEGR FERROELECTR, V24, P13, DOI 10.1080/10584589908215574; Prume K, 2007, IEEE T ULTRASON FERR, V54, P8, DOI 10.1109/TUFFC.2007.206; Kobayashi M, 2001, IEEE T MAGN, V37, P949, DOI 10.1109/20.917648; LEFKI K, 1994, J APPL PHYS, V76, P1764, DOI 10.1063/1.357693; Percin G, 2003, REV SCI INSTRUM, V74, P1120, DOI 10.1063/1.1532839; Defay E, 2002, SENSOR ACTUAT A-PHYS, V99, P64, DOI 10.1016/S0924-4247(01)00883-4; Chun DM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789347; Gerber P, 2003, REV SCI INSTRUM, V74, P2613, DOI 10.1063/1.1544415; Southin JEA, 2001, J PHYS D APPL PHYS, V34, P1456, DOI 10.1088/0022-3727/34/10/303; Bassiri-Gharb N, 2007, J ELECTROCERAM, V19, P49, DOI 10.1007/s10832-007-9001-1; Dekkers M, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/2/025008; Huang Z, 2007, SENSOR ACTUAT A-PHYS, V135, P660, DOI 10.1016/j.sna.2006.10.002; Dubois MA, 1999, SENSOR ACTUAT A-PHYS, V77, P106, DOI 10.1016/S0924-4247(99)00070-9; Hopcroft MA, 2010, J MICROELECTROMECH S, V19, P229, DOI 10.1109/JMEMS.2009.2039697; Kovacova V, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.140101; Meng-wei L. I. U., 2004, 3 INT S INSTR SCI TE, P352; Shepard JF, 1998, SENSOR ACTUAT A-PHYS, V71, P133, DOI 10.1016/S0924-4247(98)00161-7; Tomioka K, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091A1, 10.1143/JJAP.51.09LA12]	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA04	10.7567/JJAP.54.10NA04		8	Physics, Applied	Physics	CS7SO	WOS:000362286000005		
J	Ueno, S; Sakamoto, Y; Kakiuchi, H; Nakashima, K; Wada, S				Ueno, Shintaro; Sakamoto, Yasunao; Kakiuchi, Hiroyuki; Nakashima, Kouichi; Wada, Satoshi			Preparation of titanium metal/barium titanate composites with boundary layer structure by hydrothermal method and their dielectric properties	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CORE-SHELL STRUCTURE; BARIUM-TITANATE; TETRAGONAL BATIO3; BL CAPACITOR; ANATASE; PARTICLES; COMPLEX; ACID	To develop metal/insulator composite capacitors with a high effective dielectric constant, we focus on the microstructure of boundary layer (BL) capacitors. Titanium metal/barium titanate (Ti/BT) composites consisting of Ti metal grains and BT boundary nanolayers were successfully prepared from pressed Ti-BT core-shell particle compacts by a hydrothermal method below 230 degrees C. In this hydrothermal method, BT polycrystalline shell layers connected to each other by crystal growth via a dissolution and reprecipitation mechanism in barium hydroxide [Ba(OH)(2)] aqueous solutions. The thickness of BT boundary layers may increase with an increase in the Ba(OH)(2) concentration and determine electrical properties. These Ti/BT composites prepared in 250 and 500mmol/dm(3) Ba(OH)(2) solutions exhibit effective dielectric constants of over 5000 and 3000, and loss tangents below 0.075 and 0.060 in the frequency range of 100Hz-100 kHz at room temperature, respectively. (C) 2015 The Japan Society of Applied Physics	[Ueno, Shintaro; Sakamoto, Yasunao; Kakiuchi, Hiroyuki; Nakashima, Kouichi; Wada, Satoshi] Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, Kofu, Yamanashi 4008510, Japan	Ueno, S (reprint author), Univ Yamanashi, Dept Interdisciplinary Res, Grad Sch, Kofu, Yamanashi 4008510, Japan.	sueno@yamanashi.ac.jp					Eckert JO, 1996, J AM CERAM SOC, V79, P2929, DOI 10.1111/j.1151-2916.1996.tb08728.x; Moya JS, 2007, PROG MATER SCI, V52, P1017, DOI 10.1016/j.pmatsci.2006.09.003; Ichinose H, 2003, J AM CERAM SOC, V86, P1605; Pinceloup P, 1999, J EUR CERAM SOC, V19, P973, DOI 10.1016/S0955-2219(98)00356-2; Yang CF, 1996, JPN J APPL PHYS 1, V35, P1806, DOI 10.1143/JJAP.35.1806; Chen ZH, 2007, SCRIPTA MATER, V57, P921, DOI 10.1016/j.scriptamat.2007.07.020; Pecharroman C, 2000, ADV MATER, V12, P294, DOI 10.1002/(SICI)1521-4095(200002)12:4<294::AID-ADMA294>3.0.CO;2-D; WAKU S, 1967, REV ELEC COMMUN LAB, V15, P689; BASCA RR, 1995, J MATER SCI LETT, V14, P600, DOI 10.1007/BF00275390; DUTTA PK, 1994, CHEM MATER, V6, P1542, DOI 10.1021/cm00045a011; Chang HY, 2004, ACTA MATER, V52, P5389, DOI 10.1016/j.actamat.2004.07.047; Chang HY, 2003, NANOTECHNOLOGY, V14, P603, DOI 10.1088/0957-4484/14/6/307; Kakihana M, 2004, INORG CHEM, V43, P4546, DOI 10.1021/ic040031l; Ichinose H, 2001, J SOL-GEL SCI TECHN, V22, P33, DOI 10.1023/A:1011256118320; Kakihana M, 2001, INORG CHEM, V40, P891, DOI 10.1021/ic001098l; Hatano T, 2004, J EUR CERAM SOC, V24, P507, DOI 10.1016/S0955-2219(03)00199-7; Tuan WH, 2009, MATER CHEM PHYS, V118, P187, DOI 10.1016/j.matchemphys.2009.07.029; Ueno S, 2014, J CERAM SOC JPN, V122, P447, DOI 10.2109/jcersj2.122.447; Tomita K, 2006, ANGEW CHEM INT EDIT, V45, P2378, DOI 10.1002/anie.200503565; WAKU S, 1970, REV ELEC COMMUN LAB, V18, P681; TOYODA J, 1987, JPN J APPL PHYS 1, V26, P93; Asiaie R, 1996, CHEM MATER, V8, P226, DOI 10.1021/cm950327c; Kim SG, 2009, ADV POWDER TECHNOL, V20, P94, DOI 10.1016/j.apt.2008.10.006; HIREMATH BV, 1992, J AM CERAM SOC, V75, P2953, DOI 10.1111/j.1151-2916.1992.tb04370.x; FRANKEN PEC, 1981, J AM CERAM SOC, V64, P687, DOI 10.1111/j.1151-2916.1981.tb15886.x; Pecharroman C, 2001, ADV MATER, V13, P1541, DOI 10.1002/1521-4095(200110)13:20<1541::AID-ADMA1541>3.0.CO;2-X; Fujimoto M., 1985, J AM CERAM SOC, V68, DOI 10.1111/j.1151-2916.1985.tb16150.x; Huang JQ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2836764; MUHLEBAC.J, 1970, INORG CHEM, V9, P2381; Ueno S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB05; Yamaoka N., 1983, JPN J APPL PHYS, V22, P80; Yamaoka N., 1986, CERAM B, V65, P1149; Yamaoka Y., 1983, CERAM B, V62, P698	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NB07	10.7567/JJAP.54.10NB07		5	Physics, Applied	Physics	CS7SO	WOS:000362286000025		
J	Urabe, K; Muneoka, H; Stauss, S; Sakai, O; Terashima, K				Urabe, Keiichiro; Muneoka, Hitoshi; Stauss, Sven; Sakai, Osamu; Terashima, Kazuo			Laser absorption spectroscopy diagnostics of helium metastable atoms generated in dielectric barrier discharge cryoplasmas	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ATMOSPHERIC-PRESSURE; GLOW-DISCHARGE; PLASMA; MOLECULES	Cryoplasmas, which are plasmas whose gas temperatures are below room temperature (RT), have shown dynamic changes in their physical and chemical characteristics when the gas temperature in the plasmas (T-gp) was decreased from RT. In this study, we measured the temporal behavior of helium metastable (He-m) atoms generated in a parallel-plate dielectric barrier discharge at ambient gas temperatures (T-ga) of 300, 100, and 14K and with a gas density similar to atmospheric conditions by laser absorption spectroscopy. The increments of T-gp to T-ga were less than 20 K. We found from the results that the He-m lifetime and maximum density become longer and larger over one order of magnitude for lower T-ga. The reasons for the long He-m lifetime at low T-ga are decreases in the rate coefficients of three-body He-m quenching reactions and in the amounts of molecular impurities with boiling points higher than that of He. (c) 2015 The Japan Society of Applied Physics	[Urabe, Keiichiro; Muneoka, Hitoshi; Stauss, Sven; Terashima, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Urabe, Keiichiro; Muneoka, Hitoshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Sakai, Osamu] Kyoto Univ, Grad Sch Engn, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Sakai, Osamu] Univ Shiga Prefecture, Sch Engn, Dept Elect Syst Engn, Hikone, Shiga 5228533, Japan	Urabe, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan.	k.urabe@plasma.k.u-tokyo.ac.jp; kazuo@plasma.k.u-tokyo.ac.jp	Urabe, Keiichiro/G-4524-2011	Urabe, Keiichiro/0000-0001-9743-3184	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21110002]; Japan Society for the Promotion of Science [24246120, 12J03125]	This work was financially supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Frontier Science of Interactions between Plasmas and Nano-Interfaces, No. 21110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and Grants-in-Aid for Scientific Research B (No. 21360356), Scientific Research A (No. 24246120), and JSPS Fellows (No. 12J03125) from the Japan Society for the Promotion of Science.	TOKARYK DW, 1993, PHYS REV A, V48, P364, DOI 10.1103/PhysRevA.48.364; Tochikubo F, 1999, JPN J APPL PHYS 1, V38, P5244, DOI 10.1143/JJAP.38.5244; Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901; Urabe K, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/9/095201; Noma Y, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.046001; Sands BL, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/28/282001; Noma Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3552983; Dussart R, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/123001; Cadot G, 2014, IEEE T PLASMA SCI, V42, P2446, DOI 10.1109/TPS.2014.2310231; POUVESLE JM, 1988, J CHEM PHYS, V88, P3061, DOI 10.1063/1.453949; Iacopi F, 2011, PHYS CHEM CHEM PHYS, V13, P3634, DOI 10.1039/c0cp02660c; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Massines F, 1998, J APPL PHYS, V83, P2950, DOI 10.1063/1.367051; Tachibana K, 2005, J APPL PHYS, V97, DOI 10.1063/1.1922581; Sands BL, 2013, J APPL PHYS, V113, DOI 10.1063/1.4802444; Golubovskii YB, 2004, J PHYS D APPL PHYS, V37, P1346, DOI 10.1088/0022-3727/37/9/008; KOYMEN A, 1990, CHEM PHYS LETT, V168, P405, DOI 10.1016/0009-2614(90)85136-Z; Murakami T, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/2/025005; Muneoka H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.086201; Urabe K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106001; Ishihara D, 2008, PLASMA SOURCES SCI T, V17, DOI 10.1088/0963-0252/17/3/035008; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Stauss S, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/025021; LUDLUM KH, 1967, J CHEM PHYS, V46, P127, DOI 10.1063/1.1840361; Golubovskii YB, 2003, J PHYS D APPL PHYS, V36, P39, DOI 10.1088/0022-3727/36/1/306; Millard MW, 1998, PLASMA SOURCES SCI T, V7, P389, DOI 10.1088/0963-0252/7/3/017; FUGOL IY, 1971, SOV PHYS JETP-USSR, V33, P227; KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028; Choi JH, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/7/072001; Murakami T, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015003; Noma Y, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2980436; Chang J. S., 1982, DENRIKITAI GENSHI BU; Demtroder W., 2008, LASER SPECTROSCOPY; Linstrom P. J., 2014, NIST CHEM WEBBOOK; Muneoka H, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/6/065038; Pearse R. W. B., 1976, IDENTIFICATION MOL S; Stauss S, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/3/035016; The Japan Society of Plasma Science and Nuclear Fusion Research, 2006, PUR SHIND KIS OYO; Vidmar R. J., 2004, AFRISRARRE040123 AFO; YOKOYAMA T, 1990, J PHYS D APPL PHYS, V23, P1125, DOI 10.1088/0022-3727/23/8/021	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							106101	10.7567/JJAP.54.106101		8	Physics, Applied	Physics	CS7SG	WOS:000362285100027		
J	Yamada, T; Ito, D; Sakata, O; Kuroishi, J; Namazu, T; Imai, Y; Shiraishi, T; Shimizu, T; Funakubo, H; Yoshino, M; Nagasaki, T				Yamada, Tomoaki; Ito, Daisuke; Sakata, Osami; Kuroishi, Junki; Namazu, Takahiro; Imai, Yasuhiko; Shiraishi, Takahisa; Shimizu, Takao; Funakubo, Hiroshi; Yoshino, Masahito; Nagasaki, Takanori			Domain structure of tetragonal Pb(Zr,Ti)O-3 nanorods and its size dependence	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS	We fabricated {100} Pb(Zr0.35Ti0.65)O-3 (PZT) nanorods by partly etching a film grown on a Nb-doped SrTiO3 substrate using a focused ion beam, followed by annealing to recover the etching damage and promote the formation of a stable domain structure in the form of nanorods. The application of synchrotron micro-X-ray diffraction enabled the detection of the diffraction intensity from a single nanorod, which allowed us to clarify the size dependence of the domain structure of the fabricated nanorods. We found that the a-domain fraction in the tetragonal PZT nanorods decreased with decreasing rod width and that an exclusively c-domain structure was formed in nanorods of <= 1 mu m width. The preferred formation of the c-domain in these nanorods can be rationalized in terms of the large depolarizing field in the a-domain and/or the in-plane compressive strain near the PZT/substrate interface. (C) 2015 The Japan Society of Applied Physics	[Yamada, Tomoaki; Ito, Daisuke; Yoshino, Masahito; Nagasaki, Takanori] Nagoya Univ, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan; [Yamada, Tomoaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sakata, Osami] Natl Inst Mat Sci, Synchrotron Xray Stn, SPring 8, Sayo, Hyogo 6795148, Japan; [Sakata, Osami] Natl Inst Mat Sci, Synchrotron Xray Grp, Sayo, Hyogo 6795148, Japan; [Sakata, Osami; Shiraishi, Takahisa; Shimizu, Takao; Funakubo, Hiroshi] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268503, Japan; [Kuroishi, Junki; Namazu, Takahiro] Univ Hyogo, Dept Mech & Syst Engn, Himeji, Hyogo 6712280, Japan; [Imai, Yasuhiko] Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan	Yamada, T (reprint author), Nagoya Univ, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan.	t-yamada@nucl.nagoya-u.ac.jp			JSPS KAKENHI [26709047, 15K13944, 18310085, 20510113, 26220907, 15H04121]; JST-PRESTO	This work was partially supported by JSPS KAKENHI Grant Numbers 26709047 (TY), 15K13944 (TY), 18310085 (OS), 20510113 (OS), 26220907 (HF), 15H04121 (HF), and JST-PRESTO (TY). The synchrotron radiation experiments were performed at the BL13XU and BL15XU beamlines at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Numbers 2012B4906, 2012B1554, 2013A4904, 2013A1525, 2013B4908, 2014A4908, and 2014B4908).	Sakata O, 2010, AIP CONF PROC, V1234, P151, DOI 10.1063/1.3463162; Li JH, 2004, APPL PHYS LETT, V84, P2626, DOI 10.1063/1.1695641; Ma ZK, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2012527; Wada S, 2004, MATER TRANS, V45, P178, DOI 10.2320/matertrans.45.178; Fujisawa T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4889803; Fujisawa T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3073823; Yamada T, 2015, J APPL PHYS, V118, DOI 10.1063/1.4927810; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Morioka H, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906861; Xu RJ, 2015, NAT MATER, V14, P79, DOI [10.1038/nmat4119, 10.1038/NMAT4119]; Utsugi S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078400; Ganpule CS, 1999, APPL PHYS LETT, V75, P409, DOI 10.1063/1.124391; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; Nagarajan V, 2003, NAT MATER, V2, P43, DOI 10.1038/nmat800; Fujisawa T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.085001; Feigl L, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906295; Fong DD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127601; Ito D., 2015, P IEEE ISAF ISIF 201, P175; KAKEGAWA K, 1976, NIPPON KAGAKU KAISHI, P717; Xu RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4120	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA07	10.7567/JJAP.54.10NA07		4	Physics, Applied	Physics	CS7SO	WOS:000362286000008		
J	Yamashita, T; Okada, H; Itoh, T; Kobayashi, T				Yamashita, Takahiro; Okada, Hironao; Itoh, Toshihiro; Kobayashi, Takeshi			Manufacturing process for piezoelectric strain sensor sheet involving transfer printing methods	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PB(ZR,TI)O-3 THIN-FILMS; MICROCANTILEVER; CANTILEVER	In this paper, we present a novel sensor sheet manufacturing process that involves transfer printing methods using adhesive rubber stamps. By using these methods, not only ultrathin microsensors but also microcontroller and amplifier chips required for the fabrication of sensor devices can be mounted. We successfully transfer-printed a very fragile 5-mm-long, 1-mm-wide, 5-mu m-thick high-aspect-ratio ultrathin strain sensor onto a flexible printed-circuit substrate. Then, we connected the sensor to the wiring by printing a conductive paste using a screen printer. A large ferroelectric polarization-voltage hysteresis curve was obtained even after the transfer printing process. Since an output voltage corresponding to the magnitude of the strain from the developed sensor was generated, it was confirmed that ultrathin sensors could be transfer-printed to the flexible substrate by this transfer technique without damage. (C) 2015 The Japan Society of Applied Physics	[Yamashita, Takahiro; Okada, Hironao; Kobayashi, Takeshi] AIST, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan; [Yamashita, Takahiro; Okada, Hironao; Itoh, Toshihiro; Kobayashi, Takeshi] NMEMS Technol Res Org, Chiyoda Ku, Tokyo 1010026, Japan; [Itoh, Toshihiro] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778581, Japan	Yamashita, T (reprint author), AIST, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan.						Kohli M, 1997, SENSOR ACTUAT A-PHYS, V60, P147, DOI 10.1016/S0924-4247(97)01484-2; Fujii E, 2007, IEEE T ULTRASON FERR, V54, P2431, DOI 10.1109/TUFFC.2007.556; Liu HC, 2012, SENSOR ACTUAT A-PHYS, V186, P242, DOI 10.1016/j.sna.2012.01.033; Kobayashi T, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/3/035025; Kobayashi T, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2736296; Lee HC, 2007, SENSOR ACTUAT A-PHYS, V136, P282, DOI 10.1016/j.sna.2006.10.050; Morioka H, 2008, JPN J APPL PHYS, V47, P7537, DOI 10.1143/JJAP.47.7537; Wang XY, 2008, SENSOR ACTUAT A-PHYS, V143, P469, DOI 10.1016/j.sna.2007.11.027; Kobayashi T, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105030; Sirohi J, 2000, J INTEL MAT SYST STR, V11, P246, DOI 10.1106/8BFB-GC8P-XQ47-YCQ0; Song G, 2007, SMART MATER STRUCT, V16, P959, DOI 10.1088/0964-1726/16/4/003; Kobayashi T, 2007, JPN J APPL PHYS 1, V46, P7073, DOI 10.1143/JJAP.46.7073; Liu HC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723846; Hajati A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772469; Kobayashi T, 2008, JPN J APPL PHYS, V47, P7533, DOI 10.1143/JJAP.47.7533; Kobayashi T, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/6/065017; Kobayashi T, 2013, SENSOR ACTUAT A-PHYS, V198, P87, DOI 10.1016/j.sna.2013.04.016; Kobayashi T, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/11/115007; Morioka H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KA03; Murata M, 2009, PROC IEEE MICR ELECT, P507; Nogami H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD11; Nogami H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD15; Dagdeviren C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5496; Takamatsu S, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.050; Tomimatsu Y., 2013, P IEEE 8 INT C INT S, P23; Wang L.-P., 2001, MRS P, V657; Yamashita T., 2013, P 17 INT C SOL STAT, P1561; Yamashita T., 2014, P IEEE SENSORS, P742; Yamashita T., 2014, P 16 DES TEST INT PA, P54	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND08	10.7567/JJAP.54.10ND08		4	Physics, Applied	Physics	CS7SO	WOS:000362286000039		
J	Yamazaki, S; Nakamine, Y; Zheng, R; Kouge, M; Ishikawa, T; Usami, K; Kodera, T; Kawano, Y; Oda, S				Yamazaki, Shotaro; Nakamine, Yoshifumi; Zheng, Ran; Kouge, Masahiro; Ishikawa, Tetsuya; Usami, Koichi; Kodera, Tetsuo; Kawano, Yukio; Oda, Shunri			Formation of three-dimensionally integrated nanocrystalline silicon particles by dip-coating method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							COLLOIDAL CRYSTALS; BUILDING-BLOCKS; SI NANOCRYSTALS; QUANTUM DOTS; ELECTROLUMINESCENCE; TRANSISTOR; MECHANISM; SURFACES; DEVICES	Printable technologies using silicon nanoink, in which nanocrystalline silicon (nc-Si) quantum dots are dispersed in solvents, are promising for novel electron and photonic device applications. The dip-coating method is applied for the first time to fabricate three-dimensionally integrated structures of nc-Si quantum dots with a uniform size of 10nm prepared by the very high frequency plasma decomposition of silane gas. We have clarified the major problem of the dip-coating method, which is the formation of stripe structures. To circumvent this problem, we have proposed two methods: coating onto line-and-space-patterned substrates and utilization of electrophoresis force. We have successfully demonstrated the control of the position and number of layers of nc-Si by using a line-and-space-patterned substrate, however, with a limited shape. We have clarified the conditions of the formation of stripe-free regions by varying applied voltage and nc-Si concentration in the electrophoresis method. (c) 2015 The Japan Society of Applied Physics	[Oda, Shunri] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 1528552, Japan; Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Yamazaki, S (reprint author), Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Meguro Ku, Tokyo 1528552, Japan.	soda@pe.titech.ac.jp			JSPS KAKENHI [22246040, 26249048]	This work was supported in part by JSPS KAKENHI Grant Numbers 22246040 and 26249048.	Conibeer G, 2006, THIN SOLID FILMS, V511, P654, DOI 10.1016/j.tsf.2005.12.119; Nishiguchi K, 2002, J APPL PHYS, V92, P2748, DOI 10.1063/1.1497703; Tanaka A, 2008, JPN J APPL PHYS, V47, P3731, DOI 10.1143/JJAP.47.3731; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J; Kralchevsky PA, 2000, ADV COLLOID INTERFAC, V85, P145, DOI 10.1016/S0001-8686(99)00016-0; ADACHI E, 1995, LANGMUIR, V11, P1057, DOI 10.1021/la00004a003; Cho EC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245201; Cheong HJ, 2008, JPN J APPL PHYS, V47, P8137, DOI 10.1143/JJAP.47.8137; Fustin CA, 2004, LANGMUIR, V20, P9114, DOI 10.1021/la0489413; Walters RJ, 2005, NAT MATER, V4, P143, DOI 10.1038/nmat1307; Dutta A, 2000, JPN J APPL PHYS 1, V39, P4647, DOI 10.1143/JJAP.39.4647; DELLEY B, 1993, PHYS REV B, V47, P1397, DOI 10.1103/PhysRevB.47.1397; Ifuku T, 1997, JPN J APPL PHYS 1, V36, P4031, DOI 10.1143/JJAP.36.4031; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Schmid G, 2001, ADV ENG MATER, V3, P737, DOI 10.1002/1527-2648(200110)3:10<737::AID-ADEM737>3.0.CO;2-8; Tans SJ, 1998, NATURE, V393, P49; Kawata Y, 2007, JPN J APPL PHYS 1, V46, P4386, DOI 10.1143/JJAP.46.4386; Hinds BJ, 2001, J APPL PHYS, V90, P6402, DOI 10.1063/1.1413235; Tanaka A, 2006, CURR APPL PHYS, V6, P344, DOI 10.1016/j.cap.2005.11.015; Watanabe S, 2009, LANGMUIR, V25, P7287, DOI 10.1021/la900315h; Masuda Y, 2004, LANGMUIR, V20, P5588, DOI 10.1021/la049878k; Cheylan S, 2001, APPL PHYS LETT, V78, P1912, DOI 10.1063/1.1357450; Lee CH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1942641; Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012; Nakamine Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.025002; DENKOV ND, 1992, LANGMUIR, V8, P3183, DOI 10.1021/la00048a054; Isozaki K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3518469	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							105001	10.7567/JJAP.54.105001		5	Physics, Applied	Physics	CS7SG	WOS:000362285100024		
J	Yokota, H; Nozue, T; Nakamura, S; Fukunaga, M; Fuwa, A				Yokota, Hiroko; Nozue, Tomoya; Nakamura, Shin; Fukunaga, Mamoru; Fuwa, Akio			Examination of ferroelectric and magnetic properties of hexagonal ErFeO3 thin films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							YMNO3; LU; YB	Hexagonal ErFeO3 (h-ErFeO3) thin films were fabricated by a pulsed laser deposition method. X-ray diffraction experiments confirmed that single-phase h-ErFeO3 thin films were successfully obtained and were c axis-oriented. Ferroelectricity was confirmed by D-E hysteresis loop measurement at room temperature and the magnitude of spontaneous polarization was estimated to be 200 nC/cm(2). A weak ferromagnetism appeared below 120K and dielectric constants started to exhibit magnetic field dependence. These observations demonstrate the coexistence of ferroelectricity and weak ferromagnetism in h-ErFeO3 thin films. (C) 2015 The Japan Society of Applied Physics	[Yokota, Hiroko; Nozue, Tomoya] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Nakamura, Shin] Teikyo Univ, Dept Sci & Engn, Utsunomiya, Tochigi 3208551, Japan; [Nakamura, Shin] Waseda Univ, Adv Res Ctr Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Fukunaga, Mamoru] Okayama Univ, Dept Phys, Okayama 7008530, Japan; [Fuwa, Akio] Waseda Univ, Dept Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Yokota, H (reprint author), Chiba Univ, Dept Phys, Chiba 2638522, Japan.	hiroko.9bq@chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Iketani Science and Technology Foundation, Japan	H. Y. acknowledges the support by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a research grant from Iketani Science and Technology Foundation, Japan.	Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI 10.1021/jpc00114x; Wang WB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.237601; Wang HW, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.014436; Fujimura N, 1996, APPL PHYS LETT, V69, P1011, DOI 10.1063/1.117969; Iida H, 2011, PHASE TRANSIT, V84, P747, DOI 10.1080/01411594.2011.558262; Van Aken BB, 2004, NAT MATER, V3, P164, DOI 10.1038/nmat1080; Sugie H, 2002, J PHYS SOC JPN, V71, P1558, DOI 10.1143/JPSJ.71.1558; Downie LJ, 2012, J SOLID STATE CHEM, V190, P52, DOI 10.1016/j.jssc.2012.02.004; Bossak AA, 2004, CHEM MATER, V16, P1751, DOI 10.1021/cm0353660; Xu CS, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205122; Rao CNR, 2007, J MATER CHEM, V17, P4931, DOI 10.1039/b709126e; Akbashev AR, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643043; YAMAGUCHI O, 1991, J ELECTROCHEM SOC, V138, P1492, DOI 10.1149/1.2085813; Roddatis VV, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821044; Fukunaga M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.064706; Fiebig M, 2002, NATURE, V419, P818, DOI 10.1038/nature01077; Lee S, 2008, NATURE, V451, P805, DOI 10.1038/nature06507; BERTAUT EF, 1963, PHYS LETT, V5, P27, DOI 10.1016/S0375-9601(63)80014-6; Vajk OP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087601; Munoz A, 2000, PHYS REV B, V62, P9498, DOI 10.1103/PhysRevB.62.9498; Xu XS, 2014, MOD PHYS LETT B, V28, DOI 10.1142/S0217984914300087; Jeong YK, 2012, J AM CHEM SOC, V134, P1450, DOI 10.1021/ja210341b; Jeong YK, 2012, CHEM MATER, V24, P2426, DOI 10.1021/cm300846j; Fennie CJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.100103; Huang ZJ, 1997, PHYS REV B, V56, P2623, DOI 10.1103/PhysRevB.56.2623; Mizoguchi Y, 1996, MAT SCI ENG A-STRUCT, V217, P164, DOI 10.1016/S0921-5093(96)10339-7; Catalan G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177543; Iida H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.024719; Magome E, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09ME06; Pavlov VV, 2012, J APPL PHYS, V111, DOI 10.1063/1.3693588; Schmid H., 1994, Ferroelectrics, V162, DOI 10.1080/00150199408245120	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NA10	10.7567/JJAP.54.10NA10		5	Physics, Applied	Physics	CS7SO	WOS:000362286000011		
J	Yokota, Y; Ohashi, Y; Kudo, T; Kochurikhin, VV; Kurosawa, S; Kamada, K; Yoshikawa, A				Yokota, Yuui; Ohashi, Yuji; Kudo, Tetsuo; Kochurikhin, Vladimir V.; Kurosawa, Shunsuke; Kamada, Kei; Yoshikawa, Akira			Growth and piezoelectric properties of Ca3Nb(Ga1-xAlx)(3)Si2O14(x=0.25 and 0.50) single crystals	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHASE-UNIDIRECTIONAL TRANSDUCER; ACOUSTIC-WAVE PROPERTIES; PROPAGATION CHARACTERISTICS; LANGASITE; LA3TA0.5GA5.5O14	One inch Ca3NbGa3Si2O14(CNGS) and Ca3Nb(Ga1-xAlx)(3)Si2O14(CNGAS) bulk crystals with an ordered langasite-type structure were grown by a Czochralski method. CNGS bulk single crystals without cracks could be grown, while CNGAS bulk crystals with x = 0.25 and 0.50 included some cracks even under improved growth conditions. Lattice parameters and anisotropy on the structure of grown crystals were systematically decreased and increased by increasing the Al concentration, respectively. Although the density and dielectric constant epsilon(11) of an X-cut sample of the CNGAS crystal with x = 0.25 were decreased by Al substitution, the electromechanical coupling factor k(12) and piezoelectric constant d(11) were increased. The effects of Al substitution on piezoelectric properties were almost consistent with previous reports on the disordered langasite-type crystals except for their amount of change. (C) 2015 The Japan Society of Applied Physics	[Yokota, Yuui; Kurosawa, Shunsuke; Kamada, Kei; Yoshikawa, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi 9808579, Japan; [Ohashi, Yuji; Kudo, Tetsuo; Kurosawa, Shunsuke; Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kochurikhin, Vladimir V.] Inst Gen Phys, Moscow 119991, Russia; [Kamada, Kei; Yoshikawa, Akira] C&A Corp, Sendai, Miyagi 9808579, Japan	Yokota, Y (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Sendai, Miyagi 9808579, Japan.	yokota@imr.tohoku.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology of Japan [23750234]; Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST)	This work was partially supported by the New Energy and Industrial Technology Development Organization (NEDO), Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for Young Scientists (B) (23750234), and Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST).	Adachi M., 2003, FERROELECTRICS, V286, P43, DOI 10.1080/00150190390206211; Yokota Y, 2012, IEEE T ULTRASON FERR, V59, P1868, DOI 10.1109/TUFFC.2012.2398; Wang ZM, 2003, J CRYST GROWTH, V249, P240, DOI 10.1016/S0022-0248(02)02112-7; Adachi M, 1999, JPN J APPL PHYS 1, V38, P3283, DOI 10.1143/JJAP.38.3283; Zhang SJ, 2008, SOLID STATE COMMUN, V148, P213, DOI 10.1016/j.ssc.2008.08.013; Yokota Y, 2013, SENSOR ACTUAT A-PHYS, V200, P56, DOI 10.1016/j.sna.2012.10.017; Takeuchi M, 1999, JPN J APPL PHYS 1, V38, P3244, DOI 10.1143/JJAP.38.3244; Takeda H, 1997, JPN J APPL PHYS 2, V36, pL919, DOI 10.1143/JJAP.36.L919; Zhang SJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3142429; Inoue K, 1998, JPN J APPL PHYS 1, V37, P2909, DOI 10.1143/JJAP.37.2909; Inagawa K, 2000, JPN J APPL PHYS 1, V39, P3014, DOI 10.1143/JJAP.39.3014; Onozato N, 2000, JPN J APPL PHYS 1, V39, P3028, DOI 10.1143/JJAP.39.3028; Takeda H, 2001, APPL PHYS LETT, V79, P4201, DOI 10.1063/1.1426274; Yokota Y, 2015, MATERIALS, V8, P5597, DOI 10.3390/ma8095264; Yoshikawa A, 2009, MRS BULL, V34, P266, DOI 10.1557/mrs2009.77; Kumatoriya M, 2001, J CRYST GROWTH, V229, P289, DOI 10.1016/S0022-0248(01)01152-6; Takeda H, 2008, MATER RES BULL, V43, P1731, DOI 10.1016/j.materresbull.2007.07.029; Karaki T, 2004, JPN J APPL PHYS 1, V43, P6721, DOI 10.1143/JJAP.43.6721; Jung IH, 2001, JPN J APPL PHYS 1, V40, P5706, DOI 10.1143/JJAP.40.5706; Satoh H, 1997, JPN J APPL PHYS 1, V36, P3071, DOI 10.1143/JJAP.36.3071; Jung IH, 2002, J ALLOY COMPD, V339, P149, DOI 10.1016/S0925-8388(01)01961-2; Hagiwara M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD03; Tsuchida K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KD02; Karaki T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD09; Kim TH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC01; Kitanaka Y, 2012, JPN J APPL PHYS, V51, DOI [10.1143/JJAP.51.091D08, 10.1143/JJAP.51.09LD08]; Takeda H., 2005, P 2005 IEEE ULTR S, P560; Watanabe T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KC02; Yokota Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.09ND03; Yoshida H., 2012, P 33 S ULTR EL, P347	30	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10ND13	10.7567/JJAP.54.10ND13		4	Physics, Applied	Physics	CS7SO	WOS:000362286000044		
J	Yoneda, Y; Kohara, S; Nakashima, K; Nagata, H; Wada, S				Yoneda, Yasuhiro; Kohara, Shinji; Nakashima, Kouichi; Nagata, Hajime; Wada, Satoshi			Local structure analysis of KNbO3 nanocubes by solvothermal synthesis	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POTASSIUM NIOBATE; X-RAYS; DIFFRACTION; REFINEMENT; DISORDER	The atomic-scale structure of KNbO3 nanocubes synthesized by a solvothermal method has been studied using high-energy X-ray diffraction, Rietveld refinement, and the atomic pair-distribution function (PDF) technique. It was found that the local structure of KNbO3 nanocubes was rhombohedral. The rhombohedral distortion of NbO6 octahedra was maintained in the nanocubes and also observed in KNbO3 bulk ceramics. The size effect on the crystallographic structure can be understood as analogous to the temperature-driven and/or pressure-driven structural phase transitions. The tetragonal average structure of the KNbO3 nanocubes was observed as a disordered phase of the rhombohedral local structure. (C) 2015 The Japan Society of Applied Physics	[Yoneda, Yasuhiro] Japan Atom Energy Agcy, React Dynam Res Div, Sayo, Hyogo 6795148, Japan; [Kohara, Shinji] Natl Inst Mat Sci, Quantum Beam Unit, Synchrotron Xray Grp, Sayo, Hyogo 6795148, Japan; [Nakashima, Kouichi; Wada, Satoshi] Univ Yamanashi, Dept Interdisciplinary, Grad Sch, Kofu, Yamanashi 4008510, Japan; [Nagata, Hajime] Tokyo Univ Sci, Fac Sci & Technol, Dept Elect Engn, Noda, Chiba 2788510, Japan	Yoneda, Y (reprint author), Japan Atom Energy Agcy, React Dynam Res Div, Sayo, Hyogo 6795148, Japan.	yoneda@spring8.or.jp			Ministry of Education, Culture, Sports, Science and Technology [26400326]	The synchrotron radiation experiments were performed at BL04B2 and BL14B1 in SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI Proposal Nos. 2013B3607, 2014A3607, 2014B1080, 2015A1173, and 2015A3607). This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 26400326) from the Ministry of Education, Culture, Sports, Science and Technology.	Frenkel AI, 1997, PHYS REV B, V56, P10869, DOI 10.1103/PhysRevB.56.10869; Paula AJ, 2008, MATER LETT, V62, P2581, DOI 10.1016/j.matlet.2007.12.059; Tsuda K, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4791679; Yoneda Y, 2014, J PHYS CONF SER, V502, DOI 10.1088/1742-6596/502/1/012022; SICRON N, 1994, PHYS REV B, V50, P13168, DOI 10.1103/PhysRevB.50.13168; Zalar B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.037601; Isshiki M, 2001, NUCL INSTRUM METH A, V467, P663, DOI 10.1016/S0168-9002(01)00441-7; Kaseda K, 2011, J SUPERCRIT FLUID, V58, P279, DOI 10.1016/j.supflu.2011.06.009; SHIRANE G, 1954, PHYS REV, V93, P672, DOI 10.1103/PhysRev.93.672; Proffen T, 1999, J APPL CRYSTALLOGR, V32, P572, DOI 10.1107/S0021889899003532; Kumada N, 2007, MATER RES BULL, V42, P1856, DOI 10.1016/j.materresbull.2006.11.045; Shuvaeva VA, 2001, J SYNCHROTRON RADIAT, V8, P833, DOI 10.1107/S0909049500018069; Izumi F, 2007, SOL ST PHEN, V130, P15; COMES R, 1970, ACTA CRYSTALL A-CRYS, VA 26, P244, DOI 10.1107/S056773947000061X; Yoneda Y, 2001, J SYNCHROTRON RADIAT, V8, P18, DOI 10.1107/S0909049500014515; HEWAT AW, 1973, J PHYS C SOLID STATE, V6, P2559, DOI 10.1088/0022-3719/6/16/010; Nakashima K, 2014, J CERAM SOC JPN, V122, P547, DOI 10.2109/jcersj2.122.547; Nisawa A, 2013, J SYNCHROTRON RADIAT, V20, P219, DOI 10.1107/S0909049512049813; SHIRANE G, 1954, PHYS REV, V96, P581, DOI 10.1103/PhysRev.96.581; Lu CH, 2002, MATER LETT, V55, P121, DOI 10.1016/S0167-577X(01)00633-4; Billinge S. J. L., 2003, UNDERNEATH BRAGG PEA, P55; Kwei G.-H., 1995, Ferroelectrics, V164; Osward H. R., 1977, J CERAM SOC B, V56, P575; Qiu X., 2004, J APPL CRYSTALLOGR, V37, P678, DOI DOI 10.1107/S0021889804011744; Ravel B., 1995, Ferroelectrics, V164, DOI 10.1080/00150199508221849; Wada S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LC05; Yoneda Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KF01; Yoneda Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD01	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10			SI				10NC01	10.7567/JJAP.54.10NC01		6	Physics, Applied	Physics	CS7SO	WOS:000362286000027		
J	Yoshimura, S; Kiuchi, M				Yoshimura, Satoru; Kiuchi, Masato			Fragment ions produced from hexamethyldisilane in a Freeman-type ion source	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; LOW-TEMPERATURE GROWTH; HOT TUNGSTEN WIRES; METHYLSILANE; SI(100); FILMS; DIMETHYLSILANE; SUBSTRATE; PLASMA; SI	Fragment ions produced from hexamethyldisilane (HMDS) in a Freeman-type ion source with a hot tungsten wire were studied using a low-energy mass analyzed ion beam system. Dominant fragment ions from HMDS were identified to be H+, H-2(+), C+, CH3+, Si+, SiCH4+, SiC2H6+, and SiC3H9+. The rates of ion fragment production strongly depended on the tungsten temperature. We conclude that the irradiation of the mass-selected SiCH4+ ions obtained from HMDS to Si substrates is useful for the secure epitaxial growth of SiC. (c) 2015 The Japan Society of Applied Physics	[Yoshimura, Satoru; Kiuchi, Masato] Osaka Univ, Grad Sch Engn, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan; [Kiuchi, Masato] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Yoshimura, S (reprint author), Osaka Univ, Grad Sch Engn, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan.	yosimura@ppl.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25287154]	The authors would like to thank Professor S. Hamaguchi (Osaka University) for valuable suggestions. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 25287154).	Matsutani T, 2000, VACUUM, V59, P152, DOI 10.1016/S0042-207X(00)00265-7; Dimitrijev S, 2003, MICROELECTRON RELIAB, V43, P225, DOI 10.1016/S0026-2714(02)00270-6; TAKAHASHI K, 1992, J ELECTROCHEM SOC, V139, P3565, DOI 10.1149/1.2069122; Yoshimura S, 2007, JPN J APPL PHYS 1, V46, P1707, DOI 10.1143/JJAP.46.1707; Yoshimura S, 2006, JPN J APPL PHYS 1, V45, P8204, DOI 10.1143/JJAP.45.8204; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; Takeuchi T, 2002, SURF COAT TECH, V158, P408, DOI 10.1016/S0257-8972(02)00261-X; Wang L, 2009, J CRYST GROWTH, V311, P4442, DOI 10.1016/j.jcrysgro.2009.07.036; Sanchez EC, 2002, J PHYS CHEM B, V106, P8019, DOI 10.1021/jp020905u; Morikawa Y, 2007, J MATER RES, V22, P1275, DOI 10.1557/JMR.2007.0151; GOLECKI I, 1992, APPL PHYS LETT, V60, P1703, DOI 10.1063/1.107191; Yoshimura S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2364050; Liu F, 2009, J APPL PHYS, V106, DOI 10.1063/1.3157184; Saito E, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.010203; Matsumoto T, 2001, SURF SCI, V493, P426, DOI 10.1016/S0039-6028(01)01249-3; Yoshimura S, 2006, JPN J APPL PHYS 1, V45, P1813, DOI 10.1143/JJAP.45.1813; Yoshimura S., 2015, E J SURF SCI NANOTEC, V13, P174	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	OCT	2015	54	10							108001	10.7567/JJAP.54.108001		3	Physics, Applied	Physics	CS7SG	WOS:000362285100034		
J	Tsushima, T				Tsushima, Takahiro			Stable reduction of X-0(p(4))	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article								R. Coleman and K. McMurdy calculated the stable reduction of X-0(p(3)) (p >= 13) on the basis of the rigid geometry in [8]. In the present paper, we determine the stable reduction of X-0(p(4)) for primes p >= 13 on the basis of their idea. As irreducible components in the stable reduction of X-0(p(4)), a certain number of copies of the Hermitian curve, with an affine equation a(p) - a = t(p+1), appear.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Tsushima, T (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	tsushima@ms.u-tokyo.ac.jp					McMurdy K, 2008, CONTEMP MATH, V463, P91; Coleman RF, 2005, J NUMBER THEORY, V110, P3, DOI 10.1016/j.jnt.2004.07.001; Buzzard K, 2003, J AM MATH SOC, V16, P29, DOI 10.1090/S0894-0347-02-00405-8; COLEMAN R, 1988, J REINE ANGEW MATH, V385, P41; IGUSA JI, 1968, J MATH SOC JPN, V20, P96; BOSCH S, 1985, MATH ANN, V270, P349, DOI 10.1007/BF01473432; Bosch S., 1984, GRUND MATH WISS, V261; Coleman R., 1989, COMPOS MATH, V72, P205; Coleman R., 2006, DOCUMENTA MATH EXTRA, P261; Coleman R., 2010, ALGEBRA NUMBER THEOR, V4, P357; de Shalit E., 1994, CONT MATH, V165, P135; Deligne P., 1969, I HAUTES ETUDES SCI, V36, P75, DOI 10.1007/BF02684599; Deligne P., 1973, LECT NOTES MATH, V349, P143; EDIXHOVEN B, 1990, ANN I FOURIER, V40, P31; Gross B.H., 1994, CONT MATH, V158, P23; Katz N., 1973, LECT NOTES MATH, V350, P69; Katz N. M., 1985, ANN MATH STUD, V108; Krir M, 1996, ANN I FOURIER, V46, P279; Lubin J., 1964, LECT NOTES SUMMER I; Shimura G., 1971, INTRO ARITHMETIC THE; Weinstein J., 2012, PREPRINT	21	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	OCT	2015	707						1	43		10.1515/crelle-2013-0081		43	Mathematics	Mathematics	CS6WL	WOS:000362223900001		
J	Yamada, H; Funato, K; Sakurai, H				Yamada, Hiroyuki; Funato, Koji; Sakurai, Hiromu			Application of the PMP methodology to the measurement of sub-23 nm solid particles: Calibration procedures, experimental uncertainties, and data correction methods	JOURNAL OF AEROSOL SCIENCE			English	Article						Particle measurement program; Particle number; Sub-23 nm particle; Calibration; Particle concentration reduction factor	DIESEL EXHAUST; NANOPARTICLES; VEHICLE; ENGINES	This paper discusses issues which will appear if the PMP methodology is extended to the measurement of particles with sizes below 23 nm. In addition, the origins of sub 23 nm particles from three different types of engines are discussed. An increased uncertainty was observed for the detection efficiency measurements with a particle number counter (PNC) at particle sizes below 10 nm. The particle concentration reduction factor (PCRF) of a volatile particle remover for 15 nm particles was higher than those for 30, 50 and 100 nm particles because of increasing particle losses. Then, exhaust particle emissions from a gasoline direct injection (Dl) passenger car and trucks with and without a diesel particulate filter (DPF) were measured using the PMP methodology with a PNC whose D-50 value was 2.5 nm (PNC_2.5) and a normal PMP PNC (PNC_23). The fluctuations of the results for PNC_23 and PNC_2.5 were almost the same when the effect of re nucleation of semi volatile particles was removed. Different procedures for estimating the PCRF showed varying results, -23% to +41% in the worst case. The profiles of sub-23 nm particles from diesel trucks were similar to those of particles larger than 23 nm. In the case of the gasoline DI car, a peculiar emission Corresponding to hydrocarbon nucleation was observed in high-speed operation. Particles emitted from the diesel engines originated from combustion processes in the case of the truck without the DPF and were strongly affected by the DPF conditions in the case of the truck with the DPF. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Hiroyuki] Natl Traff Safety & Environm Lab, Tokyo 1820012, Japan; [Funato, Koji] Tokyo Dylec Corp, Shinjuku Ku, Tokyo 1600014, Japan; [Sakurai, Hiromu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Yamada, H (reprint author), Natl Traff Safety & Environm Lab, 7-42-27,Jindaiji Higashimachi, Tokyo 1820012, Japan.	h-yamada@ntsel.go.jp			Japanese Ministry of the Environment	A part of this work was financially supported by the Japanese Ministry of the Environment. We are grateful to AVL List GmbH, Department for Particle Emission Instruments, for performing some of the experiments.	Andersson J., 2010, PARTICLE MEASUREMENT; Andersson J., 2004, UN GRPE PMP PHASE 3; Andersson J., 2007, 22775EN EUR; Mamakos A, 2013, ATMOS ENVIRON, V77, P16, DOI 10.1016/j.atmosenv.2013.04.063; Ronkko T, 2014, ENVIRON SCI TECHNOL, V48, P2043, DOI 10.1021/es405687m; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; Ronkko T, 2007, ENVIRON SCI TECHNOL, V41, P6384, DOI 10.1021/es0705339; NIKULA KJ, 1995, FUND APPL TOXICOL, V25, P80, DOI 10.1006/faat.1995.1042; Giechaskiel B, 2008, AEROSOL SCI TECH, V42, P528, DOI 10.1080/02786820802220241; Zheng Z, 2011, J AEROSOL SCI, V42, P883, DOI 10.1016/j.jaerosci.2011.08.003; Sakurai H, 2003, ENVIRON SCI TECHNOL, V37, P5487, DOI 10.1021/es034362t; Zheng ZQ, 2012, AEROSOL SCI TECH, V46, P886, DOI 10.1080/02786826.2012.679167; Fujitani Y, 2012, SCI TOTAL ENVIRON, V437, P339, DOI 10.1016/j.scitotenv.2012.07.085; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Furuta C, 2008, TOXICOL APPL PHARM, V229, P109, DOI 10.1016/j.taap.2008.01.026; AVL Inc, ANN SERV AVL PART CO; Bakand D., 2012, INHAL TOXICOL, V24, P125; Bougher T., 2011, SAE INT J ENGINES, V4, P639; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Drossinos Y., 2010, SAE INT J ENGINES, V3, P1140; Ehara K., 2011, MEASUREMENT SCI TECH, V22, P1; Giechaskiel B, 2012, AEROSOL SCI TECH, V46, P719, DOI 10.1080/02786826.2012.661103; Gormley P. G., 1949, P ROY IRISH ACAD   A, V52, P163; Jonson K. C., 2009, AEROSOL SCI TECHNOLO, V43, P962; Kaufman S. L., 1999, J AEROSOL SCI, V30, P373; Khalek IA, 2010, SAE INT J FUELS LUBR, V3, P623, DOI DOI 10.4271/2010-01-2117; Martini G., 2013, GRPEPMP2802; Montajir R., 2007, 2007320058 SAE; Nousiainen P., 2013, 2013012575 SAE; Ntziachristos L., 2013, SAE INT J FUELS LUBR, V6, P523; Otsuki Y, 2014, 2014011604 SAE; Swanson J., 2013, SAE INT J FUELS LUBR, V6, P542, DOI [10.4271/2013-01-1570, DOI 10.4271/2013-01-1570]; [World Health Organization Regional Office for Europe], 2013, REV EV HLTH ASP AIR; Yamada H., 2013, SAE INT J ENGINES, V6, P1178	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	OCT	2015	88						58	71		10.1016/j.jacrosci.2015.06.002		14	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CS2OC	WOS:000361909600005		
J	Kasai, T; Koshiba, S; Yokoyama, J; Kigawa, T				Kasai, Takuma; Koshiba, Seizo; Yokoyama, Jun; Kigawa, Takanori			Stable isotope labeling strategy based on coding theory	JOURNAL OF BIOMOLECULAR NMR			English	Article						Amino-acid selective stable isotope labeling; Cell-free protein synthesis; Coding theory; Combinatorial selective labeling; Signal assignment	FREE PROTEIN-SYNTHESIS; CELL-FREE EXPRESSION; MEMBRANE-PROTEINS; SEQUENTIAL ASSIGNMENT; ESCHERICHIA-COLI; NMR; SYSTEM; RESONANCES; SPECTRA; DOMAIN	We describe a strategy for stable isotope-aided protein nuclear magnetic resonance (NMR) analysis, called stable isotope encoding. The basic idea of this strategy is that amino-acid selective labeling can be considered as "encoding and decoding" processes, in which the information of amino acid type is encoded by the stable isotope labeling ratio of the corresponding residue and it is decoded by analyzing NMR spectra. According to the idea, the strategy can diminish the required number of labelled samples by increasing information content per sample, enabling discrimination of 19 kinds of non-proline amino acids with only three labeled samples. The idea also enables this strategy to combine with information technologies, such as error detection by check digit, to improve the robustness of analyses with low quality data. Stable isotope encoding will facilitate NMR analyses of proteins under non-ideal conditions, such as those in large complex systems, with low-solubility, and in living cells.	[Kasai, Takuma; Koshiba, Seizo; Yokoyama, Jun; Kigawa, Takanori] RIKEN, Quantitat Biol Ctr QBiC, Lab Biomol Struct & Dynam, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kasai, Takuma; Kigawa, Takanori] JST CREST, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Koshiba, Seizo] Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, Sendai, Miyagi 9808573, Japan; [Yokoyama, Jun; Kigawa, Takanori] RIKEN, Innovat Ctr RInC, Cell Free Technol Applicat Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Jun] Taiyo Nippon Sanso Corp, SI Innovat Ctr, Tama, Tokyo 2060001, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Kigawa, T (reprint author), RIKEN, Quantitat Biol Ctr QBiC, Lab Biomol Struct & Dynam, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kigawa@riken.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25120003, 26650027, 24770108]; Japan Society for the Promotion of Science (JSPS)	We thank the lab members at RIKEN QBiC and RInC, particularly S. Watanabe, N. Matsuda, and Y. Kasai for their kind help in preparing the materials and S. Yasuda for secretarial assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 25120003), a Grant-in-Aid for Challenging Exploratory Research (Grant No. 26650027), and a Grant-in-Aid for Young Scientists (B) (Grant No. 24770108) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Japan Society for the Promotion of Science (JSPS).	IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Parker MJ, 2004, J AM CHEM SOC, V126, P5020, DOI 10.1021/ja039601r; Lohr F, 2012, J BIOMOL NMR, V52, P197, DOI 10.1007/s10858-012-9601-1; Yokoyama J, 2011, ANAL BIOCHEM, V411, P223, DOI 10.1016/j.ab.2011.01.017; KAINOSHO M, 1982, BIOCHEMISTRY-US, V21, P6273, DOI 10.1021/bi00267a036; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; Hefke F, 2011, J BIOMOL NMR, V49, P75, DOI 10.1007/s10858-010-9462-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Jaipuria G, 2012, ADV EXP MED BIOL, V992, P95, DOI 10.1007/978-94-007-4954-2_6; Cervantes CF, 2013, J MOL BIOL, V425, P902, DOI 10.1016/j.jmb.2012.12.012; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Suzuki M, 2007, NAT PROTOC, V2, P1802, DOI 10.1038/nprot.2007.252; Sobhanifar S, 2010, J BIOMOL NMR, V46, P33, DOI 10.1007/s10858-009-9364-5; Shi JX, 2004, J BIOMOL NMR, V28, P235, DOI 10.1023/B:JNMR.0000013697.10256.74; Trbovic N, 2005, J AM CHEM SOC, V127, P13504, DOI 10.1021/ja0540270; Schneider William M., 2010, Journal of Structural and Functional Genomics, V11, P143, DOI 10.1007/s10969-010-9083-x; Seki E, 2008, ANAL BIOCHEM, V377, P156, DOI 10.1016/j.ab.2008.03.001; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Maslennikov I, 2013, CURR OPIN STRUC BIOL, V23, P555, DOI 10.1016/j.sbi.2013.05.002; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Hembram DSS, 2013, BIOCHEM BIOPH RES CO, V438, P653, DOI 10.1016/j.bbrc.2013.07.127; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Staunton D, 2006, MAGN RESON CHEM, V44, pS2, DOI 10.1002/mrc.1835; Krishnarjuna B, 2011, J BIOMOL NMR, V49, P39, DOI 10.1007/s10858-010-9459-z; Wu PSC, 2006, J BIOMOL NMR, V34, P13, DOI 10.1007/s10858-005-5021-9; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	OCT	2015	63	2					213	221		10.1007/s10858-015-9978-8		9	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CS3NE	WOS:000361980400008		
J	Ose, T; Oikawa, A; Nakamura, Y; Maenaka, K; Higuchi, Y; Satoh, Y; Fujiwara, S; Demura, M; Sone, T; Kamiya, M				Ose, Toyoyuki; Oikawa, Azusa; Nakamura, Yukiko; Maenaka, Katsumi; Higuchi, Yuya; Satoh, Yuki; Fujiwara, Shiho; Demura, Makoto; Sone, Teruo; Kamiya, Masakatsu			Solution structure of an avirulence protein, AVR-Pia, from Magnaporthe oryzae	JOURNAL OF BIOMOLECULAR NMR			English	Article							RICE BLAST RESISTANCE; PLANT IMMUNE-SYSTEM; DISEASE RESISTANCE; GENE; NMR; GRISEA; SPECIFICITY; FUNGUS; IDENTIFICATION; RELAXATION		[Ose, Toyoyuki; Oikawa, Azusa; Nakamura, Yukiko; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Higuchi, Yuya; Satoh, Yuki; Fujiwara, Shiho; Sone, Teruo] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Demura, Makoto; Kamiya, Masakatsu] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Sone, T (reprint author), Hokkaido Univ, Grad Sch Agr, Kita Ku, N9,W9, Sapporo, Hokkaido 0608589, Japan.	sonet@chem.agr.hokudai.ac.jp; mkamiya@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23380024]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23380024), and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN).	Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; SWEIGARD JA, 1995, PLANT CELL, V7, P1221; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Fudal I, 2005, FUNGAL GENET BIOL, V42, P761, DOI 10.1016/j.fgb.2005.05.001; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; WISHART DS, 1995, J BIOMOL NMR, V6, P135; Li W, 2009, MOL PLANT MICROBE IN, V22, P411, DOI 10.1094/MPMI-22-4-0411; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Farman ML, 1998, GENETICS, V150, P1049; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Zhang ZM, 2013, J BIOMOL NMR, V55, P219, DOI 10.1007/s10858-012-9695-5; Satoh Y, 2014, BIOSCI BIOTECH BIOCH, V78, P680, DOI 10.1080/09168451.2014.893186; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Sone T, 2013, FEMS MICROBIOL LETT, V339, P102, DOI 10.1111/1574-6968.12058; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; MARKLEY JL, 1971, J CHEM PHYS, V55, P3604, DOI 10.1063/1.1676626; Miki S, 2009, MOL PLANT PATHOL, V10, P361, DOI [10.1111/j.1364-3703.2009.00534.x, 10.1111/J.1364-3703.2009.00534.X]; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Devanna NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104840; Guntert P, 2004, AUTOMATED NMR STRUCT, P353; Nyarko A, 2014, J BIOL CHEM, V289, P25946, DOI 10.1074/jbc.M114.569103; Sharma TR, 2012, AGR SCI, V1, P37, DOI DOI 10.1007/S40003-011-0003-5	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	OCT	2015	63	2					229	235		10.1007/s10858-015-9979-7		7	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CS3NE	WOS:000361980400010		
J	Manck, R; Ishitsuka, Y; Herrero, S; Takeshita, N; Nienhaus, GU; Fischer, R				Manck, Raphael; Ishitsuka, Yuji; Herrero, Saturnino; Takeshita, Norio; Nienhaus, G. Ulrich; Fischer, Reinhard			Genetic evidence for a microtubule-capture mechanism during polarised growth of Aspergillus nidulans	JOURNAL OF CELL SCIENCE			English	Article						Aspergillus; Polarity; Dynein; Kar9; APC	POLYPOSIS-COLI PROTEIN; END-TRACKING PROTEINS; CYTOPLASMIC MICROTUBULES; MITOTIC SPINDLE; FISSION YEAST; BUDDING YEAST; CELL POLARITY; PLUS END; IN-VIVO; SUPERRESOLUTION MICROSCOPY	The cellular switch from symmetry to polarity in eukaryotes depends on the microtubule (MT) and actin cytoskeletons. In fungi such as Schizosaccharomyces pombe or Aspergillus nidulans, the MT cytoskeleton determines the sites of actin polymerization through cortical cell-end marker proteins. Here we describe A. nidulans MT guidance protein A (MigA) as the first ortholog of the karyogamy protein Kar9 from Saccharomyces cerevisiae in filamentous fungi. A. nidulans MigA interacts with the cortical ApsA protein and is involved in spindle positioning during mitosis. MigA is also associated with septal and nuclear MT organizing centers (MTOCs). Super-resolution photoactivated localization microscopy (PALM) analyses revealed that MigA is recruited to assembling and retracting MT plus ends in an EbA-dependent manner. MigA is required for MT convergence in hyphal tips and plays a role in correct localization of the cell-end markers TeaA and TeaR. In addition, MigA interacts with a class-V myosin, suggesting that an active mechanism exists to capture MTs and to pull the ends along actin filaments. Hence, the organization of MTs and actin depend on each other, and positive feedback loops ensure robust polar growth.	[Manck, Raphael; Herrero, Saturnino; Takeshita, Norio; Fischer, Reinhard] Karlsruhe Inst Technol, Inst Appl Biosci, Dept Microbiol, D-76187 Karlsruhe, Germany; [Ishitsuka, Yuji; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76131 Karlsruhe, Germany; [Ishitsuka, Yuji; Nienhaus, G. Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76131 Karlsruhe, Germany; [Takeshita, Norio] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Fischer, R (reprint author), Karlsruhe Inst Technol, Inst Appl Biosci, Dept Microbiol, South Campus,Hertzstr 16, D-76187 Karlsruhe, Germany.	reinhard.fischer@kit.edu	Nienhaus, Gerd Ulrich/G-8698-2012; Ishitsuka, Yuji/J-1921-2014	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Ishitsuka, Yuji/0000-0002-6780-7154	Deutsche Forschungsgemeinschaft (DFG) [Fi459/13-1, TA819/2-1, FOR1334]; Baden-Wurttemberg Stiftung; Karlsruhe Institute of Technology (KIT)	The work was supported by the Deutsche Forschungsgemeinschaft (DFG) (grant numbers Fi459/13-1, TA819/2-1, FOR1334, to the Centre for Functional Nanostructures); the Baden-Wurttemberg Stiftung; and Karlsruhe Institute of Technology (KIT) in the context of the Helmholtz STN program. R.M. was a fellow of the 'Landesgraduiertenprogramm' of the state of Baden-Wurttemberg.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Wiedenmann J, 2011, J BIOPHOTONICS, V4, P377, DOI 10.1002/jbio.201000122; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; SNELL V, 1994, EMBO J, V13, P2066; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Schunck T, 2011, CURR GENET, V57, P335, DOI 10.1007/s00294-011-0351-5; Zeng CJT, 2014, MOL MICROBIOL, V94, P506, DOI 10.1111/mmi.12792; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Martin SG, 2014, FEMS MICROBIOL REV, V38, P228, DOI 10.1111/1574-6976.12055; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Suelmann R, 1998, MOL MICROBIOL, V30, P831, DOI 10.1046/j.1365-2958.1998.01115.x; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Takeshita N, 2008, MOL BIOL CELL, V19, P339, DOI 10.1091/mbc.E07-06-0523; SU LK, 1995, CANCER RES, V55, P2972; Wolf E, 1997, PROTEIN SCI, V6, P1179; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Arkowitz RA, 2011, SEMIN CELL DEV BIOL, V22, P789, DOI 10.1016/j.semcdb.2011.10.001; Higashitsuji Y, 2009, EUKARYOT CELL, V8, P957, DOI 10.1128/EC.00251-08; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Snaith HA, 2003, NATURE, V423, P647, DOI 10.1038/nature01672; Takeshita N, 2014, CURR OPIN MICROBIOL, V20, P34, DOI 10.1016/j.mib.2014.04.005; Ishitsuka Y, 2014, METHODS MOL BIOL, V1148, P239, DOI 10.1007/978-1-4939-0470-9_16; Pantazopoulou A, 2014, MOL BIOL CELL, V25, P2428, DOI 10.1091/mbc.E14-02-0710; Li YM, 2013, ACS NANO, V7, P5207, DOI 10.1021/nn4009388; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Riquelme M, 2013, ANNU REV MICROBIOL, V67, P587, DOI 10.1146/annurev-micro-092412-155652; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Barth AIM, 2002, J CELL SCI, V115, P1583; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Miller RK, 2000, MOL BIOL CELL, V11, P2949; Takeshita N, 2013, J CELL SCI, V126, P5400, DOI 10.1242/jcs.129841; FISCHER R, 1995, J CELL BIOL, V128, P485, DOI 10.1083/jcb.128.4.485; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Deka J, 1998, EUR J BIOCHEM, V253, P591, DOI 10.1046/j.1432-1327.1998.2530591.x; Yin HW, 2000, NATURE, V406, P1013; Enke C, 2007, EUKARYOT CELL, V6, P555, DOI 10.1128/EC.00266-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Cerqueira GC, 2013, NUCLEIC ACIDS RES, V42, pD705; Chen YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017844; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, V112, P571, DOI DOI 10.1385/1-59259-890-0:571; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Sambrook J, 1999, MOL CLONING LAB MANU; Stiebler AC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004685; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028575	74	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	OCT 1	2015	128	19					3569	3582		10.1242/jcs.169094		14	Cell Biology	Cell Biology	CS6JD	WOS:000362183800008		
J	Gao, K; Chi, Y; Zhang, XL; Zhang, H; Li, G; Sun, W; Takeda, M; Yao, J				Gao, Kun; Chi, Yuan; Zhang, Xiling; Zhang, Hui; Li, Gang; Sun, Wei; Takeda, Masayuki; Yao, Jian			A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						connexin 43; gap junction; oxidative stress; cytotoxicity; TXNIP; Akt	JUNCTIONAL INTERCELLULAR COMMUNICATION; THIOREDOXIN-INTERACTING PROTEIN; GAP-JUNCTIONS; CELL-DEATH; C-SRC; INDUCED APOPTOSIS; PODOCYTE INJURY; CANCER-CELLS; CONNEXIN-43; TOXICITY	Gap junctions (GJs) play an important role in the regulation of cell response to many drugs. However, little is known about their mechanisms. Using an invitro model of cytotoxicity induced by geneticin (G418), we explored the potential signalling mechanisms involved. Incubation of cells with G418 resulted in cell death, as indicated by the change in cell morphology, loss of cell viability and activation of caspase-3. Before the onset of cell injury, G418 induced reactive oxygen species (ROS) generation, activated oxidative sensitive kinase P38 and caused a shift of connexin 43 (Cx43) from non-phosphorylated form to hyperphosphorylated form. These changes were largely prevented by antioxidants, suggesting an implication of oxidative stress. Downregulation of Cx43 with inhibitors or siRNA suppressed the expression of thioredoxin-interacting protein (TXNIP), activated Akt and protected cells against the toxicity of G418. Further analysis revealed that inhibition of TXNIP with siRNA activated Akt and reproduced the protective effect of Cx43-inhibiting agents, whereas suppression of Akt sensitized cells to the toxicity of G418. Furthermore, interference of TXNIP/Akt also affected puromycin- and adriamycin-induced cell injury. Our study thus characterized TXNIP as a presently unrecognized molecule implicated in the regulatory actions of Cx43 on oxidative drug injury. Targeting Cx43/TXNIP/Akt signalling cascade might be a promising approach to modulate cell response to drugs.	[Gao, Kun; Chi, Yuan; Zhang, Xiling; Zhang, Hui; Yao, Jian] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Yamanashi, Japan; [Gao, Kun; Sun, Wei] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Li, Gang; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Gang] Liaoning Canc Hosp & Inst, Dept Urol, Shenyang, Liaoning, Peoples R China	Yao, J (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Yamanashi, Japan.	yao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26461219]; National Natural Science Foundation of China [81302918]	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (26461219 to J. Y.) and by a grant from National Natural Science Foundation of China (grant 81302918 to K. G.)	Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200; Sato H, 2007, MOL CARCINOGEN, V46, P215, DOI 10.1002/mc.20267; Zhou JB, 2013, MITOCHONDRION, V13, P163, DOI [10.1016/j.mito.2012.06.004, 10.1016/j.mito2012.06.004]; Yan QJ, 2012, FREE RADICAL BIO MED, V53, P1286, DOI 10.1016/j.freeradbiomed.2012.07.012; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132; Ogawa T, 2005, CANCER RES, V65, P9771, DOI 10.1158/0008-5472.CAN-05-0227; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Ikeyama S, 2001, FASEB J, V15, P114, DOI 10.1096/fj.01-0409fje; Huang RP, 2001, INT J CANCER, V92, P130, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.3.CO;2-7; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Gangoso E, 2012, GLIA, V60, P2040, DOI 10.1002/glia.22418; Pereira CV, 2012, EXPERT OPIN DRUG MET, V8, P219, DOI 10.1517/17425255.2012.645536; Gao K, 2014, MOL PHARMACOL, V85, P460, DOI 10.1124/mol.113.089458; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; O'Connell S, 2012, TOXICOL SCI, V126, P101, DOI 10.1093/toxsci/kfr330; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Takano Y, 2010, BIOCHEM PHARMACOL, V80, P463, DOI 10.1016/j.bcp.2010.05.016; Krutovskikh VA, 2002, ONCOGENE, V21, P1989, DOI 10.1038/sj/onc/1205187; Salameh A, 2005, BBA-BIOMEMBRANES, V1719, P36, DOI 10.1016/j.bbamem.2005.09.007; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001; Kandouz M, 2010, EXPERT OPIN THER TAR, V14, P681, DOI 10.1517/14728222.2010.487866; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Upham BL, 2007, NUTR CANCER, V57, P38; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Wang YW, 2014, MOL MED REP, V10, P515, DOI 10.3892/mmr.2014.2157; Cronier L, 2003, BIOL REPROD, V69, P1472, DOI 10.1095/biolreprod.103.016360; Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5; Leone A, 2012, PHYTOCHEM REV, V11, P285, DOI 10.1007/s11101-012-9235-7; Bruzzone S, 2001, FASEB J, V15, P10; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Lee J, 2011, BRAIN RES BULL, V86, P314, DOI 10.1016/j.brainresbull.2011.08.011; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; DAVIES J, 1980, AM J TROP MED HYG, V29, P1089; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Peterson-Roth E, 2009, CANCER RES, V69, P3619, DOI 10.1158/0008-5472.CAN-08-0985; Wilson MR, 2000, EXP CELL RES, V254, P257, DOI 10.1006/excr.1999.4771; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; Rivedal E, 2010, CHEM-BIOL INTERACT, V184, P229, DOI 10.1016/j.cbi.2009.11.013; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Chipman JK, 2003, TOXICOL SCI, V71, P146, DOI 10.1093/toxsci/71.2.146; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Cusato K, 2006, CELL DEATH DIFFER, V13, P1707, DOI 10.1038/sj.cdd.4401876; RUCH RJ, 1989, CARCINOGENESIS, V10, P1003, DOI 10.1093/carcin/10.6.1003; Choudhury D, 2006, NAT CLIN PRACT NEPHR, V2, P80, DOI 10.1038/ncpneph0076; YOTTI LP, 1979, SCIENCE, V206, P1089, DOI 10.1126/science.493994; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; SMITH CR, 1980, NEW ENGL J MED, V302, P1106, DOI 10.1056/NEJM198005153022002; Feine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041633; LOEWENST.WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Sheridan JD., 1987, CELL CELL COMMUNICAT, P187; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Xie X, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-38; Yao JA, 2010, BRIT J PHARMACOL, V160, P2055, DOI 10.1111/j.1476-5381.2010.00860.x	68	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	OCT	2015	19	10					2469	2480		10.1111/jcmm.12641		12	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	CS6WB	WOS:000362222800016		
J	Hori, Y; Ihara, N; Teramoto, N; Kunimi, M; Honda, M; Kato, K; Hanakawa, T				Hori, Yuki; Ihara, Naoki; Teramoto, Noboru; Kunimi, Masako; Honda, Manabu; Kato, Koichi; Hanakawa, Takashi			Noninvasive quantification of cerebral metabolic rate for glucose in rats using F-18-FDG PET and standard input function	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral metabolic rate for glucose; F-18-FDG; non-invasive quantification; small animal PET; standard input function	POSITRON-EMISSION-TOMOGRAPHY; ANIMAL PET; ARTERIOVENOUS SHUNT; BASAL FOREBRAIN; BLOOD-FLOW; SCANNER; FDG	Measurement of arterial input function (AIF) for quantitative positron emission tomography (PET) studies is technically challenging. The present study aimed to develop a method based on a standard arterial input function (SIF) to estimate input function without blood sampling. We performed F-18-fluolodeoxyglucose studies accompanied by continuous blood sampling for measurement of AIF in 11 rats. Standard arterial input function was calculated by averaging AIFs from eight anesthetized rats, after normalization with body mass (BM) and injected dose (ID). Then, the individual input function was estimated using two types of SIF: (1) SIF calibrated by the individual's BM and ID (estimated individual input function, EIFNS) and (2) SIF calibrated by a single blood sampling as proposed previously (EIF1S). No significant differences in area under the curve (AUC) or cerebral metabolic rate for glucose (CMRGlc) were found across the AIF-, EIFNS-, and EIF1S-based methods using repeated measures analysis of variance. In the correlation analysis, AUC or CMRGlc derived from EIFNS was highly correlated with those derived from AIF and EIF1S. Preliminary comparison between AIF and EIFNS in three awake rats supported an idea that the method might be applicable to behaving animals. The present study suggests that EIFNS method might serve as a noninvasive substitute for individual AIF measurement.	[Hori, Yuki; Ihara, Naoki; Kato, Koichi; Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Adv Neuroimaging, Tokyo 1878551, Japan; [Hori, Yuki; Ihara, Naoki; Honda, Manabu; Kato, Koichi; Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Funct Brain Res, Tokyo 1878551, Japan; [Teramoto, Noboru; Kunimi, Masako] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, Suita, Osaka, Japan; [Teramoto, Noboru] Hamaguchi Lab Inc, Dept Expt Technol, Osaka, Japan	Hori, Y (reprint author), Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Adv Neuroimaging, 4-1-1 Ogawa Higashi, Tokyo 1878551, Japan.	horiy@ncnp.go.jp; hanakawa@ncnp.go.jp			National Center of Neurology and Psychiatry Intramural Research Grant [24-10, 26-9]; Ministry of Education, Culture, Sports, Science and Technology of Japan	The present work was in part supported by grants from the National Center of Neurology and Psychiatry Intramural Research Grant (24-10, 26-9), grants for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Development of translatable biomarkers for neural circuits disturbance and recovery in cerebrovascular diseases and Parkinson's disease carried out under the Brain Mapping by Integrated Neurotechnologies for Disease Studies by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are also indebted to the technical staff Makoto Funasaka and Chiaki Masuda from the National Center of Neurology and Psychiatry, Tokyo, Japan.	Shimoji K, 2004, J NUCL MED, V45, P665; LEE HB, 1985, J NUCL MED, V26, P72; Meyer PT, 2006, EUR J NUCL MED MOL I, V33, P948, DOI 10.1007/s00259-006-0121-7; Tsuchida T, 1999, J NUCL MED, V40, P1441; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1; KEYES JW, 1995, J NUCL MED, V36, P1836; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Katsumi Y, 2000, NEUROSCI LETT, V280, P9, DOI 10.1016/S0304-3940(99)00993-3; Kudomi N, 2003, IEEE T NUCL SCI, V50, P70, DOI 10.1109/TNS.2002.807869; Xi W, 2013, J NUCL MED, V54, P1969, DOI 10.2967/jnumed.113.123000; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Katsumi Y, 1999, BRAIN RES, V837, P75, DOI 10.1016/S0006-8993(99)01530-9; Ose T, 2012, NUCL MED BIOL, V39, P730, DOI 10.1016/j.nucmedbio.2011.11.004; TAKIKAWA S, 1993, RADIOLOGY, V188, P131; Green LA, 1998, J NUCL MED, V39, P729; HAMBERG LM, 1994, J NUCL MED, V35, P1308; Hayashi T, 1999, NEUROREPORT, V10, P2113, DOI 10.1097/00001756-199907130-00022; Weber B, 2002, EUR J NUCL MED MOL I, V29, P319, DOI 10.1007/s00259-001-0712-2; Mizuta T, 2008, ANN NUCL MED, V22, P447, DOI 10.1007/s12149-008-0127-2; Shiozaki T, 2000, J NUCL MED, V41, P1612; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Iguchi S, 2013, NUCL INSTRUM METH A, V702, P111, DOI 10.1016/j.nima.2012.08.037; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716; Ouchi Y, 1996, J CEREBR BLOOD F MET, V16, P34; Koshino K, 2014, ANN NUCL MED, V28, P917, DOI 10.1007/s12149-014-0888-8; Marx C, 2012, FRONT BEHAV NEUROSCI, V6, P1, DOI 10.3389/fnbeh.2012.00004; Moore H, 2000, J CEREB BLOOD FLOW M, V20, P1492	27	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2015	35	10					1664	1670		10.1038/jcbfm.2015.104		7	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CS4KS	WOS:000362045300016		
J	Moriwaki, C; Chiba, S; Wei, HX; Aosa, T; Kitamura, H; Ina, K; Shibata, H; Fujikura, Y				Moriwaki, Chinatsu; Chiba, Seiichi; Wei, Huixing; Aosa, Taishi; Kitamura, Hirokazu; Ina, Keisuke; Shibata, Hirotaka; Fujikura, Yoshihisa			Distribution of histaminergic neuronal cluster in the rat and mouse hypothalamus	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Rat; Mouse; Hypothalamus; Histidine decarboxylase; Histamine; Neuron	L-HISTIDINE DECARBOXYLASE; VENTRAL PREMAMMILLARY NUCLEUS; CENTRAL-NERVOUS-SYSTEM; BROWN ADIPOSE-TISSUE; SPINAL-CORD-INJURY; TUBEROMAMMILLARY NUCLEUS; IMMUNOREACTIVE NEURONS; FOOD-INTAKE; FUNCTIONAL-HETEROGENEITY; BRAIN HISTAMINE	Histidine decarboxylase (HDC) catalyzes the biosynthesis of histamine from 1-histidine and is expressed throughout the mammalian nervous system by histaminergic neurons. Histaminergic neurons arise in the posterior mesencephalon during the early embryonic period and gradually develop into two histaminergic substreams around the lateral area of the posterior hypothalamus and the more anterior pen-cerebral aqueduct area before finally forming an adult-like pattern comprising five neuronal clusters, E1 , E2, E3, E4, and E5, at the postnatal stage. This distribution of histaminergic neuronal clusters in the rat hypothalamus appears to be a consequence of neuronal development and reflects the functional differentiation within each neuronal cluster. However, the close linkage between the locations of histaminergic neuronal clusters and their physiological functions has yet to be fully elucidated because of the sparse information regarding the location and orientation of each histaminergic neuronal clusters in the hypothalamus of rats and mice. To clarify the distribution of the five-histaminergic neuronal clusters more clearly, we performed an immunohistochemical study using the anti-HOC antibody on serial sections of the rat hypothalamus according to the brain maps of rat and mouse. Our results confirmed that the HDC-immunoreactive (HDCi) neuronal clusters in the hypothalamus of rats and mice are observed in the ventrolateral part of the most posterior hypothalamus (El), ventrolateral part of the posterior hypothalamus (E2), ventromedial part from the medial to the posterior hypothalamus (E3), periventricular part from the anterior to the medial hypothalamus (E4), and diffusely extended part of the more dorsal and almost entire hypothalamus (E5). The stereological estimation of the total number of HDCi neurons of each clusters revealed the larger amount of the rat than the mouse. The characterization of histaminergic neuronal clusters in the hypothalamus of rats and mice may provide useful information for further investigations. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Moriwaki, Chinatsu; Chiba, Seiichi; Wei, Huixing; Aosa, Taishi; Kitamura, Hirokazu; Ina, Keisuke; Fujikura, Yoshihisa] Oita Univ, Fac Med, Dept Mol Anat, Yufu City, Oita 8795593, Japan; [Wei, Huixing; Aosa, Taishi; Shibata, Hirotaka] Oita Univ, Fac Med, Dept Endocrinol Metab Rheumatol & Nephrol, Yufu City, Oita 8795593, Japan	Chiba, S (reprint author), Oita Univ, Fac Med, Dept Mol Anat, 1-1 Idaigaoka, Yufu City, Oita 8795593, Japan.	schiba@oita-u.ac.jp					Mahia J, 2009, EUR J NEUROSCI, V29, P1440, DOI 10.1111/j.1460-9568.2009.06686.x; Motta SC, 2013, P NATL ACAD SCI USA, V110, P14438, DOI 10.1073/pnas.1305581110; INAGAKI N, 1990, EXP BRAIN RES, V80, P374; WADA H, 1991, AGENT ACTION SUPPL, V33, P11; Mahia J, 2007, EXP BRAIN RES, V183, P27, DOI 10.1007/s00221-007-1018-9; Litvin Y, 2014, EUR J NEUROSCI, V40, P2344, DOI 10.1111/ejn.12608; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Parmentier R, 2002, J NEUROSCI, V22, P7695; Furigo IC, 2014, BRAIN RES, V1566, P47, DOI 10.1016/j.brainres.2014.04.018; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Mahia J, 2007, BEHAV BRAIN RES, V181, P147, DOI 10.1016/j.bbr.2007.03.026; Huang JH, 2007, RESP PHYSIOL NEUROBI, V158, P30, DOI 10.1016/j.resp.2007.03.010; Huston JP, 1997, BEHAV BRAIN RES, V83, P97, DOI 10.1016/S0166-4328(97)86052-4; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Michelsen KA, 2002, INFLAMM RES, V51, pS46; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Panula P, 2014, TRENDS NEUROSCI, V37, P159, DOI 10.1016/j.tins.2014.01.001; Johnson PL, 2005, EXP NEUROL, V193, P228, DOI 10.1016/j.expneurol.2004.11.022; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Nakamura W, 2008, CURR BIOL, V18, P381, DOI 10.1016/j.cub.2008.02.024; POLLARD H, 1985, NEUROSCI LETT, V54, P53; Haxhiu MA, 2001, RESP PHYSIOL, V129, P191, DOI 10.1016/S0034-5687(01)00290-0; Gaykema RPA, 2008, NEUROSCIENCE, V152, P273, DOI 10.1016/j.neuroscience.2007.10.042; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Gerashchenko D, 2004, SLEEP, V27, P1275; Schwartz MD, 2009, CHRONOBIOL INT, V26, P1290, DOI 10.3109/07420520903415742; Casatti CA, 2002, NEUROSCIENCE, V115, P899, DOI 10.1016/S0306-4522(02)00508-0; Ito C, 1996, BRAIN RES, V734, P98, DOI 10.1016/S0006-8993(96)00618-X; Umehara H, 2010, METHOD FIND EXP CLIN, V32, P733, DOI 10.1358/mf.2010.32.10.1545781; Nakamura K, 2011, J PHYSIOL-LONDON, V589, P3641, DOI 10.1113/jphysiol.2011.210047; ERICSON H, 1987, J COMP NEUROL, V263, P1, DOI 10.1002/cne.902630102; Umehara H, 2011, BRAIN RES, V1387, P61, DOI 10.1016/j.brainres.2011.02.018; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Umehara H, 2012, NEUROCHEM INT, V61, P942, DOI 10.1016/j.neuint.2012.05.022; Torrealba F, 2003, NEUROSCIENCE, V119, P1033, DOI 10.1016/S0306-4522(03)00238-0; WAGNER U, 1993, BRAIN RES, V613, P269, DOI 10.1016/0006-8993(93)90908-6; Provensi G, 2014, P NATL ACAD SCI USA, V111, P11527, DOI 10.1073/pnas.1322016111; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Krout KE, 2003, NEUROSCIENCE, V118, P853, DOI 10.1016/S0306-4522(02)00997-1; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P211; Takatsu Y, 2001, ENDOCRINOLOGY, V142, P1626, DOI 10.1210/en.142.4.1626; Kim H, 2003, BRAIN RES, V983, P201, DOI 10.1016/S0006-8993(03)03087-7; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Yu X, 2014, CURR BIOL, V24, P2838, DOI 10.1016/j.cub.2014.10.019; KOHLER C, 1985, NEUROSCIENCE, V16, P85, DOI 10.1016/0306-4522(85)90049-1; VANHALA A, 1994, J COMP NEUROL, V347, P101, DOI 10.1002/cne.903470108; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Turenius CI, 2009, BRAIN RES, V1283, P65, DOI 10.1016/j.brainres.2009.05.064; Griffond B, 1999, NEUROSCI LETT, V262, P77, DOI 10.1016/S0304-3940(98)00976-8; Miklos IH, 2003, EUR J NEUROSCI, V18, P3069, DOI 10.1046/j.1460-9568.2003.03033.x; SMOLEN AJ, 1983, J NEUROCYTOL, V12, P739, DOI 10.1007/BF01258148; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022; Dartsch C, 1999, HISTOCHEM J, V31, P507, DOI 10.1023/A:1003835905939; Nagaishi VS, 2014, NEUROSCIENCE, V259, P71, DOI 10.1016/j.neuroscience.2013.11.050; Sakata T, 2003, EXP BIOL MED, V228, P1106; PANULA P, 1988, J HISTOCHEM CYTOCHEM, V36, P259; Dere E, 2003, LEARN MEMORY, V10, P510, DOI 10.1101/lm.67603; Molina-Hernandez A, 2012, J NEUROCHEM, V122, P872, DOI 10.1111/j.1471-4159.2012.07863.x; I'Anson H, 2011, PHYSIOL BEHAV, V103, P268, DOI 10.1016/j.physbeh.2011.02.035; Flak JN, 2012, EUR J NEUROSCI, V36, P2547, DOI 10.1111/j.1460-9568.2012.08161.x; CINTRA A, 1990, BRAIN RES, V506, P139, DOI 10.1016/0006-8993(90)91210-8; Ayala C, 2013, PEPTIDES, V49, P74, DOI 10.1016/j.peptides.2013.08.016; BINGAMAN EW, 1994, BRAIN RES BULL, V35, P379, DOI 10.1016/0361-9230(94)90117-1; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Yoshimatsu H, 2002, EXP BIOL MED, V227, P63; LLORENSCORTES C, 1992, MOL BRAIN RES, V13, P277, DOI 10.1016/0169-328X(92)90210-3; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1241; MIKKELSEN JD, 1992, BRAIN RES, V597, P200, DOI 10.1016/0006-8993(92)91475-T; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; STAINES WA, 1987, NEUROSCIENCE, V23, P571, DOI 10.1016/0306-4522(87)90077-7; Castillo-Ruiz A, 2013, NEUROSCIENCE, V250, P352, DOI 10.1016/j.neuroscience.2013.07.007; AUVINEN S, 1988, J COMP NEUROL, V276, P289, DOI 10.1002/cne.902760211; Blandina Patrizio, 2012, Front Syst Neurosci, V6, P33, DOI 10.3389/fnsys.2012.00033; Bleier R., 1979, CYTOARCHITECTONIC AT; Cavalcante JC, 2014, BRAIN RES, V1582, P77, DOI 10.1016/j.brainres.2014.07.034; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P87, DOI 10.1007/s11055-008-0012-4; Matsuzaki K, 2015, J COMP NEUROL, V523, P1190, DOI 10.1002/cne.23732; Paxinos G, 2008, MOUSE BRAIN STEREOTA; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Phillips AJK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003213; Puelles L., 2012, MOUSE NERVOUS SYSTEM, P255; Rezai-Zadeh Kavon, 2014, Mol Metab, V3, P681, DOI 10.1016/j.molmet.2014.07.008; Rozov SV, 2014, EUR J NEUROSCI, V39, P218, DOI 10.1111/ejn.12397	85	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	OCT	2015	68						1	13		10.1016/j.jchemneu.2015.07.001		13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CS8AV	WOS:000362309000001		
J	Furugen, A; Kobayashi, M; Nishimura, A; Takamura, S; Narumi, K; Yamada, T; Iseki, K				Furugen, Ayako; Kobayashi, Masaki; Nishimura, Ayako; Takamura, Shigeo; Narumi, Katsuya; Yamada, Takehiro; Iseki, Ken			Quantification of new antiepileptic drugs by liquid chromatography/electrospray ionization tandem mass spectrometry and its application to cellular uptake experiment using human placental choriocarcinoma BeWo cells	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Cellular uptake experiment; Gabapentin; Lamotrigine; Levetiracetam; Liquid chromatography/tandem mass spectrometry; Topiramate	GABAPENTIN; PREGNANCY; PLASMA; FETAL	A method for quantification of new antiepileptic drugs, including lamotrigine (LTG), levetiracetam (LEV), gabapentin (GBP), and topiramate (TPM), in cellular samples, using liquid chromatography/electrospray ionization tandem mass spectrometry was developed to better understand the membrane transport mechanisms of these drugs. Cell lysate was deproteinized by methanol containing LEV-d(3) as an internal standard (IS). Chromatographic separation was performed on a C18 column using gradient elution with methanol-water-formic acid (10:90:0.1, v/v/v) and methanol-formic acid (100:0.1, v/v). Analytes were detected in positive ion electrospray mode with selected reaction monitoring (SRM). This method was applicable for a linear range of 5 to 500 pmol for LTG; 5 to 1000 pmol for LEV; 10 to 10,000 pmol for GBP; and 5 to 5000 pmol for TPM. The intra-day precision, inter-day precision, and accuracy data were assessed and found to be acceptable. This developed and validated method was then successfully applied to the investigation of uptake of the new antiepileptic drugs in placental choriocarcinoma BeWo cells. The intracellular concentration of these drugs in BeWo cells, accumulating over 30 min at 37 degrees C was in the order of GBP > LTG > LEV approximate to TPM. Furthermore, the uptake of GBP at 4 degrees C was much lower than that at 37 degrees C. The uptake of GBP was saturated at high concentrations. The kinetic parameters calculated for GBP uptake in BeWo cells were determined as K-m of 105.4 +/- 6.4 mu M and Vmax at 8153 +/- 348 pmol/mg protein/min. The novel method described here should enable investigators to elucidate the transport mechanisms of these antiepileptic drugs in BeWo cells. (C) 2015 Elsevier B.V. All rights reserved.	[Furugen, Ayako; Nishimura, Ayako; Takamura, Shigeo; Yamada, Takehiro; Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Kobayashi, Masaki; Narumi, Katsuya; Iseki, Ken] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut,Kita Ku, Sapporo, Hokkaido 0600812, Japan	Iseki, K (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut,Kita Ku, Kita 12 Jo Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki /B-1638-2015		Japan Society for the Promotion of Science (JSPS) [26926014]	This work was supported in part by a grant from Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 26926014).	Urban TJ, 2008, CLIN PHARMACOL THER, V83, P416, DOI 10.1038/sj.clpt.6100271; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Kim KB, 2011, J PHARMACEUT BIOMED, V56, P771, DOI 10.1016/j.jpba.2011.07.019; Shibata M, 2012, BIOMED CHROMATOGR, V26, P1519, DOI 10.1002/bmc.2726; Ohman I, 2005, EPILEPSIA, V46, P1621, DOI 10.1111/j.1528-1167.2005.00251.x; Dickens D, 2013, BIOCHEM PHARMACOL, V85, P1672, DOI 10.1016/j.bcp.2013.03.022; Hovinga CA, 2008, INT REV NEUROBIOL, V83, P241, DOI 10.1016/S0074-7742(08)00014-7; Bromley R.J., 2014, COCHRANE DATABASE SY; Deeb S, 2014, J ANAL TOXICOL, V38, P485, DOI 10.1093/jat/bku070; Vajda FJE, 2014, EPILEPSIA, V55, P1229, DOI 10.1111/epi.12711; Wang M.S., 2013, J CHROMATOGR B, V937, P91	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	OCT 1	2015	1002						228	233		10.1016/j.jchromb.2015.08.031		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CS5QD	WOS:000362132100028		
J	Li, XL; Li, G; Jiang, YZ; Kang, DZ; Jin, CH; Shi, Q; Jin, TF; Inoue, K; Todoroki, K; Toyo'oka, T; Min, JZ				Li, Xi-Ling; Li, Gao; Jiang, Ying-Zi; Kang, Dongzhou; Jin, Cheng Hua; Shi, Qing; Jin, Toufeng; Inoue, Koichi; Todoroki, Kenichiro; Toyo'oka, Toshimasa; Min, Jun Zhe			Human nails metabolite analysis: A rapid and simple method for quantification of uric acid in human fingernail by high-performance liquid chromatography with UV-detection	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Human fingernail; Uric acid; High-performance liquid chromatography with ultraviolet detection	DILUTION MASS-SPECTROMETRY; ASCORBIC-ACID; CAPILLARY-ELECTROPHORESIS; ELECTROCHEMICAL DETECTION; SENSITIVE DETERMINATION; BIOLOGICAL SAMPLES; HUMAN PLASMA; HUMAN-SERUM; HPLC; HYPERTENSION	A rapid and simple analytical method for the quantification of uric acid (UA) in human fingernails by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection is described. UA was extracted from human fingernail samples at 90 degrees C for 20 min, then separated on an Inertsil ODS-2 column (250 x 4.6 mm I.D., 5.0 mu m, GL Sciences) by isocratic elution using methanol: 74 mM phosphate buffer (pH 2.2) 2:98 (v/v). An UV detector was used to monitor at 284 nm. The results indicated that under optimized measurement conditions results were achieved within 8.0 min, and a good linearity was achieved from the calibration curves (r(2) >0.9999) in the range of 1.0-10000 ng; the limit of detection (S/N =3) was 2.0 pg, the inter-day and intra-day assay precisions were all less than 0.46% and the mean recoveries (%) of the uric acid spiked in the human fingernail were 101.95%. The amounts of UA in the fingernails of healthy volunteers were determined. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Xi-Ling; Li, Gao; Jiang, Ying-Zi; Kang, Dongzhou; Jin, Cheng Hua; Min, Jun Zhe] Yanbian Univ, Key Lab Nat Resource Changbai Mt & Funct Mol, Minist Educ, Coll Pharm, Yanji 133002, Jilin Province, Peoples R China; [Inoue, Koichi; Todoroki, Kenichiro; Toyo'oka, Toshimasa; Min, Jun Zhe] Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Shizuoka 4228526, Japan; [Shi, Qing; Jin, Toufeng] Yanbian Univ, Affiliated Hosp, Western Hosp Pharm, Dept Gen Surg, Yanji 133000, Jilin Province, Peoples R China	Min, JZ (reprint author), Yanbian Univ, Key Lab Nat Resource Changbai Mt & Funct Mol, Minist Educ, Coll Pharm, Yanji 133002, Jilin Province, Peoples R China.	junzhemin23@163.com			National Natural Science Foundation of China [81360487]; Japan Society for the Promotion of Science [26713021]	The present research was supported by the National Natural Science Foundation of China (81360487) and a Grant-in-Aid for Young Scientists (A) (KAKENHI, No. 26713021) from the Japan Society for the Promotion of Science.	SIEKMANN L, 1985, J CLIN CHEM CLIN BIO, V23, P129; Min JZ, 2014, BIOMED CHROMATOGR, V28, P492, DOI 10.1002/bmc.3059; Pormsila W, 2009, ANAL CHIM ACTA, V636, P224, DOI 10.1016/j.aca.2009.02.012; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; Kim KM, 2009, J CHROMATOGR B, V877, P2032, DOI 10.1016/j.jchromb.2009.05.037; Seki T, 1997, J PHARMACEUT BIOMED, V15, P1621, DOI 10.1016/S0731-7085(97)00011-3; Min JZ, 2011, CLIN CHIM ACTA, V412, P98, DOI 10.1016/j.cca.2010.09.018; Chen XB, 1998, J MASS SPECTROM, V33, P130, DOI 10.1002/(SICI)1096-9888(199802)33:2<130::AID-JMS616>3.3.CO;2-P; Jin DR, 2013, MICROCHEM J, V110, P568, DOI 10.1016/j.microc.2013.07.006; Cooper N, 2006, J CHROMATOGR B, V837, P1, DOI 10.1016/j.jchromb.2006.02.060; Ferin R, 2013, CLIN BIOCHEM, V46, P665, DOI 10.1016/j.clinbiochem.2013.01.006; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; ROSS MA, 1994, J CHROMATOGR B, V657, P197, DOI 10.1016/0378-4347(94)80087-1; Min JZ, 2011, J CHROMATOGR B, V879, P3220, DOI 10.1016/j.jchromb.2011.02.016; Min JZ, 2012, ANAL BIOCHEM, V424, P187, DOI 10.1016/j.ab.2012.02.025; Li XN, 2009, J CHROMATOGR B, V877, P853, DOI 10.1016/j.jchromb.2009.02.008; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; ELLERBE P, 1990, ANAL CHEM, V62, P2173, DOI 10.1021/ac00219a004; Dai XH, 2007, J CHROMATOGR B, V857, P287, DOI 10.1016/j.jchromb.2007.07.035; Yao X, 2007, BIOMED CHROMATOGR, V21, P520, DOI 10.1002/bmc.787; Zinellu A, 2006, J BIOCHEM BIOPH METH, V67, P95, DOI 10.1016/j.jbbm.2006.01.006; Inoue K, 2003, J CHROMATOGR B, V785, P57, DOI 10.1016/S1570-0232(02)00850-4; Min JZ, 2010, ANAL METHODS-UK, V2, P1233, DOI 10.1039/c0ay00373e; CANNON PJ, 1966, NEW ENGL J MED, V275, P457, DOI 10.1056/NEJM196609012750902; Huda N, 2014, TOXICOL APPL PHARM, V281, P11, DOI 10.1016/j.taap.2014.09.011; Min JZ, 2014, YAKUGAKU ZASSHI, V134, P1191; Min J.Z., 2014, CHROMATOGRAPHY, V35, P23; Min JZ, 2014, EUR J MASS SPECTROM, V20, P477, DOI 10.1255/ejms.1301; Pappa-Louisi Adriani, 1998, Analytical Biochemistry, V263, P176, DOI 10.1006/abio.1998.2773; Tirado-Gonzalez M, 2011, AM J DERMATOPATH, V33, P351, DOI 10.1097/DAD.0b013e3181fe4b86	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	OCT 1	2015	1002						394	398		10.1016/j.jchromb.2015.08.044		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CS5QD	WOS:000362132100049		
J	Minato, K; Suzuki, M; Nagao, H; Suzuki, R; Ochiai, H				Minato, Kouichi; Suzuki, Masanori; Nagao, Hidenori; Suzuki, Ryota; Ochiai, Hiroyuki			Development of analytical method for simultaneous determination of five rodent unique bile acids in rat plasma using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Muricholic acid; UPLC-TOF-MS; Biomarker; Liver injury; Rat Plasma; Bile acid	NAPHTHYLISOTHIOCYANATE-INDUCED CHOLESTASIS; BETA-MURICHOLIC ACID; INDUCED LIVER-INJURY; GUT MICROBIOTA; URINE; HEPATOTOXICITY; DISEASE; ANTIANDROGENS; METABOLISM; CHEMISTRY	Bile acids (BAs) are crucial for the diagnosis, follow-up, and prognostics of liver injuries and other BA metabolism related diseases. In particular, rodent unique BAs, alpha-muricholic acid (alpha-MCA), beta-MCA, omega-MCA, tauro-alpha-MCA (alpha-TMCA), and beta-TMCA, are valuable biomarkers for preclinical drug development. To the best of our knowledge, however, a simple, selective, sensitive, and robust analytical method for omega-MCA and taurine-conjugated MCAs has never been reported. We have developed a simple, selective, and sensitive analytical method for measurement of 16 BAs including the five rodent unique BAs in rat plasma using an ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS) method. Activated charcoal was utilized to prepare BA-free plasma, which served as the surrogate matrix for the preparation of calibration standards and quality control (QC) samples. Results of matrix effects evaluation suggested that the BA-free plasma could be adequate as a surrogate matrix for BAs determination. Three stable isotope labelled internal standards were separated by reverse phase UPLC using gradient elution and were detected by TOF-MS in negative ion mode. The calibration curve was linear for all BAs over a range of 10-25 ng/mL to 1000-10,000 ng/mL, with overall imprecision below 15% and 20% at lower limit of quantification (LLOQ), respectively. This analytical method was used to determine BA concentrations in more than 300 plasma samples from rats with liver injuries induced using alpha-naphthylisocyanate, carbon tetrachloride, or flutamide. The alteration of BA concentrations was most evident for necrosis, and cholestasis hepatotoxins, with more subtle effects by steatosis and idiosyncratic hepatotoxins. In conclusion, we have developed a simple, selective, and sensitive analytical method to measure plasma 16 BAs including 5 rodent unique BAs, alpha-MCA, beta-MCA, omega-MCA, alpha-TMCA, and beta-TMCA. Our data suggested that alpha-TMCA and beta-TMCA could be useful for identification or prediction of liver injuries, a currently unmet need in preclinical toxicity. Our method using TOF-MS is useful to determine BAs in rat plasma and of use in structural analyses of metabolites in early stage of drug development. (C) 2015 Elsevier B.V. All rights reserved.	[Minato, Kouichi; Nagao, Hidenori; Suzuki, Ryota; Ochiai, Hiroyuki] ASKA Pharmaceut Co Ltd, Pharmacokinet Res Dept, Takatsu Ku, Kawasaki, Kanagawa 2138522, Japan; [Suzuki, Masanori] ASKA Pharmaceut Co Ltd, Dept Analyt Res, Takatsu Ku, Kawasaki, Kanagawa 2138522, Japan	Minato, K (reprint author), ASKA Pharmaceut Co Ltd, Pharmacokinet Res Dept, Takatsu Ku, 5-36-1 Shimosakunobe, Kawasaki, Kanagawa 2138522, Japan.	minato-k@aska-pharma.ca.jp					Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; BOTHAM KM, 1983, EUR J BIOCHEM, V134, P191, DOI 10.1111/j.1432-1033.1983.tb07550.x; Aoki M, 2011, RAPID COMMUN MASS SP, V25, P1847, DOI 10.1002/rcm.5072; Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; EYSSEN HJ, 1976, EUR J BIOCHEM, V66, P507, DOI 10.1111/j.1432-1033.1976.tb10576.x; Yamazaki M, 2013, TOXICOL APPL PHARM, V268, P79, DOI 10.1016/j.taap.2013.01.018; Hofmann AF, 2009, FRONT BIOSCI, V14, P2584, DOI 10.2741/3999; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398; QUIGLEY EMM, 1993, GASTROENTEROLOGY, V104, P286; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; BREMMELGAARD A, 1979, EUR J CLIN INVEST, V9, P341, DOI 10.1111/j.1365-2362.1979.tb00894.x; CASTILLO T, 1992, HEPATOLOGY, V16, P992, DOI 10.1002/hep.1840160423; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Thole Z, 2004, UROL INT, V73, P289, DOI 10.1159/000081585; Boone L, 2005, VET CLIN PATH, V34, P182, DOI 10.1111/j.1939-165X.2005.tb00041.x; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Sharma R, 2011, CURR MED CHEM, V18, P4029; Kawai H, 2009, J TOXICOL SCI, V34, P27; Wysowski DK, 1996, J UROLOGY, V155, P209, DOI 10.1016/S0022-5347(01)66596-0; Seftel AD, 2005, J UROLOGY, V173, P173; Manso G, 2006, PHARMACOEPIDEM DR S, V15, P253, DOI 10.1002/pds.1168; Terjung B, 2009, CLIN REV ALLERG IMMU, V36, P40, DOI 10.1007/s12016-008-8088-8; Mori N, 2010, PHARMAZIE, V65, P457, DOI 10.1691/ph.2010.9419; Balkman CE, 2003, J AM VET MED ASSOC, V222, P1368, DOI 10.2460/javma.2003.222.1368; Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144; PLAA GL, 1976, PHARMACOL REV, V28, P207; Plumb RS, 2005, ANALYST, V130, P844, DOI 10.1039/b501767j; BECKER BA, 1965, TOXICOL APPL PHARM, V7, P680, DOI 10.1016/0041-008X(65)90125-0; Want EJ, 2010, ANAL CHEM, V82, P5282, DOI 10.1021/ac1007078; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Han J, 2015, ANAL CHEM, V87, P1127, DOI 10.1021/ac503816u; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; BOUCHIER IAD, 1978, GUT, V19, P492, DOI 10.1136/gut.19.6.492; Asakawa N., 1995, XENOBIOTIC METABOL D, V10, P454; Ding LL, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-249; Franklund C.V., 1990, J BIOL CHEM, V265, P98942; GOTO J, 1992, J CHROMATOGR-BIOMED, V574, P1, DOI 10.1016/0378-4347(92)80091-4; U.S. Department of Health and Human Services, 2001, GUID IND BIOAN METH; Watanabe T., 2015, DRUG METAB DISPOS, V15, P253	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	OCT 1	2015	1002						399	410		10.1016/j.jchromb.2015.08.047		12	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CS5QD	WOS:000362132100050		
J	Sabine, A; Bovay, E; Demir, CS; Kimura, W; Jaquet, M; Agalarov, Y; Zangger, N; Scallan, JP; Graber, W; Gulpinar, E; Kwak, BR; Makinen, T; Martinez-Corral, I; Ortega, S; Delorenzi, M; Kiefer, F; Davis, MJ; Djonov, V; Miura, N; Petrova, TV				Sabine, Amelie; Bovay, Esther; Demir, Cansaran Saygili; Kimura, Wataru; Jaquet, Muriel; Agalarov, Yan; Zangger, Nadine; Scallan, Joshua P.; Graber, Werner; Gulpinar, Elgin; Kwak, Brenda R.; Makinen, Taija; Martinez-Corral, Ines; Ortega, Sagrario; Delorenzi, Mauro; Kiefer, Friedemann; Davis, Michael J.; Djonov, Valentin; Miura, Naoyuld; Petrova, Tatiana V.			FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature	JOURNAL OF CLINICAL INVESTIGATION			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; ENDOTHELIAL-CELLS; ADHERENS JUNCTIONS; CONTACT INHIBITION; YAP ONCOPROTEIN; VALVE FORMATION; HIPPO PATHWAY; VE-CADHERIN; GROWTH; MICE	Biomechanical forces, such as fluid shear stress, govern multiple aspects of endothelial cell biology. In blood vessels, disturbed flow is associated with vascular diseases, such as atherosclerosis, and promotes endothelial cell proliferation and apoptosis. Here, we identified an important role for disturbed flow in lymphatic vessels, in which it cooperates with the transcription factor FOXC2 to ensure lifelong stability of the lymphatic vasculature. In cultured lymphatic endothelial cells, FOXC2 inactivation conferred abnormal shear stress sensing, promoting junction disassembly and entry into the cell cycle. Loss of FOXC2-dependent quiescence was mediated by the Hippo pathway transcriptional coactivator TAZ and, ultimately, led to cell death. In murine models, inducible deletion of Foxc2 within the lymphatic vasculature led to cell-cell junction defects, regression of valves, and focal vascular lumen collapse, which triggered generalized lymphatic vascular dysfunction and lethality. Together, our work describes a fundamental mechanism by which FOXC2 and oscillatory shear stress maintain lymphatic endothelial cell quiescence through intercellular junction and cytoskeleton stabilization and provides an essential link between biomechanical forces and endothelial cell identity that is necessary for postnatal vessel homeostasis. As FOXC2 is mutated in lymphedema-distichiasis syndrome, our data also underscore the role of impaired mechanotransduction in the pathology of this hereditary human disease.	[Sabine, Amelie; Bovay, Esther; Demir, Cansaran Saygili; Jaquet, Muriel; Agalarov, Yan; Petrova, Tatiana V.] CHUV, Dept Fundamental Oncol, CH-1066 Epalinges, Switzerland; [Sabine, Amelie; Bovay, Esther; Demir, Cansaran Saygili; Jaquet, Muriel; Agalarov, Yan; Petrova, Tatiana V.] Univ Lausanne, CH-1066 Epalinges, Switzerland; [Kimura, Wataru; Miura, Naoyuld] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; [Zangger, Nadine; Delorenzi, Mauro] SIB, Lausanne, Switzerland; [Scallan, Joshua P.; Davis, Michael J.] Univ Missouri, Columbia, MO USA; [Graber, Werner; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Gulpinar, Elgin] Harvard Univ, Cambridge, MA USA; [Kwak, Brenda R.] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Kwak, Brenda R.] Univ Geneva, Dept Med Specializat Cardiol, Geneva, Switzerland; [Makinen, Taija] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Martinez-Corral, Ines; Ortega, Sagrario] Spanish Natl Canc Res Ctr, Madrid, Spain; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Kiefer, Friedemann] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Petrova, Tatiana V.] Ecole Polytech Fed Lausanne, Swiss Canc Res Inst, Lausanne, Switzerland	Petrova, TV (reprint author), CHUV, Dept Fundamental Oncol, UNIL, Ch Boveresses 155, CH-1066 Epalinges, Switzerland.	tatiana.petrova@unil.ch			Gebert Ruf Foundation; Swiss National Science Foundation [PPP0033-114898, CRSII3-141811, 31003A_135740]; La Fondation Leenaards, Theodor and Gabriela Kummer PhD fellowship; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [317250]; National Institutes of Health [HL-120867]; Summer Undergraduate Research Programme of University of Lausanne	We thank L. Sorokin for laminin alpha 5 antibodies; O. Dormond and J.M. Calmes for help with LEC isolation; C. Beauverd for mouse genotyping, colony maintenance, and help with immunohistochemistry; and S. Piccolo, D. Kerjaschki, G. Halder, and J. Bernier-Latmani for useful discussions. Animal, Cellular Imaging, Flow Cytometry, Genomic Technologies, and Mouse Pathology Facilities of the University of Lausanne are gratefully acknowledged. This work was supported by the Gebert Ruf Foundation, the Swiss National Science Foundation (PPP0033-114898 to T.V. Petrova; CRSII3-141811 to T.V. Petrova, M. Delorenzi, and B.R. Kwak; 31003A_135740 to V. Djonov), La Fondation Leenaards, Theodor and Gabriela Kummer PhD fellowship (to E. Bovay), the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement 317250, the National Institutes of Health (HL-120867 to M.J. Davis), and the Summer Undergraduate Research Programme of University of Lausanne (to E. Gulpinar).	Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Davis MJ, 2012, AM J PHYSIOL-HEART C, V303, pH795, DOI 10.1152/ajpheart.01097.2011; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Dimova I, 2013, ANGIOGENESIS, V16, P921, DOI 10.1007/s10456-013-9366-5; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Mellor RH, 2011, J VASC RES, V48, P397, DOI 10.1159/000323484; Coso S, 2014, BLOOD, V123, P2614, DOI 10.1182/blood-2013-12-297317; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Conway DE, 2013, J CELL SCI, V126, P5101, DOI 10.1242/jcs.138313; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Norrmen C, 2010, BLOOD, V115, P906, DOI 10.1182/blood-2009-03-212274; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Ivanov KI, 2013, MOL CELL BIOL, V33, P3749, DOI 10.1128/MCB.01387-12; Kanady JD, 2011, DEV BIOL, V354, P253, DOI 10.1016/j.ydbio.2011.04.004; Fernandez-Martin L, 2012, ARTERIOSCL THROM VAS, V32, pE90, DOI 10.1161/ATVBAHA.112.252080; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Haider G., 2012, NAT REV MOL CELL BIO, V13, P591; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Scallan JP, 2013, J PHYSIOL-LONDON, V591, P443, DOI 10.1113/jphysiol.2012.237909; Shen ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117522; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanczuk L., 2015, CELL REP	43	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	OCT	2015	125	10					3861	3877		10.1172/JCI80454		17	Medicine, Research & Experimental	Research & Experimental Medicine	CS8BW	WOS:000362311700017		
J	Nakagawa, R				Nakagawa, Ryuichi			Learnability of an equilibrium with private information	JOURNAL OF ECONOMIC DYNAMICS & CONTROL			English	Article						Adaptive learning; Private information; Heterogeneous misspecification; Taylor principle	MONETARY-POLICY RULES; HETEROGENEOUS EXPECTATIONS; MACROECONOMIC STABILITY; RATIONAL-EXPECTATIONS; IMPERFECT INFORMATION; SUNSPOT EQUILIBRIA; MODEL UNCERTAINTY; MARKETS; CONVERGENCE; PERSISTENCE	This paper investigates the learnability of an equilibrium with private information. Agents of each type have their own private information about an exogenous variable and conduct adaptive learning with a heterogeneously misspecified perceived laws of motion (PLM) that includes only this variable. The paper shows that the existence of private information has a nonnegative impact on the learnability of the equilibrium; that is, the condition for learnability is unaffected or relaxed by heterogeneity and/or misspecification in PLMs caused by private information. In a New Keynesian model with private information about fundamental shocks, the learnability of the equilibrium is ensured by the Taylor principle of monetary policy. The paper also confirms that these results hold true not only in the presence of private information, but also in a variety of informational structures. (C) 2015 Elsevier B.V. All rights reserved.	Kansai Univ, Fac Econ, Suita, Osaka 5648680, Japan	Nakagawa, R (reprint author), Kansai Univ, Fac Econ, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	ryu-naka@kansai-u.ac.jp			JSPS KAKENHI [20730139, 23530234, 15K03372]; Murata Science Foundation; Nomura Foundation for Academic Promotion; Zengin Foundation for Studies on Economics and Finance	The author thanks the editor James Bullard and two anonymous referees for their valuable suggestions, which have improved the manuscript considerably. The author is also grateful to George W. Evans, Bruce McGough, Ichiro Muto and participants at the University of Oregon Macro Group, the Econometric Society, the European Economic Association, and the Royal Economic Society for their helpful comments and suggestions. An earlier version of this paper was circulated under the title "Learnability of Heterogeneous Misspecification Equilibrium." For financial support, the author thanks JSPS KAKENHI (Grant Nos. 20730139, 23530234, 15K03372), Murata Science Foundation, Nomura Foundation for Academic Promotion, and Zengin Foundation for Studies on Economics and Finance.	Levine P, 2012, ECON J, V122, P1287, DOI 10.1111/j.1468-0297.2012.02524.x; Woodford M, 1999, MANCH SCH, V67, P1, DOI 10.1111/1467-9957.67.s1.1; McGough B, 2013, J ECON DYN CONTROL, V37, P1126, DOI 10.1016/j.jedc.2013.01.012; FROOT KA, 1992, J FINANC, V47, P1461, DOI 10.2307/2328947; Branch WA, 2007, REV ECON DYNAM, V10, P207, DOI 10.1016/j.red.2006.10.002; Milani F, 2008, J ECON DYN CONTROL, V32, P3148, DOI 10.1016/j.jedc.2007.12.004; Evans GW, 2006, SCAND J ECON, V108, P15, DOI 10.1111/j.1467-9442.2006.00437.x; MARCET A, 1989, J ECON THEORY, V48, P337, DOI 10.1016/0022-0531(89)90032-X; Heinemann M, 2009, J ECON DYN CONTROL, V33, P2001, DOI 10.1016/j.jedc.2009.07.002; Bovi M, 2013, J ECON DYN CONTROL, V37, P633, DOI 10.1016/j.jedc.2012.10.005; McCallum BT, 2007, J ECON DYN CONTROL, V31, P1376, DOI 10.1016/j.jedc.2006.05.004; Mitra K, 2013, J ECON DYN CONTROL, V37, P1947, DOI 10.1016/j.jedc.2013.05.011; GROSSMAN SJ, 1980, AM ECON REV, V70, P393; Evans GW, 2003, J MONEY CREDIT BANK, V35, P1045, DOI 10.1353/mcb.2004.0026; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Evans GW, 2005, J ECON DYN CONTROL, V29, P601, DOI 10.1016/j.jedc.2003.07.005; Branch WA, 2006, J ECON THEORY, V127, P264, DOI 10.1016/j.jet.2004.11.005; Allen F, 2004, ECONOMETRICA, V72, P1023, DOI 10.1111/j.1468-0262.2004.00525.x; Honkapohja S, 2006, REV ECON DYNAM, V9, P284, DOI 10.1016/j.red.2006.01.003; Adam K, 2007, ECON J, V117, P603, DOI 10.1111/j.1468-0297.2007.02043.x; Evans GW, 2003, REV ECON STUD, V70, P807, DOI 10.1111/1467-937X.00268; Bullard J, 2014, INT ECON REV, V55, P1, DOI 10.1111/iere.12039; Branch WA, 2011, ECON THEOR, V47, P395, DOI 10.1007/s00199-010-0541-2; Duffy J, 2007, J MONETARY ECON, V54, P879, DOI 10.1016/j.jmoneco.2005.11.004; Assenza T, 2009, J ECON DYN CONTROL, V33, P1159, DOI 10.1016/j.jedc.2008.12.004; Slobodyan S, 2012, J ECON DYN CONTROL, V36, P26, DOI 10.1016/j.jedc.2011.01.016; Branch WA, 2011, ECON THEOR, V47, P365, DOI 10.1007/s00199-010-0539-9; Ellison M, 2011, J ECON THEORY, V146, P1500, DOI 10.1016/j.jet.2011.03.005; Honkapohja S, 2005, J ECON DYN CONTROL, V29, P627, DOI 10.1016/j.jedc.2003.07.006; Berardi M, 2009, J MONEY CREDIT BANK, V41, P79, DOI 10.1111/j.1538-4616.2008.00188.x; Branch WA, 2007, J ECON DYN CONTROL, V31, P245, DOI 10.1016/j.jedc.2005.11.002; Bullard J, 2002, J MONETARY ECON, V49, P1105, DOI 10.1016/S0304-3932(02)00144-7; Guse EA, 2014, J ECON DYN CONTROL, V40, P355, DOI 10.1016/j.jedc.2014.01.020; Branch WA, 2009, J ECON DYN CONTROL, V33, P1036, DOI 10.1016/j.jedc.2008.11.007; Guse EA, 2008, J ECON DYN CONTROL, V32, P1517, DOI 10.1016/j.jedc.2007.06.005; Muto I, 2011, J ECON DYN CONTROL, V35, P52, DOI 10.1016/j.jedc.2010.07.007; Adam K, 2006, J ECON DYN CONTROL, V30, P2725, DOI 10.1016/j.jedc.2005.09.003; Hommes C, 2014, J ECON THEORY, V150, P778, DOI 10.1016/j.jet.2013.09.002; Veldkamp LL, 2005, J ECON THEORY, V124, P230, DOI 10.1016/j.jet.2003.12.008; Berardi M, 2007, J ECON DYN CONTROL, V31, P3203, DOI 10.1016/j.jedc.2006.11.002; Honkapohja S, 2004, J MONETARY ECON, V51, P1743, DOI 10.1016/j.jmoneco.2004.02.003; McCallum BT, 2004, ECON LETT, V84, P55, DOI 10.1016/j.econlet.20041.01.001; Branch W.A., 2004, POSTWALRASIAN MACROE, P135; BRAY M, 1982, J ECON THEORY, V26, P318, DOI 10.1016/0022-0531(82)90007-2; CALVO GA, 1983, J MONETARY ECON, V12, P383, DOI 10.1016/0304-3932(83)90060-0; Clarida R, 2000, Q J ECON, V115, P147, DOI 10.1162/003355300554692; Evans G. W., 2001, LEARNING EXPECTATION; Fidrmuc J, 2003, EC SYSTEMS, V27, P313, DOI 10.1016/j.ecosys.2003.05.002; HIRSHLEIFER D, 1994, J FINANC, V49, P1665, DOI 10.2307/2329267; Honkapohja S., 2004, NATL GAIN GLOBAL MAR, P99; MARCET A, 1989, J POLIT ECON, V97, P1306, DOI 10.1086/261655; STIGLITZ JE, 1981, AM ECON REV, V71, P393; Taylor J. B., 1993, CARNEGIE-ROCHESTER C, V39, P195, DOI DOI 10.1016/0167-2231(93)90009-L; TRENKLER G, 1995, ECONOMET THEOR, V11, P808; WOODFORD M, 1990, ECONOMETRICA, V58, P277, DOI 10.2307/2938205; Woodford M, 2003, INTEREST AND PRICES: FOUNDATIONS OF A THEORY OF MONETARY POLICY, P1	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-1889	1879-1743		J ECON DYN CONTROL	J. Econ. Dyn. Control	OCT	2015	59						58	74		10.1016/j.jedc.2015.06.010		17	Economics	Business & Economics	CS5RM	WOS:000362135700004		
J	Lupker, SJ; Nakayama, M; Perea, M				Lupker, Stephen J.; Nakayama, Mariko; Perea, Manuel			Is There Phonologically Based Priming in the Same-Different Task? Evidence From Japanese-English Bilinguals	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE			English	Article						orthographic code; phonological priming; same-different task; cognate translation equivalents	VISUAL WORD RECOGNITION; ABSTRACT LETTER IDENTITIES; LEXICAL ACCESS; MATCHING-TASK; ORDER INFORMATION; COGNATE STATUS; PRINTED WORD; PERCEPTION; SIMILARITY; ORTHOGRAPHY	Norris and colleagues (Kinoshita & Norris, 2009; Norris & Kinoshita, 2008; Norris, Kinoshita, & van Casteren, 2010) have suggested that priming effects in the masked prime same-different task are based solely on prelexical orthographic codes. This suggestion was evaluated by examining phonological priming in that task using Japanese-English bilinguals. Targets and reference words were English words with the primes written in Katakana script, a syllabic script that is orthographically quite different from the Roman letter script used in writing English. Phonological priming was observed both when the primes were Japanese cognate translation equivalents of the English target/reference words (Experiment 1) and when the primes were phonologically similar Katakana nonwords (Experiment 2), with the former effects being substantially larger than the noncognate translation priming effects reported by Lupker, Perea, and Nakayama (2015). These results indicate that the same-different task is influenced by phonological information. One implication is that, due to the fact that phonology and orthography are inevitably confounded in Roman letter languages, previously reported priming effects in those languages may have been at least partly due to phonological, rather than orthographic, similarity. The potential extent of this problem, the nature of the matching process in the same-different task, and the implications for using this task as a means of investigating the orthographic code in reading are discussed.	[Lupker, Stephen J.] Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; [Nakayama, Mariko] Waseda Univ, Fac Letters Arts & Sci, Tokyo, Japan; [Perea, Manuel] Univ Valencia, Dept Metodol, Fac Psicol, E-46003 Valencia, Spain	Lupker, SJ (reprint author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.	lupker@uwo.ca	Perea, Manuel/B-3345-2011	Perea, Manuel/0000-0002-3291-1365	Natural Sciences and Engineering Research Council of Canada [A6333]; Japan Society for the Promotion of Science [15K04194]; Spanish Ministry of Economy and Competitiveness [PSI2014-53444-P]	Supported by the Natural Sciences and Engineering Research Council of Canada (Grant A6333), by the Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (Grant 15K04194), and by the Spanish Ministry of Economy and Competitiveness (Grant PSI2014-53444-P).	Ando E, 2014, J COGN PSYCHOL, V26, P853, DOI 10.1080/20445911.2014.971026; Grainger J, 1996, J MEM LANG, V35, P623, DOI 10.1006/jmla.1996.0033; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Lupker SJ, 2009, J EXP PSYCHOL LEARN, V35, P618, DOI 10.1037/a0015278; Pexman PM, 2001, J EXP PSYCHOL LEARN, V27, P139, DOI 10.1037//0278-7393.27.1.139; Johnson RL, 2007, J EXP PSYCHOL HUMAN, V33, P209, DOI 10.1037/0096-1523.33.1209; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Stone GO, 1997, J MEM LANG, V36, P337, DOI 10.1006/jmla.1996.2487; Norris D, 2012, PSYCHOL REV, V119, P517, DOI 10.1037/a0028450; FERRAND L, 1994, Q J EXP PSYCHOL-A, V47, P365; Kinoshita S, 2008, Q J EXP PSYCHOL, V61, P1873, DOI 10.1080/17470210701781114; Finkbeiner M, 2004, J MEM LANG, V51, P1, DOI 10.1016/j.jml.2004.01.004; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Kinoshita S, 2009, J EXP PSYCHOL LEARN, V35, P1, DOI 10.1037/a0014277; Perea M, 2003, MEM COGNITION, V31, P829, DOI 10.3758/BF03196438; Ferrand L, 2003, Q J EXP PSYCHOL-A, V56, P403, DOI 10.1080/02724980244000422; Norris D, 2010, J MEM LANG, V62, P254, DOI 10.1016/j.jml.2009.11.002; Voga M, 2007, MEM COGNITION, V35, P938, DOI 10.3758/BF03193467; Nakayama M, 2012, LANG COGNITIVE PROC, V27, P1563, DOI 10.1080/01690965.2011.606669; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Nakayama M, 2013, J COGN PSYCHOL, V25, P949, DOI 10.1080/20445911.2013.839560; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Grainger J, 2006, J EXP PSYCHOL HUMAN, V32, P865, DOI 10.1037/0096-1523.32.4.865; Pexman PM, 2002, J EXP PSYCHOL LEARN, V28, P572, DOI 10.1037//0278-7393.28.3.572; Grainger J, 2008, TRENDS COGN SCI, V12, P381, DOI 10.1016/j.tics.2008.06.006; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Lupker SJ, 2015, LANG COGN NEUROSCI, V30, P781, DOI 10.1080/23273798.2015.1015430; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; Okano K, 2013, COGN AFFECT BEHAV NE, V13, P390, DOI 10.3758/s13415-013-0149-7; Perea M, 2011, Q J EXP PSYCHOL, V64, P2065, DOI 10.1080/17470218.2011.582131; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; CHAMBERS SM, 1975, MEM COGNITION, V3, P549, DOI 10.3758/BF03197530; FERRAND L, 1992, Q J EXP PSYCHOL-A, V45, P353; MARMUREK HHC, 1989, MEM COGNITION, V17, P483, DOI 10.3758/BF03202622; Dunabeitia JA, 2010, EXP PSYCHOL, V57, P98, DOI 10.1027/1618-3169/a000013; Kinoshita S, 2012, Q J EXP PSYCHOL, V65, P1296, DOI 10.1080/17470218.2012.655749; PROCTOR RW, 1981, PSYCHOL REV, V88, P291, DOI 10.1037//0033-295X.88.4.291; Adelman JS, 2011, PSYCHOL REV, V118, P570, DOI 10.1037/a0024811; Gollan TH, 1997, J EXP PSYCHOL LEARN, V23, P1122, DOI 10.1037//0278-7393.23.5.1122; BESNER D, 1984, CAN J PSYCHOL, V38, P126, DOI 10.1037/h0080785; Allen D, 2014, BEHAV RES METHODS, V46, P540, DOI 10.3758/s13428-013-0389-z; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037//0033-2909.123.1.71; ANGIOLILLOBENT JS, 1982, J EXP PSYCHOL HUMAN, V8, P392, DOI 10.1037//0096-1523.8.3.392; CHAMBERS SM, 1979, J VERB LEARN VERB BE, V18, P225, DOI 10.1016/S0022-5371(79)90136-1; Dunabeitia JA, 2011, LANG COGNITIVE PROC, V26, P509, DOI 10.1080/01690965.2010.499215; Kelly AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072888; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Kondo H., 2000, NIHONGO NO GOI TOKUS, V7; Lupker SJ, 2015, J EXP PSYCHOL HUMAN, V41, P138, DOI 10.1037/a0038392; Nakayama M, 2014, J COGN PSYCHOL, V26, P714, DOI 10.1080/20445911.2014.953167; Kinoshita S, 2010, Q J EXP PSYCHOL, V63, P194, DOI 10.1080/17470210902957174; OCONNOR RE, 1981, MEM COGNITION, V9, P78, DOI 10.3758/BF03196953; Perea M., 2003, MASKED PRIMING STATE, P97; RUBENSTE.H, 1971, J VERB LEARN VERB BE, V10, P645, DOI 10.1016/S0022-5371(71)80071-3; Ziegler JC, 1997, J EXP PSYCHOL HUMAN, V23, P845, DOI 10.1037/0096-1523.23.3.845	60	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0096-1523	1939-1277		J EXP PSYCHOL HUMAN	J. Exp. Psychol.-Hum. Percept. Perform.	OCT	2015	41	5					1281	1299		10.1037/xhp0000087		19	Psychology; Psychology, Experimental	Psychology	CS2QN	WOS:000361916300012		
J	Takeuchi, Y; Hanafusa, M; Kanzaki, H; Ohta, T; Hanaoka, N; Yamamoto, S; Higashino, K; Tomita, Y; Uedo, N; Ishihara, R; Iishi, H				Takeuchi, Yoji; Hanafusa, Masao; Kanzaki, Hiromitsu; Ohta, Takashi; Hanaoka, Noboru; Yamamoto, Sachiko; Higashino, Koji; Tomita, Yasuhiko; Uedo, Noriya; Ishihara, Ryu; Iishi, Hiroyasu			An alternative option for "resect and discard" strategy, using magnifying narrow-band imaging: a prospective "proof-of-principle" study	JOURNAL OF GASTROENTEROLOGY			English	Article						Colonoscopy; Colorectal neoplasm; Colon polyp surveillance; Magnifying narrow-band imaging; Resect and discard	DIMINUTIVE COLONIC POLYPS; COLORECTAL-CANCER; PIT PATTERN; DIAGNOSIS; HISTOLOGY; ENDOSCOPY; NEOPLASIA; ADENOMAS; SOCIETY; TUMORS	The "resect and discard" strategy is beneficial for cost savings on screening and surveillance colonoscopy, but it has the risk to discard lesions with advanced histology or small invasive cancer (small advanced lesion; SALs). The aim of this study was to prove the principle of new "resect and discard" strategy with consideration for SALs using magnifying narrow-band imaging (M-NBI). Patients undergoing colonoscopy at a tertiary center were involved in this prospective trial. For each detected polyp < 10 mm, optical diagnosis (OD) and virtual management ("leave in situ", "discard" or "send for pathology") were independently made using non-magnifying NBI (N-NBI) and M-NBI, and next surveillance interval were predicted. Histological and optical diagnosis results of all polyps were compared. While the management could be decided in 82 % of polyps smaller than 10 mm, 24/31 (77 %) SALs including two small invasive cancers were not discarded based on OD using M-NBI. The sensitivity [90 % confidence interval (CI)] of M-NBI for SALs was 0.77 (0.61-0.89). The risk for discarding SALs using N-NBI was significantly higher than that using M-NBI (53 vs. 23 %, p = 0.02). The diagnostic accuracy (95 % CI) of M-NBI in distinguishing neoplastic from non-neoplastic lesions [0.88 (0.86-0.90)] was significantly better than that of N-NBI [0.84 (0.82-0.87)] (p = 0.005). The results of our study indicated that our "resect and discard" strategy using M-NBI could work to reduce the risk for discarding SALs including small invasive cancer (UMIN-CTR, UMIN000003740).	[Takeuchi, Yoji; Hanafusa, Masao; Kanzaki, Hiromitsu; Ohta, Takashi; Hanaoka, Noboru; Yamamoto, Sachiko; Higashino, Koji; Uedo, Noriya; Ishihara, Ryu; Iishi, Hiroyasu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Higashinari Ku, Osaka 5378511, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan	Takeuchi, Y (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	takeuti-yo@mc.pref.osaka.jp; m-hanafusa@nyc.odn.ne.jp; kanzaki@qc4.so-net.ne.jp; tks.ohta@gmail.com; hanaoka-no@mc.pref.osaka.jp; yamamoto-sa@mc.pref.osaka.jp; higasino-ko@mc.pref.osaka.jp; yasuhiko-tomita@umin.ac.jp; uedou-no@mc.pref.osaka.jp; isihara-ry@mc.pref.osaka.jp; iisi-hi@mc.pref.osaka.jp			Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases	This study was supported by a grant-in-aid from the Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases.	Takeuchi Y, 2014, DIGEST ENDOSC, V26, P90, DOI 10.1111/den.12248; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Machida H, 2004, ENDOSCOPY, V36, P1094, DOI 10.1055/s-2004-826040; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Loberg M, 2014, NEW ENGL J MED, V371, P799, DOI 10.1056/NEJMoa1315870; East JE, 2008, ENDOSCOPY, V40, P811, DOI 10.1055/s-2008-1077586; Hirata M, 2007, GASTROINTEST ENDOSC, V65, P988, DOI 10.1016/j.gie.2006.07.046; Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Takeuchi Y, 2010, GASTROINTEST ENDOSC, V72, P1006, DOI 10.1016/j.gie.2010.06.055; Hassan Cesare, 2010, Clin Gastroenterol Hepatol, V8, P865, DOI 10.1016/j.cgh.2010.05.018; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; East JE, 2007, GASTROINTEST ENDOSC, V66, P310, DOI 10.1016/j.gie.2007.02.026; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Cairns S, 2002, GUT, V51, pV1, DOI 10.1136/gut.51.suppl_5.v1; Sano Y, 2009, GASTROINTEST ENDOSC, V69, P278, DOI 10.1016/j.gie.2008.04.066; Lambert R, 2009, GASTROINTEST ENDOSC, V70, P1182, DOI 10.1016/j.gie.2009.09.015; Katagiri A, 2008, ALIMENT PHARM THER, V27, P1269, DOI 10.1111/j.1365-2036.2008.03650.x; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Gschwantler M, 2002, EUR J GASTROEN HEPAT, V14, P183, DOI 10.1097/00042737-200202000-00013; Hasaan C, 2013, ENDOSCOPY, V45, P842; Hotta K, 2015, ENDOSCOPY SUPPL 1, V18, pE2, DOI [10.1055/s-0034-1377400, DOI 10.1055/S-0034-1377400]; Wachtel MS, 1990, JAMA-J AM MED ASSOC, V263, P275	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	OCT	2015	50	10					1017	1026		10.1007/s00535-015-1048-1		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS8JS	WOS:000362334100002		
J	Ninomiya, Y; Oka, S; Tanaka, S; Nishiyama, S; Tamaru, Y; Asayama, N; Shigita, K; Hayashi, N; Chayama, K				Ninomiya, Yuki; Oka, Shiro; Tanaka, Shinji; Nishiyama, Soki; Tamaru, Yuzuru; Asayama, Naoki; Shigita, Kenjiro; Hayashi, Nana; Chayama, Kazuaki			Risk of bleeding after endoscopic submucosal dissection for colorectal tumors in patients with continued use of low-dose aspirin	JOURNAL OF GASTROENTEROLOGY			English	Article						Colorectal tumor; ESD; Low-dose aspirin; Bleeding; Complication	MUCOSAL RESECTION; EPITHELIAL NEOPLASMS; LARGE SESSILE; POLYPECTOMY; LESIONS; METAANALYSIS; STRATEGY; OUTCOMES; THERAPY; DISEASE	Although Japanese guidelines proposed by the Japan Gastroenterological Endoscopy Society for endoscopic submucosal dissection (ESD) for colorectal tumors recommend continued use of low-dose aspirin (LDA), this strategy is controversial. It was our practice to interrupt LDA therapy 5-7 days before ESD until December 2010, when we instituted the new guidelines and performed ESD without interrupting LDA therapy. The aim of the present study was to confirm the validity of the noninterrupted use of LDA inpatients undergoing ESD for colorectal tumors. We studied 582 consecutive patients with 609 colorectal tumors who underwent ESD at Hiroshima University Hospital between January 2006 and July 2014. The patients comprised three groups: LDA-interrupted group (13 patients with 13 colorectal tumors), LDA-continued group (28 patients with 31 colorectal tumors), and no anticoagulant/antiplatelet group (541 patients with 565 colorectal tumors). The en bloc resection rate was 100 % (13/13) in the LDA-interrupted group and 90.3 % (28/31) in the LDA-continued group. Incidences of poor bleeding control during the procedure and bleeding after the procedure were 7.7 % (1/13) and 15.4 % (2/13) of patients, respectively, in the LDA-interrupted group, and 3.2 % (1/31) and 16.1 % (5/31) of patients, respectively, in the LDA-continued group. No patients experienced ischemic events in the perioperative period. Our data suggest that continued use of LDA increased the risk of bleeding after ESD for colorectal tumors compared with nonuse of anticoagulant/antiplatelets. No significant difference was seen between the LDA-continued group and the LDA-interrupted group.	[Ninomiya, Yuki; Oka, Shiro; Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Minami Ku, Hiroshima 7348551, Japan; [Nishiyama, Soki; Tamaru, Yuzuru; Asayama, Naoki; Shigita, Kenjiro; Hayashi, Nana; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, Hiroshima 7348551, Japan	Oka, S (reprint author), Hiroshima Univ Hosp, Dept Endoscopy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	oka4683@hiroshima-u.ac.jp					Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Higashiyama M, 2011, DIGEST ENDOSC, V23, P290, DOI 10.1111/j.1443-1661.2011.01151.x; Probst A, 2012, ENDOSCOPY, V44, P660, DOI 10.1055/s-0032-1309403; Manocha D, 2012, AM J MED, V125, P1222, DOI 10.1016/j.amjmed.2012.05.030; Liaquat H, 2013, GASTROINTEST ENDOSC, V77, P401, DOI 10.1016/j.gie.2012.10.024; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; Sanomura Y, 2014, GASTRIC CANCER, V17, P489, DOI 10.1007/s10120-013-0305-3; Metz AJ, 2011, ENDOSCOPY, V43, P506, DOI 10.1055/s-0030-1256346; Tanaka S, 2007, GASTROINTEST ENDOSC, V66, P100, DOI 10.1016/j.gie.2007.02.032; Kobayashi N, 2012, J GASTROEN HEPATOL, V27, P728, DOI 10.1111/j.1440-1746.2011.06942.x; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Watabe H, 2006, GASTROINTEST ENDOSC, V64, P73, DOI 10.1016/j.gie.2006.02.054; Matsumoto M, 2012, JPN J CLIN ONCOL, V42, P1028, DOI 10.1093/jjco/hys131; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; Tanaka S, 2013, DIGEST ENDOSC, V25, P107, DOI 10.1111/den.12016; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Anderson MA, 2009, GASTROINTEST ENDOSC, V70, P1060, DOI 10.1016/j.gie.2009.09.040; Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497; Yasue H, 1999, AM J CARDIOL, V83, P1308, DOI 10.1016/S0002-9149(99)00091-0; Tamegai Y, 2007, ENDOSCOPY, V39, P418, DOI 10.1055/s-2007-966427; Uraoka T, 2011, SURG ENDOSC, V25, P3000, DOI 10.1007/s00464-011-1660-y; Isomoto H, 2009, ENDOSCOPY, V41, P679, DOI 10.1055/s-0029-1214979; Terasaki M, 2014, INT J COLORECTAL DIS, V29, P877, DOI 10.1007/s00384-014-1901-3; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Tanaka S, 2012, DIGEST ENDOSC, V24, P73, DOI 10.1111/j.1443-1661.2012.01252.x; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Collins R, 2009, LANCET, V373, P1849; Fujita M, 2014, DIG ENDOSC; Hui AJ, 2004, GASTROINTEST ENDOSC, V59, P44, DOI 10.1016/S0016-5107(03)02307-1; Tajiri H, 2004, DIGEST ENDOSC, V16, P134; Tanaka S, 2010, DIGEST ENDOSC, V22, pS2, DOI 10.1111/j.1443-1661.2010.00952.x; Yahagi N, 2004, DIGEST ENDOSC, V16, pS178, DOI DOI 10.1111/J.1443-1661.2004.00440.X	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	OCT	2015	50	10					1041	1046		10.1007/s00535-015-1053-4		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS8JS	WOS:000362334100004		
J	Sakaida, I; Nakajima, K; Okita, K; Hori, M; Izumi, T; Sakurai, M; Shibasaki, Y; Tachikawa, S; Tsubouchi, H; Oka, H; Kobayashi, H				Sakaida, Isao; Nakajima, Koji; Okita, Kiwamu; Hori, Masatsugu; Izumi, Tohru; Sakurai, Masaya; Shibasaki, Yoshiyuki; Tachikawa, Sayaka; Tsubouchi, Hidetsugu; Oka, Hiromi; Kobayashi, Hiroyuki			Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan	JOURNAL OF GASTROENTEROLOGY			English	Article						Tolvaptan; Initial urine volume; Albumin; Diuretics; Liver cirrhosis	HEART-FAILURE; HEPATIC EDEMA; DIURETIC THERAPY; RENAL-FUNCTION; DOUBLE-BLIND; ASCITES; FUROSEMIDE; MULTICENTER; VASOPRESSIN; RESISTANCE	Patients with hypoalbuminemia often fail to respond to increased doses of loop diuretics. We therefore performed a post hoc analysis to investigate the pharmacological action of tolvaptan and whether it is dependent on the serum albumin level. This analysis was based on four previous clinical trials of tolvaptan in patients with liver cirrhosis who exhibited insufficient response to conventional diuretics. We analyzed the correlation between the change in the initial 24-h cumulative urine volume from baseline and the serum albumin level at baseline, and assessed potential predictive factors of response to tolvaptan. The correlation coefficient was 0.029 in the placebo group and -0.112 in the 7.5 mg tolvaptan group of patients with liver cirrhosis. Administration of tolvaptan provoked a stable response regardless of the serum albumin level. Tolvaptan use was identified as a significant predictor of pharmacological action, and was shown to change the initial urine volume by 885 mL (P < 0.0001) in liver cirrhosis patients. In this post hoc analysis, tolvaptan increased the initial urine volume from baseline regardless of serum albumin levels. Use of tolvaptan as an add-on therapy to loop diuretics can be considered an optimal therapeutic option in patients with insufficient response to loop diuretics.	[Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Minami Ku, Ube, Yamaguchi 7558505, Japan; [Nakajima, Koji; Sakurai, Masaya; Shibasaki, Yoshiyuki; Tachikawa, Sayaka; Tsubouchi, Hidetsugu; Oka, Hiromi; Kobayashi, Hiroyuki] Otsuka Pharmaceut Co Ltd, Dept Med Affairs, Tokyo, Japan; [Okita, Kiwamu] Shunan Mem Hosp, Kudamatsu, Yamaguchi, Japan; [Hori, Masatsugu] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Izumi, Tohru] Kitasato Univ, Sagamihara, Kanagawa 228, Japan; [Izumi, Tohru] Kojinkai Niigata Minami Hosp, Niigata, Japan	Nakajima, K (reprint author), Otsuka Pharmaceut Co Ltd, Dept Med Affairs, Tokyo, Japan.	sakaida@yamaguchi-u.ac.jp; nakajimak@otsuka.jp			Otsuka Pharmaceutical; Takeda Pharmaceutical; MSD; Chugai Pharmaceutical	Isao Sakaida is a consultant for Otsuka Pharmaceutical and received research Grants from Otsuka Pharmaceutical, Takeda Pharmaceutical, MSD, and Chugai Pharmaceutical. Kiwamu Okita is a consultant for Otsuka Pharmaceutical. Masatsugu Hori is a consultant for Otsuka Pharmaceutical. Tohru Izumi is a consultant for Otsuka Pharmaceutical. Koji Nakajima, Masaya Sakurai, Yoshiyuki Shibasaki, Sayaka Tachikawa, Hidetsugu Tsubouchi, Hiromi Oka, and Hiroyuki Kobayashi are employees of Otsuka Pharmaceutical.	Narahara Y, 2011, J GASTROENTEROL, V46, P78, DOI 10.1007/s00535-010-0282-9; FAUCHALD P, 1986, KIDNEY INT, V29, P895, DOI 10.1038/ki.1986.83; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Sakaida I, 2014, HEPATOL RES, V44, P735, DOI 10.1111/hepr.12171; Sakaida I, 2012, J INT MED RES, V40, P2381; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; Gentilini P, 1999, J HEPATOL, V30, P639, DOI 10.1016/S0168-8278(99)80194-9; Biecker E, 2011, WORLD J GASTROENTERO, V17, P1237, DOI 10.3748/wjg.v17.i10.1237; Costanzo MR, 2012, HEART FAIL REV, V17, P313, DOI 10.1007/s10741-011-9248-0; Tanzi M, 2003, AM J HEALTH-SYST PH, V60, P1330; Sakaida I, 2013, J INT MED RES, V41, P835, DOI 10.1177/0300060513480089; INOUE M, 1987, KIDNEY INT, V32, P198, DOI 10.1038/ki.1987.192; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Hasselblad V, 2007, EUR J HEART FAIL, V9, P1064, DOI 10.1016/j.ejheart.2007.07.011; Kitsios GD, 2014, J CRIT CARE, V29, P253, DOI 10.1016/j.jcrc.2013.10.004; Na KY, 2001, J KOREAN MED SCI, V16, P448; Kaur S, 2014, DEV WORLD BIOETH, V14, P20, DOI 10.1111/dewb.12004; Brater DC, 1998, NEW ENGL J MED, V339, P387; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Dharmaraj R, 2009, PEDIATR NEPHROL, V24, P775, DOI 10.1007/s00467-008-1062-0; Kinugawa K, 2014, CIRC J, V78, P844, DOI 10.1253/circj.CJ-14-0126; ANDERSON RJ, 1985, ANN INTERN MED, V102, P164; Kasahara A, 2008, J GASTROENTEROL, V43, P464, DOI 10.1007/s00535-008-2178-5; Barchel D, 2012, INT EMERG MED S3, V7, pS193; Phakdeekitcharoen B, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-92; Furukawa M, 2011, TOLVAPTAN CARDIOV S1, V25, pS83; Hori Masatsugu, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS1, DOI 10.1007/s10557-011-6298-4; Mehta A, 2011, INT J HEPATOL, DOI [10.4061/2011/790232, DOI 10.4061/2011/790232]; Okita K, 2014, HEPATOL RES, V44, P83, DOI 10.1111/hepr.12099; Pecron JM, 2005, AM J GASTROENTEROL, V100, P2702; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098	31	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	OCT	2015	50	10					1047	1053		10.1007/s00535-015-1052-5		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS8JS	WOS:000362334100005		
J	Tanabe, K; Taura, K; Koyama, Y; Yamamoto, G; Nishio, T; Okuda, Y; Nakamura, K; Toriguchi, K; Takemoto, K; Yamanaka, K; Iwaisako, K; Seo, S; Asagiri, M; Hatano, E; Uemoto, S				Tanabe, Kazutaka; Taura, Kojiro; Koyama, Yukinori; Yamamoto, Gen; Nishio, Takahiro; Okuda, Yukihiro; Nakamura, Kojiro; Toriguchi, Kan; Takemoto, Kenji; Yamanaka, Kenya; Iwaisako, Keiko; Seo, Satoru; Asagiri, Masataka; Hatano, Etsuro; Uemoto, Shinji			Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice	JOURNAL OF GASTROENTEROLOGY			English	Article						Splenectomy; Liver fibrosis; T helper lymphocyte	HEPATIC-FIBROSIS; B-CELLS; SPLENECTOMY; TACROLIMUS; MOUSE; RATS; CYCLOSPORINE; DEPOSITION; SIROLIMUS; CIRRHOSIS	Sustained liver injury causes liver fibrosis and eventually cirrhosis. Understanding the pathophysiological mechanisms of liver fibrosis and interventions in the fibrotic process is crucial for improving the prognosis of patients with chronic liver diseases. Although studies have shown that splenectomy suppresses liver fibrosis, the mechanism by which this occurs is poorly understood. The present study focuses on the immunological functions of the spleen to investigate its role in liver fibrosis. BALB/c and severe combined immunodeficiency (SCID) mice underwent splenectomies or sham operations prior to induction of liver fibrosis with carbon tetrachloride or thioacetamide. Sirius red staining and hydroxyproline assays showed that splenectomy suppressed liver fibrogenesis in BALB/c mice. Reverse transcription PCR analysis of T helper type 1 (Th1) and T helper type 2 (Th2) cytokines demonstrated that splenectomy shifted the Th1/Th2 balance in the liver towards Th1 dominance. In SCID mice, the inhibitory effect on liver fibrosis was abrogated. The number of CD4(+) T helper lymphocytes in the spleen decreased after liver injury. Green fluorescent protein positive (GFP(+)) splenocytes were transplanted into the spleens of syngeneic wild-type mice to trace their destination after fibrosis induction. GFP(+)CD4(+) lymphocytes appeared in the liver after induction of fibrosis, and flow cytometry revealed the vast majority of them were Th2 lymphocytes. Transfer of splenocytes via the portal vein into syngeneic splenectomized mice cancelled the suppressive effect of splenectomy on liver fibrosis. The present study demonstrated that Th2-dominant splenic lymphocytes migrate into the liver and promote liver fibrosis by shifting the cytokine balance towards Th2 dominance. Splenectomy suppresses the progression of fibrosis at least partly by restoring the Th1/Th2 balance.	[Tanabe, Kazutaka; Taura, Kojiro; Koyama, Yukinori; Yamamoto, Gen; Nishio, Takahiro; Okuda, Yukihiro; Nakamura, Kojiro; Toriguchi, Kan; Takemoto, Kenji; Yamanaka, Kenya; Seo, Satoru; Hatano, Etsuro; Uemoto, Shinji] Kyoto Univ, Dept Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Iwaisako, Keiko] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Sakyo Ku, Kyoto 6068507, Japan; [Asagiri, Masataka] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat & Therapeut, Sakyo Ku, Kyoto 6068501, Japan	Taura, K (reprint author), Kyoto Univ, Dept Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	tanabe75@kuhp.kyoto-u.ac.jp; ktaura@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [23390322]	This work was supported by a grant from the Japan Society for the Promotion of Science: Grant-in-Aid for Scientific Research (B), no. 23390322.	Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Roh YS, 2015, DIGEST DIS SCI, V60, P2009, DOI 10.1007/s10620-014-3438-2; Farah IO, 2000, J IMMUNOL, V164, P5337; Subra JF, 2001, J IMMUNOL, V166, P2944; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Murata K, 2008, HEPATO-GASTROENTEROL, V55, P1407; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; NISHIMURA H, 1992, INT IMMUNOL, V4, P923, DOI 10.1093/intimm/4.8.923; Watanabe M, 2009, J GASTROEN HEPATOL, V24, P78, DOI 10.1111/j.1440-1746.2008.05497.x; Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040; van der Laan LJW, 2010, TRANSPL P, V42, P4573, DOI 10.1016/j.transproceed.2010.10.013; CHAIGNAUD BE, 1994, AM SURGEON, V60, P7; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; VIERUCCI A, 1977, ANN SCLAVO, V19, P1119; Katz SC, 2011, J IMMUNOL, V187, P1150, DOI 10.4049/jimmunol.1004077; Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065; Imura S, 2010, HEPATOL RES, V40, P894, DOI 10.1111/j.1872-034X.2010.00688.x; Arias-Diaz J, 2009, LAB INVEST, V89, P433, DOI 10.1038/labinvest.2009.3; Akahoshi T, 2002, J GASTROEN HEPATOL, V17, P59, DOI 10.1046/j.1440-1746.2002.02667.x; Baroni GS, 1996, HEPATOLOGY, V23, P1189; CZAJA MJ, 1989, HEPATOLOGY, V10, P795, DOI 10.1002/hep.1840100508; Sugawara Y, 2000, J AM COLL SURGEONS, V190, P446, DOI 10.1016/S1072-7515(99)00294-X; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; VITETTA ES, 1984, IMMUNOL REV, V78, P137, DOI 10.1111/j.1600-065X.1984.tb00480.x; Kodama Takahiro, 2010, Gastroenterology, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; Li H, 1992, J Tongji Med Univ, V12, P164	32	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	OCT	2015	50	10					1054	1068		10.1007/s00535-015-1054-3		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS8JS	WOS:000362334100006		
J	Hiramine, S; Sugiyama, M; Furusyo, N; Uto, H; Ido, A; Tsubouchi, H; Watanabe, H; Ueno, Y; Korenaga, M; Murata, K; Masaki, N; Hayashi, J; Thomas, DL; Mizokami, M				Hiramine, Satoshi; Sugiyama, Masaya; Furusyo, Norihiro; Uto, Hirofumi; Ido, Akio; Tsubouchi, Hirohito; Watanabe, Hisayoshi; Ueno, Yoshiyuki; Korenaga, Masaaki; Murata, Kazumoto; Masaki, Naohiko; Hayashi, Jun; Thomas, David L.; Mizokami, Masashi			A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus	JOURNAL OF GASTROENTEROLOGY			English	Article						Genetic marker; Microsatellite; Interferon lambda 3	INTERFERON-ALPHA-2B PLUS RIBAVIRIN; SPONTANEOUS ELIMINATION; GILBERTS-SYNDROME; GENETIC-VARIATION; NATURAL-HISTORY; INFECTION; COMBINATION; VARIANTS; PROMOTER; THERAPY	Genome-wide association studies have revealed several single-nucleotide polymorphisms around interleukin 28B (IL28B) that are strongly associated with hepatitis C virus (HCV) clearance. However, their predictive value is not perfect, which suggests that other genetic factors may also be involved in HCV clearance. We previously reported a wide variation in the length of a thymine-adenine (TA) dinucleotide repeat in the promoter region of IL28B and that the transcriptional activity of the promoter increased gradually in a TA repeat length-dependent manner. We determined the length of the TA repeats of 1,060 Japanese and 201 African-American samples to investigate the relation to spontaneous HCV clearance. The distribution of the TA repeats greatly differed between the two ethnicities. The variation ranged from 10 to 18 repeats, and the most frequent allele, 12, accounted for over 80 % for Japanese. The African-American data showed a gently sloping distribution, and the allele with six repeats was detected only in the African-American sample. The TA repeats 11 or greater were correlated with spontaneous clearance. Multiple logistic regression analysis extracted the genotype of the TA repeats as an independent factor in both the Japanese [p = 0.0004, odds ratio (OR) = 13.02 95 % confidence interval (CI) = 2.59-237.0] and African-American (p = 0.027, OR = 3.70 95 % CI = 1.16-11.8) populations. A long TA repeat in the promoter region of IL28B was associated with spontaneous HCV clearance. Although its efficacy may be limited in Japanese population because of its allele distribution, this novel genetic factor will be useful for predicting HCV clearance especially for the African Americans.	[Hiramine, Satoshi; Sugiyama, Masaya; Korenaga, Masaaki; Murata, Kazumoto; Masaki, Naohiko; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Dept Hepat Dis, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan; [Hiramine, Satoshi; Furusyo, Norihiro; Hayashi, Jun] Kyushu Univ Hosp, Gen Internal Med Dept, Fukuoka 8128582, Japan; [Uto, Hirofumi; Ido, Akio; Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 8908544, Japan; [Watanabe, Hisayoshi; Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 9909585, Japan; [Thomas, David L.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Mizokami, M (reprint author), Natl Ctr Global Hlth & Med, Dept Hepat Dis, Res Ctr Hepatitis & Immunol, 1-7-1 Kohonodi, Ichikawa, Chiba 2728516, Japan.	mmizokami@hospk.ncgm.go.jp			National Center for Global Health and Medicine of Japan [22-108, 25-202]; Japanese Ministry of Health, Labor and Welfare [H23-007]; Japanese Ministry of Education, Culture, Sports, and Science [22590750]	This work was supported by grants from the National Center for Global Health and Medicine of Japan (22-108, 25-202), from the Japanese Ministry of Health, Labor and Welfare (H23-007), and from the Japanese Ministry of Education, Culture, Sports, and Science (No. 22590750). We are also grateful to all the technical staffs of Department of Hepatic Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine for their excellent lab works on genotyping the SNPs of IL28B and TA repeat.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Kishihara Y, 2001, J INFECT DIS, V184, P1114, DOI 10.1086/323890; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Horsfall LJ, 2011, ANN HUM GENET, V75, P236, DOI 10.1111/j.1469-1809.2010.00638.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Lyamichev VI, 2000, BIOCHEMISTRY-US, V39, P9523, DOI 10.1021/bi0007829; Uto H, 2009, HEPATOLOGY, V50, P393, DOI 10.1002/hep.23002; Raijmakers MTM, 2000, J HEPATOL, V33, P348, DOI 10.1016/S0168-8278(00)80268-8; Kim WR, 2002, MICROBES INFECT, V4, P1219; Watanabe H, 2003, J MED VIROL, V71, P56, DOI 10.1002/jmv.10448; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Tanaka Y, 2010, HEPATOL RES, V40, P449, DOI 10.1111/j.1872-034X.2010.00671.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uto H, 2006, HEPATOL RES, V34, P28, DOI 10.1016/j.hepres.2005.10.004; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Furusyo N, 2008, J GASTROEN HEPATOL, V23, P1094, DOI 10.1111/j.1440-1746.2008.05319.x; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Borlak J, 2000, HEPATOLOGY, V32, P792, DOI 10.1053/jhep.2000.18193; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Seeff LB, 2000, ANN INTERN MED, V132, P105; Lankisch TO, 2008, CANCER EPIDEM BIOMAR, V17, P695, DOI [10.1158/1055-9965.EPI-07-2517, 10.1138/1055-9965.EPI-07-2517]; Lyamichev V, 1999, NAT BIOTECHNOL, V17, P292; Ishibashi M, 1996, J Epidemiol, V6, P1; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Vlahov D, 1991, NIDA Res Monogr, V109, P75	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	OCT	2015	50	10					1069	1077		10.1007/s00535-015-1056-1		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS8JS	WOS:000362334100007		
J	Joshanloo, M; Weijers, D; Jiang, DY; Han, G; Bae, J; Pang, JS; Ho, LS; Ferreira, MC; Demir, M; Rizwan, M; Khilji, IA; Achoui, M; Asano, R; Igarashi, T; Tsukamoto, S; Lamers, SMA; Turan, Y; Sundaram, S; Yeung, VWL; Poon, WC; Lepshokova, ZK; Panyusheva, T; Natalia, A				Joshanloo, Mohsen; Weijers, Dan; Jiang, Ding-Yu; Han, Gyuseog; Bae, Jaechang; Pang, Joyce S.; Ho, Lok Sang; Ferreira, Maria Cristina; Demir, Meliksah; Rizwan, Muhammad; Khilji, Imran Ahmed; Achoui, Mustapha; Asano, Ryosuke; Igarashi, Tasuku; Tsukamoto, Saori; Lamers, Sanne M. A.; Turan, Yucel; Sundaram, Suresh; Yeung, Victoria Wai Lan; Poon, Wai-Ching; Lepshokova, Zarina Kh.; Panyusheva, Tatiana; Natalia, Amerkhanova			Fragility of Happiness Beliefs Across 15 National Groups	JOURNAL OF HAPPINESS STUDIES			English	Article						Fragility of happiness; Happiness; Well-being; Culture; Fear of happiness	WELL-BEING RESEARCH; MEASUREMENT INVARIANCE; LIFE SATISFACTION; SOCIAL AXIOMS; MENTAL-HEALTH; PERSPECTIVE; SCALE; CULTURES; INDIVIDUALISM; LEVEL	The belief that happiness is fragile-that it is fleeting and may easily turn into less favourable states-is common across individuals and cultures. However, not much is known about this belief domain and its structure and correlates. In the present study, we use multigroup confirmatory factor analysis and multilevel modelling to investigate the measurement invariance, cross-level isomorphism, predictive validity, and nomological network of the fragility of happiness scale across 15 nations. The results show that this scale has good statistical properties at both individual and cultural levels, and is associated with relevant psycho-social concepts in expected directions. The importance of the results, limitations, and potential directions for future research are discussed.	[Joshanloo, Mohsen] Chungbuk Natl Univ, Dept Psychol, Cheongju 361763, Chungbuk, South Korea; [Weijers, Dan] Victoria Univ Wellington, Wellington, New Zealand; [Jiang, Ding-Yu] Natl Chung Cheng Univ, Chiayi, Taiwan; [Han, Gyuseog; Bae, Jaechang] Chonnam Natl Univ, Gwangju, South Korea; [Pang, Joyce S.] Nanyang Technol Univ, Singapore 639798, Singapore; [Ho, Lok Sang; Yeung, Victoria Wai Lan] Lingnan Univ, Hong Kong, Hong Kong, Peoples R China; [Ferreira, Maria Cristina] Univ Salgado de Oliveira, Rio De Janeiro, Brazil; [Demir, Meliksah] No Arizona Univ, Flagstaff, AZ 86011 USA; [Rizwan, Muhammad; Khilji, Imran Ahmed] Univ Karachi, Karachi, Pakistan; [Achoui, Mustapha] Arab Open Univ, Kuwait, Kuwait; [Asano, Ryosuke; Igarashi, Tasuku; Tsukamoto, Saori] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Lamers, Sanne M. A.; Turan, Yucel] Univ Twente, NL-7500 AE Enschede, Netherlands; [Sundaram, Suresh] Annamalai Univ, Annamalainagar 608002, Tamil Nadu, India; [Poon, Wai-Ching] Monash Univ, Selangor, Malaysia; [Lepshokova, Zarina Kh.; Panyusheva, Tatiana; Natalia, Amerkhanova] Natl Res Univ, Higher Sch Econ, Moscow, Russia	Joshanloo, M (reprint author), Chungbuk Natl Univ, Dept Psychol, Cheongju 361763, Chungbuk, South Korea.	mjoshanloo@hotmail.com		Weijers, Dan/0000-0001-7685-5935; Joshanloo, Mohsen/0000-0001-9350-6219			Adamopoulos J., 2008, MULTILEVEL ANAL INDI, P27; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Busseri MA, 2011, PERS SOC PSYCHOL REV, V15, P290, DOI 10.1177/1088868310391271; Charry ET, 2011, THEOL TODAY, V68, P238, DOI 10.1177/0040573611416701; Torsheim T, 2012, SOC INDIC RES, V105, P145, DOI 10.1007/s11205-010-9770-9; Wierzbicka A, 2004, DAEDALUS-US, V133, P34, DOI 10.1162/001152604323049370; Diener E, 2011, J PERS SOC PSYCHOL, V101, P1278, DOI 10.1037/a0024402; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Oishi S, 2013, PERS SOC PSYCHOL B, V39, P559, DOI 10.1177/0146167213480042; Robitschek C, 1998, MEAS EVAL COUNS DEV, V30, P183; Joshanloo M, 2014, J HAPPINESS STUD, V15, P717, DOI 10.1007/s10902-013-9489-9; Suh EM, 2007, J PERS, V75, P1321, DOI 10.1111/j.1467-6494.2007.00477.x; Peng K, 2006, LECT NOTES COMPUT SC, V4058, P247, DOI 10.1007/0-387-28662-4_11; Chen YH, 2006, INT CUL PSY, P91; Diener E, 2013, PERSPECT PSYCHOL SCI, V8, P663, DOI 10.1177/1745691613507583; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Bond MH, 2004, J CROSS CULT PSYCHOL, V35, P548, DOI 10.1177/0022022104268388; Labroo AA, 2009, J CONSUM RES, V36, P242, DOI 10.1086/597159; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; Ji LJ, 2001, PSYCHOL SCI, V12, P450, DOI 10.1111/1467-9280.00384; Davidov E, 2008, PUBLIC OPIN QUART, V72, P420, DOI 10.1093/poq/nfn035; Joshanloo M, 2013, PERS INDIV DIFFER, V54, P647, DOI 10.1016/j.paid.2012.11.011; Kjell ONE, 2011, REV GEN PSYCHOL, V15, P255, DOI 10.1037/a0024603; SMITH PB, 1995, INT J PSYCHOL, V30, P377, DOI 10.1080/00207599508246576; Hamamura T, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P557; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Lu L, 2006, ASIAN J SOC PSYCHOL, V9, P36, DOI 10.1111/j.1367-2223.2006.00183.x; Leung K, 2004, ADV EXP SOC PSYCHOL, V36, P119, DOI 10.1016/S0065-2601(04)36003-X; Robitschek C, 2009, J COUNS PSYCHOL, V56, P321, DOI 10.1037/a0013954; Schwartz SH, 2009, UNDERSTANDING CULTURE: THEORY, RESEARCH, AND APPLICATION, P127; Chiasson N, 1996, J CROSS CULT PSYCHOL, V27, P673, DOI 10.1177/0022022196276002; Suh E, 1998, J PERS SOC PSYCHOL, V74, P482, DOI 10.1037/0022-3514.74.2.482; Dambrun M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00016; Vemuri AW, 2006, ECOL ECON, V58, P119, DOI 10.1016/j.ecolecon.2005.02.008; Tay L, 2011, J PERS SOC PSYCHOL, V101, P354, DOI 10.1037/a0023779; Owe E, 2013, J CROSS CULT PSYCHOL, V44, P24, DOI 10.1177/0022022111430255; Chen FF, 2008, J PERS SOC PSYCHOL, V95, P1005, DOI 10.1037/a0013193; Schmitt N, 2008, HUM RESOUR MANAGE R, V18, P210, DOI 10.1016/j.hrmr.2008.03.003; Spector PE, 2001, J ORGAN BEHAV, V22, P815, DOI 10.1002/job.118; Joshanloo M, 2014, J HAPPINESS STUD, V15, P475, DOI 10.1007/s10902-013-9431-1; Becker D, 2008, THEOR PSYCHOL, V18, P591, DOI 10.1177/0959354308093397; Belliotti R. A., 2004, HAPPINESS IS OVERRAT; Bryk A. S., 1992, HIERARCHICAL LINEAR; Central Intelligence Agency, 2012, WORLD FACTB; De Beuckelaer A., 2011, METHODS APPL CROSS C, P117; Delle Fave A., 2011, SOCIAL INDICATORS RE, V100, P158; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037//0022-3514.69.5.851; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2013, MENTAL WELL BEING, P153; Fontaine J. R., 2008, INDIVIDUALS CULTURES, P65; Heine S. J., 2007, HDB CULTURAL PSYCHOL, P714; Hofstede G., 2005, CULTURES ORG SOFTWAR; Inglehart R., 2010, INT DIFFERENCES WELL, P351, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0012; ISEN AM, 1983, SOC COGNITION, V2, P18, DOI 10.1521/soco.1983.2.1.18; Izutsu T., 1971, CONCEPT REALITY EXIS; Joshanloo M., 2013, THESIS VICTORIA U WE; Joshanloo M, 2014, J CROSS CULT PSYCHOL, V45, P246, DOI 10.1177/0022022113505357; Kwee M. G., 2012, HUMAN QUEST MEANING, P249; Legatum Institute, 2012, 2012 LEG PROSP IND M; Leung K., 2008, INDIVIDUALS CULTURES, P197; Lu Luo, 2004, J HAPPINESS STUD, V5, P269, DOI DOI 10.1007/S10902-004-8789-5; Lu Luo, 2001, UNDERSTANDING HAPPIN, V2, P407; Lvina E., 2012, INT J CROSS CULTURAL, V12, P171; Lyubomirsky S., 2000, ANN M SOC EXP PSYCH; McCrae R. R., 2003, PERSONALITY ADULTHOO; McMahon D. M., 2008, SCI SUBJECTIVE WELL, P80; McMahon D. M., 2006, HAPPINESS HIST; Menon U., 2013, PSYCHOL DEV SOC, V25, P195; Misra G., 2009, PSYCHOL STUD, V54, P85; Nezlek J. B., 2011, MULTILEVEL MODELING; Oishi S., 2012, PSYCHOL WEALTH NATIO; Oishi S., 2010, INT DIFFERENCES WELL, P34, DOI DOI 10.1093/ACPROF:OSO/9780199732739.003.0003; Omura E., 2006, SOCIOLOGY HAPPINESS, P146; Rothbaum F., 1982, J PERS SOC PSYCHOL, V43, P5, DOI DOI 10.1037//0022-3514.42.1.5; Schimmack U., 2008, SCI SUBJECTIVE WELL, P97; Selig J. P., 2008, MULTILEVEL ANAL INDI, P93; Sheldon K. M., 2006, J HAPPINESS STUD, V7, P55, DOI DOI 10.1007/S10902-005-0868-8; Sortheix FM, 2014, J CROSS CULT PSYCHOL, V45, P282, DOI 10.1177/0022022113504621; Steinmetz H., 2011, CROSS CULTURAL ANAL, P85; Strawn B. A., 2012, BIBLE PURSUIT HAPPIN; Tatarkiewicz Wladyslaw, 1976, ANAL HAPPINESS; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tov W., 2008, COOPERATION POLITICA, P323; UNDP, 2012, UN DEV PROGR HUM DEV; Veenhoven R., 2013, WORLD DATABASE HAPPI	86	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-4978	1573-7780		J HAPPINESS STUD	J. Happiness Stud.	OCT	2015	16	5					1185	1210		10.1007/s10902-014-9553-0		26	Psychology, Multidisciplinary; Social Sciences, Interdisciplinary	Psychology; Social Sciences - Other Topics	CS8LS	WOS:000362339700006		
J	Hidaka, Y; Lin, S; Pisarski, RD; Satow, D				Hidaka, Yoshimasa; Lin, Shu; Pisarski, Robert D.; Satow, Daisuke			Dilepton and photon production in the presence of a nontrivial Polyakov loop	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						QCD Phenomenology; Heavy Ion Phenomenology	QUARK-GLUON PLASMA; HEAVY-ION COLLISIONS; THERMAL PHOTONS; QCD; PHASE; THERMODYNAMICS; CONFINEMENT; TRANSITION; DYNAMICS; EQUATION	We calculate the production of dileptons and photons in the presence of a nontrivial Polyakov loop in QCD. This is applicable to the semi-Quark Gluon Plasma (QGP), at temperatures above but near the critical temperature for deconfinement. The Polyakov loop is small in the semi-QGP, and near unity in the perturbative QGP. Working to leading order in the coupling constant of QCD, we find that there is a mild enhancement, similar to 20%, for dilepton production in the semi-QGP over that in the perturbative QGP. In contrast, we find that photon production is strongly suppressed in the semi-QGP, by about an order of magnitude, relative to the perturbative QGP. In the perturbative QGP photon production contains contributions from 2 -> 2 scattering and collinear emission with the Landau-Pomeranchuk-Migdal (LPM) effect. In the semi-QGP we show that the two contributions are modified differently. The rate for 2 -> 2 scattering is suppressed by a factor which depends upon the Polyakov loop. In contrast, in an SU(N) gauge theory the collinear rate is suppressed by 1/N, so that the LPM effect vanishes at N = infinity. To leading order in the semi-QGP at large N, we compute the rate from 2 -> 2 scattering to the leading logarithmic order and the collinear rate to leading order.	[Hidaka, Yoshimasa] RIKEN, Nishina Ctr, Theoret Res Div, Wako, Saitama 3510198, Japan; [Lin, Shu; Pisarski, Robert D.] Brookhaven Natl Lab, RIKEN BNL Res Ctr, Upton, NY 11973 USA; [Pisarski, Robert D.] Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; [Satow, Daisuke] European Ctr Theoret Studies Nucl Phys & Related, I-38123 Villazzano, TN, Italy; [Satow, Daisuke] Fdn Bruno Kessler, I-38123 Villazzano, TN, Italy	Hidaka, Y (reprint author), RIKEN, Nishina Ctr, Theoret Res Div, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hidaka@riken.jp; slin@quark.phy.bnl.gov; pisarski@bnl.gov; daisuke.sato@riken.jp			JSPS KAKENHI [24740184]; RIKEN iTHES Project; RIKEN Foreign Postdoctoral Researchers Program; DOE Contract [DE-SC0012704]; RIKEN/BNL Research Center; JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation [R2411]	R.D.P. would like to thank C. Islam, S. Majumder, N. Hague, and M. Mustafa for discussions about their work on dilepton production in the PNJL model [99] in Mumbai, at the workshop "QCD at high density", and in Kolkata, at the "7th International Conference on Physics and Astrophysics of the Quark-Gluon Plasma". 2 S.L. would like to thank B. Wu and L. Yaffe for useful discussions. Y.H. is supported by JSPS KAKENHI (Grants No. 24740184), and by the RIKEN iTHES Project. S.L. is supported by the RIKEN Foreign Postdoctoral Researchers Program. R.D.P. is supported by DOE Contract DE-SC0012704 and by the RIKEN/BNL Research Center. D.S. is supported by JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (No. R2411).	Adare A., 2012, PHYS REV LETT, V109; Fischer CS, 2014, PHYS LETT B, V732, P273, DOI 10.1016/j.physletb.2014.03.057; Huovinen P, 2010, NUCL PHYS A, V837, P26, DOI 10.1016/j.nuclphysa.2010.02.015; Herbst TK, 2011, PHYS LETT B, V696, P58, DOI 10.1016/j.physletb.2010.12.003; McLerran L, 2014, NUCL PHYS A, V929, P71, DOI 10.1016/j.nuclphysa.2014.06.004; Haas M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.091501; Hohler PM, 2014, PHYS LETT B, V731, P103, DOI 10.1016/j.physletb.2014.02.021; Lee CH, 1999, PHYS LETT B, V448, P168, DOI 10.1016/S0370-2693(99)00061-1; Dumitru A, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.065008; Reinosa U, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.025021; Hidaka Y, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.071501; Kashiwa K, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.096009; Aurenche P, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/05/043; Aurenche P, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.085003; Monnai A, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.021901; Basar G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.202303; Cassing W, 2009, NUCL PHYS A, V831, P215, DOI 10.1016/j.nuclphysa.2009.09.007; Kashiwa K, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.114029; Braun J, 2010, EUR PHYS J C, V70, P689, DOI 10.1140/epjc/s10052-010-1485-1; Fukushima K, 2004, PHYS LETT B, V591, P277, DOI 10.1016/j.physletb.2004.04.027; GAVA E, 1981, PHYS LETT B, V105, P285, DOI 10.1016/0370-2693(81)90890-X; Parnachev A, 2007, NUCL PHYS B, V768, P177, DOI 10.1016/j.nuclphysb.2007.01.015; Dumitru A, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.034022; Heinz U, 2013, ANNU REV NUCL PART S, V63, P123, DOI 10.1146/annurev-nucl-102212-170540; Dumitru A, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.105017; Pisarski RD, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.121703; Herbst TK, 2014, PHYS LETT B, V731, P248, DOI 10.1016/j.physletb.2014.02.045; Ozvenchuk V, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.024901; Hidaka Y, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.076002; Hidaka Y, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.036004; Satow D, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.056001; Linnyk O, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014905; Rapp R, 2013, ADV HIGH ENERGY PHYS, DOI 10.1155/2013/148253; Cassing W, 2007, NUCL PHYS A, V791, P365, DOI 10.1016/j.nuclphysa.2007.04.015; Dion M, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.064901; Dusling K, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.024908; Reinosa U, 2015, PHYS LETT B, V742, P61, DOI 10.1016/j.physletb.2015.01.006; BRAATEN E, 1990, PHYS REV LETT, V64, P2242, DOI 10.1103/PhysRevLett.64.2242; Andronic A, 2012, PHYS LETT B, V718, P80, DOI 10.1016/j.physletb.2012.10.001; Braun J, 2010, PHYS LETT B, V684, P262, DOI 10.1016/j.physletb.2010.01.009; KAPUSTA J, 1993, PHYS REV D, V47, P4171, DOI 10.1103/PhysRevD.47.4171; Herbst TK, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.014007; Petreczky P, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/9/093002; Bratkovskaya EL, 2011, NUCL PHYS A, V856, P162, DOI 10.1016/j.nuclphysa.2011.03.003; Chatterjee R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.202302; Cassing W, 2007, NUCL PHYS A, V795, P70, DOI 10.1016/j.nuclphysa.2007.08.010; Peshier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.172301; Baym G, 2007, PHYS LETT B, V644, P48, DOI 10.1016/j.physletb.2006.11.011; Borsanyi S, 2014, PHYS LETT B, V730, P99, DOI 10.1016/j.physletb.2014.01.007; Bratkovskaya EL, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.034905; Hidaka Y, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.074504; Wang EK, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.025008; Lin S, 2014, PHYS LETT B, V730, P236, DOI 10.1016/j.physletb.2014.01.043; Blaizot JP, 2002, PHYS REP, V359, P355, DOI 10.1016/S0370-1573(01)00061-8; Fukushima K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.071501; Schenke B, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.014903; KAPUSTA J, 1991, PHYS REV D, V44, P2774, DOI 10.1103/PhysRevD.44.2774; van Hees H, 2015, NUCL PHYS A, V933, P256, DOI 10.1016/j.nuclphysa.2014.09.009; Gale C, 2013, INT J MOD PHYS A, V28, DOI 10.1142/S0217751X13400113; DeTar CE, 2009, EUR PHYS J A, V41, P405, DOI 10.1140/epja/i2009-10825-3; Lee CH, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.025204; Fister L, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.045010; Dusling K, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.054909; Bzdak A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.192301; Linnyk O, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024910; Basar G, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.014905; Lin S, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.105002; Dusling K, 2009, NUCL PHYS A, V825, P212, DOI 10.1016/j.nuclphysa.2009.04.013; Brambilla N, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074019; Linnyk O, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034908; Aurenche P, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.096012; Arnold P, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/11/057; Arnold P. B., 2002, JHEP, V0206, P30; Arnold P, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/12/009; BAIER R, 1992, Z PHYS C PART FIELDS, V53, P433, DOI 10.1007/BF01625902; Bazavov A, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.014504; Bhattacharya T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.082001; Braun J., ARXIV14121045; Braun J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.022002; Burnier Y, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2010)054; Burnier Y., 2013, JHEP, V1301, P180; Caron-Huot S., 2006, JHEP, V12, P015; Fodor Z., ARXIV09083341; Gale C, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.072301; Ghiglieri J, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2014)029; Ghiglieri J, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2013)010; Ghosh SK, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.054030; Hansen H, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.065004; Haque N, 2014, J HIGH ENERGY PHYS, P1, DOI 10.1007/JHEP05(2014)027; Heinz U., 2010, RELATIVISTIC HEAVY I, V23, P240, DOI 10.1007/978-3-642-01539-7_9; Islam CA, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2015)011; Le Bellac M., 1996, THERMAL FIELD THEORY; Linnyk O, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.034904; Liu FM, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034906; Lohner D, 2013, J PHYS CONF SER, V446, DOI 10.1088/1742-6596/446/1/012028; Mamo KA, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2013)083; Manninen J, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1615-4; Marhauser F., ARXIV08121144; Mitter M, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.054035; Muller B, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.026013; Atmaja AN, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2010)124; Reinosa U, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.045035; Schenke B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.042301; Sharma S., 2013, ADV HIGH ENERGY PHYS, V2013; Shen C, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.044910; Shen C, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.024908; Shifman M. A., HEPPH0009131; Staig P., ARXIV10053531; van Hees H, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054906; Vujanovic G, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.034904	110	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	OCT 1	2015		10							005	10.1007/JHEP10(2015)005		57	Physics, Particles & Fields	Physics	CS7OD	WOS:000362272000004		
J	Mahmud, MR; Matsuyama, H; Hosaka, T; Numata, S; Hashim, M				Mahmud, M. Rizaludin; Matsuyama, Hiroshi; Hosaka, Tetsuro; Numata, Shinya; Hashim, Mazlan			Temporal Downscaling of TRMM Rain-Rate Images Using Principal Component Analysis during Heavy Tropical Thunderstorm Seasons	JOURNAL OF HYDROMETEOROLOGY			English	Article						Rainfall; Thunderstorms; Hydrology; Remote sensing; Principal components analysis; Tropical variability	PRECIPITATION ANALYSIS TMPA; PENINSULAR MALAYSIA; PRODUCTS; BASIN; INTENSITY; RADAR; CYCLE	This paper examines the utility of principal component analysis (PCA) in obtaining accurate daily rainfall estimates from 3-hourly Tropical Rainfall Measuring Mission (TRMM) satellite data during heavy precipitation in a humid tropical environment. A large bias during heavy thunderstorms in humid tropical catchments is indicated by the TRMM satellite and is of profound concern because it is a conspicuous constraint for practical hydrology applications and requires proper treatment, particularly in areas with sparse rain gauges. The common procedure of calculating daily rainfall estimates by direct accumulation (DA) of a series of 3-hourly rainfall estimates caused a large bias because of temporal uncertainties, upscaling effects, and different mechanisms. In this study, PCA was used to transform correlated 3-hourly rain-rate images into a minimum effective principal component and to compute the corresponding rain-rate proportion based on correlation strength. This study was conducted on 91 rainy days of various intensity, acquired from three different years, during the wettest season on the eastern coast of peninsular Malaysia. Results showed that PCA reduced the bias and daily root-mean-square error by an average of 62% and 22%, respectively, compared with the DA approach. The PCA transformation was able to produce more precise daily rainfall estimates compared to the DA approach without the use of any rain gauge references. However, the performance was varied by the threshold selection and rainfall intensity. The results of this study indicate that PCA can be a useful tool in effective temporal downscaling of TRMM satellite data during heavy thunderstorm seasons in areas where rain gauges are sparse and satellite data are pivotal as a secondary source of rainfall data.	[Mahmud, M. Rizaludin; Matsuyama, Hiroshi; Hosaka, Tetsuro; Numata, Shinya] Tokyo Metropolitan Univ, Fac Urban Environm Sci, Hachioji, Tokyo 1920397, Japan; [Hashim, Mazlan] Univ Teknol Malaysia, Geosci & Digital Earth Ctr, Res Inst Sustainabil & Environm, Johor Baharu, Malaysia	Mahmud, MR (reprint author), Tokyo Metropolitan Univ, Fac Urban Environm Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	rizal.mahmud@gmail.com			Tokyo Metropolitan Government	The authors would like to express their unending gratitude to the Tokyo Metropolitan Government for their support through the Asian Human Resources Doctoral Fellowship Program which made this research possible. Other significant thanks go to the Department of Irrigation and Drainage Malaysia, the National Aeronautics and Space Administration (NASA), and the Technology University of Malaysia (UTM) for their support in contributing enormous amounts of data for this research.	Chokngamwong R, 2008, J HYDROMETEOROL, V9, P256, DOI 10.1175/2007JHM876.1; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Su FG, 2008, J HYDROMETEOROL, V9, P622, DOI 10.1175/2007JHM944.1; Prasetia R, 2013, THEOR APPL CLIMATOL, V112, P575, DOI 10.1007/s00704-012-0756-1; Demsar U, 2013, ANN ASSOC AM GEOGR, V103, P106, DOI 10.1080/00045608.2012.689236; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Ryo M, 2014, J HYDROMETEOROL, V15, P563, DOI 10.1175/JHM-D-13-052.1; Tao K, 2010, J ATMOS OCEAN TECH, V27, P409, DOI 10.1175/2009JTECHA1219.1; Mair A, 2011, J HYDROL ENG, V16, P371, DOI 10.1061/(ASCE)HE.1943-5584.0000330; Collischonn B, 2008, J HYDROL, V360, P207, DOI 10.1016/j.jhydrol.2008.07.032; Varikoden H, 2010, J HYDROL, V387, P312, DOI 10.1016/j.jhydrol.2010.04.023; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Berne A, 2013, ADV WATER RESOUR, V51, P357, DOI 10.1016/j.advwatres.2012.05.005; Rogge D, 2014, INT J APPL EARTH OBS, V26, P387, DOI 10.1016/j.jag.2013.09.007; Varikoden H, 2011, J HYDROL, V404, P99, DOI 10.1016/j.jhydrol.2011.04.021; Semire FA, 2012, ADV SPACE RES, V50, P1241, DOI 10.1016/j.asr.2012.06.031; Mahmud MR, 2015, REMOTE SENS-BASEL, V7, P4092, DOI 10.3390/rs70404092; Omotosho TV, 2013, ANN GEOPHYS-GERMANY, V31, P2013, DOI 10.5194/angeo-31-2013-2013; Pan M, 2008, REMOTE SENS ENVIRON, V112, P1282, DOI 10.1016/j.rse.2007.02.039; OKI T, 1994, J APPL METEOROL, V33, P1445, DOI 10.1175/1520-0450(1994)033<1445:SCOTDC>2.0.CO;2; Cheang B. K., 1980, RES PUBL MALAYSIAN M, V2; DID, 2009, 1000014156 DID; DID, 2005, REP DROUGHT COND PEN; Estornell J., 2013, MODEL SCI ED LEARN, V6, P83; Jensen J.R., 1996, INTRO DIGITAL IMAGE; MACRES and UTM, 2008, SAT IM ATL MAL ATL S; Malaysian Survey Dept, 2009, 1872 JUPEM MAL SURV; Mather P., 2011, COMPUTER PROCESSING; Munyati C, 2004, GEOCARTO INT, V19, P11, DOI [10.1080/10106040408542313, DOI 10.1080/10106040408542313]; NASA, 2008, TRMM 3B42 DAT GLOB G; Peters-Lidard C., 2007, GEOPH RES ABSTR, V9; Thompson S., 1999, HYDROLOGY WATER MANA; TRMM Precipitation Radar Team, 2011, TROP RAINF MEAS MISS; Weng Q, 2011, T&F SER REMOTE SENS, P1, DOI 10.1201/b10599; Yatagai A, 2014, J CLIMATE, V27, P1062, DOI 10.1175/JCLI-D-13-00332.1	35	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1525-755X	1525-7541		J HYDROMETEOROL	J. Hydrometeorol.	OCT	2015	16	5					2264	2275		10.1175/JHM-D-14-0233.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CS6VZ	WOS:000362222500020		
J	Park, Y; Shin, HR; Yoon, JH; Kim, CH; Yoshikawa, Y				Park, Yumi; Shin, Hong-Ryeol; Yoon, Jong-Hwan; Kim, Cheol-Ho; Yoshikawa, Yutaka			Simulation of eddy-driven deep circulation in the East/Japan Sea by using a three-layer model with wind, throughflow and deep water formation forcings	JOURNAL OF MARINE SYSTEMS			English	Article						The East/Japan Sea; Three-layer model; Deep circulation of the East/Japan Sea; Deep water formation; Eddy kinetic energy; Eddy-driven circulation	TSUSHIMA WARM CURRENT; JAPAN/EAST SEA; EAST SEA; ABYSSAL CIRCULATION; WORLD OCEAN; MEAN FLOW; VARIABILITY; FLUX; CONVECTION; DYNAMICS	A three-layer model was used to investigate the impact of grid resolution, bottom topography, wind, throughflow (the Tsushima Warm Current) and deep water formation (DWF) forcing on deep circulation in the East/japan Sea. High grid resolution (1/36 degrees) and real bottom topography are essential to capture the observed features of surface and deep circulation. An increase of grid resolution from 1/12 degrees to 1/36 degrees, wind and DWF forcing dramatically increase the current velocity and eddy kinetic energy (EKE) of the lower-layer. Of the three forcings, the influence of wind forcing is the most powerful on the abyssal circulation, followed by the order of the throughflow and DWF forcing, respectively. DWF forcing does not largely change the horizontal circulation pattern of the lower-layer in the 1/36 degrees resolution model, but it increases the current velocity by 33.9%. Model results indicate that surface EKE is larger in the southern region than in the northern region of the East/japan Sea, while deep EKE is larger in the northern area. These results are in good agreement with EKE distributions obtained from the surface drifter and the ARGO float trajectories. The EKE maxima of the lower-layer is geographically concentrated on the bottom slope, indicating that the strong circulation in the lower-layer is due to the strong eddy activity on the slope. The flux calculation shows that the primary eddy fluxes of potential vorticity-driving deep circulation are layer thickness flux (LAY) and relative vorticity flux (REL). (C) 2015 Elsevier B.V. All rights reserved.	[Park, Yumi; Shin, Hong-Ryeol] Kongju Natl Univ, Dept Atmospher Sci, Kong Ju 314701, Chungnam, South Korea; [Yoon, Jong-Hwan] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8160811, Japan; [Kim, Cheol-Ho] Korea Inst Ocean Sci & Technol, Phys Oceanog Div, Ansan 426744, South Korea; [Yoshikawa, Yutaka] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Shin, HR (reprint author), Kongju Natl Univ, Dept Atmospher Sci, Kong Ju 314701, Chungnam, South Korea.	hrshin@kongju.ac.kr	Kyushu, RIAM/F-4018-2015		Kongju National University [2006-0127]; Korea Institute of Ocean Science Technology [PE99295, PM58524]; Marine Environment Group, Research Institute for East Asia Environments, Kyushu University; KISTI supercomputing center [KSC-2009-S01-0010]	This study was supported by a research grant no. 2006-0127 from the Kongju National University in 2007, and partly from research grants PE99295 and PM58524 from the Korea Institute of Ocean Science & Technology, as well as the Marine Environment Group, Research Institute for East Asia Environments, Kyushu University. The calculations were performed on a supercomputer, Hakozaki and Mikasa, at Kyushu University. The authors would like to acknowledge the support of the KISTI supercomputing center of the strategic support program for supercomputing application research [No. KSC-2009-S01-0010]. We thank the officers and the crew of the R.V. Kakuyo-maru and Nagasaki-maru of Nagasaki University. We are also grateful to Dr. A. Nakata for providing us with current-meter data for site HS, Dr. Young Jin Choi for his help with the analysis of vector correlation, and Prof. N. Hirose for his help with the numerical experiments.	ARAKAWA A, 1981, MON WEATHER REV, V109, P18, DOI 10.1175/1520-0493(1981)109<0018:APEAEC>2.0.CO;2; Senjyu T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014093; Takikawa T, 2005, J PHYS OCEANOGR, V35, P1154, DOI 10.1175/JPO2742.1; HOLLOWAY G, 1995, J MAR RES, V53, P539, DOI 10.1357/0022240953213106; CROSBY DS, 1993, J ATMOS OCEAN TECH, V10, P355, DOI 10.1175/1520-0426(1993)010<0355:APDFVC>2.0.CO;2; Greatbatch RJ, 1998, J PHYS OCEANOGR, V28, P422, DOI 10.1175/1520-0485(1998)028<0422:ETRBEI>2.0.CO;2; Fukudome K, 2010, J OCEANOGR, V66, P539; HO SEUNG YOUNG, 2012, Ocean and Polar Research, V34, P287, DOI 10.4217/OPR.2012.34.3.287; STOMMEL H, 1960, DEEP-SEA RES, V6, P140; Kawamura H, 1998, J GEOPHYS RES-OCEANS, V103, P21611, DOI 10.1029/98JC01948; Hogan PJ, 2000, J PHYS OCEANOGR, V30, P2535, DOI 10.1175/1520-0485(2000)030<2535:IOUOTC>2.0.CO;2; Greatbatch RJ, 2000, DEEP-SEA RES PT I, V47, P709, DOI 10.1016/S0967-0637(99)00078-3; Park JJ, 2013, DEEP-SEA RES PT II, V85, P169, DOI 10.1016/j.dsr2.2012.07.032; RHINES PB, 1979, DYNAM ATMOS OCEANS, V3, P289, DOI 10.1016/0377-0265(79)90015-0; Mitchell DA, 2005, J PHYS OCEANOGR, V35, P273, DOI 10.1175/JPO-2684.1; [Anonymous], 2005, OCEAN SCI J; Lee DK, 2010, DEEP-SEA RES PT I, V57, P1233, DOI 10.1016/j.dsr.2010.06.002; Teague WJ, 2005, DEEP-SEA RES PT II, V52, P1802, DOI 10.1016/j.dsr2.2003.10.014; Yoshikawa Y, 2012, J OCEANOGR, V68, P971, DOI 10.1007/s10872-012-0148-2; Senjyu T, 2005, DEEP-SEA RES PT II, V52, P1726, DOI 10.1016/j.dsr2.2003.10.013; KAWASE M, 1987, J PHYS OCEANOGR, V17, P2294, DOI 10.1175/1520-0485(1987)017<2294:EODOCD>2.0.CO;2; Choi YJ, 2010, J OCEANOGR, V66, P349; Gamo T, 2001, GEOPHYS RES LETT, V28, P4143, DOI 10.1029/2001GL013367; Kim K, 2004, PROG OCEANOGR, V61, P157, DOI 10.1016/j.pocean.2004.06.003; HELLERMAN S, 1983, J PHYS OCEANOGR, V13, P1093, DOI 10.1175/1520-0485(1983)013<1093:NMWSOT>2.0.CO;2; Hogan PJ, 2005, DEEP-SEA RES PT II, V52, P1464, DOI 10.1016/j.dsr2.2005.01.013; Yoon JH, 2005, DEEP-SEA RES PT II, V52, P1827, DOI 10.1016/j.dsr2.2004.03.004; STOMMEL H, 1960, DEEP-SEA RES, V6, P217; Kim T, 2010, CONT SHELF RES, V30, P1283, DOI 10.1016/j.csr.2010.04.006; Shin HR, 2005, DEEP-SEA RES PT II, V52, P1742, DOI 10.1016/j.dsr2.2004.10.004; Chang KI, 2002, DEEP-SEA RES PT I, V49, P2261, DOI 10.1016/S0967-0637(02)00120-6; Hase H, 1999, J OCEANOGR, V55, P217, DOI DOI 10.1023/A:1007894030095; Kim C.-H., 1996, J OCEANOGR, V52, P359, DOI 10.1007/BF02235930; Kim Y.J., 2007, THESIS KYUSHU U; Marshall J, 1999, REV GEOPHYS, V37, P1, DOI 10.1029/98RG02739; Nakata A., 1999, FALL M 1999 OC SOC J, P52; Park K.-A., 2013, SEA, V18, P234; Sakai R., 2005, ENG SCI REP KYUSHU U, V26, P423; Senjyu T., 1996, J OCEANOGR, V52, P27, DOI 10.1007/BF02236531; Seung Y. H., 1995, J OCEANOGR, V51, P61, DOI 10.1007/BF02235936; Talley L.D., 1979, NOTES POLAR OCEANOGR, V2, P97; Yamada H., 1999, UMI SORA, V74, P168	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-7963	1879-1573		J MARINE SYST	J. Mar. Syst.	OCT	2015	150						41	55		10.1016/j.jmarsys.2015.05.006		15	Geosciences, Multidisciplinary; Marine & Freshwater Biology; Oceanography	Geology; Marine & Freshwater Biology; Oceanography	CS1XQ	WOS:000361862600005		
J	Tsuru, K; Ruslin; Maruta, M; Matsuya, S; Ishikawa, K				Tsuru, Kanji; Ruslin; Maruta, Michito; Matsuya, Shigeki; Ishikawa, Kunio			Effects of the method of apatite seed crystals addition on setting reaction of alpha-tricalcium phosphate based apatite cement	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							MECHANICAL STRENGTH; BONE CEMENTS; CALCIUM; RECONSTRUCTION; PHASE	Appropriate setting time is an important parameter that determines the effectiveness of apatite cement (AC) for clinical application, given the issues of crystalline inflammatory response phenomena if AC fails to set. To this end, the present study analyzes the effects of the method of apatite seed crystals addition on the setting reaction of a-tricalcium phosphate (alpha-TCP) based AC. Two ACs, both consisting of alpha-TCP and calcium deficient hydroxyapatite (cdHAp), were analyzed in this study. In one AC, cdHAp was added externally to alpha-TCP and this AC was abbreviated as AC(EA). In the other AC, alpha-TCP was partially hydrolyzed to form cdHAp on the surface of alpha-TCP. This AC was referred to as AC(PH). Results indicate a decrease in the setting time of both ACs with the addition of cdHAp. Among them, for the given amount of added cdHAp, AC(PH) showed relatively shorter setting time than AC(EA). Besides, the mechanical strength of the set AC(PH) was also higher than that of set AC(EA). These properties of AC(PH) were attributed to the predominant crystal growth of cdHAp in the vicinity of the alpha-TCP particle surface. Accordingly, it can be concluded that the partial hydrolysis of alpha-TCP may be a better approach to add low crystalline cdHAp onto alpha-TCP based AC.	[Tsuru, Kanji; Ruslin; Ishikawa, Kunio] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128582, Japan; [Maruta, Michito; Matsuya, Shigeki] Fukuoka Dent Coll, Dept Dent Engn, Sect Bioengn, Sawara Ku, Fukuoka 8140193, Japan	Tsuru, K (reprint author), Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuru@dent.kyushu-u.ac.jp			Strategic Promotion of Innovative Research and Development Program; Japan Agency for Medical Research and Development [AJ120495]	This study was supported, in part, by the Strategic Promotion of Innovative Research and Development Program, Japan Agency for Medical Research and Development (AJ120495).	Yang QZ, 2002, BIOMATERIALS, V23, P2751, DOI 10.1016/S0142-9612(02)00010-8; Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398; Brunner TJ, 2007, J MATER CHEM, V17, P4072, DOI 10.1039/b707171j; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Ishikawa K, 2008, WOODHEAD PUBL MATER, P438, DOI 10.1533/9781845694227.2.438; Liu CS, 1997, J MATER SCI-MATER M, V8, P803, DOI 10.1023/A:1018529116330; Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017; MIYAMOTO Y, 1995, BIOMATERIALS, V16, P855, DOI 10.1016/0142-9612(95)94147-D; ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210; Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5; [Anonymous], 1978, 1566 ISO; Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111; Oda M, 2008, DENT MATER J, V27, P672; Ishikawa K, 1999, J BIOMED MATER RES, V44, P322, DOI 10.1002/(SICI)1097-4636(19990305)44:3<322::AID-JBM11>3.0.CO;2-S; Doi Y, 1987, J JAP SOC DENT MAT D, V6, P426; ISHIKAWA K, 1995, J MATER SCI-MATER M, V6, P528, DOI 10.1007/BF00151034; Unezaki Y, 1993, J JPN PROSTHODONT SO, V37, P61	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	OCT	2015	26	10							244	10.1007/s10856-015-5570-8		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CS9OA	WOS:000362419200005		
J	Avramov, P; Kuzubov, AA; Sakai, S; Entani, S; Naramoto, H; Eliseeva, N				Avramov, P.; Kuzubov, A. A.; Sakai, S.; Entani, S.; Naramoto, H.; Eliseeva, N.			Spin States of 2D Nanocomposites of Ni and V Nanoclusters on Hexagonal h-BN, BC3 and Graphene	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Article						Electronic structure; Metal nanostructure; Nanocomposites; Graphene; h-BN; BC3; Spin states	BORON-NITRIDE; FILMS	Atomic and electronic structures of adsorbed nickel and vanadium atoms and nanoclusters (Ni-n and V-n, n = 1-10) on hexagonal h-BN and BC3 lattices were studied using DFT PBE/PBC/PW (Perdew-Burke-Ernzerhof potential of density functional theory/periodic boundary conditions/plane wave basis set) technique. For the sake of comparison the structure and properties of the same nanoclusters deposited on pristine graphene were calculated as well. It was found that for all types of supports an increase of n from 1 to 10 leaded to decrease of coordination types from eta(6) to eta(2) and eta(1). The h-BN- and BC3-based nanocomposites were characterized by high (up to 18 mu for Ni10/BC3) magnetic moments of the nanoclusters and featured by positive binding energies. The graphene-based nanocomposites revealed energetic stability and, in general, lower magnetic moments per unit cell. The direct potential energy barriers for migration of Ni eta(2)/eta(2) and eta(6)/eta(6) types of dimers on graphene were low (10.9-28.9 kJ/mol) with high reverse barriers for eta(6)/eta(6) dimers, which favored dynamically equilibrated Ni clusterization on graphene. Copyright (C) 2015, The editorial office of Journal of Materials Science & Technology. Published by Elsevier Limited. All rights reserved.	[Avramov, P.] Kyungpook Natl Univ, Taegu 702701, South Korea; [Kuzubov, A. A.; Eliseeva, N.] Siberian Fed Univ, Krasnoyarsk 660041, Russia; [Kuzubov, A. A.] SB RAS, LV Kirensky Phys Inst, Krasnoyarsk 660036, Academgorodok, Russia; [Sakai, S.; Entani, S.; Naramoto, H.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan	Avramov, P (reprint author), Kyungpook Natl Univ, 1370 Sankyuk Dong, Taegu 702701, South Korea.	paul@iph.krasn.ru			Russian Scientific Foundation [14-13-00139]	The work of Russian team was supported by Russian Scientific Foundation (Grant No. 14-13-00139). P.V.A. acknowledges JAEA ASRC and Molecular Spintronics Group for hospitality and fruitful collaboration.	Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Sahoo S, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4893328; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Binz SM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.026103; Dedkov YS, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125004; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Eelbo T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.136804; Gan YJ, 2008, SMALL, V4, P587, DOI 10.1002/smll.200700929; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Abergel DSL, 2010, ADV PHYS, V59, P261, DOI 10.1080/00018732.2010.487978; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Gao W, 2013, ANGEW CHEM INT EDIT, V52, P14237, DOI 10.1002/anie.201305001; Sanchez-Paisal Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045428; Yazyev OV, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045407; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Kuzubov AA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195415; Auwarter W, 2003, SURF SCI, V545, pL735, DOI 10.1016/j.susc.2003.08.046; KOUVETAKIS J, 1986, J CHEM SOC CHEM COMM, P1758, DOI 10.1039/c39860001758; Liu XJ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.081414; Rodriguez-Manzo J. A., 2010, ACS NANO, V6, P3422; WYCKOFF RWG, 1963, CRYSTAL STRUCTURES, V0001	21	0	0	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	OCT	2015	31	10					979	985		10.1016/j.jmst.2015.08.008		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CS7TI	WOS:000362288500002		
J	Yusuf, N; Omar, MI; Zakaria, A; Masnan, MJ; Abdullah, AA; Kamarudin, LM; Shakaff, AYM; Thriumani, R; Yeap, EJ; Othman, A; Yasin, MS				Yusuf, N.; Omar, M. I.; Zakaria, A.; Masnan, M. J.; Abdullah, A. A.; Kamarudin, L. M.; Shakaff, A. Y. M.; Thriumani, R.; Yeap, E. J.; Othman, A.; Yasin, M. S.			Rapid Bacteria Identification Using Multivariate Classifier on Diabetic Foot Infection	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Diabetic Foot Infection; Gram Positive; Gram Negative; LDA; PNN; kNN; E-Nose; Cyranose320		Identification of bacteria species on diabetic foot infection at the early stage is very crucial especially to reduce the major surgery for diabetic patients. An attempt to resolve this problem is to conduct an experiment by investigating the nature of bacterial morphology from the perspective of sensor technology. Therefore, the aim of this study is to investigate the aerobic gram positive bacteria (S. aureus, S. pyogenes) and aerobic gram negative bacteria (E. coli, P aeruginosa, P mirabilis and K. pneumoniae) at the early growth of bacteria at 6 hours followed by 12 hours, 18 hours to 24 hours bacteria culture in the incubator. All the bacteria were cultured in a blood agar medium by using a swabbing technique. The bacteria samples then were sniffed using Cyranose320 (e-nose) to collect the data samples and analysed using three various classifier techniques, Linear Discriminant Analysis (LDA), Probabilistic Neural Network (PNN) and k Nearest Neighbors (kNN). The preliminary results obtained in this study have shown that the e-nose was better able to identify and classify the bacteria pathogen with up to 90% accuracy using that classifier. Based on the overall classifier performance, kNN achieved higher accuracy compare to both LDA and PNN which imply that kNN is a good model to interpret the data analysis.	[Yusuf, N.; Omar, M. I.; Zakaria, A.; Masnan, M. J.; Abdullah, A. A.; Kamarudin, L. M.; Shakaff, A. Y. M.; Thriumani, R.] Univ Malaysia Perlis, Ctr Excellence Adv Sensor Technol, Arau 02600, Perlis, Malaysia; [Kamarudin, L. M.] Univ Malaysia Perlis, Sch Comp Engn, Arau 02600, Perlis, Malaysia; [Kamarudin, L. M.] Univ Malaysia Perlis, Sch Commun Engn, Arau 02600, Perlis, Malaysia; [Abdullah, A. A.] Nara Inst Sci & Technol, Ikoma, Nara 6300192, Japan; [Masnan, M. J.] Univ Malaysia Perlis, Inst Engn Math, Arau 02600, Perlis, Malaysia; [Yeap, E. J.; Othman, A.; Yasin, M. S.] Hosp Tuanku Fauziah, Dept Microbiol, Kangar 01000, Perlis, Malaysia	Yusuf, N (reprint author), Univ Malaysia Perlis, Ctr Excellence Adv Sensor Technol, Lot 21,Taman Muhibah,Jalan Jejawi, Arau 02600, Perlis, Malaysia.				Ministry of Higher Education, Malaysia [9013-00015]	This work is supported by the PRGS grant 9013-00015 by the Ministry of Higher Education, Malaysia. The authors would like to thank Director of Hospital Tuanku Fauziah, Kangar, Perlis for their collaboration.	Abdullah A. A., 2014, ADV SCI LETT, V1, P37; Abdullah Azian Azamimi, 2013, Applied Mechanics and Materials, V339, DOI 10.4028/www.scientific.net/AMM.339.167; Abdullah A. A., 2013, INT C ADV INT SYST B; Abdulrazak A, 2005, J DIABETES COMPLICAT, V19, P138, DOI 10.1016/j.jdiacomp.2004.06.001; Roberts AD, 2012, SEMIN VASC SURG, V25, P75, DOI 10.1053/j.semvascsurg.2012.04.010; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/424846; FORBES KJ, 1991, J GEN MICROBIOL, V137, P2051; Bader MS, 2008, AM FAM PHYSICIAN, V78, P71; Ivnitski D, 1999, BIOSENS BIOELECTRON, V14, P599, DOI 10.1016/S0956-5663(99)00039-1; Mutluoglu M, 2012, J DIABETES COMPLICAT, V26, P225, DOI 10.1016/j.jdiacomp.2012.03.015; Masnan MJ, 2012, PROCEDIA CHEM, V6, P132, DOI 10.1016/j.proche.2012.10.139; Lykos P, 2001, J MICROBIOL, V39, P213; Edmonds Michael, 2009, Vasc Health Risk Manag, V5, P949; Joseph WS, 2010, J VASC SURG, V52, p67S, DOI 10.1016/j.jvs.2010.06.010; Schiffman S. S., 2000, 7 INT S OLF EL NOS B, P1; Yusuf N., 2013, 2013 IEEE C WIR SENS, P118	16	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	OCT	2015	5	6					1251	1254		10.1166/jmihi.2015.1524		4	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	CS2WV	WOS:000361933600019		
J	Urushima, H; Sanada, Y; Sakaue, M; Matsuzawa, Y; Ito, T; Maeda, K				Urushima, Hayato; Sanada, Yasuaki; Sakaue, Miki; Matsuzawa, Yuji; Ito, Toshinori; Maeda, Kazuhisa			Maltitol Prevents the Progression of Fatty Liver Degeneration in Mice Fed High-Fat Diets	JOURNAL OF MEDICINAL FOOD			English	Article						<bold>FXR</bold>; <bold>hepatic fatty degeneration</bold>; <bold>maltitol</bold>; <bold>polyol</bold>; <bold>PPAR</bold>; <bold>SREBP1c</bold>	FARNESOID-X-RECEPTOR; ALPHA PPAR-ALPHA; TERM-FOLLOW-UP; NUCLEAR RECEPTOR; BILE-ACIDS; INSULIN SENSITIVITY; DISEASE; CHOLESTEROL; HOMEOSTASIS; METABOLISM	Nonalcoholic fatty liver disease (NAFLD) progresses to nonalcoholic steatohepatitis, ultimately leading to cirrhosis and liver cancer. It is important to prevent this progression during the initial stages of hepatic fatty degeneration. Maltitol is a polyol produced by the hydrogenation of maltose. We investigated the efficacy of maltitol for treating hepatic fatty degeneration in C57BL/6 male mice using a high-fat diet model. Intake of 5.0% maltitol for 8 weeks significantly suppressed weight gain, hepatic fatty degeneration, hyperglycemia, and hypercholesterolemia. With maltitol intake, sterol regulatory element-binding protein 1c (SREBP1c) mRNA expression was significantly decreased, and farnesoid X receptor (FXR), peroxisome proliferator-activated receptor (PPAR), and hydroxymethylglutaryl-Co reductase expressions were significantly higher in the liver. The increase in SREBP1c and suppression of FXR and PPAR expressions are correlated with NAFLD. Our results suggest that maltitol may prevent steatosis of NAFLD with a high-fat diet.	[Urushima, Hayato; Sanada, Yasuaki; Sakaue, Miki; Ito, Toshinori; Maeda, Kazuhisa] Osaka Univ, Dept Integrat Med, Grad Sch Med, Osaka, Japan; [Matsuzawa, Yuji] Sumitomo Hosp, Osaka, Japan	Urushima, H (reprint author), Osaka Univ, Grad Sch Med, Dept Integrat Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	h-urushima@cam.med.osaka-u.ac.jp					Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; SECCHI A, 1986, KLIN WOCHENSCHR, V64, P265, DOI 10.1007/BF01711933; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlt.M300094-JLR200; Erkkila AT, 2006, J CARDIOVASC NURS, V21, P3; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Sakakibara S, 2006, BIOCHEM BIOPH RES CO, V344, P597, DOI 10.1016/j.bbrc.2006.03.176; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hong Q, 2015, MOL MED REP, V11, P1669, DOI 10.3892/mmr.2014.2996; Hojo M, 2011, HEPATOL RES, V41, P209, DOI 10.1111/j.1872-034X.2011.00780.x; WRIGHT RS, 1990, P SOC EXP BIOL MED, V195, P26; Bhuiyan MJH, 2011, MOL NUTR FOOD RES, V55, pS214, DOI 10.1002/mnfr.201100121; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Beards E, 2010, BRIT J NUTR, V104, P701, DOI 10.1017/S0007114510001078; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; CHEN WJL, 1984, P SOC EXP BIOL MED, V175, P215; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Kerckhoffs DAJM, 2002, J NUTR, V132, P2494; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; OKU T, 1991, J NUTR SCI VITAMINOL, V37, P529; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Izumitani A, 1989, Shoni Shikagaku Zasshi, V27, P1018; LEVIN GV, 1995, AM J CLIN NUTR, V62, P1161; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Pineda T., 2003, MOL ENDOCRINOL, V17, P259, DOI DOI 10.1210/ME.2002-0120	45	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	OCT 1	2015	18	10					1081	1087		10.1089/jmf.2014.3380		7	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	CS5LA	WOS:000362118300002		
J	Nakahara, T; Mitoma, C; Hashimoto-Hachiya, A; Takahara, M; Tsuji, G; Uchi, H; Yan, XH; Hachisuka, J; Chiba, T; Esaki, H; Kido-Nakahara, M; Furue, M				Nakahara, Takeshi; Mitoma, Chikage; Hashimoto-Hachiya, Akiko; Takahara, Masakazu; Tsuji, Gaku; Uchi, Hiroshi; Yan, Xianghong; Hachisuka, Junichi; Chiba, Takahito; Esaki, Hitokazu; Kido-Nakahara, Makiko; Furue, Masutaka			Antioxidant Opuntia ficus-indica Extract Activates AHR-NRF2 Signaling and Upregulates Filaggrin and Loricrin Expression in Human Keratinocytes	JOURNAL OF MEDICINAL FOOD			English	Article						<bold>antioxidant</bold>; <bold>aryl hydrocarbon receptor</bold>; <bold>filaggrin</bold>; <bold>Opuntia ficus-indica</bold>; <bold>extract</bold>; <bold>NRF2</bold>; <bold>NQO1</bold>	CULTURED HUMAN KERATINOCYTES; OXIDATIVE STRESS; ATOPIC-DERMATITIS; SKIN; NRF2; DIFFERENTIATION; QUERCETIN; UPDATE; RATS	Opuntia ficus-indica (OFI) is a cactus species widely used as an anti-inflammatory, antilipidemic, and hypoglycemic agent. It has been shown that OFI extract (OFIE) inhibits oxidative stress in animal models of diabetes and hepatic disease; however, its antioxidant mechanism remains largely unknown. In this study, we demonstrated that OFIE exhibited potent antioxidant activity through the activation of nuclear factor erythroid 2-related factor 2 (NRF2) and the downstream antioxidant enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1), which inhibited the generation of reactive oxygen species in keratinocytes challenged with tumor necrosis factor or benzo[]pyrene. The antioxidant capacity of OFIE was canceled in NRF2 knockdown keratinocytes. OFIE exerted this NRF2-NQO1 upregulation through activation of the aryl hydrocarbon receptor (AHR). Moreover, the ligation of AHR by OFIE upregulated the expression of epidermal barrier proteins: filaggrin and loricrin. OFIE also prevented TH2 cytokine-mediated downregulation of filaggrin and loricrin expression in an AHR-dependent manner because it was canceled in AHR knockdown keratinocytes. Antioxidant OFIE is a potent activator of AHR-NRF2-NQO1 signaling and may be beneficial in treating barrier-disrupted skin disorders.	[Nakahara, Takeshi; Furue, Masutaka] Kyushu Univ, Div Skin Surface Sensing, Fukuoka 8128582, Japan; [Nakahara, Takeshi; Mitoma, Chikage; Hashimoto-Hachiya, Akiko; Takahara, Masakazu; Tsuji, Gaku; Uchi, Hiroshi; Hachisuka, Junichi; Chiba, Takahito; Esaki, Hitokazu; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Mitoma, Chikage; Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Yan, Xianghong] P&G Innovat Godo Kaisha, Kobe, Hyogo, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp			Ministry of Health, Labour and Welfare; Ministry of the Environment, Japan	This work was partly supported by grants from the Ministry of Health, Labour and Welfare and the Environment Technology Development Fund of the Ministry of the Environment, Japan.	Ramyaa P, 2014, BBA-GEN SUBJECTS, V1840, P681, DOI 10.1016/j.bbagen.2013.10.024; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Shetty AA, 2012, J FOOD SCI TECH MYS, V49, P530, DOI 10.1007/s13197-011-0462-5; Kimura S, 2009, BIOCHEM BIOPH RES CO, V387, P109, DOI 10.1016/j.bbrc.2009.06.136; Niestroy J, 2011, TOXICOL IN VITRO, V25, P671, DOI 10.1016/j.tiv.2011.01.008; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Wu ZW, 2014, EXP DERMATOL, V23, P260, DOI 10.1111/exd.12360; Kuti JO, 2004, FOOD CHEM, V85, P527, DOI 10.1016/S0308-8146(03)00184-5; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Fischedick JT, 2012, PLANTA MED, V78, P1725, DOI 10.1055/s-0032-1315241; Butera D, 2002, J AGR FOOD CHEM, V50, P6895, DOI 10.1021/jf025696p; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Kerdel FA, 2014, SEMIN CUTAN MED SURG, V33, pS31, DOI 10.12788/j.sder.0066; Hfaiedh M, 2014, BIOL TRACE ELEM RES, V159, P304, DOI 10.1007/s12011-014-9969-8; Ikuta T, 2009, BIOCHEM PHARMACOL, V77, P588, DOI 10.1016/j.bcp.2008.10.003; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Elias PM, 2013, SEMIN CUTAN MED SURG, V32, pS21; Loertscher JA, 2002, TOXICOL SCI, V68, P465, DOI 10.1093/toxsci/68.2.465; Brahmi D, 2012, NUTR METAB, V8, P73; Feng XX, 2014, EUR J PHARM SCI, V63, P113, DOI 10.1016/j.ejps.2014.07.001; Furue M, 2014, ARCH DERMATOL RES, V306, P769, DOI 10.1007/s00403-014-1481-7; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Tsuji G, 2012, J INVEST DERMATOL, V132, P59, DOI 10.1038/jid.2011.194	26	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	OCT 1	2015	18	10					1143	1149		10.1089/jmf.2014.3396		7	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	CS5LA	WOS:000362118300010		
J	Sawanobori, E; Hung, WC; Takano, T; Hachuda, K; Horiuchi, T; Higuchi, W; Hung, WW; Iwao, Y; Nishiyama, A; Reva, I; Reva, G; Teng, LJ; Yamamoto, T				Sawanobori, Emi; Hung, Wei-Chun; Takano, Tomomi; Hachuda, Koji; Horiuchi, Tadahiro; Higuchi, Wataru; Hung, Wei-Wen; Iwao, Yasuhisa; Nishiyama, Akihito; Reva, Ivan; Reva, Galina; Teng, Lee-Jene; Yamamoto, Tatsuo			Emergence of Panton-Valentine leukocidin-positive ST59 methicillin-susceptible Staphylococcus aureus with high cytolytic peptide expression in association with community-acquired pediatric osteomyelitis complicated by pulmonary embolism	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION			English	Article						antibiotic treatment; community-associated methicillin-susceptible Staphylococcus aureus (CA-MSSA); genotype; pediatric osteomyelitis; septic pulmonary embolism	VIRULENCE DETERMINANTS; USA300 CLONE; INFECTIONS; CHILDREN; TAIWAN; MRSA; JAPAN; GUIDELINES; SEQUENCE; PLASMID	A 15-year-old boy, who had had a furuncle on his femur, developed femoral pyomyositis and osteomyelitis complicated by septic pulmonary embolism. Panton-Valentine leukocidin-positive (PVL+) ST59 methicillin-susceptible Staphylococcus aureus (MSSA) was isolated from pus and blood. Chemotherapy was started with cefazolin, followed by combination therapy with meropenem/vancomycin with surgery. The MSSA (strain KS1) was positive for increased levels of cytolytic peptide (psm alpha and hld) and staphylococcal enterotoxin B (SEB), and manifested IS1216V-mediated multidrug resistance (to erythromycin, clindamycin, kanamycin, streptomycin, and chloramphenicol), similar to a genome-analyzed reference strain (PM1) of ST59/SCCmecV(5C2&5) community-associated methicillin-resistant S. aureus (Taiwan CA-MRSA), but unlike another reference strain (M013) of Taiwan CA-MRSA in terms of resistance. The data suggest that CA-MSSA KS1, characterized by PVL, increased levels of cytolytic peptide, SEB, and multidrug resistance, is a possible ancestral strain of Taiwan CA-MRSA and causes the unique association of osteomyelitis and septic pulmonary embolism, requiring complicated management. Copyright (C) 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.	[Sawanobori, Emi] Kofu Municipal Hosp, Dept Pediat, Kofu, Yamanashi, Japan; [Hung, Wei-Chun; Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hung, Wei-Chun; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Nishiyama, Akihito; Reva, Ivan; Yamamoto, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Div Bacteriol, Dept Infect Dis Control & Int Med, Niigata, Japan; [Hachuda, Koji; Horiuchi, Tadahiro] Kofu Municipal Hosp, Dept Orthoped Surg, Kofu, Yamanashi, Japan; [Hung, Wei-Wen] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Iwao, Yasuhisa; Reva, Ivan; Reva, Galina; Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Niigata 9518116, Japan	Yamamoto, T (reprint author), Int Med Educ & Res Ctr, Chuo Ku, Fukusumi Bldg 2,1-86-12 Higashinakadori, Niigata 9518116, Japan.	tatsuoy@imerc.jp		TENG, LEE-JENE/0000-0003-0104-741X			Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Gonzalez BE, 2006, PEDIATRICS, V117, P1673, DOI 10.1052/peds.2005-2009; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Hall M, 1999, CLIN INFECT DIS, V29, P586; Jin T, 2013, CELL PHYSIOL BIOCHEM, V32, P322, DOI 10.1159/000354440; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Hung WC, 2013, J INFECT CHEMOTHER, V19, P1004, DOI 10.1007/s10156-013-0561-5; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Yamamoto T, 2012, J INFECT CHEMOTHER, V18, P187, DOI 10.1007/s10156-011-0316-0; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P292, DOI 10.1007/s10156-010-0051-y; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Belthur MV, 2012, J BONE JOINT SURG AM, V94A, P34, DOI 10.2106/JBJS.J.01915; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P144, DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Ritz N, 2012, PEDIATR INFECT DIS J, V31, P514, DOI 10.1097/INF.0b013e31824f18cb; Sletvold H, 2010, J ANTIMICROB CHEMOTH, V65, P1894, DOI 10.1093/jac/dkq219; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen CJ, 2007, PEDIATR INFECT DIS J, V26, P985, DOI 10.1097/INF.0b013e31812e62dc; Shibuya Yasuhiro, 2008, Journal of Infection and Chemotherapy, V14, P439, DOI 10.1007/s10156-008-0640-1; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Takano T, 2013, ANTIMICROB AGENTS CH, V57, P1589, DOI 10.1128/AAC.01147-12; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; McCaskill ML, 2007, PEDIATR INFECT DIS J, V26, P1122, DOI 10.1097/INF.0b013e31814536e0; Peltola H, 2014, NEW ENGL J MED, V370, P352, DOI 10.1056/NEJMra1213956; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Grimbly Chelsey, 2013, Syst Rev, V2, P92, DOI 10.1186/2046-4053-2-92; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Sina H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-188; The committee for The Japanese Respiratory Society guidelines in management of respiratory infections, 2004, RESPIROLOGY, V9, pS16; Tsuchimochi N., 2007, JPN J CHEMOTHER, V55, P363; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Yamamoto T., 2013, BIOMEDICINE, V3, P2; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187	48	1	1	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1684-1182	1995-9133		J MICROBIOL IMMUNOL	J. Microbiol. Immunol. Infect.	OCT	2015	48	5					565	573		10.1016/j.jmii.2014.04.015		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CS7QD	WOS:000362278900015		
J	Murata, H; Yoshimoto, K; Hatae, R; Akagi, Y; Mizoguchi, M; Hata, N; Kuga, D; Nakamizo, A; Amano, T; Sayama, T; Iihara, K				Murata, Hideki; Yoshimoto, Koji; Hatae, Ryusuke; Akagi, Yojiro; Mizoguchi, Masahiro; Hata, Nobuhiro; Kuga, Daisuke; Nakamizo, Akira; Amano, Toshiyuki; Sayama, Tetsuro; Iihara, Koji			Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression	JOURNAL OF NEURO-ONCOLOGY			English	Article						Proneural; Mesenchymal; Glioblastoma; P-M score; HDAC7	HISTONE DEACETYLASE 7; ANALYSIS REVEALS; CLASS-II; CANCER; GLIOMA; HETEROGENEITY; PROGNOSIS; PATHWAYS; SUBTYPES; DISEASE	Proneural and mesenchymal are two subtypes of glioblastoma identified by gene expression profiling. In this study, the primary aim was to detect markers to develop a clinically applicable method for distinguishing proneural and mesenchymal glioblastoma. The secondary aims were to investigate the temporospatial dynamics of these markers and to explore the association between these markers and the expression of chromatin-modifying genes. One hundred thirty-three glioma samples (grade II: 14 samples, grade III: 18, grade IV: 101) were analyzed. We quantified the expression of 6 signature genes associated with proneural and mesenchymal glioblastoma by quantitative reverse transcription-polymerase chain reaction. We assigned proneural (PN) and mesenchymal (MES) scores based on the average of the 6 markers and calculated a predominant metagene (P-M) score by subtracting the MES from the PN score. We used these scores to analyze correlations with malignant transformation, tumor recurrence, tumor heterogeneity, chromatin-modifying gene expression, and HDAC7 expression. The MES score positively correlated with tumor grade, whereas the PN score did not. The P-M score was able to distinguish the proneural and mesenchymal subtypes. It was decreased in cases of tumor recurrence and malignant transformation and showed variability within a tumor, suggesting intratumoral heterogeneity. The PN score correlated with the expression of multiple histone-modifying genes, whereas the MES score was associated only with HDAC7 expression. Thus, we demonstrated a simple and straightforward method of quantifying proneural/mesenchymal markers in glioblastoma. Of note, HDAC7 expression might be a novel therapeutic target in glioblastoma treatment.	[Murata, Hideki; Yoshimoto, Koji; Hatae, Ryusuke; Akagi, Yojiro; Mizoguchi, Masahiro; Kuga, Daisuke; Amano, Toshiyuki; Sayama, Tetsuro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, Fukuoka 8128582, Japan; [Hata, Nobuhiro] Natl Hosp Org, Kyushu Med Ctr, Dept Neurosurg, Clin Res Inst, Fukuoka, Japan; [Nakamizo, Akira] Steel Mem Yawata Hosp, Stroke Ctr, Fukuoka, Japan	Yoshimoto, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kyoshimo@ns.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26462185, 25293311, 26293325]	This study was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Numbers 26462185, 25293311, and 26293325).	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Ma XL, 2012, NEURO-ONCOLOGY, V14, P1153, DOI 10.1093/neuonc/nos145; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Rutledge WC, 2013, CLIN CANCER RES, V19, P4951, DOI 10.1158/1078-0432.CCR-13-0551; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Zhu CH, 2011, J MOL MED-JMM, V89, P279, DOI 10.1007/s00109-010-0701-7; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Shakespear MR, 2013, J BIOL CHEM, V288, P25362, DOI 10.1074/jbc.M113.496281; Parra M, 2015, FEBS J, V282, P1736, DOI 10.1111/febs.13061; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen AL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-35; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243; Marko NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020826; Omuro A, 2014, CLIN CANCER RES, V20, P5023, DOI 10.1158/1078-0432.CCR-14-0822; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	OCT	2015	125	1					33	41		10.1007/s11060-015-1886-y		9	Oncology; Clinical Neurology	Oncology; Neurosciences & Neurology	CS8JY	WOS:000362334800004		
J	Iijima, K; Hirato, M; Miyagishima, T; Horiguchi, K; Sugawara, K; Hirato, J; Yokoo, H; Yoshimoto, Y				Iijima, Keiya; Hirato, Masafumi; Miyagishima, Takaaki; Horiguchi, Keishi; Sugawara, Kenichi; Hirato, Junko; Yokoo, Hideaki; Yoshimoto, Yuhei			Microrecording and image-guided stereotactic biopsy of deep-seated brain tumors	JOURNAL OF NEUROSURGERY			English	Article						stereotactic biopsy; image guided; depth microrecording; burst; tumor-brain interface; epileptogenicity; stereotactic radiosurgery	MAGNETIC-RESONANCE; DIAGNOSTIC YIELD; FRAMELESS; GLIOMAS; EPILEPSY; LESIONS; SAFETY; COMPLICATIONS; INTERNEURONS; DEGENERATION	OBJECT Image-guided stereotactic brain tumor biopsy cannot easily obtain samples of small deep-seated tumor or selectively sample the most viable region of malignant tumor. Image-guided stereotactic biopsy in combination with depth microrecording was evaluated to solve such problems. METHODS Operative records, MRI findings, and pathological specimens were evaluated in 12 patients with small deep-seated brain tumor, in which image-guided stereotactic biopsy was performed with the aid of depth microrecording. The tumors were located in the caudate nucleus (1 patient), thalamus (7 patients), midbrain (2 patients), and cortex (2 patients). Surgery was performed with a frameless stereotactic system in 3 patients and with a frame-based stereotactic system in 9 patients. Microrecording was performed to study the electrical activities along the trajectory in the deep brain structures and the tumor. The correlations were studied between the electrophysiological, MRI, and pathological findings. Thirty-two patients with surface or large brain tumor were also studied, in whom image-guided stereotactic biopsy without microrecording was performed. RESULTS The diagnostic yield in the group with microrecording was 100% (low-grade glioma 4, high-grade glioma 4, diffuse large B-cell lymphoma 3, and germinoma 1), which was comparable to 93.8% in the group without microrecording. The postoperative complication rate was as low as that of the conventional image-guided method without using microelectrode recording, and the mortality rate was 0%, although the target lesions were small and deep-seated in all cases. Depth microrecording revealed disappearance of neural activity in the tumor regardless of the tumor type. Neural activity began to decrease from 6.3 +/- 4.5 mm (mean +/- SD) above the point of complete disappearance along the trajectory. Burst discharges were observed in 6 of the 12 cases, from 3 +/- 1.4 mm above the point of decrease of neural activity. Injury discharges were often found at 0.5-1 mm along the trajectory between the area of decreased and disappeared neural activity. Close correlations between electrophysiological, MRI, and histological findings could be found in some cases. CONCLUSIONS Image-guided stereotactic biopsy performed using depth microrecording was safe, it provided accurate positional information in real time, and it could distinguish the tumor from brain structures during surgery. Moreover, this technique has potential for studying the epileptogenicity of the brain tumor.	[Iijima, Keiya; Hirato, Masafumi; Miyagishima, Takaaki; Horiguchi, Keishi; Sugawara, Kenichi; Yoshimoto, Yuhei] Gunma Univ, Dept Neurosurg, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Yokoo, Hideaki] Gunma Univ, Dept Human Pathol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Hirato, Junko] Gunma Univ Hosp, Clin Dept Pathol, Maebashi, Gunma, Japan	Hirato, M (reprint author), Gunma Univ, Dept Neurosurg, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	mfhirato@gunma-u.ac.jp					Allouch H, 2014, WORLD NEUROSURG, V82, P202, DOI 10.1016/j.wneu.2013.01.019; SPIEGEL EA, 1947, SCIENCE, V106, P349, DOI 10.1126/science.106.2754.349; GREENE GM, 1989, J NEUROSURG, V71, P494, DOI 10.3171/jns.1989.71.4.0494; Dammers R, 2008, ACTA NEUROCHIR, V150, P23, DOI 10.1007/s00701-007-1473-x; Kondziolka D, 1999, J NEURO-ONCOL, V42, P205, DOI 10.1023/A:1006105415194; Dammers R, 2010, ACTA NEUROCHIR, V152, P1915, DOI 10.1007/s00701-010-0752-0; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Shamir RR, 2011, NEUROSURGERY, V68, P95, DOI 10.1227/NEU.0b013e31820828d9; Whitfield GA, 2014, CLIN ONCOL-UK, V26, P364, DOI 10.1016/j.clon.2014.04.026; Teixeira MJ, 2009, ARQ NEURO-PSIQUIAT, V67, P74, DOI 10.1590/S0004-282X2009000100018; TAKIZAWA T, 1993, ACTA NEUROCHIR, V125, P177, DOI 10.1007/BF01401848; Ius T, 2014, J NEUROSURG, V120, P12, DOI 10.3171/2013.9.JNS13728; McGirt MJ, 2005, J NEUROSURG, V102, P897, DOI 10.3171/jns.2005.102.5.0897; Ersahin M, 2011, TURK NEUROSURG, V21, P582, DOI [10.5137/1019-5149.JTN .4656-11.1, 10.5137/1019-5149.JTN.4656-11.1]; OHYE C, 1989, STEREOT FUNCT NEUROS, V52, P136, DOI 10.1159/000099494; Krieger MD, 1998, SEMIN SURG ONCOL, V14, P13; Kongkham PN, 2008, CAN J NEUROL SCI, V35, P79; Burkhardt JK, 2013, ACTA NEUROCHIR, V155, P721, DOI 10.1007/s00701-013-1639-7; Chen CC, 2009, CLIN NEUROL NEUROSUR, V111, P835, DOI 10.1016/j.clineuro.2009.08.013; ROSS DT, 1989, BRAIN RES, V501, P129, DOI 10.1016/0006-8993(89)91034-2; Beaumont A, 2000, ACTA NEUROCHIR, V142, P1, DOI 10.1007/s007010050001; Grossman R, 2005, ACTA NEUROCHIR, V147, P627, DOI 10.1007/s00701-005-0495-5; SLOPER JJ, 1980, BRAIN RES, V198, P204, DOI 10.1016/0006-8993(80)90356-X; Quinn J, 2011, NEUROSURGERY, V68, P217, DOI 10.1227/NEU.0b013e31820826c2; MAROON JC, 1977, J NEUROSURG, V46, P740, DOI 10.3171/jns.1977.46.6.0740; Kim JE, 2003, ACTA NEUROCHIR, V145, P547, DOI 10.1007/s00701-003-0048-8; KANDEL EI, 1972, J NEUROSURG, V37, P407, DOI 10.3171/jns.1972.37.4.0407; REVESZ T, 1993, BRAIN, V116, P781, DOI 10.1093/brain/116.4.781; Czyz M, 2014, NEUROSURG REV, V37, P127, DOI 10.1007/s10143-013-0486-6; Gralla J, 2003, ZBL NEUROCHIR, V64, P166; MOSSKIN M, 1989, ACTA RADIOL, V30, P225; LEKSELL L, 1985, J NEUROL NEUROSUR PS, V48, P14, DOI 10.1136/jnnp.48.1.14; Bekelis K, 2012, J NEUROSURG, V116, P1002, DOI 10.3171/2012.1.JNS111746; Breit Sorin, 2006, Neurosurgery, V58, pONS83; Ferreira MP, 2006, SURG NEUROL S1, V65, pS1; Guiot G, 1973, PROG NEUROL SURG, V5, P189; Leksell L., 1949, ACTA CHIR SCAND, V99, P229; Li CL, 1972, NEUROPHYSIOLOGY STUD, P49; Marossero F, 1973, PROG NEUROL SURG, V5, P355; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Zernov DN, 1889, P SOC PHYSICOMED MOS, V2, P70	41	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					978	988		10.3171/2014.10.JNS14963		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100023		
J	Sakai, K; Shimodaira, S; Maejima, S; Udagawa, N; Sano, K; Higuchi, Y; Koya, T; Ochiai, T; Koide, M; Uehara, S; Nakamura, M; Sugiyama, H; Yonemitsu, Y; Okamoto, M; Hongo, K				Sakai, Keiichi; Shimodaira, Shigetaka; Maejima, Shinya; Udagawa, Nobuyuki; Sano, Kenji; Higuchi, Yumiko; Koya, Terutsugu; Ochiai, Takanaga; Koide, Masanori; Uehara, Shunsuke; Nakamura, Midori; Sugiyama, Haruo; Yonemitsu, Yoshikazu; Okamoto, Masato; Hongo, Kazuhiro			Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma	JOURNAL OF NEUROSURGERY			English	Article						relapsed malignant glioma; dendritic cell; WT1; immunotherapy; oncology	NEWLY-DIAGNOSED GLIOBLASTOMA; CYTOTOXIC T-LYMPHOCYTES; WT1 PEPTIDE VACCINE; PHASE-I/II TRIAL; CANCER-IMMUNOTHERAPY; GENE-PRODUCT; ADJUVANT TEMOZOLOMIDE; CLINICAL-TRIAL; MULTIFORME; EXPRESSION	OBJECT Dendritic cell (DC) based vaccination is considered a potentially effective therapy against advanced cancer. The authors conducted a Phase I study to investigate the safety and immunomonitoring of Wilms' tumor 1 (WT1) pulsed DC vaccination therapy for patients with relapsed malignant glioma. METHODS WT1-pulsed and/or autologous tumor lysate pulsed DC vaccination therapy was performed in patients with relapsed malignant gliomas. Approximately 1 x 10(7) to 2 x 10(7) pulsed DCs loaded with WT1 peptide antigen and/or tumor lysate were intradermally injected into the axillary areas with OK-432, a streptococcal preparation, at 2-week intervals for at least 5-7 sessions (1 course) during an individual chemotherapy regimen. RESULTS Ten patients (3 men, 7 women; age range 24-64 years [median 39 years]) with the following tumors were enrolled: glioblastoma (6), anaplastic astrocytoma (2), anaplastic oligoastrocytoma (1), and anaplastic oligodendroglioma (1). Modified WT1 peptide-pulsed DC vaccine was administered to 7 patients, tumor lysate-pulsed DC vaccine to 2 patients, and both tumor lysate-pulsed and WT1-pulsed DC vaccine to 1 patient. The clinical response was stable disease in 5 patients with WT1-pulsed DC vaccination. In 2 of 5 patients with stable disease, neurological findings improved, and MR images showed tumor shrinkage. No serious adverse events occurred except Grade 1-2 erythema at the injection sites. WT1 tetramer analysis detected WT1-reactive cytotoxic T cells after vaccination in patients treated with WT1-pulsed therapy. Positivity for skin reaction at the injection sites was 80% (8 of 10 patients) after the first session, and positivity remained for these 8 patients after the final session. CONCLUSIONS This study of WT1-pulsed DC vaccination therapy demonstrated safety, immunogenicity, and feasibility in the management of relapsed malignant gliomas.	[Sakai, Keiichi; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Shimodaira, Shigetaka; Higuchi, Yumiko; Koya, Terutsugu] Shinshu Univ Hosp, Ctr Adv Cellular Therapy, Matsumoto, Nagano, Japan; [Maejima, Shinya; Udagawa, Nobuyuki] Matsumoto Dent Univ Hosp, Dendrit Cell Vaccinat Therapy Ctr, Shiojiri, Japan; [Ochiai, Takanaga] Matsumoto Dent Univ Hosp, Dept Oral Pathol, Shiojiri, Japan; [Koide, Masanori] Matsumoto Dent Univ Hosp, Inst Oral Sci, Shiojiri, Japan; [Uehara, Shunsuke; Nakamura, Midori] Matsumoto Dent Univ Hosp, Dept Biochem, Shiojiri, Japan; [Sano, Kenji] Shinshu Univ Hosp, Dept Lab, Matsumoto, Nagano, Japan; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan; [Yonemitsu, Yoshikazu] Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Higashi Ku, Fukuoka 812, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Minato Ku, Tokyo, Japan; [Sakai, Keiichi] Natl Hosp Org, Shinshu Ueda Med Ctr, Dept Neurosurg, Ueda, Nagano, Japan	Sakai, K (reprint author), Shinshu Univ, Sch Med, Dept Neurosurg, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	skeiichi@shinshu-u.ac.jp					Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Sampson JH, 2008, SEMIN IMMUNOL, V20, P267, DOI 10.1016/j.smim.2008.04.001; Takahashi H, 2013, EUR J CANCER, V49, P852, DOI 10.1016/j.ejca.2012.11.005; Chang CN, 2011, J CLIN NEUROSCI, V18, P1048, DOI 10.1016/j.jocn.2010.11.034; Kobayashi M, 2013, J GASTROINTEST SURG, V17, P1609, DOI 10.1007/s11605-013-2286-2; Morita S, 2006, JPN J CLIN ONCOL, V36, P231, DOI 10.1093/jjco/hyl005; Kimura Y, 2012, PANCREAS, V41, P195, DOI 10.1097/MPA.0b013e31822398c6; Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Yamanaka R, 2009, NEUROSURG REV, V32, P265, DOI 10.1007/s10143-009-0189-1; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Hashiba T, 2007, NEUROL MED-CHIR, V47, P165, DOI 10.2176/nmc.47.165; Bregy A, 2013, CANCER TREAT REV, V39, P891, DOI 10.1016/j.ctrv.2013.05.007; De Vleeschouwer S, 2008, CLIN CANCER RES, V14, P3098, DOI 10.1158/1078-0432.CCR-07-4875; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fujiki F, 2007, J IMMUNOTHER, V30, P282, DOI 10.1097/01.cji.0000211337.91513.94; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Saikali S, 2007, J NEURO-ONCOL, V81, P139, DOI 10.1007/s11060-006-9220-3; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Izumoto S, 2008, J NEUROSURG, V108, P963, DOI 10.3171/JNS/2008/108/5/0963; Scheibenbogen C, 2002, BLOOD, V100, P2132, DOI 10.1182/blood-2002-01-0163; Heimberger AB, 2008, NEURO-ONCOLOGY, V10, P98, DOI 10.1215/15228517-2007-046; Li ZY, 2005, INT J HEMATOL, V82, P458, DOI 10.1532/IJH97.05107; Nagayama H, 2003, MELANOMA RES, V13, P521, DOI 10.1097/01.cmr.0000056275.15046.fa; Sugiyama H, 2001, INT J HEMATOL, V73, P177, DOI 10.1007/BF02981935; Jie X, 2012, CELL BIOCHEM BIOPHYS, V62, P91, DOI 10.1007/s12013-011-9265-6; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ardon H, 2012, CANCER IMMUNOL IMMUN, V61, P2033, DOI 10.1007/s00262-012-1261-1; Sugiyama H, 2005, EXPERT REV VACCINES, V4, P503, DOI 10.1586/14760584.4.4-503; Fadul CE, 2011, J IMMUNOTHER, V34, P382, DOI 10.1097/CJI.0b013e318215e300; Kuwabara K, 2007, THYROID, V17, P53, DOI 10.1089/thy.2006.0178; Ardon H, 2010, J NEURO-ONCOL, V99, P261, DOI 10.1007/s11060-010-0131-y; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Oka Y, 2008, CURR OPIN IMMUNOL, V20, P211, DOI 10.1016/j.coi.2008.04.009; Gu Jin-Hai, 2008, Neurosci Bull, V24, P39, DOI 10.1007/s12264-008-1107-1; Hoos A, 2012, ANN ONCOL, V23, P47, DOI 10.1093/annonc/mds263; Saito S, 2015, CYTOTHERAPY, V17, P330, DOI 10.1016/j.jcyt.2014.10.003; Afra D, 2002, LANCET, V359, P1011	48	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					989	997		10.3171/2015.1.JNS141554		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100024		
J	Habu, M; Tokimura, H; Hirano, H; Yasuda, S; Nagatomo, Y; Iwai, Y; Kawagishi, J; Tatewaki, K; Yunoue, S; Campos, F; Kinoshita, Y; Shimatsu, A; Teramoto, A; Arita, K				Habu, Mika; Tokimura, Hiroshi; Hirano, Hirofumi; Yasuda, Soichiro; Nagatomo, Yasushi; Iwai, Yoshiyasu; Kawagishi, Jun; Tatewaki, Koshi; Yunoue, Shunji; Campos, Francia; Kinoshita, Yasuyuki; Shimatsu, Akira; Teramoto, Akira; Arita, Kazunori			Pituitary metastases: current practice in Japan	JOURNAL OF NEUROSURGERY			English	Article						pituitary metastasis; MRI; symptom; survival time; prognostic factor; oncology	CANCER INCIDENCE; SELLA TURCICA; GLAND; TUMORS; RADIOSURGERY; CARCINOMA; DIAGNOSIS; ADENOMA; MASSES	OBJECT With advancement of cancer treatment and development of neuroimaging techniques, contemporary clinical pictures of pituitary metastases (PMs) must have changed from past reports. The goal of this paper, was to elucidate the clinical features of PMs and current clinical practice related to those lesions. In this retrospective study, questionnaires were sent to 87 physicians who had treated PMs in Japan. RESULTS Between 1995 and 2010, 201 patients with PMs were treated by the participating physicians. The diagnosis of PM was histologically verified in 69 patients (34.3%). In the other 132 patients (65.7%), the PM was diagnosed by their physicians based on neuroimaging findings and clinical courses. The most frequent primary tumor was lung (36.8%), followed by breast (22.9%) and kidney (7.0%) cancer. The average interval between diagnosis of primary cancer and detection of PM was 2.8 +/- 3.9 (SD) years. Major symptoms at diagnosis were visual disturbance in 30.3%, diabetes insipidus in 27.4%, fatigue in 25.4%, headache in 20.4%, and double vision in 17.4%. Major neuroimaging features were mass lesion in the pituitary stalk (63.3%), constriction of tumor at the diaphragmatic hiatus (44.7%), hypothalamic mass lesion (17.4%), and hyperintensity in the optic tract (11.4%). Surgical treatment was performed in 26.9% of patients, and 74.6% had radiation therapy; 80.0% of patients who underwent radiotherapy had stereotactic radiotherapy. The median survival time was 12.9 months in total. Contributing factors for good prognosis calculated by Cox proportional hazard analysis were younger age, late metastasis to the pituitary gland, smaller PM size, and radiation therapy. The Kaplan-Meier survival was significantly better in patients with breast cancer and renal cell cancer than in those with lung cancer. CONCLUSIONS At the time of this writing, approximately 60% (120/201) of PMs had been treated by stereotactic radiation therapy in Japan. The median survival time was much longer than that reported in past series. To confirm the changes of clinical features and medical practice, a prospective and population-based survey is mandatory.	[Habu, Mika; Tokimura, Hiroshi; Hirano, Hirofumi; Yunoue, Shunji; Campos, Francia; Arita, Kazunori] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, Kagoshima 8908520, Japan; [Yasuda, Soichiro] Shiroyama Hosp, Dept Neurosurg, Habikino, Japan; [Nagatomo, Yasushi] Kouseikai Takai Hosp, Dept Neurosurg, Tenri, Nara, Japan; [Iwai, Yoshiyasu] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; [Kawagishi, Jun] Furukawa Seiryo Hosp, Jiro Suzuki Mem Gamma House, Osaka, Japan; [Tatewaki, Koshi] Shinryoku Neourosurg Clin, Yokohama CyberKnife Ctr, Yokohama, Kanagawa, Japan; [Kinoshita, Yasuyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan; [Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan; [Teramoto, Akira] Tokyo Rosai Occupat Dis & Injuries Hosp, Tokyo, Japan	Hirano, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	hirahira@m2.kufm.kagoshima-u.ac.jp			National Cancer Center Research and Development Fund [21-8-6]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20591716]; Health and Labor Sciences Research grant on "Research on Intractable Diseases in Japan: Hypothalamo-Pituitary Dysfunction"	This study was financed by the National Cancer Center Research and Development Fund (grant no. 21-8-6: "Diagnosis and Treatment of Intractable Endocrine Tumors" by principal investigator, Dr. Akira Shimatsu) and supported by a Health and Labor Sciences Research grant on "Research on Intractable Diseases in Japan: Hypothalamo-Pituitary Dysfunction," and by a grant-in-aid (no. 20591716) awarded to Dr. Kazunori Arita from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the paper reported.	BRANCH CL, 1987, J CLIN ENDOCR METAB, V65, P469; Ntyonga-Pono MP, 1999, PRESSE MED, V28, P1567; KISTLER M, 1975, AM J ROENTGENOL, V123, P13; Bakhtiar Y, 2014, PITUITARY, V17, P142, DOI 10.1007/s11102-013-0479-z; Freda PU, 1999, ENDOCRIN METAB CLIN, V28, P81, DOI 10.1016/S0889-8529(05)70058-X; Morita A, 1998, J NEUROSURG, V89, P69, DOI 10.3171/jns.1998.89.1.0069; Komninos J, 2004, J CLIN ENDOCR METAB, V89, P574, DOI 10.1210/jc.2003-030395; NELSON PB, 1987, NEUROSURGERY, V21, P941; Iwai Y, 2004, NEUROL MED-CHIR, V44, P112, DOI 10.2176/nmc.44.112; SCHUBIGER O, 1992, NEURORADIOLOGY, V34, P131; HOUCK WA, 1970, CANCER, V26, P656, DOI 10.1002/1097-0142(197009)26:3<656::AID-CNCR2820260325>3.0.CO;2-M; Gsponer J, 1999, MEDICINE, V78, P236, DOI 10.1097/00005792-199907000-00004; Zoli M, 2013, WORLD NEUROSURG, V79, P327, DOI 10.1016/j.wneu.2012.03.018; Yasuda A, 2004, NEUROSURGERY, V55, P179, DOI 10.1227/01.NEU.0000126953.59406.77; MAX MB, 1981, NEUROLOGY, V31, P998; Saeki N, 2001, BRIT J NEUROSURG, V15, P523, DOI 10.1080/026886901317195482; TEEARS RJ, 1975, CANCER, V36, P216, DOI 10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-E; Troisi R, 2012, CANCER CAUSE CONTROL, V23, P1047, DOI 10.1007/s10552-012-9973-2; Sioutos P, 1996, ANN SURG ONCOL, V3, P94, DOI 10.1007/BF02409058; Kano H, 2009, SURG NEUROL, V72, P248, DOI 10.1016/j.surneu.2008.06.003; DUCHEN LW, 1966, J PATHOL BACTERIOL, V91, P347, DOI 10.1002/path.1700910208; Pinet C, 2000, PRESSE MED, V29, P17; Bellew Susun, 2009, J Clin Aesthet Dermatol, V2, P34; CHIANA MF, 1990, NEUROCHIRURGIA, V33, P127; Committee of Brain Tumor Registry of Japan, 2009, NEUROL MED CHIR, V49, pPS1; Fassett Daniel R, 2004, Neurosurg Focus, V16, pE8; HAGERSTR.I, 1969, ACTA PATHOL MIC SC, V75, P64; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.3.CO;2-2; KOVACS K, 1973, ONCOLOGY-BASEL, V27, P533; McCormick P C, 1989, Br J Neurosurg, V3, P71, DOI 10.3109/02688698909001028; Ruelle A, 1992, J Neurosurg Sci, V36, P51	31	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					998	1007		10.3171/2014.12.JNS14870		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100025		
J	Kanamori, H; Kitamura, Y; Kimura, T; Yoshida, K; Sasaki, H				Kanamori, Hiroki; Kitamura, Yohei; Kimura, Tokuhiro; Yoshida, Kazunari; Sasaki, Hikaru			Genetic characterization of skull base chondrosarcomas	JOURNAL OF NEUROSURGERY			English	Article						skull base chondrosarcomas; chordoma; comparative genomic hybridization; IDH1; IDH2; brachyury; oncology	COMPARATIVE GENOMIC HYBRIDIZATION; IDH2 MUTATIONS; CHORDOMA; TUMORS; PROGNOSIS; BRACHYURY; CYTOGENETICS; ABERRATIONS; AGE	OBJECT Although chondrosarcomas rarely arise in the skull base, chondrosarcomas and chordomas are the 2 major malignant bone neoplasms occurring at this location. The distinction of these 2 tumors is important, but this distinction is occasionally problematic because of radiological and histological overlap. Unlike chordoma and extracranial chondrosarcoma, no case series presenting a whole-genome analysis of skull base chondrosarcomas (SBCSs) has been reported. The goal of this study is to clarify the genetic characteristics of SBCSs and contrast them with those of chordomas. METHODS The authors analyzed 7 SBCS specimens for chromosomal copy number alterations (CNAs) using comparative genomic hybridization (CGH). They also examined IDH1 and IDH2 mutations and brachyury expression. RESULTS In CGH analyses, the authors detected CNAs in 6 of the 7 cases, including chromosomal gains of 8q21.1, 19, 2q22-q32, 5qcen-q14, 8q21-q22, and 15qcen-q14. Mutation of IDH1 was found with a high frequency (5 of 7 cases, 71.4%), of which R132S was most frequently mutated. No IDH2 mutations were found, and immunohistochemical staining for brachyury was negative in all cases. CONCLUSIONS To the best of the authors' knowledge, this is the first whole-genome study of an SBSC case series. Their findings suggest that these tumors are molecularly consistent with a subset of conventional central chondrosarcomas and different from skull base chordomas.	[Kanamori, Hiroki; Kitamura, Yohei; Yoshida, Kazunari; Sasaki, Hikaru] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1608582, Japan; [Kimura, Tokuhiro] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan	Kitamura, Y (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ykita@sc4.so-net.ne.jp			Japan Society for the Promotion of Science KAKENHI [26861166]	This work was financially supported by Japan Society for the Promotion of Science KAKENHI (26861166). The authors report that they have no personal financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Szuhai K, 2012, CANCER GENET-NY, V205, P193, DOI 10.1016/j.cancergen.2012.04.001; Larramendy ML, 1997, AM J PATHOL, V150, P685; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Hirose Y, 2001, J MOL DIAGN, V3, P62, DOI 10.1016/S1525-1578(10)60653-8; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; Jambhekar NA, 2010, ARCH PATHOL LAB MED, V134, P1181, DOI 10.1043/2009-0476-OA.1; Larramendy ML, 1999, HUM PATHOL, V30, P1247, DOI 10.1016/S0046-8177(99)90045-X; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Arai M, 2012, BRAIN TUMOR PATHOL, V29, P201, DOI 10.1007/s10014-012-0085-1; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hameed M, 2009, CANCER GENET CYTOGEN, V192, P56, DOI 10.1016/j.cancergencyto.2009.03.009; Scheil-Bertram S, 2014, INT J ONCOL, V44, P1041, DOI 10.3892/ijo.2014.2268; Ozaki T, 2004, ANTICANCER RES, V24, P1721; [Anonymous], 2011, CBTRUS STAT REP PRIM; GOLLIN SM, 1994, J NEURO-ONCOL, V20, P241, DOI 10.1007/BF01053042; Almefty K, 2007, CANCER, V110, P2457, DOI 10.1002/cncr.23073; Oakley GJ, 2008, MODERN PATHOL, V21, P1461, DOI 10.1038/modpathol.2008.144; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Rozeman LB, 2006, CANCER, V107, P380, DOI 10.1002/cncr.22001; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Rosenberg AE, 1999, AM J SURG PATHOL, V23, P1370, DOI 10.1097/00000478-199911000-00007; Bohman LE, 2014, WORLD NEUROSURG, V82, P806, DOI 10.1016/j.wneu.2014.07.005; Fletcher Ch, 2013, WHO CLASSIFICATION T; Kitamura Y, 2013, J NEUROPATH EXP NEUR, V72, P816, DOI 10.1097/NEN.0b013e3182a065d0; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846	28	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					1036	1041		10.3171/2014.12.JNS142059		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100028		
J	Takahashi, N; Fujiwara, K; Saito, K; Tominaga, T				Takahashi, Noboru; Fujiwara, Kazunori; Saito, Keiichi; Tominaga, Teiji			Interdigitated craniotomy: a simple technique to fix a bone flap with only a single plate	JOURNAL OF NEUROSURGERY			English	Article						craniotomy; fixation; plate; surgical technique	FIXATION	In pterional craniotomy, fixation plates cause artifacts on postoperative radiological images; furthermore, they often disfigure the scalp in hairless areas. The authors describe a simple technique to fix a cranial bone flap with only a single plate underneath the temporalis muscle in an area with hair, rather than using a plate in a hairless area. The key to this technique is to cut the anterior site of the bone flap at alternate angles on the cut surface. Interdigitation between the bone flap and skull enables single-plate fixation in the area with hair, which reduces artifacts on postoperative radiological images and provides excellent postoperative cosmetic results.	[Takahashi, Noboru; Fujiwara, Kazunori; Saito, Keiichi] Iwate Prefectural Iwai Hosp, Dept Neurosurg, Ichinoseki, Iwate 0210192, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Takahashi, N (reprint author), Iwate Prefectural Iwai Hosp, Dept Neurosurg, 17 Odaira, Ichinoseki, Iwate 0210192, Japan.	takahashi.iwai@gmail.com					Lerch KD, 1999, NEUROSURGERY, V44, P902, DOI 10.1097/00006123-199904000-00137; Broaddus WC, 2002, J NEUROSURG, V96, P244, DOI 10.3171/jns.2002.96.2.0244; SMITH SC, 1991, NEUROSURGERY, V29, P417; Winston KR, 2003, J NEUROSURG, V99, P484, DOI 10.3171/jns.2003.99.3.0484; Spetzler RF, 1997, J NEUROSURG, V87, P475, DOI 10.3171/jns.1997.87.3.0475; MACCARTY CS, 1972, J NEUROSURG, V36, P114, DOI 10.3171/jns.1972.36.1.0114; Shimizu S, 2009, NEUROL SURG TOKYO, V37, P43; Fukunaga Y, 2011, J JPN CRANIO MAX FAC, V27, P279; Di Lorenzo N, 2004, J Neurosurg Sci, V48, P55; Okuda T, 2003, J JAPAN SOC CRANIO M, V19, P261	10	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					1055	1058		10.3171/2014.10.JNS141034		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100032		
J	Yokosuka, K; Uno, M; Matsumura, K; Takai, H; Hagino, H; Matsushita, N; Toi, H; Matsubara, S				Yokosuka, Kimihiko; Uno, Masaaki; Matsumura, Kohei; Takai, Hiroki; Hagino, Hirotaka; Matsushita, Nobuhisa; Toi, Hiroyuki; Matsubara, Shunji			Endoscopic hematoma evacuation for acute and subacute subdural hematoma in elderly patients	JOURNAL OF NEUROSURGERY			English	Article						acute subdural hematoma; elderly patients; endoscopic hematoma evacuation; subacute subdural hematoma; surgical technique	SURGERY	OBJECT Endoscopic surgery was performed for acute or subacute subdural hematoma (SDH), and its effectiveness and safety in elderly patients were evaluated. METHODS Between September 2007 and November 2013, endoscopic surgery was performed in 11 elderly patients with acute SDH (8 patients) and subacute SDH (3 patients). The criteria for surgery were as follows: 1) the presence of clinical symptoms; 2) age older than 70 years; 3) no brain injury (intracerebral hematoma, brain contusion); 4) absence of an enlarging SDH; and 5) no high risk of bleeding. Hematoma evacuation was performed with a 4-mm rigid endoscope with a 00 lens and a malleable irrigation suction cannula. RESULTS Endoscopic surgery was performed under local anesthesia. The mean age of the patients was 82.6 years (range 73-91 years). There were 5 female and 6 male patients. The mean preoperative Glasgow Coma Scale score was 12, and 5 patients had been receiving antithrombotic drug therapy. The mean operation time was 85 minutes. Only 1 patient had rebleeding, and reoperation with the same technique was performed uneventfully in this individual. A total of 7 patients had a good recovery (modified Rankin Scale Score 0-2) at discharge. CONCLUSIONS Endoscopic hematoma evacuation of acute and subacute SDH is a safe and effective method of clot removal that minimizes operative complications. This technique may be a less invasive method for treating elderly patients with acute and subacute SDHs.	[Yokosuka, Kimihiko; Uno, Masaaki; Matsumura, Kohei; Takai, Hiroki; Hagino, Hirotaka; Matsushita, Nobuhisa; Toi, Hiroyuki; Matsubara, Shunji] Kawasaki Med Univ, Dept Neurosurg, Kurashiki, Okayama 7010192, Japan	Yokosuka, K (reprint author), Kawasaki Med Univ, Dept Neurosurg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	n.s.hiko@me.com					Hellwig D, 2000, NEUROSURG CLIN N AM, V11, P525; RODZIEWICZ GS, 1995, SURG NEUROL, V43, P569, DOI 10.1016/0090-3019(95)00005-4; Codd PJ, 2013, J CLIN NEUROSCI, V20, P1751, DOI 10.1016/j.jocn.2013.02.019; Mobbs R, 2009, J CLIN NEUROSCI, V16, P701, DOI 10.1016/j.jocn.2008.06.023; Masopust V, 2003, MINIM INVAS NEUROSUR, V46, P374, DOI 10.1055/s-2003-812507; Hellwig D, 1996, SURG NEUROL, V45, P272, DOI 10.1016/0090-3019(95)00417-3; KARAKHAN VB, 1994, ACT NEUR S, V61, P84; Nagasaka T, 2009, NEUROSURGERY, V65, P826, DOI 10.1227/01.NEU.0000350985.58062.3F; Izumihara A, 2013, NEUROL MED-CHIR, V53, P323; Okumura Y, 1998, NEUROL SURG TOKYO, V26, P691; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Izumihara A, 1997, NEUROL SURG TOKYO, V25, P307; MCKISSOCK W, 1960, LANCET, V1, P1365; Izumihara A, 2010, NEUROSURG EMERG, V15, P149; Kameyama M, 2013, NEUROTRAUMATOLOGY, V36, P10; Yamada T, 2011, NEUROSURG EMERG, V16, P43	16	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2015	123	4					1065	1069		10.3171/2014.10.JNS14915		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS1XV	WOS:000361863100034		
J	Hosoki, A; Oku, H; Horie, T; Kida, T; Sugiyama, T; Nakamura, K; Ikeda, T				Hosoki, Akiko; Oku, Hidehiro; Horie, Taeko; Kida, Teruyo; Sugiyama, Tetsuya; Nakamura, Kimitoshi; Ikeda, Tsunehiko			Changes in Expression of Nestin, CD44, Vascular Endothelial Growth Factor, and Glutamine Synthetase by Mature Muller Cells After Dedifferentiation	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							MESSENGER-RNA; RAT RETINA; CHOROIDAL NEOVASCULARIZATION; INTERMEDIATE-FILAMENT; CHICKEN RETINA; RECEPTOR CD44; UP-REGULATION; HYALURONAN; DEGENERATION; ANGIOGENESIS	Purpose: Muller cells are dedifferentiated after retinal injuries and are transformed into nestin-positive progenitor cells that play crucial roles in remodeling. The purpose of this study was to determine the changes in the expression of nestin, CD44 (a receptor of hyaluronan), vascular endothelial growth factor (VEGF), and glutamine sythetase in cultured Muller cells after dedifferentiation by basic fibroblast growth factor (bFGF) and insulin. Methods: Cells from a rat retinal Muller cell line (TR-MUL5) and from primary rat retinal Muller cells were grown in culture. The cells were incubated in various concentrations of bFGF (1.0, 10, 100ng/mL) with or without insulin (5M) for 48h. Changes in the expression of nestin, CD44, VEGF, and glutamine synthetase were determined by immunoblot and immunohistochemistry. Results: Exposure of TR-MUL5 cells to 10ng/mL of bFGF led to the maximum increase in nestin by 1.5-fold, whereas the exposure had no effects on the expression of CD44. Addition of insulin (5M) to the bFGF significantly increased the CD44 level in TR-MUL5 cells by 1.4-fold. Immunohistochemistry showed that the combined treatments also upregulated the expression of nestin and CD44 in primary retinal Muller cells. Immunoblot analyses showed that exposure to bFGF and insulin caused significant increases of nestin (4.9-fold), CD44 (3.4-fold), and VEGF (1.44-fold) and decreases in glutamine synthetase (0.7-fold). Conclusions: The inflammation and angiogenesis that develop after retinal injuries may be due to an upregulation of CD44 and VEGF by the dedifferentiated Muller cells.	[Hosoki, Akiko; Oku, Hidehiro; Horie, Taeko; Kida, Teruyo; Sugiyama, Tetsuya; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka 5698686, Japan; [Nakamura, Kimitoshi] Nakamura Eye Clin, Nagano, Japan	Oku, H (reprint author), Osaka Med Coll, Dept Ophthalmol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	hidehirooku@aol.com					Adachi K, 1998, GRAEF ARCH CLIN EXP, V236, P766, DOI 10.1007/s004170050156; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.04-1376fje; MILLER JW, 1994, AM J PATHOL, V145, P574; Gao H, 1996, EXP EYE RES, V62, P181, DOI 10.1006/exer.1996.0022; CHAITIN MH, 1994, EXP EYE RES, V58, P359, DOI 10.1006/exer.1994.1026; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Cao W, 1997, INVEST OPHTH VIS SCI, V38, P1358; GAO H, 1995, DEV BIOL, V169, P168, DOI 10.1006/dbio.1995.1135; Wakabayashi Y, 2006, RETINA-J RET VIT DIS, V26, P432, DOI 10.1097/00006982-200604000-00009; Kruchkova Y, 2001, J NEUROCHEM, V77, P1641, DOI 10.1046/j.1471-4159.2001.00390.x; Xu HP, 2002, J LEUKOCYTE BIOL, V72, P1133; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Poitry S, 2000, J NEUROSCI, V20, P1809; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Li F, 1999, EXP EYE RES, V68, P19, DOI 10.1006/exer.1998.0572; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Cao W, 1998, INVEST OPHTH VIS SCI, V39, P565; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; Tomi M, 2003, GLIA, V43, P208, DOI 10.1002/glia.10253; Ambati J, 1997, ARCH OPHTHALMOL-CHIC, V115, P1161; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Krishnamoorthy R, 2000, MOL BRAIN RES, V77, P125, DOI 10.1016/S0169-328X(00)00035-8; Fischer AJ, 2002, J NEUROSCI, V22, P9387; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; LAURENT TC, 1992, FASEB J, V6, P2397; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Chaitin MH, 1998, EXP EYE RES, V67, P283, DOI 10.1006/exer.1998.0510; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; Abu El-Asrar AM, 2011, ACTA OPHTHALMOL, V89, pE115, DOI 10.1111/j.1755-3768.2010.01916.x; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063	41	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	OCT 1	2015	31	8					476	481		10.1089/jop.2014.0117		6	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	CS7NP	WOS:000362270600006		
J	Aihara, M; Adachi, M; Hamada, N; Honda, N; Koseki, N; Matsuo, H; Miyata, K; Otani, S; Unoki, K				Aihara, Makoto; Adachi, Misato; Hamada, Naoki; Honda, Norihiko; Koseki, Nobuyuki; Matsuo, Hiroshi; Miyata, Kazunori; Otani, Shin-ichiro; Unoki, Kazuhiko			Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; TARTRATE 0.2-PERCENT; CLINICAL-TRIAL; 0.5-PERCENT; MALEATE; EFFICACY; SAFETY; LATANOPROST; 1-YEAR	Purpose: To assess the efficacy and safety of switching from timolol 0.5% to brimonidine 0.1% in patients with glaucoma treated with a prostaglandin analog (PGA) and timolol combination. Methods: This prospective, open-label multicenter study enrolled patients with open-angle glaucoma or ocular hypertension who were being treated with a PGA and timolol. After baseline measurements, timolol was switched to brimonidine 0.1%, and patients were followed for 12 weeks. Patients visited at 4 and 12 weeks after switching. The main outcome measure was the change in intraocular pressure (IOP). For safety evaluations, hyperemia, formation of conjunctival follicles, superficial punctate keratopathy as a local side effect, blood pressure (BP), and heart rate (HR) were evaluated. Results: One hundred seven patients participated in this study. Among them, 103 patients completed the study. The IOP values at baseline, 4 weeks, and 12 weeks after the transition were 15.72.7, 14.3 +/- 2.8, and 14.0 +/- 2.8mmHg, respectively. IOP was significantly reduced at 4 and 12 weeks compared with baseline (p<0.001). There were no significant changes in hyperemia or follicle formation. The superficial punctate keratopathy score was significantly reduced at 12 weeks compared with baseline (p<0.05). Systolic and diastolic BP values were significantly reduced and HR significantly increased after switching (p<0.05). Conclusion: Switching from timolol 0.5% to brimonidine 0.1% may not change IOP in the combination use of timolol 0.5% and a PGA and was well tolerated by patients without severe ocular or systemic side effects.	[Aihara, Makoto] Shirato Eye Clin, Tokyo 1600004, Japan; [Adachi, Misato] Eye Rose Clin, Tokyo, Japan; [Hamada, Naoki] Omiya Hamada Eye Clin, Saitama, Kanagawa, Japan; [Honda, Norihiko] Honda Eye Clin, Saitama, Kanagawa, Japan; [Koseki, Nobuyuki] Koseki Eye Clin, Saitama, Japan; [Matsuo, Hiroshi] Matsuo Eye Clin, Tokyo, Japan; [Miyata, Kazunori] Miyata Eye Hosp, Miyazaki, Japan; [Otani, Shin-ichiro] Kagoshima Miyata Eye Clin, Miyazaki, Japan; [Unoki, Kazuhiko] Unoki Eye Clin, Kagoshima, Japan	Aihara, M (reprint author), Shirato Eye Clin, Shinjuku Ku, 1-1-2 Yotsuya, Tokyo 1600004, Japan.	aihara-tky@umin.ac.jp					WEISSMAN SS, 1990, BRIT J OPHTHALMOL, V74, P409, DOI 10.1136/bjo.74.7.409; Netland PA, 2003, ADV THER, V20, P20, DOI 10.1007/BF02850116; LeBlanc RP, 1998, OPHTHALMOLOGY, V105, P1960, DOI 10.1016/S0161-6420(98)91048-X; Baudouin C, 2008, ACTA OPHTHALMOL, V86, P716, DOI 10.1111/j.1755-3768.2008.01250.x; Katz LJ, 1999, AM J OPHTHALMOL, V127, P20, DOI 10.1016/S0002-9394(98)00286-4; Javitt JC, 2000, J GLAUCOMA, V9, P224; Stewart WC, 2002, ACTA OPHTHALMOL SCAN, V80, P277, DOI 10.1034/j.1600-0420.2002.800309.x; Melamed S, 2000, CLIN THER, V22, P103, DOI 10.1016/S0149-2918(00)87981-3; Schuman JS, 2000, OPHTHALMOLOGY, V107, P1171, DOI 10.1016/S0161-6420(00)00081-6; MACLURE GM, 1983, T OPHTHAL SOC UK, V103, P78; VANBUSKIRK EM, 1979, AM J OPHTHALMOL, V88, P739; Reis R, 2006, CLIN THER, V28, P552, DOI 10.1016/j.clinthera.2006.04.007; Stewart WC, 2004, EYE, V18, P990, DOI 10.1038/sj.eye.6701375; NORDLUND JR, 1995, ARCH OPHTHALMOL-CHIC, V113, P77; Lemp MA, 1995, EYE CONTACT LENS, V21, P221, DOI DOI 10.1016/J.SURV0PHTHAL.2007.04.009; Schuman JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P847; Wilensky JT, 1996, SURV OPHTHALMOL, V41, pS3, DOI 10.1016/S0039-6257(96)82026-1	17	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	OCT 1	2015	31	8					482	486		10.1089/jop.2014.0174		5	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	CS7NP	WOS:000362270600007		
J	Koyama, K; Miyazaki, K; Abe, K; Ikuta, K; Egawa, Y; Kitta, T; Kido, H; Sano, T; Takahashi, Y; Nezu, T; Nohara, H; Miyashita, T; Yada, H; Yamazaki, K; Watanabe, Y				Koyama, Kazuo; Miyazaki, Kinuko; Abe, Kousuke; Ikuta, Keiich; Egawa, Yoshitsugu; Kitta, Tadashi; Kido, Hirotsugu; Sano, Takashi; Takahashi, Yukinari; Nezu, Toru; Nohara, Hidenori; Miyashita, Takashi; Yada, Hiroshi; Yamazaki, Kumiko; Watanabe, Yomi			Optimization of an Indirect Enzymatic Method for the Simultaneous Analysis of 3-MCPD, 2-MCPD, and Glycidyl Esters in Edible Oils	JOURNAL OF OLEO SCIENCE			English	Article						indirect enzymatic method; lipase; 3-MCPD; 2-MCPD; glycidol	FATTY-ACID ESTERS	We developed a novel, indirect enzymatic method for the analysis of fatty acid esters of 3-monochloro-1,2-propanediol (3-MCPD), 2-monochloro-1,3-propanediol (2-MCPD), and glycidol (Gly) in edible oils and fats. Using this method, the ester analytes were rapidly cleavaged by Candida rugosa lipase at room temperature for 0.5 h. As a result of the simultaneous hydrolysis and bromination steps, 3-MCPD esters, 2-MCPD esters, and glycidyl esters were converted to free 3-MCPD, 2-MCPD, and 3-monobromo-1,2-propanediol (3-MBPD), respectively. After the addition of internal standards, the mixtures were washed with hexane, derivatized with phenylboronic acid, and analyzed by gas chromatography-mass spectrometer (GC-MS). The analytical method was evaluated in preliminary and feasibility studies performed by 13 laboratories. The preliminary study from 4 laboratories showed the reproducibility (RSDR) of < 10% and recoveries in the range of 102-111% for the spiked 3-MCPD and 2-MCPD in extra virgin olive (EVO) oil, semi-solid palm oil, and solid palm oil. However, the RSDR and recoveries of Gly in the palm oil samples were not satisfactory. The Gly content of refrigerated palm oil samples decreased whereas the samples at room temperature were stable for three months, and this may be due to the depletion of Gly during cold storage. The feasibility studies performed by all 13 laboratories were conducted based on modifications of the shaking conditions for ester cleavage, the conditions of Gly bromination, and the removal of gel formed by residual lipase. Satisfactory RSDR were obtained for EVO oil samples spiked with standard esters (4.4% for 3-MCPD, 11.2% for 2-MCPD, and 6.6% for Gly).	[Koyama, Kazuo; Miyazaki, Kinuko] House Foods Grp Inc, Cent Res & Dev Inst, Yotsukaido, Chiba 2840033, Japan; [Abe, Kousuke] Nisshin Oillio Grp Ltd, Cent Res Lab, Anal & Assessment, Yokosuka, Kanagawa 2390832, Japan; [Ikuta, Keiich] Japan Oilstuff Inspectors Corp, Analyt Tech Lab, Minami Ku, Yokohama, Kanagawa 2320073, Japan; [Egawa, Yoshitsugu] Fuji Oil Co Ltd, Qual Assurance Dept, Analyt Ctr Food Safety, Izumisano, Osaka 5988540, Japan; [Kitta, Tadashi] Japan Frozen Foods Inspect Corp, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kido, Hirotsugu] Japan Assoc Inspect & Invest Foods Including Fats, Chou Ku, Tokyo 1030007, Japan; [Sano, Takashi] J Oil Mills Inc, Fundamental Res Lab, Yokohama, Kanagawa 2300053, Japan; [Takahashi, Yukinari] House Food Analyt Lab Inc, Analyt & Technol Solut Serv, Yotsukaido, Chiba 2840033, Japan; [Nezu, Toru] ADEKA Corp, Food Dev Lab, Arakawa Ku, Tokyo 1168553, Japan; [Nohara, Hidenori] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, Tokyo 1318501, Japan; [Miyashita, Takashi] Kewpie Corp, Qual Assurance Div, Tokyo 1820002, Japan; [Yada, Hiroshi] NARO, NFRI, Tsukuba, Ibaraki 3058642, Japan; [Yamazaki, Kumiko] Saito Lab, Japan Food Res Labs, Ibaraki, Osaka 5670085, Japan; [Watanabe, Yomi] Osaka Municipal Tech Res Inst, Joto Ku, Osaka 5368553, Japan	Koyama, K (reprint author), House Foods Grp Inc, Cent Res & Dev Inst, 1-4 Takanodai, Yotsukaido, Chiba 2840033, Japan.	k-koyama@housefoods.co.jp					Am. Oil Chem. Soc, 2013, CD2810; Am. Oil Chem. Soc, 2013, CD29A; Kuhlmann J, 2011, EUR J LIPID SCI TECH, V113, P335, DOI 10.1002/ejlt.201000313; MacMahon S, 2013, FOOD ADDIT CONTAM A, V30, P2081, DOI 10.1080/19440049.2013.840805; Hori K, 2012, LWT-FOOD SCI TECHNOL, V48, P204, DOI 10.1016/j.lwt.2012.03.014; Yamazaki K, 2013, FOOD ADDIT CONTAM A, V30, P52, DOI 10.1080/19440049.2012.713031; Miyazaki K, 2012, J AM OIL CHEM SOC, V89, P1403, DOI 10.1007/s11746-012-2047-5; Weisshaar R, 2008, EUR J LIPID SCI TECH, V110, P183, DOI 10.1002/ejlt.200700197; Collison M. W., 2013, OILS 104 AOCS ANN M; Crews C., 2012, FOOD ADDIT CONTAM A, V30, P11; Japan Oil Chem. Soc, 2013, JOCS STAND METH AN F; Weisshaar R, 2010, EUR J LIPID SCI TECH, V112, P158, DOI 10.1002/ejlt.200900137; Wenzl T., 2015, EFSA SUPPORTING PUBL	13	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	OCT	2015	64	10					1057	1064		10.5650/jos.ess15100		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CS7CV	WOS:000362242600003		
J	Yamamoto, Y; Kijima, T; Morikawa, T; Nonomura, Y				Yamamoto, Yoshiaki; Kijima, Tatsuro; Morikawa, Toshiya; Nonomura, Yoshimune			Lubricant and Bactericidal Properties of Calcium Salts of Fatty Acids: Effect of Degree of Unsaturation	JOURNAL OF OLEO SCIENCE			English	Article						calcium salts of fatty acids; degree of unsaturation; crystal structure; friction property; bactericidal ability	STAPHYLOCOCCUS-AUREUS; TRIBOLOGY; MECHANISM; PROTEINS; POWDER; SOAPS	Fatty acids containing a C18 alkyl chain such as stearic acid (C18:0 fatty acid), oleic acid (C18:1 fatty acid) and linoleic acid (C18:2 fatty acid) are common emulsifiers in skin-care products and cosmetics and are also used in skin cleansers. In this study, we prepared calcium salts (Ca salts) of the above fatty acids to determine the effect of the degree of unsaturation of the alkyl chain. Scanning electron microscopy images and X-ray diffraction patterns show that C18:0 and C18:1 fatty acid Ca salts are plate-shaped, lamellar-crystalline powder, while C18:2 fatty acid Ca salt is amorphous powder. Therefore, C18:2 fatty acid Ca salt exhibits a lower lubrication ability than do C18:0 and C18:1 fatty acid Ca salts. In addition, the bactericidal ability against Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes improved with increasing degree of unsaturation. These findings suggest that Ca salts of unsaturated fatty acids have potential applications in cleansing and cosmetic products.	[Yamamoto, Yoshiaki; Kijima, Tatsuro; Nonomura, Yoshimune] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan; [Morikawa, Toshiya] Kao Corp, Skin Beauty Labs, Sumida Ku, Tokyo 1318501, Japan	Nonomura, Y (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	nonoy@yz.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22540417]	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22540417) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	FELDLAUFER MF, 1993, APIDOLOGIE, V24, P95, DOI 10.1051/apido:19930202; Bojar RA, 2004, CLIN DERMATOL, V22, P375, DOI 10.1016/j.clindermatol.2004.03.005; Sahoo RR, 2009, J COLLOID INTERF SCI, V333, P707, DOI 10.1016/j.jcis.2009.01.046; Nonomura Y, 2002, CHEM LETT, P216, DOI 10.1246/cl.2002.216; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028; Lesmes U, 2009, FOOD HYDROCOLLOID, V23, P667, DOI 10.1016/j.foodhyd.2008.04.003; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Desbois AP, 2008, APPL MICROBIOL BIOT, V81, P755, DOI 10.1007/s00253-008-1714-9; Kuramitsu K, 2013, CHEM LETT, V42, P284, DOI 10.1246/cl.2013.284; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Ralston AW, 1942, J ORG CHEM, V7, P546, DOI 10.1021/jo01200a013; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; GREGORY JN, 1947, NATURE, V159, P403, DOI 10.1038/159403a0; VOLD RD, 1949, IND ENG CHEM, V41, P2311, DOI 10.1021/ie50478a056; Yano J, 1999, J LIPID RES, V40, P140; BRISCOE BJ, 1973, PROC R SOC LON SER-A, V333, P99, DOI 10.1098/rspa.1973.0050; Beneventi D, 2001, J COLLOID INTERF SCI, V237, P142, DOI 10.1006/jcis.2001.7431; Nonomura Y, 2002, B CHEM SOC JPN, V75, P2305, DOI 10.1246/bcsj.75.2305; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233; Seidel V, 2004, INT J ANTIMICROB AG, V23, P613, DOI 10.1016/j.ijantimicag.2003.11.008; VOLD RD, 1951, J AM CHEM SOC, V73, P2006, DOI 10.1021/ja01149a032; GARNIER P, 1988, J MATER SCI, V23, P3225, DOI 10.1007/BF00551298; TAKEHARA M, 1989, COLLOID SURFACE, V38, P149, DOI 10.1016/0166-6622(89)80151-9; WENDT RE, 1954, J AM OIL CHEM SOC, V31, P590, DOI 10.1007/BF02638578; Yamamoto Y, 2015, J OLEO SCI, V64, P283, DOI 10.5650/jos.ess14176	27	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	OCT	2015	64	10					1095	1100		10.5650/jos.ess15090		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CS7CV	WOS:000362242600007		
J	Ono, T; Usami, A; Nakaya, S; Maeloa, K; Yonejima, Y; Toyoda, M; Ikeda, A; Miyazawa, M				Ono, Toshirou; Usami, Atsushi; Nakaya, Satoshi; Maeloa, Keisuke; Yonejima, Yasunori; Toyoda, Masanori; Ikeda, Atsushi; Miyazawa, Mitsuo			Chemical Compositions and Aroma Evaluation of Volatile Oil from the Industrial Cultivation Medium of Enterococcus faecalis	JOURNAL OF OLEO SCIENCE			English	Article						lactic acid bacterium (LAB); Enterococcus faecalis; utilizing liquid medium; media after incubation (MAI); aroma extract deilution analysis (AEDA)	CHARACTERISTIC ODOR COMPONENTS; EXTRACT DILUTION ANALYSIS; GC-MS ANALYSIS; AMINO-ACIDS; FLAVOR; L.; COFFEE; NATTO; IDENTIFICATION; CONSTITUENTS	Enterococcus faecalis is one of the major lactic acid bacterium (LAB) species colonizing the intestines of animals and humans. The characteristic odor of the volatile oils obtained from both the liquid medium after incubation (MAI) and liquid medium before incubation (MBI) in the cultivation process of E. faecalis was investigated to determine the utility of the liquid medium. In total, fifty-six and thirty-two compounds were detected in the volatile oils from the MAI (MAI oil) and MBI (MBI oil), respectively. The principle components of MAI oil were 2,5-dimethylpyrazine (19.3%), phenylacetaldehyde (19.3%), and phenylethyl alcohol (9.3%). The aroma extract dilution analysis (AEDA) method was performed using gas chromatography-olfactometry (GC-O). The total number of aroma-active compounds identified in the volatile oil from MBI and MAI was thirteen compounds; in particular, 5-methyl-2-furanmethanol, phenylacetaldehyde, and phenylethyl alcohol were the most primary aroma-active compounds in MAI oil. These results imply that the industrial cultivation medium after incubation of E. faecalis may be utilized as a source of volatile oils.	[Ono, Toshirou; Usami, Atsushi; Nakaya, Satoshi; Maeloa, Keisuke; Miyazawa, Mitsuo] Kinki Univ, Fac Sci & Engn, Dept Appl Chem, Higashiosaka, Osaka 5778502, Japan; [Ono, Toshirou] Narasangyo Univ, Res Inst Publ Affairs, Ikomagun, Nara 6368503, Japan; [Yonejima, Yasunori; Toyoda, Masanori; Ikeda, Atsushi] Nitto Pharmaceut Ind Ltd, Kyoto 6170006, Japan	Miyazawa, M (reprint author), Kinki Univ, Fac Sci & Engn, Dept Appl Chem, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	miyazawa@apch.kindai.ac.jp					Adams R.P., 2007, IDENTIFICATION ESSEN; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; SPADONE JC, 1990, J AGR FOOD CHEM, V38, P226, DOI 10.1021/jf00091a050; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; Alissandrakis E, 2007, J AGR FOOD CHEM, V55, P8152, DOI 10.1021/jf071442y; Miguel M, 2005, BRIT J NUTR, V94, P36, DOI 10.1079/BJN20051450; Javidnia K, 2004, FLAVOUR FRAG J, V19, P213, DOI 10.1002/ffj.1277; ITO T, 1987, NIPPON NOGEIK KAISHI, V61, P963; Sreekumar R, 2009, LETT APPL MICROBIOL, V48, P777, DOI 10.1111/j.1472-765X.2009.02610.x; SUGAWARA E, 1985, AGR BIOL CHEM TOKYO, V49, P311; Rezazadeh S, 2006, FLAVOUR FRAG J, V21, P290, DOI 10.1002/ffj.1587; Kawata J, 2008, J NAT MED, V62, P239, DOI 10.1007/s11418-007-0221-0; Ono T, 2015, J OLEO SCI, V64, P585, DOI 10.5650/jos.ess14257; Kim JS, 2009, J KOREAN SOC APPL BI, V52, P516, DOI 10.3839/jksabc.2009.088; Nakamura A, 2013, J ESSENT OIL RES, V25, P497, DOI 10.1080/10412905.2013.809320; Pino J, 2011, FOOD CHEM, V125, P860, DOI 10.1016/j.foodchem.2010.08.073; Ye M, 2012, INT DAIRY J, V23, P68, DOI 10.1016/j.idairyj.2011.09.014; Radulovic NS, 2012, CHEM BIODIVERS, V9, P1320, DOI 10.1002/cbdv.201100430; Fang Y, 2005, FLAVOUR FRAG J, V20, P22, DOI 10.1002/ffj.1551; Yasar A, 2005, PHARM BIOL, V43, P108, DOI 10.1080/13880200590919384; Methven L, 2007, J AGR FOOD CHEM, V55, P1427, DOI 10.1021/jf0625611; Xie JC, 2008, FOOD CHEM, V109, P506, DOI 10.1016/j.foodchem.2007.12.074; Miyazato H, 2013, FOOD CHEM, V138, P2346, DOI 10.1016/j.foodchem.2012.12.013; Miyazawa M, 2011, REC NAT PROD, V5, P221; Saroglou V, 2006, J CHROMATOGR A, V1104, P313, DOI 10.1016/j.chroma.2005.11.087; ITO T, 1989, J JPN SOC FOOD SCI, V36, P762; Buettner A, 1999, J AGR FOOD CHEM, V47, P5189, DOI 10.1021/jf990071l; Miyazawa M, 2006, J NAT MED, V60, P89, DOI 10.1007/s11418-005-009-z; Schwambach SL, 2006, J AGR FOOD CHEM, V54, P502, DOI 10.1021/jf0519764; Perez RA, 2007, FLAVOUR FRAG J, V22, P265, DOI 10.1002/ffj.1791; Miyazawa M, 2012, J ESSENT OIL RES, V24, P441, DOI 10.1080/10412905.2012.703475; DEMAIN AL, 1967, J BACTERIOL, V94, P323; Riu-Aumatell M, 2005, J AGR FOOD CHEM, V53, P7837, DOI 10.1021/jf051397z; Miyazawa M, 2012, PHYTOCHEM ANALYSIS, V23, P208, DOI 10.1002/pca.1344; SUGAWARA E, 1990, J JPN SOC FOOD SCI, V37, P520; Kashima Y, 2012, CHEM NAT COMPD+, V47, P998, DOI 10.1007/s10600-012-0128-1; Risticevic S, 2008, ANAL CHIM ACTA, V617, P72, DOI 10.1016/j.aca.2008.04.009; Miyazawa M, 2008, J ESSENT OIL RES, V20, P420; Qian M, 2003, FLAVOUR FRAG J, V18, P252, DOI 10.1002/ffj.1194; Brozozowski B., 2009, J SCI FOOD AGR, V89, P2467; Fujii H., 1963, NIPPON NOGEIKAGAKU K, V37, P615; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Grosch Werner, 1994, Flavour and Fragrance Journal, V9, P147, DOI 10.1002/ffj.2730090403; Menendez P., 2000, ANALES ASOCIACION QU, V88, P79; Miyazawa M., 2004, J OLEO SCI, V53, P511; Ono T, 2014, J OLEO SCI, V63, P971, DOI 10.5650/jos.ess14083; Rizzi P. G, 1988, J AGR FOOD CHEM, V36, P349; Sahasrabudhe M. M., 2011, Archives of Applied Science Research, V3, P403; Sartoratto A, 2004, BRAZ J MICROBIOL, V35, P275, DOI 10.1590/S1517-83822004000300001; da Silva UF, 1999, PHYTOCHEMISTRY, V50, P31, DOI 10.1016/S0031-9422(98)00459-2	50	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	OCT	2015	64	10					1125	1133		10.5650/jos.ess15098		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CS7CV	WOS:000362242600010		
J	Nishino, A; Ichihara, T; Takaha, T; Kuriki, T; Nihei, H; Kawamoto, K; Yasui, H; Maoka, T				Nishino, Azusa; Ichihara, Takashi; Takaha, Takeshi; Kuriki, Takashi; Nihei, Hideko; Kawamoto, Kazuhisa; Yasui, Hiroyuki; Maoka, Takashi			Accumulation of Paprika Carotenoids in Human Plasma and Erythrocytes	JOURNAL OF OLEO SCIENCE			English	Article						paprika; carotenoid; accumulation; plasma; erythrocyte	SENIOR JAPANESE SUBJECTS; PEPPERS CAPSICUM-ANNUUM; RED-BLOOD-CELLS; SINGLET OXYGEN; STRUCTURAL ELUCIDATION; SUPEROXIDE; QUANTIFICATION; IDENTIFICATION; SUPPLEMENTATION; METABOLITES	The accumulation (incorporation) of paprika carotenoid in human plasma and erythrocytes was investigated. A paprika carotenoid supplement (14 mg/day) was ingested for 4 weeks by 5 young healthy volunteers (3 men and 2 women). After 2 weeks of carotenoid ingestion, the carotenoid levels in plasma and erythrocytes increased by 1.2-fold and 2.2-fold, respectively. Characteristic carotenoids found in paprika (capsanthin, cucurbitaxanthin A, and cryptocapsin) were detected in both plasma and erythrocytes. An oxidative metabolite of capsanthin (capsanthone) was also found in both plasma and erythrocytes.	[Nishino, Azusa; Ichihara, Takashi; Takaha, Takeshi; Kuriki, Takashi] Ezaki Glico Co Ltd, Inst Hlth Sci, Nishiyodogawa Ku, Osaka 5558502, Japan; [Nihei, Hideko] Sports Div, Fukushima 9608605, Japan; [Kawamoto, Kazuhisa] Fukushima Univ, Fac Human Dev & Culture, Fukushima 9601296, Japan; [Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Div Analyt & Phys Chem, Dept Analyt & Bioinorgan Chem, Yamashina Ku, Kyoto 6078414, Japan; Res Inst Prod Dev, Sakyo Ku, Kyoto 6060805, Japan	Nishino, A (reprint author), Ezaki Glico Co Ltd, Inst Hlth Sci, Nishiyodogawa Ku, 4-6-5 Utajima, Osaka 5558502, Japan.	nishino-azusa@gf.glico.co.jp					Miyazawa T, 2013, J OLEO SCI, V62, P873, DOI 10.5650/jos.62.873; Etoh H, 2000, BIOSCI BIOTECH BIOCH, V64, P1096, DOI 10.1271/bbb.64.1096; Yasui H, 2000, BIOCHEM BIOPH RES CO, V269, P131, DOI 10.1006/bbrc.2000.2254; Miyazawa T, 2011, J OLEO SCI, V60, P495, DOI 10.5650/jos.60.495; ALMELA L, 1991, J AGR FOOD CHEM, V39, P1606, DOI 10.1021/jf00009a013; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; Miyazawa T, 2013, J OLEO SCI, V62, P773, DOI 10.5650/jos.62.773; KHACHIK F, 1992, ANAL CHEM, V64, P2111, DOI 10.1021/ac00042a016; KOGA S, 1991, ARCH BIOCHEM BIOPHYS, V289, P223, DOI 10.1016/0003-9861(91)90465-U; MINGUEZMOSQUERA MI, 1994, J AGR FOOD CHEM, V42, P1555, DOI 10.1021/jf00043a031; Nakagawa K, 2008, ANAL BIOCHEM, V381, P129, DOI 10.1016/j.ab.2008.06.038; MATSUNO T, 1986, PHYTOCHEMISTRY, V25, P2837, DOI 10.1016/S0031-9422(00)83753-X; Khachik F, 1998, J AGR FOOD CHEM, V46, P4874, DOI 10.1021/jf980322a; Murakami A, 2000, CANCER LETT, V149, P115, DOI 10.1016/S0304-3835(99)00351-1; Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i; SAITO I, 1983, J AM CHEM SOC, V105, P3200, DOI 10.1021/ja00348a040; PARKES KEB, 1986, TETRAHEDRON LETT, V27, P2535, DOI 10.1016/S0040-4039(00)84578-5; Kopec RE, 2010, J AGR FOOD CHEM, V58, P3290, DOI 10.1021/jf100415z; Fotouhi N, 1996, AM J CLIN NUTR, V63, P553; Hayashi Seiko, 2005, Drug Metab Pharmacokinet, V20, P14, DOI 10.2133/dmpk.20.14; Khachik F., PURE APPL CHEM, V63, P35; Kiko T., 2008, J ALZHEIMERS DIS, V28, P593; Maoka T., 2012, OLEO SCI, V12, P485; Maoka T., 2001, Journal of Oleo Science, V50, P663; Maoka T., 2010, FUNCTIONAL FOODS E, P85; MARKIFISCHER E, 1985, HELV CHIM ACTA, V68, P1708, DOI 10.1002/hlca.19850680627; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Nakagawa Kiyotaka, 2009, Br J Nutr, V102, P1280, DOI 10.1017/S0007114509990316; Tsuboi M., 2011, J AGR FOOD CHEM, V59, P10872	29	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	OCT	2015	64	10					1135	1142		10.5650/jos.ess15118		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CS7CV	WOS:000362242600011		
J	Hamano, J; Morita, T; Ozawa, T; Shishido, H; Kawahara, M; Aoki, S; Demizu, A; Goshima, M; Goto, K; Gyoda, Y; Hashimoto, K; Otomo, S; Sekimoto, M; Shibata, T; Sugimoto, Y; Matsunaga, M; Takeda, Y; Nagayama, J; Kinoshita, H				Hamano, Jun; Morita, Tatsuya; Ozawa, Taketoshi; Shishido, Hideki; Kawahara, Masanori; Aoki, Shigeru; Demizu, Akira; Goshima, Masahiro; Goto, Keiji; Gyoda, Yasuaki; Hashimoto, Kotaro; Otomo, Sen; Sekimoto, Masako; Shibata, Takemi; Sugimoto, Yuka; Matsunaga, Mikako; Takeda, Yukihiko; Nagayama, Jun; Kinoshita, Hiroya			Validation of the Simplified Palliative Prognostic Index Using a Single Item From the Communication Capacity Scale	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Palliative Prognostic Index; Communication Capacity Scale; delirium	ILL CANCER-PATIENTS; TERMINALLY-ILL; DELIRIUM; CARE; PREDICTION; SURVIVAL	Context. Although the Palliative Prognostic Index (PPI) is a reliable and validated tool to predict the survival of terminally ill cancer patients, all clinicians cannot always precisely diagnose delirium. Objectives. The primary aim of this study was to examine the predictive value of a simplified PPI. In the simplified PPI, a single item from the Communication Capacity Scale was substituted for the delirium item of the original. Methods. This multicenter prospective cohort study was conducted in Japan from September 2012 through April 2014 and involved 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services. Palliative care physicians recorded clinical variables at the first assessment and followed up patients six months later. Results. A total of 2425 subjects were recruited; 2343 had analyzable data. The C-statistics of the original and simplified PPIs were 0.801 and 0.800 for three week and 0.800 and 0.781 for six-week survival predictions, respectively. The sensitivity and specificity for survival predictions using the simplified PPI were 72.9% and 67.6% (for three week) and 80.3% and 61.8% (for six week), respectively. Conclusion. The simplified PPI showed essentially the same predictive value as the original PPI and is an alternative when clinicians have difficulties in diagnosing delirium. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Hamano, Jun] Univ Tsukuba, Div Clin Med, Fac Med, Tsukuba, Ibaraki, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat & Support Care Div, Hamamatsu, Shizuoka, Japan; [Ozawa, Taketoshi] Megumi Zaitaku Clin, Yokohama, Kanagawa, Japan; [Shishido, Hideki] Shishido Internal Med Clin, Sakura, Chiba, Japan; [Kawahara, Masanori] Soshukai Okabe Clin, Natori, Miyagi, Japan; [Aoki, Shigeru] Sakanoue Family Clin, Hamamatsu, Shizuoka, Japan; [Demizu, Akira] Demizu Clin, Kishiwada, Osaka, Japan; [Goshima, Masahiro] Homecare Clin Kobe, Kobe, Hyogo, Japan; [Goto, Keiji] Himawari Zaitaku Clin, Kumamoto, Kumamoto, Japan; [Gyoda, Yasuaki] Kanamecho Home Care Clin, Tokyo, Tokyo, Japan; [Hashimoto, Kotaro] Fukushima Home Palliat Care Clin, Fukushima, Fukushima, Japan; [Otomo, Sen] Shonan Int Village Clin, Hayama, Kanagawa, Japan; [Sekimoto, Masako] Sekimoto Clin, Kobe, Hyogo, Japan; [Shibata, Takemi] Kanwakeakurinikku Eniwa, Eniwa, Hokkaido, Japan; [Sugimoto, Yuka] Sugimoto Homecare Clin, Nagoya, Aichi, Japan; [Matsunaga, Mikako] Senri Pain Clin, Toyonaka, Osaka, Japan; [Takeda, Yukihiko] Hidamari Clin, Takasaki, Gumma, Japan; [Nagayama, Jun] Peace Clin Nakai, Nakai, Kanagawa, Japan; [Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan	Kinoshita, H (reprint author), Natl Canc Ctr Hosp East, Dept Palliat Med, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hikinosh@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-22]	This work was supported in part by The National Cancer Center Research and Development Fund (25-A-22). The authors declare no conflicts of interest.	Bush SH, 2009, ONCOLOGIST, V14, P1039, DOI 10.1634/theoncologist.2009-0122; GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P760; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Breitbart W, 2000, CLIN GERIATR MED, V16, P357, DOI 10.1016/S0749-0690(05)70061-6; Alshemmari S, 2012, J PALLIAT MED, V15, P200, DOI 10.1089/jpm.2011.0253; Morita T, 2005, J PAIN SYMPTOM MANAG, V30, P320, DOI 10.1016/j.jpainsymman.2005.08.017; Baba M, 2015, J PAIN SYMPTOM MANAG, V49, P853, DOI 10.1016/j.jpainsymman.2014.10.010; Maltoni M, 2012, ONCOLOGIST, V17, P446, DOI 10.1634/theoncologist.2011-0397; Morita T, 2001, PALLIATIVE MED, V15, P197, DOI 10.1191/026921601678576185; FARRELL KR, 1995, ARCH INTERN MED, V155, P2459, DOI 10.1001/archinte.155.22.2459; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Subramaniam Sivakumar, 2013, BMJ Support Palliat Care, V3, P324, DOI 10.1136/bmjspcare-2012-000239	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	OCT	2015	50	4					542	U263		10.1016/j.jpainsymman.2015.04.021		10	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CS5CN	WOS:000362093800016		
J	Tagami, K; Mawatari, H; Abe, K; Takeno, N; Syuuto, C; Saito, O; Akagi, T; Matoba, M				Tagami, Keita; Mawatari, Hironori; Abe, Kentaro; Takeno, Nobuhiro; Syuuto, Chio; Saito, Osamu; Akagi, Toru; Matoba, Motohiro			Perospirone Exhibits Antiemetic Efficacy against Opioid-Induced Nausea in Patients with Advanced Cancer	JOURNAL OF PALLIATIVE MEDICINE			English	Letter									[Tagami, Keita; Syuuto, Chio; Saito, Osamu; Matoba, Motohiro] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan; [Tagami, Keita] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan; [Mawatari, Hironori] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan; [Abe, Kentaro; Akagi, Toru] Natl Canc Ctr, Dept Hosp Pharm, Tokyo, Japan; [Takeno, Nobuhiro] Canc Inst Hosp, Dept Hosp Pharm, Tokyo, Japan	Tagami, K (reprint author), Natl Canc Ctr Hosp East, Dept Palliat Med, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	katagami@ncc.go.jp					Kishi T, 2013, CNS DRUGS, V27, P731, DOI 10.1007/s40263-013-0085-7; Ohno Y, 1997, PHARMACOL BIOCHEM BE, V57, P889, DOI 10.1016/S0091-3057(96)00468-6; Yomiya Kinomi, 2008, Gan To Kagaku Ryoho, V35, P625	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	OCT 1	2015	18	10					823	824		10.1089/jpm.2015.0219		2	Health Care Sciences & Services	Health Care Sciences & Services	CS7MY	WOS:000362268900005		
J	Nishikawa, M; Tan, LH; Nakabayashi, Y; Hasegawa, T; Shiroishi, W; Kawahara, S; Saito, N; Nosaka, A; Nosaka, Y				Nishikawa, Masami; Tan, Lee Hua; Nakabayashi, Yukihiro; Hasegawa, Takahiro; Shiroishi, Wataru; Kawahara, Seiichi; Saito, Nobuo; Nosaka, Atsuko; Nosaka, Yoshio			Visible light responsive vanadium-substituted hydroxyapatite photocatalysts	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Hydroxyapatite; Vanadium; Photocatalyst; Visible light; Photocatalytic reaction mechanism; Active oxygen	TIO2 PHOTOCATALYSTS; CALCIUM-PHOSPHATE; UV-IRRADIATION; DECOMPOSITION; OXIDATION; VANADATE; ADSORPTION; OXIDES; TI(IV); IONS	Hydroxyapatite (HAp) has a potential to be an excellent photocatalyst because of its strong adsorption ability for organic substances. However, the HAp has a poor photocatalytic ability without modification. We firstly revealed that after substitution of a part of Ca ions by V ions in HAp lattice (V:HAp), visible light driven photocatalytic activity appeared. The substituted V ions were pentavalent at bivalent Ca sites, causing the introduction of amounts of Ca defects in the HAp lattice to keep electric neutrality. In spite of any amount of the Ca defects, the HAp structure of V:HAp was kept after calcination at 400 degrees C. Then, the photocatalytic activity was increased with V content. The visible light response of V:HAp would be owing to the generation of an acceptor level due to V ions of which the redox potential was enough negative to reduce O-2 to H2O2 via two electron process. (C) 2015 Elsevier B.V. All rights reserved.	[Nishikawa, Masami; Tan, Lee Hua; Nakabayashi, Yukihiro; Hasegawa, Takahiro; Shiroishi, Wataru; Kawahara, Seiichi; Saito, Nobuo; Nosaka, Atsuko; Nosaka, Yoshio] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Nishikawa, M (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	nishikawa@vos.nagaokaut.ac.jp					Anmin H., 2007, J MOL CATAL A-CHEM, V267, P79; Wakamura M, 2003, LANGMUIR, V19, P3428, DOI 10.1021/la0208169; Nishikawa H, 2003, J MOL CATAL A-CHEM, V206, P331, DOI 10.1016/S1381-1169(03)00414-X; Boechat CB, 2000, PHYS CHEM CHEM PHYS, V2, P4225; Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112; Nishikawa M, 2013, J MOL CATAL A-CHEM, V378, P314, DOI 10.1016/j.molcata.2013.07.002; Kaneda K, 2010, CATAL TODAY, V152, P93, DOI 10.1016/j.cattod.2009.08.018; Irie H, 2009, J PHYS CHEM C, V113, P10761, DOI 10.1021/jp903063z; Silversmit G, 2004, J ELECTRON SPECTROSC, V135, P167, DOI 10.1016/j.elspec.2004.03.004; Hu C, 2007, APPL CATAL B-ENVIRON, V73, P345, DOI 10.1016/j.apcatb.2007.01.006; Abe R, 2008, J AM CHEM SOC, V130, P7780, DOI 10.1021/ja800835q; Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069; Wakamura M, 2011, ADV POWDER TECHNOL, V22, P498, DOI 10.1016/j.apt.2010.10.012; Maeda Y, 2004, TETRAHEDRON, V60, P9031, DOI 10.1016/j.tet.2004.08.004; Tsukada M, 2011, J MOL CATAL A-CHEM, V338, P18, DOI 10.1016/j.molcata.2011.01.017; Nosaka Y, 2011, J PHYS CHEM C, V115, P21283, DOI 10.1021/jp2070634; Arai T, 2007, J PHYS CHEM C, V111, P7574, DOI 10.1021/jp0725533; Demeter M, 2000, SURF SCI, V454, P41, DOI 10.1016/S0039-6028(00)00111-4; Hirakawa T, 2008, J PHYS CHEM C, V112, P15818, DOI 10.1021/jp8055015; Nishikawa H, 2004, J MOL CATAL A-CHEM, V207, P149, DOI 10.1016/S1381-1169(03)00472-2; Nishikawa H, 2002, J MOL CATAL A-CHEM, V179, P193, DOI 10.1016/S1381-1169(01)00325-9; Hara T, 2006, J ORG CHEM, V71, P7455, DOI 10.1021/jo0614745; Calderin L., 2015, PHYS REV B, V67; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tagaya M, 2010, MATER SCI ENG B-ADV, V173, P176, DOI 10.1016/j.mseb.2010.01.034; Yongli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159	26	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 1	2015	311						30	34		10.1016/j.jphotochem.2015.06.005		5	Chemistry, Physical	Chemistry	CS2UW	WOS:000361928500004		
J	Kitagawa, Y; Ogasawara, S; Kosumi, D; Hashimoto, H; Tamiaki, H				Kitagawa, Yuichi; Ogasawara, Shin; Kosumi, Daisuke; Hashimoto, Hideki; Tamiaki, Hitoshi			Unique photophysical properties of chlorophyll derivatives linked with CO2-reducing moiety along the Qy axis	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Chlorophyll; Photochemical CO2 reduction; Photosensitizer	GREEN PHOTOSYNTHETIC BACTERIA; ELECTRON-TRANSFER REACTIONS; CARBON-DIOXIDE REDUCTION; RHENIUM BIPYRIDINE; PHOTOCHEMICAL REDUCTION; HOMOGENEOUS CATALYSTS; CHARGE-SEPARATION; ZINC PORPHYRIN; REMOTE SITE; COMPLEXES	The electron transport system along the Qy axis of the chlorophyll derivatives has attracted considerable attention. Recently, we achieved the first photochemical CO2 reduction using very low energy light (>650 nm) and a synthetic chlorophyll derivative covalently linked with a rhenium bipyridine complex at the Qy axis. This result prompted us to construct an efficient photochemical CO2 reduction system with harvesting red light absorbed by a chlorophyll electron donor. In this study, we discuss the photophysical properties of modified chlorophyll and rhenium bipyridine conjugates comparing with the original one. (C) 2015 Elsevier B.V. All rights reserved.	[Kitagawa, Yuichi; Ogasawara, Shin; Tamiaki, Hitoshi] Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan; [Kitagawa, Yuichi] Hokkaido Univ, Div Mat Chem, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Kosumi, Daisuke; Hashimoto, Hideki] Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 5588585, Japan	Kitagawa, Y (reprint author), Ritsumeikan Univ, Grad Sch Life Sci, Kusatsu, Shiga 5258577, Japan.	y-kitagawa@eng.hokudai.ac.jp; tamiaki@fc.ritsumei.ac.jp	Kosumi, Daisuke/F-6753-2010		JSPS [256913]	This work was supported by Grants-in-Aid for JSPS Fellows (256913) as well as for Scientific Research on Innovative Areas "Artificial Photosynthesis (AnApple)" from JSPS. We are particularly grateful for experimental assistance by Prof. K. Ishii of the University of Tokyo as well as Prof. O. Ishitani and Dr. H. Takeda of Tokyo Institute of Technology.	Koike K, 2009, J PHOTOCH PHOTOBIO A, V207, P109, DOI 10.1016/j.jphotochem.2008.12.014; KEEGAN JD, 1982, J AM CHEM SOC, V104, P4317, DOI 10.1021/ja00380a002; Kitagawa Y, 2012, CHEM COMMUN, V48, P5091, DOI 10.1039/c2cc30996c; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Ohkubo K, 2002, J PHYS CHEM A, V106, P10991, DOI 10.1021/jp026603+; Imahori H, 2001, J AM CHEM SOC, V123, P2607, DOI 10.1021/ja003346i; Hartwich G, 1998, J AM CHEM SOC, V120, P3675, DOI 10.1021/ja970874u; Miyatake T, 2007, TETRAHEDRON LETT, V48, P2251, DOI 10.1016/j.tetlet.2007.02.002; Tamiaki H, 2011, HANDB PORPHYR SCI, V11, P223; Kou Y, 2014, J CATAL, V310, P57, DOI 10.1016/j.jcat.2013.03.025; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; Tamiaki H, 1996, PHOTOCHEM PHOTOBIOL, V63, P92, DOI 10.1111/j.1751-1097.1996.tb02997.x; Wang XF, 2008, J PHYS CHEM C, V112, P4418, DOI 10.1021/jp710580h; Windle CD, 2012, CHEM COMMUN, V48, P8189, DOI 10.1039/c2cc33308b; Kitagawa Y, 2014, CHEM LETT, V43, P1383, DOI 10.1246/cl.140439; Casanova M, 2008, INORG CHEM, V47, P10407, DOI 10.1021/ic800971e; Kitagawa Y, 2015, B CHEM SOC JPN, V88, P346, DOI 10.1246/bcsj.20140326; Stranius K, 2014, J PHYS CHEM A, V118, P1420, DOI 10.1021/jp412442t; Tamaki Y, 2013, INORG CHEM, V52, P11902, DOI 10.1021/ic4015543; FUHRHOP JH, 1973, J AM CHEM SOC, V95, P5140; Kiyosawa K, 2009, J PHYS CHEM C, V113, P11667, DOI 10.1021/jp901548y; Gatti T, 2013, INORG CHEM, V52, P3190, DOI 10.1021/ic302663c; Kunieda M, 2008, J ORG CHEM, V73, P7686, DOI 10.1021/jo8014402; Kataoka Y, 2010, CHEM LETT, V39, P953, DOI 10.1246/cl.2010.953; Schneider J, 2011, INORG CHEM, V50, P11877, DOI 10.1021/ic200243y; Smieja JM, 2010, INORG CHEM, V49, P9283, DOI 10.1021/ic1008363; HAWECKER J, 1986, HELV CHIM ACTA, V69, P1990, DOI 10.1002/hlca.19860690824; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; FUHROP JH, 1969, J AM CHEM SOC, V91, P4174, DOI 10.1021/ja01043a027; Fujita E, 1999, COORDIN CHEM REV, V185-6, P373, DOI 10.1016/S0010-8545(99)00023-5; Gabrielsson A, 2008, DALTON T, P4259, DOI 10.1039/b806267f; Gabrielsson A, 2002, CHEM COMMUN, P950, DOI 10.1039/b200127f; HAWECKER J, 1985, J CHEM SOC CHEM COMM, P56, DOI 10.1039/c39850000056; Ishii K., 2014, HDB PORPHYRIN SCI AP, V32, P173; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; Morris A.J, 2009, ACCOUNTS CHEM RES, V12, P1983; Nyokong T, 2007, COORDIN CHEM REV, V251, P1707, DOI 10.1016/j.ccr.2006.11.011; Wang XF, 2009, CHEM COMMUN, P1523, DOI 10.1039/b820540j	38	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 1	2015	311						104	111		10.1016/j.jphotochem.2015.06.016		8	Chemistry, Physical	Chemistry	CS2UW	WOS:000361928500013		
J	Watanabe, Y; Tanaka, T; Fukuyoshi, S; Oda, A				Watanabe, Yurie; Tanaka, Tomohiro; Fukuyoshi, Shuichi; Oda, Akifumi			Investigation of photoreaction for 2-nitrobenzofuran and its 3-methyl derivative	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						2-Nitrobenzofuran derivatives; Nitro-nitrite rearrangement; Aromatic nitro compounds	POLYCYCLIC AROMATIC-HYDROCARBONS; PHOTO-SMILES REARRANGEMENT; NITRO-COMPOUNDS; FLUTAMIDE PHOTOSENSITIVITY; ATMOSPHERIC CHEMISTRY; REACTION-MECHANISM; PHOTOCHEMISTRY; PHOTOSUBSTITUTION; NITROBENZENE; REDUCTION	Aromatic nitro compounds undergo various photoreactions such as photosubstitution, photoredox reactions, photodissociation, and photoinduced nitro-nitrite rearrangements. The reaction mechanisms for these photoreactions, especially nitro-nitrite rearrangement reactions have never been completely understood. It was originally assumed that the potential cause for a nitro-nitrite rearrangement originates from the twisted dihedral angle between the plane of the nitro group and the plane of the aromatic ring [O.L. Chapman et al., J. Am. Chem. Soc. 88 (1966) 5550-5554]. Although the majority of aromatic nitro compounds have coplanar conformation and undergo nitro-nitrite rearrangement, no studies clearly substantiate this theory. This study reports on the photochemical reactions of 2-nitrobenzofuran and the effects of 3-methyl substituent on the compound. The results show that a nitro-nitrite rearrangement selectively occurs in deaerated acetonitrile solution for the photoreactions of 2-nitrobenzofuran. Moreover, nitro-nitrite rearrangement might occur in the photoreaction of 3-methyl-2-nitrobenzofuran. The quantum yield of degradation for 3-methyl-2-nitrobenzofuran was higher than that for 2-nitrobenzofuran, indicating that the methyl substituent at the 3-position changes the photoreactivity of 2-nitrobenzofuran. (C) 2015 Elsevier B.V. All rights reserved.	[Watanabe, Yurie; Tanaka, Tomohiro; Fukuyoshi, Shuichi; Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan; [Oda, Akifumi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Oda, A (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	oda@p.kanazawa-u.ac.jp					Aktiengesellschaft B., 1973, Ger. Often., Patent No. [DE 2162717, 2162717]; LIPPERT E, 1978, HELV CHIM ACTA, V61, P279, DOI 10.1002/hlca.19780610125; He YG, 2006, CHEM-ASIAN J, V1, P56, DOI 10.1002/asia.200600107; ATKINSON R, 1994, ENVIRON HEALTH PERSP, V102, P117, DOI 10.2307/3431940; Sortino S, 2001, PHOTOCHEM PHOTOBIOL, V73, P6, DOI 10.1562/0031-8655(2001)073<0006:TPOFAI>2.0.CO;2; Ornstein DK, 1996, UROLOGY, V48, P901, DOI 10.1016/S0090-4295(96)00315-9; Kameda T, 2011, J HEALTH SCI, V57, P504; Leroy D, 1996, PHOTODERMATOL PHOTO, V12, P216; HAMANOUE K, 1984, J AM CHEM SOC, V106, P5993, DOI 10.1021/ja00332a041; YOKOYAMA K, 1980, B CHEM SOC JPN, V53, P2472, DOI 10.1246/bcsj.53.2472; CHAPMAN OL, 1966, J AM CHEM SOC, V88, P5550, DOI 10.1021/ja00975a037; YOKOYAMA K, 1980, B CHEM SOC JPN, V53, P3474, DOI 10.1246/bcsj.53.3474; FINNEGAN RA, 1968, J AM CHEM SOC, V90, P1670, DOI 10.1021/ja01008a061; Nakagaki R, 1996, B CHEM SOC JPN, V69, P261, DOI 10.1246/bcsj.69.261; Vilaplana J, 1998, CONTACT DERMATITIS, V38, P68, DOI 10.1111/j.1600-0536.1998.tb05655.x; Udagawa C, 2011, J PHOTOCH PHOTOBIO A, V226, P57, DOI 10.1016/j.jphotochem.2011.10.015; HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102; MUTAI K, 1985, B CHEM SOC JPN, V58, P2066, DOI 10.1246/bcsj.58.2066; HURLEY R, 1966, J AM CHEM SOC, V88, P4330, DOI 10.1021/ja00971a005; NAKAGAKI R, 1985, CHEM PHYS LETT, V121, P262, DOI 10.1016/0009-2614(85)85522-6; COOMBES GEA, 1967, TETRAHEDRON, V23, P1341, DOI 10.1016/0040-4020(67)85086-5; Plaza-Medina EF, 2011, J PHYS CHEM A, V115, P577, DOI 10.1021/jp109041y; BARLTROP JA, 1968, J CHEM SOC C, P1467, DOI 10.1039/j39680001467; CHAPMAN OL, 1966, CHEM COMMUN, P101, DOI 10.1039/c19660000101; Doepp D., 1995, HDB ORGANIC PHOTOCHE, P1019; Hahimoto S., 1969, TETRAHEDRON LETT, V32, P2733; Hunt R., 1972, J CHEM SOC PERK T, P2527; HUNT R, 1970, J CHEM SOC CHEM COMM, P1576; James L.B., 1969, TETRAHEDRON LETT, V38, P3263; Kjtaura Y., 1971, TETRAHEDRON, V27, P1583, DOI 10.1016/S0040-4020(01)98024-X; MUTAI K, 1978, TETRAHEDRON LETT, P1273; PARKER CA, 1953, PROC R SOC LON SER-A, V220, P104, DOI 10.1098/rspa.1953.0175; SAITO I, 1975, TETRAHEDRON LETT, P3155; Tanemura K., 2003, J CHEM RES, V49, P7; Watanabe Y, 2015, J PHOTOCH PHOTOBIO A, V298, P55, DOI 10.1016/j.jphotochem.2014.10.009	35	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 1	2015	311						137	143		10.1016/j.jphotochem.2015.06.024		7	Chemistry, Physical	Chemistry	CS2UW	WOS:000361928500017		
J	Kamioka, H; Tsukada, H; Yamaguchi, R; Tateno, T; Suzuki, Y; Fukui, Y				Kamioka, Hayato; Tsukada, Hiroyuki; Yamaguchi, Ryotaro; Tateno, Takeru; Suzuki, Yudai; Fukui, Yuki			Time-resolved imaging and spectroscopy for the photo-induced phase transition in Ti4O7	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Titanium oxides; Magneli phase; Photo-induced phase transition; Time-resolved measurements	METAL-INSULATOR TRANSITIONS; SINGLE-CRYSTALS; OXIDES	Time-resolved reflection imaging and spectroscopy were performed for single crystals of reduced-type titanium oxide Ti4O7. This shows two-step phase transition at 140 K from the low temperature (LT) phase to the intermediate (IT) phase and at 160 K from the IT phase to the high temperature (HT) phase. After the photo-irradiation in the IT phase, the time profiles of the reflection spectra and the excited area images showed spontaneous domain growth of the photo-induced HT phase. Analysis of the reflection images with the dielectric functions derived the growth velocity of the induced HT state. The value is close to that of the acoustic phonon in the core titanium dioxide. (C) 2015 Elsevier B.V. All rights reserved.	[Kamioka, Hayato; Tsukada, Hiroyuki; Yamaguchi, Ryotaro; Tateno, Takeru; Suzuki, Yudai; Fukui, Yuki] Nihon Univ, Setagaya Ku, Tokyo 1568550, Japan	Kamioka, H (reprint author), Nihon Univ, Setagaya Ku, 3-25-40 Sakurajosui, Tokyo 1568550, Japan.	kamioka@phys.chs.nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25400315]	This work was supported by Grants-in-Aid (Grants No. 25400315) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Liborio L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104104; MERCIER J, 1973, J CRYST GROWTH, V20, P195, DOI 10.1016/0022-0248(73)90004-3; LAKKIS S, 1976, PHYS REV B, V14, P1429, DOI 10.1103/PhysRevB.14.1429; Acha C, 2003, EUR PHYS J B, V34, P421, DOI 10.1140/epjb/e2003-00240-2; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Watanabe M, 2007, J LUMIN, V122, P393, DOI 10.1016/j.jlumin.2006.01.149; Iwai S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.097402; Caravaca MA, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/015501; DEGIORGI L, 1989, PHYSICA B, V161, P341, DOI 10.1016/0921-4526(89)90159-2; Chollet M, 2005, SCIENCE, V307, P86, DOI 10.1126/science.1105067; MAREZIO M, 1973, J SOLID STATE CHEM, V6, P213, DOI 10.1016/0022-4596(73)90184-9; Okimoto Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161101; Watanabe M, 2009, J PHYS CONF SER, V148, DOI 10.1088/1742-6596/148/1/012017; Harada S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3498801; Murata S, 1999, PHYSICA B, V263, P647, DOI 10.1016/S0921-4526(98)01439-2; Taguchi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106401; Itoh C, 2009, J PHYS CONF SER, V148, DOI 10.1088/1742-6596/148/1/012022; Ohkoshi S, 2010, NAT CHEM, V2, P539, DOI [10.1038/nchem.670, 10.1038/NCHEM.670]; ABBATE M, 1995, PHYS REV B, V51, P10150, DOI 10.1103/PhysRevB.51.10150; Koshihara S, 1999, J PHYS CHEM B, V103, P2592, DOI 10.1021/jp984172i; BARTHOLO.RF, 1969, PHYS REV, V187, P828, DOI 10.1103/PhysRev.187.828; SCHLENKER C, 1980, PHILOS MAG B, V42, P453, DOI 10.1080/01418638008221887; TRAYLER JG, 1971, PHYS REV B, V3, P3457, DOI 10.1103/PhysRevB.3.3457; Wall S., 2011, NAT COMMUN, V3, P721	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 1	2015	311						154	159		10.1016/j.jphotochem.2015.06.027		6	Chemistry, Physical	Chemistry	CS2UW	WOS:000361928500019		
J	Tsuruoka, A; Isobe, T; Matsushita, S; Wakamura, M; Nakajima, A				Tsuruoka, Ayumi; Isobe, Toshihiro; Matsushita, Sachiko; Wakamura, Masato; Nakajima, Akira			Comparison of photocatalytic activity and surface friction force variation on Ti-doped hydroxyapatite and anatase under UV illumination	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Friction force; Photocatalyst; Ti-HAp; Anatase	PROTEIN ADSORPTION BEHAVIORS; THIN-FILM; APATITE; WETTABILITY; PARTICLES	Photocatalytic activity and surface friction variation were evaluated on Ti-doped hydroxyapatite (Ti-HAp) and anatase-type TiO2 powders under UV illumination. Although the adsorption capability of Ti-HAp against gaseous 2-propanol (IPA) in the dark was greater than that of anatase, photocatalytic decomposition activity and water adsorption capability of Ti-HAp under UV illumination were inferior to those of anatase. Experiments using powder/epoxy composites revealed that Ti-HAp does not exhibit photocatalytic wettability conversion to a hydrophilic state, which was confirmed on anatase. The surface friction force variation of anatase under UV illumination was similar to previously reported trend for rutile ceramics. That of Ti-HAp exhibited a different trend against anatase, suggesting that its surface was originally more hydrophobic than anatase or cantilever. (C) 2015 Elsevier B.V. All rights reserved.	[Tsuruoka, Ayumi; Isobe, Toshihiro; Matsushita, Sachiko; Nakajima, Akira] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528552, Japan; [Wakamura, Masato] Fujitsu Labs Ltd, Device & Mat Lab, Atsugi, Kanagawa 2430197, Japan	Nakajima, A (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Met & Ceram Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	anakajim@ceram.titech.ac.jp	Isobe, Toshihiro/I-6521-2013	Isobe, Toshihiro/0000-0002-2726-6728	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H04120]	The authors are grateful to the staff of the Center of Advanced Materials Analysis at the Tokyo Institute of Technology for helpful cooperation in materials characterization. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (15H04120).	Miyauchi M, 2000, CHEM MATER, V12, P3, DOI 10.1021/cm990556p; Kandori K, 2011, COLLOID SURFACE B, V87, P472, DOI 10.1016/j.colsurfb.2011.06.010; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Xu L, 1998, SURF SCI, V407, P251, DOI 10.1016/S0039-6028(98)00199-X; Okudaira K, 2011, J PHOTOCH PHOTOBIO A, V222, P64, DOI 10.1016/j.jphotochem.2011.05.002; Kandori K, 2012, J MOL CATAL A-CHEM, V360, P54, DOI 10.1016/j.molcata.2012.04.009; Kandori K, 2013, COLLOID SURFACE B, V101, P68, DOI 10.1016/j.colsurfb.2012.06.017; Misra DN, 1999, J BIOMED MATER RES, V48, P848, DOI 10.1002/(SICI)1097-4636(1999)48:6<848::AID-JBM13>3.0.CO;2-M; Takeuchi M, 2005, J PHYS CHEM B, V109, P7387, DOI 10.1021/jp040630d; Ohko Y, 1997, J PHYS CHEM A, V101, P8057, DOI 10.1021/jp972002k; Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M; Yoshida N, 2005, CHEM LETT, V34, P1666, DOI 10.1246/cl.2005.1666; Chen XB, 1997, WATER AIR SOIL POLL, V98, P57, DOI 10.1023/A:1026425931811; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Yang ZP, 2011, BIOSENS BIOELECTRON, V29, P167, DOI 10.1016/j.bios.2011.08.012; Tsukada M, 2011, J MOL CATAL A-CHEM, V338, P18, DOI 10.1016/j.molcata.2011.01.017; Choudary BM, 2005, J AM CHEM SOC, V127, P9948, DOI 10.1021/ja0436594; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0; Hashimoto K., 1998, TIO2 PHOTOCATALYSIS, P31; Nosaka Y., 2004, NYUMON HIKARI SHOKUB, P63; SUZUKI T, 1981, J CHEM SOC FARAD T 1, V77, P1059, DOI 10.1039/f19817701059; Wakamura K., 2003, LANGMUIR, V19, P3428; Wakamura M., 2006, J SOC INORG MAT JPN, V13, P516	25	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 1	2015	311						160	165		10.1016/j.jphotochem.2015.07.001		6	Chemistry, Physical	Chemistry	CS2UW	WOS:000361928500020		
J	Schutz, M; Sakota, K; Moritz, R; Schmies, M; Ikeda, T; Sekiya, H; Dopfer, O				Schuetz, Markus; Sakota, Kenji; Moritz, Raphael; Schmies, Matthias; Ikeda, Takamasa; Sekiya, Hiroshi; Dopfer, Otto			Simultaneous Interaction of Hydrophilic and Hydrophobic Solvents with Ethylamino Neurotransmitter Radical Cations: Infrared Spectra of Tryptamine(+)-(H2O)(m)-(N-2)(n), Clusters (m,n <= 3)	JOURNAL OF PHYSICAL CHEMISTRY A			English	Article							HYDROGEN-BONDED CLUSTERS; DOUBLE-RESONANCE SPECTROSCOPY; BIOMOLECULAR BUILDING-BLOCKS; IONIZATION-INDUCED SWITCH; IR-SPECTRA; ELECTRONIC SPECTROSCOPY; CONFORMATIONAL ISOMERIZATION; WATER CLUSTERS; COMPLEXES L; PHOTODISSOCIATION SPECTRA	Solvation of biomolecules by a hydrophilic and hydrophobic environment strongly affects their structure and function. Here, the structural, vibrational, and energetic properties of size-selected clusters of the micro-hydrated tryptamine cation with N-2 ligands, TRA(+)-(H2O)(m)-(N-2)(n), (m,n <= 3), are characterized by infrared photodissociation spectroscopy in the 2800-3800 cm(-1) range and dispersion-corrected density functional theory calculations at the omega B97X-D/cc-pVTZ level to investigate the simultaneous solvation of this prototypical neurotransmitter by dipolar water and quadrupolar N-2 ligands. In the global minimum structure of TRA(+)-H2O generated by electron ionization, H2O is strongly hydrogen-bonded (H-bonded) as proton acceptor to the acidic indolic NH group. In the TRA(+)-H2O-(N-2) clusters, the weakly bonded N-2 ligands do not affect the H-bonding motif of TRA(+)-H2O and are preferentially H-bonded to the OH groups of the H2O ligand, whereas stacking to the aromatic pi electron system of the pyrrole ring of TRA(+) is less favorable. The natural bond orbital analysis reveals that the H-bond between the N-2 ligand and the OH group of H2O cooperatively strengthens the adjacent H-bond between the indolic NH group of TRA(+) and H2O, while pi stacking is slightly noncooperative. In the larger TRA(+)-(H2O)(m) clusters, the H2O ligands form a H-bonded solvent network attached to the indolic NH proton, again stabilized by strong cooperative effects arising from the nearby positive charge. Comparison with the corresponding neutral TRA-(1120), clusters illustrates the strong impact of the excess positive charge on the structure of the microhydration network.	[Schuetz, Markus; Moritz, Raphael; Schmies, Matthias; Dopfer, Otto] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; [Sakota, Kenji; Ikeda, Takamasa; Sekiya, Hiroshi] Kyushu Univ, Dept Chem, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan; [Sakota, Kenji; Ikeda, Takamasa; Sekiya, Hiroshi] Kyushu Univ, Grad Sch Sci, Dept Mol Chem, Higashi Ku, Fukuoka 8128581, Japan	Sakota, K (reprint author), Kyushu Univ, Dept Chem, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	sakota@chem.kyushu-univ.jp; dopfer@physik.tu-berlin.de			German-Israel Foundation for Scientific Research and Development [1164-158.5/2011]; Deutsche Forschungsgemeinschaft [DO 729/4]; JSPS core-to-core program [22003];  [25410022];  [26288010];  [26104527]	This research was supported by the German-Israel Foundation for Scientific Research and Development (No. 1164-158.5/2011), Deutsche Forschungsgemeinschaft (DO 729/4), the JSPS core-to-core program (22003), and the Grants-in-Aid for Scientific Research C (No. 25410022), Scientific Research B (No. 26288010), Scientific Research on Innovative Area (No. 26104527). We thank I. Bar and M. Fujii for fruitful discussions.	Bouchet A, 2015, PHYS CHEM CHEM PHYS, V17, P25742, DOI 10.1039/c5cp00221d; Rizzo TR, 2009, INT REV PHYS CHEM, V28, P481, DOI 10.1080/01442350903069931; Savoca M, 2013, PHYS CHEM CHEM PHYS, V15, P2774, DOI 10.1039/c2cp43773b; Gerhards M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2008255; Dopfer O, 2002, INT J MASS SPECTROM, V218, P281, DOI 10.1016/S1387-3806(02)00737-6; Andrei HS, 2005, J PHYS CHEM A, V109, P3598, DOI 10.1021/jp0441487; Andrei HS, 2006, CHEMPHYSCHEM, V7, P107, DOI 10.1002/cphc.200500432; PARK YD, 1986, J CHEM PHYS, V84, P6539, DOI 10.1063/1.450705; Mayorkas N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798218; Dopfer O, 1997, INT J MASS SPECTROM, V167, P637, DOI 10.1016/S0168-1176(97)00111-0; Sakota K, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769878; Caminati W, 2004, PHYS CHEM CHEM PHYS, V6, P2806, DOI 10.1039/b315707e; Kleinermanns K, 1997, BER BUNSEN PHYS CHEM, V101, P1785; Sakota K, 2014, PHYS CHEM CHEM PHYS, V16, P3798, DOI 10.1039/c3cp54127d; Bieske EJ, 2000, CHEM REV, V100, P3963, DOI 10.1021/cr990064w; Bohm M, 2009, J PHYS CHEM A, V113, P448, DOI 10.1021/jp8087989; Nakamura T, 2014, CHEM-EUR J, V20, P2031, DOI 10.1002/chem.201303321; Muller-Dethlefs K, 2000, CHEM REV, V100, P143, DOI 10.1021/cr9900331; Solca N, 2003, J PHYS CHEM A, V107, P4046, DOI 10.1021/jp022286v; Unterberg C, 2000, J CHEM PHYS, V113, P7945, DOI 10.1063/1.1315610; Garand E, 2012, SCIENCE, V335, P694, DOI 10.1126/science.1214948; Solca N, 2001, J PHYS CHEM A, V105, P5637, DOI 10.1021/jp004002h; Ishiuchi S, 2005, ANGEW CHEM INT EDIT, V44, P6149, DOI 10.1002/anie.200501430; Braun JE, 2000, INT J MASS SPECTROM, V203, P1, DOI 10.1016/S1387-3806(00)00384-5; Ellington TL, 2013, COMPUT THEOR CHEM, V1021, P109, DOI 10.1016/j.comptc.2013.06.035; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Dopfer O, 2000, J PHYS CHEM A, V104, P11702, DOI 10.1021/jp0024773; Schmitt M, 2005, J AM CHEM SOC, V127, P10356, DOI 10.1021/ja0522377; Carney JR, 2000, J PHYS CHEM A, V104, P8677, DOI 10.1021/jp001433r; Alonso JL, 2011, J MOL SPECTROSC, V269, P41, DOI 10.1016/j.jms.2011.04.009; Schmies M, 2014, PHYS CHEM CHEM PHYS, V16, P7980, DOI 10.1039/c4cp00401a; Dopfer O, 2003, INT REV PHYS CHEM, V22, P437, DOI 10.1080/0144235031000112878; Solca N, 2004, J CHEM PHYS, V120, P10470, DOI 10.1063/1.1687674; Solca N, 2002, EUR PHYS J D, V20, P469, DOI 10.1140/epjd/e2002-00147-6; Savoca M, 2013, ANGEW CHEM INT EDIT, V52, P1568, DOI 10.1002/anie.201208958; Andrei HS, 2004, PHYS CHEM CHEM PHYS, V6, P3801, DOI 10.1039/b403970j; Solca N, 2001, J MOL STRUCT, V563, P241, DOI 10.1016/S0022-2860(00)00835-8; Solca N, 2001, CHEM PHYS LETT, V347, P59, DOI 10.1016/S0009-2614(01)01005-3; Klyne J, 2014, J PHYS CHEM B, V118, P3005, DOI 10.1021/jp5011988; Gu QL, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4752080; Zwier TS, 2006, J PHYS CHEM A, V110, P4133, DOI 10.1021/jp056390z; TOMODA S, 1983, CHEM PHYS LETT, V102, P560, DOI 10.1016/0009-2614(83)87466-1; Klyne J, 2015, J PHYS CHEM B, V119, P1388, DOI 10.1021/jp511421h; PETEANU LA, 1988, J PHYS CHEM-US, V92, P6554, DOI 10.1021/j100334a016; Wolk AB, 2014, ACCOUNTS CHEM RES, V47, P202, DOI 10.1021/ar400125a; George MAR, 2013, CHEM-EUR J, V19, P15315, DOI 10.1002/chem.201302189; Brause R, 2006, CHEM PHYS, V327, P43, DOI 10.1016/j.chemphys.2006.03.029; Pasker FM, 2006, J PHYS CHEM A, V110, P12793, DOI 10.1021/jp064571a; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305; Duncan MA, 2000, INT J MASS SPECTROM, V200, P545, DOI 10.1016/S1387-3806(00)00366-3; Chakraborty S, 2010, CHEM PHYS LETT, V485, P49, DOI 10.1016/j.cplett.2009.12.036; Solca N, 2004, PHYS CHEM CHEM PHYS, V6, P2732, DOI 10.1039/b313110f; Schmies M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4901893; Zwier TS, 1996, ANNU REV PHYS CHEM, V47, P205, DOI 10.1146/annurev.physchem.47.1.205; O'Neill JC, 2000, J MOL BIOL, V295, P737, DOI 10.1006/jmbi.1999.3403; Belau L, 2007, J PHYS CHEM A, V111, P10075, DOI 10.1021/jp075263v; Chakraborty S, 2010, INT J MASS SPECTROM, V297, P85, DOI 10.1016/j.ijms.2010.06.026; Wohlgemuth M, 2014, ANGEW CHEM INT EDIT, V53, P14601, DOI 10.1002/anie.201409047; Fujii M, 2012, INT REV PHYS CHEM, V31, P131, DOI 10.1080/0144235X.2012.656013; Schmies M, 2013, CHEMPHYSCHEM, V14, P728, DOI 10.1002/cphc.201200790; Weiler M, 2012, CHEMPHYSCHEM, V13, P3875, DOI 10.1002/cphc.201200704; Lorenz U, 2005, CHEM PHYS LETT, V406, P321, DOI 10.1016/j.cplett.2005.02.077; Tanabe K, 2012, ANGEW CHEM INT EDIT, V51, P6604, DOI 10.1002/anie.201203296; Dopfer O, 2002, CHEM PHYS, V283, P85; Nagornova NS, 2012, SCIENCE, V336, P320, DOI 10.1126/science.1218709; Goebbert DJ, 2004, EUR J MASS SPECTROM, V10, P837, DOI 10.1255/ejms.684; Solca N, 2003, CHEM PHYS LETT, V369, P68, DOI 10.1016/S0009-2614(02)01929-2; Miyazaki M, 2011, PHYS CHEM CHEM PHYS, V13, P2744, DOI 10.1039/c0cp01961e; Huisken F, 1996, J CHEM PHYS, V104, P17, DOI 10.1063/1.470871; Carney JR, 2001, J AM CHEM SOC, V123, P5596, DOI 10.1021/ja015863m; Dian BC, 2004, SCIENCE, V303, P1169, DOI 10.1126/science.1093731; Ishiuchi SI, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2775935; Clarkson JR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1924454; Clarkson JR, 2005, SCIENCE, V307, P1443, DOI 10.1126/science.1106977; Dopfer O, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869341; Patzer A, 2013, J PHYS CHEM A, V117, P9785, DOI 10.1021/jp312581v; Dopfer O, 2005, Z PHYS CHEM, V219, P125, DOI 10.1524/zpch.219.2.125.57302; Solca N, 2000, CHEM PHYS LETT, V325, P354, DOI 10.1016/S0009-2614(00)00675-8; Clarkson JR, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2713109; Dopfer O, 1996, CHEM PHYS, V207, P437, DOI 10.1016/0301-0104(96)00010-9; MULLERDETHLEFS K, 1994, CHEM REV, V94, P1845; PRIBBLE RN, 1994, SCIENCE, V265, P75, DOI 10.1126/science.265.5168.75; Alata I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554416; Ikeda T, 2012, J PHYS CHEM A, V116, P3816, DOI 10.1021/jp301804w; Ebata T, 1998, INT REV PHYS CHEM, V17, P331, DOI 10.1080/014423598230081; Ishiuchi S, 2011, PHYS CHEM CHEM PHYS, V13, P2409, DOI 10.1039/c0cp01926g; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+; Miyazaki M, 2001, CHEM PHYS LETT, V349, P431, DOI 10.1016/S0009-2614(01)01239-8; PHILIPS LA, 1988, J CHEM PHYS, V89, P85, DOI 10.1063/1.455464; HUANG ZS, 1989, J CHEM PHYS, V91, P6613, DOI 10.1063/1.457380; DOMELSMITH LN, 1977, J AM CHEM SOC, V99, P4311, DOI 10.1021/ja00455a018; Frisch M. J. T., 2009, GAUSSIAN09; Glendening E. D., 2013, NBO 6 0; Kuyanov-Prozument K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3276459; LEUNG HO, 1989, J CHEM PHYS, V90, P700, DOI 10.1063/1.456149; Patter A., 2012, ANGEW CHEM INT EDIT, V51, P4925; Roscioli JR, 2007, SCIENCE, V316, P249, DOI 10.1126/science.1138962	97	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1089-5639			J PHYS CHEM A	J. Phys. Chem. A	OCT 1	2015	119	39					10035	10051		10.1021/acs.jpca.5b07408		17	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CS9BP	WOS:000362384400010		
J	Nagata, T				Nagata, Takeshi			Growth inhibition and IRT1 induction of Arabidopsis thaliana in response to bismuth	JOURNAL OF PLANT BIOLOGY			English	Article						Arabidopsis thaliana; Bismuth; Gene expression; Iron; Iron-Regulated Transporter 1; Microarray	IRON UPTAKE; METAL TRANSPORTER; TOXICITY; NICKEL; PLANTS; ACCUMULATION; ERADICATION; HOMEOSTASIS; EXPRESSION; TOLERANCE	Bismuth (Bi) is used in cosmetics and in semiconductor. And more, Bismuth is used in water pipes as substitute of lead. However, the Bi concentration in soil has not been investigated and no environmental quality standard is available in Japan. Here we investigated the effect of Bi on growth of Arabidopsis thaliana and identified the responsible genes with microarray analysis. The seeds, which were soaked with various concentrations of Bi including agar medium, were not able to germinate by more than 7 A mu M Bi. The root elongation and shoot growth were significantly inhibited by more than 2 A mu M Bi. Then, the mRNA was extracted from 2 A mu M Bi treated seedlings and the gene expression levels were analyzed by microarray. In response to Bi, 13 metal homeostasis genes were expressed 2-fold higher than that of control. The relative transcription level of AtIRT1, the primary Fe2+ uptake transporter in the root, was about 5-fold higher compared to the control. This data is indicating that Bi induces AtIRT1 expression in roots. Moreover, ferritin protein coding genes were one half lesser than that of the control. Bi exposure increased Fe accumulation in roots. These results suggest that Bi might disturb iron homeostasis in seedlings.	Setsunan Univ, Fac Sci & Engn, Neyagawa, Osaka 5728508, Japan	Nagata, T (reprint author), Setsunan Univ, Fac Sci & Engn, 17-8 Ikedanakamachi, Neyagawa, Osaka 5728508, Japan.	t-nagata@lif.setsunan.ac.jp					Nishida S, 2011, PLANT CELL PHYSIOL, V52, P1433, DOI 10.1093/pcp/pcr089; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Shanmugam V, 2011, NEW PHYTOL, V190, P125, DOI 10.1111/j.1469-8137.2010.03606.x; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Sano Y, 2005, J OCCUP HEALTH, V47, P242, DOI 10.1539/joh.47.242; Yang X, 1996, J PLANT NUTR, V19, P265, DOI 10.1080/01904169609365121; Pandey N, 2002, PLANT SCI, V163, P753, DOI 10.1016/S0168-9452(02)00210-8; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Nagata T, 2010, APPL MICROBIOL BIOT, V87, P781, DOI 10.1007/s00253-010-2572-9; CATALDO DA, 1978, PLANT PHYSIOL, V62, P563, DOI 10.1104/pp.62.4.563; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Sano Y, 2005, J OCCUP HEALTH, V47, P293, DOI 10.1539/joh.47.293; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vert G, 2009, PLANTA, V229, P1171, DOI 10.1007/s00425-009-0904-8; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Jihou-sha, 2011, JAPANESE PHARMACOPOE; Nishida Sho, 2012, Plant Signal Behav, V7, P329, DOI 10.4161/psb.19263; Srinarong C, 2014, ASIAN PAC J CANCER P, V15, P9909, DOI 10.7314/APJCP.2014.15.22.9909; WILHELMSEN I, 1994, HEPATO-GASTROENTEROL, V41, P43	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1226-9239	1867-0725		J PLANT BIOL	J. Plant Biol.	OCT	2015	58	5					311	317		10.1007/s12374-015-0256-9		7	Plant Sciences	Plant Sciences	CS7VZ	WOS:000362296400005		
J	Jang, S; Yamaoka, Y; Ko, DH; Kurita, T; Kim, K; Song, WY; Hwang, JU; Kang, BH; Nishida, I; Lee, Y				Jang, Sunghoon; Yamaoka, Yasuyo; Ko, Dong-hwi; Kurita, Tomokazu; Kim, Kyungyoon; Song, Won-Yong; Hwang, Jae-Ung; Kang, Byung-Ho; Nishida, Ikuo; Lee, Youngsook			Characterization of a Chlamydomonas reinhardtii mutant defective in a maltose transporter	JOURNAL OF PLANT BIOLOGY			English	Article						Chloroplast; Maltose exporter; Mutant screening; Starch accumulation	STARCH; PROTEINS; RICE	Microalgae are potential sources of energy and high-value materials. To decipher the process of energy metabolism in green algae, we created a mutant pool of strain CC-503 of the model green microalga Chlamydomonas reinhardtii, by random insertion of an antibiotic resistance gene, and screened the pool for lines with altered carbon metabolism. We identified a mutant that harbored the antibiotic resistance gene in CrMEX1, a putative Maltose Exporter-Like protein 1 (Cre12.g486600.t1.2). The mutant had reduced levels of CrMEX1 expression and, similarly to the Arabidopsis mex1 knockout mutant, which cannot export maltose from the chloroplast, it over-accumulated starch granules in the chloroplast. The mutant's lipid levels were slightly higher than those of the wild type, and its initial growth kinetics were not significantly different from those of the wild type, but the mutant culture did not reach the same high cell density as the wild type in acetate-containing culture medium under continuous light. These results suggest that CrMEX1 encodes a maltose transporter protein, and that export of photoassimilates from chloroplasts is necessary for normal Chlamydomonas growth, even under continuous light with an ample supply of carbon in the form of acetate.	[Jang, Sunghoon; Yamaoka, Yasuyo; Kim, Kyungyoon; Song, Won-Yong; Hwang, Jae-Ung; Lee, Youngsook] POSTECH, Dept Life Sci, Pohang 790784, South Korea; [Ko, Dong-hwi; Lee, Youngsook] POSTECH, Dept Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Kurita, Tomokazu; Nishida, Ikuo] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Kurita, Tomokazu; Nishida, Ikuo] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Kang, Byung-Ho] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	Lee, Y (reprint author), POSTECH, Dept Life Sci, Pohang 790784, South Korea.	ylee@postech.ac.kr			Global Frontier Program of the Republic of Korea [2011-0031345]; Japan Science and Technology Agency; Chinese University of Hong Kong [4053098]	This research was supported by a grant from the Global Frontier Program (2011-0031345) of the Republic of Korea awarded to Youngsook Lee, by a Grant-in-Aid for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency to Ikuo Nishida, and Direct Grant for Research (The Chinese University of Hong Kong, 4053098) to BK. We thank the Chlamydomonas Genetics Center (USA) for providing the CC-503 Chlamydomonas reinhardtii line and Hanul Kim and Jihyun Lee for their technical help.	Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Kang BH, 2010, METHOD CELL BIOL, V96, P259, DOI 10.1016/S0091-679X(10)96012-3; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Hostettler C, 2011, METHODS MOL BIOL, V775, P387, DOI 10.1007/978-1-61779-237-3_21; RAMAZANOV Z, 1994, PLANTA, V195, P210; Schottkowski M, 2012, P NATL ACAD SCI USA, V109, P19286, DOI 10.1073/pnas.1209860109; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; Heinnickel ML, 2013, PHOTOSYNTH RES, V116, P427, DOI 10.1007/s11120-013-9882-6; Shimogawara K, 1998, GENETICS, V148, P1821; Kim SR, 2011, METHODS MOL BIOL, V678, P139, DOI 10.1007/978-1-60761-682-5_11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ryoo N, 2013, J KOREAN SOC APPL BI, V56, P149, DOI 10.1007/s13765-012-3266-z; CANVIN DT, 1961, J BIOL CHEM, V236, P988; Borkhsenious ON, 1998, PLANT PHYSIOL, V116, P1585, DOI 10.1104/pp.116.4.1585; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Fukuzawa H, 2001, P NATL ACAD SCI USA; Harris EH, 1989, CHLAMYDOMONAS SOURCE, V2; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081978; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING, V2; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tuncay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074763; ZUCKERKANDL EMILE, 1965, P97	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1226-9239	1867-0725		J PLANT BIOL	J. Plant Biol.	OCT	2015	58	5					344	351		10.1007/s12374-015-0377-1		8	Plant Sciences	Plant Sciences	CS7VZ	WOS:000362296400009		
J	Koyanagi, A; Stickley, A				Koyanagi, Ai; Stickley, Andrew			The association between psychosis and severe pain in community-dwelling adults: Findings from 44 low- and middle-income countries	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Low-income countries; Middle-income countries; Pain; Psychotic symptoms; Schizophrenia	DIAGNOSTIC INTERVIEW CIDI; MAJOR DEPRESSIVE EPISODES; ANXIETY DISORDERS; MENTAL-HEALTH; SCHIZOPHRENIA; LIFE; METAANALYSIS; EXPERIENCES; PERCEPTION; CONTINUUM	Previous studies examining the association between schizophrenia and pain have produced mixed results and data on sub-threshold psychosis or psychotic symptoms and pain are scarce. This study assessed the association between psychosis and severe pain among community-dwelling adults in 44 low- and middle-income countries (LMICs) where no data exists. Data on 235,370 adults aged >= 18 years from the World Health Survey (WHS) 2002-2004 were analyzed. The presence of past 12-month psychotic symptoms was established using four questions from the Composite International Diagnostic Interview. Participants were categorized into four mutually exclusive groups based on whether they had at least one psychotic symptom and/or a lifetime psychosis or schizophrenia diagnosis. Multivariable logistic regression was used to estimate the association between psychosis and past 30-day severe pain. The prevalence of severe pain among those with 0, 1, 2, >= 3 psychotic symptoms was 8.7%, 16.7%, 21.8%, 30.5% respectively. Compared to those with no psychotic symptoms or diagnosis, the ORs (95%CIs) were: at least one symptom without diagnosis [2.17 (1.99 -2.38)]; no symptom with diagnosis [2.33 (1.71-3.17)]; at least one symptom and diagnosis [4.27 (3.20 -5.71)]. Associations were partly mediated by chronic physical conditions, anxiety, and depression. Despite some limitations such as the use of a single-item question to assess pain, the results of this study suggest that individuals with psychotic symptoms or a psychosis diagnosis should be systematically assessed for pain, and if necessary, receive treatment for pain and its underlying conditions. Future research on the effect of pain management on psychosis outcome is warranted. (C) 2015 Elsevier Ltd. All rights reserved.	[Koyanagi, Ai] Univ Barcelona, Fundacio St Joan Deu, Res & Dev Unit, Parc Sanit St Joan Deu, Barcelona, Spain; [Koyanagi, Ai; Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden; [Koyanagi, Ai] CIBERSAM, Inst Salud Carlos III, Madrid, Spain; [Stickley, Andrew] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Stickley, Andrew] Natl Ctr Neurol & Psychiat, Dept Child & Adolescent Mental Hlth, Natl Inst Mental Hlth, Kodaira, Tokyo, Japan	Koyanagi, A (reprint author), Univ Barcelona, Fundacio St Joan Deu, Res & Dev Unit, Parc Sanit St Joan Deu, Dr Antoni Pujadas 42, Barcelona, Spain.	a.koyanagi@pssjd.org			Miguel Servet contract [CP13/00150]; ISCIII - General Branch Evaluation and Promotion of Health Research; ISCIII - European Regional Development Fund (ERDF-FEDER)	Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13/00150 project, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER).	Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Moreno C, 2013, WORLD PSYCHIATRY, V12, P251, DOI 10.1002/wps.20070; DeVylder JE, 2015, EARLY INTERV PSYCHIA, V9, P331, DOI 10.1111/eip.12161; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Kaymaz N, 2010, PSYCHOL MED, V40, P1963, DOI 10.1017/S0033291710000358; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/01.BRS.0000032130.45175.66; Seidel S, 2010, J PAIN SYMPTOM MANAG, V39, P768, DOI 10.1016/j.jpainsymman.2009.09.008; Scheller-Gilkey G, 2004, SCHIZOPHR RES, V69, P167, DOI 10.1016/S0920-9964(03)00188-9; Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Birgenheir DG, 2013, GEN HOSP PSYCHIAT, V35, P480, DOI 10.1016/j.genhosppsych.2013.03.019; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Cooper L, 1998, J PSYCHIAT RES, V32, P361, DOI 10.1016/S0022-3956(98)00021-1; Bonnot O, 2009, CLIN J PAIN, V25, P244, DOI 10.1097/AJP.0b013e318192be97; Konig HH, 2007, EUR PSYCHIAT, V22, P177, DOI 10.1016/j.eurpsy.2006.08.004; Strassnig M, 2003, SCHIZOPHR RES, V62, P73, DOI 10.1016/S0920-9964(02)00441-3; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Varghese D, 2011, SCHIZOPHRENIA BULL, V37, P389, DOI 10.1093/schbul/sbp083; Tsuang MT, 2013, SCHIZOPHR RES, V150, P31, DOI 10.1016/j.schres.2013.05.004; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099; Feigenson KA, 2014, NEUROSCI BIOBEHAV R, V38, P72, DOI 10.1016/j.neubiorev.2013.11.006; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Saha S, 2011, SCHIZOPHR RES, V127, P246, DOI 10.1016/j.schres.2010.12.012; Haibach JP, 2014, MED CARE, V52, P322, DOI 10.1097/MLR.0000000000000098; Cifuentes M, 2008, SOC SCI MED, V67, P529, DOI 10.1016/j.socscimed.2008.04.003; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Degenhardt L., 2015, DRUG ALCOHOL REV; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235; Earl TR, 2015, ETHNIC HEALTH, V20, P273, DOI 10.1080/13557858.2014.921888; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Husebo BS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4065; Johnson AC, 2014, J PHARMACOL EXP THER, V351, P327, DOI 10.1124/jpet.114.218065; LeBlanc D. M., 2015, ALCOHOL; MCGRATH PA, 1994, ARCH ORAL BIOL, V39, pS55, DOI 10.1016/0003-9969(94)90189-9; Morales-Chávez Mariana C, 2014, J Clin Exp Dent, V6, pe7, DOI 10.4317/jced.51147; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018566; Stickley A., 2015, EUR J PAIN; Stubbs B, 2014, SCHIZOPHR RES, V160, P1, DOI 10.1016/j.schres.2014.10.017; Stubbs B, 2015, GEN HOSP PSYCHIAT, V37, P126, DOI 10.1016/j.genhosppsych.2015.01.004; WHO (World Health Organization), 2000, INT GUID MON ALC CON; Wong KO, 2013, PULM MED, V2013	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2015	69						19	26		10.1016/j.jpsychires.2015.07.020		8	Psychiatry	Psychiatry	CS2UP	WOS:000361927800004		
J	Matsuda, Y; Kobayashi, K; Fukuta, F; Mori, M; Masumori, N				Matsuda, Y.; Kobayashi, K.; Fukuta, F.; Mori, M.; Masumori, N.			NOCTURIA IS A PREDICTOR OF ERECTILE DYSFUNCTION	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract									[Matsuda, Y.; Kobayashi, K.; Fukuta, F.; Mori, M.; Masumori, N.] Sapporo Med Univ, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	OCT	2015	12			6	SI	068	408	409				2	Urology & Nephrology	Urology & Nephrology	CS6HA	WOS:000362177900077		
J	Nagao, K; Tai, T; Tanaka, N; Kobayashi, H; Nakajima, K				Nagao, K.; Tai, T.; Tanaka, N.; Kobayashi, H.; Nakajima, K.			17 YEARS EXPERIENCE OF PEYRONIE'S DISEASE IN TOHO UNIVERSITY	JOURNAL OF SEXUAL MEDICINE			English	Meeting Abstract									[Nagao, K.; Tai, T.; Tanaka, N.; Kobayashi, H.; Nakajima, K.] Toho Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-6095	1743-6109		J SEX MED	J. Sex. Med.	OCT	2015	12			6	SI	076	410	410				1	Urology & Nephrology	Urology & Nephrology	CS6HA	WOS:000362177900083		
J	Shinoda, M; Fujii, M; Takahashi, O; Kawatsu, A; Uemura, A; Niimi, Y				Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Kawatsu, Akiko; Uemura, Akihiro; Niimi, Yasunari			Inverse Relationship between Coffee Consumption and Cerebral Microbleeds in Men, but Not Women	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Coffee consumption; microbleeds; small-vessel disease; beverage	RISK; STROKE; METAANALYSIS; DRINKING; TEA	Background: Studies evaluating the association between coffee consumption and neurovascular diseases have frequently yielded contradictory results. The aim of this study was to investigate the association of coffee consumption with small-vessel disease (SVD) incidence in a healthy urban population while accounting for multiple demographic and lifestyle risk factors. Methods: This prospective study conducted from May 2013 through March 2014 included 455 participants (314 men and 141 women) aged 25 to 92 years. All subjects completed a questionnaire on coffee consumption and received a comprehensive neurologic examination, including magnetic resonance imaging, at St. Luke's International Hospital (Tokyo, Japan). Results: Incidence of SVD was lower in male daily coffee drinkers than male nondrinkers and occasional drinkers, whereas incidence of white matter lesions was lower in female daily coffee drinkers than female nondrinkers or occasional drinkers. In multivariate analyses including age, sex, smoking status, and BMI, as well as coffee consumption, incidence of microbleeds was significantly lower in male daily coffee drinkers compared to nondrinkers. Conclusions: Daily coffee consumption is associated with reduced risk of cerebral microbleeds in men.	[Shinoda, Masaki; Fujii, Motoharu] St Lukes Int Hosp, Dept Neurosurg, Tokyo 1048560, Japan; [Fujii, Motoharu; Uemura, Akihiro; Niimi, Yasunari] St Lukes Int Hosp, Dept Neuroendovasc Therapy, Tokyo 1048560, Japan; [Takahashi, Osamu; Kawatsu, Akiko] St Lukes Int Hosp, Dept Internal Med, Div Gen Internal Med, Tokyo 1048560, Japan	Shinoda, M (reprint author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mashino@luke.ac.jp			All Japan Coffee Association	This study was partly supported by a grant from the All Japan Coffee Association.	Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787; Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131; Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226; Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205; Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500; Vlak MHM, 2011, STROKE, V42, P1878, DOI 10.1161/STROKEAHA.110.606558; Jee SH, 1999, HYPERTENSION, V33, P647; Isaksen J, 2002, J NEUROL NEUROSUR PS, V73, P185, DOI 10.1136/jnnp.73.2.185; Soo YOY, 2008, J NEUROL, V255, P1679, DOI 10.1007/s00415-008-0967-7; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2196	2199		10.1016/j.jstrokecerebrovasdis.2015.04.032		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400009		
J	Takeshima, Y; Miyake, H; Nakagawa, I; Motoyama, Y; Park, YS; Nakase, H				Takeshima, Yasuhiro; Miyake, Hitoshi; Nakagawa, Ichiro; Motoyama, Yasushi; Park, Young-Su; Nakase, Hiroyuki			Visualization of Regional Cerebral Blood Flow Dynamics during Cortical Venous Occlusion using Laser Speckle Contrast Imaging in a Rat Model	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						CBF dynamics; cerebral ischemia; cerebral venous ischemia; regional cerebral blood flow; laser speckle contrast imaging; cortical infarction	DOPPLER; THROMBOSIS; SINUS; DISTURBANCE; INFARCTION	Background: Cerebral venous ischemia (CVI) is a rare but potentially significant complication of neurosurgical procedures. However, it is still unclear how cerebral venous occlusion (VO) affects regional cerebral blood flow (rCBF) dynamics. To elucidate its pathophysiology in detail, we examined the real-time perfusion dynamics during adjacent vein occlusions using laser speckle contrast imaging (LSCI) in a rat 2-vein occlusion model. Methods: Two cortical veins were occluded photochemically using rose Bengal dye in 6 male Wistar rats; rCBF was measured in real time with an LSCI before and after VO. Regions of interest were defined between the 2 veins (A) and on the opposite side of the first occluded vein (B) on semi-quantitative pseudocolor images for off-line analysis. Histopathologic evaluation was performed 3 days after the procedure to assess the extent of infarction. Results: LSCI revealed a stepwise reduction in CBF, with a sudden decrease just after the first vein occlusion (similar to 20%) and a further decrease after the second (similar to 30%). Significant differences were observed between rCBF dynamics within regions of interest A and B (P = .0004). All rats exhibited infarcts in the superficial cerebral cortex histopathologically. Conclusions: This is the first report of LSCI specifically applied to the study of CVI. The extensive real-time measurement with high temporal and spatial resolution revealed the stepwise reduction in rCBF during sequential VO and the ensuing infarcts.	[Takeshima, Yasuhiro; Miyake, Hitoshi; Nakagawa, Ichiro; Motoyama, Yasushi; Park, Young-Su; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Sch Med, Kashihara, Nara 6348521, Japan	Takeshima, Y (reprint author), Nara Med Univ, Dept Neurosurg, Sch Med, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	takeshim@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791516]; Takeda Science Foundation	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24791516), and it was partially supported by research grants from the Takeda Science Foundation.	Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Dusch M, 2007, NEUROREPORT, V18, P1101, DOI 10.1097/WNR.0b013e3281e72cff; Parthasarathy AB, 2010, BIOMED OPT EXPRESS, V1, P246; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P289; Klijn E, 2013, J NEUROSURG, V118, P280, DOI 10.3171/2012.10.JNS1219; GOTOH M, 1993, ACTA NEUROCHIR, V124, P120, DOI 10.1007/BF01401133; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; Nakase H, 2002, NEUROL MED-CHIR, V42, P1, DOI 10.2176/nmc.42.1; Takeshima Y, 2011, NEUROSURGERY, V68, P1334, DOI 10.1227/NEU.0b013e31820c048e; Nakase H, 1997, J NEUROSURG, V87, P307, DOI 10.3171/jns.1997.87.2.0307; FRIES G, 1992, J NEUROSURG, V77, P127, DOI 10.3171/jns.1992.77.1.0127; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Wajima D, 2010, BRAIN RES, V1309, P126, DOI 10.1016/j.brainres.2009.10.061; HEIMANN A, 1994, J CEREBR BLOOD F MET, V14, P1100; Sindou M, 2005, ACT NEUR S, V94, P167; Nakase H, 1996, J CEREBR BLOOD F MET, V16, P720; Schaller B, 2004, CEREBROVASC DIS, V18, P179, DOI 10.1159/000079939; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195; Durduran T, 2004, J CEREBR BLOOD F MET, V24, P518; Hecht N, 2013, J CEREBR BLOOD F MET, V33, P1000, DOI 10.1038/jcbfm.2013.42; Inui T, 2013, NEUROSCIENCE, V242, P1, DOI 10.1016/j.neuroscience.2013.03.018; Bentley JN, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09166; Hecht N, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09148; Murozono Michihiro, 2013, Acta Neurochir Suppl, V118, P71, DOI 10.1007/978-3-7091-1434-6_12; Nakase H, 1995, NEUROSURGERY, V37, P5; NAKASE H, 1995, NEUROSURGERY, V37, P280	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2200	2206		10.1016/j.jstrokecerebrovasdis.2015.04.048		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400010		
J	Kato, Y; Hayashi, T; Tanahashi, N; Kobayashi, S				Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio; Kobayashi, Shotai		Japan Stand Stroke Registry Study	Influence of Antiplatelet Drugs on the Outcome of Subarachnoid Hemorrhage Differs with Age	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Age stratification; subarachnoid hemorrhage; antiplatelet drugs; Japanese	DELAYED CEREBRAL-ISCHEMIA; CILOSTAZOL; ASPIRIN; VASOSPASM; STROKE; CONTRACTION; POPULATION; MECHANISM	Background: The aim of this study was to examine the risk factor profiles and functional outcomes of subarachnoid hemorrhage (SAH) in different age groups, focusing on the effect of antiplatelet drugs when used before stroke. Methods: A total of 5344 patients with SAH were included in a multicenter, hospital-based registration study involving 95 Japanese institutes from 2000 to 2012. Patients' profiles and use of antithrombotic agents were retrospectively reviewed. A modified Rankin Scale score of 4 or more at discharge was defined as poor outcome. Results: The frequency of antithrombotic agent use increased with age; it reached its peak (10.9%) among patients in their 80s and remained constant at 7.5% for those 90 years or older. Poorer outcomes were evident as age increased. The frequency of hypertension increased with age, whereas current smoking and heavy drinking reached its peak among patients in their 40s and 50s, respectively. The use of antiplatelet agents significantly improved outcome in patients younger than 60 years (P = .04). In contrast, in the older group (>= 60 years), the use of antiplatelet agents tended to worsen the outcome; patients aged 70-79 years who had used these agents had a significantly worse outcome compared with those who had not (P = .03). Conclusions: In the present study, the influence of antiplatelet agents was different among age groups. The potential beneficial effects of antiplatelet agents must be weighed against their potential adverse effects in the context of SAH, considering the differences in age-related outcomes.	[Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio] Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, Hidaka, Saitama 3501298, Japan; [Kobayashi, Shotai] Shimane Univ, Dept Neurol, Matsue, Shimane, Japan	Kato, Y (reprint author), Saitama Med Univ, Saitama Int Med Ctr, Dept Neurol & Cerebrovasc Med, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	yujik@saitama-med.ac.jp			Japanese Ministry of Welfare [H11-21]	Japan Standard Stroke Registry Study was developed with support ("21st Century Type Promoting Development of Clinical Research Fund'') from the Japanese Ministry of Welfare (grant number: H11-21 century(life)-33) during 1999 to 2001.	Yamaguchi-Okada M, 2009, CEREBROVASC DIS, V28, P135, DOI 10.1159/000223439; OKAMOTO S, 1984, STROKE, V15, P60; Scholler K, 2013, J NEUROL, V260, P1052, DOI 10.1007/s00415-012-6758-1; Rinkel GJE, 1997, STROKE, V28, P6; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; Kobayashi S, 2006, AM J PREV MED, V31, pS240, DOI 10.1016/j.amepre.2006.08.011; Yoshimoto T, 2009, NEUROL MED-CHIR, V49, P235; TODA N, 1980, J NEUROSURG, V53, P312, DOI 10.3171/jns.1980.53.3.0312; Senbokuya N, 2013, J NEUROSURG, V118, P121, DOI 10.3171/2012.9.JNS12492; ELLIS EF, 1977, STROKE, V8, P480; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Chalouhi N, 2014, NEUROSURGERY, V74, P147, DOI 10.1227/NEU.0000000000000164; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Garcia-Rodriguez LA, 2013, NEUROLOGY, V81, P566, DOI 10.1212/WNL.0b013e31829e6ffa; Toussaint LG, 2004, J NEUROSURG, V101, P921, DOI 10.3171/jns.2004.101.6.0921; Kozak N, 2007, J NEUROSURG, V106, P234, DOI 10.3171/jns.2007.106.2.234; JUVELA S, 1995, J NEUROSURG, V82, P945, DOI 10.3171/jns.1995.82.6.0945; Gross BA, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.03.072; Hasan DM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000019; Hudson JS, 2013, FUTURE NEUROL, V8	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2252	2255		10.1016/j.jstrokecerebrovasdis.2015.06.021		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400018		
J	Yoshioka, K; Watanabe, K; Zeniya, S; Ito, Y; Hizume, M; Kanazawa, T; Tomita, M; Ishibashi, S; Miake, H; Tanaka, H; Yokota, T; Mizusawa, H				Yoshioka, Kotaro; Watanabe, Kosuke; Zeniya, Satoshi; Ito, Yoko; Hizume, Masaki; Kanazawa, Toshiro; Tomita, Makoto; Ishibashi, Satoru; Miake, Hirotomo; Tanaka, Hiroaki; Yokota, Takanori; Mizusawa, Hidehiro			A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Acute ischemic stroke; paroxysmal atrial fibrillation; cardioembolism; brain natriuretic peptide	ACUTE ISCHEMIC-STROKE; BRAIN NATRIURETIC PEPTIDE; CRYPTOGENIC STROKE; ATTACK; PREVENTION; GUIDELINES; THERAPY; ASPIRIN; TRIAL; STAF	Background: Detection of paroxysmal atrial fibrillation (PAF) after a stroke is challenging. The purpose of this study was to develop a clinical score to predict PAF in a cohort of acute ischemic stroke patients prospectively and to validate it in an independent cohort. Methods: Consecutive acute ischemic stroke patients without permanent atrial fibrillation were enrolled in a derivation sample (n = 294) or a validation sample (n = 155). We developed a score for predicting PAF by independent risk factors derived from a logistic regression analysis of the derivation cohort and validated the score in the external cohort. Results: Multivariate analysis in the derivation cohort identified 3 variables independently associated with PAF. We calculated a score from these variables (history of arrhythmia or antiarrhythmic agent use [yes, 3 points], left atrial dilation [>= 40 mm, 1 point], brain natriuretic peptide [BNP, >50 pg/mL, 1 point; >90 pg/mL, 2 points; >150 pg/ml, 3 points], total score, 0-7). The iPAB score (identified by past history of arrhythmia or antiarrhythmic agent use, atrial dilation, and BNP elevation) predicted PAF in the derivation (c statistic,.90) and validation (. 94) cohorts at levels statistically superior to other biomarkers and clinical scores. For a total score 2 or more, the sensitivity and specificity were 93% and 71%, respectively. For a total score of 4 or more, the corresponding values were 60% and 95%. Conclusions: Our prospective study suggests that this simple risk score superior to other scores help clinicians predict PAF or identify good candidates for further evaluation to detect PAF.	[Yoshioka, Kotaro; Ishibashi, Satoru; Yokota, Takanori; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1130034, Japan; [Yoshioka, Kotaro; Watanabe, Kosuke; Hizume, Masaki; Kanazawa, Toshiro; Tanaka, Hiroaki] Yokohama City Minato Red Cross Hosp, Dept Neurol, Yokohama, Kanagawa, Japan; [Zeniya, Satoshi; Ito, Yoko; Miake, Hirotomo] Natl Disaster Med Ctr, Dept Neurol, Tachikawa, Tokyo, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Clin Res Ctr, Bunkyo Ku, Tokyo 1130034, Japan	Yoshioka, K (reprint author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.	kotanuro@tmd.ac.jp					Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Prasad V, 2012, CEREBROVASC DIS, V33, P199, DOI 10.1159/000334979; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Sposato LA, 2012, J STROKE CEREBROVASC, V21, P210, DOI 10.1016/j.jstrokecerebrovasdis.2010.06.010; Suissa L, 2013, J STROKE CEREBROVASC, V22, P991, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.015; Suissa L, 2011, CEREBROVASC DIS, V31, P442, DOI 10.1159/000323852; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Chevalier J, 2013, CEREBROVASC DIS, V35, P320, DOI 10.1159/000347074; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Flint AC, 2012, STROKE, V43, P2788, DOI 10.1161/STROKEAHA.112.665844; Horstmann S, 2013, EUR J NEUROL, V20, P147, DOI 10.1111/j.1468-1331.2012.03816.x; Shibazaki K, 2012, AM J CARDIOL, V109, P1303, DOI 10.1016/j.amjcard.2011.12.022; Suissa L, 2009, STROKE, V40, P2866, DOI 10.1161/STROKEAHA.109.552679; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Lazzaro MA, 2012, J STROKE CEREBROVASC, V21, P89, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.006; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Stahrenberg R, 2011, STROKE, V42, P3643, DOI 10.1161/STROKEAHA.111.632836; Higgins P, 2013, STROKE, V44, P2525, DOI 10.1161/STROKEAHA.113.001927; Rizos T, 2011, CEREBROVASC DIS, V32, P276, DOI 10.1159/000330348; Fujii S, 2013, J NEUROL SCI, V328, P83, DOI 10.1016/j.jns.2013.02.025; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Goldstein LB, 2001, STROKE, V32, P1091; Inoue S, 2000, J CARD FAIL, V6, P92, DOI 10.1054/jcaf.2000.8185; Okada Y, 2010, EUR J NEUROL, V17, P326, DOI 10.1111/j.1468-1331.2009.02813.x; Chang SL, 2008, J CARDIOVASC ELECTR, V19, P367, DOI 10.1111/j.1540-8167.2007.01065.x; Berntsson J, 2014, CEREBROVASC DIS, V37, P444, DOI 10.1159/000363279; Fujii Shuichi, 2009, Rinsho Shinkeigaku, V49, P629; [Anonymous], 2006, J AM COLL CARDIOL; Khachab H, 2011, INT J CARDIOL, V166, P221; Meschia James F, 2006, J Stroke Cerebrovasc Dis, V15, P266, DOI 10.1016/j.jstrokecerebrovasdis.2006.07.001; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Suissa L, 2013, J STROKE CEREBROVASC, V7, P103	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2263	2269		10.1016/j.jstrokecerebrovasdis.2015.06.019		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400020		
J	Kawase, S; Kowa, H; Suto, Y; Fukuda, H; Kusumi, M; Nakayasu, H; Nakashima, K				Kawase, Shinya; Kowa, Hisanori; Suto, Yutaka; Fukuda, Hiroki; Kusumi, Masayoshi; Nakayasu, Hiroyuki; Nakashima, Kenji			Plasma Brain Natriuretic Peptide is a Marker of Prognostic Functional Outcome in Non-Cardioembolic Infarction	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						modified Rankin Scale; brain damage; neurohumoral change; renin-angiotensin aldosterone system; sympathetic nervous system	ACUTE ISCHEMIC-STROKE; CHRONIC HEART-FAILURE; CEREBRAL INFARCTION; BLOOD-PRESSURE; MORTALITY	Background: High plasma levels of brain natriuretic peptide (BNP) may also be observed in patients with non-cardioembolic infarction (CEI). We aimed to evaluate the relation between plasma BNP level, clinical parameters, and functional outcome in patients with and without CEI. Method: This study analyzed consecutive Japanese patients with acute ischemic stroke. Correlations between plasma BNP level and conventional risk factors for ischemic stroke were examined. Values of P less than .05 were considered statistically significant. Results: This study analyzed 718 acute ischemic stroke patients (445 men and 273 women; mean age, 73.9 years). Mean plasma level of BNP was significantly higher for CEI (366.6 pg/ml) than for non-CEI (105.6 pg/ml; P < .01). Poor outcome (modified Rankin Scale score >= 3) at hospitalization and discharge were associated with significantly higher plasma BNP level than good outcome (modified Rankin Scale score <= 2) for both CEI and non-CEI. On multiple regression analysis, log-BNP was significantly associated with female sex, smoking, triglyceride, and creatinine clearance in CEI. In non-CEI, log-BNP was significantly associated with systolic/diastolic blood pressure, triglyceride, high-density lipoprotein cholesterol, and creatinine clearance. Conclusion: Irrespective of the presence of CEI, plasma BNP offers a marker of prognostic functional outcome. We clarified the characteristics and differences associated with plasma BNP in CEI and non-CEI, and our results suggest that plasma BNP can provide a useful marker of brain damage and neurohumoral dynamics in acute ischemic stroke.	[Kawase, Shinya; Kowa, Hisanori; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, Yonago, Tottori 6838504, Japan; [Suto, Yutaka; Nakayasu, Hiroyuki] Tottori Prefectural Cent Hosp, Dept Neurol, Tottori, Japan; [Fukuda, Hiroki] Matsue Red Cross Hosp, Dept Neurol, Matsue, Shimane, Japan; [Kusumi, Masayoshi] Sanin Rosai Hosp, Dept Neurol, Yonago, Tottori, Japan	Kawase, S (reprint author), Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neurol, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	charley.sk@med.tottori-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [22590655]	This work was supported by Japan Society for the Promotion of Science KAKENHI (grant number 22590655).	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Nakagawa K, 2005, CEREBROVASC DIS, V19, P157, DOI 10.1159/000083249; IWASAKI Y, 1989, JPN J MED, V28, P156; CARLBERG B, 1991, STROKE, V22, P527; Tsutamoto T, 1997, CIRCULATION, V96, P509; VANSWIETEN JC, 1988, STROKE, V19, P604; Makikallio AM, 2005, STROKE, V36, P1016, DOI 10.1161/01.STR.0000162751.54349.ae; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Shibazaki K, 2012, AM J CARDIOL, V109, P1303, DOI 10.1016/j.amjcard.2011.12.022; Butterworth RJ, 1997, CEREBROVASC DIS, V7, P10, DOI 10.1159/000108156; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Treib J, 1996, J NEUROL, V243, P575, DOI 10.1007/BF00900944; Soda T, 2004, ACTA NEUROL SCAND, V110, P343, DOI 10.1111/j.1600-0404.2004.00290.x; HARPER G, 1994, STROKE, V25, P1726; [Anonymous], 1990, STROKE, V21, P637; MYERS MG, 1981, STROKE, V12, P200; Suto Y, 2009, EUR NEUROL, V62, P304, DOI 10.1159/000235943; FASSBENDER K, 1994, STROKE, V25, P1105; Tomita H, 2008, HYPERTENS RES, V31, P1695, DOI 10.1291/hypres.31.1695; Maruyama K, 2014, J STROKE CEREBROVASC, V23, P967, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.003; Shibazaki K, 2009, INTERNAL MED, V48, P259, DOI 10.2169/internalmedicine.48.1475; Iltumur K, 2006, AM HEART J, V151, P1115, DOI 10.1016/j.ahj.2005.05.022; Garcia-Berrocoso T, 2013, NEUROLOGY, V81, P1976, DOI 10.1212/01.wnl.0000436937.32410.32	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2285	2290		10.1016/j.jstrokecerebrovasdis.2015.06.006		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400023		
J	Endo, H; Fujimura, M; Shimizu, H; Inoue, T; Sato, K; Niizuma, K; Tominaga, T				Endo, Hidenori; Fujimura, Miki; Shimizu, Hiroaki; Inoue, Takashi; Sato, Kenichi; Niizuma, Kuniyasu; Tominaga, Teiji			Cerebral Blood Flow after Acute Bypass with Parent Artery Trapping in Patients with Ruptured Supraclinoid Internal Carotid Artery Aneurysms	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Bypass surgery; cerebral blood flow; internal carotid artery aneurysms; parent artery occlusion; subarachnoid hemorrhage	EXTRACRANIAL-INTRACRANIAL BYPASS; BLISTER-LIKE ANEURYSMS; SUBARACHNOID HEMORRHAGE; ISCHEMIC COMPLICATIONS; SURGICAL-TREATMENT; CIRCULATION; OCCLUSION; GRAFT; REVASCULARIZATION; SURGERY	Background: Bypass with parent artery trapping is an alternative treatment method for ruptured internal carotid artery (ICA) aneurysms when clipping or coiling is contraindicated. However, the efficacy and safety of this strategy during the acute stage of subarachnoid hemorrhage (SAH) is undetermined. Methods: A retrospective review of 955 consecutive patients presenting SAH between 2006 and 2014 identified 17 patients with ruptured ICA aneurysms treated by bypass with parent artery trapping within 72 hours after the bleeding (bypass group). The 26 cases with ruptured posterior communicating artery aneurysms treated with clipping during the same period were defined as a control group (clipping group). Postoperative cerebral blood flow (CBF) was evaluated by single photon emission computed tomography (SPECT). We analyzed the postoperative hemodynamic status, surgical complications, and the clinical outcomes. Results: Postoperative rebleeding did not occur in any of the cases. CBF in the first postoperative week in the bypass group was lower than that in the clipping group (P = .0165). This CBF decrease improved in the second postoperative week and did not differ from that of the clipping group. The incidence of acute ischemic complications was significantly higher in the bypass group (P = .0284), but the incidence of delayed cerebral ischemia did not differ between the 2 groups. The incidence of favorable outcomes at 6 months was 82.4% in the bypass group and 81% in the clipping group. Conclusions: Although the transient CBF decrease with acute ischemic complications should be noted, acute bypass with parent artery trapping is safe and effective for unclippable/uncoilable ruptured ICA aneurysms.	[Endo, Hidenori] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Fujimura, Miki; Niizuma, Kuniyasu; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan; [Shimizu, Hiroaki] Akita Univ, Grad Sch Med, Dept Neurosurg, Akita 010, Japan; [Inoue, Takashi] Natl Hosp Org, Sendai Med Ctr, Dept Neurosurg, Sendai, Miyagi, Japan; [Sato, Kenichi] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi, Japan	Endo, H (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachi Minami, Sendai, Miyagi 9828523, Japan.	hideendo@gmail.com					Buijs PC, 1998, RADIOLOGY, V209, P667; Sekhar LN, 2001, NEUROSURGERY, V49, P646, DOI 10.1097/00006123-200109000-00023; Ramanathan D, 2012, NEUROSURGERY, V70, P1442, DOI 10.1227/NEU.0b013e31824c046f; Shimizu H, 2010, NEUROSURG REV, V33, P205, DOI 10.1007/s10143-009-0234-0; Meling TR, 2008, J NEUROSURG, V108, P662, DOI 10.3171/JNS/2008/108/4/0662; TRANQUART F, 1993, EUR J NUCL MED, V20, P53, DOI 10.1007/BF02261246; Hongo K, 2003, NEUROSURGERY, V52, P597, DOI 10.1227/01.NEU.0000047892.12003.58; Egge A, 2005, NEUROSURGERY, V57, P237, DOI 10.1227/01.NEU.0000166538.60333.D6; Kazumata K, 2014, NEUROSURGERY, V10, P66, DOI 10.1227/NEU.0000000000000076; Shimizu H, 2011, NEUROSURGERY, V69, P677, DOI 10.1227/NEU.0b013e3182195509; VANSWIETEN JC, 1988, STROKE, V19, P604; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; DRAKE CG, 1994, J NEUROSURG, V81, P656, DOI 10.3171/jns.1994.81.5.0656; Lawton MT, 1996, NEUROSURGERY, V38, P83, DOI 10.1097/00006123-199601000-00020; GELBER BR, 1980, J NEUROSURG, V52, P1, DOI 10.3171/jns.1980.52.1.0001; Murai Y, 2012, WORLD NEUROSURG, V77, P166, DOI 10.1016/j.wneu.2011.05.020; Murakami K, 2009, SURG NEUROL, V71, P434, DOI 10.1016/j.surneu.2008.03.036; Henderson RD, 2000, STROKE, V31, P128; Ishikawa T, 2009, NEUROL MED-CHIR, V49, P553; Endo H, 2012, AM J NEURORADIOL, V33, P500, DOI 10.3174/ajnr.A2828; MINOSHIMA S, 1994, J NUCL MED, V35, P949; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; Morton RP, 2014, NEUROSURGERY, V74, P62, DOI 10.1227/NEU.0000000000000198; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Shimizu H, 2010, CLIN NEUROL NEUROSUR, V112, P32, DOI 10.1016/j.clineuro.2009.10.002; FISHER CM, 1980, NEUROSURGERY, V6, P1; KAK VK, 1973, J NEUROSURG, V39, P503, DOI 10.3171/jns.1973.39.4.0503; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; Hayashi T, 2000, J NEUROSURG, V93, P1014, DOI 10.3171/jns.2000.93.6.1014; Kamijo K, 2010, J NEUROSURG, V113, P781, DOI 10.3171/2009.10.JNS09970; Hendrikse J, 2003, NEUROSURGERY, V53, P858, DOI 10.1227/01.NEU.0000083552.45265.46; Baskaya MK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E13; Cantore G, 2008, NEUROSURGERY, V63, P279, DOI 10.1227/01.NEU.0000313122.58694.91; Cantore G, 2008, NEUROSURGERY, V63, P89; Hendrikse J, 2003, NEUROSURGERY, V53, P63; Jafar JJ, 2002, NEUROSURGERY, V51, P138, DOI 10.1227/01.NEU.0000017194.72280.D6; Jafar JJ, 2002, NEUROSURGERY, V51, P44; Sato K, 2014, J CEREBR BLOOD F MET, V34, P136, DOI 10.1038/jcbfm.2013.176	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2358	2368		10.1016/j.jstrokecerebrovasdis.2015.06.028		11	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400032		
J	Ishihara, KK; Kokubo, Y; Yokota, C; Hida, E; Miyata, T; Toyoda, K; Matsumoto, M; Minematsu, K; Miyamoto, Y				Ishihara, Kayoko Kawase; Kokubo, Yoshihiro; Yokota, Chiaki; Hida, Eisuke; Miyata, Toshiyuki; Toyoda, Kazunori; Matsumoto, Masayasu; Minematsu, Kazuo; Miyamoto, Yoshihiro			Effect of Plasma Fibrinogen, High-Sensitive C-Reactive Protein, and Cigarette Smoking on Carotid Atherosclerosis: The Suita Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Review						Intima-media thickness; plaque; risk factors; inflammatory marker	CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; BLOOD-PRESSURE; RISK-FACTORS; ASSOCIATIONS; STROKE; HEALTH; GENES	Background: Few studies have reported on the association between inflammatory markers and atherosclerosis by smoking status. We investigated the effect of plasma levels of fibrinogen and high-sensitive C-reactive protein (hsCRP) on subclinical atherosclerosis stratified by smoking in a general urban population. Methods: From participants of the Suita study without a history of cardiovascular diseases, a total of 2502 subjects (805 men, median age 64 years) who underwent carotid ultrasonography were enrolled. Subjects were divided into current smokers (n = 566) and never-smokers. Ex-smokers were not included in the study. Each group was subdivided according to the median levels of markers (plasma fibrinogen [2.99 g/L] and hsCRP [.51 mg/L]) and the smoking amounts. We compare the adjusted maximum and mean intima-media thickness (IMT). Results: In men and women, maximum IMT and mean IMT of the high fibrinogen and high hsCRP (Fib(H) CRP(H)) with smoking were thicker than those of the low fibrinogen and low hsCRP (Fib(L) CRP(L)) without smoking, the Fib(L) CRP(L) with smoking, and the Fib(H) CRP(H) without smoking after adjusting for covariates. The Fib(L) CRP(L) with smoking had thicker IMTs than the Fib(L) CRP(L) without smoking. There was a dose-dependent smoking effect on IMT in men. These trends were similar in age 60, 65, and 70. Conclusions: Plasma fibrinogen and hsCRP levels were related to multivariate-adjusted IMT, and smoking was associated with IMT in men. The combination of plasma fibrinogen and hsCRP levels could be a potential marker on subclinical carotid atherosclerosis in urban people.	[Ishihara, Kayoko Kawase; Yokota, Chiaki; Toyoda, Kazunori; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Ishihara, Kayoko Kawase; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Kokubo, Yoshihiro; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Hida, Eisuke] Hiroshima Univ Hosp, Ctr Integrated Med Res, Dept Data Sci, Hiroshima, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka 5658565, Japan	Yokota, C (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	cyokota@ncvc.go.jp			Intramural Research Fund of the National Cerebral and Cardiovascular Center [22-4-1]; Ministry of Health, Labour and Welfare of Japan and the Takeda Science Foundation [23592110]	The Intramural Research Fund of the National Cerebral and Cardiovascular Center (22-4-1), grants-in-aid from the Ministry of Health, Labour and Welfare (23592110) of Japan and the Takeda Science Foundation.	Martina V, 2008, DIABETES CARE, V31, P940, DOI 10.2337/dc07-2251; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Mannami T, 1997, STROKE, V28, P518; Kikuchi M, 2007, ASIAN PAC J CANCER P, V8, P87; Magyar MT, 2003, STROKE, V34, P58, DOI 10.1161/01.STR.0000048845.83285.AC; Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273; Horn CS, 2009, J NEUROL, V256, P783, DOI 10.1007/s00415-009-5017-6; Newby DE, 1999, CIRCULATION, V99, P1411; Morita A, 2006, AM J HYPERTENS, V19, P593, DOI 10.1016/j.amjhyper.2005.11.015; Grebe MT, 2010, J ATHEROSCLER THROMB, V17, P1003; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160; Nagasawa S, 2015, J ATHEROSCLER THROMB, V22, P590, DOI 10.5551/jat.23580; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Willeit P, 2014, EUR J PREV CARDIOL; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025	16	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2385	2389		10.1016/j.jstrokecerebrovasdis.2015.06.039		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400035		
J	Tanikawa, H; Kagaya, H; Saitoh, E; Ozaki, K; Hirano, S; Itoh, N; Yamada, J; Kanada, Y				Tanikawa, Hiroki; Kagaya, Hitoshi; Saitoh, Eiichi; Ozaki, Kenichi; Hirano, Satoshi; Itoh, Norihide; Yamada, Junya; Kanada, Yoshikiyo			Efficacy of Botulinum Toxin A Treatment for Pes Varus during Gait	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Botulinum toxin A; gait analysis; hemiplegia; pes varus; spasticity; treadmill	MODIFIED ASHWORTH SCALE; PLACEBO-CONTROLLED TRIAL; TRAUMATIC BRAIN-INJURY; LOWER-LIMB SPASTICITY; DOUBLE-BLIND; CEREBRAL-PALSY; TREADMILL WALKING; HEMIPARETIC PATIENTS; KINEMATIC ANALYSIS; STROKE	Background: The efficacy of botulinum toxin A (BoNTA) injection on spasticity is usually measured using Modified Ashworth Scale (MAS), but this only evaluates muscle tone at rest and has poor reliability. There are no reports that quantitatively evaluate pes varus during walking after botulinum treatment. The purpose of this study was to evaluate the efficacy of BoNTA injection on pes varus during gait using 3-dimensional motion analysis. Methods: Twenty-four hemiplegic patients with spastic pes varus deformity during gait received BoNTA injection into lower limb muscles. MAS score, comfortable overground gait velocity, and pes varus angle during treadmill walking were evaluated before, 2, 6, and 12 weeks after the injection. Five healthy subjects were also recruited to develop the pes varus/valgus angle as a normal reference. Results: The median MAS scores were significantly lower at 2 and 6 weeks after the injection. The maximum pes varus angle during the swing phase was significantly lower at 2, 6, and 12 weeks after the injection. It was significantly lower at 6 weeks after the injection during stance phase. The comfortable overground gait velocity was also improved after the injection. However, 2 patients experienced pain during gait and their pes varus angle increased during the follow-up period. Conclusions: BoNTA injection improved pes varus angle during gait. Evaluating motion in addition to spasticity at rest is recommended because improvements in limb function do not always parallel improvements in spasticity at rest.	[Tanikawa, Hiroki; Itoh, Norihide; Kanada, Yoshikiyo] Fujita Hlth Univ, Fac Rehabil, Sch Hlth Sci, Toyoake, Aichi 4701192, Japan; [Kagaya, Hitoshi; Saitoh, Eiichi; Hirano, Satoshi] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi 4701192, Japan; [Ozaki, Kenichi] Natl Hosp Geriatr Med, Dept Rehabil Med, Obu, Aichi, Japan; [Yamada, Junya] Fujita Hlth Univ Hosp, Dept Rehabil, Toyoake, Aichi, Japan	Tanikawa, H (reprint author), Fujita Hlth Univ, Fac Rehabil, Sch Hlth Sci, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	tanikawa@fujita-hu.ac.jp					Wright CJ, 2011, GAIT POSTURE, V33, P108, DOI 10.1016/j.gaitpost.2010.10.084; Craven BC, 2010, SPINAL CORD, V48, P207, DOI 10.1038/sc.2009.107; Lee JH, 2009, J REHABIL MED, V41, P740, DOI 10.2340/16501977-0418; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Mackey AH, 2008, EUR J NEUROL, V15, P1191, DOI 10.1111/j.1468-1331.2008.02271.x; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Dunne JW, 2012, CLIN REHABIL, V26, P787, DOI 10.1177/0269215511432016; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Bang MS, 2002, AM J PHYS MED REHAB, V81, P760, DOI 10.1097/01.PHM.0000027421.68357.8A; Rousseaux M, 2005, J NEUROL SCI, V232, P51, DOI 10.1016/j.jns.2005.01.009; Papadonikolakis AS, 2003, ACTA ORTHOP SCAND, V74, P749, DOI 10.1080/00016470310018315; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Francis HP, 2004, J NEUROL NEUROSUR PS, V75, P1547, DOI 10.1136/jnnp.2003.025551; Novak AC, 2009, TOP STROKE REHABIL, V16, P367, DOI 10.1310/tsr1605-367; Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; Sutherland DH, 1999, GAIT POSTURE, V10, P1, DOI 10.1016/S0966-6362(99)00012-0; Haas BM, 1996, SPINAL CORD, V34, P560; Farina S, 2008, FUNCT NEUROL, V23, P87; Gracies JM, 2007, DISABIL REHABIL, V29, P1789, DOI 10.1080/09638280701568437; Bohannon R. W., 1987, PHYS THER, V67, P206; Burbaud P, 1996, J NEUROL NEUROSUR PS, V61, P265, DOI 10.1136/jnnp.61.3.265; Esquenazi A., 2010, SPASTICITY DIAGNOSIS, P119; Itoh N, 2012, JPN J COMPR REHABIL, V3, P78; Kaji R, 2012, J NEUROL, V257, P1330; Ohtsuka K, 2015, JPN J COMPR REHABIL, V6, P33; Sloan R L, 1992, Int J Rehabil Res, V15, P158, DOI 10.1097/00004356-199206000-00009; Teranishi T, 2009, SOGO REHABIL, V37, P939	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2416	2422		10.1016/j.jstrokecerebrovasdis.2015.06.035		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400040		
J	Nakase, T; Yamamoto, Y; Takagi, M				Nakase, Taizen; Yamamoto, Yasumasa; Takagi, Makoto		Japan Branch Atheromatous Dis	The Impact of Diagnosing Branch Atheromatous Disease for Predicting Prognosis	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Acute stroke; diagnosis; prognosis; MRI	PARAMEDIAN PONTINE INFARCTION; COMMUNITY STROKE PROJECT; DELAYED NEURONAL DEATH; ISCHEMIC-STROKE; NEUROLOGICAL DETERIORATION; CIGARETTE-SMOKING; INCREASE; VOLUME	Background: We had reported that, in the acute phase of the brain penetrating artery infarction, patients with branch atheromatous disease (BAD) tended to be worsened compared with the lacunar infarction (LI). Because no prospective study has been reported, we composed a multicenter study (Japan Branch Atheromatous Disease [J-BAD] Registry) in which patients of penetrating artery infarction were prospectively enrolled for exploring the clinical features of BAD. Methods: From the associated 9 hospitals, acute ischemic stroke patients were asked to be enrolled in the JBAD Registry and classified into the lenticulostriate arterial (LSA) infarction (n = 124) and the pontine penetrating arterial (PPA) infarction (n 5 42) groups. The clinical courses and the repeated magnetic resonance imaging findings were investigated. Results: Neurologic worsening was observed at a significantly higher rate in BAD compared with the LI patients in both the LSA and PPA groups (P < .01, 45.1% versus 22.6% and 46.7% versus 0%, respectively). In the LSA group, the enlargement of the ischemic lesion was significantly more frequent in BAD compared with the LI patients (P < .01, 66.2% and 34.0%, respectively). There was a significant relation between the enlargement of the lesion and the worsening of neurologic deficits (P < .001). Moreover, the clinical features, which predict the lesion enlargement, were BAD and older age. Conclusions: LSA infarction of BAD diagnosis or older age patients might show an increase of lesion size and a tendency of neurologic worsening. It could be important to discriminate BAD from other ischemic stroke subtypes, in regard to the prediction of prognosis.	[Nakase, Taizen] Res Inst Brain & Blood Vessels, Dept Stroke Sci, Akita 0100874, Japan; [Yamamoto, Yasumasa] Kyoto Katsura Hosp, Dept Neurol, Kyoto, Japan; [Yamamoto, Yasumasa] Saieikai Cent Hosp, Tokyo, Japan; [Takagi, Makoto] Saiseikai Cent Hosp, Dept Neurol, Tokyo, Japan	Nakase, T (reprint author), Res Inst Brain & Blood Vessels, Dept Stroke Sci, 6-10 Sensyu Kubota Machi, Akita 0100874, Japan.	nakase@akita-noken.jp					Kwan MWM, 2011, J NEUROL SCI, V303, P80, DOI 10.1016/j.jns.2011.01.008; Li FH, 2000, STROKE, V31, P946; Di Carlo A, 2006, J NEUROL SCI, V244, P143, DOI 10.1016/j.jns.2006.01.016; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Davalos A, 1999, STROKE, V30, P2631; Yamamoto Y, 2011, J NEUROL SCI, V304, P78, DOI 10.1016/j.jns.2011.02.006; Campagne MV, 1999, J CEREBR BLOOD F MET, V19, P1354; CAPLAN LR, 1989, NEUROLOGY, V39, P1246; FUKUDA H, 1995, STROKE, V26, P1593; Tei H, 2000, STROKE, V31, P2049; Kunz S, 2003, EUR NEUROL, V50, P136, DOI 10.1159/000073053; Kataoka S, 1997, STROKE, V28, P809; Terasawa Y, 2008, J NEUROL SCI, V269, P35, DOI 10.1016/j.jns.2007.12.014; Nakase T, 2014, J STROKE CEREBROVASC, V23, P1409, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.023; Nakase T, 2013, J STROKE CEREBROVASC, V22, P406, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.005; Hoshino H, 2011, JPN J STROKE, V33, P37; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Nakase Taizen, 2014, Ann Clin Transl Neurol, V1, P75, DOI 10.1002/acn3.25; Shinohara Y, 2009, JAPANESE GUIDELINES; Umemura T, 2008, JPN J STROKE, V30, P397; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					2423	2428		10.1016/j.jstrokecerebrovasdis.2015.06.044		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400041		
J	Kanai, R; Shinoda, J; Akatsuka, S				Kanai, Ryuichi; Shinoda, Jun; Akatsuka, Seiya			Infratentorial Pial Arteriovenous Fistula in the Elderly	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Pial arteriovenous fistula; infratentorial arteriovenous fistula; elderly patients; suboccipital transtentorial approach; coil embolization	SINUS THROMBOSIS; BRAIN	Background: Intracranial pial arteriovenous fistulas (pAVFs) are rare vascular lesions, which may present with, but are distinct from arteriovenous malformation and dural arteriovenous fistula. They most often manifest during infancy or early childhood, but rarely in adulthood. Methods: We report an exceptionally rare case of infratentorial pAVF in a 73-year-old man, who presented with progressive gait disturbance due to cerebellar edema resulting from arteriovenous shunts. Results: The patient was successfully treated by endovascular flow reduction followed by surgical extirpation of the fistula. The diagnosis was confirmed by pathological findings. Conclusions: Pial arteriovenous fistula is rare, but can occur in the elderly. Combination of endovascular flow reduction and surgical disconnection yielded an excellent clinical outcome.	[Kanai, Ryuichi; Shinoda, Jun] Eiju Gen Hosp, Dept Neurosurg, Tokyo 1108645, Japan; [Akatsuka, Seiya] Eiju Gen Hosp, Dept Pathol, Tokyo 1108645, Japan	Kanai, R (reprint author), Eiju Gen Hosp, Dept Neurosurg, Taito Ku, 2-23-16 Higashi Ueno, Tokyo 1108645, Japan.	ryuryukanai@gmail.com					Hoh BL, 2001, NEUROSURGERY, V49, P1351, DOI 10.1097/00006123-200112000-00011; Phatouros CC, 1999, STROKE, V30, P2487; HALBACH VV, 1989, AM J NEURORADIOL, V10, P747; TOMLINSON FH, 1993, J NEUROSURG, V79, P16, DOI 10.3171/jns.1993.79.1.0016; Yang WH, 2011, BRIT J NEUROSURG, V25, P580, DOI 10.3109/02688697.2011.566382; Ozawa T, 1998, STROKE, V29, P1721; GARCIAMONACO R, 1995, NEURORADIOLOGY, V37, P60; Lv X, 2009, AM J NEURORADIOL, V30, P851, DOI 10.3174/ajnr.A1436; Matsubara S, 2014, NEUROL MED-CHIR, V54, P245, DOI 10.2176/nmc.cr2012-0311; Hoh BL, 2001, NEUROSURGERY, V49, P63; Wang YC, 2004, J NEUROSURG, V100, P201	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					E307	E309		10.1016/j.jstrokecerebrovasdis.2015.07.003		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400005		
J	Noda, K; Nakajima, S; Sasaki, F; Ito, Y; Kawajiri, S; Tomizawa, Y; Hattori, N; Yamamoto, T; Okuma, Y				Noda, Kazuyuki; Nakajima, Sho; Sasaki, Fuyuko; Ito, Yoshitaka; Kawajiri, Sumihiro; Tomizawa, Yuji; Hattori, Nobutaka; Yamamoto, Takuji; Okuma, Yasuyuki			Middle Cerebral Artery Occlusion Presenting as Upper Limb Monochorea	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Chorea; TIA; middle cerebral artery occlusion; cerebral blood flow	HEMICHOREA; ISCHEMIA; STENOSIS	Background: Hemichorea is usually caused by a structural lesion in the contralateral basal ganglia or subthalamic nuclei or it develops as a form of a neurologic complication including hyperglycemia. We report a rare case of a patient who developed choreic movement in the right upper extremity associated with a contralateral middle cerebral artery (MCA) occlusion. Methods: A 76-year-old man presented with chorea in the right upper limb, known as monochorea, which occurred after recovery from losing consciousness while standing. He was found to have idiopathic orthostatic hypotension. His diffusion-weighted magnetic resonance imaging did not show signal changes indicative of acute ischemic lesions. A left carotid artery angiogram showed occlusion of the left MCA. I-123-N-isopropyl-4-iodoamphetamine single-photon emission computed tomography of the brain showed marked hypoperfusion in the left MCA territory. His cerebrovascular reserve capacity determined using acetazolamide was relatively decreased in this territory. This decrease in cerebrovascular reserve capacity, however, did not require surgical treatment, such as extracranial-intracranial bypass surgery. Results: The recurrence of chorea was not observed after antiplatelet therapy and instruction on how to cope with orthostatic hypotension. Conclusions: It is considered that transient hemodynamic ischemia in the right basal ganglia-thalamocortical circuits because of the combination of MCA occlusion and hypotension was the underlying cause of the monochorea in this patient. Vascular imaging studies for early identification of occlusion or severe stenosis of cerebral major arteries should be carried out in patients acutely presenting with chorea, even in the absence of other clinical signs.	[Noda, Kazuyuki; Nakajima, Sho; Sasaki, Fuyuko; Kawajiri, Sumihiro; Tomizawa, Yuji; Okuma, Yasuyuki] Juntendo Univ, Shizuoka Hosp, Dept Neurol, Izunokuni, Shizuoka, Japan; [Nakajima, Sho; Sasaki, Fuyuko; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Ito, Yoshitaka; Yamamoto, Takuji] Juntendo Univ, Shizuoka Hosp, Dept Neurosurg, Izunokuni, Shizuoka, Japan	Noda, K (reprint author), Juntendo Univ, Shizuoka Hosp, Dept Neurol, 1129 Nagaoka, Izunokuni, Shizuoka, Japan.	k-noda@juntendo.ac.jp					Galea I, 2008, NEUROLOGY, V71, pE80, DOI 10.1212/01.wnl.0000336975.80810.74; Cheshire WP, 2006, CLIN AUTON RES, V16, P243, DOI 10.1007/s10286-006-0344-5; Irioka T, 2010, J NEUROL, V257, P1756, DOI 10.1007/s00415-010-5596-2; DOBKIN BH, 1989, NEUROLOGY, V39, P30; Morigaki R, 2006, J NEUROSURG, V105, P142, DOI 10.3171/jns.2006.105.1.142; Kim Jung-Mee, 2006, J Stroke Cerebrovasc Dis, V15, P69, DOI 10.1016/j.jstrokecerebrovasdis.2005.12.002; Littleton Edward T, 2015, Pract Neurol, V15, P218, DOI 10.1136/practneurol-2014-000961; Parces I, 2011, J NEUROL SCI, V300, P185	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					E291	E293		10.1016/j.jstrokecerebrovasdis.2015.06.009		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400002		
J	Sakuta, K; Sengoku, R; Mitsumura, H; Kono, Y; Kan, I; Kaku, S; Iguchi, Y				Sakuta, Kenichi; Sengoku, Renpei; Mitsumura, Hidetaka; Kono, Yu; Kan, Issei; Kaku, Shogo; Iguchi, Yasuyuki			Malignant Middle Cerebral Artery Infarction Resulting from Dissection of Middle Cerebral Artery	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Middle cerebral artery; dissection; malignant middle cerebral artery infarction; skin biopsy; acute ischemic stroke	CONNECTIVE-TISSUE ABNORMALITIES	A 30-year-old man presented with headache, left hemiparesis, and uncal herniation. Magnetic resonance imaging showed acute infarction in the right middle cerebral artery (MCA). Lifesaving craniotomy proceeded because of the uncal herniation. Assessment of brain tissue led to a diagnosis of MCA dissection. His skin biopsy showed ultrastructural abnormalities of dermal connective tissue. This is the unique case that dissection was diagnosed from both a biopsy specimen of the MCA and the dermal connective tissue.	[Sakuta, Kenichi; Mitsumura, Hidetaka; Kono, Yu; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan; [Sengoku, Renpei] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan; [Kan, Issei; Kaku, Shogo] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo 1058461, Japan	Sakuta, K (reprint author), Jikei Univ, Sch Med, Dept Neurol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kenichisakuta@yahoo.co.jp					Ohkuma H, 2003, NEURORADIOLOGY, V45, P143, DOI 10.1007/s00234-002-0919-3; Brandt T, 2001, NEUROLOGY, V57, P24; Lin CH, 2005, J NEUROL SCI, V235, P37, DOI 10.1016/j.jns.2005.03.047; Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9; Hausser I, 2004, ACTA NEUROPATHOL, V107, P509, DOI 10.1007/s00401-004-0839-x; Brandt T, 1998, ANN NEUROL, V44, P281, DOI 10.1002/ana.410440224; Lee JS, 2006, J NEUROL SCI, V250, P162, DOI 10.1016/j.jns.2006.07.006; SHARIF AA, 1995, NEUROLOGY, V45, P1929; Volker W, 2008, J NEUROL NEUROSUR PS, V79, P1007, DOI 10.1136/jnnp.2007.115634; Tsukahara T, 2010, ACT NEUR S, V107, P35, DOI 10.1007/978-3-211-99373-6_5	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2015	24	10					E287	E289		10.1016/j.jstrokecerebrovasdis.2015.04.008		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CS6IG	WOS:000362181400001		
J	Omori, Y; Ikei, H; Kugimiya, Y; Masuda, T				Omori, Yasutomo; Ikei, Hideaki; Kugimiya, Yasuo; Masuda, Toshiaki			Nanometre-scale faulting in quartz under an atomic force microscope	JOURNAL OF STRUCTURAL GEOLOGY			English	Article						Atomic force microscope; Indentation; Linear displacement length scaling relationship; Nanometre-scale faulting; Quartz	LENGTH; DISPLACEMENTS; DEFORMATION; DIMENSIONS; GROWTH; MODEL	We conducted nano-indentation tests of quartz under a load of 294 mN at room temperature and ambient pressure. Using an atomic force microscope, we performed topographic mapping of the indented surface immediately after the nano-indentation test and again 46 h later. Differences in the contour patterns of the two surface topographies reveal that a new fault developed in the quartz specimen while it was secured on the specimen stage of the atomic force microscope between the two mapping times. The fault length is similar to 2 mu m and the maximum displacement on the fault plane is similar to 20 nm. When combined with existing displacement length data from natural faults, the data suggest that a linear displacement-length scaling relationship can be extrapolated to nanometre-scale faulting. (C) 2015 Elsevier Ltd. All rights reserved.	[Omori, Yasutomo; Ikei, Hideaki; Kugimiya, Yasuo; Masuda, Toshiaki] Shizuoka Univ, Inst Geosci, Suruga Ku, Shizuoka 4228529, Japan	Omori, Y (reprint author), Shizuoka Univ, Inst Geosci, Suruga Ku, Ohya 836, Shizuoka 4228529, Japan.	f5844006@ipc.shizuoka.ac.jp			JSPS [12354005]	We thank Chie Sawatari for allowing us to use the AFM (SPA 300) in her laboratory, and Aaron Stallard for constructive criticism and for correcting the English of the manuscript. We also thank Mineo Kumazawa and Naoyuki Fujii for encouragement, Hideki Mori for preparation of the quartz specimen, and Andy Nicol, Toru Takeshita and two anonymous reviewers for constructive comments. This study was financially supported by JSPS (12354005 to TM).	MURAOKA H, 1983, J STRUCT GEOL, V5, P483, DOI 10.1016/0191-8141(83)90054-8; COWIE PA, 1992, J STRUCT GEOL, V14, P1149, DOI 10.1016/0191-8141(92)90066-6; Ferrill DA, 2008, GEOL SOC SPEC PUBL, V299, P113, DOI 10.1144/SP299.7; Xu SS, 2006, INT J EARTH SCI, V95, P841, DOI 10.1007/s00531-005-0065-3; Clark RM, 1996, J STRUCT GEOL, V18, P147, DOI 10.1016/S0191-8141(96)80040-X; Schlische RW, 1996, GEOLOGY, V24, P683, DOI 10.1130/0091-7613(1996)024<0683:GASROA>2.3.CO;2; Walsh JJ, 2002, J STRUCT GEOL, V24, P1669, DOI 10.1016/S0191-8141(01)00165-1; WALSH JJ, 1988, J STRUCT GEOL, V10, P239, DOI 10.1016/0191-8141(88)90057-0; GILLESPIE PA, 1992, J STRUCT GEOL, V14, P1157, DOI 10.1016/0191-8141(92)90067-7; Torabi A, 2011, MAR PETROL GEOL, V28, P1444, DOI 10.1016/j.marpetgeo.2011.04.003; WATTERSON J, 1986, PURE APPL GEOPHYS, V124, P365, DOI 10.1007/BF00875732; Schultz RA, 2008, J STRUCT GEOL, V30, P1405, DOI 10.1016/j.jsg.2008.08.001; Masuda T, 2000, GEOPHYS RES LETT, V27, P2773, DOI 10.1029/1999GL008460; COWIE PA, 1992, J STRUCT GEOL, V14, P1133, DOI 10.1016/0191-8141(92)90065-5; MARRETT R, 1991, J STRUCT GEOL, V13, P735, DOI 10.1016/0191-8141(91)90034-G; Masuda T, 2011, AM MINERAL, V96, P283, DOI 10.2138/am.2011.3529; Billings M.P., 1972, STRUCTURAL GEOLOGY; Fischer-Cripps A.C., 2004, NANOINDENTATION; Jaeger J.C., 1969, FUNDAMENTALS ROCK ME; Johnson K.L., 1985, CONTACT MECH; Scholz C.H., 2002, MECH FAULTING EARTHQ	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8141			J STRUCT GEOL	J. Struct. Geol.	OCT	2015	79						75	79		10.1016/j.jsg.2015.07.008		5	Geosciences, Multidisciplinary	Geology	CS1WN	WOS:000361859700006		
J	Ozaki, S; Hinata, K; Senatore, C; Iagnemma, K				Ozaki, Shingo; Hinata, Kosuke; Senatore, Carmine; Iagnemma, Karl			Finite element analysis of periodic ripple formation under rigid wheels	JOURNAL OF TERRAMECHANICS			English	Article						FEM; Wheel-soil interaction; Plasticity; Friction; Multi-pass effect	SUBLOADING SURFACE MODEL; TIRE-SOIL INTERACTION; SIMULATION; PLASTICITY	In recent years, various numerical simulation methods have been applied to vehicle terrain interaction problems. In this study, the formation of periodic ripples under a rigid wheel was investigated within the framework of finite element (FE) analysis. First, the capability of FEM to analyze periodic ripple formation was demonstrated under relatively low slippage. Then, a hypothesis for the generation mechanism of periodic ripples was provided: periodic ripples are formed under conditions in which clear local failure zones occur and soil is translated vertically via wheel shear deformation action. Furthermore, the characteristics of ripple periodicity (i.e. ripple pitch and period) were discussed. It was also revealed that ripple formation has an impact on the multi-pass scenario for lightweight small vehicles. (C) 2015 ISTVS. Published by Elsevier Ltd. All rights reserved.	[Ozaki, Shingo; Hinata, Kosuke] Yokohama Natl Univ, Div Syst Res, Fac Engn, Hodogaya ku, Yokohama, Kanagawa 2408501, Japan; [Senatore, Carmine] Exponent Inc, Natick, MA 01760 USA; [Iagnemma, Karl] MIT, Lab Mfg & Prod, Cambridge, MA 02139 USA	Ozaki, S (reprint author), Yokohama Natl Univ, Div Syst Res, Fac Engn, Hodogaya ku, Tokiwadai 79-5, Yokohama, Kanagawa 2408501, Japan.	s-ozaki@ynu.ac.jp					AIFANTIS EC, 1984, J ENG MATER-T ASME, V106, P326; Senatore C, 2013, J TERRAMECHANICS, V50, P311, DOI 10.1016/j.jterra.2013.09.004; Shikanai T, 2000, J TERRAMECHANICS, V37, P21, DOI 10.1016/S0022-4898(99)00011-7; Fervers CW, 2004, J TERRAMECHANICS, V41, P87, DOI 10.1016/j.jterra.2004.02.012; Taberlet N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068003; WONG JY, 1967, J AGR ENG RES, V12, P257; Hiroma T, 1997, J TERRAMECHANICS, V34, P225, DOI 10.1016/S0022-4898(98)00002-0; HASHIGUCHI K, 1989, INT J SOLIDS STRUCT, V25, P917, DOI 10.1016/0020-7683(89)90038-3; REGLI G, 1993, J TERRAMECHANICS, V30, P165, DOI 10.1016/0022-4898(93)90004-H; Hashiguchi K, 2007, INT J PLASTICITY, V23, P767, DOI 10.1016/j.ijplas.2006.08.005; Chiroux RC, 2005, APPL MATH COMPUT, V162, P707, DOI 10.1016/j.amc.2004.01.013; Hambleton JP, 2009, INT J MECH SCI, V51, P846, DOI 10.1016/j.ijmecsci.2009.09.024; Liu CH, 2000, COMPUT STRUCT, V74, P253, DOI 10.1016/S0045-7949(99)00049-8; Hambleton JP, 2008, J TERRAMECHANICS, V45, P201, DOI 10.1016/j.jterra.2008.11.001; Mohsenimanesh A, 2009, BIOSYST ENG, V104, P191, DOI 10.1016/j.biosystemseng.2009.06.020; Hambleton JP, 2009, J TERRAMECHANICS, V46, P35, DOI 10.1016/j.jterra.2009.02.003; Liu CH, 1996, J TERRAMECHANICS, V33, P209, DOI 10.1016/S0022-4898(97)00005-0; Xia KM, 2011, J TERRAMECHANICS, V48, P113, DOI 10.1016/j.jterra.2010.05.001; Hashiguchi K., 2013, ELASTOPLASTICITY THE; Irani R., 2011, THESIS DALHOUSIE U; LSTC, 2014, LS DYNA KEYW US MAN; Nakashima H., 1990, P 10 INT C ISTVS, P277; NEXCO, 2014, STAND DES SPEC, V1; Ozaki S., 2007, JSAE T, V38, P9; Pruiksma J.P., 2011, TRACTIVE PERFORMANCE; Ueno M., 1990, P 10 INT C ISTVS KOB, P253; Vardoulakis I., 1995, BIFURCATION ANAL GEO; Varghese A.G., 2012, SIMULIA COMM C, P1; Wong J.Y., 1966, P 2 INT C ISTVS QUEB; Yong R.N., 1966, P 2 INT C ISTVS QUEB; Young R.N., J TERRAMECH, V13, P227	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4898	1879-1204		J TERRAMECHANICS	J. Terramech.	OCT	2015	61						11	22		10.1016/j.jterra.2015.06.003		12	Engineering, Environmental	Engineering	CS5RF	WOS:000362135000002		
J	Sumida, M; Doi, K; Ogasawara, E; Yamashita, T; Hamasaki, Y; Kariya, T; Takimoto, E; Yahagi, N; Nangaku, M; Noiri, E				Sumida, Maki; Doi, Kent; Ogasawara, Emi; Yamashita, Tetsushi; Hamasaki, Yoshifumi; Kariya, Taro; Takimoto, Eiki; Yahagi, Naoki; Nangaku, Masaomi; Noiri, Eisei			Regulation of Mitochondrial Dynamics by Dynamin-Related Protein-1 in Acute Cardiorenal Syndrome	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; CYTOCHROME-C RELEASE; ISCHEMIA/REPERFUSION INJURY; RENAL ISCHEMIA; LUNG INJURY; CELL-DEATH; FISSION; APOPTOSIS; DRP1	Experimental, evidence has clarified distant organ dysfunctions induced by AKI. Crosstalk between the kidney and heart, which has been recognized recently as cardiorenal syndrome, appears to have an important role in clinical settings, but the mechanisms by which AKI causes cardiac injury remain poorly understood. Both the kidney and heart are highly energy-demanding organs that are rich in mitochondria. Therefore, we investigated the role of mitochondrial dynamics in kidney heart organ crosstalk. Renal ischemia reperfusion (IR) injury was induced by bilateral renal artery clamping for 30 min in 8-week-old male C57BL/6 mice. Electron microscopy showed a significant increase of mitochondrial fragmentation in the heart at 24 h. Cardiomyocyte apoptosis and cardiac dysfunction, evaluated by echocardiography, were observed at 72 h. Among the mitochondrial dynamics regulating molecules, dynamin-related protein 1 (Drp1), which regulates fission, and mitofusin 1, mitofusin 2, and optic atrophy 1, which regulate fusion, only Drp1 was increased in the mitochondrial fraction of the heart. A Drp1 inhibitor, mdivi-1, administered before IR decreased mitochondrial fragmentation and cardiomyocyte apoptosis significantly and improved cardiac dysfunction induced by renal IR. This study showed that renal IR injury induced fragmentation of mitochondria in a fission-dominant manner with Drp1 activation and subsequent cardiomyocyte apoptosis in the heart. Furthermore, cardiac dysfunction induced by renal IR was improved by Drp1 inhibition. These data suggest that mitochondrial fragmentation by fission machinery may be a new therapeutic target in cardiac dysfunction induced by AKI.	[Sumida, Maki; Doi, Kent; Ogasawara, Emi; Yamashita, Tetsushi; Hamasaki, Yoshifumi; Nangaku, Masaomi; Noiri, Eisei] Univ Tokyo, Dept Nephrol & Endocrinol, Tokyo 1138655, Japan; [Doi, Kent; Yahagi, Naoki] Univ Tokyo, Dept Emergency & Crit Care Med, Tokyo 1138655, Japan; [Hamasaki, Yoshifumi] Univ Tokyo, Century Med & Res Ctr 22, Tokyo 1138655, Japan; [Kariya, Taro; Takimoto, Eiki] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Noiri, Eisei] Japan Sci & Technol Agcy, Japan Int Cooperat Agcy Sci & Technol Res Partner, Tokyo, Japan	Doi, K (reprint author), Univ Tokyo, Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kdoi-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390212, 25461211, 25860288]; SENSHIN Medical Research Foundation; Takeda Science Foundation, Japan	Partly supported by grants-in-aid for scientific research (24390212 to E.N., 25461211 to K.D., and 25860288 to Y.H.) from the Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation (to E.N.), and the Takeda Science Foundation, Japan (to K.D.).	Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI [10.1016/j.devcel.2007.11.019, 10.1016/j.devce1.2007.11.019]; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Santel A, 2001, J CELL SCI, V114, P867; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; ROBINSON SC, 1992, J PHARM PHARMACOL, V44, P1007; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Alexander C, 2000, NAT GENET, V26, P211; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Kellum JA, 2012, JAMA-J AM MED ASSOC, V307, P2265, DOI 10.1001/jama.2012.4315; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Andres-Hernando A, 2011, AM J PHYSIOL-RENAL, V301, pF907, DOI 10.1152/ajprenal.00107.2011; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Rosner MH, 2012, SEMIN NEPHROL, V32, P70, DOI 10.1016/j.semnephrol.2011.11.010; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Chawla LS, 2014, CLIN J AM SOC NEPHRO, V9, P448, DOI 10.2215/CJN.02440213; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Bagshaw SM, 2013, CONTRIB NEPHROL, V182, P137, DOI 10.1159/000349971; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Zhang N, 2013, NEUROSCI LETT, V535, P104, DOI 10.1016/j.neulet.2012.12.049; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Doi K, 2014, KIDNEY INT, V86, P316, DOI 10.1038/ki.2014.62; Yuen PST, 2004, AM J PHYSIOL-RENAL, V286, pF1116, DOI 10.1152/ajprenal.00366.2003; Nath KA, 2005, AM J PATHOL, V166, P963, DOI 10.1016/S0002-9440(10)62318-8; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; U.S. Department of Health and Human Services Public Health Services, 1985, NIH PUBLICATION, V86-23	43	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	OCT	2015	26	10					2378	2387		10.1681/ASN.2014080750		10	Urology & Nephrology	Urology & Nephrology	CS5ZL	WOS:000362156700011		
J	Marumo, T; Yagi, S; Kawarazaki, W; Nishimoto, M; Ayuzawa, N; Watanabe, A; Ueda, K; Hirahashi, J; Hishikawa, K; Sakurai, H; Shiota, K; Fujita, T				Marumo, Takeshi; Yagi, Shintaro; Kawarazaki, Wakako; Nishimoto, Mitsuhiro; Ayuzawa, Nobuhiro; Watanabe, Atsushi; Ueda, Kohei; Hirahashi, Junichi; Hishikawa, Keiichi; Sakurai, Hiroyuki; Shiota, Kunio; Fujita, Toshiro			Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							RESISTANCE-ASSOCIATED PROTEIN-4; SALT-SENSITIVE HYPERTENSION; RENAL ANGIOTENSIN-II; GENE-EXPRESSION; MOUSE KIDNEY; DISEASE; NEPHROPATHY; PROMOTER; INJURY; MICE	Epigenetic mechanisms may underlie the progression of diabetic kidney disease. Because the kidney is a heterogeneous organ with different cell types, we investigated DNA methylation status of the kidney in a cell type specific manner. We first identified genes specifically demethylated in the normal proximal tubules obtained from control db/m mice, and next delineated the candidate disease-modifying genes bearing aberrant DNA methylation induced by diabetes using db/db mice. Genes involved in glucose metabolism, including Sglt2, Pck1, and G6pc, were selectively hypomethylated in the proximal tubules in control mice. Hnf4a, a transcription factor regulating transporters for reabsorption, was also selectively demethylated. In diabetic mice, aberrant hypomethylation of Agt, Abcc4, Cyp4a10, Glut5, and Met and hypermethylation of Kif20b, Cldn18, and Slco1a1 were observed. Time-dependent demethylation of Agt, a marker of diabetic kidney disease, was accompanied by histone modification changes. Furthermore, inhibition of DNA methyltransferase or histone deacetylase increased Agt mRNA in cultured human proximal tubular cells. Aberrant DNA methylation and concomitant changes in histone modifications and mRNA expression in the diabetic kidney were resistant to antidiabetic treatment with pioglitazone. These results suggest that an epigenetic switch involving aberrant DNA methylation causes persistent mRNA expression of select genes that may lead to phenotype changes of the proximal tubules in diabetic kidney disease.	[Marumo, Takeshi; Kawarazaki, Wakako; Nishimoto, Mitsuhiro; Ayuzawa, Nobuhiro; Watanabe, Atsushi; Ueda, Kohei; Fujita, Toshiro] Univ Tokyo, Div Clin Epigenet, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Yagi, Shintaro; Shiota, Kunio] Univ Tokyo, Lab Cellular Biochem, Dept Anim Resource Sci Vet Med Sci, Tokyo 1538904, Japan; [Hishikawa, Keiichi] Univ Tokyo, Dept Adv Nephrol & Regenerat Med, Tokyo 1538904, Japan; [Marumo, Takeshi; Fujita, Toshiro] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Hirahashi, Junichi] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Tokyo, Japan; [Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol, Tokyo, Japan	Fujita, T (reprint author), Univ Tokyo, Div Clin Epigenet, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	tmarumo-npr@umin.ac.jp; Toshiro.FUJITA@rcast.u-tokyo.ac.jp		Nishimoto, Mitsuhihiro/0000-0001-9542-847X	JSPS KAKENHI [21229012, 22590879, 24659410, 25461230, 26670426]; Japan Foundation for Applied Enzymology; Daiwa Securities Health Foundation	This work was supported by JSPS KAKENHI (grant numbers 21229012, 22590879, 24659410, 25461230, and 26670426), Japan Foundation for Applied Enzymology, and Daiwa Securities Health Foundation.	Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Takizawa F, 2013, BIOCHEM BIOPH RES CO, V433, P66, DOI 10.1016/j.bbrc.2013.02.064; Lo CS, 2012, DIABETES, V61, P2597, DOI 10.2337/db11-1349; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433; Ying J, 2012, AM J HYPERTENS, V25, P684, DOI 10.1038/ajh.2012.16; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Hasegawa M, 2007, J AM SOC NEPHROL, V18, P37, DOI 10.1681/ASN.2005090966; Ortiz-Melo DI, 2014, KIDNEY INT, V85, P1009, DOI 10.1038/ki.2013.440; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; Makino H, 2006, DIABETES, V55, P2747, DOI 10.2337/db05-1683; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Stanescu DE, 2012, J CLIN ENDOCR METAB, V97, pE2026, DOI 10.1210/jc.2012-1356; Cruzado JM, 2004, DIABETES, V53, P1119, DOI 10.2337/diabetes.53.4.1119; Reudelhuber TL, 2013, J CLIN INVEST, V123, P1934, DOI 10.1172/JCI69296; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Sekine M, 2006, J BIOL CHEM, V281, P1008, DOI 10.1074/jbc.M509307200; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI 10.1681/ASN.2004080648; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Sugawara-Yokoo M, 1999, KIDNEY INT, V56, P1022, DOI 10.1046/j.1523-1755.1999.00635.x; Jiang S, 2003, NUCL RECEPT, V1, P5, DOI 10.1186/1478-1336-1-5; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; More VR, 2012, COMP HEPATOL, V11, P11, DOI DOI 10.1186/1476-5926-11-1; Wu GY, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-58; Yu ASL, 2015, J AM SOC NEPHROL, V26, P11, DOI 10.1681/ASN.2014030284	42	1	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	OCT	2015	26	10					2388	2397		10.1681/ASN.2014070665		10	Urology & Nephrology	Urology & Nephrology	CS5ZL	WOS:000362156700012		
J	Du, SL; Wang, R; Shi, P; Shi, Y				Du, Sheng-Li; Wang, Rui; Shi, Peng; Shi, Yan			Input-to-state stability for networked control system with predictive scheme	JOURNAL OF THE FRANKLIN INSTITUTE-ENGINEERING AND APPLIED MATHEMATICS			English	Article							AVERAGE DWELL-TIME; NONLINEAR-SYSTEMS; LINEAR-SYSTEMS; DELAY SYSTEMS; FEEDBACK; STABILIZATION; UNCERTAINTIES; QUANTIZATION; CHANNELS; DESIGN	This paper studies the input-to-state stability (ISS) problem for a class of networked control systems (NCSs). The improved varying controller gain predictive scheme is used to compensate the effects of network-induced delays and packet dropouts. By introducing a new auxiliary variable and analyzing the relationship of the network-induced delays and packet dropouts between two consecutive sampling instants, the considered networked control system (NCS) is converted into a coupled switched system. Based on the small gain theorem, a novel stability criterion is proposed to guarantee the ISS property of the considered system. Compared with existing works in literature, the stability criterion obtained here is easier to test and is much less conservative. A numerical simulation is presented to show the effectiveness of the proposed method. (C) 2015 The Franklin Institute. Published by Elsevier Ltd. All rights reserved.	[Du, Sheng-Li] Dalian Univ Technol, Sch Control Sci & Engn, Dalian 116024, Peoples R China; [Wang, Rui] Dalian Univ Technol, Sch Aeronaut & Astronaut, Dalian 116024, Peoples R China; [Shi, Peng] Harbin Engn Univ, Coll Automat, Harbin 150001, Heilongjiang, Peoples R China; [Shi, Peng] Victoria Univ, Coll Engn & Sci, Melbourne, Vic 8001, Australia; [Shi, Yan] Tokai Univ, Grad Sch Sci & Technol, Kumamoto 8628652, Japan	Wang, R (reprint author), Dalian Univ Technol, Sch Aeronaut & Astronaut, Dalian 116024, Peoples R China.	ruiwang@dlut.edu.cn			National Science Foundation of China [61374072]; Australian Research Council [DP140102180, LP140100471, LE150100079]; 111 Project [B12018]	This work was supported in part by the National Science Foundation of China (61374072), the Australian Research Council (DP140102180, LP140100471, LE150100079), and the 111 Project (B12018).	Hespanha JP, 2007, P IEEE, V95, P138, DOI 10.1109/JPROC.2006.887288; Sun XM, 2010, INT J ROBUST NONLIN, V20, P1774, DOI 10.1002/rnc.1550; Sun XM, 2014, IEEE T IND ELECTRON, V61, P3519, DOI 10.1109/TIE.2013.2278953; Li FB, 2015, AUTOMATICA, V51, P385, DOI 10.1016/j.automatica.2014.10.065; Lin H, 2009, IEEE T AUTOMAT CONTR, V54, P308, DOI 10.1109/TAC.2008.2012009; Dong HL, 2015, AUTOMATICA, V52, P355, DOI 10.1016/j.automatica.2014.11.020; Basin M, 2007, J FRANKLIN I, V344, P830, DOI 10.1016/j.jfranklin.2006.10.002; Wang R, 2010, IEEE T CONTR SYST T, V18, P1226, DOI 10.1109/TCST.2009.2035611; Liu GP, 2007, IEEE T IND ELECTRON, V54, P1282, DOI 10.1109/TIE.2007.893073; Hu J, 2013, INT J CONTROL, V86, P650, DOI 10.1080/00207179.2012.756149; Yang RN, 2011, AUTOMATICA, V47, P2805, DOI 10.1016/j.automatica.2011.09.007; Liu GP, 2007, IEEE T SYST MAN CY C, V37, P173, DOI 10.1109/TSMCC.2006.886987; Du SL, 2014, CHIN CONT DECIS CONF, P893; Zhang LX, 2013, IEEE T IND INFORM, V9, P403, DOI 10.1109/TII.2012.2219540; Nesic D, 2004, AUTOMATICA, V40, P2121, DOI 10.1016/j.automatica.2004.07.003; Ding DR, 2015, AUTOMATICA, V55, P37, DOI 10.1016/j.automatica.2015.02.024; Hu WS, 2007, IEEE T IND ELECTRON, V54, P1603, DOI 10.1109/TIE.2007.894720; Xiong JL, 2007, AUTOMATICA, V43, P80, DOI 10.1016/j.automatica.2006.07.017; Zhang W, 2001, IEEE CONTR SYST MAG, V21, P84; Jiang ZP, 2001, AUTOMATICA, V37, P857, DOI 10.1016/S0005-1098(01)00028-0; SONTAG ED, 1989, IEEE T AUTOMAT CONTR, V34, P435, DOI 10.1109/9.28018; Wang YE, 2012, J FRANKLIN I, V349, P3159, DOI 10.1016/j.jfranklin.2012.10.003; Xu XX, 2008, IEEE T COMPUT AID D, V27, P1315, DOI 10.1109/TCAD.2008.923092; Hu J, 2013, IEEE T SIGNAL PROCES, V61, P1230, DOI 10.1109/TSP.2012.2232660; Kim DS, 2003, CONTROL ENG PRACT, V11, P1301, DOI 10.1016/S0967-0661(02)00238-1; Choi J. H., 2015, IEEE T SIGNAL PROCES, V56, P1730; EI Ghaoui L., 1997, IEEE T AUTOMAT CONTR, V42, P1171, DOI [10.1109/9.618250, DOI 10.1109/9.618250]; Li F., 2013, INT J INNOV COMPUT I, V9, P4889; Su Qingyu, 2013, [自动化学报, Acta Automatica Sinica], V39, P919; Sun XM, 2014, IEEE T CIRCUITS-II, V61, P453, DOI 10.1109/TCSII.2014.2319935; Tian Zhongda, 2014, [International Journal of Automation and Computing, 国际自动化与计算杂志], V11, P19; Vesely Vojtech, 2013, International Journal of Innovative Computing, Information & Control, V9; Wafa E., 2014, INT J AUTOM COMPUT, V11, P653; Wang R, 2010, IEEE T CIRCUITS-II, V57, P310, DOI 10.1109/TCSII.2010.2043386; Wang R., 2012, J FRANKLIN I, V350, P2028	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-0032	1879-2693		J FRANKLIN I	J. Frankl. Inst.-Eng. Appl. Math.	OCT	2015	352	10					4565	4578		10.1016/j.jfranklin.2015.06.021		14	Automation & Control Systems; Engineering, Multidisciplinary; Engineering, Electrical & Electronic; Mathematics, Interdisciplinary Applications	Automation & Control Systems; Engineering; Mathematics	CS2TP	WOS:000361925200036		
J	Gui, G; Xu, L; Matsushita, SY				Gui, Guan; Xu, Li; Matsushita, Shin-ya			Improved adaptive sparse channel estimation using mixed square/fourth error criterion	JOURNAL OF THE FRANKLIN INSTITUTE-ENGINEERING AND APPLIED MATHEMATICS			English	Article							ALGORITHM; SYSTEMS	Sparse channel estimation problem is one of challenge technical issues in broadband wireless communications. Square error criterion based adaptive sparse channel estimation (SEC-ASCE) algorithms, e.g., zero-attracting least mean square (ZA-LMS) and reweighted ZA LMS (RZA-LMS), have been proposed to mitigate noises as well as to exploit the channel sparsity. However, the conventional SEC-ASCE algorithms are vulnerable to performance deteriorate due to 1) random scaling of input training signal, and 2) unable to balance between convergence speed and transient-state mean square error (MSE) performance. In this paper, a mixed square/fourth error criterion (SPEC) based ASCE algorithms (SEFCA-SCE), i.e., zero-attracting least mean square/fourth error (ZA-LMS/F) and reweighted ZA-LMS/F (RZA-LMS/F), are proposed to enhance estimation performance while without exhausting a lot computational complexity. First, regularization parameters of the ZA-LMS/F and RZA-LMS/F algorithms are selected by means of Monte-Carlo simulations. Second, lower bounds of the proposed channel estimation algorithms are derived and analyzed. Finally, simulation results are given to show that the proposed sparse LMS/F-type algorithms achieve better estimation performance than the conventional algorithms. (C) 2015 The Franklin Institute. Published by Elsevier Ltd. All rights reserved.	[Gui, Guan; Xu, Li; Matsushita, Shin-ya] Akita Prefectural Univ, Dept Elect & Informat Syst, Akita 0150055, Japan	Gui, G (reprint author), Akita Prefectural Univ, Dept Elect & Informat Syst, Akita 0150055, Japan.	guitohoku2009@gmail.com			Japan Society for the Promotion of Science (JSPS) [26889050, 15K06072]; National Natural Science Foundation of China [61401069, 61271240]	The authors would like to thank Dr. Koichi Adachi of Institute for Infocomm Research (I<SUP>2</SUP>R) for his valuable comments and helpful suggestions. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) research Grants (nos. 26889050, 15K06072), and the National Natural Science Foundation of China Grants (nos. 61401069, 61271240).	Adachi F, 2009, IEICE T COMMUN, VE92B, P2789, DOI 10.1587/transcom.E92.B.2789; [Anonymous], 2011, P IEEE INT C AC SPEE; Chen YL, 2009, INT CONF ACOUST SPEE, P3125; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Lim SJ, 1997, ELECTRON LETT, V33, P467, DOI 10.1049/el:19970311; Ghofrani S, 2015, MULTIDIM SYST SIGN P, V26, P693, DOI 10.1007/s11045-013-0266-z; Gui GA, 2015, WIREL COMMUN MOB COM, V15, P1649, DOI 10.1002/wcm.2453; Dai LL, 2012, IEEE COMMUN MAG, V50, P150; Shi K, 2010, SIGNAL PROCESS, V90, P3289, DOI 10.1016/j.sigpro.2010.05.015; Vuokko L, 2007, IEEE T ANTENN PROPAG, V55, P3361, DOI 10.1109/TAP.2007.908844; Gui G, 2013, UEEE INT SYM PERS IN, P296; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Czink N, 2007, IEEE T WIREL COMMUN, V6, P1465, DOI 10.1109/TWC.2007.05595; Eweda E, 2012, IEEE T SIGNAL PROCES, V60, P6235, DOI 10.1109/TSP.2012.2215607; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Gui G, 2014, INT J COMMUN SYST, V27, P3147, DOI [10.1002/dac.2517, 10.1002/dac.2531]; Gui G., 2008, IEEE TENCON, P1; Hayashi K, 2013, IEICE T COMMUN, VE96B, P685, DOI 10.1587/transcom.E96.B.685; Huang Z., 2013, P 19 AS PAC C COMM A, P1; Lee D., 2010, IEICE TECH REP, V109, P21; Lee D., 2010, IEICE TECH REP, V110, P9; Su GL, 2012, IEEE T SIGNAL PROCES, V60, P2223, DOI 10.1109/TSP.2012.2184537; WALACH E, 1984, IEEE T INFORM THEORY, V30, P275, DOI 10.1109/TIT.1984.1056886; Widrow B., 1985, ADAPTIVE SIGNAL PROC; Yi L., 2013, IEEE T WIREL COMMUN, V13, P99; Zhu W., 2013, MULTIDIM SYST SIGN P, V26, P113	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-0032	1879-2693		J FRANKLIN I	J. Frankl. Inst.-Eng. Appl. Math.	OCT	2015	352	10					4579	4594		10.1016/j.jfranklin.2015.07.006		16	Automation & Control Systems; Engineering, Multidisciplinary; Engineering, Electrical & Electronic; Mathematics, Interdisciplinary Applications	Automation & Control Systems; Engineering; Mathematics	CS2TP	WOS:000361925200037		
J	Sezai, A; Osaka, S; Yaoita, H; Ishii, Y; Arimoto, M; Hata, H; Shiono, M				Sezai, Akira; Osaka, Shunji; Yaoita, Hiroko; Ishii, Yusuke; Arimoto, Munehito; Hata, Hiroaki; Shiono, Motomi			Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						beta blocker; atrial fibrillation; cardiac surgery; left ventricular dysfunction	ACTING BETA-BLOCKER; ARTERY-BYPASS SURGERY; OPEN-HEART-SURGERY; MYOCARDIAL-INFARCTION; ESMOLOL; TACHYARRHYTHMIAS; BETA-1-BLOCKER; METOPROLOL; MANAGEMENT; DILTIAZEM	Objectives: We previously conducted a prospective study of landiolol hydrochloride (INN landiolol), an ultrashort-acting beta-blocker, and reported that it could prevent atrial fibrillation after cardiac surgery. This trial was performed to investigate the safety and efficacy of landiolol hydrochloride in patients with left ventricular dysfunction undergoing cardiac surgery. Methods: Sixty patients with a preoperative left ventricular ejection fraction of less than 35% were randomly assigned to 2 groups before cardiac surgery and then received intravenous infusion with landiolol hydrochloride (landiolol group) or without landiolol (control group). The primary end point was occurrence of atrial fibrillation as much as 1 week postoperatively. The secondary end points were blood pressure, heart rate, intensive care unit and hospital stays, ventilation time, ejection fraction, biomarkers of ischemia, and brain natriuretic peptide. Results: Atrial fibrillation occurred in 3 patients (10%) in the landiolol group versus 12 (40%) in the control group, and its frequency was significantly lower in the landiolol group (P = .002). During the early postoperative period, levels of brain natriuretic peptide and ischemic biomarkers were significantly lower in the landiolol group than the control group. The landiolol group also had a significantly shorter hospital stay (P = .019). Intravenous infusion was not discontinued for hypotension or bradycardia in either group. Conclusions: Low-dose infusion of landiolol hydrochloride prevented atrial fibrillation after cardiac surgery in patients with cardiac dysfunction and was safe, with no effect on blood pressure. This intravenous b-blocker seems useful for perioperative management of cardiac surgical patients with left ventricular dysfunction.	[Sezai, Akira; Osaka, Shunji; Yaoita, Hiroko; Ishii, Yusuke; Arimoto, Munehito; Hata, Hiroaki; Shiono, Motomi] Nihon Univ, Sch Med, Dept Cardiovasc Surg, Tokyo 1738610, Japan	Sezai, A (reprint author), Nihon Univ, Sch Med, Dept Cardiovasc Surg, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	asezai.med@gmail.com			Japanese Ministry of Education, Culture, Sports, Science, and Technology [24592075]	Supported by a grant for scientific research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (No. 24592075).	Sezai A, 2013, CIRC J, V77, P2244, DOI 10.1253/circj.CJ-13-0754; Sezai A, 2009, J THORAC CARDIOV SUR, V137, P895, DOI 10.1016/j.jtcvs.2008.10.003; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Nagaoka E, 2014, ANN THORAC CARDIOVAS, V20, P129, DOI 10.5761/atcs.oa.12.02003; Sezai A, 2012, J THORAC CARDIOV SUR, V144, P1241, DOI 10.1016/j.jtcvs.2012.06.042; Greenberg MD, 2000, J AM COLL CARDIOL, V35, P1416, DOI 10.1016/S0735-1097(00)00610-0; Sakamoto A, 2012, CIRC J, V76, P1097, DOI 10.1253/circj.CJ-11-1332; Ito N, 2012, HEART SURG FORUM, V15, pE189, DOI 10.1532/HSF98.20111152; Chen ZM, 2005, LANCET, V366, P1622; Sakamoto A, 2014, ADV THER, V31, P440, DOI 10.1007/s12325-014-0116-x; Budeus M, 2006, EUR HEART J, V27, P1584, DOI 10.1093/eurheartj/ehl082; Sugiyama A, 1999, J CARDIOVASC PHARM, V34, P70, DOI 10.1097/00005344-199907000-00012; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; Plosker GL, 2013, DRUGS, V73, P959, DOI 10.1007/s40265-013-0077-4; Brinkman W, 2014, JAMA INTERN MED, V174, P1320, DOI 10.1001/jamainternmed.2014.2356; Dargie HJ, 2001, LANCET, V357, P1385; GRAY RJ, 1985, J AM COLL CARDIOL, V5, P1451; Sezai A, 2011, J THORAC CARDIOV SUR, V141, P1478, DOI 10.1016/j.jtcvs.2010.10.045; Maaroos M, 2012, SCAND J SURG, V101, P292; Mooss AN, 2000, AM HEART J, V140, P176, DOI 10.1067/mhj.2000.106917; Sasao J, 2001, CAN J ANAESTH, V48, P985; IGUCHI S, 1992, CHEM PHARM BULL, V40, P1462; Nagai R, 2013, CIRC J, V77, P908, DOI 10.1253/circj.CJ-12-1618; Halonen J, 2006, CIRCULATION S, V114, pI1, DOI 10.1161/CIRCULATIONAHA.105.000851; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Maniar Parimal B, 2003, Card Electrophysiol Rev, V7, P158, DOI 10.1023/A:1027467617722; Sezai A, 2014, ANN THORAC CARDIOVAS, V20, P261, DOI 10.5761/atcs.ed.13-00374; Shea J, 2014, J THORAC CARDIOV SUR, V148, P1752, DOI 10.1016/j.jtcvs.2014.05.046	29	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	OCT	2015	150	4					957	964		10.1016/j.jtcvs.2015.07.003		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS2KW	WOS:000361900500055		
J	Yoshitake, A; Hachiya, T; Hayashi, K; Shimizu, H				Yoshitake, Akihiro; Hachiya, Takashi; Hayashi, Kanako; Shimizu, Hideyuki			The kissing stents technique for a patient with chronic type B aortic dissection	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material							ENDOVASCULAR REPAIR; OUTCOMES		[Yoshitake, Akihiro; Hachiya, Takashi; Hayashi, Kanako; Shimizu, Hideyuki] Keio Univ, Sch Med, Dept Cardiovasc Surg, Tokyo, Japan	Yoshitake, A (reprint author), Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	akihiro197253@yahoo.co.jp					Kang WC, 2011, J THORAC CARDIOV SUR, V142, P1074, DOI 10.1016/j.jtcvs.2011.03.008; Kolbel T, 2013, J ENDOVASC THER, V20, P484, DOI 10.1583/13-4318.1; Fattori R, 2013, JACC-CARDIOVASC INTE, V6, P876, DOI 10.1016/j.jcin.2013.05.003; Patterson BO, 2014, ANN THORAC SURG, V97, P588, DOI 10.1016/j.athoracsur.2013.07.128; Idrees J, 2014, J VASC SURG, V60, P1507, DOI 10.1016/j.jvs.2014.08.094	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	OCT	2015	150	4					995	997		10.1016/j.jtcvs.2015.07.004		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS2KW	WOS:000361900500063		
J	Bando, K				Bando, Ko			Rome was not built in a day	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material							AORTIC-VALVE-REPLACEMENT; MITRAL-VALVE; IN-VALVE; TRANSCATHETER; IMPLANTATION; REPAIR; RING		[Bando, Ko] Jikei Univ, Sch Med, Dept Cardiac Surg, Tokyo, Japan	Bando, K (reprint author), 3-25-8 Nishi Shinbashi,Minato Ku, Tokyo 1058461, Japan.	kobando@jikei.ac.jp					Wilbring M, 2013, ANN THORAC SURG, V95, P111, DOI 10.1016/j.athoracsur.2012.08.004; Tommaso CL, 2014, J THORAC CARDIOV SUR, V148, P387, DOI 10.1016/j.jtcvs.2014.06.014; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Wilbring M, 2014, J THORAC CARDIOV SUR, V147, P210, DOI 10.1016/j.jtcvs.2013.09.021; Wilbring M, 2015, J THORAC CARDIOV SUR, V149, pE92, DOI 10.1016/j.jtcvs.2015.03.047; Dvir D, 2014, JAMA-J AM MED ASSOC, V312, P162, DOI 10.1001/jama.2014.7246; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	OCT	2015	150	4					E49	E50		10.1016/j.jtcvs.2015.06.025		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS2KW	WOS:000361900500001		
J	Liu, ZQ; Ishihara, T				Liu, Zhenqing; Ishihara, Takeshi			Numerical study of turbulent flow fields and the similarity of tornado vortices using large-eddy simulations	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Tornado vortex; LES; Swirl ratio; Turbulent flow fields; Force balance; Similarity	SWIRL RATIO; SOUTH-DAKOTA; 1998 SPENCER; VORTEX; DYNAMICS; SURFACE; INTENSIFICATION; STORM; MODEL	Tornado vortices are investigated using large-eddy simulations of a single vortex evolving into a multi-vortex. Four typical tornado configurations, including a weak vortex, a vortex breakdown, a vortex touchdown and a multi-vortex, are investigated to provide detailed information on the turbulent flow fields. The force balances in the radial and vertical directions are also evaluated using axsymmetrically and time averaged results. The local corner swirl ratio is used as an index to describe the surface intensification and the geometry of tornado vortices; the similarity between the simulated tornadoes and a full-scale tornado in nature is examined. Good agreements between the data of scaled tornado in simulation and the observed data of the full-scale tornado in nature are achieved. (C) 2015 Elsevier Ltd. All rights reserved.	[Liu, Zhenqing] Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Hubei, Peoples R China; [Ishihara, Takeshi] Univ Tokyo, Dept Civil Engn, Sch Engn, Tokyo 113, Japan	Liu, ZQ (reprint author), Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Hubei, Peoples R China.	liuzhenqing1984@hotmail.com; ishihara@bridge.tu-tokyo.ac.jp					Alexander CR, 2005, MON WEATHER REV, V133, P72, DOI 10.1175/MWR-2855.1; WAN CA, 1972, J ATMOS SCI, V29, P116, DOI 10.1175/1520-0469(1972)029<0116:MOTVFI>2.0.CO;2; Oka S, 2009, J WIND ENG IND AEROD, V97, P548, DOI 10.1016/j.jweia.2009.08.006; Wurman J, 2005, MON WEATHER REV, V133, P97, DOI 10.1175/MWR-2856.1; MONJI N, 1985, J METEOROL SOC JPN, V63, P703; Tari PH, 2010, J WIND ENG IND AEROD, V98, P936, DOI 10.1016/j.jweia.2010.10.001; CHURCH CR, 1979, J ATMOS SCI, V36, P1755, DOI 10.1175/1520-0469(1979)036<1755:COTLVA>2.0.CO;2; Hangan H, 2008, WIND STRUCT, V11, P291; Lewellen DC, 2007, J ATMOS SCI, V64, P2176, DOI 10.1175/JAS3965.1; ROTUNNO R, 1977, J ATMOS SCI, V34, P1942, DOI 10.1175/1520-0469(1977)034<1942:NSOALV>2.0.CO;2; Ishihara T, 2011, J WIND ENG IND AEROD, V99, P239, DOI 10.1016/j.jweia.2011.01.014; Lewellen DC, 2000, J ATMOS SCI, V57, P527, DOI 10.1175/1520-0469(2000)057<0527:TIOALS>2.0.CO;2; Haan FL, 2008, ENG STRUCT, V30, P1146, DOI 10.1016/j.engstruct.2007.07.0; WILSON T, 1986, PHYS FLUIDS, V29, P3993, DOI 10.1063/1.865740; Nolan DS, 1999, J ATMOS SCI, V56, P2908, DOI 10.1175/1520-0469(1999)056<2908:TSADOT>2.0.CO;2; Baker G. L., 1981, THESIS PURDUE U W LA; Ferziger J.H., 2002, COMPUTATIONAL METHOD; Ishihara T, 2014, WIND STRUCT, V19, P89; Kuai L., 2008, WIND STRUCT, V11, P1; Lewellen WS, 1997, J ATMOS SCI, V54, P581, DOI 10.1175/1520-0469(1997)054<0581:LESOAT>2.0.CO;2; Matsui M., 2009, P 5 EUR AFR C WIND E; Mishra Alt, 2008, J WIND ENG IND AEROD, V96, P1234; Mitsuta Y., 1984, NATURAL DISASTER SCI, V6, P43; WARD NB, 1972, J ATMOS SCI, V29, P1194, DOI 10.1175/1520-0469(1972)029<1194:TEOCFO>2.0.CO;2	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	OCT	2015	145						42	60		10.1016/j.jweia.2015.05.008		19	Engineering, Civil; Mechanics	Engineering; Mechanics	CS5VF	WOS:000362145700004		
J	Kim, YC; Bandi, EK; Yoshida, A; Tamura, Y				Kim, Y. C.; Bandi, E. K.; Yoshida, A.; Tamura, Y.			Response characteristics of super-tall buildings - Effects of number of sides and helical angle	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Wind tunnel test; Spectral modal method; Response characteristics; Straight and helical super-tall buildings; Polygonal section	WIND; COMPONENTS; CYLINDERS	Wind tunnel tests were conducted on 13 straight and helical super-tall buildings with various polygonal cross-sections, including triangular, square, pentagon, hexagon, octagon, dodecagon, and circular. The primary purpose of the present study was to investigate the effects of increasing number of sides on response characteristics rather than other aerodynamic characteristics for straight super-tall buildings and the effect of helical shape on polygonal section super-tall buildings. The results show that the overturning moment coefficients, the spectral values and responses decrease with increasing number of sides, and the largest mean and fluctuating overturning moments were found for the straight triangular model and the largest spectral values and responses were found for the straight square model. The largest peak accelerations for annual design wind speed were similar when the number of sides were larger than 5, but some variations were observed in the largest maximum displacements among models. The effects of helical shape on the response characteristics decreased with increasing number of sides, and it can be generally said that the effect of helical shape becomes small when the number of sides is 5 or more. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Y. C.; Yoshida, A.] Tokyo Polytech Univ, Atsugi, Kanagawa, Japan; [Bandi, E. K.] MITS, Madanapalle, Andhra Pradesh, India; [Tamura, Y.] Beijing Jiaotong Univ, Beijing, Peoples R China	Kim, YC (reprint author), Tokyo Polytech Univ, Atsugi, Kanagawa, Japan.	gentle95@gmail.com			National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A6A3A01064632]; Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program [H13]; 111 Project of China [B13002]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A01064632). This study was partly funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program, 2008-2012 (H13) and 111 Project of China (B13002). The authors gratefully acknowledge their support.	THORODDSEN ST, 1988, J WIND ENG IND AEROD, V28, P351, DOI 10.1016/0167-6105(88)90131-6; Kim YC, 2014, J WIND ENG IND AEROD, V133, P191, DOI 10.1016/j.jweia.2014.06.004; SZALAY Z, 1989, J WIND ENG IND AEROD, V32, P135, DOI 10.1016/0167-6105(89)90024-X; Tanaka H, 2012, J WIND ENG IND AEROD, V107, P179, DOI 10.1016/j.jweia.2012.04.014; Chien CW, 2010, J CHIN INST ENG, V33, P597, DOI 10.1080/02533839.2010.9671648; KANDA J, 1992, J WIND ENG IND AEROD, V41, P785, DOI 10.1016/0167-6105(92)90497-X; Tang JW, 2013, STRUCT DES TALL SPEC, V22, P62, DOI 10.1002/tal.657; Bandi EK, 2013, J WIND ENG IND AEROD, V122, P60, DOI 10.1016/j.jweia.2013.07.002; Tamura Y., 2012, INT J HIGH RISE BUIL, V1, P1; Tamura Y., 2006, P 12 AWES WIND ENG W	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	OCT	2015	145						252	262		10.1016/j.jweia.2015.07.001		11	Engineering, Civil; Mechanics	Engineering; Mechanics	CS5VF	WOS:000362145700022		
J	McNally, J; Fernandez, E; Robertson, G; Kumar, R; Taira, K; Alvi, F; Yamaguchi, Y; Murayama, K				McNally, Jonathan; Fernandez, Erik; Robertson, Gregory; Kumar, Rajan; Taira, Kunihiko; Alvi, Farrukh; Yamaguchi, Yoshihiro; Murayama, Kei			Drag reduction on a flat-back ground vehicle with active flow control	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Aerodynamics; LES; Experiments; Road vehicles; Active flow control; Drag reduction	NEAR-WAKE; BODY; MODEL; JET	Active flow control is applied to the Honda Simplified Body (HSB), a flat-back ground vehicle model, for aerodynamic drag reduction. The use of small scale, steady jets (microjets) in normal and tangential injection orientations is investigated through experimental parametric studies and companion numerical simulations. Parameters such as injection location relative to separation point, jet diameter, and blowing ratio are explored. The flow response is characterized experimentally by aerodynamic force measurements and velocity field measurements. The computational effort utilizes Large Eddy Simulation (LES) to uncover how flow control with a steady microjet array modifies the wake and the corresponding drag. The impact of the microjets on the baseline flow field is discussed. The computational study introduces the actuator array on the top surface of the model body to support the experimental study that examines the effectiveness of flow control with microjets installed on multiple side surfaces. From both experimental and numerical analyses, it is observed that the wake can be modified with microjets such that the drag experienced by the HSB is reduced by nearly 3% with net reduction in power consumption. (C) 2015 Elsevier Ltd. All rights reserved.	[McNally, Jonathan; Fernandez, Erik; Robertson, Gregory; Kumar, Rajan; Taira, Kunihiko; Alvi, Farrukh] Florida A&M Univ, FCAAP, Tallahassee, FL 32310 USA; [McNally, Jonathan; Fernandez, Erik; Robertson, Gregory; Kumar, Rajan; Taira, Kunihiko; Alvi, Farrukh] Florida State Univ, Tallahassee, FL 32310 USA; [Yamaguchi, Yoshihiro; Murayama, Kei] Honda Res & Dev Co Ltd, Fundamental Technol Res Ctr, Wako, Saitama 3510193, Japan	McNally, J (reprint author), Florida A&M Univ, FCAAP, 2003 Levy Ave, Tallahassee, FL 32310 USA.	jwm06e@fsu.edu			Fundamental Technology Research Center at Honda RD Co., Ltd; National Science Foundation PIRE program [OISE-0968313]	This research was supported by the Fundamental Technology Research Center at Honda R&D Co., Ltd as well as the National Science Foundation PIRE program through grant OISE-0968313. We greatly acknowledge the technical discussions with Mr. Minoru Teramura as well as the experimental testing assistance from Ms. Shannon Berger and Mr. Cory Gainus.	Ahmed S., 1984, SAE CHANGES, V2012, P11; Ahmed S. R., 1983, Transactions of the ASME. Journal of Fluids Engineering, V105; Gillieron P, 2010, EXP FLUIDS, V48, P1, DOI 10.1007/s00348-009-0705-7; Pujals G, 2010, EXP FLUIDS, V49, P1085, DOI 10.1007/s00348-010-0857-5; Westerweel J, 2005, EXP FLUIDS, V39, P1096, DOI 10.1007/s00348-005-0016-6; Beaudoin JF, 2008, EXP FLUIDS, V44, P491, DOI 10.1007/s00348-007-0392-1; Roumeas M, 2009, COMPUT FLUIDS, V38, P60, DOI 10.1016/j.compfluid.2008.01.009; Fernandez E, 2013, J PROPUL POWER, V29, P867, DOI 10.2514/1.B34413; Krajnovic S, 2003, J FLUID ENG-T ASME, V125, P500, DOI 10.1115/1.1567305; Joseph P, 2012, EXP FLUIDS, V52, P1169, DOI 10.1007/s00348-011-1245-5; Aubrun S, 2011, EXP FLUIDS, V51, P1177, DOI 10.1007/s00348-011-1132-0; FRIC TF, 1994, J FLUID MECH, V279, P1, DOI 10.1017/S0022112094003800; Vino G, 2005, J FLUID STRUCT, V20, P673, DOI 10.1016/j.jfluidstructs.2005.03.006; Vreman AW, 2004, PHYS FLUIDS, V16, P3670, DOI 10.1063/1.1785131; Park H, 2013, J MECH SCI TECHNOL, V27, P3721, DOI 10.1007/s12206-013-0917-x; Littlewood RP, 2012, EXP FLUIDS, V53, P519, DOI 10.1007/s00348-012-1306-4; Bruneau C.-H., 2012, J APPL FLUID MECH, V5; Choi H, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3676783; Gilhome B., 2001, FUTURE, V2013, P07; Ham F., 2004, ANN RES BRIEFS, V2004, P3; Ham F., 2006, ANN RES BRIEFS, P243; Hunt J.C.R., 1988, STUDYING TURBULENCE, V2, P193, DOI DOI 10.1017/S002211200800236X; Krajnovic S., 2014, J FLUIDS ENG, V136, P1; Kreth P., 2014, J FLOW CONTROL MEAS; Kumar V., 2008, THESIS FLORIDA STATE; Lahaye Arnaud, 2014, International Journal of Aerodynamics, V4; McNally J., 2012, 6 AIAA FLOW CONTR C; Pfeiffer J., 2012, 6 AIAA FLOW CONTR C; Sims-Williams D.B., 2003, SAE T, V112, P1385; Wieneke B., 2010, 15 INT S APPL LAS TE	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	OCT	2015	145						292	303		10.1016/j.jweia.2015.03.006		12	Engineering, Civil; Mechanics	Engineering; Mechanics	CS5VF	WOS:000362145700027		
J	Takeshita, K; Ishizaki, M; Mitsuya, R; Takahashi, H; Yoshida, T; Igota, H; Ikeda, T; Kubo, MO; Kaji, K				Takeshita, K.; Ishizaki, M.; Mitsuya, R.; Takahashi, H.; Yoshida, T.; Igota, H.; Ikeda, T.; Kubo, M. O.; Kaji, K.			Temporal changes in molar wear rate of a sika deer population under density-dependent food limitation	JOURNAL OF ZOOLOGY			English	Article						density-dependent food limitation; fallen leaves; hypsodonty; Nakanoshima Island; sex difference; sika deer; temporal change; molar wear	LIFE-HISTORY TRAITS; CERVUS-NIPPON POPULATIONS; TOOTH WEAR; RED DEER; SEXUAL SELECTION; NORTHERN JAPAN; WILD REINDEER; BODY-SIZE; EVOLUTION; SENESCENCE	Negative effects of density-dependent food limitation on molar wear rate in ungulate populations, as well as unworn molar size and its sex differences in ruminants, have been studied for a long time. However, these studies were based on comparisons of populations from different districts or habitats. If drastic changes in food habits and life history occurred under density-dependent resource limitation, it is of great interest whether this change caused temporal changes in molar wear rate, and whether the degree of hypsodonty changed under this short but intensive selective pressure. We examined the temporal change in molar wear rate using long-term monitoring data of a sika deer (Cervus nipon) population on Nakanoshima Island, Hokkaido, Japan. Corresponding to the change in food habits, the molar wear rate changed mainly because of the amount of soil that was secondarily ingested when deer fed on fallen leaves. Molar wear rate was the fastest level after the first population crash on Nakanoshima Island among extant sika deer populations. Nevertheless, we did not find any evidence of increased hypsodonty in Nakanoshima deer. It is possible that natural selection for increased molar durability (hypsodonty) has been working on Nakanoshima deer, but the adaptive change has not yet appeared at a statistically significant level.	[Takeshita, K.; Ishizaki, M.; Mitsuya, R.; Ikeda, T.; Kaji, K.] Tokyo Univ Agr & Technol, Dept Agr, Lab Wildlife Management, Fuchu, Tokyo 1838509, Japan; [Takahashi, H.] Kansai Res Ctr, Forestry & Forest Prod Res Inst, Kyoto, Japan; [Yoshida, T.; Igota, H.] Rakuno Gakuen Univ, Dept Environm & Symbiot Sci, Ebetsu, Hokkaido, Japan; [Kubo, M. O.] Univ Tokyo, Univ Museum, Tokyo, Japan	Takeshita, K (reprint author), Tokyo Univ Agr & Technol, Dept Agr, Lab Wildlife Management, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	kazutaka.takeshita.0716@gmail.com			Hokkaido Government; Japan Society for the Promotion of Science (JSPS) KAKENHI [19380084, 21248019, 26650157]	Many people helped with the field research on Nakanoshima Island over 30 years, including numerous students from Tokyo University of Agriculture & Technology, Hokkaido University and Rakuno Gakuen University, to whom we give our heartfelt thanks. N. Ohtaishi and M. Eda are acknowledged for allowing us to use deer specimens in their charge. We would like to thank G. Suwa for his permission to use the micro X-ray CT machine at the University Museum, the University of Tokyo. This work was supported in part by the Hokkaido Government and by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number 19380084, 21248019, 26650157) to K.K.	Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; Veiberg V, 2007, OIKOS, V116, P1805, DOI 10.1111/j.2007.0030-1299.16159.x; Kubo Mugino Ozaki, 2014, Zitteliana Reihe B, V32, P163; SKOGLAND T, 1989, OIKOS, V55, P101, DOI 10.2307/3565879; KOIKE H, 1985, J ARCHAEOL SCI, V12, P443, DOI 10.1016/0305-4403(85)90004-4; Kaji Koichi, 2009, P421, DOI 10.1007/978-4-431-09429-6_30; Kojola I, 1998, OECOLOGIA, V117, P26, DOI 10.1007/s004420050627; Kubo MO, 2013, BIOL J LINN SOC, V110, P384, DOI 10.1111/bij.12128; Kaji K, 2010, POPUL ECOL, V52, P373, DOI 10.1007/s10144-010-0219-4; KAJI K, 1988, ACTA THERIOL, V33, P187; Perez-Barberia FJ, 2015, CAN J ZOOL, V93, P61, DOI 10.1139/cjz-2014-0150; Carranza J, 2007, AM NAT, V170, P370, DOI 10.1086/519852; Rivals F, 2014, J MAMMAL, V95, P1043, DOI 10.1644/14-MAMM-A-097; Loe LE, 2003, OECOLOGIA, V135, P346, DOI 10.1007/s00442-003-1192-9; Takahashi H, 2001, ECOL RES, V16, P257, DOI 10.1046/j.1440-1703.2001.00391.x; Nussey DH, 2007, J ANIM ECOL, V76, P402, DOI 10.1111/j.1365-2656.2007.01212.x; Simard MA, 2008, J ANIM ECOL, V77, P678, DOI 10.1111/j.1365-2656.2008.01374.x; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Ozaki M, 2010, J ZOOL, V280, P202, DOI 10.1111/j.1469-7998.2009.00653.x; Ueno M, 2007, ACTA THERIOL, V52, P119, DOI 10.1007/BF03194207; Miyaki M, 2004, ECOL RES, V19, P405, DOI 10.1111/j.1440-1703.2004.00651.x; Tremblay JP, 2005, CAN J ZOOL, V83, P1087, DOI 10.1139/Z05-090; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Veiberg V, 2007, J ANIM ECOL, V76, P1139, DOI 10.1111/j.1365-2656.2007.01265.x; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; Kubo MO, 2011, ANTHROPOL SCI, V119, P183, DOI 10.1537/ase.091215; Ozaki M, 2007, J ZOOL, V272, P244, DOI 10.1111/j.1469-7998.2006.00264.x; Jordana X, 2012, P ROY SOC B-BIOL SCI, V279, P3339, DOI 10.1098/rspb.2012.0689; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; Padmalal UKGK, 1994, ECOL RES, V9, P251, DOI 10.1007/BF02348411; Burnham K. P., 1998, MODEL SELECTION INFE; Kaji K., 2006, CONSERVATION MANAGEM, P43; Kubo MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090745; R Core Team, 2014, R LANG ENV STAT COMP; Takahashi Hiroshi, 1999, Mammal Study, V24, P17, DOI 10.3106/mammalstudy.24.17; Tyler N. J. C., 1986, RANGIFER, P311	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-8369	1469-7998		J ZOOL	J. Zool.	OCT	2015	297	2					139	145		10.1111/jzo.12258		7	Zoology	Zoology	CS6WW	WOS:000362225100007		
J	Hamano, T				Hamano, Takayuki			Klotho upregulation by rapamycin protects against vascular disease in CKD	KIDNEY INTERNATIONAL			English	Editorial Material							CALCINEURIN INHIBITOR; RANDOMIZED-TRIAL; CALCIFICATION; EVEROLIMUS; RECIPIENTS; MTOR	Medial arterial calcification involves chondrogenic/osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs). Zhao et al. report that phosphate activates the mammalian target of rapamycin (mTOR) cascade in VSMCs, leading to downregulation of Klotho. Furthermore, rapamycin was shown to halt medial calcification. This effect was blunted in the absence of Klotho. Given the concomitant anti-atherosclerotic effects of the mTOR inhibitor, this agent has clinical potential as an inhibitor of intimal atherosclerosis and medial calcification.	Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan	Hamano, T (reprint author), Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hamatea@kid.med.osaka-u.ac.jp					Martinet W, 2014, ATHEROSCLEROSIS, V233, P601, DOI 10.1016/j.atherosclerosis.2014.01.040; Mjornstedt L, 2012, AM J TRANSPLANT, V12, P2744, DOI 10.1111/j.1600-6143.2012.04162.x; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Elloso MM, 2003, AM J TRANSPLANT, V3, P562, DOI 10.1034/j.1600-6143.2003.00094.x; Arora S, 2015, AM J TRANSPLANT, V15, P1967, DOI 10.1111/ajt.13214; Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; Khattab Ahmed A, 2007, J Interv Cardiol, V20, P100, DOI 10.1111/j.1540-8183.2007.00243.x; Vervloet MG, 2014, SEMIN NEPHROL, V34, P578, DOI 10.1016/j.semnephrol.2014.09.003	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	OCT	2015	88	4					660	662		10.1038/ki.2015.223		3	Urology & Nephrology	Urology & Nephrology	CS6UY	WOS:000362219600002		
J	Wakino, S; Hasegawa, K; Itoh, H				Wakino, Shu; Hasegawa, Kazuhiro; Itoh, Hiroshi			Sirtuin and metabolic kidney disease	KIDNEY INTERNATIONAL			English	Review						cell signaling; chronic kidney disease; diabetic nephropathy; mitochondria; podocyte; proximal tu bule	SACCHAROMYCES-CEREVISIAE; DIABETIC-NEPHROPATHY; CALORIE RESTRICTION; HISTONE DEACETYLASE; ISCHEMIA-REPERFUSION; LIFE-SPAN; RESVERATROL; INJURY; ACTIVATION; MITOCHONDRIAL	Sirtuin is a nicotinamide adenine dinucleotide-dependent deacetylase. One of its isoforms, Sirt1, is a key molecule in glucose, lipid, and energy metabolism. The renal protective effects of Sirt1 are found in various models of renal disorders with metabolic impairment, such as diabetic nephropathy. Protective effects include the maintenance of glomerular barrier function, anti-fibrosis effects, anti-oxidative stress effects, and regulation of mitochondria function and energy metabolism. Various target molecules subject to direct deacetylation or epigenetic gene regulation have been identified as effectors of the renal protective function of sirtuin. Recently, it was demonstrated that Sirt1 expression decreases in proximal tubules before albuminuria in a mouse model of diabetic nephropathy, and that albuminuria is suppressed in proximal tubule-specific mice overexpressing Sirt1. These findings suggest that decreased Sirt1 expression in proximal tubular cells causes abnormal nicotine metabolism and reduces the supply of nicotinamide mononucleotide from renal tubules to glomeruli. This further decreases expression of Sirt1 in glomerular podocytes and increases expression of a tight junction protein, claudin-1, which results in albuminuria. Activators of the sirtuin family of proteins, including resveratrol, may be important in the development of new therapeutic strategies for treating metabolic kidney diseases, including diabetic nephropathy.	[Wakino, Shu; Hasegawa, Kazuhiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Wakino, S (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	shuwakino@z8.keio.jp					Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; IVY JM, 1986, MOL CELL BIOL, V6, P688; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Vasko R, 2014, J AM SOC NEPHROL, V25, P276, DOI 10.1681/ASN.2013010069; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Zhou X, 2014, HUM MOL GENET, V23, P1644, DOI 10.1093/hmg/ddt556; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Funk JA, 2013, TOXICOL APPL PHARM, V273, P345, DOI 10.1016/j.taap.2013.09.026; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Imai S, 2000, NATURE, V403, P795; Ponnusamy M, 2014, J PHARMACOL EXP THER, V350, P243, DOI 10.1124/jpet.113.212076; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P230; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Ooi A, 2013, CANCER RES, V73, P2044, DOI 10.1158/0008-5472.CAN-12-3227; Tikoo K, 2008, FREE RADICAL RES, V42, P397, DOI 10.1080/10715760801998646; Kim S, 1999, MOL BIOL CELL, V10, P3125; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Khader A, 2014, TRANSPLANTATION, V98, P148, DOI 10.1097/TP.0000000000000194; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Gillum MP, 2011, DIABETES, V60, P3235, DOI 10.2337/db11-0616; Fan H, 2013, KIDNEY INT, V83, P404, DOI 10.1038/ki.2012.394; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Chuang PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023566; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Jung YJ, 2014, J AM SOC NEPHROL; Motonishi S, 2014, J AM SOC NEPHROL; Pan JS, 2014, J AM SOC NEPHROL, V26, P364; Shang GG, 2013, BBA-MOL BASIS DIS, V1832, P674, DOI 10.1016/j.bbadis.2013.01.023	49	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	OCT	2015	88	4					691	698		10.1038/ki.2015.157		8	Urology & Nephrology	Urology & Nephrology	CS6UY	WOS:000362219600010		
J	Hayashi, K; Sasamura, H; Nakamura, M; Sakamaki, Y; Azegami, T; Oguchi, H; Tokuyama, H; Wakino, S; Hayashi, K; Itoh, H				Hayashi, Kaori; Sasamura, Hiroyuki; Nakamura, Mari; Sakamaki, Yusuke; Azegami, Tatsuhiko; Oguchi, Hideyo; Tokuyama, Hirobumi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi			Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria	KIDNEY INTERNATIONAL			English	Article						angiotensin; chronic kidney disease; proteinuria	ACTIVE DNA DEMETHYLATION; GENE-EXPRESSION; CONVERTING ENZYME; TRANSGENIC MICE; KIDNEY-DISEASE; INHIBITION; NEPHRIN; GLOMERULOSCLEROSIS; SYSTEM; MICRODISSECTION	Proteinuria is a central component of chronic kidney disease and an independent risk factor for cardiovascular disease. Kidney podocytes have an essential role as a filtration barrier against proteinuria. Kruppel-like Factor 4 (KLF4) is expressed in podocytes and decreased in glomerular diseases leading to methylation of the nephrin promoter, decreased nephrin expression and proteinuria. Treatment with an angiotensin receptor blocker (ARB) reduced methylation of the nephrin promoter in murine glomeruli of an adriamycin nephropathy model with recovery of KLF4 expression and a decrease in albuminuria. In podocyte-specific KLF4 knockout mice, the effect of ARB on albuminuria and the nephrin promoter methylation was attenuated. In cultured human podocytes, angiotensin II reduced KLF4 expression and caused methylation of the nephrin promoter with decreased nephrin expression. In patients, nephrin promoter methylation was increased in proteinuric kidney diseases with decreased KLF4 and nephrin expression. KLF4 expression in ARB-treated patients was higher in patients with than without ARB treatment. Thus, angiotensin II can modulate epigenetic regulation in podocytes and ARB inhibits these actions in part via KLF4 in proteinuric kidney diseases. This study provides a new concept that renin-angiotensin system blockade can exert therapeutic effects through epigenetic modulation of the kidney gene expression.	[Hayashi, Kaori; Sasamura, Hiroyuki; Nakamura, Mari; Sakamaki, Yusuke; Azegami, Tatsuhiko; Oguchi, Hideyo; Tokuyama, Hirobumi; Wakino, Shu; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan	Hayashi, K (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kaorihayashi@keio.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25860687]; Keio University Research Grants for Life Science and Medicine; Japan Kidney Foundation [JKF14-1]; Banyu Life Science Foundation International; Japan Foundation for Applied Enzymology	This study was supported by Grants for Scientific Research (25860687) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Keio University Research Grants for Life Science and Medicine, a grant from The Japan Kidney Foundation (JKF14-1), Banyu Life Science Foundation International, and a grant from the Japan Foundation for Applied Enzymology.	Silva GC, 2011, J ETHNOPHARMACOL, V137, P709, DOI 10.1016/j.jep.2011.06.031; Lemley KV, 2013, J AM SOC NEPHROL, V24, P1193, DOI 10.1681/ASN.2012111078; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liebau MC, 2006, AM J PHYSIOL-RENAL, V290, pF710, DOI 10.1152/ajprenal.00475.2004; Nicholas SB, 2011, AM J NEPHROL, V33, P1, DOI 10.1159/000327564; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; White KE, 2004, KIDNEY INT, V66, P663, DOI 10.1111/j.1523-1755.2004.00787.x; Sasamura H, 2013, AM J HYPERTENS, V26, P1381, DOI 10.1093/ajh/hpt105; Shimizu-Hirota R, 2004, CIRC RES, V94, P1067, DOI 10.1161/01.RES.0000126049.79800.CA; Hayashi K, 2014, J CLIN INVEST, V124, P2523, DOI 10.1172/JCI69557; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Furness PN, 1999, NEPHROL DIAL TRANSPL, V14, P1234, DOI 10.1093/ndt/14.5.1234; Reddy MA, 2014, KIDNEY INT, V85, P362, DOI 10.1038/ki.2013.387; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Hayashi K, 2010, KIDNEY INT, V78, P69, DOI 10.1038/ki.2010.81; Lo PK, 2009, J MOL DIAGN, V11, P400, DOI 10.2353/jmoldx.2009.080126; Nishiyama A, 2002, HYPERTENSION, V39, P129, DOI 10.1161/hy0102.100536; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Zhong YF, 2013, J AM SOC NEPHROL, V24, P801, DOI 10.1681/ASN.2012060590; Ishiguro K, 2009, HYPERTENSION, V53, P83, DOI 10.1161/HYPERTENSIONAHA.108.122721; Nishiyama A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026610.48842.CB; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Lo YMD, 1999, CANCER RES, V59, P3899; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Kohda Y, 2000, KIDNEY INT, V57, P321, DOI 10.1046/j.1523-1755.2000.00824.x; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988; Krause MW, 2011, KIDNEY INT, V80, P245, DOI 10.1038/ki.2011.142; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; Reddy MA, 2011, J AM SOC NEPHROL, V22, P2182, DOI 10.1681/ASN.2011060629; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; van Kats JP, 2001, KIDNEY INT, V60, P2311, DOI 10.1046/j.1523-1755.2001.00049.x; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Saleem MA, 2002, J AM SOC NEPHROL, V13; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Iwai Masaru, 2011, Biochem Biophys Res Commun, V406, P123, DOI 10.1016/j.bbrc.2011.02.007	46	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	OCT	2015	88	4					745	753		10.1038/ki.2015.178		9	Urology & Nephrology	Urology & Nephrology	CS6UY	WOS:000362219600015		
J	Sakaguchi, Y; Iwatani, H; Hamano, T; Tomida, K; Kawabata, H; Kusunoki, Y; Shimomura, A; Matsui, I; Hayashi, T; Tsubakihara, Y; Isaka, Y; Rakugi, H				Sakaguchi, Yusuke; Iwatani, Hirotsugu; Hamano, Takayuki; Tomida, Kodo; Kawabata, Hiroaki; Kusunoki, Yasuo; Shimomura, Akihiro; Matsui, Isao; Hayashi, Terumasa; Tsubakihara, Yoshiharu; Isaka, Yoshitaka; Rakugi, Hiromi			Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease	KIDNEY INTERNATIONAL			English	Article						chronic kidney disease; hyperphosphatemia; magnesium	PERMEABILITY TRANSITION PORE; RENAL-FUNCTION; SEVELAMER HYDROCHLORIDE; CARDIOVASCULAR-DISEASE; ARTERY CALCIFICATION; MINERAL METABOLISM; DIETARY MAGNESIUM; PHOSPHORUS; CALCIUM; RATS	It is known that magnesium antagonizes phosphate-induced apoptosis of vascular smooth muscle cells and prevents vascular calcification. Here we tested whether magnesium can also counteract other pathological conditions where phosphate toxicity is involved, such as progression of chronic kidney disease (CKD). We explored how the link between the risk of CKD progression and hyperphosphatemia is modified by magnesium status. A post hoc analysis was run in 311 non-diabetic CKD patients who were divided into four groups according to the median values of serum magnesium and phosphate. During a median follow-up of 44 months, 135 patients developed end-stage kidney disease (ESKD). After adjustment for relevant clinical factors, patients in the lower magnesium-higher phosphate group were at a 2.07-fold (95% CI: 1.23-3.48) risk for incident ESKD and had a significantly faster decline in estimated glomerular filtration rate compared with those in the higher magnesium-higher phosphate group. There were no significant differences in the risk of these renal outcomes among the higher magnesium-higher phosphate group and both lower phosphate groups. Incubation of tubular epithelial cells in high phosphate and low magnesium medium in vitro increased apoptosis and the expression levels of profibrotic and proinflammatory cytokine; these changes were significantly suppressed by increasing magnesium concentration. Thus, magnesium may act protectively against phosphate-induced kidney injury.	[Sakaguchi, Yusuke; Iwatani, Hirotsugu; Kawabata, Hiroaki; Kusunoki, Yasuo; Shimomura, Akihiro; Matsui, Isao; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Hamano, Takayuki; Tsubakihara, Yoshiharu] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan; [Tomida, Kodo; Hayashi, Terumasa] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Osaka, Japan	Isaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp					Sim JJ, 2013, AM J MED, V126, P311, DOI 10.1016/j.amjmed.2012.08.018; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Chue CD, 2011, NEPHROL DIAL TRANSPL, V26, P2576, DOI 10.1093/ndt/gfq787; Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Kanbay M, 2012, AM J NEPHROL, V36, P228, DOI 10.1159/000341868; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Nagano N, 2003, NEPHROL DIAL TRANSPL, V18, P2014, DOI 10.1093/ndt/gfg309; O'Seaghdha CM, 2011, NEPHROL DIAL TRANSPL, V26, P2885, DOI 10.1093/ndt/gfq808; Cozzolino M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025782.24383.0D; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Namba T, 2014, J AM SOC NEPHROL, V25, P2254, DOI 10.1681/ASN.2013090986; Aihara K, 2003, KIDNEY INT, V64, P1283, DOI 10.1046/j.1523-1755.2003.00226.x; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Del Gobbo LC, 2013, AM J CLIN NUTR, V98, P160, DOI 10.3945/ajcn.112.053132; Vinals F, 1997, MOL CELL BIOCHEM, V171, P69, DOI 10.1023/A:1006836001489; Mehrotra R, 2013, KIDNEY INT, V84, P989, DOI 10.1038/ki.2013.145; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; GRAFTON G, 1992, DIABETES, V41, P35, DOI 10.2337/diabetes.41.1.35; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175; Sakaguchi Y, 2012, DIABETES CARE, V35, P1591, DOI 10.2337/dc12-0226; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Bellasi A, 2011, CLIN J AM SOC NEPHRO, V6, P883, DOI 10.2215/CJN.07810910; IBELS LS, 1978, NEW ENGL J MED, V298, P122, DOI 10.1056/NEJM197801192980302; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Rodriguez-Moran M, 2003, DIABETES CARE, V26, P1147, DOI 10.2337/diacare.26.4.1147; GIMENEZ LF, 1987, KIDNEY INT, V31, P93, DOI 10.1038/ki.1987.14; Matsuzaki H, 2006, MAGNESIUM RES, V19, P255; Chiu YW, 2010, CLIN J AM SOC NEPHRO, V5, P2093, DOI 10.2215/CJN.03730410; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Lutsey PL, 2014, AM J CLIN NUTR, V100, P756, DOI 10.3945/ajcn.114.085167; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Chartsrisak K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-14; Hruby A, 2014, JACC-CARDIOVASC IMAG, V7, P59, DOI 10.1016/j.jcmg.2013.10.006; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720	41	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	OCT	2015	88	4					833	842		10.1038/ki.2015.165		10	Urology & Nephrology	Urology & Nephrology	CS6UY	WOS:000362219600024		
J	Taguchi, K; Tokuno, M; Yamasaki, K; Kadowaki, D; Seo, H; Otagiri, M				Taguchi, K.; Tokuno, M.; Yamasaki, K.; Kadowaki, D.; Seo, H.; Otagiri, M.			Establishment of a model of acetaminophen-induced hepatotoxicity in different weekly-aged ICR mice	LABORATORY ANIMALS			English	Article						acetaminophen; weekly-age; hepatotoxicology	INDUCED LIVER-INJURY; COVALENT BINDING; SUSCEPTIBILITY; GENDER; PARACETAMOL; METABOLITES; PROTECTION; DEPLETION; OVERDOSE; VOLUME	Acetaminophen (APAP), a widely used analgesic and antipyretic drug, has the potential to cause lethal hepatotoxicity. Mice are widely used for developing murine models of APAP-induced hepatotoxicity, and many researchers have used these models for APAP-related studies including the fields of biology, pharmacology and toxicology. Although drug-induced hepatotoxicity is dependent on a number of factors (species, gender and age), very few studies have investigated the effect of aging on APAP hepatotoxicity. In this study, we evaluated the effect of age on APAP-induced hepatotoxicity in different weekly-aged mice to establish a model of APAP-induced hepatotoxicity that is an accurate reflection of general experimental conditions. Male ICR mice 4, 6, 8, 10 and 12 weeks old were given APAP intraperitoneally, and mortality, hepatic damage and the plasma concentration of APAP metabolites were evaluated. It was found that younger male ICR mice were relatively resistant to hepatotoxicity induced by intraperitoneal APAP administration. In addition, the APAP-glucuronide concentration in plasma remained essentially the same among the differently-aged mice, while APAP-sulfate levels were dramatically decreased in an age-dependent manner. Thus, it is recommended that mice of the same ages be used in studies related to APAP-induced hepatotoxixity. These results provide evidence in support of not only the age-related changes in susceptibility to APAP-derived hepatotoxicity in mice but also in developing mouse models for APAP-related studies.	[Taguchi, K.; Tokuno, M.; Yamasaki, K.; Seo, H.; Otagiri, M.] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8620082, Japan; [Yamasaki, K.; Seo, H.; Otagiri, M.] Sojo Univ, DDS Res Inst, Kumamoto 8620082, Japan; [Kadowaki, D.; Otagiri, M.] Kumamoto Univ, Dept Biopharmaceut, Kumamoto, Japan	Otagiri, M (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8620082, Japan.	otagirim@ph.sojo-u.ac.jp			Sojo University	This work was supported by a research grant from Sojo University.	BEIERSCHMITT WP, 1989, TOXICOL APPL PHARM, V98, P517, DOI 10.1016/0041-008X(89)90180-4; GREEN MD, 1984, TOXICOL APPL PHARM, V74, P116, DOI 10.1016/0041-008X(84)90277-1; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222; Reilly TP, 2001, BIOCHEM BIOPH RES CO, V282, P321, DOI 10.1006/bbrc.2001.4576; Mohar I, 2014, REDOX BIOL, V2, P377, DOI 10.1016/j.redox.2014.01.008; Dai GL, 2006, TOXICOL SCI, V92, P33, DOI 10.1093/toxsci/kfj192; Tanaka R, 2014, MOL PHARMACEUT, V11, P1228, DOI 10.1021/mp400690v; Tarloff JB, 1996, FUND APPL TOXICOL, V30, P13, DOI 10.1006/faat.1996.0038; Bjornsson E, 2006, DIGEST LIVER DIS, V38, P33, DOI 10.1016/j.dld.2005.06.004; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Shimizu D, 2014, PHARMACOL RES, V87, P26, DOI 10.1016/j.phrs.2014.06.003; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; Botta D, 2006, J BIOL CHEM, V281, P28865, DOI 10.1074/jbc.M605143200; ESTEBAN A, 1993, METHOD FIND EXP CLIN, V15, P125; LECOUTEUR D, 1995, INT HEPATOL COMMUN, V3, P244, DOI 10.1016/0928-4346(94)00186-9; Williams CD, 2014, TOXICOL APPL PHARM, V274, P417, DOI 10.1016/j.taap.2013.12.003; ADAMSON GM, 1988, BIOCHEM PHARMACOL, V37, P4183, DOI 10.1016/0006-2952(88)90114-1; Brunner LJ, 1999, J CHROMATOGR B, V732, P323, DOI 10.1016/S0378-4347(99)00290-X; DAVIS DC, 1974, LIFE SCI, V14, P2099, DOI 10.1016/0024-3205(74)90092-7; Matsunaga N, 2004, J PHARMACOL EXP THER, V311, P594, DOI 10.1124/jpet.104.069062; Martin-Murphy BV, 2013, HEPATOLOGY, V57, P1575, DOI 10.1002/hep.26134; HART JG, 1979, BIOCHEM PHARMACOL, V28, P3015, DOI 10.1016/0006-2952(79)90602-6; Masubuchi Y, 2011, TOXICOLOGY, V287, P54, DOI 10.1016/j.tox.2011.05.018; Ryan PM, 2012, CHEM RES TOXICOL, V25, P83, DOI 10.1021/tx2003992; Feng DC, 2014, J IMMUNOL, V193, P2512, DOI 10.4049/jimmunol.1400588; Mitchell SJ, 2011, CURR GERONTOL GERIAT, V2011; Sheng Yuchen, 2013, Drug Discov Ther, V7, P78; Taguchi K, 2014, NAT PROD RES, V28, P2211, DOI 10.1080/14786419.2014.919285; Tomishima Y, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-21	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0023-6772	1758-1117		LAB ANIM-UK	Lab. Anim.	OCT	2015	49	4					294	301		10.1177/0023677215573041		8	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CS2MB	WOS:000361903900004		
J	Nagataki, S; Kasagi, F				Nagataki, Shigenobu; Kasagi, Fumiyoshi			INWORKS study: risk of leukaemia from protracted radiation exposure	LANCET HAEMATOLOGY			English	Letter							NUCLEAR INDUSTRY; WORKERS		[Nagataki, Shigenobu] Nagasaki Univ, Nagasaki 852, Japan; [Nagataki, Shigenobu; Kasagi, Fumiyoshi] Radiat Effects Assoc, Inst Radiat Epidemiol, Tokyo 1010044, Japan	Nagataki, S (reprint author), Nagasaki Univ, Nagasaki 852, Japan.	kasagi@rea.or.jp					Iwasaki T, 2003, RADIAT RES, V159, P228, DOI 10.1667/0033-7587(2003)159[0228:SAOMON]2.0.CO;2; Leuraud K, 2015, LANCET HAEMATOL, V2, pE276, DOI 10.1016/S2352-3026(15)00094-0; Krestinina LY, 2013, BRIT J CANCER, V109, P2886, DOI 10.1038/bjc.2013.614; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2352-3026			LANCET HAEMATOL	Lancet Haematol.	OCT	2015	2	10					E404	E404				1	Hematology	Hematology	CS4VY	WOS:000362075400007		
J	Grant, EJ; Furukawa, K; Sakata, R; Sugiyama, H; Sadakane, A; Takahashi, I; Utada, M; Shimizu, Y; Ozasa, K				Grant, Eric J.; Furukawa, Kyoji; Sakata, Ritsu; Sugiyama, Hiromi; Sadakane, Atsuko; Takahashi, Ikuno; Utada, Mai; Shimizu, Yukiko; Ozasa, Kotaro			Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study	LANCET ONCOLOGY			English	Article							CANCER INCIDENCE; RADIATION; MORTALITY; REGRESSION; DISEASES; RATES	Background No clear epidemiological hereditary effects of radiation exposure in human beings have been reported. However, no previous studies have investigated mortality into middle age in a population whose parents were exposed to substantial amounts of radiation before conception. We assessed mortality in children of the atomic bomb survivors after 62 years of follow-up. Methods In this prospective cohort study, we assessed 75 327 singleton children of atomic bomb survivors in Hiroshima and Nagasaki and unexposed controls, born between 1946 and 1984, and followed up to Dec 31, 2009. Parental gonadal doses of radiation from the atomic bombings were the primary exposures. The primary endpoint was death due to cancer or non-cancer disease, based on death certificates. Findings Median follow-up was 54.3 years (IQR 45.4-59.3). 5183 participants died from disease. The mean age of the 68 689 surviving children at the end of follow-up was 53.1 years (SD 7.9) with 15 623 (23%) older than age 60 years. For parents who were exposed to a non-zero gonadal dose of radiation, the mean dose was 264 mGy (SD 463). We detected no association between maternal gonadal radiation exposure and risk of death caused by cancer (hazard ratio [HR] for 1 Gy change in exposure 0.891 [95% CI 0.693-1.145]; p=0.36) or risk of death caused by non-cancer diseases (0.973 [0.849-1.115]; p=0.69). Likewise, paternal exposure had no effect on deaths caused by cancer (0.815 [0.614-1.083]; p=0.14) or deaths caused by non-cancer disease (1.103 [0.979-1.241]; p=0.12). Age or time between parental exposure and delivery had no effect on risk of death. Interpretation Late effects of ionising radiation exposure include increased mortality risks, and models of the transgenerational effects of radiation exposure predict more genetic disease in the children of people exposed to radiation. However, children of people exposed to the atomic bombs in Hiroshima and Nagasaki had no indications of deleterious health effects after 62 years. Epidemiological studies complemented by sensitive molecular techniques are needed to understand the overall effects of preconception exposure to ionising radiation on human beings.	[Grant, Eric J.; Furukawa, Kyoji; Sakata, Ritsu; Sugiyama, Hiromi; Sadakane, Atsuko; Takahashi, Ikuno; Utada, Mai; Shimizu, Yukiko; Ozasa, Kotaro] Radiat Effects Res Fdn, Minami Ku, Hiroshima 7320815, Japan	Grant, EJ (reprint author), Radiat Effects Res Fdn, Minami Ku, Hiroshima 7320815, Japan.	egrant@rerf.or.jp			Japanese Ministry of Health, Labour and Welfare; US Department of Energy; Department of Energy [DE-HS0000031]; Radiation Effects Research Foundation [4-75]	We thank the participants for their cooperation, without which, this study would have been impossible. We also thank Dale Preston and Roy Shore for their many valuable comments. The Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan is a public interest foundation funded by the Japanese Ministry of Health, Labour and Welfare and the US Department of Energy. The research was also funded in part through Department of Energy award DE-HS0000031 to the National Academy of Sciences. This publication was supported by Radiation Effects Research Foundation Research Protocol 4-75. The views of the authors do not necessarily reflect those of the two governments.	Cologne JB, 2001, HEALTH PHYS, V80, P491, DOI 10.1097/00004032-200105000-00010; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Signorello LB, 2012, J CLIN ONCOL, V30, P239, DOI 10.1200/JCO.2011.37.2938; Izumi S, 2003, INT J CANCER, V107, P292, DOI 10.1002/ijc.11400; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; KODAIRA M, 1995, AM J HUM GENET, V57, P1275; Dubrova YE, 2006, MUTAT RES-FUND MOL M, V602, P74, DOI 10.1016/j.mrfmmm.2006.08.001; NEEL JV, 1974, GENETICS, V76, P311; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; COX DR, 1972, J R STAT SOC B, V34, P187; YOSHIMOTO Y, 1990, JAMA-J AM MED ASSOC, V264, P596, DOI 10.1001/jama.264.5.596; Tawn EJ, 2011, INT J RADIAT BIOL, V87, P330, DOI 10.3109/09553002.2011.530338; Izumi S, 2003, BRIT J CANCER, V89, P1709, DOI 10.1038/sj.bjc.6601322; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; BEEBE GW, 1962, RADIAT RES, V16, P253, DOI 10.2307/3571157; Neel JV, 1998, P NATL ACAD SCI USA, V95, P5432, DOI 10.1073/pnas.95.10.5432; [Anonymous], 2007, ANN ICRP, V37, P1, DOI 10.1016/j.icrp.2007.09.001; Little MP, 2013, MUTAT RES-REV MUTAT, V753, P50, DOI 10.1016/j.mrrev.2013.04.001; Kodaira M, 2010, RADIAT RES, V173, P205, DOI 10.1667/RR1991.1; Ozasa K, 2013, AM J EPIDEMIOL, V177, P569, DOI 10.1093/aje/kws474; Livshits LA, 2001, RADIAT RES, V155, P74, DOI 10.1667/0033-7587(2001)155[0074:COCCWD]2.0.CO;2; Tatsukawa Y, 2013, J RADIOL PROT, V33, P281, DOI 10.1088/0952-4746/33/2/281; YOSHIMOTO Y, 1991, J RADIAT RES, V32, P327, DOI 10.1269/jrr.32.327; Hosmer DW, 2000, APPL LOGISTIC REGRES; National Research Council, 2006, HLTH RISKS EXP LOW L; UN, 2001, HER EFF RAD; UNSCEAR, 2001, SOURC EFF ION RAD; World Health Organization, 1977, INT CLASS DIS; Young RW, 2005, REASSESSMENT ATOMIC	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	OCT	2015	16	13					1316	1323		10.1016/S1470-2045(15)00209-0		8	Oncology	Oncology	CS3BO	WOS:000361946300038		
J	Bruix, J; Takayama, T; Mazzaferro, V; Chau, GY; Yang, JM; Kudo, M; Cai, JQ; Poon, RT; Han, KH; Tak, WY; Lee, HC; Song, TQ; Roayaie, S; Bolondi, L; Lee, KS; Makuuchi, M; Souza, F; Le Berre, MA; Meinhardt, G; Llovet, JM				Bruix, Jordi; Takayama, Tadatoshi; Mazzaferro, Vincenzo; Chau, Gar-Yang; Yang, Jiamei; Kudo, Masatoshi; Cai, Jianqiang; Poon, Ronnie T.; Han, Kwang-Hyub; Tak, Won Young; Lee, Han Chu; Song, Tianqiang; Roayaie, Sasan; Bolondi, Luigi; Lee, Kwan Sik; Makuuchi, Masatoshi; Souza, Fabricio; Le Berre, Marie-Aude; Meinhardt, Gerold; Llovet, Josep M.		STORM Investigators	Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial	LANCET ONCOLOGY			English	Article							CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; RISK-FACTORS; RECURRENCE; PREVENTION; THERAPY; CANCER; ANGIOGENESIS; PERSPECTIVES; MANAGEMENT	Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy and safety of sorafenib versus placebo as adjuvant therapy in patients with hepatocellular carcinoma after surgical resection or local ablation. Methods We undertook this phase 3, double-blind, placebo-controlled study of patients with hepatocellular carcinoma with a complete radiological response after surgical resection (n=900) or local ablation (n=214) in 202 sites (hospitals and research centres) in 28 countries. Patients were randomly assigned (1: 1) to receive 400 mg oral sorafenib or placebo twice a day, for a maximum of 4 years, according to a block randomisation scheme (block size of four) using an interactive voice-response system. Patients were stratified by curative treatment, geography, Child-Pugh status, and recurrence risk. The primary outcome was recurrence-free survival assessed after database cut-off on Nov 29, 2013. We analysed efficacy in the intention-to-treat population and safety in randomly assigned patients receiving at least one study dose. The final analysis is reported. This study is registered with ClinicalTrials.gov, number NCT00692770. Findings We screened 1602 patients between Aug 15, 2008, and Nov 17, 2010, and randomly assigned 1114 patients. Of 556 patients in the sorafenib group, 553 (> 99%) received the study treatment and 471 (85%) terminated treatment. Of 558 patients in the placebo group, 554 (99%) received the study treatment and 447 (80%) terminated treatment. Median duration of treatment and mean daily dose were 12.5 months (IQR 2.6-35.8) and 577 mg per day (SD 212.8) for sorafenib, compared with 22.2 months (8.1-38.8) and 778.0 mg per day (79.8) for placebo. Dose modification was reported for 497 (89%) of 559 patients in the sorafenib group and 206 (38%) of 548 patients in the placebo group. At final analysis, 464 recurrence-free survival events had occurred (270 in the placebo group and 194 in the sorafenib group). Median follow-up for recurrence-free survival was 8.5 months (IQR 2.9-19.5) in the sorafenib group and 8.4 months (2.9-19.8) in the placebo group. We noted no difference in median recurrence-free survival between the two groups (33.3 months in the sorafenib group vs 33.7 months in the placebo group; hazard ratio [HR] 0.940; 95% CI 0.780-1.134; one-sided p=0.26). The most common grade 3 or 4 adverse events were hand-foot skin reaction (154 [28%] of 559 patients in the sorafenib group vs four [<1%] of 548 patients in the placebo group) and diarrhoea (36 [6%] vs five [< 1%] in the placebo group). Sorafenib-related serious adverse events included hand-foot skin reaction (ten [2%]), abnormal hepatic function (four [< 1%]), and fatigue (three [< 1%]). There were four (< 1%) drug-related deaths in the sorafenib group and two (< 1%) in the placebo group. Interpretation Our data indicate that sorafenib is not an effective intervention in the adjuvant setting for hepatocellular carcinoma following resection or ablation.	[Bruix, Jordi; Llovet, Josep M.] Univ Barcelona, BCLC Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBERehd, E-08036 Barcelona, Spain; [Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Itabashi Ku, Tokyo, Japan; [Mazzaferro, Vincenzo] Fdn IRCCS Ist Nazl Tumori, Liver Unit, Hepatooncol Grp, Milan, Italy; [Chau, Gar-Yang] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Jiamei] Eastern Hepatobiliary Hosp, Shanghai, Peoples R China; [Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; [Cai, Jianqiang] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Poon, Ronnie T.] Queen Mary Hosp, Pok Fu Lam, Hong Kong, Peoples R China; [Han, Kwang-Hyub] Severance Hosp, Seoul, South Korea; [Tak, Won Young] Kyungpook Natl Univ, Dept Internal Med, Liver Res Inst, Grad Sch Med, Daegu, South Korea; [Lee, Han Chu] Asan Med Ctr, Seoul, South Korea; [Song, Tianqiang] Tianjin Med Univ, Canc Hosp Huanhuxilu, Tianjin, Peoples R China; [Roayaie, Sasan] Lenox Hill Hosp, Liver Canc Program, Hofstra North Shore LIJ Sch Med, New York, NY 10021 USA; [Bolondi, Luigi] Univ Bologna, Bologna, Italy; [Lee, Kwan Sik] Gangnam Severance Hosp, Seoul, South Korea; [Makuuchi, Masatoshi] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan; [Souza, Fabricio] Bayer HealthCare Pharmaceut, Sao Paulo, Brazil; [Le Berre, Marie-Aude] Bayer HealthCare Pharmaceut, Loos, France; [Meinhardt, Gerold] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Llovet, Josep M.] Mt Sinai Med Ctr, Liver Canc Program, New York, NY 10029 USA	Bruix, J (reprint author), Univ Barcelona, BCLC Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBERehd, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es		Bruix, Jordi/0000-0002-9826-0753	Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals; Bayer HealthCare	STORM was sponsored by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals. Kieran Davey (Complete HealthVizion, Macclesfield, UK) provided medical writing assistance based on detailed discussion and feedback from the authors, funded by Bayer HealthCare.	Bolondi L, 2015, FUTURE ONCOL, V11, P449, DOI 10.2217/fon.14.261; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Chan EY, 2008, LIVER TRANSPLANT, V14, P956, DOI 10.1002/lt.21449; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Gao J, 2012, ASIAN PAC J CANCER P, V13, P743, DOI 10.7314/APJCP.2012.13.3.743; Yoshida H, 2011, HEPATOLOGY, V54, P532, DOI 10.1002/hep.24430; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Lencioni R, 2014, INT J CLIN PRACT, V68, P609, DOI 10.1111/ijcp.12352; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruix J, 2015, J HEPATOL, V62, pS144, DOI 10.1016/j.jhep.2015.02.007; Bruix J, 2015, INT LIV CANC ASS ANN, P248; Colombo M, 2014, BEST PRACT RES CL GA, V28, P771, DOI 10.1016/j.bpg.2014.07.017; Llovet JM, 2012, J HEPATOL, V56, P908; Haas NB, 2015, P AM SOC CLIN ONC S7, V33; Hsu YC, 2015, SEMIN ONCOL, V42, P329, DOI 10.1053/j.seminoncol.2014.12.023; Lu LC, 2014, SEMIN LIVER DIS, V34, P427, DOI 10.1055/s-0034-1394141; Mazzaferro V, 2014, SEMIN LIVER DIS, V34, P415, DOI 10.1055/s-0034-1394365; Okita K, 2015, J GASTROENTEROL, V50, P191, DOI 10.1007/s00535-014-0956-9; Schulz KF, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c332; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Poon RTP, 2000, ANN SURG, V232, P10; Zhuang LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061361	34	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	OCT	2015	16	13					1344	1354		10.1016/S1470-2045(15)00198-9		11	Oncology	Oncology	CS3BO	WOS:000361946300041		
J	Gyawali, B; Shimokata, T; Ando, Y				Gyawali, Bishal; Shimokata, Tomoya; Ando, Yuichi			Discordance between the results and conclusions of ICON7	LANCET ONCOLOGY			English	Letter							PHASE-III TRIAL; RECURRENT OVARIAN-CANCER; OPEN-LABEL; EPITHELIAL OVARIAN; PRIMARY PERITONEAL; FALLOPIAN-TUBE; BEVACIZUMAB; CHEMOTHERAPY; CARBOPLATIN; PACLITAXEL		[Gyawali, Bishal; Shimokata, Tomoya; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Showa Ku, Nagoya, Aichi 4668550, Japan	Gyawali, B (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Showa Ku, Nagoya, Aichi 4668550, Japan.	bg.bishalgyawali@gmail.com					Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; [Anonymous], 2015, GYNECOL ONCOL S1; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Witteveen P, 2013, EUR J CANCER, V49, pS3	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	OCT	2015	16	13					E478	E478				1	Oncology	Oncology	CS3BO	WOS:000361946300001		
J	Ohtaki, M; Tonda, T; Aihara, K				Ohtaki, Megu; Tonda, Tetsuji; Aihara, Kazuyuki			A two-phase Poisson process model and its application to analysis of cancer mortality among A-bomb survivors	MATHEMATICAL BIOSCIENCES			English	Article						Excess hazard ratio; Latency of cancer; Multistage model; Poisson process; Radiation carcinogenesis; Single point exposure	MULTISTAGE CARCINOGENESIS; GENOMIC INSTABILITY; AGE DISTRIBUTION; FRAILTY MODEL; EXPOSURE; TIME; EPIDEMIOLOGY; HALLMARKS; ARMITAGE; TUMORS	We consider a two-phase Poisson process model where only early successive transitions are assumed to be sensitive to exposure. In the case where intensity transitions are low, we derive analytically an approximate formula for the distribution of time to event for the excess hazard ratio (EHR) due to a single point exposure. The formula for EHR is a polynomial in exposure dose. Since the formula for EHR contains no unknown parameters except for the number of total stages, number of exposure-sensitive stages, and a coefficient of exposure effect, it is applicable easily under a variety of situations where there exists a possible latency time from a single point exposure to occurrence of event. Based on the multistage hypothesis of cancer, we formulate a radiation carcinogenesis model in which only some early consecutive stages of the process are sensitive to exposure, whereas later stages are not affected. An illustrative analysis using the proposed model is given for cancer mortality among A-bomb survivors. (C) 2015 Elsevier Inc. All rights reserved.	[Ohtaki, Megu] Hiroshima Univ, Dept Environmetr & Biometr, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348551, Japan; [Tonda, Tetsuji] Prefectural Univ Hiroshima, Fac Management & Informat Syst, Dept Management Informat Syst, Minami Ku, Hiroshima 7348558, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Ohtaki, M (reprint author), Hiroshima Univ, Dept Environmetr & Biometr, Res Inst Radiat Biol & Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	ohtaki@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24249039]; Aihara Project, the FIRST program from JSPS; CSTP; CREST, JST; Japanese Ministry of Health, Labor and Welfare (MHLW); U.S. Department of Energy (DOE) [DE-HS0000031]	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology, Scientific Research (A) #24249039 (2012-2014), and by the Aihara Project, the FIRST program from JSPS, initiated by CSTP, and CREST, JST.; This report makes use of data obtained from the Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan. RERF is a private, non-profit foundation funded by the Japanese Ministry of Health, Labor and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. The conclusions in this report are those of the authors and do not necessarily reflect the scientific judgment of RERF or its funding agencies. The authors would like to thank the editor and referees for their constructive comments on the earlier version of this paper.	Akaike H., 1992, 2 INT S INF THEOR, V1, P610; Akaike H., 1973, P 2 INT S INF THEOR, P267; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Pierce DA, 2003, BIOSTATISTICS, V4, P231, DOI 10.1093/biostatistics/4.2.231; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Doi M, 2011, AM J EPIDEMIOL, V173, P659, DOI 10.1093/aje/kwq426; Pierce DA, 1996, RADIAT RES, V146, P1, DOI 10.2307/3579391; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; CHIANG CL, 1979, MATH BIOSCI, V43, P159, DOI 10.1016/0025-5564(79)90045-2; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; DAY NE, 1983, CANCER SURV, V2, P577; Izumi S, 2004, ENVIRONMETRICS, V15, P209, DOI 10.1002/env.635; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; Travis LB, 2006, CANCER EPIDEM BIOMAR, V15, P2020, DOI 10.1158/1055-9965.EPI-06-0414; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Ohtaki M, 2001, RADIAT RES, V156, P672, DOI 10.1667/0033-7587(2001)156[0672:AMMORC]2.0.CO;2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; WHITTEMORE AS, 1977, AM J EPIDEMIOL, V106, P418; NOMURA T, 1982, NATURE, V296, P575, DOI 10.1038/296575a0; Aalen OO, 1999, CANCER CAUSE CONTROL, V10, P285, DOI 10.1023/A:1008916718152; Kai M, 1997, RADIAT RES, V148, P348, DOI 10.2307/3579520; OHTAKI M, 1985, JPN J CLIN ONCOL, V15, P325; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Izumi S, 2007, BIOMETRICAL J, V49, P539, DOI 10.1002/bimj.200510336; Muller HJ, 1951, SCIENCE PROGR, V7, P93; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Ohtaki M., 1981, J JPN STAT SOC, V11, P111; Shimizu Y., 1991, J RAD RES S2, pS54; STOCKS P, 1953, BRIT J CANCER, V7, P407, DOI 10.1038/bjc.1953.39; Turner H., 2007, R NEWS, V7, P8	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-5564	1879-3134		MATH BIOSCI	Math. Biosci.	OCT	2015	268						31	37		10.1016/j.mbs.2015.07.004		7	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CS5QK	WOS:000362132800004		
J	Sumitani, M; Misaki, M; Kumagaya, S; Yozu, A; Otake, Y; Osumi, M; Miyauchi, S				Sumitani, Masahiko; Misaki, Masaya; Kumagaya, Shin-ichiro; Yozu, Arito; Otake, Yuko; Osumi, Michihiro; Miyauchi, Satoru			Internally-represented space and its mirror-reversed image of the visuospatial representation: A possible association	MEDICAL HYPOTHESES			English	Article							PAIN SYNDROME CRPS; VESTIBULAR STIMULATION; PARIETAL CORTEX; PERCEPTION; NEGLECT; NUMBER; BRAIN; HEMINEGLECT; HUMANS	The cognitive capacity for number representation is thought to be a functional isomorphism of space representation. Numbers are represented in a left-to-right-oriented mental number line and hemispatial neglect patients consistently demonstrate rightward midline shift of visuospace, the internal space and number representation. However, patients with pathologic pain in one limb showed a negative correlation between midline shift of the visuospace and number representation. The purpose of the present study is to ascertain whether such dissociation in accessing space and number representation is observed in another neuropathic pain condition, and then to propose a theoretical model regarding an intimate relationship between visuospace and internal space representations. Using patients with deafferentation pain caused by a nerve lesion in a limb, we investigated whether number representation is closely linked to space representation by evaluating visual subjective body-midline judgments in dark and light conditions (egocentric- and allocentric-spaces, respectively). We also used a number-interval-bisection task to analyze this question. All of the patients perceived allocentric-space accurately. Respective patients showed perceptual shifts in egocentric-space and number representation, however they did not demonstrate any trend of the shifted-direction. Direct comparison revealed that number representation is negatively correlated with not allocentric-space but egocentric-space: a leftward midline-shift of egocentric-space was linked with a rightward midline-shift of number bisection, and vice-versa. Internally-represented space demonstrated a mirror-reversed image of the visuospatial representation, similar to our previous finding. To explain the inverted representation, we can propose a theoretical model that spacing between mentally-aligned numbers in a left-to-right sequential line is anisometric. (C) 2015 Elsevier Ltd. All rights reserved.	[Sumitani, Masahiko] Tokyo Univ Hosp, Dept Pain & Palliat Med, Tokyo 113, Japan; [Misaki, Masaya; Miyauchi, Satoru] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Kobe, Hyogo, Japan; [Kumagaya, Shin-ichiro] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Yozu, Arito; Otake, Yuko] Tokyo Univ Hosp, Dept Rehabil Med, Tokyo 113, Japan; [Osumi, Michihiro] Kio Univ, Neurorehabilitat Res Ctr, Nara, Japan	Sumitani, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sumitanim-ane@h.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture [25462425, 24119006]	This study has been partially funded by the Ministry of Education, Science, Sports and Culture (Grant-in-Aid for Scientific Research (C) #25462425 to Sumitani M. and Innovative Areas "Constructive Developmental Science" #24119006 to Kumagaya S.).	Ricci R, 2004, EXP BRAIN RES, V154, P226, DOI 10.1007/s00221-003-1650-y; Savazzi S, 2007, BRAIN, V130, P2070, DOI 10.1093/brain/awm143; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; RODE G, 1994, NEUROREPORT, V5, P869, DOI 10.1097/00001756-199404000-00004; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.neuro.18.1.19; Pisella L, 2006, CURR OPIN NEUROL, V19, P534, DOI 10.1097/WCO.0b013e328010924b; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; BISIACH E, 1981, NEUROPSYCHOLOGIA, V19, P543, DOI 10.1016/0028-3932(81)90020-8; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; VENTRE J, 1984, NEUROPSYCHOLOGIA, V22, P797, DOI 10.1016/0028-3932(84)90104-0; KARNATH HO, 1994, EXP BRAIN RES, V101, P140; Uematsu H, 2009, ANN ACAD MED SINGAP, V38, P931; Sumitani M, 2007, NEUROLOGY, V68, P152, DOI 10.1212/01.wnl.0000250335.56958.f0; Galton E., 1880, NATURE, V21, P252; Kamath HO, 1997, PHILOS T R SOC LON B, V352, P1401; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; Sumitani M, 2014, BRAIN COGNITION, V90, P151, DOI 10.1016/j.bandc.2014.07.001	19	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2015	85	4					500	505		10.1016/j.mehy.2015.06.035		6	Medicine, Research & Experimental	Research & Experimental Medicine	CS1WY	WOS:000361860800024		
J	Fukuda, K				Fukuda, K.			Integrated theory to unify status among schizophrenia and manic depressive illness	MEDICAL HYPOTHESES			English	Article							TPH1 A218C POLYMORPHISM; BIPOLAR-I-DISORDER; TRYPTOPHAN-HYDROXYLASE; MAJOR DEPRESSION; LIFE EVENTS; L-DOPA; SEROTONIN; TETRAHYDROBIOPTERIN; MOOD; METAANALYSIS	Tryptophan hydroxylase 1 is primarily expressed in the gastrointestinal tract, and has been associated with both schizophrenia and depression. Although decreased serotonin activity has been reported in both depression and mania, it is important to investigate the interaction between serotonin and other neurotransmitter systems. There are competitive relationships between branched-chain amino acids, and tryptophan and tyrosine that relate to physical activity, and between L-3,4-dihydroxyphenylalanine (L-DOPA) and 5-hydroxytryptophan (5-HTP), both highly dependent on intracellular tetrahydrobiopterin concentrations. Here, I propose a chaos theory for schizophrenia, mania, and depression using the competitive interaction between tryptophan and tyrosine with regard to the blood-brain barrier and coenzyme tetrahydrobiopterin. Mania may be due to the initial conditions of physical hyperactivity and hypofunctional 5-HTP-producing cells inducing increased dopamine. Depression may be due to the initial conditions of physical hypoactivity and hypofunctional 5-HTP-producing cells inducing decreased serotonin. Psychomotor excitation may be due to the initial conditions of physical hyperactivity and hyperfunctional 5-HTP-producing cells inducing increased serotonin and substantially increased dopamine. The hallucinatory-paranoid state may be due to the initial conditions of physical hypoactivity and hyperfunctional 5-HTP-producing cells inducing increased serotonin and dopamine. (C) 2015 Elsevier Ltd. All rights reserved.	Soka Clin Psychosomat Med, Soka, Saitama 3400015, Japan	Fukuda, K (reprint author), Soka Clin Psychosomat Med, Fujimoto Bld 4F,2-18-16 Takasago, Soka, Saitama 3400015, Japan.	katsu853@theia.ocn.ne.jp					Andre K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-118; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Zaboli G, 2006, BIOL PSYCHIAT, V60, P563, DOI 10.1016/j.biopsych.2006.03.033; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Johnson SL, 2008, J ABNORM PSYCHOL, V117, P268, DOI 10.1037/0021-843X.117.2.268; Richardson MA, 2005, NEUROPSYCHOBIOLOGY, V52, P190, DOI 10.1159/000089002; Munk-Olsen T, 2009, ARCH GEN PSYCHIAT, V66, P189, DOI 10.1001/archgenpsychiatry.2008.528; Koszewska I, 2009, NEUROPSYCHOBIOLOGY, V59, P12, DOI 10.1159/000202824; Breier A, 1998, SYNAPSE, V29, P142, DOI 10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7; Sumi-Ichinose C, 2001, J BIOL CHEM, V276, P41150, DOI 10.1074/jbc.M102237200; Dias RS, 2011, AM J PSYCHIAT, V168, P386, DOI 10.1176/appi.ajp.2010.09121816; Riddell DR, 1999, VITAM HORM, V57, P25; Guillemin GJ, 2000, REDOX REP, V5, P108, DOI 10.1179/135100000101535375; HARSCH HH, 1985, J CLIN PSYCHOPHARM, V5, P338; MATHEW MRK, 1994, J AFFECT DISORDERS, V32, P157, DOI 10.1016/0165-0327(94)90013-2; Nagatsu T, 1999, MOL NEUROBIOL, V19, P79, DOI 10.1007/BF02741379; Chen DY, 2012, J AFFECT DISORDERS, V138, P27, DOI 10.1016/j.jad.2011.04.018; Viikki M, 2010, NEUROSCI LETT, V468, P80, DOI 10.1016/j.neulet.2009.10.069; Nakamura K, 2008, AM J PATHOL, V172, P333, DOI 10.2353/ajpath.2008.070358; Correll CU, 2014, BIPOLAR DISORD, V16, P478, DOI 10.1111/bdi.12194; Vasquez-Vivar J, 2003, FREE RADICAL RES, V37, P121, DOI 10.1080/1071576021000040655; Meyer T, 1999, DIGESTION, V60, P63, DOI 10.1159/000007590; SILVERSTONE T, 1985, J AFFECT DISORDERS, V8, P225, DOI 10.1016/0165-0327(85)90020-5; Arias B, 2013, NEUROPSYCHOBIOLOGY, V67, P41, DOI 10.1159/000343388; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Farkas E, 1998, BRAIN RES, V792, P179, DOI 10.1016/S0006-8993(98)00029-8; Scarna A, 2003, BRIT J PSYCHIAT, V182, P210, DOI 10.1192/bjp.182.3.210; MCINNES RR, 1984, J CLIN INVEST, V73, P458, DOI 10.1172/JCI111232; Pearce RKB, 2001, PSYCHOPHARMACOLOGY, V156, P402; Shiah IS, 2000, BIPOLAR DISORD, V2, P77, DOI 10.1034/j.1399-5618.2000.020201.x; Blau N, 2009, J INHERIT METAB DIS, V32, P1, DOI 10.1007/s10545-009-9967-8; Saetre P, 2010, AM J MED GENET B, V153B, P387, DOI 10.1002/ajmg.b.30991; Otto MW, 2007, J CLIN PSYCHIAT, V68, P669; Payne JL, 2007, J AFFECT DISORDERS, V99, P221, DOI 10.1016/j.jad.2006.08.013; Gurrera RJ, 1999, AM J PSYCHIAT, V156, P169; Leucht S, 2011, BRIT J PSYCHIAT, V199, P269, DOI 10.1192/bjp.bp.111.095323; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Craft LL, 1998, J SPORT EXERCISE PSY, V20, P339; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Kim DR, 2011, CURR PSYCHIAT REP, V13, P500, DOI 10.1007/s11920-011-0233-z; HASHIGUTI H, 1993, J NEURAL TRANSM-GEN, V93, P213, DOI 10.1007/BF01244998; MELTZER HY, 1984, ARCH GEN PSYCHIAT, V41, P366; Cookson JC, 2008, ADV PSYCHIAT TREAT, V14, P17; Fernstrom J. D., 2005, J NUTR, V135, P1539; Fukuda K, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0372-y; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; HASHIMOTO R, 1990, BIOL PSYCHIAT, V28, P526, DOI 10.1016/0006-3223(90)90487-M; Jendzjowsky NG, 2014, PHYSL REP, V2; Kamińska Teresa, 2003, Med Sci Monit, V9, pCS71; Mary KK, 2011, OXIDATIVE STRESS FRE, P225; Okusaga O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085945; Pukuda K, 2013, MED HYPOTHESES, V82, P20	53	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2015	85	4					506	511		10.1016/j.mehy.2015.06.012		6	Medicine, Research & Experimental	Research & Experimental Medicine	CS1WY	WOS:000361860800025		
J	Miyata, Y; Asai, A; Mitsunari, K; Matsuo, T; Ohba, K; Sakai, H				Miyata, Yasuyoshi; Asai, Akihiro; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki			Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer	MEDICAL ONCOLOGY			English	Article						Urothelial cancer; Paclitaxel; Gemcitabine; Sorafenib; QoL; Pain relief	METASTATIC BLADDER-CANCER; TARGETED THERAPIES; PROGNOSTIC-FACTORS; PHASE-II; CARCINOMA; MULTICENTER; RECURRENCE; INHIBITOR; SURVIVAL; TRIAL	Various regimens including molecular targeted agents have been examined in patients with cisplatin (CDDP)-resistant urothelial cancer (UC). However, some studies have been stopped owing to the development of severe adverse events. The main aim of this study was to examine the anticancer effects, changes in the quality of life (QoL), and safety of combined therapy of low-dose gemcitabine, paclitaxel, and sorafenib (LD-GPS) in patients with CDDP-resistant UC. Twenty patients were treated with gemcitabine (700 mg/m(2) on day 1), paclitaxel (70 mg/m(2) on day 1), and sorafenib (400 mg/day on days 8-22). QoL and pain relief were evaluated using the short-form survey (SF)-36 for bodily pain and the visual analog scale (VAS). VAS scores were significantly decreased by both the second- and third-line therapies (P = 0.012 and 0.028, respectively). The bodily pain score from the SF-36 survey was also significantly (P = 0.012) decreased. Complete responses, partial responses, and stable disease were found in 0 (0.0 %), 1 (5.0 %), and 13 patients (65 %), respectively. The median (interquartile range) period of overall survival after starting of this therapy was 7 (5-11) months. Three patients (15.0 %) stopped therapy because of grade 3 fatigue and hand foot reactions. LD-GPS therapy was well tolerated by patients with CDDP-resistant UC. QoL was maintained, and improvements in their pain levels were found after treatment; pain relief was detected after third-line therapy. We suggest that this treatment regimen is worthy of consideration as second- and thirdline therapy for patients with CDDP-resistant UC.	[Miyata, Yasuyoshi; Asai, Akihiro; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki] Nagasaki Univ, Dept Urol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Miyata, Yasuyoshi; Asai, Akihiro; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 8528501, Japan	Miyata, Y (reprint author), Nagasaki Univ, Dept Urol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	int.doc.miya@m3.dion.ne.jp			Japan Society for the Promotion of Science [25462487]	This study is supported in part by a Grant-in-Aid from Japan Society for the Promotion of Science (No. 25462487).	Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Rose A, 2010, BRIT J PHARMACOL, V160, P1690, DOI 10.1111/j.1476-5381.2010.00838.x; Sternberg CN, 2000, SEMIN ONCOL, V27, P31; Knievel J, 2014, INT J MOL SCI, V15, P20500, DOI 10.3390/ijms151120500; Grandinetti CA, 2007, PHARMACOTHERAPY, V27, P1125, DOI 10.1592/phco.27.8.1125; von der Maase H, 2000, J CLIN ONCOL, V18, P3068; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Miyata Y, 2012, CANCER CHEMOTH PHARM, V70, P451, DOI 10.1007/s00280-012-1938-3; Sridhar SS, 2011, INVEST NEW DRUG, V29, P1045, DOI 10.1007/s10637-010-9408-4; Dreicer R, 2009, CANCER, V115, P4090, DOI 10.1002/cncr.24467; Ploeg M, 2011, CLIN GENITOURIN CANC, V9, P14, DOI 10.1016/j.clgc.2011.05.004; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ghosh M, 2014, CURR OPIN ONCOL, V26, P305, DOI 10.1097/CCO.0000000000000064; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Sio TT, 2014, INT J UROL, V21, P630, DOI 10.1111/iju.12407; Deng LF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-363; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Harn NM, 2011, J CLIN ONCOL, V29, P1525; Krege S, 2014, BJU INT, V113, P429, DOI 10.1111/bju.12437; Philips GK, 2008, BJU INT, V101, P20, DOI 10.1111/j.1464-410X.2007.07226.x; Pla FA, 2014, BMC CANCER, V14, P939	21	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	OCT	2015	32	10							235	10.1007/s12032-015-0683-y		7	Oncology	Oncology	CS2LM	WOS:000361902400005		
J	Usui, M; Shirakawa, T; Fukuda, A; Tamura, Y				Usui, Masaru; Shirakawa, Takahiro; Fukuda, Akira; Tamura, Yutaka			The Role of Flies in Disseminating Plasmids with Antimicrobial-Resistance Genes Between Farms	MICROBIAL DRUG RESISTANCE			English	Article							ESCHERICHIA-COLI; BACTERIA; EPIDEMIOLOGY; DETERMINANTS	Dissemination of antimicrobial resistance is a major global public health concern. To clarify the role of flies in disseminating antimicrobial resistance between farms, we isolated and characterized tetracycline-resistant Escherichia coli strains isolated from flies and feces of livestock from four locations housing swine (abattoir, three farms) and three cattle farms. The percentages of isolates from flies resistant to tetracycline, dihydrostreptomycin, ampicillin, and chloramphenicol (80.8%, 61.5%, 53.8%, and 50.0%, respectively) and those from animal feces (80.5%, 78.0%, 41.5%, and 46.3%, respectively) in locations housing swine were significantly higher than those from cattle farms (p<0.05). The rates of resistance in E. coli derived from flies reflected those derived from livestock feces at the same locations, suggesting that antimicrobial resistance spreads between livestock and flies on the farms. The results of pulsed-field gel electrophoresis (PFGE) analysis showed that, with a few exceptions, all E. coli isolates differed. Two pairs of tetracycline-resistant strains harbored similar plasmids with the same tetracycline-resistance genes, although the origin (fly or feces), site of isolation, and PFGE patterns of these strains differed. Therefore, flies may disseminate the plasmids between farms. Our results suggest that flies may be involved not only in spreading clones of antimicrobial-resistant bacteria within a farm but also in the widespread dissemination of plasmids with antimicrobial resistance genes between farms.	[Usui, Masaru; Shirakawa, Takahiro; Fukuda, Akira; Tamura, Yutaka] Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido 0698501, Japan	Tamura, Y (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, 582 Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	tamuray@rakuno.ac.jp			MEXT; MEXT KAKENHI [24590754]	We thank the staff of the Prefectural Livestock Hygiene Service Center (Northern Okinawa, Japan) for identifying the farms. This study was partially supported by a MEXT-supported program of the strategic research foundation at private universities and MEXT KAKENHI Grant No. 24590754.	Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Akhtar M, 2009, MICROB ECOL, V58, P509, DOI 10.1007/s00248-009-9533-9; Macovei L, 2006, APPL ENVIRON MICROB, V72, P4028, DOI 10.1128/AEM.00034-06; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; Zurek L, 2014, APPL ENVIRON MICROB, V80, P3562, DOI 10.1128/AEM.00600-14; Forster M, 2007, PARASITOL RES, V101, P243, DOI 10.1007/s00436-007-0522-y; Roberts MC, 1996, FEMS MICROBIOL REV, V19, P1; Jun LJ, 2004, AQUACULTURE, V240, P89, DOI 10.1016/j.aquaculture.2004.07.025; Kim SR, 2004, FEMS MICROBIOL LETT, V237, P147, DOI 10.1016/j.femsle.2004.06.026; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; Schwaiger K, 2010, VET MICROBIOL, V142, P329, DOI 10.1016/j.vetmic.2009.09.066; [Anonymous], 1969, REPORT JOINT COMMITT; KADO CI, 1981, J BACTERIOL, V145, P1365; Usui M, 2012, JPN J INFECT DIS, V65, P252; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Petridis M, 2006, J MED ENTOMOL, V43, P288, DOI 10.1603/0022-2585(2006)043[0288:HTOSTA]2.0.CO;2; Binh CTT, 2008, FEMS MICROBIOL ECOL, V66, P25, DOI 10.1111/j.1574-6941.2008.00526.x; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242; Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13; Centers for Disease Control and Prevention, 2004, PULSENET PFGE MAN; Clinical Laboratory Standards Institute, 2008, M31A3 CLSI; Koo HJ, 2011, INT J FOOD MICROBIOL, V145, P407, DOI 10.1016/j.ijfoodmicro.2011.01.003; Ministry of Agriculture Forestry and Fisheries [MAFF], 2012, SAL AM MED QUAS MED; National Veterinary Assay Laboratory Ministry of Agriculture Forestry and Fisheries, 2012, REP JAP VET ANT RES; Radhouani H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00023; Sambrook J, 2001, MOL CLONING LAB MANU; Usui M, 2013, MICROB DRUG RESIST, V15, P415, DOI DOI 10.1089/MDR.2012.0251; Von Salviati C., 2015, VET MICROBIOL, V30, P77	29	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1076-6294	1931-8448		MICROB DRUG RESIST	Microb. Drug Resist.	OCT 1	2015	21	5					562	569		10.1089/mdr.2015.0033		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	CS6IE	WOS:000362181200010		
J	Miura, T; Niswati, A; Swibawa, IG; Haryani, S; Gunito, H; Shimano, S; Fujie, K; Kaneko, N				Miura, Toshiko; Niswati, Ainin; Swibawa, I. G.; Haryani, Sri; Gunito, Heru; Shimano, Satoshi; Fujie, Koichi; Kaneko, Nobuhiro			Diversity of Fungi on Decomposing Leaf Litter in a Sugarcane Plantation and Their Response to Tillage Practice and Bagasse Mulching: Implications for Management Effects on Litter Decomposition	MICROBIAL ECOLOGY			English	Article						Fungi; Internal transcribed spacer region; Next-generation sequencing; Residue management; Nutrient cycling	SOIL ORGANIC-MATTER; MYCORRHIZAL FUNGI; NO-TILLAGE; CROPPING SYSTEMS; LAND MANAGEMENT; CARBON STOCKS; COMMUNITIES; FOREST; BRAZIL; MAIZE	To minimize the degradation of soil organic matter (SOM) content in conventional sugarcane cropping, it is important to understand how the fungal community contributes to SOM dynamics during the decomposition of sugarcane leaf litter. However, our knowledge of fungal diversity in tropical agroecosystems is currently limited. Thus, we determined the fungal community structure on decomposing sugarcane leaf litter and their response to different soil management systems using the internal transcribed spacer region 1 (ITS1) amplicon sequencing method afforded by Ion Torrent Personal Genome Machine (PGM). The results indicate that no-tillage had positive effects on the relative abundance of Zygomycota and of some taxa that may prefer a moist environment over conventional tillage, whereas bagasse mulching decreased the richness of operational taxonomic units (OTUs) and had positive effect on the relative abundance of slow-growing taxa, which may prefer poor nutrient substrates. Furthermore, a combination of no-tillage and bagasse mulching increased the abundance of unique OTUs. We suggest that the alteration of fungal communities through the changes in soil management practices produces an effect on litter decomposition.	[Miura, Toshiko; Fujie, Koichi; Kaneko, Nobuhiro] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Niswati, Ainin] Univ Lampung, Dept Soil Sci, Bandar Lampung, Indonesia; [Swibawa, I. G.] Univ Lampung, Dept Plant Pest & Dis, Bandar Lampung, Indonesia; [Haryani, Sri; Gunito, Heru] PT Gunung Madu Plantat, Div Res & Dev, Sumatra, Indonesia; [Shimano, Satoshi] Miyagi Univ Educ, Environm Educ Ctr, Sendai, Miyagi, Japan	Miura, T (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	toshikom@ynu.ac.jp	Miura, Toshiko/F-7627-2013	Miura, Toshiko/0000-0002-3092-4496	Asian Viewpoints [E03]; YNU International Environmental Leaders Program in Sustainable Living with Environmental Risk - Promoting Science and Technology System Reform of the Promotion of Science and Technology, Japan; Yokohama National University; MEXT KAKENHI [25220104]	Our study was supported in part by a Grant-in-Aid for the Global COE Program E03 for Global Eco-Risk Management from Asian Viewpoints; the YNU International Environmental Leaders Program in Sustainable Living with Environmental Risk funded by Promoting Science and Technology System Reform of the Promotion of Science and Technology, Japan; and a grant from Yokohama National University and MEXT KAKENHI Grant Number 25220104. We thank the staff at the Gunung Madu Plantations for permitting this study and supporting the field experiment, Prof. John Hendri and Prof. Andi Setiawan in the Department of Chemistry FMIPA at the University of Lampung, and Dr. Udin Hasanuddin in the Department of Agroindustrial Technology, Faculty of Agriculture at the University of Lampung for supporting the field and laboratory experiments. We are also grateful to Dr. T. Nakamori at the Graduate School of Environment and Information Sciences, Yokohama National University, for helpful conversations regarding sequencing analysis. The data parsing processes were performed using the super computer system provided by the National Institute of Genetics (NIG), Japan.	Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Magyar D, 2011, MYCOL PROG, V10, P307, DOI 10.1007/s11557-010-0703-4; Kivlin SN, 2011, NEW PHYTOL, V189, P526, DOI 10.1111/j.1469-8137.2010.03494.x; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Cai L, 2006, MYCOL RES, V110, P137, DOI 10.1016/j.mycres.2005.09.014; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Niwa S, 2008, SOIL BIOL BIOCHEM, V40, P699, DOI 10.1016/j.soilbio.2007.10.004; Dominy CS, 2002, BIOL FERT SOILS, V36, P298, DOI 10.1007/s00374-002-0542-9; TAJA H, 1991, TROP AGR, V68, P111; Jimenez JJ, 2006, CRIT REV PLANT SCI, V25, P337, DOI 10.1080/0735268060094240; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Miller AN, 2004, MYCOLOGIA, V96, P1106, DOI 10.2307/3762093; Neubert K, 2006, APPL ENVIRON MICROB, V72, P1118, DOI 10.1128/AEM.72.2.1118-1128.2006; Herrera J, 2010, MYCOLOGIA, V102, P1012, DOI 10.3852/09-264; Germain H, 2002, CAN J PLANT PATHOL, V24, P194; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Chandel AK, 2012, J CHEM TECHNOL BIOT, V87, P11, DOI 10.1002/jctb.2742; van Elsas JD, 2011, EUR J SOIL BIOL, V47, P77, DOI 10.1016/j.ejsobi.2010.11.010; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Neto MS, 2010, SOIL TILL RES, V110, P187, DOI 10.1016/j.still.2010.07.010; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Stirling GR, 2010, APPL SOIL ECOL, V46, P470, DOI 10.1016/j.apsoil.2010.08.015; Galdos MV, 2009, GEODERMA, V153, P347, DOI 10.1016/j.geoderma.2009.08.025; Sommer J, 2012, AM J BOT, V99, P1133, DOI 10.3732/ajb.1100575; Rajulu MBG, 2014, MYCOL PROG, V13, P1049, DOI 10.1007/s11557-014-0992-0; Hollister EB, 2010, SOIL BIOL BIOCHEM, V42, P1816, DOI 10.1016/j.soilbio.2010.06.022; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; Zeng HL, 2014, SOIL BIOL BIOCHEM, V75, P254, DOI 10.1016/j.soilbio.2014.04.024; Deacon LJ, 2006, SOIL BIOL BIOCHEM, V38, P7, DOI 10.1016/j.soilbio.2005.04.013; Zifcakova L, 2012, FUNGAL ECOL, V5, P481, DOI 10.1016/j.funeco.2012.05.001; Scopel E, 2005, AGRON SUSTAIN DEV, V25, P425, DOI 10.1051/argo:2005041; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; NAKASONE KK, 1984, MYCOLOGIA, V76, P40, DOI 10.2307/3792834; Davis EC, 2008, AM J BOT, V95, P914, DOI 10.3732/ajb.2006463; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Shrestha P, 2011, APPL ENVIRON MICROB, V77, P5490, DOI 10.1128/AEM.02996-10; Luangsa-Ard JJ, 2011, FUNGAL BIOL-UK, V115, P608, DOI 10.1016/j.funbio.2011.03.002; Nakasone KK, 2007, CAN J BOT, V85, P420, DOI 10.1139/B07-035; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Jimenez DJ, 2014, APPL MICROBIOL BIOT, V98, P2789, DOI 10.1007/s00253-013-5253-7; Kjoller AH, 2002, BOOK SOIL P, P267; Arhipova N, 2012, SCAND J FOREST RES, V27, P327, DOI 10.1080/02827581.2012.670727; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; Machado PLOD, 2001, NUTR CYCL AGROECOSYS, V61, P119; Verkley GJM, 2014, PERSOONIA, V32, P25, DOI 10.3767/003158514X679191; BONDE TA, 1992, SOIL BIOL BIOCHEM, V24, P275, DOI 10.1016/0038-0717(92)90230-U; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Grantina-Ievina L, 2013, APPL MICROBIOL BIOT, V97, P10541, DOI 10.1007/s00253-013-4825-x; Herrera J., 2011, Ecosphere, V2, part50, DOI 10.1890/ES11-00001.1; Conant RT, 2007, SOIL TILL RES, V95, P1, DOI 10.1016/j.still.2006.12.006; Hartemink AE, 1998, GEODERMA, V85, P283, DOI 10.1016/S0016-7061(98)00048-2; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Miura T, 2013, SOIL BIOL BIOCHEM, V58, P27, DOI 10.1016/j.soilbio.2012.10.042; Singh P, 2008, WORLD J MICROB BIOT, V24, P667, DOI 10.1007/s11274-007-9522-4; Morakotkarn D, 2007, FEMS MICROBIOL LETT, V266, P10, DOI 10.1111/j.1574-6968.2006.00489.x; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Couteaux MM, 1991, OIKOS, V61, P54; Driessen P., 2001, LECT NOTES MAJOR SOI; FAO, 2008, FAO AGR SER, V39; FAO, 2014, FAOSTAT ONL STAT SER; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192; Marincowitz S, 2008, CBS BIODIVERSITY SER, V7, P515; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Oliveira SF, 2014, MYCORRHIZA, V24, P55, DOI 10.1007/s00572-013-0512-0; Osher LJ, 2003, BIOGEOCHEMISTRY, V65, P213, DOI 10.1023/A:1026048612540; R Development Core Team, 2009, LANG ENV STAT COMP; Rodrigues A, 2014, J BASIC MICROB, V54, P1186, DOI 10.1002/jobm.201200458; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Stielow B, 2013, MYCOL PROG, V12, P675, DOI 10.1007/s11557-012-0875-1; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863	76	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	OCT	2015	70	3					646	658		10.1007/s00248-015-0620-9		13	Ecology; Marine & Freshwater Biology; Microbiology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	CS3OT	WOS:000361984700006		
J	Hayashi, S; Itoh, K; Suyama, K				Hayashi, Shohei; Itoh, Kazuhito; Suyama, Kousuke			Genes of Bacillus subtilis 168 that Support Growth of the Cyanobacterium, Synechococcus leopoliensis CCAP1405/1 on Agar Media	MICROBIAL ECOLOGY			English	Editorial Material						Bacillus subtilis; Cyanobacteria; Synechococcus; Solid media; Mutual interaction	ACETOIN CATABOLIC PATHWAY; MOLECULAR CHARACTERIZATION; PROCHLOROCOCCUS; DIVERSITY; BACTERIA; STRAINS; GENOME; OPERON	Synechococcus leopoliensis CCAP1405/1 cannot grow on common solid media; however, the strain can grow when co-cultured with Bacillus subtilis 168. Gene-disruptant strains of B. subtilis 168 by pMUTINs at the following sites lost the ability to support the growth of S. leopoliensis CCAP1405/1 on agar media: yxeO and yufO (transporter), yxdK (histidine kinase), sdhC (succinate dehydrogenase), yvgQR (sulfite reductase), acoB (acetoin dehydrogenase), yusE (thioredoxin), yrdA (function unknown). Involvement of the assimilatory sulfate reduction pathway was the suggested reason for loss of the function.	[Hayashi, Shohei; Itoh, Kazuhito; Suyama, Kousuke] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Itoh, K (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.	itohkz@life.shimane-u.ac.jp					ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; MARLER JE, 1965, J PHYCOL, V1, P180, DOI 10.1111/j.1529-8817.1965.tb04580.x; Vagner V, 1998, MICROBIOL-UK, V144, P3097; KA JO, 1994, APPL ENVIRON MICROB, V60, P1106; Sanchez O, 2005, MICROB ECOL, V50, P580, DOI 10.1007/s00248-005-5061-4; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.4875-4884.2004; THIEL T, 1989, FEMS MICROBIOL LETT, V61, P27, DOI 10.1016/0378-1097(89)90164-X; SHIRAI M, 1989, APPL ENVIRON MICROB, V55, P2569; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Huang M, 1999, J BACTERIOL, V181, P3837; Ali NO, 2001, J BACTERIOL, V183, P2497; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353; Crispim CA, 2004, INT BIODETER BIODEGR, V54, P121, DOI 10.1016/j.ibiod.2004.03.001; Hayashi S, 2011, MICROBES ENVIRON, V26, P120, DOI 10.1264/jsme2.ME10193; HEDERSTEDT L, 1986, METHOD ENZYMOL, V126, P399; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; van der Ploeg JR, 2001, FEMS MICROBIOL LETT, V201, P29, DOI 10.1016/S0378-1097(01)00225-7; LURIA SE, 1960, VIROLOGY, V12, P348, DOI 10.1016/0042-6822(60)90161-6; YOSHIDA K, 1994, MICROBIOL-UK, V140, P2289; MELIN L, 1987, J BACTERIOL, V169, P3232; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Gorham PR, 1981, CULTURE PLANKTONIC C; Kawachi M, 2013, MCC NIES LIST STRAIN; Lock MA, 1993, ATTACHED MICROBIAL C; Watanabe Makoto M., 1998, Physiological Research, V46, P71, DOI 10.1111/j.1440-1835.1998.tb00274.x	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-3628	1432-184X		MICROB ECOL	Microb. Ecol.	OCT	2015	70	3					849	852		10.1007/s00248-015-0610-y		4	Ecology; Marine & Freshwater Biology; Microbiology	Environmental Sciences & Ecology; Marine & Freshwater Biology; Microbiology	CS3OT	WOS:000361984700021		
J	Nakayama, A; Abe, S; Nishi, Y; Watanabe, N; Okabe, Y				Nakayama, Akiyoshi; Abe, Susumu; Nishi, Yohei; Watanabe, Norimichi; Okabe, Yoichi			Two-dimensional magnetic field dependence of zero and finite voltage steps in current-voltage characteristics of superconducting quantum interference devices	MICROELECTRONIC ENGINEERING			English	Article						Superconducting quantum interference device; Superconducting device; Josephson junctions; Two-dimensional magnetic field dependence; Finite voltage resonant current steps; Superconducting planar circuit model	JOSEPHSON TUNNEL-JUNCTIONS; MICROWAVE	Modulation characteristics of Josephson current through superconducting quantum interference devices (SQUIDs) by two dimensional scanning of external magnetic field have been studied. Vertical type SQUIDs composed of two niobium/aluminum-oxide/niobium (Nb/Al-oxide/Nb) tunnel junctions are fabricated using magnetron sputtering system. In order to measure the magnetic dependence of the critical current I-c through SQUIDs, H-x and H-y magnetic field components parallel to junction edges are scanned in two dimensions (2-D) by using two pairs of Helmholtz coils driven in GPIB (General Purpose Interface Bus) system. The 2-D magnetic field (H-x, H-y) dependences of the Josephson current I-c and the resonant current steps I-step at finite voltage in the current-voltage curves of SQUIDs have been obtained. Modulation characteristics of SQUIDs with different junction separation are measured. The resonant current steps I-step are also studied using superconducting planar circuit model. (C) 2015 Elsevier B.V. All rights reserved.	[Nakayama, Akiyoshi; Abe, Susumu; Nishi, Yohei; Watanabe, Norimichi] Kanagawa Univ, Fac Engn, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan; [Okabe, Yoichi] Open Univ Japan, Chiba 2618586, Japan	Nakayama, A (reprint author), Kanagawa Univ, Fac Engn, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	nakayama@ee.kanagawa-u.ac.jp			Ministry of Education, Science, Sports and Culture (Japan) [21560372]	This research is supported in part by the Ministry of Education, Science, Sports and Culture (Japan) [Grant Number 21560372]. We would like to thank Dr Takaharu HIRAOKA for preparing GIF pictures.	Tolpygo SK, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2227438; GIJSBERTSEN JG, 1995, PHYSICA C, V249, P12, DOI 10.1016/0921-4534(95)00297-9; KROGER H, 1981, APPL PHYS LETT, V39, P280, DOI 10.1063/1.92672; Hidaka M, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2237471; Nakayama A, 2012, J NANOSCI NANOTECHNO, V12, P5016, DOI 10.1166/jnn.2012.4903; NAKAYAMA A, 1994, IEICE T ELECTRON, VE77C, P1164; Nakayama A, 2012, J APPL PHYS, V111, DOI 10.1063/1.4724340; PETERSON RL, 1991, CRYOGENICS, V31, P132, DOI 10.1016/0011-2275(91)90259-Y; OKOSHI T, 1972, IEEE T MICROW THEORY, VMT20, P245, DOI 10.1109/TMTT.1972.1127730; Kikuchi K, 2000, APPL PHYS LETT, V77, P3660, DOI 10.1063/1.1328045; Nakayama A, 2013, MICROELECTRON ENG, V108, P163, DOI 10.1016/j.mee.2013.01.056; Coon D. D., 1965, PHYS REV A, V138, P744; de Gennes P., 1967, SUPERCONDUCTIVITY ME; FISKE MD, 1964, REV MOD PHYS, V36, P221, DOI 10.1103/RevModPhys.36.221; Jul-Pang Hsu, 1983, IEEE T MICROW THEORY, V2, P574; Kawabe U., 1995, SUPERCONDUCTING ELEC; Paterno G., 1982, PHYS APPL JOSEPHSON; LANGENBE.DN, 1966, PR INST ELECTR ELECT, V54, P560, DOI 10.1109/PROC.1966.4776; Watanabe N, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830839; Watanabe N, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072446	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9317	1873-5568		MICROELECTRON ENG	Microelectron. Eng.	OCT 1	2015	146						19	25		10.1016/j.mee.2015.02.019		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Optics; Physics, Applied	Engineering; Science & Technology - Other Topics; Optics; Physics	CS5QP	WOS:000362133300005		
J	Tomita, S; Kikuti, YY; Carreras, J; Kojima, M; Ando, K; Takasaki, H; Sakai, R; Takata, K; Yoshino, T; Bea, S; Campo, E; Nakamura, N				Tomita, Sakura; Kikuti, Yara Y.; Carreras, Joaquim; Kojima, Minoru; Ando, Kiyoshi; Takasaki, Hirotaka; Sakai, Rika; Takata, Katsuyoshi; Yoshino, Tadashi; Bea, Silvia; Campo, Elias; Nakamura, Naoya			Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan	MODERN PATHOLOGY			English	Article							INTRAEPITHELIAL LYMPHOCYTES; CELIAC-DISEASE; MALT LYMPHOMAS; EXPRESSION; CARMA1; LIGASE; GAINS; CARD9; TUMOR; HACE1	Enteropathy-associated T-cell lymphoma (EATL) is a rare primary T-cell lymphoma of the digestive tract. EATL is classified as either Type I, which is frequently associated with and thought to arise from celiac disease and is primarily observed in Northern Europe, and Type II, which occurs de novo and is distributed all over the world with predominance in Asia. The pathogenesis of EATL in Asia is unknown. We aimed to clarify the histological and genomic profiles of EATL in Japan in a homogeneous series of 20 cases. The cases were characterized by immunohistochemistry, high-resolution oligonucleotide microarray, and fluorescence in situ hybridization (FISH) at five different loci: 1q21.3 (CKS1B), 6q16.3 (HACE1), 7p22.3 (MAFK), 9q33.3 (PPP6C), and 9q34.3 (ASS1, CARD9) using formalin-fixed paraffin-embedded sections. The histological appearance of EATL ranged from medium-to large-sized cells in 13 cases (65%), small-to medium-sized cells in five cases (25%), and medium-sized in two cases (10%). The immunophenotype was CD2(+) (60%), CD3 epsilon(+) (100%), CD4(+) (10%), CD7(+) (95%), CD8(+) (80%), CD56(+) (85%), TIA-1(+) (100%), Granzyme B+ (25%), T-cell receptor (TCR)beta(+) (10%), TCR gamma(+) (35%), TCR gamma delta(+) (50%), and double negative for TCR (six cases, 30%). All cases were EBER-. The genomic profile showed recurrent copy number gains of 1q32.3, 4p15.1, 5q34, 7q34, 8p11.23, 9q22.31, 9q33.2, 9q34.13, and 12p13.31, and losses of 7p14.1. FISH showed 15 patients (75%) with a gain of 9q34.3 with good correlation with array comparative genomic hybridization. EATL in Japan is characterized by non-monomorphic cells with a cytotoxic CD8(+) CD56(+) phenotype similar to EATL Type II. The genomic profile is comparable to EATL of Western countries, with more similarity to Type I (gain of 1q and 5q) rather than Type II (gain of 8q24, including MYC). The 9q34.3 gain was the most frequent change confirmed by FISH irrespective of the cell origin of alpha beta-T-cells and gamma delta-T-cells.	[Tomita, Sakura; Kikuti, Yara Y.; Carreras, Joaquim; Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan; [Kojima, Minoru; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Hematol, Isehara, Kanagawa 2591193, Japan; [Takasaki, Hirotaka; Sakai, Rika] Kanagawa Canc Ctr, Dept Oncol, Yokohama, Kanagawa 2410815, Japan; [Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan; [Bea, Silvia; Campo, Elias] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain; [Bea, Silvia; Campo, Elias] Univ Barcelona, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Hosp Clin Barcelona, Hematopathol Unit, Barcelona, Spain	Nakamura, N (reprint author), Tokai Univ, Sch Med, Dept Pathol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	naoya@is.icc.u-tokai.ac.jp			Ministry of Education, Science, and Culture of Japan [25860278]	We thank Dr Lluis Armengol from Quantitative Genomic Medicine Laboratories (Barcelona, Spain) for his work in the array comparative genomic hybridization technique. This study was supported in part by a grant-in-aid for Scientific Research (no. 25860278) from the Ministry of Education, Science, and Culture of Japan.	Salaverria I, 2013, BLOOD, V121, P1394, DOI 10.1182/blood-2012-08-452284; Zettl A, 2002, AM J PATHOL, V161, P1635, DOI 10.1016/S0002-9440(10)64441-0; Takeshita M, 2011, HISTOPATHOLOGY, V58, P395, DOI 10.1111/j.1365-2559.2011.03768.x; Tan SY, 2013, LEUKEMIA, V27, P1688, DOI 10.1038/leu.2013.41; Chan JKC, 2011, AM J SURG PATHOL, V35, P1557, DOI 10.1097/PAS.0b013e318222dfcd; Einarsdottir E, 2011, EUR J HUM GENET, V19, P682, DOI 10.1038/ejhg.2011.2; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Akyurek N, 2010, HUM PATHOL, V41, P1448, DOI 10.1016/j.humpath.2010.04.001; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Yasuoka H, 2007, INTERNAL MED, V46, P1219, DOI 10.2169/internalmedicine.46.6377; Deleeuw RJ, 2007, GASTROENTEROLOGY, V132, P1902, DOI 10.1053/j.gastro.2007.03.036; Ye HT, 2003, BLOOD, V102, P1012, DOI 10.1182/blood-2002-11-3502; Ogata M, 2014, CELL TISSUE RES, V356, P217, DOI 10.1007/s00441-013-1786-4; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Zhou YP, 2007, HAEMATOL-HEMATOL J, V92, P921, DOI 10.3324/haematol.10191; Ferreri AJM, 2011, CRIT REV ONCOL HEMAT, V79, P84, DOI 10.1016/j.critrevonc.2010.06.006; Tse E, 2012, AM J HEMATOL, V87, P663, DOI 10.1002/ajh.23213; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621; Chanudet E, 2009, J PATHOL, V217, P420, DOI 10.1002/path.2466; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Raderer M, 2012, ANN HEMATOL, V91, P57, DOI 10.1007/s00277-011-1236-x; Delabie J, 2011, BLOOD, V118, P148, DOI 10.1182/blood-2011-02-335216; Roullet M, 2009, AM J CLIN PATHOL, V131, P820, DOI 10.1309/AJCPMG37MXKYPUBE; Ogata M, 2013, CELL TISSUE RES, V352, P287, DOI 10.1007/s00441-012-1549-7; Huang YL, 2010, BLOOD, V115, P1226, DOI 10.1182/blood-2009-05-221275; Verkarre V, 2003, GASTROENTEROLOGY, V125, P40, DOI 10.1016/S0016-5085(03)00692-9; Garcia-Herrera A, 2011, AM J SURG PATHOL, V8, P1214; Han S.-H., 2013, HELICOBACTER, V81, P290; Isaacson PG, 2008, WHO CLASSIFICATION T, P289; Kato Aiko, 2011, J Clin Exp Hematop, V51, P119; Lepretre F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1215	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	OCT	2015	28	10					1286	1296		10.1038/modpathol.2015.85		11	Pathology	Pathology	CS6NH	WOS:000362195900001		
J	Kamikawa, R; Tanifuji, G; Ishikawa, SA; Ishii, KI; Matsuno, Y; Onodera, NT; Ishida, KI; Hashimoto, T; Miyashita, H; Mayama, S; Inagaki, Y				Kamikawa, Ryoma; Tanifuji, Goro; Ishikawa, Sohta A.; Ishii, Ken-Ichiro; Matsuno, Yusei; Onodera, Naoko T.; Ishida, Ken-Ichiro; Hashimoto, Tetsuo; Miyashita, Hideaki; Mayama, Shigeki; Inagaki, Yuji			Proposal of a Twin Aarginine Translocator System-Mediated Constraint against Loss of ATP Synthase Genes from Nonphotosynthetic Plastid Genomes	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						apochlorotic diatoms; nonphotosynthetic plastid genome; genome reduction; ATP synthase complex; twin arginine translocator	PARASITIC PLANTS; DIATOM PLASTIDS; PROTEIN; CHLOROPLAST; EVOLUTION; DEGRADATION; REDUCTION; SEQUENCE; PHOTOSYNTHESIS; MECHANISMS	Organisms with nonphotosynthetic plastids often retain genomes; their gene contents provide clues as to the functions of these organelles. Yet the functional roles of some retained genes-such as those coding for ATP synthase-remain mysterious. In this study, we report the complete plastid genome and transcriptome data of a nonphotosynthetic diatom and propose that its ATP synthase genes may function in ATP hydrolysis to maintain a proton gradient between thylakoids and stroma, required by the twin arginine translocator (Tat) system for translocation of particular proteins into thylakoids. Given the correlated retention of ATP synthase genes and genes for the Tat system in distantly related nonphotosynthetic plastids, we suggest that this Tat-related role for ATP synthase was a key constraint during parallel loss of photosynthesis in multiple independent lineages of algae/plants.	[Kamikawa, Ryoma; Ishii, Ken-Ichiro; Miyashita, Hideaki] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Kamikawa, Ryoma; Matsuno, Yusei; Miyashita, Hideaki] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Tanifuji, Goro; Ishida, Ken-Ichiro; Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ishikawa, Sohta A.] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Onodera, Naoko T.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan; [Mayama, Shigeki] Tokyo Gakugei Univ, Dept Biol, Tokyo, Japan	Kamikawa, R (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	kamikawa.ryoma.7v@kyoto-u.ac.jp	Tanifuji, Goro/O-9172-2015		Institute for Fermentation, Osaka, Japan; Japanese Society for Promotion of Sciences (JSPS) [15H05606, 15K14591]; JSPS [24007, 23247038, 23117006]	The authors appreciate the useful comments of Professors Michael W. Gray and Andrew J. Roger (Dalhousie University). They also thank Dr Daniel Moog (Dalhousie University) for his technical advice regarding in silico prediction of plastid localization. This work was supported by a grant from the Institute for Fermentation, Osaka, Japan (awarded to R.K.), and by grants from the Japanese Society for Promotion of Sciences (JSPS; nos 15H05606 and 15K14591 awarded to R.K.). S.A.I., T.H., and Y.I. were supported by a grant from JSPS (nos 24007, 23247038, and 23117006, respectively).	Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gould SB, 2008, J PHYCOL, V44, P23, DOI 10.1111/j.1529-8817.2007.00437.x; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Ast M, 2009, P NATL ACAD SCI USA, V106, P3621, DOI 10.1073/pnas.0808862106; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Gray MW, 2010, EMBO REP, V11, P562, DOI 10.1038/embor.2010.107; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Vernon D, 2001, MOL BIOL EVOL, V18, P1810; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; Allen JF, 2003, PHILOS T ROY SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Smith DR, 2014, PLANT PHYSIOL, V164, P1812, DOI 10.1104/pp.113.233718; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Kamikawa R, 2015, GENOME BIOL EVOL, V7, P1133, DOI 10.1093/gbe/evv060; Hempel F, 2014, ADVAN PL BIO, V5, P291, DOI 10.1007/978-1-4939-1136-3_11; Choquet Y, 2000, BIOCHIMIE, V82, P615, DOI 10.1016/S0300-9084(00)00609-X; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Westwood JH, 2012, WEED SCI, V60, P295, DOI 10.1614/WS-D-11-00113.1; de Vries J, 2013, GENOME BIOL EVOL, V5, P2540, DOI 10.1093/gbe/evt205; Wickett NJ, 2011, CURR BIOL, V21, P2098, DOI 10.1016/j.cub.2011.11.011; Kohzuma K, 2012, P NATL ACAD SCI USA, V109, P3293, DOI 10.1073/pnas.1115728109; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Apt KE, 2002, J CELL SCI, V115, P4061, DOI 10.1242/jcs.00092; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Ruck EC, 2014, GENOME BIOL EVOL, V6, P644, DOI 10.1093/gbe/evu039; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Robinson C, 2001, TRAFFIC, V2, P245, DOI 10.1034/j.1600-0854.2001.1r010.x; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; Knauf U, 2002, MOL GENET GENOMICS, V267, P492, DOI 10.1007/s00438-002-0681-6; Kamikawa R, 2015, PHYCOL RES, V63, P19, DOI 10.1111/pre.12072; Martin M, 1998, NATURE, V393, P162; Wilson RJM, 1996, J MOL BIOL, V261, P155	45	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	OCT	2015	32	10					2598	2604		10.1093/molbev/msv134		7	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CS3PQ	WOS:000361987100008		
J	Manes, NP; Angermann, BR; Koppenol-Raab, M; An, E; Sjoelund, VH; Sun, J; Ishii, M; Germain, RN; Meier-Schellersheim, M; Nita-Lazar, A				Manes, Nathan P.; Angermann, Bastian R.; Koppenol-Raab, Marijke; An, Eunkyung; Sjoelund, Virginie H.; Sun, Jing; Ishii, Masaru; Germain, Ronald N.; Meier-Schellersheim, Martin; Nita-Lazar, Aleksandra			Targeted Proteomics-Driven Computational Modeling of Macrophage S1P Chemosensing	MOLECULAR & CELLULAR PROTEOMICS			English	Article							RNA-SEQ EXPERIMENTS; MASS-SPECTROMETRY; CELL-MIGRATION; QUANTITATIVE PROTEOMICS; PROTEIN IDENTIFICATION; ACTIN CYTOSKELETON; BONE HOMEOSTASIS; SYSTEMS BIOLOGY; LIVING CELLS; IN-VIVO	Osteoclasts are monocyte-derived multinuclear cells that directly attach to and resorb bone. Sphingosine-1-phosphate (S1P)(1) regulates bone resorption by functioning as both a chemoattractant and chemorepellent of osteoclast precursors through two G-protein coupled receptors that antagonize each other in an S1P-concentration-dependent manner. To quantitatively explore the behavior of this chemosensing pathway, we applied targeted proteomics, transcriptomics, and rule-based pathway modeling using the Simmune toolset. RAW264.7 cells (a mouse monocyte/macrophage cell line) were used as model osteoclast precursors, RNA-seq was used to identify expressed target proteins, and selected reaction monitoring (SRM) mass spectrometry using internal peptide standards was used to perform absolute abundance measurements of pathway proteins. The resulting transcript and protein abundance values were strongly correlated. Measured protein abundance values, used as simulation input parameters, led to in silico pathway behavior matching in vitro measurements. Moreover, once model parameters were established, even simulated responses toward stimuli that were not used for parameterization were consistent with experimental findings. These findings demonstrate the feasibility and value of combining targeted mass spectrometry with pathway modeling for advancing biological insight.	[Manes, Nathan P.; Angermann, Bastian R.; Koppenol-Raab, Marijke; An, Eunkyung; Sjoelund, Virginie H.; Sun, Jing; Germain, Ronald N.; Meier-Schellersheim, Martin; Nita-Lazar, Aleksandra] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Nita-Lazar, A (reprint author), NIAID, LSB, Cellular Net Works Prote Unit, NIH, 9000 Rockville Pike,4-101, Bethesda, MD 20892 USA.	nitalazarau@niaid.nih.gov	Manes, Nathan/E-2817-2012; Nita, Loredana Elena/B-3612-2012	Manes, Nathan/0000-0001-6701-3314; 	National Institute of Allergy and Infectious Diseases, National Institutes of Health	This study used the Office of Cyber Infrastructure and Computational Biology (OCICB) High Performance Computing (HPC) cluster at the National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	An E, 2014, MOL CELL PROTEOMICS, V13, P2687, DOI 10.1074/mcp.M113.034371; Gygi SP, 1999, MOL CELL BIOL, V19, P1720; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Aguilar-Cuenca R, 2014, CELL MOL LIFE SCI, V71, P479, DOI 10.1007/s00018-013-1439-5; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/nchembio.392, 10.1038/NCHEMBIO.392]; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Edfors F, 2014, MOL CELL PROTEOMICS, V13, P1611, DOI 10.1074/mcp.M113.034140; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/nmeth.2015, 10.1038/NMETH.2015]; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Tolbert CE, 2013, CELL ADHES MIGR, V7, P219, DOI [10.4161/cam.23184, 10.1074/jbc.M111.244293]; Park H, 2011, ARCH BIOCHEM BIOPHYS, V510, P101, DOI 10.1016/j.abb.2011.02.019; Lam H, 2008, NAT METHODS, V5, P873, DOI [10.1038/nmeth.1254, 10.1038/NMETH.1254]; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Edelstein-Keshet L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0003; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; PACE CN, 1995, PROTEIN SCI, V4, P2411; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Angermann BR, 2012, NAT METHODS, V9, P283, DOI [10.1038/nmeth.1861, 10.1038/NMETH.1861]; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1575, DOI 10.1073/pnas.1220755110; Tabb DL, 2006, NAT PROTOC, V1, P2213, DOI 10.1038/nprot.2006.330; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Resat Haluk, 2009, V541, P311, DOI 10.1007/978-1-59745-243-4_14; Ishii M, 2013, BBA-MOL CELL BIOL L, V1831, P223, DOI 10.1016/j.bbalip.2012.06.002; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Kollipara L, 2013, PROTEOMICS, V13, P941, DOI 10.1002/pmic.201200452; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.1631.01631; Ishii T, 2011, MOL CELLS, V31, P399, DOI 10.1007/s10059-011-1010-x; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Infante E, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0013; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Chylek LA, 2014, WIRES SYST BIOL MED, V6, P13, DOI 10.1002/wsbm.1245; Zhang FK, 2013, BIOINFORMATICS, V29, P1229, DOI 10.1093/bioinformatics/btt134; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, V112, P571, DOI DOI 10.1385/1-59259-890-0:571; Holmes WR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002793; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Jovancvic M, 2015, SCIENCE, V347, DOI DOI 10.1126/SCIENCE.1259038; Meier-Schellersheim M, 2009, WIRES SYST BIOL MED, V1, P4, DOI 10.1002/wsbm.33; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Nagano M., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/310616; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Parameswaran N, 2013, IMMUNOL REV, V256, P63, DOI 10.1111/imr.12104; Rougerie P, 2013, IMMUNOL REV, V256, P222, DOI 10.1111/imr.12118; Schwanhausser B., 2011, NATURE, V473, P337, DOI DOI 10.1038/NATURE10098; Sekar John A P, 2012, Methods Mol Biol, V880, P139, DOI 10.1007/978-1-61779-833-7_9; UniProt Consortium, 2014, Nucleic Acids Res, V42, pD191, DOI 10.1093/nar/gkt1140; Vicente-Manzanares M, 2011, METHODS MOL BIOL, V769, P1, DOI 10.1007/978-1-61779-207-6_1; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Xu XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000980	94	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	OCT	2015	14	10					2661	2681		10.1074/mcp.M115.048918		21	Biochemical Research Methods	Biochemistry & Molecular Biology	CS6KA	WOS:000362186200008		
J	Mikami, Y; Iwase, T; Komiyama, Y; Matsumoto, N; Oki, H; Komiyama, K				Mikami, Yoshikazu; Iwase, Takashi; Komiyama, Yusuke; Matsumoto, Naoyuki; Oki, Hidero; Komiyama, Kazuo			Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-kappa B signaling pathway	MOLECULAR IMMUNOLOGY			English	Article						SLPI; pIgR; Epithelial cells; NF-kappa B	INTESTINAL EPITHELIAL-CELLS; PROTEINASE-INHIBITOR; HUSI-I; COMPONENT; ANTILEUKOPROTEASE; INFLAMMATION; ACTIVATION; GAMMA; SLPI; BETA	Polymeric immunoglobulin receptor (pIgR) plays an important role in mucosal immune systems. Secretory immunoglobulin A, composed of secretory component of pIgR and a dimeric form of immunoglobulin A, is secreted on mucosal surfaces and serves as a biological defense factor. pIgR gene expression is reportedly induced by activation of the transcription factor nuclear factor (NF)-kappa B. On the other hand, secretory leukocyte protease inhibitor (SLPI) is a glycoprotein that functions as a serine protease inhibitor. In alveolar epithelial cells, SLPI increases the level of I kappa B beta, which indicates that it is an inhibitor of NF-kappa B at the protein level. Taken together, SLPI may regulate plgR expression; however, the specific mechanism by which this occurs is unclear. Therefore, the aim of this study was to elucidatethe influence of SLPI on pIgR expression. SLPI and pIgR localized in goblet cells and ciliated epithelial cells of the gastrointestinal tract, respectively. No cells were detected in which SLPI and pIgR were co-expressed. In addition, recombinant human SLPI stimulation of an epithelial cell line (HT-29) decreased the pIgR expression. The pIgR expression was also higher in SLPI-deficient Ca9-22 cells than in wild-type Ca9-22 cells. Furthermore, a luciferase assay using a NF-kappa B reporter plasmid and real-time RT-PCR analysis indicated that when SLPI was present, the transcriptional activity of NF-kappa B protein was suppressed, which was accompanied by anincrease in the protein, but not the mRNA,expression of I kappa B beta. These results demonstrate that SLPI down-regulates pIgR expression through the NF-kappa B signaling pathway by inhibiting degradation of I kappa B beta protein. (C) 2015 The Authors. Published by Elsevier Ltd.	[Mikami, Yoshikazu; Iwase, Takashi; Matsumoto, Naoyuki; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Chiyoda Ku, Tokyo 1018310, Japan; [Komiyama, Yusuke] Dokkyo Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Mibu, Tochigi 3210293, Japan; [Oki, Hidero] Nihon Univ, Sch Dent, Dept Maxillofacial Surg, Chiyoda Ku, Tokyo 1018310, Japan	Komiyama, K (reprint author), Nihon Univ, Sch Dent, Dept Pathol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	komiyama.kazuo@nihon-u.ac.jp			Dental Research Center; Sato Fund of the Nihon University School of Dentistry; JSPS KAKENHI [24593066]	This work was supported in part by JSPS KAKENHI (#24593066), grants from the Dental Research Center, and the Sato Fund of the Nihon University School of Dentistry.	PHILLIPS JO, 1990, J IMMUNOL, V145, P1740; KVALE D, 1988, J IMMUNOL, V140, P3086; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; FRANKEN C, 1989, J HISTOCHEM CYTOCHEM, V37, P493; Bergenfeldt M, 1996, J GASTROENTEROL, V31, P18, DOI 10.1007/BF01211182; Johansen FE, 1998, EUR J IMMUNOL, V28, P1161, DOI 10.1002/(SICI)1521-4141(199804)28:04<1161::AID-IMMU1161>3.0.CO;2-S; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; Pilette C, 2003, AM J RESP CELL MOL, V28, P485, DOI 10.1165/rcmb.4913; Si-Tahar M, 2000, GASTROENTEROLOGY, V118, P1061, DOI 10.1016/S0016-5085(00)70359-3; SEEMULLER U, 1986, FEBS LETT, V199, P43, DOI 10.1016/0014-5793(86)81220-0; VANSEUNINGEN I, 1995, J HISTOCHEM CYTOCHEM, V43, P645; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; SOLLID LM, 1987, J IMMUNOL, V138, P4303; [Anonymous], CLIN EXP IMMUNOL; Brandtzaeg P., 1994, HDB MUCOSAL IMMUNOLO, P113; FRITZ H, 1988, BIOL CHEM H-S, V369, P79; FRYKSMARK U, 1989, Rhinology (Utrecht), V27, P97; Vogelmeier C, 1996, CHEST, V110, pS261, DOI 10.1378/chest.110.6_Supplement.261S; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095389	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0161-5890			MOL IMMUNOL	Mol. Immunol.	OCT	2015	67	2	B				568	574		10.1016/j.molimm.2015.07.021		7	Biochemistry & Molecular Biology; Immunology	Biochemistry & Molecular Biology; Immunology	CS2SQ	WOS:000361922400042		
J	Gromova, I; Gromov, P; Honma, N; Kumar, S; Rimm, D; Talman, MLM; Wielenga, VT; Moreira, JMA				Gromova, Irina; Gromov, Pavel; Honma, Naoko; Kumar, Sudha; Rimm, David; Talman, Maj-Lis Moller; Wielenga, Vera Timmermans; Moreira, Jose M. A.			High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy	MOLECULAR ONCOLOGY			English	Article						Breast cancer; "Basal-type" breast cancer; Proteomics; Phgdh; Serine biosynthesis	POTENTIAL THERAPEUTIC TARGET; HUMAN MAMMARY-GLAND; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; APOCRINE CARCINOMAS; TISSUE MICROARRAYS; ANDROGEN RECEPTOR; DUCTAL CARCINOMA; IN-SITU; CANCER	We have previously reported the 2D PAGE-based proteomic profiling of a prospective cohort of 78 triple negative breast cancer (TNBC) patients, and the establishment of a cumulative TNBC protein database. Analysis of this database identified a number of proteins as being specifically overexpressed in TNBC samples. One such protein was D-3-phosphoglycerate dehydrogenase (Phgdh), a candidate oncogene. We analysed expression of Phgdh in normal and TNBC mammary tissue samples by 2D gel-based proteomics and immunohistochemistry (IHC), and show here that high-level expression of Phgdh in mammary epithelial cells is primarily associated with cell lineage, as we found that Phgdh expression was predominant in CK5-positive cells, normal as well as malignant, thus identifying an association of this protein with the basal phenotype. Quantitative IHC analysis of Phgdh expression in normal breast tissue showed high-level expression of Phgdh in normal CK5-positive mammary epithelial cells, indicating that expression of this protein was not associated with malignancy, but rather with cell lineage. However, proteomic profiling of Phgdh showed it to be expressed in two major protein forms, and that the ratio of expression between these variants was associated with malignancy. Overexpression of Phgdh in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and cancer types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	[Gromova, Irina; Gromov, Pavel] Danish Canc Soc, Res Ctr, Genome Integr Unit, Canc Prote, Copenhagen, Denmark; [Gromova, Irina; Gromov, Pavel; Moreira, Jose M. A.] Danish Ctr Translat Breast Canc Res DCTB, Copenhagen, Denmark; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Kumar, Sudha; Rimm, David] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Talman, Maj-Lis Moller; Wielenga, Vera Timmermans] Copenhagen Univ Hosp, Ctr Diagnost Invest, Dept Pathol, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, DK-1168 Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sinodanish Breast Canc Res Ctr, DK-1168 Copenhagen, Denmark	Moreira, JMA (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, DK-1168 Copenhagen, Denmark.	jomo@sund.ku.dk		Moreira, Jose/0000-0002-9944-1214	Danish Cancer Society through the budget of the Danish Cancer Society Research Center; "Race against Breast Cancer" foundation; John and Birthe Meyer Foundation	The authors wish to thank Genkichi Iwakoshi, Sofia Svensson, and Anni Handesten for expert technical assistance. We would also like to thank Niels Kroman, Department of Breast Surgery, Copenhagen University Hospital, Denmark, for his invaluable support. This work was supported by the Danish Cancer Society through the budget of the Danish Cancer Society Research Center, and by grants from the "Race against Breast Cancer" foundation, and the John and Birthe Meyer Foundation.	Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Honma N, 2007, HISTOPATHOLOGY, V50, P425, DOI 10.1111/j.1365-2559.2007.02636.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Montagna E, 2013, CLIN BREAST CANCER, V13, P31, DOI 10.1016/j.clbc.2012.09.002; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Rastelli F, 2010, TUMORI, V96, P875; Dolled-Filhart M, 2010, METHODS MOL BIOL, V664, P151, DOI 10.1007/978-1-60761-806-5_15; Gromov P, 2010, J PROTEOME RES, V9, P3941, DOI 10.1021/pr100160u; Tsutsumi Y, 2012, JPN J CLIN ONCOL, V42, P375, DOI 10.1093/jjco/hys034; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Camp RL, 2003, CANCER RES, V63, P1445; Neumeister VM, 2012, BREAST CANCER RES TR, V136, P67, DOI 10.1007/s10549-012-2232-0; Irshad S, 2011, CURR OPIN ONCOL, V23, P566, DOI 10.1097/CCO.0b013e32834bf8ae; PIZER LI, 1963, J BIOL CHEM, V238, P3934; Yamamoto T, 2001, INT J ONCOL, V19, P271; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Moreira JMA, 2010, MOL ONCOL, V4, P539, DOI 10.1016/j.molonc.2010.09.005; Wells CA, 2007, J CLIN PATHOL, V60, P1313, DOI 10.1136/jcp.2006.040626; Egeblad M, 2001, INT J CANCER, V94, P185, DOI 10.1002/ijc.1459; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Olsen E, 1995, ELECTROPHORESIS, V16, P2241, DOI 10.1002/elps.11501601356; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Celis JE, 2009, MOL ONCOL, V3, P220, DOI 10.1016/j.molonc.2009.01.005; Celis JE, 2006, MOL CELL PROTEOMICS, V5, P462, DOI 10.1074/mcp.M500348-MCP200; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Dellapasqua S, 2013, CLIN BREAST CANCER, V13, P95, DOI 10.1016/j.clbc.2012.11.004; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; O'Malley FP, 2008, HISTOPATHOLOGY, V52, P3, DOI 10.1111/j.1365-2559.2007.02888.x; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Yamamoto Y, 2010, INT J CLIN ONCOL, V15, P341, DOI 10.1007/s10147-010-0106-1; Leal C, 2001, HUM PATHOL, V32, P487, DOI 10.1053/hupa.2001.24327; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Puig P, 2003, CLIN CANCER RES, V9, P5642; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Liu JL, 2013, J NEURO-ONCOL, V111, P245, DOI 10.1007/s11060-012-1018-x; Noh S, 2014, TUMOR BIOL, V35, P4457, DOI 10.1007/s13277-013-1588-z; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Celis JE, 2008, MOL CELL PROTEOMICS, V7, P1795, DOI 10.1074/mcp.R800011-MCP200; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; Honma N, 2005, HISTOPATHOLOGY, V47, P195, DOI 10.1111/j.1365-2559.2005.02181.x; Jeon HM, 2013, TUMORI, V99, P555, DOI 10.1700/1361.15110; Celis J.E., 2005, CELL BIOL LAB HDB, P165; Kim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101004; Maddocks O.D., 2013, NATURE, V493, P542; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; TAYLORPAPADIMITRIOU J, 1982, CELL DIFFER DEV, V11, P169, DOI 10.1016/0045-6039(82)90008-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Vander HM, 2011, NAT REV DRUG DISCOV, V10, P671, DOI DOI 10.1038/NRD3504	70	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1574-7891	1878-0261		MOL ONCOL	Mol. Oncol.	OCT	2015	9	8					1636	1654		10.1016/j.molonc.2015.05.003		19	Oncology	Oncology	CS8AQ	WOS:000362308500011		
J	Xie, SP; Deser, C; Vecchi, GA; Collins, M; Delworth, TL; Hall, A; Hawkins, E; Johnson, NC; Cassou, C; Giannini, A; Watanabe, M				Xie, Shang-Ping; Deser, Clara; Vecchi, Gabriel A.; Collins, Matthew; Delworth, Thomas L.; Hall, Alex; Hawkins, Ed; Johnson, Nathaniel C.; Cassou, Christophe; Giannini, Alessandra; Watanabe, Masahiro			Towards predictive understanding of regional climate change	NATURE CLIMATE CHANGE			English	Review							SEA-SURFACE TEMPERATURE; EL-NINO; SUBTROPICAL PRECIPITATION; ATMOSPHERIC CIRCULATION; TROPICAL CIRCULATION; MULTIMODEL ENSEMBLE; HYDROLOGICAL CYCLE; CHANGE PROJECTIONS; SPATIAL-PATTERNS; CONVERGENCE ZONE	Regional information on climate change is urgently needed but often deemed unreliable. To achieve credible regional climate projections, it is essential to understand underlying physical processes, reduce model biases and evaluate their impact on projections, and adequately account for internal variability. In the tropics, where atmospheric internal variability is small compared with the forced change, advancing our understanding of the coupling between long-term changes in upper-ocean temperature and the atmospheric circulation will help most to narrow the uncertainty. In the extratropics, relatively large internal variability introduces substantial uncertainty, while exacerbating risks associated with extreme events. Large ensemble simulations are essential to estimate the probabilistic distribution of climate change on regional scales. Regional models inherit atmospheric circulation uncertainty from global models and do not automatically solve the problem of regional climate change. We conclude that the current priority is to understand and reduce uncertainties on scales greater than 100 km to aid assessments at finer scales.	[Xie, Shang-Ping; Johnson, Nathaniel C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Deser, Clara] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Vecchi, Gabriel A.; Delworth, Thomas L.] Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Collins, Matthew] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Hall, Alex] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Hawkins, Ed] Univ Reading, Dept Meteorol, Natl Ctr Atmospher Sci, Reading RG6 6BB, Berks, England; [Johnson, Nathaniel C.] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Johnson, Nathaniel C.] Princeton Univ, Cooperat Inst Climate Sci, Princeton, NJ 08540 USA; [Cassou, Christophe] CNRS CERFACS, F-31057 Toulouse, France; [Giannini, Alessandra] Columbia Univ, Int Res Inst Climate & Soc, Palisades, NY 10964 USA; [Watanabe, Masahiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan	Xie, SP (reprint author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sxie@ucsd.edu	Vecchi, Gabriel/A-2413-2008; Collins, Matthew/F-8473-2011; Delworth, Thomas/C-5191-2014; Hawkins, Ed/B-7921-2011	Vecchi, Gabriel/0000-0002-5085-224X; Collins, Matthew/0000-0003-3785-6008; Hawkins, Ed/0000-0001-9477-3677	National Science Foundation (NSF); National Oceanic and Atmospheric Administration (NOAA); NERC [NE/I022841/1]; NSF	S.M. Long drew Figures 2 and 3. S.P.X. is supported by the National Science Foundation (NSF) and National Oceanic and Atmospheric Administration (NOAA); and M.C. by NERC NE/I022841/1. NCAR is supported by the NSF.	Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Scheff J, 2012, J CLIMATE, V25, P4330, DOI 10.1175/JCLI-D-11-00393.1; Xie SP, 2013, NAT GEOSCI, V6, P828, DOI 10.1038/NGEO1931; Taschetto AS, 2008, METEOROL ATMOS PHYS, V100, P23, DOI 10.1007/s00703-008-0293-8; Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; Marshall J, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0040; Power S, 2013, NATURE, V502, P541, DOI 10.1038/nature12580; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI 10.1038/NCLIMATE2100; Harris GR, 2013, CLIM DYNAM, V40, P2937, DOI 10.1007/s00382-012-1647-y; Raisanen J, 2001, J CLIMATE, V14, P3212, DOI 10.1175/1520-0442(2001)014<3212:APADMA>2.0.CO;2; Leung LR, 2004, CLIMATIC CHANGE, V62, P75, DOI 10.1023/B:CLIM.0000013692.50640.55; Brown JN, 2013, CLIMATIC CHANGE, V119, P147, DOI 10.1007/s10584-012-0603-5; Chou C, 2004, J CLIMATE, V17, P2688, DOI 10.1175/1520-0442(2004)017<2688:MOGWIO>2.0.CO;2; Walton DB, 2015, J CLIMATE, V28, P4597, DOI 10.1175/JCLI-D-14-00196.1; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Manabe S, 2007, J METEOROL SOC JPN, V85B, P385, DOI 10.2151/jmsj.85B.385; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Chang CY, 2011, J CLIMATE, V24, P2540, DOI 10.1175/2010JCLI4065.1; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Yokohata T, 2012, CLIM DYNAM, V39, P599, DOI 10.1007/s00382-011-1203-1; Seth A, 2013, J CLIMATE, V26, P7328, DOI 10.1175/JCLI-D-12-00726.1; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; Zhao M, 2012, J CLIMATE, V25, P2995, DOI 10.1175/JCLI-D-11-00313.1; Griffiths GM, 2005, INT J CLIMATOL, V25, P1301, DOI 10.1002/joc.1194; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Deser Clara, 2012, Climate Dynamics, V38, DOI 10.1007/s00382-010-0977-x; Dirmeyer PA, 2013, J HYDROMETEOROL, V14, P829, DOI 10.1175/JHM-D-12-0107.1; Webb MJ, 2013, CLIM DYNAM, V40, P677, DOI 10.1007/s00382-012-1336-x; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Li XQ, 2015, J CLIMATE, V28, P4107, DOI 10.1175/JCLI-D-14-00559.1; Vecchi GA, 2014, J CLIMATE, V27, P7994, DOI 10.1175/JCLI-D-14-00158.1; van Oldenborgh GJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014055; Delworth TL, 2012, J CLIMATE, V25, P2755, DOI 10.1175/JCLI-D-11-00316.1; Chadwick R, 2013, J CLIMATE, V26, P3803, DOI 10.1175/JCLI-D-12-00543.1; Collins M, 2012, NAT CLIM CHANGE, V2, P403, DOI 10.1038/NCLIMATE1414; Biasutti M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041303; Barnes EA, 2013, J CLIMATE, V26, P7117, DOI 10.1175/JCLI-D-12-00536.1; Walsh KJE, 2015, B AM METEOROL SOC, V96, P997, DOI 10.1175/BAMS-D-13-00242.1; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015<2103:TRTATI>2.0.CO;2; DiNezio PN, 2012, J CLIMATE, V25, P7399, DOI 10.1175/JCLI-D-11-00494.1; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684; Boe JL, 2009, NAT GEOSCI, V2, P341, DOI 10.1038/NGEO467; Berckmans J, 2013, ATMOS SCI LETT, V14, P34, DOI 10.1002/asl2.412; Hwang YT, 2013, P NATL ACAD SCI USA, V110, P4935, DOI 10.1073/pnas.1213302110; Ming Y, 2011, J CLIMATE, V24, P5125, DOI 10.1175/2011JCLI4108.1; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Joshi MM, 2013, CLIMATIC CHANGE, V117, P951, DOI 10.1007/s10584-013-0715-6; Ma J, 2013, J CLIMATE, V26, P2482, DOI 10.1175/JCLI-D-12-00283.1; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Seager R, 2010, J CLIMATE, V23, P4651, DOI 10.1175/2010JCLI3655.1; Li WH, 2012, NAT GEOSCI, V5, P830, DOI 10.1038/NGEO1590; Hung MP, 2013, J CLIMATE, V26, P6185, DOI 10.1175/JCLI-D-12-00541.1; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Shindell DT, 2012, ATMOS CHEM PHYS, V12, P6969, DOI 10.5194/acp-12-6969-2012; Anderson BT, 2015, GEOPHYS RES LETT, V42, P1190, DOI 10.1002/2014GL062593; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Rougier J, 2007, CLIMATIC CHANGE, V81, P247, DOI 10.1007/s10584-006-9156-9; Ricke KL, 2014, NAT CLIM CHANGE, V4, P333, DOI 10.1038/NCLIMATE2186; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253; Vecchi GA, 2008, SCIENCE, V322, P687, DOI 10.1126/science.1164396; van Oldenborgh GJ, 2005, OCEAN SCI, V1, P81; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/nclimate2106, 10.1038/NCLIMATE2106]; Partin JW, 2013, GEOLOGY, V41, P1143, DOI 10.1130/G34718.1; Neelin JD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018625; Huang P, 2013, NAT GEOSCI, V6, P357, DOI [10.1038/NGEO1792, 10.1038/ngeo1792]; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Watanabe M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053305; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Delworth TL, 2014, NAT GEOSCI, V7, P583, DOI 10.1038/NGEO2201; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Murakami H, 2013, NAT CLIM CHANGE, V3, P749, DOI [10.1038/nclimate1890, 10.1038/NCLIMATE1890]; Bracegirdle TJ, 2013, J CLIMATE, V26, P669, DOI 10.1175/JCLI-D-12-00537.1; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Wang CZ, 2014, NAT CLIM CHANGE, V4, P201, DOI 10.1038/NCLIMATE2118; Screen JA, 2014, NAT CLIM CHANGE, V4, P577, DOI [10.1038/nclimate2268, 10.1038/NCLIMATE2268]; Giannini A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024010; Li WH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006355; Hall A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032012; Liu ZY, 2005, J CLIMATE, V18, P4684, DOI 10.1175/JCLI3579.1; Goddard L, 2013, CLIM DYNAM, V40, P245, DOI 10.1007/s00382-012-1481-2; Bellenger H, 2014, CLIM DYNAM, V42, P1999, DOI 10.1007/s00382-013-1783-z; Christensen J. H., 2013, CLIMATE CHANGE 2013, P1217, DOI [DOI 10.1017/CB09781107415324, 10.1017/CBO9781107415324]; Collins M, 2013, CLIMATE CHANGE 2013, P1029, DOI DOI 10.1017/CBO9781107415324.024; Dawson A, 2015, CLIM DYNAM, V44, P2177, DOI 10.1007/s00382-014-2238-x; Hall A, 2014, SCIENCE, V346, P1461, DOI 10.1126/science.aaa0629; Lu J, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL028443; Meehl GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023680; Phillips Adam S., 2014, Eos, Transactions American Geophysical Union, V95, DOI 10.1002/2014EO490002; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Schneider D. P., 2013, EOS T AGU, V94, P121, DOI [10.1002/2013EO130001, DOI 10.1002/2013EO130001]; Seneviratne S. I., 2013, MANAGING RISKS EXTRE, P109; Stocker T F, 2013, CLIMATE CHANGE 2013, P1; Wallace J. M., WORLD SCI S IN PRESS, V6; Widlansky MJ, 2013, NAT CLIM CHANGE, V3, P417, DOI [10.1038/nclimate1726, 10.1038/NCLIMATE1726]; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	100	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-678X	1758-6798		NAT CLIM CHANGE	Nat. Clim. Chang.	OCT	2015	5	10					921	930		10.1038/NCLIMATE2689		10	Environmental Sciences; Environmental Studies; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CS1PX	WOS:000361840600012		
J	Schoenfelder, S; Sugar, R; Dimond, A; Javierre, BM; Armstrong, H; Mifsud, B; Dimitrova, E; Matheson, L; Tavares-Cadete, F; Furlan-Magaril, M; Segonds-Pichon, A; Jurkowski, W; Wingett, SW; Tabbada, K; Andrews, S; Herman, B; LeProust, E; Osborne, CS; Koseki, H; Fraser, P; Luscombe, NM; Elderkin, S				Schoenfelder, Stefan; Sugar, Robert; Dimond, Andrew; Javierre, Biola-Maria; Armstrong, Harry; Mifsud, Borbala; Dimitrova, Emilia; Matheson, Louise; Tavares-Cadete, Filipe; Furlan-Magaril, Mayra; Segonds-Pichon, Anne; Jurkowski, Wiktor; Wingett, Steven W.; Tabbada, Kristina; Andrews, Simon; Herman, Bram; LeProust, Emily; Osborne, Cameron S.; Koseki, Haruhiko; Fraser, Peter; Luscombe, Nicholas M.; Elderkin, Sarah			Polycomb repressive complex PRC1 spatially constrains the mouse embryonic stem cell genome	NATURE GENETICS			English	Article							GROUP PROTEINS RING1A/B; CAPTURE HI-C; REGULATORY CIRCUITRY; PLURIPOTENCY FACTORS; CHROMATIN-STRUCTURE; H2A UBIQUITYLATION; HIGH-RESOLUTION; BREAST-CANCER; HOX GENES; CONTACTS	The Polycomb repressive complexes PRC1 and PRC2 maintain embryonic stem cell (ESC) pluripotency by silencing lineage-specifying developmental regulator genes(1). Emerging evidence suggests that Polycomb complexes act through controlling spatial genome organization(2-9). We show that PRC1 functions as a master regulator of mouse ESC genome architecture by organizing genes in three-dimensional interaction networks. The strongest spatial network is composed of the four Hox gene clusters and early developmental transcription factor genes, the majority of which contact poised enhancers. Removal of Polycomb repression leads to disruption of promoter-promoter contacts in the Hox gene network. In contrast, promoter-enhancer contacts are maintained in the absence of Polycomb repression, with accompanying widespread acquisition of active chromatin signatures at network enhancers and pronounced transcriptional upregulation of network genes. Thus, PRC1 physically constrains developmental transcription factor genes and their enhancers in a silenced but poised spatial network. We propose that the selective release of genes from this spatial network underlies cell fate specification during early embryonic development.	[Schoenfelder, Stefan; Dimond, Andrew; Javierre, Biola-Maria; Armstrong, Harry; Dimitrova, Emilia; Matheson, Louise; Furlan-Magaril, Mayra; Jurkowski, Wiktor; Wingett, Steven W.; Tabbada, Kristina; Osborne, Cameron S.; Fraser, Peter; Elderkin, Sarah] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Sugar, Robert; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Mifsud, Borbala; Tavares-Cadete, Filipe; Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3PX, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, London, England; [Dimitrova, Emilia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Segonds-Pichon, Anne; Wingett, Steven W.; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Herman, Bram; LeProust, Emily] Agilent Technol, Santa Clara, CA USA; [Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol Grad Univ, Okinawa, Japan	Elderkin, S (reprint author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	sarah.elderkin@babraham.ac.uk		Mifsud, Borbala/0000-0003-3429-3094	Wellcome Trust [WT085102MA]; Biotechnology and Biological Science Research Council; Medical Research Council UK; European Union Framework Programme 7 Epigenesys Network of Excellence	We thank members of the Elderkin, Fraser and Luscombe groups for discussions and J. Houseley and P. Rugg-Gunn for commenting on the manuscript. We thank F. Krueger for help with data processing and formatting. We thank R.J. Klose and N. Brockdorff for sequencing. We thank D. Bolland, J. Martins and A. Corcoran for help and advice with the three-dimensional DNA FISH and MetaCyte data analyses. This work was funded by the Wellcome Trust (WT085102MA) (S.E.), the Biotechnology and Biological Science Research Council, the Medical Research Council UK (P.F.) and the European Union Framework Programme 7 Epigenesys Network of Excellence (N.M.L.).	Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Vieux-Rochas M, 2015, P NATL ACAD SCI USA, V112, P4672, DOI 10.1073/pnas.1504783112; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Williamson I, 2012, DEVELOPMENT, V139, P3157, DOI 10.1242/dev.081174; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Rosa S, 2013, GENE DEV, V27, P1845, DOI 10.1101/gad.221713.113; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/nmeth.1491, 10.1038/NMETH.1491]; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Bolland DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50587; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Love M. I., 2014, BIORXIV, V15, P550, DOI [10.1101/002832, DOI 10.1101/002832]; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	43	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2015	47	10					1179	+		10.1038/ng.3393		11	Genetics & Heredity	Genetics & Heredity	CS3JR	WOS:000361969900013		
J	Chattarji, S; Tomar, A; Suvrathan, A; Ghosh, S; Rahman, MM				Chattarji, Sumantra; Tomar, Anupratap; Suvrathan, Aparna; Ghosh, Supriya; Rahman, Mohammed Mostafizur			Neighborhood matters: divergent patterns of stress-induced plasticity across the brain	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; ANXIETY-LIKE BEHAVIOR; TISSUE-PLASMINOGEN ACTIVATOR; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENOCORTICAL AXIS; INHIBITORY AVOIDANCE TASK; MAJOR DEPRESSIVE DISORDER; HIPPOCAMPAL CA3C NEURONS; DENDRITIC SPINE LOSS	The fact that exposure to severe stress leads to the development of psychiatric disorders serves as the basic rationale for animal models of stress disorders. Clinical and neuroimaging studies have shown that three brain areas involved in learning and memory-the hippocampus, amygdala and prefrontal cortex-undergo distinct structural and functional changes in individuals with stress disorders. These findings from patient studies pose several challenges for animal models of stress disorders. For instance, why does stress impair cognitive function, yet enhance fear and anxiety? Can the same stressful experience elicit contrasting patterns of plasticity in the hippocampus, amygdala and prefrontal cortex? How does even a brief exposure to traumatic stress lead to long-lasting behavioral abnormalities? Thus, animal models of stress disorders must not only capture the unique spatio-temporal features of structural and functional alterations in these brain areas, but must also provide insights into the underlying neuronal plasticity mechanisms. This Review will address some of these key questions by describing findings from animal models on how stress-induced plasticity varies across different brain regions and thereby gives rise to the debilitating emotional and cognitive symptoms of stress-related psychiatric disorders.	[Chattarji, Sumantra; Rahman, Mohammed Mostafizur] Natl Ctr Biol Sci, Ctr Brain Dev & Repair, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Tomar, Anupratap] RIKEN Brain Sci Inst, Lab Circuit & Behav Physiol, Wako, Saitama, Japan; [Suvrathan, Aparna] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Ghosh, Supriya] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Chattarji, S (reprint author), Natl Ctr Biol Sci, Ctr Brain Dev & Repair, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India.	shona@ncbs.res.in		Rahman, Mohammed Mostafizur/0000-0002-9355-4867	Department of Biotechnology (DBT); Defense Research and Development Organization (DRDO), Government of India; Wadhwani Foundation; National Centre for Biological Sciences (NCBS), India	This work was supported by the Department of Biotechnology (DBT) and Defense Research and Development Organization (DRDO), Government of India, the Wadhwani Foundation, and the National Centre for Biological Sciences (NCBS), India.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Kim EJ, 2015, CURR BIOL, V25, P1362, DOI 10.1016/j.cub.2015.03.048; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460.9568.2004.03294.x; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037//0735-7044.113.5.902; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Kole MHP, 2004, NEUROSCIENCE, V125, P337, DOI 10.1016/j.neuroscience.2004.02.014; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Abe K, 2001, JPN J PHARMACOL, V86, P18, DOI 10.1254/jjp.86.18; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Wang MN, 2012, J PSYCHOPHARMACOL, V26, P56, DOI 10.1177/0269881111409606; RUBIN RT, 1966, SCIENCE, V153, P767, DOI 10.1126/science.153.3737.767; PITKANEN A, 1994, J NEUROSCI, V14, P2200; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487; Rao RP, 2012, BIOL PSYCHIAT, V72, P466, DOI 10.1016/j.biopsych.2012.04.008; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Shors TJ, 1998, LEARN MEMORY, V5, P220; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; SMITH MA, 1995, J NEUROSCI, V15, P1768; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Maroun M, 2003, J NEUROSCI, V23, P4406; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Shirayama Y, 2002, J NEUROSCI, V22, P3251; Schelling G, 2006, ANN NY ACAD SCI, V1071, P46, DOI 10.1196/annals.1364.005; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Herman JP, 2002, PHARMACOL BIOCHEM BE, V71, P457, DOI 10.1016/S0091-3057(01)00681-5; Armony JL, 2005, AM J PSYCHIAT, V162, P1961, DOI 10.1176/appi.ajp.162.10.1961; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Stewart MG, 2005, NEUROSCIENCE, V131, P43, DOI 10.1016/j.neuroscience.2004.10.031; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; de Kloet CS, 2006, J PSYCHIAT RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Francis DD, 2002, J NEUROSCI, V22, P7840; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Vyas A, 2002, J NEUROSCI, V22, P6810; Vouimba RM, 2006, STRESS, V9, P29, DOI 10.1080/10253890600610973; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Akirav I, 2002, J NEUROSCI, V22, P9912; LEDOUX JE, 1994, SCI AM, V270, P50; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Kim JJ, 2001, J NEUROSCI, V21, P5222; DIAMOND DM, 1994, ANN NY ACAD SCI, V746, P411; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; LIANG KC, 1994, BEHAV NEUROSCI, V108, P241, DOI 10.1037/0735-7044.108.2.241; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Akirav I, 1999, J NEUROSCI, V19, P10530; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Davis M, 1999, ANN NY ACAD SCI, V877, P281, DOI 10.1111/j.1749-6632.1999.tb09273.x; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Padival M, 2013, NEUROPSYCHOPHARMACOL, V38, P1748, DOI 10.1038/npp.2013.74; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Liang ZF, 2014, NEUROIMAGE, V103, P485, DOI 10.1016/j.neuroimage.2014.08.050; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MANDELL AJ, 1963, SCIENCE, V139, P1212, DOI 10.1126/science.139.3560.1212; Roberson-Nay R, 2006, BIOL PSYCHIAT, V60, P966, DOI 10.1016/j.biopsych.2006.02.018; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Bauer EP, 2002, J NEUROSCI, V22, P5239; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Arnsten AFT, 2015, NAT NEUROSCI, V18, P1376, DOI 10.1038/nn.4087; Bardeleben U, 1989, J Neuroendocrinol, V1, P485, DOI 10.1111/j.1365-2826.1989.tb00150.x; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; File S.E., 2000, AMYGDALA FUNCTIONAL, P195; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Jose M., 2001, AM J PSYCHIAT, V158, P1321; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; MCDONALD A J, 1992, P67; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; MCDONALD AJ, 1992, BRAIN RES BULL, V28, P179, DOI 10.1016/0361-9230(92)90177-Y; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Sandi Carmen, 2007, Neural Plast, V2007, P78970; JACOBSON L, 1991, ENDOCR REV, V12, P118; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Starkman MN, 1999, BIOL PSYCHIAT, V46, P1595, DOI 10.1016/S0006-3223(99)00203-6; Tomar A, 2015, HIPPOCAMPUS, V25, P38, DOI 10.1002/hipo.22348	146	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1364	1375		10.1038/nn.4115		12	Neurosciences	Neurosciences & Neurology	CS2OK	WOS:000361910600005		
J	Nishizumi, H; Sakano, H				Nishizumi, Hirofumi; Sakano, Hitoshi			Decoding and deorphanizing an olfactory map	NATURE NEUROSCIENCE			English	Editorial Material							ODORANT RECEPTOR; FUNCTIONAL EXPRESSION; BULB; IDENTIFICATION; NEURONS	As conversion of odor signals to a two-dimensional map of activated glomeruli in the olfactory bulb is the key to odor recognition, decoding and deorphanizing of odorant receptors in the olfactory map is of great interest. Two genome-wide techniques now offer the ability to pair any odorant with its receptors.	[Nishizumi, Hirofumi] Toko Univ, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan; [Sakano, Hitoshi] Univ Fukui, Dept Brain Funct, Sch Med Sci, Fukui 910, Japan	Nishizumi, H (reprint author), Toko Univ, Dept Biol Sci, Grad Sch Sci, Tokyo, Japan.	sakano.hts@gmail.com					Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Bozza T, 2002, J NEUROSCI, V22, P3033; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; ONODA N, 1992, NEUROSCI LETT, V137, P157, DOI 10.1016/0304-3940(92)90393-L; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Inaki K, 2002, EUR J NEUROSCI, V15, P1563, DOI 10.1046/j.1460-9568.2002.01991.x; Arzi A, 2011, TRENDS COGN SCI, V15, P537, DOI 10.1016/j.tics.2011.09.007; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Jiang Y, 2015, NAT NEUROSCI, V18, P1446, DOI 10.1038/nn.4104; McClintock TS, 2014, J NEUROSCI, V34, P15669, DOI 10.1523/JNEUROSCI.3625-14.2014; von der Weid B, 2015, NAT NEUROSCI, V18, P1455, DOI 10.1038/nn.4100	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1432	1433		10.1038/nn.4121		2	Neurosciences	Neurosciences & Neurology	CS2OK	WOS:000361910600012		
J	Yalgin, C; Ebrahimi, S; Delandre, C; Yoong, LF; Akimoto, S; Tran, H; Amikura, R; Spokony, R; Torben-Nielsen, B; White, KP; Moore, AW				Yalgin, Cagri; Ebrahimi, Saman; Delandre, Caroline; Yoong, Li Foong; Akimoto, Saori; Tran, Heidi; Amikura, Reiko; Spokony, Rebecca; Torben-Nielsen, Benjamin; White, Kevin P.; Moore, Adrian W.			Centrosomin represses dendrite branching by orienting microtubule nucleation	NATURE NEUROSCIENCE			English	Article							FINGER PROTEIN ABRUPT; SENSORY NEURONS; SPINE MORPHOLOGY; MICRORNA BANTAM; GOLGI OUTPOSTS; DROSOPHILA; CDK5RAP2; GROWTH; KNOT/COLLIER; NEOCORTEX	Neuronal dendrite branching is fundamental for building nervous systems. Branch formation is genetically encoded by transcriptional programs to create dendrite arbor morphological diversity for complex neuronal functions. In Drosophila sensory neurons, the transcription factor Abrupt represses branching via an unknown effector pathway. Targeted screening for branching-control effectors identified Centrosomin, the primary centrosome-associated protein for mitotic spindle maturation. Centrosomin repressed dendrite branch formation and was used by Abrupt to simplify arbor branching. Live imaging revealed that Centrosomin localized to the Golgi cis face and that it recruited microtubule nucleation to Golgi outposts for net retrograde microtubule polymerization away from nascent dendrite branches. Removal of Centrosomin enabled the engagement of wee Augmin activity to promote anterograde microtubule growth into the nascent branches, leading to increased branching. The findings reveal that polarized targeting of Centrosomin to Golgi outposts during elaboration of the dendrite arbor creates a local system for guiding microtubule polymerization.	[Yalgin, Cagri; Ebrahimi, Saman; Delandre, Caroline; Yoong, Li Foong; Akimoto, Saori; Tran, Heidi; Amikura, Reiko; Moore, Adrian W.] RIKEN Brain Sci Inst, Lab Genet Control Neuronal Architecture, Wako, Saitama, Japan; [Yalgin, Cagri] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Japan; [Spokony, Rebecca; White, Kevin P.] Univ Chicago, Dept Human Genet, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Torben-Nielsen, Benjamin] Grad Univ, Okinawa Inst Sci & Technol, Computat Neurosci Unit, Kunigami, Okinawa, Japan	Moore, AW (reprint author), RIKEN Brain Sci Inst, Lab Genet Control Neuronal Architecture, Wako, Saitama, Japan.	adrianm@brain.riken.jp	Torben-Nielsen, Benjamin/B-6898-2015	Torben-Nielsen, Benjamin/0000-0003-4203-9942	Human Frontiers Program Long-Term Fellowship; RIKEN Brain Science Institute (BSI) core grant	We thank T. Hayashi and I. Nikaido, RIKEN Advanced Center for Computing and Communication (ACCC) for experimental advice, Jared Levine for technical support, and Charles Yokoyama and members of the BSI Laboratory for Genetic Control of Neuronal Architecture for discussion. This work was funded by a Human Frontiers Program Long-Term Fellowship to L.F.Y and a RIKEN Brain Science Institute (BSI) core grant to A.W.M.	Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Sitaram P, 2012, DEVELOPMENT, V139, P2945, DOI 10.1242/dev.077511; Stewart A, 2012, J NEUROSCI, V32, P11631, DOI 10.1523/JNEUROSCI.0729-12.2012; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Zhang L, 2012, CEREB CORTEX, V22, P1510, DOI 10.1093/cercor/bhr215; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Yau KW, 2014, NEURON, V82, P1058, DOI 10.1016/j.neuron.2014.04.019; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hattori Y, 2013, DEV CELL, V27, P530, DOI 10.1016/j.devcel.2013.10.024; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Karim MR, 2011, J NEUROSCI, V31, P17017, DOI 10.1523/JNEUROSCI.2815-11.2011; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Song YQ, 2012, GENE DEV, V26, P1612, DOI 10.1101/gad.193243.112; Hayward D, 2014, DEV CELL, V28, P81, DOI 10.1016/j.devcel.2013.12.001; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Karim M.R., 2011, JOVE-J VIS EXP, V57, pe3111; Meireles Ana M, 2009, J Cell Biol, V184, P777, DOI 10.1083/jcb.200811102; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Richardson CE, 2014, ELIFE, V3, DOI 10.7554/eLife.01498; Sanchez-Huertas C, 2015, CURR BIOL, V25, pR294, DOI 10.1016/j.cub.2015.02.006; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Yalgin C., 2011, JOVE-J VIS EXP, V57, pe3662	53	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1437	+		10.1038/nn.4099		10	Neurosciences	Neurosciences & Neurology	CS2OK	WOS:000361910600015		
J	Hama, H; Hioki, H; Namiki, K; Hoshida, T; Kurokawa, H; Ishidate, F; Kaneko, T; Akagi, T; Saito, T; Saido, T; Miyawaki, A				Hama, Hiroshi; Hioki, Hiroyuki; Namiki, Kana; Hoshida, Tetsushi; Kurokawa, Hiroshi; Ishidate, Fumiyoshi; Kaneko, Takeshi; Akagi, Takumi; Saito, Takashi; Saido, Takaomi; Miyawaki, Atsushi			Sca/eS: an optical clearing palette for biological imaging	NATURE NEUROSCIENCE			English	Article							SINGLE-CELL RESOLUTION; AMYLOID DEPOSITION; TRANSGENIC MICE; ALZHEIMERS-DISEASE; MOUSE MODELS; HUMAN BRAIN; TISSUE; RECONSTRUCTION; VISUALIZATION; MECHANISMS	Optical clearing methods facilitate deep biological imaging by mitigating light scattering in situ. Multi-scale high-resolution imaging requires preservation of tissue integrity for accurate signal reconstruction. However, existing clearing reagents contain chemical components that could compromise tissue structure, preventing reproducible anatomical and fluorescence signal stability. We developed Sca /eS, a sorbitol-based optical clearing method that provides stable tissue preservation for immunochemical labeling and three-dimensional (3D) signal rendering. Sca /eS permitted optical reconstructions of aged and diseased brain in Alzheimer's disease models, including mapping of 3D networks of amyloid plaques, neurons and microglia, and multi-scale tracking of single plaques by successive fluorescence and electron microscopy. Human clinical samples from Alzheimer's disease patients analyzed via reversible optical re-sectioning illuminated plaque pathogenesis in the z axis. Comparative benchmarking of contemporary clearing agents showed superior signal and structure preservation by Sca /eS. These findings suggest that Sca /eS is a simple and reproducible method for accurate visualization of biological tissue.	[Hama, Hiroshi; Namiki, Kana; Kurokawa, Hiroshi; Ishidate, Fumiyoshi; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan; [Hioki, Hiroyuki; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Kyoto, Japan; [Hoshida, Tetsushi; Miyawaki, Atsushi] RIKEN, Biotechnol Opt Res Team, Ctr Adv Photon, Wako, Saitama, Japan; [Akagi, Takumi] RIKEN, Support Unit Anim Resources Dev, Brain Sci Inst, Wako, Saitama, Japan; [Saito, Takashi; Saido, Takaomi] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan	Miyawaki, A (reprint author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan.	matsushi@brain.riken.jp	Saito, Takashi/G-2563-2015		Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED	We thank H. Sakurai for general assistance, RIKEN BSI-Olympus Collaboration Center for technical support, K. Higuchi, K. Ishihara, D. Nishiwaki, Y. Ue, K. Okazaki, A. Yaguchi, Y. Sato, H. Sakuma, K. Koga and B. Zimmermann for help with acquiring and analyzing LM images, K. Okamoto-Furuta and H. Kohda (Division of Electron Microscopic Study Center for Anatomical Studies, Graduate School of Medicine, Kyoto University) for their technical assistance in EM, G. Augustine (Duke University) for the ChR2-YFP Tg mice, J.R. Sanes (Harvard University) for the YFP-H line, R. Takahashi, Dr. K. Sohya and T. Tsumoto for advice on Tg mice, and C. Yokoyama and A. Terashima for critical reading and editing of the manuscript. This work was supported in part by grants from the Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas, the Human Frontier Science Program, and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED.	Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; OZAKI HS, 1992, J COMP NEUROL, V323, P81, DOI 10.1002/cne.903230107; Zhu DY, 2003, J NEUROSCI, V23, P223; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Wilcock DM, 2003, J NEUROSCI, V23, P3745; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hou B, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00019; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P462, DOI 10.1097/NEN.0b013e3182933788; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Thal DR, 2008, ACTA NEUROPATHOL, V115, P175, DOI 10.1007/s00401-007-0330-6; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; Davanlou M., 2004, Image Analysis & Stereology, V23; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Murak R.E, 2012, INT J ALZHEIMERS DIS, DOI [10.1155/2012/165021, DOI 10.1155/2012/165021]; Oh KJ, 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/780102, DOI 10.4061/2010/780102]; Ono M, 2009, BIOORGAN MED CHEM, V17, P7002, DOI 10.1016/j.bmc.2009.08.032; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Thal D.T., 2006, SCI AGING KNOWLEDGE, V6, P1; Torres-Platas S.G, 2014, J NEUROINFLAMM, V11, P1; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Yoshikawa F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013932	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1518	+		10.1038/nn.4107		14	Neurosciences	Neurosciences & Neurology	CS2OK	WOS:000361910600024		
J	He, H; Nakagawa, K; Wang, YS; Hosokawa, Y; Goda, K				He, Hao; Nakagawa, Keiichi; Wang, Yisen; Hosokawa, Yoichiro; Goda, Keisuke			Mechanism for microtsunami-induced intercellular mechanosignalling	NATURE PHOTONICS			English	Letter									[He, Hao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Med X Res Inst, Shanghai 200031, Peoples R China; [He, Hao; Wang, Yisen] Tianjin Univ, Coll Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China; [Nakagawa, Keiichi; Wang, Yisen; Goda, Keisuke] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan; [Hosokawa, Yoichiro] Nara Inst Sci & Technol, Ikoma 6300192, Japan; [Goda, Keisuke] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	He, H (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Med X Res Inst, Shanghai 200031, Peoples R China.	goda@chem.s.u-tokyo.ac.jp					Compton JL, 2014, NAT PHOTONICS, V8, P710, DOI [10.1038/nphoton.2014.165, 10.1038/NPHOTON.2014.165]; He H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4707375; Liu XL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3080218; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Rau KR, 2004, APPL PHYS LETT, V84, P2940, DOI 10.1063/1.1705728; Bootman MD, 2009, J CELL SCI, V122, P2337, DOI 10.1242/jcs.028100; Zhao YA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3454390; Schwiebert EM, 2000, AM J PHYSIOL-CELL PH, V279, pC281	8	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	OCT	2015	9	10					623	623		10.1038/nphoton.2015.164		1	Optics; Physics, Applied	Optics; Physics	CS3KY	WOS:000361974200001		
J	Pirandola, S; Eisert, J; Weedbrook, C; Furusawa, A; Braunstein, SL				Pirandola, S.; Eisert, J.; Weedbrook, C.; Furusawa, A.; Braunstein, S. L.			Advances in quantum teleportation	NATURE PHOTONICS			English	Review							CONTINUOUS-VARIABLE ENTANGLEMENT; PODOLSKY-ROSEN CHANNELS; EXPERIMENTAL REALIZATION; COHERENCE TIME; ATOMIC QUBITS; ONE 2ND; STATE; MEMORY; SYSTEMS; CLONING	Quantum teleportation is one of the most important protocols in quantum information. By exploiting the physical resource of entanglement, quantum teleportation serves as a key primitive across a variety of quantum information tasks and represents an important building block for quantum technologies, with a pivotal role in the continuing progress of quantum communication, quantum computing and quantum networks. Here we summarize the basic theoretical ideas behind quantum teleportation and its variant protocols. We focus on the main experiments, together with the technical advantages and disadvantages associated with the use of the various technologies, from photonic qubits and optical modes to atomic ensembles, trapped atoms and solid-state systems. After analysing the current state-of-the-art, we finish by discussing open issues, challenges and potential future implementations.	[Pirandola, S.; Braunstein, S. L.] Univ York, Comp Sci & York Ctr Quantum Technol, York YO10 5GH, N Yorkshire, England; [Eisert, J.] Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, D-14195 Berlin, Germany; [Weedbrook, C.] Univ Toronto, Dept Phys, Toronto, ON M5S 3G4, Canada; [Furusawa, A.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Pirandola, S (reprint author), Univ York, Comp Sci & York Ctr Quantum Technol, York YO10 5GH, N Yorkshire, England.	stefano.pirandola@york.ac.uk			Leverhulme Trust (qBIO); EPSRC, via qDATA [EP/L011298/1]; UK Quantum Communications Hub [EP/M013472/1]; BMBF (Q.com); EU; ERC	S.P. was supported by the Leverhulme Trust (qBIO) and the EPSRC, via qDATA (Grant No. EP/L011298/1) and the UK Quantum Communications Hub (Grant No. EP/M013472/1). J.E. was supported by BMBF (Q.com), the EU (SIQS, RAQUEL, AQuS) and the ERC (TAQ). The authors would like to acknowledge useful feedback from U.L. Andersen, G. Chiribella, N. Gisin, A. Imamoglu, C.-Y. Lu, P. van Loock, S. Mancini, C. Monroe, S. Olmschenk, J. W. Pan, W. Pfaff, E. Polzik, S. Popescu, T. C. Ralph, V. Scarani, F. Sciarrino, C. Simon, R. Thew, W. Tittel, A. Wallraff and D. J. Wineland.	Aliferis P, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062314; Braunstein SI, 1998, NATURE, V394, P840, DOI 10.1038/29674; Eisert J, 2003, INT J QUANTUM INF, V1, P479, DOI 10.1142/S0219749903000371; Andersen UL, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050504; Vidal G, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032314; Ishizaka S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.240501; Cerf NJ, 2000, PHYS REV LETT, V85, P1754, DOI 10.1103/PhysRevLett.85.1754; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Werner RF, 2001, J PHYS A-MATH GEN, V34, P7081, DOI 10.1088/0305-4470/34/35/332; Braunstein SL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.022321; Gao WB, 2010, P NATL ACAD SCI USA, V107, P20869, DOI 10.1073/pnas.1005720107; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Bowen WP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.032302; Steffen L, 2013, NATURE, V500, P319, DOI 10.1038/nature12422; Beigi S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093036; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Nielsen MA, 1998, NATURE, V396, P52, DOI 10.1038/23891; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Zhong MJ, 2015, NATURE, V517, P177, DOI 10.1038/nature14025; Braunstein SL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130502; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Wang XL, 2015, NATURE, V518, P516, DOI 10.1038/nature14246; Hammerer K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.150503; Pirandola S, 2015, NAT PHOTONICS, V9, P397, DOI 10.1038/NPHOTON.2015.83; Yonezawa H, 2004, NATURE, V431, P430, DOI 10.1038/nature02858; Yokoyama S, 2013, NAT PHOTONICS, V7, P982, DOI [10.1038/nphoton.2013.287, 10.1038/NPHOTON.2013.287]; Pirandola S, 2006, LASER PHYS, V16, P1418, DOI 10.1134/S1054660X06100057; Braunstein SL, 2000, PHYS REV LETT, V84, P3486, DOI 10.1103/PhysRevLett.84.3486; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Eisert J, 2004, ANN PHYS-NEW YORK, V311, P431, DOI 10.1016/j.aop.2003.12.008; Lee N, 2011, SCIENCE, V332, P330, DOI 10.1126/science.1201034; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Jia XJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250503; Pan JW, 2003, NATURE, V421, P721, DOI 10.1038/nature01412; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Buzek V, 1996, PHYS REV A, V54, P1844, DOI 10.1103/PhysRevA.54.1844; Karlsson A, 1998, PHYS REV A, V58, P4394, DOI 10.1103/PhysRevA.58.4394; ZUKOWSKI M, 1993, PHYS REV LETT, V71, P4287, DOI 10.1103/PhysRevLett.71.4287; Polkinghorne RES, 1999, PHYS REV LETT, V83, P2095, DOI 10.1103/PhysRevLett.83.2095; Chiribella G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.010501; Zhang J, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.032318; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Radnaev AG, 2010, NAT PHYS, V6, P894, DOI [10.1038/nphys1773, 10.1038/NPHYS1773]; Takeda S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100501; Pirandola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150403; Bruss D, 1998, PHYS REV A, V57, P2368, DOI 10.1103/PhysRevA.57.2368; Raussendorf R, 2001, PHYS REV LETT, V86, P5188, DOI 10.1103/PhysRevLett.86.5188; Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370; Nielsen MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040503; VAIDMAN L, 1994, PHYS REV A, V49, P1473, DOI 10.1103/PhysRevA.49.1473; Zhang TC, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.033802; Lloyd S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040403; Marcikic I, 2003, NATURE, V421, P509, DOI 10.1038/nature01376; van Loock P, 2000, PHYS REV A, V62; Jin XM, 2010, NAT PHOTONICS, V4, P376, DOI 10.1038/NPHOTON.2010.87; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; Koike S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.060504; Giacomini S, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.030302; Takei N, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042304; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Calsamiglia J, 2001, APPL PHYS B-LASERS O, V72, P67, DOI 10.1007/s003400000484; Abdi M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.143601; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Jobez P, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230502; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Plenio MB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090503; Yukawa M, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022314; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Press D, 2010, NAT PHOTONICS, V4, P367, DOI 10.1038/NPHOTON.2010.83; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Krauter H, 2013, NAT PHYS, V9, P400, DOI 10.1038/nphys2631; Brassard G, 1998, PHYSICA D, V120, P43, DOI 10.1016/S0167-2789(98)00043-8; Ursin R, 2004, NATURE, V430, P849, DOI 10.1038/430849a; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Fattal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037904; Menicucci NC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.110501; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Hucul D, 2015, NAT PHYS, V11, P37, DOI 10.1038/NPHYS3150; Specht HP, 2011, NATURE, V473, P190, DOI 10.1038/nature09997; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Brendel J, 1999, PHYS REV LETT, V82, P2594, DOI 10.1103/PhysRevLett.82.2594; Simon C, 2010, EUR PHYS J D, V58, P1, DOI 10.1140/epjd/e2010-00103-y; Owari M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113014; Grice WP, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.042331; Landry O, 2007, J OPT SOC AM B, V24, P398, DOI 10.1364/JOSAB.24.000398; Murao M, 1999, PHYS REV A, V59, P156, DOI 10.1103/PhysRevA.59.156; Lance AM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.177903; Hillery M, 1999, PHYS REV A, V59, P1829, DOI 10.1103/PhysRevA.59.1829; Scarani V, 2005, REV MOD PHYS, V77, P1225, DOI 10.1103/RevModPhys.77.1225; WEINFURTER H, 1994, EUROPHYS LETT, V25, P559, DOI 10.1209/0295-5075/25/8/001; Gross D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220503; Bennett CH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077902; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Xiang ZL, 2013, REV MOD PHYS, V85, P623, DOI 10.1103/RevModPhys.85.623; Bao XH, 2012, P NATL ACAD SCI USA, V109, P20347, DOI 10.1073/pnas.1207329109; van Loock P, 2000, PHYS REV LETT, V84, P3482, DOI 10.1103/PhysRevLett.84.3482; Pfaff W, 2014, SCIENCE, V345, P532, DOI 10.1126/science.1253512; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Ishizaka S, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.042306; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Gottesman D, 1999, NATURE, V402, P390; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Riebe M, 2004, NATURE, V429, P734, DOI 10.1038/nature02570; Metcalf BJ, 2014, NAT PHOTONICS, V8, P770, DOI [10.1038/nphoton.2014.217, 10.1038/NPHOTON.2014.217]; Lombardi E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.070402; Bar-Gill N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2771; Barrett MD, 2004, NATURE, V429, P737, DOI 10.1038/nature02608; Braunstein S. L., 1999, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.010302; BRAUNSTEIN SL, 1995, PHYS REV A, V51, pR1727; Buhrman H, 2015, QUANTUM COMMUNICATIO; Bussieres F, 2014, NAT PHOTONICS, V8, P775, DOI [10.1038/nphoton.2014.215, 10.1038/NPHOTON.2014.215]; Calsamiglia J, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.050301; de Riedmatten H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047904; Eisert J, 2001, THESIS POTSDAM U; Ewert F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.140403; Fort C.H., 1931, LOL; Yonezawa H, 2007, PHYS REV LETT, V99, DOI [10.1103/PhysRevLett.99.110503, 10.1103/PhyRevLett.99.110503]; Furusawa A., 2011, QUANTUM TELEPORTATIO; Gao WB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3744; Harty TP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220501; Kurizki G, 2015, P NATL ACAD SCI USA, V112, P3866, DOI 10.1073/pnas.1419326112; Lee H.-W., 2000, PHYS REV A, V63, DOI DOI 10.1103/PHYSREVA.63.012305; Nielsen M, 2000, QUANTUM COMPUTATION; O'Brien C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.063603; Strelchuk S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010505; Pirandola S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062317; Reagor M, 2015, QUANTUM MEMORY NEAR; Riebe M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/211; Schori C, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033802; Takei N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220502; van Loock P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.247901; Walls D. F., 1994, QUANTUM OPTICS; Wilde M. M., 2013, QUANTUM INFORM THEOR; Zaidi HA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.260501; Zhao Z, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030502	139	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	OCT	2015	9	10					641	652		10.1038/NPHOTON.2015.154		12	Optics; Physics, Applied	Optics; Physics	CS3KY	WOS:000361974200009		
J	Adam, J; Adamova, D; Aggarwal, MM; Rinella, GA; Agnello, M; Agrawal, N; Ahammed, Z; Ahmed, I; Ahn, SU; Aimo, I; Aiola, S; Ajaz, M; Akindinov, A; Alam, SN; Aleksandrov, D; Alessandro, B; Alexandre, D; Molina, RA; Alici, A; Alkin, A; Alme, J; Alt, T; Altinpinar, S; Altsybeev, I; Prado, CAG; Andrei, C; Andronic, A; Anguelov, V; Anielski, J; Anticic, T; Antinori, F; Antonioli, P; Aphecetche, L; Appelshauser, H; Arcelli, S; Armesto, N; Arnaldi, R; Aronsson, T; Arsene, IC; Arslandok, M; Augustinus, A; Averbeck, R; Azmi, MD; Bach, M; Badala, A; Baek, YW; Bagnasco, S; Bailhache, R; Bala, R; Baldisseri, A; Ball, M; Pedrosa, FBDS; Baral, RC; Barbano, AM; Barbera, R; Barile, F; Barnafoldi, GG; Barnby, LS; Barret, V; Bartalini, P; Bartke, J; Bartsch, E; Basile, M; Bastid, N; Basu, S; Bathen, B; Batigne, G; Camejo, AB; Batyunya, B; Batzing, PC; Bearden, IG; Beck, H; Bedda, C; Behera, NK; Belikov, I; Bellini, F; Martinez, HB; Bellwied, R; Belmont, R; Belmont-Moreno, E; Belyaev, V; Bencedi, G; Beole, S; Berceanu, I; Bercuci, A; Berdnikov, Y; Berenyi, D; Bertens, RA; Berzano, D; Betev, L; Bhasin, A; Bhat, IR; Bhati, AK; Bhattacharjee, B; Bhom, J; Bianchi, L; Bianchi, N; Bianchin, C; Bielcik, J; Bielcikova, J; Bilandzic, A; Biswas, S; Bjelogrlic, S; Blanco, F; Blau, D; Blume, C; Bock, F; Bogdanov, A; Boggild, H; Boldizsar, L; Bombara, M; Book, J; Borel, H; Borissov, A; Borri, M; Bossu, F; Botje, M; Botta, E; Bottger, S; Braun-Munzinger, P; Bregant, M; Breitner, T; Broker, TA; Browning, TA; Broz, M; Brucken, EJ; Bruna, E; Bruno, GE; Budnikov, D; Buesching, H; Bufalino, S; Buncic, P; Busch, O; Buthelezi, Z; Buxton, JT; Caffarri, D; Cai, X; Caines, H; Diaz, LC; Caliva, A; Villar, EC; Camerini, P; Carena, F; Carena, W; Castellanos, JC; Castro, AJ; Casula, EAR; Cavicchioli, C; Sanchez, CC; Cepila, J; Cerello, P; Chang, B; Chapeland, S; Chartier, M; Charvet, JL; Chattopadhyay, S; Chattopadhyay, S; Chelnokov, V; Cherney, M; Cheshkov, C; Cheynis, B; Barroso, VC; Chinellato, DD; Chochula, P; Choi, K; Chojnacki, M; Choudhury, S; Christakoglou, P; Christensen, CH; Christiansen, P; Chujo, T; Chung, SU; Cicalo, C; Cifarelli, L; Cindolo, F; Cleymans, J; Colamaria, F; Colella, D; Collu, A; Colocci, M; Balbastre, GC; del Valle, ZC; Connors, ME; Contreras, JG; Cormier, TM; Morales, YC; Maldonado, IC; Cortese, P; Cosentino, MR; Costa, F; Crochet, P; Albino, RC; Cuautle, E; Cunqueiro, L; Dahms, T; Dainese, A; Danu, A; Das, D; Das, I; Das, S; Dash, A; Dash, S; De, S; De Caro, A; de Cataldo, G; de Cuveland, J; De Falco, A; De Gruttola, D; De Marco, N; De Pasquale, S; Deisting, A; Deloff, A; Denes, E; D'Erasmo, G; Di Bari, D; Di Mauro, A; Di Nezza, P; Corchero, MAD; Dietel, T; Dillenseger, P; Divia, R; Djuvsland, O; Dobrin, A; Dobrowolski, T; Gimenez, DD; Donigus, B; Dordic, O; Dubey, AK; Dubla, A; Ducroux, L; Dupieux, P; Ehlers, RJ; Elia, D; Engel, H; Erazmus, B; Erhardt, F; Eschweiler, D; Espagnon, B; Estienne, M; Esumi, S; Evans, D; Evdokimov, S; Eyyubova, G; Fabbietti, L; Fabris, D; Faivre, J; Fantoni, A; Fasel, M; Feldkamp, L; Felea, D; Feliciello, A; Feofilov, G; Ferencei, J; Tellez, AF; Ferreiro, EG; Ferretti, A; Festanti, A; Figiel, J; Figueredo, MAS; Filchagin, S; Finogeev, D; Fionda, FM; Fiore, EM; Fleck, MG; Floris, M; Foertsch, S; Foka, P; Fokin, S; Fragiacomo, E; Francescon, A; Frankenfeld, U; Fuchs, U; Furget, C; Furs, A; Girard, MF; Gaardhoje, JJ; Gagliardi, M; Gago, AM; Gallio, M; Gangadharan, DR; Ganoti, P; Gao, C; Garabatos, C; Garcia-Solis, E; Gargiulo, C; Gasik, P; Germain, M; Gheata, A; Gheata, M; Ghosh, P; Ghosh, SK; Gianotti, P; Giubellino, P; Giubilato, P; Gladysz-Dziadus, E; Glassel, P; Coral, DMG; Ramirez, AG; Gonzalez-Zamora, P; Gorbunov, S; Gorlich, L; Gotovac, S; Grabski, V; Graczykowski, LK; Grelli, A; Grigoras, A; Grigoras, C; Grigoriev, V; Grigoryan, A; Grigoryan, S; Grinyov, B; Grion, N; Grosse-Oetringhaus, JF; Grossiord, JY; Grosso, R; Grigoryan, A; Grigoryan, S; Grinyov, B; Grion, N; Grosse-Oetringhaus, JF; Grossiord, JY; Grosso, R; Guber, F; Guernane, R; Guerzoni, B; Gulbrandsen, K; Gulkanyan, H; Gunji, T; Gupta, A; Gupta, R; Haake, R; Haaland, O; Hadjidakis, C; Haiduc, M; Hamagaki, H; Hamar, G; Hanratty, LD; Hansen, A; Harris, JW; Hartmann, H; Harton, A; Hatzifotiadou, D; Hayashi, S; Heckel, ST; Heide, M; Helstrup, H; Herghelegiu, A; Corral, GH; Hess, BA; Hetland, KF; Hilden, TE; Hillemanns, H; Hippolyte, B; Hristov, P; Huang, M; Humanic, TJ; Hussain, N; Hussain, T; Hutter, D; Hwang, DS; Ilkaev, R; Ilkiv, I; Inaba, M; Ionita, C; Ippolitov, M; Irfan, M; Ivanov, M; Ivanov, V; Izucheev, V; Jacobs, PM; Jahnke, C; Jang, HJ; Janik, MA; Jayarathna, PHSY; Jena, C; Jena, S; Bustamante, RTJ; Jones, PG; Jung, H; Jusko, A; Kalinak, P; Kalweit, A; Kamin, J; Kang, JH; Kaplin, V; Kar, S; Uysal, AK; Karavichev, O; Karavicheva, T; Karpechev, E; Kebschull, U; Keidel, R; Keijdener, DLD; Keil, M; Khan, KH; Khan, MM; Khan, P; Khan, SA; Khanzadeev, A; Kharlov, Y; Kileng, B; Kim, B; Kim, DW; Kim, DJ; Kim, H; Kim, JS; Kim, M; Kim, M; Kim, S; Kim, T; Kirsch, S; Kisel, I; Kiselev, S; Kisiel, A; Kiss, G; Klay, JL; Klein, C; Klein, J; Klein-Bosing, C; Kluge, A; Knichel, ML; Knospe, AG; Kobayashi, T; Kobdaj, C; Kofarago, M; Kohler, MK; Kollegger, T; Kolojvari, A; Kondratiev, V; Kondratyeva, N; Kondratyuk, E; Konevskikh, A; Kour, M; Kouzinopoulos, C; Kovalenko, V; Kowalski, M; Kox, S; Meethaleveedu, GK; Kral, J; Kralik, I; Kravcakova, A; Krelina, M; Kretz, M; Krivda, M; Krizek, F; Kryshen, E; Krzewicki, M; Kubera, AM; Kucera, V; Kucheriaev, Y; Kugathasan, T; Kuhn, C; Kuijer, PG; Kulakov, I; Kumar, A; Kumar, J; Kumar, L; Kurashvili, P; Kurepin, A; Kurepin, AB; Kuryakin, A; Kushpil, S; Kweon, MJ; Kwon, Y; La Pointe, SL; La Rocca, P; Fernandes, CL; Lakomov, I; Langoy, R; Lara, C; Lardeux, A; Lattuca, A; Laudi, E; Lea, R; Leardini, L; Lee, GR; Lee, S; Legrand, I; Lehnert, J; Lemmon, RC; Lenti, V; Leogrande, E; Monzon, IL; Leoncino, M; Levai, P; Li, S; Li, X; Lien, J; Lietava, R; Lindal, S; Lindenstruth, V; Lippmann, C; Lisa, MA; Ljunggren, HM; Lodato, DF; Loenne, PI; Loggins, VR; Loginov, V; Loizides, C; Lopez, X; Torres, EL; Lowe, A; Lu, XG; Luettig, P; Lunardon, M; Luparello, G; Maevskaya, A; Mager, M; Mahajan, S; Mahmood, SM; Maire, A; Majka, RD; Malaev, M; Cervantes, IM; Malinina, L; Mal'Kevich, D; Malzacher, P; Mamonov, A; Manceau, L; Manko, V; Manso, F; Manzari, V; Marchisone, M; Mares, J; Margagliotti, GV; Margotti, A; Margutti, J; Marin, A; Markert, C; Marquard, M; Martashvili, I; Martin, NA; Blanco, JM; Martinengo, P; Martinez, MI; Garcia, GM; Pedreira, MM; Martynov, Y; Mas, A; Masciocchi, S; Masera, M; Masoni, A; Massacrier, L; Mastroserio, A; Matyja, A; Mayer, C; Mazer, J; Mazzoni, MA; Mcdonald, D; Meddi, F; Menchaca-Rocha, A; Meninno, E; Perez, JM; Meres, M; Miake, Y; Mieskolainen, MM; Mikhaylov, K; Milano, L; Milosevic, J; Minervini, LM; Mischke, A; Mishra, AN; Miskowiec, D; Mitra, J; Mitu, CM; Mohammadi, N; Mohanty, B; Molnar, L; Zetina, LM; Montes, E; Morando, M; De Godoy, DAM; Moreno, LAP; Moretto, S; Morreale, A; Morsch, A; Muccifora, V; Mudnic, E; Muhlheim, D; Muhuri, S; Mukherjee, M; Muller, H; Mulligan, JD; Munhoz, MG; Murray, S; Musa, L; Musinsky, J; Nandi, BK; Nania, R; Nappi, E; Naru, MU; Nattrass, C; Nayak, K; Nayak, TK; Nazarenko, S; Nedosekin, A; Nellen, L; Ng, F; Nicassio, M; Niculescu, M; Niedziela, J; Nielsen, BS; Nikolaev, S; Nikulin, S; Nikulin, V; Noferini, F; Nomokonov, P; Nooren, G; Norman, J; Nyanin, A; Nystrand, J; Oeschler, H; Oh, S; Oh, SK; Ohlson, A; Okatan, A; Okubo, T; Olah, L; Oleniacz, J; Da Silva, ACO; Oliver, MH; Onderwaater, J; Oppedisano, C; Velasquez, AO; Oskarsson, A; Otwinowski, J; Oyama, K; Ozdemir, M; Pachmayer, Y; Pagano, P; Paic, G; Pajares, C; Pal, SK; Pan, J; Pandey, AK; Pant, D; Papikyan, V; Pappalardo, GS; Pareek, P; Park, WJ; Parmar, S; Passfeld, A; Paticchio, V; Paul, B; Pawlak, T; Peitzmann, T; Da Costa, HP; De Oliveira, EP; Peresunko, D; Lara, CEP; Peskov, V; Pestov, Y; Petracek, V; Petrov, V; Petrovici, M; Petta, C; Piano, S; Pikna, M; Pillot, P; Pinazza, O; Pinsky, L; Piyarathna, DB; Ploskon, M; Planinic, M; Pluta, J; Pochybova, S; Podesta-Lerma, PLM; Poghosyan, MG; Polichtchouk, B; Poljak, N; Poonsawat, W; Pop, A; Porteboeuf-Houssais, S; Porter, J; Pospisil, J; Prasad, SK; Preghenella, R; Prino, F; Pruneau, CA; Pshenichnov, I; Puccio, M; Puddu, G; Pujahari, P; Punin, V; Putschke, J; Qvigstad, H; Rachevski, A; Raha, S; Rajput, S; Rak, J; Rakotozafindrabe, A; Ramello, L; Raniwala, R; Raniwala, S; Rasanen, SS; Rascanu, BT; Rathee, D; Razazi, V; Read, KF; Real, JS; Redlich, K; Reed, RJ; Rehman, A; Reichelt, P; Reicher, M; Reidt, F; Ren, X; Renfordt, R; Reolon, AR; Reshetin, A; Rettig, F; Revol, JP; Reygers, K; Riabov, V; Ricci, RA; Richert, T; Richter, M; Riedler, P; Riegler, W; Riggi, F; Ristea, C; Rivetti, A; Rocco, E; Cahuantzi, MR; Manso, AR; Roed, K; Rogochaya, E; Rohr, D; Rohrich, D; Romita, R; Ronchetti, F; Ronflette, L; Rosnet, P; Rossi, A; Roukoutakis, F; Roy, A; Roy, C; Roy, P; Montero, AJR; Rui, R; Russo, R; Ryabinkin, E; Ryabov, Y; Rybicki, A; Sadovsky, S; Safarik, K; Sahlmuller, B; Sahoo, P; Sahoo, R; Sahoo, S; Sahu, PK; Saini, J; Sakai, S; Saleh, MA; Salgado, CA; Salzwedel, J; Sambyal, S; Samsonov, V; Castro, XS; Sandor, L; Sandoval, A; Sano, M; Santagati, G; Sarkar, D; Scapparone, E; Scarlassara, F; Scharenberg, RP; Schiaua, C; Schicker, R; Schmidt, C; Schmidt, HR; Schuchmann, S; Schukraft, J; Schulc, M; Schuster, T; Schutz, Y; Schwarz, K; Schweda, K; Scioli, G; Scomparin, E; Scott, R; Seeder, KS; Seger, JE; Sekiguchi, Y; Selyuzhenkov, I; Senosi, K; Seo, J; Serradilla, E; Sevcenco, A; Shabanov, A; Shabetai, A; Shadura, O; Shahoyan, R; Shangaraev, A; Sharma, A; Sharma, M; Sharma, N; Shigaki, K; Shtejer, K; Sibiriak, Y; Siddhanta, S; Sielewicz, KM; Siemiarczuk, T; Silvermyr, D; Silvestre, C; Simatovic, G; Simonetti, G; Singaraju, R; Singh, R; Singha, S; Singhal, V; Sinha, BC; Sinha, T; Sitar, B; Sitta, M; Skaali, TB; Slupecki, M; Smirnov, N; Snellings, RJM; Snellman, TW; Sogaard, C; Soltz, R; Song, J; Song, M; Song, Z; Soramel, F; Sorensen, S; Spacek, M; Spiriti, E; Sputowska, I; Spyropoulou-Stassinaki, M; Srivastava, BK; Stachel, J; Stan, I; Stefanek, G; Steinpreis, M; Stenlund, E; Steyn, G; Stiller, JH; Stocco, D; Strmen, P; Suaide, AAP; Sugitate, T; Suire, C; Suleymanov, M; Sultanov, R; Sumbera, M; Symons, TJM; Szabo, A; de Toledo, AS; Szarka, I; Szczepankiewicz, A; Szymanski, M; Takahashi, J; Tanaka, N; Tangaro, MA; Takaki, JDT; Peloni, AT; Tariq, M; Tarzila, MG; Tauro, A; Munoz, GT; Telesca, A; Terasaki, K; Terrevoli, C; Teyssier, B; Thader, J; Thomas, D; Tieulent, R; Timmins, AR; Toia, A; Trogolo, S; Trubnikov, V; Trzaska, WH; Tsuji, T; Tumkin, A; Turrisi, R; Tveter, TS; Ullaland, K; Uras, A; Usai, GL; Utrobicic, A; Vajzer, M; Vala, M; Palomo, LV; Vallero, S; Van der Maarel, J; Van Hoorne, JW; van Leeuwen, M; Vanat, T; Vande Vyvre, P; Varga, D; Vargas, A; Vargyas, M; Varma, R; Vasileiou, M; Vasiliev, A; Vauthier, A; Vechernin, V; Veen, AM; Veldhoen, M; Velure, A; Venaruzzo, M; Vercellin, E; Limon, SV; Vernet, R; Verweij, M; Vickovic, L; Viesti, G; Viinikainen, J; Vilakazi, Z; Baillie, OV; Tello, AV; Vinogradov, A; Vinogradov, L; Vinogradov, Y; Virgili, T; Vislavicius, V; Viyogi, YP; Vodopyanov, A; Volkl, MA; Voloshin, K; Voloshin, SA; Volpe, G; von Haller, B; Vorobyev, I; Vranic, D; Vrlakova, J; Vulpescu, B; Vyushin, A; Wagner, B; Wagner, J; Wang, H; Wang, M; Wang, Y; Watanabe, D; Weber, M; Weber, SG; Wessels, JP; Westerhoff, U; Wiechula, J; Wikne, J; Wilde, M; Wilk, G; Wilkinson, J; Williams, MCS; Windelband, B; Winn, M; Yaldo, CG; Yamaguchi, Y; Yang, H; Yang, P; Yano, S; Yasnopolskiy, S; Yin, Z; Yokoyama, H; Yoo, IK; Yurchenko, V; Yushmanov, I; Zaborowska, A; Zaccolo, V; Zaman, A; Zampolli, C; Zanoli, HJC; Zaporozhets, S; Zarochentsev, A; Zavada, P; Zaviyalov, N; Zbroszczyk, H; Zgura, IS; Zhalov, M; Zhang, H; Zhang, X; Zhang, Y; Zhao, C; Zhigareva, N; Zhou, D; Zhou, Y; Zhou, Z; Zhu, H; Zhu, J; Zhu, X; Zichichi, A; Zimmermann, A; Zimmermann, MB; Zinovjev, G; Zyzak, M				Adam, J.; Adamova, D.; Aggarwal, M. M.; Rinella, G. Aglieri; Agnello, M.; Agrawal, N.; Ahammed, Z.; Ahmed, I.; Ahn, S. U.; Aimo, I.; Aiola, S.; Ajaz, M.; Akindinov, A.; Alam, S. N.; Aleksandrov, D.; Alessandro, B.; Alexandre, D.; Alfaro Molina, R.; Alici, A.; Alkin, A.; Alme, J.; Alt, T.; Altinpinar, S.; Altsybeev, I.; Alves Garcia Prado, C.; Andrei, C.; Andronic, A.; Anguelov, V.; Anielski, J.; Anticic, T.; Antinori, F.; Antonioli, P.; Aphecetche, L.; Appelshaeuser, H.; Arcelli, S.; Armesto, N.; Arnaldi, R.; Aronsson, T.; Arsene, I. C.; Arslandok, M.; Augustinus, A.; Averbeck, R.; Azmi, M. D.; Bach, M.; Badala, A.; Baek, Y. W.; Bagnasco, S.; Bailhache, R.; Bala, R.; Baldisseri, A.; Ball, M.; Pedrosa, F. Baltasar Dos Santos; Baral, R. C.; Barbano, A. M.; Barbera, R.; Barile, F.; Barnafoeldi, G. G.; Barnby, L. S.; Barret, V.; Bartalini, P.; Bartke, J.; Bartsch, E.; Basile, M.; Bastid, N.; Basu, S.; Bathen, B.; Batigne, G.; Camejo, A. Batista; Batyunya, B.; Batzing, P. C.; Bearden, I. G.; Beck, H.; Bedda, C.; Behera, N. K.; Belikov, I.; Bellini, F.; Bello Martinez, H.; Bellwied, R.; Belmont, R.; Belmont-Moreno, E.; Belyaev, V.; Bencedi, G.; Beole, S.; Berceanu, I.; Bercuci, A.; Berdnikov, Y.; Berenyi, D.; Bertens, R. A.; Berzano, D.; Betev, L.; Bhasin, A.; Bhat, I. R.; Bhati, A. K.; Bhattacharjee, B.; Bhom, J.; Bianchi, L.; Bianchi, N.; Bianchin, C.; Bielcik, J.; Bielcikova, J.; Bilandzic, A.; Biswas, S.; Bjelogrlic, S.; Blanco, F.; Blau, D.; Blume, C.; Bock, F.; Bogdanov, A.; Boggild, H.; Boldizsar, L.; Bombara, M.; Book, J.; Borel, H.; Borissov, A.; Borri, M.; Bossu, F.; Botje, M.; Botta, E.; Boettger, S.; Braun-Munzinger, P.; Bregant, M.; Breitner, T.; Broker, T. A.; Browning, T. A.; Broz, M.; Brucken, E. J.; Bruna, E.; Bruno, G. E.; Budnikov, D.; Buesching, H.; Bufalino, S.; Buncic, P.; Busch, O.; Buthelezi, Z.; Buxton, J. T.; Caffarri, D.; Cai, X.; Caines, H.; Diaz, L. Calero; Caliva, A.; Villar, E. Calvo; Camerini, P.; Carena, F.; Carena, W.; Castellanos, J. Castillo; Castro, A. J.; Casula, E. A. R.; Cavicchioli, C.; Ceballos Sanchez, C.; Cepila, J.; Cerello, P.; Chang, B.; Chapeland, S.; Chartier, M.; Charvet, J. L.; Chattopadhyay, Subhasis; Chattopadhyay, Sukalyan; Chelnokov, V.; Cherney, M.; Cheshkov, C.; Cheynis, B.; Barroso, V. Chibante; Chinellato, D. D.; Chochula, P.; Choi, K.; Chojnacki, M.; Choudhury, S.; Christakoglou, P.; Christensen, C. H.; Christiansen, P.; Chujo, T.; Chung, S. U.; Cicalo, C.; Cifarelli, L.; Cindolo, F.; Cleymans, J.; Colamaria, F.; Colella, D.; Collu, A.; Colocci, M.; Balbastre, G. Conesa; del Valle, Z. Conesa; Connors, M. E.; Contreras, J. G.; Cormier, T. M.; Morales, Y. Corrales; Cortes Maldonado, I.; Cortese, P.; Cosentino, M. R.; Costa, F.; Crochet, P.; Cruz Albino, R.; Cuautle, E.; Cunqueiro, L.; Dahms, T.; Dainese, A.; Danu, A.; Das, D.; Das, I.; Das, S.; Dash, A.; Dash, S.; De, S.; De Caro, A.; de Cataldo, G.; de Cuveland, J.; De Falco, A.; De Gruttola, D.; De Marco, N.; De Pasquale, S.; Deisting, A.; Deloff, A.; Denes, E.; D'Erasmo, G.; Di Bari, D.; Di Mauro, A.; Di Nezza, P.; Corchero, M. A. Diaz; Dietel, T.; Dillenseger, P.; Divia, R.; Djuvsland, O.; Dobrin, A.; Dobrowolski, T.; Domenicis Gimenez, D.; Doenigus, B.; Dordic, O.; Dubey, A. K.; Dubla, A.; Ducroux, L.; Dupieux, P.; Ehlers, R. J.; Elia, D.; Engel, H.; Erazmus, B.; Erhardt, F.; Eschweiler, D.; Espagnon, B.; Estienne, M.; Esumi, S.; Evans, D.; Evdokimov, S.; Eyyubova, G.; Fabbietti, L.; Fabris, D.; Faivre, J.; Fantoni, A.; Fasel, M.; Feldkamp, L.; Felea, D.; Feliciello, A.; Feofilov, G.; Ferencei, J.; Fernandez Tellez, A.; Ferreiro, E. G.; Ferretti, A.; Festanti, A.; Figiel, J.; Figueredo, M. A. S.; Filchagin, S.; Finogeev, D.; Fionda, F. M.; Fiore, E. M.; Fleck, M. G.; Floris, M.; Foertsch, S.; Foka, P.; Fokin, S.; Fragiacomo, E.; Francescon, A.; Frankenfeld, U.; Fuchs, U.; Furget, C.; Furs, A.; Girard, M. Fusco; Gaardhoje, J. J.; Gagliardi, M.; Gago, A. M.; Gallio, M.; Gangadharan, D. R.; Ganoti, P.; Gao, C.; Garabatos, C.; Garcia-Solis, E.; Gargiulo, C.; Gasik, P.; Germain, M.; Gheata, A.; Gheata, M.; Ghosh, P.; Ghosh, S. K.; Gianotti, P.; Giubellino, P.; Giubilato, P.; Gladysz-Dziadus, E.; Glaessel, P.; Gomez Coral, D. M.; Ramirez, A. Gomez; Gonzalez-Zamora, P.; Gorbunov, S.; Goerlich, L.; Gotovac, S.; Grabski, V.; Graczykowski, L. K.; Grelli, A.; Grigoras, A.; Grigoras, C.; Grigoriev, V.; Grigoryan, A.; Grigoryan, S.; Grinyov, B.; Grion, N.; Grosse-Oetringhaus, J. F.; Grossiord, J. -Y.; Grosso, R.; Grigoryan, A.; Grigoryan, S.; Grinyov, B.; Grion, N.; Grosse-Oetringhaus, J. F.; Grossiord, J. -Y.; Grosso, R.; Guber, F.; Guernane, R.; Guerzoni, B.; Gulbrandsen, K.; Gulkanyan, H.; Gunji, T.; Gupta, A.; Gupta, R.; Haake, R.; Haaland, O.; Hadjidakis, C.; Haiduc, M.; Hamagaki, H.; Hamar, G.; Hanratty, L. D.; Hansen, A.; Harris, J. W.; Hartmann, H.; Harton, A.; Hatzifotiadou, D.; Hayashi, S.; Heckel, S. T.; Heide, M.; Helstrup, H.; Herghelegiu, A.; Herrera Corral, G.; Hess, B. A.; Hetland, K. F.; Hilden, T. E.; Hillemanns, H.; Hippolyte, B.; Hristov, P.; Huang, M.; Humanic, T. J.; Hussain, N.; Hussain, T.; Hutter, D.; Hwang, D. S.; Ilkaev, R.; Ilkiv, I.; Inaba, M.; Ionita, C.; Ippolitov, M.; Irfan, M.; Ivanov, M.; Ivanov, V.; Izucheev, V.; Jacobs, P. M.; Jahnke, C.; Jang, H. J.; Janik, M. A.; Jayarathna, P. H. S. Y.; Jena, C.; Jena, S.; Jimenez Bustamante, R. T.; Jones, P. G.; Jung, H.; Jusko, A.; Kalinak, P.; Kalweit, A.; Kamin, J.; Kang, J. H.; Kaplin, V.; Kar, S.; Uysal, A. Karasu; Karavichev, O.; Karavicheva, T.; Karpechev, E.; Kebschull, U.; Keidel, R.; Keijdener, D. L. D.; Keil, M.; Khan, K. H.; Khan, M. Mohisin; Khan, P.; Khan, S. A.; Khanzadeev, A.; Kharlov, Y.; Kileng, B.; Kim, B.; Kim, D. W.; Kim, D. J.; Kim, H.; Kim, J. S.; Kim, Mimae; Kim, Minwoo; Kim, S.; Kim, T.; Kirsch, S.; Kisel, I.; Kiselev, S.; Kisiel, A.; Kiss, G.; Klay, J. L.; Klein, C.; Klein, J.; Klein-Boesing, C.; Kluge, A.; Knichel, M. L.; Knospe, A. G.; Kobayashi, T.; Kobdaj, C.; Kofarago, M.; Koehler, M. K.; Kollegger, T.; Kolojvari, A.; Kondratiev, V.; Kondratyeva, N.; Kondratyuk, E.; Konevskikh, A.; Kour, M.; Kouzinopoulos, C.; Kovalenko, V.; Kowalski, M.; Kox, S.; Meethaleveedu, G. Koyithatta; Kral, J.; Kralik, I.; Kravcakova, A.; Krelina, M.; Kretz, M.; Krivda, M.; Krizek, F.; Kryshen, E.; Krzewicki, M.; Kubera, A. M.; Kucera, V.; Kucheriaev, Y.; Kugathasan, T.; Kuhn, C.; Kuijer, P. G.; Kulakov, I.; Kumar, A.; Kumar, J.; Kumar, L.; Kurashvili, P.; Kurepin, A.; Kurepin, A. B.; Kuryakin, A.; Kushpil, S.; Kweon, M. J.; Kwon, Y.; La Pointe, S. L.; La Rocca, P.; Lagana Fernandes, C.; Lakomov, I.; Langoy, R.; Lara, C.; Lardeux, A.; Lattuca, A.; Laudi, E.; Lea, R.; Leardini, L.; Lee, G. R.; Lee, S.; Legrand, I.; Lehnert, J.; Lemmon, R. C.; Lenti, V.; Leogrande, E.; Leon Monzon, I.; Leoncino, M.; Levai, P.; Li, S.; Li, X.; Lien, J.; Lietava, R.; Lindal, S.; Lindenstruth, V.; Lippmann, C.; Lisa, M. A.; Ljunggren, H. M.; Lodato, D. F.; Loenne, P. I.; Loggins, V. R.; Loginov, V.; Loizides, C.; Lopez, X.; Lopez Torres, E.; Lowe, A.; Lu, X. -G.; Luettig, P.; Lunardon, M.; Luparello, G.; Maevskaya, A.; Mager, M.; Mahajan, S.; Mahmood, S. M.; Maire, A.; Majka, R. D.; Malaev, M.; Maldonado Cervantes, I.; Malinina, L.; Mal'Kevich, D.; Malzacher, P.; Mamonov, A.; Manceau, L.; Manko, V.; Manso, F.; Manzari, V.; Marchisone, M.; Mares, J.; Margagliotti, G. V.; Margotti, A.; Margutti, J.; Marin, A.; Markert, C.; Marquard, M.; Martashvili, I.; Martin, N. A.; Blanco, J. Martin; Martinengo, P.; Martinez, M. I.; Garcia, G. Martinez; Pedreira, M. Martinez; Martynov, Y.; Mas, A.; Masciocchi, S.; Masera, M.; Masoni, A.; Massacrier, L.; Mastroserio, A.; Matyja, A.; Mayer, C.; Mazer, J.; Mazzoni, M. A.; Mcdonald, D.; Meddi, F.; Menchaca-Rocha, A.; Meninno, E.; Perez, J. Mercado; Meres, M.; Miake, Y.; Mieskolainen, M. M.; Mikhaylov, K.; Milano, L.; Milosevic, J.; Minervini, L. M.; Mischke, A.; Mishra, A. N.; Miskowiec, D.; Mitra, J.; Mitu, C. M.; Mohammadi, N.; Mohanty, B.; Molnar, L.; Montano Zetina, L.; Montes, E.; Morando, M.; De Godoy, D. A. Moreira; Moreno, L. A. P.; Moretto, S.; Morreale, A.; Morsch, A.; Muccifora, V.; Mudnic, E.; Muehlheim, D.; Muhuri, S.; Mukherjee, M.; Mueller, H.; Mulligan, J. D.; Munhoz, M. G.; Murray, S.; Musa, L.; Musinsky, J.; Nandi, B. K.; Nania, R.; Nappi, E.; Naru, M. U.; Nattrass, C.; Nayak, K.; Nayak, T. K.; Nazarenko, S.; Nedosekin, A.; Nellen, L.; Ng, F.; Nicassio, M.; Niculescu, M.; Niedziela, J.; Nielsen, B. S.; Nikolaev, S.; Nikulin, S.; Nikulin, V.; Noferini, F.; Nomokonov, P.; Nooren, G.; Norman, J.; Nyanin, A.; Nystrand, J.; Oeschler, H.; Oh, S.; Oh, S. K.; Ohlson, A.; Okatan, A.; Okubo, T.; Olah, L.; Oleniacz, J.; Oliveira Da Silva, A. C.; Oliver, M. H.; Onderwaater, J.; Oppedisano, C.; Ortiz Velasquez, A.; Oskarsson, A.; Otwinowski, J.; Oyama, K.; Ozdemir, M.; Pachmayer, Y.; Pagano, P.; Paic, G.; Pajares, C.; Pal, S. K.; Pan, J.; Pandey, A. K.; Pant, D.; Papikyan, V.; Pappalardo, G. S.; Pareek, P.; Park, W. J.; Parmar, S.; Passfeld, A.; Paticchio, V.; Paul, B.; Pawlak, T.; Peitzmann, T.; Da Costa, H. Pereira; Pereira De Oliveira Filho, E.; Peresunko, D.; Lara, C. E. Perez; Peskov, V.; Pestov, Y.; Petracek, V.; Petrov, V.; Petrovici, M.; Petta, C.; Piano, S.; Pikna, M.; Pillot, P.; Pinazza, O.; Pinsky, L.; Piyarathna, D. B.; Ploskon, M.; Planinic, M.; Pluta, J.; Pochybova, S.; Podesta-Lerma, P. L. M.; Poghosyan, M. G.; Polichtchouk, B.; Poljak, N.; Poonsawat, W.; Pop, A.; Porteboeuf-Houssais, S.; Porter, J.; Pospisil, J.; Prasad, S. K.; Preghenella, R.; Prino, F.; Pruneau, C. A.; Pshenichnov, I.; Puccio, M.; Puddu, G.; Pujahari, P.; Punin, V.; Putschke, J.; Qvigstad, H.; Rachevski, A.; Raha, S.; Rajput, S.; Rak, J.; Rakotozafindrabe, A.; Ramello, L.; Raniwala, R.; Raniwala, S.; Rasanen, S. S.; Rascanu, B. T.; Rathee, D.; Razazi, V.; Read, K. F.; Real, J. S.; Redlich, K.; Reed, R. J.; Rehman, A.; Reichelt, P.; Reicher, M.; Reidt, F.; Ren, X.; Renfordt, R.; Reolon, A. R.; Reshetin, A.; Rettig, F.; Revol, J. -P.; Reygers, K.; Riabov, V.; Ricci, R. A.; Richert, T.; Richter, M.; Riedler, P.; Riegler, W.; Riggi, F.; Ristea, C.; Rivetti, A.; Rocco, E.; Rodriguez Cahuantzi, M.; Manso, A. Rodriguez; Roed, K.; Rogochaya, E.; Rohr, D.; Roehrich, D.; Romita, R.; Ronchetti, F.; Ronflette, L.; Rosnet, P.; Rossi, A.; Roukoutakis, F.; Roy, A.; Roy, C.; Roy, P.; Rubio Montero, A. J.; Rui, R.; Russo, R.; Ryabinkin, E.; Ryabov, Y.; Rybicki, A.; Sadovsky, S.; Safarik, K.; Sahlmuller, B.; Sahoo, P.; Sahoo, R.; Sahoo, S.; Sahu, P. K.; Saini, J.; Sakai, S.; Saleh, M. A.; Salgado, C. A.; Salzwedel, J.; Sambyal, S.; Samsonov, V.; Castro, X. Sanchez; Sandor, L.; Sandoval, A.; Sano, M.; Santagati, G.; Sarkar, D.; Scapparone, E.; Scarlassara, F.; Scharenberg, R. P.; Schiaua, C.; Schicker, R.; Schmidt, C.; Schmidt, H. R.; Schuchmann, S.; Schukraft, J.; Schulc, M.; Schuster, T.; Schutz, Y.; Schwarz, K.; Schweda, K.; Scioli, G.; Scomparin, E.; Scott, R.; Seeder, K. S.; Seger, J. E.; Sekiguchi, Y.; Selyuzhenkov, I.; Senosi, K.; Seo, J.; Serradilla, E.; Sevcenco, A.; Shabanov, A.; Shabetai, A.; Shadura, O.; Shahoyan, R.; Shangaraev, A.; Sharma, A.; Sharma, M.; Sharma, N.; Shigaki, K.; Shtejer, K.; Sibiriak, Y.; Siddhanta, S.; Sielewicz, K. M.; Siemiarczuk, T.; Silvermyr, D.; Silvestre, C.; Simatovic, G.; Simonetti, G.; Singaraju, R.; Singh, R.; Singha, S.; Singhal, V.; Sinha, B. C.; Sinha, T.; Sitar, B.; Sitta, M.; Skaali, T. B.; Slupecki, M.; Smirnov, N.; Snellings, R. J. M.; Snellman, T. W.; Sogaard, C.; Soltz, R.; Song, J.; Song, M.; Song, Z.; Soramel, F.; Sorensen, S.; Spacek, M.; Spiriti, E.; Sputowska, I.; Spyropoulou-Stassinaki, M.; Srivastava, B. K.; Stachel, J.; Stan, I.; Stefanek, G.; Steinpreis, M.; Stenlund, E.; Steyn, G.; Stiller, J. H.; Stocco, D.; Strmen, P.; Suaide, A. A. P.; Sugitate, T.; Suire, C.; Suleymanov, M.; Sultanov, R.; Sumbera, M.; Symons, T. J. M.; Szabo, A.; Szanto de Toledo, A.; Szarka, I.; Szczepankiewicz, A.; Szymanski, M.; Takahashi, J.; Tanaka, N.; Tangaro, M. A.; Takaki, J. D. Tapia; Peloni, A. Tarantola; Tariq, M.; Tarzila, M. G.; Tauro, A.; Tejeda Munoz, G.; Telesca, A.; Terasaki, K.; Terrevoli, C.; Teyssier, B.; Thaeder, J.; Thomas, D.; Tieulent, R.; Timmins, A. R.; Toia, A.; Trogolo, S.; Trubnikov, V.; Trzaska, W. H.; Tsuji, T.; Tumkin, A.; Turrisi, R.; Tveter, T. S.; Ullaland, K.; Uras, A.; Usai, G. L.; Utrobicic, A.; Vajzer, M.; Vala, M.; Palomo, L. Valencia; Vallero, S.; Van der Maarel, J.; Van Hoorne, J. W.; van Leeuwen, M.; Vanat, T.; Vande Vyvre, P.; Varga, D.; Vargas, A.; Vargyas, M.; Varma, R.; Vasileiou, M.; Vasiliev, A.; Vauthier, A.; Vechernin, V.; Veen, A. M.; Veldhoen, M.; Velure, A.; Venaruzzo, M.; Vercellin, E.; Vergara Limon, S.; Vernet, R.; Verweij, M.; Vickovic, L.; Viesti, G.; Viinikainen, J.; Vilakazi, Z.; Baillie, O. Villalobos; Villatoro Tello, A.; Vinogradov, A.; Vinogradov, L.; Vinogradov, Y.; Virgili, T.; Vislavicius, V.; Viyogi, Y. P.; Vodopyanov, A.; Voelkl, M. A.; Voloshin, K.; Voloshin, S. A.; Volpe, G.; von Haller, B.; Vorobyev, I.; Vranic, D.; Vrlakova, J.; Vulpescu, B.; Vyushin, A.; Wagner, B.; Wagner, J.; Wang, H.; Wang, M.; Wang, Y.; Watanabe, D.; Weber, M.; Weber, S. G.; Wessels, J. P.; Westerhoff, U.; Wiechula, J.; Wikne, J.; Wilde, M.; Wilk, G.; Wilkinson, J.; Williams, M. C. S.; Windelband, B.; Winn, M.; Yaldo, C. G.; Yamaguchi, Y.; Yang, H.; Yang, P.; Yano, S.; Yasnopolskiy, S.; Yin, Z.; Yokoyama, H.; Yoo, I. -K.; Yurchenko, V.; Yushmanov, I.; Zaborowska, A.; Zaccolo, V.; Zaman, A.; Zampolli, C.; Zanoli, H. J. C.; Zaporozhets, S.; Zarochentsev, A.; Zavada, P.; Zaviyalov, N.; Zbroszczyk, H.; Zgura, I. S.; Zhalov, M.; Zhang, H.; Zhang, X.; Zhang, Y.; Zhao, C.; Zhigareva, N.; Zhou, D.; Zhou, Y.; Zhou, Z.; Zhu, H.; Zhu, J.; Zhu, X.; Zichichi, A.; Zimmermann, A.; Zimmermann, M. B.; Zinovjev, G.; Zyzak, M.		ALICE Collaboration	Precision measurement of the mass difference between light nuclei and anti-nuclei	NATURE PHYSICS			English	Article							SPECTROSCOPY; ANTIHYDROGEN; ANTIPROTON; ELECTRON	The measurement of the mass differences for systems bound by the strong force has reached a very high precision with protons and anti-protons(1,2). The extension of such measurement from (anti-)baryons to (anti-) nuclei allows one to probe any difference in the interactions between nucleons and anti-nucleons encoded in the (anti-) nuclei masses. This force is a remnant of the underlying strong interaction among quarks and gluons and can be described by effective theories(3), but cannot yet be directly derived from quantum chromodynamics. Here we report a measurement of the difference between the ratios of the mass and charge of deuterons (d) and anti-deuterons ((d) over bar), and He-3 and (3)(He) over bar nuclei carried out with the ALICE (A Large Ion Collider Experiment)(4) detector in Pb-Pb collisions at a centre-of-mass energy per nucleon pair of 2.76 TeV. Our direct measurement of the mass-over-charge differences confirms CPT invariance to an unprecedented precision in the sector of light nuclei(5,6). This fundamental symmetry of nature, which exchanges particles with anti-particles, implies that all physics laws are the same under the simultaneous reversal of charge(s) (charge conjugation C), reflection of spatial coordinates (parity transformation P) and time inversion (T).	[Grigoryan, A.; Gulkanyan, H.; Papikyan, V.] Yerevan Phys Inst, AI Alikhanyan Natl Sci Lab, Yerevan 375036, Armenia; [Bello Martinez, H.; Cortes Maldonado, I.; Fernandez Tellez, A.; Martinez, M. I.; Moreno, L. A. P.; Rodriguez Cahuantzi, M.; Tejeda Munoz, G.; Vargas, A.; Vergara Limon, S.; Villatoro Tello, A.] Benemerita Univ Autonoma Puebla, Puebla, Mexico; [Alkin, A.; Chelnokov, V.; Grinyov, B.; Martynov, Y.; Shadura, O.; Trubnikov, V.; Yurchenko, V.; Zinovjev, G.] Bogolyubov Inst Theoret Phys, Kiev, Ukraine; [Das, S.; Ghosh, S. K.; Prasad, S. K.; Raha, S.] Bose Inst, Dept Phys, Kolkata, India; [Das, S.; Ghosh, S. K.; Prasad, S. K.; Raha, S.] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Pestov, Y.] Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Klay, J. L.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Bartalini, P.; Cai, X.; Gao, C.; Li, S.; Ren, X.; Song, Z.; Wang, M.; Yang, P.; Yin, Z.; Zhang, H.; Zhang, Y.; Zhou, D.; Zhu, H.; Zhu, J.; Zhu, X.] Cent China Normal Univ, Wuhan, Peoples R China; [Vernet, R.] IN2P3, Ctr Calcul, Villeurbanne, France; [Ceballos Sanchez, C.; Lopez Torres, E.; Shtejer, K.] Ctr Aplicac Tecnol & Desarrollo Nucl CEADEN, Havana, Cuba; [Blanco, F.; Corchero, M. A. Diaz; Gonzalez-Zamora, P.; Montes, E.; Rubio Montero, A. J.; Serradilla, E.] CIEMAT, Ctr Invest Energet Medioambientales & Tecnol, E-28040 Madrid, Spain; [Contreras, J. G.; Cruz Albino, R.; Herrera Corral, G.; Montano Zetina, L.; Rodriguez Cahuantzi, M.] CINVESTAV, Ctr Invest & Estudios Avanzados, Mexico City 14000, DF, Mexico; [Alici, A.; Cifarelli, L.; De Caro, A.; De Gruttola, D.; Noferini, F.; Revol, J. -P.; Zichichi, A.] Ctr Fermi Museo Stor Fis & Ctr Studi & Ric Enrico, Rome, Italy; [Garcia-Solis, E.; Harton, A.] Chicago State Univ, Chicago, IL USA; [Li, X.] China Inst Atom Energy, Beijing, Peoples R China; [Baldisseri, A.; Borel, H.; Castellanos, J. Castillo; Charvet, J. L.; Lardeux, A.; Da Costa, H. Pereira; Rakotozafindrabe, A.] IRFU, Commiss Energie Atom, Saclay, France; [Ahmed, I.; Ajaz, M.; Khan, K. H.; Naru, M. U.; Suleymanov, M.; Zaman, A.] COMSATS Inst Informat Technol, Islamabad, Pakistan; [Armesto, N.; Ferreiro, E. G.; Pajares, C.; Salgado, C. A.] Univ Santiago de Compostela, Dept Fis Particulas, Santiago De Compostela, Spain; [Armesto, N.; Ferreiro, E. G.; Pajares, C.; Salgado, C. A.] Univ Santiago de Compostela, IGFAE, Santiago De Compostela, Spain; [Altinpinar, S.; Djuvsland, O.; Haaland, O.; Huang, M.; Loenne, P. I.; Nystrand, J.; Rehman, A.; Roehrich, D.; Ullaland, K.; Velure, A.; Wagner, B.; Zhang, H.; Zhou, Z.; Zhu, H.] Univ Bergen, Dept Phys & Technol, Bergen, Norway; [Azmi, M. D.; Hussain, T.; Irfan, M.; Khan, M. Mohisin; Tariq, M.] Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India; [Buxton, J. T.; Humanic, T. J.; Kubera, A. M.; Lisa, M. A.; Salzwedel, J.; Steinpreis, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Hwang, D. S.; Kim, S.] Sejong Univ, Dept Phys, Seoul, South Korea; [Arsene, I. C.; Batzing, P. C.; Dordic, O.; Lindal, S.; Mahmood, S. M.; Milosevic, J.; Qvigstad, H.; Richter, M.; Roed, K.; Skaali, T. B.; Tveter, T. S.; Wikne, J.; Zhao, C.] Univ Oslo, Dept Phys, Oslo, Norway; [Minervini, L. M.] Dipartimento Elettrotecn & Elettron Politecn, Bari, Italy; [Meddi, F.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Mazzoni, M. A.; Meddi, F.] Sezione Ist Nazl Fis Nucl, Rome, Italy; [Casula, E. A. R.; Collu, A.; De Falco, A.; Puddu, G.; Razazi, V.; Terrevoli, C.; Usai, G. L.] Univ Cagliari, Dipartimento Fis, Cagliari, Italy; [Casula, E. A. R.; Cicalo, C.; Collu, A.; De Falco, A.; Masoni, A.; Puddu, G.; Razazi, V.; Siddhanta, S.; Terrevoli, C.; Usai, G. L.] Sezione Ist Nazl Fis Nucl, Cagliari, Italy; [Camerini, P.; Lea, R.; Luparello, G.; Margagliotti, G. V.; Rui, R.] Univ Trieste, Dipartimento Fis, Trieste, Italy; [Camerini, P.; Fragiacomo, E.; Grion, N.; Lea, R.; Luparello, G.; Margagliotti, G. V.; Piano, S.; Rachevski, A.; Rui, R.] Sezione Ist Nazl Fis Nucl, Trieste, Italy; [Beole, S.; Berzano, D.; Bianchi, L.; Botta, E.; Morales, Y. Corrales; Ferretti, A.; Gagliardi, M.; Gallio, M.; Lattuca, A.; Leoncino, M.; Marchisone, M.; Masera, M.; Russo, R.; Shtejer, K.; Vallero, S.; Vercellin, E.] Univ Turin, Dipartimento Fis, Turin, Italy; [Agnello, M.; Aimo, I.; Alessandro, B.; Arnaldi, R.; Bagnasco, S.; Barbano, A. M.; Bedda, C.; Beole, S.; Berzano, D.; Bianchi, L.; Botta, E.; Bruna, E.; Bufalino, S.; Cerello, P.; Morales, Y. Corrales; De Marco, N.; Feliciello, A.; Ferretti, A.; Gagliardi, M.; Gallio, M.; La Pointe, S. L.; Lattuca, A.; Leoncino, M.; Manceau, L.; Marchisone, M.; Masera, M.; Oppedisano, C.; Prino, F.; Puccio, M.; Rivetti, A.; Russo, R.; Scomparin, E.; Shtejer, K.; Trogolo, S.; Vallero, S.; Vercellin, E.] Sezione Ist Nazl Fis Nucl, Turin, Italy; [Arcelli, S.; Basile, M.; Bellini, F.; Cifarelli, L.; Colocci, M.; Guerzoni, B.; Scioli, G.; Zichichi, A.] Univ Bologna, Dipartimento Fis & Astron, Bologna, Italy; [Alici, A.; Antonioli, P.; Arcelli, S.; Basile, M.; Bellini, F.; Cifarelli, L.; Cindolo, F.; Colocci, M.; Guerzoni, B.; Hatzifotiadou, D.; Margotti, A.; Nania, R.; Noferini, F.; Pinazza, O.; Preghenella, R.; Scapparone, E.; Scioli, G.; Williams, M. C. S.; Zampolli, C.; Zichichi, A.] Sezione Ist Nazl Fis Nucl, Bologna, Italy; [Barbera, R.; La Rocca, P.; Petta, C.; Riggi, F.; Santagati, G.] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Badala, A.; Barbera, R.; La Rocca, P.; Pappalardo, G. S.; Petta, C.; Riggi, F.; Santagati, G.] Sezione Ist Nazl Fis Nucl, Catania, Italy; [Caffarri, D.; Festanti, A.; Francescon, A.; Giubilato, P.; Jena, C.; Lunardon, M.; Morando, M.; Moretto, S.; Scarlassara, F.; Soramel, F.; Terrevoli, C.; Viesti, G.] Univ Padua, Dipartimento Fis & Astron, Padua, Italy; [Antinori, F.; Caffarri, D.; Dainese, A.; Fabris, D.; Festanti, A.; Francescon, A.; Giubilato, P.; Jena, C.; Lunardon, M.; Morando, M.; Moretto, S.; Scarlassara, F.; Soramel, F.; Terrevoli, C.; Turrisi, R.; Viesti, G.] Sezione Ist Nazl Fis Nucl, Padua, Italy; [De Caro, A.; De Gruttola, D.; De Pasquale, S.; Girard, M. Fusco; Meninno, E.; Pagano, P.; Virgili, T.] Univ Salerno, Dipartimento Fis ER Caianiello, I-84100 Salerno, Italy; [De Caro, A.; De Gruttola, D.; De Pasquale, S.; Girard, M. Fusco; Meninno, E.; Pagano, P.; Virgili, T.] Ist Nazl Fis Nucl, Grp Collegato, Salerno, Italy; [Cortese, P.; Ramello, L.; Sitta, M.] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy; [Barile, F.; Bruno, G. E.; Colamaria, F.; Colella, D.; D'Erasmo, G.; Di Bari, D.; Fiore, E. M.; Mastroserio, A.; Tangaro, M. A.] Ist Nazl Fis Nucl, Grp Collegato, Alessandria, Italy; [Barile, F.; Bruno, G. E.; Colamaria, F.; Colella, D.; D'Erasmo, G.; Di Bari, D.; Fiore, E. M.; Mastroserio, A.; Tangaro, M. A.] Dipartimento Interateneo Fis M Merlin, Bari, Italy; [Barile, F.; Bruno, G. E.; Colamaria, F.; Colella, D.; de Cataldo, G.; D'Erasmo, G.; Di Bari, D.; Elia, D.; Fionda, F. M.; Fiore, E. M.; Lenti, V.; Manzari, V.; Mastroserio, A.; Minervini, L. M.; Nappi, E.; Paticchio, V.; Tangaro, M. A.] Sezione Ist Nazl Fis Nucl, Bari, Italy; [Christiansen, P.; Ljunggren, H. M.; Oskarsson, A.; Richert, T.; Silvermyr, D.; Sogaard, C.; Stenlund, E.; Vislavicius, V.] Lund Univ, Div Expt High Energy Phys, Lund, Sweden; [Hess, B. A.; Schmidt, H. R.; Wiechula, J.] Univ Tubingen, Tubingen, Germany; [Rinella, G. Aglieri; Augustinus, A.; Pedrosa, F. Baltasar Dos Santos; Berzano, D.; Betev, L.; Bufalino, S.; Buncic, P.; Caffarri, D.; Carena, F.; Carena, W.; Cavicchioli, C.; Chapeland, S.; Barroso, V. Chibante; Chochula, P.; Costa, F.; Cunqueiro, L.; Di Mauro, A.; Divia, R.; Erazmus, B.; Floris, M.; Francescon, A.; Fuchs, U.; Gargiulo, C.; Gheata, A.; Gheata, M.; Giubellino, P.; Grigoras, A.; Grigoras, C.; Grosse-Oetringhaus, J. F.; Grosso, R.; Hillemanns, H.; Hristov, P.; Ionita, C.; Kalweit, A.; Keil, M.; Kluge, A.; Kofarago, M.; Kouzinopoulos, C.; Kowalski, M.; Kryshen, E.; Kugathasan, T.; Lakomov, I.; Laudi, E.; Legrand, I.; Mager, M.; Manzari, V.; Martinengo, P.; Pedreira, M. Martinez; Milano, L.; Morsch, A.; Mueller, H.; Musa, L.; Niculescu, M.; Niedziela, J.; Ohlson, A.; Pinazza, O.; Preghenella, R.; Reidt, F.; Riedler, P.; Riegler, W.; Rossi, A.; Safarik, K.; Schukraft, J.; Schutz, Y.; Shahoyan, R.; Sielewicz, K. M.; Simonetti, G.; Szczepankiewicz, A.; Tauro, A.; Telesca, A.; Van Hoorne, J. W.; Vande Vyvre, P.; Volpe, G.; von Haller, B.; Vranic, D.; Weber, M.; Zimmermann, M. B.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Dahms, T.; Fabbietti, L.; Gasik, P.; Vorobyev, I.] Tech Univ Munich, Excellence Cluster Univ, D-80290 Munich, Germany; [Alme, J.; Helstrup, H.; Hetland, K. F.; Kileng, B.] Bergen Univ Coll, Fac Engn, Bergen, Norway; [Meres, M.; Pikna, M.; Sitar, B.; Strmen, P.; Szabo, A.; Szarka, I.] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Adam, J.; Bielcik, J.; Broz, M.; Cepila, J.; Contreras, J. G.; Eyyubova, G.; Krelina, M.; Petracek, V.; Schulc, M.; Spacek, M.] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic; [Bombara, M.; Kravcakova, A.; Vrlakova, J.] Safarik Univ, Fac Sci, Kosice, Slovakia; [Langoy, R.; Lien, J.] Buskerud & Vestfold Univ Coll, Fac Technol, Vestfold, Norway; [Alt, T.; Bach, M.; de Cuveland, J.; Eschweiler, D.; Gorbunov, S.; Hartmann, H.; Hutter, D.; Kirsch, S.; Kisel, I.; Kollegger, T.; Kretz, M.; Krzewicki, M.; Kulakov, I.; Lindenstruth, V.; Rettig, F.; Rohr, D.; Zyzak, M.] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Baek, Y. W.; Jung, H.; Kim, D. W.; Kim, J. S.; Kim, Mimae] Gangneung Wonju Natl Univ, Kangnung, South Korea; [Bhattacharjee, B.; Hussain, N.] Gauhati Univ, Dept Phys, Gauhati, India; [Brucken, E. J.; Hilden, T. E.; Mieskolainen, M. M.; Rasanen, S. S.] Helsinki Inst Phys, Helsinki, Finland; [Okubo, T.; Shigaki, K.; Sugitate, T.; Yano, S.] Hiroshima Univ, Hiroshima, Japan; [Agrawal, N.; Behera, N. K.; Dash, S.; Meethaleveedu, G. Koyithatta; Kumar, J.; Nandi, B. K.; Pandey, A. K.; Pant, D.; Varma, R.] Indian Inst Technol, Bombay 400076, Maharashtra, India; [Behera, N. K.; Mishra, A. N.; Pareek, P.; Roy, A.; Sahoo, P.; Sahoo, R.] Indian Inst Technol Indore, Indore, Madhya Pradesh, India; [Kweon, M. J.] Inha Univ, Inchon, South Korea; [del Valle, Z. Conesa; Das, I.; Espagnon, B.; Hadjidakis, C.; Lakomov, I.; Suire, C.; Takaki, J. D. Tapia] Univ Paris 11, CNRS, IN2P3, Inst Phys Nucl Orsay, F-91405 Orsay, France; [Boettger, S.; Breitner, T.; Engel, H.; Ramirez, A. Gomez; Kebschull, U.; Lara, C.] Goethe Univ Frankfurt, Inst Informat, D-60054 Frankfurt, Germany; [Appelshaeuser, H.; Arslandok, M.; Bailhache, R.; Bartsch, E.; Beck, H.; Blume, C.; Book, J.; Broker, T. A.; Buesching, H.; Dillenseger, P.; Doenigus, B.; Heckel, S. T.; Kamin, J.; Klein, C.; Lehnert, J.; Luettig, P.; Marquard, M.; Ozdemir, M.; Peskov, V.; Rascanu, B. T.; Reichelt, P.; Renfordt, R.; Sahlmuller, B.; Schuchmann, S.; Peloni, A. Tarantola; Toia, A.] Goethe Univ Frankfurt, Inst Kernphys, Frankfurt, Germany; [Anielski, J.; Bathen, B.; Feldkamp, L.; Haake, R.; Heide, M.; Klein-Boesing, C.; Muehlheim, D.; Passfeld, A.; Wessels, J. P.; Westerhoff, U.; Wilde, M.; Zimmermann, M. B.] Univ Munster, Inst Kernphys, D-48149 Munster, Germany; [Belikov, I.; Hippolyte, B.; Kuhn, C.; Maire, A.; Molnar, L.; Roy, C.; Castro, X. Sanchez] Univ Strasbourg, CNRS, IN2P3, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Finogeev, D.; Furs, A.; Guber, F.; Karavichev, O.; Karavicheva, T.; Karpechev, E.; Konevskikh, A.; Kurepin, A.; Kurepin, A. B.; Maevskaya, A.; Pshenichnov, I.; Reshetin, A.; Shabanov, A.] Russian Acad Sci, Inst Nucl Res, Moscow 117312, Russia; [Bertens, R. A.; Bianchin, C.; Bjelogrlic, S.; Caliva, A.; Dobrin, A.; Dubla, A.; Grelli, A.; Keijdener, D. L. D.; Leogrande, E.; Lodato, D. F.; Luparello, G.; Margutti, J.; Mischke, A.; Mohammadi, N.; Nooren, G.; Peitzmann, T.; Reicher, M.; Rocco, E.; Snellings, R. J. M.; Thomas, D.; Van der Maarel, J.; van Leeuwen, M.; Veen, A. M.; Veldhoen, M.; Wang, H.; Yang, H.; Zhou, Y.] Univ Utrecht, Inst Subat Phys, Utrecht, Netherlands; [Akindinov, A.; Kiselev, S.; Mal'Kevich, D.; Mikhaylov, K.; Nedosekin, A.; Sultanov, R.; Voloshin, K.; Zhigareva, N.] Inst Theoret & Expt Phys, Moscow 117259, Russia; [Kalinak, P.; Kralik, I.; Krivda, M.; Musinsky, J.; Sandor, L.; Vala, M.] Slovak Acad Sci, Inst Expt Phys, Kosice 04353, Slovakia; [Mares, J.; Zavada, P.] Acad Sci Czech Republic, Inst Phys, Prague, Czech Republic; [Baral, R. C.; Sahoo, S.; Sahu, P. K.; Sharma, N.] Inst Phys, Bhubaneswar 751007, Orissa, India; [Danu, A.; Felea, D.; Gheata, M.; Haiduc, M.; Mitu, C. M.; Niculescu, M.; Ristea, C.; Sevcenco, A.; Stan, I.; Zgura, I. S.] Inst Space Sci, Bucharest, Romania; [Cuautle, E.; Jimenez Bustamante, R. T.; Maldonado Cervantes, I.; Nellen, L.; Ortiz Velasquez, A.; Paic, G.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Alfaro Molina, R.; Belmont-Moreno, E.; Gomez Coral, D. M.; Grabski, V.; Menchaca-Rocha, A.; Sandoval, A.; Serradilla, E.] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 01000, DF, Mexico; [Bossu, F.; Buthelezi, Z.; Foertsch, S.; Murray, S.; Senosi, K.; Steyn, G.] Natl Res Fdn, iThemba LABS, Somerset West, South Africa; [Batyunya, B.; Grigoryan, A.; Malinina, L.; Mikhaylov, K.; Nomokonov, P.; Rogochaya, E.; Vodopyanov, A.; Zaporozhets, S.] Joint Inst Nucl Res, Dubna, Russia; [Oh, S. K.; Seo, J.] Konkuk Univ, Seoul, South Korea; [Ahn, S. U.; Jang, H. J.; Kim, D. W.] Korea Inst Sci & Technol Informat, Taejon, South Korea; [Uysal, A. Karasu; Okatan, A.] KTO Karatay Univ, Konya, Turkey; [Barret, V.; Bastid, N.; Camejo, A. Batista; Crochet, P.; Dupieux, P.; Li, S.; Lopez, X.; Manso, F.; Porteboeuf-Houssais, S.; Rosnet, P.; Palomo, L. Valencia; Vulpescu, B.] Univ Clermont Ferrand, Univ Blaise Pascal, CNRS, Phys Corpusculaire Lab,IN2P3, Clermont Ferrand, France; [Balbastre, G. Conesa; Faivre, J.; Furget, C.; Guernane, R.; Kox, S.; Real, J. S.; Silvestre, C.; Vauthier, A.] Univ Grenoble Alpes, CNRS, IN2P3, Lab Phys Subat & Cosmol, Grenoble, France; [Bianchi, N.; Diaz, L. Calero; Di Nezza, P.; Fantoni, A.; Gianotti, P.; Muccifora, V.; Reolon, A. R.; Ronchetti, F.; Sakai, S.; Spiriti, E.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; [Ricci, R. A.; Venaruzzo, M.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Bock, F.; Fasel, M.; Gangadharan, D. R.; Jacobs, P. M.; Loizides, C.; Ploskon, M.; Porter, J.; Symons, T. J. M.; Thaeder, J.; Zhang, X.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Soltz, R.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Belyaev, V.; Bogdanov, A.; Grigoriev, V.; Ippolitov, M.; Kaplin, V.; Kondratyeva, N.; Loginov, V.; Peresunko, D.] Moscow Engn Phys Inst, Moscow 115409, Russia; [Deloff, A.; Dobrowolski, T.; Ilkiv, I.; Kurashvili, P.; Redlich, K.; Siemiarczuk, T.; Stefanek, G.; Wilk, G.] Natl Ctr Nucl Studies, Warsaw, Poland; [Andrei, C.; Berceanu, I.; Bercuci, A.; Herghelegiu, A.; Petrovici, M.; Pop, A.; Schiaua, C.; Tarzila, M. G.] Natl Inst Phys & Nucl Engn, Bucharest, Romania; [Biswas, S.; Kumar, L.; Mohanty, B.; Nayak, K.; Singh, R.; Singha, S.] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Bearden, I. G.; Bilandzic, A.; Boggild, H.; Chojnacki, M.; Christensen, C. H.; Gaardhoje, J. J.; Gulbrandsen, K.; Hansen, A.; Nielsen, B. S.; Zaccolo, V.; Zhou, Y.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Botje, M.; Christakoglou, P.; Dobrin, A.; Kuijer, P. G.; Lara, C. E. Perez; Manso, A. Rodriguez] Nikhef, Natl Inst Subatomaire Fys, Amsterdam, Netherlands; [Borri, M.; Lemmon, R. C.] STFC Daresbury Lab, Nucl Phys Grp, Daresbury, England; [Adamova, D.; Bielcikova, J.; Ferencei, J.; Krizek, F.; Kucera, V.; Kushpil, S.; Pospisil, J.; Sumbera, M.; Vajzer, M.; Vanat, T.] Acad Sci Czech Republic, Inst Nucl Phys, CZ-25068 Rez, Czech Republic; [Adamova, D.; Bielcikova, J.; Ferencei, J.; Krizek, F.; Kucera, V.; Kushpil, S.; Pospisil, J.; Sumbera, M.; Vajzer, M.; Vanat, T.] Acad Sci Czech Republic, Inst Nucl Phys, Prague, Czech Republic; [Cormier, T. M.; Silvermyr, D.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Berdnikov, Y.; Ivanov, V.; Khanzadeev, A.; Malaev, M.; Nikulin, V.; Riabov, V.; Ryabov, Y.; Samsonov, V.; Zhalov, M.] Petersburg Nucl Phys Inst, Gatchina, Russia; [Cherney, M.; Poghosyan, M. G.; Seger, J. E.] Creighton Univ, Dept Phys, Omaha, NE 68178 USA; [Aggarwal, M. M.; Bhati, A. K.; Kumar, L.; Parmar, S.; Rathee, D.] Panjab Univ, Dept Phys, Chandigarh 160014, India; [Ganoti, P.; Roukoutakis, F.; Spyropoulou-Stassinaki, M.; Vasileiou, M.] Univ Athens, Dept Phys, Athens, Greece; [Cleymans, J.; Dietel, T.] Univ Cape Town, Dept Phys, ZA-7925 Cape Town, South Africa; [Bala, R.; Bhasin, A.; Bhat, I. R.; Gupta, A.; Gupta, R.; Kour, M.; Kumar, A.; Mahajan, S.; Rajput, S.; Sambyal, S.; Sharma, A.; Sharma, M.; Singh, R.] Univ Jammu, Dept Phys, Jammu 180004, India; [Raniwala, R.; Raniwala, S.] Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India; [Ball, M.; Dahms, T.; Fabbietti, L.; Gasik, P.; Vorobyev, I.] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany; [Anguelov, V.; Bock, F.; Busch, O.; Deisting, A.; Fleck, M. G.; Glaessel, P.; Klein, J.; Knichel, M. L.; Leardini, L.; Lu, X. -G.; Perez, J. Mercado; Oeschler, H.; Oyama, K.; Pachmayer, Y.; Reidt, F.; Reygers, K.; Schicker, R.; Stachel, J.; Stiller, J. H.; Voelkl, M. A.; Wang, Y.; Wilkinson, J.; Windelband, B.; Winn, M.; Zimmermann, A.] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [Aimo, I.] Politecn Torino, Turin, Italy; [Browning, T. A.; Scharenberg, R. P.; Srivastava, B. K.] Purdue Univ, W Lafayette, IN 47907 USA; [Borissov, A.; Choi, K.; Chung, S. U.; Seo, J.; Song, J.; Yoo, I. -K.] Pusan Natl Univ, Pusan 609735, South Korea; [Andronic, A.; Averbeck, R.; Braun-Munzinger, P.; Deisting, A.; Foka, P.; Frankenfeld, U.; Garabatos, C.; Ivanov, M.; Koehler, M. K.; Kollegger, T.; Krzewicki, M.; Lippmann, C.; Malzacher, P.; Marin, A.; Martin, N. A.; Masciocchi, S.; Miskowiec, D.; Nicassio, M.; Onderwaater, J.; Otwinowski, J.; Park, W. J.; Schmidt, C.; Schwarz, K.; Schweda, K.; Selyuzhenkov, I.; Thaeder, J.; Vranic, D.; Wagner, J.; Weber, S. G.] GSI Helmholtzzentrum Schwerionenforsch, Div Res, Darmstadt, Germany; [Andronic, A.; Averbeck, R.; Braun-Munzinger, P.; Deisting, A.; Foka, P.; Frankenfeld, U.; Garabatos, C.; Ivanov, M.; Koehler, M. K.; Kollegger, T.; Krzewicki, M.; Lippmann, C.; Malzacher, P.; Marin, A.; Martin, N. A.; Masciocchi, S.; Miskowiec, D.; Nicassio, M.; Onderwaater, J.; Otwinowski, J.; Park, W. J.; Schmidt, C.; Schwarz, K.; Schweda, K.; Selyuzhenkov, I.; Thaeder, J.; Vranic, D.; Wagner, J.; Weber, S. G.] GSI Helmholtzzentrum Schwerionenforsch, ExtreMe Matter Inst EMMI, Darmstadt, Germany; [Anticic, T.] Rudjer Boskovic Inst, Zagreb, Croatia; [Budnikov, D.; Filchagin, S.; Ilkaev, R.; Kuryakin, A.; Mamonov, A.; Nazarenko, S.; Punin, V.; Tumkin, A.; Vinogradov, Y.; Vyushin, A.; Zaviyalov, N.] Russian Fed Nucl Ctr VNIIEF, Sarov, Russia; [Aleksandrov, D.; Blau, D.; Fokin, S.; Ippolitov, M.; Kucheriaev, Y.; Manko, V.; Nikolaev, S.; Nikulin, S.; Nyanin, A.; Peresunko, D.; Ryabinkin, E.; Sibiriak, Y.; Vasiliev, A.; Vinogradov, A.; Yasnopolskiy, S.; Yushmanov, I.] Russian Res Ctr, Kurchatov Inst, Moscow, Russia; [Chattopadhyay, Sukalyan; Das, D.; Das, I.; Khan, P.; Paul, B.; Roy, P.; Sinha, T.] Saha Inst Nucl Phys, Kolkata, India; [Alexandre, D.; Barnby, L. S.; Evans, D.; Hanratty, L. D.; Jones, P. G.; Jusko, A.; Krivda, M.; Lee, G. R.; Lietava, R.; Baillie, O. Villalobos] Univ Birmingham, Sch Phys & Astron, Birmingham, W Midlands, England; [Villar, E. Calvo; Gago, A. M.] Pontificia Univ Catolica Peru, Dept Ciencias, Sec Fis, Lima, Peru; [Evdokimov, S.; Izucheev, V.; Kharlov, Y.; Kondratyuk, E.; Petrov, V.; Polichtchouk, B.; Sadovsky, S.; Shangaraev, A.] NRC Kurchatov Inst, SSC IHEP, Protvino, Russia; [Aphecetche, L.; Batigne, G.; Erazmus, B.; Estienne, M.; Germain, M.; Blanco, J. Martin; Garcia, G. Martinez; Massacrier, L.; De Godoy, D. A. Moreira; Morreale, A.; Pillot, P.; Ronflette, L.; Schutz, Y.; Shabetai, A.; Stocco, D.; Wang, M.; Zhu, J.] Univ Nantes, CNRS, IN2P3, Ecole Mines Nantes,SUBATECH, Nantes, France; [Kobdaj, C.; Poonsawat, W.] Suranaree Univ Technol, Nakhon Ratchasima, Thailand; [Gotovac, S.; Mudnic, E.; Vickovic, L.] Tech Univ Split FESB, Split, Croatia; [Bartke, J.; Figiel, J.; Gladysz-Dziadus, E.; Goerlich, L.; Kowalski, M.; Matyja, A.; Mayer, C.; Otwinowski, J.; Rybicki, A.; Sputowska, I.] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, Krakow, Poland; [Knospe, A. G.; Markert, C.; Thomas, D.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Leon Monzon, I.; Podesta-Lerma, P. L. M.] Univ Autonoma Sinaloa, Culiacan, Mexico; [Alves Garcia Prado, C.; Bregant, M.; Cosentino, M. R.; Domenicis Gimenez, D.; Jahnke, C.; Lagana Fernandes, C.; Mas, A.; Munhoz, M. G.; Oliveira Da Silva, A. C.; Pereira De Oliveira Filho, E.; Seeder, K. S.; Suaide, A. A. P.; Szanto de Toledo, A.; Zanoli, H. J. C.] Univ Sao Paulo, Sao Paulo, Brazil; [Chinellato, D. D.; Dash, A.; Takahashi, J.] Univ Estadual Campinas, UNICAMP, Campinas, Brazil; [Bellwied, R.; Bianchi, L.; Jayarathna, P. H. S. Y.; Jena, S.; Mcdonald, D.; Ng, F.; Pinsky, L.; Piyarathna, D. B.; Timmins, A. R.; Weber, M.] Univ Houston, Houston, TX USA; [Chang, B.; Kim, D. J.; Kral, J.; Rak, J.; Slupecki, M.; Snellman, T. W.; Trzaska, W. H.; Vargyas, M.; Viinikainen, J.] Univ Jyvaskyla, Jyvaskyla, Finland; [Chartier, M.; Figueredo, M. A. S.; Norman, J.; Romita, R.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Castro, A. J.; Martashvili, I.; Mazer, J.; Nattrass, C.; Read, K. F.; Scott, R.; Sharma, N.; Sorensen, S.] Univ Tennessee, Knoxville, TN USA; [Vilakazi, Z.] Univ Witwatersrand, Johannesburg, South Africa; [Gunji, T.; Hamagaki, H.; Hayashi, S.; Sekiguchi, Y.; Terasaki, K.; Tsuji, T.; Yamaguchi, Y.] Univ Tokyo, Tokyo, Japan; [Bhom, J.; Chujo, T.; Esumi, S.; Inaba, M.; Kobayashi, T.; Miake, Y.; Sano, M.; Tanaka, N.; Watanabe, D.; Yokoyama, H.] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Erhardt, F.; Planinic, M.; Poljak, N.; Simatovic, G.; Utrobicic, A.] Univ Zagreb, Zagreb 41000, Croatia; [Cheshkov, C.; Cheynis, B.; Ducroux, L.; Grossiord, J. -Y.; Teyssier, B.; Tieulent, R.; Uras, A.] Univ Lyon 1, CNRS, IN2P3, IPN Lyon, F-69622 Villeurbanne, France; [Altsybeev, I.; Feofilov, G.; Kolojvari, A.; Kondratiev, V.; Kovalenko, V.; Vechernin, V.; Vinogradov, L.; Zarochentsev, A.] St Petersburg State Univ, V Fock Inst Phys, St Petersburg 199034, Russia; [Ahammed, Z.; Alam, S. N.; Basu, S.; Chattopadhyay, Subhasis; Choudhury, S.; De, S.; Dubey, A. K.; Ghosh, P.; Kar, S.; Khan, S. A.; Mitra, J.; Mohanty, B.; Muhuri, S.; Mukherjee, M.; Nayak, T. K.; Pal, S. K.; Saini, J.; Sarkar, D.; Singaraju, R.; Singha, S.; Singhal, V.; Sinha, B. C.; Viyogi, Y. P.] Ctr Variable Energy Cyclotron, Kolkata, India; [Graczykowski, L. K.; Janik, M. A.; Kisiel, A.; Oleniacz, J.; Pawlak, T.; Pluta, J.; Szymanski, M.; Zaborowska, A.; Zbroszczyk, H.] Warsaw Univ Technol, Warsaw, Poland; [Belmont, R.; Bianchin, C.; Loggins, V. R.; Pan, J.; Pruneau, C. A.; Pujahari, P.; Putschke, J.; Reed, R. J.; Saleh, M. A.; Verweij, M.; Voloshin, S. A.; Yaldo, C. G.] Wayne State Univ, Detroit, MI USA; [Barnafoeldi, G. G.; Bencedi, G.; Berenyi, D.; Boldizsar, L.; Denes, E.; Hamar, G.; Kiss, G.; Levai, P.; Lowe, A.; Olah, L.; Pochybova, S.; Varga, D.; Volpe, G.] Hungarian Acad Sci, Wigner Res Ctr Phys, Budapest, Hungary; [Aiola, S.; Aronsson, T.; Caines, H.; Connors, M. E.; Ehlers, R. J.; Harris, J. W.; Majka, R. D.; Mulligan, J. D.; Oh, S.; Oliver, M. H.; Schuster, T.; Smirnov, N.] Yale Univ, New Haven, CT USA; [Kang, J. H.; Kim, B.; Kim, H.; Kim, Minwoo; Kim, T.; Kwon, Y.; Lee, S.; Song, M.] Yonsei Univ, Seoul 120749, South Korea; [Keidel, R.] Fachhsch Worms, Zentrum Technol Transfer & Telekommun, Worms, Germany	Adam, J (reprint author), Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague, Czech Republic.		Pshenichnov, Igor/A-4063-2008; Usai, Gianluca/E-9604-2015; Rui, Rinaldo/L-1926-2015; Zarochentsev, Andrey/J-6253-2013; Kovalenko, Vladimir/C-5709-2013; Altsybeev, Igor/K-6687-2013; Vinogradov, Leonid/K-3047-2013; Kondratiev, Valery/J-8574-2013; Vechernin, Vladimir/J-5832-2013; Takahashi, Jun/B-2946-2012; Naru, Muhammad Umair/N-5547-2015; Janik, Malgorzata/O-7520-2015; Graczykowski, Lukasz/O-7522-2015; Bregant, Marco/I-7663-2012; 	Pshenichnov, Igor/0000-0003-1752-4524; Usai, Gianluca/0000-0002-8659-8378; Feliciello, Alessandro/0000-0001-5823-9733; Jena, Satyajit/0000-0002-6220-6982; Rui, Rinaldo/0000-0002-6993-0332; De Pasquale, Salvatore/0000-0001-9236-0748; Scomparin, Enrico/0000-0001-9015-9610; Zarochentsev, Andrey/0000-0002-3502-8084; Kovalenko, Vladimir/0000-0001-6012-6615; Altsybeev, Igor/0000-0002-8079-7026; Vinogradov, Leonid/0000-0001-9247-6230; Kondratiev, Valery/0000-0002-0031-0741; Vechernin, Vladimir/0000-0003-1458-8055; Takahashi, Jun/0000-0002-4091-1779; Naru, Muhammad Umair/0000-0001-6489-0784; Janik, Malgorzata/0000-0002-3356-3438; Virgili, Tiziano/0000-0003-0471-7052; Di Bari, Domenico/0000-0002-5559-8906; Guerzoni, Barbara/0000-0003-3187-7051	State Committee of Science, Armenia; World Federation of Scientists (WFS), Armenia; Swiss Fonds Kidagan, Armenia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Natural Science Foundation of China (NSFC); Chinese Ministry of Education (CMOE); Ministry of Science and Technology of China (MSTC); Ministry of Education and Youth of the Czech Republic; Danish Natural Science Research Council; Carlsberg Foundation; Danish National Research Foundation; European Research Council under the European Community's Seventh Framework Programme; Helsinki Institute of Physics; Academy of Finland; French CNRS-IN2P3; 'Region Pays de Loire', France; 'Region Alsace', France; 'Region Auvergne', France; CEA, France; German Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF); Helmholtz Association; General Secretariat for Research and Technology, Ministry of Development, Greece; Hungarian Orszagos Tudomanyos Kutatasi Alappgrammok (OTKA); National Office for Research and Technology (NKTH); Department of Atomic Energy and Department of Science and Technology of the Government of India; Istituto Nazionale di Fisica Nucleare (INFN), Italy; Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche 'Enrico Fermi', Italy; MEXT, Japan; Joint Institute for Nuclear Research, Dubna; National Research Foundation of Korea (NRF); Consejo Nacional de Cienca y Tecnologia (CONACYT), Mexico; Direccion General de Asuntos del Personal Academico (DGAPA), Mexico; Amerique Latine Formation academique European Commission (ALFA-EC); EPLANET Program (European Particle Physics Latin American Network) Stichting voor Fundamenteel Onderzoek der Materie (FOM), Netherlands; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Netherlands; Research Council of Norway (NFR); National Science Centre, Poland; Ministry of National Education/Institute for Atomic Physics; Consiliul Naional al Cercetrii tiinifice-Executive Agency for Higher Education Research Development and Innovation Funding (CNCS-UEFISCDI)-Romania; Ministry of Education and Science of Russian Federation; Russian Academy of Sciences; Russian Federal Agency of Atomic Energy; Russian Federal Agency for Science and Innovations; Russian Foundation for Basic Research; Ministry of Education of Slovakia; Department of Science and Technology, South Africa; Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT); E-Infrastructure shared between Europe and Latin America (EELA); Ministerio de Economia y Competitividad (MINECO) of Spain; Xunta de Galicia (Conselleria de Educacion); Centro de Aplicaciones Tecnolgicas y Desarrollo Nuclear (CEADEN); Cubaenergia; Cuba; IAEA (International Atomic Energy Agency); Swedish Research Council (VR); Knut & AliceWallenberg Foundation (KAW); Ukraine Ministry of Education and Science; United Kingdom Science and Technology Facilities Council (STFC); United States Department of Energy; United States National Science Foundation; State of Texas; State of Ohio; Ministry of Science, Education and Sports of Croatia, Croatia; Unity through Knowledge Fund, Croatia; Council of Scientific and Industrial Research (CSIR), New Delhi, India	The ALICE Collaboration would like to thank all its engineers and technicians for their invaluable contributions to the construction of the experiment and the CERN accelerator teams for the outstanding performance of the LHC complex. The ALICE Collaboration gratefully acknowledges the resources and support provided by all Grid centres and the Worldwide LHC Computing Grid (WLCG) collaboration.; The ALICE Collaboration acknowledges the following funding agencies for their support in building and running the ALICE detector: State Committee of Science, World Federation of Scientists (WFS) and Swiss Fonds Kidagan, Armenia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Natural Science Foundation of China (NSFC), the Chinese Ministry of Education (CMOE) and the Ministry of Science and Technology of China (MSTC); Ministry of Education and Youth of the Czech Republic; Danish Natural Science Research Council, the Carlsberg Foundation and the Danish National Research Foundation; The European Research Council under the European Community's Seventh Framework Programme; Helsinki Institute of Physics and the Academy of Finland; French CNRS-IN2P3, the 'Region Pays de Loire', 'Region Alsace', 'Region Auvergne' and CEA, France; German Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) and the Helmholtz Association; General Secretariat for Research and Technology, Ministry of Development, Greece; Hungarian Orszagos Tudomanyos Kutatasi Alappgrammok (OTKA) and National Office for Research and Technology (NKTH); Department of Atomic Energy and Department of Science and Technology of the Government of India; Istituto Nazionale di Fisica Nucleare (INFN) and Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche 'Enrico Fermi', Italy; MEXT Grant-in-Aid for Specially Promoted Research, Japan; Joint Institute for Nuclear Research, Dubna; National Research Foundation of Korea (NRF); Consejo Nacional de Cienca y Tecnologia (CONACYT), Direccion General de Asuntos del Personal Academico (DGAPA), Mexico; Amerique Latine Formation academique European Commission (ALFA-EC) and the EPLANET Program (European Particle Physics Latin American Network) Stichting voor Fundamenteel Onderzoek der Materie (FOM) and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Netherlands; Research Council of Norway (NFR); National Science Centre, Poland; Ministry of National Education/Institute for Atomic Physics and Consiliul Naional al Cercetrii tiinifice-Executive Agency for Higher Education Research Development and Innovation Funding (CNCS-UEFISCDI)-Romania; Ministry of Education and Science of Russian Federation, Russian Academy of Sciences, Russian Federal Agency of Atomic Energy, Russian Federal Agency for Science and Innovations and The Russian Foundation for Basic Research; Ministry of Education of Slovakia; Department of Science and Technology, South Africa; Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT), E-Infrastructure shared between Europe and Latin America (EELA), Ministerio de Economia y Competitividad (MINECO) of Spain, Xunta de Galicia (Conselleria de Educacion), Centro de Aplicaciones Tecnolgicas y Desarrollo Nuclear (CEADEN), Cubaenergia, Cuba, and IAEA (International Atomic Energy Agency); Swedish Research Council (VR) and Knut & AliceWallenberg Foundation (KAW); Ukraine Ministry of Education and Science; United Kingdom Science and Technology Facilities Council (STFC); The United States Department of Energy, the United States National Science Foundation, the State of Texas, and the State of Ohio; Ministry of Science, Education and Sports of Croatia and Unity through Knowledge Fund, Croatia; Council of Scientific and Industrial Research (CSIR), New Delhi, India.	Aamodt K, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/03/P03003; Aamodt K, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08002; Abelev B, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X14300440; Akindinov A, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13044-x; Ambrosino F., 2006, JHEP, V0612; Amole C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4955; Alme J, 2010, NUCL INSTRUM METH A, V622, P316, DOI 10.1016/j.nima.2010.04.042; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130801; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; FEE MS, 1993, PHYS REV A, V48, P192, DOI 10.1103/PhysRevA.48.192; MASSAM T, 1965, NUOVO CIMENTO, V39, P10, DOI 10.1007/BF02814251; CRESTI M, 1988, PHYS LETT B, V200, P587; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; ABE F, 1990, PHYS REV LETT, V65, P2243, DOI 10.1103/PhysRevLett.65.2243; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; Agakishiev H, 2011, NATURE, V473, P353, DOI 10.1038/nature10079; DORFAN DE, 1965, PHYS REV LETT, V14, P1003, DOI 10.1103/PhysRevLett.14.1003; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; CRESTI M, 1986, PHYS LETT B, V177, P206, DOI 10.1016/0370-2693(86)91058-0; Kessler EG, 1999, PHYS LETT A, V255, P221, DOI 10.1016/S0375-9601(99)00078-X; Van Kolck U, 1999, PROG PART NUCL PHYS, V43, P337, DOI 10.1016/S0146-6410(99)00097-6; ANTIPOV YM, 1971, NUCL PHYS B, VB 31, P235, DOI 10.1016/0550-3213(71)90228-8; DENISOV SP, 1971, NUCL PHYS B, VB 31, P253, DOI 10.1016/0550-3213(71)90229-X; HARRIS JW, 1994, NUCL PHYS A, V566, pC277; Kostelecky VA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.11; Luders G., 1954, KONG DAN VID SEL MAT, V28, P1; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Nagamiya S., 1994, NUCL PHYS A, V566, P287, DOI 10.1016/0375-9474(94)90634-3; Pauli W., 1955, N BOHR DEV PHYSICS, P30	30	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	OCT	2015	11	10					811	U120		10.1038/NPHYS3432		7	Physics, Multidisciplinary	Physics	CS6KX	WOS:000362188600013		
J	Tosaki, M; Rauhala, E				Tosaki, Mitsuo; Rauhala, Eero			Energy-loss of He ions in carbon allotropes studied by elastic resonance in backscattering spectra	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Carbon allotropes; Stopping cross-section; Energy-loss straggling; Allotropic effect; Bunching phenomenon	STOPPING POWER; GRAPHITE; PROTONS; DIAMOND	Backscattering spectra for He-4 ions incident on carbon allotropes have been measured in the energy range from 4.30 to 4.95 MeV in steps of 50-100 keV at scattering angles of 106 degrees and 170 degrees. We used three carbon allotropes: graphite, diamond and amorphous carbon. For all these allotropes, we can observe the sharp (He-4, C-12) elastic nuclear resonance at the He ion energy of 4.265 MeV in the backscattering spectra. By varying the incident He energy, we have systematically analyzed the profiles of the resonance peaks to study the energy-loss processes: stopping cross-sections and energy-loss straggling around the interesting region of the stopping maximum at about 500 keV. We focus on the resonance profiles and investigate an allotropic effect concerning the energy-loss. Furthermore, an energy bunching effect on the straggling is presented and the mechanism is discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Tosaki, Mitsuo] Kyoto Univ, Radioisotope Res Ctr, Kyoto 6068501, Japan; [Rauhala, Eero] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland	Tosaki, M (reprint author), Kyoto Univ, Radioisotope Res Ctr, Kyoto 6068501, Japan.	tosaki.mitsuo.3v@kyoto-u.ac.jp					Ajzenberg-Selove F., 1993, NUCL PHYS A, V564, P1; Tosaki M, 2000, NUCL INSTRUM METH B, V168, P543, DOI 10.1016/S0168-583X(00)00062-8; Konac G, 1998, NUCL INSTRUM METH B, V136, P159, DOI 10.1016/S0168-583X(98)80016-5; TSCHALAR C, 1968, NUCL INSTRUM METHODS, V61, P141, DOI 10.1016/0029-554X(68)90535-1; Calliari L, 2007, CARBON, V45, P1410, DOI 10.1016/j.carbon.2007.03.034; MATTESON S, 1976, PHYS REV A, V14, P169, DOI 10.1103/PhysRevA.14.169; Sigmund P, 2003, EUR PHYS J D, V23, P201, DOI [10.1140/epjd/e2003-00032-x, 10.1140/epjd.e2003-00032-x]; Tosaki M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2168299; Tosaki M, 2009, NUCL INSTRUM METH B, V267, P2643, DOI 10.1016/j.nimb.2009.05.039; SOFTKY SD, 1961, PHYS REV, V123, P1685, DOI 10.1103/PhysRev.123.1685; BAEK WY, 1987, PHYS REV A, V35, P51, DOI 10.1103/PhysRevA.35.51; Kaferbock W, 1997, PHYS REV B, V55, P13275, DOI 10.1103/PhysRevB.55.13275; Ferrari S. A.C., 2000, PHYS REV B, V61; Molina R.G., 2006, NUCL I METH B, VB249, P6; Rauhala E., 2009, HDB MODERN ION BEAM, P5; Roy R.R., 1967, NUCL PHYS THEORY EXP; Takahiro K., 2006, NUCL I METH B, V249, P543; Wilken E., 1976, NUCL INSTRUM METHODS, V138, P331; Ziegler J.F., STOPPING RANGE PART; Ziegler J.F., COMPUTER CODE SRIM 2	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	OCT 1	2015	360						16	22		10.1016/j.nimb.2015.07.114		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CS1WL	WOS:000361859500003		
J	Zhao, JT; Wang, Q; Liu, DD; Wang, ZH; Fang, KH; Wang, TS; Kasagi, J				Zhao, J. T.; Wang, Q.; Liu, D. D.; Wang, Z. H.; Fang, K. H.; Wang, T. S.; Kasagi, J.			Dynamical concentration and static retention of deuterium in tungsten foil studied by low energy D(d,p)T reaction and elastic recoil detection	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Tungsten; Saturated deuterium concentration; Static deuterium retention	IONS; BERYLLIUM; FLUENCES; TITANIUM; METALS; DEPTHS; CARBON	The deposition behavior of hydrogen isotopes in tungsten is essential in fusion material research. A tungsten (W) foil was pre-implanted by deuterium ions (D-3(+)) with an energy of 20 keV/D and flux of 3.0 x 10(14) D/(cm(2) s) at room temperature until saturation state was confirmed by the proton yield of D (d,p)T reaction. The changes of D-concentration in surface layer have been obtained by D-D reaction analysis with low flux (0.6 mu A) and high energy (75 key) D+ beam at several storage time after the implantation terminated. Furthermore, the static D-retention in this sample was also measured by elastic recoil detection analysis one year later. The saturated value of n(D)/n(W) in surface layer of W foil is (42 +/- 3) at.% at fluence of 1.5 x 10(18) D/cm(2). After beam stopped, the D-concentration decreased, and a static D-retention of about 3 at.% was found one year later. These results showed that more than 92% of deuterium precipitated in tungsten metal at saturated state was unstable. (C) 2015 Elsevier B.V. All rights reserved.	[Zhao, J. T.; Wang, Q.; Liu, D. D.; Wang, Z. H.; Fang, K. H.; Wang, T. S.] Lanzhou Univ, Sch Nucl Sci & Technol, Lanzhou 730000, Gansu, Peoples R China; [Kasagi, J.] Tohoku Univ, Res Ctr Electron Photon Sci, Sendai, Miyagi 9808578, Japan	Zhao, JT (reprint author), Lanzhou Univ, Sch Nucl Sci & Technol, Lanzhou 730000, Gansu, Peoples R China.	zhaojt@lzu.edu.cn; tswang@lzu.edu.cn			National Nature Science Foundation of China (NSFC) [11275085, 11305080, 11405079]; Fundamental Research Funds for Central University of China [lzujbky-2014-11]; JSPS [19340051]	The elastic recoil detection experiment was performed in the Center for Ion Beam Application in National University of Singapore with the help of Prof. Thomas Osipowicz and Dr. Chan Taw Kuei. We would like to thank their contribution in this work. This work is supported by National Nature Science Foundation of China (NSFC, Nos. 11275085, 11305080, 11405079), Fundamental Research Funds for Central University of China (No. lzujbky-2014-11), and JSPS KAKENHI Grant Number 19340051.	Alimov VK, 2001, J NUCL MATER, V290, P389, DOI 10.1016/S0022-3115(00)00580-8; Alimov V.K., 2007, PHYS SCRIPTA, V2007, P6; Wang T, 2002, J PHYS-CONDENS MAT, V14, P11605, DOI 10.1088/0953-8984/14/45/304; Kawachi N, 2002, NUCL INSTRUM METH B, V190, P195, DOI 10.1016/S0168-583X(01)01261-7; Causey RA, 2002, J NUCL MATER, V300, P91, DOI 10.1016/S0022-3115(01)00732-2; Alimov VK, 2003, J NUCL MATER, V313, P599, DOI 10.1016/S0022-3115(02)01430-7; Alimov VK, 2005, J NUCL MATER, V337, P619, DOI 10.1016/j.jnucmat.2004.10.082; Sang CF, 2013, J NUCL MATER, V443, P403, DOI 10.1016/j.jnucmat.2013.07.052; CONDON JB, 1993, J NUCL MATER, V207, P1, DOI 10.1016/0022-3115(93)90244-S; Tian Z, 2010, J NUCL MATER, V399, P101, DOI 10.1016/j.jnucmat.2010.01.007; Haasz AA, 2001, J NUCL MATER, V290, P85, DOI 10.1016/S0022-3115(00)00615-2; Tyburska B, 2009, J NUCL MATER, V395, P150, DOI 10.1016/j.jnucmat.2009.10.046; Kudo H, 1998, J NUCL MATER, V258, P622, DOI 10.1016/S0022-3115(98)00244-X; Haasz AA, 1998, J NUCL MATER, V258, P889, DOI 10.1016/S0022-3115(98)00072-5; Sang CF, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/4/043003; Balden M, 2011, J NUCL MATER, V414, P69, DOI 10.1016/j.jnucmat.2011.04.031; Zhao JT, 2013, NUCL INSTRUM METH B, V316, P13, DOI 10.1016/j.nimb.2013.08.028; Raiola F, 2002, PHYS LETT B, V547, P193, DOI 10.1016/S0370-2693(02)02774-0; Wampler WR, 2011, J NUCL MATER, V415, pS653, DOI 10.1016/j.jnucmat.2010.11.043; Alimov VK, 2010, J NUCL MATER, V399, P225, DOI 10.1016/j.jnucmat.2010.01.024; Ahlgren T, 2006, NUCL INSTRUM METH B, V249, P436, DOI 10.1016/j.nimb.2006.03.025; Guseva MI, 2001, J NUCL MATER, V290, P1069, DOI 10.1016/S0022-3115(00)00471-2; Yuki H, 1997, J PHYS SOC JPN, V66, P73, DOI 10.1143/JPSJ.66.73; Haasz AA, 1997, J NUCL MATER, V241, P1076, DOI 10.1016/S0022-3115(97)80197-3; Bizyukov I, 2007, J NUCL MATER, V363, P1184, DOI 10.1016/j.jnucmat.2007.01.152; ASTM American Society for Testing and Materials, 1996, ANN BOOK ASTM STAND; Hoen M.H.J.t., 2012, NUCL FUSION, V52; Mayer M, 2009, NUCL INSTRUM METH B, V267, P506, DOI 10.1016/j.nimb.2008.11.033; Mayer M, 1997, SIMNRA USERS GUIDE R, V9, P113; Raiola F., 2005, THESIS RUHR U BOCHUM; Ziegler J., SRIM 2013 SOFTWARE	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	OCT 1	2015	360						139	144		10.1016/j.nimb.2015.08.069		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CS1WL	WOS:000361859500020		
J	Jokura, H; Watanabe, I; Umeda, M; Hase, T; Shimotoyodome, A				Jokura, Hiroko; Watanabe, Isamu; Umeda, Mika; Hase, Tadashi; Shimotoyodome, Akira			Coffee polyphenol consumption improves postprandial hyperglycemia associated with impaired vascular endothelial function in healthy male adults	NUTRITION RESEARCH			English	Article						Blood glucose; Coffee polyphenol; Flow-mediated dilatation; GLP-1; Insulin	GLUCAGON-LIKE PEPTIDE-1; LEFT-VENTRICULAR PERFORMANCE; MYOCARDIAL GLUCOSE-UPTAKE; TYPE-2 DIABETES PATIENTS; DILATED CARDIOMYOPATHY; METABOLIC SYNDROME; CHLOROGENIC ACIDS; FAT UTILIZATION; CONSCIOUS DOGS; CAFFEINE	Epidemiological studies indicate that habitual coffee consumption lowers the risk of diabetes and cardiovascular diseases. Postprandial hyperglycemia is a direct and independent risk factor for cardiovascular diseases. We previously demonstrated that coffee polyphenol ingestion increased secretion of Glucagon-like peptide 1 (GLP-1), which has been shown to exhibit antidiabetic and cardiovascular effects. We hypothesized coffee polyphenol consumption may improve postprandial hyperglycemia and vascular endothelial function by increasing GLP-1 release and/or reducing oxidative stress. To examine this hypothesis, we conducted a randomized, acute, crossover, intervention study in healthy male adults, measuring blood parameters and flow-mediated dilation (FMD) after ingestion of a meal with or without coffee polyphenol extract (CPE). Nineteen subjects consumed a test meal with either a placebo- or CPE-containing beverage. Blood biomarkers and FMD were measured at fasting and up to 180 minutes postprandially. The CPE beverage led to a significantly lower peak postprandial increase in blood glucose and diacron-reactive oxygen metabolite, and significantly higher postprandial FMD than the placebo beverage. Postprandial blood GLP-1 increase tended to be higher after ingestion of the CPE beverage, compared with placebo. Subclass analysis revealed that the CPE beverage significantly improved postprandial blood GLP-1 response and reduced blood glucose increase in the subjects with a lower insulinogenic index. Correlation analysis showed postprandial FMD was negatively associated with blood glucose increase after ingestion of the CPE beverage. In conclusion, these results suggest that coffee polyphenol consumption improves postprandial hyperglycemia and vascular endothelial function, which is associated with increased GLP-1 secretion and decreased oxidative stress in healthy humans. (C) 2015 Elsevier Inc. All rights reserved.	[Jokura, Hiroko; Watanabe, Isamu; Umeda, Mika; Hase, Tadashi; Shimotoyodome, Akira] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan	Shimotoyodome, A (reprint author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.	shimotoyodome.akira@kao.co.jp			Kao Corporation	We thank Takuya Watanabe and Kiyoshi Kataoka for preparing the test beverages. Our deep gratitude is expressed to Kentaro Okamoto, Dokkyo Medical University, for supervising this clinical study. All of the authors are employees of Kao Corporation. The present study was supported financially by Kao Corporation.	Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287; Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053; Buscemi S, 2010, EUR J CLIN NUTR, V64, P1242, DOI 10.1038/ejcn.2010.137; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Shechter M, 2011, AM J CARDIOL, V107, P1255, DOI 10.1016/j.amjcard.2010.12.035; Liu HB, 2009, J ENDOCRINOL, V201, P59, DOI 10.1677/JOE-08-0468; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166; Carrel G, 2011, AM J CLIN NUTR, V94, P997, DOI 10.3945/ajcn.111.017574; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731; Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; Johnston KL, 2003, AM J CLIN NUTR, V78, P728; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; Karamanlis A, 2007, AM J CLIN NUTR, V86, P1364; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; Johnson KMS, 2007, AM J PHYSIOL-ENDOC M, V293, pE1085, DOI 10.1152/ajpendo.00275.2007; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Whitehead N, 2013, J HUM NUTR DIET, V26, P111, DOI 10.1111/jhn.12033; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745; CHERASKI.E, 1967, LANCET, V1, P1299; Fujii Y, 2015, J NUTR SCI, V4, P1; Grosso G, 2014, EUR J NUTR; Lawrence M, 2000, J AM COLL CARDIOL, V36, P2185; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Singh B, 2010, WORLD J DIABETES, V15, P36, DOI DOI 10.4239/WJD.V1.I2.36; Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147	38	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	OCT	2015	35	10					873	881		10.1016/j.nutres.2015.07.005		9	Nutrition & Dietetics	Nutrition & Dietetics	CS8BS	WOS:000362311300004		
J	Downes, SM; Farneti, R; Uotila, P; Griffies, SM; Marsland, SJ; Bailey, D; Behrens, E; Bentsen, M; Bi, DH; Biastoch, A; Boning, C; Bozec, A; Canuto, VM; Chassignet, E; Danabasoglu, G; Danilov, S; Diansky, N; Drange, H; Fogli, PG; Gusev, A; Howard, A; Ilicak, M; Jung, T; Kelley, M; Large, WG; Leboissetier, A; Long, M; Lu, JH; Masina, S; Mishra, A; Navarra, A; Nurser, AJG; Patara, L; Samuels, BL; Sidorenko, D; Spence, P; Tsujino, H; Wang, Q; Yeager, SG				Downes, Stephanie M.; Farneti, Riccardo; Uotila, Petteri; Griffies, Stephen M.; Marsland, Simon J.; Bailey, David; Behrens, Erik; Bentsen, Mats; Bi, Daohua; Biastoch, Arne; Boening, Claus; Bozec, Alexandra; Canuto, Vittorio M.; Chassignet, Eric; Danabasoglu, Gokhan; Danilov, Sergey; Diansky, Nikolay; Drange, Helge; Fogli, Pier Giuseppe; Gusev, Anatoly; Howard, Armando; Ilicak, Mehmet; Jung, Thomas; Kelley, Maxwell; Large, William G.; Leboissetier, Anthony; Long, Matthew; Lu, Jianhua; Masina, Simona; Mishra, Akhilesh; Navarra, Antonio; Nurser, A. J. George; Patara, Lavinia; Samuels, Bonita L.; Sidorenko, Dmitry; Spence, Paul; Tsujino, Hiroyuki; Wang, Qiang; Yeager, Stephen G.			An assessment of Southern Ocean water masses and sea ice during 1988-2007 in a suite of interannual CORE-II simulations	OCEAN MODELLING			English	Article						Southern Ocean; CORE-II experiments; Water masses; Sea ice; Ocean model intercomparison	SUB-ANTARCTIC MODE; COUPLED CLIMATE MODEL; MIXED-LAYER DEPTHS; ANNULAR MODE; WEDDELL POLYNYA; NORTH-ATLANTIC; CIRCULATION; TRENDS; TRANSFORMATION; VARIABILITY	We characterise the representation of the Southern Ocean water mass structure and sea ice within a suite of 15 global ocean-ice models run with the Coordinated Ocean-ice Reference Experiment Phase II (CORE-II) protocol. The main focus is the representation of the present (1988-2007) mode and intermediate waters, thus framing an analysis of winter and summer mixed layer depths; temperature, salinity, and potential vorticity structure; and temporal variability of sea ice distributions. We also consider the interannual variability over the same 20 year period. Comparisons are made between models as well as to observation-based analyses where available. The CORE-II models exhibit several biases relative to Southern Ocean observations, including an underestimation of the model mean mixed layer depths of mode and intermediate water masses in March (associated with greater ocean surface heat gain), and an overestimation in September (associated with greater high latitude ocean heat loss and a more northward winter sea-ice extent). In addition, the models have cold and fresh/warm and salty water column biases centred near 50 degrees S. Over the 1933-2007 period, the CORE-II models consistently simulate spatially variable trends in sea-ice concentration, surface freshwater fluxes, mixed layer depths, and 200-700 in ocean heat content. In particular, sea-ice coverage around most of the Antarctic continental shelf is reduced, leading to a cooling and freshening of the near surface waters. The shoaling of the mixed layer is associated with increased surface buoyancy gain, except in the Pacific where sea ice is also influential. The models are in disagreement, despite the common CORE-II atmospheric state, in their spatial pattern of the 20-year trends in the mixed layer depth and sea-ice. (C) 2015 Elsevier Ltd. All rights reserved,	[Downes, Stephanie M.] Australian Natl Univ, Res Sch Earth Sci, Acton, Australia; [Downes, Stephanie M.] Australian Natl Univ, ARC Ctr Excellence Climate Syst Sci, Acton, Australia; [Farneti, Riccardo] Abdus Salaam Int Ctr Theoret Phys, Earth Syst Phys, Trieste, Italy; [Uotila, Petteri; Marsland, Simon J.; Bi, Daohua] CSIRO, Ctr Australian Weather & Climate Res, Aspendale, Vic, Australia; [Uotila, Petteri] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Griffies, Stephen M.; Samuels, Bonita L.] NOAA Geophys Fluid Dynam Lab, Princeton, NJ USA; [Bailey, David; Danabasoglu, Gokhan; Large, William G.; Long, Matthew; Yeager, Stephen G.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Behrens, Erik; Biastoch, Arne; Boening, Claus; Patara, Lavinia] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Behrens, Erik] Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand; [Bentsen, Mats; Ilicak, Mehmet] Uni Res AS, Uni Climate, Bergen, Norway; [Bentsen, Mats; Drange, Helge; Ilicak, Mehmet] Bjerknes Ctr Climate Res, Bergen, Norway; [Bozec, Alexandra; Chassignet, Eric; Lu, Jianhua; Mishra, Akhilesh] Florida State Univ, Ctr Ocean Atmospher Predict Studies, Tallahassee, FL 32306 USA; [Canuto, Vittorio M.; Howard, Armando; Kelley, Maxwell; Leboissetier, Anthony] NASA Goddard Inst Space Studies GISS, New York, NY USA; [Danilov, Sergey; Jung, Thomas; Sidorenko, Dmitry; Wang, Qiang] Alfred Wegener Inst, Bremerhaven, Germany; [Diansky, Nikolay; Gusev, Anatoly] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Drange, Helge] Univ Bergen, Bergen, Norway; [Fogli, Pier Giuseppe; Masina, Simona; Navarra, Antonio] Ctr Euromediterraneo Cambiamenti Climat CMCC, Bologna, Italy; [Leboissetier, Anthony] Trinnovim LLC, New York, NY USA; [Masina, Simona; Navarra, Antonio] Ist Nazl Geofis & Vulcanol, Bologna, Italy; [Nurser, A. J. George] Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Spence, Paul] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia; [Tsujino, Hiroyuki] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan	Downes, SM (reprint author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, 20 Castray Esplanade, Hobart, Tas 7000, Australia.		Marsland, Simon/A-1453-2012; Uotila, Petteri/A-1703-2012; Farneti, Riccardo/B-5183-2011; ILICAK, Mehmet/H-2219-2011; Bi, Daohua/O-4508-2015; Gusev, Anatoly/A-8528-2014	Uotila, Petteri/0000-0002-2939-7561; ILICAK, Mehmet/0000-0002-4777-8835; Gusev, Anatoly/0000-0002-6463-3179	international CLIVAR project office; U.S. CLIVAR project office; ARC Centre of Excellence for Climate System Science [CE110001028]; Australian Government Department of the Environment; Bureau of Meteorology; CSIRO through the Australian Climate Change Science Programme; Helmholtz Climate Initiative REKLIM (Regional Climate Change); Helmholtz Association of German research centers (HGF) [REKLIM-2009-07-16]; Cluster of Excellence 'The Future Ocean'; Research Council of Norway through the EarthClim [207711/E10]; NOTUR/NorStore projects; Centre for Climate Dynamics at the Bjerknes Centre for Climate Research; Italian Ministry of Education, University, and Research; Italian Ministry of Environment, Land, and Sea; U.S. National Science Foundation (NSF); NOAA Climate Program Office [NA09OAR4310163]	The CLIVAR Ocean Model Development Panel (OMDP) is responsible for organising the Coordinated Ocean-sea ice Reference Experiments, with support from international CLIVAR and U.S. CLIVAR project offices, particularly Anna Pirani. We are grateful for the efforts of modellers who have contributed to the simulation and processing of the CORE 11 experiments. S. M. Downes was supported by the ARC Centre of Excellence for Climate System Science (grant CE110001028). The ACCESS model is supported by the Australian Government Department of the Environment, the Bureau of Meteorology and CSIRO through the Australian Climate Change Science Programme. A.W.I. is a member of the Helmholtz Association of German Research Centers. Q. Wang and D. Sidorenko are funded by the Helmholtz Climate Initiative REKLIM (Regional Climate Change), a joint research project of the Helmholtz Association of German research centers (HGF) under grant: REKLIM-2009-07-16. The GEOMAR model integrations were built on developments in the DRAKKAR collaboration, were performed at the North German Supercomputing Alliance (HLRN), and were supported by the Cluster of Excellence 'The Future Ocean', The BERGEN contribution is supported by the Research Council of Norway through the EarthClim (207711/E10) and NOTUR/NorStore projects, as well as the Centre for Climate Dynamics at the Bjerknes Centre for Climate Research, The CMCC contribution received funding from the Italian Ministry of Education, University, and Research and the Italian Ministry of Environment, Land, and Sea under the GEMINA project. NCAR is sponsored by the U.S. National Science Foundation (NSF). S. G. Yeager was supported by the NOAA Climate Program Office under Climate Variability and Predictability Program grant NA09OAR4310163. We thank Carolina Dufour and Adele Morrison for their useful comments on earlier drafts, and two anonymous reviewers for their constructive comments, all of which helped improve the paper.	Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Durack PJ, 2010, J CLIMATE, V23, P4342, DOI 10.1175/2010JCLI3377.1; Sloyan BM, 2007, J CLIMATE, V20, P5061, DOI 10.1175/JCLI4295.1; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Helm KP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049513; Talley LD, 2008, PROG OCEANOGR, V78, P257, DOI 10.1016/j.pocean.2008.05.001; Mathiot P, 2010, OCEAN MODEL, V35, P146, DOI 10.1016/j.ocemod.2010.07.001; CARSEY FD, 1980, MON WEATHER REV, V108, P2032, DOI 10.1175/1520-0493(1980)108<2032:MOOTWP>2.0.CO;2; Simpkins GR, 2013, GEOPHYS RES LETT, V40, P3643, DOI 10.1002/grl.50715; Cerovecki I, 2013, J PHYS OCEANOGR, V43, P1485, DOI 10.1175/JPO-D-12-0121.1; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Griffies SM, 2009, OCEAN MODEL, V26, P1, DOI 10.1016/j.ocemod.2008.08.007; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1845, DOI 10.1002/jgrc.20157; Delworth TL, 2012, J CLIMATE, V25, P2755, DOI 10.1175/JCLI-D-11-00316.1; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Garabato ACN, 2009, J CLIMATE, V22, P3661, DOI 10.1175/2009JCLI2621.1; Downes SM, 2010, J CLIMATE, V23, P6526, DOI 10.1175/2010JCLI3620.1; Gnanadesikan A, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002097; Marsland SJ, 2001, J GEOPHYS RES-OCEANS, V106, P2723, DOI 10.1029/2000JC900086; Zwally HJ, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000733; Downes SM, 2011, J PHYS OCEANOGR, V41, P1756, DOI 10.1175/2011JPO4586.1; MARSHALL JC, 1993, J PHYS OCEANOGR, V23, P1315, DOI 10.1175/1520-0485(1993)023<1315:ITSRAP>2.0.CO;2; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/ngeo1767, 10.1038/NGEO1767]; Sallee JB, 2010, NAT GEOSCI, V3, P273, DOI [10.1038/ngeo812, 10.1038/NGEO812]; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Speer K, 2000, TELLUS A, V52, P554, DOI 10.1034/j.1600-0870.2000.01060.x; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; Marsh R, 2000, J PHYS OCEANOGR, V30, P1013, DOI 10.1175/1520-0485(2000)030<1013:WMTITS>2.0.CO;2; Comiso JC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004257; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1830, DOI 10.1002/jgrc.20135; Uotila P, 2014, OCEAN MODEL, V79, P33, DOI 10.1016/j.ocemod.2014.04.004; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; MARTINSON DG, 1981, J PHYS OCEANOGR, V11, P466, DOI 10.1175/1520-0485(1981)011<0466:ACMFTW>2.0.CO;2; Sallee JB, 2010, J PHYS OCEANOGR, V40, P509, DOI 10.1175/2009JPO4291.1; Pezza AB, 2012, CLIM DYNAM, V38, P57, DOI 10.1007/s00382-011-1044-y; Large WG, 2012, J CLIMATE, V25, P6123, DOI 10.1175/JCLI-D-11-00148.1; Abram NJ, 2013, NAT GEOSCI, V6, P404, DOI [10.1038/ngeo1787, 10.1038/NGEO1787]; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Farneti R, 2010, J PHYS OCEANOGR, V40, P1539, DOI 10.1175/2010JPO4353.1; Hartin CA, 2011, DEEP-SEA RES PT I, V58, P524, DOI 10.1016/j.dsr.2011.02.010; WALIN G, 1982, TELLUS, V34, P187; Barthelemy A, 2012, OCEAN MODEL, V48, P45, DOI 10.1016/j.ocemod.2012.03.002; Antonov J.I., 2010, NOAA ATLAS NESDIS, V1, P184; Chen G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031200; Danabasoglu G, 2014, OCEAN MODEL, V73, P76, DOI 10.1016/j.ocemod.2013.10.005; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Dong S., 2008, J GEOPHYS RES, V113, P2156; Farneti R., 2015, OCEAN MODEL, V94, P67; Fetterer F., 2009, TECHNICAL REPORT; Griffies S.M., 2014, OCEAN MODEL IN PRESS, DOI [10.1016/j.ocemod.7011.03,001, DOI 10.1016/J.0CEM0D.7011.03]; Hanawa K., 2001, OCEAN CIRCULATION CL; Herraiz-Borreguero L, 2011, OCEAN DYNAM, V61, P103, DOI 10.1007/s10236-010-0352-9; Large W., 2004, NCARTN460STR CGD DIV; Locarnini R. A., 2010, 68 NOAA NESDIS ATL, V1; Parkinson C. L., 2004, NIMBUS 5 ESMR POLAR; Rintoul S.R., 2013, INT GEOPHYS SER, P471; Spence Paul, 2014, Journal of Physical Oceanography, V44, DOI 10.1175/JPO-D-13-0108.1; Stossel A., 2011, J GEOPHYS RES, V116, P1; Zwally H.J., 1983, SP459 NASA	63	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1463-5003	1463-5011		OCEAN MODEL	Ocean Model.	OCT	2015	94						67	94		10.1016/j.ocemod.2015.07.022		28	Meteorology & Atmospheric Sciences; Oceanography	Meteorology & Atmospheric Sciences; Oceanography	CS4AF	WOS:000362016400006		
J	Nomoto, E; Hiruma, K; Sugawara, T; Tanaka, K; Lee, Y				Nomoto, Etsuko; Hiruma, Kenji; Sugawara, Toshiki; Tanaka, Kenichi; Lee, Yong			SC-type multi-core optical-fiber connectors using a pressurization spring	OPTICAL REVIEW			English	Article						Fiber-optics systems; Fiber optics; Optical-fiber devices; Multicore fiber; Space division multiplexing		Prototype standard-connector (SC)-type physical-contact connectors were designed and fabricated for a seven-core fiber. The ferrule in the connector has a capillary inserted into a pipe, which fits into a flange with freedom to slide. After the capillary (with the seven-core fiber) and the flange are aligned and adhered, a pressurization spring is used to press fit the flange to a plug frame in a housing. Several prototype connectors have been used to achieve a low attenuation (less than 0.5 dB) and high return loss (40 dB or more). These coupling characteristics indicate that these SC-type physical-contact connectors will be one of the key devices for achieving space division multiplexing (SDM).	[Nomoto, Etsuko; Hiruma, Kenji; Sugawara, Toshiki; Tanaka, Kenichi; Lee, Yong] Hitachi Ltd, Res & Dev Grp, Kokubunji, Tokyo 1858601, Japan	Nomoto, E (reprint author), Hitachi Ltd, Res & Dev Grp, Minato Ku, Akasaka Biz Tower,3-1,Akasaka 5 Chome, Tokyo 1076323, Japan.	etsuko.nomoto.me@hitachi.com			Ministry of Internal Affairs and Communications, Japan	This work was partly supported by "The research and development project for the ultra-high speed and green photonic networks" of the Ministry of Internal Affairs and Communications, Japan.	MARCUSE D, 1977, AT&T TECH J, V56, P703; Nagase R, 2013, IEICE T ELECTRON, VE96C, P1173, DOI 10.1587/transele.E96.C.1173; SUGITA E, 1989, J LIGHTWAVE TECHNOL, V7, P1689, DOI 10.1109/50.45890; Kobayashi T., 2014, P 2014 IEICE GEN C N; Lee Y, 2014, IEEE PHOTONIC TECH L, V26, P538, DOI 10.1109/LPT.2013.2296100; Lee Y., 2014, P 12 INT C OPT INT C; Lee Y., 2014, EXAT2013920142 IEICE, P13; Sakaguchi J., P OPT FIB COMM C OFC; Shikama K., 2013, P OPT FIB COMM C OFC; Takara H., 2012, P 38 EUR C EXH OPT C	10	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					679	685		10.1007/s10043-015-0127-0		7	Optics	Optics	CT0MW	WOS:000362491100001		
J	Anna, T; Kimura, S; Mehta, DS; Sato, M				Anna, Tulsi; Kimura, Satoshi; Mehta, Dalip Singh; Sato, Manabu			Reflection, phase and en-face sectional imaging of scattering objects using quasi-single-shot wide-field optical coherence tomography	OPTICAL REVIEW			English	Article						Quantitative phase imaging; Single-shot wide-field OCT; Polarization Michelson interferometer; Low-coherence interferometry	MICROSCOPY; DYNAMICS	We report a quasi-single-shot wide-field optical coherence tomography system that enables to measure the reflection, phase and en-face OCT images from the same setup using the glass jig. The jig consisting of a wedge glass substrate and a glue dot is contacted to the tissue surfaces, and the data within glue dot is used to reduce the phase noise of the interference signal. The reconstructed image size of the object was 4.0 mm x 4.3 mm. The standard deviation (STD) of the phase variation was minimized by 54 % and obtained to be 0.027 rad for the poke tissue. The corresponding STD in optical path length change was measured to be 1.4 nm. The refractive index of the water and poke tissue at the surface is also evaluated as 1.36 and 1.39, respectively, using reflection intensity images. Further, the en-face sectional images of the tissue sample are also measured.	[Anna, Tulsi; Kimura, Satoshi; Sato, Manabu] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Mehta, Dalip Singh] Indian Inst Technol Delhi, Dept Phys, New Delhi 110016, India	Anna, T (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Johnan, Yonezawa, Yamagata 9928510, Japan.	tulsianna@gmail.com; msato@yz.yamagata-u.ac.jp			 [2503044]	This work is supported by the grant-in-aid for Japan Society for the Promotion of Science Fellows JSPS KAKENHI Grant Number 2503044.	Anna T., J MODERN OPT; Joo C, 2010, OPT EXPRESS, V18, P2858, DOI 10.1364/OE.18.002858; Bulow T, 2001, IEEE T SIGNAL PROCES, V49, P2844, DOI 10.1109/78.960432; Anna T, 2011, APPL OPTICS, V50, P6343, DOI 10.1364/AO.50.006343; Ellerbee AK, 2007, OPT EXPRESS, V15, P8115, DOI 10.1364/OE.15.008115; Creath K, 2012, BIOMED OPT EXPRESS, V3, P2866, DOI 10.1364/BOE.3.002866; Helderman F, 2013, OPT LETT, V38, P431, DOI 10.1364/OL.38.000431; Bhaduri B, 2014, ADV OPT PHOTONICS, V6, P57, DOI 10.1364/AOP.6.000057; Sarunic MV, 2006, OPT LETT, V31, P1462, DOI 10.1364/OL.31.001462; Yaqoob Z, 2009, OPT EXPRESS, V17, P10681, DOI 10.1364/OE.17.010681; Joo CM, 2007, OPT LETT, V32, P2426, DOI 10.1364/OL.32.002426; Choi W, 2013, OPT LETT, V38, P338, DOI 10.1364/OL.38.000338; Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002; Akkin T, 2004, OPT EXPRESS, V12, P2377, DOI 10.1364/OPEX.12.002377; Choma MA, 2005, OPT LETT, V30, P1162, DOI 10.1364/OL.30.001162; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Hrebesh M.S., 2009, P SOC PHOTO-OPT INS, V71681; Liu B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753410; Tuchin V., 2000, TISSUE OPTICS LIGHT, VTT38; Yaqoob Z., 2011, OPT EXPRESS, V19, P7588	20	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					706	716		10.1007/s10043-015-0124-3		11	Optics	Optics	CT0MW	WOS:000362491100005		
J	Hayasaki, Y				Hayasaki, Yoshio			Achromatic-phase-shifting low-coherence digital holography: theoretical analyses of zero-phase-shifting error condition and linear and nonlinear calibrations	OPTICAL REVIEW			English	Article						Phase-shifting digital holography; Broadband light source; Low coherence; Achromatic-phase shifting	ROTATING POLARIZER; MICROSCOPY; RECONSTRUCTION; TOMOGRAPHY	Some methods for decreasing a measurement error derived from a phase-shifting error for broadband light in phase-shifting low-coherence digital holography are proposed based on theoretical analysis and numerical calculations. It is well-known that an achromatic-phase shifter based on a rotating polarizer drastically decreases the error, but it is found that a small error remains according to the imperfection of the achromatic-phase shifter. It is also found that an ideal achromatic-phase shifter perfectly eliminates the error only when the light source has a symmetrical spectrum. Furthermore, it is demonstrated that a simple linear calibration method decreases the error in a narrow range of optical path differences if a light source with an asymmetrical spectrum is used. Finally, a nonlinear calibration method that can further decrease the error in a wide range of optical path differences is discussed.	Utsunomiya Univ, Ctr Opt Res & Educ CORE, Utsunomiya, Tochigi 3218585, Japan	Hayasaki, Y (reprint author), Utsunomiya Univ, Ctr Opt Res & Educ CORE, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	hayasaki@opt.utsunomiya-u.ac.jp					POON TC, 1995, OPT ENG, V34, P1338, DOI 10.1117/12.201662; Pedrini G, 2000, J MOD OPTIC, V47, P1447, DOI 10.1080/09500340008235115; Indebetouw G, 2000, OPT LETT, V25, P212, DOI 10.1364/OL.25.000212; Massatsch P, 2005, APPL OPTICS, V44, P1806, DOI 10.1364/AO.44.001806; Pedrini G, 2002, APPL OPTICS, V41, P4489, DOI 10.1364/AO.41.004489; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Pedrini G, 2001, OPTIK, V112, P427, DOI 10.1078/0030-4026-00083; Tamano S, 2006, APPL OPTICS, V45, P953, DOI 10.1364/AO.45.000953; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; Tamano S, 2008, JPN J APPL PHYS, V47, P8844, DOI 10.1143/JJAP.47.8844; Helen SS, 1998, OPT COMMUN, V154, P249, DOI 10.1016/S0030-4018(98)00292-2; Takaki Y, 1999, APPL OPTICS, V38, P4990, DOI 10.1364/AO.38.004990; Watanabe Y, 2005, APPL OPTICS, V44, P1387, DOI 10.1364/AO.44.001387; ONURAL L, 1987, OPT ENG, V26, P1124; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268	15	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					731	735		10.1007/s10043-015-0133-2		5	Optics	Optics	CT0MW	WOS:000362491100008		
J	Oya, M; Nishikawa, J; Horie, M; Sato, K; Murakami, N; Kotani, T; Kumagai, S; Tamura, M; Tanaka, Y; Kurokawa, T				Oya, Masahito; Nishikawa, Jun; Horie, Masaaki; Sato, Kazuma; Murakami, Naoshi; Kotani, Takayuki; Kumagai, Shiomi; Tamura, Motohide; Tanaka, Yosuke; Kurokawa, Takashi			Coronagraph experiment on dark-hole control by speckle area nulling method	OPTICAL REVIEW			English	Article						Coronagraph; Adaptive optics; Dark hole; Speckle; Nulling; Exo-planet; Wavefront	LABORATORY DEMONSTRATION; SPACE; MASK	In high-contrast imaging optical systems for direct observation of planets outside our solar system, adaptive optics with an accuracy of lambda/10,000 root mean square is required to reduce the speckle noise down to 1 x 10(-10) level in addition to the nulling coronagraph which eliminate the diffracted light. We developed the speckle area nulling (SAN) method as a new dark-hole control algorithm which is capable of controlling speckle electric field in a wide area quickly, despite an extension of speckle nulling, and is robust not relying upon an optical model. We conducted a validation experiment for the SAN method with a monochromatic light and succeeded in reducing the intensity of areal speckles by 4.4 x 10(-2).	[Oya, Masahito; Horie, Masaaki] Nihon Univ, Grad Sch Sci & Technol, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan; [Oya, Masahito; Sato, Kazuma] Natl Astron Observ Japan, Div Opt & Infrared Astron, Mitaka, Tokyo 1818588, Japan; [Nishikawa, Jun; Kotani, Takayuki; Tamura, Motohide; Kurokawa, Takashi] Natl Astron Observ Japan, Extra Solar Planet Off, Mitaka, Tokyo 1818588, Japan; [Nishikawa, Jun] Grad Univ Adv Studies, Sch Phys Sci, Mitaka, Tokyo 1818588, Japan; [Nishikawa, Jun; Kotani, Takayuki; Tamura, Motohide] Natl Inst Nat Sci, Astrobiol Ctr, Mitaka, Tokyo 1818588, Japan; [Sato, Kazuma] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan; [Murakami, Naoshi] Hokkaido Univ, Div Appl Phys, Fac Engn, Sapporo, Hokkaido 0608588, Japan; [Kumagai, Shiomi] Nihon Univ, Fac Sci & Technol, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan; [Tamura, Motohide] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Tanaka, Yosuke; Kurokawa, Takashi] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Fac Engn, Koganei, Tokyo 1848588, Japan	Oya, M (reprint author), Nihon Univ, Grad Sch Sci & Technol, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan.	masahito.ooya@nao.ac.jp			MEXT [24360029]	A part of this work was supported by Grants-in-Aid (No. 24360029) from the MEXT. This experiment was being performed in the optical experiment facility of Advanced Technology Center of NAOJ.	Trauger JT, 2007, NATURE, V446, P771, DOI 10.1038/nature05729; Kuchner MJ, 2002, ASTROPHYS J, V570, P900, DOI 10.1086/339625; Mawet D, 2011, PROC SPIE, V8151, DOI 10.1117/12.896070; Murakami N, 2013, OPT EXPRESS, V21, P7400, DOI 10.1364/OE.21.007400; Murakami N, 2012, PROC SPIE, V8442, DOI 10.1117/12.925613; Mawet D, 2005, ASTROPHYS J, V633, P1191, DOI 10.1086/462409; Mas M, 2012, PROC SPIE, V8446, DOI 10.1117/12.926586; Borde PJ, 2006, ASTROPHYS J, V638, P488, DOI 10.1086/498669; Give'on A, 2011, PROC SPIE, V8151, DOI 10.1117/12.895117; MALBET F, 1995, PUBL ASTRON SOC PAC, V107, P386, DOI 10.1086/133563; Trauger J, 2012, PROC SPIE, V8442, DOI 10.1117/12.926663; Trauger J, 2004, P SOC PHOTO-OPT INS, V5487, P1330, DOI 10.1117/12.552520	12	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					736	740		10.1007/s10043-015-0118-1		5	Optics	Optics	CT0MW	WOS:000362491100009		
J	Nakajima, N				Nakajima, Nobuharu			Coherent diffractive imaging with an aperture-array filter: relaxation of the aperture's size condition	OPTICAL REVIEW			English	Article						Phase retrieval; Diffractive imaging; Coherent X-ray imaging; Aperture array	DETERMINISTIC PHASE-RETRIEVAL	An improvement of the noniterative phase-retrieval method using an aperture-array filter in coherent diffractive imaging is proposed, in which the condition of the aperture's size can be relaxed. In the previous method, we used a Gaussian approximation of the aperture function of the filter, which is satisfied if the Fresnel number N-F concerning each aperture of the filter is <1. Using the improved method, the condition of the Fresnel number is extended to 1 < N-F < 2. This enables us to use an array filter with a larger aperture size than that for N-F < 1, or to more flexibly set the distance parameters of the measurement system. This improvement is useful for the fabrication of the aperture-array filter, particularly in cases of X-ray, electron, and atomic waves, because the smaller extent of the aperture is needed for phase retrieval with decreasing wavelength. Using computer simulations, it is demonstrated that the performance of object reconstruction by the improved method is almost equal to that by the previous method with the same system parameters except for the size of each aperture.	Shizuoka Univ, Fac Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Nakajima, N (reprint author), Shizuoka Univ, Fac Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tsnnaka@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science [26390081]	This research was supported by a Grant-in-Aid for Scientific Research (Grant No. 26390081) from the Japan Society for the Promotion of Science.	Nakajima N, 1998, APPL OPTICS, V37, P6219, DOI 10.1364/AO.37.006219; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Nakajima N, 2008, J OPT SOC AM A, V25, P742, DOI 10.1364/JOSAA.25.000742; Nakajima N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.223901; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; Nakajima N, 1998, J OPT SOC AM A, V15, P402, DOI 10.1364/JOSAA.15.000402; Nakajima N, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053819; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Nakajima N, 1996, APPL OPTICS, V35, P4581, DOI 10.1364/AO.35.004581; GUREYEV TE, 1995, J OPT SOC AM A, V12, P1932, DOI 10.1364/JOSAA.12.001932; Nakajima N, 2013, APPL OPTICS, V52, pC1, DOI 10.1364/AO.52.0000C1; Kamimura O, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3582240; Nakajima N, 2011, OPT LETT, V36, P2284, DOI 10.1364/OL.36.002284; GERCHBER.RW, 1972, OPTIK, V35, P237; TEAGUE MR, 1983, J OPT SOC AM, V73, P1434	17	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					753	761		10.1007/s10043-015-0121-6		9	Optics	Optics	CT0MW	WOS:000362491100011		
J	Mochizuki, K; Oosumi, K; Koizumi, F; Shinohara, Y; Tagaya, A; Koike, Y				Mochizuki, Keiichi; Oosumi, Kazumasa; Koizumi, Fumiaki; Shinohara, Yoshinori; Tagaya, Akihiro; Koike, Yasuhiro			Distribution angle control of a light-emitting diode downlight lens with high color uniformity using a scattering polymer (vol 22, pg 422, 2015)	OPTICAL REVIEW			English	Correction									[Mochizuki, Keiichi; Oosumi, Kazumasa; Koizumi, Fumiaki; Shinohara, Yoshinori] Nittoh Kogaku KK, Nagano 3920021, Japan; [Mochizuki, Keiichi; Tagaya, Akihiro; Koike, Yasuhiro] Keio Univ, Keio Photon Res Inst, Kawasaki, Kanagawa 2120032, Japan	Mochizuki, K (reprint author), Nittoh Kogaku KK, Nagano 3920021, Japan.	kmochizuki@nittohkogaku.co.jp					Mochizuki K, 2015, OPT REV, V22, P422, DOI 10.1007/s10043-015-0085-6	1	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					827	827		10.1007/s10043-015-0114-5		1	Optics	Optics	CT0MW	WOS:000362491100018		
J	Zang, JL; Wu, AA; Liu, Y; Wang, J; Lin, X; Tan, XD; Shimura, T; Kuroda, K				Zang, Jinliang; Wu, An'an; Liu, Ying; Wang, Jue; Lin, Xiao; Tan, Xiaodi; Shimura, Tsutomu; Kuroda, Kazuo			Characteristics of volume polarization holography with linear polarization light	OPTICAL REVIEW			English	Article; Proceedings Paper	8th International Workshop on Holography and related Technologies (IWH)	OCT 15-17, 2014	Beijing Inst Technol, Beijing, PEOPLES R CHINA	Tsinghua Univ, Holog Syst Dev Forum, Utsunomiya Univ, Ctr Opt Res & Educ, Chinese Opt Soc, Holog & Opt Informat Proc Comm, Res Grp Volume Holog Memory Technol, Holog Display Artists & Engineers Club, Grp Informat Photon, Grp Digital Opt, Opt Soc Japan, Japan Soc Appl Phys, Japan Soc Promot Sci	Beijing Inst Technol	Holographic data storage; Polarization holography; Anisotropic material; Polarization characteristics; Linear polarization	STORAGE	Volume polarization holographic recording in phenanthrenequinone-doped poly(methyl methacrylate) (PQ-PMMA) photopolymer with linear polarized light is obtained. The characteristics of the volume polarization hologram are experimentally investigated. It is found that beyond the paraxial approximation the polarization states of the holographic reconstruction light are generally different from the signal light. Based on vector wave theoretical analyses and material properties, the special exposure condition for correctly holographic reconstruction is obtained and experimentally demonstrated.	[Zang, Jinliang; Wu, An'an; Liu, Ying; Wang, Jue; Lin, Xiao; Tan, Xiaodi; Kuroda, Kazuo] Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China; [Shimura, Tsutomu] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Kuroda, Kazuo] Utsunomiya Univ, CORE, Utsunomiya, Tochigi 3218585, Japan	Tan, XD (reprint author), Beijing Inst Technol, Sch Optoelect, 5 South Zhongguancun St, Beijing 100081, Peoples R China.	zangjinliang1987@163.com; tan@bit.edu.cn			National Natural Science Foundation of China [61475019, 61205053]	This work is supported by a grant from the National Natural Science Foundation of China (Grant Nos. 61475019 and 61205053).	Horimai H, 2007, IEEE T MAGN, V43, P943, DOI 10.1109/TMAG.2006.888528; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; Barada D, 2012, OPT LETT, V37, P4528, DOI 10.1364/OL.37.004528; Lin SH, 2011, OPT LETT, V36, P3039, DOI 10.1364/OL.36.003039; Lin SH, 2006, J NONLINEAR OPT PHYS, V15, P239, DOI 10.1142/S0218863506003244; Kuroda K, 2011, OPT REV, V18, P374, DOI 10.1007/s10043-011-0072-5; Lin S.H., 2014, OPT EXPRESS, V14, P14944; Nikolova L, 2009, POLARIZATION HOLOGRAPHY, P1, DOI 10.1017/CBO9780511581489; Wu A., 2014, DH	9	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					829	831		10.1007/s10043-015-0122-5		3	Optics	Optics	CT0MW	WOS:000362491100020		
J	Guo, JX; Fujii, R; Tomita, Y				Guo, Jinxin; Fujii, Ryuta; Tomita, Yasuo			Volume holographic recording in nanoparticle-polymer composites doped with multifunctional chain transfer agents	OPTICAL REVIEW			English	Article; Proceedings Paper	8th International Workshop on Holography and related Technologies (IWH)	OCT 15-17, 2014	Beijing Inst Technol, Beijing, PEOPLES R CHINA	Tsinghua Univ, Holog Syst Dev Forum, Utsunomiya Univ, Ctr Opt Res & Educ, Chinese Opt Soc, Holog & Opt Informat Proc Comm, Res Grp Volume Holog Memory Technol, Holog Display Artists & Engineers Club, Grp Informat Photon, Grp Digital Opt, Opt Soc Japan, Japan Soc Appl Phys, Japan Soc Promot Sci	Beijing Inst Technol	Nanocomposite materials; Holographic recording materials; Chain transfer reaction; Nanoparticles	DIFFRACTION EFFICIENCY; PHOTOPOLYMER; GRATINGS; MODEL; FILMS	We report on an experimental investigation of the properties of volume holographic recording in photopolymerizable nanoparticle-polymer composites (NPCs) doped with chain transferring multifunctional di- and tri-thiols as chain transfer agents. It is shown that the incorporation of the multifunctional thiols into NPCs more strongly influences on volume holographic recording than that doped with mono-thiol since more chemical reactions involve in the polymer network formation. It is found that, as similar to the case of mono-thiol doping, there exist optimum concentrations of di- and tri-thiols for maximizing the saturated refractive index modulation. It is also seen that recording sensitivity monotonically decreases with an increase in multifunctional thiol concentration due to the partial inhibition of the photopolymerization event by excessive thiols.	[Guo, Jinxin; Fujii, Ryuta; Tomita, Yasuo] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan	Guo, JX (reprint author), Univ Electrocommun, Dept Engn Sci, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	jinxin@bellevue.ee.uec.ac.jp			JSPS KAKENHI [25 03052]	One of the authors, J. Guo, acknowledges the financial support by JSPS KAKENHI grant number 25 03052.	Naydenova I, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044019; Momose K, 2012, OPT LETT, V37, P2250, DOI 10.1364/OL.37.002250; Guo JX, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/9/095602; Suzuki N, 2002, APPL PHYS LETT, V81, P4121, DOI 10.1063/1.1525391; Ortuno M, 2011, PROC SPIE, V8204, DOI 10.1117/12.902889; Tomita Y, 2005, OPT LETT, V30, P839, DOI 10.1364/OL.30.8.000839; Tomita Y, 2008, OPT LETT, V33, P1750, DOI 10.1364/OL.33.001750; Gleeson MR, 2011, OPT EXPRESS, V19, P26325, DOI 10.1364/OE.19.026325; UCHIDA N, 1973, J OPT SOC AM, V63, P280, DOI 10.1364/JOSA.63.000280; Qi Y, 2014, OPT COMMUN, V320, P114, DOI 10.1016/j.optcom.2014.01.026; Suzuki N, 2006, OPT EXPRESS, V14, P12712, DOI 10.1364/OE.14.012712; Sanchez C, 2005, ADV FUNCT MATER, V15, P1623, DOI 10.1002/adfm.200500095; Gleeson MR, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/2/024008; Liu XM, 2012, OPT EXPRESS, V20, P13457, DOI 10.1364/OE.20.013457; Sheridan JT, 2000, J OPT SOC AM A, V17, P1108, DOI 10.1364/JOSAA.17.001108; Suzuki N, 2004, APPL OPTICS, V43, P2125, DOI 10.1364/AO.43.002125; Guo JX, 2014, OPT LETT, V39, P6743, DOI 10.1364/OL.39.006743; Guo JX, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/9/095601; Naydenova I, 2006, P SOC PHOTO-OPT INS, V6252, P25206, DOI 10.1117/12.676503; Gleeson MR, 2008, J OPT SOC AM B, V25, P396, DOI 10.1364/JOSAB.25.000396; Fujii R, 2014, OPT LETT, V39, P3453, DOI 10.1364/OL.39.003453; Caputo R, 2001, CHEM PHYS, V271, P323, DOI 10.1016/S0301-0104(01)00441-4; Hata E, 2011, OPT MATER EXPRESS, V1, P207; Sakhno OV, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105704; Fally M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123904; Fukuda Y., 2012, P SOC PHOTO-OPT INS, V8429; Tomita Y., 2011, ENCY NANOSCIENCE NAN, V15, P191	27	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					832	836		10.1007/s10043-015-0084-7		5	Optics	Optics	CT0MW	WOS:000362491100021		
J	Liu, Y; Li, ZZ; Zang, JL; Wu, AA; Wang, J; Lin, X; Tan, XD; Barada, D; Shimura, T; Kuroda, K				Liu, Ying; Li, Zhenzhen; Zang, Jinliang; Wu, An'an; Wang, Jue; Lin, Xiao; Tan, Xiaodi; Barada, Daisuke; Shimura, Tsutomu; Kuroda, Kazuo			The optical polarization properties of phenanthrenequinone-doped Poly(methyl methacrylate) photopolymer materials for volume holographic storage	OPTICAL REVIEW			English	Article; Proceedings Paper	8th International Workshop on Holography and related Technologies (IWH)	OCT 15-17, 2014	Beijing Inst Technol, Beijing, PEOPLES R CHINA	Tsinghua Univ, Holog Syst Dev Forum, Utsunomiya Univ, Ctr Opt Res & Educ, Chinese Opt Soc, Holog & Opt Informat Proc Comm, Res Grp Volume Holog Memory Technol, Holog Display Artists & Engineers Club, Grp Informat Photon, Grp Digital Opt, Opt Soc Japan, Japan Soc Appl Phys, Japan Soc Promot Sci	Beijing Inst Technol	Phenanthrenequinone; Polarization holography; Holography material; Diffraction efficiency; Polarization characteristic	DIFFUSION	We present an experimental study on the optical polarization properties of the phenanthrenequinone-doped poly(methyl methacrylate) photopolymer materials. We discuss the diffraction efficiency with different weight ratios of phenanthrenequinone that was dissolved in the materials. In addition, we observe the diffraction efficiency difference between polarization holography and traditional holography.	[Liu, Ying; Li, Zhenzhen; Zang, Jinliang; Wu, An'an; Wang, Jue; Lin, Xiao; Tan, Xiaodi; Kuroda, Kazuo] Beijing Inst Technol, Sch Optoelect, Beijing 100081, Peoples R China; [Barada, Daisuke; Kuroda, Kazuo] Utsunomiya Univ, CORE, Utsunomiya, Tochigi 3218585, Japan; [Shimura, Tsutomu] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Liu, Y (reprint author), Beijing Inst Technol, Sch Optoelect, 5 South Zhongguancun St, Beijing 100081, Peoples R China.	yueying_zhun@163.com; tan@bit.edu.cn			National Natural Science Foundation of China [61475019, 61205053]	This work is supported by a grant from the National Natural Science Foundation of China (Grant No. 61475019 and 61205053).	PSALTIS D, 1995, SCI AM, V273, P70; Veniaminov AV, 1999, MACROMOLECULES, V32, P1828, DOI 10.1021/ma981312d; Horimai H, 2007, IEEE T MAGN, V43, P943, DOI 10.1109/TMAG.2006.888528; Horimai H, 2005, APPL OPTICS, V44, P2575, DOI 10.1364/AO.44.002575; Veniaminov AV, 2008, J OPT TECHNOL+, V75, P306, DOI 10.1364/JOT.75.000306; Lin SH, 2006, J NONLINEAR OPT PHYS, V15, P239, DOI 10.1142/S0218863506003244; Kuroda K, 2011, OPT REV, V18, P374, DOI 10.1007/s10043-011-0072-5; Wu AA, 2015, OPT EXPRESS, V23, P8880, DOI 10.1364/OE.23.008880; Tan XD, 2001, APPL OPTICS, V40, P4721, DOI 10.1364/AO.40.004721; Mogil'nyi V. V., 2008, P 7 INT C LAS PHYS O, P147	10	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					837	840		10.1007/s10043-015-0108-3		4	Optics	Optics	CT0MW	WOS:000362491100022		
J	Jiao, SM; Yoshikawa, H				Jiao Shuming; Yoshikawa, Hiroshi			Fast computer simulation of reconstructed image from rainbow hologram based on GPU	OPTICAL REVIEW			English	Article; Proceedings Paper	8th International Workshop on Holography and related Technologies (IWH)	OCT 15-17, 2014	Beijing Inst Technol, Beijing, PEOPLES R CHINA	Tsinghua Univ, Holog Syst Dev Forum, Utsunomiya Univ, Ctr Opt Res & Educ, Chinese Opt Soc, Holog & Opt Informat Proc Comm, Res Grp Volume Holog Memory Technol, Holog Display Artists & Engineers Club, Grp Informat Photon, Grp Digital Opt, Opt Soc Japan, Japan Soc Appl Phys, Japan Soc Promot Sci	Beijing Inst Technol	Rainbow hologram; Reconstruction; Simulation; Fourier transform; GPU	ALGORITHM	A fast computer simulation solution for rainbow hologram reconstruction based on GPU is proposed. In the commonly used segment Fourier transform method for rainbow hologram reconstruction, the computation of 2D Fourier transform on each hologram segment is very time consuming. GPU-based parallel computing can be applied to improve the computing speed. Compared with CPU computing, simulation results indicate that our proposed GPU computing can effectively reduce the computation time by as much as eight times.	[Jiao Shuming] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Yoshikawa, Hiroshi] Nihon Univ, Dept Comp Engn, Coll Sci & Technol, Optoelect Lab, Funabashi, Chiba 2748501, Japan	Jiao, SM (reprint author), City Univ Hong Kong, Dept Elect Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	albertjiaoee@gmail.com					COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Yu LF, 2001, J OPT SOC AM A, V18, P1033, DOI 10.1364/JOSAA.18.001033; Pan YC, 2009, OPT EXPRESS, V17, P18543, DOI 10.1364/OE.17.018543; Frigo M., FFTW LIB; Kang Hoonjong, 2009, APPL OPTICS, V48, P137; Nobuyuki M., 2006, OPT EXPRESS, V14, P603; Sergio D.N., 2005, OPT EXPRESS, V13, P9935; Tomoyoshi S., 2010, OPT EXPRESS, V18, P9955; Tomoyoshi S., 2008, OPT EXPRESS, V16, P11776; Tsang P. W. M., 2010, 3D Research, V1, DOI 10.1007/3DRes.02(2010)03; Ulf S., 1994, APPL OPTICS, V33, P179; Ulf S., 2002, MEASUREMENT SCI TECH, V13, pR85; Yasuda T, 2009, P SOC PHOTO-OPT INS, V7233, DOI 10.1117/12.809774; Yasuhiro T., 1999, APPL OPTICS, V38, P2204; Yoshikawa H., 2007, DTUD3	15	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					841	843		10.1007/s10043-015-0102-9		3	Optics	Optics	CT0MW	WOS:000362491100023		
J	Kujime, R; Suyama, S; Yamamoto, H				Kujime, Ryosuke; Suyama, Shiro; Yamamoto, Hirotsugu			Different aerial image formation into two directions by crossed-mirror array	OPTICAL REVIEW			English	Article; Proceedings Paper	8th International Workshop on Holography and related Technologies (IWH)	OCT 15-17, 2014	Beijing Inst Technol, Beijing, PEOPLES R CHINA	Tsinghua Univ, Holog Syst Dev Forum, Utsunomiya Univ, Ctr Opt Res & Educ, Chinese Opt Soc, Holog & Opt Informat Proc Comm, Res Grp Volume Holog Memory Technol, Holog Display Artists & Engineers Club, Grp Informat Photon, Grp Digital Opt, Opt Soc Japan, Japan Soc Appl Phys, Japan Soc Promot Sci	Beijing Inst Technol	Crossed-mirror array; Aerial image; Two-direction imaging; One-sided mirror; Anisotropy	PARALLAX-BARRIER; DISPLAY	Different aerial images in two directions can be formed by using a crossed-mirror array (CMA). The array is composed of reflective imaging elements based on dihedral corner mirrors and is used to form an aerial LED image. However, as CMA is formed from one-sided mirrors for keeping down the cost, only two of the four aperture walls of CMA are mirrors and the other two are back sides of the mirrors. As a dihedral corner mirror needs double reflections, aerial image quality varies with the incidence direction of light on the CMA. In this paper, we propose a new CMA configuration for forming aerial images in two directions more clearly. Clear different aerial images in two directions can be successfully formed by using the new CMA configuration.	[Kujime, Ryosuke; Suyama, Shiro; Yamamoto, Hirotsugu] Univ Tokushima, Tokushima, Tokushima 7708506, Japan; [Yamamoto, Hirotsugu] Utsunomiya Univ, Utsunomiya, Tochigi 3218585, Japan	Kujime, R (reprint author), Univ Tokushima, 2-1 Minamijosanjima, Tokushima, Tokushima 7708506, Japan.	c501448001@tokushima-u.ac.jp					Lindlein N, 2002, J OPT A-PURE APPL OP, V4, pS1, DOI 10.1088/1464-4258/4/4/351; Takaki Y, 2010, OPT EXPRESS, V18, P8824, DOI 10.1364/OE.18.008824; Hembd-Solner C, 1999, J OPT A-PURE APPL OP, V1, P94, DOI 10.1088/1464-4258/1/1/013; Jang JS, 2002, OPT LETT, V27, P1144, DOI 10.1364/OL.27.001144; Son JY, 2004, APPL OPTICS, V43, P4985, DOI 10.1364/AO.43.004985; Wang QH, 2010, OPTIK, V121, P2008, DOI 10.1016/j.ijleo.2009.07.002; Son JY, 2010, J DISP TECHNOL, V6, P394, DOI 10.1109/JDT.2010.2045636; KAWAZU M, 1985, APPL OPTICS, V24, P4300; Inneman A, 1999, P SOC PHOTO-OPT INS, V3766, P72, DOI 10.1117/12.363660; Tao YH, 2009, OPT LETT, V34, P3220, DOI 10.1364/OL.34.003220; Volkel R, 1996, OPT ENG, V35, P3323; Aria J., 1998, APPL OPTICS, V37, P2034; Hornbeck L. J., 1988, SPAT LIGHT MOD APPL, V8, P107; Hudec R., 2010, XRAY OPT INSTRUM, V2010, P39; Ishikawa M., 2003, PIONEER R D, V12, P47; Maekawa S, 2008, PROC SPIE, V6803, DOI 10.1117/12.767198; Maekawa Satoshi, 2006, Proceedings of the SPIE - The International Society for Optical Engineering, V6392, DOI 10.1117/12.690574; Miyazaki D, 2010, PROC SPIE, V7524, DOI 10.1117/12.840212; Okano F., 2002, APPL OPTICS, V41, P414	19	0	0	OPTICAL SOC JAPAN	TOKYO	KUDAN-KITA BLDG 5F, 1-12-3, KUDAN-KITA CHIYODA-KU, TOKYO, 102, JAPAN	1340-6000	1349-9432		OPT REV	Opt. Rev.	OCT	2015	22	5					862	867		10.1007/s10043-015-0132-3		6	Optics	Optics	CT0MW	WOS:000362491100026		
J	Sakai, T; Gekka, T; Kohzaki, K; Horiguchi, H; Shikishima, K; Tsuneoka, H				Sakai, Tsutomu; Gekka, Tamaki; Kohzaki, Kenichi; Horiguchi, Hiroshi; Shikishima, Keigo; Tsuneoka, Hiroshi			Improved Photoreceptor Function in Male Acute Zonal Occult Outer Retinopathy	OPTOMETRY AND VISION SCIENCE			English	Article						acute zonal occult outer retinopathy; spectral domain optical coherence tomography; photoreceptor; steroid	TERM-FOLLOW-UP; SEGMENT	Purpose To describe male acute zonal occult outer retinopathy (AZOOR) patients with improvement of photoreceptor structure and visual function. Case Series Medical records for eight eyes in seven patients (mean age, 36.9 years; range, 22 to 57 years) with AZOOR were reviewed retrospectively. Of the seven patients, four were treated with high-dose methylprednisolone therapy and three were not treated. All patients presented with photopsias and severe vision loss in the affected eyes. Visual acuity ranged from 0.2 to 1.5 on a Snellen decimal scale and Humphrey visual field testing showed blind spot enlargement or ring scotomas. Fundus and angiographic examinations found no specific abnormalities, leading to a diagnosis of AZOOR. Spectral domain optical coherence tomography showed attenuation of the photoreceptor inner segment ellipsoid zone. Multifocal electroretinography demonstrated that there were decreased responses at the site of the spectral domain optical coherence tomography abnormalities and corresponding visual field loss. Three patients had a spontaneous resolution with restoration of photoreceptor structure and visual function, and four patients had a visual improvement with restoration of photoreceptor structure and visual function after steroid pulse therapy. Conclusions These results suggest that male AZOOR patients may have a tendency of visual improvement both with and without treatment.	[Sakai, Tsutomu; Gekka, Tamaki; Kohzaki, Kenichi; Horiguchi, Hiroshi; Shikishima, Keigo; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo 1058461, Japan	Sakai, T (reprint author), Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	tstmski@jikei.ac.jp					Monson DM, 2011, SURV OPHTHALMOL, V56, P23, DOI 10.1016/j.survophthal.2010.07.004; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Jampol LM, 2003, AM J OPHTHALMOL, V135, P376, DOI 10.1016/S0002-9394(02)02088-3; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217; Marmor MF, 2003, DOC OPHTHALMOL, V106, P105, DOI 10.1023/A:1022591317907; Hoang QV, 2013, RETINA-J RET VIT DIS, V33, P1325, DOI 10.1097/IAE.0b013e318286cc57; Mkrtchyan M, 2012, AM J OPHTHALMOL, V153, P757, DOI 10.1016/j.ajo.2011.09.007; Gass JD, 2002, AM J OPHTHALMOL, V134, P329, DOI 10.1016/S0002-9394(02)01640-9; Fujiwara T, 2010, RETINA-J RET VIT DIS, V30, P1206, DOI 10.1097/IAE.0b013e3181e097f0; Li D, 2007, ARCH OPHTHALMOL-CHIC, V125, P1194, DOI 10.1001/archopht.125.9.1194; Mrejen S, 2014, JAMA OPHTHALMOL, V132, P1089, DOI 10.1001/jamaophthalmol.2014.1683	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	OCT	2015	92	10					e371	e379		10.1097/OPX.0000000000000683		9	Ophthalmology	Ophthalmology	CS5HC	WOS:000362107600004		
J	Izumi, H; Minegishi, M; Sato, Y; Shimizu, T; Sekine, K; Takase, M				Izumi, Hirohisa; Minegishi, Mario; Sato, Yohei; Shimizu, Takashi; Sekine, Kazunori; Takase, Mitsunori			Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats	PEDIATRIC RESEARCH			English	Article							DEXTRAN SULFATE SODIUM; BREAST-MILK; COLITIS; INFANTS; BACTERIA; MICE; PCR; SYNBIOTICS; MICROBIOTA; INDUCTION	BACKGROUND: Bifidobacterium breve M-16V (M16V) is a probiotic bacterial strain with a long tradition of use in neonatal intensive care units in some countries. Previous study showed that the effects of. M16V administration on gene expression were greater during the weaning period than in the neonatal period and were greater in the colon than in the small intestine and spleen, suggesting that M16V has anti-inflammatory effects. In this study, we evaluated the effects of inflammation during the weaning period and the effects of M16V on normal and inflammatory conditions. METHODS: From postnatal day (PD) 21 to 34, weanling rats were administered of 2.5 x 10(9) of M16V daily, and colitis was induced by administration of 2% dextran sulfate sodium from PD28 to 35. Colitis severity, immune function, and microbiota were investigated. RESULTS: Colitis caused a reduction in body weight gain, colon shortening, poor nutritional status, anemia, changes in blood and spleen lymphocyte populations, spleen T-cell malfunctions, and alterations in colon microbiota. M16V administration improved some but not all of the changes induced by colitis. CONCLUSION: M16V could suppress inflammation and, therefore, can be considered a safe strain to use not only during the neonatal period but also the weaning period.	[Izumi, Hirohisa; Minegishi, Mario; Sato, Yohei; Shimizu, Takashi; Sekine, Kazunori; Takase, Mitsunori] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa, Japan	Izumi, H (reprint author), Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa, Japan.	h-izumi@morinagamilk.co.jp			Morinaga Milk Industry Co., Ltd.	This study was funded by Morinaga Milk Industry Co., Ltd.	Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Inoue Y, 2009, BIOL PHARM BULL, V32, P760, DOI 10.1248/bpb.32.760; Calder PC, 2006, BRIT J NUTR, V96, P774, DOI 10.1079/BJN20061917; Yoshihara K, 2006, GUT, V55, P334, DOI 10.1136/gut.2005.076000; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lee WH, 1996, J NUTR, V126, P849; Kostadinova FI, 2010, J LEUKOCYTE BIOL, V88, P133, DOI 10.1189/jlb.1109768; Tannock GW, 2013, APPL ENVIRON MICROB, V79, P3040, DOI 10.1128/AEM.03910-12; Nakao A, 1998, INT IMMUNOL, V10, P387, DOI 10.1093/intimm/10.4.387; Ohtsuka Y, 2012, PEDIATR RES, V71, P46, DOI 10.1038/pr.2011.11; Abe F, 2010, ANAEROBE, V16, P131, DOI 10.1016/j.anaerobe.2009.07.006; Kainonen E, 2013, BRIT J NUTR, V109, P1962, DOI 10.1017/S0007114512004229; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Braegger C, 2011, J PEDIATR GASTR NUTR, V52, P238, DOI 10.1097/MPG.0b013e3181fb9e80; Vicario M, 2005, DIGEST DIS SCI, V50, P143, DOI 10.1007/s10620-005-1292-y; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Schouten B, 2009, J NUTR, V139, P1398, DOI 10.3945/jn.109.108514; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; Kataoka K, 2008, DIGEST DIS SCI, V53, P1601, DOI 10.1007/s10620-007-0063-3; Li YD, 2004, PEDIATR INT, V46, P509, DOI 10.1111/j.1442-200x.2004.01953.x; Fitzpatrick LR, 2007, J PEDIATR GASTR NUTR, V44, P561, DOI 10.1097/MPG.0b013e31803bda51; Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301; Shlomai NO, 2014, NEONATOLOGY, V105, P64, DOI 10.1159/000354891; ZHAO ZR, 1995, J NUTR, V125, P2064; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Fredin MF, 2007, SCAND J IMMUNOL, V65, P421, DOI 10.1111/j.1365-3083.2007.01923.x; Odamaki T, 2007, J INVEST ALLERG CLIN, V17, P92; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056547; Patole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089511; Pharmingen BD, RAT IMM GEN PROT CEL; Tomosada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059259; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	OCT	2015	78	4					407	416		10.1038/pr.2015.115		10	Pediatrics	Pediatrics	CS9DI	WOS:000362388900008		
J	Fukui, T; Nishida, H; Takanashi, S				Fukui, T.; Nishida, H.; Takanashi, S.			Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal Coating (TM)	PERFUSION-UK			English	Article						biocompatible coatings; cardiopulmonary bypass; cardiovascular surgery; inflammatory response	HEPARIN-COATED CIRCUITS; INFLAMMATORY RESPONSE; EXTRACORPOREAL CIRCUITS; COMPLEMENT ACTIVATION; CARDIAC-SURGERY; PHOSPHORYLCHOLINE; MULTICENTER; THROMBIN; TRIAL	Objective: The aim of this study was to compare the biocompatibility of a new Senko E-Ternal coating (SEC) for cardiopulmonary bypass (CPB) circuits with the well-established poly-2-methoxyethyl acrylate (PMEA) coating. Methods: Forty patients undergoing aortic valve replacement were randomly assigned to either an SEC-coated group (n = 20) or a PMEA-coated group (n = 20). Clinical data and the following markers were analyzed: platelet count, platelet factor (PF) 4, fibrinogen, fibrinogen degradation products (FDPs), antithrombin III (AT III), thrombin-antithrombin complex (TAT), plasminogen, complement hemolytic activity (CH50), complement 3 (C3) and interleukin-6 (IL-6). Blood samples were obtained at five time points in both groups. Results: CPB time, aortic cross-clamp time and blood loss and transfusion were similar in both groups. There were no significant differences between the groups in terms of platelet count, PF4 and all coagulation and fibrinolytic parameters (FDP, AT III, TAT, and plasminogen) at any time points. Inflammatory markers (CH50, C3 and IL-6) were also similar in both groups at all time points. Conclusions: The SEC-coated circuit demonstrated equivalent biocompatibility to the PMEA-coated circuit. SEC-coated circuits are, therefore, favorably comparable to PMEA-coated circuits for clinical use in CPB.	[Fukui, T.; Nishida, H.; Takanashi, S.] Sakakibara Heart Inst, Dept Cardiovascul Surg, Fuchu, Tokyo 1830003, Japan	Fukui, T (reprint author), Sakakibara Heart Inst, Dept Cardiovascul Surg, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	tfukui.cvs@gmail.com					Edmunds LH, 2004, NEW ENGL J MED, V351, P1603, DOI 10.1056/NEJMp048212; SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198; Ninomiya M, 2003, ANN THORAC SURG, V75, P913, DOI 10.1016/S0003-4975(02)04407-7; Suzuki Y, 2008, J ARTIF ORGANS, V11, P111, DOI 10.1007/s10047-008-0415-6; YU J, 1994, INT J ARTIF ORGANS, V17, P499; KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845; Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4; Ikuta T, 2004, ANN THORAC SURG, V77, P1678, DOI 10.1016/j.athoracsur.2003.10.060; Shann KG, 2006, J THORAC CARDIOV SUR, V132, P283, DOI 10.1016/j.jtcvs.2006.03.027; Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8; Reser D, 2012, PERFUSION-UK, V27, P530, DOI 10.1177/0267659112454558; Fosse E, 1997, EUR J CARDIO-THORAC, V11, P320, DOI 10.1016/S1010-7940(96)01062-7; Lundblad R, 1997, ANN THORAC SURG, V63, P1361, DOI 10.1016/S0003-4975(97)00088-X; Baykut D, 2001, EUR J MED RES, V6, P297; Edmunds LH, 2006, ANN THORAC SURG, V82, P2315, DOI 10.1016/j.athoracsur.2006.06.072; Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x; KHURI SF, 1995, ANN THORAC SURG, V60, P1008, DOI 10.1016/0003-4975(95)00668-B; Jansen PGM, 1996, ANN THORAC SURG, V61, P1363, DOI 10.1016/0003-4975(96)00056-2; Thiara AS, 2011, PERFUSION-UK, V26, P107, DOI 10.1177/0267659110392438; ZILLA P, 1989, J THORAC CARDIOV SUR, V97, P379; Boning A, 2004, J THORAC CARDIOV SUR, V127, P1458, DOI 10.1016/j.jtcvs.2003.08.051; Belboul A, 2000, EUR J CARDIO-THORAC, V17, P580, DOI 10.1016/S1010-7940(00)00392-4; SOWER LE, 1995, J IMMUNOL, V155, P895; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; De Somer F, 2002, Perfusion, V17, P39; Izuha Hitoshi, 2005, J Artif Organs, V8, P41, DOI 10.1007/s10047-004-0280-x; Raja Shahzad G, 2005, Asian Cardiovasc Thorac Ann, V13, P382; Silvetti S, 2015, ARTIF ORGANS, V39, P176, DOI 10.1111/aor.12335; Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0267-6591	1477-111X		PERFUSION-UK	Perfusion-UK	OCT	2015	30	7					572	579		10.1177/0267659115580666		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS3MG	WOS:000361978000013		
J	Nakagawa, Y; Chiba, K				Nakagawa, Yutaka; Chiba, Kenji			Diversity and plasticity of microglial cells in psychiatric and neurological disorders	PHARMACOLOGY & THERAPEUTICS			English	Review						M1/M2 polarization; Neuroinflammation; Neural network dysfunction; Psychiatric disorders; Obesity; Neurological diseases	AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; MEDIAL TEMPORAL-LOBE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RELAPSING MULTIPLE-SCLEROSIS; PLACEBO-CONTROLLED TRIAL; BRAIN-BARRIER INTEGRITY; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; HIGH-ENERGY DIET	Recent advanced immunological analyses have revealed that the diversity and plasticity of macrophages lead to the identification of functional polarization states (classically activated M1 type and alternatively activated M2 type) which are dependent on the extracellular environment. M1 and M2 polarization states of macrophages play an important role in controlling the balance between pro-inflammatory and anti-inflammatory conditions. Microglial cells are resident mononuclear phagocytes in the central nervous system (CNS), express several macrophage-associated markers, and appear to display functional polarization states similar to macrophages. Like M1 macrophages, M1 polarized microglia can produce pro-inflammatory cytokines and mediators such as interleukin (IL) 1 beta, IL-6, tumor necrosis factor-alpha, CC-chemokine ligand 2, nitric oxide, and reactive oxygen species, suggesting that these molecules contribute to dysfunction of neural network in the CNS. On the other hand, M2 polarized microglia can produce anti-inflammatory cytokine, IL-10 and express several receptors that are implicated in inhibiting inflammation and restoring homeostasis. In this review, we summarize the diversity, plasticity, and immunoregulatory functions of M1 and M2 microglia in psychiatric and neurological disorders. Based on these aspects, we propose a contribution of imbalance between M1 and M2 polarization of microglia in bipolar disorder, obesity, amyotrophic lateral sclerosis, and Rett syndrome. Consequently, molecules that normalize the imbalance between M1 and M2 microglial polarization states may provide a beneficial therapeutic target for the treatment of these disorders. (C) 2015 Elsevier Inc. All rights reserved.	[Nakagawa, Yutaka] Mitsubishi Tanabe Pharma Corp, Div Res, Res Strategy & Planning Dept, Yokohama, Kanagawa 2270033, Japan; [Chiba, Kenji] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 1, Yokohama, Kanagawa 2270033, Japan	Nakagawa, Y (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, Res Strategy & Planning Dept, Yokohama, Kanagawa 2270033, Japan.	Nakagawa.Yutaka@mf.mt-pharma.co.jp					Alexopoulos G S, 1999, Dialogues Clin Neurosci, V1, P68; Almeida J. R. C., 2013, BIOL PSYCHIAT, V73, P111; Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Konner AC, 2011, CELL METAB, V13, P720, DOI 10.1016/j.cmet.2011.03.021; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Adam D, 2013, NATURE, V496, P416, DOI 10.1038/496416a; Petrulis A, 2013, FRONT NEUROENDOCRIN, V34, P255, DOI 10.1016/j.yfrne.2013.07.007; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; Morris AA, 2012, PSYCHOSOM MED, V74, P483, DOI 10.1097/PSY.0b013e31824f5de0; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Spoletini I, 2011, SCHIZOPHRENIA BULL, V37, P118, DOI 10.1093/schbul/sbp058; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.ndb.2003.12.012; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Van der Schot A, 2010, PSYCHIAT RES-NEUROIM, V184, P135, DOI 10.1016/j.pscychresns.2010.07.009; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Varga K, 1998, FASEB J, V12, P1035; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; Ito R, 2008, J NEUROSCI, V28, P6950, DOI 10.1523/JNEUROSCI.1615-08.2008; Jiang H, 2008, EXP NEUROL, V212, P532, DOI 10.1016/j.expneurol.2008.05.006; Lustig RH, 2006, NAT CLIN PRACT ENDOC, V2, P447, DOI 10.1038/ncpendmet0220; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Laake JPS, 2014, DIABETES CARE, V37, P2186, DOI 10.2337/dc13-2522; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Potschka H, 2011, NEUROPHARMACOLOGY, V61, P909, DOI 10.1016/j.neuropharm.2011.06.018; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Eker C, 2014, BIPOLAR DISORD, V16, P249, DOI 10.1111/bdi.12181; Martens MJI, 2013, AM J CLIN NUTR, V97, P471, DOI 10.3945/ajcn.112.044024; Meyer U, 2011, PHARMACOL THERAPEUT, V132, P96, DOI 10.1016/j.pharmthera.2011.06.003; Mikita J, 2011, MULT SCLER, V17, P2, DOI 10.1177/1352458510379243; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Weissman DH, 2008, NEUROIMAGE, V40, P955, DOI 10.1016/j.neuroimage.2007.12.021; Moon M, 2009, NEUROTOX RES, V15, P332, DOI 10.1007/s12640-009-9037-x; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Erion JR, 2014, J NEUROSCI, V34, P2618, DOI 10.1523/JNEUROSCI.4200-13.2014; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Schneider MR, 2012, BIPOLAR DISORD, V14, P356, DOI 10.1111/j.1399-5618.2012.01024.x; Srinivasan M, 2008, J ENDOCRINOL, V197, P565, DOI 10.1677/JOE-08-0021; Zhong MT, 2011, BIOL PSYCHOL, V88, P233, DOI 10.1016/j.biopsycho.2011.08.007; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Martinez D, 2014, CELL METAB, V19, P941, DOI 10.1016/j.cmet.2014.03.026; Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Doty TJ, 2008, PSYCHIAT RES-NEUROIM, V163, P84, DOI 10.1016/j.pscychresns.2007.08.003; Stoll AL, 1999, ARCH GEN PSYCHIAT, V56, P407, DOI 10.1001/archpsyc.56.5.407; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Yoshida-Komiya H, 2014, PSYCHIAT CLIN NEUROS, V68, P574, DOI 10.1111/pcn.12160; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Davidson TL, 2012, PHYSIOL BEHAV, V107, P26, DOI 10.1016/j.physbeh.2012.05.015; Chiba K, 2011, INT IMMUNOPHARMACOL, V11, P366, DOI 10.1016/j.intimp.2010.10.005; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Di Leone RJ, 2012, NAT NEUROSCI, V15, P1330, DOI 10.1038/nn.3202; Dong JJ, 2009, J MOL NEUROSCI, V37, P182, DOI 10.1007/s12031-008-9162-7; ROBINSON RG, 1982, STROKE, V13, P635; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Huang Y, 2005, ACTA PHARMACOL SIN, V26, P952, DOI 10.1111/j.1745-7254.2005.00136.x; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Mason L, 2014, BRAIN, V137, P2346, DOI 10.1093/brain/awu152; Nusslock R, 2012, BIPOLAR DISORD, V14, P249, DOI 10.1111/j.1399-5618.2012.01012.x; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Brooks SJ, 2013, INT J OBESITY, V37, P230, DOI 10.1038/ijo.2012.13; Nery FG, 2008, HUM PSYCHOPHARM CLIN, V23, P87, DOI 10.1002/hup.912; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Zhao M, 2013, CELL PHYSIOL BIOCHEM, V32, P601, DOI 10.1159/000354464; Hassel S, 2008, BIPOLAR DISORD, V10, P916, DOI 10.1111/j.1399-5618.2008.00641.x; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Soderlund J, 2011, J PSYCHIATR NEUROSCI, V36, P114, DOI 10.1503/jpn.100080; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Ozanne SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE534; Pillai JJ, 2002, PSYCHIAT RES-NEUROIM, V114, P51, DOI 10.1016/S0925-4927(01)00129-9; Park SJ, 2014, CELL SIGNAL, V26, P2249, DOI 10.1016/j.cellsig.2014.07.009; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Townsend JD, 2012, BIPOLAR DISORD, V14, P442, DOI 10.1111/j.1399-5618.2012.01020.x; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; FUJIKAWA T, 1993, STROKE, V24, P1631; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Gavin AR, 2010, PUBLIC HEALTH REP, V125, P698; Rosenberg PB, 2008, WORLD PSYCHIATRY, V7, P72; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Lee S, 2012, KOREAN J PHYSIOL PHA, V16, P43, DOI 10.4196/kjpp.2012.16.1.43; Passarotti AM, 2011, PSYCHOPHARMACOLOGY, V216, P485, DOI 10.1007/s00213-011-2243-2; Vadacca M, 2011, CELL MOL IMMUNOL, V8, P203, DOI 10.1038/cmi.2010.75; Barbosa IG., 2014, NEURAL PLAST, V2014; Bayliss Jacqueline A, 2013, Ther Adv Endocrinol Metab, V4, P25, DOI 10.1177/2042018813479645; Blaas K, 2008, CANNABINOIDS, V3, P8; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Breton C, 2013, J ENDOCRINOL, V216, pR19, DOI 10.1530/JOE-12-0157; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013, NAT GENET, V45, P984; Demers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007728; Diwadkar Vaibhav A, 2014, Front Psychiatry, V5, P50, DOI 10.3389/fpsyt.2014.00050; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Hafeman DM, 2014, J PSYCHIATR RES, V58, P129, DOI 10.1016/j.jpsychires.2014.07.023; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Jastroch M, 2014, BEST PRACT RES CL EN, V28, P661, DOI 10.1016/j.beem.2014.02.002; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Liu G., 2012, AM J NEURODEGENER DI, V1, P60; Maletic Vladimir, 2014, Front Psychiatry, V5, P98, DOI 10.3389/fpsyt.2014.00098; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153; Matloubian M., 2004, NATURE, V427, P355; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nakagawa Yutaka, 2014, Pharmaceuticals (Basel), V7, P1028, DOI 10.3390/ph7121028; Owen MJ, 2014, NEURON, V84, P564, DOI 10.1016/j.neuron.2014.10.028; Pergola G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00162; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Shishido M., 2013, PSYCHIAT CLIN NEUROS, V68, P85; Stahl S, 2008, STAHLS ESSENTIAL PSY; Varela L, 2011, J MOL ENDOCRINOL, V46, pR43, DOI 10.1677/JME-10-0068; Watkins BA, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01506; Watkins CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.119; Williamson PC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00184; World Health Organization (WHO), 2015, OV OB; Yan Xu, 2013, J Genomics, V1, P29, DOI 10.7150/jgen.3930	183	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0163-7258			PHARMACOL THERAPEUT	Pharmacol. Ther.	OCT	2015	154						21	35		10.1016/j.pharmthera.2015.06.010		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS5VN	WOS:000362146500003		
J	Anh, LD; Hai, PN; Kasahara, Y; Iwasa, Y; Tanaka, M				Le Duc Anh; Pham Nam Hai; Kasahara, Yuichi; Iwasa, Yoshihiro; Tanaka, Masaaki			Modulation of ferromagnetism in (In, Fe) As quantum wells via electrically controlled deformation of the electron wave functions	PHYSICAL REVIEW B			English	Article							ROOM-TEMPERATURE; SEMICONDUCTOR; HETEROJUNCTIONS; COBALT; GAAS	We demonstrate electrical control of ferromagnetism in field-effect transistors with a trilayer quantum well (QW) channel containing an ultrathin n-type ferromagnetic semiconductor (In, Fe) As layer. A gate voltage is applied to control the electron wave functions phi(i) in the QW, such that the overlap of phi(i) and the (In, Fe) As layer is modified. The Curie temperature is largely changed by 42%, whereas the change in sheet carrier concentration is two to three orders of magnitude smaller than that of previous gating experiments. This result provides an approach for versatile, low power, and ultrafast manipulation of magnetization.	[Le Duc Anh; Pham Nam Hai; Tanaka, Masaaki] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Pham Nam Hai] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1520033, Japan; [Kasahara, Yuichi; Iwasa, Yoshihiro] Univ Tokyo, QPEC, Bunkyo Ku, Tokyo 1138656, Japan; [Kasahara, Yuichi; Iwasa, Yoshihiro] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Iwasa, Yoshihiro] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Tanaka, M (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	masaaki@ee.t.u-tokyo.ac.jp			Specially Promoted Research [23000010, 25000003, 2474022, 257388]; Project for Developing Innovation Systems of MEXT; Strategic International Collaboration Research Program (SICORP-LEMSUPER) from JST; JSPS Fellowship for Young Scientists; Program for Leading Graduate Schools (MERIT); Yazaki Memorial Foundation for Science and Technology; Murata Science Foundation; Toray Science Foundation	This work was partially supported by Grants-in-Aid for Scientific Research (Grants No. 23000010, No. 25000003, No. 2474022, and No. 257388), including the Specially Promoted Research, the Project for Developing Innovation Systems of MEXT, and the Strategic International Collaboration Research Program (SICORP-LEMSUPER) from JST. L.D.A. acknowledges the support from the JSPS Fellowship for Young Scientists and the Program for Leading Graduate Schools (MERIT). P.N.H acknowledges support from the Yazaki Memorial Foundation for Science and Technology, the Murata Science Foundation, and the Toray Science Foundation.	Anh L. D., 2014, APPL PHYS LETT, V104; Endo M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429592; SAKAKI H, 1982, JPN J APPL PHYS 2, V21, pL381, DOI 10.1143/JJAP.21.L381; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Seki T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595318; HIRAKAWA K, 1985, PHYS REV LETT, V54, P1279, DOI 10.1103/PhysRevLett.54.1279; Hai PN, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764947; Lee B, 2000, PHYS REV B, V61, P15606, DOI 10.1103/PhysRevB.61.15606; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Hai PN, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730955; Hai PN, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772630; Takahashi KS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057204; Stolichnov I, 2008, NAT MATER, V7, P464, DOI 10.1038/nmat2185; Chiba D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106601; Chiba D, 2003, SCIENCE, V301, P943, DOI 10.1126/science.1086608; Zhernenkov M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024420; NAKAGAWA A, 1989, APPL PHYS LETT, V54, P1893, DOI 10.1063/1.101233; Kim N, 2005, J SUPERCOND, V18, P189, DOI 10.1007/s10948-005-3357-8; Chiba D, 2011, NAT MATER, V10, P853, DOI [10.1038/nmat3130, 10.1038/NMAT3130]; Tanaka M, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4840136; Lee B, 2002, SEMICOND SCI TECH, V17, P393, DOI 10.1088/0268-1242/17/4/311; Chiba D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362971; Yamada Y, 2011, SCIENCE, V332, P1065, DOI 10.1126/science.1202152; Xiu FX, 2010, NAT MATER, V9, P337, DOI [10.1038/nmat2716, 10.1038/NMAT2716]; Sasaki D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870970; Sawicki M, 2010, NAT PHYS, V6, P22, DOI 10.1038/NPHYS1455; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; Boukari H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207204; Cabral ED, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085315; Dietl T, 1997, PHYS REV B, V55, pR3347	30	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 1	2015	92	16							161201	10.1103/PhysRevB.92.161201		5	Physics, Condensed Matter	Physics	CS4ZY	WOS:000362086300001		
J	Nishihara, H; Furuhashi, A; Yamaguchi, N; Koborinai, R; Katsufuji, T				Nishihara, H.; Furuhashi, A.; Yamaguchi, N.; Koborinai, R.; Katsufuji, T.			Coupling between Mott excitation and d-d transitions in CoV2O4	PHYSICAL REVIEW B			English	Article								We studied the optical properties of CoV2O4, in which a broad spectrum arising from the Mott excitation of the V d states and sharp peaks from the intra-atomic d-d transitions in the Co ions coexist. We found that the width of the d-d transition peaks decreases and that Fano resonance appears in the steady-state optical spectrum with decreasing temperature. We also found that the width of the d-d transition peaks increases less than 1 ps after a pump pulse is applied to the Mott excitation. These results indicate that the Mott excitation and the d-d transitions are strongly coupled in this compound.	[Nishihara, H.; Furuhashi, A.; Yamaguchi, N.; Koborinai, R.; Katsufuji, T.] Waseda Univ, Dept Phys, Tokyo 1698555, Japan; [Katsufuji, T.] Waseda Univ, Kagami Mem Res Inst Mat Sci & Technol, Tokyo 1690051, Japan	Katsufuji, T (reprint author), Waseda Univ, Dept Phys, Tokyo 1698555, Japan.				JSPS KAKENHI [25287090]	This work was partly supported by JSPS KAKENHI Grant No. 25287090.	Iwai S, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011007; Huang YJ, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/5/056003; Kismarahardja A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.056602; Takubo K, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214416; Dodge JS, 1999, PHYS REV LETT, V83, P4650, DOI 10.1103/PhysRevLett.83.4650; Kimel AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287401; Katsufuji T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054424; Ohgushi K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.034713; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Kiswandhi A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.205138; Furuhashi A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060410; Novelli F, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165135; Tanabe Y., 1970, MULTIPLETS TRANSITIO; Wall S., 2010, NATURE PHYS, V7, P114	14	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 1	2015	92	14							140401	10.1103/PhysRevB.92.140401		5	Physics, Condensed Matter	Physics	CS4ZD	WOS:000362084000001		
J	Otsuka, H				Otsuka, Hiromi			Loop-string algorithm for Monte Carlo simulations of dipolar spin ice	PHYSICAL REVIEW B			English	Article							MAGNETIC MONOPOLES; HO2TI2O7	Recently, we proposed the loop-string algorithm (LSA) for the Monte Carlo simulations of the nearest-neighbor (NN) spin-ice model [Phys. Rev. B 90, 220406(R) (2014)]. Here we discuss its advancement to a dipolar spin ice (DSI) such as Ho2Ti2O7 and Dy2Ti2O7. For this purpose, based on the dumbbell representation, we express DSI as a NN spin-ice model described by Hamiltonian H-0 perturbed by the Coulomb interactions among defects H-1. Then we apply LSA to H-0 and decompose the system into a mixture of loops and strings interacting via H-1. In simulation of the mixture, we employ the Metropolis algorithm. Our approach possesses two advantages: First, it is free of the so-called spin freezing problem; second, the computational cost for H-1 decreases exponentially with temperature, which can be viewed as an algorithmic realization of the projective equivalence concept. We compare numerical data with experimental results for Ho2Ti2O7 and Dy2Ti2O7 to demonstrate its predictability for these frustrated magnets.	Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan	Otsuka, H (reprint author), Tokyo Metropolitan Univ, Dept Phys, Tokyo 1920397, Japan.				JSPS KAKENHI [26400399]	The author thanks Kouji Chie, Yutaka Okabe, Masafumi Fujimoto, Hiroshi Takatsu, and Hiroaki Kadowaki for stimulating discussions. The main computations were performed using the facilities of Cyberscience Center in Tohoku University. This work was supported by JSPS KAKENHI, Grant No. 26400399.	Allen M. P., 1987, COMPUTER SIMULATION; Giblin SR, 2011, NAT PHYS, V7, P252, DOI [10.1038/nphys1896, 10.1038/NPHYS1896]; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; den Hertog BC, 2000, PHYS REV LETT, V84, P3430, DOI 10.1103/PhysRevLett.84.3430; Ryzhkin IA, 2005, J EXP THEOR PHYS+, V101, P481, DOI 10.1134/1.2103216; Harris MJ, 1998, J MAGN MAGN MATER, V177, P757, DOI 10.1016/S0304-8853(97)00796-8; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Lin SC, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.220402; Barkema GT, 1998, PHYS REV E, V57, P1155, DOI 10.1103/PhysRevE.57.1155; Jaubert LDC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067207; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Isakov SV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217201; Castelnovo C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144435; Melko RG, 2004, J PHYS-CONDENS MAT, V16, pR1277, DOI 10.1088/0953-8984/16/43/R02; WOLFF U, 1988, PHYS REV LETT, V60, P1461, DOI 10.1103/PhysRevLett.60.1461; SYOZI I, 1951, PROG THEOR PHYS, V6, P306; Jaubert LDC, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011014; Snyder J, 2001, NATURE, V413, P48, DOI 10.1038/35092516; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Bramwell ST, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047205; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Sen A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.107202; Bramwell ST, 2009, NATURE, V461, P956, DOI 10.1038/nature08500; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Bovo L, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/386002; Matsuhira K, 2001, J PHYS-CONDENS MAT, V13, pL737, DOI 10.1088/0953-8984/13/31/101; Kadowaki H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.103706; Bjerrum N., 1951, VIDENSK SELSK MAT FY, V27, P1; Bramwell ST, 2012, PHILOS T R SOC A, V370, P5738, DOI 10.1098/rsta.2011.0596; Jaubert L. D. C., 2009, THESIS ECOLE NORMALE; Lacroix C, 2011, SPRINGER SER SOLID-S, V164, P1, DOI 10.1007/978-3-642-10589-0; Melko RG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067203; Otsuka H, 2001, PHYS REV B, V64; Otsuka H, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.220406; Otsuka H, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.144428; Zhou HD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1483	37	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 1	2015	92	13							134401	10.1103/PhysRevB.92.134401		5	Physics, Condensed Matter	Physics	CS4YL	WOS:000362082200004		
J	Silaeva, EP; Uchida, K; Suzuki, Y; Watanabe, K				Silaeva, Elena P.; Uchida, Kazuki; Suzuki, Yasumitsu; Watanabe, Kazuyuki			Energetics and dynamics of laser-assisted field evaporation: Time-dependent density functional theory simulations	PHYSICAL REVIEW B			English	Article							ATOM-PROBE TOMOGRAPHY; ULTRA-FAST LASER; ELECTRIC-FIELD; REAL-TIME; SURFACE; 1ST-PRINCIPLES; MICROSCOPY; INTERFACES	High positive electrostatic (dc) field can break the bonds in molecules and strip away atoms from the solid surfaces. The dynamics of this field evaporation under laser pulse is studied for a H-2 molecule and a Si-4 cluster using time-dependent density functional theory combined with molecular dynamics. This allows us to monitor the position and charge state of the evaporated atom in real time. Our simulations demonstrate that the critical dc field for the evaporation is lower if the molecule/cluster is illuminated by a laser pulse. The behavior of the evaporation threshold as a function of laser intensity and dc field is in qualitative agreement with experiments and provides important insights into the mechanisms of laser-assisted field evaporation. Additionally, the laser-assisted field evaporation is found to be sensitive to the laser energy according to the photoabsorption spectra that demonstrate a pronounced redshift in the lower energy region at higher dc field values.	[Silaeva, Elena P.; Uchida, Kazuki; Suzuki, Yasumitsu; Watanabe, Kazuyuki] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Silaeva, EP (reprint author), Tokyo Univ Sci, Dept Phys, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	kazuyuki@rs.kagu.tus.ac.jp			MEXT [25400409]	K.W. and Y.S. acknowledge partial financial support from MEXT through a Grant-in-Aid (Grant No. 25400409). Numerical calculations were performed on the supercomputers of the Institute for Solid State Physics, University of Tokyo, and at the Research Center for Computational Science, Okazaki, Japan.	MCMULLEN ER, 1987, PHYS REV B, V36, P2598, DOI 10.1103/PhysRevB.36.2598; Vella A, 2013, ULTRAMICROSCOPY, V132, P5, DOI 10.1016/j.ultramic.2013.05.016; Durach M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.086803; Nakaoka N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155424; Yabana K, 1996, PHYS REV B, V54, P4484, DOI 10.1103/PhysRevB.54.4484; Karahka M, 2011, PHYS CHEM CHEM PHYS, V13, P11027, DOI 10.1039/c1cp20273a; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; Sanchez CG, 2004, MOL PHYS, V102, P1045, DOI 10.1080/00268970410001727673; Grenier A, 2014, ULTRAMICROSCOPY, V136, P185, DOI 10.1016/j.ultramic.2013.10.001; Nakatsukasa T, 2001, J CHEM PHYS, V114, P2550, DOI 10.1063/1.1338527; Silaeva EP, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113026; Silaeva EP, 2013, APPL PHYS A-MATER, V110, P703, DOI 10.1007/s00339-012-7189-7; Kelly TF, 2014, CURR OPIN SOLID ST M, V18, P81, DOI 10.1016/j.cossms.2013.11.001; Mancini L, 2014, J PHYS CHEM C, V118, P24136, DOI 10.1021/jp5071264; Martin YC, 2001, J APPL PHYS, V89, P5774, DOI 10.1063/1.1354655; Vella A, 2013, ANN PHYS-BERLIN, V525, pL1, DOI 10.1002/andp.201200182; Haruyama J, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062511; Peralta J, 2013, ULTRAMICROSCOPY, V132, P143, DOI 10.1016/j.ultramic.2013.02.007; Mazumder B, 2015, THIN SOLID FILMS, V589, P38, DOI 10.1016/j.tsf.2015.04.079; Nishimura A, 2009, ULTRAMICROSCOPY, V109, P467, DOI 10.1016/j.ultramic.2008.11.027; KELLOGG GL, 1983, SURF SCI, V124, pL55, DOI 10.1016/0039-6028(83)90792-6; Sugino O, 1999, PHYS REV B, V59, P2579, DOI 10.1103/PhysRevB.59.2579; Mazumder B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113029; Bertsch GF, 2000, PHYS REV B, V62, P7998, DOI 10.1103/PhysRevB.62.7998; Devaraj A, 2014, J PHYS CHEM LETT, V5, P1361, DOI 10.1021/jz500259c; Utsugi D, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.105101; Ghimire S, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/20/204030; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; MULLER EW, 1956, PHYS REV, V102, P618, DOI 10.1103/PhysRev.102.618; Silaeva EP, 2013, CURR OPIN SOLID ST M, V17, P211, DOI 10.1016/j.cossms.2013.08.001; Karahka M, 2013, ULTRAMICROSCOPY, V132, P54, DOI 10.1016/j.ultramic.2012.10.007; Kreuzer HJ, 2004, SURF INTERFACE ANAL, V36, P372, DOI [10.1002/sia.1895, 10.1002/sia.1985]; Taguchi K, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.094707; Ono T, 2004, J APPL PHYS, V95, P1568, DOI 10.1063/1.1636258; Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686; Silaeva EP, 2014, NANO LETT, V14, P6066, DOI [10.1021/nl502715s, 10.1021/n1502715s]; KREUZER HJ, 1987, SURF SCI, V183, P591, DOI 10.1016/S0039-6028(87)80230-3; Hommelhoff P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.077401; Moutanabbir O, 2013, NATURE, V496, P78, DOI 10.1038/nature11999; Xia Y, 2015, J APPL PHYS, V118, DOI 10.1063/1.4926489; Djurabekova F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026704; Gault B, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194089; Greiwe GH, 2014, ULTRAMICROSCOPY, V141, P51, DOI 10.1016/j.ultramic.2014.03.007; Liddicoat PV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1062; London AJ, 2015, ULTRAMICROSCOPY, V159, P360, DOI 10.1016/j.ultramic.2015.02.013; Marques M. A. L., 2006, LECT NOTES PHYS, V706; Miller M., 2014, ATOM PROBE TOMOGRAPH; Sato SA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174303; Tamura H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195430; Valley JW, 2014, NAT GEOSCI, V7, P219, DOI [10.1038/ngeo2075, 10.1038/NGEO2075]; Vurpillot F, 2015, ULTRAMICROSCOPY, V159, P202, DOI 10.1016/j.ultramic.2014.12.013	51	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 1	2015	92	15							155401	10.1103/PhysRevB.92.155401		7	Physics, Condensed Matter	Physics	CS4ZN	WOS:000362085100005		
J	Yuryeva, OP; Rakhmanova, MI; Nadolinny, VA; Zedgenizov, DA; Shatsky, VS; Kagi, H; Komarovskikh, AY				Yuryeva, Olga P.; Rakhmanova, Mariana I.; Nadolinny, Vladimir A.; Zedgenizov, Dmitry A.; Shatsky, Vladislav S.; Kagi, Hiroyuki; Komarovskikh, Andrey Yu.			The characteristic photoluminescence and EPR features of superdeep diamonds (So-Luis, Brazil)	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Superdeep diamond; Photoluminescence (PL) spectroscopy; EPR; Electron irradiation; Annealing	CONTAINING CENTERS; NATURAL DIAMONDS; IA DIAMONDS; MATO-GROSSO; JUINA AREA; NITROGEN; LUMINESCENCE; IMPURITY; AGGREGATION; CATHODOLUMINESCENCE	Photoluminescence (PL) spectroscopy and electron paramagnetic resonance (EPR) were used for the first time to characterize properties of superdeep diamonds from the So-Luis alluvial deposits (Brazil). The infrared measurements showed the low nitrogen content (> 50 of 87 diamonds from this locality were nitrogen free and belonged to type IIa) and simultaneously the extremely high level of nitrogen aggregation (pure type IaB being predominant), which indicates that diamonds under study might have formed under high pressure and temperature conditions. In most cases, PL features excited at various wavelengths (313, 473, and 532 nm) were indicative of different growth and post-growth processes during which PL centers could be formed via interaction between vacancies and nitrogen atoms. The overall presence of the 490.7 nm, H3, and H4 centers in the luminescence spectra attests to strong plastic deformations in these diamonds. The neutral vacancy known as the GR1 center has probably occurred in a number of crystals due to radiation damage in the post-growth period. The 558.5 nm PL center is found to be one of the most common defects in type IIa samples which is accompanied by the EPR center with g-factor of 2.00285. The 536 and 576 nm vibronic systems totally dominated the PL spectra of superdeep diamonds, while none of "normal" diamonds from the Mir pipe (Yakutia) with similar nitrogen characteristics showed the latter three PL centers.	[Yuryeva, Olga P.; Rakhmanova, Mariana I.; Nadolinny, Vladimir A.; Komarovskikh, Andrey Yu.] Nikolaev Inst Inorgan Chem SB RAS, Novosibirsk 630090, Russia; [Zedgenizov, Dmitry A.; Shatsky, Vladislav S.] VS Sobolev Inst Geol & Mineral SB RAS, Novosibirsk 630090, Russia; [Zedgenizov, Dmitry A.; Shatsky, Vladislav S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Shatsky, Vladislav S.] AP Vinogradov Inst Geochem SB RAS, Irkutsk 664033, Russia; [Kagi, Hiroyuki] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Tokyo 1130033, Japan	Yuryeva, OP (reprint author), Nikolaev Inst Inorgan Chem SB RAS, 3 Lavrentyev Ave, Novosibirsk 630090, Russia.	olgayurjeva@mail.ru	Zedgenizov, Dmitry/A-3282-2014		Siberian Branch of the Russian Academy of Sciences [16]; Ministry of Education and Science of the Russian Federation [14.B25.31.0032]; Russian Foundation for Basic Research [15-55-50033, 14-05-92107]	The study was supported in part by the Siberian Branch of the Russian Academy of Sciences (Integration Project No. 16), the Ministry of Education and Science of the Russian Federation (Project No. 14.B25.31.0032), and the Russian Foundation for Basic Research (Grants No. 15-55-50033, 14-05-92107). The authors would like to thank the two anonymous reviewers for the constructive comments to make the publication of this paper possible.	Kaminsky FV, 2001, CAN MINERAL, V39, P1733, DOI 10.2113/gscanmin.39.6.1733; GRAHAM RJ, 1994, PHILOS MAG B, V70, P1177, DOI 10.1080/01418639408240282; Titkov SV, 2008, GEMS GEMOL, V44, P56; Palyanov YN, 2013, CRYST GROWTH DES, V13, P5411, DOI 10.1021/cg4013476; Zedgenizov DA, 2014, CHEM GEOL, V363, P114, DOI 10.1016/j.chemgeo.2013.10.033; Nadolinny V, 2009, APPL MAGN RESON, V36, P109, DOI 10.1007/s00723-009-0013-7; Steeds JW, 1999, DIAM RELAT MATER, V8, P1847, DOI 10.1016/S0925-9635(99)00144-2; PEREIRA E, 1993, PHYSICA B, V185, P222, DOI 10.1016/0921-4526(93)90241-W; COLLINS AT, 1982, PHILOS MAG B, V45, P385, DOI 10.1080/01418638208227446; Taylor WR, 1996, GEOCHIM COSMOCHIM AC, V60, P4725, DOI 10.1016/S0016-7037(96)00302-X; Hutchison MT, 2001, CONTRIB MINERAL PETR, V142, P119; De Weerdt F, 2007, DIAM RELAT MATER, V16, P512, DOI 10.1016/j.diamond.2006.10.003; Rakhmanova MI, 2013, PHYS SOLID STATE+, V55, P127, DOI 10.1134/S1063783413010289; Nadolinny VA, 1999, J PHYS-CONDENS MAT, V11, P7357, DOI 10.1088/0953-8984/11/38/314; Shiryaev AA, 2001, PHYSICA B, V308, P598, DOI 10.1016/S0921-4526(01)00750-5; Lindblom J, 2005, AM MINERAL, V90, P428, DOI 10.2138/am.2005.1681; Nadolinny VA, 1997, APPL MAGN RESON, V12, P543; Bruce LF, 2011, AM MINERAL, V96, P14, DOI 10.2138/am.2011.3467; Iakoubovskii K, 2002, DIAM RELAT MATER, V11, P125, DOI 10.1016/S0925-9635(01)00533-7; Twitchen DJ, 2000, PHYS REV B, V61, P9, DOI 10.1103/PhysRevB.61.9; NAZARE MH, 1992, MAT SCI ENG B-SOLID, V11, P341, DOI 10.1016/0921-5107(92)90237-4; Kaminsky FV, 2001, CONTRIB MINERAL PETR, V140, P734; Mita Y, 1996, PHYS REV B, V53, P11360, DOI 10.1103/PhysRevB.53.11360; Collins AT, 2000, DIAM RELAT MATER, V9, P417, DOI 10.1016/S0925-9635(99)00314-3; KAISER W, 1959, PHYS REV, V115, P857, DOI 10.1103/PhysRev.115.857; Nadolinny VA, 2009, LITHOS, V112, P865, DOI 10.1016/j.lithos.2009.05.045; Tretiakova L, 2009, EUR J MINERAL, V21, P43, DOI 10.1127/0935-1221/2009/0021-1885; Gaillou E, 2010, DIAM RELAT MATER, V19, P1207, DOI 10.1016/j.diamond.2010.06.015; Kupriyanov IN, 2000, J PHYS-CONDENS MAT, V12, P7843, DOI 10.1088/0953-8984/12/35/318; TAYLOR WR, 1990, AM MINERAL, V75, P1290; Hayman PC, 2005, CONTRIB MINERAL PETR, V149, P430, DOI 10.1007/s00410-005-0657-8; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Fritsch E, 2007, NEW DIAM FRONT C TEC, V17, P63; EVANS T, 1982, P ROY SOC LOND A MAT, V381, P159, DOI 10.1098/rspa.1982.0063; Araujo DP, 2013, P 10 INT KIMB C, P255, DOI DOI 10.1007/978-81-322-1170-9_16; Astrom M, 2013, DETECTING HPHT TREAT; Brookes EJ, 1993, J HARD MATER, V4, P98; Collins AT, 2002, J PHYS-CONDENS MAT, V14, pL467, DOI 10.1088/0953-8984/14/25/105; Collins AT, 2005, J APPL PHYS, V97, DOI 10.1063/1.1866501; DAVIES G, 1972, J PHYS PART C SOLID, V5, P2534, DOI 10.1088/0022-3719/5/17/027; Deljanin B., 2008, DIAM RELAT MATER, V17, P1169, DOI DOI 10.1016/J.DIA-M0ND.2008.03.014; Dobrinets I, 2013, SPRINGER SERIES MAT, V181, P257; Epelboym M, 2011, G G, V47, P133; Fisher D, 2000, GEMS GEMOL, V36, P42, DOI 10.5741/GEMS.36.1.42; Hainschwang T, 2005, J GEMMOL, V29, P261, DOI 10.15506/JoG.2005.29.5.261; HANLEY PL, 1977, PHIL T R SOC       A, V284, P329, DOI 10.1098/rsta.1977.0012; Harlow G.E., 1998, NATURE DIAMONDS; Harte B., 1994, MINERAL MAG A, VA58, P384, DOI 10.1180/minmag.1994.58A.1.201; Isaenko SI, 2003, P 12 SCI C I GEOL KO, P95; Jorge M. I. B., 1983, Portugaliae Physica, V14; Mendelssohn M.J., 1995, INT GEOL REV, V37, P285; NADOLINNYI VA, 1995, DOKL AKAD NAUK+, V341, P516; Smith CP, 2000, GEMS GEMOL, V36, P192, DOI 10.5741/GEMS.36.3.192; Sobolev EV, 1969, SOV PHYS-SOLID STATE, V11, P938; Taylor WR, 1995, 6 INT KIMB C NOV, P620; Tretiakova L, 2008, 9 INT KIMB C, V1; Wilding MC, 1991, 5 INT KIMB C AR, P456; Yang Z, 2012, ISRN SPECTROSC, DOI [10.5402/2012/871824, DOI 10.5402/2012/871824]; Yuryeva OP, 1986, OPTICAL SPECTROSCOPY, P60; Zaitsev A. M., 2001, OPTICAL PROPERTIES D	60	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	OCT	2015	42	9					707	722		10.1007/s00269-015-0756-7		16	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	CS9OO	WOS:000362420800001		
J	Ono, S; Mibe, K				Ono, Shigeaki; Mibe, Kenji			Influence of pressure and temperature on the electrical conductivity of dolomite	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Dolomite; Carbonate; Electrical conductivity; High pressures; High temperatures	ARAGONITE PLUS MAGNESITE; EARTHS LOWER MANTLE; PHASE-TRANSFORMATIONS; IMPEDANCE SPECTROSCOPY; CARBONATE STABILITY; MINERAL INCLUSIONS; DIAMONDS; OLIVINE; CACO3; TRANSITION	The electrical conductivity of dolomite, (Mg, Ca)CO3, was investigated under conditions of 650-1000 K and 3-6 GPa with a multi-anvil press and an impedance spectroscopy analyzer with a frequency range of 0.05-10(6) Hz. As pressure increased, an increase in the electrical conductivity and a decrease in the calculated activation enthalpy were observed. The negative activation volume observed in this study suggests that the hopping of polarons is the dominant mechanism for the electrical conductivity across the pressure and temperature range investigated. This mechanism is the same as that of magnesite, MgCO3, which has the similar structure of dolomite. In contrast, the mechanism of the ionic conduction was reported in aragonite, CaCO3. These results indicate that the mechanism for the electrical conductivity of carbonate minerals varies because of a crystallographic difference between the calcite- and the aragonite-type structure.	[Ono, Shigeaki] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Mibe, Kenji] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Ono, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Ocean Drilling Sci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	sono@jamstec.go.jp			JSPS KAKENHI [22340131]; Earthquake Research Institute cooperative research program, Japan	This work was partially supported by JSPS KAKENHI Grant Number 22340131 and the Earthquake Research Institute cooperative research program, Japan.	Antao SM, 2004, AM MINERAL, V89, P1142; Constable S, 2006, GEOPHYS J INT, V166, P435, DOI 10.1111/j.1365-246X.2006.03041.x; Sobolev NV, 1997, LITHOS, V39, P135, DOI 10.1016/S0024-4937(96)00022-9; Korsakov AV, 2006, EARTH PLANET SC LETT, V241, P104, DOI 10.1016/j.epsl.2005.10.037; Ono S, 2013, EUR J MINERAL, V25, P11, DOI 10.1127/0935-1221/2013/0025-2254; Ono S, 2013, PHYS CHEM MINER, V40, P811, DOI 10.1007/s00269-013-0615-3; Martinez I, 1996, AM MINERAL, V81, P611; Yaxley GM, 2004, CONTRIB MINERAL PETR, V146, P606, DOI 10.1007/s00410-003-0517-3; Heege JH, 2007, PHYS CHEM MINER, V34, P445, DOI 10.1007/s00269-007-0162-x; Shirasaka M, 2002, AM MINERAL, V87, P922; Goddat A, 1999, PHYS CHEM MINER, V27, P81, DOI 10.1007/s002690050243; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P16, DOI 10.1007/s004100000174; Yoshino T, 2009, EARTH PLANET SC LETT, V288, P291, DOI 10.1016/j.epsl.2009.09.032; Hammouda T, 2011, CONTRIB MINERAL PETR, V161, P439, DOI 10.1007/s00410-010-0541-z; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1; Kent AJR, 2001, GEOCHIM COSMOCHIM AC, V65, P311, DOI 10.1016/S0016-7037(00)00528-7; Sakamoto D, 2002, J PHYS-CONDENS MAT, V14, P11375, DOI 10.1088/0953-8984/14/44/485; OKAY AI, 1993, EUR J MINERAL, V5, P659; Reynard B, 2011, EARTH PLANET SC LETT, V307, P387, DOI 10.1016/j.epsl.2011.05.013; Dobrzhinetskaya LF, 2006, EARTH PLANET SC LETT, V243, P85, DOI 10.1016/j.epsl.2005.11.030; LIU LG, 1995, EARTH PLANET SC LETT, V134, P297, DOI 10.1016/0012-821X(95)00130-5; Mibe K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001960; Perraki M, 2006, EARTH PLANET SC LETT, V241, P672, DOI 10.1016/j.epsl.2005.11.014; BOSE K, 1995, AM MINERAL, V80, P231; Wang A, 1996, EARTH PLANET SC LETT, V141, P293, DOI 10.1016/0012-821X(96)00053-2; Franzolin E, 2012, AM MINERAL, V97, P1676; DALTON JA, 1995, EUR J MINERAL, V7, P883; Keppler H, 2003, NATURE, V424, P414, DOI 10.1038/nature01828; Wang DJ, 2006, NATURE, V443, P977, DOI 10.1038/nature05256; Oganov AR, 2008, EARTH PLANET SC LETT, V273, P38, DOI 10.1016/j.epsl.2008.06.005; Mibe K, 2011, PHYSICA B, V406, P2018, DOI 10.1016/j.physb.2011.03.009; Merlini M, 2012, EARTH PLANET SC LETT, V333, P265, DOI 10.1016/j.epsl.2012.04.036; Buob A, 2006, AM MINERAL, V91, P435, DOI 10.2138/am.2006.1910; Shcheka SS, 2006, EARTH PLANET SC LETT, V245, P730, DOI 10.1016/j.epsl.2006.03.036; Ono S, 2007, AM MINERAL, V92, P1246, DOI 10.2138/am.2007.2649; SAMARA GA, 1984, SOLID STATE PHYS, V38, P1; Sato K, 2001, EARTH PLANET SC LETT, V184, P529, DOI 10.1016/S0012-821X(00)00346-0; Ono S, 2005, AM MINERAL, V90, P667, DOI 10.2138/am.2005.1610; Fiquet G, 2002, AM MINERAL, V87, P1261; Molina JF, 2000, EARTH PLANET SC LETT, V176, P295, DOI 10.1016/S0012-821X(00)00021-2; Bagdassarov NS, 2003, PHASE TRANSIT, V76, P1015, DOI 10.1080/0141159031000098233; BIELLMANN C, 1993, EARTH PLANET SC LETT, V118, P31, DOI 10.1016/0012-821X(93)90157-5; Lazarus D, 1963, SOLIDS PRESSURE, P43; Luth RW, 2001, CONTRIB MINERAL PETR, V141, P222; MEYER HOA, 1986, J GEOL, V94, P600; Papathanassiou AN, 1996, PHYS REV B, V53, P16247, DOI 10.1103/PhysRevB.53.16247; Papathanassiou AN, 1998, PHYS REV B, V58, P4432, DOI 10.1103/PhysRevB.58.4432; SOBOLEV NV, 1990, NATURE, V343, P742, DOI 10.1038/343742a0; Yang X, 2011, J GEOPHYS RES, V113	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	OCT	2015	42	9					773	779		10.1007/s00269-015-0761-x		7	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	CS9OO	WOS:000362420800006		
J	Sulieman, S; Tran, LSP				Sulieman, Saad; Tran, Lam-Son Phan			Phosphorus homeostasis in legume nodules as an adaptive strategy to phosphorus deficiency	PLANT SCIENCE			English	Review						Acid phosphatase; Molecular adaptation; Nitrogenase activity; P deficiency; P homeostasis; Symbiosis capacity	SYMBIOTIC NITROGEN-FIXATION; BEAN PHASEOLUS-VULGARIS; AFFINITY PHOSPHATE TRANSPORTER; MEDICAGO-TRUNCATULA; ACID-PHOSPHATASE; N-2 FIXATION; RHIZOBIUM-MELILOTI; PHYTASE ACTIVITIES; EXPRESSION; ROOTS	Legumes have a significant role in effective management of fertilizers and improving soil health in sustainable agriculture. Because of the high phosphorus (P) requirements of N-2-fixing nodule, P deficiency represents an important constraint for legume crop production, especially in tropical marginal countries. P deficiency is an important constraint for legume crop production, especially in poor soils present in many tropical degraded areas. Unlike nitrogen, mineral P sources are nonrenewable, and high-grade rock phosphates are expected to be depleted in the near future. Accordingly, developing legume cultivars with effective N-2 fixation under P-limited conditions could have a profound significance for improving agricultural sustainability. Legumes have evolved strategies at both morphological and physiological levels to adapt to P deficiency. Molecular mechanisms underlying the adaptive strategies to P deficiency have been elucidated in legumes. These include maintenance of the P-homeostasis in nodules as a main adaptive strategy for rhizobia-legume symbiosis under P deficiency. The stabilization of P levels in the symbiotic tissues can be achieved through several mechanisms, including elevated P allocation to nodules, formation of a strong P sink in nodules, direct P acquisition via nodule surface and P remobilization from organic-P containing substances. The detailed biochemical, physiological and molecular understanding will be essential to the advancement of genetic and molecular approaches for enhancement of legume adaptation to P deficiency. In this review, we evaluate recent progress made to gain further and deeper insights into the physiological, biochemical and molecular reprogramming that legumes use to maintain P-homeostasis in nodules during P scarcity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sulieman, Saad] Univ Khartoum, Dept Agron, Fac Agr, Shambat 13314, Khartoum North, Sudan; [Tran, Lam-Son Phan] RIKEN, CSRS, Signaling Pathway Res Unit, Tsurumi, Yokohama 2300045, Japan	Sulieman, S (reprint author), Univ Khartoum, Dept Agron, Fac Agr, Shambat 13314, Khartoum North, Sudan.	saadsulieman@hotmail.com; son.tran@riken.jp	Tran, Lam-Son/A-1346-2009	Tran, Lam-Son/0000-0001-9883-9768	JSPS (Japan Society for the Promotion of Science)	This work was supported by a grant provided by JSPS (Japan Society for the Promotion of Science) to Saad Sulieman.	Jebara M, 2005, J PLANT PHYSIOL, V162, P309, DOI 10.1016/j.jplph.2004.06.015; Schulze J, 2004, J PLANT NUTR SOIL SC, V167, P125, DOI 10.1002/jpln.200320358; Le Roux MR, 2008, NEW PHYTOL, V177, P956, DOI 10.1111/j.1469-8137.2007.02305.x; Hernandez G, 2009, PLANT PHYSIOL, V151, P1221, DOI 10.1104/pp.109.143842; Horvath B, 2011, MOL PLANT MICROBE IN, V24, P1345, DOI 10.1094/MPMI-01-11-0015; Qin L, 2012, PLANT PHYSIOL, V159, P1634, DOI 10.1104/pp.112.199786; Lazali M, 2014, PLANT PHYSIOL BIOCH, V80, P53, DOI 10.1016/j.plaphy.2014.03.023; Roussis A, 2003, PLANT PHYSIOL BIOCH, V41, P719, DOI 10.1016/S0981-9428(03)00096-2; Al-Niemi TS, 1998, PLANT SOIL, V198, P71, DOI 10.1023/A:1004200903458; Wang XR, 2011, MYCORRHIZA, V21, P173, DOI 10.1007/s00572-010-0319-1; Li CC, 2012, ANN BOT-LONDON, V109, P275, DOI 10.1093/aob/mcr246; Sulieman S, 2010, J PLANT PHYSIOL, V167, P683, DOI 10.1016/j.jplph.2009.12.016; Le Roux MR, 2009, SYMBIOSIS, V48, P102; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; Raghothama KG, 2000, CURR OPIN PLANT BIOL, V3, P182, DOI 10.1016/S1369-5266(00)00062-5; Vance CP, 2011, PLANT PHYSIOL, V156, P987, DOI 10.1104/pp.111.900415; Chaudhary MI, 2008, ACTA PHYSIOL PLANT, V30, P537, DOI 10.1007/s11738-008-0152-8; Kouas S, 2009, SYMBIOSIS, V47, P141; L'taief B, 2012, AFR J MICROBIOL RES, V6, P4205, DOI 10.5897/AJMR10.720; Schulze J, 2006, ANN BOT-LONDON, V98, P731, DOI 10.1093/aob/mcl154; Esfahani MN, 2014, PLANT J, V79, P964, DOI 10.1111/tpj.12599; Maougal RT, 2014, PLANTA, V239, P901, DOI 10.1007/s00425-013-2023-9; Sulieman S, 2013, J EXP BOT, V64, P2701, DOI 10.1093/jxb/ert122; Schulze J, 2005, J EXP BOT, V56, P1779, DOI 10.1093/jxb/eri166; Penheiter AR, 1997, PLANT PHYSIOL, V114, P597, DOI 10.1104/pp.114.2.597; Sulieman S, 2013, CRIT REV BIOTECHNOL, V33, P309, DOI 10.3109/07388551.2012.695770; Ribet J, 1996, NEW PHYTOL, V132, P383, DOI 10.1111/j.1469-8137.1996.tb01858.x; Sulieman S, 2010, PHYSIOL PLANTARUM, V140, P21, DOI 10.1111/j.1399-3054.2010.01380.x; Oldroyd GED, 2014, CURR OPIN BIOTECH, V26, P19, DOI [10.1016/j.copbio.2013.08.006, 10.1016/j.copbio.2013.08:006]; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Cabeza RA, 2014, J EXP BOT, V65, P6035, DOI 10.1093/jxb/eru341; Lazali M, 2013, PLANTA, V238, P317, DOI 10.1007/s00425-013-1893-1; AlNiemi TS, 1997, PLANT PHYSIOL, V113, P1233; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Tang C, 2001, ANN BOT-LONDON, V88, P131, DOI 10.1006/anbo.2001.1440; Bargaz A, 2013, PLANTA, V238, P107, DOI 10.1007/s00425-013-1877-1; Kouas S, 2005, AGRON SUSTAIN DEV, V25, P389, DOI 10.1051/agro:2005034; Rotaru V, 2009, ENVIRON EXP BOT, V66, P94, DOI 10.1016/j.envexpbot.2008.12.001; Thuynsma R, 2014, J PLANT PHYSIOL, V171, P285, DOI [10.1016/j.jplph.2013.09.001, 10.1016/j.jpiph.2013.09.001]; Araujo SS, 2015, CRIT REV PLANT SCI, V34, P237, DOI 10.1080/07352689.2014.898450; Bargaz A, 2012, J EXP BOT, V63, P4723, DOI 10.1093/jxb/ers151; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Sulieman S, 2013, INT J MOL SCI, V14, P5198, DOI 10.3390/ijms14035198; Le Roux MR, 2006, NEW PHYTOL, V169, P399, DOI 10.1111/j.1469-8137.2005.01594.x; Lopez-Arredondo DL, 2014, ANNU REV PLANT BIOL, V65, P95, DOI 10.1146/annurev-arplant-050213-035949; Araujo AP, 2008, PLANT SOIL, V312, P129, DOI 10.1007/s11104-008-9595-3; FINAN TM, 1985, CELL, V40, P869, DOI 10.1016/0092-8674(85)90346-0; Kleinert A, 2014, J PLANT PHYSIOL, V171, P1619, DOI 10.1016/j.jplph.2014.07.017; Le Roux M, 2014, J PLANT PHYSIOL, V171, P1609, DOI 10.1016/j.jplph.2014.07.020; Liu P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-18; SA TM, 1991, PLANT PHYSIOL, V97, P928, DOI 10.1104/pp.97.3.928; Sulieman S., 2014, J PLANT PHYSL, V171; Tajini F., 2009, BMC PLANT BIOL, V9; Valentine A.J., 2011, ANN PLANT REV, P207; Vardien W, 2014, J PLANT PHYSIOL, V171, P1732, DOI 10.1016/j.jplph.2014.08.005; Zhang ZL, 2014, J INTEGR PLANT BIOL, V56, P192, DOI 10.1111/jipb.12163	58	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	OCT	2015	239						36	43		10.1016/j.plantsci.2015.06.018		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CS7ZY	WOS:000362306700005		
J	Sarazin, V; Duclercq, J; Mendou, B; Aubanelle, L; Nicolas, V; Aono, M; Pilard, S; Guerineau, F; Sangwan-Norreel, B; Sangwan, RS				Sarazin, Vivien; Duclercq, Jerome; Mendou, Benjamin; Aubanelle, Laurent; Nicolas, Veyres; Aono, Mitsuko; Pilard, Serge; Guerineau, Francois; Sangwan-Norreel, Brigitte; Sangwan, Rajbir S.			Arabidopsis BNT1, an atypical TIR-NBS-LRR gene, acting as a regulator of the hormonal response to stress	PLANT SCIENCE			English	Article						Arabidopsis; Abiotic stress; Biotic stress; BURNOUT; TIR-NBS-LRR; Plant hormone	DISEASE RESISTANCE; ABSCISIC-ACID; PHENOTYPIC PLASTICITY; PLANT DEVELOPMENT; CELL ELONGATION; INNATE IMMUNITY; LOW-TEMPERATURE; DROUGHT STRESS; ABIOTIC STRESS; CROSSTALK	During their life cycle, plants have to cope with fluctuating environmental conditions. The perception of the stressful environmental conditions induces a specific stress hormone signature specifying a proper response with an efficient fitness. By reverse genetics, we isolated and characterized a novel mutation in Arabidopsis, associated with environmental stress responses, that affects the At5g11250/BURNOUT1 (BNT1) gene which encode a Toll/Interleukin1 receptor-nucleotide binding site leucine-rich repeat (TIR-NBS-LRR) protein. The knock-out bnt1 mutants displayed, in the absence of stress conditions, a multitude of growth and development defects, suchas severe dwarfism, early senescence and flower sterility, similar to those observed in vitro in wild type plants upon different biotic and/or abiotic stresses. The disruption of BNT1 causes also a drastic increase of the jasmonic, salicylic and abscisic acids as well as ethylene levels. Which was consistent with the expression pattern observed in bnt1 showing an over representation of genes involved in the hormonal response to stress? Therefore, a defect in BNT1 forced the plant to engage in an exhausting general stress response, which produced frail, weakened and poorly adapted plants expressing "burnout" syndromes. Furthermore, by in vitro phenocopying experiments, physiological, chemical and molecular analyses, we propose that BNT1 could represent a molecular link between stress perception and specific hormonal signature. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sarazin, Vivien; Duclercq, Jerome; Mendou, Benjamin; Aubanelle, Laurent; Nicolas, Veyres; Sangwan-Norreel, Brigitte; Sangwan, Rajbir S.] UPJV, CNRS FRE EDYSAN 3498, Unite Ecol & Dynam Syst Anthropises, Amiens, France; [Aono, Mitsuko] Natl Inst Environm Studies, Div Environm Biol, Tsukuba, Ibaraki, Japan; [Pilard, Serge] UPJV, Plateforme Analyt, Amiens, France; [Guerineau, Francois] UPJV, Unite BIOPI, Amiens, France; [Sarazin, Vivien] Laboulet Semences, Airaines, France	Sangwan, RS (reprint author), UPJV, CNRS FRE EDYSAN 3498, Unite Ecol & Dynam Syst Anthropises, Amiens, France.	rajbir.sangwan@u-picardie.fr			CNRS; Ministry of Science and technology (MNER); Conseil Regional de Picardie (CRP); Laboulet	Work at UPJV was supported by CNRS, Ministry of Science and technology (MNER) and Conseil Regional de Picardie (CRP). NV, LA and BM were supported by Ph.D. Fellowships. VS was supported by Laboulet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Chater CCC, 2014, NEW PHYTOL, V202, P376, DOI 10.1111/nph.12713; Stes E, 2011, PLANT PHYSIOL, V156, P712, DOI 10.1104/pp.110.171561; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Hyun Y, 2008, DEV CELL, V14, P183, DOI 10.1016/j.devcel.2007.11.010; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1102/tpc.009308; Dubois F, 1996, PLANT J, V10, P47, DOI 10.1046/j.1365-313X.1996.10010047.x; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zbierzak AM, 2013, PLANT J, V75, P539, DOI 10.1111/tpj.12219; Heidrich K, 2012, CURR OPIN PLANT BIOL, V15, P385, DOI 10.1016/j.pbi.2012.03.015; Franchel J, 2013, THEOR APPL GENET, V126, P359, DOI 10.1007/s00122-012-1984-6; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; SANGWAN RS, 1991, MOL GEN GENET, V230, P475, DOI 10.1007/BF00280305; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Clarke JD, 2001, PLANT J, V26, P409, DOI 10.1046/j.1365-313X.2001.2641041.x; Yang HB, 2010, PLANT J, V63, P283, DOI 10.1111/j.1365-313X.2010.04241.x; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Duclercq J, 2011, PLANT BIOLOGY, V13, P317, DOI 10.1111/j.1438-8677.2010.00363.x; Huang XZ, 2010, PLANT PHYSIOL, V154, P796, DOI 10.1104/pp.110.157610; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Pennisi E, 2009, SCIENCE, V324, P1012, DOI 10.1126/science.324_1012; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Campbell SA, 2014, PLANT J, V78, P481, DOI 10.1111/tpj.12492; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Heinrich M, 2013, PLANT J, V73, P591, DOI 10.1111/tpj.12058; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Veyres N, 2008, PLANT J, V55, P665, DOI 10.1111/j.1365-313X.2008.03541.x; Sultan SE, 2010, CURR OPIN PLANT BIOL, V13, P96, DOI 10.1016/j.pbi.2009.09.021; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Aboul-Soud MAM, 2009, NEW PHYTOL, V183, P1163, DOI 10.1111/j.1469-8137.2009.02902.x; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Glowacki S, 2011, CELL MOL BIOL LETT, V16, P1, DOI 10.2478/s11658-010-0024-2; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Borhan MH, 2010, MOL PLANT PATHOL, V11, P283, DOI 10.1111/j.1364-3703.2009.00599.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bhattacharjee S., 2011, SCIENCE, V334; Cesari S., 2014, FRONT PLANT SCI, V5; de la Torre-Hernandez E., 2010, PHYSIOL MOL PLANT P, V74, P337; Dempsey D.A., 2011, ARABIDOPSIS BOOK; Silberbush M, 2013, PLANT ROOTS: THE HIDDEN HALF, 4TH EDITION; Flor H.H., 1971, ANN REV PHYTOPATHOL; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; Gimenez-Ibanez S., 2013, FRONT PLANT SCI, V4; Mang H.-G., 2012, PLANT CELL ONLINE, V24; McKnight P.E., 2010, CORSINI ENCY PSYCHOL; O'Brien JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00451; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; Teng S., 2005, PLANT PHYSIOL, V139, P1840; Xin HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058740; Yu YW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004025	80	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	OCT	2015	239						216	229		10.1016/j.plantsci.2015.07.017		14	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CS7ZY	WOS:000362306700022		
J	Kobayashi, S; Denda, T; Mashiba, S; Iwamoto, T; Doi, T; Izawa, M				Kobayashi, Shun; Denda, Tetsuo; Mashiba, Shigehiko; Iwamoto, Toshitaka; Doi, Teruo; Izawa, Masako			Pollination partners of Mucuna macrocarpa (Fabaceae) at the northern limit of its range	PLANT SPECIES BIOLOGY			English	Article						explosive opening; Macaca fuscata; Martes melampus; Mucuna macrocarpa; pollination	NECTAR; LEGUMINOSAE; BEHAVIOR; FLOWERS	Mucuna macrocarpa is a plant found in tropical and subtropical regions that requires an explosive opening. Explosive opening is the process that exposes the stamen and pistil from the opening of the carina. This process is needed for cross pollination; however, the plant cannot open itself and opening by an animal is needed. The most common opener of Mucuna flowers is several nectar-eating bats (e.g., Syconycteris), but the flying fox, Pteropus dasymallus, is the only opener of M.macrocarpa on the subtropical island of Okinawajima. Here, we present the explosive openers and possible pollinators in the northernmost and temperate Kamae region, Kyushu, Japan, where nectar-eating bats are absent. The Japanese macaque, Macaca fuscata, and the Japanese marten, Martes melampus, were the explosive openers observed during our survey in Kamae. Martens opened flowers using their snout in a manner similar to that of the flying fox, whereas macaques opened flowers using their hands. This is the first time that an animal has been observed opening these flowers with its hands rather than snout. In total, 97% (n=283) of explosively opened flowers were opened by macaques, and the macaque largely contributed to the overall flower opening. Because many pollen grains become attached to the explosive openers, they are considered to be primary pollinators. Furthermore, two bee species, Apis cerana japonica and Bombus ardens ardens, also visited opened flowers and collected pollen, and they were possibly secondary pollinators.	[Kobayashi, Shun] Grad Sch Engn & Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kobayashi, Shun] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Denda, Tetsuo; Izawa, Masako] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 90301, Japan; [Iwamoto, Toshitaka] Miyazaki Univ, Fac Educ & Culture, Miyazaki, Japan	Kobayashi, S (reprint author), Grad Sch Engn & Sci, Chiyoda Ku, Koji Machi 5-3-1, Tokyo 1020083, Japan.	cheirotonus.jambar@gmail.com			University of the Ryukyus; Fujifilm Green Fund;  [25.114]	We are grateful to J. Kawano and Y. Tateishi for valuable help and advice. We thank C. Toyama, K. Okuda, A. Irimoto, S. Furuta, D. Kakazu, H. Ui, K. Matsumoto, and T. Ohtani for their help in conducting the field survey, representatives of local government offices of Oita and Saiki for granting us permission to conduct this research, and Wiley Editing Services for editing our English. Our thanks are also due to two reviewers for their valuable comments. This study was partly supported by grants from the "International Research Hub Project for Climate Change and Coral Reef/Island Dynamics" from the University of the Ryukyus, the Fujifilm Green Fund in 2012 and Grant-in-Aid for JSPS Fellows Grant Number 25.114.	Mora JM, 1999, REV BIOL TROP, V47, P719; Andriafidison D, 2006, BIOTROPICA, V38, P85, DOI 10.1111/j.1744-7429.2006.00112.x; Cotton PA, 2001, BIOTROPICA, V33, P662, DOI 10.1111/j.1744-7429.2001.tb00223.x; TATEISHI Y, 1981, BOT MAG TOKYO, V94, P91, DOI 10.1007/BF02488268; Toyama C, 2012, MAMM STUDY, V37, P205, DOI 10.3106/041.037.0304; Sazima M, 1999, ANN BOT-LONDON, V83, P705, DOI 10.1006/anbo.1999.0876; GARBER PA, 1988, BIOTROPICA, V20, P100, DOI 10.2307/2388181; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Agostini K, 2006, BIOTROPICA, V38, P674, DOI 10.1111/j.1744-7429.2006.00191.x; Agostini K, 2011, NATURWISSENSCHAFTEN, V98, P933, DOI 10.1007/s00114-011-0844-6; Carthew SM, 1997, TRENDS ECOL EVOL, V12, P104, DOI 10.1016/S0169-5347(96)10067-7; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Amorim FW, 2013, PLANT BIOLOGY, V15, P317, DOI 10.1111/j.1438-8677.2012.00643.x; Arai S, 2003, MAMMALIAN SCI, V43, P19; Azuma S., 2002, CHECK LIST INSECT RY; Baker H. G., 1970, REV BIOL TROP, V17, P187; Chen Gao, 2012, Shengwu Duoyangxing, V20, P360; desAssumpcao C. T., 1981, J MAMMAL, V62, P386; Faegri K., 1979, PRINCIPLES POLLINATI; GRAND TI, 1972, J MAMMAL, V53, P198, DOI 10.2307/1378849; Hatsushima S., 1994, FLORA RYUKYUS S AMAM; Hopkins H. C. F., 1993, Kew Bulletin, V48, P297, DOI 10.2307/4117936; Kawanishi H., 2001, RED DATA BOOK OITA, P7; Kinjo K., 2009, WILD MAMMALS JAPAN, P52; Koike S., 2008, Journal of the Japanese Forest Society, V90, P26, DOI 10.4005/jjfs.90.26; Mashiba S., 1971, COLLECTING BREADING, V33, P214; Reeder D. M., 2005, MAMMAL SPECIES WORLD; Schrire BD, 2005, LEGUMES WORLD, P393; Tatara Masaya, 1994, P272; Van der PIJL L., 1941, ANN JARD BOT BUITENZORG, V51, P83; vansLeeuwen W. M. D., 1938, ANN JARDIN BOT BUITE, V48, P27; vonsHelversen D., 2003, J COMP PHYSIOL A, V189, P327; Willmer P., 2011, POLLINATION FLORAL E; YOTSUMOTO N, 1976, Primates, V17, P183, DOI 10.1007/BF02382850	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	OCT	2015	30	4					272	278		10.1111/1442-1984.12065		7	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CS8UE	WOS:000362363300003		
J	Arriesgado, DM; Kurokochi, H; Lian, CL; Nakajima, Y; Matsuki, Y; Nagai, S; Yasuike, M; Nakamura, Y; Uy, WH; Fortes, MD; Campos, WL; Nadaoka, K				Arriesgado, Dan M.; Kurokochi, Hiroyuki; Lian, Chunlan; Nakajima, Yuichi; Matsuki, Yu; Nagai, Satoshi; Yasuike, Motoshige; Nakamura, Yoji; Uy, Wilfredo H.; Fortes, Miguel D.; Campos, Wilfredo L.; Nadaoka, Kazuo			Isolation and characterization of novel microsatellite markers for Cymodocea serrulata (Cymodoceaceae), a seagrass distributed widely in the Indo-Pacific region	PLANT SPECIES BIOLOGY			English	Editorial Material						clonal plant; Cymodocea serrulata; next generation sequencing; seagrass; SSR markers	DIVERSITY; L.	Cymodocea serrulata is a tropical seagrass species distributed widely in the Indo-Pacific region. We developed 16 novel microsatellite (simple sequence repeat) markers for C. serrulata using next-generation sequencing for use in genetic studies. The applicability of these markers was attested by genotyping of 40 individuals collected from a natural population in the Philippines. Of the 16 loci, 15 showed polymorphism. For the 15 polymorphic markers, the number of alleles per locus ranged from two to seven, and the observed and expected heterozygosities ranged from 0.131-1.000 and 0.124-0.788, respectively. These markers are useful tools for elucidating genetic diversity, connectivity, and structure in this foundational coastal species.	[Arriesgado, Dan M.; Nadaoka, Kazuo] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Tokyo 152, Japan; [Arriesgado, Dan M.; Kurokochi, Hiroyuki; Lian, Chunlan; Nakajima, Yuichi; Matsuki, Yu] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo, Japan; [Nagai, Satoshi; Yasuike, Motoshige; Nakamura, Yoji] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan; [Arriesgado, Dan M.; Uy, Wilfredo H.] Mindanao State Univ, Inst Fisheries Res & Dev, Naawan, Misamis Orienta, Philippines; [Fortes, Miguel D.] Univ Philippines, Marine Sci Inst CS, Quezon City 1101, Philippines; [Campos, Wilfredo L.] Univ Philippines Visayas, Coll Arts & Sci, Div Biol Sci, Iloilo, Philippines	Lian, CL (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo, Japan.	danarriesgado@gmail.com; lian@anesc.u-tokyo.ac.jp	Nakajima, Yuichi/A-4330-2013; 悠, 松木/D-4526-2011	Nakajima, Yuichi/0000-0001-6558-5378; 			Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Islam MS, 2006, MOL ECOL NOTES, V6, P30, DOI 10.1111/j.1471-8286.2005.01127.x; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Terrados J, 1998, ESTUAR COAST SHELF S, V46, P757, DOI 10.1006/ecss.1997.0304; Goudet J, 1995, J HERED, V86, P485; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Tanaka Y, 2006, BOT MAR, V49, P365, DOI 10.1515/BOT.2006.047; Nakamura Y, 2013, ICHTHYOL RES, V60, P184, DOI 10.1007/s10228-012-0317-8; Davison G. W. H., 2008, SINGAPORE RED BOOK T; Fricano A, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-18; Pan JJ, 2001, EVOL ECOL, V15, P583, DOI 10.1023/A:1016065705539; Short F. T., 2010, CYMODOCEA SERRULATA	12	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0913-557X	1442-1984		PLANT SPEC BIOL	Plant Spec. Biol.	OCT	2015	30	4					297	299		10.1111/1442-1984.12064		3	Plant Sciences; Ecology	Plant Sciences; Environmental Sciences & Ecology	CS8UE	WOS:000362363300007		
J	duPont, W; Noy, I; Okuyama, Y; Sawada, Y				duPont, William; Noy, Ilan; Okuyama, Yoko; Sawada, Yasuyuki			The Long-Run Socio-Economic Consequences of a Large Disaster: The 1995 Earthquake in Kobe	PLOS ONE			English	Article							HANSHIN-AWAJI EARTHQUAKE; NATURAL DISASTERS; ECONOMIC-GROWTH; IMPACT; RECOVERY; CATASTROPHE	We quantify the 'permanent' socio-economic impacts of the Great Hanshin-Awaji (Kobe) earthquake in 1995 by employing a large-scale panel dataset of 1,719 cities, towns, and wards from Japan over three decades. In order to estimate the counterfactual-i.e., the Kobe economy without the earthquake-we use the synthetic control method. Three important empirical patterns emerge: First, the population size and especially the average income level in Kobe have been lower than the counterfactual level without the earthquake for over fifteen years, indicating a permanent negative effect of the earthquake. Such a negative impact can be found especially in the central areas which are closer to the epicenter. Second, the surrounding areas experienced some positive permanent impacts in spite of short-run negative effects of the earthquake. Much of this is associated with movement of people to East Kobe, and consequent movement of jobs to the metropolitan center of Osaka, that is located immediately to the East of Kobe. Third, the furthest areas in the vicinity of Kobe seem to have been insulated from the large direct and indirect impacts of the earthquake.	[duPont, William] St Johns Univ, Dept Econ, Coll St Benedict|, St Joseph, MN USA; [Noy, Ilan] Victoria Univ Wellington, Sch Econ & Finance, Wellington, New Zealand; [Okuyama, Yoko] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Sawada, Yasuyuki] Univ Tokyo, Grad Sch Econ, Tokyo, Japan; [Sawada, Yasuyuki] Res Inst Econ Trade & Ind, Tokyo, Japan	Noy, I (reprint author), Victoria Univ Wellington, Sch Econ & Finance, Wellington, New Zealand.	Ilan.Noy@vuw.ac.nz			Research Institute of Economy, Trade and Industry (Japan); NOAA-USA [NA09OAR4170060]	YS received funding from the Research Institute of Economy, Trade and Industry (Japan). IN received funding from NOAA-USA (Sea Grant NA09OAR4170060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2010, J AM STAT ASSOC, V105, P493; Abadie Alberto, 2003, AM ECON REV, V93, P112; Aldrich D. P., 2012, BUILDING RESILIENCE; Klomp J, 2014, GLOBAL ENVIRON CHANG, V26, P183, DOI 10.1016/j.gloenvcha.2014.02.006; Sawada Y, 2011, REV ECON HOUSEHOLD, V9, P429, DOI 10.1007/s11150-011-9124-7; Hornbeck R, 2012, AM ECON REV, V102, P1477, DOI 10.1257/aer.102.4.1477; Davis DR, 2002, AM ECON REV, V92, P1269, DOI 10.1257/000282802762024502; Okuyama Y, 2014, ECON SYST RES, V26, P98, DOI 10.1080/09535314.2013.871506; Evans RW, 2010, J POPUL ECON, V23, P1, DOI 10.1007/s00148-008-0219-2; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; Aldrich DP, 2011, NAT HAZARDS, V56, P595, DOI 10.1007/s11069-010-9577-7; Hornbeck R, 2014, AM ECON REV, V104, P963, DOI 10.1257/aer.104.3.963; Horwich G, 2000, ECON DEV CULT CHANGE, V48, P521, DOI 10.1086/452609; Oishi S, 2015, J RES PERS, V55, P84, DOI 10.1016/j.jrp.2015.02.001; Hirayama Y, 2000, HOUSING STUD, V15, P111, DOI 10.1080/02673030082504; Schultz J, 2013, POPUL ENVIRON, V34, P293, DOI 10.1007/s11111-012-0171-7; duPont W, 2015, ECON DEV CULT CHANGE, V63, P777, DOI 10.1086/681129; Xiao Y, 2011, J REGIONAL SCI, V51, P804, DOI 10.1111/j.1467-9787.2011.00717.x; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; Kohara M, 2006, HITOTSUB J ECON, V47, P219; Chang SE, 2010, DISASTERS, V34, P303, DOI [10.1111/j.1467-7717.2009.01130.x, 10.1111/j.0361-3666.2009.01130.x]; Beniya S., 2007, 2 INT C URB DIS RED; Chang S. E., 1995, J TRANSP GEOGR, V8, P53; City of Kobe, 2011, GREAT HANSHIN AWAJI; Cole M, 2104 IPAG; Davis DR, 2008, J REGIONAL SCI, V48, P29; Edgington DW, 2010, RECONSTRUCTING KOBE: THE GEOGRAPHY OF CRISIS AND OPPORTUNITY, P1; Fujiki H, 2015, J ECONOMETRICS, V186, P66, DOI 10.1016/j.jeconom.2014.10.010; IPCC, 2012, SPECIAL REPORT WORKI; Karim A, 2013, POVERTY NATURAL DISA; Ohtake F, 2012, E W CTR DEC; Ohtake F, 2012, E W CTR; Sasaki M., 2012, JAP LABOR REV, V9, P42; Takeda J., 2003, NAT HAZARDS, V29, P567, DOI 10.1023/A:1024705420074; United Nations Office for Disaster Risk Reduction (UNISDR), 2013, GLOB ASS REP DIS RIS; Yamamura E., 2013, 44493 MPRA U LIB MUN	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138714	10.1371/journal.pone.0138714		17	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100018		
J	Fujita, Y; Fujiwara, K; Zenitani, S; Yamashita, T				Fujita, Yuki; Fujiwara, Kei; Zenitani, Shigetake; Yamashita, Toshihide			Acetylation of NDPK-D Regulates Its Subcellular Localization and Cell Survival	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE-KINASE; SIRT1 DEACETYLASE; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; SYNAPTIC PLASTICITY; CALORIE RESTRICTION; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53; MITOCHONDRIA	Nucleoside diphosphate kinases (NDPK) are ubiquitous enzymes that catalyze the reversible phosphotransfer of gamma-phosphates between di- and triphosphonucleosides. NDPK-D (Nm23-H4) is the only member of the NDPK family with a mitochondrial targeting sequence. Despite the high expression of NDPK-D in the developing central nervous system, its function remains to be determined. In this study, we show that NDPK-D knockdown induces apoptosis in neuroblastoma cells as well as in mouse cortex, suggesting that NDPK-D is required for neuronal survival. We identified NDPK-D as a binding partner of NAD+-dependent histone deacetylase, SIRT1, by yeast two-hybrid screening. NDPK-D co-localized with SIRT1, and the association of these molecules was confirmed by co-immunoprecipitation. Inhibition of SIRT1 increases the acetylation of NDPK-D. Overexpression of NDPK-D along with SIRT1, or mutation in the acetylated lysine residues in NDPK-D, increases its nuclear accumulation. Furthermore, the NDPK-D acetylation-mimic mutant increased apoptosis in N1E-115 cells. Our data demonstrate that acetylation regulates the shuttling of NDPK-D between nucleus and cytoplasm, and increased acetylation of NDPK-D causes apoptosis.	[Fujita, Yuki; Fujiwara, Kei; Zenitani, Shigetake; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Fujita, Yuki; Fujiwara, Kei; Yamashita, Toshihide] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	Yamashita, T (reprint author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26830028]; JSPS [25221309]	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (26830028) to Y.F. and a Grant-in-Aid for Scientific Research (S) from the JSPS (25221309) to T.Y.	Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rumi M, 2006, BIOCHEM BIOPH RES CO, V339, P540, DOI 10.1016/j.bbrc.2005.11.037; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Zhao YN, 2013, BIOCHEM BIOPH RES CO, V435, P597, DOI 10.1016/j.bbrc.2013.05.025; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Koyama Y, 2008, J CHEM NEUROANAT, V36, P209, DOI 10.1016/j.jchemneu.2008.08.006; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Imai S, 2000, NATURE, V403, P795; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Ogawa T, 2011, CONGENIT ANOM, V51, P70, DOI 10.1111/j.1741-4520.2010.00304.x; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; RINE J, 1979, GENETICS, V93, P877; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; KLAR AJS, 1979, GENETICS, V93, P37; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Fujita Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-6; Fujita Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.85; Guarente Leonard, 2011, Cold Spring Harb Symp Quant Biol, V76, P81, DOI 10.1101/sqb.2011.76.010629; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200	59	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139616	10.1371/journal.pone.0139616		18	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100082		
J	Knop, J; Misaka, S; Singer, K; Hoier, E; Muller, F; Glaeser, H; Konig, J; Fromm, MF				Knop, Jana; Misaka, Shingen; Singer, Katrin; Hoier, Eva; Mueller, Fabian; Glaeser, Hartmut; Koenig, Joerg; Fromm, Martin F.			Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; MULTIDRUG-RESISTANCE; IN-VITRO; CELLS; DETERMINANTS; PHARMACOKINETICS; MECHANISM; CATECHINS; JUICE	Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substratesmetformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.	[Knop, Jana; Misaka, Shingen; Singer, Katrin; Hoier, Eva; Mueller, Fabian; Glaeser, Hartmut; Koenig, Joerg; Fromm, Martin F.] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Misaka, Shingen] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan	Fromm, MF (reprint author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	martin.fromm@fau.de			Sanofi-Aventis Deutschland	F.M. holds a minor share of stock in Novartis, received research funding from Sanofi-Aventis Deutschland and is now an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. M. F.F. reported receiving personal compensation for expert testimony from Boehringer Ingelheim Pharma and payments for lectures from Bayer-Schering Pharma, Boehringer Ingelheim Pharma, Sanofi-Aventis Deutschland and Merck KGaA. M.F.F.'s institution received compensation for commissioned research of his group from Merck KGaA and Sanofi-Aventis Deutschland and for supply for in vitro studies from Gilead. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The remaining authors declare no conflicts of interest.	Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Muller F, 2013, BIOCHEM PHARMACOL, V86, P808, DOI 10.1016/j.bcp.2013.07.008; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Ito K, 1998, PHARMACOL REV, V50, P387; Paine MF, 2007, EXPERT OPIN DRUG MET, V3, P67, DOI 10.1517/17425255.3.1.67; Engdal S, 2008, XENOBIOTICA, V38, P559, DOI 10.1080/00498250801986969 ; Jodoin J, 2002, BBA-MOL CELL RES, V1542, P149, DOI 10.1016/S0167-4889(01)00175-6; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Donovan JL, 2004, DRUG METAB DISPOS, V32, P906, DOI 10.1124/dmd.104.000083; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693; Roth M, 2011, DRUG METAB DISPOS, V39, P920, DOI 10.1124/dmd.110.036640; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Cui YH, 1999, MOL PHARMACOL, V55, P929; Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Misaka S, 2014, CLIN PHARMACOL THER, V95, P432, DOI 10.1038/clpt.2013.241; Mizukami Y, 2007, J AGR FOOD CHEM, V55, P4957, DOI 10.1021/jf070323f; Zolk O, 2009, N-S ARCH PHARMACOL, V379, P337, DOI 10.1007/s00210-008-0369-5; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; Konig J, 2011, BRIT J PHARMACOL, V163, P546, DOI 10.1111/j.1476-5381.2010.01052.x; Yang CS, 2000, J NUTR, V130, P2409; Zhu M, 2001, XENOBIOTICA, V31, P51, DOI 10.1080/00498250010024988; Chow HHS, 2006, CANCER EPIDEM BIOMAR, V15, P2473, DOI 10.1158/1055-9965.EPI-06-0365; Muller F, 2011, ANTIMICROB AGENTS CH, V55, P3091, DOI 10.1128/AAC.01835-10; Fleisher B, 2015, J PHARM SCI-US, V104, P266, DOI 10.1002/jps.24289; Fujita Ken-ichi, 2004, Drug Metabolism and Drug Interactions, V20, P195; Group SC, 2008, NEW ENGL J MED, V359, P789, DOI DOI 10.1056/NEJM0A0801936; Huber S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133743; Werba JP, 2015, CURR PHARM DESIGN, V21, P1213, DOI 10.2174/1381612820666141013135045	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139370	10.1371/journal.pone.0139370		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100053		
J	Murakami, T; Hiroshima, Y; Zhang, Y; Chishima, T; Tanaka, K; Bouvet, M; Endo, I; Hoffman, RM				Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Fluorescence-Guided Surgery of Liver Metastasis in Orthotopic Nude-Mouse Models	PLOS ONE			English	Article							HUMAN COLON-CANCER; ANTI-CEA ANTIBODY; KILLER-REPORTER ADENOVIRUS; SURGICAL NAVIGATION; IMAGING-SYSTEM; RESECTION; GFP	We report here the development of fluorescence-guided surgery of liver metastasis. HT29 human colon cancer cells expressing green fluorescent protein (GFP) were initially injected in the spleen of nude mice. Three weeks later, established liver metastases were harvested and implanted on the left lobe of the liver in other nude mice in order to make an orthotopic liver metastasis model. Fourteen mice with a single liver metastasis were randomized into bright-light surgery (BLS) or fluorescence-guided surgery (FGS) groups. Seven mice were treated with BLS, seven were treated with FGS. Three weeks after implantation, the left lobe of the liver with a single metastasis was exposed through a median abdominal incision. BLS was performed under white light. FGS was performed using a hand-held portable fluorescence imaging system (Dino-Lite). Post-surgical residual tumor fluorescence was visualized with the OV100 Small Animal Imaging System. Residual tumor fluorescence after BLS was clearly visualized at high magnification with the OV100. In contrast, residual tumor fluorescence after FGS was not detected even at high magnification with the OV100. These results demonstrate the feasibility of FGS for liver metastasis.	[Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Murakami, Takashi; Hiroshima, Yukihiko; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Murakami, Takashi; Hiroshima, Yukihiko; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Hoffman, RM (reprint author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com			National Cancer Institute [CA132971, CA142669]; JSPS KAKENHI [26830081, 26462070, 24592009]; AntiCancer Inc.	This study was supported by National Cancer Institute grant numbers CA132971 to MB and CA142669 to MB and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AntiCancer Inc. provided support in the form of salary for an author YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Yano S, 2015, ONCOTARGET, V6, P13133; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Yano S, 2015, MOL THER, V23, P1182, DOI 10.1038/mt.2015.63; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138752	10.1371/journal.pone.0138752		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100019		
J	Murata, Y; Yasuda, T; Watanabe-Asaka, T; Oda, S; Mantoku, A; Takeyama, K; Chatani, M; Kudo, A; Uchida, S; Suzuki, H; Tanigaki, F; Shirakawa, M; Fujisawa, K; Hamamoto, Y; Terai, S; Mitani, H				Murata, Yasuhiko; Yasuda, Takako; Watanabe-Asaka, Tomomi; Oda, Shoji; Mantoku, Akiko; Takeyama, Kazuhiro; Chatani, Masahiro; Kudo, Akira; Uchida, Satoko; Suzuki, Hiromi; Tanigaki, Fumiaki; Shirakawa, Masaki; Fujisawa, Koichi; Hamamoto, Yoshihiko; Terai, Shuji; Mitani, Hiroshi			Histological and Transcriptomic Analysis of Adult Japanese Medaka Sampled Onboard the International Space Station	PLOS ONE			English	Article							AMPHIBIAN PLEURODELES-WALTL; GENE-EXPRESSION; IMMUNE FUNCTION; SPACEFLIGHT; FISH; MICROGRAVITY; ENVIRONMENT	To understand how humans adapt to the space environment, many experiments can be conducted on astronauts as they work aboard the Space Shuttle or the International Space Station (ISS). We also need animal experiments that can apply to human models and help prevent or solve the health issues we face in space travel. The Japanese medaka (Oryzias latipes) is a suitable model fish for studying space adaptation as evidenced by adults of the species having mated successfully in space during 15 days of flight during the second International Microgravity Laboratory mission in 1994. The eggs laid by the fish developed normally and hatched as juveniles in space. In 2012, another space experiment ("Medaka Osteoclast") was conducted. Six-week-old male and female Japanese medaka (Cab strain osteoblast transgenic fish) were maintained in the Aquatic Habitat system for two months in the ISS. Fish of the same strain and age were used as the ground controls. Six fish were fixed with paraformaldehyde or kept in RNA stabilization reagent (n = 4) and dissected for tissue sampling after being returned to the ground, so that several principal investigators working on the project could share samples. Histology indicated no significant changes except in the ovary. However, the RNA-seq analysis of 5345 genes from six tissues revealed highly tissue-specific space responsiveness after a two-month stay in the ISS. Similar responsiveness was observed among the brain and eye, ovary and testis, and the liver and intestine. Among these six tissues, the intestine showed the highest space response with 10 genes categorized as oxidation-reduction processes (gene ontogeny term GO: 0055114), and the expression levels of choriogenin precursor genes were suppressed in the ovary. Eleven genes including klf9, klf13, odc1, hsp70 and hif3a were upregulated in more than four of the tissues examined, thus suggesting common immunoregulatory and stress responses during space adaptation.	[Murata, Yasuhiko] Tohoku Univ, Dept Radiat Biol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Yasuda, Takako; Watanabe-Asaka, Tomomi; Oda, Shoji; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Mantoku, Akiko; Takeyama, Kazuhiro; Chatani, Masahiro; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan; [Uchida, Satoko; Suzuki, Hiromi] Japan Space Forum, Tokyo, Japan; [Tanigaki, Fumiaki; Shirakawa, Masaki] Japan Aerosp Explorat Agcy, Ibaraki, Japan; [Fujisawa, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan; [Hamamoto, Yoshihiko] Yamaguchi Univ, Grad Sch Med, Dept Biomol Engn, Yamaguchi, Japan; [Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan	Terai, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.	terais@med.niigata-u.ac.jp; mitani@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science [25220102]; Technology of Japan; Japan Aerospace eXploration Agency	This research was supported by a Grant-in-Aid for Scientific Research (S) Number 25220102 to H.M. from the Ministry of Education, Culture, Sports, Science and the unspecified fund from Technology of Japan and Japan Aerospace eXploration Agency.	Takei Y, 2008, GEN COMP ENDOCR, V157, P3, DOI 10.1016/j.ygcen.2008.03.021; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Ijiri K, 2003, ADV SPACE B, V9, P201; Inohaya K, 2010, DEVELOPMENT, V137, P1807, DOI 10.1242/dev.051540; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Forsman AD, 2012, ADV SPACE RES, V49, P807, DOI 10.1016/j.asr.2011.11.033; Chapes SK, 1999, ADV SPACE RES, V23, P1955, DOI 10.1016/S0273-1177(99)00456-1; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Morey-Holton E. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P17; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Capulli M, 2009, J CELL BIOCHEM, V107, P240, DOI 10.1002/jcb.22120; Masukawa M, 2003, ADV SPACE RES, V32, P1541, DOI 10.1016/S0273-1177(03)90393-0; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Droppert P M, 1990, J Br Interplanet Soc, V43, P19; Gabriel Martin, 2012, J Exp Zool A Ecol Genet Physiol, V317, P333, DOI 10.1002/jez.1727; Gridley DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075097; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031292; Mao XW, 2013, RADIAT RES, V180, P340, DOI 10.1667/RR3309.1; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Oda S, 2014, CYTOMET RES, V24, P9; Ronca AE, 2013, GRAVITAT SPACE RES, V1, P105; Sakimura T, 2003, UCHU SEIBUTSU KAGAKU, V17, P240; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Santucci D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040112; Smith IM, 2012, GRAVITAT SPACE RES, V26, P30; Terada M, 2013, ADV BIOSCI BIOTECHNO, V4, P75; Watanabe-Asaka T, 2010, UCHU SEIBUTSU KAGAKU, V24, P3; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yasuda T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.133; Yoshioka H, 1976, SEIBUTSU KYOZAI, V11, P5	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138799	10.1371/journal.pone.0138799		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100020		
J	Nagaoka, N; Jonas, JB; Morohoshi, K; Moriyama, M; Shimada, N; Yoshida, T; Ohno-Matsui, K				Nagaoka, Natsuko; Jonas, Jost B.; Morohoshi, Kei; Moriyama, Muka; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko			Glaucomatous-Type Optic Discs in High Myopia	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE DAMAGE; RISK-FACTORS; BEIJING EYE; GAMMA ZONE; POPULATION; PROGRESSION; REGION	Purpose To assess the prevalence of glaucoma in patients with high myopia defined as myopic refractive error of >-8 diopters or axial length >= 26.5 mm. Methods The hospital-based observational study included 172 patients (336 eyes) with a mean age of 61.9 +/- 12.3 years and mean axial length of 30.1 +/- 2.3 mm (range: 24.7-39.1mm). Glaucomatous-type optic discs were defined by glaucomatous optic disc appearance. Glaucoma was defined by glaucomatous optic disc appearance and glaucomatous Goldmann visual field defects not corresponding with myopic macular changes. Results Larger disc area (mean: 3.18 +/- 1.94 mm(2)) was associated with longer axial length (P<0.001; standardized correlation coefficient: 0.45). Glaucoma was detected in 94 (28%; 95% Confidence intervals: 23%, 33%) eyes. In multivariate analysis, glaucoma prevalence was 3.2 times higher (P<0.001) in megalodiscs (>3.79 mm(2)) than in normal-sized discs or small discs (<1.51 mm(2)) after adjusting for older age. Axial length was not significantly (P = 0.38) associated with glaucoma prevalence in that model. Glaucoma prevalence increased by a factor of 1.39 for each increase in optic disc area by one mm(2). Again, axial length was not significantly (P = 0.38) associated with glaucoma prevalence when added to this multivariate model. Conclusion Within highly myopic individuals, glaucoma prevalence increased with larger optic disc size beyond a disc area of 3.8 mm(2). Highly myopic megalodiscs as compared to normal sized discs or small discs had a 3.2 times higher risk for glaucomatous optic nerve neuropathy. The increased glaucoma prevalence in axial high myopia was primarily associated with axial myopia associated disc enlargement and not with axial elongation itself.	[Nagaoka, Natsuko; Morohoshi, Kei; Moriyama, Muka; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, D-68167 Mannheim, Germany	Ohno-Matsui, K (reprint author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	k.ohno.oph@tmd.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25670727, 15H04993, 15K15629]	This study was supported by research grants 25670727, 15H04993 and 15K15629 from the Japan Society for the Promotion of Science, Tokyo, Japan.	Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Ramakrishnan R, 2003, OPHTHALMOLOGY, V110, P1484, DOI 10.1016/S0161-6420(03)00564-5; Jonas JB, 2011, ACTA OPHTHALMOL, V89, P505, DOI 10.1111/j.1755-3768.2010.01915.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas JB, 2005, EUR J OPHTHALMOL, V15, P41; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Dai Y, 2015, RETINA-J RET VIT DIS, V35, P655, DOI 10.1097/IAE.0000000000000358; Investigators A., 2002, AM J OPHTHALMOL, V134, P499; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Morgan IG, 2012, LANCET, V37, P1739; Spaide R, 2014, PATHOLOGIC MYOPIA MY	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138825	10.1371/journal.pone.0138825		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100021		
J	Sakai, H; Nagao, H; Sakurai, M; Okumura, T; Nagai, Y; Shikuma, J; Ito, R; Imazu, T; Miwa, T; Odawara, M				Sakai, Hiroyuki; Nagao, Hidenori; Sakurai, Mamoru; Okumura, Takako; Nagai, Yoshiyuki; Shikuma, Junpei; Ito, Rokuro; Imazu, Tetsuya; Miwa, Takashi; Odawara, Masato			Correlation between Serum Levels of 3,3 ',5 '-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay	PLOS ONE			English	Article							ELECTROSPRAY-IONIZATION; ANTIBODY INTERFERENCE; THYROXINE; RADIOIMMUNOASSAY; TRIIODOTHYRONINE; DEIODINASE; ASSAYS; T3	Objective For measuring serum 3,3',5'-triiodothyronine (rT3) levels, radioimmunoassay (RIA) has traditionally been used owing to the lack of other reliable methods; however, it has recently become difficult to perform. Meanwhile, liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been attracting attention as a novel alternative method in clinical chemistry. To the best of our knowledge, there are no studies to date comparing results of the quantification of human serum rT3 between LC-MS/MS and RIA. We therefore examined the feasibility of LC-MS/MS as a novel alternative method for measuring serum rT3, thyroxine (T4), and 3,5,3'-triiodothyronine (T3) levels. Methods Assay validation was performed by LC-MS/MS using quality control samples of rT3, T4, and T3 at 4 various concentrations which were prepared from reference compounds. Serum samples of 50 outpatients in our department were quantified both by LC-MS/MS and conventional immunoassay for rT3, T4, and T3. Correlation coefficients between the 2 measurement methods were statistically analyzed respectively. Results Matrix effects were not observed with our method. Intra-day and inter-day precisions were less than 10.8% and 9.6% for each analyte at each quality control level, respectively. Intra-day and inter-day accuracies were between 96.2% and 110%, and between 98.3% and 108.6%, respectively. The lower limit of quantification was 0.05 ng/mL. Strong correlations were observed between the 2 measurement methods (correlation coefficient, T4: 0.976, p < 0.001; T3: 0.912, p < 0.001; rT3: 0.928, p < 0.001). Conclusions Our LC-MS/MS system requires no manual cleanup operation, and the process after application of a sample is fully automated; furthermore, it was found to be highly sensitive, and superior in both precision and accuracy. The correlation between the 2 methods over a wide range of concentrations was strong. LC-MS/MS is therefore expected to become a useful tool for clinical diagnosis and research.	[Sakai, Hiroyuki; Sakurai, Mamoru; Okumura, Takako; Nagai, Yoshiyuki; Shikuma, Junpei; Ito, Rokuro; Miwa, Takashi; Odawara, Masato] Tokyo Med Univ, Dept Diabet Endocrinol & Metab, Tokyo 1608402, Japan; [Nagao, Hidenori; Imazu, Tetsuya] ASKA Pharmaceut Co Ltd, Pharmacokinet Res Dept, Kawasaki, Kanagawa, Japan	Sakai, H (reprint author), Tokyo Med Univ, Dept Diabet Endocrinol & Metab, Tokyo 1608402, Japan.	hirosaka@tokyo-med.ac.jp			ASKA Pharmaceutical Co., Ltd.	The authors declare that ASKA Pharmaceutical Co., Ltd. provided support in the form of salaries for authors HN and TI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Soukhova N, 2004, CLIN CHIM ACTA, V343, P185, DOI 10.1016/j.cccn.2004.01.007; Mebis L, 2007, J CLIN ENDOCR METAB, V92, P3330, DOI 10.1210/jc.2007-0510; Wang DL, 2010, ANAL BIOANAL CHEM, V397, P1831, DOI 10.1007/s00216-010-3705-9; Visser WE, 2013, CLIN ENDOCRINOL, V78, P310, DOI 10.1111/cen.12023; Tyan YC, 2013, CLIN CHIM ACTA, V420, P99, DOI 10.1016/j.cca.2012.10.014; Sakai H, 2009, ENDOCR J, V56, P435; Tai SSC, 2004, ANAL CHEM, V76, P5092, DOI 10.1021/ac049516h; Soldin OP, 2004, CLIN CHIM ACTA, V347, P61, DOI 10.1016/j.cccn.2004.03.033; Yue BF, 2008, CLIN CHEM, V54, P642, DOI 10.1373/clinchem.2007.098293; Kumar AP, 2010, J AM SOC MASS SPECTR, V21, P14, DOI 10.1016/j.jasms.2009.07.004; Jonklaas J, 2008, THYROID, V18, P1303, DOI 10.1089/thy.2008.0155; Wu AHB, 2013, CLIN CHIM ACTA, V420, P4, DOI 10.1016/j.cca.2012.10.026; Tai SSC, 2002, CLIN CHEM, V48, P637; Peeters RP, 2005, J CLIN ENDOCR METAB, V90, P4559, DOI 10.1210/jc.2005-0535; Jonklaas J, 2014, CLIN BIOCHEM, V47, P1272, DOI 10.1016/j.clinbiochem.2014.06.007; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Halsall DJ, 2013, ANN CLIN BIOCHEM, V50, P397, DOI 10.1177/0004563213499554; PREMACHANDRA BN, 1978, J CLIN ENDOCR METAB, V47, P746; Kricka LJ, 1999, CLIN CHEM, V45, P942; Nagao H, 2011, J ENDOCRINOL, V210, P117, DOI 10.1530/JOE-10-0484; Chace DH, 2009, CLIN CHIM ACTA, V403, P178, DOI 10.1016/j.cca.2009.02.012; Soldin OP, 2004, CLIN CHIM ACTA, V349, P181, DOI 10.1016/j.cccn.2004.06.021; Gielen M, 2012, J CLIN ENDOCR METAB, V97, P3569, DOI 10.1210/jc.2012-2240; Zhang YT, 2005, J AM SOC MASS SPECTR, V16, P1781, DOI 10.1016/j.jasms.2005.06.017; Bolstad N, 2013, BEST PRACT RES CL EN, V27, P647, DOI [10.1016/j.beem.2013.05.011, 10.1016/j.beem.2013.005.011]; CHOPRA IJ, 1974, J CLIN INVEST, V54, P583, DOI 10.1172/JCI107795; Huang SA, 2010, THYROID FUNCTION TES, V28, P13; Krasowski Matthew D, 2014, BMC Clin Pathol, V14, P33, DOI 10.1186/1472-6890-14-33	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138864	10.1371/journal.pone.0138864		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100024		
J	Shobayashi, K; Inoue, T; Kawai, M; Iwao, K; Ohira, S; Kojima, S; Kuroda, U; Nakashima, KI; Tanihara, H				Shobayashi, Kohei; Inoue, Toshihiro; Kawai, Motofumi; Iwao, Keiichiro; Ohira, Saori; Kojima, Sachi; Kuroda, Utako; Nakashima, Kei-Ichi; Tanihara, Hidenobu			Postoperative Changes in Aqueous Monocyte Chemotactic Protein-1 Levels and Bleb Morphology after Trabeculectomy vs. ExPRESS Shunt Surgery	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; PSEUDOPHAKIC EYES; SCLERAL FLAP; PHACOEMULSIFICATION; HUMOR; CHEMOKINES; MITOMYCIN; DEVICE	Purpose To evaluate the postoperative changes in blebs and levels of aqueous monocyte chemotactic protein-1 (MCP-1) after trabeculectomy vs. Ex-PRESS tube shunt surgery. Methods Rabbits were subjected to trabeculectomy or Ex-PRESS tube shunt surgery and observed for up to 3 months. Intraocular pressure (IOP) was measured using a rebound tonometer. The MCP-1 level was measured by enzyme-linked immunosorbent assay (ELISA). Bleb morphology was evaluated using photos and anterior-segment optical coherence tomography (OCT). Results There were no differences in bleb appearance or IOP at any time between the groups. Bleb wall density in the anterior-segment OCT image was significantly lower 1 week after surgery in the Ex-PRESS group than the trabeculectomy group. The MCP-1 level in control eyes was 304.1 +/- 45.2 pg/mL. In the trabeculectomy group, the mean aqueous MCP-1 level was 1444.9, 1914.3, 1899.8, 516.4, 398.3, 427.3, 609.5, 1612.7, 386.2, and 167.9 pg/mL at 3, 6, and 12 h, and 1, 2, 5, 7, 14, 30, and 90 days after surgery, respectively. In the Ex-PRESS group, the corresponding values were 1744.0, 1372.0, 932.5, 711.7, 396.1, 487.3, 799.5, 1327.9, 293.6, and 184.0 pg/mL. There were no significant differences in the aqueous MCP-1 level between the groups at any time point. Conclusion The postoperative changes were similar in the Ex-PRESS and trabeculectomy groups, except for bleb wall density in the anterior-segment OCT image. The postoperative aqueous MCP-1 level had bimodal peaks in both groups.	[Shobayashi, Kohei; Inoue, Toshihiro; Kawai, Motofumi; Iwao, Keiichiro; Ohira, Saori; Kojima, Sachi; Kuroda, Utako; Nakashima, Kei-Ichi; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Kawai, Motofumi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan	Inoue, T (reprint author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp			JSPS KAKENHI [23390403, 25861640, 23791994]	This work was supported in part by JSPS KAKENHI Grant Numbers 23390403, 25861640 and 23791994. The sponsor or funding organization had no role in the design or conduct of this research. There was no additional external funding received for this study.	Netland PA, 2014, AM J OPHTHALMOL, V157, P433, DOI 10.1016/j.ajo.2013.09.014; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; Ramulu PY, 2007, OPHTHALMOLOGY, V114, P2265, DOI 10.1016/j.ophtha.2007.02.005; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Buys YM, 2013, CURR OPIN OPHTHALMOL, V24, P111, DOI 10.1097/ICU.0b013e32835907a6; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Hara T, 1998, GRAEF ARCH CLIN EXP, V236, P420, DOI 10.1007/s004170050100; Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017; Inoue T, 2012, INVEST OPHTH VIS SCI, V53, P8288, DOI 10.1167/iovs.12-10941; Fukagawa Kazumi, 2009, Allergology International, V58, P499, DOI 10.2332/allergolint.09-OA-0092; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Beltran-Agullo L, 2015, J GLAUCOMA, V24, P181, DOI 10.1097/IJG.0b013e31829e1b68; de Jong Leo, 2011, Clin Ophthalmol, V5, P527, DOI 10.2147/OPTH.S18565; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI 10.3928/15428877-20110224-04; Sugiyama Tetsuya, 2011, Clin Ophthalmol, V5, P1063, DOI 10.2147/OPTH.S23129; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI [10.1001/jamaophthalmol.2013.5605, 10.1001/jamaophthalmo1.2013.5605]; Wagschal LD, J GLAUCOMA IN PRESS	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139751	10.1371/journal.pone.0139751		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CS6GT	WOS:000362177100092		
J	Liu, L; Yang, XY; Santosh, M; Aulbach, S; Zhou, HY; Geng, JZ; Sun, WD				Liu, Lei; Yang, Xiaoyong; Santosh, M.; Aulbach, S.; Zhou, Hongying; Geng, Jianzhen; Sun, Weidong			Neoproterozoic intraplate crustal accretion on the northern margin of the Yangtze Block: Evidence from geochemistry, zircon SHRIMP U-Pb dating and Hf isotopes from the Fuchashan Complex	PRECAMBRIAN RESEARCH			English	Article						Zircon U-Pb geochronology; Yangtze Block; Neoproterozoic; Bimodal rift magmatism; Fuchashan Complex	TAN-LU FAULT; ULTRAHIGH-PRESSURE ECLOGITE; DABIE OROGEN IMPLICATIONS; SOUTH CHINA CONSTRAINTS; HIGH-GRADE METAMORPHISM; ISUA GREENSTONE-BELT; RARE-EARTH-ELEMENTS; TRACE-ELEMENT; VOLCANIC-ROCKS; JIANGNAN OROGEN	The South China Block preserves important imprints of Neoproterozoic intraplate magmatism in a continental setting associated with the amalgamation of the Yangtze and Cathaysia sub-blocks. Here we investigate the Fuchashan Complex exposed to the east of the NE to NNE trending Tan-Lu Fault (TLF) that dissects the North China Craton (NCC) and South China Block (SCB) in East China. We performed an integrated geochemical and geochronologic study on the basaltic to granitic rocks from the complex. Most of the zircons from one amphibolite, two diorites and one granitoid are characterized by oscillatory zoning with homogeneous cores, high Th/U ratios, variable negative Eu anomalies, and extremely HREE-enriched patterns, attesting to magmatic origin. Zircons from the four samples yield consistent Neoproterozoic ages (ca. 794-812 Ma), correlating with the widespread bimodal rift magmatism along the northern margin of SCB, possibly related to the Mid-Neoproterozoic breakup of the supercontinent Rodinia. The zircons from amphibolites show negative epsilon(Hf)(t) values of -16.4 and -8.3 and Hf model ages of 1699 +/- 14 Ma and 2023 +/- 10 Ma, indicating origin from partial melting of Paleoproterozoic enriched mantle. Their low SiO2 (48.28-51.75 wt%) contents also support mantle affinity. Furthermore, their high Mg numbers (54-60), and Cr (90-190 ppm) and Ni (31.6-51.1 ppm) content indicate primary and less evolved source magma. The markedly negative zircon epsilon(Hf)(t) values in the diorites and granitoids suggest partial melting of the Neoarchean to Paleoproterozoic lower crust. The extremely low zircon epsilon(Hf)(t) of -26.5 from a granitoid suggest reworking of Mesoarchean basement. A probable scenario for the generation of the extensive ca. 800 Ma bimodal suite in this region is the widespread Mid-Neoproterozoic intraplate magmatism triggered by asthenosphere upwelling, resulting in the partial melting of enriched subcontinental lithospheric mantle and underplating of mafic magma. Heat input from this magma led to further melting of lower continental crust at depths of 35-40 km, and the melt compositions controlled by fractionation of clinopyroxene and minor plagioclase under high fO(2) conditions. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Lei; Yang, Xiaoyong] Univ Sci & Technol China, Sch Earth & Space Sci, CAS Key Lab Crust Mantle Mat & Environm, Hefei 230026, Peoples R China; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Div Interdisciplinary Sci, Fac Sci, Kochi 7808520, Japan; [Aulbach, S.] Goethe Univ Frankfurt, Inst Geowissensch, D-60438 Frankfurt, Germany; [Zhou, Hongying; Geng, Jianzhen] Tianjin Inst Geol & Mineral Resources, Tianjin 300170, Peoples R China; [Sun, Weidong] Chinese Acad Sci, Key Lab Mineral & Metallogeny, Guangzhou Inst Geochemistry, Guangzhou 510640, Guangdong, Peoples R China	Yang, XY (reprint author), Univ Sci & Technol China, Sch Earth & Space Sci, CAS Key Lab Crust Mantle Mat & Environm, 96 Jinzhai Rd, Hefei 230026, Peoples R China.	xyyang555@163.com			State Key Basic Research Development Program of China [2012CB416602]; Natural Science Foundation of China [41090372, 41373053]; Fundamental Research Funds for the Central Universities; China Postdoctoral Science Foundation [2014M561832]	We are indebted to Prof. Chang, Y. F., Yao, Z. B., Shi, Y. H. and Dr. Chen Y. X. for their kind guidance during this research. Li, N., Hu, Z. L. and Chu, G. are acknowledged for their help with the zircon SHRIMP U-Pb analyses. Comments from Associate editor Dr. Wan Y. S. and two anonymous reviewers are gratefully acknowledged. This study was supported by the State Key Basic Research Development Program of China (2012CB416602), Natural Science Foundation of China (41090372, 41373053), the Fundamental Research Funds for the Central Universities and the China Postdoctoral Science Foundation (2014M561832).	Frost BR, 2001, J PETROL, V42, P2033, DOI 10.1093/petrology/42.11.2033; Zheng JP, 2006, GEOLOGY, V34, P417, DOI 10.1130/G22282; Griffin WL, 2002, LITHOS, V61, P237, DOI 10.1016/S0024-4937(02)00082-8; KRETZ R, 1983, AM MINERAL, V68, P277; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Manikyamba C, 2014, PRECAMBRIAN RES, V252, P1, DOI 10.1016/j.precamres.2014.06.014; SMEDLEY PL, 1986, EARTH PLANET SC LETT, V77, P113, DOI 10.1016/0012-821X(86)90137-8; Rubatto D, 2003, GEOCHIM COSMOCHIM AC, V67, P2173, DOI 10.1016/S0016-7037(02)01321-2; MIDDLEMOST EAK, 1994, EARTH-SCI REV, V37, P215, DOI 10.1016/0012-8252(94)90029-9; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; Duan LA, 2011, GONDWANA RES, V19, P141, DOI 10.1016/j.gr.2010.05.005; ANDERSON JL, 1985, GEOLOGY, V13, P177, DOI 10.1130/0091-7613(1985)13<177:PATGSP>2.0.CO;2; PEARCE JA, 1979, CONTRIB MINERAL PETR, V69, P33, DOI 10.1007/BF00375192; Santosh M, 2014, GONDWANA RES, V25, P945, DOI 10.1016/j.gr.2013.03.013; Zhang SB, 2008, PRECAMBRIAN RES, V163, P210, DOI 10.1016/j.precamres.2007.12.003; Zheng YF, 2009, CHINESE SCI BULL, V54, P3347, DOI 10.1007/s11434-009-0458-y; Tang J, 2008, PRECAMBRIAN RES, V161, P389, DOI 10.1016/j.precanires.2007.09.008; Wu FY, 2006, CHEM GEOL, V234, P105, DOI 10.1016/j.chemgeo.2006.05.003; Ling WL, 2003, PRECAMBRIAN RES, V122, P111, DOI 10.1016/S0301-9268(02)00222-X; Zhao JH, 2011, GEOLOGY, V39, P299, DOI 10.1130/G31701.1; PEARCE JA, 1984, J PETROL, V25, P956; Nance RD, 2014, GONDWANA RES, V25, P4, DOI 10.1016/j.gr.2012.12.026; Zhao ZF, 2008, CHEM GEOL, V253, P222, DOI 10.1016/j.chemgeo.2008.05.011; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Li XH, 2009, PRECAMBRIAN RES, V174, P117, DOI 10.1016/j.precamres.2009.07.004; Zheng YF, 2008, CHINESE SCI BULL, V53, P3081, DOI 10.1007/s11434-008-0388-0; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Xia QX, 2009, LITHOS, V112, P477, DOI 10.1016/j.lithos.2009.04.015; Wang XC, 2012, PRECAMBRIAN RES, V222, P386, DOI 10.1016/j.precamres.2011.06.001; WHITE R, 1989, J GEOPHYS RES-SOLID, V94, P7685, DOI 10.1029/JB094iB06p07685; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Li XH, 2014, GONDWANA RES, V25, P1202, DOI 10.1016/j.gr.2014.01.003; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Kim SW, 2014, GONDWANA RES, V26, P1009, DOI 10.1016/j.gr.2013.08.020; Said N, 2010, LITHOS, V115, P82, DOI 10.1016/j.lithos.2009.11.008; Yuan HL, 2004, GEOSTAND GEOANAL RES, V28, P353, DOI 10.1111/j.1751-908X.2004.tb00755.x; Jiao WF, 2009, SCI CHINA SER D, V52, P1393, DOI [10.1007/S11430-009-0135-7, 10.1007/s11430-009-0135-7]; HART WK, 1989, J GEOPHYS RES-SOLID, V94, P7731, DOI 10.1029/JB094iB06p07731; Li WX, 2005, PRECAMBRIAN RES, V136, P51, DOI 10.1016/j.precamres.2004.09.008; Li XH, 2006, PRECAMBRIAN RES, V146, P1, DOI 10.1016/j.precamres.2005.12.007; Gao S, 2011, AM J SCI, V311, P153, DOI 10.2475/02.2011.03; Zhu G, 2009, INT J EARTH SCI, V98, P135, DOI 10.1007/s00531-007-0225-8; Polat A, 2003, PRECAMBRIAN RES, V126, P197, DOI 10.1016/S0301-9268(03)00095-0; Yao JL, 2014, PRECAMBRIAN RES, V243, P39, DOI 10.1016/j.precamres.2013.12.027; Zhao GC, 2012, PRECAMBRIAN RES, V222, P13, DOI 10.1016/j.precamres.2012.09.017; Cawood PA, 2013, GEOLOGY, V41, P903, DOI 10.1130/G34395.1; Wu YB, 2008, CONTRIB MINERAL PETR, V155, P123, DOI 10.1007/s00410-007-0231-7; Watson EB, 2006, CONTRIB MINERAL PETR, V151, P413, DOI 10.1007/s00410-006-0068-5; Zhou MF, 2006, EARTH PLANET SC LETT, V248, P286, DOI 10.1016/j.epsl.2006.05.032; Wang XL, 2007, PRECAMBRIAN RES, V159, P117, DOI 10.1016/j.precamres.2007.06.005; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P51, DOI 10.1016/S0012-821X(01)00595-7; Li XH, 2003, PRECAMBRIAN RES, V122, P45, DOI 10.1016/S0301-9268(02)00207-3; Zhao GC, 1999, AM J SCI, V299, P309, DOI 10.2475/ajs.299.4.309; Rubatto D, 2002, CHEM GEOL, V184, P123, DOI 10.1016/S0009-2541(01)00355-2; Liu FL, 2012, GONDWANA RES, V22, P169, DOI 10.1016/j.gr.2011.11.007; BATCHELOR RA, 1985, CHEM GEOL, V48, P43, DOI 10.1016/0009-2541(85)90034-8; PEARCE JA, 1973, EARTH PLANET SC LETT, V19, P290, DOI 10.1016/0012-821X(73)90129-5; Aulbach S, 2008, NAT GEOSCI, V1, P468, DOI 10.1038/ngeo226; LI ZX, 1994, GEOLOGY, V22, P739, DOI 10.1130/0091-7613(1994)022<0739:CBTNAS>2.3.CO;2; Yao JL, 2013, J ASIAN EARTH SCI, V74, P225, DOI 10.1016/j.jseaes.2013.08.010; Zack T, 2002, J PETROL, V43, P1947, DOI 10.1093/petrology/43.10.1947; Nowell GM, 1998, CHEM GEOL, V149, P211, DOI 10.1016/S0009-2541(98)00036-9; Zhu G, 2010, J GEOL, V118, P277, DOI 10.1086/651540; Chen YX, 2014, AM J SCI, V314, P357, DOI 10.2475/01.2014.10; MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2; Xiong XL, 2011, GEOCHIM COSMOCHIM AC, V75, P1673, DOI 10.1016/j.gca.2010.06.039; Xu XB, 2014, GONDWANA RES, V25, P368, DOI 10.1016/j.gr.2013.03.020; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; Klemme S, 2005, GEOCHIM COSMOCHIM AC, V69, P2361, DOI 10.1016/j.gca.2004.11.015; Black LP, 2003, CHEM GEOL, V200, P155, DOI 10.1016/S0009-2541(03)00165-7; Hoskin PWO, 2000, J METAMORPH GEOL, V18, P423; Liu L, 2014, J ASIAN EARTH SCI, V89, P123, DOI 10.1016/j.jseaes.2014.04.003; Rubatto D, 2009, CONTRIB MINERAL PETR, V158, P703, DOI 10.1007/s00410-009-0406-5; Wang XL, 2004, PRECAMBRIAN RES, V135, P79, DOI 10.1016/j.precamres.2004.07.006; Kang T, 2013, ACTA PETROL SIN, V29, P3142; Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; Barth MG, 2000, CHEM GEOL, V165, P197, DOI 10.1016/S0009-2541(99)00173-4; Griffin WL, 2000, GEOCHIM COSMOCHIM AC, V64, P133, DOI 10.1016/S0016-7037(99)00343-9; Zhang SB, 2013, GONDWANA RES, V23, P1241, DOI 10.1016/j.gr.2012.09.005; Schmidt MW, 2004, EARTH PLANET SC LETT, V226, P415, DOI 10.1016/j.epsl.2004.08.010; Lin W, 2009, LITHOS, V109, P285, DOI 10.1016/j.lithos.2008.10.007; Niu ML, 2010, ACTA PETROL SIN, V26, P2783; Xia QX, 2010, LITHOS, V114, P385, DOI 10.1016/j.lithos.2009.09.013; XU JW, 1987, TECTONOPHYSICS, V134, P273, DOI 10.1016/0040-1951(87)90342-8; Wang XC, 2007, GEOLOGY, V35, P1103, DOI 10.1130/G23878A.1; Li XH, 2008, LITHOS, V102, P341, DOI 10.1016/j.lithos.2007.04.007; Zhou MF, 2006, PRECAMBRIAN RES, V144, P19, DOI 10.1016/j.precamres.2005.11.002; Liu YC, 2011, LITHOS, V122, P107, DOI 10.1016/j.lithos.2010.12.005; COMPSTON W, 1992, J GEOL SOC LONDON, V149, P171, DOI 10.1144/gsjgs.149.2.0171; Rubatto D, 2007, ELEMENTS, V3, P31, DOI 10.2113/gselements.3.1.31; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; Peccerillo A, 2003, J PETROL, V44, P2003, DOI 10.1093/petrology/egg068; Zhang Q, 2007, GEOL SOC AM SPEC PAP, V434, P167, DOI 10.1130/2007.2434(09); Yao JL, 2011, GONDWANA RES, V20, P553, DOI 10.1016/j.gr.2011.01.005; Lin W, 2005, J ASIAN EARTH SCI, V25, P121, DOI 10.1016/j.jseaes.2004.01.014; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Schaltegger U, 1999, CONTRIB MINERAL PETR, V134, P186, DOI 10.1007/s004100050478; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; Polat A, 2002, CHEM GEOL, V184, P231, DOI 10.1016/S0009-2541(01)00363-1; Xia QX, 2008, CHEM GEOL, V247, P36, DOI 10.1016/j.chemgeo.2007.09.013; Zhang SB, 2009, LITHOS, V113, P347, DOI 10.1016/j.lithos.2009.04.024; Foley SF, 2000, GEOCHIM COSMOCHIM AC, V64, P933, DOI 10.1016/S0016-7037(99)00355-5; Li ZX, 2003, PRECAMBRIAN RES, V122, P85, DOI 10.1016/S0301-9268(02)00208-5; Liu DY, 2006, EARTH PLANET SC LETT, V250, P650, DOI 10.1016/j.epsl.2006.07.043; Zheng YF, 2005, EARTH PLANET SC LETT, V240, P378, DOI 10.1016/j.epsl.2005.09.025; Zheng YF, 2006, CHEM GEOL, V231, P135, DOI 10.1016/j.chemgeo.2006.01.005; Shi YH, 2009, ACTA PETROL SIN, V25, P3335; Wang J, 2003, PRECAMBRIAN RES, V122, P141, DOI 10.1016/S0301-9268(02)00209-7; Xiong XL, 2005, CHEM GEOL, V218, P339, DOI 10.1016/j.chemgeo.2005.01.014; EBY GN, 1990, LITHOS, V26, P115, DOI 10.1016/0024-4937(90)90043-Z; Li WX, 2010, AM J SCI, V310, P951, DOI 10.2475/09.2010.08; Watkins JM, 2007, CONTRIB MINERAL PETR, V154, P91, DOI 10.1007/s00410-007-0181-0; Arndt N.T., 1994, ARCHEAN CRUSTAL EVOL, P11; Hanchar J.M., 2003, ZIRCON REV MINERAL G, V16, P1; Jing Y., 1991, PRECAMBRIAN HIGH PRE, P1; Kelemen PB, 2003, TREATISE GEOCHEMISTR, V3, P593, DOI DOI 10.1016/B0-08-043751-6/03035-8; Li X.H., 2002, SCI CHINA SER D, V32, P60; Li Xian-hua, 2012, Bulletin of Mineralogy, Petrology and Geochemistry, V31; Liu L., 2014, CONTRIB MINERAL PETR, V167, P1; Loiselle M.C., 1979, ANN M GEOL SOC AM AS, V11, P468; Ludwig K.R., 2001, BERKLEY GEOCHRONOL A, P55; Pearce JA, 1996, TRACE ELEMENT GEOCHE, V12, P79; Rudnick RL, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Tong J.S., 2000, GEOL ANHUI, V10, P9; Wang XL, 2014, CHEM GEOL, V389, P122, DOI 10.1016/j.chemgeo.2014.09.013; Wang XL, 2014, PRECAMBRIAN RES, V242, P154, DOI 10.1016/j.precamres.2013.12.023; WATSON EB, 1983, EARTH PLANET SC LETT, V64, P295, DOI 10.1016/0012-821X(83)90211-X; Whalen J.B., 1987, CONTRIB MINERAL PETR, V95, P405; Whitehouse MJ, 2003, CONTRIB MINERAL PETR, V145, P61, DOI 10.1007/s00410-002-0432-z; Williams I. S., 1998, REV EC GEOLOGY, V7, P1; Xiao L, 2007, LITHOS, V95, P399, DOI DOI 10.1016/J.LITH0S; Xu W., 2002, GEOL ANHUI, V12, P25; Zhao G.C, 2014, GONDWANA RES; [朱光 Zhu Guang], 2002, [地质学报, Acta Geologica Sinica], V76, P325	137	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-9268	1872-7433		PRECAMBRIAN RES	Precambrian Res.	OCT	2015	268						97	114		10.1016/j.precamres.2015.07.004		18	Geosciences, Multidisciplinary	Geology	CS5WF	WOS:000362148300006		
J	Krah, A				Krah, Alexander			Linking structural features from mitochondrial and bacterial F-type ATP synthases to their distinct mechanisms of ATPase inhibition	PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY			English	Review						F-type ATP synthase; F-1-domain; IF1-inhibition; epsilon inhibition	BOVINE HEART-MITOCHONDRIA; THERMOPHILIC BACILLUS PS3; ISOLATED EPSILON-SUBUNIT; F-1-ATPASE BINDS ATP; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; CROSS-LINKING; DELTA-SUBUNIT; CRYSTAL-STRUCTURE; CATALYTIC SITE	ATP synthases are molecular motors, which synthesize ATP, the ubiquitous energy source in all living cells. They use an electrochemical gradient to drive a rotation in the membrane embedded F-0 domain, namely the c-ring, causing a conformational change in the soluble F-1 domain which leads to the catalytic event. In the opposite fashion, they can also hydrolyse ATP to maintain the ion gradient across the membrane. To prevent wasteful ATP hydrolysis, bacteria and mammals have developed peculiar mechanistic features in addition to a common one, namely MgADP inhibition. Here I discuss the distinct ATPase inhibition mechanism in mitochondrial (IF1) and bacterial (subunits epsilon and zeta) F-type ATP synthases, based on available structural, biophysical and biochemical data. (C) 2015 Elsevier Ltd. All rights reserved.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	Krah, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	krah@theory.biophys.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [P13705]	I would like to thank Peter J. Bond (A*STAR Bioinformatics Institute, Singapore) for carefully reading the manuscript and Shoji Takada (Kyoto University) for his continuous support during my stay in his group. This work was supported by a Postdoctoral Fellowship for Foreign Researchers of the Japan Society for the Promotion of Science (JSPS-ID: P13705).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Silverstein TP, 2014, J BIOENERG BIOMEMBR, V46, P229, DOI 10.1007/s10863-014-9547-y; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; FEARNLEY IM, 1986, EMBO J, V5, P2003; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Priya R, 2013, J BIOENERG BIOMEMBR, V45, P121, DOI 10.1007/s10863-012-9486-4; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Lee J, 2015, J BIOL CHEM, V290, P13308, DOI 10.1074/jbc.M115.645283; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; Ichikawa N, 2001, J BIOCHEM-TOKYO, V130, P687; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; McLachlin DT, 1998, J BIOL CHEM, V273, P15162, DOI 10.1074/jbc.273.24.15162; Zarco-Zavala M, 2014, FASEB J, V28, P2146, DOI 10.1096/fj.13-241430; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; Havlickova V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009; Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513; Ito Y, 2015, BIOPHYS J, V108, P85, DOI 10.1016/j.bpj.2014.11.1853; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Krah A, 2015, BBA-BIOENERGETICS, V1847, P1101, DOI 10.1016/j.bbabio.2015.05.018; GAY NJ, 1981, NUCLEIC ACIDS RES, V9, P3919, DOI 10.1093/nar/9.16.3919; YAMADA EW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P143, DOI 10.1016/0925-4439(92)90093-3; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Rubinstein JL, 2002, J MOL BIOL, V321, P613, DOI 10.1016/S0022-2836(02)00671-X; Koga N, 2006, P NATL ACAD SCI USA, V103, P5367, DOI 10.1073/pnas.0509642103; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Jones PC, 2000, J BIOL CHEM, V275, P31340, DOI 10.1074/jbc.M003687200; Wu Q, 2014, BBA-BIOENERGETICS, V1837, P761, DOI 10.1016/j.bbabio.2014.01.023; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; vanRaaij MJ, 1996, BIOCHEMISTRY-US, V35, P15618, DOI 10.1021/bi960628f; Bockmann RA, 2002, NAT STRUCT BIOL, V9, P198, DOI 10.1038/nsb760; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; ZHANG Y, 1995, J BIOL CHEM, V270, P24609; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; Serrano P, 2014, J MOL BIOL, V426, P2547, DOI 10.1016/j.jmb.2014.05.004; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Biukovic G, 2013, ANTIMICROB AGENTS CH, V57, P168, DOI 10.1128/AAC.01039-12; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Hilbers F, 2013, J BIOL CHEM, V288, P25880, DOI 10.1074/jbc.M113.484675; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Abrahams JP, 1996, P NATL ACAD SCI USA, V93, P9420, DOI 10.1073/pnas.93.18.9420; DeLeon-Rangel J, 2013, FEBS LETT, V587, P892, DOI 10.1016/j.febslet.2013.02.012; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Bason John V, 2011, J Mol Biol, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; Faccenda D., 2012, INT J CELL BIOL; Haruyama T., 2010, BIOPHYSICS-USSR, P59; Ho J., 2015, J MOL BIOL; Iino R., 2005, J BIOL CHEM, V280, P40130, DOI DOI 10.1074/JBC.M506160200; Mizumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073888; Okazaki K, 2013, P NATL ACAD SCI USA, V110, P16468, DOI 10.1073/pnas.1305497110; Preiss L, 2015, SCI ADV, V1, DOI [10.1126/sciadv.1500106, DOI 10.1126/SCIADV.1500106]; Robinson G. C., 2013, OPEN BIOL, V3; Runswick MJ., 2013, OPEN BIOL, V3; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; WALKER JE, 1982, FEBS LETT, V146, P393, DOI 10.1016/0014-5793(82)80960-5; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007	114	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0079-6107			PROG BIOPHYS MOL BIO	Prog. Biophys. Mol. Biol.	OCT	2015	119	1					94	102		10.1016/j.pbiomolbio.2015.06.005		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS2VC	WOS:000361929100012		
J	Kunugi, H; Hori, H; Ogawa, S				Kunugi, Hiroshi; Hori, Hiroaki; Ogawa, Shintaro			Biochemical markers subtyping major depressive disorder	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						dopamine; hypothalamic-pituitary-adrenal axis; inflammation; stress; tryptophan	DEXAMETHASONE-SUPPRESSION TEST; PITUITARY-ADRENAL AXIS; CSF AMINE METABOLITES; ALPHA-INDUCED CHANGES; PLASMA L-TRYPTOPHAN; C-REACTIVE PROTEIN; DEX-CRH TEST; MONOAMINE METABOLITES; CORTISOL RESPONSE; HOMOVANILLIC-ACID	The pathophysiology of major depressive disorder (MDD) remains elusive, and there is no established biochemical marker used in the daily clinical setting. This situation may result in part from the heterogeneity of MDD, which might include heterogeneous subgroups with different biological mechanisms. In this review, we discuss three promising biological systems/markers to potentially subtype MDD: the dopamine system, the hypothalamic-pituitary-adrenal axis, and chronic inflammatory markers. Several lines of evidence suggest that a facet of MDD is a dopamine agonist-responsive subtype. Focusing on the hypothalamic-pituitary-adrenal axis, depressive spectrum disorders show hypercortisolism to hypocortisolism, which could be detected by hormonal challenge tests, such as the dexamethasone/corticotrophin-releasing hormone test. Finally, accumulating evidence suggests that at least some MDD patients show characteristics similar to those of chronic inflammatory diseases, including neuroinflammatory markers and reduced tryptophan due to the increased activation of the tryptophan-kynurenine pathway. Future studies should examine the inter-relations between these systems/markers to subtype and integrate the pathophysiology of MDD.	[Kunugi, Hiroshi; Hori, Hiroaki; Ogawa, Shintaro] Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Natl Inst Neurosci, Tokyo, Japan	Kunugi, H (reprint author), Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Natl Inst Neurosci, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	hkunugi@ncnp.go.jp			NCNP [24-11]; Japan Society for the Promotion of Science (JSPS) [25253075]	This study was supported by the Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (24-11) and a Grant-in-Aid for Scientific Research (A) (25253075) from the Japan Society for the Promotion of Science (JSPS). All authors declare that they have no conflicts of interest.	ELCHISAK MA, 1978, LIFE SCI, V23, P2339, DOI 10.1016/0024-3205(78)90200-X; Watson S, 2006, PSYCHONEUROENDOCRINO, V31, P889, DOI 10.1016/j.psyneuen.2006.03.001; ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193; Hori H, 2014, J AFFECT DISORDERS, V152, P441, DOI 10.1016/j.jad.2013.10.013; Gaab J, 2002, PSYCHOSOM MED, V64, P311; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Hori H, 2012, SCI WORLD J, DOI 10.1100/2012/372474; RUBIN RT, 1995, ARCH GEN PSYCHIAT, V52, P213; Yehuda R, 2004, PSYCHONEUROENDOCRINO, V29, P389, DOI 10.1016/S0306-4530(03)00052-0; SCHEININ H, 1987, PHARMACOL TOXICOL, V61, P167; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; HOLSBOER F, 1987, BIOL PSYCHIAT, V22, P228, DOI 10.1016/0006-3223(87)90237-X; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Kunugi H, 2010, PSYCHIAT CLIN NEUROS, V64, P447, DOI 10.1111/j.1440-1819.2010.02135.x; DEBELLIS MD, 1993, BIOL PSYCHIAT, V33, P636, DOI 10.1016/0006-3223(93)90103-K; Sublette ME, 2011, BRAIN BEHAV IMMUN, V25, P1272, DOI 10.1016/j.bbi.2011.05.002; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; CHEETHAM SC, 1989, BRAIN RES, V502, P332, DOI 10.1016/0006-8993(89)90629-X; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; GREDEN JF, 1983, ARCH GEN PSYCHIAT, V40, P493; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Wahlberg K, 2009, BIOL PSYCHIAT, V65, P742, DOI 10.1016/j.biopsych.2008.10.035; MIGNOT E, 1984, J NEUROCHEM, V42, P819, DOI 10.1111/j.1471-4159.1984.tb02754.x; Schreiber W, 1996, NEUROPSYCHOPHARMACOL, V15, P7, DOI 10.1016/0893-133X(95)00146-5; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Sasayama D, 2013, J PSYCHIATR RES, V47, P401, DOI 10.1016/j.jpsychires.2012.12.001; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Gervasoni N, 2004, J PSYCHIAT RES, V38, P553, DOI 10.1016/j.jpsychires.2004.04.008; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; Hatzinger M, 2002, J PSYCHIAT RES, V36, P287, DOI 10.1016/S0022-3956(02)00021-3; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Zobel AW, 1999, AM J PSYCHIAT, V156, P949; Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Aiken CB, 2007, J CLIN PSYCHIAT, V68, P1230; Van Den Eede F, 2006, J AFFECT DISORDERS, V93, P259, DOI 10.1016/j.jad.2006.03.020; MELLSOP GW, 1985, BRIT MED J, V290, P1804; Chiba S, 2010, PSYCHOPHARMACOLOGY, V211, P291, DOI 10.1007/s00213-010-1894-8; Carpenter LL, 2009, PSYCHONEUROENDOCRINO, V34, P1208, DOI 10.1016/j.psyneuen.2009.03.009; SCHATZBERG AF, 1984, PSYCHOPHARMACOL BULL, V20, P362; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271; Appelhof BC, 2006, BIOL PSYCHIAT, V59, P696, DOI 10.1016/j.biopsych.2005.09.008; TANDA G, 1994, PSYCHOPHARMACOLOGY, V115, P285, DOI 10.1007/BF02244785; MAES M, 1990, ACTA PSYCHIAT SCAND, V81, P19, DOI 10.1111/j.1600-0447.1990.tb06443.x; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Wingenfeld K, 2007, J PSYCHOSOM RES, V62, P85, DOI 10.1016/j.jpsychores.2006.06.006; CEULEMANS DLS, 1985, PSYCHIAT RES, V14, P189, DOI 10.1016/0165-1781(85)90013-7; Kaestner F, 2005, J AFFECT DISORDERS, V87, P305, DOI 10.1016/j.jad.2005.03.012; Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144; Kunzel HE, 2003, NEUROPSYCHOPHARMACOL, V28, P2169, DOI 10.1038/sj.npp.1300280; Aubry JM, 2007, J PSYCHIAT RES, V41, P290, DOI 10.1016/j.jpsychires.2006.07.007; Hori H, 2013, J AFFECT DISORDERS, V147, P128, DOI 10.1016/j.jad.2012.10.022; Levitan RD, 2002, J PSYCHIATR NEUROSCI, V27, P47; HOLSBOER F, 1982, J AFFECT DISORDERS, V4, P93, DOI 10.1016/0165-0327(82)90039-8; SALTER M, 1985, BIOCHEM J, V229, P499; Maes M, 2012, PSYCHIAT RES, V196, P243, DOI 10.1016/j.psychres.2011.09.029; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Hori H, 2013, PSYCHOGERIATRICS, V13, P189, DOI 10.1111/psyg.12014; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Kunugi H, 2004, J PSYCHIAT RES, V38, P123, DOI 10.1016/S0022-3956(03)00103-1; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; PEABODY CA, 1987, PSYCHIAT RES, V21, P1, DOI 10.1016/0165-1781(87)90056-4; KASA K, 1982, BIOL PSYCHIAT, V17, P877; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Weber J, 2008, CNS DRUGS, V22, P807, DOI 10.2165/00023210-200822100-00002; Baghai TC, 2002, PSYCHONEUROENDOCRINO, V27, P385, DOI 10.1016/S0306-4530(01)00060-9; GJERRIS A, 1987, J AFFECT DISORDERS, V13, P279, DOI 10.1016/0165-0327(87)90048-6; Capuron L, 2003, BIOL PSYCHIAT, V54, P906, DOI 10.1016/S0006-3223(03)00173-2; Rinne T, 2002, BIOL PSYCHIAT, V52, P1102, DOI 10.1016/S0006-3223(02)01395-1; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Kamijima K, 2013, J AFFECT DISORDERS, V151, P899, DOI 10.1016/j.jad.2013.07.035; Ara I, 2012, PHARMACOL REP, V64, P558; Hiles SA, 2012, PSYCHOL MED, V42, P2015, DOI 10.1017/S0033291712000128; BROWN GL, 1982, AM J PSYCHIAT, V139, P741; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Gillihan SJ, 2011, J CLIN PSYCHIAT, V72, P1383, DOI 10.4088/JCP.10r06332gre; DEGRELL I, 1990, BIOL PSYCHIAT, V27, P1179, DOI 10.1016/0006-3223(90)90055-7; REDDY PL, 1992, BIOL PSYCHIAT, V31, P112; Watson S, 2002, PSYCHOL MED, V32, P1021, DOI 10.1017/S0033291702005998; MOLCHAN SE, 1991, BIOL PSYCHIAT, V29, P1110, DOI 10.1016/0006-3223(91)90253-I; Xu HB, 2012, PSYCHIAT RES, V200, P1054, DOI 10.1016/j.psychres.2012.05.027; Bonaccorso S, 2002, J CLIN PSYCHOPHARM, V22, P86, DOI 10.1097/00004714-200202000-00014; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Veen G, 2009, EUR NEUROPSYCHOPHARM, V19, P409, DOI 10.1016/j.euroneuro.2009.02.007; MacMaster FP, 2004, J PSYCHIAT RES, V38, P231, DOI 10.1016/j.jpsychires.2003.11.001; ASBERG M, 1984, ACTA PSYCHIAT SCAND, V69, P201, DOI 10.1111/j.1600-0447.1984.tb02488.x; Bertolote José Manoel, 2004, Crisis, V25, P147, DOI 10.1027/0227-5910.25.4.147; BRADDOCK L, 1986, BRIT J PSYCHIAT, V148, P363, DOI 10.1192/bjp.148.4.363; CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Cowen PJ, 2009, UNDERSTANDING DEPRES, P171; DEROGATI.LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Horia H, 2010, J PSYCHIATR RES, V44, P865, DOI 10.1016/j.jpsychires.2010.02.007; Ogawa S, 2014, J CLIN PSYCHIAT, V75, pE906, DOI 10.4088/JCP.13r08908; Rydmark Ingrid, 2006, Biol Psychiatry, V60, P867, DOI 10.1016/j.biopsych.2006.04.029	100	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	OCT	2015	69	10					597	608		10.1111/pcn.12299		12	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CS9NY	WOS:000362419000001		
J	Inoue, Y; Yagi, K; Ikeda, A; Sasagawa, M; Ishida, S; Suzuki, A; Yoshida, K				Inoue, Yushi; Yagi, Kazuichi; Ikeda, Akio; Sasagawa, Mutsuo; Ishida, Shigenobu; Suzuki, Atsushi; Yoshida, Katsumi		Japan Levetiracetam N01221 Study G	Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						adjunctive therapy; antiepileptic drug; efficacy; levetiracetam; partial-onset seizures	REFRACTORY PARTIAL SEIZURES; PLACEBO-CONTROLLED TRIAL; MULTICENTER DOUBLE-BLIND; ADD-ON THERAPY; 2000 MG/DAY; EPILEPSY; DISABILITY; BINDING; PROTEIN; SAFETY	AimsThe aim of this study was to confirm the efficacy and safety of adjunctive levetiracetam in adult Japanese patients with uncontrolled partial-onset seizures. MethodsIn a double-blind, placebo-controlled, confirmatory trial, eligible patients were randomized to receive levetiracetam 500, 1000, 2000, or 3000mg/day or placebo for 16 weeks. The primary end-point was percentage reduction from baseline in seizure frequency/week over a 12-week evaluation period. Tolerability assessments were also conducted. Findings of this and a previous randomized, double-blind trial were compared. ResultsOf 401 patients screened, 352 were randomized and 316 completed the study. Median percentage reduction in seizure frequency/week from baseline was 12.92%, 18.00%, 11.11% and 31.67% in the levetiracetam 500, 1000, 2000 and 3000-mg groups, respectively, compared with 12.50% in the placebo group. Unlike the previous trial, the primary efficacy analysis between the levetiracetam 1000 and 3000-mg and placebo groups did not reach statistical significance (P=0.067). Exploratory analyses demonstrated that the difference in seizure reduction versus placebo was 14.93% (95% confidence interval, 1.98-27.64; P=0.025) for the levetiracetam 3000-mg group. All levetiracetam doses were well tolerated. The main difference between the two trials was a high placebo response in the present trial. ConclusionsThe primary efficacy analysis did not reach statistical significance, a finding that could be attributed to an unexpectedly high placebo response. Nonetheless, exploratory analysis suggests that levetiracetam at 3000mg/day may, at least marginally, be beneficial for patients with uncontrolled partial-onset seizures.	[Inoue, Yushi; Yagi, Kazuichi] Shizuoka Inst Epilepsy & Neurol Disorders, NHO, Shizuoka 4208688, Japan; [Yagi, Kazuichi] Yaizu Hosp, Yaizu, Shizuoka, Japan; [Ikeda, Akio] Kyoto Univ, Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto 606, Japan; [Sasagawa, Mutsuo] Toyosato Hosp, Tsukuba, Ibaraki, Japan; [Ishida, Shigenobu] Akeno Med Clin, Ohita, Japan; [Suzuki, Atsushi; Yoshida, Katsumi] UCB Pharma, Tokyo, Japan	Inoue, Y (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Aoi Ku, Urushiyama 886, Shizuoka 4208688, Japan.	yinoue-jes@umin.net		Ikeda, Akio/0000-0002-0790-2598	UCB Pharma; Dainippon-Sumitomo; UCB; Otsuka; GSK; Kyowa-Kirin	This trial was sponsored by UCB Pharma. Atsushi Suzuki and Katsumi Yoshida are employees of UCB Pharma. According to the Conflict of Interest guidelines of The Japan Epilepsy Society, Dr Inoue reports receiving writing fees from Dainippon-Sumitomo; Dr Yagi, consulting fees from UCB and honoraria and speaking fees from Dainippon-Sumitomo, Kyowa-Kirin and Otsuka; Dr Sasagawa, speaker fees from Otsuka, GSK and Kyowa-Kirin; Dr Ishida, speaker fees from Otsuka and GSK; and Dr Ikeda, grant support and speaker fees from Dainippon-Sumitomo, Kyowa-Kirin, UCB Pharma, GSK and Otsuka. Dr Ikeda is a recipient of an endowed chair supported by multiple companies, including UCB Pharma, but not at the time when this trial was being conducted and data finalized. Other authors have no conflicts of interest to report. The authors thank Max Frenzel PhD (QXV Communications, Macclesfield, UK) and Azita Tofighy PhD, UCB Pharma, for assistance with writing the manuscript, and Mayumi Yamada PhD UCB Pharma, for coordinating manuscript preparation.	Mula M, 2003, NEUROLOGY, V61, P704; Wu XY, 2009, EPILEPSIA, V50, P398, DOI 10.1111/j.1528-1167.2008.01729.x; Pina-Garza JE, 2009, EPILEPSIA, V50, P1141, DOI 10.1111/j.1528-1167.2008.01981.x; White JR, 2003, NEUROLOGY, V61, P1218; Shorvon SD, 2000, EPILEPSIA, V41, P1179, DOI 10.1111/j.1528-1157.2000.tb00323.x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Bowley C, 2000, J INTELL DISABIL RES, V44, P529, DOI 10.1046/j.1365-2788.2000.00270.x; Cereghino JJ, 2000, NEUROLOGY, V55, P236; Kaminski RM, 2008, NEUROPHARMACOLOGY, V54, P715, DOI 10.1016/j.neuropharm.2007.11.021; Martin JP, 2009, EPILEPSY BEHAV, V15, pS64, DOI 10.1016/j.yebeh.2009.03.017; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Sillanpaa M, 2004, EPILEPSY BEHAV, V5, P937, DOI 10.1016/j.yebeh.2004.08.008; Glauser TA, 2006, NEUROLOGY, V66, P1654, DOI 10.1212/01.wnl.0000217916.00225.3a; Tsai JJ, 2006, EPILEPSIA, V47, P72, DOI 10.1111/j.1528-1167.2006.00372.x; Boon P, 2002, EPILEPSY RES, V48, P77, DOI 10.1016/S0920-1211(01)00323-0; Beavis J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858; desBoer HM, 2008, EPILEPSY BEHAV, V12, P540; Heo K, 2007, SEIZURE-EUR J EPILEP, V16, P402, DOI 10.1016/j.seizure.2007.02.011; BANCAUD J, 1981, EPILEPSIA, V22, P489; Stockis Armel, 2009, Expert Rev Clin Pharmacol, V2, P339, DOI 10.1586/ecp.09.16; Yagi K, 2010, J JPN EPIL SOC, V28, P3	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	OCT	2015	69	10					640	648		10.1111/pcn.12300		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CS9NY	WOS:000362419000005		
J	Tateno, M; Teo, AR; Tateno, Y				Tateno, Masaru; Teo, Alan R.; Tateno, Yukie			Eleven-year follow up of boy with Asperger's syndrome and comorbid gender identity disorder of childhood	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Tateno, Masaru; Tateno, Yukie] Sapporo Med Univ, Tokiwa Child Dev Ctr, Tokiwa Hosp, Sapporo, Hokkaido, Japan; [Tateno, Masaru] Sapporo Med Univ, Sch Med, Dept Neuropsychiat, Sapporo, Hokkaido, Japan; [Teo, Alan R.] Oregon Hlth & Sci Univ, Ctr Improve Vet Involvement Care, VA Portland Hlth Care Syst, Portland, OR 97201 USA; [Teo, Alan R.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	Tateno, M (reprint author), Sapporo Med Univ, Tokiwa Child Dev Ctr, Tokiwa Hosp, Sapporo, Hokkaido, Japan.	tatema@sapmed.ac.jp					Tateno M, 2008, PSYCHIAT CLIN NEUROS, V62, P238, DOI 10.1111/j.1440-1819.2008.01761.x; APA, 2013, DIAGN STAT MAN MENT; desVries AL, 2010, J AUTISM DEV DISORD, V40, P930	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	OCT	2015	69	10					658	658		10.1111/pcn.12328		1	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CS9NY	WOS:000362419000007		
J	Tomoda, A; Takiguchi, S; Fujisawa, TX; Yatsuga, C; Kumazaki, H; Fujioka, T; Suzuki, H; Matsuzaki, H; Kosaka, H; Tanaka, S				Tomoda, Akemi; Takiguchi, Shinichiro; Fujisawa, Takashi X.; Yatsuga, Chiho; Kumazaki, Hirokazu; Fujioka, Toru; Suzuki, Hitomi; Matsuzaki, Hideo; Kosaka, Hirotaka; Tanaka, Shiho			Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4-week, open-label clinical study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Tomoda, Akemi; Takiguchi, Shinichiro; Fujisawa, Takashi X.; Yatsuga, Chiho; Kumazaki, Hirokazu; Fujioka, Toru; Matsuzaki, Hideo; Kosaka, Hirotaka; Tanaka, Shiho] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Tomoda, Akemi; Takiguchi, Shinichiro; Yatsuga, Chiho; Kumazaki, Hirokazu; Fujioka, Toru; Suzuki, Hitomi; Matsuzaki, Hideo; Kosaka, Hirotaka] Univ Fukui Hosp, Dept Child & Adolescent Psychol Med, Fukui, Japan	Tomoda, A (reprint author), Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan.						American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Pliszka SR, 2005, BIOL PSYCHIAT, V57, P1385, DOI 10.1016/j.biopsych.2004.08.026; Takahama K., 2009, V187, P219; Sasaki T, 2014, NEUROPSYCH DIS TREAT, V10, P147, DOI 10.2147/NDT.S58480	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	OCT	2015	69	10					658	659		10.1111/pcn.12336		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CS9NY	WOS:000362419000008		
J	Vivat, B; Young, T; Winstanley, J; Arraras, JI; Black, K; Bredart, A; Costantini, A; Fisher, S; Guo, JB; Irarrazaval, ME; Kobayashi, K; Kruizinga, R; Navarro, M; Omidvari, S; Rohde, G; Serpentini, S; Spry, N; van Laarhoven, HW; Yang, G				Vivat, Bella; Young, Teresa; Winstanley, Julie; Arraras, Juan I.; Black, Kath; Bredart, Anne; Costantini, Anna; Fisher, Sheila; Guo, Jingbo; Irarrazaval, M. Elisa; Kobayashi, Kunihiko; Kruizinga, Renske; Navarro, Mariana; Omidvari, Sepideh; Rohde, Gudrun; Serpentini, Samantha; Spry, Nigel; van Laarhoven, Hanneke W.; Yang, Grace			Is there a relationship between spiritual wellbeing (SWB) and QOL? Findings from international validation of the EORTC QLQ-SWB32	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Vivat, Bella] UCL, London, England; [Young, Teresa] Mt Vernon Canc Ctr, Lynda Jackson Macmillan Ctr, Northwood, Middx, England; [Winstanley, Julie] Patricia Ritchie Ctr Canc Care & Res, Sydney, NSW, Australia; [Arraras, Juan I.] Complejo Hosp Navarra, Dept Oncol, Pamplona, Spain; [Black, Kath] St Gemmas Hosp, Leeds, W Yorkshire, England; [Bredart, Anne] Inst Curie, Psychiat & Psychooncol Unit, Paris, France; [Costantini, Anna] Dept Oncol Sci, Psychoncol Unit, Rome, Italy; [Fisher, Sheila] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Guo, Jingbo] China Med Univ, Shengjing Hosp, Palliat Ward, Shenyang, Liaoning, Peoples R China; [Irarrazaval, M. Elisa] Ctr Los Juncos, Santiago, Chile; [Kobayashi, Kunihiko] Saitama Int Med Ctr, Dept Resp Med, Hidaka City, Japan; [Kruizinga, Renske] Univ Amsterdam, Acad Med Ctr, Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [Navarro, Mariana] Inst Nacl Cancerol, Mexico City, DF, Mexico; [Omidvari, Sepideh] Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, ACECR, Tehran, Iran; [Omidvari, Sepideh] Canc Inst Iran, Canc Res Ctr, TUMS, Tehran, Iran; [Rohde, Gudrun] Univ Agder, Fac Hlth & Sport Sci, Dept Clin Res, Kristiansand, Norway; [Rohde, Gudrun] Sorlandet Hosp, Kristiansand, Norway; [Serpentini, Samantha] IOV IRCCS, Psychoncol Unit, Padua, Italy; [Serpentini, Samantha] Azienda Ulss 3, Psychoncol Serv, Bassano Del Grappa, Italy; [Spry, Nigel] Sir Charles Gairdner Hosp, Canc Ctr Radiat Oncol, Nedlands, WA 6009, Australia; [van Laarhoven, Hanneke W.] Univ Amsterdam, Acad Med Ctr, Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [Yang, Grace] Natl Canc Ctr, Singapore, Singapore								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		101.5	13	13				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100037		
J	King, M; Stockler, M; O'Connell, R; Joly, F; Lanceley, A; Hilpert, F; Okamoto, A; Aotani, E; Pignata, S; Donnellan, P; Oza, A; Avall-Lundqvist, E; Berek, J; Buizen, L; Sjoquist, K; Gillies, K; Butow, P; Friedlander, M				King, Madeleine; Stockler, Martin; O'Connell, Rachel; Joly, Florence; Lanceley, Anne; Hilpert, Felix; Okamoto, Aikou; Aotani, Eriko; Pignata, Sandro; Donnellan, Paul; Oza, Amit; Avall-Lundqvist, Elisabeth; Berek, Jonathan; Buizen, Luke; Sjoquist, Katrin; Gillies, Kim; Butow, Phyllis; Friedlander, Michael		GCIG Symptom Benefit Study Grp; Gynecologic Canc Intergrp GCIG	Validation of the measure of ovarian symptoms and treatment concerns (MOST), a patient-reported outcome measure (PROM) of symptom burden and subjective benefit with chemotherapy in recurrent ovarian cancer (ROC)	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[King, Madeleine] Univ Sydney, Sydney, NSW 2006, Australia; [Stockler, Martin; O'Connell, Rachel; Buizen, Luke] NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Joly, Florence] Ctr Francois Baclesse, GINECO, F-14021 Caen, France; [Lanceley, Anne] UCL, London, England; [Hilpert, Felix] UKSH, Klin Gynakol & Geburtshilfe, Kiel, Germany; [Okamoto, Aikou] Jikei Univ, Sch Med, Tokyo, Japan; [Aotani, Eriko] Kitasato Acad Res Org, Tokyo, Japan; [Pignata, Sandro] Natl Canc Inst, Naples, Italy; [Donnellan, Paul] Galway Univ Hosp, Galway, Ireland; [Oza, Amit] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Avall-Lundqvist, Elisabeth] Linkoping Univ, NSGO, Linkoping, Sweden; [Berek, Jonathan] Stanford Womens Canc Ctr, Stanford, CA USA; [Sjoquist, Katrin; Gillies, Kim] NHMRC Clin Trials Ctr, ANZGOG, Sydney, NSW, Australia; [Butow, Phyllis] Univ Sydney, Psychooncol Res Grp PoCoG, Sydney, NSW 2006, Australia; [Friedlander, Michael] Prince Wales Hosp, ANZGOG, Sydney, NSW, Australia								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		105.3	22	23				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100056		
J	Sasahara, S; Sakano, J; Langeland, E; Sollesnes, R; Oi, YC; Usami, K; Yamazaki, Y; Matsuzaki, I				Sasahara, Shinichiro; Sakano, Junko; Langeland, Eva; Sollesnes, Ragnhild; Oi, Yuichi; Usami, Kazuya; Yamazaki, Yoshihiko; Matsuzaki, Ichiyo			Sense of coherence (SOC) among Japanese white collar workers participating in "Salutogenic Cafe''. A 6 months follow-up study investigating development of SOC and the use of new skills	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Sasahara, Shinichiro] Univ Tsukuba, Occupat Psychiat, Tsukuba, Ibaraki, Japan; [Sakano, Junko] Okayama Prefectural Univ, Hlth & Welf Sci, Okayama, Japan; [Langeland, Eva; Sollesnes, Ragnhild] Univ Coll Bergen, Bergen, Norway; [Oi, Yuichi; Usami, Kazuya; Matsuzaki, Ichiyo] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yamazaki, Yoshihiko] Nihon Fukushi Univ, Nagoya, Aichi, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		303.5	69	70				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100155		
J	Obbarius, A; Clark, D; Crocker, AG; Emmelkamp, P; Furukawa, TA; Hedman, E; Kangas, M; Lesage, A; Mwesigire, DM; Nolte, S; Patel, V; Pilkonis, P; Pincus, HA; Reis, RA; Rojas, G; Sherbourne, C; Stowell, C; Rose, M				Obbarius, Alexander; Clark, David; Crocker, Anne G.; Emmelkamp, Paul; Furukawa, Toshi A.; Hedman, Erik; Kangas, Maria; Lesage, Alain; Mwesigire, Doris M.; Nolte, Sandra; Patel, Vikram; Pilkonis, Paul; Pincus, Harold A.; Reis, Roberta A.; Rojas, Graciela; Sherbourne, Cathy; Stowell, Caleb; Rose, Matthias			A proposal for standardization of health outcome measures for depression and anxiety	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Obbarius, Alexander; Nolte, Sandra; Rose, Matthias] Charite, D-13353 Berlin, Germany; [Clark, David] Univ Oxford, Oxford, England; [Crocker, Anne G.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Emmelkamp, Paul] Netherlands Inst Adv Study Humanities & Social Sci, Ctr Social & Humanities Res, Jeddah, Saudi Arabia; [Furukawa, Toshi A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan; [Hedman, Erik] Karolinska Inst, Solna, Sweden; [Kangas, Maria] Macquarie Univ, Dept Psychol, Ctr Emot Hlth, Sydney, NSW 2109, Australia; [Lesage, Alain] Univ Montreal, Inst Univ Sante Mentale Montreal, Montreal, PQ, Canada; [Lesage, Alain] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Mwesigire, Doris M.] Makerere Coll Hlth Sci, Kampala, Uganda; [Patel, Vikram] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Patel, Vikram] Publ Hlth Fdn India, Sangath, Goa, India; [Pilkonis, Paul] Univ Pittsburgh, Pittsburgh, PA USA; [Pincus, Harold A.] Columbia Univ, Dept Psychiat, New York, NY USA; [Reis, Roberta A.] Univ Fed Rio Grande do Sul, Grp CNPq USP GPEMSA Sao Paulo Univ Hlth, Sao Paulo, Brazil; [Rojas, Graciela] Univ Chile, Dept Psychiat, Clin Hosp, Santiago, Chile; [Sherbourne, Cathy] RAND Corp, Santa Monica, CA USA; [Stowell, Caleb] Int Consortium Hlth Outcomes Measurement ICHOM, Boston, MA USA			Nolte, Sandra/B-7498-2008	Nolte, Sandra/0000-0001-6185-9423				0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		1088	110	111				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100246		
J	Sakano, J; Yajima, Y; Yamazaki, Y; Seki, A; Ono, K; Hayashi, N				Sakano, Junko; Yajima, Yuki; Yamazaki, Yoshihiko; Seki, Asuka; Ono, Kaori; Hayashi, Naoki			Development and psychometric testing of the Japanese Version of the 13-item Sense of Coherence Scale-Revised (SOC13-RJ) among Japanese community-dwelling elderly	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Sakano, Junko] Okayama Prefectural Univ, Hlth & Welf Sci, Soja, Okayama, Japan; [Yajima, Yuki] Niimi Coll, Niimi, Okayama, Japan; [Yamazaki, Yoshihiko] Nihon Fukushi Univ, Nagoya, Aichi, Japan; [Seki, Asuka; Ono, Kaori; Hayashi, Naoki] INCAjinomoto Co Inc, Kawasaki, Kanagawa, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		1098	112	113				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100250		
J	Ando, Y; Ueki, Y; Yamawaki, T; Ozaki, I; Abe, A; Inukai, A; Aiba, I; Saito, Y; Kawaminami, K; Matsukawa, N; Kobayashi, T				Ando, Yukako; Ueki, Yoshino; Yamawaki, Takemori; Ozaki, Itsuko; Abe, Akemi; Inukai, Akira; Aiba, Ikuko; Saito, Yufuko; Kawaminami, Katsuhiko; Matsukawa, Noriyuki; Kobayashi, Toshio			Self-management behaviors and psychological and social factors influencing QOL in patients with parkinson disease	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Ando, Yukako; Ueki, Yoshino; Ozaki, Itsuko; Matsukawa, Noriyuki] Nagoya City Univ, Nagoya, Aichi, Japan; [Yamawaki, Takemori] Hiroshima City Hosp, Hiroshima, Japan; [Abe, Akemi] Hatsukaichi City Hlth Ctr, Hatsukaichi City, Japan; [Inukai, Akira; Aiba, Ikuko; Saito, Yufuko] Higashi Nagoya Natl Hosp, Nagoya, Aichi, Japan; [Kawaminami, Katsuhiko] Asaka City Publ Hlth Ctr, Asaka, Japan; [Kobayashi, Toshio] Hiroshima Univ, Hiroshima, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		2090	153	153				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100338		
J	Tamura, N; Okamoto, H; Kaihara, T; Uchino, H; Fukuoka, T				Tamura, Nobuichiro; Okamoto, Hiroshi; Kaihara, Toshie; Uchino, Hayaki; Fukuoka, Toshio			The quality of life in trauma patients at 6 months after injury: a prospective cohort study	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Tamura, Nobuichiro; Okamoto, Hiroshi; Kaihara, Toshie; Uchino, Hayaki; Fukuoka, Toshio] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		2102	155	155				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100344		
J	Hayashida, R; Mandai, T; Tsukihashi, A; Shimagami, H; Yamamoto, A; Chang, LS; Omura, T; Tairako, Y; Suzuki, S; Tada, Y; Nagano, I; Kaketaka, K; Yamashita, S; Kusuda, M; Fukuoka, A; Fujita, H; Maruyama, S; Kobayashi, M; Adachi, K; Sobue, T				Hayashida, Rika; Mandai, Takashi; Tsukihashi, Ayako; Shimagami, Hiroshi; Yamamoto, Akihiro; Chang, Li-sa; Omura, Taiji; Tairako, Yoshihiro; Suzuki, Shinichi; Tada, Yoshie; Nagano, Ichirou; Kaketaka, Kouki; Yamashita, Shuuto; Kusuda, Masaya; Fukuoka, Atsuhiko; Fujita, Haruyasu; Maruyama, Souichirou; Kobayashi, Michiko; Adachi, Kouzaburou; Sobue, Tomotaka			Quality of life in residents for earthquake, tsunami and radiation disaster in Fukushima, Japan	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Hayashida, Rika] Nagasaki Univ, Nagasaki 852, Japan; [Mandai, Takashi; Tsukihashi, Ayako; Shimagami, Hiroshi; Yamamoto, Akihiro; Chang, Li-sa; Omura, Taiji; Nagano, Ichirou; Kaketaka, Kouki; Yamashita, Shuuto; Kusuda, Masaya; Fukuoka, Atsuhiko; Fujita, Haruyasu; Maruyama, Souichirou; Kobayashi, Michiko; Adachi, Kouzaburou] Japanese Soc Qual Life Res, Kobe, Hyogo, Japan; [Tairako, Yoshihiro] Tounou Sangyou Sinkou Jigyou Cooperat, Iwaki, Fukushima, Japan; [Suzuki, Shinichi] Kashima Hosp, Iwaki, Fukushima, Japan; [Tada, Yoshie] Iwaki Off, Iwaki, Fukushima, Japan; [Sobue, Tomotaka] Osaka Univ, Grad Sch Med, Osaka, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		3067	170	171				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100374		
J	Naito, M; Suzukamo, Y; Miyake, T; Wakai, K				Naito, Mariko; Suzukamo, Yoshimi; Miyake, Tatsuro; Wakai, Kenji			Impact of socio-economic factors on oral health related quality of life in Japanese population	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Naito, Mariko; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Suzukamo, Yoshimi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Miyake, Tatsuro] Baika Womans Univ, Ibaraki, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		3087	173	173				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100380		
J	Saito, S; Shiroiwa, T; Ikeda, S; Noto, S; Igarashi, A; Fukuda, T; Shimozuma, K				Saito, Shinya; Shiroiwa, Takeru; Ikeda, Shunya; Noto, Shinichi; Igarashi, Ataru; Fukuda, Takashi; Shimozuma, Kojiro			Developing and testing national tariff for EQ-5D-5L in Japan with special reference to statistical methods to obtain QOL score	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Saito, Shinya] Okayama Univ, Okayama, Japan; [Shiroiwa, Takeru] Natl Inst Publ Hlth, Pharm, Wako, Saitama 3510197, Japan; [Ikeda, Shunya] Int Univ Hlth & Welf, Med, Ohtawara, Tochigi, Japan; [Noto, Shinichi] Niigata Univ Hlth & Welf, Hlth Care, Niigata, Japan; [Igarashi, Ataru] Univ Tokyo, Pharm, Tokyo, Japan; [Fukuda, Takashi] Natl Inst Publ Hlth, Hlth Care, Wako, Saitama 3510197, Japan; [Shimozuma, Kojiro] Ritsumeikan Univ, Med, Kusatsu, Shiga, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		3032	180	180				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100398		
J	Kobayashi, T; Furuyashiki, A; Okuda, S; Yabase, K				Kobayashi, Toshio; Furuyashiki, Akemi; Okuda, Suzumi; Yabase, Kousuke			Effect of health promotion seminars using traditional drum performance on the QOL and physical status of Japanese community elderly	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Kobayashi, Toshio; Furuyashiki, Akemi; Okuda, Suzumi; Yabase, Kousuke] Hiroshima Univ, Hiroshima, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		3064	186	186				1	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100413		
J	Hayashida, R; Kobayashi, M; Mandai, T				Hayashida, Rika; Kobayashi, Michiko; Mandai, Takashi			Quality of Life (Qol) Questionnaire for mothers of schoolchildren	QUALITY OF LIFE RESEARCH			English	Meeting Abstract									[Hayashida, Rika] Nagasaki Univ, Nagasaki 852, Japan; [Kobayashi, Michiko; Mandai, Takashi] Japanese Soc Qual Life Res, Kobe, Hyogo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2015	24			1		3090	189	190				2	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS3RA	WOS:000361991100423		
J	Khishgee, C; Akasaka, M				Khishgee, Chinbat; Akasaka, Masahide			Mineralogy of the Boroo Gold Deposit in the North Khentei Gold Belt, Central Northern Mongolia	RESOURCE GEOLOGY			English	Article						Boroo deposit; Mongolia; North Khentei gold belt	ARSENIAN PYRITE; MINERALIZATION; ARSENOPYRITE; SYSTEMS	Mineral assemblages and chemical compositions of ore minerals from the Boroo gold deposit in the North Khentei gold belt of Mongolia were studied to characterize the gold mineralization, and to clarify crystallization processes of the ore minerals. The gold deposit consists of low-grade disseminated and stockwork ores in granite, metasedimentary rocks and diorite dikes. Moderate to high-grade auriferous quartz vein ores are present in the above lithological units. The ore grades of the former range from about 1 to 3g/t, and those of the latter from 5 to 10g/t, or more than 10g/t Au. The main sulfide minerals in the ores are pyrite and arsenopyrite, both of which are divisible into two different stages (pyrite-I and pyrite-II; arsenopyrite-I and arsenopyrite-II). Sphalerite, galena, chalcopyrite, and tetrahedrite are minor associated minerals, with trace amounts of bournonite, boulangerite, geerite, alloclasite, native gold, and electrum. The ore minerals in the both types of ores are variable in distribution, abundance and grain size. Four modes of gold occurrence are recognized: (i) invisible gold in pyrite and arsenopyrite in the disseminated and stockwork ores, and in auriferous quartz vein ores; (ii) microscopic native gold, 3 to 100 mu m in diameter, that occurs as fine grains or as an interstitial phase in sulfides in the disseminated and stockwork ores, and in auriferous quartz vein ores; (iii) visible native gold, up to 1cm in diameter, in the auriferous quartz vein ores; and (iv) electrum in the auriferous quartz vein ores. The gold mineralization of the disseminated and stockwork ores consists of four stages characterized by the mineral assemblages of: (i) pyrite-I+arsenopyrite-I; (ii) pyrite-II+arsenopyrite-II; (iii) sphalerite+galena+chalcopyrite+tetrahedrite+bournonite+boulangerite+alloclasite+native gold; and (iv) native gold. In the auriferous quartz vein ores, five mineralization stages are defined by the following mineral assemblages: (i) pyrite-I; (ii) pyrite-II+arsenopyrite; (iii) sphalerite+galena+chalcopyrite; (iv) Ag-rich tetrahedrite-tennantite+bournonite+geerite+native gold; and (v) electrum. The As-Au relations in pyrite-II and arsenopyrite suggest that gold detected as invisible gold is mostly attributed to Au+1 in those minerals. By applying the arsenopyrite geothermometer to arsenopyrite-II in the disseminated and stockwork ores, crystallization temperature and logfs(2) are estimated to be 365 to 300 degrees C and -7.5 to -10.1, respectively.	[Khishgee, Chinbat; Akasaka, Masahide] Shimane Univ, Grad Sch Sci & Engn, Dept Geosci, Matsue, Shimane 6908504, Japan	Khishgee, C (reprint author), Shimane Univ, Grad Sch Sci & Engn, Dept Geosci, Matsue, Shimane 6908504, Japan.	chinbat0905@yahoo.com			Japanese Government	We gratefully thank Dr. Yasushi Watanabe (Akita University) for his critical comments on this study, and Dr. Barry Roser (Shimane University) for his valuable advice during the study and the English checking in the manuscript. We also express our gratitude to Boroo Gold Company for their permission for this study, and for access to the samples. Special thanks are due to Batbayar Dorjsuren (mining geologist, Boroo Gold Co.) and Bilegtuvshin Dorj (senior geologist, Boroo Gold Co.) for their help and guidance during sample collection from the mining site. We thank Dr. Yasushi Watanabe and an anonymous reviewer for their helpful reviews and valuable comments. We gratefully acknowledge the Japanese Government for financial support (MEXT scholarship) to the first author.	Morey AA, 2008, ECON GEOL, V103, P599, DOI 10.2113/gsecongeo.103.3.599; Zorin YA, 2001, ORE GEOL REV, V17, P215, DOI 10.1016/S0169-1368(00)00015-9; MUMIN AH, 1994, MINER DEPOSITA, V29, P445; Reich M, 2005, GEOCHIM COSMOCHIM AC, V69, P2781, DOI 10.1016/j.gca.2005.01.011; Bigot L, 2015, ECON GEOL, V110, P315; Badarch G, 2002, J ASIAN EARTH SCI, V21, P87, DOI 10.1016/S1367-9120(02)00017-2; SHARP ZD, 1985, CAN MINERAL, V23, P517; Blanchard M, 2007, GEOCHIM COSMOCHIM AC, V71, P624, DOI 10.1016/j.gca.2006.09.021; FLEET ME, 1993, CAN MINERAL, V31, P1; Hem SR, 2004, CAN MINERAL, V42, P43, DOI 10.2113/gscanmin.42.1.43; Khishgee C, 2014, RESOUR GEOL, V64, P1, DOI 10.1111/rge.12022; Mikucki EJ, 1998, ORE GEOL REV, V13, P307, DOI 10.1016/S0169-1368(97)00025-5; Baasandolgor L., 2003, THESIS MONGOLIAN TU, P1; Clark L. A., 1960, ECON GEOL, V55, P1345; Cluer J. K., 2005, GEODYNAMICS METALLOG, P105; Dejidmaa G, 1996, MONGOLIAN GEOSCI, V1, P6; Dejidmaa G., 1999, PRELIMINARY PUBLICAT, P99; Gerel O., 1999, MONGOLIAN GEOSCI, V14, P110; Goldfarb R.J., 2013, GONDWANA RES, V25, P48; Hendry J. W., 2006, TECHNICAL REPORT GAT; [侯万荣 Hou Wanrong], 2010, [地球学报, Acta Geoscientia Sinica], V31, P331; Kotlyar B., 1999, MONGOLIAN GEOSCI, V14, P107; Kretschmar U., 1976, CAN MINERAL, V14, P364; Raponi T. R., 2009, TECHNICAL REPORT BOR, P1; Tumur S., 1995, 4859 GEOL INF CTR	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	OCT	2015	65	4					311	327		10.1111/rge.12073		17	Geology; Mineralogy	Geology; Mineralogy	CS6XI	WOS:000362226500001		
J	Budinov, ZD; Yonezu, K; Tindell, T; Gabo-Ratio, JA; Milutinovic, S; Boyce, AJ; Watanabe, K				Budinov, Zhivko D.; Yonezu, Kotaro; Tindell, Thomas; Gabo-Ratio, Jillian Aira; Milutinovic, Stanoje; Boyce, Adrian J.; Watanabe, Koichiro			Copper-Gold Skarn Mineralization at the Karavansalija Ore Zone, Rogozna Mountain, Southwestern Serbia	RESOURCE GEOLOGY			English	Article						Cu-Au skarn; fluid inclusion microthermometry; S-isotopes; Rogozna Mountain; Serbia; sulfide mineralogy	CENTRAL BALKAN PENINSULA; FLUID INCLUSIONS; METALLOGENIC BELT; LASER COMBUSTION; SULFUR ISOTOPE; HIGH-PRECISION; DEPOSITS; PROVINCE; TEMPERATURE; DELTA-S-34	Karavansalija ore zone is situated in the Serbian part of the Serbo-Macedonian magmatic and metallogenic belt. The Cu-Au mineralization is hosted mainly by garnet-pyroxene-epidote skarns and shifts to lesser presence towards the nearby quartz-epidotized rocks and the overlying volcanic tuffs. Within the epidosites the sulfide mineralogy is represented by disseminated cobalt-nickel sulfides from the gersdorfite-krutovite mineral series and cobaltite, and pyrite-marcasite-chalcopyrite-base metal aggregates. The skarn sulfide mineralization is characterized by chalcopyrite, pyrite, pyrrhotite, bismuth-phases (bismuthinite and cosalite), arsenopyrite, gersdorffite, and sphalerite. The sulfides can be observed in several types of massive aggregates, depending on the predominant sulfide phases: pyrrhotite-chalcopyrite aggregates with lesser amount of arsenopyrite and traces of sphalerite, arsenopyrite-bismuthinite-cosalite aggregates with subordinate sphalerite and sphalerite veins with bismuthinite, pyrite and arsenopyrite. In the overlying volcanoclastics, the studied sulfide mineralization is represented mainly by arsenopyrite aggregates with subordinate amounts of pyrite and chalcopyrite. Gold is present rarely as visible aggregate of native gold and also as invisible element included in arsenopyrite. The fluid inclusion microthermometry data suggest homogenization temperature in the range of roughly 150-400 degrees C. Salinities vary in the ranges of 0.5-8.5wt% NaCl eq for two-phase low density fluid inclusions and 15-41wt% NaCl eq for two-phase high-salinity and three-phase high-salinity fluid inclusions. The broad range of salinity values and the different types of fluid inclusions co-existing in the same crystals suggest that at least two fluids with different salinities contributed to the formation of the Cu-Au mineralization. Geothermometry, based on EPMA data of arsenopyrite co-existing with pyrite and pyrrhotite, suggests a temperature range of 240-360 degrees C for the formation of the arsenopyrite, which overlaps well with the data for the formation temperature obtained through fluid inclusion microthermometry. The sulfur isotope data on arsenopyrite, chalcopyrite, pyrite and marcasite from the different sulfide assemblages (ranging from 0.4 parts per thousand to +3.9 parts per thousand S-34(CDT) with average of 2.29 S-34(CDT) and standard deviation of 1.34 S-34(CDT)) indicates a magmatic source of sulfur for all of the investigated phases. The narrow range of the data points to a common source for all of the investigated sulfides, regardless of the host rock and the paragenesis. The sulfur isotope data shows good overlap with that from nearby base-metal deposits; therefore the Cu-Au mineralization and the emblematic base-metal sulfide mineralization from this metallogenic belt likely share same fluid source.	[Budinov, Zhivko D.; Yonezu, Kotaro; Tindell, Thomas; Gabo-Ratio, Jillian Aira; Watanabe, Koichiro] Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Fukuoka 8190395, Japan; [Milutinovic, Stanoje] South Danube Met, Belgrade, Serbia; [Boyce, Adrian J.] Scottish Univ, Environm Res Ctr, Environm Res Council, E Kilbride, Lanark, Scotland	Budinov, ZD (reprint author), Kyushu Univ, Fac Engn, Dept Earth Resources Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	budinov@mine.kyushu-u.ac.jp	Boyce, Adrian/D-2263-2010	Boyce, Adrian/0000-0002-9680-0787	Global Center of Excellence in Novel Carbon Resource Sciences, Kyushu University; Japan Mining Promotive Foundation	We are grateful for the financial assistance, provided by the Global Center of Excellence in Novel Carbon Resource Sciences, Kyushu University and by The Japan Mining Promotive Foundation. We would like to express our gratitude to the geologists of Euromax Resources LTD and South Danube Metals-Belgarade for their support during the fieldwork and their helpful comments and to Dr. Tsubasa Otake and Mr. Kou Ishikawa from the Laboratory of Environmental Geology, Division of Sustainable Resources Engineering, Faculty of Engineering, Hokkaido University for their assistance for the EPMA analyses.	BODNAR RJ, 1993, GEOCHIM COSMOCHIM AC, V57, P683, DOI 10.1016/0016-7037(93)90378-A; KELLEY SP, 1992, SCANNING MICROSCOPY, V6, P129; Radosavljevic SA, 2015, ORE GEOL REV, V65, P213, DOI 10.1016/j.oregeorev.2014.09.029; Serafimovski T, 2010, GEOL ORE DEPOSIT+, V52, P179, DOI 10.1134/S1075701510030013; Sostaric SB, 2012, LITHOS, V148, P176, DOI 10.1016/j.lithos.2012.05.028; KELLEY SP, 1990, GEOCHIM COSMOCHIM AC, V54, P883, DOI 10.1016/0016-7037(90)90381-T; Wilkinson JJ, 2001, LITHOS, V55, P229, DOI 10.1016/S0024-4937(00)00047-5; Sostaric SB, 2011, ORE GEOL REV, V40, P65, DOI 10.1016/j.oregeorev.2011.05.002; Jankovic S, 1997, MINER DEPOSITA, V32, P426, DOI 10.1007/s001260050110; ERWOOD RJ, 1979, ECON GEOL, V74, P95; BARKER CE, 1990, GEOLOGY, V18, P1003, DOI 10.1130/0091-7613(1990)018<1003:FITFDM>2.3.CO;2; Wagner T, 2002, GEOCHIM COSMOCHIM AC, V66, P2855, DOI 10.1016/S0016-7037(02)00891-8; Heinrich CA, 2002, MINER DEPOSITA, V37, P533, DOI 10.1007/s00126-002-0271-x; Yang YL, 2013, J ASIAN EARTH SCI, V73, P362, DOI 10.1016/j.jseaes.2013.04.036; AHMAD SN, 1980, ECON GEOL, V75, P229; Imai A, 2000, RESOUR GEOL, V50, P213, DOI 10.1111/j.1751-3928.2000.tb00071.x; Neubauer F, 2002, GEOL SOC SPEC PUBL, V204, P81, DOI 10.1144/GSL.SP.2002.204.01.06; Cvetkovic V, 2004, LITHOS, V73, P161, DOI 10.1016/j.lithos.2003.12.004; FALLICK AE, 1992, CHEM GEOL, V101, P53, DOI 10.1016/0009-2541(92)90202-G; STERNER SM, 1988, GEOCHIM COSMOCHIM AC, V52, P989, DOI 10.1016/0016-7037(88)90254-2; Boev B., 1996, P ANN M IGCP SOF, V1, P75; Dusanic S., 2006, SERBIAN GEOLOGY I FO, P1; Guillong M., 2008, MINERALOGICAL ASS CA, V40, P328; Harkovska A., 1998, ACTA VULCANOL, V10, P199; Jankovic S., 1990, ORE DEPOSITS SERBIA; Jankovic S., 1995, P INT S GEOL MET DIN, V1, P79; Jankovic S., 1980, SGA SPEC PUBL, V1, P96; Kandic M., 1987, METALLOGENIC CHARACT; Karamata S, 2006, GEOL SOC SPEC PUBL, V260, P155, DOI 10.1144/GSL.SP.2006.260.01.07; Kretschmar U., 1976, CAN MINERAL, V14, P364; Mankov S., 2006, ANN U MINING GEOLO 1, V49; Meinert LD, 2005, ECON GEOL, V100, P299; Miletic G., 1998, SYNTHESIS GEOLOGIC I, P1; Milutinovic S., 2000, REPORT COMPLETED BAS, P1; Milutinovic S., 1998, 13 C GEOL JUG BOOK 4, P525; Monthel J., 2002, MINERAL DEPOSITS MIN, P1; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, V3, P517; Palinkas SS, 2013, ECON GEOL, V108, P135; Robertson A., 2008, LITHOS, V108, P1; Roedder E., 1972, 440JJ US GEOL SURV; Roedder E., 1984, REV MINERAL, V12, P12; Seal I.R., 2006, REV MINERAL GEOCHEM, V61, P633, DOI DOI 10.2138/RMG.2006.61.12	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	OCT	2015	65	4					328	345		10.1111/rge.12075		18	Geology; Mineralogy	Geology; Mineralogy	CS6XI	WOS:000362226500002		
J	Miyoshi, Y; Ishibashi, J; Shimada, K; Inoue, H; Uehara, S; Tsukimura, K				Miyoshi, Youko; Ishibashi, Jun-ichiro; Shimada, Kazuhiko; Inoue, Hiroyasu; Uehara, Seiichiro; Tsukimura, Katsuhiro			Clay Minerals in an Active Hydrothermal Field at Iheya-North-Knoll, Okinawa Trough	RESOURCE GEOLOGY			English	Article						back-arc basin; di-octahedral clay mineral; hydrothermal alteration; Integrated Ocean Drilling Program (IODP) Expedition 331; tri-octahedral clay mineral	BACK-ARC BASIN; JUAN-DE-FUCA; MANUS BASIN; MICROBIAL COMMUNITY; FLUID GEOCHEMISTRY; PHASE-SEPARATION; MIDDLE-VALLEY; VENT FLUIDS; SUBMARINE; SYSTEM	Iheya-North-Knoll is one of the small knolls covered with thick sediments in the Okinawa Trough back-arc basin. At the east slope of Iheya-North-Knoll, nine hydrothermal vents with sulfide mounds are present. The Integrated Ocean Drilling Program (IODP) Expedition 331 studied Iheya-North-Knoll in September 2010. The expedition provided us with the opportunity to study clay minerals in deep sediments in Iheya-North-Knoll. To reveal characteristics of clay minerals in the deep sediments, samples from the drilling cores at three sites close to the most active hydrothermal vent were analyzed by X-ray diffraction, scanning electron microscope and transmission electron microscope. The sediments are classified into Layer 0 (shallow), Layer 1 (deep), Layer 2 (deeper) and Layer 3 (deepest) on the basis of the assemblage of clay minerals. Layer 0 contains no clay minerals. Layer 1 contains smectite, kaolinite and illite/smectite mixed-layer mineral. Layer 2 contains chlorite, corrensite and chlorite/smectite mixed-layer mineral. Layer 3 is grouped into three sub-layers, 3A, 3B and 3C; Sub-layer 3A contains chlorite and illite/smectite mixed-layer mineral, sub-layer 3B contains chlorite/smectite and illite/smectite mixed-layer minerals, and sub-layer 3C contains chlorite and illite. Large amounts of di-octahedral clay minerals such as smectite, kaolinite, illite and illite/smectite mixed-layer mineral are found in Iheya-North-Knoll, which is rarely observed in hydrothermal fields in mid-ocean ridges. Tri-octahedral clay minerals such as chlorite, corrensite and chlorite/smectite mixed-layer mineral in Iheya-North-Knoll have low Fe/(Fe+Mg) ratios compared with those in mid-ocean ridges. In conclusion, the characteristics of clay minerals in Iheya-North-Knoll differ from those in mid-ocean ridges; di-octahedral clay minerals and Fe-poor tri-octahedral clay minerals occur in Iheya-North-Knoll but not in mid-ocean ridges.	[Miyoshi, Youko; Ishibashi, Jun-ichiro; Shimada, Kazuhiko; Inoue, Hiroyasu; Uehara, Seiichiro] Kyushu Univ, Grad Sch Sci, Dept Earth & Planetary Sci, Fukuoka 812, Japan; [Miyoshi, Youko; Tsukimura, Katsuhiro] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki 3058567, Japan	Miyoshi, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Cent 7,1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	youko-miyoshi@aist.go.jp			Japan Agency for Marine-Earth Science and Technology (JAMSTEC); U.S. Science Support Program of the Joint Oceanographic Institution, Inc. (JOI); European Consortium for Ocean Research Drilling (ECORD); Ministry of Science and Technology (MOST) of the People's Republic of China; Faculty of Sciences, Kyushu University; TAIGA project - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20109004]	We are grateful to Captain Yuji Onda, the operation superintendents Tomokazu Saruhashi and Ikuo Sawada, the crew, and the onboard technical staff of the R/V Chikyu during Integrated Ocean Drilling Program (IODP) Expedition 331. We appreciate the help of the co-chief scientists Ken Takai and Mike Mottl, the staff scientist Simon H.H. Nielsen, and the onboard scientists. This research used the samples and data provided by the Integrated Ocean Drilling Program (IODP). Financial support for various parts of this research was provided by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), the U.S. Science Support Program of the Joint Oceanographic Institution, Inc. (JOI), the European Consortium for Ocean Research Drilling (ECORD), and the Ministry of Science and Technology (MOST) of the People's Republic of China. This article is a part of the doctoral thesis of the first author (Y. M.). This study was supported by a Scholarship for Ph.D. candidates of the Faculty of Sciences, Kyushu University [to the first author (Y. M.)]. We thank the staff in the Research Laboratory for High Voltage Electron Microscopy at Kyushu University for their support for TEM analysis. This study was also partly supported by the "TAIGA project," which was funded by a Grant-in-Aid for Scientific Research on Innovative Areas (#20109004) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	LETOUZEY J, 1986, TECTONOPHYSICS, V125, P209, DOI 10.1016/0040-1951(86)90015-6; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Libbey RB, 2013, CLAY CLAY MINER, V61, P204, DOI 10.1346/CCMN.2013.0610304; Giorgetti G, 2006, CLAY CLAY MINER, V54, P240, DOI 10.1346/CCMN.2006.0540209; Jiang FQ, 2011, QUATERN INT, V230, P13, DOI 10.1016/j.quaint.2009.11.025; Kawagucci S, 2011, GEOCHEM J, V45, P109; Miyoshi Y, 2013, CHEM GEOL, V355, P28, DOI 10.1016/j.chemgeo.2013.05.033; Ishibashi J, 2014, GEOCHEM J, V48, P357, DOI 10.2343/geochemj.2.0311; Inoue A, 2004, CLAY CLAY MINER, V52, P66, DOI 10.1346/CCMN.2004.0520108; Marumo K, 1999, GEOCHIM COSMOCHIM AC, V63, P2785, DOI 10.1016/S0016-7037(99)00158-1; BUATIER MD, 1995, CONTRIB MINERAL PETR, V122, P134, DOI 10.1007/s004100050117; Tivey MK, 2007, OCEANOGRAPHY, V20, P50; Glasby GP, 2003, ORE GEOL REV, V23, P299, DOI 10.1016/j.orgeorev.2003.07.001; Suzuki R, 2008, RESOUR GEOL, V58, P267, DOI 10.1111/j.1751-3928.2008.00061.x; Beaulieu SE, 2013, GEOCHEM GEOPHY GEOSY, V14, P4892, DOI 10.1002/2013GC004998; Lackschewitz KS, 2000, ECON GEOL BULL SOC, V95, P361, DOI 10.2113/95.2.361; Lackschewitz KS, 2004, GEOCHIM COSMOCHIM AC, V68, P4405, DOI 10.1016/j.gca.2004.04.016; Tsuji T, 2012, J VOLCANOL GEOTH RES, V213, P41, DOI 10.1016/j.jvolgeores.2011.11.007; Monecke T, 2007, J VOLCANOL GEOTH RES, V160, P23, DOI 10.1016/j.jvolgeores.2006.08.007; Shanks WC, 2001, REV MINERAL GEOCHEM, V43, P469, DOI 10.2138/gsrmg.43.1.469; Buatier M. D., 1994, P ODP SCI RESULTS, P133; Chiba H., 1996, JAMSTEC J DEEP SEA R, V12, P211; Fornari D., 1995, GEOPHYS MONOGR, V91, P1; Henley R.W., 1984, REV EC GEOL, V1, P267; Ishibashi J. -I., 1995, BACKARC BASINS TECTO, P451; Karpov I. K., 1971, CHEM THERMODYNAMICS; Miyawaki R, 2010, J CLAY SCI SOC JPN, V48, P158; Miyoshi Y., 2015, SUBSEAFLOOR BIOSPHER, P567; Murey G. W., 1962, GEOCHIM COSMOCHIM AC, V26, P1029; Naumov G. B., 1974, HDB THERMODYNAMIC DA; Suzuki R., 2007, THESIS KYUSHU U; Takai K., 2011, P INTEGRATED OCEAN D; Tsukimura K., 1995, MINERAL J, V17, P322, DOI 10.2465/minerj.17.322; Uehara S., 2011, ANN REPORTS HVEM LAB, V34, P53; WILLIAMS DL, 1979, J GEOPHYS RES, V84, P7467; Yanagawa K, 2014, APPL ENVIRON MICROB, V80, P6126, DOI 10.1128/AEM.01741-14; Zierenberg R. A., 1994, US GEOLOGICAL SURVEY, P257	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	OCT	2015	65	4					346	360		10.1111/rge.12078		15	Geology; Mineralogy	Geology; Mineralogy	CS6XI	WOS:000362226500003		
J	Fujino, S				Fujino, Shigehiro			Amber-bearing Bed in a Shallow Marine Setting, an Example from the Lower Cretaceous Miyako Group, Northeastern Japan	RESOURCE GEOLOGY			English	Article						amber; amber-bearing bed; shallow marine; Lower Cretaceous	DEPOSITS; SPAIN; FLOWS	A previously unknown amber-bearing bed in the Lower Cretaceous Miyako Group, northeastern Japan, was deposited within a sequence that contains abundant marine macrofossils and wave-generated sedimentary structures that suggest deposition in an open shallow marine environment. How the amber was transported from its terrestrial origin to the marine environment is unclear, but sedimentary gravity flow is a strong candidate. Our observations suggest that the occurrence of amber clasts in sediments deposited in open and closed shallow marine environments is not uncommon. Thus, in addition to terrestrial sediments, sediments of marine origin have potential as targets for amber exploration.	Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Fujino, S (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	shige-fujino@geol.tsukuba.ac.jp					Penalver E, 2007, CRETACEOUS RES, V28, P791, DOI 10.1016/j.cretres.2006.12.004; Fujino S, 2013, J ASIAN EARTH SCI, V64, P168, DOI 10.1016/j.jseaes.2012.12.013; Pereira R, 2009, ORG GEOCHEM, V40, P863, DOI 10.1016/j.orggeochem.2009.05.002; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Bray PS, 2009, SCIENCE, V326, P132, DOI 10.1126/science.1177539; Mulder T, 2001, SEDIMENTOLOGY, V48, P269, DOI 10.1046/j.1365-3091.2001.00360.x; Cruickshank RD, 2003, J ASIAN EARTH SCI, V21, P441, DOI 10.1016/S1367-9120(02)00044-5; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Hanai T., 1968, Memoirs of the National Science Museum (Tokyo), VNo. 1, P20; Kimura Y., 2005, FUKUOKA U SCI REPORT, V35, P31; LOWE DR, 1982, J SEDIMENT PETROL, V52, P279; Tanaka K., 1978, CHISHITSU NEWS, V291, P32; Terui K., 1995, MEMOIRS GEOLOGICAL S, V45, P238; Umetsu K., 2013, J GEOL SOC JPN S, V119, P82	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	OCT	2015	65	4					389	393		10.1111/rge.12079		5	Geology; Mineralogy	Geology; Mineralogy	CS6XI	WOS:000362226500006		
J	Nagata, K; Morimoto, T; Fujimoto, D; Otoshi, T; Nakagawa, A; Otsuka, K; Seo, R; Atsumi, T; Tomii, K				Nagata, Kazuma; Morimoto, Takeshi; Fujimoto, Daichi; Otoshi, Takehiro; Nakagawa, Atsushi; Otsuka, Kojiro; Seo, Ryutaro; Atsumi, Takahiro; Tomii, Keisuke			Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical Ventilation	RESPIRATORY CARE			English	Article						acute hypoxemic respiratory failure; respiratory support; high-flow nasal cannula; invasive ventilation; noninvasive ventilation; ventilator-free days	POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; NONINVASIVE VENTILATION; ACUTE EXACERBATIONS; OXYGEN-THERAPY; CLINICAL-RESEARCH; CARE PATIENTS; MULTICENTER	BACKGROUND: We evaluated the efficacy of high-flow nasal cannula (HFNC) therapy, a promising respiratory support method for acute hypoxemic respiratory failure (AHRF). METHODS: We conducted a retrospective single-center cohort study comparing the periods before (June 2010 to May 2012) and after (June 2012 to May 2014) HFNC introduction (pre- and post-HFNC periods). During these periods, we retrieved cases of AHRF treated with any respiratory support (invasive ventilation, noninvasive ventilation [NIV], and HFNC) and compared in-hospital mortality, ICU/intermediate care unit/hospital stay, and need for mechanical ventilation. RESULTS: Eighty-three subjects (65 treated with NIV, and 18 treated with invasive ventilation) and 89 subjects (33 treated with HFNC, 43 treated with NIV, and 13 treated with invasive ventilation) identified from 782 pre-HFNC and 930 post-HFNC records of acute respiratory failure who required emergent admissions to the respiratory care department were analyzed. Overall, the in-hospital mortality rate was similar, although there was a non-significant and slight decrease from 35 to 27% (P = .26). There was no significant difference among ICU, intermediate care unit (P = .80), and hospital (P = .33) stay. In the post-HFNC period, significantly fewer subjects required mechanical ventilation (NIV or invasive ventilation) (100% vs 63%, P < .01). Additionally, there were significantly fewer ventilator days (median [interquartile range] of 5 [2-11] vs 2 [1-5] d, P < .05) and more ventilator-free days (median [interquartile range] of 18 [0-25] vs 26 [20-27] d, P < .01). CONCLUSIONS: HFNC might be an alternative for AHRF subjects with NIV intolerance. (C) 2015 Daedalus Enterprises	[Nagata, Kazuma; Fujimoto, Daichi; Otoshi, Takehiro; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo 6500047, Japan; [Morimoto, Takeshi] Kobe City Med Ctr Gen Hosp, Clin Res Ctr, Kobe, Hyogo 6500047, Japan; [Seo, Ryutaro] Kobe City Med Ctr Gen Hosp, Dept Anesthesia, Kobe, Hyogo 6500047, Japan; [Atsumi, Takahiro] Kobe City Med Ctr Gen Hosp, Dept Emergency Med, Kobe, Hyogo 6500047, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Ctr Clin Res & Educ, Dept Clin Epidemiol, Nishinomiya, Hyogo 6638501, Japan	Nagata, K (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	kazuma_n1101@yahoo.co.jp					Brochard L, 2002, EUR RESPIR J, V19, P712, DOI 10.1183/09031936.02.00295502; Carlucci A, 2001, AM J RESP CRIT CARE, V163, P874; Gotera C, 2013, REV PORT PNEUMOL, V19, P217, DOI 10.1016/j.rppneu.2013.03.005; Lenglet H, 2012, RESP CARE, V57, P1873, DOI 10.4187/respcare.01575; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; Roca O, 2010, RESP CARE, V55, P408; Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7; Keenan SP, 2004, CRIT CARE MED, V32, P2516, DOI 10.1097/01.CCM.0000148011.51681.E2; Sztrymf B, 2011, INTENS CARE MED, V37, P1780, DOI 10.1007/s00134-011-2354-6; Hill NS, 2007, CRIT CARE MED, V35, P2402, DOI 10.1097/01.CCM.0000284587.36541.7F; Peter JV, 2002, CRIT CARE MED, V30, P555, DOI 10.1097/00003246-200203000-00010; Parke RL, 2011, RESP CARE, V56, P265, DOI 10.4187/respcare.00801; Dysart K, 2009, RESP MED, V103, P1400, DOI 10.1016/j.rmed.2009.04.007; Ricard JD, 2012, MINERVA ANESTESIOL, V78, P836; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Antonelli M, 2001, INTENS CARE MED, V27, P1718; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Berg KM, 2012, INTERN EMERG MED, V7, P539, DOI 10.1007/s11739-012-0856-z; Devlin JW, 2007, CRIT CARE MED, V35, P2298, DOI 10.1097/01.CCM.0000284512.21942.F8; Anton A, 2000, CHEST, V117, P828, DOI 10.1378/chest.117.3.828; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Keenan SP, 2003, ANN INTERN MED, V138, P861; Cook D, 2002, CRIT CARE MED, V30, P1636, DOI 10.1097/00003246-200207000-00039; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Epstein SK, 2009, RESP CARE, V54, P198; Epstein SK., 2009, RESP CARE, V54, P208; Sztrymf B, 2012, J CRIT CARE, V27; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	29	1	1	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	OCT	2015	60	10					1390	1396		10.4187/respcare.04026		7	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CS7MV	WOS:000362268600007		
J	Koyama, K; Ohshima, N; Kawashima, M; Okuda, K; Sato, R; Nagai, H; Matsui, H; Ohta, K				Koyama, Kazuya; Ohshima, Nobuharu; Kawashima, Masahiro; Okuda, Kenichi; Sato, Ryota; Nagai, Hideaki; Matsui, Hirotoshi; Ohta, Ken			Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy	RESPIRATORY MEDICINE			English	Article						Mycobacterium avium complex; Bronchiectasis; Solitary nodule; Prevalence; Latent infecction	CYSTIC FIBROSIS BRONCHIECTASIS; THIN-SECTION CT; NONTUBERCULOUS MYCOBACTERIA; INTRACELLULARE COMPLEX; IMMUNOCOMPETENT PATIENTS; ADULT PATIENTS; LUNG-DISEASE; INFECTIONS; PREVALENCE	Background: We occasionally experience cases suspected of pulmonary Mycobacterium avium complex (MAC) disease without positive bacterial cultures. Objective: To evaluate features of pulmonary MAC cases diagnosed later in the follow-up after negative intensive investigation. Methods: We defined and compared three groups; the first study negative (FSN) group, the first study positive (FSP) group, and MAC negative group. The FSN group consisted of patients negative for MAC isolation by bronchial washing performed between 2007 and 2011, but positive later. Patients with positive MAC cultures in the first study were incorporated into the FSP group. MAC negative group consisted of MAC suspects without MAC isolation in the follow-up. Results: Twenty-four patients were classified as FSN group, 61 as MAC negative group and 265 as FSP group. FSN group exhibited more solitary nodule pattern (n = 7 in FSN, n = 6 in FSP; p < 0.001) and less nodular/bronchiectatic (NB) diseases (n = 17 in FSN, n = 245 in FSP; p < 0.001). When limited to NB type, the FSP group had more cavitations (6% in FSN, 32% in FSP; p = 0.028). Patients with more than three lung lobes involved were more frequent in the FSN group compared with FSP group with negative sputum cultures (65% vs 34%; p = 0.014) and with MAC negative group (65% vs 28%; p = 0.009). Conclusions: Patients diagnosed as pulmonary MAC disease in the follow-up duration tend to show solitary nodular pattern or NB pattern without cavitation. In FSN patients with NB pattern, more lung lobes were involved in the first study, suggesting subsequent MAC infection onto the underlying ectatic bronchi. (C) 2015 Elsevier Ltd. All rights reserved.	[Koyama, Kazuya; Kawashima, Masahiro; Okuda, Kenichi; Sato, Ryota; Nagai, Hideaki; Matsui, Hirotoshi; Ohta, Ken] Tokyo Natl Hosp, Natl Hosp Org, Ctr Pulm Dis, Tokyo, Japan; [Ohshima, Nobuharu; Ohta, Ken] Tokyo Natl Hosp, Natl Hosp Org, Ctr Asthma & Allergy, Tokyo, Japan	Koyama, K (reprint author), Tokyo Natl Hosp, Natl Hosp Org, Ctr Pulm Dis, Tokyo, Japan.	koyamak@tokyo-hosp.jp					Roux AL, 2009, J CLIN MICROBIOL, V47, P4124, DOI 10.1128/JCM.01257-09; Polverosi R, 2010, RADIOL MED, V115, P191, DOI 10.1007/s11547-009-0479-2; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Mirsaeidi M, 2013, INT J INFECT DIS, V17, pE1000, DOI 10.1016/j.ijid.2013.03.018; Tanaka E, 1997, AM J RESP CRIT CARE, V155, P2041; Fowler SJ, 2006, EUR RESPIR J, V28, P1204, DOI 10.1183/09031936.06.00149805; Wickremasinghe M, 2005, THORAX, V60, P1045, DOI 10.1136/thx.2005.046631; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Wittram C, 2002, BRIT J RADIOL, V75, P340; Winthrop KL, 2009, EMERG INFECT DIS, V15, P1556, DOI 10.3201/eid1510.090310; Yonemori K, 2007, INT J TUBERC LUNG D, V11, P215; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; AITKEN ML, 1993, CHEST, V103, P1096, DOI 10.1378/chest.103.4.1096; Kitada S, 2012, INT J TUBERC LUNG D, V16, P660, DOI 10.5588/ijtld.11.0534; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277; Koh WJ, 2005, RADIOLOGY, V235, P282, DOI 10.1148/radiol.2351040371; Aksamit TR, 2014, RESP MED, V108, P417, DOI 10.1016/j.rmed.2013.09.014; Kobashi Y, 2006, RESPIROLOGY, V11, P317, DOI 10.1111/j.1440-1843.2006.00847.x; Jeong YJ, 2004, RADIOLOGY, V231, P880, DOI 10.1148/radiol.2313030833; Lee Geewon, 2013, Ann Am Thorac Soc, V10, P299, DOI 10.1513/AnnalsATS.201303-062OC; McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI; KILBY JM, 1992, CHEST, V102, P70, DOI 10.1378/chest.102.1.70; Lim J, 2010, INT J TUBERC LUNG D, V14, P1635; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; McShane PJ, 2012, CHEST, V142, P159, DOI 10.1378/chest.11-1024; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Ito Y, 2012, INT J TUBERC LUNG D, V16, P408, DOI 10.5588/ijtld.11.0148; Sugihara Eiichiro, 2003, Journal of Infection and Chemotherapy, V9, P328, DOI 10.1007/s10156-003-0267-1; Tsuji T, 2015, RESPIROLOGY, V20, P80, DOI 10.1111/resp.12412	29	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	OCT	2015	109	10					1347	1353		10.1016/j.rmed.2015.08.016		7	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	CS7NZ	WOS:000362271600018		
J	Ando, Y; Inoue, M; Ohno-Matsui, K; Kusumi, Y; Iida, T; Hirakata, A				Ando, Yoshimasa; Inoue, Makoto; Ohno-Matsui, Kyoko; Kusumi, Yumi; Iida, Tomohiro; Hirakata, Akito			MACULAR DETACHMENT ASSOCIATED WITH INTRACHOROIDAL CAVITATION IN NONPATHOLOGICAL MYOPIC EYES	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						optical coherence tomography; intrachoroidal cavitation; vitrectomy; macular detachment; macular retinoschisis; myopia	OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGICAL MYOPIA; PERIPAPILLARY DETACHMENT; RETINAL-DETACHMENT; GAS TAMPONADE; DISC PIT; VITRECTOMY; FOVEOSCHISIS; NERVE	Purpose:To report the characteristics of a macular detachment associated with peripapillary intrachoroidal cavitation (ICC) and the outcomes of vitrectomy.Methods:The medical records of 69 eyes of 61 patients who underwent vitrectomy for macular detachment or macular retinoschisis but without vitreomacular traction or optic disc pit were reviewed. Optical coherence tomography was used to determine the morphology of the ICC. The outcomes of vitrectomy including the creation of a posterior vitreous detachment and internal limiting membrane peeling were evaluated.Results:An ICC was detected in 3 of 3 eyes without pathologic myopia but none in 66 eyes with pathologic myopia (P < 0.0001). Myopic peripapillary conus was present in all 3 eyes, tilted disc in 2 eyes (67%), posterior staphyloma in 1 eye (33%), and no preoperative posterior vitreous detachment in all eyes. Optical coherence tomography detected a connection between the vitreous cavity and the ICC in two eyes with pit-like splitting and between the subretinal space and the ICC in two eyes. The macular detachment was resolved 5 months to 6 months postoperatively with improvement of vision.Conclusion:A macular detachment with ICC can be present in nonpathological myopic eyes. Vitreous surgery to create a posterior vitreous detachment with internal limiting membrane peeling may help resolve the macular detachment.	[Ando, Yoshimasa; Inoue, Makoto; Kusumi, Yumi; Hirakata, Akito] Kyorin Univ, Sch Med, Dept Ophthalmol, Kyorin Eye Ctr, Tokyo, Japan; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan	Hirakata, A (reprint author), Kyorin Univ, Sch Med, Dept Ophthalmol, Kyorin Eye Ctr, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	hirakata@eye-center.org					Akimoto Masayuki, 2012, Case Rep Ophthalmol, V3, P169, DOI 10.1159/000339292; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Yeh SI, 2013, OPHTHALMOLOGY, V120, P544, DOI 10.1016/j.ophtha.2012.08.028; Shimada N, 2006, ARCH OPHTHALMOL-CHIC, V124, P46, DOI 10.1001/archopht.124.1.46; Wei YH, 2009, EYE, V23, P141, DOI 10.1038/sj.eye.6702961; Ohno-Matsui K, 2013, EYE, V27, P630, DOI 10.1038/eye.2013.16; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P89, DOI 10.1097/00006982-200601000-00014; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; How ACS, 2009, ARCH OPHTHALMOL-CHIC, V127, P894, DOI 10.1001/archophthalmol.2009.134; Hirakata A, 2012, OPHTHALMOLOGY, V119, P810, DOI 10.1016/j.ophtha.2011.09.026; Freund KB, 2011, ARCH OPHTHALMOL-CHIC, V129, P1096, DOI 10.1001/archophthalmol.2011.208; Kanda S, 2003, AM J OPHTHALMOL, V136, P177, DOI 10.1016/S0002-9394(03)00243-5; Ohno-Matsui K, 2012, OPHTHALMOLOGY, V119, P1685, DOI 10.1016/j.ophtha.2012.01.047; Freund KB, 2003, ARCH OPHTHALMOL-CHIC, V121, P197; Kim KS, 2012, AM J OPHTHALMOL, V153, P320, DOI 10.1016/j.ajo.2011.07.007; Shimada Noriaki, 2009, International Ophthalmology, V29, P99, DOI 10.1007/s10792-007-9174-2; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; CURTIN BJ, 1979, OPHTHALMOLOGY, V86, P681; Toranzo J, 2005, AM J OPHTHALMOL, V140, P731, DOI 10.1016/j.ajo.2005.03.063; Faghihi Hooshang, 2010, J Ophthalmic Vis Res, V5, P110; Yoshizawa C, 2014, OSLI RETINA, V45, P350, DOI 10.3928/23258160-20140617-03; Zheng B, 2011, RETINA-J RET VIT DIS, V31, P692, DOI 10.1097/IAE.0b013e3181f84fc1	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	OCT	2015	35	10					1943	1950		10.1097/IAE.0000000000000575		8	Ophthalmology	Ophthalmology	CS6US	WOS:000362219000003		
J	Hirashima, T; Moriya, T; Bun, T; Utsumi, T; Hirose, M; Oh, H				Hirashima, Takafumi; Moriya, Takeshi; Bun, Toshitaka; Utsumi, Takao; Hirose, Miou; Oh, Hideyasu			OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						age-related macular degeneration; ellipsoid layer; OCT findings; plasminogen activator-assisted vitrectomy; submacular hemorrhage	SUBRETINAL HEMORRHAGE; PNEUMATIC DISPLACEMENT; NATURAL-HISTORY; VISUAL PROGNOSIS; INJECTION; MANAGEMENT; GAS; EYES; REMOVAL	Purpose:To study the relationship between morphologic findings using spectral domain optical coherence tomography and surgical outcomes in patients with submacular hemorrhage (SMH) secondary to age-related macular degeneration.Methods:Medical charts of nine eyes of nine patients who underwent tissue plasminogen activator-assisted vitrectomy for SMH secondary to age-related macular degeneration were retrospectively reviewed. The preoperative height and lateral width of both SMH and pigment epithelial detachment documented with optical coherence tomography, were measured. The status of ellipsoid layers was also analyzed.Results:Complete displacement of SMH from the fovea was achieved in all nine eyes. The preoperative status of the ellipsoid layer under the fovea was detectable in four eyes and absent in the remaining five eyes. Postoperative best-corrected visual acuity was significantly better in eyes with preoperative detectable ellipsoid layers (P < 0.01). Eyes with preoperative SMH heights <400 m also exhibited better best-corrected visual acuity (P < 0.05). There was no significant correlation between postoperative best-corrected visual acuity and the specific features of pigment epithelial detachment, including height, lateral width, and number.Conclusion:The preoperative presence of detectable ellipsoid layers and a lower height of SMH may predict good visual prognosis. In contrast, no specific features of pigment epithelial detachment correlated with postoperative best-corrected visual acuity.	[Hirashima, Takafumi; Moriya, Takeshi; Bun, Toshitaka; Utsumi, Takao; Hirose, Miou; Oh, Hideyasu] Hyogo Kenritsu Amagasaki Hosp, Dept Ophthalmol, Amagasaki, Hyogo 6600828, Japan	Oh, H (reprint author), Hyogo Kenritsu Amagasaki Hosp, Dept Ophthalmol, Higashidaimotsu Cho1-1-1, Amagasaki, Hyogo 6600828, Japan.	hideyasu@kuhp.kyoto-u.ac.jp					Kamei M, 1996, AM J OPHTHALMOL, V121, P267; Ohji M, 1998, ARCH OPHTHALMOL-CHIC, V116, P1326; Treumer F, 2010, BRIT J OPHTHALMOL, V94, P48, DOI 10.1136/bjo.2009.164707; Landa G, 2011, RETINA-J RET VIT DIS, V31, P364, DOI 10.1097/IAE.0b013e3181e91132; Sandberg MA, 2005, INVEST OPHTH VIS SCI, V46, P3349, DOI 10.1167/iovs.04-1383; Papavasileiou E, 2013, RETINA-J RET VIT DIS, V33, P846, DOI 10.1097/IAE.0b013e318271f278; Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Chang W, 2014, AM J OPHTHALMOL, V157, P1250, DOI 10.1016/j.ajo.2014.02.007; Ota M, 2008, AM J OPHTHALMOL, V145, P273, DOI 10.1016/j.ajo.2007.09.019; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1800, DOI 10.1097/IAE.0b013e31829c3765; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; ELBABA F, 1986, OPHTHALMOLOGY, V93, P1581; Hayashi H, 2009, AM J OPHTHALMOL, V148, P83, DOI 10.1016/j.ajo.2009.01.017; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; POLINER LS, 1986, OPHTHALMOLOGY, V93, P543; Maheshwary AS, 2010, AM J OPHTHALMOL, V150, P63, DOI 10.1016/j.ajo.2010.01.039; Hillenkamp J, 2010, GRAEF ARCH CLIN EXP, V248, P5, DOI 10.1007/s00417-009-1158-7; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Ueda-Arakawa N, 2012, JPN J OPHTHALMOL, V56, P589, DOI 10.1007/s10384-012-0191-y; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723; Haupert CL, 2001, AM J OPHTHALMOL, V131, P208, DOI 10.1016/S0002-9394(00)00734-0; Kim JH, 2014, OPHTHALMOLOGY, V121, P926, DOI 10.1016/j.ophtha.2013.11.004; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; Cheung CMG, 2013, GRAEF ARCH CLIN EXP, V251, P19, DOI 10.1007/s00417-012-2029-1; BENNETT SR, 1990, AM J OPHTHALMOL, V109, P33; Pauleikhoff D, 2002, GRAEF ARCH CLIN EXP, V240, P533, DOI 10.1007/s00417-002-0505-8; IBANEZ HE, 1995, ARCH OPHTHALMOL-CHIC, V113, P62; Kapran Z, 2013, OPHTHAL SURG LAS IM, V44, P471, DOI 10.3928/23258160-20130909-09; Lim JI, 1995, OPHTHALMOLOGY, V240, P717; Sandhu Sukhpal Singh, 2010, Clin Ophthalmol, V4, P637; Schulze SD, 2002, GRAEFES ARCH CLIN EX, V109, P723; Submacular Surgery Trials (SST) Research Group, 2004, AM J OPHTHALMOL, V111, P2007; VANDER JF, 1992, OPHTHALMIC SURG LAS, V23, P361	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	OCT	2015	35	10					1969	1978		10.1097/IAE.0000000000000574		10	Ophthalmology	Ophthalmology	CS6US	WOS:000362219000007		
J	Yamada, Y; Suzuma, K; Matsumoto, M; Tsuiki, E; Fujikawa, A; Harada, T; Kitaoka, T				Yamada, Yoshihisa; Suzuma, Kiyoshi; Matsumoto, Makiko; Tsuiki, Eiko; Fujikawa, Azusa; Harada, Takafumi; Kitaoka, Takashi			RETINAL BLOOD FLOW CORRELATES TO AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR IN CENTRAL RETINAL VEIN OCCLUSION	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						arteriovenous passage time; central retinal vein occlusion; laser speckle flowgraphy; retinal blood flow; vascular endothelial growth factor	OPTIC-NERVE HEAD; LASER SPECKLE FLOWGRAPHY; MACULAR EDEMA SECONDARY; NATURAL-HISTORY; VITREOUS LEVELS; TRAP-EYE; MICROCIRCULATION; CIRCULATION; RANIBIZUMAB	Purpose:As laser speckle flowgraphy can measure blood flow distribution in the ocular fundus, the authors analyzed the relationship between retinal blood flow and aqueous vascular endothelial growth factor (VEGF) concentration in central retinal vein occlusion.Methods:This prospective observational study examined 45 eyes of 45 patients with central retinal vein occlusion before treatment. Blood flow in large vessels around and at the optic disk, aqueous VEGF concentration, and arteriovenous passage time were examined. Blood flow was evaluated as mean blur rate by laser speckle flowgraphy.Results:Fluorescein angiography found 20 ischemic and 25 nonischemic type eyes. Aqueous VEGF concentration in the ischemic type was significantly higher than that in the nonischemic type (P = 0.01). Arteriovenous passage time was significantly correlated to the logarithm of the aqueous VEGF concentration (P = 0.0001). Mean blur rate of the affected eye/mean blur rate of the unaffected eye of the ischemic type was significantly lower than the nonischemic type (P = 0.039). Additionally, mean blur rate was significantly correlated both to the logarithm of the aqueous VEGF concentration (P < 0.0001) and to the arteriovenous passage time (P = 0.0001).Conclusion:Laser speckle flowgraphy may be useful for predicting aqueous VEGF concentration and severity of central retinal vein occlusion.	[Yamada, Yoshihisa; Suzuma, Kiyoshi; Matsumoto, Makiko; Tsuiki, Eiko; Fujikawa, Azusa; Kitaoka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Nagasaki 8528501, Japan; [Harada, Takafumi] Yaizukogawa Eye Clin, Yaizu, Japan	Suzuma, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	suzuma@nagasaki-u.ac.jp					Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Noma H, 2009, OPHTHALMOLOGY, V116, P87, DOI 10.1016/j.ophtha.2008.09.034; Tamaki Y, 2001, OPHTHALMOLOGY, V108, P627, DOI 10.1016/S0161-6420(00)00541-8; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Varma R, 2012, OPHTHALMOLOGY, V119, P2108, DOI 10.1016/j.ophtha.2012.05.017; Nelson DA, 2005, OPHTHAL SURG LAS IM, V36, P57; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Yaoeda K, 2000, AM J OPHTHALMOL, V129, P734, DOI 10.1016/S0002-9394(00)00382-2; RIVA CE, 1978, AM J PHYSIOL, V234, pH315; Brown DM, 2014, RETINA-J RET VIT DIS, V34, P1728, DOI 10.1097/IAE.0000000000000191; YOSHIDA A, 1983, AM J OPHTHALMOL, V95, P182, DOI 10.1016/0002-9394(83)90012-0; Boyer D, 2012, OPHTHALMOLOGY, V119, P1024, DOI 10.1016/j.ophtha.2012.01.042; Crama N, 2010, RETINA-J RET VIT DIS, V30, P1692, DOI 10.1097/IAE.0b013e3181d8e7e8; WILLIAMSON TH, 1994, OPHTHALMOLOGY, V101, P1362; SERVAIS GE, 1986, OPHTHALMOLOGY, V93, P301; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P278, DOI 10.1136/bjophthalmol-2012-301504; Hayreh SS, 2011, OPHTHALMOLOGY, V118, P119, DOI 10.1016/j.ophtha.2010.04.019; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Arsene S, 2002, BRIT J OPHTHALMOL, V86, P1243, DOI 10.1136/bjo.86.11.1243; Horio N, 2006, AM J OPHTHALMOL, V141, P31, DOI 10.1016/j.ajo.2005.08.015; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Yaoeda K, 2000, AM J OPHTHALMOL, V130, P606, DOI 10.1016/S0002-9394(00)00723-6; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Noma H, 2008, EYE, V22, P42, DOI 10.1038/sj.eye.6702498; Michelson G, 1997, OPHTHALMOLOGY, V104, P659; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; LIEB WE, 1991, ARCH OPHTHALMOL-CHIC, V109, P527	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	OCT	2015	35	10					2037	2042		10.1097/IAE.0000000000000595		6	Ophthalmology	Ophthalmology	CS6US	WOS:000362219000015		
J	Okamoto, F; Sugiura, Y; Okamoto, Y; Hiraoka, T; Oshika, T				Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro			INNER NUCLEAR LAYER THICKNESS AS A PROGNOSTIC FACTOR FOR METAMORPHOPSIA AFTER EPIRETINAL MEMBRANE SURGERY	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						epiretinal membrane; metamorphopsia; inner nuclear layer; optical coherence tomography	OPTICAL COHERENCE TOMOGRAPHY; OUTER SEGMENT TIPS; MACULAR PUCKER; PREMACULAR FIBROPLASIA; VISUAL RECOVERY; TIME-COURSE; FOLLOW-UP; VITRECTOMY; REMOVAL; ASSOCIATIONS	Purpose:To evaluate prognostic factors for metamorphopsia in patients undergoing vitrectomy for epiretinal membrane using spectral domain optical coherence tomography.Methods:This study included 53 eyes of 53 patients undergoing vitrectomy for idiopathic epiretinal membrane. The authors examined visual acuity, severity of metamorphopsia with M-CHARTS, and retinal microstructures with spectral domain optical coherence tomography before surgery and 3 months and 6 months after surgery. Central foveal thickness, parafoveal retinal thickness, macular volume, thickness of the ganglion cell layer, inner nuclear layer, and outer retinal layer (ONL + OPL: outer nuclear layer and outer plexiform layer) were analyzed using an image processing program. The status of the outer retinal lines was also evaluated.Results:Preoperative metamorphopsia score (M-score) significantly correlated with central foveal thickness, inner nuclear layer thickness, and ONL + OPL thickness. Postoperative M-score significantly correlated with postoperative central foveal thickness and inner nuclear layer thickness. Inner nuclear layer thickness had significant correlation with M-score at each time point by multiple regression analysis, whereas other parameters were not relevant. Multiple regression analysis showed that preoperative inner nuclear layer thickness yielded the highest regression coefficient with postoperative M-score.Conclusion:Inner nuclear layer thickness was found to be a good indicator of metamorphopsia both before and after surgery and a predictor of postoperative metamorphopsia in patients with epiretinal membrane.	[Okamoto, Fumiki; Sugiura, Yoshimi; Okamoto, Yoshifumi; Hiraoka, Takahiro; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Okamoto, F (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	fumiki-o@md.tsukuba.ac.jp					Arichika S, 2010, RETINA-J RET VIT DIS, V30, P503, DOI 10.1097/IAE.0b013e3181bd2d65; POLINER LS, 1988, ARCH OPHTHALMOL-CHIC, V106, P761; Mitamura Y, 2009, BRIT J OPHTHALMOL, V93, P171, DOI 10.1136/bjo.2008.146381; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; Itoh Y, 2013, INVEST OPHTH VIS SCI, V54, P7302, DOI 10.1167/iovs.13-12702; Arimura E, 2005, INVEST OPHTH VIS SCI, V46, P2961, DOI 10.1167/iovs.04-1104; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Kinoshita T, 2012, INVEST OPHTH VIS SCI, V53, P3592, DOI 10.1167/iovs.12-9493; Kim J, 2010, AM J OPHTHALMOL, V150, P701, DOI 10.1016/j.ajo.2010.05.037; Wong JG, 2005, CLIN EXP OPHTHALMOL, V33, P373, DOI 10.1111/j.1442-9071.2005.01025.x; Ooto S, 2011, OPHTHALMOLOGY, V118, P873, DOI 10.1016/j.ophtha.2010.08.032; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Okamoto F, 2009, AM J OPHTHALMOL, V147, P869, DOI 10.1016/j.ajo.2008.11.018; Bouwens MD, 2003, GRAEF ARCH CLIN EXP, V241, P89, DOI 10.1007/s00417-002-0613-5; Tanikawa A, 1999, AM J OPHTHALMOL, V127, P559, DOI 10.1016/S0002-9394(98)00447-4; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Kim JH, 2013, GRAEF ARCH CLIN EXP, V251, P1055, DOI 10.1007/s00417-012-2120-7; MARGHERIO RR, 1985, OPHTHALMOLOGY, V92, P1075; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shimada H, 2009, OPHTHALMOLOGY, V116, P1370, DOI 10.1016/j.ophtha.2009.01.024; TRESE MT, 1983, GRAEF ARCH CLIN EXP, V221, P12, DOI 10.1007/BF02171725; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; PESIN SR, 1991, OPHTHALMOLOGY, V98, P1109; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Falkner-Radler CI, 2010, OPHTHALMOLOGY, V117, P798, DOI 10.1016/j.ophtha.2009.08.034; RICE TA, 1986, OPHTHALMOLOGY, V93, P602; Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046; Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404; Inoue M, 2011, RETINA-J RET VIT DIS, V31, P1366, DOI 10.1097/IAE.0b013e318203c156; Inoue M, 2010, AM J OPHTHALMOL, V150, P834, DOI 10.1016/j.ajo.2010.06.006; DEBUSTROS S, 1988, BRIT J OPHTHALMOL, V72, P692, DOI 10.1136/bjo.72.9.692; Hibi N, 2013, INVEST OPHTH VIS SCI, V54, P7207, DOI 10.1167/iovs.13-12884; Bae SH, 2013, AM J OPHTHALMOL, V155, P109, DOI 10.1016/j.ajo.2012.07.007; Matsumoto C, 2003, INVEST OPHTH VIS SCI, V44, P4012, DOI 10.1167/iovs.03-0117; Ko TH, 2005, OPHTHALMOLOGY, V112; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Wilkins JR, 1996, OPHTHALMOLOGY, V103, P2142	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	OCT	2015	35	10					2107	2114		10.1097/IAE.0000000000000602		8	Ophthalmology	Ophthalmology	CS6US	WOS:000362219000024		
J	Yamane, S; Hayashi, R				Yamane, Shoko; Hayashi, Ryohei			Peer Effects among Swimmers	SCANDINAVIAN JOURNAL OF ECONOMICS			English	Article						Online data; swimming	FAVORITISM; WORKPLACE	We develop a novel identification strategy and examine various aspects of peer effects using swimming data. We find that the performance of adjacent competitors positively influences swimmers' performances. In particular, swimmers are influenced by slower-lane peers, suggesting that being chased improves one's performance. We use absenteeism data to directly compare the performances of swimmers with and without peers. We have found that swimmers swim faster with peers swimming behind them than when swimming alone, but that they swim slower with peers swimming ahead. Finally, we find that observability is a key determinant of peer effects, by comparing freestyle and backstroke competitions.	[Yamane, Shoko] Kinki Univ, Higashiosaka, Osaka 5778502, Japan; [Hayashi, Ryohei] Kagoshima Natl Coll Technol, Kirishima 8995193, Japan	Yamane, S (reprint author), Kinki Univ, Higashiosaka, Osaka 5778502, Japan.	syamane@kindai.ac.jp; hayashi@kagoshima-ct.ac.jp					Gould ED, 2011, LABOUR ECON, V18, P338, DOI 10.1016/j.labeco.2010.10.004; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Rivkin SG, 2001, ECON EDUC REV, V20, P201, DOI 10.1016/S0272-7757(00)00032-7; Gneezy U, 2004, AM ECON REV, V94, P377, DOI 10.1257/0002828041301821; Mas A, 2009, AM ECON REV, V99, P112, DOI 10.1257/aer.99.1.112; Angrist JD, 2004, AM ECON REV, V94, P1613, DOI 10.1257/0002828043052169; Zimmerman DJ, 2003, REV ECON STAT, V85, P9, DOI 10.1162/003465303762687677; Guryan J, 2009, AM ECON J-APPL ECON, V1, P34, DOI 10.1257/app.1.4.34; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Bandiera O, 2010, REV ECON STUD, V77, P417, DOI 10.1111/j.1467-937X.2009.00574.x; Pessin J, 1933, AM J PSYCHOL, V45, P263, DOI 10.2307/1414277; Brown J, 2011, J POLIT ECON, V119, P982, DOI 10.1086/663306; Sutter M, 2004, J ECON PSYCHOL, V25, P461, DOI 10.1016/S0167-4870(03)00013-8; Garicano L, 2005, REV ECON STAT, V87, P208, DOI 10.1162/0034653053970267; Boozer M., 2001, 832 YAL EC GROWTH CT; Case A.C., 1991, 3705 NBER; EVANS WN, 1992, J POLIT ECON, V100, P966, DOI 10.1086/261848; Falk A., 2006, J LABOR ECON, V24, P39, DOI 10.1086/497818; Hoxby C. M., 2000, 7867 NBER; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Paserman D., 2009, 6335 CEPR; Pettersson-Lidbom P., 2013, ECON LETT, V108, P212; Priks M., 2013, 4481 CESIFO; Sacerdote B, 2010, HDB EC ED, V3, P249; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI 10.2307/1412188	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0347-0520	1467-9442		SCAND J ECON	Scand. J. Econ.	OCT	2015	117	4					1230	1255		10.1111/sjoe.12124		26	Economics	Business & Economics	CS6QW	WOS:000362207000007		
J	Koyanagi, A; Stickley, A; Haro, JM				Koyanagi, Ai; Stickley, Andrew; Haro, Josep Maria			Subclinical psychosis and suicidal behavior in England: Findings from the 2007 Adult Psychiatric Morbidity Survey	SCHIZOPHRENIA RESEARCH			English	Article						Suicide; Suicidal behavior; Epidemiology; Psychotic symptom	GENERAL-POPULATION; DISORDERS; SCHIZOPHRENIA; EXPERIENCES; RISK; SYMPTOMS; DEPRESSION; PREVALENCE; THOUGHTS; ANXIETY	Background: Psychotic disorders have been associated with suicidality but information on the association between subclinical psychosis and suicidality in the general adult population is scarce. Methods: Data from the 2007 Adult Psychiatric Morbidity Survey (n= 7403) were analyzed. This was a nationally representative survey of the English adult household population (aged >= 16 years). Five types of psychotic symptoms (hypomania, thought control, paranoia, strange experience, auditory hallucination) occurring in the past 12 months were assessed with the Psychosis Screening Questionnaire. Participants with probable or definite psychosis were excluded. Logistic regression analysis was used to assess the association between psychotic symptoms and suicidal ideation and suicide attempt in the past 12 months. Results: The prevalence of at least one psychotic symptom was 5.4%. After adjusting for potential confounders including mental disorders, each individual psychotic symptom was significantly associated with suicidal ideation with odds ratios (ORs) ranging from 3.22 to 4.20. With the exception of thought control, all symptoms were also associated with significantly higher odds for suicide attempt (ORs 3.95 to 10.23). Having at least one psychotic symptom was associated with ORs of 3.13 (95% CI 2.09-4.68) and 3.84 (95% CI 1.67-8.83) for suicidal ideation and suicide attempt respectively. In addition, a greater number of psychotic symptoms was associated with higher odds for suicidal ideation and suicide attempt. Conclusions: Psychotic symptoms, regardless of the type, were independently associated with higher odds for suicidal ideation and suicide attempt. Assessment and management of suicide risk in individuals with psychotic symptoms may be important for suicide prevention. (C) 2015 Elsevier B.V. All rights reserved.	[Koyanagi, Ai; Haro, Josep Maria] Univ Barcelona, Fundacio St Joan Deu, Barcelona 08830, Spain; [Koyanagi, Ai; Haro, Josep Maria] CIBERSAM, Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid 28029, Spain; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, S-14189 Huddinge, Sweden; [Stickley, Andrew] Univ Tokyo, Dept Human Ecol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Stickley, Andrew] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo 1878553, Japan	Koyanagi, A (reprint author), Fundacio St Joan Deu, Res & Dev Unit, Parc Sanitari St Joan Deu,Dr Antoni Pujadas 42, Barcelona 08830, Spain.	a.koyanagi@pssjd.org; andrew.stickley@sh.se; jmharo@pssjd.org			ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER);  [CP13/00150]	Ai Koyanagi's work was supported by the Miguel Servet contract financed by the CP13/00150 project, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). These organizations had no role in the study design, collection, analysis and interpretation; in the writing of the manuscript; and in the decision to submit the paper for publication.	ALLEBECK P, 1989, SCHIZOPHRENIA BULL, V15, P81; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; DeVylder JE, 2015, EARLY INTERV PSYCHIA, V9, P331, DOI 10.1111/eip.12161; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Kaymaz N, 2010, PSYCHOL MED, V40, P1963, DOI 10.1017/S0033291710000358; Woznica AA, 2015, SLEEP MED REV, V22, P37, DOI 10.1016/j.smrv.2014.10.004; Freeman D, 2012, SOC PSYCH PSYCH EPID, V47, P1195, DOI 10.1007/s00127-011-0433-1; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Boyda D, 2015, PSYCHIAT RES, V226, P376, DOI 10.1016/j.psychres.2015.01.023; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; [Anonymous], 2013, OFF NAT STAT STAT B; Jonas S, 2014, EPIDEMIOL PSYCH SCI, V23, P189, DOI 10.1017/S2045796013000292; CALDWELL CB, 1992, SUICIDE LIFE-THREAT, V22, P479; Peraala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Jenkins R, 2009, SOC PSYCH PSYCH EPID, V44, P899, DOI 10.1007/s00127-009-0112-7; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Varghese D, 2011, SCHIZOPHRENIA BULL, V37, P389, DOI 10.1093/schbul/sbp083; Tsuang MT, 2013, SCHIZOPHR RES, V150, P31, DOI 10.1016/j.schres.2013.05.004; Saha S, 2011, SCHIZOPHR RES, V132, P197, DOI 10.1016/j.schres.2011.07.012; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037//0022-006X.68.3.371; Taylor PJ, 2015, PSYCHOL MED, V45, P911, DOI 10.1017/S0033291714002074; Peralta V, 1999, SCHIZOPHR RES, V38, P13, DOI 10.1016/S0920-9964(99)00003-1; Saha S, 2011, SCHIZOPHR RES, V127, P246, DOI 10.1016/j.schres.2010.12.012; VazquezBarquero JL, 1996, BRIT J PSYCHIAT, V168, P693, DOI 10.1192/bjp.168.6.693; Kasckow J, 2011, CNS DRUGS, V25, P129, DOI 10.2165/11586450-000000000-00000; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; DeVylder JE, 2015, JAMA PSYCHIAT, V72, P219, DOI 10.1001/jamapsychiatry.2014.2663; Gunnell D, 2004, BRIT J PSYCHIAT, V185, P385, DOI 10.1192/bjp.185.5.385; McManus S, 2009, ADULT PSYCHIAT MORBI; Stickley A., 2015, SLEEP IN PRESS; Wing J. K, 1974, DESCRIPTION CLASSIFI; World Health Organization, 2014, PREV SUIC GLOB IMP; World Health Organization, 1992, SCAN SCHED CLIN ASS	34	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					62	67		10.1016/j.schres.2015.07.041		6	Psychiatry	Psychiatry	CS1LK	WOS:000361826400010		
J	Fujita, J; Takahashi, Y; Nishida, A; Okumura, Y; Ando, S; Kawano, M; Toyohara, K; Sho, N; Minami, T; Arai, T				Fujita, Junichi; Takahashi, Yuichi; Nishida, Atsushi; Okumura, Yasuyuki; Ando, Shuntaro; Kawano, Miho; Toyohara, Koji; Sho, Noriko; Minami, Tatsuya; Arai, Takashi			Auditory verbal hallucinations increase the risk for suicide attempts in adolescents with suicidal ideation	SCHIZOPHRENIA RESEARCH			English	Article						Auditory verbal hallucination; Suicide attempt; Depression; Early adolescents; Child and adolescent mental health clinic	PSYCHOTIC-LIKE EXPERIENCES; SELF-HARM; BEHAVIOR; CARE; PREDICTORS; PREVENTION; DEPRESSION; CHILDREN; VOICES; SAMPLE	Objective: It is important to prevent patients with suicidal ideation from actually attempting suicide. A school based cohort study suggested that auditory verbal hallucinations (AVHs) might play an important role in driving young people with mental health problems to attempt suicide. However, no clinical study to date has specifically investigated the association between AVHs and suicide attempts among young patients with suicidal ideation. Method: We conducted a cross-sectional study of first-visit psychiatric referrals aged 10-15 years at two general child and adolescent mental health hospitals in Japan. We administered self-reported questionnaires to measure suicidal ideation and suicide attempts, AVHs, and depression in the two weeks prior to the date of first-visit. Results: Among 188 patients with suicidal ideation, the presence of AVHs was associated with increased odds of suicide attempts (OR 3.4, 95% CI 1.7-6.9; p < 0.05); however, depression was not associated with a significant change of odds (OR 0.7, 95% CI 0.4-1.3; p = 0.29). Conclusions: AVHs may increase the risk of suicide attempts made by adolescents with suicidal ideation. Clinicians should consider AVHs when adolescent patients present with suicidal ideation. (C) 2015 Elsevier B.V. All rights reserved.	[Fujita, Junichi; Toyohara, Koji; Sho, Noriko; Minami, Tatsuya; Arai, Takashi] Kanagawa Childrens Med Ctr, Dept Child & Adolescent Psychiat, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Takahashi, Yuichi] Yokohama City Univ, Med Ctr, Ctr Psychiat, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Nishida, Atsushi; Ando, Shuntaro] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan; [Okumura, Yasuyuki] Inst Hlth Econ & Policy, Minato Ku, Tokyo 1050003, Japan; [Kawano, Miho] Tokyo Womens Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1628666, Japan; [Fujita, Junichi] Yokohama City Univ Med, Dept Child Psychiat, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Fujita, J (reprint author), Kanagawa Childrens Med Ctr, Dept Child & Adolescent Psychiat, Minami Ward, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	juniteef@gmail.com			Health and Labour Sciences Research Grant for a general research project for mental and physical disabilities from the Japanese Ministry of Health, Labour and Welfare [22-101]	This work was supported by a Health and Labour Sciences Research Grant for a general research project for mental and physical disabilities in 2010, from the Japanese Ministry of Health, Labour and Welfare (Grant No. 22-101). The opinions expressed in this article are those of the authors and do not represent the official views of the Ministry.	Nishida A, 2010, ACTA PSYCHIAT SCAND, V121, P301, DOI 10.1111/j.1600-0447.2009.01439.x; Kelleher I, 2014, PSYCHOL MED, V44, P1615, DOI 10.1017/S0033291713002122; Nishida A, 2008, SCHIZOPHR RES, V99, P125, DOI 10.1016/j.schres.2007.11.038; Page A, 2011, BRIT J PSYCHIAT, V199, P423, DOI 10.1192/bjp.bp.111.093856; Caetano SC, 2006, J AFFECT DISORDERS, V91, P33, DOI 10.1016/j.jad.2005.12.008; Aleman A, 2014, NATURE, V509, P421; Gardner W, 2010, PEDIATRICS, V125, P945, DOI 10.1542/peds.2009-1964; Wichstrom L, 2009, ARCH SUICIDE RES, V13, P105, DOI 10.1080/13811110902834992; Escher S, 2002, BRIT J PSYCHIAT, V181, pS10, DOI 10.1192/bjp.181.43.s10; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Yoshizumi T, 2004, J AM ACAD CHILD PSY, V43, P1030, DOI 10.1097/01.chi.0000126937.44875.6b; Hysinger EB, 2011, PEDIATRICS, V128, P447, DOI 10.1542/peds.2010-3262; Kelleher I, 2013, JAMA PSYCHIAT, V70, P940, DOI 10.1001/jamapsychiatry.2013.140; de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Spirito A, 2003, J CLIN CHILD ADOLESC, V32, P284, DOI 10.1207/S15374424JCCP3202_14; Bucci S, 2013, SCHIZOPHR RES, V147, P163, DOI 10.1016/j.schres.2013.02.037; Klonsky ED, 2014, SUICIDE LIFE-THREAT, V44, P1, DOI 10.1111/sltb.12068; Miranda R, 2013, ANN NY ACAD SCI, V1304, P14, DOI 10.1111/nyas.12291; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Reinherz HZ, 2006, AM J PSYCHIAT, V163, P1226, DOI 10.1176/appi.ajp.163.7.1226; Escher S, 2004, INT J SOC WELF, V13, P208, DOI 10.1111/j.1369-6866.2004.00315.x; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; McFeeters D., 2014, J AFFECT DISORDERS, V175, P192	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					209	212		10.1016/j.schres.2015.07.028		4	Psychiatry	Psychiatry	CS1LK	WOS:000361826400030		
J	Takahashi, S; Glatt, SJ; Uchiyama, M; Faraone, SV; Tsuang, MT				Takahashi, Sakae; Glatt, Stephen J.; Uchiyama, Makoto; Faraone, Stephen V.; Tsuang, Ming T.			Meta-analysis of data from the Psychiatric Genomics Consortium and additional samples supports association of CACNA1C with risk for schizophrenia	SCHIZOPHRENIA RESEARCH			English	Article						Schizophrenia; Genome-wide association study; PGC; Follow-up study; Meta-analysis; CACNA1C	WIDE ASSOCIATION; COMMON VARIANTS; GENOMEWIDE ASSOCIATION; HAN CHINESE; LOCI; ENVIRONMENT; LINKAGE; TAIWAN; GENES	Recently, numerous genome-wide association studies (GWASs) have identified numerous risk loci for schizophrenia, but follow-up studies are still essential to confirm those results. Therefore, we followed up on top GWAS hits by genotyping implicated loci in additional schizophrenia family samples from our own collection. Five-hundred thirty-six Asian families (comprising 1633 members including 698 schizophrenics) were genotyped in this study. We analyzed 12 single nucleotide polymorphisms (SNPs) in strongly implicated candidate genes revealed by GWASs and their follow-up studies. We then used meta-analysis to combine our results with those of the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC). In our newly genotyped samples, there were no significant associations of any of the 12 candidate SNPs with schizophrenia; however, all genome-wide significant results from the schizophrenia PGC analysis were maintained after combination with our new data by meta-analysis. One SNP (rs4765905 in CACNA1C) showed a stronger effect and decreased p-value (5.14e-17) after meta-analysis relative to the original PGC results, with no significant between-study heterogeneity. The findings of this study support the significant results in the PGC, especially for CACNA1C. The sample size in our study was considerably smaller than that in the PGC-SCZ study; thus, the weights carried by our samples in the meta-analysis were small. Therefore, our data could not vastly reduce PGC association signals. However, we considered that the well replicated results from the PGC hold up in our new samples, and may suggest that the top hits from the PGC are generalizable, even to other ancestral groups. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Sakae; Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Div Psychiat, Tokyo, Japan; [Tsuang, Ming T.] Univ Calif San Diego, Ctr Behav Gen, Dept Psychiat, La Jolla, CA 92093 USA; [Tsuang, Ming T.] Univ Calif San Diego, Inst Gen Med, La Jolla, CA 92093 USA; [Tsuang, Ming T.] Harvard Univ, Sch Publ Hlth, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; [Glatt, Stephen J.; Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Glatt, Stephen J.; Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	Tsuang, MT (reprint author), Univ Calif San Diego, Ctr Behav Gen, Dept Psychiat, MTF 453,MC 0603,9500 Gilman Dr, La Jolla, CA 92093 USA.	mtsuang@ucsd.edu		Glatt, Stephen/0000-0002-0360-7567; Faraone, Stephen/0000-0002-9217-3982	Japanese Ministry of Education, Science, Sports and Culture of Japan [23591683]; U.S. National Institute of Mental Health; Gerber Foundation; Sidney R. Baer, Jr. Foundation; NARSAD: The Brain and Behavior Research Foundation	This research was supported in part by grants from the Scientific Research on Priority Areas (C) of the Japanese Ministry of Education, Science, Sports and Culture of Japan, 23591683 (S. T.) and by grants from the U.S. National Institute of Mental Health, the Gerber Foundation, the Sidney R. Baer, Jr. Foundation, and NARSAD: The Brain and Behavior Research Foundation (S.J.G.).	Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Glatt SJ, 2009, MOL PSYCHIATR, V14, P885, DOI 10.1038/mp.2008.30; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Purcell SM, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 2011, NAT GENET, V43, P969	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					429	433		10.1016/j.schres.2015.07.033		5	Psychiatry	Psychiatry	CS1LK	WOS:000361826400061		
J	Yamada, K; Hattori, E; Iwayama, Y; Toyota, T; Iwata, Y; Suzuki, K; Kikuchi, M; Hashimoto, T; Kanahara, N; Mori, N; Yoshikawa, T				Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Toyota, Tomoko; Iwata, Yasuhide; Suzuki, Katsuaki; Kikuchi, Mitsuru; Hashimoto, Tasuku; Kanahara, Nobuhisa; Mori, Norio; Yoshikawa, Takeo			Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility	SCHIZOPHRENIA RESEARCH			English	Article						Major histocompatibility complex; Schizophrenia; Single nucleotide polymorphism; Association study; Solute carrier family 44 member 4 mutS homolog 5-suppressor APC domain containing 1	GENOME-WIDE ASSOCIATION; COMMON VARIANTS; SIALIDOSIS; HLA	There is consistent data from European cohorts suggesting a genetic contribution from the major histocompatibility complex (MHC) to the pathogenesis of schizophrenia. However, the genomic complexity and ethnicity-specific diversity found in the MHC cause difficulties in identifying causal variants or genes, and there is a need for studies encompassing the entire MHC region in multiple ethnic populations. Here, we report on association signals in the MHC region, with schizophrenia in the Japanese population. We genotyped and imputed a total of 10,131 single nucleotide polymorphisms (SNPs), spanning the entire MHC interval. The analysis included 3302 participants (1518 schizophrenics and 1784 healthy controls) from the Japanese population. In this study, we present evidence for association at rs494620, located in the SLC44A4 gene. The association survived after correction for multiple testing (unadjusted P = 7.78 x 10(-5), empirical P = 0.0357). The imputation results detected the highest association at rs707937 in the MSH5-SAPCD1 gene (imputed P = 8.40 x 10(-5)). In expression analysis using postmortem brains from schizophrenia and control samples, MSH5-SAPCD1 showed marginally significant expression differences in Brodmann's area 46 (P = 0.044 by unpaired t test with Welch's correction, P = 0.099 by Mann-Whitney U test). Our study further strengthens evidence for the involvement of the MHC in schizophrenia across populations, and provides insight into population-specific mechanisms for the MHC region in schizophrenia susceptibility. (C) 2015 Elsevier B.V. All rights reserved.	[Yamada, Kazuo; Hattori, Eiji; Iwayama, Yoshimi; Toyota, Tomoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Iwata, Yasuhide; Suzuki, Katsuaki; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan; [Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9208641, Japan; [Hashimoto, Tasuku; Kanahara, Nobuhisa] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba 2608677, Japan	Yoshikawa, T (reprint author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan.	takeo@brain.riken.jp			Japan Society for the Promotion of Science (JSPS), Japan; RIKEN Brain Science Institute Funds	This study was supported in part by Grants-in-Aid for Scientific Research (K.Y. and T.Y.) and by Grant-in-Aid for Scientific Research on Innovative Areas (T.Y.), from the Japan Society for the Promotion of Science (JSPS), Japan. In addition, this study was supported by RIKEN Brain Science Institute Funds (T.Y.), and a part of this study is the result of the "Development of biomarker candidates for social behavior" (T.Y.) and "Integrated research on neuropsychiatric disorders" projects (N.M.), carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; Wang ZQ, 2006, AM J MED GENET B, V141B, P902, DOI 10.1002/ajmg.b.30383; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Uhl J, 2002, FEBS LETT, V521, P19, DOI 10.1016/S0014-5793(02)02748-5; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Muller N, 2014, NEUROIMMUNOMODULAT, V21, P109, DOI 10.1159/000356538; Viatte S, 2015, JAMA-J AM MED ASSOC, V313, P1645, DOI 10.1001/jama.2015.3435; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich HA, 2013, DIABETES, V62, P2618, DOI 10.2337/db12-1387; Ikeda M, 2013, MOL PSYCHIATR, V18, P636, DOI 10.1038/mp.2012.74; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Wright P, 2001, SCHIZOPHR RES, V47, P1, DOI 10.1016/S0920-9964(00)00022-0; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Inazu M, 2014, BIOPHARM DRUG DISPOS, V35, P431, DOI 10.1002/bdd.1892; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Song GG, 2013, MOL BIOL REP, V40, P2557, DOI 10.1007/s11033-012-2341-1; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Balan S., 2014, J NEURAL TRANSM, V122, P477; Maekawa M., 2014, BIOL PSYCHIAT, V78, P116; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Purcell SM, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; Rakshambikai R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078753; Schizophrenia Working Group of the Psychiatric Genomics C, 2014, NATURE, V511, P421, DOI DOI 10.1038/NATURE13595; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					444	449		10.1016/j.schres.2015.08.018		6	Psychiatry	Psychiatry	CS1LK	WOS:000361826400063		
J	Hashioka, S; McGeer, PL; Miyaoka, T; ReiWake; Horiguchi, J				Hashioka, Sadayuki; McGeer, Patrick L.; Miyaoka, Tsuyoshi; ReiWake; Horiguchi, Jun			Can inhibition of microglial activation cure schizophrenia?	SCHIZOPHRENIA RESEARCH			English	Letter									[Hashioka, Sadayuki; Miyaoka, Tsuyoshi; ReiWake; Horiguchi, Jun] Shimane Univ, Fac Med, Dept Psychiat, Izumo, Shimane 6938501, Japan; [McGeer, Patrick L.] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada	Hashioka, S (reprint author), Shimane Univ, Fac Med, Dept Psychiat, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	hashioka@f2.dion.ne.jp			JSPS [24591721]	Sincere appreciation is extended to Dr. Edith G. McGeer for her invaluable support. This work was supported by JSPS KAKENHI Grant Number 24591721 (SH).	Radewicz K, 2000, J NEUROPATH EXP NEUR, V59, P137; SMITH RS, 1995, MED HYPOTHESES, V45, P135, DOI 10.1016/0306-9877(95)90062-4; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174; Bayer TA, 1999, NEUROSCI LETT, V271, P126, DOI 10.1016/S0304-3940(99)00545-5; Del Rio-Hortega P., 1932, CYTOLOGY CELLULAR PA, P482; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; McGeer E. G., 2014, EXPER OPIN THER TAR, P1	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					583	584		10.1016/j.schres.2015.07.042		2	Psychiatry	Psychiatry	CS1LK	WOS:000361826400087		
J	Yada, Y; Yoshimura, B; Kishi, Y				Yada, Yuji; Yoshimura, Bunta; Kishi, Yoshiki			Correlation between delay in initiating clozapine and symptomatic improvement	SCHIZOPHRENIA RESEARCH			English	Letter						Clozapine; Schizophrenia; Treatment-resistant; Delay	UNTREATED PSYCHOSIS; RESISTANT SCHIZOPHRENIA; DURATION; AUGMENTATION; METAANALYSIS		[Yada, Yuji; Yoshimura, Bunta; Kishi, Yoshiki] Okayama Psychiat Med Ctr, Dept Psychiat, Okayama 7000915, Japan	Yoshimura, B (reprint author), Okayama Psychiat Med Ctr, Kita Ku, 3-16 Shikatahonmachi, Okayama 7000915, Japan.	hajime-greentea@hotmail.co.jp					Howes OD, 2012, BRIT J PSYCHIAT, V201, P481, DOI 10.1192/bjp.bp.111.105833; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Penttila M, 2014, BRIT J PSYCHIAT, V205, P88, DOI 10.1192/bjp.bp.113.127753; Nielsen J, 2010, J PSYCHOPHARMACOL, V24, P965, DOI 10.1177/0269881108100320; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Guy W., 1976, ECDEU ASSESSMENT MAN; Miyamoto S, 2015, CURR OPIN PSYCHIATR, V28, P243, DOI 10.1097/YCO.0000000000000159; Muscatello MRA, 2014, EXPERT OPIN PHARMACO, V15, P2329, DOI 10.1517/14656566.2014.956082; Petrides G, 2015, AM J PSYCHIAT, V172, P52, DOI 10.1176/appi.ajp.2014.13060787	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	OCT	2015	168	1-2					585	586		10.1016/j.schres.2015.07.045		2	Psychiatry	Psychiatry	CS1LK	WOS:000361826400088		
J	Hagiwara, K; Gailhouste, L; Yasukawa, K; Kosaka, N; Ochiya, T				Hagiwara, Keitaro; Gailhouste, Luc; Yasukawa, Ken; Kosaka, Nobuyoshi; Ochiya, Takahiro			A robust screening method for dietary agents that activate tumour-suppressor microRNAs	SCIENTIFIC REPORTS			English	Article							PANCREATIC-CANCER CELLS; NF-KAPPA-B; BREAST-CANCER; NATURAL-PRODUCTS; E-CADHERIN; INVASION; PATHWAY; EXPRESSION; MIR-200; METASTASIS	Certain dietary agents, such as natural products, have been reported to show anti-cancer effects. However, the underlying mechanisms of these substances in human cancer remain unclear. We recently found that resveratrol exerts an anti-cancer effect by upregulating tumour-suppressor microRNAs (miRNAs). In the current study, we aimed to identify new dietary products that have the ability to activate tumour-suppressor miRNAs and that therefore may serve as novel tools for the prevention and treatment of human cancers. We describe the generation and use of an original screening system based on a luciferase-based reporter vector for monitoring miR-200c tumour-suppressor activity. By screening a library containing 139 natural substances, three natural compounds -enoxolone, magnolol and palmatine chloride -were identified as being capable of inducing miR-200c expression in breast cancer cells at 10 mu M. Moreover, these molecules suppressed the invasiveness of breast cancer cells in vitro. Next, we identified a molecular pathway by which the increased expression of miR-200c induced by natural substances led to ZEB1 inhibition and E-cadherin induction. These results indicate that our method is a valuable tool for a fast identification of natural molecules that exhibit tumour-suppressor activity in human cancer through miRNA activation.	[Hagiwara, Keitaro; Gailhouste, Luc; Yasukawa, Ken; Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Yasukawa, Ken] Waseda Univ, Grad Sch Sci & Engn, Integrat Biosci & Biomed Engn, Shinjuku Ku, Tokyo 1628480, Japan	Ochiya, T (reprint author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tochiya@ncc.go.jp			Ministry of Education, Culture, Sports, Science and Technology; National Cancer Center Research and Development Fund; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); Project for Development of Innovative Research on Cancer Therapeutics; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&Don Science and Technology (FIRST Program)"	This work was supported in part by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, a Grant-in-Aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology, the National Cancer Center Research and Development Fund, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), Project for Development of Innovative Research on Cancer Therapeutics, and the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&Don Science and Technology (FIRST Program)" initiated by the Council for Science and Technology Policy (CSTP). We thank Ayako Inoue for excellent technical assistance. We thank Takeshi Katsuda for providing the information regarding primers for qRT-PCR.	Akl MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097622; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; COLEMAN DL, 1990, DIABETES, V39, P432, DOI 10.2337/diabetes.39.4.432; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Jayasooriya RGPT, 2014, TOXICOL IN VITRO, V28, P751, DOI 10.1016/j.tiv.2014.02.015; VENNERSTROM JL, 1988, J MED CHEM, V31, P1084, DOI 10.1021/jm00401a006; Epstein LH, 1998, PEDIATRICS, V101, P554; PERDUE RE, 1976, CANCER TREAT REP, V60, P987; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lee HS, 2002, J AGR FOOD CHEM, V50, P7013, DOI 10.1021/jf020674o; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Davis CD, 2007, NUTR REV, V65, P88, DOI 10.1301/nr.2007.feb.88-94; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Sharma G, 2012, J CELL PHYSIOL, V227, P1923, DOI 10.1002/jcp.22920; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Hammell CM, 2009, CELL, V136, P926, DOI 10.1016/j.cell.2009.01.053; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Fu YH, 2013, J ETHNOPHARMACOL, V145, P193, DOI 10.1016/j.jep.2012.10.051; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Hagiwara K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00314; Hambright HG, 2015, MOL CARCINOGEN, V54, P1227, DOI 10.1002/mc.22192; Liu Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03098; Takeshita F, 2009, MOL THER, V18, P181	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14697	10.1038/srep14697		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CS5CP	WOS:000362094000002		
J	Jiang, LL; Li, WJ; Wang, Z				Jiang, Luo-Luo; Li, Wen-Jing; Wang, Zhen			Multiple effect of social influence on cooperation in interdependent network games	SCIENTIFIC REPORTS			English	Article							EVOLUTIONARY GAMES; PRISONERS-DILEMMA; EMERGENCE; SELECTION; GRAPHS; IMPACT	The social influence exists widely in the human society, where individual decision-making process (from congressional election to electronic commerce) may be affected by the attitude and behavior of others belonging to different social networks. Here, we couple the snowdrift (SD) game and the prisoner's dilemma (PD) game on two interdependent networks, where strategies in both games are associated by social influence to mimick the majority rule. More accurately, individuals' strategies updating refers to social learning (based on payoff difference) and above-mentioned social influence (related with environment of interdependent group), which is controlled by social influence strength s. Setting s = 0 decouples the networks and returns the traditional network game; while its increase involves the interactions between networks. By means of numerous Monte Carlo simulations, we find that such a mechanism brings multiple influence to the evolution of cooperation. Small s leads to unequal cooperation level in both games, because social learning is still the main updating rule for most players. Though intermediate and large s guarantees the synchronized evolution of strategy pairs, cooperation finally dies out and reaches a completely dominance in both cases. Interestingly, these observations are attributed to the expansion of cooperation clusters. Our work may provide a new understanding to the emergence of cooperation in intercorrelated social systems.	[Jiang, Luo-Luo] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Peoples R China; [Li, Wen-Jing] Zhejiang DongFang Vocat & Tech Coll, Wenzhou 325035, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Wang, Zhen] Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China	Jiang, LL (reprint author), Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Peoples R China.	jiangluoluo@gmail.com; zhenwang0@gmail.com	Wang, Zhen/H-5017-2011		National Natural Science Foundation of China [61203145, 11047012]	This work is supported by: The National Natural Science Foundation of China (Grant Nos 61203145 and 11047012).	Aguirre J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.248701; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Lewis K, 2012, P NATL ACAD SCI USA, V109, P68, DOI 10.1073/pnas.1109739109; Lee S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061148; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Wang Y, 2012, PHYS LETT A, V376, P2689, DOI 10.1016/j.physleta.2012.07.037; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Gelimson A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042711; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Portillo IG, 2014, PHYSICA A, V394, P198, DOI 10.1016/j.physa.2013.10.008; Balinski M, 2007, P NATL ACAD SCI USA, V104, P8720, DOI 10.1073/pnas.0702634104; Cui PB, 2013, PHYSICA A, V392, P1500, DOI 10.1016/j.physa.2012.10.039; Oprea RD, 2007, P NATL ACAD SCI USA, V104, P1093, DOI 10.1073/pnas.0609866104; Shao S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032812; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Axelrod R., 1984, EVOLUTION COOPERATIO; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Grund T, 2013, NAT SCI REP, V3, P1480; Halu A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/16002; Jiang LL, 2007, J PHYS A-MATH THEOR, V40, P11271, DOI 10.1088/1751-8113/40/37/005; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Szolnoki A, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/28004; Santos MD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04436; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szolnoki A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1299; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A., 2015, NEW J PHYS, V15; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z., PHYS LIFE R IN PRESS; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14657	10.1038/srep14657		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CS4ZL	WOS:000362084900002		
J	Katsura, Y; Kubota, H; Kunida, K; Kanno, A; Kuroda, S; Ozawa, T				Katsura, Yoshihiro; Kubota, Hiroyuki; Kunida, Katsuyuki; Kanno, Akira; Kuroda, Shinya; Ozawa, Takeaki			An optogenetic system for interrogating the temporal dynamics of Akt	SCIENTIFIC REPORTS			English	Article							AKT/PROTEIN KINASE-B; LIVING CELLS; TRANSCRIPTION FACTORS; GLUT4 TRANSLOCATION; POSITIVE FEEDBACK; ACTIVATION; PATHWAY; SIGNALS; PHOSPHORYLATION; DOWNSTREAM	The dynamic activity of the serine/threonine kinase Akt is crucial for the regulation of diverse cellular functions, but the precise spatiotemporal control of its activity remains a critical issue. Herein, we present a photo-activatable Akt (PA-Akt) system based on a light-inducible protein interaction module of Arabidopsis thaliana cryptochrome2 (CRY2) and CIB1. Akt fused to CRY2phr, which is a minimal light sensitive domain of CRY2 (CRY2-Akt), is reversibly activated by light illumination in several minutes within a physiological dynamic range and specifically regulates downstream molecules and inducible biological functions. We have generated a computational model of CRY2-Akt activation that allows us to use PA-Akt to control the activity quantitatively. The system provides evidence that the temporal patterns of Akt activity are crucial for generating one of the downstream functions of the Akt-FoxO pathway; the expression of a key gene involved in muscle atrophy (Atrogin-1). The use of an optical module with computational modeling represents a general framework for interrogating the temporal dynamics of biomolecules by predictive manipulation of optogenetic modules.	[Katsura, Yoshihiro; Kanno, Akira; Ozawa, Takeaki] Univ Tokyo, Dept Chem, Sch Sci, Tokyo 1130033, Japan; [Kubota, Hiroyuki; Kunida, Katsuyuki; Kuroda, Shinya] Univ Tokyo, Dept Biol Sci, Sch Sci, Tokyo 1130033, Japan; [Kubota, Hiroyuki] Kyushu Univ, Div Integrated Omics, Res Ctr Trans Med, Med Inst Bioregulat,Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Kubota, Hiroyuki; Kunida, Katsuyuki; Kuroda, Shinya; Ozawa, Takeaki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Ozawa, T (reprint author), Univ Tokyo, Dept Chem, Sch Sci, 7-3-1 Bunkyo Ku, Tokyo 1130033, Japan.	ozawa@chem.s.u-tokyo.ac.jp			CREST from Japan Science and Technology (JST); JSPS KAKENHI, Japan [26220805, 26620128]; Naito Foundation; Astellas Foundation	We thank Genki Kawamura for technical assistances. This work was supported by CREST from Japan Science and Technology (JST), and JSPS KAKENHI Grant Numbers 26220805, 26620128, Japan. This work was also supported in part by grants from the Naito Foundation and the Astellas Foundation to T.O.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Miura H, 2014, CELL STRUCT FUNCT, V39, P9; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/nmeth.1700, 10.1038/NMETH.1700]; Ali IU, 1999, J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI [10.1038/nmeth.1524, 10.1038/NMETH.1524]; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14589	10.1038/srep14589		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CS4YJ	WOS:000362082000001		
J	Nagata, M; Nakamura, T; Hata, Y; Yamaguchi, S; Kaku, T; Kinoshita, S				Nagata, Maho; Nakamura, Takahiro; Hata, Yuiko; Yamaguchi, Shumpei; Kaku, Taiichi; Kinoshita, Shigeru			JBP485 promotes corneal epithelial wound healing	SCIENTIFIC REPORTS			English	Article							EPIDERMAL GROWTH-FACTOR; OCULAR SURFACE RECONSTRUCTION; INDUCED LIVER-INJURY; SUBSTANCE-P; NEUROTROPHIC KERATOPATHY; PLACENTAL EXTRACTS; AMNIOTIC MEMBRANE; AUTOLOGOUS SERUM; PEPTIDE PHSRN; EYE-DROPS	Proper wound healing is vital for maintenance of corneal integrity and transparency. Corneal epithelial damage is one of the most frequently observed ocular disorders. Because clinical options are limited, further novel treatments are needed to improve clinical outcomes for this type of disease. In the present study, it was found that placental extract-derived dipeptide (JBP485) significantly increased the proliferation and migration of corneal epithelial cells (CECs). Moreover, JBP485 accelerated corneal epithelial wound healing in vivo without inflammation and neovascularization and was found to be effective for the treatment of corneal damage. These data indicate that JBP485 efficiently activates the viability of CECs and has potential as a novel treatment for various kinds of corneal epithelial disease.	[Nagata, Maho; Nakamura, Takahiro; Hata, Yuiko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Nakamura, Takahiro] Doshisha Univ, Res Ctr Inflammat & Regenerat Med, Kyoto 602, Japan; [Yamaguchi, Shumpei; Kaku, Taiichi] Japan Bio Prod Co Ltd, Shibuya Ku, Tokyo 1510063, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	tnakamur@koto.kpu-m.ac.jp			Kyoto Foundation for the Promotion of Medical Science	The authors wish to thank T. Horikiri, S. Mano, S. Okura, M. Iwamoto, and H. Kato for assisting with the experimental procedures. This study was supported in part by Grants-in-Aid for scientific research from the research grant from Kyoto Foundation for the Promotion of Medical Science.	Kimura K, 2007, INVEST OPHTH VIS SCI, V48, P1110, DOI 10.1167/iovs.06-0704; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Liu T, 2012, TOXICOL APPL PHARM, V264, P423, DOI 10.1016/j.taap.2012.08.019; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Yang T, 2009, J PHARM PHARMACOL, V61, P767, DOI [10.1211/jpp.61.06.0009, 10.1211/jpp/61.06.0009]; Nakamura Y, 2001, EXP EYE RES, V72, P511, DOI 10.1006/exer.2000.0979; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; KITAZAWA T, 1990, INVEST OPHTH VIS SCI, V31, P1773; AOTA S, 1994, J BIOL CHEM, V269, P24756; Cang JA, 2010, DRUG METAB PHARMACOK, V25, P500, DOI 10.2133/dmpk.DMPK-10-RG-045; Wu JJ, 2008, BIOL PHARM BULL, V31, P2040, DOI 10.1248/bpb.31.2040; Yamada N, 2008, BRIT J OPHTHALMOL, V92, P896, DOI 10.1136/bjo.2007.130013; WATANABE K, 1988, INVEST OPHTH VIS SCI, V29, P572; Yamada N, 2012, CORNEA, V31, P1408, DOI 10.1097/ICO.0b013e31824afd6c; Nagano T, 2003, INVEST OPHTH VIS SCI, V44, P3810, DOI 10.1167/iovs.03-0189; NEZU E, 1992, JPN J OPHTHALMOL, V36, P401; Biswas TK, 2001, ACTA PHARMACOL SIN, V22, P1113; SAKAMOTO K, 1986, JPN J PHARMACOL, V41, P424, DOI 10.1254/jjp.41.424; Jung J, 2011, INT IMMUNOPHARMACOL, V11, P976, DOI 10.1016/j.intimp.2011.02.012; FOX RI, 1984, ARTHRITIS RHEUM, V27, P459, DOI 10.1002/art.1780270415; Sur TK, 2003, ACTA PHARMACOL SIN, V24, P187; Lu L, 2001, EXP BIOL MED, V226, P653; Nishida T, 1996, J CELL PHYSIOL, V169, P159, DOI 10.1002/(SICI)1097-4652(199610)169:1<159::AID-JCP16>3.0.CO;2-8; Wu CH, 2003, BRIT J DERMATOL, V148, P236, DOI 10.1046/j.1365-2133.2003.05164.x; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Liu KX, 2000, J PHARMACOL EXP THER, V294, P510; Nagata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093164; Nakamura T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10248; Quinto GG, 2008, ARQ BRAS OFTALMOL, V71, P47, DOI 10.1590/S0004-27492008000700010; Shukla V K, 2004, J Wound Care, V13, P177; Yagi Akira, 1998, Natural Medicines, V52, P156	32	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14776	10.1038/srep14776		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CS5DL	WOS:000362096500001		
J	Ohfuji, H; Irifune, T; Litasov, KD; Yamashita, T; Isobe, F; Afanasiev, VP; Pokhilenko, NP				Ohfuji, Hiroaki; Irifune, Tetsuo; Litasov, Konstantin D.; Yamashita, Tomoharu; Isobe, Futoshi; Afanasiev, Valentin P.; Pokhilenko, Nikolai P.			Natural occurrence of pure nano-polycrystalline diamond from impact crater	SCIENTIFIC REPORTS			English	Article							HIGH-PRESSURE; DIRECT CONVERSION; PHASE-TRANSITION; HIGH-TEMPERATURE; GRAPHITE; TRANSFORMATION; MECHANISM; MICROSTRUCTURES; COMPRESSION; LONSDALEITE	Consolidated bodies of polycrystalline diamond with grain sizes less than 100 nm, nano-polycrystalline diamond (NPD), has been experimentally produced by direct conversion of graphite at high pressure and high temperature. NPD has superior hardness, toughness and wear resistance to single-crystalline diamonds because of its peculiar nano-textures, and has been successfully used for industrial and scientific applications. Such sintered nanodiamonds have, however, not been found in natural mantle diamonds. Here we identified natural pure NPD, which was produced by a large meteoritic impact about 35 Ma ago in Russia. The impact diamonds consist of well-sintered equigranular nanocrystals (5-50 nm), similar to synthetic NPD, but with distinct [111] preferred orientation. They formed through the martensitic transformation from single-crystal graphite. Stress-induced local fragmentation of the source graphite and subsequent rapid transformation to diamond in the limited time scale result in multiple diamond nucleation and suppression of the overall grain growth, producing the unique nanocrystalline texture of natural NPD. A huge amount of natural NPD is expected to be present in the Popigai crater, which is potentially important for applications as novel ultra-hard material.	[Ohfuji, Hiroaki; Irifune, Tetsuo; Yamashita, Tomoharu; Isobe, Futoshi] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Irifune, Tetsuo] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528550, Japan; [Litasov, Konstantin D.; Afanasiev, Valentin P.; Pokhilenko, Nikolai P.] RAS, Siberian Branch, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia; [Litasov, Konstantin D.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Ohfuji, H (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	ohfuji@sci.ehime-u.ac.jp	Litasov, Konstantin/A-5366-2014		Japan Society for the Promotion of Science (JSPS) [20740255]; Ministry of Education and Science of Russian Federation [14.B25.31.0032]; Russian Foundation for Basic Research [13-05-00568]	We acknowledge financial support from the Japan Society for the Promotion of Science (JSPS) (Nos. 20740255). The work is partially supported by Ministry of Education and Science of Russian Federation (NO 14.B25.31.0032) and Russian Foundation for Basic Research (No. 13-05-00568).	Wen B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/5/062; Sumiya H, 2007, J MATER RES, V22, P2345, DOI 10.1557/JMR.2007.0295; Isobe F, 2013, J NANOMATER, DOI 10.1155/2013/380165; Koeberl C, 1997, GEOLOGY, V25, P967, DOI 10.1130/0091-7613(1997)025<0967:DFTPIS>2.3.CO;2; Nishiyama N, 2012, SCRIPTA MATER, V67, P955, DOI 10.1016/j.scriptamat.2012.08.028; Garvie LAJ, 2014, AM MINERAL, V99, P531, DOI 10.2138/am.2014.4658; Hough RM, 1997, GEOLOGY, V25, P1019, DOI 10.1130/0091-7613(1997)025<1019:DFTIRK>2.3.CO;2; Nishiyama N, 2013, SCRIPTA MATER, V69, P362, DOI 10.1016/j.scriptamat.2013.05.017; Sumiya H, 2012, DIAM RELAT MATER, V24, P44, DOI 10.1016/j.diamond.2011.10.013; Ohfuji H, 2010, HIGH PRESSURE RES, V30, P142, DOI 10.1080/08957951003600764; Khaliullin RZ, 2011, NAT MATER, V10, P693, DOI [10.1038/nmat3078, 10.1038/NMAT3078]; HIRAI H, 1991, SCIENCE, V253, P772, DOI 10.1126/science.253.5021.772; ENDO S, 1994, PHYS REV B, V49, P22, DOI 10.1103/PhysRevB.49.22; Nakamuta Y, 2013, AM MINERAL, V98, P574, DOI 10.2138/am.2013.4341; Langenhorst F, 1999, GEOLOGY, V27, P747, DOI 10.1130/0091-7613(1999)027<0747:DOIDIA>2.3.CO;2; Ohfuji H, 2009, J MINER PETROL SCI, V104, P307, DOI 10.2465/jmps.090622i; Mao WL, 2003, SCIENCE, V302, P425, DOI 10.1126/science.1089713; Masaitis VL, 1998, METEORIT PLANET SCI, V33, P349; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Yamada K, 2002, CARBON, V40, P261, DOI 10.1016/S0008-6223(01)00086-0; Ohfuji H, 2012, PHYS CHEM MINER, V39, P543, DOI 10.1007/s00269-012-0510-3; Ovid'ko IA, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/33/335301; Irifune T, 2003, NATURE, V421, P599, DOI 10.1038/421599b; El Goresy A, 2003, CR GEOSCI, V335, P889, DOI 10.1016/j.crte.2003.07.001; Haggerty SE, 2014, EARTH-SCI REV, V130, P49, DOI 10.1016/j.earscirev.2013.12.008; HOUGH RM, 1995, NATURE, V378, P41, DOI 10.1038/378041a0; Yamada K, 1999, CARBON, V37, P275, DOI 10.1016/S0008-6223(98)00175-4; Masaitis VL, 1999, GEOL S AM S, P317; Britun VF, 2004, POWDER METALL MET C+, V43, P87, DOI 10.1023/B:PMMC.0000028276.63784.8e; Kvasnytsya V, 2013, DIAM RELAT MATER, V32, P7, DOI 10.1016/j.diamond.2012.11.010; Irifune T, 2004, PHYS EARTH PLANET IN, V143, P593, DOI 10.1016/j.pepi.2003.06.004; HIRAI H, 1995, J APPL PHYS, V78, P3052, DOI 10.1063/1.360056; Glimour I., 1992, SCIENCE, V258, P1624; Guillou C. L., 2010, GEOCHIM COSMOCHIM AC, V74, P4167; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Langenhorst F, 2003, MITT OSTERR MINER GE, V148, P401; Lapenkova M., 2012, POPIGAI RUSSIAS VAST; Masaitis V. L., 1972, ZAPISKI VSESOYUZNOGO, V101, P108; Masaitis V. L., 1975, POPIGAI METEOR CRATE, P123; Massaitis V. L., 2013, GEOL ORE DEPOSIT+, V55, P607; TRUEB LF, 1972, AM MINERAL, V57, P1664	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14702	10.1038/srep14702		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CS5CQ	WOS:000362094100002		
J	Shimada, T; Van Lich, L; Nagano, K; Wang, J; Kitamura, T				Shimada, Takahiro; Van Lich, Le; Nagano, Koyo; Wang, Jie; Kitamura, Takayuki			Hierarchical ferroelectric and ferrotoroidic polarizations coexistent in nano-metamaterials	SCIENTIFIC REPORTS			English	Article							VORTEX DOMAIN-STRUCTURE; SINGLE-CRYSTAL BATIO3; MECHANICAL METAMATERIALS; THIN-FILMS; TRANSFORMATION; TRANSITIONS; TERAHERTZ; PATTERNS; INDEX	Tailoring materials to obtain unique, or significantly enhanced material properties through rationally designed structures rather than chemical constituents is principle of metamaterial concept, which leads to the realization of remarkable optical and mechanical properties. Inspired by the recent progress in electromagnetic and mechanical metamaterials, here we introduce the concept of ferroelectric nano-metamaterials, and demonstrate through an experiment in silico with hierarchical nanostructures of ferroelectrics using sophisticated real-space phase-field techniques. This new concept enables variety of unusual and complex yet controllable domain patterns to be achieved, where the coexistence between hierarchical ferroelectric and ferrotoroidic polarizations establishes a new benchmark for exploration of complexity in spontaneous polarization ordering. The concept opens a novel route to effectively tailor domain configurations through the control of internal structure, facilitating access to stabilization and control of complex domain patterns that provide high potential for novel functionalities. A key design parameter to achieve such complex patterns is explored based on the parity of junctions that connect constituent nanostructures. We further highlight the variety of additional functionalities that are potentially obtained from ferroelectric nano-metamaterials, and provide promising perspectives for novel multifunctional devices. This study proposes an entirely new discipline of ferroelectric nano-metamaterials, further driving advances in metamaterials research.	[Shimada, Takahiro; Van Lich, Le; Nagano, Koyo; Kitamura, Takayuki] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan; [Wang, Jie] Zhejiang Univ, Sch Aeronaut & Astronaut, Dept Engn Mech, Hangzhou 310027, Zhejiang, Peoples R China	Shimada, T (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan.	shimada@me.kyoto-u.ac.jp; le.lich.68m@st.kyoto-u.ac.jp	Shimada, Takahiro/G-2167-2014		JSPS KAKENHI [25000012, 26289006]	This work was supported in part by JSPS KAKENHI Grant Number 25000012 and 26289006.	Balakrishna AR, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913917; Buckmann T, 2012, ADV MATER, V24, P2710, DOI 10.1002/adma.201200584; Wang J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.012101; Pushp A, 2013, NAT PHYS, V9, P505, DOI [10.1038/nphys2669, 10.1038/NPHYS2669]; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Kauranen M, 2012, NAT PHOTONICS, V6, P737, DOI [10.1038/nphoton.2012.244, 10.1038/NPHOTON.2012.244]; Xu RJ, 2015, NAT MATER, V14, P79, DOI [10.1038/nmat4119, 10.1038/NMAT4119]; Nicolaou ZG, 2012, NAT MATER, V11, P608, DOI [10.1038/nmat3331, 10.1038/NMAT3331]; Wang J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917715; Datta A, 2014, ADV FUNCT MATER, V24, P2638, DOI 10.1002/adfm.201303290; Pilania G, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155442; Farnell DJJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184407; Schilling A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024115; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; McGilly LJ, 2010, NANO LETT, V10, P4200, DOI 10.1021/nl102566y; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Glaum J, 2013, J AM CERAM SOC, V96, P2881, DOI 10.1111/jace.12405; Choi M, 2011, NATURE, V470, P369, DOI 10.1038/nature09776; Ng N, 2012, ACTA MATER, V60, P3632, DOI 10.1016/j.actamat.2012.02.053; Decker M, 2007, OPT LETT, V32, P856, DOI 10.1364/OL.32.000856; Naumov II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197601; Wegener M, 2013, SCIENCE, V342, P939, DOI 10.1126/science.1246545; Fong DD, 2004, SCIENCE, V304, P1650, DOI 10.1126/science.1098252; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Wang JJ, 2013, ACTA MATER, V61, P7591, DOI 10.1016/j.actamat.2013.08.055; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Landy NI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207402; Chang LW, 2013, NANO LETT, V13, P2553, DOI 10.1021/nl400629m; Prosandeev S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.012101; Buckmann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5130; Wu CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03946; Chen WJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00796; Grunbaum B., 1986, TILINGS PATTERNS; Hong E. S., 2014, EMERGING NONVOLATILE; Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; Lich L. V., 2015, ACTA MAT, V88, P147; Matzen S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5415; McQuaid RGP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1413; Ramesh R., 1997, THIN FILMS FERROELEC; Scott J. F., 2000, FERROELECTRIC MEMORI	43	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14653	10.1038/srep14653		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CS4YW	WOS:000362083300002		
J	Yanagi, I; Ishida, T; Fujisaki, K; Takeda, K				Yanagi, Itaru; Ishida, Takeshi; Fujisaki, Koji; Takeda, Ken-ichi			Fabrication of 3-nm-thick Si3N4 membranes for solid-state nanopores using the poly-Si sacrificial layer process	SCIENTIFIC REPORTS			English	Article							NUCLEIC-ACID ANALYSIS; DNA TRANSLOCATION; GRAPHENE NANOPORES; ETCH RATES; ION-BEAM; SINGLE; SENSORS; RESOLUTION; PRECISION; PLATFORM	To improve the spatial resolution of solid-state nanopores, thinning the membrane is a very important issue. The most commonly used membrane material for solid-state nanopores is silicon nitride (Si3N4). However, until now, stable wafer-scale fabrication of Si3N4 membranes with a thickness of less than 5 nm has not been reported, although a further reduction in thickness is desired to improve spatial resolution. In the present study, to fabricate thinner Si3N4 membranes with a thickness of less than 5 nm in a wafer, a new fabrication process that employs a polycrystalline-Si (poly-Si) sacrificial layer was developed. This process enables the stable fabrication of Si3N4 membranes with thicknesses of 3 nm. Nanopores were fabricated in the membrane using a transmission electron microscope (TEM) beam. Based on the relationship between the ionic current through the nanopores and their diameter, the effective thickness of the nanopores was estimated to range from 0.6 to 2.2 nm. Moreover, DNA translocation through the nanopores was observed.	[Yanagi, Itaru; Ishida, Takeshi; Fujisaki, Koji; Takeda, Ken-ichi] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 1858603, Japan	Yanagi, I (reprint author), Hitachi Ltd, Cent Res Lab, 1-280 Higashi Koigakubo, Kokubunji, Tokyo 1858603, Japan.	itaru.yanagi.yr@hitachi.com			NIMS Microstructural Characterization Platform (NMCP) as a program of the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We thank Dr. Yusuke Goto, Dr. Rena Akahori, Dr. Yoshikazu Nara, Dr. Takahide Yokoi, Dr. Kazuma Matsui, and Dr. Naoshi Itabashi of Hitachi for their valuable discussions and critical comments on the manuscript. Part of this work was supported by the NIMS Microstructural Characterization Platform (NMCP) as a program of the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We are grateful to Dr. Noriko Isaka at NMCP for her support regarding the operation of the TEM.	Ayub M, 2012, NANO LETT, V12, P5637, DOI 10.1021/nl3027873; Garaj S, 2013, P NATL ACAD SCI USA, V110, P12192, DOI 10.1073/pnas.1220012110; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; van den Hout M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115304; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Farimani AB, 2014, ACS NANO, V8, P7914, DOI 10.1021/nn5029295; Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388; Taniguchi M, 2015, ANAL CHEM, V87, P188, DOI 10.1021/ac504186m; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Kumar A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/49/495503; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/nnano.2011.217, 10.1038/NNANO.2011.217]; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/nnano.2011.129, 10.1038/NNANO.2011.129]; Zwolak M, 2008, REV MOD PHYS, V80, P141, DOI 10.1103/RevModPhys.80.141; Tsutsui M, 2010, NAT NANOTECHNOL, V5, P286, DOI [10.1038/nnano.2010.42, 10.1038/NNANO.2010.42]; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/nmeth.1932, 10.1038/NMETH.1932]; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Yang JJ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285310; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Sawafta F, 2014, SENSORS-BASEL, V14, P8150, DOI 10.3390/s140508150; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Briggs K, 2014, SMALL, V10, P2077, DOI 10.1002/smll.201303602; Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; Schneider GF, 2010, NANO LETT, V10, P3163, DOI 10.1021/nl102069z; Carlsen AT, 2014, ACS NANO, V8, P4754, DOI 10.1021/nn501694n; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Skinner GM, 2009, NANO LETT, V9, P2953, DOI 10.1021/nl901370w; Jiang Z., 2010, J PHYS CONDENS MATT, V22; Kowalczyk S. W., 2012, 1 INT C NAN BIOAN AP, P24, DOI [10.1039/9781849735278-00024, DOI 10.1039/9781849735278-00024]; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Lee MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07448; Liang F, 2015, SCI BULL, V60, P296, DOI 10.1007/s11434-014-0629-3; Liu X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7222; Ohshiro T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00501; Schneider GF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3619; Waduge P, 2015, SMALL, V11, P597, DOI 10.1002/smll.201402230; Wang Yue, 2015, Frontiers in Genetics, V5, P449, DOI 10.3389/fgene.2014.00449; Williams KR, 1996, J MICROELECTROMECH S, V5, P256, DOI 10.1109/84.546406; Williams KR, 2003, J MICROELECTROMECH S, V12, P761, DOI 10.1109/JMEMS.2003.820936; Yanagi I., 2013, IEDM; Yanagi I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05000; Zhou Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03287	47	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2015	5								14656	10.1038/srep14656		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CS4ZL	WOS:000362084900001		
J	Hopkins, JAF				Hopkins, John A. F.			Icarus ignored: Riffaterre and Eagleton on Auden's Musee des Beaux Arts	SEMIOTICA			English	Article						Riffaterre; Eagleton; Auden; indirect signification; matricial structure; interpretant		In his 2007 book dealing with poetry in English, Terry Eagleton sacrifices integrity on the altar of the popularizing impulse. His partial analysis of an Auden poem also treated by Michael Riffaterre reveals the advantages of a semiotic approach, which can show how images on the textual surface signify indirectly by pointing to an underlying matricial structure. The author's expanded version of Riffaterrian theory accounts for the added complexity conferred by two matrices, each founded on a proposition. In sum, Eagleton's employment of a traditional "lit-crit" approach - with its prose- based preoccupation with surface details - fails to identify the semiotic structure of the poem as a signifying totality.	[Hopkins, John A. F.] Tamagawa Univ, Tokyo, Japan		jafh@sky.plala.or.jp					Hopkins JAF, 2007, SEMIOTICA, V166, P279, DOI 10.1515/SEM.2007.059; Auden W. H., 1976, COLLECTED POEMS; Culler J., 1981, THE PURSUIT OF SIGNS; Eagleton Terry, 2007, HOW TO READ A POEM; Eliot T. S., 1932, SELECTED ESSAYS; Eliot T. S, 1971, WASTE LAND FACSIMILE; Hopkins J. A. F., 1994, CRIT THEOR SEM LIT M; Jakobson R, 1981, SELECTED WRITINGS, VIII, P18; Peirce C. S., 1931, COLLECTED PAPERS CS; Peirce Charles S., 1982, WRITINGS CS PEIRCE; Riffaterre Michael, 1966, YALE FRENCH STUDIES, V36, P200; Riffaterre Michael, 1986, TEXTUAL ANAL SOME RE, P1; Riffaterre Michel, 1978, SEMIOTICS POETRY	13	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0037-1998	1613-3692		SEMIOTICA	Semiotica	OCT	2015	207						185	200		10.1515/sem-2015-0049		16	Humanities, Multidisciplinary	Arts & Humanities - Other Topics	CS1MO	WOS:000361830200008		
J	Aritake, S; Blackwell, T; Peters, KW; Rueschman, M; Mobley, D; Morrical, MG; Platt, SF; Dam, TTL; Redline, S; Winkelman, JW				Aritake, Sayaka; Blackwell, Terri; Peters, Katherine W.; Rueschman, Michael; Mobley, Daniel; Morrical, Michael G.; Platt, Samuel F.; Dam, Thuy-Tien L.; Redline, Susan; Winkelman, John W.		Osteoporotic Fractures Men MrOS	Prevalence and associations of respiratory-related leg movements: the MrOS sleep study	SLEEP MEDICINE			English	Article						Leg movement; Obstructive sleep apnea; Respiratory-related events; Cardiovascular disease; Hypertension	PERIODIC LIMB MOVEMENTS; TO-NIGHT VARIABILITY; OSTEOPOROTIC FRACTURES; BLOOD-PRESSURE; OLDER MEN; APNEA; SCALE; HYPERTENSION; HYPOXEMIA; AROUSALS	Objectives: Obstructive respiratory events often terminate with an associated respiratory-related leg movement (RRLM). Such leg movements are not scored as periodic leg movements (periodic limb movements during sleep, PLMS), although the criteria for distinguishing RRLM from PLMS differ between the American Academy of Sleep Medicine (AASM) and the World Association of Sleep Medicine (WASM)/International Restless Legs Syndrome Study Group (IRLSSG) scoring manuals. Such LMs may be clinically significant in patients with obstructive sleep apnea (OSA). The prevalence and correlation of RRLM in men with OSA were examined. Methods: A case-control sample of 575 men was selected from all men with an apnea-hypopnea index (AHI, >= 3% desaturation criteria) >= 10 and good data from piezoelectric leg movement sensors at the first in-home sleep study in the MrOS cohort (mean age = 76.8 years). Sleep studies were rescored for RRLMs using five different RRLM definitions varying in both latency of leg movement onset from respiratory event termination and duration of the leg movement. The quartile of RRLM% (the number of RRLM/the number of hypopneas + apneas) was derived. Results: The nonparametric densities of RRLM% were most influenced by alterations in the latency rather than the duration of the LM. The most liberal RRLM definition (latency 0-5 s, duration 0.5-10 s) led to a median RRLM% of 23.4 (interquartile range 12.41, 37.12) in this sample. The average AHI and arousal index increased as the quartile of RRLM% increased, as well as the prevalence of chronic obstructive pulmonary disease (COPD). The prevalence of those with a history of hypertension decreased as RRLM% increased. The non-Caucasian race was associated with lower RRLM%. Conclusion: Within an elderly sample with moderate to severe OSA, piezoelectric-defined RRLM% is associated with a number of sleep-related and demographic factors. Further study of the optimal definition, predictors, and consequences of RRLM is warranted. (C) 2015 Elsevier B.V. All rights reserved.	[Aritake, Sayaka; Winkelman, John W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med,Dept Med, Boston, MA 02115 USA; [Aritake, Sayaka] Japan Soc Promot Sci, Tokyo, Japan; [Blackwell, Terri; Peters, Katherine W.] San Francisco Coordinating Ctr, Calif Pacific Med Ctr Res Inst, San Francisco, CA USA; [Rueschman, Michael; Mobley, Daniel; Morrical, Michael G.; Platt, Samuel F.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Dam, Thuy-Tien L.] Columbia Univ, Dept Med, Div Geriatr Med & Aging, New York, NY USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Winkelman, JW (reprint author), Massachusetts Gen Hosp, Dept Psychiat, 1 Bowdoin Sq, Boston, MA 02114 USA.	jwwinkelman@partners.org			National Institutes of Health; National Institute on Aging (NIA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Sciences (NCATS); NIH Roadmap for Medical Research [U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, UL1 TR000128]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, R01 HL070839]	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, and UL1 TR000128. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study "Outcomes of Sleep Disorders in Older Men" under the following grant numbers: R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and R01 HL070839.	AASM American Academy of Sleep Medicine, 2005, INT CLASSIFICATION S; AASM American Academy of Sleep Medicine, 2007, AASM MAN SCOR SLEEP; Al-Alawi Alia, 2006, J Clin Sleep Med, V2, P281; O'Brien LM, 2007, SLEEP MED, V8, P240, DOI 10.1016/j.sleep.2006.08.009; Goerke M, 2013, PHARMACOPSYCHIATRY, V46, P108, DOI 10.1055/s-0032-1331702; Yeboah J, 2011, ATHEROSCLEROSIS, V219, P963, DOI 10.1016/j.atherosclerosis.2011.08.021; Zhang B, 2013, SLEEP MED, V14, P1405, DOI 10.1016/j.sleep.2013.07.019; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Yang CK, 2006, SLEEP, V29, P553; EDINGER JD, 1992, SLEEP, V15, P156; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Kobayashi M, 2014, SLEEP MED, V15, P138, DOI 10.1016/j.sleep.2013.08.790; Scofield H, 2008, SLEEP, V31, P1221; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Chervin RD, 2001, AM J RESP CRIT CARE, V164, P1454; Claman DM, 2013, J CLIN SLEEP MED, V9, P1109, DOI 10.5664/jcsm.3146; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Yang C, 2005, BIOL PSYCHIAT, V58, P510, DOI 10.1016/j.biopsych.2005.04.022; Ferrillo F, 2004, SLEEP MED, V5, P407, DOI 10.1016/j.sleep.2004.01.008; Kohnlein T, 2002, THORAX, V57, P547, DOI 10.1136/thorax.57.6.547; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Valipour A, 2011, SLEEP MED, V12, P367, DOI 10.1016/j.sleep.2010.08.017; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Sforza E, 2005, SLEEP MED, V6, P259, DOI 10.1016/j.sleep.2004.11.006; Quan SF, 1997, SLEEP, V20, P1077; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Redline S, 1998, SLEEP, V21, P759; Guilleminault C, 2005, SLEEP MED, V6, P451, DOI 10.1016/j.sleep.2005.03.014; HARDY JC, 1994, J APPL PHYSIOL, V77, P2360; Simms T, 2013, J CLIN SLEEP MED, V9, P773, DOI 10.5664/jcsm.2918; ASDA American Sleep Disorders Association, 1992, SLEEP, V15, P173; Claman Faith, 2006, J Pediatr Health Care, V20, P329, DOI 10.1016/j.pedhc.2006.06.001; JOHNS MW, 1992, SLEEP, V15, P376; JOHNS MW, 1991, SLEEP, V14, P540; Manconi M, 2015, SLEEP, V38, P295, DOI 10.5665/sleep.4418; BONNET M, 1993, SLEEP, V16, P748; Phillips C., 2013, NAT SCI SLEEP, V10, P43, DOI DOI 10.2147/NSS.S34841; Rechtschaffen A., 1968, MANUAL STANDARDIZED; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	OCT	2015	16	10					1236	1244		10.1016/j.sleep.2015.06.012		9	Clinical Neurology	Neurosciences & Neurology	CS5BQ	WOS:000362091100011		
J	Koike, S; Yamaguchi, S; Ojio, Y; Shimada, T; Watanabe, K; Ando, S				Koike, Shinsuke; Yamaguchi, Sosei; Ojio, Yasutaka; Shimada, Takafumi; Watanabe, Kei-ichiro; Ando, Shuntaro			Long-term effect of a name change for schizophrenia on reducing stigma	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article						Stigma; Schizophrenia; Stereotyping; Name change; Terminology	HEALTH-RELATED STIGMA; MENTAL-ILLNESS; RENAMING SCHIZOPHRENIA; YOUNG-PEOPLE; ATTITUDES; METAANALYSIS; PREVALENCE; DISORDERS; PSYCHOSIS; JAPAN	A name change for schizophrenia was first implemented in Japan for reducing stigma in 2002; however, little is known of its long-term impact. Total 259 students from 20 universities answered an anonymous self-administered questionnaire about their mental health-related experiences, and stigma scales including feasible knowledge and negative stereotypes for four specific diseases, including schizophrenia (old and new names), depression, and diabetes mellitus. We also asked to choose the old and new names of schizophrenia and dementia among ten names for mental and physical illnesses and conditions. The participants had more feasible knowledge and fewer negative stereotypes for the new name of schizophrenia than the old name, but were still significantly worse than for depression and diabetes mellitus (p < 0.01). Direct contact experiences with those who have mental health problems were associated with feasible knowledge for schizophrenia but not negative stereotypes (beta = 0.13, p = 0.020). The rate of correct responses for the old and new names of schizophrenia was significantly lower than that of dementia (41 vs. 87 %, p < 0.001). Mental health-related experience from media was associated with the recognition of name change for schizophrenia (p = 0.008), which was associated with less feasible knowledge for new name of schizophrenia. The name change of schizophrenia has reduced stigma since 12 years have passed. More effective campaigns, educational curricula, and policy making are needed to reduce stigma toward schizophrenia.	[Koike, Shinsuke; Shimada, Takafumi; Watanabe, Kei-ichiro] Univ Tokyo, Div Counseling & Support, Off Mental Hlth Support, Bunkyo Ku, Tokyo 1138654, Japan; [Koike, Shinsuke] UCL, Med Res Council, Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Yamaguchi, Sosei] Natl Ctr Neurol & Psychiat, Dept Psychiat Rehabil, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Ojio, Yasutaka] Univ Tokyo, Dept Phys & Hlth Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Ando, Shuntaro] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Setagaya Ku, Tokyo 1568506, Japan	Koike, S (reprint author), Univ Tokyo, Div Counseling & Support, Off Mental Hlth Support, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	skoike-tky@umin.ac.jp			JSPS/MEXT [25870143, 26118703]; JSPS/MEXT (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation); Takeda Science Foundation; Uehiro Foundation on Ethics and Education	I would like to thank Ryoko Anazawa, Kazusa Ohta, Sho Kanata, Mika Yamagishi, and Eriko Ichikawa for substantial support of data collection in this study. This study was supported by grants from the JSPS/MEXT (No. 25870143, 26118703, and Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation), Takeda Science Foundation, and the Uehiro Foundation on Ethics and Education to SK.	Keshavan MS, 2013, SCHIZOPHR RES, V148, P1, DOI 10.1016/j.schres.2013.06.037; Bertolote J, 2005, BRIT J PSYCHIAT, V187, pS116, DOI 10.1192/bjp.187.48.s116; Yamaguchi S, 2014, PSYCHIAT CLIN NEUROS, V68, P448, DOI 10.1111/pcn.12151; Corrigan PW, 2012, PSYCHIAT SERV, V63, P963, DOI [10.1176/appi.ps.201100529, 10.1176/appi.ps.005292011]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Sato M, 2006, WORLD PSYCHIATRY, V5, P53; Romer D, 2008, J HEALTH COMMUN, V13, P742, DOI 10.1080/10810730802487406; Tanaka G, 2003, PSYCHIAT CLIN NEUROS, V57, P595, DOI 10.1046/j.1440-1819.2003.01173.x; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI 10.1176/appi.ps.62.6.675; Griffiths KM, 2014, WORLD PSYCHIATRY, V13, P161, DOI 10.1002/wps.20129; George B, 2013, PSYCHOL MED, V43, P1555, DOI 10.1017/S0033291713000895; Keshavan MS, 2011, SCHIZOPHR RES, V127, P3, DOI 10.1016/j.schres.2011.01.011; van Os J, 2009, ACTA PSYCHIAT SCAND, V120, P363, DOI 10.1111/j.1600-0447.2009.01456.x; Takahashi H, 2009, SCHIZOPHR RES, V112, P149, DOI 10.1016/j.schres.2009.03.037; Sartorius N, 2014, SCHIZOPHRENIA BULL, V40, P255, DOI 10.1093/schbul/sbt231; Ando S, 2011, SCHIZOPHR RES, V133, P8, DOI 10.1016/j.schres.2011.09.011; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Schomerus G, 2014, PSYCHOL MED, V44, P303, DOI 10.1017/S003329171300072X; Morgan AJ, 2009, AUST NZ J PSYCHIAT, V43, P866, DOI 10.1080/00048670903107567; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Chiu CPY, 2010, EARLY INTERV PSYCHIA, V4, P270, DOI 10.1111/j.1751-7893.2010.00203.x; Evans-Lacko S, 2011, EPIDEMIOL PSYCH SCI, V20, P263, DOI 10.1017/S2045796011000308; Clement S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009453.pub2; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; Ando S, 2013, PSYCHIAT CLIN NEUROS, V67, P471, DOI 10.1111/pcn.12086; Clement S., 2014, PSYCHOL MED, V26, P1, DOI DOI 10.1017/S0033291714000129; Kim SW, 2012, J KOREAN NEUROPSYCHI, V51, P210; Koike S, 2013, SCHIZOPHRENIA, V5, P53; Lasalvia A, 2015, SCHIZOPHR RES, V162, P276, DOI 10.1016/j.schres.2015.01.031; Nakane Y, 2013, JPN B SOC PSYCHIAT, V22, P452; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Thornicroft G., 2006, SHUNNED DISCRIMINATI; Thornicroft G, 2008, BETTER MENTAL HLTH C; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df	35	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	OCT	2015	50	10					1519	1526		10.1007/s00127-015-1064-8		8	Psychiatry	Psychiatry	CS3WN	WOS:000362006000006		
J	Inaba, Y; Wada, Y; Ichida, Y; Nishikawa, M				Inaba, Yoji; Wada, Yuri; Ichida, Yukinobu; Nishikawa, Masashi			Which part of community social capital is related to life satisfaction and self-rated health? A multilevel analysis based on a nationwide mail survey in Japan	SOCIAL SCIENCE & MEDICINE			English	Article						Social capital; Income inequality; Life satisfaction; Self-rated health	INCOME INEQUALITY; POPULATION HEALTH; PERCEIVED HEALTH; NEW-ZEALAND; ASSOCIATION; MORTALITY; DEPRIVATION	This paper aims to clarify the association between various social capital components at the municipal level (community social capital) and two quality-of-life factors at the individual level [individual self-rated life satisfaction and self-rated health (SRH)] based on data from a nationwide social capital survey that the authors carried out in 2013 in Japan (N = 3406 in 99 municipalities). The survey covers residents in Japan between the ages of 20 and 79 years. We focus on both contextual social capital and household income inequality in terms of the Gini coefficient at the municipality level since, to the best of our knowledge, no paper has explicitly dealt with municipalities in Japan as the units of contextual social capital and the Gini. Our analyses show that the subjective life satisfaction of individuals, after controlling for socioeconomic status and health at the individual level, is associate with both an income gap and social capital at the municipal level. Every component of community social capital in this study except for generalized reciprocity, both cognitive (generalized trust, particularized trust, and particularized reciprocity), and structural (three types of group participation and daily contacts with neighbors, friends/acquaintances, and colleagues), and the Gini coefficient on earned income were associated with self-rated life satisfaction at the individual level with statistical significance. However, SRH is associated only with cognitive social capital at the community level. SRH has no significant association with structural components of community social capital or with a community income gap in terms of the Gini coefficient on personal income. Judging from the results of estimates in the study, most of the components of community social capital at the municipal level seem to play an important role in enhancing self-rated life satisfaction. Life satisfaction may be associated with the broad atmosphere of the municipal level where one resides, while SRH is associated with cognitive social capital rather than structural social capital. However, the difference in the impact of contextual social capital between the two QOL indices may indicate the importance of considering a proper contextual level that is suitable for the outcome. (C) 2015 Elsevier Ltd. All rights reserved.	[Inaba, Yoji] Nihon Univ, Coll Law, Chiyoda Ku, Tokyo, Japan; [Wada, Yuri] Doctoral Inst Evidence Based Policy Inc, Tokyo, Japan; [Ichida, Yukinobu] Nihon Fukusi Univ, Mihama, Japan; [Nishikawa, Masashi] Aoyama Gakuin Univ, Tokyo 150, Japan	Inaba, Y (reprint author), Nihon Univ, Coll Law, Chiyoda Ku, 2-3-1 Misakicho, Tokyo, Japan.	yoinaba@law.nihon-u.ac.jp			Japanese Society for the Promotion of Science (JSPS) [24243040]; JSPS [23243070]	The nationwide survey on which this study is based was conducted with financial support from the Japanese Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (A) Grant Number 24243040. The contents of our analyses for this study were based on the workshops supported by the JSPS Grant-in-Aid for Scientific Research (A) Grant Number 23243070. The authors are grateful for the support.	Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Hibino Yuri, 2012, Environmental Health and Preventive Medicine, V17, P44, DOI 10.1007/s12199-011-0218-x; Kondo N, 2008, SOC SCI MED, V67, P982, DOI 10.1016/j.socscimed.2008.06.002; Alesina A, 2004, J PUBLIC ECON, V88, P2009, DOI 10.1016/j.jpubeco.2003.07.006; Verhaeghe PP, 2012, SOC SCI MED, V75, P349, DOI 10.1016/j.socscimed.2012.02.057; Veenstra G, 2002, SOC SCI MED, V54, P849, DOI 10.1016/S0277-9536(01)00049-1; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003; Shibuya K, 2002, BRIT MED J, V324, P16, DOI 10.1136/bmj.324.7328.16; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Muller A, 2002, BRIT MED J, V324, P23, DOI 10.1136/bmj.324.7328.23; Oshio T, 2010, SOC SCI MED, V70, P1358, DOI 10.1016/j.socscimed.2010.01.010; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Aminzadeh K, 2013, SOC SCI MED, V84, P13, DOI 10.1016/j.socscimed.2013.02.012; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Verhaeghe PP, 2012, HEALTH PLACE, V18, P358, DOI 10.1016/j.healthplace.2011.11.005; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Oshio T, 2009, SOC SCI MED, V69, P317, DOI 10.1016/j.socscimed.2009.06.004; Murayama H, 2012, SOC SCI MED, V75, P2472, DOI 10.1016/j.socscimed.2012.09.027; Elgar FJ, 2011, HEALTH PLACE, V17, P1044, DOI 10.1016/j.healthplace.2011.06.010; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Blakely TA, 2001, J EPIDEMIOL COMMUN H, V55, P352, DOI 10.1136/jech.55.5.352; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Ferlander S, 2009, SOC SCI MED, V69, P1323, DOI 10.1016/j.socscimed.2009.08.009; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Blakely T, 2003, J EPIDEMIOL COMMUN H, V57, P279, DOI 10.1136/jech.57.4.279; Coleman J. S., 1990, FDN SOCIAL THEORY; Goldstein H., 2003, MULTILEVEL STAT MODE; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Inaba Y., 2005, PLAN ADM, V28, P17; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Kawachi I., 2008, SOCIAL CAPITAL HLTH; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I. O., 2003, NEIGHBORHOODS HLTH; Kawachi Ichiro, 2013, GLOBAL PERSPECTIVES; Lin N., 2001, SOCIAL CAPITAL THEOR; Murayama H., 2014, SOC SCI MED, V124, P171; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1993, MAKING DEMOCRACY WOR; Sabatini F., 2009, J SOCIO-ECON, V38, P429, DOI 10.1016/j.socec.2008.06.001	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	OCT	2015	142						169	182		10.1016/j.socscimed.2015.08.007		14	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	CS4QL	WOS:000362060900019		
J	Gao, ZD; Zhao, M; Zhuang, DM; Fu, EG; Li, XL; Ouyang, LQ; Guo, L; Sun, RJ; Kimura, K; Nakajima, K				Gao, Zedong; Zhao, Ming; Zhuang, Daming; Fu, Engang; Li, Xiaolong; Ouyang, Liangqi; Guo, Li; Sun, Rujun; Kimura, Kenji; Nakajima, Kaoru			Study on the performance of Tungsten-Titanium alloy film as a diffusion barrier for iron in a flexible CIGS solar cell	SOLAR ENERGY			English	Article						Tungsten-Titanium; Diffusion barrier; CIGS solar cell; RBS; Annealing	CU(IN,GA)SE-2 THIN-FILM; QUATERNARY TARGET; STAINLESS-STEEL; EFFICIENCIES; MODULES; FOILS	A Tungsten-Titanium (W-Ti) diffusion barrier was prepared on an iron (Fe) substrate by means of magnetron sputtering with subsequent annealing at different temperatures. Rutherford Backscattering Spectrometry (RBS) was used to analyze the Fe distribution in the W-Ti layer. The diffusion constant D-0 = 3.4 x 10(-16) m(2)/s and the activation energy Q = 43 kJ/mol of the Fe diffusing in the W-Ti layer were subsequently calculated based on Fick's Second Law. The results demonstrated that a 291 nm-thick W-Ti barrier layer can be used to block Fe from diffusing into a CIGS solar cell for 20 years at a work temperature of 308 K (35 degrees C). (C) 2015 Elsevier Ltd. All rights reserved.	[Gao, Zedong; Zhao, Ming; Zhuang, Daming; Li, Xiaolong; Ouyang, Liangqi; Guo, Li; Sun, Rujun] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Fu, Engang] Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Kimura, Kenji; Nakajima, Kaoru] Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan	Zhuang, DM (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.	dmzhuang@tsinghua.edu.cn			Key Laboratory for Advanced Materials Processing Technology, Ministry of Education, P. R. China; State Key Laboratory of New Ceramics and Fine Processing, P. R. China	We acknowledge the support by Key Laboratory for Advanced Materials Processing Technology, Ministry of Education, P. R. China and State Key Laboratory of New Ceramics and Fine Processing, P. R. China.	Kimura K, 2008, SURF INTERFACE ANAL, V40, P423, DOI 10.1002/sia.2628; Wang HW, 2000, J MATER SCI-MATER EL, V11, P17, DOI 10.1023/A:1008995902371; Khelifi S, 2010, ENRGY PROCED, V2, P109, DOI 10.1016/j.egypro.2010.07.017; Reinhard P, 2013, IEEE J PHOTOVOLT, V3, P572, DOI 10.1109/JPHOTOV.2012.2226869; Otte K, 2006, THIN SOLID FILMS, V511, P613, DOI 10.1016/j.tsf.2005.11.068; Bergstrom DB, 1997, J APPL PHYS, V82, P2312, DOI 10.1063/1.366039; Zhao M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717539; Dhere NG, 2004, SOL ENERGY, V77, P697, DOI 10.1016/j.solener.2004.05.018; Liu J, 2013, PROG NAT SCI-MATER, V23, P133, DOI 10.1016/j.pnsc.2013.02.006; Nakajima K, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777107; Wuerz R, 2011, THIN SOLID FILMS, V519, P7268, DOI 10.1016/j.tsf.2011.01.399; Liu J, 2012, J MATER RES, V27, P2639, DOI 10.1557/jmr.2012.204; Thongkham W, 2013, SOL ENERGY, V92, P189, DOI 10.1016/j.solener.2013.03.010; Pianezzi F, 2012, PROG PHOTOVOLTAICS, V20, P253, DOI 10.1002/pip.1247; Kessler F, 2004, SOL ENERGY, V77, P685, DOI 10.1016/j.solener.2004.04.010; Ouyang LQ, 2014, MATER LETT, V137, P249, DOI 10.1016/j.matlet.2014.09.020; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Reinhard P, 2013, SOL ENERG MAT SOL C, V119, P287, DOI 10.1016/j.solmat.2013.08.030; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Blosch P, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789616; Bhagat S, 2006, THIN SOLID FILMS, V515, P1998, DOI 10.1016/j.tsf.2006.03.049; Razykov TM, 2011, SOL ENERGY, V85, P1580, DOI 10.1016/j.solener.2010.12.002; Lee WJ, 2014, MATER CHEM PHYS, V147, P783, DOI 10.1016/j.matchemphys.2014.06.021; Wuerz R, 2014, SOL ENERG MAT SOL C, V130, P107, DOI 10.1016/j.solmat.2014.06.038; Cai J. M., 2009, J MAT ENG, V8, P84; Chirila A., 2013, NAT MATER, V12, P1107; Jackson P., 2004, P 19 EUR PHOT SOL EN, P1936; Kimura K., 2006, ENCY ANAL CHEM, P12809	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-092X			SOL ENERGY	Sol. Energy	OCT	2015	120						357	362		10.1016/j.solener.2015.07.027		6	Energy & Fuels	Energy & Fuels	CS5TV	WOS:000362142100035		
J	Kobayashi, S; Suzuki, Y; Meir, A; Al-Khudairi, N; Nakane, T; Hayakawa, K				Kobayashi, Shigeru; Suzuki, Yoshihiko; Meir, Adam; Al-Khudairi, Naji; Nakane, Takashi; Hayakawa, Katsuhiko			Circulatory dynamics of the cauda equina in lumbar canal stenosis using dynamic contrast-enhanced magnetic resonance imaging	SPINE JOURNAL			English	Article						Lumbar spinal canal stenosis; Neurogenic intermittent claudication; Blood-nerve barrier; Edema; Dynamic contrast-enhanced MR imaging; Cauda equina	NERVE ROOT COMPRESSION; NEUROGENIC INTERMITTENT CLAUDICATION; CRANIAL COMPUTED TOMOGRAPHY; MECHANICAL COMPRESSION; SPINAL STENOSIS; EXTRAVASCULAR COMPONENT; BLOOD-FLOW; DIFFUSION; EDEMA; MR	BACKGROUND CONTEXT: There has been no study regarding the cauda equina circulation of patients with neurogenic intermittent claudication (NIC) in lumbar spinal canal stenosis (LSCS) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). PURPOSE: The mechanism responsible for the onset of NIC was investigated using DCE-MRI to examine changes in cauda equina blood flow in patients with LSCS. STUDY DESIGN: This was a retrospective longitudinal registry and magnetic resonance imaging study. PATIENT SAMPLE: The subjects consisted of 23 patients who had LSCS associated with NIC (stenosis group). Ten asymptomatic volunteers who did not have NIC served as controls (control group). In the LSCS group, the cross-sectional area of the dural sac was! 75 mm 2 at the site of most severe stenosis. These patients were further divided into single and double stenosis subgroups. OUTCOME MEASURES: The main measures we used were the signal intensity (S-I) ratio and the shape and size of the time intensity (T-I) curves. We compared these between the stenosis and control groups. METHODS: At first, plain T1-weighted MR images were obtained and the lumbar dural sac crosssectional area was measured using a digitizer. For DCE-MRI, sagittal T1-weighted images of the same slice were acquired continuously for 10 minutes after administration of gadolinium as an intravenous bolus to observe the distribution of contrast medium (gadolinium) in the cauda equina. To objectively evaluate changes in contrast enhancement of the cauda equina at the site of canal stenosis, regions of interest were established. The signal intensity (SI) ratio was calculated to compare the signal intensities before and after contrast enhancement, and time-intensity curves were prepared to investigate changes over time. RESULTS: The static imaging findings and the changes of gadolinium uptake showed striking differences between the study and control patients. In the stenosis group, abnormal intrathecal enhancement showed around the site of stenosis on enhanced MR imaging. The SI ratio at the site of canal stenosis had a slower increase in the arterial phase when compared with that in the control group and remained high in the venous phase for up to 10 minutes. Finally, abnormal intrathecal enhancement was visible around the site of stenosis on enhanced MR imaging in all patients. CONCLUSIONS: These clinical data indicate that cauda equina nerve roots in the LSCS patients are pathologic even when symptoms are not elicited in the supine position, suggesting that intraradicular venous congestion and edema themselves do not influence the existence of radicular symptoms. (C) 2015 Elsevier Inc. All rights reserved.	[Kobayashi, Shigeru] Univ Fukui, Dept Orthopaed & Rehabil Med, Fac Med, Fukui 9101193, Japan; [Kobayashi, Shigeru] Univ Fukui, Res & Educ Program Life Sci, Fukui 9101193, Japan; [Suzuki, Yoshihiko] Suzuki Orthopaed Clin, Gifu 5095124, Japan; [Meir, Adam; Al-Khudairi, Naji] Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; [Nakane, Takashi; Hayakawa, Katsuhiko] Aiko Orthopaed Hosp, Dept Radiol & Orthopaed, Midori, Aichi 4580911, Japan	Kobayashi, S (reprint author), Univ Fukui, Dept Orthopaed & Rehabil Med, Fac Med, 23-3 Shimoaizuki, Fukui 9101193, Japan.	kshigeru@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [25460719]	This work was supported by Grant-in Aid from the Ministry of Education, Science and Culture of Japan (25460719).	Matsui T, 1998, SPINE, V23, P1931, DOI 10.1097/00007632-199809150-00002; RYDEVIK B, 1990, ACTA PHYSIOL SCAND, V138, P247, DOI 10.1111/j.1748-1716.1990.tb08843.x; SUZUKI K, 1989, NEUROSURGERY, V24, P521; Kobayashi S, 2000, SPINE, V25, P298, DOI 10.1097/00007632-200002010-00007; WATANABE R, 1986, J NEUROSURG, V64, P64, DOI 10.3171/jns.1986.64.1.0064; PARKE WW, 1985, SPINE, V10, P508, DOI 10.1097/00007632-198507000-00004; Takahashi K, 1995, SPINE, V20, P2746, DOI 10.1097/00007632-199512150-00017; DORAN M, 1990, J COMPUT ASSIST TOMO, V14, P865, DOI 10.1097/00004728-199011000-00001; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Baur A, 1998, RADIOLOGY, V207, P349; RYDEVIK BL, 1989, SPINE, V14, P574, DOI 10.1097/00007632-198906000-00004; SPARROW JR, 1981, ACTA NEUROPATHOL, V53, P181; YOSHIZAWA H, 1989, SPINE, V14, P1220, DOI 10.1097/00007632-198911000-00015; OLMARKER K, 1989, SPINE, V14, P569, DOI 10.1097/00007632-198906000-00003; Rajasekaran S, 2007, J MAGN RESON IMAGING, V25, P410, DOI 10.1002/jmr.20853; Akansel G, 1997, AM J NEURORADIOL, V18, P443; Kobayashi S, 2008, J ORTHOP RES, V26, P1533, DOI 10.1002/jor.20696; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230; GADO MH, 1975, RADIOLOGY, V117, P589; RYDEVIK B, 1984, SPINE, V9, P7, DOI 10.1097/00007632-198401000-00004; EHNI G, 1969, J NEUROSURG, V31, P490, DOI 10.3171/jns.1969.31.5.0490; YOSHIZAWA H, 1991, ORTHOP CLIN N AM, V22, P195; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; TAKAHASHI K, 1993, J ORTHOPAED RES, V11, P104, DOI 10.1002/jor.1100110112; SEITZ RJ, 1989, MUSCLE NERVE, V12, P627, DOI 10.1002/mus.880120803; Ikawa M, 2005, SPINE, V30, P2393, DOI 10.1097/01.brs.0000184718.56122.90; BLAU JN, 1961, LANCET, V1, P1081; Bailey P, 1911, J NERV MENT DIS, V38, P588, DOI 10.1097/00005053-191110000-00002; Kobayashi S, 2006, AM J NEURORADIOL, V27, P346; GADO MH, 1975, RADIOLOGY, V117, P595; Clark CA, 2000, MAGN RESON MED, V43, P133; YOSHIZAWA H, 1995, SPINE, V20, P397, DOI 10.1097/00007632-199502001-00001; Kobayashi S, 2004, J ORTHOPAED RES, V22, P170, DOI 10.1016/S0736-0266(03)00131-1; PARKE WW, 1981, J BONE JOINT SURG AM, V63, P53; MELLICK RS, 1968, BRAIN, V91, P141, DOI 10.1093/brain/91.1.141; KOBAYASHI S, 1993, SPINE, V18, P1410; ARNOLDI CC, 1976, CLIN ORTHOP RELAT R, P4; Crock HV, 1986, CONUS MEDULLARIS CAU; Crock HV, 1977, J BONE JOINT SURG AM; EVANS JG, 1964, BRIT MED J, V2, P985; Jinkins R., 1993, J COMPUT ASSIST TOMO, V17, P555; Jinkins R., 1993, NEUROIMAG CLIN N AM, V3, P525; Jinkins R., 1993, AM J NEURORADIOL, V14, P193; KAVANAUG.GJ, 1968, J AMER MED ASSOC, V206, P2477, DOI 10.1001/jama.206.11.2477; Myers RR., 1997, LOW BACK PAIN SCI CL, P247; Olmarker K, 1991, Acta Orthop Scand Suppl, V242, P1; SCHONSTROM N, 1988, SPINE, V13, P385; VERBIEST H, 1955, J BONE JOINT SURG BR, V37, P576; VERBIEST H, 1950, Ned Tijdschr Geneeskd, V94, P2415; Verbiest H., 1949, HOMMAGE CLOVIS VINCE, P161; Verbiest H., 1976, NEUROGENIC INTERMITT, P749	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	OCT 1	2015	15	10					2132	2141		10.1016/j.spinee.2015.05.014		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS3JA	WOS:000361967700032		
J	Kato, G; Kawaguchi, K; Tsukamoto, N; Komiyama, K; Mizuta, K; Onohara, T; Okano, H; Hotokezaka, S; Mae, T				Kato, Go; Kawaguchi, Kenichi; Tsukamoto, Nobuaki; Komiyama, Keisuke; Mizuta, Kazutaka; Onohara, Takayuki; Okano, Hirofumi; Hotokezaka, Shunsuke; Mae, Takao			Recurrent dislocations of the atlantooccipital and atlantoaxial joints in a halo vest fixator are resolved by backrest elevation in an elevation angle-dependent manner	SPINE JOURNAL			English	Article						Trauma; Preoperative management; Atlantoaxial; Atlantooccipital; Dislocation; Re-dislocation; Halo vest; External fixation	CERVICAL-SPINE; OCCIPITAL DISLOCATION; INTRACRANIAL-PRESSURE; BLOOD-FLOW; DISTRACTION; SURVIVAL; CHILDREN; CORD	BACKGROUND CONTEXT: Halo fixation is now universally performed in the initial reduction and fixation of unstable upper cervical spine injuries; however, persistent high instability and recurrent dislocations of the atlantooccipital and atlantoaxial joints after fixation are not well recognized. PURPOSE: The aim was to describe persistent instability of traumatic dislocations of the atlantooccipital and atlantoaxial joints after halo fixation and a useful method for preventing instability. STUDY DESIGN: This was a case report of a patient who survived traumatic dislocations of the atlantooccipital and atlantoaxial joints. PATIENT SAMPLE: A 73-year-old woman diagnosed with dislocations of the atlantooccipital and atlantoaxial joints along with multiple other injuries sustained in a traffic accident was included. METHODS: After initial closed reduction and halo fixation, congruity of the atlantooccipital and atlantoaxial joints was evaluated using, condylar gap, atlantodental interval, and flexion angulation of C1-C2 after the initial examination and before surgery. RESULTS: Changes in parameters 12 hours after halo fixation revealed re-dislocations and instability of the joints. Backrest elevation with halo fixation tended to reduce re-dislocations. Therefore, we carefully increased the backrest angle and measured the parameters at several angles of elevation within a range that did not affect vital signs to observe the effectiveness of elevation against redislocations. Elevation changed the parameters in an elevation angle-dependent manner, and these changes suggested that elevation was effective for reducing re-dislocation of both the atlantooccipital and atlantoaxial joints during halo fixation. With no major complications, this method enabled us to maintain good congruity of the joints for approximately 2 weeks until posterior spinal fusion with internal fixation. CONCLUSIONS: Backrest elevation with halo fixation appears safe to be performed without any other devices and is beneficial for blocking re-dislocation of both the atlantooccipital and atlantoaxial joints as well as possible secondary damage to the upper cervical spinal cord during the external fixation period. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, Go; Kawaguchi, Kenichi] Saga Ken Med Ctr Koseikan, Dept Spine Surg, Saga 8408571, Japan; [Kato, Go; Tsukamoto, Nobuaki; Komiyama, Keisuke; Mae, Takao] Saga Ken Med Ctr Koseikan, Dept Trauma Ctr, Saga 8408571, Japan; [Tsukamoto, Nobuaki; Komiyama, Keisuke; Mizuta, Kazutaka; Hotokezaka, Shunsuke; Mae, Takao] Saga Ken Med Ctr Koseikan, Dept Orthopaed Surg, Saga 8408571, Japan; [Onohara, Takayuki] Saga Ken Med Ctr Koseikan, Dept Emergency Med, Saga 8408571, Japan; [Okano, Hirofumi] Kumamoto Red Cross Hosp, Dept Orthopaed Surg, Higashi Ku, Kumamoto 8618039, Japan	Kato, G (reprint author), Saga Ken Med Ctr Koseikan, Dept Spine Surg, 400 Nakabaru,Kase Machi, Saga 8408571, Japan.	gkato23@yahoo.co.jp					Steinmetz MP, 2002, J NEUROSURG, V96, P346, DOI 10.3171/spi.2002.96.3.0346; LIND B, 1988, SPINE, V13, P162, DOI 10.1097/00007632-198802000-00006; TRAYNELIS VC, 1986, J NEUROSURG, V65, P863, DOI 10.3171/jns.1986.65.6.0863; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; POWERS B, 1979, NEUROSURGERY, V4, P12, DOI 10.1097/00006123-197901000-00004; Lovell AT, 2000, ANESTH ANALG, V90, P372, DOI 10.1097/00000539-200002000-00025; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P335, DOI 10.1016/j.otsr.2010.10.001; Chattar-Cora D, 2000, J ORTHOP TRAUMA, V14, P370, DOI 10.1097/00005131-200006000-00013; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; BENZEL EC, 1989, J NEUROSURG, V70, P411, DOI 10.3171/jns.1989.70.3.0411; BULAS DI, 1993, RADIOLOGY, V188, P155; WOODRING JH, 1981, AM J ROENTGENOL, V137, P21; Roberts LH, 2001, SURG CLIN N AM, V81, P1345; DOLAN EJ, 1980, J NEUROSURG, V53, P756, DOI 10.3171/jns.1980.53.6.0756; Richter D, 2001, J TRAUMA, V50, P848, DOI 10.1097/00005373-200105000-00012; Gonzalez LF, 2005, J NEUROSURG-SPINE, V3, P318, DOI 10.3171/spi.2005.3.4.0318; CUSICK JF, 1982, J NEUROSURG, V57, P651, DOI 10.3171/jns.1982.57.5.0651; Hamai S, 2006, SPINE, V31, pE421, DOI 10.1097/01.brs.0000220224.01886.b3; Kawahara N, 2005, SPINE, V30, P613, DOI 10.1097/01.brs.0000155407.87439.a2; Jerin C, 2014, EXP BRAIN RES, V232, P2273, DOI 10.1007/s00221-014-3918-9; Kleweno CP, 2008, SPINE, V33, pE659, DOI 10.1097/BRS.0b013e318182272a; DICKMAN CA, 1993, J SPINAL DISORD, V6, P300; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119; KOCH R A, 1978, Spine, V3, P103, DOI 10.1097/00007632-197806000-00002; van de Pol GJ, 2005, SPINE, V30, pE424, DOI 10.1097/01.brs.0000170595.83169.94; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	OCT 1	2015	15	10					E69	E74		10.1016/j.spinee.2015.06.009		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS3JA	WOS:000361967700027		
J	Tabata, R; Tabata, C; Ishikawa, T; Yasumizu, R				Tabata, Rie; Tabata, Chiharu; Ishikawa, Takami; Yasumizu, Ryoji			Extranodal non-Hodgkin's lymphoma with multiple vertebral and hepatic lesions without involvement of lymph nodes	SPINE JOURNAL			English	Editorial Material							LIVER; BONE		[Tabata, Rie] Hyogo Prefectural Tsukaguchi Hosp, Dept Hematol & Oncol, Amagasaki, Hyogo 6610012, Japan; [Tabata, Chiharu] Hyogo Coll Med, Ctr Canc, Nishinomiya, Hyogo 6638501, Japan; [Ishikawa, Takami] Hyogo Prefectural Tsukaguchi Hosp, Dept Orthoped, Amagasaki, Hyogo 6610012, Japan; [Yasumizu, Ryoji] Hyogo Prefectural Tsukaguchi Hosp, Dept Pathol, Amagasaki, Hyogo 6610012, Japan	Tabata, R (reprint author), Hyogo Prefectural Tsukaguchi Hosp, Dept Hematol & Oncol, 6-8-17 Minamitsukaguchi, Amagasaki, Hyogo 6610012, Japan.						Kikuma K, 2012, VIRCHOWS ARCH, V460, P379, DOI 10.1007/s00428-012-1199-x; Heyning FH, 1999, LEUKEMIA, V13, P2094, DOI 10.1038/sj.leu.2401582; Tabata R, 2008, ANN HEMATOL, V87, P581, DOI 10.1007/s00277-007-0433-0; Noronha V, 2005, CRIT REV ONCOL HEMAT, V53, P199, DOI 10.1016/j.critrevonc.2004.10.010; Cheng G, 2010, CLIN IMAG, V34, P476, DOI 10.1016/j.clinimag.2009.11.013; Ebus S C M, 2002, Spine (Phila Pa 1976), V27, pE271, DOI 10.1097/00007632-200205150-00025	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	OCT 1	2015	15	10					E13	E14		10.1016/j.spinee.2015.05.012		2	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CS3JA	WOS:000361967700006		
J	Mizuno, H				Mizuno, Hiroshi			Ethical Issues for Clinical Studies That use Human Embryonic Stem Cells: The 2014 Revisions to the Japanese Guidelines	STEM CELL REVIEWS AND REPORTS			English	Article						Bioethics; Personal information; Anonymization; Incidental findings; Informed consent	MACULAR DEGENERATION	The use of human embryonic stem cells (hESCs) in clinical studies has been expanding in recent years. The application of hESCs in clinical studies raises ethical issues from a different standpoint compared with the use of other types of stem cells. In Japan, the Guidelines on the Derivation of Human Embryonic Stem Cells, and Guidelines on the Distribution and Utilization of Human Embryonic Stem Cells had been revised for clinical studies in 2014. In the revised guidelines, the method for protection of personal information was changed to offer the choice between unlinkable anonymization and linkable anonymization, to enable the use of information on diseases suffered by donors and the assurance of traceability for safety. Procedures for re-consent are generally prohibited out of consideration for donors' feelings. However, obtaining re-consent is permitted when consent for re-consent has been received in advance and approval has been given by an ethical review board, in which case the donors may be contacted. Incidental findings obtained from hESCs are not disclosed individually to donors, while the research results should be actively published for the common good. These guidelines have enabled the derivation, distribution, and use of hESCs for clinical studies.	Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Mizuno, H (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan.	hmizuno@nias.affrc.go.jp					Isasi R, 2014, CELL STEM CELL, V14, P427, DOI 10.1016/j.stem.2014.03.014; Isasi RM, 2009, STEM CELL REV REP, V5, P108, DOI 10.1007/s12015-009-9067-z; Kawakami M, 2010, CELL STEM CELL, V6, P415, DOI 10.1016/j.stem.2010.04.010; Wadman M, 2010, NATURE, V464, P967, DOI 10.1038/464967a; Ben-David U, 2012, CELL STEM CELL, V10, P666, DOI 10.1016/j.stem.2012.05.003; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hug K, 2011, STEM CELL REV REP, V7, P761, DOI 10.1007/s12015-011-9257-3; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; [Anonymous], 2015, GUIDANCE GUIDELINES; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Isasi R, 2012, REGEN MED, V7, P439, DOI [10.2217/rme.12.23, 10.2217/RME.12.23]; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada & Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Council for Science Technology and Policy, 2004, BAS ID HANDL HUM EMB; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Lomax GP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt154; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; The International Society for Stem Cell Research (ISSCR), 2006, GUID COND HUM EMBR S	18	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1550-8943	1558-6804		STEM CELL REV REP	Stem Cell Rev. Rep.	OCT	2015	11	5					676	680		10.1007/s12015-015-9607-7		5	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	CS7PD	WOS:000362275700002		
J	Banno, H; Marzelle, J; Becquemin, JP				Banno, Hiroshi; Marzelle, Jean; Becquemin, Jean-Pierre			Who should do endovascular repair of complex aortic aneurysms and how should they do them?	SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND			English	Article						Complex aortic aneurysm; Endovascular aortic repair; Fenestrated; Branched; Fenestrated endovascular aortic repair (FEVAR); Branched endovascular aortic repair (BEVAR)	SINGLE-CENTER EXPERIENCE; BRANCHED STENT GRAFTS; UNITED-STATES; FENESTRATED ENDOGRAFTS; HOSPITAL VOLUME; SURGEON VOLUME; MORTALITY; OUTCOMES	Background: Cure of aneurysms which involve the aorta at the level of the visceral arteries and the thoracoabdominal segment remains a considerable surgical enterprise with a relatively high mortality and morbidity despite improvements of the surgical procedure and anesthetic technique. Fenestrated and branched endovascular stent grafts are currently available offering an attractive less invasive option especially for most frail patients. These grafts are relatively recent, technically more demanding to insert than the current stent graft for infrarenal aneurysm and besides, given the relative low frequency of the disease, they are much less used by practitioners. Thus, unconditional widespread of this sophisticated technique may not necessarily benefit patients. Methods: We reviewed our experiences and articles regarding this concern, 1) who should perform this new technique and 2) in what kind of setting. Conclusion: Based on the combined complexities of 1) patients selection, 2) proper planning and manufacturing of the graft, 3) the need for outstanding imaging and operating facilities, 4) and the required endovascular skill of physicians involved in the procedure, we feel that only highly specialized centers should be allowed to perform this complex procedure. (C) 2015 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.	[Banno, Hiroshi] Nagoya Univ Hosp, Dept Vasc Surg, Nagoya, Aichi 4668550, Japan; [Marzelle, Jean; Becquemin, Jean-Pierre] Henri Mondor Hosp, Dept Vasc Surg, Creteil, France	Banno, H (reprint author), Nagoya Univ Hosp, Dept Vasc Surg, Syowa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	hbanno@med.nagoya-u.ac.jp					Marzelle J, 2015, ANN SURG, V261, P197, DOI 10.1097/SLA.0000000000000612; Patel R, 2009, J VASC SURG, V50, P15, DOI 10.1016/j.jvs.2008.12.051; Rigberg DA, 2006, J VASC SURG, V43, P217, DOI 10.1016/j.jvs.2005.10.070; Linsen MAM, 2012, J VASC SURG, V56, P238, DOI 10.1016/j.jvs.2011.10.092; Oderich GS, 2014, J VASC SURG, V59, P1456, DOI 10.1016/j.jvs.2013.10.060; Eagleton MJ, 2014, J VASC SURG, V59, P89, DOI 10.1016/j.jvs.2013.07.007; Chuter TAM, 2008, J VASC SURG, V47, P6, DOI 10.1016/j.jvs.2007.08.032; Dimick JB, 2008, J VASC SURG, V47, P1150, DOI 10.1016/j.jvs.2008.01.054; Semmens JB, 2006, J ENDOVASC THER, V13, P320, DOI 10.1583/05-1686.1; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Laheij RJF, 2002, EUR J VASC ENDOVASC, V24, P128, DOI 10.1053/ejvs.2002.1670; Sobocinski J, 2013, EUR J VASC ENDOVASC, V46, P418, DOI 10.1016/j.ejvs.2013.07.018; Tacher V, 2013, J VASC INTERV RADIOL, V24, P1698, DOI 10.1016/j.jvir.2013.07.016; Dijkstra ML, 2011, J VASC SURG, V53, P583, DOI 10.1016/j.jvs.2010.09.039; Verhoeven ELG, 2010, EUR J VASC ENDOVASC, V39, P529, DOI 10.1016/j.ejvs.2010.01.004; Park JH, 1996, J VASC INTERV RADIOL, V7, P819, DOI 10.1016/S1051-0443(96)70854-0; Verhoeven EL, 2009, EUR J VASC ENDOVASC, V38, P155, DOI 10.1016/j.ejvs.2009.05.002; Gasper WJ, 2013, J VASC SURG, V57, P1553, DOI 10.1016/j.jvs.2012.12.021; O'Neill S, 2006, EUR J VASC ENDOVASC, V32, P115, DOI 10.1016/j.ejvs.2006.01.015; Banno H, 2014, J VASC SURG, V60, P31, DOI 10.1016/j.jvs.2014.01.036; Banno H, 2014, EUR J VASC ENDOVASC, V47, P45, DOI 10.1016/j.ejvs.2013.10.008; Cowan JA, 2003, J VASC SURG, V37, P1169, DOI 10.1016/S0741-5214(03)00085-5; Haulon S, 2010, EUR J VASC ENDOVASC, V39, P171, DOI 10.1016/j.ejvs.2009.11.009; Huynh TTT, 2002, J VASC SURG, V36, P469, DOI 10.1067/mva.2002.127348; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Ambler G, 2012, CIRCULATION, V125, P2707, DOI 10.1161/CIRCULATIONAHA.111.070334; Forbes Thomas L, 2007, Vasc Endovascular Surg, V41, P14, DOI 10.1177/1538574406297254; Kalteis Manfred, 2012, Int J Angiol, V21, P223, DOI 10.1055/s-0032-1331159; NHS Commissioning Board, 2013, CLIN COMM POL COMPL; The Leapfrog Group, EV BAS HOSP REF	30	0	0	ROYAL COLLEGE SURGEONS EDINBURGH	EDINBURGH	NICOLSON ST, EDINBURGH EH8 9DW, SCOTLAND	1479-666X			SURG-J R COLL SURG E	Surg. J. R. Coll. Surg. Edinb. Irel.	OCT	2015	13	5					286	291		10.1016/j.surge.2015.03.004		6	Surgery	Surgery	CS5SX	WOS:000362139700009		
J	Wada, K; Takaori, K; Traverso, LW				Wada, Keita; Takaori, Kyoichi; Traverso, L. William			Screening for Pancreatic Cancer	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Familial pancreatic cancer; Pancreatic cancer; Pancreatic intraepithelial neoplasia; Intraductal papillary mucinous neoplasm; Screening	PAPILLARY MUCINOUS NEOPLASMS; HIGH-RISK INDIVIDUALS; COMPARING STANDARD PANCREATICODUODENECTOMY; INTERNATIONAL CONSENSUS GUIDELINES; PEUTZ-JEGHERS-SYNDROME; INTRAEPITHELIAL NEOPLASIA; HEREDITARY PANCREATITIS; DUCTAL CARCINOMA; EXTENDED LYMPHADENECTOMY; HEAD ADENOCARCINOMA	Neither extended surgery nor extended indication for surgery has improved survival in patients with pancreatic cancer. According to autopsy studies, presumably 90% are metastatic. The only cure is complete removal of the tumor at an early stage before it becomes a systemic disease or becomes invasive. Early detection and screening of individuals at risk is currently under way. This article reviews the evidence and methods for screening, either familial or sporadic. Indication for early-stage surgery and precursors are discussed. Surgeons should be familiar with screening because it may provide patients with a chance for cure by surgical resection.	[Wada, Keita] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan; [Takaori, Kyoichi] Kyoto Univ, Grad Sch Med, Dept Surg,Div Hepatobiliary Pancreat Surg & Trans, Sakyo Ku, Kyoto 6065807, Japan; [Traverso, L. William] St Lukes Ctr Pancreat & Liver Dis, Boise, ID 83712 USA	Takaori, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg,Div Hepatobiliary Pancreat Surg & Trans, Sakyo Ku, 54 Kawahara Cho, Kyoto 6065807, Japan.	takaori@kuhp.kyoto-u.ac.jp					Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Brentnall TA, 1999, ANN INTERN MED, V131, P247; Crippa S, 2010, CLIN GASTROENTEROL H, V8, P213, DOI 10.1016/j.cgh.2009.10.001; Poley JW, 2009, AM J GASTROENTEROL, V104, P2175, DOI 10.1038/ajg.2009.276; Lynch HT, 2008, FAM CANCER, V7, P103, DOI 10.1007/s10689-007-9166-4; Verna EC, 2010, CLIN CANCER RES, V16, P5028, DOI 10.1158/1078-0432.CCR-09-3209; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Maisonneuve P, 2007, GUT, V56, P1327, DOI 10.1136/gut.2007.125278; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Howes N, 2004, CLIN GASTROENTEROL H, V2, P252, DOI 10.1053/S1542-3565(04)00013-8; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Egawa S, 2004, PANCREAS, V28, P235, DOI 10.1097/00006676-200404000-00004; MANABE T, 1989, CANCER, V64, P1132, DOI 10.1002/1097-0142(19890901)64:5<1132::AID-CNCR2820640528>3.0.CO;2-V; KAMISAWA T, 1995, PANCREAS, V11, P345, DOI 10.1097/00006676-199511000-00005; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; IKEDA M, 1994, PANCREAS, V9, P508, DOI 10.1097/00006676-199407000-00014; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Canto MI, 2013, GUT, V62, P339, DOI 10.1136/gutjnl-2012-303108; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Shi CJ, 2009, CLIN CANCER RES, V15, P7737, DOI 10.1158/1078-0432.CCR-09-0004; Roberts NJ, 2012, CANCER DISCOV, V2, P41, DOI 10.1158/2159-8290.CD-11-0194; TSUCHIYA R, 1990, INT J PANCREATOL, V7, P117; Lucenteforte E, 2012, ANN ONCOL, V23, P374, DOI 10.1093/annonc/mdr120; Jang JY, 2014, ANN SURG, V259, P656, DOI 10.1097/SLA.0000000000000384; Ishikawa O, 1999, HEPATO-GASTROENTEROL, V46, P8; FORTNER JG, 1977, ANN SURG, V186, P42, DOI 10.1097/00000658-197707000-00007; Naderi A, 2002, J GASTROINTEST CANC, V31, P99; Petersen GM, 2006, CANCER EPIDEM BIOMAR, V15, P704, DOI 10.1158/1055-9965.EPl-05-0734; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Klein AP, 2007, CANCER BIOL THER, V6, P320; NEUMANN HPH, 1991, GASTROENTEROLOGY, V101, P465; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Rebours V, 2008, AM J GASTROENTEROL, V103, P111, DOI 10.1111/j.1572-0241.2007.01597.x; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Hahn SA, 2003, J NATL CANCER I, V95, P214; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U; Kimmey MB, 2002, GASTROINTEST ENDOSC, V56, pS82, DOI 10.1067/mge.2002.127753; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Vasen HFA, 2011, GASTROENTEROLOGY, V140, P850, DOI 10.1053/j.gastro.2010.11.048; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Nimura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P230, DOI 10.1007/s00534-011-0466-6; Canto MI, 2004, CLIN GASTROENTEROL H, V2, P606, DOI 10.1053/S1542-3565(04)00244-7; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Takaori K, 2004, PANCREAS, V28, P257, DOI 10.1097/00006676-200404000-00008; Schneider R, 2011, FAM CANCER, V10, P323, DOI 10.1007/s10689-010-9414-x; Thompson D, 2002, J NATL CANCER I, V94, P1358; Brune KA, 2010, J NATL CANCER I, V102, P119, DOI 10.1093/jnci/djp466; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Egawa S, 2012, PANCREAS, V41, P985, DOI 10.1097/MPA.0b013e318258055c; Ludwig E, 2011, AM J GASTROENTEROL, V106, P946, DOI 10.1038/ajg.2011.65; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; LYNCH HT, 1985, BRIT J CANCER, V52, P271, DOI 10.1038/bjc.1985.187; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Langer P, 2009, GUT, V58, P1410, DOI 10.1136/gut.2008.171611; ISHIKAWA O, 1988, ANN SURG, V208, P215, DOI 10.1097/00000658-198808000-00014; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Zubarik R, 2011, GASTROINTEST ENDOSC, V74, P87, DOI 10.1016/j.gie.2011.03.1235; Ben Q, 2011, EUR J CANCER, V47, P1928, DOI [10.1016/j.ejca.2011.03.003, DOI 10.1016/J.EJCA.2011.03.003]; Cameron JL, 2015, J AM COLL SURGEONS, V220, P530, DOI 10.1016/j.jamcollsurg.2014.12.031; Michelassi F, 2005, SURGERY, V138, P628; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gotoh M, 2015, SURG TODAY; KOZUKA S, 1979, Cancer, V43, P1418, DOI 10.1002/1097-0142(197904)43:4<1418::AID-CNCR2820430431>3.0.CO;2-O; Lacobuzio-Donahue C. A., 2009, J CLIN ONCOL, V27, P1806, DOI DOI 10.1200/JC0.2008.17.7188; lodice S, 2008, LANGENBECK ARCH SURG, V393, P535; Sukhni AI- W, 2012, J GASTROINTEST SURG, V16, P771; Takaori K, 2006, Adv Med Sci, V51, P23; Trikudanathan Guru, 2011, JOP, V12, P26; Yeo CJ, 2002, ANN SURG, V236, P366	78	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	OCT	2015	95	5					1041	+		10.1016/j.suc.2015.05.010		13	Surgery	Surgery	CS4OM	WOS:000362055300011		
J	Hasegawa, S; Nishikawa, G; Hida, K; Kawada, K; Sakai, Y				Hasegawa, S.; Nishikawa, G.; Hida, K.; Kawada, K.; Sakai, Y.			Laparoscopic pelvic sidewall dissection with combined resection of internal iliac vessels for local recurrence of rectal cancer	TECHNIQUES IN COLOPROCTOLOGY			English	Editorial Material							EXCISION		[Hasegawa, S.; Nishikawa, G.; Hida, K.; Kawada, K.; Sakai, Y.] Kyoto Univ, Dept Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan	Hasegawa, S (reprint author), Kyoto Univ, Dept Surg, Grad Sch Med, Sakyo Ku, 54 Shogoinkawaharacho, Kyoto 6068507, Japan.	shase@kuhp.kyoto-u.ac.jp					Lin MB, 2011, AM J SURG, V201, P537, DOI 10.1016/j.amjsurg.2009.12.010; Nagasaki Toshiya, 2014, Asian J Endosc Surg, V7, P52, DOI 10.1111/ases.12068; Shaikh I, 2014, TECH COLOPROCTOL, V18, P1161, DOI 10.1007/s10151-014-1234-9; Ueda Takeshi, 2014, Gan To Kagaku Ryoho, V41, P1488; Uehara K, 2015, SURG ENDOSC	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1123-6337	1128-045X		TECH COLOPROCTOL	Tech. Coloproctology	OCT	2015	19	10			SI		659	660		10.1007/s10151-015-1345-y		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CS3RW	WOS:000361993500011		
J	Manabe, Y; Shibamoto, Y; Sugie, C; Hayashi, A; Murai, T; Yanagi, T				Manabe, Yoshihiko; Shibamoto, Yuta; Sugie, Chikao; Hayashi, Akihiro; Murai, Taro; Yanagi, Takeshi			Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer	TECHNOLOGY IN CANCER RESEARCH & TREATMENT			English	Article						Dynamic jaws; Lung cancer; Static port; Tomotherapy		With the newly developed dynamic jaws technology, radiation dose for the cranio-caudal edges of a target can be lowered in the treatment with tomotherapy. We compared dynamic-jaw- and fixed-jaw-mode plans for lung cancer. In 35 patients, four plans using the 2.5-cm dynamic-, 2.5-cm fixed-, 5.0-cm dynamic-, and 5.0-cm fixed-jaw modes were generated. For 10 patients with upper lobe stage I lung cancer, the helical tomotherapy mode was used. Fifty-six Gy in 8 fractions was prescribed as a minimum coverage dose for 95% of the target (D95%). For 25 patients with locally advanced lung cancer, plans using four static ports (TomoDirect (R) mode) were made. Sixty Gy in 30 daily fractions for the primary tumor and swollen lymph nodes and 51 Gy in 30 fractions for prophylactic lymph node areas were prescribed as median doses. The mean conformity index of the planning target volume were similar among the four plans. The mean V5 Gy of the lung for 2.5-cm dynamic-, 2.5-cm fixed-, 5.0-cm dynamic-, and 5.0-cm fixed-jaw mode plans were 18.5%, 21.8%, 20.1%, and 29.4%, respectively (p < 0.0001), for patients with stage I lung cancer, and 37.3%, 38.7%, 40.4%, and 44.0%, respectively (p < 0.0001), for patients with locally advanced lung cancer. The mean V5 Gy of the whole body was 1,826, 2,143, 1,983, and 2,939 ml, respectively (p < 0.0001), for patients with stage I lung cancer and 4,849, 5,197, 5,220, and 6,154 ml, respectively (p < 0.0001), for patients with locally advanced lung cancer. Treatment time was reduced by 21-39% in 5.0-cm dynamic-jaw plans compared to 2.5-cm plans. Regarding dose distribution, 2.5-cm dynamic-jaw plans were the best, and 5.0-cm dynamic-jaw plans were comparable to 2.5-cm fixed-jaw plans with shorter treatment times. The dynamic-jaw mode should be used instead of the conventional fixed-jaw mode in tomotherapy for lung cancer.	[Manabe, Yoshihiko; Shibamoto, Yuta; Sugie, Chikao; Hayashi, Akihiro; Murai, Taro; Yanagi, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Manabe, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	nabe.ncu@gmail.com			Accuray, Japan	This study was carried out by an offered mechanical option of tomotherapy from Accuray, Japan without any financial support.		0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-0346	1533-0338		TECHNOL CANCER RES T	Technol. Cancer Res. Treat.	OCT	2015	14	5					583	591		10.7785/tcrtexpress.2013.600280		9	Oncology	Oncology	CR7KF	WOS:000361527700009		
J	Iwamoto, T; Monma, F; Fujieda, A; Nakatani, K; Gayle, AA; Nobori, T; Katayama, N; Okuda, M				Iwamoto, Takuya; Monma, Fumihiko; Fujieda, Atsushi; Nakatani, Kaname; Gayle, Alberto A.; Nobori, Tsutomu; Katayama, Naoyuki; Okuda, Masahiro			Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation	THERAPEUTIC DRUG MONITORING			English	Article						tacrolimus; CYP3A5; CYP2C19; genetic polymorphism; drug interaction	DONOR LIVER-TRANSPLANTATION; DRUG-INTERACTION; RECIPIENTS; PHARMACOKINETICS; LANSOPRAZOLE; RABEPRAZOLE; MUTATIONS; GENOTYPE; IMPACT; GUIDELINES	Background:Blood tacrolimus (TAC) concentration delivered via intravenous administration is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole antifungal agents. However, interindividual variability of blood TAC concentration is as of yet still difficult to predict during the early stages of hematopoietic stem cell transplantation (HSCT). This study was conducted to assess the wide variability of blood TAC concentrations because of the hepatic metabolic activities of CYP3A and CYP2C19 in HSCT recipients.Methods:This study is a single-institute prospective study that includes 21 adult patients who underwent HSCT and received 24 hours continuous intravenous administration of TAC at the Mie University Hospital between January 2009 and March 2014. After HSCT, the changes in blood TAC concentration/dose (C/D) ratio and TAC dose reduction from initial dose were investigated.Results:Significant differences between HSCT recipients with CYP3A5*1 allele and CYP3A5*3/*3 genotype were observed with respect to the median TAC C/D ratio on day 14 (563 versus 742 ng/mL per mg/kg, P < 0.01) and day 21 (672 versus 777 ng/mL per mg/kg, P < 0.05) after HSCT. Concomitant administration of voriconazole (VRCZ), but not of lansoprazole, was found to significantly increase the median TAC C/D ratio on day 14 (557 versus 723 ng/mL per mg/kg, P < 0.01). Possession of the CYP3A5*3/*3 genotype (day 14: odds ratio, 32.2; day 21: odds ratio, 33.0; P < 0.05) and concomitant administration of VRCZ (day 14: odds ratio, 37.8; P < 0.05) were found to be independent risk factors, which significantly contributed to an increased TAC C/D ratio. In HSCT recipients with CYP3A5*3/*3 genotype (78.0%), the median TAC dose ratio (day 21/day -1) was significantly lower compared with HSCT recipients with the CYP3A5*1 allele (94.1%), whereas VRCZ administration itself had no significant influence. Interestingly, in HSCT recipients with CYP2C19*1/*1, we found that the influence of VRCZ on the TAC dose ratio (85.7%) was relatively mild, even in a recipient with CYP3A5*3/*3.Conclusions:In HSCT recipients, the variability of intravenous TAC concentration in the blood could be explained in part by the genetic variation of CYP3A5. The study results also strongly imply that the magnitude of hepatic interaction between TAC and VRCZ is affected by the genetic polymorphism of both CYP3A5 and CYP2C19 genes.	[Iwamoto, Takuya; Okuda, Masahiro] Mie Univ Hosp, Dept Pharm, Tsu, Mie, Japan; [Monma, Fumihiko; Fujieda, Atsushi; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Fac Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Nakatani, Kaname; Nobori, Tsutomu] Mie Univ, Grad Sch Med, Fac Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Gayle, Alberto A.] Mie Univ, Grad Sch Med, Ctr Med & Nursing Educ, Tsu, Mie 5148507, Japan	Iwamoto, T (reprint author), Mie Univ, Fac Med, Mie Univ Hosp, Dept Pharm, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	taku-iwa@clin.medic.mie-u.ac.jp		Nakatani, Kaname/0000-0001-6709-541X	Mie University	Supported in part by a grant-in-aid for laboratory management from Mie University.	Iwamoto T, 2011, CLIN THER, V33, P1077, DOI 10.1016/j.clinthera.2011.07.006; Arai S, 2000, BLOOD REV, V14, P190, DOI 10.1054/blre.2000.0137; Mori T, 2012, INT J HEMATOL, V95, P564, DOI 10.1007/s12185-012-1057-2; Rogan PK, 2003, PHARMACOGENETICS, V13, P207, DOI 10.1097/01.fpc.0000054078.64000.de; Miura M, 2007, BIOPHARM DRUG DISPOS, V28, P167, DOI 10.1002/bdd.544; Yamazaki H, 2010, BRIT J CLIN PHARMACO, V69, P593, DOI 10.1111/j.1365-2125.2010.03656.x; Weiss J, 2009, J CLIN PHARMACOL, V49, P196, DOI 10.1177/0091270008327537; Glowacki F, 2011, NEPHROL DIAL TRANSPL, V26, P3046, DOI 10.1093/ndt/gfr253; Vannaprasaht S, 2013, CLIN THER, V35, P1762, DOI 10.1016/j.clinthera.2013.08.019; Kawazoe H, 2006, BIOL PHARM BULL, V29, P2528, DOI 10.1248/bpb.29.2528; Trifilio SM, 2010, BONE MARROW TRANSPL, V45, P1352, DOI 10.1038/bmt.2009.345; Onizuka M, 2011, BONE MARROW TRANSPL, V46, P1113, DOI 10.1038/bmt.2010.273; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; [Anonymous], 2013, PROGRAF R; [Anonymous], 2014, VFEND R; Saad AH, 2006, PHARMACOTHERAPY, V26, P1730, DOI 10.1592/phco.26.12.1730; Diaz-Molina B, 2012, TRANSPL P, V44, P2635, DOI 10.1016/j.transproceed.2012.09.062; Hosohata K, 2008, DRUG METAB PHARMACOK, V23, P134, DOI 10.2133/dmpk.23.134; Itagaki F, 2004, J PHARM PHARMACOL, V56, P1055, DOI 10.1211/0022357043914; JUSKO WJ, 1995, THER DRUG MONIT, V17, P606, DOI 10.1097/00007691-199512000-00011; Muraki Y, 2011, ANN TRANSPL, V16, P55; Mori T, 2009, BONE MARROW TRANSPL, V44, P371, DOI 10.1038/bmt.2009.38; Ji E, 2012, TRANSPLANTATION, V94, P866, DOI 10.1097/TP.0b013e318263700a; Dykewicz CA, 2001, BIOL BLOOD MARROW TR, V7, p19S, DOI 10.1053/bbmt.2001.v7.pm11777100; Moes D J A R, 2014, CPT Pharmacometrics Syst Pharmacol, V3, pe100, DOI 10.1038/psp.2013.78; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	OCT	2015	37	5					581	588		10.1097/FTD.0000000000000182		8	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	CS0LB	WOS:000361749500005		
J	Oiso, S; Morinaga, O; Goroku, T; Uto, T; Shoyama, Y; Kariyazono, H				Oiso, Shigeru; Morinaga, Osamu; Goroku, Takaaki; Uto, Takuhiro; Shoyama, Yukihiro; Kariyazono, Hiroko			Generation of an anti-Dabigatran Monoclonal Antibody and Its Use in a Highly Sensitive and Specific Enzyme-Linked Immunosorbent Assay for Serum Dabigatran	THERAPEUTIC DRUG MONITORING			English	Article						dabigatran; monoclonal antibody; enzyme-linked immunosorbent assay; serum ultrafiltrate	IONIZATION MASS-SPECTROMETRY; EASTERN BLOTTING TECHNIQUE; DIRECT THROMBIN INHIBITOR; ALBUMIN CONJUGATE; GLYCYRRHIZIN; ETEXILATE; FORSKOLIN; WARFARIN; ELISA; ACID	Background:Dabigatran (DT) is a direct thrombin inhibitor used to prevent venous and arterial thromboembolism due to atrial fibrillation. DT is the active form of the commercially available prodrug DT etexilate. Although DT has many clinical advantages over warfarin, it increases the incidence of bleeding in patients with renal dysfunction. Circulating levels of DT are increased in such patients because it is mainly eliminated by renal excretion. Therapeutic drug monitoring may therefore help to prevent adverse DT effects, but no method for measuring circulating DT levels has been reported, except for an analysis by liquid chromatography-tandem mass spectrometry. This study sought to develop a novel enzyme-linked immunosorbent assay (ELISA) to measure DT concentrations.Methods:Mice were immunized with a DT-keyhole limpet hemocyanin conjugate to generate an anti-DT antibody. Immunized mouse splenocytes and myeloma cells (SP2/0) were fused to obtain an anti-DT monoclonal antibody (DT-mAb). DT-mAb and DT solutions were added to microplate wells coated with a DT-human serum albumin conjugate. DT concentrations were determined based on the principles of ELISA.Results:DT-mAb was successfully purified from a hybridoma, and the competitive ELISA developed using this DT-mAb could evaluate DT concentrations ranging from 7.8 to 125 ng/mL. The ELISA signal was not linear using DT-spiked serum; however, it was linear when serum ultrafiltrate was used. Weak cross-reactivity with DT etexilate was detected, but no cross-reactivity was observed with other structurally related drugs or drugs commonly used for the treatment of atrial fibrillation.Conclusions:The developed competitive ELISA is a valuable and specific tool to analyze free DT in serum ultrafiltrate for therapeutic drug monitoring and pharmacokinetic studies.	[Oiso, Shigeru; Morinaga, Osamu; Uto, Takuhiro; Shoyama, Yukihiro; Kariyazono, Hiroko] Nagasaki Int Univ, Grad Sch Pharmaceut Sci, Nagasaki 8593298, Japan; [Oiso, Shigeru; Goroku, Takaaki; Kariyazono, Hiroko] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care Sci, Nagasaki 8593298, Japan; [Morinaga, Osamu; Uto, Takuhiro; Shoyama, Yukihiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharmacognosy, Nagasaki 8593298, Japan	Oiso, S (reprint author), Nagasaki Int Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Hlth Care Sci, 2825-7 Huis Ten Bosch Sasebo, Nagasaki 8593298, Japan.	shige@niu.ac.jp			JSPS KAKENHI [24659355]	Supported by JSPS KAKENHI Grant Number 24659355.	Laizure SC, 2014, DRUG METAB DISPOS, V42, P201, DOI 10.1124/dmd.113.054353; Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; SHOYAMA Y, 1993, BIOL PHARM BULL, V16, P1051; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eisert WG, 2010, ARTERIOSCL THROM VAS, V30, P1885, DOI 10.1161/ATVBAHA.110.203604; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; GOTO Y, 1994, ORG MASS SPECTROM, V29, P668, DOI 10.1002/oms.1210291115; SAKATA R, 1994, CYTOTECHNOLOGY, V16, P101, DOI 10.1007/BF00754612; Ortel TL, 2012, BLOOD, V120, P4699, DOI 10.1182/blood-2012-05-423228; Shan SJ, 2001, ANAL CHEM, V73, P5784, DOI 10.1021/ac0106997; Tanaka H, 1998, BIOL PHARM BULL, V21, P1391; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Li XW, 2013, PHYTOCHEM ANALYSIS, V24, P645, DOI 10.1002/pca.2448; Morinaga O, 2001, ANALYST, V126, P1372, DOI 10.1039/b103153h; Saita T, 2004, BIOL PHARM BULL, V27, P94, DOI 10.1248/bpb.27.94; Saita T, 2005, BIOL PHARM BULL, V28, P1833, DOI 10.1248/bpb.28.1833; WEILER EW, 1976, PHYTOCHEMISTRY, V15, P1537, DOI 10.1016/S0031-9422(00)88933-5; SHOYAMA Y, 1993, ORG MASS SPECTROM, V28, P987, DOI 10.1002/oms.1210280910; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Dahl Ola E, 2012, Vasc Health Risk Manag, V8, P45, DOI 10.2147/VHRM.S26482; Galfrè G, 1981, Methods Enzymol, V73, P3; GODING JW, 1980, J IMMUNOL METHODS, V39, P285, DOI 10.1016/0022-1759(80)90230-6; Norgard Nicholas B, 2012, Ther Adv Chronic Dis, V3, P123, DOI 10.1177/2040622312438934	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	OCT	2015	37	5					594	599		10.1097/FTD.0000000000000184		6	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	CS0LB	WOS:000361749500007		
J	Miyata, T; Uchida, Y; Ohta, T; Urayama, K; Yoshida, Y; Fujimura, Y				Miyata, Toshiyuki; Uchida, Yumiko; Ohta, Toshiyuki; Urayama, Kohtaro; Yoshida, Yoko; Fujimura, Yoshihiro			Atypical haemolytic uraemic syndrome in a Japanese patient with DGKE genetic mutations	THROMBOSIS AND HAEMOSTASIS			English	Letter							MICROANGIOPATHY; VARIANTS		[Miyata, Toshiyuki; Uchida, Yumiko] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka 5658565, Japan; [Ohta, Toshiyuki; Urayama, Kohtaro] Hiroshima Prefectural Hosp, Dept Pediat Nephrol, Hiroshima, Japan; [Yoshida, Yoko; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan	Miyata, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, 5-7-1 Fujishiro Dal, Suita, Osaka 5658565, Japan.	miyata@ncvc.go.jp					Ozaltin F, 2013, J AM SOC NEPHROL, V24, P377, DOI 10.1681/ASN.2012090903; Fujimura Y, 2011, J THROMB HAEMOST, V9, P283, DOI 10.1111/j.1538-7836.2011.04341.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Westland R, 2014, J AM SOC NEPHROL, V25, P1408, DOI 10.1681/ASN.2013080886; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Chinchilla DS, 2014, CLIN J AM SOC NEPHRO, V9, P1611, DOI 10.2215/CJN.01640214; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Bruneau S, 2015, BLOOD, V125, P1038, DOI 10.1182/blood-2014-06-579953; Matsumoto T, 2014, INT J HEMATOL, V100, P444, DOI 10.1007/s12185-014-1655-2; Ohta T, 2015, PEDIATR NEPHROL, V30, P603, DOI 10.1007/s00467-014-2975-4	12	0	0	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0340-6245			THROMB HAEMOSTASIS	Thromb. Haemost.	OCT	2015	114	4					862	863		10.1160/TH15-01-0007		2	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CS5UR	WOS:000362144300024		
J	Ting, SYW; Montagne, K; Nishimura, Y; Ushida, T; Furukawa, KS				Ting, Stephanie Yin Wai; Montagne, Kevin; Nishimura, Yoshihiro; Ushida, Takashi; Furukawa, Katsuko S.			Modulation of the Effect of Transforming Growth Factor-beta 3 by Low-Intensity Pulsed Ultrasound on Scaffold-Free Dedifferentiated Articular Bovine Chondrocyte Tissues	TISSUE ENGINEERING PART C-METHODS			English	Article							MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; ENGINEERED CARTILAGE; GENE-EXPRESSION; BONE-MARROW; MATRIX; OSTEOARTHRITIS; REGENERATION; STIMULATION; HYPERTROPHY	The aim of this study was to evaluate how low-intensity pulsed ultrasound (LIPUS) modulates the effect of transforming growth factor-3 (TGF-3) on the differentiation of scaffold-free dedifferentiated bovine articular chondrocyte tissues toward a cartilage-like phenotype. Specifically, the effect of these stimuli on the expression of hypertrophic markers collagen type I, collagen type X, and cartilage-degrading collagenase gene expression for a scaffold-free model was analyzed. A bioreactor that applied LIPUS directly from the transducer through a silicone gel to a six-well plate containing the tissues allowed simple, sterile, and large-scale experiments. Tissues were subjected to LIPUS of 55mW/cm(2) in a 200s burst sine wave of 1MHz over a 10-day period with or without TGF-3 (10ng/mL). Tissues exposed to TGF-3 had significantly increased glycosaminoglycan and total collagen protein production along with upregulated cartilage-specific gene expression, resulting in tissues with a higher Young's Modulus. However, these tissues had also upregulated gene expression for hypertrophic markers collagen type I, collagen type X, MMP-1, MMP-13, MMP-2, and also an increase in the phosphorylation of p38. The expression of these matrix-degrading enzymes was remediated by hypertrophic development and differentiate dedifferentiated bovine articular chondrocytes towards a chondrogenic lineage allowing it to be a valuable tool in cartilage tissue engineering.	[Ting, Stephanie Yin Wai; Montagne, Kevin; Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, Dept Mech Engn, Tokyo 1138656, Japan; [Nishimura, Yoshihiro] Sigmax, Tokyo, Japan; [Ushida, Takashi; Furukawa, Katsuko S.] Univ Tokyo, Dept Bioengn, Tokyo 1138656, Japan	Furukawa, KS (reprint author), Univ Tokyo, Sch Engn, Dept Mech Engn, Engn Bldg 5,Room 621,7-3-1 Hongo, Tokyo 1138656, Japan.	furukawa@mech.t.u-tokyo.ac.jp			program of Next Generation on World-Leading Researchers (NEXT), Japan Society for the Promotion of Science (JSPS); Global COE Program (GCOE), Medical System Innovation on Multidisciplinary Integration, MEXT, Japan	This work was supported by the program of Next Generation on World-Leading Researchers (NEXT), Japan Society for the Promotion of Science (JSPS) and, in part, by the Global COE Program (GCOE), Medical System Innovation on Multidisciplinary Integration, MEXT, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Ebisawa K, 2004, TISSUE ENG, V10, P921, DOI 10.1089/1076327041348437; Lee HJ, 2006, ARTIF ORGANS, V30, P707, DOI 10.1111/j.1525-1594.2006.00288.x; Marlovits S, 2003, TISSUE ENG, V9, P1215, DOI 10.1089/10763270360728125; Ikeda K, 2006, LIFE SCI, V79, P1936, DOI 10.1016/j.lfs.2006.06.029; Stoddart MJ, 2006, J CELL MOL MED, V10, P480, DOI 10.1111/j.1582-4934.2006.tb00413.x; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254; Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; THORP BH, 1992, DEVELOPMENT, V114, P907; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Mukai S, 2005, ULTRASOUND MED BIOL, V31, P1713, DOI 10.1016/j.ultrasmedbio.2005.07.012; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674; Kock LM, 2013, TISSUE ENG PT A, V19, P1621, DOI [10.1089/ten.TEA.2012.0541, 10.1089/ten.tea.2012.0541]; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Karsenty G, 1998, DEV GENET, V22, P301; Kang SW, 2008, BIOTECHNOL LETT, V30, P435, DOI 10.1007/s10529-007-9576-2; Nishikori T, 2002, J BIOMED MATER RES, V59, P201, DOI 10.1002/jbm.1226; Mouw JK, 2007, STEM CELLS, V25, P655, DOI 10.1634/stemcells.2006-0435; Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Furukawa KS, 2003, CELL TRANSPLANT, V12, P475; BALLOCK RT, 1993, DEV BIOL, V158, P414, DOI 10.1006/dbio.1993.1200; Shlopov BV, 1999, ARTHRITIS RHEUM, V42, P719, DOI 10.1002/1529-0131(199904)42:4<719::AID-ANR15>3.0.CO;2-T; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; OKAYAMA M, 1976, P NATL ACAD SCI USA, V73, P3224, DOI 10.1073/pnas.73.9.3224; van Beuningen HM, 2000, OSTEOARTHR CARTILAGE, V8, P25, DOI 10.1053/joca.1999.0267; Blaney DE, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; Blaney DE, 2007, OSTEOARTHR CARTILAGE, V15, P597; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; Kawanishi M, 2007, TISSUE ENG, V13, P957, DOI 10.1089/ten.2006.0176; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; Schiltz J. R., 1973, DIFFERENTIATION, V1, P97, DOI 10.1111/j.1432-0436.1973.tb00106.x; Shafaei Hajar, 2013, Adv Biomed Res, V2, P79, DOI 10.4103/2277-9175.120867; VONDERMARK K, 1992, ARTHRITIS RHEUM, V35, P806, DOI 10.1002/art.1780350715	42	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	OCT 1	2015	21	10					1005	1014		10.1089/ten.tec.2014.0428		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CS5AI	WOS:000362087300002		
J	Okeyo, KO; Kurosawa, O; Yamazaki, S; Oana, H; Kotera, H; Nakauchi, H; Washizu, M				Okeyo, Kennedy Omondi; Kurosawa, Osamu; Yamazaki, Satoshi; Oana, Hidehiro; Kotera, Hidetoshi; Nakauchi, Hiromitsu; Washizu, Masao			Cell Adhesion Minimization by a Novel Mesh Culture Method Mechanically Directs Trophoblast Differentiation and Self-Assembly Organization of Human Pluripotent Stem Cells	TISSUE ENGINEERING PART C-METHODS			English	Article							LINEAGE SPECIFICATION; CADHERIN EXPRESSION; EMBRYOID BODIES; CDX2; TROPHECTODERM; TISSUE; MATRIX; ESTABLISHMENT; MORPHOGENESIS; ARCHITECTURE	Mechanical methods for inducing differentiation and directing lineage specification will be instrumental in the application of pluripotent stem cells. Here, we demonstrate that minimization of cell-substrate adhesion can initiate and direct the differentiation of human pluripotent stem cells (hiPSCs) into cyst-forming trophoblast lineage cells (TLCs) without stimulation with cytokines or small molecules. To precisely control cell-substrate adhesion area, we developed a novel culture method where cells are cultured on microstructured mesh sheets suspended in a culture medium such that cells on mesh are completely out of contact with the culture dish. We used microfabricated mesh sheets that consisted of open meshes (100 approximate to 200m in pitch) with narrow mesh strands (3-5m in width) to provide support for initial cell attachment and growth. We demonstrate that minimization of cell adhesion area achieved by this culture method can trigger a sequence of morphogenetic transformations that begin with individual hiPSCs attached on the mesh strands proliferating to form cell sheets by self-assembly organization and ultimately differentiating after 10-15 days of mesh culture to generate spherical cysts that secreted human chorionic gonadotropin (hCG) hormone and expressed caudal-related homeobox 2 factor (CDX2), a specific marker of trophoblast lineage. Thus, this study demonstrates a simple and direct mechanical approach to induce trophoblast differentiation and generate cysts for application in the study of early human embryogenesis and drug development and screening.	[Okeyo, Kennedy Omondi; Oana, Hidehiro; Washizu, Masao] Univ Tokyo, Sch Engn, Dept Mech Engn, Tokyo 1138656, Japan; [Kurosawa, Osamu; Washizu, Masao] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Therapy, Tokyo 1138656, Japan; [Kotera, Hidetoshi] Kyoto Univ, Postgrad Sch Engn, Dept Microengn, Kyoto, Japan	Okeyo, KO (reprint author), Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	okeyo@washizu.t.u-tokyo.ac.jp	OANA, HIDEHIRO/C-6992-2009		Japan MEXT KAKENHI [25790034, 23246045]; Grant-in-Aid for Scientific Research on Innovative Areas; Hyper Bio Assembler for 3D Cellular Innovations [26106710]	We are particularly grateful to Dr. Takashi Tada of Kyoto University for providing the hiPSCs used in this study and for helpful discussions. We thank Dr. Satoshi Tanaka of the University of Tokyo for insightful discussions on characterization of trophoblasts. We would also like to acknowledge the help of Dr. Keiichiro Kushiro of The University of Tokyo in performing ELISA analyses. Finally, we thank Dr. Yuji Teramura of the University of Tokyo and Dr. Yasuhiko Sato of Carl Zeiss Microscopy Co. Ltd for assistance with confocal imaging of trophoblast cysts, and TOBIC (The University of Tokyo IMCB-Olympus Bioimaging Center) for support with immunofluorescence imaging of E-cadherin and vinculin. This work was supported by Japan MEXT KAKENHI grant nos. 25790034 and 23246045, and the Grant-in-Aid for Scientific Research on Innovative Areas; Hyper Bio Assembler for 3D Cellular Innovations no. 26106710.	Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Schiffmacher AT, 2013, MOL REPROD DEV, V80, P826, DOI 10.1002/mrd.22212; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/nmat3980, 10.1038/NMAT3980]; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; RISAU W, 1988, DEVELOPMENT, V102, P471; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Jiang ZP, 2014, CELL MOL IMMUNOL, V11, P17, DOI 10.1038/cmi.2013.62; Chen Y, 2013, BIOCHEM BIOPH RES CO, V436, P677, DOI 10.1016/j.bbrc.2013.06.016; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; De Los Angeles A, 2013, NATURE, V502, P309, DOI 10.1038/nature12559; Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Huang XH, 2014, STEM CELLS DEV, V23, P1501, DOI 10.1089/scd.2013.0329; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Oda M, 2009, P NATL ACAD SCI USA, V106, P16293, DOI 10.1073/pnas.0908009106; Roper S, 2009, CELL CYCLE, V8, P1515; Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Pieters T, 2014, J CELL SCI, V127, P2603, DOI 10.1242/jcs.146720; Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066; Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110; Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002; Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340; Miyoshi H, 2014, TISSUE ENG PART B-RE, V20, P609, DOI [10.1089/ten.TEB.2013.0728, 10.1089/ten.teb.2013.0728]; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Chen Y, 2013, BIOCHEM BIOPH RES CO, V431, P197, DOI 10.1016/j.bbrc.2012.12.135; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Schulz L. C., 2008, PLACENTA S, V29, P10, DOI 10.1016/j.placenta.2007.10.009; Tamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081156; Xu R., 2002, NAT BIOTECHNOL, V284, P143	45	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	OCT 1	2015	21	10					1105	1115		10.1089/ten.tec.2015.0038		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CS5AI	WOS:000362087300012		
J	Shirakawa, M; Sekine, S; Tanaka, A; Horie, T; Ito, K				Shirakawa, Maho; Sekine, Shuichi; Tanaka, Ayaka; Horie, Toshiharu; Ito, Kousei			Metabolic activation of hepatotoxic drug (benzbromarone) induced mitochondrial membrane permeability transition	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Benzbromarone; Drug-induced liver toxicity; Membrane permeability transition; Mitochondria; Reactive metabolite	INDUCED-LIVER-INJURY; CYTOCHROMES P450; IN-VITRO; INHIBITION; MECHANISMS; SUSCEPTIBILITY; BIOACTIVATION; CONSEQUENCES; CYCLOSPORINE; DERIVATIVES	The risk of drug-induced liver injury (DILL) is of great concern to the pharmaceutical industry. It is well-known that metabolic activation of drugs to form toxic metabolites (TMs) is strongly associated with DILL onset. Drug-induced mitochondrial dysfunction is also strongly associated with increased risk of DILI. However, it is difficult to determine the target of TMs associated with exacerbation of DILI because of difficulties in identifying and purifying TMs. In this study, we propose a sequential in vitro assay system to assess TM formation and their ability to induce mitochondrial permeability transition (MPT) in a one-pot process. In this assay system, freshly-isolated rat liver mitochondria were incubated with reaction solutions of 44 test drugs preincubated with liver microsomes in the presence or absence of NADPH; then, NADPH-dependent MET pore opening was assessed as mitochondrial swelling. In this assay system, several hepatotoxic drugs, including benzbromarone (BBR), significantly induced MPT in a NADPH-dependent manner. We investigated the rationality of using BBR as a model drug, since it showed the most prominent MPT in our assay system. Both the production of a candidate toxic metabolite of BBR (1',6-(OH)(2) BBR) and NADPH-dependent MPT were inhibited by several cytochrome P450 (CYP) inhibitors (clotrimazole and SKF-525A, 100 mu M). In summary, this assay system can be used to evaluate comprehensive metabolite-dependent MPT without identification or purification of metabolites. (C) 2015 Elsevier Inc. All rights reserved.	[Shirakawa, Maho; Sekine, Shuichi; Tanaka, Ayaka; Ito, Kousei] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chiba, Japan; [Horie, Toshiharu] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo, Japan	Ito, K (reprint author), Inohana 1-8-1,Chuo Ku, Chiba 2608675, Japan.	itokousei@chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [30323405, 26460190]	This work was supported by a Grant-in-Aid for Scientific Research (B) (30323405) and Grant-in-Aid for Scientific Research (C) (26460190) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The metabolites of BBR (1 '-OH BBR; 6-OH BBR; and 5,6-(OH)<INF>2</INF> BBR) were offered by Toni Pharmaceutical Co. Ltd. (Chiba, Japan).	Velho JA, 2006, TOXICOLOGY, V219, P124, DOI 10.1016/j.tox.2005.11.007; Haouzi D, 2000, HEPATOLOGY, V32, P303, DOI 10.1053/jhep.2000.9034; Zhou SF, 2007, THER DRUG MONIT, V29, P687; FAGIAN MM, 1990, J BIOL CHEM, V265, P19955; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188; Tafazoli S, 2009, TOXICOLOGY, V256, P101, DOI 10.1016/j.tox.2008.11.006; Lammert C, 2010, HEPATOLOGY, V51, P615, DOI 10.1002/hep.23317; Kobayashi K, 2012, BIOPHARM DRUG DISPOS, V33, P466, DOI 10.1002/bdd.1813; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; Fortes F, 2001, J BIOENERG BIOMEMBR, V33, P43, DOI 10.1023/A:1005672623709; Wu HQ, 2012, J CHROMATOGR B, V911, P122, DOI 10.1016/j.jchromb.2012.10.035; Mancy A, 1996, BIOCHEMISTRY-US, V35, P16205, DOI 10.1021/bi961950t; Zuber R, 2002, J CELL MOL MED, V6, P189, DOI 10.1111/j.1582-4934.2002.tb00186.x; Okuda T, 2010, TOXICOL APPL PHARM, V248, P242, DOI 10.1016/j.taap.2010.08.007; Masubuchi Y, 2006, TOXICOLOGY, V222, P233, DOI 10.1016/j.tox.2006.02.017; Labbe G, 2008, FUND CLIN PHARMACOL, V22, P335, DOI 10.1111/j.1472-8206.2008.00608.x; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370; Masubuchi Y, 2002, HEPATOLOGY, V35, P544, DOI 10.1053/jhep.2002.31871; Laine JE, 2009, XENOBIOTICA, V39, P11, DOI [10.1080/00498250802512830 , 10.1080/00498250802512830]; Kobayashi K, 2003, DRUG METAB DISPOS, V31, P833, DOI 10.1124/dmd.31.7.833; McDonald MG, 2007, CHEM RES TOXICOL, V20, P1833, DOI 10.1021/tx7001228; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Sekine S, 2013, BIOCHEM PHARMACOL, V86, P1507, DOI 10.1016/j.bcp.2013.08.027; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Amundsen R, 2012, DRUG METAB DISPOS, V40, P655, DOI 10.1124/dmd.111.043018; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649; Iwamura A, 2011, DRUG METAB DISPOS, V39, P838, DOI 10.1124/dmd.110.037259; CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H; Emoto Chie, 2003, Drug Metab Pharmacokinet, V18, P287, DOI 10.2133/dmpk.18.287; Pessayre D, 2010, HDB EXP PHARM, V196, P311	36	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	OCT 1	2015	288	1					12	18		10.1016/j.taap.2015.06.018		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CS5VE	WOS:000362145600002		
J	Fujimura, M; Usuki, F				Fujimura, Masatake; Usuki, Fusako			Low concentrations of methylmercury inhibit neural progenitor cell proliferation associated with up-regulation of glycogen synthase kinase 3 beta and subsequent degradation of cyclin E in rats	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Methylmercury; Neural progenitor cell; Proliferation; Cyclin E; Degradation; Glycogen synthase kinase 3 beta	STEM-CELLS; NEURONAL DIFFERENTIATION; DEVELOPMENTAL EXPOSURE; BRAIN; NEUROGENESIS; DEFICITS; PATHWAY; DEATH	Methylmercury (MeHg) is an environmental neurotoxicant. The developing nervous system is susceptible to low concentrations of MeHg; however, the effect of MeHg on neural progenitor cell (NPC) proliferation, a key stage of neurogenesis during development, remains to be clarified. In this study, we investigated the effect of low concentrations of MeHg on NPCs by using a primary culture system developed using the embryonic rat cerebral cortex. NPC proliferation was suppressed 48 h after exposure to 10 nM MeHg, but cell death was not observed. Western blot analyses for cyclins A, B, D1, and E demonstrated that MeHg down-regulated cyclin E, a promoter of the G1/S cell cycle transition. Cyclin E has been shown to be degraded following the phosphorylation by glycogen synthase kinase 3 beta (GSK-3 beta). The time course study showed that GSK-3 beta was up-regulated 3 h after exposure to 10 nM MeHg, and cyclin E degradation 48 h after MeHg exposure. We further demonstrated that GSK-3 beta inhibitors, lithium and SB-415286, suppressed MeHg-induced inhibition of NPC proliferation by preventing cyclin E degradation. These results suggest that the inhibition of NPC proliferation induced by low concentration of MeHg was associated with up-regulation of GSK-3 beta at the early stage and subsequent degeneration of cyclin E. (C) 2015 Elsevier Inc. All rights reserved.	[Fujimura, Masatake] Natl Inst Minamata Dis, Dept Basic Med Sci, Minamata, Kumamoto 8670008, Japan; [Usuki, Fusako] Natl Inst Minamata Dis, Dept Clin Med, Minamata, Kumamoto 8670008, Japan	Fujimura, M (reprint author), Natl Inst Minamata Dis, Dept Basic Med Sci, 4058-18 Hama, Minamata, Kumamoto 8670008, Japan.	fujimura@nimd.go.jp			Ministry of Education, Science, Sports and Culture, (Japan) [26460187]	We are grateful to Ayumi Onitsuka and Michiko Fuchigami for their excellent technical assistance. This research was partially supported by the Ministry of Education, Science, Sports and Culture (Grant-in-Aid for Scientific Research, 26460187, 2014, Japan (M.F.)).	Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/01.wnr.0000082022.91120.a7; Falluel-Morel A, 2007, J NEUROCHEM, V103, P1968, DOI 10.1111/j.1471-4159.2007.04882.x; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Sproule B, 2002, CLIN PHARMACOKINET, V41, P639, DOI 10.2165/00003088-200241090-00002; GEELEN JAG, 1990, ACTA NEUROPATHOL, V80, P432; Xu MY, 2010, BRAIN RES, V1359, P272, DOI 10.1016/j.brainres.2010.08.069; Won KA, 1996, EMBO J, V15, P4182; Eto K, 1997, TOXICOL PATHOL, V25, P614; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Zimmer B, 2012, ENVIRON HEALTH PERSP, V120, P1116, DOI 10.1289/ehp.1104489; Ferraro L, 2009, INT J DEV NEUROSCI, V27, P165, DOI 10.1016/j.ijdevneu.2008.11.004; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Tamm C, 2006, J NEUROCHEM, V97, P69, DOI 10.1111/j.1471-4159.2006.03718.x; Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134; Fujimura M, 2011, TOXICOL APPL PHARM, V250, P1, DOI 10.1016/j.taap.2010.09.011; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Onishchenko N, 2007, TOXICOL SCI, V97, P428, DOI 10.1093/toxsci/kfl199; Burke K, 2006, NEUROTOXICOLOGY, V27, P970, DOI 10.1016/j.neuro.2006.09.001; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Stringari J, 2008, TOXICOL APPL PHARM, V227, P147, DOI 10.1016/j.taap.2007.10.01; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P1000, DOI 10.1016/j.neuro.2009.08.001; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P16, DOI 10.1016/j.neuro.2008.10.002; Esfandiari F, 2012, STEM CELLS DEV, V21, P3233, DOI 10.1089/scd.2011.0678; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Sokolowski K, 2011, NEUROTOXICOLOGY, V32, P535, DOI 10.1016/j.neuro.2011.06.003; Faustman EM, 2002, ENVIRON HEALTH PERSP, V110, P859	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	OCT 1	2015	288	1					19	25		10.1016/j.taap.2015.07.006		7	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CS5VE	WOS:000362145600003		
J	Abiko, K; Iwayama, A; Shiomi, K				Abiko, Keisuke; Iwayama, Ayane; Shiomi, Kazuo			Detection and some properties of a high molecular weight toxin in the hypobranchial gland of strawberry conch Strombus luhuanus	TOXICON			English	Article						Hypobranchial gland; Marine gastropod; Strawberry conch; Strombus luhuanus; Toxin	GASTROPOD MONOPLEX-ECHO; SALIVARY-GLAND; TETRAMINE; PEPTIDES	The extract from the hypobranchial gland of strawberry conch Strombus luhuanus was found to be lethal to mice. There were no marked regional and seasonal variations in toxicity although a considerable individual variation was recognized. The toxin was thermostable and extractable with aqueous solvents but not with organic solvents. Behaviors in dialysis, ultrafiltration and column chromatography on various adsorbents suggested that the toxin is a high molecular weight acidic substance of 400-500 k. (C) 2015 Elsevier Ltd. All rights reserved.	[Abiko, Keisuke; Iwayama, Ayane; Shiomi, Kazuo] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Shiomi, K (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Konan 4, Tokyo 1088477, Japan.	mkazusan21@s4.dion.ne.jp			Ministry of Health, Labour and Welfare of Japan [H22-Food-General-011]	This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan (H22-Food-General-011).	Gunji K, 2010, PROTEIN J, V29, P487, DOI 10.1007/s10930-010-9277-x; Roseghini M, 1996, TOXICON, V34, P33, DOI 10.1016/0041-0101(95)00104-2; Kawashima Y, 2003, TOXICON, V42, P491, DOI 10.1016/S0041-0101(03)00226-5; Brady RM, 2013, MAR DRUGS, V11, P2293, DOI 10.3390/md11072293; Shiomi K, 1998, TOXICON, V36, P795, DOI 10.1016/S0041-0101(97)00166-9; ANTHONI U, 1989, TOXICON, V27, P707, DOI 10.1016/0041-0101(89)90037-8; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Kawashima Y, 2002, J FOOD HYG SOC JPN, V43, P385; Kelley WP, 2003, J BIOL CHEM, V278, P34934, DOI 10.1074/jbc.M301271200; Shiomi K, 2002, TOXICON, V40, P563, DOI 10.1016/S0041-0101(01)00256-2; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	OCT	2015	105						1	3		10.1016/j.toxicon.2015.08.011		3	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CS5SY	WOS:000362139800001		
J	Ikehara, T; Nakashima, J; Nakashima, S; Yasumoto, T				Ikehara, Tsuyoshi; Nakashima, Junichi; Nakashima, Shihoko; Yasumoto, Takeshi			Different responses of primary normal human hepatocytes and human hepatoma cells toward cyanobacterial hepatotoxin microcystin-LR	TOXICON			English	Article						Microcystin-LR; Human hepatocytes; Hepatotoxicty; Protein phosphatase 2A (PP2A) inhibition assay	TUMOR PROMOTION; LIVER; TOXICITY; INHIBITOR; POTENT; PLANTS; TOXINS; BRAZIL	Microcystins (MCs) are potent hepatotoxins produced by cyanobacteria in aquatic environments. MC-LR, a representative MC, strongly inhibits protein phosphatases 1 and 2A, leading to cell collapse in animal hepatocytes due to hyperphospholylation of the cytoskeleton and apoptosis due to stimulation of the relevant systems. However, the molecular mechanisms and the metabolic pathways responsible for MC-LR toxicity are poorly understood. In the present study, we compared the cytotoxic effects of MC-LR in two cell lines: normal human hepatocytes (h-Nheps) and human hepatoma cell line HepG2. We also discussed the suitability of cellular assays for evaluating the toxicity of MCs. To obtain further insight into the molecular mechanism, the uptake, excretion, and intracellular distribution of MC-LR were analyzed using an antibody and assay kit targeting the catalytic subunit of protein phosphatase 2A (the PP2A assay kit). The responses toward MC-LR were distinctly different between the two cell lines. In HepG2 cells, MC-LR did not induce morphological change, did not reveal cytotoxicity, and accumulated to a lesser extent despite a slightly elevated expression of the MC transporter protein. MC-LR also did not alter the MC-binding potency of subcellular proteins. All these results indicate that HepG2 cells are inappropriate for the evaluation of MC-LR toxicity. The PP2A assay kits were useful not only for assessing PP2A-inhibitory potency, but also for determining the concentration of MCs in biological systems. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikehara, Tsuyoshi] Natl Fisheries Univ, Dept Food Sci & Technol, Shimonoseki, Yamaguchi 7596595, Japan; [Nakashima, Junichi] Fukuoka Inst Hlth & Environm Sci, Fukuoka 8180135, Japan; [Nakashima, Shihoko] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 8140180, Japan; [Yasumoto, Takeshi] Japan Food Res Labs, Tama Ku, Tokyo 2060025, Japan	Ikehara, T (reprint author), Natl Fisheries Univ, Dept Food Sci & Technol, 2-7-1 Nagata Honmachi, Shimonoseki, Yamaguchi 7596595, Japan.	ikehara@fish-u.ac.jp					Ikehara T, 2009, TOXICON, V54, P539, DOI 10.1016/j.toxicon.2009.05.028; CODD GA, 1989, TOXIC ASSESS, V4, P499, DOI 10.1002/tox.2540040409; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; FALCONER IR, 1991, ENVIRON TOXIC WATER, V6, P177, DOI 10.1002/tox.2530060207; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; Ito E, 2000, TOXICON, V38, P37, DOI 10.1016/S0041-0101(99)00084-7; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; Meriluoto JAO, 2008, ADV EXP MED BIOL, V619, P483, DOI 10.1007/978-0-387-75865-7_21; AUNE T, 1986, J TOXICOL ENV HEALTH, V19, P325; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; Imanishi S, 2004, TOXICON, V43, P651, DOI 10.1016/j.toxicon.2004.02.026; Pouria S, 1998, LANCET, V352, P21, DOI 10.1016/S0140-6736(97)12285-1; Rao PVL, 2005, COMP BIOCHEM PHYS C, V140, P11, DOI 10.1016/j.cca.2004.11.008; Ikehara T, 2008, TOXICON, V51, P1368, DOI 10.1016/j.toxicon.2008.03.003; Heinze R., 1996, Phycologia, V35, P89, DOI 10.2216/i0031-8884-35-6S-89.1; Hoeger SJ, 2005, TOXICOL APPL PHARM, V203, P231, DOI 10.1016/j.taap.2004.04.015; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; YU SZ, 1995, J GASTROEN HEPATOL, V10, P674, DOI 10.1111/j.1440-1746.1995.tb01370.x	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	OCT	2015	105						4	9		10.1016/j.toxicon.2015.08.025		6	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CS5SY	WOS:000362139800002		
J	Alanova, P; Huskova, Z; Kopkan, L; Sporkova, A; Jichova, S; Neckar, J; Imig, JD; Klevstig, M; Kolar, F; Reddy, NR; Falck, JR; Sadowski, J; Nishiyama, A; Kramer, HJ; Melenovsy, V; Cervenkova, L; Kujal, P; Vernerova, Z; Cervenka, L				Alanova, Petra; Huskova, Zuzana; Kopkan, Libor; Sporkova, Alexandra; Jichova, Sarka; Neckar, Jan; Imig, John D.; Klevstig, Martina; Kolar, Frantisek; Reddy, N. Rami; Falck, John R.; Sadowski, Janusz; Nishiyama, Akira; Kramer, Herbert J.; Melenovsy, Vojtech; Cervenkova, Lenka; Kujal, Petr; Vernerova, Zdenka; Cervenka, Ludek			Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats	VASCULAR PHARMACOLOGY			English	Article						Renovascular hypertension; Myocardial ischemia/reperfusion injury; 14,15-Epoxyeicosatrienoic acid analog; Renin - angiotensin system	SOLUBLE EPOXIDE HYDROLASE; ISCHEMIA-REPERFUSION INJURY; LEFT-VENTRICULAR HYPERTROPHY; SALT-SENSITIVE RAT; ANGIOTENSIN-II; NITRIC-OXIDE; TRANSGENIC RATS; BLOOD-PRESSURE; CYTOCHROME-P-450 METABOLITES; ISCHEMIA/REPERFUSION INJURY	This study examined the effects of a novel orally active 14,15-epoxyeicosatrienoic acid analog (EET-A) on blood pressure (BP) and myocardial infarct size (IS) in two-kidney, one-clip (2K1C) Goldblatt hypertensive rats during sustained phase of hypertension. Between days 31 and 35 after clip placement the rats were treated with EET-A and BP was monitored by radiotelemetry; sham-operated normotensive rats were used as controls. Tissue concentrations of epoxyeicosatrienoic acids served as a marker of production of epoxygenase metabolites. The rats were subjected to acute myocardial ischemia/reperfusion (I/R) injury and IS was determined. We found that EET-A treatment did not lower BP in 2K1C rats and did not alter availability of biologically active epoxygenase metabolites in 2K1C or in sham-operated rats. The myocardial IS was significantly smaller in untreated 2K1C rats as compared with normotensive controls and EET-A reduced it in controls but not in 2K1C rats. Our findings suggest that during the phase of sustained hypertension 2K1C Goldblatt hypertensive rats exhibit increased cardiac tolerance to I/R injury as compared with normotensive controls, and that in this animal model of human renovascular hypertension short-term treatment with EET-A does not induce any antihypertensive and cardioprotective actions. (C) 2015 Elsevier Inc. All rights reserved.	[Alanova, Petra; Neckar, Jan; Klevstig, Martina; Kolar, Frantisek] Acad Sci Czech Republic, Inst Physiol, Dept Dev Cardiol, Prague, Czech Republic; [Huskova, Zuzana; Kopkan, Libor; Sporkova, Alexandra; Jichova, Sarka; Cervenkova, Lenka; Kujal, Petr; Vernerova, Zdenka; Cervenka, Ludek] Inst Clin & Expt Med, Ctr Med Expt, CZ-14000 Prague 4, Czech Republic; [Neckar, Jan; Imig, John D.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI USA; [Reddy, N. Rami; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Sadowski, Janusz] Polish Acad Sci, Dept Renal & Body Fluid Physiol, M Mossakowski Med Res Ctr, Warsaw, Poland; [Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Kramer, Herbert J.] Univ Bonn, Nephrol Sect, Med Polyclin, Dept Med, Bonn, Germany; [Melenovsy, Vojtech] Inst Clin & Expt Med, Dept Cardiol, CZ-14000 Prague 4, Czech Republic; [Kujal, Petr; Vernerova, Zdenka] Charles Univ Prague, Dept Pathol, Fac Med 3, Prague, Czech Republic; [Cervenka, Ludek] Charles Univ Prague, Dept Pathophysiol, Fac Med 2, Prague, Czech Republic	Cervenka, L (reprint author), Inst Clin & Expt Med, Ctr Med Expt, 1958-9 Videnska, CZ-14000 Prague 4, Czech Republic.	Petra.Alanova@fgu.cas.cz; zuzka.huska@email.cz; likp@medicon.cz; alhc@medicon.cz; savr@medicon.cz; neckar@biomed.cas.cz; jdimig@mcw.edu; kolar@biomed.cas.cz; kolar@biomed.cas.cz; J.Falck@UTSouthwestern.edu; J.Falck@UTSouthwestern.edu; sajan0@op.pl; akira@kms.ac.jp; hkramer@uni-bonn.de; vome@medicon.cz; cerl@medicon.cz; luce@medicon.cz	Kolar, Frantisek/A-7852-2012		Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/12171-5]; Grant Agency of the Charles University [411911]; Czech Science Foundation [15-07544S, 303/12/1162]; European Commission; project "Rozvoj infrastruktury PEM" [CZ.2.16/3.1.00/28025]; USPHS NIH [DK38226]	This study was principally supported by grant No. NT/12171-5 awarded by the Internal Grant Agency of the Ministry of Health of the Czech Republic to Z.H. P.A. is supported by grant No. 411911 awarded by the Grant Agency of the Charles University. Z.H. and F.K. are supported by Czech Science Foundation grant Nos. 15-07544S and 303/12/1162. L.C and L.K. are supported by the project of Ministry of Health of the Czech Republic for the development of research organization 00023001 (IKEM) - institutional support. The Center for Experimental Medicine (IKEM) received financial support from the European Commission within the Operational Program Prague - Competitiveness; project "Rozvoj infrastruktury PEM" (#CZ.2.16/3.1.00/28025). J.D.I. and J.R.F. were supported by the USPHS NIH (DK38226) and J.R.F. had additional aid from the Robert A. Welch Foundation (GL625910).	Alanova P., 2015, PHYSL RES; Koid SS, 2014, HYPERTENSION, V63, P768, DOI 10.1161/HYPERTENSIONAHA.113.02902; Kohagura K, 2000, ACTA PHYSIOL SCAND, V168, P107, DOI 10.1046/j.1365-201X.2000.00638.x; Benter IF, 2011, J CARDIOVASC PHARM, V57, P559, DOI 10.1097/FJC.0b013e31821324b6; Wang D, 2003, KIDNEY INT, V63, P2187, DOI 10.1046/j.1523-1755.2003.00036.x; Burgelova M, 2009, J HYPERTENS, V27, P1988, DOI 10.1097/HJH.0b013e32832f0d06; Matsuhisa S, 2008, AM J PHYSIOL-HEART C, V294, pH2473, DOI 10.1152/ajpheart.91533.2007; Oni-Orisan A, 2014, J MOL CELL CARDIOL, V74, P199, DOI 10.1016/j.yjmcc.2014.05.016; Gross GJ, 2008, AM J PHYSIOL-HEART C, V294, pH2838, DOI 10.1152/ajpheart.00186.2008; [Anonymous], 2013, J HYPERTENS, V31, P1925; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; ANDERSON PG, 1987, AM J PATHOL, V129, P152; Saupe KW, 2000, HYPERTENSION, V35, P1167; Buzello M, 2003, VIRCHOWS ARCH, V442, P364, DOI 10.1007/s00428-003-0775-5; Chaudhary KR, 2013, J CARDIOVASC PHARM, V61, P258, DOI 10.1097/FJC.0b013e31827afcee; Benes J, 2011, CLIN SCI, V121, P29, DOI 10.1042/CS20100527; Alonso-Galicia M, 2002, AM J PHYSIOL-REG I, V283, pR60, DOI 10.1152/ajpregu.00664.2001; Khan MAH, 2014, CLIN SCI, V127, P463, DOI 10.1042/CS20130479; Giricz Z, 2006, J PHARMACOL EXP THER, V316, P154, DOI 10.1124/jpet.105.091140; Falck JR, 2003, AM J PHYSIOL-HEART C, V284, pH337, DOI 10.1152/ajpheart.00831.2001; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Sivaraman V, 2014, J CARDIOVASC PHARM T, V19, P83, DOI 10.1177/1074248413499973; Khan MAH, 2013, HYPERTENSION, V62, P905, DOI 10.1161/HYPERTENSIONAHA.113.01949; SNOECKX LHEH, 1986, CARDIOVASC RES, V20, P67, DOI 10.1093/cvr/20.1.67; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; MINOR T, 1994, ANN CARDIOL ANGEIOL, V43, P395; Kocsis GF, 2012, AM J PHYSIOL-HEART C, V303, pH1229, DOI 10.1152/ajpheart.00379.2012; Gross GJ, 2013, J MOL CELL CARDIOL, V59, P20, DOI 10.1016/j.yjmcc.2013.02.003; SPEECHLYDICK ME, 1994, CARDIOVASC RES, V28, P1025, DOI 10.1093/cvr/28.7.1025; Kopkan L, 2012, KIDNEY BLOOD PRESS R, V35, P595, DOI 10.1159/000339883; Varcabova S, 2013, CLIN EXP PHARMACOL P, V40, P273, DOI 10.1111/1440-1681.12018; Elmarakby AA, 2012, AM J PHYSIOL-REG I, V302, pR321, DOI 10.1152/ajpregu.00606.2011; Sporkova A, 2011, AM J PHYSIOL-REG I, V300, pR1468, DOI 10.1152/ajpregu.00215.2010; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Imig JD, 2001, J HYPERTENS, V19, P983, DOI 10.1097/00004872-200105000-00020; Wagner C, 2013, J CARDIOVASC PHARM, V61, P35, DOI 10.1097/FJC.0b013e3182760c4d; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Dikow R, 2004, J AM SOC NEPHROL, V15, P1530, DOI 10.1097/01.ASN.0000130154.42061.C6; Chaudhary KR, 2010, J CARDIOVASC PHARM, V55, P67, DOI 10.1097/FJC.0b013e3181c37d69; Ebrahim Z, 2007, PHARMACOL RES, V55, P42, DOI 10.1016/j.phrs.2006.10.004; COOLEY DA, 1972, AM J CARDIOL, V29, P575, DOI 10.1016/0002-9149(72)90454-7; Mozaffari MS, 2003, HYPERTENSION, V42, P1042, DOI 10.1161/01.HYP.0000095614.91961.40; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Neckar J, 2012, CLIN SCI, V122, P513, DOI 10.1042/CS20110622; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Cervenka L, 2002, HYPERTENSION, V40, P735, DOI 10.1161/01.HYP.0000036452.28493.74; Dai WD, 2010, CARDIOVASC THER, V28, P30, DOI 10.1111/j.1755-5922.2009.00108.x; Falck JR, 2009, J MED CHEM, V52, P5069, DOI 10.1021/jm900634w; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; HEARSE DJ, 1978, EUR J CARDIOL, V7, P437; Walkowska A, 2010, J HYPERTENS, V28, P582, DOI 10.1097/HJH.0b013e328334dfd4; Batchu SN, 2012, J MOL CELL CARDIOL, V53, P43, DOI 10.1016/j.yjmcc.2012.04.008; Joly E, 2006, AM J PHYSIOL-REG I, V291, pR977, DOI 10.1152/apregu.00401.2005; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kujal P, 2014, CLIN EXP PHARMACOL P, V41, P227, DOI 10.1111/1440-1681.12204; Asemu G, 2000, PHYSIOL RES, V49, P597; Cervenka L, 2015, CLIN EXP PHARM PHYSL; de Mendoca L., 2007, INT J EXP PATHOL, V88, P301; Hall J.E., 2000, KIDNEY PHYSL PATHOPH, P1009; Hampl V, 2015, PHYSIOL RES, V64, P25; Honetschlagerova Z, 2011, J HYPERTENS, V29, P1590, DOI 10.1097/HJH.0b013e328349062f; Honetschlagerova Z, 2013, J HYPERTENS, V31, P321, DOI 10.1097/HJH.0b013e32835b50aa; Honetschlagerova Z, 2011, J PHYSIOL-LONDON, V589, P207, DOI 10.1113/jphysiol.2010.199505; Imig JD, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00157; Mozaffari Mahmood S, 2013, Am J Cardiovasc Dis, V3, P180; Nithipatikom K, 2006, AM J PHYSIOL-HEART C, V290, pH500, DOI 10.1152/ajphcart.00918.2005; Park B.M., 2013, PHYSL REP; Pechanova O, 2015, BRIT J PHARMACOL, V172, P1415, DOI 10.1111/bph.12960; Spector A.A., 2014, BIOCH BIOPHYS ACTA	70	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1537-1891	1879-3649		VASC PHARMACOL	Vasc. Pharmacol.	OCT	2015	73						45	56		10.1016/j.vph.2015.08.013		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4OY	WOS:000362056600008		
J	Hiramatsu, C; Fujita, K				Hiramatsu, Chihiro; Fujita, Kazuo			Visual categorization of surface qualities of materials by capuchin monkeys and humans	VISION RESEARCH			English	Article						Material perception; Texture; Comparative perception; Capuchin monkeys	INFERIOR TEMPORAL CORTEX; CEBUS-APELLA; IMAGE STATISTICS; COLOR-VISION; PERCEPTION; REPRESENTATION; PRIMATES; SELECTIVITY; RESPONSES; NEURONS	Visually identifying and categorizing the material composition of objects before actually interacting with them is an important skill for operating smoothly and safely in the world. This ability is assumed to have been shaped by evolution; therefore, non-human animals should share similar categorization abilities. Little is known, however, about how non-human animals do this. We tested whether tufted capuchin monkeys (Cebus apella) were able to visually categorize images that represented nine different materials (metal, ceramic, glass, stone, bark, wood, leather, fabric, and fur), and we compared their performance with that of humans. Capuchins showed excellent categorization abilities for images of fur, which is a familiar material to captive monkeys. Humans showed a tendency to confuse material categories that resembled each other visually and/or semantically. Correlation analyses on reaction time showed that both species made correct choices rapidly in selecting glossy categories like metal and ceramic compared with matte categories like fabric and stone, which contain minute patterns. Overall, our results suggest that monkeys share similar perceptual tendencies with humans in visual categorization of material images to some extent and the potential to categorize materials frequently encountered in their daily lives by visual observation. (C) 2015 Elsevier Ltd. All rights reserved.	[Hiramatsu, Chihiro; Fujita, Kazuo] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan	Hiramatsu, C (reprint author), Kyushu Univ, Fac Design, Dept Human Sci, Minami Ku, 4-9-1 Shiobaru, Fukuoka 8158540, Japan.	chihiro@design.kyushu-u.ac.jp; kfujita@bun.kyoto-u.ac.jp			JSPS [20220004, 25240020];  [10J04395]	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 10J04395) to C. Hiramatsu and JSPS Grants-in-Aide for Scientific Research Nos. 20220004 and 25240020 to K. Fujita. We thank the anonymous reviewers for their valuable comments and suggestions to improve the manuscript. We are grateful to H. Kuroshima, T. Matsuno and A. Takimoto for initial training of the matching-to-sample task for the monkeys; to T. Matsuno for providing a program for the task; to N. Goda for providing programs for the analysis; and to H. Komatsu for helpful comments and discussions.	Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Freeman J, 2013, NAT NEUROSCI, V16, P974, DOI 10.1038/nn.3402; MOLLON JD, 1989, J EXP BIOL, V146, P21; Fujita K, 2009, ANIM COGN, V12, P575, DOI 10.1007/s10071-009-0217-0; Yang JL, 2011, PERCEPTION, V40, P1491, DOI 10.1068/p6893; Nishio A, 2014, J NEUROSCI, V34, P11143, DOI 10.1523/JNEUROSCI.1451-14.2014; Fujita K, 2005, J EXP PSYCHOL ANIM B, V31, P387, DOI 10.1037/0097-7403.31.4.387; Okazawa G, 2015, P NATL ACAD SCI USA, V112, pE351, DOI 10.1073/pnas.1415146112; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Wright AA, 1999, J COMP PSYCHOL, V113, P74, DOI 10.1037//0735-7036.113.1.74; Koteles K, 2008, EUR J NEUROSCI, V27, P466, DOI 10.1111/j.1460-9568.2007.06008.x; Anderson JR, 2005, J EXP PSYCHOL ANIM B, V31, P71, DOI 10.1037/0097-7403-31.1.71; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Fleming RW, 2013, J VISION, V13, DOI 10.1167/13.8.9; Spinozzi G, 2004, J COMP PSYCHOL, V118, P297, DOI 10.1037/0735-7036.118.3.297; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Hiramatsu C, 2005, AM J PRIMATOL, V67, P447, DOI 10.1002/ajp.20199; Anderson BL, 2011, CURR BIOL, V21, pR978, DOI 10.1016/j.cub.2011.11.022; Goda N, 2014, J NEUROSCI, V34, P2660, DOI 10.1523/JNEUROSCI.2593-13.2014; Okazawa G, 2012, NEUROIMAGE, V63, P1321, DOI 10.1016/j.neuroimage.2012.07.052; Arcizet F, 2008, EXP BRAIN RES, V189, P109, DOI 10.1007/s00221-008-1406-9; Hiramatsu C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003356; IZAWA K, 1975, Primates, V16, P295, DOI 10.1007/BF02381557; IZAWA K, 1978, Primates, V19, P633, DOI 10.1007/BF02373631; Kiesling J. N. M., 2014, MOL PHYLOGENET EVOL, DOI [http://dx.doi.org/10.1016/j.ympev.2014.03.027, DOI 10.1016/J.YMPEV.2014.03.027]; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Maloney LT, 2010, J VISION, V10, DOI 10.1167/10.9.19; Wolfe JM, 2010, J VISION, V10, DOI 10.1167/10.9.8; Nagai T, 2015, VISION RES, V115, P259, DOI 10.1016/j.visres.2014.12.011; Sharan L, 2014, J VISION, V14, DOI 10.1167/14.9.12	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		A				71	82		10.1016/j.visres.2015.07.006		12	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CS9CU	WOS:000362387500008		
J	Ogata, Y; Ishigaki, T; Ebie, Y; Sutthasil, N; Chiemchaisri, C; Yamada, M				Ogata, Yuka; Ishigaki, Tomonori; Ebie, Yoshitaka; Sutthasil, Noppharit; Chiemchaisri, Chart; Yamada, Masato			Water reduction by constructed wetlands treating waste landfill leachate in a tropical region	WASTE MANAGEMENT			English	Article						Constructed wetland; Landfill leachate; Tropical region; Water reduction; Pollutants removal efficiency	NUTRIENT REMOVAL; PHRAGMITES-AUSTRALIS; EVAPOTRANSPIRATION; PERFORMANCE; TRANSPIRATION; CLIMATE	One of the key challenges in landfill leachate management is the prevention of environmental pollution by the overflow of untreated leachate. To evaluate the feasibility of constructed wetlands (CWs) for the treatment of waste landfill leachate in tropical regions, water reduction and pollutant removal by a CW subjected to different flow patterns (i.e., horizontal subsurface flow (HSSF) and free water surface (FWS)) were examined in both rainy and dry seasons in Thailand. A pilot-scale CW planted with cattail was installed at a landfill site in Thailand. With HSSF, the CW substantially removed pollutants from the landfill leachate without the need to harvest plants, whereas with FWS, it only slightly removed pollutants. Under both flow patterns, the CW significantly reduced the leachate volume to a greater extent than surface evaporation, which is regarded as an effect of the storage pond. Additionally, water reduction occurred regardless of season and precipitation, within the range 0-9 mm d(-1). In the case of low feeding frequency, water reduction by the CW with HSSF was lower than that with FWS. However, high feeding frequency improved water reduction by the CW with HSSF and resulted in a similar reduction to that observed with FWS, which exhibited maximum evapotranspiration. In terms of water reduction, with both HSSF in conjunction with high frequency feeding and FWS, the CW provided a high degree of evapotranspiration. However, pollutant removal efficiencies with HSSF were higher than for FWS. The present study suggested that CWs with HSSF and high frequency feeding could be useful for the prevention of uncontrollable dispersion of polluted leachate in the tropical climate zone. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogata, Yuka; Ishigaki, Tomonori; Ebie, Yoshitaka; Yamada, Masato] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Sutthasil, Noppharit; Chiemchaisri, Chart] Kasetsart Univ, Dept Environm Engn, Fac Engn, Bangkok 10900, Thailand	Ogata, Y (reprint author), Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	ogata.yuka@nies.go.jp			Environment Research and Technology Development Fund from the Ministry of the Environment, Japan [3K113027]	This research was supported by the Environment Research and Technology Development Fund (3K113027) from the Ministry of the Environment, Japan.	Allen R. G., 1998, 56 FAO; Headley TR, 2012, WATER RES, V46, P345, DOI 10.1016/j.watres.2011.10.042; Lin YF, 2002, AQUACULTURE, V209, P169, DOI 10.1016/S0044-8486(01)00801-8; Polprasert C, 2006, WATER SCI TECHNOL, V54, P147, DOI 10.2166/wst.2006.847; Kadlec RH, 2010, ECOL ENG, V36, P946, DOI 10.1016/j.ecoleng.2010.04.013; Kato K, 2013, ECOL ENG, V51, P256, DOI 10.1016/j.ecoleng.2012.12.002; Tao WD, 2006, ECOL ENG, V26, P252, DOI 10.1016/j.ecoleng.2005.10.006; Milani M, 2013, J ENVIRON SCI HEAL A, V48, P568, DOI 10.1080/10934529.2013.730457; Mufarrege MM, 2011, ECOTOXICOLOGY, V20, P457, DOI 10.1007/s10646-011-0598-0; Chiemchaisri C, 2009, BIORESOURCE TECHNOL, V100, P3808, DOI 10.1016/j.biortech.2008.12.028; Pedescoll A, 2013, ECOL ENG, V58, P335, DOI 10.1016/j.ecoleng.2013.07.007; Papaevangelou VA, 2012, J ENVIRON SCI HEAL A, V47, P766, DOI 10.1080/10934529.2012.660111; Tanner CC, 2005, AGR ECOSYST ENVIRON, V105, P145, DOI 10.1016/j.agee.2004.05.008; Klomjek P, 2005, CHEMOSPHERE, V58, P585, DOI 10.1016/j.chemosphere.2004.08.073; Vymazal J, 2010, WATER-SUI, V2, P530, DOI 10.3390/w2030530; Bulc TG, 2006, ECOL ENG, V26, P365, DOI 10.1016/j.ecoleng.2006.01.003; Koottatep T, 1997, WATER SCI TECHNOL, V36, P1, DOI 10.1016/S0273-1223(97)00725-7; Oren R, 2001, OECOLOGIA, V127, P549, DOI 10.1007/s004420000622; Akinbile CO, 2012, WASTE MANAGE, V32, P1387, DOI 10.1016/j.wasman.2012.03.002; Poyatos R, 2005, HYDROL EARTH SYST SC, V9, P493; Bialowiec A, 2014, ECOL ENG, V67, P89, DOI 10.1016/j.ecoleng.2014.03.032; Bojcevska H, 2007, ECOL ENG, V29, P66, DOI 10.1016/j.ecoleng.2006.07.015; Taniguchi T, 2009, WATER SCI TECHNOL, V59, P295, DOI 10.2166/wst.2009.853; APHA, 1998, STANDARD METHODS EXA; Ishigaki T., 2014, APPROPRIATE COUNTERM; Johannessen L.M., 1999, OBSERVATIONS SOLID W	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	OCT	2015	44						164	171		10.1016/j.wasman.2015.07.019		8	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CS4QF	WOS:000362060300018		
J	Harada, N; Shirabe, K; Maeda, T; Kayashima, H; Ishida, T; Maehara, Y				Harada, Noboru; Shirabe, Ken; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi; Maehara, Yoshihiko			Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices	WORLD JOURNAL OF SURGERY			English	Article							VENOUS-PRESSURE GRADIENT; PORTAL-HYPERTENSION; PROPHYLACTIC SCLEROTHERAPY; CIRRHOTIC-PATIENTS; HEPATIC RESECTION; LIVER RESECTION; CONTRAINDICATION; TRANSPLANTATION; HEMORRHAGE; SURGERY	Background The management of hepatocellular carcinoma (HCC) in patients with concomitant esophageal varices (EV) remains controversial. We assessed the surgical outcome of hepatectomy and aimed to clarify the indications and management of HCC in patients with concomitant EV. Methods We retrospectively enrolled 502 patients with HCC (100 with and 402 without EV), who underwent curative hepatectomy. We analyzed the prognostic outcomes and risk factors for EV bleeding after hepatectomy. Results Overall survival (OS) was significantly lower in HCC patients with EV than in those without EV (p = 0.003), although recurrence-free survival was similar in both groups. Multivariate analysis showed that indocyanine green retention test at 15 min (ICGR(15)) >17 % (p = 0.007) and a-fetoprotein >12.5 ng/ml (p = 0.003) was independent predictors of poorer OS. Among patients with EV who underwent hepatectomy, multivariate analysis identified ICGR(15) >17 % (p = 0.03) as the only independent predictor of poorer OS. There was no significant difference in OS between HCC patients with EV and ICGR(15) <= 17.0 % and HCC patients without EV. Ten patients experienced EV bleeding after hepatectomy. Multivariate analysis showed that preoperative endoscopic findings of blue color EV (p = 0.008) and red color sign (p = 0.0005) were independent predictors of EV bleeding in patients with HCC after hepatectomy. Conclusions These results suggest that HCC patients with EV and ICGR(15) <= 17 % may be suitable for surgery, but patients with preoperative endoscopic blue color EV and red color sign need to be managed appropriately.	[Harada, Noboru; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima 7308619, Japan; [Harada, Noboru; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi] Atom Bomb Survivors Hosp, Hiroshima 7308619, Japan; [Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Med Sci, Fukuoka 812, Japan	Harada, N (reprint author), Hiroshima Red Cross Hosp, Dept Surg, Hiroshima 7308619, Japan.	nharada@surg2.med.kyushu-u.ac.jp					Boleslawski E, 2012, BRIT J SURG, V99, P855, DOI 10.1002/bjs.8753; Lay CS, 1997, HEPATOLOGY, V25, P1346, DOI 10.1002/hep.510250608; Shirabe K, 2011, WORLD J SURG, V35, P1072, DOI 10.1007/s00268-011-1013-y; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; Stremitzer S, 2011, BRIT J SURG, V98, P1752, DOI 10.1002/bjs.7672; D'Amico G, 2003, HEPATOLOGY, V38, P599, DOI 10.1053/jhep.2003.50385; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Akahoshi T, 2014, DIGEST ENDOSC, V26, P172, DOI 10.1111/den.12119; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Kokudo N, 2015, WORLD J SURG, V39, P469, DOI 10.1007/s00268-014-2915-2; Takeishi K, 2011, WORLD J SURG, V35, P1063, DOI 10.1007/s00268-011-1017-7; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Capussotti L, 2006, WORLD J SURG, V30, P992, DOI 10.1007/s00268-005-0524-9; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1016/0270-9139(95)90388-7; Llop E, 2012, J HEPATOL, V56, P103, DOI 10.1016/j.jhep.2011.06.027; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Miyoshi H, 1997, GASTROINTEST ENDOSC, V45, P498, DOI 10.1016/S0016-5107(97)70180-9; Yamashita Y, 2014, AM J SURG, V207, P890, DOI 10.1016/j.amjsurg.2013.07.028; BENDSTEN F, 1991, HEPATOLOGY, V14, P1016; GREGORY PB, 1991, NEW ENGL J MED, V324, P1779	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	OCT	2015	39	10					2510	2518		10.1007/s00268-015-3110-9		9	Surgery	Surgery	CS8GJ	WOS:000362324100018		
J	Bekki, Y; Yamashita, Y; Itoh, S; Harimoto, N; Shirabe, K; Maehara, Y				Bekki, Yuki; Yamashita, Yo-ichi; Itoh, Shinji; Harimoto, Norifumi; Shirabe, Ken; Maehara, Yoshihiko			Predictors of the Effectiveness of Prophylactic Drains After Hepatic Resection	WORLD JOURNAL OF SURGERY			English	Article							3-DIMENSIONAL COMPUTED-TOMOGRAPHY; HEPATOCELLULAR-CARCINOMA; LIVER RESECTION; ABDOMINAL DRAINAGE; RANDOMIZED TRIAL; CLASSIFICATION; HEPATECTOMIES; EXPERIENCE; FAILURE; SYSTEM	Background Randomized clinical trials have demonstrated the limited efficacy of prophylactic drains following hepatic resection. However, many surgeons still insist on using prophylactic drains. This study was designed to identify patients who require prophylactic drains to manage or monitor postoperative complications after hepatic resection. Methods Data were retrospectively collected from 316 patients who underwent hepatic resection and received a prophylactic drain. The patients were divided into two groups according to whether the drain was used to manage or monitor the following postoperative complications: bile leakage (prophylactic drains were used to monitor and treat bile leakage) and postoperative hemorrhage (the drainage fluid was macroscopically bloody and required drain fluid blood counts and monitoring to assess the need for transfusion or reoperation). The results were then validated in a separate cohort of 101 patients. Results In 25/316 patients (7.9 %), the prophylactic drains were clinically effective, being used to manage bile leakage in 18 patients and hemorrhage in 8. Intraoperative bile leakage (P = 0.021) and long operation time (>= 360 min) (P = 0.017) were independent predictors of bile leakage. Intraoperative blood loss (>= 650 ml) (P = 0.0009) was an independent predictor of hemorrhage. In the subsequent 101 patients, prophylactic drains were clinically effective in patients with one of these predictors with sensitivity, specificity, and false-negative rates of 88.9, 62.0, and 1.7 %, respectively. Conclusion A prophylactic drain should be considered following hepatic resection for patients with intraoperative bile leakage, operation time of >= 360 min, or blood loss of >= 650 ml.	[Bekki, Yuki; Yamashita, Yo-ichi; Itoh, Shinji; Harimoto, Norifumi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan	Bekki, Y (reprint author), Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	y-bekki@surg2.med.kyushu-u.ac.jp; yamashi@surg2.med.kyushu-u.ac.jp; itoshin@surg2.med.kyushu-u.ac.jp; harimoto@surg2.med.kyushu-u.ac.jp; kshirabe@surg2.med.kyushu-u.ac.jp; maehara@surg2.med.kyushu-u.ac.jp					Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; BELGHITI J, 1993, ANN SURG, V218, P748, DOI 10.1097/00000658-199312000-00008; Torzilli G, 2005, HEPATO-GASTROENTEROL, V52, P1206; Taketomi A, 2007, J AM COLL SURGEONS, V204, P580, DOI 10.1016/j.jamcollsurg.2007.01.035; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Ishizawa T, 2014, HPB, V16, P494, DOI 10.1111/hpb.12165; Ikeda T, 2014, SURG ENDOSC, V28, P2484, DOI 10.1007/s00464-014-3469-y; SHIMADA M, 1994, J AM COLL SURGEONS, V178, P498; Yamashita Y, 2001, ANN SURG, V233, P45, DOI 10.1097/00000658-200101000-00008; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Itoh S, 2012, SURG TODAY, V42, P1176, DOI 10.1007/s00595-012-0306-6; Yamazaki S, 2012, BRIT J SURG, V99, P1584, DOI 10.1002/bjs.8916; Hirokawa F, 2011, AM SURGEON, V77, P539; Sun HC, 2006, BRIT J SURG, V93, P422, DOI 10.1002/bjs.5260; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Yamashita Y, 2001, ARCH SURG-CHICAGO, V136, P328, DOI 10.1001/archsurg.136.3.328; Tanaka K, 2013, SURG TODAY, V43, P372, DOI 10.1007/s00595-012-0254-1; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; Liu CL, 2004, ANN SURG, V239, P194, DOI 10.1097/01.sla.0000109153.71725.8c; Yamashita Y, 2014, AM J SURG, V207, P890, DOI 10.1016/j.amjsurg.2013.07.028; Kayashima H, 2014, SURG TODAY, V44, P2077, DOI 10.1007/s00595-014-0836-1; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P196; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P133	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	OCT	2015	39	10					2543	2549		10.1007/s00268-015-3116-3		7	Surgery	Surgery	CS8GJ	WOS:000362324100022		
J	Honjo, H; Mike, M; Kano, N; Kusanagi, H				Honjo, Hirotaka; Mike, Makio; Kano, Nobuyasu; Kusanagi, Hiroshi			Reduction of Adult Intussusception: More Benefit than Harm: Reply	WORLD JOURNAL OF SURGERY			English	Letter									[Honjo, Hirotaka; Mike, Makio; Kano, Nobuyasu; Kusanagi, Hiroshi] Kameda Med Ctr, Dept Surg, Kamogawa, Japan	Honjo, H (reprint author), Kameda Med Ctr, Dept Surg, Kamogawa, Japan.	h-honjo@wood.odn.ne.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	OCT	2015	39	10					2607	2607		10.1007/s00268-015-3123-4		1	Surgery	Surgery	CS8GJ	WOS:000362324100033		
J	Motojima, K				Motojima, Kiyoto			Lessons Learned after 25 Years of Studies on the Physiological Roles of the Peroxisome Proliferator-activated Receptor	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						peroxisome proliferator-activated receptor (PPAR); lipid homeostasis; diabetes; thiazolidinedione (TZD); phenotypic screening	FATTY ALDEHYDE DEHYDROGENASE; PPAR-GAMMA; ENDOPLASMIC-RETICULUM; MOUSE INTESTINE; VITAL ROLE; ALPHA; TISSUE; ACID; HEPATOCARCINOGENESIS; EXPRESSION	The peroxisome proliferator-activated receptor (PPAR) was discovered a quarter of a century ago. PPAR was soon recognized as a general transcriptional regulator of lipid homeostasis, and several hypolipidemic and antidiabetic agents were shown to be effective ligands for it. Since then, many attempts to develop more potent drugs have been made worldwide, but most were unsuccessful due to serious side effects. It appears that the PPAR boom has ended. This review summarizes the short history of PPAR studies, including our own results, and discusses the lessons learned from the rise and fall of studies in this field for next-generation basic studies and drug development research.	Meiji Pharmaceut Univ, Dept Biochem, Kiyose, Tokyo 2048588, Japan	Motojima, K (reprint author), Meiji Pharmaceut Univ, Dept Biochem, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan.	motopda@gmail.com					American Diabetes Association, 2015, DIABETES CARE S1, V38, pS4; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Yokoi Y, 2007, FEBS J, V274, P4837, DOI 10.1111/j.1742-4658.2007.06005.x; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; MOTOJIMA K, 1993, CELL STRUCT FUNCT, V18, P267; Motojima K, 2004, EUR J BIOCHEM, V271, P4141, DOI 10.1111/j.1432-1033.2004.04352.x; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Aishan H, 2010, BIOL PHARM BULL, V33, P351; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ashibe B, 2009, FEBS J, V276, P6956, DOI 10.1111/j.1742-4658.2009.07404.x; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7; Ashibe B, 2012, PPAR RES, DOI 10.1155/2012/814945; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Motojima K, 2006, FEBS J, V273, P292, DOI 10.1111/j.1742-4658.2005.05060.x; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; Jia Y, 2014, GENE EXPRESSION, V16, P63, DOI 10.3727/105221614X13919976902219; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Choi JH, 2014, GENE DEV, V28, P2361, DOI 10.1101/gad.249367.114; Conlon D, 2006, BR J DIABETES VASC D, V6, P135, DOI 10.1177/14746514060060030601; Fodell J. D., 2013, BIOCHIM BIOPHYS ACTA, V1830, P3867; Friedland S. N., 2011, AM J MED, V125, P126; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Motojima K., 2000, FARUMASHIA, V36, P771; Motojima K., 1991, FARUMASHIA, V27, P1175; Osumi T., 1987, PEROXISOMES BIOL MED, P105; Qu AJ, 2014, J HEPATOL, V60, P331, DOI 10.1016/j.jhep.2013.09.024; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; U.S. Food and Drug Administration, 2000, SAF AL HUM MED PROD; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Xie XN, 2015, BBA-GEN SUBJECTS, V1850, P62, DOI 10.1016/j.bbagen.2014.09.027	44	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1083	1089				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600001		
J	Tanaka, N				Tanaka, Naonobu			Search for Structurally Unique Bioactive Natural Products	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						natural product; marine organism; plant	SPONGE AGELAS SP; HYPERICUM-CHINENSE; PRENYLATED ACYLPHLOROGLUCINOLS; BROMOPYRROLE ALKALOIDS; HALICHONDRIA SP; HYRTIOS SP; A-C; MEROTERPENOIDS; SESQUITERPENOIDS	In our continuing search for structurally and biologically interesting metabolites from marine organisms and plants, we investigated the constituents of Okinawan marine sponges and Hypericum plants, resulting in the isolation of several new and unique natural products. Their structures were elucidated on the basis of spectroscopic analyses and chemical conversions. Novel bromopyrrole alkaloids, nagelamides X-Z, were isolated from a sponge Agelas sp. Heteroaromatic alkaloids, hyrtimomines A and B, were isolated from a sponge Hyrtios sp. together with bisindole alkaloids, hyrtimomines C-E. An oxylipin with a trimeric structure, manzamenone O, was obtained from a sponge Plakortis sp. Dimeric eudesmane sesquiterpenes connected through various linker moieties, halichonadins K-L, were isolated from a sponge Halichondria sp., and isomalabaricane triterpenes, stelliferins J-N, were obtained from a sponge Rhabdastrella sp. The investigation for the extracts of Hypericum plants gave new meroterpenes, acylphloroglucinols, and xanthones. Biyoulactones A-E are meroterpenoids from the roots of Hypericum chinense. Acylphloroglucinols, chipericumines A-D, and highly prenylated xanthones, biyouxanthones A-D, were also isolated from the same origin. Tricyclic meroterpenes, yezo'otogirins A-C, and liner meroterpenos, yojironins A and B, were isolated from Hypericum yezoense and Hypericum yojiroanum, respectively.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Tanaka, N (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	ntanak@tokushima-u.ac.jp					Tanaka N, 2011, TETRAHEDRON, V67, P6689, DOI 10.1016/j.tet.2011.04.095; Tanaka N, 2013, ORG LETT, V15, P3262, DOI 10.1021/ol401291n; Kusama T, 2014, CHEM PHARM BULL, V62, P499; Tanaka N, 2013, ORG LETT, V15, P2518, DOI 10.1021/ol4009975; Momose R, 2013, ORG LETT, V15, P2010, DOI 10.1021/ol400687b; Tanaka N, 2009, TETRAHEDRON LETT, V50, P4747, DOI 10.1016/j.tetlet.2009.06.021; Tanaka N, 2010, HETEROCYCLES, V80, P613, DOI 10.3987/COM-09-S(S)28; Tanaka N, 2013, TETRAHEDRON LETT, V54, P3794, DOI 10.1016/j.tetlet.2013.05.023; Abe S, 2012, J NAT PROD, V75, P484, DOI 10.1021/np200741x; Tanaka N, 2012, ORG LETT, V14, P3498, DOI 10.1021/ol3014705; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Tanaka N, 2013, TETRAHEDRON LETT, V54, P4038, DOI 10.1016/j.tetlet.2013.05.073; Tanaka N, 2012, TETRAHEDRON LETT, V53, P1507, DOI 10.1016/j.tetlet.2012.01.052; Mamemura T, 2011, TETRAHEDRON LETT, V52, P3575, DOI 10.1016/j.tetlet.2011.04.106; Tanaka N, 2011, ORG LETT, V13, P5488, DOI 10.1021/ol2021548; Suto S, 2011, TETRAHEDRON LETT, V52, P3470, DOI 10.1016/j.tetlet.2011.04.105; Tanaka N, 2015, HETEROCYCLES, V90, P23, DOI 10.3987/REV-14-SR(K)1	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1091	1097				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600002		
J	Yoshida, M				Yoshida, Masahito			Total Synthesis of Biologically Active Natural Products toward Elucidation of the Mode of Action	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						natural product; total synthesis; cyclodepsipeptide; macrolactonization; solid-phase synthesis	ACYL TRANSFER-CYCLIZATION; VACUOLAR H+-ATPASE; DESTRUXIN-E; AMINO-ACID; 2-METHYL-6-NITROBENZOIC ANHYDRIDE; ASYMMETRIC DIHYDROXYLATION; REGIOSELECTIVE CYCLIZATION; METARHIZIUM-ANISOPLIAE; O-ALKYNOYLPHENOLS; CARBOXYLIC ESTERS	Total synthesis of biologically active cyclodepsipeptide destruxin E using solid- and solution-phase synthesis is described. The solid-phase synthesis of destruxin E was initially investigated for the efficient synthesis of destruxin analogues. Peptide elongation from polymer-supported,beta-alanine was efficiently performed using DIC/HOBt or PyBroP/DIEA, and subsequent cleavage from the polymer-support under weakly acidic conditions furnished a cyclization precursor in moderate yield. Macrolactonization of the cyclization precursor was smoothly performed using 2-methy1-6-nitrobenzoic anhydride (MNBA) /4- (dimethylamino) pyridine N-oxide (DMAPO) to afford macrolactone in moderate yield. Finally, formation of the epoxide in the side chain via three steps provided destruxin E, and the stereochemistry of the epoxide was determined to be S. Its diastereomer, epi-destruxin E, was also synthesized in the same manner used to synthesize the natural product. The stereochemistry of the epoxide was critical for the V-ATPase inhibition; natural product destruxin E exhibited 10-fold more potent V-ATPase inhibition than epi-destruxin E. Next, the scalable synthesis of destruxin E for in vivo study was also performed via solution-phase synthesis. The scalable synthesis of a key component, (S) -HA-Pro-OH, was achieved using osmium-catalyzed diastereoselective dihydroxylation with (DHQD)(2) PHAL as a chiral ligand; peptide synthesis using Cbz-protected amino acid derivatives furnished the cyclization precursor on a gram-scale. Macrolactonization smoothly provided the macrolactone without forming a dimerized product, even at 6 mm, and the synthesis of destruxin E was achieved via three steps on a gram scale in high purity (>98%)	Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Yoshida, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aza Aoba, Sendai, Miyagi 9808578, Japan.	masahito@mail.pharm.tohoku.ac.jp					PAIS M, 1981, PHYTOCHEMISTRY, V20, P715, DOI 10.1016/0031-9422(81)85160-6; Shiina I, 2014, B CHEM SOC JPN, V87, P196, DOI 10.1246/bcsj.20130216; ODIER F, 1992, BIOL CELL, V74, P267, DOI 10.1016/0248-4900(92)90037-2; NAGANUMA S, 1992, BIOCHIM BIOPHYS ACTA, V1126, P41, DOI 10.1016/0005-2760(92)90214-G; Ast T, 2001, J PEPT RES, V58, P1, DOI 10.1034/j.1399-3011.2001.00856.x; Doi T, 2006, ORG LETT, V8, P4165, DOI 10.1021/ol061793i; Yoshida M, 2010, ORG LETT, V12, P3792, DOI 10.1021/ol101449x; EVANS DA, 1985, J AM CHEM SOC, V107, P4346, DOI 10.1021/ja00300a054; Shiina I, 2005, CHEM-EUR J, V11, P6601, DOI 10.1002/chem.200500417; Ohsawa K, 2013, J ORG CHEM, V78, P3438, DOI 10.1021/jo400056k; Yoshida M, 2014, J ORG CHEM, V79, P296, DOI 10.1021/jo402437z; Yoshida M, 2011, TETRAHEDRON, V67, P9993, DOI 10.1016/j.tet.2011.09.063; Yoshida M, 2012, CHEM COMMUN, V48, P11796, DOI 10.1039/c2cc37015h; Ward DE, 1997, TETRAHEDRON LETT, V38, P339, DOI 10.1016/S0040-4039(96)02346-5; CALMES M, 1993, INT J PEPT PROT RES, V41, P528; FREROT E, 1991, TETRAHEDRON, V47, P259, DOI 10.1016/S0040-4020(01)80922-4; Vazquez MJ, 2005, CHEM BIODIVERS, V2, P123, DOI 10.1002/cbdv.200490163; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Shiina I, 2004, J ORG CHEM, V69, P1822, DOI 10.1021/jo030367x; Shiina I, 2002, TETRAHEDRON LETT, V43, P7535, DOI 10.1016/S0040-4039(02)01819-1; Saito K, 2015, CHEM LETT, V44, P141, DOI 10.1246/cl.140910; Shibata K, 2013, B CHEM SOC JPN, V86, P1453, DOI 10.1246/bcsj.20130198; ROTH GA, 1995, J ORG CHEM, V60, P8105, DOI 10.1021/jo00129a065; ANTEUNIS MJO, 1988, INT J PEPT PROT RES, V31, P301; Doi T, 2014, CHEM SCI, V5, P1860, DOI 10.1039/c3sc53237b; Crimmins MT, 2000, ORG LETT, V2, P2165, DOI 10.1021/ol006091m; KOBAYASHI M, 1994, CHEM PHARM BULL, V42, P2394; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Pascolutti M, 2014, DRUG DISCOV TODAY, V19, P215, DOI 10.1016/j.drudis.2013.10.013; JACOBSEN EN, 1988, J AM CHEM SOC, V110, P1968, DOI 10.1021/ja00214a053; Doi T, 2011, ORG BIOMOL CHEM, V9, P387, DOI 10.1039/c0ob00513d; KUYAMA S, 1965, AGR BIOL CHEM TOKYO, V29, P168; Shibata K, 2010, TETRAHEDRON LETT, V51, P1674, DOI 10.1016/j.tetlet.2010.01.064; Yoshida M, 2011, ORG LETT, V13, P4526, DOI 10.1021/ol2016934; Ward DE, 2001, J ORG CHEM, V66, P7832, DOI 10.1021/jo015953; SHARPLESS KB, 1992, J ORG CHEM, V57, P2768, DOI 10.1021/jo00036a003; Kobayashi T, 2004, BIOL PHARM BULL, V27, P587, DOI 10.1248/bpb.27.587; EVANS DA, 1982, J AM CHEM SOC, V104, P1737, DOI 10.1021/ja00370a050; Nakagawa H, 2003, BONE, V33, P443, DOI 10.1016/S8756-3282(03)00201-1; Cavelier F, 1996, TETRAHEDRON, V52, P6173, DOI 10.1016/0040-4020(96)00242-6; Cavelier F, 1998, PESTIC SCI, V52, P81, DOI 10.1002/(SICI)1096-9063(199801)52:1<81::AID-PS666>3.3.CO;2-8; Cavelier F, 1997, J PEPT RES, V50, P94; Dornetshuber-Fleiss R, 2013, BIOCHEM PHARMACOL, V86, P361, DOI 10.1016/j.bcp.2013.05.022; GUPTA S, 1989, J CHEM SOC PERK T 1, P2347, DOI 10.1039/p19890002347; LEE S, 1975, TETRAHEDRON LETT, P883; Shiina I, 2002, CHEM LETT, P286, DOI 10.1246/cl.2002.286; Yoshida M, 2014, TETRAHEDRON, V70, P3452, DOI 10.1016/j.tet.2014.03.073	49	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1099	1108				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600003		
J	Yokosuka, A				Yokosuka, Akihito			Discovery of Novel Biologically Active Compounds of Natural Origin, with a Focus on Anti-tumor Activity	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						natural product; anti-tumor activity; apoptosis; isoflavone; alkaloid; glycoside	CYTOTOXIC ACTIVITY; TACCA-CHANTRIERI; STEROIDAL GLYCOSIDES; UNDERGROUND PARTS; STRYPHNODENDRON-FISSURATUM; TRITERPENE GLYCOSIDES; CHOLESTANE GLYCOSIDES; AGAVE-UTAHENSIS; GLAZIOVIANIN-A; RHIZOMES	Numerous clinically valuable medicines, including anticancer drugs, have been developed from biologically active natural compounds and their structurally related derivatives. This review discusses novel natural compounds with promising biological activities and those with novel chemical structures. Glaziovianin A, an isoflavone isolated from the leaves of Ateleia glazioviana (Legminosae), inhibited cell cycle progression at the M-phase with an abnormal spindle structure. AU-1 and YG-1, 5 beta-steroidal glycosides isolated from the whole plants of Agave utahensis and the underground parts of Yucca glauca (Agavaceae), induced apoptosis of HL-60 cells via caspase-3 activation. Lycolicidinol, an alkaloid isolated from the bulbs of Lycoris albiflora (Amaryllidaceae), induced transient autophagy and morphological changes in mitochondria in the early stage of the apoptotic cell death process in HSC-2 cells. Taccasterosides isolated from the rhizomes of Tacca chantrieri (Taccaceae) and stryphnosides isolated from the pericarps of Stryphnodendron fissuratum (Legminosae) are steroidal and triterpene glycosides with unique chemical structures having novel sugar sequences.	Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Pharmacognosy, Hachioji, Tokyo 1920392, Japan	Yokosuka, A (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Pharmacognosy, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yokosuka@toyaku.ac.jp					Yokosuka A, 2007, BIOORG MED CHEM LETT, V17, P3091, DOI 10.1016/j.bmcl.2007.03.044; Yokosuka A, 2007, CHEM PHARM BULL, V55, P145, DOI 10.1248/cpb.55.145; Yokosuka A, 2012, CHEM PHARM BULL, V60, P275, DOI 10.1248/cpb.60.275; Chinen T, 2013, ACS CHEM BIOL, V8, P884, DOI 10.1021/cb300641h; Yokosuka A, 2004, CHEM PHARM BULL, V52, P1396, DOI 10.1248/cpb.52.1396; Yokosuka A, 2002, J NAT PROD, V65, P283, DOI 10.1021/np010470m; Yokosuka A, 2008, PHYTOCHEMISTRY, V69, P2724, DOI 10.1016/j.phytochem.2008.08.004; Yokosuka A, 2007, CHEM PHARM BULL, V55, P273, DOI 10.1248/cpb.55.273; Yokosuka A, 2008, TETRAHEDRON, V64, P1474, DOI 10.1016/j.tet.2007.11.041; Ikedo A, 2010, BIOORG MED CHEM LETT, V20, P5402, DOI 10.1016/j.bmcl.2010.07.111; Yokosuka A, 2002, J NAT PROD, V65, P1293, DOI 10.1021/np0200941; Hayakawa I, 2007, CHEM LETT, V36, P1382, DOI 10.1246/cl.2007.1382; Jitsuno M, 2011, NAT PROD COMMUN, V6, P187; Yokosuka A, 2013, J NAT MED-TOKYO, V67, P590, DOI 10.1007/s11418-012-0718-z; Yokosuka A, 2002, PHYTOCHEMISTRY, V61, P73, DOI 10.1016/S0031-9422(02)00168-1; Yokosuka A, 2009, J NAT PROD, V72, P1399, DOI 10.1021/np900168d; Yokosuka A, 2003, J NAT PROD, V66, P876, DOI 10.1021/np0206099; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Yokosuka A, 2011, PHYTOCHEM LETT, V4, P259, DOI 10.1016/j.phytol.2011.04.010; Yamori T, 1999, CANCER RES, V59, P4042; Yokosuka A, 2009, PHYTOCHEMISTRY, V70, P807, DOI 10.1016/j.phytochem.2009.02.013; Yokosuka A, 2005, STEROIDS, V70, P257, DOI 10.1016/j.steroids.2004.11.006; Hayakawa I, 2012, BIOORGAN MED CHEM, V20, P5745, DOI 10.1016/j.bmc.2012.08.005; Yokosuka A, 2009, CHEM PHARM BULL, V57, P1161, DOI 10.1248/cpb.57.1161; Yokosuka A, 2014, PHYTOCHEMISTRY, V101, P109, DOI 10.1016/j.phytochem.2014.02.002; Yokosuka Akihito, 2002, Natural Medicines, V56, P208	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1109	1114				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600004		
J	Katoh, M				Katoh, Miki			Effects of Xenobiotics on Drug Pharmacokinetics and Safety	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						carbon nanotubes; cell toxicity; stress-responsive genes; drug-metabolizing enzyme	WALLED CARBON NANOTUBES; ARYL-HYDROCARBON RECEPTOR; RESPIRATORY-TRACT CELLS; HUMAN LUNG; IN-VIVO; EXPRESSION; DELIVERY; EXPOSURE; ENZYMES; STRESS	The use of nanotechnology has increased over the past 10 years, and various nanomaterials with a wide range of applications have been developed. Carbon nanotubes (CNTs), which are cylindrical molecules consisting of hexagonally arranged carbon atoms, are nanomaterials with high utility. Recently, applications of single-walled CNT (SWCNT) in the medical field for drug-delivery and as gene-delivery agents have been proposed. Due to its structural characteristics and physicochemical properties, the inhalation of SWCNT could be considered as one route for targeted drug delivery into the lungs. Therefore, it is necessary to investigate the effects of SWCNT on the physiological state and response of the cells upon delivery into the lung. We clarified the different response of two carcinoma cell lines to SWCNT exposure, and determined these differences may be due to different cell functions. Furthermore, SWCNT exposure resulted in a global downregulation of stress-responsive genes in normal human bronchial epithelial cells, thereby indicating that the factors involved in the stress responses were not activated by SWCNT. We then tried to ascertain the possible effect of SWCNT on the fate of drugs delivered with SWCNT. Exposure to SWCNT down-regulated the mRNA expression and enzymatic activity of CYP1A1 and CYP1B1 by preventing the binding of activated aryl hydrocarbon receptors to the enhancer region of these genes. This review provides basic information for the prediction of human responses to SWCNT exposure by inhalation, and in its use as a drug delivery carrier.	Meijo Univ, Fac Pharm, Tenpaku Ku, Nagoya, Aichi 4688503, Japan	Katoh, M (reprint author), Meijo Univ, Fac Pharm, Tenpaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	mkatoh@meijo-u.ac.jp					Cheng YW, 2000, EUR J CANCER, V36, P1381, DOI 10.1016/S0959-8049(00)00131-3; Hitoshi K, 2012, DRUG METAB DISPOS, V40, P579, DOI 10.1124/dmd.111.043455; Hitoshi K, 2011, J TOXICOL SCI, V36, P379; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Beedanagari SR, 2009, TOXICOL SCI, V110, P61, DOI 10.1093/toxsci/kfp079; Muller L, 2010, J R SOC INTERFACE, V7, pS27, DOI 10.1098/rsif.2009.0161.focus; Zhang N, 2007, CARDIOVASC TOXICOL, V7, P282, DOI 10.1007/s12012-007-9007-6; Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468; Herzog E, 2009, TOXICOL APPL PHARM, V234, P378, DOI 10.1016/j.taap.2008.10.015; Hitoshi K, 2012, BIOL PHARM BULL, V35, P455; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566; Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Yang R, 2006, GENE THER, V13, P1714, DOI 10.1038/sj.gt.3302808; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Hukkanen J, 2002, CRIT REV TOXICOL, V32, P391, DOI 10.1080/20024091064273; Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1115	1122				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600005		
J	Mino, Y				Mino, Yasuaki			Optimization of Immunosuppression and the Prevention of Fungal Infection in Autoimmune Diseases	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						autoimmune disease; immunosuppressant; antifungal agent; optimization	LUPUS-ERYTHEMATOSUS PATIENTS; REMISSION-MAINTENANCE PHASE; MYCOPHENOLIC-ACID; GLUCURONIDE; PHARMACOKINETICS	Mycophenolate mofetil (MMF) has recently been reported to be effective in the treatment of systemic lupus erythematosus (SLE). The therapeutic range of mycophenolic acid (MPA) and its 7-O-glucuronide (MPAG), and factors affecting their pharmacokinetics, remain to be clarified. The influence of the pharmacokinetics of MPA and MPAG on the activity of inosine 5'-monophosphate dehydrogenase (IMPDH), a target of the MPA, also remains to be revealed. The pharmacokinetic variability of hydroxy-itraconazole (OH-ITZ), an active metabolite of itraconazole frequently co-administered with immunosuppressants in immunocompromised patients, is not fully known. The aim of this study was to establish the optimal dosage and administration of immunosuppressants and antifungal agents. MMF improved clinical laboratory markers and reduced prednisolone dosage in 31 SLE patients, with a pre-dose plasma concentration of MPA and MPAG in the interquartile ranges of 0.94-2.96 and 18.6-53.7 mu g/mL, respectively. Renal function and co-administered metal influenced the pharmacokinetics of MPA and MPAG in 31 SLE patients in the remission maintenance phase. IMPDH activity was induced in 29 SLE patients receiving the MMF therapy. This induction was dependent on the plasma concentration of MPAG, but not MPA. In addition, IMPDH activity was negatively correlated with complement fraction C3. MPA exposure and disease activity in SLE patients may determine IMPDH activity. The pharmacokinetic variability of OH-ITZ was associated with saturated metabolism to keto-itraconazole, serum concentration of albumin, and renal function in 46 immunocompromised patients. Prevention of fungal infections and drug-drug interactions in immunocompromised patients can be obtained by considering these identified confounding factors.	Hamamatsu Univ Sch Med, Dept Hosp Pharm, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Mino, Y (reprint author), Hamamatsu Univ Sch Med, Dept Hosp Pharm, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	minoy@hama-med.ac.jp					Mino Y, 2008, J PHARMACEUT BIOMED, V46, P603, DOI 10.1016/j.jpba.2007.11.018; Mino Y, 2012, J CLIN PHARM THER, V37, P217, DOI 10.1111/j.1365-2710.2011.01269.x; Mino Y, 2008, THER DRUG MONIT, V30, P656, DOI 10.1097/FTD.0b013e31818b8244; Mino Y, 2013, CLIN CHIM ACTA, V415, P128, DOI 10.1016/j.cca.2012.10.028; Mino Y, 2011, BIOL PHARM BULL, V34, P755; Naito T, 2008, BIOL PHARM BULL, V31, P1292, DOI 10.1248/bpb.31.1292	6	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1123	1127				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600006		
J	Iwao, Y				Iwao, Yasunori			Efficient Pharmaceutical Formulation Designs and Their Development Using Mathematical and Statistical Analysis	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						statistical analysis; available surface area (S(t)); dissolution rate; lubricant; disintegrant	AVAILABLE SURFACE-AREA; MULTIFUNCTIONAL ROTOR PROCESSOR; FINE GLOBULAR GRANULES; SHEAR MELT GRANULATION; FATTY-ACID ESTERS; FLUFENAMIC ACID; DISSOLUTION PROFILE; MAGNESIUM STEARATE; DRUG-RELEASE; LUBRICANTS	With the aim of directly predicting the functionality and mechanism of pharmaceutical excipients, we investigated an analysis method based on available surface area (S (t)), which is the surface area of a drug in direct contact with the external solvent during dissolution. First, to study the effect of lubricant concentration on the dissolution rate of acetaminophen (APAP), the dissolution behaviors as well as the change over time in S(t) of APAP tablets were examined. In the dissolution tests, a retarded dissolution of APAP was not observed with new lubricant triglycerin full behenate (TR-FB), whereas magnesium stearate (Mg-St) retarded the dissolution. The S (t) profiles for APAP with Mg-St at>0.5% showed downward curvature indicating a gradual decrease in surface area over time. Conversely, with TR-FB, even when its concentration was increased, the S (t) profile for APAP had a maximum value. The differences between Mg-St and TR-FB could be explained by the differences in extensibility deriving from their morphology. Next, we evaluated the effect of disintegtant concentration using five disintegrants. When disintegrant was added to ethenzamide tablet formulation, an increase in the dissolution rate and S (t) dependent on disintegrant concentration was observed, according to the type of disintegrant. It was found that the water absorption ability of disintegrants had strong correlations with the parameters of S(t). Taken together, this study demonstrates that analysis of S(t) can directly provide useful information, especially about the functionality of pharmaceutical excipients.	Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn & Drug Delivery Sci, Suruga Ku, Shizuoka 4228526, Japan	Iwao, Y (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn & Drug Delivery Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	yasuiwao@u-shizuoka-ken.ac.jp					Aoki H, 2015, INT J PHARMACEUT, V478, P530, DOI 10.1016/j.ijpharm.2014.11.058; Otsuka T, 2011, INT J PHARMACEUT, V409, P81, DOI 10.1016/j.ijpharm.2011.02.044; Uchimoto T, 2010, INT J PHARMACEUT, V386, P91, DOI 10.1016/j.ijpharm.2009.11.001; STRICKLAND WA, 1956, J AM PHARM ASSOC, V45, P51; ITAI S, 1985, CHEM PHARM BULL, V33, P5464; Aoshima H, 2005, INT J PHARM, V293, P25, DOI 10.1016/j.ijpharm.2004.12.007; ITAI S, 1986, CHEM PHARM BULL, V34, P1264; UDEALA OK, 1980, J PHARM PHARMACOL, V32, P6; KOUCHIWA S, 1985, CHEM PHARM BULL, V33, P1641; Uchimoto T, 2011, EUR J PHARM BIOPHARM, V78, P492, DOI 10.1016/j.ejpb.2011.01.014; Flores LE, 2000, DRUG DEV IND PHARM, V26, P297, DOI 10.1081/DDC-100100357; Shiino K, 2010, INT J PHARMACEUT, V395, P71, DOI 10.1016/j.ijpharm.2010.05.007; JOHANSSON ME, 1985, J PHARM PHARMACOL, V37, P681; CHOWHAN ZT, 1986, J PHARM SCI, V75, P542, DOI 10.1002/jps.2600750604; Kimura S, 2010, INT J PHARMACEUT, V391, P244, DOI 10.1016/j.ijpharm.2010.03.005; Shiino K, 2012, INT J PHARMACEUT, V431, P70, DOI 10.1016/j.ijpharm.2012.04.031; MURTHY KS, 1977, J PHARM SCI, V66, P1215, DOI 10.1002/jps.2600660903; Uchimoto T, 2013, CHEM PHARM BULL, V61, P1143; Iwao Y, 2013, INT J PHARMACEUT, V448, P1, DOI 10.1016/j.ijpharm.2013.03.012; Aoki H, 2015, EUR J PHARM BIOPHARM, V92, P22, DOI 10.1016/j.ejpb.2015.02.012; Iwao Y, 2015, CHEM PHARM BULL, V63, P95, DOI 10.1248/cpb.c14-00687; Kimura S, 2014, CHEM PHARM BULL, V62, P309; Shibata D, 2002, J PHARM SCI TECHNOL, V62, P133	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1129	1134				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600007		
J	Kubo, Y				Kubo, Yoshiyuki			Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						membrane transport; transporter; blood-retinal barrier (BRB); blood-brain barrier (BBB); cationic drugs; neuroprotective agent	PIGMENT EPITHELIAL-CELLS; RETINAL BARRIER; BRAIN-BARRIER; MOUSE MODEL; INVOLVEMENT; RAT; PERMEABILITY; DEGENERATION; NICOTINE; LINES	Studies of neurological dysfunction have revealed the neuroprotective effect of several cationic drugs, suggesting their usefulness in the treatment of neurological diseases. In the brain and retina, blood-tissue barriers such as blood-brain barrier (BBB) and blood-retinal barrier (BRB) are formed to restrict nonspecific solute transport between the circulating blood and neural tissues. Therefore study of cationic drug transport at these barriers is essential to achieve systemic delivery of neuroprotective agents into the neural tissues. In the retina, severe diseases such as diabetic retinopathy and macular degeneration can cause neurological dysfunction that dramatically affects patients' QOL. The BRB is formed by retinal capillary endothelial cells (inner BRB) and retinal pigment epithelial cells (outer BRB). Blood-to-retina transport of cationic drugs was investigated at the inner BRB, which is known to nourish two thirds of the retina. Blood-to-retinal transport of verapamil suggested that the barrier function of the BRB differs from that of the BBB. Moreover, carrier-mediated transport of verapamil and pyrilamine revealed the involvement of novel organic cation transporters at the inner BRB. The identified transport systems for cationic drugs are sensitive to several cationic neuroprotective and anti-angiogenic agents such as clonidine and propranolol, and the involvement of novel transporters was also suggested in their blood-to-retina transport across the inner BRB.	Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama 9300194, Japan	Kubo, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, 2630 Sugitani, Toyama 9300194, Japan.	kuboyosh@pha.u-toyama.ac.jp					TEIXEIRA AA, 1989, BRIT J PHARMACOL, V97, P95; Ristori C, 2011, INVEST OPHTH VIS SCI, V52, P155, DOI 10.1167/iovs.10-5536; Han YH, 2001, J PHARMACOL EXP THER, V296, P450; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65; Zhang N, 2006, INVEST OPHTH VIS SCI, V47, P287, DOI 10.1167/iovs.05-0189; ALM A, 1981, ACTA PHYSIOL SCAND, V113, P73, DOI 10.1111/j.1748-1716.1981.tb06864.x; Okura T, 2011, J PHARM SCI-US, V100, P3924, DOI 10.1002/jps.22594; Hosoya K, 2010, PHARM RES-DORDR, V27, P2715, DOI 10.1007/s11095-010-0272-x; Chothe PP, 2010, INVEST OPHTH VIS SCI, V51, P413, DOI 10.1167/iovs.09-4048; CUNHAVAZ JG, 1966, BRIT J OPHTHALMOL, V50, P441, DOI 10.1136/bjo.50.8.441; Tega Y, 2013, NEUROCHEM INT, V62, P173, DOI 10.1016/j.neuint.2012.11.014; Kubo Y, 2014, MOL PHARMACEUT, V11, P3747, DOI 10.1021/mp500516j; Kubo Y, 2013, PHARM RES-DORDR, V30, P847, DOI 10.1007/s11095-012-0926-y; Rojas JC, 2008, BRAIN RES, V1215, P208, DOI [10.1016/j.brainres.2008.04.001, 10.1016/j.brainres.2009.04.001]; Hosoya K, 2001, EXP EYE RES, V72, P163, DOI 10.1006/exer.2000.0941; Tega Y, 2015, J PHARM SCI-US, V104, P3069, DOI 10.1002/jps.24453; YAMAZAKI M, 1994, PHARMACEUT RES, V11, P975, DOI 10.1023/A:1018923017954; Okura T, 2008, DRUG METAB DISPOS, V36, P2005, DOI 10.1124/dmd.108.022087; Hosoya K, 2011, EXPERT OPIN DRUG DEL, V8, P1571, DOI 10.1517/17425247.2011.628983; Hosoya K, 2005, BIOL PHARM BULL, V28, P1, DOI 10.1248/bpb.28.1; Kubo Y, 2012, J PHARM SCI-US, V101, P2596, DOI 10.1002/jps.23171; Kitamura A, 2014, J PHARM SCI-US, V103, P3335, DOI 10.1002/jps.24129; Kubo Y, 2013, J PHARM SCI-US, V102, P3332, DOI 10.1002/jps.23535	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1135	1140				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600008		
J	Takayama, K				Takayama, Kazuo			Establishment of a Method of Hepatocyte Differentiation from Human Pluripotent Stem Cells for Innovative Drug Development	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						hepatocyte; human embryonic stem cells; human induced pluripotent stem cells; drug metabolism; drug screening	FUNCTIONAL HEPATOCYTES; TRANSDUCTION; GENERATION	Hepatocyte-like cells differentiated from human pluripotent stem cells (such as human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells) are expected to be utilized in drug screening. However, the hepatocyte differentiation efficiency and hepatic functions of hepatocyte-like cells were not sufficient to perform ES/iPS cell-based drug discovery. Therefore, we decided to improve the method of hepatocyte differentiation from human ES/iPS cells. To enhance this hepatocyte differentiation efficiency, hepatocyte-related transcription factors, such as forkhead box protein A2 (FOXA2) and hepatocyte nuclear factor 1 alpha (HNF1 alpha), were overexpressed during the hepatocyte differentiation process. In addition, to enhance the functions of hepatocyte-like cells, these cells were cultured in three dimensional (3D) conditions using a Nanopillar plate. By FOXA2 and HNF1 alpha overexpression, human ES/iPS cells could efficiently (more than 80%) differentiate into albumin-positive hepatocyte-like cells. Various hepatic functions, including albumin secretion and drug metabolism capacities, of the hepatocyte-like cells were significantly enhanced by performing 3D cell culture. These results suggest that the method of hepatocyte differentiation could be improved by using gene transfer and 3D cell culture technologies. We believe that these new hepatocyte-like cells would be useful tools in drug development.	[Takayama, Kazuo] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, Suita, Osaka 5650871, Japan; [Takayama, Kazuo] Osaka Univ, Grad Sch Pharmaceut Sci, Biochem & Mol Biol Lab, Suita, Osaka 5650871, Japan; [Takayama, Kazuo] Natl Inst Biomed Innovat Hlth & Nutr, Lab Hepatocyte Regulat, Ibaraki, Osaka 5670085, Japan	Takayama, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	takayama@phs.osaka-u.ac.jp					Takayama K, 2014, P NATL ACAD SCI USA, V111, P16772, DOI 10.1073/pnas.1413481111; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Tashiro K, 2010, CELL REPROGRAM, V12, P501, DOI 10.1089/cell.2010.0023; Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Koizumi N, 2003, J GENE MED, V5, P267, DOI 10.1002/jgm.348; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Nagamoto Y, 2015, CELL TRANSPLANT, V24, P1127, DOI 10.3727/096368914X681702; Takayama K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021780; Watanabe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090791	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1141	1146				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600009		
J	Kubo, M				Kubo, Miwa			Search of Neurotrophin-mimic Natural Products for Prevention and Treatment of Neurodegenerative Disease	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						neurotrophin-mimic active compound; Illicium jiadifengpi; Zingiber purpureum; PC12 cell; amyloid beta (A beta) 42	ZINGIBER-PURPUREUM; AMYLOID FIBRILS; CURCUMIN	As part of our continuing studies on neurotrophin-mimic active compounds in natural products, we investigated the chemical constituents of the pericarps of Illicium jiadifengpi and the roots of Indonesian ginger Zingiber purpureurn, resulting in the isolation of new seco-prezizaane-type sesquiterpenoid 1 and phenylbutenoid dimer 3-4 and two new curcuminoids 5-6. The MeOH extract of I. jiadifengpi was fractionated, leading to the isolation of compound 1. Compound 1 significantly enhanced neurite outgrowth in primary cell cultures of fetal rat cortical neurons. It is noteworthy that compound 1 has potential significantly to promote differentiation of multipotent neural stem cell line (MEB5 cells) into neurons. Additionally, we investigated the Me0H extract of the root of Bangle (Z. purpureum) that exhibited neuritogenesis activity in PC12 cells at 25 mu g/mL, resulting in the isolation of neurotrophic phenylbutenoid dimers 3-4 and new compounds 5-6. Compounds 3 and 4 were found not only significantly to induce neurite sprouting of PC12 cells but also to increase the neurite length and number of neurites in primary cultured rat cortical neurons, and also showed protective activity against cell death caused by deprivation of serum. Furthermore, chronic treatment with these compounds enhanced hippocampal neurogenesis in dementia model olfactory bulbectomized (OBX) mice. Compounds 5 and 6 had significant NGF-potentiating effects on PC12 cells whereas compound 5 enhanced prevention of amyloid beta (A beta) 42 aggregation.	Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan	Kubo, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, 180 Yamashiro Cho, Tokushima 7708514, Japan.	miwa-k@ph.bunri-u.ac.jp					Matsui N, 2012, NEUROSCI LETT, V513, P72, DOI 10.1016/j.neulet.2012.02.010; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Kubo M, 2009, ORG LETT, V11, P5190, DOI 10.1021/ol9021029; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Kubo M, 2012, TETRAHEDRON LETT, V53, P1231, DOI 10.1016/j.tetlet.2011.12.107; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Kubo M, 2010, BIOORG MED CHEM LETT, V20, P2566, DOI 10.1016/j.bmcl.2010.02.085; Backman C, 1996, J NEUROSCI, V16, P5437; Kubo M, 2015, BIOORG MED CHEM LETT, V25, P1586, DOI 10.1016/j.bmcl.2015.02.005; Kubo M, 2013, J NAT PROD, V76, P769, DOI 10.1021/np300911b; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Nakagaito Y, 1998, IN VITRO CELL DEV-AN, V34, P585; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Woodruff RH, 1997, HISTOL HISTOPATHOL, V12, P459; Kubo M., 2009, 51 S CHEM NAT PROD N, P485; Promjit S., 1993, MED PLANTS THAILAND, V1, P195	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1147	1152				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600010		
J	Okuyama, S				Okuyama, Satoshi			Effects of Bioactive Substances from Citrus on the Central Nervous System and Utilization as Food Material	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						brain; citrus; heptamethoxyflavone; auraptene; brain-derived neurotrophic factor; inflammation	CEREBRAL GLOBAL-ISCHEMIA; NEUROTROPHIC FACTOR; AURAPTENE; BRAIN; MICE	We have recently shown that 3,5,6,7,8,3',4'-heptamethoxyflavone (HMF) and auraptene (AUR) have neuroprotective effects on the central nervous system. HMF, a citrus flavonoid, altered NMDA-type glutamate receptor antagonist MK-801-induced memory dysfunction and schizophrenia-positive symptom-like behavior. HMF also showed a protective effect against ischemia-induced short-term memory dysfunction. In the ischemic brain, HMF induced the following protective effects against brain dysfunction: 1) rescue of neuronal cell death in the hippocampus; 2) increased production of brain-derived neurotrophic factor; 3) stimulation of neurogenesis in the dentate gyrus subgranular zone; 4) activation of the autophosphorylation of calcium calmodulin-dependent protein kinase II; and 5) suppression of microglial activation. On the other hand, AUR, a citrus coumarin, ameliorated lipopolysaccharide-induced inflammation in the brain as shown by inhibition of microglial activation and inhibition of cyclooxygenase (COX) -2 expression in the hippocampus. AUR also showed antiinflammatory effects on the ischemic brain by inhibiting microglial activation, COX-2 expression, and neuronal cell death in the hippocampus. The peel of kawachibankan (Citrus kawachiensis), a noted citrus product of Ehime prefecture, Japan, contains AUR, HMF, naringin, and narirutin. The dried powder of both the peel and juice had antiinflammatory effects in the mouse hippocampus, suggesting that citrus compounds may be beneficial as neuroprotective agents in the treatment of neurological disorders.	Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan	Okuyama, S (reprint author), Matsuyama Univ, Coll Pharmaceut Sci, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	sokuyama@cc.matsuyama-u.ac.jp					Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P121, DOI 10.1016/S0149-7634(96)00001-2; Murakami A, 2000, CARCINOGENESIS, V21, P1843, DOI 10.1093/carcin/21.10.1843; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220; Okuyama S, 2013, J FUNCT FOODS, V5, P2002, DOI 10.1016/j.jff.2013.07.016; Okuyama S, 2013, EUR J PHARMACOL, V699, P118, DOI 10.1016/j.ejphar.2012.11.043; Okuyama S, 2012, NEUROSCI LETT, V528, P190, DOI 10.1016/j.neulet.2012.08.079; Furukawa Y, 2012, INT J MOL SCI, V13, P1832, DOI 10.3390/ijms13021832; Okuyama S, 2013, INT J MOL SCI, V14, P9767, DOI 10.3390/ijms14059767; Amakura Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1977, DOI 10.1271/bbb.130324; Okuyama S, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/408503; Yamakuni Tohru, 2008, Folia Pharmacologica Japonica, V132, P155, DOI 10.1254/fpj.132.155; Manthey JA, 1999, J NAT PROD, V62, P441, DOI 10.1021/np980431j; Furukawa Y, 2012, INT J MOL SCI, V13, P5338, DOI 10.3390/ijms13055338; Furukawa Y., 2012, BIOINTERFACE RES APP, V2, P432; Okuyama Satoshi, 2015, Brain Sci, V5, P118, DOI 10.3390/brainsci5020118; Okuyama S, 2014, NEUROCHEM INT, V70, P30, DOI 10.1016/j.neuint.2014.03.008	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1153	1159				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600011		
J	Takagi, T; van Bennekom, C; Amann, S; Hattori, C; Shirakuni, Y; Sato, T; Nasu, M				Takagi, Tatsuya; van Bennekom, Carla; Amann, Steffen; Hattori, Chizuko; Shirakuni, Yuko; Sato, Tsugumichi; Nasu, Masao			Risk Management of Teratogenic Drugs similar to The Current States of Practice in Europe, US and Japan similar to	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						thalidomide; teratogenic; Risk Evaluation and Mitigation Strategies (REMS); pregnancy prevention program (PPP)	THALIDOMIDE EMBRYOPATHY	Thalidomide was approved for the treatment of multiple myeloma in Japan under a risk management program, named TERMS, in 2008. Since then, we have been conducting a survey of the stakeholders to assess the effectiveness of TERMS. These surveys showed patients had enough knowledge of the risks of thalidomide. In the USA, legislation in 2007 granted its U.S. Food and Drug Administration (FDA) the authority to require Risk Evaluation and Mitigation Strategies (REMS) when necessary to ensure that a drug's benefits outweigh its risks. As of 2015, more than 70 drugs, including thalidomide, have REMS programs. In Germany, in the early 1960s, over 5000 children were born with deformities. Therefore, the safety regulations in Germany go far beyond the European Medicines Agency (EMA) safety regulations at the time of thalidomide re-approval; thalidomide can be prescribed by a special prescribing form, including both proof of the patients' awareness of information about the risks, and participation in a pregnancy prevention program. While Japan has taken similar safety measures, a portion of thalidomide is still privately imported there. By March 2013, 594 patients have been registered to Japan's Safety Management System for Unapproved Drugs (SMUD), which was introduced by the Ministry of Health, Labour and Welfare (MHLW) in 2009. The number of females of child bearing potential (FCBPs) was 33 and the fraction (33/594=5.6%) was higher than that (48/7370=0.7%) in the case of TERMS. Risk management of thalidomide is described in this review.	[Takagi, Tatsuya; Hattori, Chizuko; Shirakuni, Yuko; Nasu, Masao] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Takagi, Tatsuya] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [van Bennekom, Carla] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Amann, Steffen] Hosp Pharm, Municipal Hosp Munich, D-80804 Munich, Germany; [Sato, Tsugumichi] ISHIZUE Fdn, Meguro Ku, Tokyo 1530063, Japan; [Sato, Tsugumichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Pharm, Noda, Chiba 2788510, Japan	Nasu, M (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	nasu@phs.osaka-u.ac.jp					HORGAN C, 1990, HEALTH AFFAIR, V9, P66, DOI 10.1377/hlthaff.9.3.66; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Crane E, 2005, CANCER INVEST, V23, P625, DOI 10.1080/07357900500283101; Vianna FSL, 2013, CLIN DYSMORPHOL, V22, P59, DOI 10.1097/MCD.0b013e32835ffc58; Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; MITCHELL AA, 1995, NEW ENGL J MED, V333, P101, DOI 10.1056/NEJM199507133330206; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), T REG; Celgene Corporation REMS-Pharmacy Network, REMS PHARM NETW; Deutsches Institut fur Medizinische Dokumentation und Information (DIMDI), GERM REG MAIL ORD PH; Dorks M., 2013, MED INFORM BIOM EPID, V9, P12; Sembritzki J., USE DEV HLTH CARDS E; Shirakuni Y., 2012, MED DRUG J, V48, P2653; U.S. Food and Drug Administration, THAL REMS; U.S. Food and Drug Administration, REMS IPLEDGE PROGR S	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1161	1168				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600012		
J	Tanaka, R; Miyata, Y; Minakuchi, N; Murakami, A; Sakazaki, F				Tanaka, Ryuichirou; Miyata, Yuuma; Minakuchi, Naoki; Murakami, Ayako; Sakazaki, Fumitoshi			The Xanthine Oxidase Inhibitory Activity and Hypouricemic Effects of Crude Drugs Obtained from the Silkworm in Mice	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						hypouricemia effect; plasma uric acid level; xanthine oxidase inhibition; silkworm with botrytis		This study evaluated the effects of crude drugs obtained from the silkworm in mice with oxonic acid-induced hyperuricemia using xanthine oxidase inhibitory activity and plasma uric acid levels. The plasma uric acid level was analyzed using an improved HPLC with UV detection (HPLC-UV) method, which enabled high-sensitivity analysis of a microliter of plasma. Using this method, we evaluated natural products administered orally to the hypouricemic mice. The plasma uric acid level of mice administered a water-soluble extract from silkworm larvae with botrytis (used in traditional Chinese medicine to reduce wind, lower blood pressure, and change platelet coagulation) was significantly lower than in the control group 1, 2, and 3 h after treatment. In addition, water soluble extracts from a fungus (NBRC 31161) metabolite and silkworm pupae and larvae reduced the plasma uric acid levels in mice compared with the control group.	[Tanaka, Ryuichirou; Miyata, Yuuma; Minakuchi, Naoki; Murakami, Ayako] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Sakazaki, Fumitoshi] Osaka Ohtani Univ, Fac Pharm, Tondabaya, Osaka 5848540, Japan	Tanaka, R (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	tanaka-r@pharm.setsunan.ac.jp	Sakazaki, Fumitoshi/K-4137-2014	Sakazaki, Fumitoshi/0000-0003-0586-4986			Ando S., 2010, 2010 ANN M JAP SOC B; Unno T, 2000, J JPN SOC FOOD SCI, V47, P740; Watanabe T, 2014, NUCLEOS NUCLEOT NUCL, V33, P192, DOI 10.1080/15257770.2013.865742; HATANO T, 1990, CHEM PHARM BULL, V38, P1224; Yoshizumi K, 2005, YAKUGAKU ZASSHI, V125, P315, DOI 10.1248/yakushi.125.315; Chikaura Y., 1993, B GINKYO COLL MED TE, V17, P21; Committee on Biochemical Constituents and Their Analytical Reagents, 1993, JPN J CLIN CHEM, V22, P300; [傅岚 Fu Lan], 2004, [生命科学研究, Life science research], V8, P1; Hiroshige Kinya, 1992, Journal of UOEH, V14, P211; Hiroshige Kinya, 1994, Journal of UOEH, V16, P167; Horiuchi S., 1989, BIOL REFERENCE DATA, P158; Japan Society of Clinical Chemistry, 2012, COMP REC METH 2012 E, P374; Japanese Society of Gout and Nucleic Acid Metabolism, 2010, GUID MAN HYP GOUT; Masuda K., 2009, B JIN AI COLL, V41, P29; Nakashima Y., 2002, J FOREST RES, V55, P209; Tanaka R., 2013, GOUT NUCL ACID METAB, V37, P117; Watanabe T., 2013, GOUT NUCL ACID METAB, V37, P61	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1169	1176				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600013		
J	Motoi, R; Yano, I; Ozaki, J; Hokoyama, K; Yamamoto, T; Fukatsu, S; Ishizuka, R; Matsumura, Y; Taniguchi, M; Higashimura, K; Matsubara, K				Motoi, Reiko; Yano, Ikuko; Ozaki, Junko; Hokoyama, Kanae; Yamamoto, Takashi; Fukatsu, Sachio; Ishizuka, Ryoko; Matsumura, Yumi; Taniguchi, Masahiro; Higashimura, Kyoji; Matsubara, Kazuo			Effect of Water Intake on Allergy-like Events Associated with Non-ionic Iodine Contrast Agents	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						iodine contrast agent; water intake; allergy-like symptom	ADVERSE-REACTIONS; MEDIA; OSMOLALITY; RELEASE; TRIAL	The use of iodine contrast agents occasionally causes serious allergic symptoms including anaphylaxis. At Kyoto University Hospital to prevent nephropathy we began recommending water intake before and after administration of iodine contrast agents in September 2012. In the present study we investigated the effect of water intake on the incidence of allergy-like events after the use of non-ionic iodine contrast agents. We extracted the occurrence of allergy-like events from the incident report system in our hospital from January 2011 to September 2014, and classified these events into the following 3 grades: 1+ (follow-up); 2+ (medication treatment); and 3+ (hospitalization). The allergy-like incidence rate was calculated for subsequent evaluation according to season and water intake. Allergy-like events significantly decreased from 0.49% before the recommendation of water intake to 0.26% at 1 year and 0.20% at 2 years after implementing the recommendation. The incidence of allergy-like events was significantly higher in summer than in winter before water intake was recommended. After implementing the recommendation, the value for summer significantly decreased to an incidence similar to that of winter. Respiratory and gastrointestinal allergy-like symptoms were dramatically decreased after implementing the recommendation. Water intake may be useful for preventing allergy-like events associated with non-ionic iodine contrast agents, especially during the summer.	[Motoi, Reiko; Yano, Ikuko; Ozaki, Junko; Hokoyama, Kanae; Fukatsu, Sachio; Ishizuka, Ryoko; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Yamamoto, Takashi; Matsumura, Yumi] Kyoto Univ Hosp, Patient Safety Unit, Sakyo Ku, Kyoto 6068507, Japan; [Taniguchi, Masahiro; Higashimura, Kyoji] Kyoto Univ Hosp, Clin Radiol Serv, Sakyo Ku, Kyoto 6068507, Japan	Matsubara, K (reprint author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kmatsuba@kuhp.kyoto-u.ac.jp					Moloney ED, 2003, RESP MED, V97, P928, DOI 10.1016/S0954-6111(03)00119-7; [Anonymous], 2012, GUID IOD CONTR AG US; FINDLAY SR, 1981, J CLIN INVEST, V67, P1604, DOI 10.1172/JCI110195; KATAYAMA H, 1990, RADIOLOGY, V175, P621; BARRETT BJ, 1993, RADIOLOGY, V188, P171; Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Davenport MS, 2012, RADIOLOGY, V262, P475, DOI 10.1148/radiol.11111282; [Anonymous], 2014, IOPAMIRON INJ 150 30; WOLF GL, 1989, AM J ROENTGENOL, V152, P939; European Society of Urogenital Radiology (ESUR), ESUR GUID CONTR MED; Fujiwara N., 2013, PLOS ONE, V8; Kim MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100154; Pradubpongsa P, 2013, ASIAN PAC J ALLERGY, V31, P299, DOI 10.12932/AP0297.31.4.2013	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1177	1184				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600014		
J	Harada, A; Sugihara, K; Watanabe, Y; Yamaji, S; Kitamura, S; Ohta, S				Harada, Akiko; Sugihara, Kazumi; Watanabe, Yoko; Yamaji, Seiichi; Kitamura, Shigeyuki; Ohta, Shigeru			Aryl Hydrocarbon Receptor Ligand Activity of Extracts from 62 Herbal Medicines and Effect on Cytochrome P450 Activity	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						62 herbal extract; Ah receptor ligand activity; cytochrome P450; baicalein; wogonin	2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; VEGETABLE CONSTITUENTS; GENE-EXPRESSION; AH RECEPTOR; GREEN TEA; ACTIVATION; BINDING; CYP1A1; MICE; IDENTIFICATION	Aryl hydrocarbon receptor (AhR) ligand activity of the extracts of 62 herbal medicines was examined using yeast reporter assay. Fifty-eight herbal extracts exhibited AhR ligand activity. The highest activity was observed with Ogon (Scutellariae Radix), followed by Oren (Coptidis Rhizoma), Kujin (Sophorae Radix) and Shoma (Cimicifiigae Rhizoma). When these extracts were treated with hesperinase, a hydrolase for sugar conjugates, the aglycones showed higher activity than the parent extracts. Among the constituents of Ogon extract, baicalein and wogonin showed AhR ligand activity, while the sugar conjugate of baicalein, baicalin, was inactive. Among the flavonoid components of these herbal medicines, flavone and chrysin exhibited high ligand activity for AhR. Ethoxyresorufin O-dealkylase (EROD) activity due to CYP1A1 in HepG2 cells was enhanced by the addition of baicalein. Baicalein also decreased the 3-methylcholanthrene-induced increase of EROD activity, but this effect was not statistically significant. When wogonin or baicalein was orally administered at the dose of 100 mg/kg to mice, EROD activity in liver was only slightly changed. Furthermore, when Ogon extract was co-administered with 3-methylcholanthrene, the EROD and methoxyresorufin O-dealkylase activities were not significantly changed. These results indicate that many herbal extracts have AhR ligand activity, and their inducing effect on CYP1A1/2 can be evaluated in HepG2 cells.	[Harada, Akiko; Ohta, Shigeru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan; [Sugihara, Kazumi] Hiroshima Int Univ, Fac Pharmaceut Sci, Kure, Hiroshima 7370112, Japan; [Watanabe, Yoko; Yamaji, Seiichi; Kitamura, Shigeyuki] Nihon Pharmaceut Univ, Ina, Saitama 3620806, Japan	Kitamura, S (reprint author), Nihon Pharmaceut Univ, Komuro 10281, Ina, Saitama 3620806, Japan.	kitamura@nichiyaku.ac.jp					Palermo CM, 2003, CHEM RES TOXICOL, V16, P865, DOI 10.1021/tx025672c; EMA M, 1994, J BIOL CHEM, V269, P27337; DEVITO MJ, 1994, TOXICOL APPL PHARM, V124, P82, DOI 10.1006/taap.1994.1011; Williams SN, 2000, CHEM-BIOL INTERACT, V128, P211, DOI 10.1016/S0009-2797(00)00204-0; Amakura Y, 2003, BIOL PHARM BULL, V26, P532, DOI 10.1248/bpb.26.532; NARASIMHAN TR, 1994, FUND APPL TOXICOL, V23, P598, DOI 10.1006/faat.1994.1146; Zhou JG, 2003, MOL PHARMACOL, V63, P915, DOI 10.1124/mol.63.4.915; Kasai A, 2008, BIOL PHARM BULL, V31, P838, DOI 10.1248/bpb.31.838; Henry EC, 1999, MOL PHARMACOL, V55, P716; Jeuken A, 2003, J AGR FOOD CHEM, V51, P5478, DOI 10.1021/jf030252u; Casper RF, 1999, MOL PHARMACOL, V56, P784; Sugihara K, 2004, BIOCHEM BIOPH RES CO, V318, P571, DOI 10.1016/j.bbrc.2004.04.066; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Amakura Y, 2003, BIOL PHARM BULL, V26, P1754, DOI 10.1248/bpb.26.1754; Ciolino HP, 1999, BRIT J CANCER, V79, P1340, DOI 10.1038/sj.bjc.6690216; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Adachi J, 2001, J BIOL CHEM, V276, P31475, DOI 10.1074/jbc.C100238200; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Zhou JG, 2003, ARCH BIOCHEM BIOPHYS, V416, P68, DOI 10.1016/S0003-9861(03)00274-1; Fernandez Salguero P. M., 1996, TOXICOL APPL PHARM, V140, P173	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	OCT	2015	135	10					1185	1196				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LP	WOS:000362047600015		
J	Kitagawa, T; Hosoya, K				Kitagawa, Tetsuro; Hosoya, Kazumi			An Anomalous Hatchery-Reared Biwa Rock Catfish, Silurus lithophilus (Teleostei: Siluridae), with an Adipose Fin-Like Projection	ZOOLOGICAL SCIENCE			English	Article						dysplasia; evolution; artificial breeding; fin-ray; endemic species		An anomalous individual with an adipose fin-like projection was discovered during seedling production of Biwa rock catfish, Silurus lithophilus (Teleostei: Siluridae). The external shape of the projection resembled an adipose fin, but soft rays were clearly observed within it. The projection was proximally supported by a series of pterygiophores and by 14 soft rays. The projection can be explained as: I, homologous with a primitive adipose fin, which occurred as a result of localized ontogenetic reversion; II, an extra fin that occurred as a result of abnormal expression of a regeneration mechanism; III, a remnant of a dorsal fin and/or a second dorsal fin; and IV, an inversion phenomenon of the polarity in the formation process of the anal fin.	[Kitagawa, Tetsuro; Hosoya, Kazumi] Kinki Univ, Fac Agr, Nara 6318505, Japan	Kitagawa, T (reprint author), Kinki Univ, Fac Agr, Nakamachi, Nara 6318505, Japan.	tkfe1985@gmail.com					Stewart TA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2159; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Temple NF, 2008, CAN J ZOOL, V86, P1079, DOI 10.1139/Z08-086; Eissa AE, 2009, CHEMOSPHERE, V77, P419, DOI 10.1016/j.chemosphere.2009.06.050; Stewart S, 2014, CELL REP, V6, P482, DOI 10.1016/j.celrep.2014.01.010; Stewart TA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3120; Bridge TW, 1932, FISHES CAMBRIDGE NAT, V7, P397; Buckland-Nicks J. A., 2011, P ROYAL SOC, V279, P553, DOI DOI 10.1098/RSPB.2011.1009; Burgess W. E., 1989, ATLAS FRESHWATER MAR; Crossman E. J., 1961, Copeia, V1961, P235, DOI 10.2307/1440012; Diogo Rui, 2009, P465; GHOSH T K, 1986, Indian Journal of Environmental Health, V28, P247; Hosoya K, 1983, FRESHWATER FISHES, V9, P43; Hubbs C. L., 2004, FISHES GREAT LAKES R; KOBAYAKAWA M, 1989, JPN J ICHTHYOL, V36, P155, DOI 10.1007/BF02914319; Kobayakawa M, 2008, CATFISH, P142; Kobayakawa M, 2001, FRESHWATER FISHES JA, P420; Matsuoka M, 1982, J J ICHTHYOL, V30, P37; Matsusato T, 1986, B NATL RES I AQUACUL, V10, P57; Sandon FZSH, 1956, P ZOOL SOC LOND, V127, P453; Takashima F., 1976, Journal Tokyo Univ Fish, V62, P91; Welch E. B., 1963, Transactions of the American Fisheries Society, V92, P67, DOI 10.1577/1548-8659(1963)92[67:ATWTDF]2.0.CO;2	22	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					435	437		10.2108/zs140296		3	Zoology	Zoology	CS3EU	WOS:000361955400003		
J	Anzai, W; Cadiz, A; Endo, H				Anzai, Wataru; Cadiz, Antonio; Endo, Hideki			Sexual Dimorphisms of Appendicular Musculoskeletal Morphology Related to Social Displayin in Cuban Anolis Lizards	ZOOLOGICAL SCIENCE			English	Article						adaptation; Anolis; musculature; sexual dimorphisms; social behavior	DIFFERENT LOCOMOTOR HABITS; GREEN ANOLE; FUNCTIONAL-MORPHOLOGY; ADAPTIVE RADIATION; DEWLAP DIVERSITY; SIZE; EVOLUTION; CAROLINENSIS; PERFORMANCE; MUSCULATURE	In Anolis lizards, sexual dimorphism has been reported in morphological and ecological traits. Males show larger body size and longer limbs related to territorial combat and courtship display with the dewlap. Although functional-anatomical traits are closely related to locomotor behaviors, differences between sexes in musculoskeletal traits on limbs remain unclear. We explored the relationships among sexual dimorphisms in musculoskeletal morphology, habitat, and locomotor traits in Anolis lizards. Specifically, we examined appendicular musculoskeletal morphology in three species of Cuban Anolis by measuring muscle mass and lengths of moment arms. Through comparisons of crossing locomotion, we found that the runner species possessed larger extensors in hindlimbs, which are advantageous for running, whereas the masses of the humeral and femoral retractors were larger in climber species, allowing these lizards to hold up their bodies and occupy tree substrates. Comparisons between the sexes showed different trends among the three species. Males of A. porcatus, which inhabit narrow branches or leaves, had stronger elbow extensors that maintain the display posture. In contrast, males of A. sagrei, which occupy broad surfaces, did not show sexual differences that affected social display. Moreover, A. bartschi indicated sexual differences despite the absence of dewlapping behavior. Our findings suggest that both sexes show fundamentally similar relationships between muscular morphology and locomotor habits to adapt arboreal or terrestrial substrates, and yet sexual dimorphism in forelimb muscles may additionally affected by male specific display with the dewlap.	[Anzai, Wataru; Endo, Hideki] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan; [Anzai, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Cadiz, Antonio] Univ Havana, Fac Biol, Havana 10400, Cuba	Anzai, W (reprint author), Univ Tokyo, Univ Museum, Tokyo 1130033, Japan.	watanzai@um.u-tokyo.ac.jp					AN KN, 1984, J BIOMECH ENG-T ASME, V106, P280; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; Losos JB, 1998, COPEIA, P430, DOI 10.2307/1447437; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.2307/2409282; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Foster KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3331; SCHOENER TW, 1969, SYST ZOOL, V18, P386, DOI 10.2307/2412183; Herrel A, 2007, BIOL J LINN SOC, V91, P111, DOI 10.1111/j.1095-8312.2007.00772.x; Fujiwara S, 2011, J ANAT, V219, P176, DOI 10.1111/j.1469-7580.2011.01379.x; Fieler CL, 1998, J EXP BIOL, V201, P609; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Poe S, 2004, HERPETOL MONOGR, V18, P37, DOI 10.1655/0733-1347(2004)018[0037:POA]2.0.CO;2; Lailvaux SP, 2007, AM NAT, V170, P573, DOI 10.1086/521234; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Thomas GH, 2009, EVOLUTION, V63, P2017, DOI 10.1111/j.1558-5646.2009.00694.x; Johnson MA, 2010, EVOLUTION, V64, P1151, DOI 10.1111/j.1558-5646.2009.00881.x; Anzai W, 2014, ZOOL SCI, V31, P454, DOI 10.2108/zs130062; Vanhooydonck B, 2006, EVOLUTION, V60, P2137, DOI 10.1111/j.0014-3820.2006.tb01851.x; Foster KL, 2012, J EXP BIOL, V215, P2288, DOI 10.1242/jeb.069856; Herrel Anthony, 2008, Bulletin of the Museum of Comparative Zoology, V159, P213, DOI 10.3099/0027-4100-159.4.213; FONT E, 1990, J MORPHOL, V206, P245, DOI 10.1002/jmor.1052060210; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077; Johnson MA, 2010, P ROY SOC B-BIOL SCI, V277, P1711, DOI 10.1098/rspb.2009.2323; Vanhooydonck B, 2009, J EVOLUTION BIOL, V22, P293, DOI 10.1111/j.1420-9101.2008.01643.x; Vanhooydonck B, 2005, BEHAV ECOL SOCIOBIOL, V59, P157, DOI 10.1007/s00265-005-0022-y; O'Bryant EL, 1999, J NEUROBIOL, V40, P202, DOI 10.1002/(SICI)1097-4695(199908)40:2<202::AID-NEU6>3.0.CO;2-A; COLLETTE BRUCE B., 1961, BULL MUS COMP ZOOL HARVARD UNIV, V125, P135; Fitch HS, 1976, OCCAS PAP MUS NAT HI, V21, P1; Jenssen TA, 1977, INTEGR COMP BIOL, V17, P203, DOI 10.1093/icb/17.1.203; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Nicholson KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000274; OKA Y, 1984, J MORPHOL, V180, P297, DOI 10.1002/jmor.1051800310; Peterson JA, 1973, THESIS U CHICAGO; Reilly Stephen M., 1995, Zoology (Jena), V98, P263; Russell AP, 2008, BIOL REPTILIA, P1; Schettino L, 1999, IGUANID LIZARDS CUBA	36	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					438	446		10.2108/zs150027		9	Zoology	Zoology	CS3EU	WOS:000361955400004		
J	Baria, MVB; Kurihara, H; Harii, S				Baria, Maria Vanessa B.; Kurihara, Haruko; Harii, Saki			Tolerance to Elevated Temperature and Ocean Acidification of the Larvae of the Solitary Corals Fungia fungites (Linnaues, 1758) and Lithophyllon repanda (Dana, 1846)	ZOOLOGICAL SCIENCE			English	Article						scleractinia; larvae; survival; temperature; ocean acidification	LIFE-HISTORY STAGES; SCLERACTINIAN CORAL; ACROPORA-PALMATA; REDUCES SURVIVORSHIP; CLIMATE-CHANGE; FAVIA-FRAGUM; REEF CORALS; SETTLEMENT; METAMORPHOSIS; PATTERNS	Increase in atmospheric CO2 is the main driver of global climate change and is projected to elevate sea surface temperature by at least 2 degrees C and to decrease oceanic pH by 0.3 to 0.4 units by the end of the century. These factors seriously threaten coral reef ecosystems worldwide. In Okinawa, solitary corals are an important feature of the coral community structure. While previous studies on the effects of ocean warming (OW), ocean acidification (OA) and its combination on larval survival focused on colonial coral species, the present study assessed the effect of high temperature on larvae from solitary corals. In this study, we examined the influence of OW (control = 28 degrees C; control + 3 = 31 degrees C; control + 6 = 34 degrees C) and OA (control, pCO(2) = 400 to 500 mu atm; medium, pCO(2) = 1000 to 1300 mu atm; high, pCO(2) = 1700 to 2200 mu atm) on the larval survival of two solitary corals, Fungia fungites and Lithophyllon repanda for eight days. Results showed that F. fungites was neither affected by OW, OA, nor its combination. Similarly, survival of L. repanda was not affected by OA however it was significantly affected by temperature. Temperature tolerance varies between species; L. repanda (+3 degrees C above ambient) has lower tolerance than F. fungites (+6 degrees C above ambient). This observation suggests that fungiid larvae had higher tolerance to elevated temperature stress relative to other scleractinian corals. With the projected increase in OW and OA in the future, fungiids may retain good potential to widely disperse and successfully recruit to natal and other neighbouring reefs.	[Baria, Maria Vanessa B.; Harii, Saki] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa 9020227, Japan; [Kurihara, Haruko] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan	Baria, MVB (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa 9020227, Japan.	vanessa.baria@gmail.com			Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency; Sasakawa Scientific Research Grant from Japan Science Society [26-717]	We are grateful to Prof. Yossi Loya, Dr. James Guest, and two anonymous reviewers for the valuable comments and suggestions in improving the manuscript. We thank Prof. Andrew Baird and Drs., Joana Figueiredo and Vivian Cumbo for providing us fungiid larvae. We also thank the laboratory members of Harii and Kurihara and Sesoko Station staff for the field and laboratory assistance. This study was funded by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency and a Grant-in-Aid for Scientific Research on Innovative Areas and the Sasakawa Scientific Research Grant from The Japan Science Society(26-717).	Albright R, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/473615; Nakamura M, 2012, AQUAT BIOL, V15, P299, DOI 10.3354/ab00436; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Edmunds PJ, 2001, MAR BIOL, V139, P981; Negri AP, 2001, MAR ENVIRON RES, V51, P17, DOI 10.1016/S0141-1136(00)00029-5; Medina-Rosas P, 2013, INVERTEBR REPROD DEV, V57, P132, DOI 10.1080/07924259.2012.704407; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Randall CJ, 2009, BIOL BULL-US, V217, P269; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Hoeksema BW, 2012, RAFFLES B ZOOL, V60, P183; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Chua CM, 2013, MAR ECOL PROG SER, V486, P143, DOI 10.3354/meps10318; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; HOEKSEMA BW, 1991, MAR ECOL PROG SER, V74, P225, DOI 10.3354/meps074225; Hoeksema BW, 2009, RAFFLES B ZOOL, P91; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690; Hoeksema BW, 2012, MAR ECOL PROG SER, V445, P209, DOI 10.3354/meps09460; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Buckley BA, 2001, J EXP BIOL, V204, P3571; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeksema BW, 2011, CORAL REEFS, V30, P975, DOI 10.1007/s00338-011-0784-9; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Woolsey ES, 2013, MAR ECOL PROG SER, V493, P179, DOI 10.3354/meps10499; Loya Y, 2001, ECOL LETT, V4, P122; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Cumbo VR, 2013, J EXP MAR BIOL ECOL, V439, P100, DOI 10.1016/j.jembe.2012.10.019; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Loya Y, 2008, P ROY SOC B-BIOL SCI, V275, P2335, DOI 10.1098/rspb.2008.0675; Nozawa Y, 2011, BIOL BULL-US, V220, P15; Edmunds PJ, 2011, J EXP BIOL, V214, P2783, DOI 10.1242/jeb.055343; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Hoeksema BW, 2011, CORAL REEFS, V30, P95, DOI 10.1007/s00338-010-0675-5; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Atkinson M., 2005, J GEOPHYS RES-OCEANS, V110, DOI DOI 10.1029/2004JC002576; Baird A. H., 2006, P 10 INT COR REEF S, V1, P38; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, P7; Harrison P.L., 1990, ECOSYSTEMS WORLD, P133; Hoeksema BW, 1989, ZOOL VERH-LEIDEN, V254, P1; Iguchi A, 2015, ZYGOTE, V23, P631, DOI 10.1017/S0967199414000185; Keshavmurthy S, 2014, SCI REPORTS, V4; Lewis E., 1998, PROGRAM DEV CO2 SYST; Loya Yossi, 2009, Galaxea - Tokyo, V11, P119; Loya Y, 2012, P 12 INT CORAL REEF, V12, P263; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Merhbach C, 1973, LIMNOL OCEANOGR, V18, P897; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Rodgriguez-Lanetty M, 2009, MOL ECOL, V18, P5101; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; Woolsey ES, 2014, CORAL REEFS, P1	68	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					447	454		10.2108/zs150036		8	Zoology	Zoology	CS3EU	WOS:000361955400005		
J	Nozu, R; Murakumo, K; Matsumoto, R; Nakamura, M; Ueda, K; Sato, K				Nozu, Ryo; Murakumo, Kiyomi; Matsumoto, Rui; Nakamura, Masaru; Ueda, Keiichi; Sato, Keiichi			Gonadal Morphology, Histology, and Endocrinological Characteristics of Immature Female Whale Sharks, Rhincodon typus	ZOOLOGICAL SCIENCE			English	Article						whale shark; female; immature; ovary; histology; sex steroid hormones	STEROID-HORMONES; WESTERN GULF; SERUM CONCENTRATIONS; SEXUAL-MATURITY; SPHYRNA-TIBURO; LONG-TERM; SKATE; REPRODUCTION; BIOLOGY; MAINE	Captive breeding of whale sharks is one of the great challenges for aquariums. However, there is limited information available related to reproductive physiology due to the difficulty of sampling and long-term observation. In the present report, we provide information on the reproductive physiology of female whale sharks, which were incidentally captured as bycatch in a set-net off the coast of Okinawa, Japan. Total lengths of three captured female whale sharks were 403, 665, and 761 cm, respectively, at the time of their death. Collected paired ovaries differed in size between right and left. However, it seems not to determine which side of ovary becomes developed. Histological observations revealed that oocytes surrounded by follicle cell layers localized in the developed ovary, and most developed oocytes exhibited yolk vesicle stage. Additionally, in the largest specimen, there were low levels of three steroid hormones (Testosterone, Dihydrotestosterone, and Estradiol-17 beta) that did not show seasonal variation. The present results indicate that even the whale shark over 7 m in TL are still histologically and endocrinologically immature. We expect that the present data will provide fundamental information related to reproductive physiology of female whale sharks, and will contribute to protection activities and increased success in captive breeding of whale sharks.	[Nozu, Ryo; Nakamura, Masaru; Sato, Keiichi] Okinawa Churashima Fdn, Res Ctr, Motobu, Okinawa 9050206, Japan; [Murakumo, Kiyomi; Matsumoto, Rui; Ueda, Keiichi] Okinawa Churaumi Aquarium, Motobu, Okinawa 9050206, Japan	Nozu, R (reprint author), Okinawa Churashima Fdn, Res Ctr, 888 Ishikawa, Motobu, Okinawa 9050206, Japan.	r-nozu@okichura.jp					HISAW FL, 1947, BIOL BULL, V92, P187, DOI 10.2307/1538305; Sulikowski JA, 2005, ENVIRON BIOL FISH, V72, P429, DOI 10.1007/s10641-004-2866-9; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; Gelsleichter J, 2002, FISH PHYSIOL BIOCHEM, V26, P389, DOI 10.1023/B:FISH.0000009292.70958.65; Awruch CA, 2008, MAR ECOL PROG SER, V355, P277, DOI 10.3354/meps07227; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Awruch CA, 2013, GEN COMP ENDOCR, V192, P60, DOI 10.1016/j.ygcen.2013.05.021; Sulikowski JA, 2007, ENVIRON BIOL FISH, V80, P285, DOI 10.1007/s10641-007-9257-y; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1006/jfbi.1997.0526; ASAHINA K, 1995, FISHERIES SCI, V61, P491; KOOB TJ, 1986, BIOL REPROD, V35, P267, DOI 10.1095/biolreprod35.2.267; Hoffmayer ER, 2010, ENVIRON BIOL FISH, V88, P1, DOI 10.1007/s10641-010-9603-3; Bradshaw CJA, 2008, BIOL CONSERV, V141, P1894, DOI 10.1016/j.biocon.2008.05.007; RASMUSSEN LEL, 1993, ENVIRON BIOL FISH, V38, P167, DOI 10.1007/BF00842913; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; RASMUSSEN LEL, 1992, AUST J MAR FRESH RES, V43, P273; Theberge MM, 2006, ORYX, V40, P337, DOI 10.1017/S0030605306000998; Henningsen AD, 2008, FISH PHYSIOL BIOCHEM, V34, P437, DOI 10.1007/s10695-008-9202-9; Awruch CA, 2008, J EXP ZOOL PART A, V309A, P184, DOI 10.1002/jez.445; Williams LJ, 2013, FISH PHYSIOL BIOCHEM, V39, P1089, DOI 10.1007/s10695-012-9766-2; CHEN CT, 1988, FISH B-NOAA, V86, P389; Sulikowski JA, 2006, J FISH BIOL, V69, P1449, DOI 10.1111/j.1095-8649.01207.x; WOLFSON FH, 1983, J FISH BIOL, V22, P647, DOI 10.1111/j.1095-8649.1983.tb04224.x; Compagno L. J., 2001, SHARKS WORLD ANNOTAT; Hamlett WC, 1999, SHARKS, SKATES, AND RAYS, P398; Lutton Bram V., 2005, P237; PAI M V, 1983, Indian Journal of Fisheries, V30, P157; PRATT HL, 1979, FISH B-NOAA, V77, P445; Rao KS, 1986, MARINE FISHHERIES IN, V66, P22; SCHLERNI.DA, 1966, J MORPHOL, V120, P219, DOI 10.1002/jmor.1051200302; Setna SB, 1948, REC INDIAN MUS, V46, P1	32	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					455	458		10.2108/zs150040		4	Zoology	Zoology	CS3EU	WOS:000361955400006		
J	Kato, M; Hiruta, C; Tochinai, S				Kato, Miku; Hiruta, Chizue; Tochinai, Shin			Androgenic Gland Implantation Induces Partial Masculinization in Marmorkrebs Procambarus fallax f. virginalis	ZOOLOGICAL SCIENCE			English	Article						androgenic gland; masculinization; parthenogenesis; implantation; Marmorkrebs	MACROBRACHIUM-ROSENBERGII; SEXUAL CHARACTERISTICS; DECAPOD CRUSTACEANS; MARBLED CRAYFISH; FEMALE CRAYFISH; CLARKII; DISCOVERY	The androgenic gland in malacostracan crustacean species produces and secretes androgenic gland hormone, which is responsible for male sexual differentiation, such as the induction and development of male sexual traits, and in turn the suppression of female sexual traits. Marmorkrebs, Procambarus fallax forma virginalis, which was identified as the first parthenogenetic species in decapod crustaceans, produces only female offspring. In this study, in order to reveal whether the Marmorkrebs crayfish is sensitive to androgenic gland hormone, we transplanted an androgenic gland from a related congener, P. clarkii, to P. fallax f. virginalis. In androgenic gland-implanted specimens, partial masculinization was confirmed: the masculinization of several external sexual characteristics (i.e., thickening of the first and second pleopods; formation of reverse spines on the third and fourth pereopods) was detected, whereas that of internal sexual characteristics (e.g., the formation of ovotestes and male gonoducts) was not. Our results imply that P. fallax f. virginalis still has sensitivity to the androgenic gland hormone and, at least partly, the hormone should be able to induce male characteristics, even in parthenogenetic Marmorkrebs.	[Kato, Miku] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Hiruta, Chizue] Iwate Med Univ, Ctr Liberal Arts & Sci, Dept Biol, Yahaba, Iwate 0283694, Japan; [Tochinai, Shin] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido 0600811, Japan	Kato, M (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Kita 10 Nishi 8, Sapporo, Hokkaido 0600810, Japan.	mikuk28@gmail.com					Scholtz G, 2003, NATURE, V421, P806, DOI 10.1038/421806a; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P442, DOI 10.1016/0016-6480(80)90049-0; Taketomi Y, 1996, J CRUSTACEAN BIOL, V16, P24, DOI 10.2307/1548927; Martin P, 2010, CONTRIB ZOOL, V79, P107; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Sagi A, 1997, INVERTEBR REPROD DEV, V31, P55, DOI 10.1080/07924259.1997.9672563; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Taketomi Y, 1996, J CRUSTACEAN BIOL, V16, P232, DOI 10.2307/1548879; Aflalo ED, 2006, AQUACULTURE, V256, P468, DOI 10.1016/j.aquaculture.2006.01.035; Ventura T, 2011, GEN COMP ENDOCR, V173, P381, DOI 10.1016/j.ygcen.2011.05.018; NAGAMINE C, 1987, INT J INVER REP DEV, V11, P77; Yue GH, 2008, INT J BIOL SCI, V4, P279; De Grave S, 2009, RAFFLES B ZOOL, P1; Murakami T, 2004, FISHERIES SCI, V70, P561, DOI 10.1111/j.1444-2906.2004.00841.x; Buric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020281; CHARNIAUXCOTTON H, 1954, CR HEBD ACAD SCI, V239, P780; Charniaux-Cotton H, 1992, REPROD BIOL INVERTEB, P217; CHARNIAUX-COTTON H, 1985, P217; Holdich D. M., 2002, P3; KATAKURA Y, 1967, Gunma Symposia on Endocrinology, V4, P49; Lee Tai-hung, 1993, Suisan Zoshoku, V41, P311; Payen G, 1990, RECENT ADV COMP ARTH, P439; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Sagi A., 1990, World Aquaculture, V21, P87	25	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					459	464		10.2108/zs150028		6	Zoology	Zoology	CS3EU	WOS:000361955400007		
J	Shimada, T; Matsui, M; Nishikawa, K; Eto, K				Shimada, Tomohiko; Matsui, Masafumi; Nishikawa, Kanto; Eto, Koshiro			New Species of Meristogenys (Anura: Ranidae) from Sarawak, Borneo	ZOOLOGICAL SCIENCE			English	Article						Meristogenys penrissenensis sp nov.; mtDNA phylogeny; larval morphology; taxonomy; Borneo	AMOROPALAMUS AMPHIBIA; AMOLOPS; SABAH; FROGS	A cryptic Bornean torrent frog of the genus Meristogenys, which is divergent genetically and morphologically from all known congeners, is described from mountain streams of western Sarawak, East Malaysia (Borneo). The species occurs sympatrically with the type species of the genus, M. jerboa, but apparently differs from it in adult coloration and larval morphology, such as keratodont formulae and glands in tail fins. Females of the new species possess much larger and fewer eggs than in sympatric M. jerboa, suggesting significantly different reproductive traits between these species. A key to larvae of known species of the genus is provided.	[Shimada, Tomohiko] Aichi Univ Educ, Kariya, Aichi 4488542, Japan; [Matsui, Masafumi; Nishikawa, Kanto; Eto, Koshiro] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Eto, Koshiro] Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan	Shimada, T (reprint author), Aichi Univ Educ, Kariya, Aichi 4488542, Japan.	shimadatom@gmail.com			MEXT through JSPS [23405014]; JSPS research fellowship for young scientist	State Government of Sarawak, and the Forest Department, Sarawak kindly permitted us to conduct this study. We are grateful to the following for their encouragements and/or permission to conduct research and export specimens, and field companionship: Datu Haji Len Talif Salleh, Haji ali Bin Yusop, Marker Nyogin, Mohd. Shabudin Sabki, Uning, Haji Abang Mohamad Mohtar Bin Abang Pawozan, Paulus Ak Meleng, T. Ichioka, and S. T. Yeo. Our field trip was supported by a Grant-in Aid from MEXT through the JSPS (Field Research, No. 23405014) to M. Matsui, and JSPS research fellowship for young scientist to T. Shimada.	HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Leache AD, 2002, SYSTEMATIC BIOL, V51, P44, DOI 10.1080/106351502753475871; Matsui M, 2006, MOL PHYLOGENET EVOL, V38, P659, DOI 10.1016/j.ympev.2005.11.019; Shimada T, 2011, ZOOTAXA, P33; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Shimada T, 2008, ZOOTAXA, P24; Shimada T, 2011, ZOOL J LINN SOC-LOND, V161, P157, DOI 10.1111/j.1096-3642.2010.00641.x; Inger RF, 2009, RAFFLES B ZOOL, V57, P527; Shimada T, 2007, ZOOL J LINN SOC-LOND, V151, P173, DOI 10.1111/j.1096-3642.2007.00319.x; Bagon M, 2005, ECOLOGY FROM INDIVID; Boulenger G. A., 1882, CATALOGUE BATRACHIA; Boulenger G. A., 1920, Records of the Indian Museum, V20; Boulenger G.A., 1893, ANN MUSEO CIVICO STO, V13, P304; Boulenger G.A., 1912, VERTEBRATE FAUNA MAL; de Elera C, 1895, CATALOGO SISTEMATICO; Duellman WE, 1986, BIOL AMPHIBIANS; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Gosner K. L., 1960, Herpetologica, V16, P183; Gunther A.C.L.G., 1972, P ZOOL SOC LOND, V1872, P586; Inger RF, 1985, FIELDIANA ZOOL, V26, P1; INGER ROBERT F., 1966, FIELDI ANA ZOOL, V52, P1; Inger RF, 1983, FIELDIANA ZOOL, V19, P1; Jobb G, 2011, TREEFINDER VERSION M; Matsui M, 2010, ZOOL SCI, V27, P61, DOI 10.2108/zsj.27.61; MATSUI M, 1986, COPEIA, P623; MATSUI M, 1984, Contributions from the Biological Laboratory Kyoto University, V26, P209; McDiarmid R, 1999, TADPOLES BIOL ANURAN; SMITH MALCOLM A., 1931, BULL RAFFLES MUS [SINGAPORE], V5, P3; Smith MA, 1925, SARAWAK MUS J, V3, P15; Tanabe AS, 2010, KAKUSAN4 VERSION 0 1; TAYLOR EDWARD H., 1962, UNIV KANSAS SCI BULL, V43, P265; van Kampen PN, 1923, AMPHIBIA INDO AUSTR; Yang D. T., 1991, FIELDIANA ZOOLOGY, V63, P1	33	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					474	484		10.2108/zs140289		11	Zoology	Zoology	CS3EU	WOS:000361955400009		
J	Ito, M; Onishi, T; Dick, MH				Ito, Minako; Onishi, Takumi; Dick, Matthew H.			Cribrilina mutabilis n. sp., an Eelgrass-Associated Bryozoan (Gymnolaemata: Cheilostomata) with Large Variation in Zooid Morphology Related to Life History	ZOOLOGICAL SCIENCE			English	Article						COI; epibiont; haplotype; heterochrony; invasive species; Japan; ontogeny; plasticity; polyphenism; Zostera marina	MOLECULAR PHYLOGENY; COMPARATIVE ANATOMY; AKKESHI BAY; JAPAN; HOKKAIDO; DIVERSITY; EVOLUTION; PATTERNS; ANNULATA; GENUS	We describe the cribrimorph cheilostome bryozoan Cribrilina mutabilis n. sp., which we detected as an epibiont on eelgrass (Zostera marina) at Akkeshi, Hokkaido, northern Japan. This species shows three distinct zooid types during summer: the R (rib), I (intermediate), and S (shield) types. Evidence indicates that zooids commit to development as a given type, rather than transform from one type to another with age. Differences in the frontal spinocyst among the types appear to be mediated by a simple developmental mechanism, acceleration or retardation in the production of lateral costal fusions as the costae elongate during ontogeny. Colonies of all three types were identical, or nearly so, in partial nucleotide sequences of the mitochondrial COI gene (555-631 bp), suggesting that they represent a single species. Zooid types varied temporally in overall frequency in the population: colonies contained nearly exclusively R-type zooids in mid-June; predominantly I-type, or both R- and I-type, zooids in mid-July; and I-type, S-type, or both I- and S-type zooids (interspersed or in discrete bands) in mid- to late August. Reproduction occurred throughout the season, but peaked in July, with only R- and I- type zooids reproducing. Reproductive zooids bear a vestigial compound (tripartite) ooecium and brood internally; S-type zooids, first appearing in August, were non-reproductive, which suggests that they may serve as an overwintering stage. As this species is easily accessible, common, and simple in form, it is potentially useful as a model system for studying polyphenism at multiple levels (zooid, colony, and population) in the context of life-history adaptations.	[Ito, Minako] Hokkaido Univ, Grad Sch Environm Sci, Akkeshi 0881113, Japan; [Onishi, Takumi; Dick, Matthew H.] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Dick, MH (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, N10 W8, Sapporo, Hokkaido 0600810, Japan.	mhdick@mail.sci.hokudai.ac.jp			KAKENHI Grant from Japan Society for the Promotion of Science [233670038]	This study was supported in part by a KAKENHI Grant (233670038) to MHD from the Japan Society for the Promotion of Science. We thank Prof. Masahiro Nakaoka, Ms Naoko Kouchi, Prof. Hiroshi Mukai, and the general staff of the Akkeshi Marine Biological Station for assistance in many ways; Dr Andrei Grischenko for discussion and a summary of records in the Russian literature of nominal Membraniporella aragoi in northeastern Asia; Dr Hiroshi Yamasaki for help with Fig. 1; Dr Andrew Ostrovsky and Dr Dennis Gordon for information and discussion; and Dr Ostrovsky, Dr Grischenko, and an anonymous reviewer for highly constructive comments during peer review.	Androsova EI, 1971, DESCRIPTION EGYPTE H, V8, P144; Androsova EI, 1971, DESCRIPTION EGYPTE H, V8, P310; Yamada K, 2007, HYDROBIOLOGIA, V592, P345, DOI 10.1007/s10750-007-0767-6; IKEZAWA H, 1993, ZOOL SCI, V10, P1029; Lidgard S, 2012, EVOL ECOL, V26, P233, DOI 10.1007/s10682-011-9513-7; Dick MH, 2005, J NAT HIST, V39, P3687, DOI 10.1080/00222930500415195; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ostrovsky AN, 2007, ZOOL SCI, V24, P1187, DOI 10.2108/zsj.24.1187; Lepoint G, 2014, BELG J ZOOL, V144, P51; Waeschenbach A, 2012, MOL PHYLOGENET EVOL, V62, P718, DOI 10.1016/j.ympev.2011.11.011; Dick MH, 2003, MOL PHYLOGENET EVOL, V27, P355, DOI 10.1016/S1055-7903(03)00025-3; Grischenko AV, 2007, J NAT HIST, V41, P1047, DOI 10.1080/00222930701391773; Mackie JA, 2006, MAR BIOL, V149, P285, DOI 10.1007/s00227-005-0196-x; Watanabe M, 2005, BOT MAR, V48, P266, DOI 10.1515/BOT.2005.036; Suwa T, 1998, J NAT HIST, V32, P895, DOI 10.1080/00222939800770461; POWELL NA, 1967, J FISH RES BOARD CAN, V24, P1905; Ostrovsky AN, 2009, ZOOMORPHOLOGY, V128, P13, DOI 10.1007/s00435-008-0070-8; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Ostrovsky AN, 1998, ACTA ZOOL-STOCKHOLM, V79, P287; Kouchi N, 2006, MAR ECOL-EVOL PERSP, V27, P145, DOI 10.1111/j.1439-0485.2006.00092.x; Ostrovsky AN, 2009, J MORPHOL, V270, P1413, DOI 10.1002/jmor.10767; MAWATARI SF, 1986, J NAT HIST, V20, P193, DOI 10.1080/00222938600770161; Audouin JV, 1826, DESCRIPTION EGYPTE H, V1, P225; Bishop J.D.D., 1987, Bulletin of the British Museum (Natural History) Zoology, V53, P1; Bock PE, 2006, INDEXES BRYOZOAN TAX; Bock P. E., 2001, Memoirs of Museum of Victoria, V58, P191; BOCK PE, 1994, OLSEN INT S, P33; DI MARTINO E., 2014, STUDI TRENTINI SCI N, V94, P79; GAUTIER Y., 1954, VIE ET MILIEU, V5, P66; Gontar VI, 2014, ECOL SAFETY, V8, P361; Gordon D.P., 1984, NZ OCEANOGRAPHIC I M, V91, P1; Gordon D.P., 1993, MEMOIRES MUSEUM NATL, V11, P299; Gordon DP, 2014, BRYOZOA CHEILOSTOMAT; Gray J. E., 1848, LIST SPECIMENS BRI 1; Grischenko A.V., 2012, Rossiskii Zhurnal Biologicheskikh Invazii, V2, P42; Hayward P.J., 1998, SYNOPSES BRIT FAUNA, V10, P1; Hincks T, 1881, ANN MAG NAT HIST, V5, P1; Kluge H, 1914, DTSCH SUDPOL EXP 190, V7, P599; Kubanin AA, 1998, TAXONOMIC CATALOGUE, P300; Kubanin AA, 1997, CHECK LIST ANIMALS P, P119; Kubanin AA, 1975, FOULING JAPAN OKHOTS, P108; Kubanin AA, 1987, EXPLORATIONS INTERTI, P121; Kubanin AA, 1984, THESIS ACAD SCI USSR; Larwood G. P., 1962, Bulletin of the British Museum (Natural History) Geology, V6, P1; Levinsen G. M. R., 1909, MORPHOLOGICAL SYSTEM; De la Cuadra CML, 2000, J NAT HIST, V34, P755, DOI 10.1080/002229300299408; Mawatari S, 1981, P JAPANESE SOC SYSTE, V21, P41; Mayr E, 1963, ANIMAL SPECIES EVOLU; Moyano G.H.I., 1991, GAYANA ZOOLOGIA CONC, V55, P305; Nakaoka M, 2001, OTSUCHI MAR SCI, V26, P7; Nordmann A de, 1839, ANN SCI NAT 2, V11, P185; Ostrovsky AN., 2013, EVOLUTION SEXUAL REP	52	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	OCT	2015	32	5					485	497		10.2108/zs150079		13	Zoology	Zoology	CS3EU	WOS:000361955400010		
J	Sugaya, T; Sakamoto, S; Tominaga, K; Nakano, M; Sugaya, H; Hiraishi, H				Sugaya, Takeshi; Sakamoto, Setsu; Tominaga, Keiichi; Nakano, Masakazu; Sugaya, Hitoshi; Hiraishi, Hideyuki			Feasibility of detecting small intestinal disease by FDG-PET/CT	ABDOMINAL IMAGING			English	Article						FDG; PET/CT; Small intestine; Accumulation; Distribution	CANCER	Positron emission tomography (PET)/computed tomography with F-18-fluorodeoxyglucose (FDG) is widely used for the diagnosis of malignant tumors. However, we occasionally encounter cases in which pathological accumulation is indistinguishable from physiological accumulation. We conducted a retrospective study of the maximum standardized uptake value (SUVmax) and the distribution pattern of FDG accumulation in 80 evaluable patients with records of accumulation in the small intestine identified from data acquired at Dokkyo Medical University PET Center from March 2005 to December 2010. Our aim was to distinguish pathological accumulation from physiological accumulation. Nineteen of the 80 patients had lesions that required some form of treatment. These lesions were categorized as pathological accumulation, while other 65 lesions in 61 patients were categorized as physiological accumulation. Cases with diffuse accumulation in the intestinal tract were assigned to Group L (linear), all others to Group F (focal), in our analysis. Lesions were focal in 22 patients and linear in 62. The pathological accumulation group had a mean SUVmax of 12.2, which was higher than that of 5.0 in the physiological accumulation group, and included more lesions that were categorized into Group F (16 of 19 lesions). The sensitivity and specificity for detecting focal accumulation regarded as being pathological accumulation were 84% and 91%, respectively, and accuracy was 89%. The sensitivity and specificity with a cut-off SUVmax of 5.87 obtained in the ROC analysis were 84% and 78%, respectively, and accuracy was 80%. Evaluation of SUVmax in the small intestine and the distribution pattern of FDG accumulation may be useful for diagnosing lesions in the small intestine.	[Sugaya, Takeshi; Tominaga, Keiichi; Nakano, Masakazu; Sugaya, Hitoshi; Hiraishi, Hideyuki] Dokkyo Med Univ, Dept Gastroenterol, Shimotsuga, Tochigi 3210293, Japan; [Sakamoto, Setsu] Dokkyo Med Univ, PET Ctr, Shimotsuga, Tochigi 3210293, Japan	Sugaya, T (reprint author), Dokkyo Med Univ, Dept Gastroenterol, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan.	t-sugaya@dokkyomed.ac.jp					Abouzied Mohei M, 2005, J Nucl Med Technol, V33, P145; Diederichs CG, 1998, J NUCL MED, V39, P1030; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kubota K, 2001, EUR J NUCL MED, V28, P696, DOI 10.1007/s002590100537; Toriihara A, 2011, ANN NUCL MED, V25, P173, DOI 10.1007/s12149-010-0439-x; Mitsui K, 2009, GASTROINTEST ENDOSC, V70, P498, DOI 10.1016/j.gie.2008.12.242; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Prabhakar HB, 2007, RADIOGRAPHICS, V27, P145, DOI 10.1148/rg.271065080; Tatlidil R, 2002, RADIOLOGY, V224, P783, DOI 10.1148/radiol.2243011214; Hara T, 2009, ANN NUCL MED, V23, P657, DOI 10.1007/s12149-009-0288-7; Yamato M, 2009, J NUCL MED, V50, P266, DOI 10.2967/jnumed.108.057943; Minamimoto R, 2013, ANN NUCL MED, V27, P468, DOI 10.1007/s12149-013-0712-x; Kumar R, 2005, J NUCL MED, V46, P1819; Gutman F, 2005, AM J ROENTGENOL, V185, P495; LINDHOLM P, 1993, J NUCL MED, V34, P1; Lodge M, 2005, EUR J NUCL MED, V26, P22	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	OCT	2015	40	7					2193	2199		10.1007/s00261-015-0457-1		7	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CS1OJ	WOS:000361835700012		
J	Numata, K; Fukuda, H; Nihonmatsu, H; Kondo, M; Nozaki, A; Chuma, M; Morimoto, M; Oshima, T; Okada, M; Murakami, T; Takebayashi, S; Maeda, S; Inayama, Y; Nakano, M; Tanaka, K				Numata, Kazushi; Fukuda, Hiroyuki; Nihonmatsu, Hiromi; Kondo, Masaaki; Nozaki, Akito; Chuma, Makoto; Morimoto, Manabu; Oshima, Takashi; Okada, Masahiro; Murakami, Takamichi; Takebayashi, Shigeo; Maeda, Shin; Inayama, Yoshiaki; Nakano, Masayuki; Tanaka, Katsuaki			Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease	ABDOMINAL IMAGING			English	Article						Contrast-enhanced ultrasonography; Early hepatocellular carcinoma; Regenerative nodule; High-grade dysplastic nodule; Tumor vessel	BUDD-CHIARI-SYNDROME; GD-EOB-DTPA; ULTRASOUND; CIRRHOSIS; INVASION; LESIONS; EFFICACY; MRI	We evaluated the use of tumor vessel patterns observed during arterial-phase contrast-enhanced ultrasonography (US) to differentiate regenerative nodules (RN) from early hepatocellular carcinoma (HCC) or high-grade dysplastic nodules (HGDN) in patients with chronic liver disease. Pathologically confirmed lesions (83 early HCC, 6 HGDN, and 13 RN with mean maximal diameters of 15.4, 15.3, and 16.2 mm, respectively) were enrolled in this retrospective study. We performed contrast-enhanced US using a perflubutane-based contrast agent. We then classified the tumor vessels observed during the arterial phase of contrast-enhanced US into two patterns: peripheral vessels (centripetal pattern) and central vessels (centrifugal pattern). Eighty-one (97.6%) of the 83 early HCC exhibited various enhancement patterns (hypovascular, 44.6%; isovascular, 25.3%; and hypervascular, 27.7%) and a peripheral vessel pattern, while the remaining 2 lesions (2.4%) exhibited hypovascular enhancement and a central vessel pattern. All 6 HGDN lesions were hypovascular with a peripheral vessel pattern. Twelve (92.3%) of the 13 RN were hypovascular with a central vessel pattern, and the remaining one (7.7%) was hypervascular with a central vessel pattern. When lesions exhibiting a central vessel pattern during arterial-phase contrast-enhanced US were diagnosed as RN, the sensitivity, specificity, and accuracy of these diagnoses were 100%, 97.8%, and 98.0%, respectively. The tumor vessel patterns observed during arterial-phase contrast-enhanced US may be useful for differentiating RN from early HCC or HGDN in patients with chronic liver disease.	[Numata, Kazushi; Fukuda, Hiroyuki; Nihonmatsu, Hiromi; Kondo, Masaaki; Nozaki, Akito; Chuma, Makoto; Morimoto, Manabu; Oshima, Takashi; Tanaka, Katsuaki] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Okada, Masahiro] Univ Hosp Ryukyus, Dept Radiol, Nishihara, Okinawa 9030215, Japan; [Murakami, Takamichi] Kinki Univ, Dept Radiol, Fac Med, Osaka, Osaka 5898511, Japan; [Takebayashi, Shigeo] Yokohama City Univ, Med Ctr, Dept Radiol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Maeda, Shin] Yokohama City Univ, Div Gastroenterol, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Inayama, Yoshiaki] Yokohama City Univ, Dept Pathol, Med Ctr, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Nakano, Masayuki] Shonan Fujisawa Tokusyukai Hosp, Dept Pathol, Fujisawa, Kanagawa 2510041, Japan	Numata, K (reprint author), Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	kz-numa@urahp.yokohama-cu.ac.jp					Luo W, 2009, EUR J RADIOL, V72, P425, DOI 10.1016/j.ejrad.2008.09.003; Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Gatto A, 2013, ABDOM IMAGING, V38, P736, DOI 10.1007/s00261-012-9950-y; Desmet VJ, 2009, HEPATOLOGY, V49, P355, DOI 10.1002/hep.22681; Park YN, 2007, CANCER, V109, P915, DOI 10.1002/cncr.22460; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483; Kobayashi S, 2012, DIGEST DIS, V30, P574, DOI 10.1159/000343069; Kim TK, 2011, ABDOM IMAGING, V36, P244, DOI 10.1007/s00261-011-9686-0; Takahashi M, 2013, EUR J RADIOL, V82, P75, DOI 10.1016/j.ejrad.2012.05.035; Nakano M, 1997, LIVER, V17, P41; Kudo M, 2010, ONCOLOGY-BASEL, V78, P60, DOI 10.1159/000315232; Maetani Y, 2002, AM J ROENTGENOL, V178, P869; Kobayashi M, 2006, CANCER, V106, P636, DOI 10.1002/cncr.21607; Zhang RF, 2012, EUR J RADIOL, V81, P2984, DOI 10.1016/j.ejrad.2012.01.023; Renzulli M, 2011, HEPATOB PANCREAT DIS, V10, P439; Kunishi Y, 2012, AM J ROENTGENOL, V198, P106, DOI 10.2214/AJR.10.6039; Takizawa K, 2013, EUR J RADIOL, V82, P1471, DOI 10.1016/j.ejrad.2013.04.045; Gentilucci UV, 2011, WORLD J GASTROENTERO, V17, P2580, DOI 10.3748/wjg.v17.i20.2580; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Jang HJ, 2009, EUR J RADIOL, V72, P418, DOI 10.1016/j.ejrad.2008.08.011; Lim JH, 1999, RADIOLOGY, V210, P451; Tanaka H, 2014, J GASTROENTEROL, V49, P755, DOI 10.1007/s00535-013-0830-1; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; WANLESS IR, 1995, HEPATOLOGY, V22, P983, DOI 10.1002/hep.1840220341; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Numata K, 2014, EUR J RADIOL, V83, P95, DOI 10.1016/j.ejrad.2013.09.025; Suzuki M, 2004, ALCOHOL CLIN EXP RES, V28, P153	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	OCT	2015	40	7					2372	2383		10.1007/s00261-015-0489-6		12	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CS1OJ	WOS:000361835700031		
J	Takeuchi, M; Matsuzaki, K; Harada, M				Takeuchi, Mayumi; Matsuzaki, Kenji; Harada, Masafumi			Susceptibility-weighted MRI of extra-ovarian endometriosis: preliminary results	ABDOMINAL IMAGING			English	Article						Endometriosis; Extra-ovarian endometriosis; Susceptibility-weighted imaging (SWI); Magnetic resonance imaging (MRI); Female pelvis	PATHOLOGICAL CORRELATION; PELVIC ENDOMETRIOSIS; IMAGING FINDINGS; MASSES; DIAGNOSIS	Extra-ovarian endometriosis (EOE) usually appears as solid masses mimicking neoplasms both clinically and radiologically. Detection of blood products within a lesion may be suggestive of its endometriotic nature. We present a descriptive study of MR imaging findings that include susceptibility-weighted imaging (SWI) for patients with EOE. Eight pathologically proven EOE (3 bowel, 2 bladder and 3 abdominal wall) were evaluated. Fat-saturated T1-weighted images (fsT1WI) and SWI were obtained using 1.5T MR imaging. Images were reviewed for the presence of signal voids on SWI and of high-intensity foci on fsT1WI. High-intensity foci reflecting subacute hemorrhage were detected in 4 of 8 lesions (50%) on fsT1WI, whereas signal voids reflecting acute to chronic hemorrhage were detected in all 8 lesions (100%) on SWI. SWI is a sensitive MRI technique which demonstrates hemorrhage of varying chronicity in patients with EOE and may improve future MRI characterization of EOE.	[Takeuchi, Mayumi; Matsuzaki, Kenji; Harada, Masafumi] Univ Tokushima, Dept Radiol, Tokushima 7708503, Japan	Takeuchi, M (reprint author), Univ Tokushima, Dept Radiol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mayumi@tokushima-u.ac.jp					Choudhary S, 2009, AM J ROENTGENOL, V192, P1632, DOI 10.2214/AJR.08.1560; Gidwaney R, 2012, RADIOGRAPHICS, V32, P2031, DOI 10.1148/rg.327125024; Busard MPH, 2012, EUR J RADIOL, V81, P1376, DOI 10.1016/j.ejrad.2011.03.038; SIEGELMAN ES, 1994, AM J ROENTGENOL, V163, P357; Siegelman ES, 1999, RADIOLOGY, V212, P5; Gougoutas CA, 2000, AM J ROENTGENOL, V175, P353; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Busard MPH, 2012, EUR J RADIOL, V81, P2106, DOI 10.1016/j.ejrad.2011.08.007; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Lobel U, 2010, NEURORADIOLOGY, V52, P1167, DOI 10.1007/s00234-010-0771-9; Takeuchi M, 2008, AM J ROENTGENOL, V191, P1366, DOI 10.2214/AJR.07.3974; TOGASHI K, 1991, RADIOLOGY, V180, P73; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Busard MPH, 2010, EUR RADIOL, V20, P1267, DOI 10.1007/s00330-009-1658-1; Solak A, 2013, EUR J RADIOL, V82, pE411, DOI 10.1016/j.ejrad.2013.04.030; Wong-You-Cheong JJ, 2006, RADIOGRAPHICS, V26, P1847, DOI 10.1148/rg.266065126; Bazot M, 2004, RADIOLOGY, V232, P379, DOI 10.1148/radiol.2322030762	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	OCT	2015	40	7					2512	2516		10.1007/s00261-015-0378-z		5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	CS1OJ	WOS:000361835700044		
J	Matsumoto, H; Ohnishi, M; Takegawa, R; Hirose, T; Hattori, Y; Shimazu, T				Matsumoto, Hisatake; Ohnishi, Mitsuo; Takegawa, Ryosuke; Hirose, Tomoya; Hattori, Yuji; Shimazu, Takeshi			Effect of lipid emulsion during resuscitation of a patient with cardiac arrest after overdose of chlorpromazine and mirtazapine	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							INFUSION	No specific treatment exists for poisoning with most fat-soluble drugs. Intravenous lipid emulsion (ILE) may be effective therapy against such drugs, but effects of ILE treatment are unclear. A 24-year-old woman with depression seen sleeping in the morning was found comatose in the evening, and an emerging lifesaving technologies service was called. After emerging lifesaving technologies departure to hospital, she stopped breathing, became pulseless, and cardiopulmonary life support was started immediately. Electrocardiographic monitoring showed asystole during resuscitation even after arrival at hospital. Empty packaging sheets of 60-tablet chlorpromazine (CPZ) (50 mg/tablet) and 66-tablet mirtazapine (MZP) (15 mg/tablet) found at the scene suggested drug-related cardiopulmonary arrest. Alongwith conventional administration of adrenaline (total dose, 5mg), 20% Intralipid 100mL was given intravenously 8 minutes after hospital arrival and readministered 27 minutes after hospital arrival because of continued asystole. Return of spontaneous circulation occurred 29 minutes after arrival (70 minutes after cardiac arrest). The patient recovered without any major complications and was transferred to another hospital for psychiatric treatment 70 days after admission. Concentrations of CPZ and MZP were still high when return of spontaneous circulation was achieved with ILE. This case suggested the possible benefit of ILE in treating life-threatening cardiotoxicity from CPZ and MZP overdose.	[Matsumoto, Hisatake; Ohnishi, Mitsuo; Takegawa, Ryosuke; Hirose, Tomoya; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan; [Hattori, Yuji] Kyoto Med Ctr, Natl Hosp Org, Dept Pharm, Kyoto, Japan	Matsumoto, H (reprint author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	h.matsumoto0828@gmail.com					Kirkton C, 2006, J ANAL TOXICOL, V30, P687; Cave G, 2011, EMERG MED AUSTRALAS, V23, P123, DOI 10.1111/j.1742-6723.2011.01398.x; DORSON PG, 1988, DRUG INTEL CLIN PHAR, V22, P776; Fettiplace MR, 2013, CRIT CARE MED, V41, pE156, DOI 10.1097/CCM.0b013e318287f874; Weinberg GL, 2012, ANESTHESIOLOGY, V117, P180, DOI 10.1097/ALN.0b013e31825ad8de; Weinberg GL, 1998, ANESTHESIOLOGY, V88, P1071, DOI 10.1097/00000542-199804000-00028	6	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2015	33	10							1541.e1	10.1016/j.ajem.2015.07.059		2	Emergency Medicine	Emergency Medicine	CS1PM	WOS:000361839300061		
J	Ono, Y; Hayakawa, M; Maekawa, K; Mizugaki, A; Katabami, K; Wada, T; Sawamura, A; Gando, S				Ono, Yuichi; Hayakawa, Mineji; Maekawa, Kunihiko; Mizugaki, Asumi; Katabami, Kenichi; Wada, Takeshi; Sawamura, Atsushi; Gando, Satoshi			Should laryngeal tubes or masks be used for out-of-hospital cardiac arrest patients?	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							EMERGENCY CARDIOVASCULAR CARE; AIRWAY MANAGEMENT; CARDIOPULMONARY-RESUSCITATION; ENDOTRACHEAL INTUBATION; PREHOSPITAL AIRWAY; LT-D; PARAMEDICS; GUIDELINES; DEVICES; ART	Objective: Few studies have compared airway management via laryngeal masks (LM) or laryngeal tubes (LT) in patients with out-of-hospital cardiac arrest (OHCA). This study evaluated whether LT insertion by emergency medical service (EMS) personnel affected ventilation and outcomes in OHCA patients (vs. the standard LM treatment). Methods: This prospective, cluster-randomized, and open-label study evaluated data that were collected by the Sapporo Fire Department between June 2012 and January 2013. We selected the 14 EMS teams that treated the greatest number of OHCA patients in Sapporo, Japan during 2011, and randomized the teams into Groups A and B. In the first study period (June 2012 to September 2012), Group A treated OHCA patients via LT and Group B treated OHCA patients via LM. In the second period (October 2012 to January 2013), Group A treated OHCA patients via LM and Group B treated OHCA patients via LT. If necessary, both groups were allowed to use an esophageal obturator airway (EOA) kit. The primary endpoints were time from cardiopulmonary resuscitation to device insertion and the rate of successful pre-hospital ventilation. The secondary endpoints were return of spontaneous circulation and survival and favorable neurological outcomes at 1 month after cardiac arrest. Results: LT was used in 148 OHCA patients and LM was used in 165 OHCA patients. Our intention-to-treat analyses revealed no significant differences in the primary and secondary outcomes of the LT-and LM-treated groups. Conclusion: Prehospital advanced airway management via LT provides similar outcomes to those of LM in OHCA patients. (C) 2015 Elsevier Inc. All rights reserved.	[Ono, Yuichi; Hayakawa, Mineji; Maekawa, Kunihiko; Mizugaki, Asumi; Katabami, Kenichi; Wada, Takeshi; Sawamura, Atsushi; Gando, Satoshi] Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Ono, Y (reprint author), Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Grad Sch Med,Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	rjtkk3299@yahoo.co.jp					Agro F, 1999, RESUSCITATION, V41, P284; Schalk R, 2011, PREHOSP EMERG CARE, V15, P347, DOI 10.3109/10903127.2011.561405; Dorges V, 2000, ANESTH ANALG, V90, P1220; BASS RR, 1982, ANN EMERG MED, V11, P358, DOI 10.1016/S0196-0644(82)80361-2; Hayakawa M, 2009, AM J EMERG MED, V27, P470, DOI 10.1016/j.ajem.2008.03.043; Lyon RM, 2010, EMERG MED J, V27, P321, DOI 10.1136/emj.2009.076737; Brimacombe JR, 1998, INT ANESTHESIOL CLIN, V36, P139, DOI 10.1097/00004311-199803620-00011; REINHART DJ, 1994, ANN EMERG MED, V24, P260, DOI 10.1016/S0196-0644(94)70139-3; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Vezina MC, 2007, CAN J ANAESTH, V54, P124; Asai T, 2005, BRIT J ANAESTH, V95, P729, DOI 10.1093/bja/aei269; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; SAMARKANDI AH, 1994, RESUSCITATION, V28, P103, DOI 10.1016/0300-9572(94)90080-9; Wang HE, 2012, RESUSCITATION, V83, P405, DOI 10.1016/j.resuscitation.2011.12.030; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; BRAIN AIJ, 1991, EUR J ANAESTH, P5; Wiese CHR, 2009, RESUSCITATION, V80, P194, DOI 10.1016/j.resuscitation.2008.08.023; Cone DC, 2012, RESUSCITATION, V83, P275, DOI 10.1016/j.resuscitation.2011.12.024; Kurola J, 2004, RESUSCITATION, V61, P149, DOI 10.1016/j.resuscitation.2004.01.014; Deakin CD, 2005, EMERG MED J, V22, P64, DOI 10.1136/emj.2004.017178; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Gahan K, 2011, RESUSCITATION, V82, P1525, DOI 10.1016/j.resuscitation.2011.06.036; PENNANT JH, 1992, ANESTH ANALG, V74, P531; Barnes TA, 2001, ANN EMERG MED, V37, pS145, DOI 10.1067/mem.2001.114123; Gaitini L, 2008, Rev Esp Anestesiol Reanim, V55, P232; Jokela Jorma, 2009, Prehosp Disaster Med, V24, P63; Kajino K, 2011, CRIT CARE, V15, DOI 10.1186/cc10483; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2015	33	10					1360	1363		10.1016/j.ajem.2015.07.043		4	Emergency Medicine	Emergency Medicine	CS1PM	WOS:000361839300006		
J	Hagiwara, Y; Watase, H; Okamoto, H; Goto, T; Hasegawa, K				Hagiwara, Yusuke; Watase, Hiroko; Okamoto, Hiroshi; Goto, Tadahiro; Hasegawa, Kohei		Japanese Emergency Med Network	Prospective validation of the modified LEMON criteria to predict difficult intubation in the ED	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRACHEAL INTUBATION; ENDOTRACHEAL INTUBATION; AIRWAY MANAGEMENT; SCORE; GUIDELINES; OUTCOMES	Background: Evidence to predict difficult intubation remains scarce in the emergency department (ED) setting. A previously defined clinical decision rule, the modified LEMON criteria, may provide a reliable and reproducible means of identifying difficult intubations. We aimed to prospectively evaluate the external validity of the modified LEMON criteria in the EDs. Methods: We conducted a 13-center prospective observational study, the second Japanese Emergency Airway Network study. We prospectively collected data on all patients undergoing intubations in the ED from February 2012 through September 2014. The primary outcomes were sensitivity, specificity, and predictive values of the modified LEMON criteria for predicting difficult intubation (>= 2 attempts by emergency attending physicians or anesthesiologists). Results: The database recorded a total of 4034 encounters (capture rate, 96%) in the EDs. Of these, 3313 patients (84%) underwent the intubation attempt with a direct laryngoscope and 610 patients (16%) with a video laryngoscope. The proportion of difficult intubation was 5.4% (95% confidence interval [CI], 4.7%-6.2%) in the direct laryngoscope group and 7.4% (95% CI, 5.6%-9.7%) in the video laryngoscope group. The sensitivity was 85.7% (95% CI, 79.3%-90.4%) with direct laryngoscope and 94.9% (95% CI, 83.5%-98.6%) with video laryngoscope. The specificity was 47.6% (95% CI, 47.2%-47.9%) and 40.3% (95% CI, 39.4%-40.6%), respectively. The negative predictive value was 98.2% (95% CI, 97.5%-98.8%) and 99.0% (95% CI, 96.6%-99.7%), respectively. Conclusions: In this multicenter prospective study, we found a high sensitivity and a negative predictive value of the modified LEMON criteria for predicting difficult intubation. The modified LEMON might assist ED providers in better identifying difficult intubations. (C) 2015 Elsevier Inc. All rights reserved.	[Hagiwara, Yusuke] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Emergency & Crit Care Med, Fuchu, Tokyo 1838561, Japan; [Watase, Hiroko] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Okamoto, Hiroshi] Kurashiki Cent Hosp, Dept Emergency Med, Kurashiki, Okayama, Japan; [Goto, Tadahiro; Hasegawa, Kohei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA	Hagiwara, Y (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Emergency & Crit Care Med, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	yusukehagiwara-tky@umin.ac.jp; hiroko7@uw.edu; hiroshi.okamota.1121@gmail.com; tadahirogoto@gmail.com; khasegawa@partners.org			St Luke's Life Science Institute	This study was supported by a grant from St Luke's Life Science Institute. The study sponsors have no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	CAPLAN RA, 1993, ANESTHESIOLOGY, V78, P597; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Burkle CM, 2005, CAN J ANAESTH, V52, P634; Hasegawa K, 2012, ANN EMERG MED, V60, P749, DOI 10.1016/j.annemergmed.2012.04.005; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Eberhart LHJ, 2010, EUR J ANAESTH, V27, P935, DOI 10.1097/EJA.0b013e328338883c; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Soyuncu S, 2009, AM J EMERG MED, V27, P905, DOI 10.1016/j.ajem.2008.07.003; Langeron O, 2012, ANESTHESIOLOGY, V117, P1223, DOI 10.1097/ALN.0b013e31827537cb; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; L'Hermite J, 2009, EUR J ANAESTH, V26, P1003, DOI 10.1097/EJA.0b013e32832efc71; Crosby ET, 1998, CAN J ANAESTH, V45, P757; BENUMOF JL, 1991, ANESTHESIOLOGY, V75, P1087; Martin LD, 2011, ANESTHESIOLOGY, V114, P42, DOI 10.1097/ALN.0b013e318201c415; Apfelbaum Jeffrey L, 2013, Anesthesiology, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; Goto T, 2014, EMERG MED J, P1; Goto T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-014-0085-8; Goto Y, 2014, ACUTE MED SURG, V1, P214; Graciano AL, 2014, INTENS CARE MED, V40, P1659, DOI 10.1007/s00134-014-3407-4; 서석환, 2012, Korean Journal of Anesthesiology, V63, P491	21	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2015	33	10					1492	1496		10.1016/j.ajem.2015.06.038		5	Emergency Medicine	Emergency Medicine	CS1PM	WOS:000361839300032		
J	Murayama, H; Liang, J; Bennett, JM; Shaw, BA; Botoseneanu, A; Kobayashi, E; Fukaya, T; Shinkai, S				Murayama, Hiroshi; Liang, Jersey; Bennett, Joan M.; Shaw, Benjamin A.; Botoseneanu, Anda; Kobayashi, Erika; Fukaya, Taro; Shinkai, Shoji			Trajectories of Body Mass Index and Their Associations With Mortality Among Older Japanese: Do They Differ From Those of Western Populations?	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						body mass index; Japan; mortality; older adults; trajectories	INTENTIONAL WEIGHT-LOSS; ALL-CAUSE MORTALITY; AGED ADULTS; WOMEN; MEN; BMI; OVERWEIGHT; AMERICANS; OBESITY; HEIGHT	Few studies have focused on the relationship between the trajectories of long-term changes in body mass index (BMI; weight (kg)/height (m)(2)) and all-cause mortality in old age, particularly in non-Western populations. We evaluated this association by applying group-based mixture models to data derived from the National Survey of the Japanese Elderly, which included 4,869 adults aged 60 or more years, with up to 7 repeated observations between 1987 and 2006. Four distinct BMI trajectories were identified: "low-normal weight, decreasing" (baseline BMI = 18.7; 23.8% of sample); "mid-normal weight, decreasing" (baseline BMI = 21.9; 44.6% of sample); "high-normal weight, decreasing" (baseline BMI = 24.8; 26.5% of sample); and "overweight, stable" (baseline BMI = 28.7; 5.2% of sample). Survival analysis with an average follow-up of 13.8 years showed that trajectories of higher BMI were associated with lower mortality. In particular, relative to those with a mid-normal weight, decreasing BMI trajectory, those with an overweight, stable BMI trajectory had the lowest mortality, and those with a low-normal, decreasing BMI trajectory had the highest mortality. In sharp contrast with prior observations from Western populations, BMI changes lie primarily within the normal-weight range, and virtually no older Japanese are obese. The association between BMI trajectories and mortality varies according to the distribution of BMI within the population.	[Murayama, Hiroshi; Liang, Jersey; Bennett, Joan M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Murayama, Hiroshi; Kobayashi, Erika; Fukaya, Taro; Shinkai, Shoji] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo 1730015, Japan; [Shaw, Benjamin A.] SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, Rensselaer, NY USA; [Botoseneanu, Anda] Univ Michigan, Dept Behav Sci, Dearborn, MI 48128 USA; [Botoseneanu, Anda] Yale Univ, Dept Internal Med Geriatr, New Haven, CT USA	Murayama, H (reprint author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	murayama@tmig.or.jp			National Institute on Aging [R01 AG031109]; National Institutes of Health [P60 AG024824]	This work was supported by the National Institute on Aging (grant R01 AG031109) and the National Institutes of Health (grant P60 AG024824).	Saito I, 2009, J EPIDEMIOL COMMUN H, V63, P447, DOI 10.1136/jech.2008.082065; Nanri A, 2010, INT J OBESITY, V34, P348, DOI 10.1038/ijo.2009.234; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; Chiu CJ, 2013, J GEN INTERN MED, V28, P1150, DOI 10.1007/s11606-013-2399-z; Botoseneanu A, 2013, J AGING HEALTH, V25, P342, DOI 10.1177/0898264312468593; Uchitomi Y, 1997, ANN NY ACAD SCI, V809, P290, DOI 10.1111/j.1749-6632.1997.tb48092.x; Maru S, 2004, AM J CLIN NUTR, V80, P231; Droyvold WB, 2005, J INTERN MED, V257, P338; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Gregg EW, 2003, ANN INTERN MED, V138, P383; Tamakoshi A, 2010, OBESITY, V18, P362, DOI 10.1038/oby.2009.190; Botoseneanu A, 2012, J GERONTOL A-BIOL, V67, P1075, DOI 10.1093/gerona/gls073; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Zajacova A, 2014, GERONTOLOGIST, V54, P221, DOI 10.1093/geront/gns164; Botoseneanu A, 2011, J AGING HEALTH, V23, P454, DOI 10.1177/0898264310385930; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Gunnell D, 2000, INT J EPIDEMIOL, V29, P456, DOI 10.1093/ije/29.3.456; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; Sahyoun NR, 1996, J CLIN EPIDEMIOL, V49, P981, DOI 10.1016/0895-4356(96)00135-7; Inoue K, 2006, AGING CLIN EXP RES, V18, P205; Amador LF, 2006, AGING CLIN EXP RES, V18, P196; Kuchibhatla MN, 2013, J GERONTOL A-BIOL, V68, P699, DOI 10.1093/gerona/gls215; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179; Sergi G, 2005, J GERONTOL A-BIOL, V60, P866; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Nakamura K, 1999, J BIOSOC SCI, V31, P555, DOI 10.1017/S0021932099005556; Fuemmeler BF, 2012, HEALTH PSYCHOL, V31, P441, DOI 10.1037/a0027927; Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P990, DOI 10.1093/ije/dyn059; Ozasa K, 2008, J EPIDEMIOL, V18, P111, DOI 10.2188/jea.JE2007416; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x; Takata Y, 2013, ARCH GERONTOL GERIAT, V57, P46, DOI 10.1016/j.archger.2013.02.006; Abe T, 2011, J SPORT SCI MED, V10, P145; Barba C, 2004, LANCET, V363, P157; Chandra R, 1997, AM J CLIN NUTR, V122, P460; Enders C, 2010, APPL MISSING DATA AN; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; de Leon CFM, 2007, J GERONTOL B-PSYCHOL, V62, pS198; Ministry of Health Labour and Welfare, 2013, NAT HLTH NUTR SURV J; Nagin D, 2005, GROUP BASED MODELING; Schafer J. L., 1997, ANAL INCOMPLETE MULT; Schoenborn CA, 2013, VITAL HLTH STAT, V10, P60; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802; Sorensen TIA, 2005, PLOS MED, V2, P510, DOI 10.1371/journal.pmed.0020171; Visser M., 2012, SARCOPENIA, P1	53	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	OCT 1	2015	182	7					597	605		10.1093/aje/kwv107		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CS1GL	WOS:000361811100006		
J	Oda, E				Oda, Eiji			Does Serum Bilirubin Predict Incident Metabolic Syndrome?	AMERICAN JOURNAL OF MEDICINE			English	Editorial Material							OXIDATIVE STRESS; RISK-FACTOR; MEN		Tachikawa Med Ctr, Med Check Up Ctr, Nagaoka, Niigata, Japan	Oda, E (reprint author), Tachikawa Med Ctr, Med Check Up Ctr, Nagaoka, Niigata, Japan.						Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; Oda E, 2012, ACTA DIABETOL, V49, P89, DOI 10.1007/s00592-011-0309-6; Oda E, 2012, KIDNEY BLOOD PRESS R, V36, P47, DOI 10.1159/000339027; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Huang S-S, 2015, AM J MED, V128; Lee MJ, 2014, DIABETES METAB, V40, P305, DOI 10.1016/j.diabet.2014.04.006	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	OCT	2015	128	10					1047	1047		10.1016/j.amjmed.2015.05.022		1	Medicine, General & Internal	General & Internal Medicine	CR9DE	WOS:000361652600033		
J	Hidaka, K; Hojo, K; Fujioka, S; Nukuzuma, S; Tsuda, Y				Hidaka, Koushi; Hojo, Keiko; Fujioka, Shio; Nukuzuma, Souichi; Tsuda, Yuko			Oligomerization of neutral peptides derived from the JC virus agnoprotein through a cysteine residue	AMINO ACIDS			English	Article						Agnoprotein; Disulfide bond; JC virus; Oligomerization; Transmembrane	POLYOMAVIRUS JC; CELLS; INFECTION; CONFORMATION; REPLICATION; PROTEINS; MUTANTS; HELIX	The JC virus is the causative agent of progressive multifocal leukoencephalopathy. The viral genome encodes a multifunctional protein known as agnoprotein which is essential for viral proliferation and reported to possess the oligomerization sequence. However, the structural relationship with the oligomerization is unclear. We synthesized 23 amino acid residue neutral peptides derived from the JC virus agnoprotein, Lys22 to Asp44. The secondary structures of these peptides were beta-sheet in aqueous buffer that converted to a helical structure in a hydrophobic environment. These peptides interestingly formed dimers and oligomers under oxidizing conditions. The oligomerization was facilitated by addition of bismaleimides and the derivative without thiol group did not form such oligomers. These results suggest that Agno(22-44) could be transmembrane and one disulfide bond between Cys40 triggers the oligomerization.	[Hidaka, Koushi; Hojo, Keiko; Fujioka, Shio; Tsuda, Yuko] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Hidaka, Koushi; Hojo, Keiko; Tsuda, Yuko] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Kobe, Hyogo 6508586, Japan; [Nukuzuma, Souichi] Kobe Inst Hlth, Dept Infect Dis, Kobe, Hyogo 6500046, Japan	Hidaka, K (reprint author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	khida@pharm.kobegakuin.ac.jp			Strategic Research Foundation at Private Universities from MEXT, Japan	We are sincerely grateful to Dr. M. Otani for technical advice and to Dr. T. Yamashita for graphical advice on the electrophoresis. This research was supported in part by the Strategic Research Foundation at Private Universities from MEXT, Japan.	Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Nukuzuma S, 2013, J MED VIROL, V85, P132, DOI 10.1002/jmv.23443; Shishido-Hara Y, 2010, ACTA NEUROPATHOL, V120, P403, DOI 10.1007/s00401-010-0694-x; Reshetnyak YK, 2006, P NATL ACAD SCI USA, V103, P6460, DOI 10.1073/pnas.0601463103; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Vernieri E, 2014, AMINO ACIDS, V46, P395, DOI 10.1007/s00726-013-1629-3; Nukuzuma S, 2009, MICROBIOL IMMUNOL, V53, P496, DOI 10.1111/j.1348-0421.2009.00156.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Giovanna C, 2010, AMINO ACIDS, V38, P1101, DOI 10.1007/s00726-009-0319-7; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Unterstab G, 2010, VIROLOGY, V399, P322, DOI 10.1016/j.virol.2010.01.011; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; Suzuki T, 2013, P NATL ACAD SCI USA, V110, P18668, DOI 10.1073/pnas.1311457110; Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957; Otlu O, 2014, VIROLOGY, V468, P88, DOI 10.1016/j.virol.2014.07.054; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Saribas AS, 2011, VIROLOGY, V420, P51, DOI 10.1016/j.virol.2011.08.015; Coric P, 2014, J VIROL, V88, P6556, DOI 10.1128/JVI.00146-14; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saribas AS, 2012, VIROLOGY, V433, P12, DOI 10.1016/j.virol.2012.06.017; Sariyer IK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-255; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Rauk A, 2008, DALTON T, P1273, DOI 10.1039/b718601k; Matoba T, 2008, NEUROPATHOLOGY, V28, P286, DOI 10.1111/j.1440-1789.2007.00878.x; Hellwig K, 2011, J NEUROL, V258, P1920, DOI 10.1007/s00415-011-6116-8; Eleonora T, 2012, REV MED VIROL, V22, P18; Ellis LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080840; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; LOVEGREN ES, 1988, J PROTEIN CHEM, V7, P35, DOI 10.1007/BF01025412; Maltsev AS, 2014, BIOCHEMISTRY-US, V51, P5004; Mudiyanselage APKKK, 2013, BIOCHEMISTRY-US, V52, P6127, DOI 10.1021/bi4007176; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Walker D L, 1983, Prog Clin Biol Res, V105, P99	34	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	OCT	2015	47	10					2205	2213		10.1007/s00726-015-2004-3		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CS1AA	WOS:000361792600014		
J	Hameed, S; Ikegami, K; Sugiyama, E; Matsushita, S; Kimura, Y; Hayasaka, T; Sugiura, Y; Masaki, N; Waki, M; Ohta, I; Hossen, MA; Setou, M				Hameed, Saira; Ikegami, Koji; Sugiyama, Eiji; Matsushita, Shoko; Kimura, Yoshishige; Hayasaka, Takahiro; Sugiura, Yuki; Masaki, Noritaka; Waki, Michihiko; Ohta, Isao; Hossen, Md Amir; Setou, Mitsutoshi			Direct profiling of the phospholipid composition of adult Caenorhabditis elegans using whole-body imaging mass spectrometry	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Caenorhabditis elegans; Cuticle; Exoskeleton; Freeze-cracking; Matrix-assisted laser desorption/ionization-imaging mass spectrometry; Phosphatidylcholine; Phosphatidylinositol	THIN POLYMER MEMBRANE; C-ELEGANS; ARABIDOPSIS-THALIANA; TISSUE-SECTIONS; HIGH-VACUUM; MATRIX; LIPIDS; MS; PHOSPHATIDYLINOSITOL; VISUALIZATION	A protocol for the direct analysis of the phospholipid composition in the whole body of adult soil nematode, Caenorhabditis elegans (C. elegans), was developed, which combined freeze-cracking of the exoskeletal cuticle and matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS). Biomolecules in the m/z range from 700 to 900 were more effectively detected in the freeze-cracked than from simple frozen adult nematode bodies. Different distribution of biomolecules was observed in a nematode body when the matrix was applied with a sublimation deposition method. The whole-body IMS technique was applied on genetically deficient mutant C. elegans to combine whole-body lipidomics and genetics, by comparing the fatty acid compositions, especially of the phosphatidylcholine (PC) species, between the wild-type and fat-1 mutants, which lack the gene encoding an n-3 fatty acid desaturase. A significant reduction of PC(20:5/20:5) and PC(20:4/20:5) and a marked increase of PC(20:4/20:4), PC(20:3/20:4), and PC(20:3/20:3) were detected in the fat-1 mutants in positive ion mode. In addition, phospholipid compositions other than PCs were analyzed in negative ion mode. A loss of a possible phosphatidylinositol (PI) with 18:0/20:5 and a compensative accumulation of putative PI(18:0/20:4) were detected in the fat-1 mutants. In conclusion, the whole-body MALDI-IMS technique is useful for the profiling of multiple biomolecules in C. elegans in both intra- and inter-individual levels.	[Hameed, Saira; Ikegami, Koji; Sugiyama, Eiji; Matsushita, Shoko; Kimura, Yoshishige; Hayasaka, Takahiro; Sugiura, Yuki; Masaki, Noritaka; Waki, Michihiko; Hossen, Md Amir; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Ohta, Isao] Hamamatsu Univ, Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Setou, M (reprint author), Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp			National Center for Research Resources, National Institutes of Health (NIH); JSPS KAKENHI for Scientific Research on Innovative Areas "Machinery of bioactive lipids in homeostasis and disease" [25116712]; JSPS KAKENHI for Kiban-B [25293044]; JSPS KAKENHI for Kiban-C [25440082]; MEXT Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure; Otsuka Toshimi Foundation; JASSO	We would like to thank Drs. Naoko Goto-Inoue and Dan Nicolaescu for their critical reading of the manuscript and constructive comments. The nematode strains used in this work were donated by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources, National Institutes of Health (NIH). This work was supported by JSPS KAKENHI for Scientific Research on Innovative Areas "Machinery of bioactive lipids in homeostasis and disease" (25116712) and for Kiban-B (25293044) (to M.S.), by JSPS KAKENHI for Kiban-C (25440082) (to Y.K.) and by the MEXT Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure. S.H. is receiving a scholarship from MEXT and formerly from JASSO and the Otsuka Toshimi Foundation.	Takaku Y, 2013, P NATL ACAD SCI USA, V110, P7631, DOI 10.1073/pnas.1221341110; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wei YB, 2015, ANALYST, V140, P1298, DOI 10.1039/c4an01964d; Durrant SF, 2005, J ANAL ATOM SPECTROM, V20, P821, DOI 10.1039/b502206a; Ellis SR, 2013, PROG LIPID RES, V52, P329, DOI 10.1016/j.plipres.2013.04.005; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; Eberlin LS, 2011, ANAL CHEM, V83, P8366, DOI 10.1021/ac202016x; Matsumoto J, 2011, ANAL BIOANAL CHEM, V400, P1933, DOI 10.1007/s00216-011-4909-3; Urban PL, 2011, ANAL CHEM, V83, P3918, DOI 10.1021/ac200481j; Ferreira MS, 2014, J MASS SPECTROM, V49, P86, DOI 10.1002/jms.3308; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Wahlby C, 2014, METHODS, V68, P492, DOI 10.1016/j.ymeth.2014.04.017; Niehoff AC, 2014, ANAL CHEM, V86, P11086, DOI 10.1021/ac503171f; Brinkhaus SG, 2014, METALLOMICS, V6, P617, DOI 10.1039/c3mt00334e; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Thomas A, 2012, ANAL CHEM, V84, P2048, DOI 10.1021/ac2033547; Mahanti P, 2014, CELL METAB, V19, P73, DOI 10.1016/j.cmet.2013.11.024; Hicks AM, 2006, BBA-MOL CELL BIOL L, V1761, P1022, DOI 10.1016/j.bbalip.2006.05.010; Hanc A, 2011, ANAL BIOANAL CHEM, V399, P3221, DOI 10.1007/s00216-011-4729-5; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; O'Reilly LP, 2014, ADV DRUG DELIVER REV, V69, P247, DOI 10.1016/j.addr.2013.12.001; Petkovic M, 2001, ANAL BIOCHEM, V289, P202, DOI 10.1006/abio.2000.4926; Cerruti CD, 2012, ANAL CHEM, V84, P2164, DOI 10.1021/ac2025317; Chansela P, 2012, PEPTIDES, V34, P10, DOI 10.1016/j.peptides.2011.03.021; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Jun JH, 2010, ANAL CHEM, V82, P3255, DOI 10.1021/ac902990p; Fuchs B, 2010, PROG LIPID RES, V49, P450, DOI 10.1016/j.plipres.2010.07.001; Geier FM, 2013, SURF INTERFACE ANAL, V45, P234, DOI 10.1002/sia.5110; Uchiyama Y, 2014, ANAL BIOANAL CHEM, V406, P1307, DOI 10.1007/s00216-013-7062-3; Hirano H, 2014, ANAL BIOANAL CHEM, V406, P1355, DOI 10.1007/s00216-013-7075-y; Vrkoslav V, 2010, J AM SOC MASS SPECTR, V21, P220, DOI 10.1016/j.jasms.2009.10.003; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; BRENNER S, 1974, GENETICS, V77, P71; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Fay D, 2006, WORMBOOK, V17, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hameed S, 2012, NANOMEDICINE NERVOUS; Hill SJ, 2005, INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY HANDBOOK, P1; Murphy RC, 2015, NEW DEV MASS SPECTRO; Ohta I, 2014, MICROSCOPY-JPN, V63, P295, DOI 10.1093/jmicro/dfu015; Page AP, 2007, C ELEGANS RES COMMUN, DOI 10.1895/wormbook.1.138.1; Van Assche R, 2015, J MOL BIOL, V427, P3441, DOI 10.1016/j.jmb.2015.03.015; Vickerman J. C., 2013, TOF SIMS MAT ANAL MA	51	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	OCT	2015	407	25					7589	7602		10.1007/s00216-015-8932-7		14	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CR8WA	WOS:000361633700005		
J	Reynolds, AM; Ropert-Coudert, Y; Kato, A; Chiaradia, A; MacIntosh, AJJ				Reynolds, Andrew M.; Ropert-Coudert, Yan; Kato, Akiko; Chiaradia, Andre; MacIntosh, Andrew J. J.			A priority-based queuing process explanation for scale-free foraging behaviours	ANIMAL BEHAVIOUR			English	Article						decision making; foraging; penguins; power laws; randomness	SLEEP-WAKE TRANSITIONS; FRACTAL ANALYSIS; SEARCH BEHAVIOR; ANIMAL BEHAVIOR; DIVING SEABIRD; CHAOS THEORY; COMPLEXITY; PATTERNS; LEVY; CORTICOSTERONE	Spatial scale-invariant Levy walk (power-law) patterns seem common among animals that move continually during searching. Scaling laws also describe well the spontaneous patterns of waiting times of sit-and-wait ambush predators, which show random 'burstiness' that appears scale-invariant across a broad set of scales. The occurrence of these scaling laws has been attributed to stochastic decision-based queuing processes. Taken together these various studies suggest that stochastic decision-based queuing processes may apply more generally across taxa with divergent foraging strategies, ranging from highly mobile pursuit predators to the less mobile ambush predators. Here we provide support for this proposition by demonstrating that simple stochastic priority processes capture accurately the timings of dives made by little penguins, Eudyptula minor, in their natural habitat, whose use of space and time falls between that of sit-and-wait predators and Levy walkers. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Reynolds, Andrew M.] Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Ropert-Coudert, Yan; Kato, Akiko] CNRS, UMR7178, Strasbourg, France; [Ropert-Coudert, Yan; Kato, Akiko] Univ Strasbourg, IPHC, Strasbourg, France; [Chiaradia, Andre] Phillip Isl Nat Parks, Res Dept, Cowes, Vic, Australia; [MacIntosh, Andrew J. J.] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan; [MacIntosh, Andrew J. J.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	Reynolds, AM (reprint author), Rothamsted Res, Harpenden AL5 2JQ, Herts, England.	andy.reynolds@rothamsted.ac.uk	MacIntosh, Andrew/B-2242-2013	Chiaradia, Andre/0000-0002-6178-4211; MacIntosh, Andrew/0000-0002-9136-7099	Biotechnology and Biological Sciences Research Council; Japan Society for the Promotion of Science; Australian Academy of Science; Penguin Foundation	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council. This work was further supported by the Japan Society for the Promotion of Science, the Australian Academy of Science and the Penguin Foundation. We thank L. Pelletier for help collecting the little penguin data, as well as the Research Department of Phillip Island Nature Parks for their continued support.	Asher L, 2009, J R SOC INTERFACE, V6, P1103, DOI 10.1098/rsif.2009.0221; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Rutherford KMD, 2004, ANIM WELFARE, V13, pS99; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Alados CL, 1996, ANIM BEHAV, V51, P437, DOI 10.1006/anbe.1996.0040; Cottin M, 2014, MAR ECOL PROG SER, V496, P249, DOI 10.3354/meps10618; Butler PJ, 2006, COMP BIOCHEM PHYS A, V145, P1, DOI 10.1016/j.cbpa.2006.06.006; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Harnos A, 2000, PHYSICA A, V286, P312, DOI 10.1016/S0378-4371(00)00332-0; Sims DW, 2014, P NATL ACAD SCI USA, V111, P11073, DOI 10.1073/pnas.1405966111; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Reynolds AM, 2011, PHYSICA A, V390, P245, DOI 10.1016/j.physa.2010.09.020; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; MacIntosh AJJ, 2011, J R SOC INTERFACE, V8, P1497, DOI 10.1098/rsif.2011.0049; Mori Y, 2001, BEHAVIOUR, V138, P1451, DOI 10.1163/156853901317367690; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; Saraux C, 2011, ECOLOGY, V92, P1909; Blumberg M. S., 2005, P NATL ACAD SCI USA, V102, P14680; Hays G.C., 2011, P ROYAL SOC B, V279, P465; Houston A. I., 1999, MODELS ADAPTIVE BEHA; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; MacIntosh AJJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01884; Stephens DW, 1986, FORAGING THEORY; Viswanathan G., 2011, PHYS FORAGING; Wearmouth VJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2997	33	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	OCT	2015	108						67	71		10.1016/j.anbehav.2015.07.022		5	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CR7ZE	WOS:000361570000009		
J	Ota, K; Kohda, M				Ota, Kazutaka; Kohda, Masanori			How and to what extent do sneakers gain proximity to females in an externally fertilizing fish?	ANIMAL BEHAVIOUR			English	Article						alternative reproductive tactics; decision making; ejaculate timing; sneaking behaviour; sperm competition; territorial defence	ALTERNATIVE REPRODUCTIVE TACTICS; CHARR SALVELINUS-ALPINUS; MATURE MALE PARR; SPERM COMPETITION; ATLANTIC SALMON; ONCORHYNCHUS-MYKISS; SPAWNING BEHAVIOR; BLUEGILL SUNFISH; SEXUAL SELECTION; MIDSHIPMAN FISH	Recent studies have shown that fertilization success in external fertilization systems is influenced by differences in the temporal and spatial positions of competing males at ejaculation, as is the case for internal fertilization systems. Little is known about how these positions differ between competitors. We tackled this issue in the triplefin fish Enneapterygius etheostoma, which spawns in turbulent flow environments, and which employs external fertilization and alternative reproductive tactics (i.e. sneakers and territorial males). A frame-by-frame analysis of video images of sneaking behaviours recorded in the wild revealed that sneakers ejaculated later, and further from the spawning female, than territorial males. The majority of sneaking attempts failed because of attacks by territorial males. Successful sneakers mostly hid behind shelters around the spawning sites and then rushed into the site (i.e. were undetected), or were detected and attacked as they approached the site or hid near it, but rushed in anyway (attack-initiated sneaking). Of the undetected successful sneakers, a minority rushed in when the spawning female was being ignored by a territorial male that was attacking other sneakers (induced sneaking) and the others rushed in when there was no territorial attack (attack-free sneaking). Attack-free sneaking was carried out by sneakers that hid closer to the spawning female for longer, and were spatially and temporally closer to territorial males at ejaculation. Altogether, we conclude that the abilities to get past territorial vigilance and observe gamete release of spawning pairs at a hiding place are key factors that helped sneakers to improve their position at ejaculation, and thus perhaps their fertilization success. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Ota, Kazutaka; Kohda, Masanori] Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 5588585, Japan	Ota, K (reprint author), Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 5588585, Japan.	otkztk@gmail.com			JSPS KAKENHI [15K18614, 26118511, 26540070]	We are very grateful to Hatsune Nonogaki and our colleagues of the laboratory for their fruitful discussion. We thank Ivar Folstad and the anonymous referees for constructive and helpful comments on the manuscript. This work was partly supported by JSPS KAKENHI grant numbers 15K18614, 26118511, 26540070.	Yeates S, 2007, J FISH BIOL, V70, P318, DOI 10.1111/j.1095-8649.2006.01294.x; Berejikian BA, 2010, CAN J FISH AQUAT SCI, V67, P1933, DOI 10.1139/F10-112; Grimardias D, 2010, J FISH BIOL, V77, P2460, DOI 10.1111/j.1095-8649.2010.02808.x; Watanabe M, 2008, CAN J ZOOL, V86, P1121, DOI 10.1139/Z08-093; Urbach D, 2005, BEHAV ECOL SOCIOBIOL, V57, P438, DOI 10.1007/s00265-004-0876-4; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Sato T, 2004, ETHOLOGY, V110, P49, DOI 10.1046/j.1439-0310.2003.00944.x; Scaggiante M, 1999, J EXP ZOOL, V283, P81, DOI 10.1002/(SICI)1097-010X(19990101)283:1<81::AID-JEZ9>3.0.CO;2-9; Ioannou CC, 2009, BIOL LETTERS, V5, P191, DOI 10.1098/rsbl.2008.0758; Kanoh Y, 1996, ETHOLOGY, V102, P883; Sorum V, 2011, BEHAVIOUR, V148, P1157, DOI 10.1163/000579511X596615; Morris MR, 2010, ANIM BEHAV, V79, P673, DOI 10.1016/j.anbehav.2009.12.018; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105; Lee JSF, 2006, BEHAV ECOL, V17, P670, DOI 10.1093/beheco/ark015; Hoysak DJ, 2004, CAN J ZOOL, V82, P1017, DOI 10.1139/Z04-073; Weiss MR, 2004, ANIM BEHAV, V68, P45, DOI 10.1016/j.anbehav.2003.07.010; DONNELLY WA, 1984, J FISH BIOL, V25, P183, DOI 10.1111/j.1095-8649.1984.tb04865.x; Ota K, 2010, BEHAV ECOL, V21, P1293, DOI 10.1093/beheco/arq146; Rosengrave P, 2008, BEHAV ECOL, V19, P1179, DOI 10.1093/beheco/arn089; Thomaz D, 1997, P ROY SOC B-BIOL SCI, V264, P219; Wojtczak M, 2007, AQUACULTURE, V270, P259, DOI 10.1016/j.aquaculture.2007.03.010; Neat FC, 2003, J FISH BIOL, V62, P1381, DOI 10.1046/j.1095-8649.2003.00122.x; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Marconato A, 1996, ENVIRON BIOL FISH, V46, P321, DOI 10.1007/BF00005009; Lee JSF, 2004, NATURWISSENSCHAFTEN, V91, P338, DOI 10.1007/s00114-004-0531-y; GILE SR, 1995, ENVIRON BIOL FISH, V42, P267, DOI 10.1007/BF00004920; BIRKHEAD TR, 1990, TRENDS ECOL EVOL, V5, P48, DOI 10.1016/0169-5347(90)90047-H; Ota D, 1996, J FISH BIOL, V49, P246, DOI 10.1111/j.1095-8649.1996.tb00021.x; Pateman-Jones C, 2011, BIOL J LINN SOC, V103, P622; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Blanchfield PJ, 2003, MOL ECOL, V12, P2417, DOI 10.1046/j.1365-294X.2003.01917.x; Reichard M, 2007, ANIM BEHAV, V74, P679, DOI 10.1016/j.anbehav.2007.03.005; GROSS MR, 1985, NATURE, V313, P47, DOI 10.1038/313047a0; Ota K, 2014, J ZOOL, V293, P63, DOI 10.1111/jzo.12125; PETERSEN CW, 1992, ECOLOGY, V73, P391, DOI 10.2307/1940747; Stoltz JA, 2006, BEHAV ECOL SOCIOBIOL, V59, P811, DOI 10.1007/s00265-005-0127-3; Hoysak DJ, 2001, J FISH BIOL, V58, P1286, DOI 10.1006/jfbi.2000.1536; Koseki Y, 2002, ENVIRON BIOL FISH, V64, P87, DOI 10.1023/A:1016096701472; Liljedal S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1805, DOI 10.1007/s00265-008-0609-1; Stoltz JA, 2006, J EVOLUTION BIOL, V19, P1873, DOI 10.1111/j.1420-9101.2006.01165.x; Bakker Theo C. M., 2006, BMC Ecology, V6, P7, DOI 10.1186/1472-6785-6-7; GROSS MR, 1991, PHILOS T R SOC B, V332, P59, DOI 10.1098/rstb.1991.0033; Hamada H., 1989, SCI B FACULTY AGR KY, V73, P127; Mjjolnerod I. B., 1998, CAN J ZOOL, V76, P70; Ota K., 2015, TACTIC SPECIFI UNPUB; Ota K., NONINDEPENDENT UNPUB; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI 10.1016/B978-012100543-6/50026-X; R Development Core Team, 2014, R LANG ENV STAT COMP; SHIOGAKI M, 1973, Japanese Journal of Ichthyology, V20, P42; SHIOGAKI M, 1973, Japanese Journal of Ichthyology, V20, P36; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Troscianko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073733	52	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	OCT	2015	108						129	136		10.1016/j.anbehav.2015.07.029		8	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CR7ZE	WOS:000361570000016		
J	Hasegawa, M; Giraudeau, M; Kutsukake, N; Watanabe, M; McGraw, KJ				Hasegawa, Masaru; Giraudeau, Mathieu; Kutsukake, Nobuyuki; Watanabe, Mamoru; McGraw, Kevin J.			Bayesian estimation of competitiveness in male house finches: small-billed males are more competitive	ANIMAL BEHAVIOUR			English	Article						aggression; Bayesian approach; bill size; dominance; Haemorhous mexicanus; latent variable	CHAIN MONTE-CARLO; SONG CHARACTERISTICS; PLUMAGE COLORATION; DOMINANCE; PERFORMANCE; AGGRESSION; MORPHOLOGY; BEHAVIOR	A common method for assessing the competitiveness of animals, especially in birds, is to pit pairs of unfamiliar individuals against each other in contests for limited resources under controlled conditions. Although this approach can clarify dominant-subordinate relationships within dyads, it is often difficult to determine competitiveness for a large group of individuals. Here, by using Bayesian statistical inference and 'hypothetical competition groups', which are formed when individuals experience a series of paired contests, we estimated social competitiveness of male house finches, Haemorhous mexicanus. First, Bayesian competitiveness estimates from paired contests successfully predicted future contest outcomes among four unfamiliar individuals (i.e. social dominance). When data of all rank combinations were pooled, future dominant males had, on average, higher competitiveness estimates than future subordinate males. Similarly, Bayesian statistical inference and hypothetical competition groups identified accurately the relative competitiveness of four subgroups of males (i.e. colourful and drab males from urban and rural sites), which matched the result of direct contests when they were all put into the same cage. This consistency reinforces the validity of Bayesian competitiveness estimation based on hypothetical competition groups. Moreover, we found that the competitiveness estimate was negatively linked to male beak size in the Bayesian framework. Males with smaller bills were more competitive than those with larger bills, perhaps due to their elevated foraging motivation (i.e. limited ability to consume or husk large, valuable seeds). We argue that Bayesian competitiveness estimations, together with a series of paired contests, is a sophisticated approach for acquiring a broad understanding of social and individual competitiveness. (C) 2015 The Association for the Study of Animal Behaviour. Published by Elsevier Ltd. All rights reserved.	[Hasegawa, Masaru; Kutsukake, Nobuyuki] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Giraudeau, Mathieu; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Watanabe, Mamoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Hasegawa, M (reprint author), 1560-35 Kamiyamaguchi, Hayama, Kanagawa 2400115, Japan.	perorobomusadiobe@gmail.com					BOYD R, 1983, ANIM BEHAV, V31, P45, DOI 10.1016/S0003-3472(83)80172-9; Kass RE, 1998, AM STAT, V52, P93, DOI 10.2307/2685466; Mennill DJ, 2006, ETHOLOGY, V112, P174, DOI 10.1111/j.1439-0310.2006.01145.x; Grava A, 2012, BEHAV ECOL, V23, P566, DOI 10.1093/beheco/arr229; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Sherratt TN, 2013, ANIMAL CONTESTS, P33; Cardoso GC, 2012, BEHAV ECOL, V23, P237, DOI 10.1093/beheco/arr200; Romero T, 2010, J ETHOL, V28, P113, DOI 10.1007/s10164-009-0162-z; McGraw KJ, 2000, CONDOR, V102, P456, DOI 10.1650/0010-5422(2000)102[0456:PBABSD]2.0.CO;2; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Sustaita D, 2014, BIOL J LINN SOC, V112, P485, DOI 10.1111/bij.12298; Briffa M, 2013, ANIMAL CONTESTS, P47; Adams ES, 2005, ANIM BEHAV, V69, P1191, DOI 10.1016/j.anbehav.2004.08.011; Badyaev AV, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P155; BELTHOFF JR, 1991, CONDOR, V93, P1010, DOI 10.2307/3247737; Amy M, 2007, ANIM BEHAV, V74, P57, DOI 10.1016/j.anbehav.2006.07.019; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McGraw KJ, 2007, BEHAVIOUR, V144, P165, DOI 10.1163/156853907779947328; McGraw KJ, 2000, BEHAV ECOL, V11, P520, DOI 10.1093/beheco/11.5.520; Shev A, 2012, ANIM BEHAV, V84, P1523, DOI 10.1016/j.anbehav.2012.09.026; KOIVULA K, 1993, BEHAV ECOL SOCIOBIOL, V33, P283, DOI 10.1007/BF02027126; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Nolan PM, 2004, ANIM BEHAV, V67, P403, DOI 10.1016/j.anbehav.2003.03.018; Christensen R, 2006, J AVIAN BIOL, V37, P617, DOI 10.1111/j.0908-8857.2006.03684.x; Mutshinda CM, 2011, J ANIM ECOL, V80, P101, DOI 10.1111/j.1365-2656.2010.01743.x; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Badyaev AV, 2008, EVOLUTION, V62, P1951, DOI 10.1111/j.1558-5646.2008.00428.x; Freire R, 2011, J ANIM SCI, V89, P1201, DOI 10.2527/jas.2010-3129; Gonzalez G, 2002, ETHOLOGY, V108, P289, DOI 10.1046/j.1439-0310.2002.00779.x; Edler AU, 2010, ETHOLOGY, V116, P806, DOI 10.1111/j.1439-0310.2010.01799.x; Rico-Guevara A, 2015, BEHAV ECOL, V26, P21, DOI 10.1093/beheco/aru182; Belthoff James R., 1996, Bird Behavior, V11, P1; Gelman A., 2013, BAYESIAN DATA ANAL; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Giraudeau M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0083-8; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Hasegawa M, 2014, BEHAV ECOL, V25, DOI 10.1093/beheco/aru034; Hasegawa M, 2015, BEHAV ECOL SOCIOBIOL, V69, P89, DOI 10.1007/s00265-014-1821-9; Loretto M.-C., 2012, INT J COMP PSYCHOL, V25, P180; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Plummer M., 2006, R NEWS, V6, P7; R Development Core Team, 2013, R LANG ENV STAT COMP; Santos E. S. A., 2009, BEHAV ECOLOGY, V20, P353; Senar J.C., 2006, FUNCTION EVOLUTION, V2, P87; Spenckle J. M., 1984, WILSON B, V96, P184; Spiegelhalter D., 2003, WINBUGS USER MANUAL	46	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0003-3472	1095-8282		ANIM BEHAV	Anim. Behav.	OCT	2015	108						207	214		10.1016/j.anbehav.2015.07.027		8	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	CR7ZE	WOS:000361570000025		
J	Onogi, A; Ogino, A; Komatsu, T; Shoji, N; Shimizu, K; Kurogi, K; Yasumori, T; Togashi, K; Iwata, H				Onogi, A.; Ogino, A.; Komatsu, T.; Shoji, N.; Shimizu, K.; Kurogi, K.; Yasumori, T.; Togashi, K.; Iwata, H.			Whole-genome prediction of fatty acid composition in meat of Japanese Black cattle	ANIMAL GENETICS			English	Article						beef cattle; blupf90; genomic selection; prediction error	UNIFIED APPROACH; FULL PEDIGREE; INFORMATION	Because fatty acid composition influences the flavor and texture of meat, controlling it is particularly important for cattle breeds such as the Japanese Black, characterized by high meat quality. We evaluated the predictive ability of single-step genomic best linear unbiased prediction (ssGBLUP) in fatty acid composition of Japanese Black cattle by assessing the composition of seven fatty acids in 3088 cattle, of which 952 had genome-wide marker genotypes. All sires of the genotyped animals were genotyped, but their dams were not. Cross-validation was conducted for the 952 animals. The prediction accuracy was higher with ssGBLUP than with best linear unbiased prediction (BLUP) for all traits, and in an empirical investigation, the gain in accuracy of using ssGBLUP over BLUP increased as the deviations in phenotypic values of the animals increased. In addition, the superior accuracy of ssGBLUP tended to be more evident in animals whose maternal grandsire was genotyped than in other animals, although the effect was small.	[Onogi, A.; Iwata, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo 1138657, Japan; [Ogino, A.; Shimizu, K.; Kurogi, K.] Livestock Improvement Assoc Japan Inc, Maebashi Inst Anim Sci, Maebashi, Gumma 3710121, Japan; [Komatsu, T.; Shoji, N.] Agr Res Ctr, Shinjo, Yamagata 9960041, Japan; [Yasumori, T.; Togashi, K.] Livestock Improvement Assoc Japan Inc, Cattle Breeding Dept Beef, Tokyo 1350041, Japan	Onogi, A (reprint author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	onogiakio@gmail.com					Akaike H., 1992, 2 INT S INF THEOR, V1, P610; Onogi A, 2014, J ANIM SCI, V92, P1931, DOI 10.2527/jas.2014-7168; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Inoue K, 2011, ANIMAL, V5, P987, DOI 10.1017/S1751731111000012; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Nogi T, 2011, J ANIM SCI, V89, P615, DOI 10.2527/jas.2009-2300; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; MISZTAL I., 2002, P 7 WORLD C GEN APPL, P28; Onogi A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-263	11	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	OCT	2015	46	5					557	559		10.1111/age.12300		3	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CS1QR	WOS:000361843200009		
J	Arakawa, A; Okumura, N; Taniguchi, M; Hayashi, T; Hirose, K; Fukawa, K; Ito, T; Matsumoto, T; Uenishi, H; Mikawa, S				Arakawa, A.; Okumura, N.; Taniguchi, M.; Hayashi, T.; Hirose, K.; Fukawa, K.; Ito, T.; Matsumoto, T.; Uenishi, H.; Mikawa, S.			Genome-wide association QTL mapping for teat number in a purebred population of Duroc pigs	ANIMAL GENETICS			English	Article						Bayesian method; genome-wide association study; swine	QUANTITATIVE TRAIT LOCI; RESOURCE POPULATION; IDENTIFICATION; SELECTION; SCAN; GENE	Because of increasing litter size in Western pig breeds, additional teats are desirable to increase the capacity for nursing offspring. We applied genome-wide SNP markers to detect QTL regions that affect teat number in a Duroc population. We phenotyped 1024 animals for total teat number. A total of 36 588 SNPs on autosomes were used in the analysis. The estimated heritability for teat number was 0.34 +/- 0.05 on the basis of a genomic relationship matrix constructed from all SNP markers. Using a BayesC method, we identified a total of 18 QTL regions that affected teat number in Duroc pigs; 9 of the 18 regions were newly detected.	[Arakawa, A.; Taniguchi, M.; Uenishi, H.; Mikawa, S.] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Okumura, N.] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Anim Res Div, Tsukuba, Ibaraki 3050854, Japan; [Hayashi, T.] Agr Res Ctr, Natl Agr & Food Res Org, Agroinformat Div, Tsukuba, Ibaraki 3058666, Japan; [Hirose, K.; Fukawa, K.; Ito, T.] Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock ZEN NOH, Kamishihoro, Hokkaido 0801406, Japan; [Matsumoto, T.] Natl Inst Agrobiol Sci, Adv Genom Lab, Tsukuba, Ibaraki 3058634, Japan; [Uenishi, H.] Natl Inst Agrobiol Sci, Anim Immune & Cell Biol Res Unit, Tsukuba, Ibaraki 3058602, Japan	Mikawa, S (reprint author), Natl Inst Agrobiol Sci, Anim Genome Res Unit, 2 Ikenodai, Tsukuba, Ibaraki 3058602, Japan.	mikawa@affrc.go.jp					KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Guo YM, 2008, ANIM GENET, V39, P486, DOI 10.1111/j.1365-2052.2008.01756.x; Holl JW, 2004, J ANIM SCI, V82, P3421; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Sato S, 2006, J ANIM SCI, V84, P2895, DOI 10.2527/jas.2006-176; Bidanel JP, 2008, ANIMAL, V2, P813, DOI 10.1017/S1751731108002097; Hirooka H, 2001, J ANIM SCI, V79, P2320; Hirose K, 2013, ANIM SCI J, V84, P213, DOI 10.1111/j.1740-0929.2012.01066.x; Tomiyama M, 2009, J ANIM SCI, V87, P1613, DOI 10.2527/jas.2008-1214; Gu MX, 1996, P NATL ACAD SCI USA, V93, P12980, DOI 10.1073/pnas.93.23.12980; Veerkamp RF, 2011, J DAIRY SCI, V94, P4189, DOI 10.3168/jds.2011-4223; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Wada Y, 2000, ANIM GENET, V31, P376, DOI 10.1046/j.1365-2052.2000.00696.x; Knurr T, 2011, GENET RES, V93, P303, DOI 10.1017/S0016672311000164; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Ding NS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-6; Duijvesteijn N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-542; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Lopes M. S., 2014, PLOS ONE, V9, P8; Mikawa S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-5; Okumura N, 2013, ANIM GENET, V44, P454, DOI 10.1111/age.12018; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	OCT	2015	46	5					571	575		10.1111/age.12331		5	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CS1QR	WOS:000361843200012		
J	Tonoike, A; Hori, Y; Inoue-Murayama, M; Konno, A; Fujita, K; Miyado, M; Fukami, M; Nagasawa, M; Mogi, K; Kikusui, T				Tonoike, A.; Hori, Y.; Inoue-Murayama, M.; Konno, A.; Fujita, K.; Miyado, M.; Fukami, M.; Nagasawa, M.; Mogi, K.; Kikusui, T.			Copy number variations in the amylase gene (AMY2B) in Japanese native dog breeds	ANIMAL GENETICS			English	Article						agriculture; AMY2B expansion; ancient breeds; domestication; Shiba; wolf	DOMESTICATION; DIET	A recent study suggested that increased copy numbers of the AMY2B gene might be a crucial genetic change that occurred during the domestication of dogs. To investigate AMY2B expansion in ancient breeds, which are highly divergent from modern breeds of presumed European origins, we analysed copy numbers in native Japanese dog breeds. Copy numbers in the Akita and Shiba, two ancient breeds in Japan, were higher than those in wolves. However, compared to a group of various modern breeds, Akitas had fewer copy numbers, whereas Shibas exhibited the same level of expansion as modern breeds. Interestingly, average AMY2B copy numbers in the Jomon-Shiba, a unique line of the Shiba that has been bred to maintain their appearance resembling ancestors of native Japanese dogs and that originated in the same region as the Akita, were lower than those in the Shiba. These differences may have arisen from the earlier introduction of rice farming to the region in which the Shiba originated compared to the region in which the Akita and the Jomon-Shiba originated. Thus, our data provide insights into the relationship between the introduction of agriculture and AMY2B expansion in dogs.	[Tonoike, A.; Nagasawa, M.; Mogi, K.; Kikusui, T.] Azabu Univ, Sch Vet Med, Compan Anim Res, Sagamihara, Kanagawa 2525201, Japan; [Hori, Y.; Inoue-Murayama, M.; Konno, A.; Fujita, K.] Kyoto Univ, Dept Psychol, Sakyo Ku, Kyoto 6068501, Japan; [Miyado, M.; Fukami, M.] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo 1578535, Japan; [Nagasawa, M.] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi 3290498, Japan	Mogi, K (reprint author), Azabu Univ, Sch Vet Med, Compan Anim Res, Sagamihara, Kanagawa 2525201, Japan.	mogik@azabu-u.ac.jp			JSPS KAKENHI [25118007, 25290082, 25118005]; MEXT*; Azabu University; Wildlife Research Center, Kyoto University	This work was supported by JSPS KAKENHI (grant numbers 25118007, 25290082, and 25118005), a research project grant MEXT*-Supported Program for the Strategic Research Foundation at Private Universities, a research project grant awarded by Azabu University and the Cooperation Research Program of Wildlife Research Center, Kyoto University. We thank Mrs. Maki Kuroi and Dr. Eri Iwata for kindly providing us dog photos.	TANABE Y, 1991, ZOOL SCI, V8, P639; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Arendt M, 2014, ANIM GENET, V45, P716, DOI 10.1111/age.12179; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Hudson Mark J., 1999, RUINS IDENTITY ETHNO	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0268-9146	1365-2052		ANIM GENET	Anim. Genet.	OCT	2015	46	5					580	583		10.1111/age.12344		4	Agriculture, Dairy & Animal Science; Genetics & Heredity	Agriculture; Genetics & Heredity	CS1QR	WOS:000361843200014		
J	Agaimy, A; Thiel, F; Hartmann, A; Fukunaga, M				Agaimy, Abbas; Thiel, Falk; Hartmann, Arndt; Fukunaga, Masaharu			SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						small cell carcinoma; ovary; hypercalcemia; SMARCA4; BRG1; rhabdoid	INI1 EXPRESSION; SMARCA4 MUTATIONS; RHABDOID FEATURES; TUMORS; VARIANT; BRG1; OLD	Small cell carcinoma of the ovary, hypercalcemic type is a very rare aggressive neoplasm of unknown histogenesis, affecting mainly girls and young women. Recently, inactivating mutations in SMARCA4 (BRG1), a member of the switch/sucrose nonfermenting chromatin remodeling complex, has been identified as driver events in most cases. We herein describe 3 cases in 34, 34, and 37-year-old women. Symptoms were mainly abdominal pain and mass. One patient was normocalcemic, and the other 2 had no preoperative serum calcium values available. All patients received radical hysterectomy with salpingo-oophorectomy, lymphadenectomy, and variable multimodality therapy. Two developed abdominal recurrences/metastases and died of disease at 4 and 12 months. One patient was alive without disease 17 months after surgery and radiochemotherapy. Histologic examination showed undifferentiated neoplasms composed of diffuse sheets, nests and cords of noncohesive monomorphic small blue/basaloid cells (classic variant, 1 case), and large undifferentiated/rhabdoid cells with abundant cytoplasm (large cell/rhabdoid variant, 2 case) admixed with minor small cell areas. One case contained rare isolated goblet cells, but true glandular component was absent. All tumors expressed vimentin and variably pancytokeratin and WT1. Nuclear SMARCB1 was intact in all cases (1 case showed small foci with mosaic loss). All tumors showed complete loss of SMARCA4. In conclusion, SMARCA4 immunohistochemistry represents a highly valuable emerging tool in identifying small cell carcinoma of the ovary, hypercalcemic type in routine practice. Distinguishing this aggressive neoplasm from juvenile granulosa cell tumor and other undifferentiated ovarian cancers is mandatory in selecting appropriate chemotherapeutic regimens and would allow better characterization of this entity, for which targeted molecular therapy still remains to be established. (C) 2015 Elsevier Inc. All rights reserved.	[Agaimy, Abbas; Hartmann, Arndt] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany; [Thiel, Falk] Univ Erlangen Nurnberg, Dept Obstet & Gynecol, D-91054 Erlangen, Germany; [Fukunaga, Masaharu] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan	Agaimy, A (reprint author), Univ Klinikum Erlangen, Inst Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany.	abbas.agaimy@uk-erlangen.de					Agaimy A, 2014, ADV ANAT PATHOL, V21, P394, DOI 10.1097/PAP.0000000000000038; Agaimy A, 2015, MODERN PATHOL, V28, P248, DOI 10.1038/modpathol.2014.100; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Fukunaga M, 1997, PATHOL INT, V47, P250, DOI 10.1111/j.1440-1827.1997.tb04487.x; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Rao Q, 2014, INT J CLIN EXP PATHO, V7, P1782; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; PRAT J, 1982, CANCER, V50, P300, DOI 10.1002/1097-0142(19820715)50:2<300::AID-CNCR2820500222>3.0.CO;2-E; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Strehl JD, 2015, ANN DIAGN PATHOL, V19, P198, DOI 10.1016/j.anndiagpath.2015.04.001; McCluggage WG, 2004, INT J GYNECOL PATHOL, V23, P330, DOI 10.1097/01.pgp.0000139644.38835.9.d; Cheng JX, 2008, MODERN PATHOL, V21, P647, DOI 10.1038/modpathol.2008.44; Young RH, 2014, SEMIN DIAGN PATHOL, V31, P382, DOI 10.1053/j.semdp.2014.08.001; EICHHORN JH, 1992, AM J SURG PATHOL, V16, P926, DOI 10.1097/00000478-199210000-00002; Florell SR, 1999, MED PEDIATR ONCOL, V32, P304, DOI 10.1002/(SICI)1096-911X(199904)32:4<304::AID-MPO13>3.0.CO;2-M; Judkins AR, 2007, ADV ANAT PATHOL, V14, P335, DOI 10.1097/PAP.0b013e3180ca8b08; YOUNG RH, 1984, AM J SURG PATHOL, V8, P575, DOI 10.1097/00000478-198408000-00002; Agaimy A, 2014, AM J SURG PATHOL, V38, P910, DOI 10.1097/PAS.0000000000000173; Foulkes WD, 2014, J PATHOL, V233, P209, DOI 10.1002/path.4362; YOUNG RH, 1994, AM J SURG PATHOL, V18, P1102, DOI 10.1097/00000478-199411000-00004; ZALOUDEK C, 1982, AM J SURG PATHOL, V6, P503, DOI 10.1097/00000478-198209000-00002; Cho YM, 2006, PATHOL INT, V56, P702, DOI 10.1111/j.1440-1827.2006.02033.x; Hasselblatt M, 2011, AM J SURG PATHOL, V35, P933, DOI 10.1097/PAS.0b013e3182196a39; DICKERSIN GR, 1982, CANCER, V49, P188; LAMOVEC J, 1995, ARCH PATHOL LAB MED, V119, P523; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Kupryjanczyk J, 2013, POL J PATHOL, V64, P238, DOI 10.5114/PJP.2013.39331; Rao Q, 2014, HISTOPATHOLOGY; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	OCT	2015	19	5					283	287		10.1016/j.anndiagpath.2015.06.001		5	Pathology	Pathology	CR8ZI	WOS:000361642600002		
J	Saito, M; Imada, H; Suzuki, T; Sata, N; Yasuda, Y; Maetani, I; Fukushima, N				Saito, Michihiro; Imada, Hiroki; Suzuki, Tsukasa; Sata, Naohiro; Yasuda, Yoshikazu; Maetani, Iruru; Fukushima, Noriyoshi			Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Intraductal papillary mucinous neoplasm; Gastric subtype; Intestinal subtype; Inflammatory cell; Edema; Stroma	CANCER; CLASSIFICATION; PROGRESSION; EXPRESSION; TUMOR	Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are primary pancreatic neoplasms that can act as precursors to invasive adenocarcinoma of the pancreas. The peritumoral stroma has been increasingly recognized to play an important role in many types of tumors. Therefore, to investigate the clinicopathological significance of the peritumoral stroma in IPMNs, we examined the histological features of the peritumoral stroma in each subtype and histological grade of IPMNs. Eighty-two patients with IPMN, who underwent surgical resection, were reviewed clinicopathologically. Intraductal papillary mucinous neoplasms (86 lesions in total) were histologically subclassified into gastric (n = 51), intestinal (n = 22), pancreatobiliary (n = 11), and oncocytic (n = 2) subtypes. Peritumoral histological features between the gastric and intestinal subtypes were evaluated by each histological grade. The results showed that subepithelial edema and inflammatory cell infiltration were more commonly observed in the gastric subtype (74% and 79%, respectively) than in the intestinal subtype (12% and 25%, respectively) of low-grade IPMNs. On the other hand, mucus lakes were more commonly observed in the intestinal subtype (100%) than in the gastric subtype (0%) of high-grade IPMNs. In addition, pancreatobiliary subtype IPMNs tended to exhibit acute inflammation such as neutrophil predominance. This study showed that peritumoral histological features differed among subtypes of IPMNs from low-grade tumors. These differences suggest the possibility that each subtype of IPMNs has a distinct mechanism from an early stage of tumor progression, which is reflected in the properties of the peritumoral stroma. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Michihiro; Imada, Hiroki; Suzuki, Tsukasa; Fukushima, Noriyoshi] Jichi Med Univ Hosp, Dept Diagnost Pathol, Shimotsuke, Tochigi 3290498, Japan; [Saito, Michihiro; Maetani, Iruru] Toho Univ, Ohashi Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1538515, Japan; [Sata, Naohiro; Yasuda, Yoshikazu] Jichi Med Univ Hosp, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Fukushima, N (reprint author), Jichi Med Univ Hosp, Dept Diagnost Pathol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	nfukushima@jichi.ac.jp			Japan Society for the Promotion of Science [26460425]	This work was supported by Japan Society for the Promotion of Science KAKENHI (grant number 26460425). The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Adsay NV, 2010, PATHOLOGY GENETICS T, P304; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Nakamura A, 2002, J PATHOL, V197, P201, DOI 10.1002/path.1109; Distler M, 2014, BIOMED RES INT, DOI 10.1155/2014/474905; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Shindo K, 2014, VIRCHOWS ARCH, V465, P265, DOI 10.1007/s00428-014-1610-x; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Fukushima N, 1997, HUM PATHOL, V28, P1010, DOI 10.1016/S0046-8177(97)90053-8; Ban S, 2006, AM J SURG PATHOL, V30, P1561, DOI 10.1097/01.pas.0000213305.98187.d4; Hamada S, 2014, J GASTROENTEROL, V49, P605, DOI 10.1007/s00535-013-0915-x; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Ishida M, 2007, PANCREAS, V35, P348; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Mohri D, 2012, J GASTROENTEROL, V47, P203, DOI 10.1007/s00535-011-0482-y; Hamada S, 2013, FRONT PHYSIOL, V4, P1; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Reid MD, 2011, MODERN PATHOL, V24, P1612	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	OCT	2015	19	5					347	352		10.1016/j.anndiagpath.2015.07.005		6	Pathology	Pathology	CR8ZI	WOS:000361642600014		
J	Ikeda, A; Mitomi, K; Konishi, T; Matsuzaki, K; Jikuya, T; Hiramatsu, Y				Ikeda, Akihiko; Mitomi, Kisato; Konishi, Taisuke; Matsuzaki, Kanji; Jikuya, Tomoaki; Hiramatsu, Yuji			Endovascular Repair of a False Aneurysm Developing from IgG4-Related Periaortitis during Corticosteroid Therapy	ANNALS OF VASCULAR SURGERY			English	Article							AUTOIMMUNE PANCREATITIS; SYSTEMIC-DISEASE; RETROPERITONEAL; MANIFESTATIONS	Immunoglobulin G4 (IgG4)-related disease is a systemic autoimmune disease that can affect various organs. Corticosteroid therapy is generally an effective treatment; however, IgG4-related aortic lesions pose a risk of aortic rupture related to corticosteroid use. Here, we report a case of IgG4-related periaortitis complicated with a false aneurysm during corticosteroid therapy. Although endovascular repair was successfully performed, autoimmune pancreatitis and sclerosing cholangitis emerged after surgery. The multiple lesions associated with IgG4-related disease were resolved through continuous corticosteroid therapy. Our case suggests that both appropriate surgical intervention and continuous corticosteroid therapy are essential for the treatment of IgG4-related periaortitis.	[Ikeda, Akihiko; Mitomi, Kisato; Konishi, Taisuke; Matsuzaki, Kanji; Jikuya, Tomoaki] Tsukuba Med Ctr Hosp, Dept Cardiovasc Surg, Tsukuba, Ibaraki 3058558, Japan; [Hiramatsu, Yuji] Univ Tsukuba, Dept Cardiovasc Surg, Tsukuba, Ibaraki, Japan	Ikeda, A (reprint author), Tsukuba Med Ctr Hosp, Dept Cardiovasc Surg, 1-3-1 Amakubo, Tsukuba, Ibaraki 3058558, Japan.	ai-cvs@sd6.so-net.ne.jp					Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Zen Y, 2012, SEMIN DIAGN PATHOL, V29, P212, DOI 10.1053/j.semdp.2012.07.003; Kasashima S, 2009, J VASC SURG, V49, P1264, DOI 10.1016/j.jvs.2008.11.072; Schepens MA, 2009, EUR J VASC ENDOVASC, V37, P640, DOI 10.1016/j.ejvs.2009.03.011; Kasashima S, 2014, J ENDOVASC THER, V21, P589, DOI 10.1583/14-4670R.1; Shu HJ, 2012, J DIGEST DIS, V13, P280, DOI 10.1111/j.1751-2980.2012.00585.x; Taketani T, 2005, J VASC SURG, V41, P597, DOI 10.1016/j.jvs.2005.01.022; Stone JR, 2011, CURR OPIN RHEUMATOL, V23, P88, DOI 10.1097/BOR.0b013e3283412f7c; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Paravastu SCV, 2009, EUR J VASC ENDOVASC, V38, P291, DOI 10.1016/j.ejvs.2009.05.005; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Stone WM, 2012, SEMIN VASC SURG, V25, P227, DOI 10.1053/j.semvascsurg.2012.09.008; Cho C, 2010, ANN VASC SURG, V24, P694; Mizushima I, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4671; O'Reilly DA, 2014, WORLD J GASTROINTEST, V15, P71; Price TP, 2014, ANN VASC SURG, V28, P1314	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	OCT	2015	29	7							1452.e5	10.1016/j.avsg.2015.04.070		5	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CR8UO	WOS:000361629800038		
J	Shiraki, T; Iida, O; Okamoto, S; Ishihara, T; Fujita, M; Uematsu, M				Shiraki, Tatsuya; Iida, Osamu; Okamoto, Shin; Ishihara, Takayuki; Fujita, Masashi; Uematsu, Masaaki			Usefulness of Endovascular Therapy for Penile Gangrene Secondary to Calciphylaxis: A Case Report	ANNALS OF VASCULAR SURGERY			English	Article							CHRONIC-RENAL-FAILURE; ERECTILE DYSFUNCTION; MORTALITY; NECROSIS; SURGERY	We here report a case of successful endovascular therapy for penile gangrene in a patient with calciphylaxis and a long history of diabetes mellitus and end-stage renal disease on dialysis. The internal iliac artery, with 75% stenosis, was treated with balloon-expandable bare metal stent implantation, whereas the inferior gluteal artery, 75% stenosis, was treated with balloon dilatation. After endovascular therapy, the intractable penile pain immediately resolved, and penile salvage with complete wound healing was achieved 6 months after the procedure.	[Shiraki, Tatsuya; Iida, Osamu; Okamoto, Shin; Ishihara, Takayuki; Fujita, Masashi; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6608511, Japan	Shiraki, T (reprint author), Kansai Rosai Hosp, Ctr Cardiovasc, 3-1-69 Inabasou, Amagasaki, Hyogo 6608511, Japan.	shiraki.tatsuya@gmail.com		Shiraki, Tatsuya/0000-0003-1901-1642			STEIN M, 1994, J UROLOGY, V152, P2014; Rogers JH, 2012, J AM COLL CARDIOL, V60, P2618, DOI 10.1016/j.jacc.2012.08.1016; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; KAWAMORI R, 1992, DIABETES CARE, V15, P1290, DOI 10.2337/diacare.15.10.1290; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Karpman E, 2003, J UROLOGY, V169, P2206, DOI 10.1097/01.ju.0000064334.85656.a1; Hafner J, 1998, VASA-J VASCULAR DIS, V27, P137; FELDMAN HA, 1994, J UROLOGY, V151, P54; Ohta A, 2007, INTERNAL MED, V46, P985, DOI 10.2169/internalmedicine.46.6201; Akai A, 2013, J VASC SURG, V58, P1665, DOI 10.1016/j.jvs.2013.02.030; Giugliano F, 2010, INT J IMPOT RES, V22, P204, DOI 10.1038/ijir.2010.1; LEWIS DC, 1995, BRIT J UROL, V75, P412, DOI 10.1111/j.1464-410X.1995.tb07361.x; Barthelmes L., 2002, International Urology and Nephrology, V34, P231, DOI 10.1023/A:1023258127729	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	OCT	2015	29	7							1451.e11	10.1016/j.avsg.2015.04.068		5	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CR8UO	WOS:000361629800035		
J	Hiraoka, A; Chikazawa, G; Ishida, A; Miyake, K; Totsugawa, T; Tamura, K; Sakaguchi, T; Yoshitaka, H				Hiraoka, Arudo; Chikazawa, Genta; Ishida, Atsuhisa; Miyake, Koichi; Totsugawa, Toshinori; Tamura, Kentaro; Sakaguchi, Taichi; Yoshitaka, Hidenori			Impact of Age and Intraluminal Thrombus Volume on Abdominal Aortic Aneurysm Sac Enlargement after Endovascular Repair	ANNALS OF VASCULAR SURGERY			English	Article							OPEN SURGICAL REPAIR; II ENDOLEAK; OUTCOMES; ANTICOAGULATION; EMBOLIZATION; DURABILITY; MANAGEMENT; EXPANSION; WARFARIN; SURVIVAL	Background: Abdominal aneurysmal sac enlargement after endovascular aortic repair (EVAR) is a critical issue. However, the predictors have not yet been fully determined. Although unrecognized, intraluminal thrombus volume (ITV) is an important index. Therefore, we retrospectively evaluated the correlation among preoperative ITV, residual type II endoleak, and sac enlargement after EVAR, based on the long-term follow-up. Methods: Between 2006 and 2011, 151 consecutive patients underwent EVAR at a single cardiovascular institute. Emergency surgery was performed on 7 patients (4.7%). Of 148 patients excluding 3 patients with residual type I endoleak, sac enlargement (>= 5 mm progression) after EVAR was observed in 24 patients (16.2%) and 8 patients required reintervention. The mean follow-up period was 2.4 +/- 1.4 years. The outer volume and enhanced luminal volume were calculated from enhanced 1-mm slice computed tomography, and the difference was defined as ITV. Results: Age (hazard ratio [HR] 1.12, 95% confidence interval [CI] 1.04-1.20, P = 0.0007), outer volume (HR 1.04, 95% CI 1.01-1.07, P = 0.0118), percentage of ITV (HR 0.90, 95% CI 0.84-0.96, P =.0027), and type II endoleak (HR 10.15, 95% CI 3.55-31.10, P < 0.0001) were isolated as predictors of sac enlargement by multivariate analysis. Also, patent inferior mesenteric artery (odds ratio [OR] 4.45, 95% CI 1.38-20.07, P = 0.0105) and percentage of ITV < 30.1% (OR 3.52, 95% CI 1.32-10.30, P = 0.0112) were detected as independent risk factors for residual type II endoleaks. Additionally, in patients without endoleak, patient age (>= 83 years) was an independent risk factor for sac enlargement after EVAR (P = 0.0056). Conclusion: Age and ITV percentage had significantly great impact on sac enlargement and type II endoleak after EVAR.	[Hiraoka, Arudo; Chikazawa, Genta; Ishida, Atsuhisa; Miyake, Koichi; Totsugawa, Toshinori; Tamura, Kentaro; Sakaguchi, Taichi; Yoshitaka, Hidenori] Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Okayama 7000804, Japan	Hiraoka, A (reprint author), Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, 2-5-1 Nakaicho, Okayama 7000804, Japan.	bassbord1028@yahoo.co.jp					Al-Jubouri M, 2013, ANN SURG, V258, P652, DOI 10.1097/SLA.0000000000000157; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Parr A, 2011, J VASC SURG, V53, P28, DOI 10.1016/j.jvs.2010.08.013; Jackson RS, 2012, JAMA-J AM MED ASSOC, V307, P1621, DOI 10.1001/jama.2012.453; Lederle FA, 2012, NEW ENGL J MED, V367, P1988, DOI 10.1056/NEJMoa1207481; Johnson MS, 2013, J VASC SURG, V58, P319, DOI 10.1016/j.jvs.2012.12.082; Jonker FHW, 2009, SEMIN VASC SURG, V22, P165, DOI 10.1053/j.semvascsurg.2009.07.008; Murphy EH, 2013, J VASC SURG, V58, P1179, DOI 10.1016/j.jvs.2013.04.040; Mehta M, 2013, J VASC SURG, V57, P368, DOI 10.1016/j.jvs.2012.09.003; Aziz A, 2012, J VASC SURG, V55, P1263, DOI 10.1016/j.jvs.2011.10.131; Speelman L, 2010, J VASC SURG, V51, P19, DOI 10.1016/j.jvs.2009.08.075; Bobadilla JL, 2010, J VASC SURG, V52, P267, DOI 10.1016/j.jvs.2010.02.290; Keith CJ, 2013, J VASC SURG, V58, P1458, DOI 10.1016/j.jvs.2013.06.060; Sadek M, 2013, ANN VASC SURG, V27, P1036, DOI 10.1016/j.avsg.2013.04.006; Yeung JJ, 2009, J ENDOVASC THER, V16, P380, DOI 10.1583/09-2732.1; Schanzer A, 2011, CIRCULATION, V123, P2848, DOI 10.1161/CIRCULATIONAHA.110.014902; Gallagher KA, 2012, J ENDOVASC THER, V19, P182, DOI 10.1583/11-3653.1; Fillinger M, 2006, J VASC SURG, V43, P888, DOI 10.1016/j.jvs.2005.12.067; Cornelissen SAP, 2010, INVEST RADIOL, V45, P548, DOI 10.1097/RLI.0b013e3181e992ac; Abularrage CJ, 2010, J VASC SURG, V52, P19, DOI 10.1016/j.jvs.2010.02.023; Sarac TP, 2012, J VASC SURG, V55, P33, DOI 10.1016/j.jvs.2011.07.092; Falagas ME, 2007, J VASC INTERV RADIOL, V18, P697, DOI 10.1016/j.jvir.2007.04.015; Chikazawa Genta, 2014, Ann Vasc Dis, V7, P280, DOI 10.3400/avd.oa.14-00050; Lazarides MK, 2014, J ENDOVASC THER, V21, P148, DOI 10.1583/13-4462R.1; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Wild JB, 2014, ANN VASC SURG, V28, P554, DOI 10.1016/j.avsg.2013.03.013	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	OCT	2015	29	7					1440	1446		10.1016/j.avsg.2015.05.022		7	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CR8UO	WOS:000361629800016		
J	Kabilaphat, J; Khaorapapong, N; Saito, K; Ogawa, M				Kabilaphat, Jirabhorn; Khaorapapong, Nithima; Saito, Kanji; Ogawa, Makoto			Preparation of metal sulfide mixtures in montmorillonite by solid-solid reactions	APPLIED CLAY SCIENCE			English	Article						Manganese; Zinc; Cadmium; Sulfide; Montmorillonite; Solid-solid reaction	ZNS QUANTUM DOTS; STATE INTERCALATION; INTERLAYER SPACES; CDS NANOCRYSTALS; NANOPARTICLES; SMECTITES; NANOCOMPOSITES; COMPLEX; OXIDE; BLUE	Novel hybrids composed of mixed metal sulfides (manganese sulfide and zinc sulfide (MnS/ZnS) or cadmium sulfide (MnS/CdS), as well as zinc sulfide and cadmium sulfide (ZnS/CdS)) with montmorillonite were synthesized by solid-solid reactions between the ion exchanged montmorillonite and sodium sulfide. The products were characterized by powder X-ray diffraction, transmission electron microscopy, as well as Raman, UV-visible and photoluminescence spectroscopies. The Raman spectra indicated the presence of manganese sulfide, zinc sulfide, and/or cadmium sulfide in the products. The absorption onsets observed at 318-366 nm for MnS/ZnS@ montmorillonite, at 330-521 nm for MnS/CdS@montmorillonite, and at 360-480 nm for ZnS/CdS@montmorillonite indicated the formation of two metal sulfides in the interlayer spaces. In comparison with those of bulk MnS (340 nm), ZnS (360 nm) and CdS (525 nm), the absorption onsets owing to both metal sulfides were blue shifted probably due to quantum confinement effect, suggesting that the products are composed of nanometer sized sulfide particles. The photoluminescence bands owing to manganese sulfide (416 and 435 nm), zinc sulfide (413 and 440 nm), and cadmium sulfide (451 and 469 nm) were also seen. The emission intensity of MnS/ZnS@ montmorillonite was stronger than that of MnS/CdS@montmorillonite, probably due to the higher band gap energy of MnS/ZnS system that resulted in the increase of recombination of excitons. (C) 2015 Elsevier B.V. All rights reserved.	[Kabilaphat, Jirabhorn; Khaorapapong, Nithima] Fac Sci, Dept Chem, Mat Chem Res Ctr, Khon Kaen 40002, Thailand; [Kabilaphat, Jirabhorn; Khaorapapong, Nithima] Fac Sci, Ctr Excellence Innovat Chem, Khon Kaen 40002, Thailand; [Saito, Kanji] Waseda Univ, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan; [Saito, Kanji] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698050, Japan; [Ogawa, Makoto] Vidyasirimedhi Inst Sci & Technol, Sch Energy Sci & Engn, Dept Chem Engn & Biomol Engn, Rayong 21210, Thailand	Khaorapapong, N (reprint author), Fac Sci, Dept Chem, Mat Chem Res Ctr, Khon Kaen 40002, Thailand.	nithima@kku.ac.th			Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Advanced Functional Materials Cluster of Khon Kaen University; Center of Excellence for Innovation in Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of Education Thailand	The authors would like to thank the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Advanced Functional Materials Cluster of Khon Kaen University and the Center of Excellence for Innovation in Chemistry (PERCH-CIC), Commission on Higher Education, Ministry of Education Thailand for the financial support.	Ogawa M, 1997, B CHEM SOC JPN, V70, P2593, DOI 10.1246/bcsj.70.2593; Zheng JJ, 2009, J PHYS CHEM C, V113, P16969, DOI 10.1021/jp906390y; Khaorapapong N, 2008, J PHYS CHEM SOLIDS, V69, P941, DOI 10.1016/j.jpcs.2007.10.092; Labiadh H, 2013, MATER CHEM PHYS, V140, P674, DOI 10.1016/j.matchemphys.2013.04.023; Khaorapapong N, 2010, J PHYS CHEM SOLIDS, V71, P1644, DOI 10.1016/j.jpcs.2010.09.001; Yang RD, 2003, J VAC SCI TECHNOL B, V21, P984, DOI 10.1116/1.1568350; Hu H, 2006, OPT MATER, V28, P536, DOI 10.1016/j.optmat.2005.03.015; KOTOV NA, 1993, COLLOID SURFACE A, V71, P317, DOI 10.1016/0927-7757(93)80047-I; Viswanath R, 2014, SPECTROCHIM ACTA A, V125, P222, DOI 10.1016/j.saa.2014.01.022; Hsu YJ, 2005, ADV FUNCT MATER, V15, P1350, DOI 10.1002/adfm.200400563; Ge MY, 2011, COLLOID SURFACE A, V384, P574, DOI 10.1016/j.colsurfa.2011.05.014; Smith AM, 2010, ACCOUNTS CHEM RES, V43, P190, DOI 10.1021/ar9001069; Denzler D, 1998, J APPL PHYS, V84, P2841, DOI 10.1063/1.368425; Khaorapapong N, 2010, APPL CLAY SCI, V50, P19, DOI 10.1016/j.clay.2010.06.013; Liu XM, 2011, MATER CHEM PHYS, V130, P909, DOI 10.1016/j.matchemphys.2011.08.009; Soltani N, 2013, SOL ENERGY, V97, P147, DOI 10.1016/j.solener.2013.08.023; Rajeshwar K, 2001, CHEM MATER, V13, P2765, DOI 10.1021/cm010254z; Liu ZH, 2003, J COLLOID INTERF SCI, V265, P115, DOI 10.1016/S0021-9797(03)00407-7; Jia L, 2011, J PHYS CHEM C, V115, P11466, DOI 10.1021/jp2023617; Nascimento CC, 2012, J PHYS CHEM C, V116, P21992, DOI 10.1021/jp3019556; Miao SD, 2006, J COLLOID INTERF SCI, V301, P116, DOI 10.1016/j.jcis.2006.04.080; Okada T, 2014, J NANOSCI NANOTECHNO, V14, P2121, DOI 10.1166/jnn.2014.8597; Khaorapapong N, 2011, DALTON T, V40, P5964, DOI 10.1039/c0dt01736a; Szabo T, 2003, COLLOID SURFACE A, V230, P23, DOI 10.1016/j.colsurfa.2003.09.0; Khaorapapong N, 2001, APPL CLAY SCI, V19, P69, DOI 10.1016/S0169-1317(01)00055-2; Khaorapapong N, 2008, MATER LETT, V62, P3722, DOI 10.1016/j.matlet.2008.04.040; Hassan ML, 2008, J CRYST GROWTH, V310, P5252, DOI 10.1016/j.jcrysgro.2008.09.009; Stievano L, 2006, J PHYS CHEM SOLIDS, V67, P1363, DOI 10.1016/j.jpcs.2006.01.124; Cao HQ, 2006, INORG CHEM, V45, P5103, DOI 10.1021/ic060440c; Okada T, 2012, CHEM-ASIAN J, V7, P1980, DOI 10.1002/asia.201101015; OGAWA M, 1995, CHEM REV, V95, P399, DOI 10.1021/cr00034a005; Tedsana W, 2013, ANAL CHIM ACTA, V783, P65, DOI 10.1016/j.aca.2013.04.037; Yang F, 2012, J PHYS CHEM C, V116, P9078, DOI 10.1021/jp300939q; Khaorapapong N, 2007, APPL CLAY SCI, V35, P31, DOI 10.1016/j.clay.2006.08.003; Ontam A, 2012, J MATER CHEM, V22, P20001, DOI 10.1039/c2jm33327a; Khachatryan G, 2009, J ALLOY COMPD, V481, P402, DOI 10.1016/j.jallcom.2009.03.011; Pimchan P, 2011, APPL CLAY SCI, V54, P287, DOI 10.1016/j.clay.2011.09.002; Khumchoo N, 2015, APPL CLAY SCI, V105, P236, DOI 10.1016/j.clay.2015.01.001; Praus P, 2013, APPL SURF SCI, V275, P369, DOI 10.1016/j.apsusc.2012.11.155; Sharma G, 2014, J LUMIN, V145, P557, DOI 10.1016/j.jlumin.2013.08.021; Khaorapapong N, 2009, APPL CLAY SCI, V43, P238, DOI 10.1016/j.clay.2008.07.027; Raubach CW, 2012, CHEM PHYS LETT, V536, P96, DOI 10.1016/j.cplett.2012.03.090; Bailey G. W., 1973, CLAY CLAY MINER, V21, P51; Dekany I., 1999, APPL CLAY SCI, V15, P221; Dekany I., 1995, LANGMUIR, V11, P2285; Galbacs G., 1999, J COLLOID INTERF SCI, V213, P584; Kabilaphat J, 2015, EUR J INORG CHEM, P1631, DOI 10.1002/ejic.201403164; Khaorapapong N, 2015, APPL CLAY SCI, V104, P238, DOI 10.1016/j.clay.2014.11.038; Khaorapapong N., 2011, Clay Science, V15, P147; Kumbhakar P., 2011, APPL NANOSCI, V2, P15; Lagaly G, 2006, DEV CLAY SCI, V1, P309, DOI 10.1016/S1572-4352(05)01010-X; Liu D., 2013, ACTUAT B CHEM, V186, P235; Maity R., 2006, PHYSICA E, V33, P104; Ogawa M., 2004, HDB LAYERED MAT, P191; OGAWA M, 1991, INORG CHEM, V30, P584, DOI 10.1021/ic00003a050; OGAWA M, 1992, CLAY CLAY MINER, V40, P485, DOI 10.1346/CCMN.1992.0400501; Sun Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01749	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	OCT	2015	115						248	253		10.1016/j.clay.2015.07.028		6	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CR8BX	WOS:000361577200029		
J	Zhou, SH; Fang, LG; Liu, BC				Zhou, Suhua; Fang, Ligang; Liu, Baochen			Slope unit-based distribution analysis of landslides triggered by the April 20, 2013, Ms 7.0 Lushan earthquake	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Earthquake-induced landsides; Statistical analysis; Slope unit; Geographic Information System (GIS)	HAZARD ASSESSMENT; SEISMIC-WAVES; SUSCEPTIBILITY; GIS; EROSION; NORTHRIDGE; INCISION; RELIEF; AREAS; SCALE	On April 20, 2013, a series of earthquakes with a maximum Ms = 7.0 hit central Sichuan, China. Thousands of landslides were triggered. One thousand two hundred eighty-nine earthquake-induced landslides were visually interpreted on Geographic Information System (GIS). Study area was divided into 1745 slope units through watershed segmentation of the ridgeline and valley line. This study was to investigate correlations between landslide and geologic, geomorphologic, and earthquake factors using two indexes. Landslide-area ratio (LAR), defined as the percentage of the area affected by landslides, was only 0.58 %. However, landslide number percentage (LR), ratio of slope units with landslides on all slope units, was 33.97 %. Results showed that LAR and LR had a positive relationship with slope gradients. Landslides occurred not only on steep slopes but also over a large distribution of gentle slopes. Gradients of all 1745 slope units were normally distributed, and so was that of 438 slope units with landslide occurrence, which might indicate a threshold state of slope units due to long-term and intensive modern tectonization in this area. The seismogenic fault had an strong impact on the spatial distribution of landslides: LAR and LR had a strong positive correlation with distance from the main seismogenic fault and the peak ground acceleration (PGA); they were higher on hanging wall than on footwall; landslide occurrences were concentrated slope units facing towards east, southeast, and south, coinciding with the trend of the seismogenic fault. Besides, slope composed of Triassic and Cretaceous were more susceptible to landslides.	[Zhou, Suhua; Fang, Ligang; Liu, Baochen] Cent S Univ, Dept Civil Engn, Changsha 410075, Hunan, Peoples R China; [Zhou, Suhua] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 8190395, Japan	Fang, LG (reprint author), Cent S Univ, Dept Civil Engn, Changsha 410075, Hunan, Peoples R China.	suhua_zhou@hotmail.com; fangligang_csu@163.com; liubaochen_csu@163.com			State Key Development Program of Basic Research of China [2011CB710601]	This research was supported by the State Key Development Program of Basic Research of China (Grant 2011CB710601). The data used in this paper is provided by the Department of Geotechnical Engineering, Central South University, China. We wish to express our sincere appreciation for the generous support.	Alfaro P, 2011, ENG GEOL, V137-138, P40; Xu C, 2013, LANDSLIDES, V10, P421, DOI 10.1007/s10346-012-0340-x; Erener A, 2012, ENVIRON EARTH SCI, V66, P859, DOI 10.1007/s12665-011-1297-0; Parise M, 2000, ENG GEOL, V58, P251, DOI 10.1016/S0013-7952(00)00038-7; Wang HB, 2007, NAT HAZARDS, V41, P43, DOI 10.1007/s11069-006-9009-x; Xie MW, 2003, J GEOTECH GEOENVIRON, V129, P1109, DOI 10.1061/(ASCE)1090-0241(2003)129:12(1109); Rodriguez CE, 1999, SOIL DYN EARTHQ ENG, V18, P325, DOI 10.1016/S0267-7261(99)00012-3; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Khazai B, 2004, ENG GEOL, V71, P79, DOI 10.1016/S0013-7952(03)00127-3; Guzzetti F, 2005, GEOMORPHOLOGY, V72, P272, DOI 10.1016/j.geomorph.2005.06.002; Malamud BD, 2004, EARTH PLANET SC LETT, V229, P45, DOI 10.1016/j.epsl.2004.10.018; Guzzetti F, 2002, EARTH PLANET SC LETT, V195, P169, DOI 10.1016/S0012-821X(01)00589-1; Lenti L, 2013, B SEISMOL SOC AM, V103, P33, DOI 10.1785/0120120019; Egholm DL, 2013, NATURE, V498, P475, DOI 10.1038/nature12218; Ghosh S, 2012, ENG GEOL, V128, P49, DOI 10.1016/j.enggeo.2011.03.016; Lee CT, 2008, ENG GEOL, V100, P43, DOI 10.1016/j.enggeo.2008.03.004; Calvello M, 2013, GEOMORPHOLOGY, V182, P33, DOI 10.1016/j.geomorph.2012.10.026; Tucker GE, 1998, WATER RESOUR RES, V34, P2751, DOI 10.1029/98WR01474; TIBALDI A, 1995, GEOMORPHOLOGY, V11, P215, DOI 10.1016/0169-555X(94)00060-5; Chen YW, 2013, MEDIA CULT SOC, V35, P234, DOI 10.1177/0163443712468776; Lu SN, 2013, EARTHQ ENG ENG VIB, V12, P1, DOI 10.1007/s11803-012-0146-9; Gorum T, 2013, GEOMORPHOLOGY, V184, P127, DOI 10.1016/j.geomorph.2012.11.027; Chigira M, 2010, GEOMORPHOLOGY, V118, P225, DOI 10.1016/j.geomorph.2010.01.003; Dai FC, 2011, J ASIAN EARTH SCI, V40, P883, DOI 10.1016/j.jseaes.2010.04.010; Keefer DK, 2002, SURV GEOPHYS, V23, P473, DOI 10.1023/A:1021274710840; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Guthrie RH, 2008, LANDSLIDES, V5, P151, DOI 10.1007/s10346-007-0104-1; Lenti L, 2012, ENG GEOL, V126, P19, DOI 10.1016/j.enggeo.2011.12.002; Delgado J, 2011, ENG GEOL, V123, P204, DOI 10.1016/j.enggeo.2011.08.002; Malamud BD, 2004, EARTH SURF PROC LAND, V29, P687, DOI [10.1002/esp.1064, 10.1002/esq.1064]; Kamp U, 2008, GEOMORPHOLOGY, V101, P631, DOI 10.1016/j.geomorph.2008.03.003; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Meunier P, 2008, EARTH PLANET SC LETT, V275, P221, DOI 10.1016/j.epsl.2008.07.020; Korup O, 2010, GEOMORPHOLOGY, V120, P77, DOI 10.1016/j.geomorph.2009.09.017; Sharma LP, 2012, ARAB J GEOSCI, V5, P421, DOI 10.1007/s12517-010-0205-3; Roering J, 2012, NAT GEOSCI, V5, P446, DOI 10.1038/ngeo1511; Dai FC, 2002, GEOMORPHOLOGY, V42, P213, DOI 10.1016/S0169-555X(01)00087-3; ten Brink US, 2009, EARTH PLANET SC LETT, V287, P31, DOI 10.1016/j.epsl.2009.07.031; Xu C, 2012, ENVIRON EARTH SCI, V66, P1603, DOI 10.1007/s12665-012-1624-0; Martino S, 2014, NAT HAZARD EARTH SYS, V14, P799, DOI 10.5194/nhess-14-799-2014; BeguerIa S, 2002, LANDSLIDE HAZARD MAP; CARRARA A, 1995, ADV NAT TECHNOL HAZ, V5, P135; Chen X, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.5194/NHESSD-1-3891-2013; Chien-Yuan C, 2007, EARTH SURF PROCESSES, V32, P197, DOI 10.1002/esp.1400; Donnarumma A, 2013, LANDSLIDE SCI PRACTI, P425; Evangelista D, 2006, NAT HAZARDS EARTH SY, V6; Hansen A, 1984, LANDSLIDE HAZARD ANA, P523; Hasi B, 2010, CONTROLS DISTRIBUTIO, P3827; KEEFER DK, 1984, GEOL SOC AM BULL, V95, P406; Liang MJ, 2013, SEISMOL GEOL, V35, P641; Maidment D. R., 2002, ARC HYDRO; Dietrich WE, 1998, SCALE DEPENDENCE AND SCALE INVARIANCE IN HYDROLOGY, P30, DOI 10.1017/CBO9780511551864.003; Mowen X, 2003, CHIN J ROCK MECH ENG, V6, P017; Peng WF, 2009, COMPUT GEOSCI-UK, V35, P946, DOI 10.1016/j.cageo.2008.09.007; Rose A.Z., 2007, ENV HAZARDS, V7, P383, DOI DOI 10.1016/J.ENVHAZ.2007.10.001; SCHMIDT KM, 1995, SCIENCE, V270, P617, DOI 10.1126/science.270.5236.617; Survey USG, 2013, USGS PEAK ACCEL MAP; Tian Y, 2010, SLOPE UNIT BASED LAN, P1; Xu C, 2010, CHIN J ROCK MECH ENG, V29, P2972; Xu Chong, 2012, Science & Technology Review, V30, DOI [10.3981/j.issn.1000-7857.2012.25.001, 10.3981/j.issn.1000-7857.2012.01.002]	60	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	OCT	2015	8	10					7855	7868		10.1007/s12517-015-1835-2		14	Geosciences, Multidisciplinary	Geology	CS1ML	WOS:000361829800011		
J	Takla, EM; Odah, H; Abd Elaal, EM; Yoshikawa, A; Kawano, H; Uozumi, T				Takla, E. M.; Odah, H.; Abd Elaal, E. M.; Yoshikawa, A.; Kawano, H.; Uozumi, T.			The 2011 eruption of Aso volcano, Japan, and its signature on the geomagnetic field measurements	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Geomagnetic variations; Volcanic activity; ULF emissions; Aso volcano	EARTHQUAKES	High-resolution (1-s) geomagnetic data from the MAGDAS Network, Kyushu University, Japan, were examined to detect any local anomalous geomagnetic behavior that is possibly linked with the eruption of the Aso volcano, Kyushu Island, Japan, during 2011. Geomagnetic data recorded in the vicinity of the Aso volcano at the Kuju (KUJ) station, Japan, were analyzed and compared with those recorded at the Darwin (DAW) station in Australia, near the conjugate point of the KUJ station. The KUJ station is located about 20 km northeast of the Aso volcano. The amplitude range of daily variations was calculated and examined for the three geomagnetic components (H-, D-, and Z-components) along with the amplitude of ultra-low-frequency emissions in the Pc3-4 ranges (Pc3; 10-45 s and Pc4; 45-150 s). Data possessing and analysis reveal some local anomalous geomagnetic variations at the KUJ station during the 2011 volcanic activities of the Aso volcano. On the other hand, no anomalous changes were observed at the DAW station during that time. Therefore, the observed anomalous geomagnetic variations are considered to be of a local volcanic origin.	[Takla, E. M.; Odah, H.; Abd Elaal, E. M.] NRIAG, Cairo 11421, Egypt; [Yoshikawa, A.; Kawano, H.] Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 812, Japan; [Yoshikawa, A.; Kawano, H.; Uozumi, T.] Kyushu Univ, Int Ctr Space Weather Sci & Educ, Fukuoka 812, Japan	Takla, EM (reprint author), NRIAG, Cairo 11421, Egypt.	emad_nriag@yahoo.com			Ministry of Education, Science and Culture of Japan Society for the Promotion of Science (JSPS) [15253005, 18253005, 22253007]; JSPS	The authors would like to thank the MAGDAS group for their tireless support to the MAGDAS Project. The MAGDAS Project was financially supported by the Ministry of Education, Science and Culture of Japan Society for the Promotion of Science (JSPS) as Grant-in-Aid for Overseas Scientific Survey (15253005, 18253005, and 22253007). JSPS Core-to-Core Program, B. Asia-Africa Science Platforms, also supported this work.	JOHNSTON MJ, 1969, J GEOPHYS RES, V74, P6541, DOI 10.1029/JB074i027p06541; Yumoto K, 2007, B ASTRON SOC INDIA, V35, P511; Uyeda S, 2002, P NATL ACAD SCI USA, V99, P7352, DOI 10.1073/pnas.072208499; GOUGH DI, 1973, GEOPHYS J ROY ASTR S, V35, P83; QUIST AS, 1968, J PHYS CHEM-US, V72, P684, DOI 10.1021/j100848a050; YUKUTAKE T, 1990, J GEOMAGN GEOELECTR, V42, P277; TANAKA Y, 1993, J VOLCANOL GEOTH RES, V56, P319, DOI 10.1016/0377-0273(93)90024-L; Uozumi T, 2008, EARTH PLANETS SPACE, V60, P785; Ismaguilov VS, 2001, NAT HAZARD EARTH SYS, V1, P23; Sasai Y, 2002, EARTH PLANET SC LETT, V203, P769, DOI 10.1016/S0012-821X(02)00857-9; Kopytenko YA, 2004, ANN GEOPHYS-ITALY, V47, P101; Yumoto K, 1996, J GEOMAGN GEOELECTR, V48, P1297; [Anonymous], 2011, B GLOBAL VOLCANISM N; STACEY FD, 1965, PURE APPL GEOPHYS, V62, P96, DOI 10.1007/BF00875290; ROSSIGNOL JC, 1982, GEOPHYS SURV, V4, P435, DOI 10.1007/BF01449110; Del Negro C, 2000, GEOPHYS J INT, V140, P83, DOI 10.1046/j.1365-246x.2000.00987.x; Hattori K, 2004, TERR ATMOS OCEAN SCI, V15, P329; Johnston MJS, 1997, SURV GEOPHYS, V18, P441, DOI 10.1023/A:1006500408086; Kotsarenko A, 2008, ADV GEOSCI, V14, P21; Okubo A, 2006, ANN DISASTER PREV RE, V49 C, P211; Takla E. M., 2011, International Journal of Geophysics, DOI 10.1155/2011/848467; Takla EM, 2014, NRIAG J ASTRON GEOPH, DOI [10.1016/j.nrjag.2014.09.001, DOI 10.1016/J.NRJAG.2014.09.001]; Takla EM, 2012, TECTONOPHYSICS, V524, P29, DOI 10.1016/j.tecto.2011.12.008; Yumoto K, 2006, MAGDAS PROJECT ITS A, P399	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	OCT	2015	8	10					8497	8503		10.1007/s12517-015-1858-8		7	Geosciences, Multidisciplinary	Geology	CS1ML	WOS:000361829800058		
J	Hua, YL; Ekkhara, W; Sansenya, S; Srisomsap, C; Roytrakul, S; Saburi, W; Takeda, R; Matsuura, H; Mori, H; Cairns, JRK				Hua, Yanling; Ekkhara, Watsamon; Sansenya, Sompong; Srisomsap, Chantragan; Roytrakul, Sittiruk; Saburi, Wataru; Takeda, Ryosuke; Matsuura, Hideyuki; Mori, Haruhide; Cairns, James R. Ketudat			Identification of rice Os4BGlu13 as a beta-glucosidase which hydrolyzes gibberellin A4 1-O-beta-D-glucosyl ester, in addition to tuberonic acid glucoside and salicylic acid derivative glucosides	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						beta-glucosidase; Rice; Gibberellin glucosyl ester; Recombinant expression; Phytohormone conjugates	ORYZA-SATIVA L.; D-GLUCOPYRANOSIDE; EXPRESSION; METABOLISM	Gibberellin 1-O-beta-D-glucose ester hydrolysis activity has been detected in rice seedling extracts, but no enzyme responsible for this activity has ever been purified and identified. Therefore, gibberellin A4 glucosyl ester (GA(4)-GE) beta-D-glucosidase activity was purified from ten-day rice seedling stems and leaves. The family 1 glycoside hydrolase Os4BGlu13 was identified in the final purification fraction. The Os4BGlu13 cDNA was amplified from rice seedlings and expressed as an N-terminal thioredoxin-tagged fusion protein in Escherichia coll. The purified recombinant Os4BGlu13 protein (rOs4BGlu13) had an optimum pH of 4.5, for hydrolysis of p-nitrophenyl beta-D-glucopyranoside (pNPGlc), which was the best substrate identified, with a k(cat)/K-m of 637 mM(-1) s(-1). rOs4BGlu13 hydrolyzed helicin best among natural glycosides tested (K-cat/K-m, of 74.4 mM(-1) s(-1)). Os4BGlu13 was previously designated tuberonic acid glucoside (TAG) beta-glucosidase (TAGG), and here the k(cat)/K-m of rOsBGlu13 for TAG was 6.68 mM(-1) s(-1), while that for GA4-GE was 3.63 mM(-1) s(-1) and for salicylic acid glucoside (SAG) is 0.88 mM(-1) s(-1). rOs4BGlu13 also hydrolyzed oligosaccharides, with preference for short beta-(1 -> 3)-linked over beta-(1 -> 4)linked glucooligosaccharides. The enzymatic data suggests that Os4BGlu13 may contribute to TAG, SAG, oligosaccharide and GA4-GE hydrolysis in the rice plant, although helicin or a similar compound may be its primary target. (C) 2015 Elsevier Inc. All rights reserved.	[Hua, Yanling] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima 30000, Thailand; [Hua, Yanling; Ekkhara, Watsamon; Cairns, James R. Ketudat] Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Nakhon Ratchasima 30000, Thailand; [Ekkhara, Watsamon; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Sansenya, Sompong] Rajamangala Univ Technol, Dept Chem, Fac Sci, Thanyaburi 12110, Pathun Thani, Thailand; [Srisomsap, Chantragan; Cairns, James R. Ketudat] Chulabhorn Res Inst, Bangkok 10210, Thailand; [Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand; [Saburi, Wataru; Takeda, Ryosuke; Matsuura, Hideyuki; Mori, Haruhide] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Cairns, JRK (reprint author), Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand.	cairns@sut.ac.th		Ketudat Cairns, James/0000-0003-3042-1626	Suranaree University of Technology [SUT1-102-55-36-01]; National Research University Project of the Commission on Higher Education of Thailand; Thailand Research Fund [BRG5680012]	We thank Ms. Chiraporn Saetang for assistance with protein purification and Ms. Daranee Chokchaichamnankit from the Chulabhorn Research Institute (CRI) and Ms. Atchara Paemanee from the National Center for Genetic Engineering and Biotechnology (BIOTEC) for their help on peptide analysis by LC-MS. This work was supported by Suranaree University of Technology (SUT1-102-55-36-01), the National Research University Project of the Commission on Higher Education of Thailand and the Thailand Research Fund (Grant BRG5680012).	Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Reuveni M, 1999, PLANT SCI, V147, P19, DOI 10.1016/S0168-9452(99)00097-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; GRYNKIEWICZ G, 1993, POL J CHEM, V67, P1251; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004; SCHNEIDER G, 1992, P NATL ACAD SCI USA, V89, P8045, DOI 10.1073/pnas.89.17.8045; Matsuura H, 2000, BIOSCI BIOTECH BIOCH, V64, P2380, DOI 10.1271/bbb.64.2380; HIRAGA K, 1974, PHYTOCHEMISTRY, V13, P2371; Hua YL, 2013, ARCH BIOCHEM BIOPHYS, V537, P39, DOI 10.1016/j.abb.2013.06.005; Caboni P, 2013, J AGR FOOD CHEM, V61, P1794, DOI 10.1021/jf305164m; SCHLIEMANN W, 1984, J PLANT PHYSIOL, V116, P123, DOI 10.1016/S0176-1617(84)80069-3; Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025; Sansenya S, 2011, ARCH BIOCHEM BIOPHYS, V510, P62, DOI 10.1016/j.abb.2011.04.005; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Kai K, 2007, PHYTOCHEMISTRY, V68, P2512, DOI 10.1016/j.phytochem.2007.05.040; Barleben L, 2005, BBA-PROTEINS PROTEOM, V1747, P89, DOI 10.1016/j.bbapap.2004.09.026; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Duroux L, 1998, BIOCHEM J, V333, P275; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Davies P. J., 1995, PLANT HORMONES PHYSL; FOWLER T, 1993, ACS SYM SER, V533, P56; Gupta R., 2005, NETNGLYC PREDICTION; Koshioka M., 13 INT C PLANT GROWT, P217; Mauseth J. D., 1991, BOT INTRO PLANT BIOL, P348; Opassiri R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-33; Raven P. H., 1992, BIOL PLANTS, P545; Roepke J, 2015, PHYTOCHEMISTRY, V109, P14, DOI 10.1016/j.phytochem.2014.10.028; Rouyi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096712; Salisbury F. B., 1992, PLANT PHYSIOL, p[357, 531]; Schneider G., 1983, BIOCH PHYSL GIBBEREL, V1, P389; Sponsel V. M., 2004, PLANT HORMONES BIOSY, P62; Wakuta S., 2011, J APPL GLYCOSCI, V58, P67	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	OCT 1	2015	583						36	46		10.1016/j.abb.2015.07.021		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CR9AA	WOS:000361644400005		
J	Homma, T; Kurahashi, T; Lee, J; Kang, ES; Fujii, J				Homma, Takujiro; Kurahashi, Toshihiro; Lee, Jaeyong; Kang, Eun Sil; Fujii, Junichi			SOD1 deficiency decreases proteasomal function, leading to the accumulation of ubiquitinated proteins in erythrocytes	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						SOD1; Oxidative stress; Proteasome; Anemia; Protein degradation	20 S PROTEASOME; OXIDATIVE-STRESS; 26S PROTEASOME; ALZHEIMERS-DISEASE; OXIDIZED PROTEINS; HEMOLYTIC-ANEMIA; MICE; LIVER; AGE; PHENYLHYDRAZINE	We previously demonstrated that elevated levels of ROS in red blood cells (RBCs) are responsible for anemia in SOD1-deficient mice, suggesting that the oxidative stress-induced massive destruction of RBCs is an underlying mechanism for autoimmune hemolytic anemia. In the current study, we examined the issue of how elevated ROS are involved in the destruction of RBCs and the onset of anemia from the view point of the proteolytic removal of oxidatively-damaged proteins. We found that poly-ubiquitinated proteins had accumulated and had undergone aggregation in RBCs from SOD1-deficient mice and from phenylhydrazine-induced anemic mice. Although the protein levels of the three catalytic components of the proteasome, beta(1), beta(2), and beta(5), were not significantly altered, their proteolytic activities were decreased in the SOD1-deficient RBCs. These data suggest that oxidative-stress triggers the dysfunction of the proteasomal system, which results in the accumulation of the aggregation of poly-ubiquitinated proteins. We conclude that an oxidative stress-induced malfunction in the scavenging activity of proteasomes accelerates the accumulation of damaged proteins, leading to a shortened lifespan of RBCs and, hence, anemia. (C) 2015 Elsevier Inc. All rights reserved.	[Homma, Takujiro; Kurahashi, Toshihiro; Lee, Jaeyong; Kang, Eun Sil; Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Yamagata 9909585, Japan	Fujii, J (reprint author), Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	jfujii@med.id.yamagata-u.ac.jp			Otsuka Toshimi Scholarship Foundation; Tokyo Biochemical Research Foundation; Japan Society for the Promotion of Science [S2402]	J.L. is a scholarship recipient from the Otsuka Toshimi Scholarship Foundation. E.S.K. is supported by the Tokyo Biochemical Research Foundation Postdoctoral Fellowship for Asian Researchers in Japan. This work was supported by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science (S2402).	Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; DICOLA D, 1989, FREE RADICAL RES COM, V6, P379; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; SHETLAR MD, 1985, ENVIRON HEALTH PERSP, V64, P265, DOI 10.2307/3430016; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Reinheckel T, 1998, BIOCHEM J, V335, P637; Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6; Neslund-Dudas C, 2012, BIOL TRACE ELEM RES, V149, P5, DOI 10.1007/s12011-012-9391-z; Majetschak M, 2008, J IMMUNOL METHODS, V334, P91, DOI 10.1016/j.jim.2008.02.004; Konno T, 2013, FREE RADICAL BIO MED, V65, P1378, DOI 10.1016/j.freeradbiomed.2013.09.021; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Takabe W, 2006, FREE RADICAL RES, V40, P21, DOI 10.1080/10715760500354430; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; GOLDBERG B, 1976, J BIOL CHEM, V251, P3045; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Cecarini V, 2007, FREE RADICAL RES, V41, P673, DOI 10.1080/10715760701286159; Hohn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176; Goldberg B., 1975, J BIOL CHEM, P2401; Luchi Y, 2010, FREE RADIC BIOL MED, V48, P935; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137; Vilchez D., 2014, NAT COMMUN, V5, P1	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	OCT 1	2015	583						65	72		10.1016/j.abb.2015.07.023		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CR9AA	WOS:000361644400008		
J	Kim, M; Cho, HJ; Jeong, YJ; Chung, IK; Magae, J; Chang, YC				Kim, Mihyun; Cho, Hyun-Ji; Jeong, Yun-Jeong; Chung, Il-Kyung; Magae, Junji; Chang, Young-Chae			4-O-methylascochlorin suppresses differentiation of 3T3-L1 preadipocytes by inhibiting PPAR gamma expression through regulation of AMPK/mTOR signaling pathways	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Adipocyte; Differentiation; PPAR gamma; AMPK; mTOR	ACTIVATED-RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; PROTEIN-KINASE; CARCINOMA CELLS; ADIPOGENIC DIFFERENTIATION; CLONAL EXPANSION; MAMMALIAN TARGET; AMPK ACTIVATION	Obesity increases the risk of developing many chronic diseases, including type 2 diabetes and certain cancers, and is thereby associated with premature death. The present study was conducted to identify the inhibitory effect of the ascochlorin derivative 4-O-methylascochlorin (MAC) on the differentiation of 3T3-L1 preadipocytes. MAC suppressed the differentiation of 3T3-L1 preadipocytes and inhibited the expression of adipocyte differentiation marker genes, FABP4, PPAR gamma and C/EBP alpha. In addition, we found that the inhibitory effects of MAC on differentiation of 3T3-L1 preadipocytes were caused by suppression of mTORC1 via inhibition of mTOR/p7056K/4E-BP1 phosphorylation and activation of Raptor phosphorylation. MAC also regulated the PPAR gamma expression and the mTORC1 activation by increasing AMPK phosphorylation and inhibiting PI3K/Akt, which suggest that MAC suppresses the differentiation of 3T3-L1 adipocytes by regulating the AMPK- and PI3K-mTOR-PPAR gamma signaling pathways. Furthermore, animal model results showed that the phosphorylation of AMPK was enhanced in the liver of C57BL/6 mice intraperitoneally injected with MAC. These results indicate that MAC could be a therapeutic agent for obesity involving PPAR gamma and AMPK. (C) 2015 Elsevier Inc. All rights reserved.	[Kim, Mihyun] Inje Univ, Dept Phys Therapy, Gimhae 621749, South Korea; [Cho, Hyun-Ji; Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu 705718, South Korea; [Cho, Hyun-Ji; Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu 705718, South Korea; [Chung, Il-Kyung] Catholic Univ Daegu, Dept Biotechnol, Gyongsan 712702, South Korea; [Magae, Junji] Magae Biosci Inst, Tsukuba, Ibaraki 3001263, Japan	Chang, YC (reprint author), Catholic Univ Daegu, Dept Cell Biol, Sch Med, 3056-6,Daemyung 4 Dong, Daegu 705718, South Korea.	ycchang@cu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A1A11050776]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2014R1A2A1A11050776).	Lee YK, 2010, CARCINOGENESIS, V31, P1092, DOI 10.1093/carcin/bgq040; Kola B, 2008, FRONT HORM RES, V36, P198, DOI 10.1159/0000115366; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Tsuruga M, 2007, J ANTIBIOT, V60, P20; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217; Jeong JH, 2012, J CELL BIOCHEM, V113, P1302, DOI 10.1002/jcb.24001; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Kang JH, 2007, J CELL BIOCHEM, V102, P506, DOI 10.1002/jcb.21312; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kang JH, 2012, J BIOL CHEM, V287, P15661, DOI 10.1074/jbc.M112.358473; Togashi M, 2003, J MED CHEM, V46, P4113, DOI 10.1021/jm0205649; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Blanchard PG, 2012, J LIPID RES, V53, P1117, DOI 10.1194/jlr.M021485; Tsuruga M, 2004, APOPTOSIS, V9, P429, DOI 10.1023/B:APPT.0000031456.09297.8f; Lee YH, 2013, CELL MOL LIFE SCI, V70, P3959, DOI 10.1007/s00018-013-1363-8; Arai K, 2004, METABOLISM, V53, P28, DOI 10.1016/j.metabol.2003.08.007; Pung YF, 2013, ARTERIOSCL THROM VAS, V33, P1911, DOI 10.1161/ATVBAHA.113.301591; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Togashi M, 2002, J ANTIBIOT, V55, P417; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x; Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716; Jeong JH, 2011, BIOCHEM BIOPH RES CO, V406, P353, DOI 10.1016/j.bbrc.2011.02.043; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Gregoire FM, 1998, PHYSIOL REV, V78, P783; Dudley GB, 2000, ORG LETT, V2, P3407, DOI 10.1021/ol006561c; Jeong JH, 2010, BIOCHEM BIOPH RES CO, V398, P68, DOI 10.1016/j.bbrc.2010.06.037; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Walczak R, 2002, J LIPID RES, V43, P177; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; HOSOKAWA T, 1981, EUR J PHARMACOL, V69, P429, DOI 10.1016/0014-2999(81)90446-5; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Tao Rong, 2010, J Mol Signal, V5, P1, DOI 10.1186/1750-2187-5-1; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	OCT 1	2015	583						79	86		10.1016/j.abb.2015.07.007		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CR9AA	WOS:000361644400010		
J	Sumi, D; Tsurumoto, M; Yoshino, Y; Inoue, M; Yokobori, T; Kuwano, H; Himeno, S				Sumi, Daigo; Tsurumoto, Miyu; Yoshino, Yuri; Inoue, Masahisa; Yokobori, Takehiko; Kuwano, Hiroyuki; Himeno, Seiichiro			High accumulation of arsenic in the esophagus of mice after exposure to arsenite	ARCHIVES OF TOXICOLOGY			English	Article						Aquaglyceroporin; Arsenic; Esophagus; Glutathione; Multidrug-resistance protein; Nrf2	MULTIDRUG-RESISTANCE PROTEIN-1; KIDNEY COLLECTING DUCT; TRANSCRIPTION FACTOR; GLUTATHIONE CONJUGATE; EXPRESSION; NRF2; BIOTRANSFORMATION; METHYLTRANSFERASE; TRANSPORT; GLYCEROL	Arsenic-induced toxicity appears to be dependent on the tissue- or cell-specific accumulation of this metalloid. An early study showed that arsenic was retained in the esophagus as well as the liver, kidney cortex and skin of marmosets after intraperitoneal administration of As-74-arsenite. However, there is little available information regarding the distribution of arsenic in the esophagus. Here, we compared the retention of arsenic in the esophagus, liver, lung, kidney and heart in mice intraperitoneally administered 1 or 5 mg/kg sodium arsenite (As(III)) daily for 3 or 7 days. The results showed that the arsenic concentration was highest in the esophagus. We compared the mRNA levels of aquaglyceroporin (AQP) 3, AQP7 and AQP9, which are responsible for arsenic influx, and those of multidrug-resistance protein (MRP) 1 and MRP2, which are responsible for arsenic efflux. The levels of AQP3 mRNA in the esophagus were much higher than those in liver, lung and heart, while the mRNA levels of MRP2 were very low in the esophagus. In addition, we found extremely low expression of Nrf2 in the esophagus at the basal and under the activated conditions, which might have resulted in low levels of glutamyl-cysteine ligase catalytic and modulatory subunits, and subsequently in the low levels of glutathione. Thus, the highest retention of arsenic was detected in the esophagus after intraperitoneal administration of As(III) to mice, and this appeared to result from multiple factors, including high expression of AQP3, low expression of MRP2, low capacity of glutathione synthesis and low activation of Nrf2.	[Sumi, Daigo; Tsurumoto, Miyu; Yoshino, Yuri; Himeno, Seiichiro] Tokushima Bunri Univ, Lab Mol Nutr & Toxicol, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan; [Inoue, Masahisa] Tokushima Bunri Univ, Lab Funct Morphol, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan; [Yokobori, Takehiko; Kuwano, Hiroyuki] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Maebashi, Gumma 3718511, Japan	Himeno, S (reprint author), Tokushima Bunri Univ, Lab Mol Nutr & Toxicol, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan.	himenos@ph.bunri-u.ac.jp					ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Kimura A, 2005, TOXICOL APPL PHARM, V203, P53, DOI 10.1016/j.taap.2004.07.013; Liu ZJ, 2004, BIOCHEM BIOPH RES CO, V316, P1178, DOI 10.1016/j.bbrc.2004.03.003; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kadono T, 2002, INT J DERMATOL, V41, P841, DOI 10.1046/j.1365-4362.2002.01668.x; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Kala SV, 2000, J BIOL CHEM, V275, P33404, DOI 10.1074/jbc.M007030200; STEVENS JT, 1977, ENVIRON HEALTH PERSP, V19, P151; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161; Waalkes MP, 2000, TOXICOL SCI, V56, P255, DOI 10.1093/toxsci/56.2.255; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Lorico A, 2002, BIOCHEM BIOPH RES CO, V291, P617, DOI 10.1006/bbrc.2002.6489; BERTOLERO F, 1981, TOXICOLOGY, V20, P35, DOI 10.1016/0300-483X(81)90103-7; Healy SM, 1999, BIOL TRACE ELEM RES, V68, P249, DOI 10.1007/BF02783907; McMahon M, 2001, CANCER RES, V61, P3299; MA TH, 1994, J BIOL CHEM, V269, P21845; [Anonymous], BIOL CHEM, V281, P18401; CRECELIUS EA, 1977, ENVIRON HEALTH PERSP, V19, P147, DOI 10.2307/3428467; Lee TC, 2006, J BIOL CHEM, V281, P18401, DOI 10.1074/jbc.M601266200; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Koyama Y, 1999, AM J PHYSIOL-CELL PH, V276, pC621; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Leslie EM, 2012, J INORG BIOCHEM, V108, P141, DOI 10.1016/j.jinorgbio.2011.11.009; VAHTER M, 1982, ARCH TOXICOL, V51, P65, DOI 10.1007/BF00279322; CHEN CJ, 1995, HYPERTENSION, V25, P53; IARC monographs on the evaluation of carcinogenic risks to humans, 2012, ARS MET FIBR DUSTS C, V100C, P41; McWalter GK, 2004, J NUTR, V134, p3499S	36	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	OCT	2015	89	10					1751	1758		10.1007/s00204-014-1326-3		8	Toxicology	Toxicology	CR7NC	WOS:000361536100006		
J	Nagai, M; Omatsu, T; Aoki, H; Otomaru, K; Uto, T; Koizumi, M; Minami-Fukuda, F; Takai, H; Murakami, T; Masuda, T; Yamasato, H; Shiokawa, M; Tsuchiaka, S; Naoi, Y; Sano, K; Okazaki, S; Katayama, Y; Oba, M; Furuya, T; Shirai, J; Mizutani, T				Nagai, Makoto; Omatsu, Tsutomu; Aoki, Hiroshi; Otomaru, Konosuke; Uto, Takehiko; Koizumi, Motoya; Minami-Fukuda, Fujiko; Takai, Hikaru; Murakami, Toshiaki; Masuda, Tsuneyuki; Yamasato, Hiroshi; Shiokawa, Mai; Tsuchiaka, Shinobu; Naoi, Yuki; Sano, Kaori; Okazaki, Sachiko; Katayama, Yukie; Oba, Mami; Furuya, Tetsuya; Shirai, Junsuke; Mizutani, Tetsuya			Full genome analysis of bovine astrovirus from fecal samples of cattle in Japan: identification of possible interspecies transmission of bovine astrovirus	ARCHIVES OF VIROLOGY			English	Article							PHYLOGENETIC ANALYSIS; PIGS; DISEASE	A viral metagenomics approach was used to investigate fecal samples of Japanese calves with and without diarrhea. Of the different viral pathogens detected, read counts gave nearly complete astrovirus-related RNA sequences in 15 of the 146 fecal samples collected in three distinct areas (Hokkaido, Ishikawa, and Kagoshima Prefectures) between 2009 and 2015. Due to the lack of genetic information about bovine astroviruses (BoAstVs) in Japan, these sequences were analyzed in this study. Nine of the 15 Japanese BoAstVs were closely related to Chinese BoAstVs and clustered into a lineage (tentatively named lineage 1) in all phylogenetic trees. Three of 15 strains were phylogenetically separate from lineage 1, showing low sequence identities, and clustered instead with an American strain isolated from cattle with respiratory disease (tentatively named lineage 2). Interestingly, two of 15 strains clustered with lineage 1 in the open reading frame (ORF)1a and ORF1b regions, while they clustered with lineage 2 in the ORF2 region. Remarkably, one of 15 strains exhibited low amino acid sequence similarity to other BoAstVs and was clustered separately with porcine astrovirus type 5 in all trees, and ovine astrovirus in the ORF2 region, suggesting past interspecies transmission.	[Nagai, Makoto; Omatsu, Tsutomu; Tsuchiaka, Shinobu; Naoi, Yuki; Sano, Kaori; Okazaki, Sachiko; Katayama, Yukie; Oba, Mami; Furuya, Tetsuya; Shirai, Junsuke; Mizutani, Tetsuya] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan; [Aoki, Hiroshi; Shiokawa, Mai] Nippon Vet & Life Sci Univ, Fac Vet Sci, Musashino, Tokyo 1808602, Japan; [Otomaru, Konosuke] Kagoshima Univ, Joint Fac Vet Med, Korimoto, Kagoshima 8900065, Japan; [Uto, Takehiko] Kumage Agr Mutual Aid Associat, Noma Nakatane, Kagoshima 8913604, Japan; [Koizumi, Motoya] Hokusatsu Agr Mutual Aid Associat, Todoro Satsuma, Kagoshima 8951813, Japan; [Minami-Fukuda, Fujiko; Takai, Hikaru; Murakami, Toshiaki] Ishikawa Hokubu Livestock Hyg Serv Ctr, Nanao, Ishikawa 9292126, Japan; [Masuda, Tsuneyuki; Yamasato, Hiroshi] Kurayoshi Livestock Hyg Serv Ctr, Kurayoshi, Tottori 6830017, Japan	Nagai, M (reprint author), Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan.	m-nagai@cc.tuat.ac.jp; tmizutan@cc.tuat.ac.jp			Research Project for Improving Food Safety and Animal Health of Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by the Research Project for Improving Food Safety and Animal Health of the Ministry of Agriculture, Forestry and Fisheries of Japan.	Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Candido M, 2015, ARCH VIROL, V160, P1519, DOI 10.1007/s00705-015-2400-8; Bouzalas IG, 2014, J CLIN MICROBIOL, V52, P3318, DOI 10.1128/JCM.01195-14; Wolfaardt M, 2011, J CLIN MICROBIOL, V49, P728, DOI 10.1128/JCM.01093-10; WOODE GN, 1985, J CLIN MICROBIOL, V22, P668; Tse H, 2011, J GEN VIROL, V92, P1888, DOI 10.1099/vir.0.030817-0; WOODE GN, 1978, J MED MICROBIOL, V11, P441; Xiao CT, 2013, J GEN VIROL, V94, P570, DOI 10.1099/vir.0.048744-0; Ulloa JC, 2010, CAN J MICROBIOL, V56, P569, DOI [10.1139/w10-042, 10.1139/W10-042]; Li LL, 2013, EMERG INFECT DIS, V19, P1385, DOI 10.3201/eid1909.130682; Walter JE, 2001, ARCH VIROL, V146, P2357, DOI 10.1007/s007050170008; SNODGRASS DR, 1977, ARCH VIROL, V55, P287, DOI 10.1007/BF01315050; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Reuter G, 2012, ARCH VIROL, V157, P323, DOI 10.1007/s00705-011-1151-4; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Lole KS, 1999, J VIROL, V73, P152; Laurin MA, 2011, ARCH VIROL, V156, P2095, DOI 10.1007/s00705-011-1088-7; Glass R I, 1996, Arch Virol Suppl, V12, P287; Smits SL, 2010, J GEN VIROL, V91, P2719, DOI 10.1099/vir.0.024067-0; Brnic D, 2013, INFECT GENET EVOL, V14, P258, DOI 10.1016/j.meegid.2012.12.027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Batty EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066129; Bosch A., 2011, VIRUS TAXONOMY CLASS, P953; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Mendez E, 2007, VIROLOGY, P981; Oem JK, 2014, VIRUS GENES, V48, P372, DOI 10.1007/s11262-013-1013-0	28	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	OCT	2015	160	10					2491	2501		10.1007/s00705-015-2543-7		11	Virology	Virology	CS1IN	WOS:000361817600011		
J	Masuda, T; Murakami, S; Takahashi, O; Miyazaki, A; Ohashi, S; Yamasato, H; Suzuki, T				Masuda, Tsuneyuki; Murakami, Satoshi; Takahashi, Osamu; Miyazaki, Ayako; Ohashi, Seiichi; Yamasato, Hiroshi; Suzuki, Tohru			New porcine epidemic diarrhoea virus variant with a large deletion in the spike gene identified in domestic pigs	ARCHIVES OF VIROLOGY			English	Article							UNITED-STATES; CORONAVIRUS; STRAINS; SWINE	From October 2013 to date, approximately 1,000 outbreaks of porcine epidemic diarrhoea virus (PEDV) have occurred in Japan. Porcine epidemic diarrhoea with non-lethal effects in piglets was identified in Tottori prefecture in October 2014. Complete genome analysis revealed that the causative pathogen, Tottori2, is a new PEDV variant with a large (582 nt) deletion in the spike gene. Phylogenetic analysis indicated that the Tottori2 PEDV strain might have been derived from the current PEDV strains circulating in domestic pigs. Moreover, the Tottori2 PEDV strain was successfully isolated in Vero cells by serial passage.	[Masuda, Tsuneyuki; Yamasato, Hiroshi] Kurayoshi Livestock Hyg Serv Ctr, Kurayoshi, Tottori, Japan; [Murakami, Satoshi; Takahashi, Osamu] Life Technol Japan Ltd, Thermo Fisher Sci, Tokyo, Japan; [Miyazaki, Ayako; Ohashi, Seiichi; Suzuki, Tohru] Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	Suzuki, T (reprint author), Natl Agr & Food Res Org, Viral Dis & Epidemiol Res Div, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	t_suzuki@affrc.go.jp			National Institute of Animal Health, NARO	We are grateful to the personnel at the Kurayoshi Livestock Hygiene Service Center, Tottori prefecture, for their help and cooperation with sample collection and diagnostic tests. This work was supported in part by a grant from the National Institute of Animal Health, NARO.	Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; WOOD EN, 1977, VET REC, V100, P243; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; Chen JF, 2013, VIRUSES-BASEL, V5, P2601, DOI 10.3390/v5102601; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; VANREETH K, 1994, VET REC, V135, P594; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; CALLEBAUT P, 1988, J GEN VIROL, V69, P1725, DOI 10.1099/0022-1317-69-7-1725; Chiou M, 2014, AUSTIN VIROL RETROVI, V1; Marthaler D, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00555-13; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	OCT	2015	160	10					2565	2568		10.1007/s00705-015-2522-z		4	Virology	Virology	CS1IN	WOS:000361817600018		
J	Thammakarn, C; Tsujimura, M; Satoh, K; Hasegawa, T; Tamura, M; Kawamura, A; Ishida, Y; Suguro, A; Hakim, H; Ruenphet, S; Takehara, K				Thammakarn, Chanathip; Tsujimura, Misato; Satoh, Keisuke; Hasegawa, Tomomi; Tamura, Miho; Kawamura, Akinobu; Ishida, Yuki; Suguro, Atsushi; Hakim, Hakimullah; Ruenphet, Sakchai; Takehara, Kazuaki			Efficacy of scallop shell powders and slaked lime for inactivating avian influenza virus under harsh conditions	ARCHIVES OF VIROLOGY			English	Article							H5N1; VACCINES; VACCINATION; PERSISTENCE; EVOLUTION; CHINA; FECES; WATER	The efficacy and stability of scallop shell powder (SSP) were investigated, in terms of its capacity to inactivate avian influenza virus (AIV), and compared with slaked lime (SL). An environmental simulation was conducted by emulating sunlight and wet-dry conditions. The powders were collected at consecutive 2-week intervals under sunlight and upon every resuspension. These materials were tested by mixing them with AIV and incubating the mixture for 3 min or 20 h, followed by AIV titration. At the same time, a pH buffering test was conducted by neutralization with Tris-HCl. The results revealed that SSP and SL have high alkalinity and excellent ability to inactivate AIV. In a simulated harsh environment, SSP and SL retained a satisfactory ability to inactivate AIV within 20 h throughout the experimental procedure. However, SSP was able to inactivate AIV during a short contact period (3 min), even under harsh conditions, and it was more resistant than SL to neutralization.	[Thammakarn, Chanathip; Tsujimura, Misato; Satoh, Keisuke; Hasegawa, Tomomi; Tamura, Miho; Kawamura, Akinobu; Ishida, Yuki; Suguro, Atsushi; Takehara, Kazuaki] Tokyo Univ Agr & Technol, Dept Vet Med, Hlth Anim Lab, Fac Agr, Tokyo 1838509, Japan; [Thammakarn, Chanathip; Hakim, Hakimullah; Takehara, Kazuaki] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Ruenphet, Sakchai] Mahanakorn Univ Technol, Dept Virol & Immunol, Fac Vet Med, Bangkok 10530, Thailand	Takehara, K (reprint author), Tokyo Univ Agr & Technol, Dept Vet Med, Hlth Anim Lab, Fac Agr, Tokyo 1838509, Japan.	takehara@cc.tuat.ac.jp			Kieikai Research Foundation	The authors thank C&C Co., Ltd. for providing SSP for this experiment, as well as Dr. Dany Shoham, Bar Ilan University, Israel, for the grammatical review of the manuscript. This work was supported in part by a grant in aid from Kieikai Research Foundation.	Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Jahangir A, 2009, VIRUS RES, V143, P44, DOI 10.1016/j.virusres.2009.02.018; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Pfeiffer J, 2010, AVIAN DIS, V54, P262, DOI 10.1637/8715-031909-Reg.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Wanaratana S, 2010, VET MICROBIOL, V140, P43, DOI 10.1016/j.vetmic.2009.07.008; Kouzu M, 2008, FUEL, V87, P2798, DOI 10.1016/j.fuel.2007.10.019; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Takehara K, 2009, AVIAN DIS, V53, P34, DOI 10.1637/8382-062008-Reg.1; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Pearce JM, 2012, J WILDLIFE DIS, V48, P812; Qiao CL, 2006, ANN NY ACAD SCI, V1081, P182, DOI 10.1196/annals.1373.022; Lee CW, 2004, J VIROL, V78, P8372, DOI 10.1128/jvi.78.15.8372-8381.2004; Zhang PH, 2008, J GEN VIROL, V89, P3102, DOI 10.1099/vir.0.2008/005652-0; Li XH, 2011, AVIAN DIS, V55, P21, DOI 10.1637/9306-031710-Reg.1; PURI A, 1990, J VIROL, V64, P3824; Jahangir A, 2010, VIRUS GENES, V40, P94, DOI 10.1007/s11262-009-0423-5; Lombardi ME, 2008, AVIAN DIS, V52, P118, DOI 10.1637/8055-070907-Reg; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; El-Zoghby EF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-294; Escorcia M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-15; Fuller TL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-187; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; MATUMOTO M., 1949, JAP JOUR EXPTL MED, V20, P175; Muhmmad K., 2001, International Journal of Agriculture and Biology, V3, P416; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Shoham D, 2012, INFLUENZA RES TREAT, V2012; Sims LD, 2007, AVIAN DIS, V51, P174, DOI 10.1637/7637-042806R.1; Thammakarn C, 2014, J VET MED SCI, V76, P1277, DOI 10.1292/jvms.14-0158; Tsujimura M, 2012, T MAT RES SOC JPN, V37, P567	33	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	OCT	2015	160	10					2577	2581		10.1007/s00705-015-2517-9		5	Virology	Virology	CS1IN	WOS:000361817600020		
J	Zeng, LF; Li, Y; Yang, JY; Wang, G; Margariti, A; Xiao, QZ; Zampetaki, A; Yin, XK; Mayr, M; Mori, K; Wang, W; Hu, YH; Xu, QB				Zeng, Lingfang; Li, Yi; Yang, Juanyao; Wang, Gang; Margariti, Andriana; Xiao, Qingzhong; Zampetaki, Anna; Yin, Xiaoke; Mayr, Manuel; Mori, Kazutoshi; Wang, Wen; Hu, Yanhua; Xu, Qingbo			XBP 1-Deficiency Abrogates Neointimal Lesion of Injured Vessels Via Cross Talk With the PDGF Signaling	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						inositol; microRNAs; proteomics; signal transduction; vascular remodeling	SMOOTH-MUSCLE-CELLS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; BONE MORPHOGENETIC PROTEIN-2; MESSENGER-RNA; GROWTH-FACTOR; ENDOTHELIAL-CELLS; VASCULAR DYSFUNCTION; KINASE ACTIVATION; TUMOR-SUPPRESSOR	Objective Smooth muscle cell (SMC) migration and proliferation play an essential role in neointimal formation after vascular injury. In this study, we intended to investigate whether the X-box-binding protein 1 (XBP1) was involved in these processes. Approach and Results In vivo studies on femoral artery injury models revealed that vascular injury triggered an immediate upregulation of XBP1 expression and splicing in vascular SMCs and that XBP1 deficiency in SMCs significantly abrogated neointimal formation in the injured vessels. In vitro studies indicated that platelet-derived growth factor-BB triggered XBP1 splicing in SMCs via the interaction between platelet-derived growth factor receptor and the inositol-requiring enzyme 1. The spliced XBP1 (XBP1s) increased SMC migration via PI3K/Akt activation and proliferation via downregulating calponin h1 (CNN1). XBP1s directed the transcription of mir-1274B that targeted CNN1 mRNA degradation. Proteomic analysis of culture media revealed that XBP1s decreased transforming growth factor (TGF)- family proteins secretion via transcriptional suppression. TGF-3 but not TGF-1 or TGF-2 attenuated XBP1s-induced CNN1 decrease and SMC proliferation. Conclusions This study demonstrates for the first time that XBP1 is crucial for SMC proliferation via modulating the platelet-derived growth factor/TGF- pathways, leading to neointimal formation.	[Zeng, Lingfang; Li, Yi; Yang, Juanyao; Zampetaki, Anna; Yin, Xiaoke; Mayr, Manuel; Hu, Yanhua; Xu, Qingbo] Kings Coll London, Cardiovasc Div, London BHF Ctr, London SE5 9NU, England; [Yang, Juanyao; Wang, Wen] Queen Mary Univ London, Inst Bioengn, London, England; [Xiao, Qingzhong] Queen Mary Univ London, Ctr Clin Pharmacol, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Wang, Gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, Xian 710049, Peoples R China; [Margariti, Andriana] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan	Zeng, LF (reprint author), Kings Coll London, Cardiovasc Div, 125 Coldharbour Lane, London SE5 9NU, England.	lingfang.zeng@kcl.ac.uk; qingbo.xu@kcl.ac.uk			British Heart Foundation; Oak Foundation	This work was supported by Grants from British Heart Foundation and the Oak Foundation.	Holy E, 2014, EUR HEART J, V35, P808, DOI 10.1093/eurheartj/eht496; Yin XK, 2013, MOL CELL PROTEOMICS, V12, P956, DOI 10.1074/mcp.M112.024018; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI 10.4161/rna.7.4.13141; Kingston PA, 2003, CIRCULATION, V108, P2819, DOI 10.1161/01.CIR.0000097068.49080.A0; Shinozuka E, 2013, BIOCHEM BIOPH RES CO, V430, P101, DOI 10.1016/j.bbrc.2012.11.005; Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M60230200; Oikawa D, 2011, METHOD ENZYMOL, V490, P195, DOI 10.1016/B978-0-12-385114-7.00012-X; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI [10.1016/j.bbrc.2011.08.114, 10.1016/j.bbrc.2011.083.114]; Silvestre JS, 2013, CIRCULATION, V127, P1644, DOI 10.1161/CIRCULATIONAHA.113.002336; MARMUR JD, 1992, CIRCULATION, V86, P53; Turner NA, 2007, J VASC SURG, V45, P1022, DOI 10.1016/j.jvs.2007.01.061; Zeng LF, 2013, CIRCULATION, V127, P1712, DOI 10.1161/CIRCULATIONAHA.112.001337; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Miano JM, 1996, J BIOL CHEM, V271, P7095; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Cattaruzza M, 2012, FASEB J, V26, P4864, DOI 10.1096/fj.12-210302; Austin KM, 2013, J BIOL CHEM, V288, P23105, DOI 10.1074/jbc.M113.467019; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Miyauchi K, 1998, CARDIOVASC DRUG THER, V12, P251, DOI 10.1023/A:1007761631674; Montague CR, 2006, CIRC RES, V99, P477, DOI 10.1161/01.RES.00002387.72592.A2; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Sugenoya Y, 2002, J AM SOC NEPHROL, V13, P322; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Lee YK, 1999, MOL BIOL CELL, V10, P2209; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Li L, 2011, J CELL BIOCHEM, V112, P289, DOI 10.1002/jcb.22924; Horiuchi A, 1999, MOL HUM REPROD, V5, P139, DOI 10.1093/molehr/5.2.139; Mourani PM, 2004, CIRCULATION, V109, P1299, DOI 10.1161/01.CIR.0000118462.22970.BE; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Liu L, 2013, AM J PATHOL, V182, P1412, DOI 10.1016/j.ajpath.2012.12.020; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Samaha FF, 1996, J BIOL CHEM, V271, P395; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Xu Q, 2005, ARCH MAL COEUR VAISS, V98, P672; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Long XC, 2011, ARTERIOSCL THROM VAS, V31, P2172, DOI 10.1161/ATVBAHA.111.232785; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Horiuchi A, 1999, J NATL CANCER I, V91, P790, DOI 10.1093/jnci/91.9.790; Bornfeldt KE, 1995, ANN NY ACAD SCI, V766, P416, DOI 10.1111/j.1749-6632.1995.tb26691.x; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; Shigematsu K, 2000, ARTERIOSCL THROM VAS, V20, P2373; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; RAINES EW, 1993, BRIT HEART J, V69, pS30; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tellides G, 2015, CIRC RES, V116, P312, DOI 10.1161/CIRCRESAHA.116.301312; Zhou Y, NATURE MED, V17, P356	66	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	OCT	2015	35	10					2134	2144		10.1161/ATVBAHA.115.305420		11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CR8NL	WOS:000361610700010		
J	Ellawindy, A; Satoh, K; Sunamura, S; Kikuchi, N; Suzuki, K; Minami, T; Ikeda, S; Tanaka, S; Shimizu, T; Enkhjargal, B; Miyata, S; Taguchi, Y; Handoh, T; Kobayashi, K; Kobayashi, K; Nakayama, K; Miura, M; Shimokawa, H				Ellawindy, Alia; Satoh, Kimio; Sunamura, Shinichiro; Kikuchi, Nobuhiro; Suzuki, Kota; Minami, Tatsuro; Ikeda, Shohei; Tanaka, Shinichi; Shimizu, Toru; Enkhjargal, Budbazar; Miyata, Satoshi; Taguchi, Yuhto; Handoh, Tetsuya; Kobayashi, Kenta; Kobayashi, Kazuto; Nakayama, Keiko; Miura, Masahito; Shimokawa, Hiroaki			Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						cytoskeletal filaments; desmosomes; myocardial fatty change; PPAR; Rho-kinase; Wnt signaling pathway	WNT SIGNALING PATHWAYS; NUCLEAR PLAKOGLOBIN; THERAPEUTIC TARGET; PROGENITOR CELLS; TGF-BETA; ADIPOGENESIS; CATENIN; DYSPLASIA/CARDIOMYOPATHY; HEART; DIFFERENTIATION	Objective Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty changes of the right ventricle, ventricular arrhythmias, and sudden death. Though ARVC is currently regarded as a disease of the desmosome, desmosomal gene mutations have been identified only in half of ARVC patients, suggesting the involvement of other associated mechanisms. Rho-kinase signaling is involved in the regulation of intracellular transport and organizes cytoskeletal filaments, which supports desmosomal protein complex at the myocardial cell-cell junctions. Here, we explored whether inhibition of Rho-kinase signaling is involved in the pathogenesis of ARVC. Approach and Results Using 2 novel mouse models with SM22- or MHC-restricted overexpression of dominant-negative Rho-kinase, we show that mice with Rho-kinase inhibition in the developing heart (SM22-restricted) spontaneously develop cardiac dilatation and dysfunction, myocardial fibrofatty changes, and ventricular arrhythmias, resulting in premature sudden death, phenotypes fulfilling the criteria of ARVC in humans. Rho-kinase inhibition in the developing heart results in the development of ARVC phenotypes in dominant-negative Rho-kinase mice through 3 mechanisms: (1) reduction of cardiac cell proliferation and ventricular wall thickness, (2) stimulation of the expression of the proadipogenic noncanonical Wnt ligand, Wnt5b, and the major adipogenic transcription factor, PPAR (peroxisome proliferator activated receptor-), and inhibition of Wnt/-catenin signaling, and (3) development of desmosomal abnormalities. These mechanisms lead to the development of cardiac dilatation and dysfunction, myocardial fibrofatty changes, and ventricular arrhythmias, ultimately resulting in sudden premature death in this ARVC mouse model. Conclusions This study demonstrates a novel crucial role of Rho-kinase inhibition during cardiac development in the pathogenesis of ARVC in mice.	[Ellawindy, Alia; Satoh, Kimio; Sunamura, Shinichiro; Kikuchi, Nobuhiro; Suzuki, Kota; Minami, Tatsuro; Ikeda, Shohei; Tanaka, Shinichi; Shimizu, Toru; Enkhjargal, Budbazar; Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Minami, Tatsuro; Tanaka, Shinichi] Asahi Kasei Pharma Corp, Pharmaceut Res Ctr, Pharmacol Lab, Izunokuni, Japan; [Taguchi, Yuhto; Handoh, Tetsuya; Miura, Masahito] Tohoku Univ, Grad Sch Med, Hlth Sci, Dept Clin Physiol, Sendai, Miyagi 9808574, Japan; [Kobayashi, Kenta; Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Core Ctr Canc Res,Div Cell Proliferat, Sendai, Miyagi 9808574, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [21790698, 23659408, 24390193, 15H02535, 15H04816, 15K15046]; Ministry of Health, Labor, and Welfare, Tokyo, Japan [10102895, 15545346]	This work was supported in part by the Takeda Science Foundation, the grant-in-aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine, and the grants-in-aid for Scientific Research (21790698, 23659408, 24390193, 15H02535, 15H04816, and 15K15046), all of which are from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan; and the grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare, Tokyo, Japan (10102895, 15545346).	Kemp TJ, 2004, J MOL CELL CARDIOL, V37, P603, DOI 10.1016/j.yjmcc.2004.04.022; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212; Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Corrado D, 2011, HEART, V97, P530, DOI 10.1136/hrt.2010.193276; Li L, 1996, CIRC RES, V78, P188; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Marcus F, 2006, CIRCULATION, V114, P1794, DOI 10.1161/CIRCULATIONAHA.106.653493; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Lodder EM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00221; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Wei L, 2001, DEVELOPMENT, V128, P2953; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Pilichou K, 2009, J EXP MED, V206, P1787, DOI 10.1084/jem.20090641; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; van Tienen FHJ, 2009, BIOCHEM BIOPH RES CO, V387, P207, DOI 10.1016/j.bbrc.2009.07.004; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Godsel LM, 2010, MOL BIOL CELL, V21, P2844, DOI 10.1091/mbc.E10-02-0131; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Li L, 2011, BIOCHEM CELL BIOL, V89, P515, DOI [10.1139/o11-048, 10.1139/O11-048]; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Todorovic V, 2010, J CELL SCI, V123, P3576, DOI 10.1242/jcs.070391; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Rustico MA, 2001, FETAL DIAGN THER, V16, P433, DOI 10.1159/000053954; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Basso C, 2012, NAT REV CARDIOL, V9, P223, DOI 10.1038/nrcardio.2011.173; Kaufman MH, 2010, ATLAS MOUSE DEV; NG WA, 1991, CIRC RES, V68, P1742; Turrini P, 2001, Images Paediatr Cardiol, V3, P18; Yang Maozhou, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P12	50	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	OCT	2015	35	10					2172	2184		10.1161/ATVBAHA.115.305872		13	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CR8NL	WOS:000361610700014		
J	Bando, S; Fukuda, D; Soeki, T; Nishimoto, S; Uematsu, E; Matsuura, T; Ise, T; Tobiume, T; Yamaguchi, K; Yagi, S; Iwase, T; Yamada, H; Wakatsuki, T; Shimabukuro, M; Sata, M				Bando, Sachiko; Fukuda, Daiju; Soeki, Takeshi; Nishimoto, Sachiko; Uematsu, Etsuko; Matsuura, Tomomi; Ise, Takayuki; Tobiume, Takeshi; Yamaguchi, Koji; Yagi, Shusuke; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Sata, Masataka			Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis	ATHEROSCLEROSIS			English	Article						Atherosclerosis; Adipose tissue; Inflammation; NLRP3 inflammasome; Lifestyle-related disease	INSULIN SENSITIVITY; REGIONAL ADIPOSITY; VISCERAL FAT; MACROPHAGE POLARIZATION; INFLAMMASOME ACTIVATION; CARDIOVASCULAR-DISEASE; OBESITY; RESISTANCE; DEPOSITION; PATHWAY	Objectives: The promotion of adipose tissue inflammation by lifestyle-related diseases such as obesity and diabetes accelerates atherogenesis; however, the underlying mechanisms remain incompletely understood. Nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome contributes to chronic inflammation in adipose tissue. Here, we investigated the link between NLRP3 expression in subcutaneous adipose tissue (SAT) and the severity of coronary atherosclerosis. Methods and results: SAT was obtained from 72 patients who underwent heart device implantation and coronary angiography. Expression of NLRP3 inflammasome-related molecules (NLRP3, IL-1b and IL-18) in SAT were evaluated by quantitative RT-PCR. Laboratory markers related to lifestyle-related diseases were measured. Patients with obesity, dyslipidemia (P < 0.05, respectively), diabetes or hyperuricemia (P < 0.01, respectively) had significantly higher expression of NLRP3. Multivariate analysis demonstrated that body mass index and serum level of uric acid were predictors of NLRP3 expression in SAT. The expression of NLRP3 in SAT correlated negatively with serum adiponectin level (r = -0.23, P < 0.05). Patients with coronary artery disease showed higher NLRP3 expression than patients without significant stenosis (P < 0.01). Furthermore, the expression of NLRP3 in SAT correlated positively with the severity of coronary atherosclerosis as determined by Gensini score (r = 0.47, P < 0.0001) or SYNTAX score (r = 0.55, P < 0.0001). Multiple regression analysis revealed that the expression of NLRP3 in SAT remains as an independent predictors for the severity of coronary atherosclerosis. Conclusions: The expression of NLRP3 in SAT, which is affected by lifestyle-related diseases, is associated with the severity of coronary atherosclerosis. Our results suggest that NLRP3 inflammasome in SAT may have a role in atherogenesis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Bando, Sachiko; Fukuda, Daiju; Soeki, Takeshi; Uematsu, Etsuko; Matsuura, Tomomi; Ise, Takayuki; Tobiume, Takeshi; Yamaguchi, Koji; Yagi, Shusuke; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Sata, Masataka] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Nishimoto, Sachiko] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Nutr & Metab, Tokushima 7708503, Japan; [Shimabukuro, Michio] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima 7708503, Japan	Fukuda, D (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiovasc Med, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	daiju.fukuda@tokushima-u.ac.jp			JSPS Kakenhi Grant [25460369, 24659392, 22390159, 25670390, 25293184]; MEXT KAKENHI Grant [21117007]; Young Investigator Imura Award	This work was partially supported by JSPS Kakenhi Grants (Number 25460369 to D.F. and Number 24659392, 22390159, 25670390, 25293184 to M. Sata) and MEXT KAKENHI Grant Number 21117007 (M. Sata). This study was partially supported by Young Investigator Imura Award.	Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Abate N, 1996, DIABETES, V45, P1684, DOI 10.2337/diabetes.45.12.1684; Akahoshi T, 2007, CURR OPIN RHEUMATOL, V19, P146, DOI 10.1097/BOR.0b013e328014529a; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Iglseder B, 2005, STROKE, V36, P2577, DOI 10.1161/01.STR.0000190834.00284.fd; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Jensen MD, 1996, METABOLISM, V45, P662, DOI 10.1016/S0026-0495(96)90040-2; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Satoh M, 2014, CLIN SCI, V126, P233, DOI [10.1042/CS20130043, 10.1042/C520130043]; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; ABATE N, 1995, PROG LIPID RES, V34, P53, DOI 10.1016/0163-7827(94)00006-8; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Ferreira I, 2005, ARCH INTERN MED, V165, P875, DOI 10.1001/archinte.165.8.875; Hirata Y, 2011, J AM COLL CARDIOL, V58, P248, DOI 10.1016/j.jacc.2011.01.048; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Sianos Georgios, 2005, EuroIntervention, V1, P219; Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wang MX, 2015, EUR J PHARMACOL, V747, P59, DOI 10.1016/j.ejphar.2014.11.035	34	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					407	414		10.1016/j.atherosclerosis.2015.07.043		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000005		
J	Tomiyama, H; Kohro, T; Higashi, Y; Takase, B; Suzuki, T; Ishizu, T; Ueda, S; Yamazaki, T; Furumoto, T; Kario, K; Inoue, T; Koba, S; Watanabe, K; Takemoto, Y; Hano, T; Sata, M; Ishibashi, Y; Node, K; Maemura, K; Ohya, Y; Furukawa, T; Ito, H; Ikeda, H; Yamashina, A				Tomiyama, Hirofumi; Kohro, Takahide; Higashi, Yukihito; Takase, Bonpei; Suzuki, Toru; Ishizu, Tomoko; Ueda, Shinichiro; Yamazaki, Tsutomu; Furumoto, Tomoo; Kario, Kazuomi; Inoue, Teruo; Koba, Shinji; Watanabe, Kentaro; Takemoto, Yasuhiko; Hano, Takuzo; Sata, Masataka; Ishibashi, Yutaka; Node, Koichi; Maemura, Koji; Ohya, Yusuke; Furukawa, Taiji; Ito, Hiroshi; Ikeda, Hisao; Yamashina, Akira			Reliability of measurement of endothelial function across multiple institutions and establishment of reference values in Japanese	ATHEROSCLEROSIS			English	Article						Endothelial function; Reference value; Standardization; Reliability	FLOW-MEDIATED DILATION; INCIDENT CARDIOVASCULAR EVENTS; BRACHIAL-ARTERY REACTIVITY; RISK-FACTORS; VASODILATATION; REPRODUCIBILITY; MULTICENTER; DILATATION; VARIABILITY; PREDICTION	Aims: For the standardization of flow-mediated vasodilatation (FMD) assessment as a clinical tool, validation of its reliability across multiple institutions and the establishment of normal/reference values based on reliable data from multiple institutions are needed. Methods and results: In Study 1, assessment of FMD (scan recording and analysis) using an ultrasonographic semi-automatic measuring system (sFMD) was conducted at 18 participating institutions (sFMDINST) (n = 981). All of the brachial arterial scans were also analyzed at a core laboratory (sFMD-COLB). After 111 subjects with inadequate sFMD recordings were excluded (n = 880), the correlation between the sFMD-INST and sFMD-COLB improved from R = 0.725 to R = 0.838 (p < 0.001). In Study 2, based on good-quality sFMD data obtained from 6660 subjects without cardiovascular disease (CVD) and 729 subjects with CVD from 27 institutions, reference values of sFMD are proposed by the Framingham risk score (FRS)-based risk categories and according to gender and age. The receiver-operating characteristic curve analysis revealed a significant power of sFMD values in reference ranges to discriminate between subjects with and without CVD (e.g., area under curve = 0.64 in the FRS-low risk group). Conclusions: When the analysis was limited to cases with clear sFMD recordings, the reliability of the sFMD assessment (scan and its analysis) conducted in individual institutions appeared to be acceptable. Reference sFMD values (lower cuff occlusion) for the Japanese population are proposed based on reliable data derived from multiple institutions, and the reference values may identify patients without advanced vascular damage. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Tomiyama, Hirofumi; Yamashina, Akira] Tokyo Med Univ, Dept Cardiol, Tokyo 1600023, Japan; [Kohro, Takahide] Jichi Med Univ, Sch Med, Dept Clin Informat, Shimotsuke, Tochigi, Japan; [Higashi, Yukihito] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan; [Takase, Bonpei] Natl Def Med Coll, Res Inst, Div Biomed Engn, Saitama, Japan; [Suzuki, Toru] Univ Leicester, Cardiovasc Med, Leicester, Leics, England; [Ishizu, Tomoko] Univ Tsukuba, Div Cardiovasc, Inst Clin Med, Ibaraki, Japan; [Ueda, Shinichiro] Univ Ryukyus, Sch Med, Dept Clin Pharmacol & Therapeut, Okinawa, Japan; [Yamazaki, Tsutomu] Univ Tokyo, Fac Med, Dept Clin Epidemiol & Syst, Tokyo 113, Japan; [Furumoto, Tomoo] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 060, Japan; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Inoue, Teruo] Dokkyo Med Univ, Dept Cardiovasc Med, Mibu, Tochigi, Japan; [Koba, Shinji] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan; [Watanabe, Kentaro] Yamagata Univ, Sch Med, Dept Neurol Hematol Metaboism Endocrinol & Diabet, Yamagata 99023, Japan; [Takemoto, Yasuhiko] Osaka City Univ, Grad Sch Med, Dept Internal Med & Cardiol, Osaka 558, Japan; [Hano, Takuzo] Wakayama Med Univ, Postgrad Med Sch, Dept Med Educ & Populat Based Med, Wakayama, Japan; [Sata, Masataka] Univ Tokushima, Grad Sch, Dept Cardiovasc Med, Inst Hlth Biosci, Tokushima 770, Japan; [Ishibashi, Yutaka] Shimane Univ, Fac Med, Dept Gen Med, Izumo, Shimane, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc & Renal Med, Saga 840, Japan; [Maemura, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Course Med & Dent Sci, Nagasaki 852, Japan; [Ohya, Yusuke] Univ Ryukyus, Dept Internal Med 3, Okinawa, Japan; [Furukawa, Taiji] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan; [Ikeda, Hisao] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan	Tomiyama, H (reprint author), Tokyo Med Univ, Dept Cardiol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	tomiyama@tokyo-med.ac.jp			Japanese Atherosclerosis Prevention Research Fund	The present study was supported by the Japanese Atherosclerosis Prevention Research Fund (A study of Multi-center Assessment on the Clinical Usefulness of Semi-automatic Measurement of Flow-mediated Vasodilatation of the Brachial Artery: FMD-J study).	Hamburg NM, 2011, HYPERTENSION, V57, P390, DOI 10.1161/HYPERTENSIONAHA.110.160812; Atkinson G, 2013, J HYPERTENS, V31, P287, DOI 10.1097/HJH.0b013e32835b8164; Tomiyama H, 2012, INT HEART J, V53, P170; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Wilson PWF, 1998, CIRCULATION, V97, P1837; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; Tomiyama H, 2008, HYPERTENS RES, V31, P2019, DOI 10.1291/hypres.31.2019; Charakida M, 2013, EUR HEART J, V34, P3501, DOI 10.1093/eurheartj/eht223; Faita F, 2011, J HYPERTENS, V29, P85, DOI 10.1097/HJH.0b013e32833fc938; Thijssen DHJ, 2009, AM J PHYSIOL-HEART C, V296, pH57, DOI 10.1152/ajpheart.00980.2008; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Maruhashi T, 2013, HEART, V99, P1837, DOI 10.1136/heartjnl-2013-304739; Montalcini T, 2012, NUTR METAB CARDIOVAS, V22, P8, DOI 10.1016/j.numecd.2011.09.005; Kelly AS, 2004, ULTRASOUND MED BIOL, V30, P1447, DOI 10.1016/j.ultrasmedbio.2004.08.019; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Haluska B, 2001, ULTRASOUND MED BIOL, V27, P1285, DOI 10.1016/S0301-5629(01)00406-9; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Brook R, 2005, AM J CARDIOL, V96, P1345, DOI 10.1016/j.amjcard.2005.06.086; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Ghiadoni L, 2012, J HYPERTENS, V30, P1399, DOI 10.1097/HJH.0b013e328353f222; Bots ML, 2005, EUR HEART J, V26, P363, DOI 10.1093/eurheathj/ehi017; Tomiyama H, 2014, HYPERTENS RES, V37, P914, DOI 10.1038/hr.2014.103	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					433	442		10.1016/j.atherosclerosis.2015.08.001		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000009		
J	Satoh-Asahara, N; Kotani, K; Yamakage, H; Yamada, T; Araki, R; Okajima, T; Adachi, M; Oishi, M; Shimatsu, A				Satoh-Asahara, Noriko; Kotani, Kazuhiko; Yamakage, Hajime; Yamada, Tsutomu; Araki, Rika; Okajima, Taiichiro; Adachi, Masahiro; Oishi, Mariko; Shimatsu, Akira		Japan Obesity and Metab Syndrome S	Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS)	ATHEROSCLEROSIS			English	Article						Obesity; Arterial stiffness; Cardio-ankle vascular index; Cardiovascular diseases; Cardiovascular diseases incidence rate	PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; HEART-DISEASE; RISK-FACTORS; CORONARY ATHEROSCLEROSIS; DIABETES COMPLICATIONS; HYPERTENSIVE PATIENTS; BLOOD-PRESSURE; MORTALITY; CAVI	Objective: The cardio-ankle vascular index (CAVI) is an index of arterial stiffness less dependent on blood pressure and an indicator suitable for assessing the arterial dysfunction. However, it remains unclear whether CAVI can predict the outcome of cardiovascular diseases (CVD) in obese patients. Methods: A total of 425 obese Japanese outpatients (189 men and 236 women, mean age: 51.5 years) were enrolled in a multicenter prospective cohort Japan, the Japan Obesity and Metabolic Syndrome Study (JOMS). Primary analysis regarding measurements of cardiovascular risk factors including CAVI and the occurrence of macrovascular complications was based on following the participants over a 5-year period. Results: Of the eligible patients, 300 (78%) were followed into the fifth year. During the study period, 15 coronary heart disease, 7 stroke, and 6 arteriosclerosis obliterans events occurred. All events occurred in 28 patients, and CVD incidence rate was 15.8 per 1000 person-years. In the analysis of adjusted models for traditional risk factors, CAVI was a significant factor for the incidence of events. In addition, high CAVI and low HDL-cholesterol were significant factors for the incidence of events in Cox stepwise multivariate analysis when age- and sex-adjusted (CAVI [per 1]: HR = 1.44 [1.02-2.02], p = 0.037; HDL-cholesterol [per 1 mmol/L]: HR = 0.20 [0.06-0.69], p = 0.011). In addition, CAVI added value to atherosclerotic cardiovascular disease risk score in predicting the development of CVD. Conclusion: This study demonstrates for the first time that CAVI is an effective predictor of CVD events in obese patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Satoh-Asahara, Noriko; Kotani, Kazuhiko; Yamakage, Hajime; Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Div Diabet Res, Kyoto 6128555, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Div Community & Family Med, Shimotsuke, Japan; [Yamada, Tsutomu] Natl Hosp Org, Nagoya Med Ctr, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Araki, Rika] Natl Hosp Org, Mie Hosp, Internal Med, Tsu, Mie, Japan; [Okajima, Taiichiro; Adachi, Masahiro] Natl Hosp Org, Kokura Med Ctr, Dept Internal Med, Kitakyushu, Fukuoka, Japan; [Okajima, Taiichiro; Adachi, Masahiro] Natl Hosp Org, Kokura Med Ctr, Dept Clin Res, Kitakyushu, Fukuoka, Japan; [Oishi, Mariko] Oishi Clin, Kyoto, Japan	Satoh-Asahara, N (reprint author), Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst Endocrine Metab Dis, Fushimi Ku, 1-1 Fukakusa Mukaihata Cho, Kyoto 6128555, Japan.	nsatoh@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan [15ek0210029h0002]; National Hospital Organization for Collaborative Clinical Research [H26-NHO-02]; Smoking Research Foundation; Japanese Society of Anti-Aging Medicine; Mitsui Life Social Welfare Foundation; Danone Institute of Japan Foundation; JSPS KAKENHI [24590719, 15K08634]	We thank Hiromichi Wada, MD, PhD, Masashi Tanaka, PhD, Yoshiyuki Matsuo, PhD, and Kazuya Muranaka, Bsc, for their technical assistance and valuable discussions. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, JSPS KAKENHI, Grant Number 24590719 and 15K08634; the Ministry of Health, Labour, and Welfare of Japan (15ek0210029h0002); and grants from the National Hospital Organization for Collaborative Clinical Research (H26-NHO-02), the Smoking Research Foundation, the Research Award of Japanese Society of Anti-Aging Medicine, the Mitsui Life Social Welfare Foundation and Danone Institute of Japan Foundation for a financial support of the 2015 DIJF (to N. S-A.).	Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P835; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Satoh N, 2008, HYPERTENS RES, V31, P1921, DOI 10.1291/hypres.31.1921; Li YL, 2014, SCAND J CLIN LAB INV, V74, P155, DOI 10.3109/00365513.2013.864787; Satoh N, 2003, DIABETES CARE, V26, P2493, DOI 10.2337/diacare.26.9.2493; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Yambe T, 2004, BIOMED PHARMACOTHER, V58, pS95, DOI 10.1016/S0753-3322(04)80015-5; Sone H, 2011, J CLIN ENDOCR METAB, V96, P3448, DOI 10.1210/jc.2011-0622; Yoshida M, 2012, DIABETES CARE, V35, P178, DOI 10.2337/dc11-1333; Mansour AS, 2013, J HYPERTENS, V31, P1584, DOI 10.1097/HJH.0b013e3283613074; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Ito N, 2006, HYPERTENS RES, V29, P989, DOI 10.1291/hypres.29.989; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Mizuguchi Y, 2007, J CARD FAIL, V13, P744, DOI 10.1016/j.cardfail.2007.05.010; Okura T, 2007, HYPERTENS RES, V30, P335, DOI 10.1291/hypres.30.335; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Miyoshi T, 2010, J ATHEROSCLER THROMB, V17, P249; Nakamura K, 2008, CIRC J, V72, P598; Morishita R, 2012, CURR VASC PHARMACOL, V10, P178; Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Peltonen M, 1998, STROKE, V29, P1358; Tariq SM, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0398-0; Kumagai T, 2009, CHEST, V136, P779, DOI 10.1378/chest.09-0178; Kim HJ, 2009, DIABETES RES CLIN PR, V85, P30, DOI 10.1016/j.diabres.2009.03.013; Sone H, 2002, HORM METAB RES, V34, P509, DOI 10.1055/s-2002-34791; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Furukawa Y, 2010, STROKE, V41, P550, DOI 10.1161/STROKEAHA.109.569145; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Gomez-Marcos M.A., 2015, CARDIOVASC DIABETOL, V14, P1; Janic M, 2014, BIOMED RES INT, DOI 10.1155/2014/621437; Keymel Stefanie, 2011, Am J Cardiovasc Dis, V1, P68; Kim Eun-Young, 2008, Electrolyte Blood Press, V6, P61, DOI 10.5049/EBP.2008.6.2.61; Kubota Y, 2011, ARTERY RES, V5, P91; Ibata Junko, 2008, Diabetes Res Clin Pract, V80, P265, DOI 10.1016/j.diabres.2007.12.016; Nye E., 1964, BRIT HEART J, V266, P261; Shirai Kohji, 2013, Curr Hypertens Rev, V9, P66, DOI 10.2174/1573402111309010010; Sone H, 2010, DIABETOLOGIA, V53, P419, DOI 10.1007/s00125-009-1622-2; Matsuzawa Y, 2002, CIRC J, V66, P987	44	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					461	468		10.1016/j.atherosclerosis.2015.08.003		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000012		
J	Khalifa, M; Noureen, A; Ertelthalner, K; Bandegi, AR; Delport, R; Firdaus, WJJ; Geethanjali, FS; Luthra, K; Makemaharn, O; Pang, RWC; Salem, AH; Sasaki, J; Schiefenhoevel, W; Lingenhel, A; Kronenberg, F; Utermann, G; Schmidt, K				Khalifa, Mahmoud; Noureen, Asma; Ertelthalner, Kathrin; Bandegi, Ahmad Reza; Delport, Rhena; Firdaus, Wance J. J.; Geethanjali, Finney S.; Luthra, Kalpana; Makemaharn, Orawan; Pang, Richard W. C.; Salem, Abdel-Halim; Sasaki, Jun; Schiefenhoevel, Wulf; Lingenhel, Arno; Kronenberg, Florian; Utermann, Gerd; Schmidt, Konrad			Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians	ATHEROSCLEROSIS			English	Article						Copy number variation; Coronary artery disease; Genetic variation; Lipoprotein(a); Population genetics	CORONARY-ARTERY-DISEASE; KRINGLE-IV REPEATS; CARDIOVASCULAR-DISEASE; APO(A) GENE; PLASMA LIPOPROTEIN(A); MOLECULAR-BASIS; HEART-DISEASE; OXIDIZED PHOSPHOLIPIDS; LP(A) CONCENTRATION; ASPIRIN THERAPY	Objective: The variant allele of rs3798220 in the apolipoprotein(a) gene (LPA) is used to assess the risk for coronary artery disease (CAD) in Europeans, where it is associated with short alleles of the Kringle IV-2 (KIV-2) copy number variation (CNV) and high lipoprotein(a) (Lp(a)) concentrations. No association of rs3798220 with CAD was detected in a GWAS of East Asians. Our study investigated the association of rs3798220 with Lp(a) concentrations and KIV-2 CNV size in non-European populations to explain the missing association of the variant with CAD in Asians. Methods: We screened three populations from Africa and seven from Asia by TaqMan Assay for rs3798220 and determined KIV-2 CNV sizes of LPA alleles by pulsed-field gel electrophoresis (PFGE). Additionally, CAD cases from India were analysed. To investigate the phylogenetic origin of rs3798220, 40 LPA alleles from Chinese individuals were separated by PFGE and haplotyped for further SNPs. Results: The variant was not found in Africans. Allele frequencies in East and Southeast Asians ranged from 2.9% to 11.6%, and were very low (0.15%) in CAD cases and controls from India. The variant was neither associated with short KIV-2 CNV alleles nor elevated Lp(a) concentrations in Asians. Conclusion: Our study shows that rs3798220 is no marker for short KIV-2 CNV alleles and high Lp(a) in East and Southeast Asians, although the haplotype background is shared with Europeans. It appears unlikely that this SNP confers atherogenic potential on its own. Furthermore, this SNP does not explain Lp(a) attributed risk for CAD in Asian Indians. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Khalifa, Mahmoud; Noureen, Asma; Ertelthalner, Kathrin; Lingenhel, Arno; Kronenberg, Florian; Schmidt, Konrad] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Khalifa, Mahmoud; Noureen, Asma; Bandegi, Ahmad Reza; Delport, Rhena; Firdaus, Wance J. J.; Geethanjali, Finney S.; Luthra, Kalpana; Makemaharn, Orawan; Pang, Richard W. C.; Salem, Abdel-Halim; Lingenhel, Arno; Utermann, Gerd; Schmidt, Konrad] Med Univ Innsbruck, Div Human Genet, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Delport, Rhena] Univ Pretoria, Fac Hlth Sci, Dept Chem Pathol, ZA-0002 Pretoria, South Africa; [Geethanjali, Finney S.] Christian Med Coll Vellore, Dept Clin Biochem, Vellore, Tamil Nadu, India; [Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Makemaharn, Orawan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Obstet & Gynaecol, Bangkok 10700, Thailand; [Pang, Richard W. C.] Queen Mary Hosp, Div Clin Biochem, Hong Kong, Hong Kong, Peoples R China; [Sasaki, Jun] Int Univ Hlth & Welf, Grad Sch Pharmaceut Med, Fukuoka, Japan; [Schiefenhoevel, Wulf] Max Planck Inst Ornithol, Andechs, Germany; [Schmidt, Konrad] Albert Schweitzer Hosp, Ctr Rech Med Lambarene, Lambarene, Gabon; [Schmidt, Konrad] Univ Tubingen, Dept Trop Med, Tubingen, Germany	Schmidt, K (reprint author), Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Schopfstr 41, A-6020 Innsbruck, Austria.	konrad.schmidt@i-med.ac.at	Kronenberg, Florian/B-1736-2008	Kronenberg, Florian/0000-0003-2229-1120	Medical University of Innsbruck [P5030-011-011]	The study was funded by Research Project Fund P5030-011-011 "Clinical Genetics" of the Medical University of Innsbruck to the Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology.	Tsimikas S, 2009, CIRCULATION, V119, P1711, DOI 10.1161/CIRCULATIONAHA.108.836940; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Geethanjali FS, 2003, ATHEROSCLEROSIS, V169, P121, DOI 10.1016/S0021-9150(03)00143-6; Chen TJ, 2009, ACTA PAEDIATR, V98, P1029, DOI 10.1111/j.1651-2227.2009.01257.x; Leebmann J, 2013, CIRCULATION, V128, P2567, DOI 10.1161/CIRCULATIONAHA.113.002432; SANDHOLZER C, 1992, J CLIN INVEST, V89, P1040, DOI 10.1172/JCI115645; KRONENBERG F, 1994, J LIPID RES, V35, P1318; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58; Parson W, 2004, HUM MUTAT, V24, P474, DOI 10.1002/humu.20101; MOOSER V, 1995, HUM MOL GENET, V4, P173, DOI 10.1093/hmg/4.2.173; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Scholz M, 1999, EUR J HUM GENET, V7, P169, DOI 10.1038/sj.ejhg.5200290; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Shiffman D, 2012, CLIN THER, V34, P1387, DOI 10.1016/j.clinthera.2012.04.004; Hoogeveen RC, 2001, J LIPID RES, V42, P631; Chasman DI, 2009, ATHEROSCLEROSIS, V203, P371, DOI 10.1016/j.atherosclerosis.2008.07.019; Gambhir JK, 2008, CLIN BIOCHEM, V41, P453, DOI 10.1016/j.clinbiochem.2008.01.016; Anderson JL, 2013, AM J CARDIOL, V112, P799, DOI 10.1016/j.amjcard.2013.05.009; Schmidt K, 2006, EUR J HUM GENET, V14, P190, DOI 10.1038/sj.ejhg.5201512; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Haibach C, 1998, GENE, V208, P253, DOI 10.1016/S0378-1119(97)00657-4; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; Rao VS, 2009, THROMB HAEMOSTASIS, V102, P379, DOI 10.1160/TH08-01-0018; KRAFT HG, 1992, HUM GENET, V90, P220; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; Kronenberg F, 2014, J INTERN MED, V276, P243, DOI 10.1111/joim.12207; Arai K, 2010, ATHEROSCLEROSIS, V209, P498, DOI 10.1016/j.atherosclerosis.2009.09.077; Erqou S, 2010, J AM COLL CARDIOL, V55, P2160, DOI 10.1016/j.jacc.2009.10.080; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; Rowland CM, 2014, THROMB RES, V133, P863, DOI 10.1016/j.thromres.2014.01.024; Erdel M, 1999, NAT GENET, V21, P357; Ogorelkova M, 1999, HUM MOL GENET, V8, P2087, DOI 10.1093/hmg/8.11.2087; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Brunner C, 1996, J BIOL CHEM, V271, P32403; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Banerjee D., 2011, J LIPIDS, V2011, DOI DOI 10.1155/2011/291954; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Coronary Artery Disease Genetics Consortium, 2011, NAT GENET, V43, P339; Kraft HG, 1996, ATHEROSCLEROSIS, V125, P53, DOI 10.1016/0021-9150(96)05844-3; Li ZG, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-127; Noureen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121582; Qin S, 1995, Zhonghua Yi Xue Za Zhi, V75, P588; WHITE AL, 1994, J BIOL CHEM, V269, P9060	50	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					521	528		10.1016/j.atherosclerosis.2015.07.015		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000021		
J	Izuhara, M; Ono, K; Shiomi, H; Morimoto, T; Furukawa, Y; Nakagawa, Y; Shizuta, S; Tada, T; Tazaki, J; Horie, T; Kuwabara, Y; Baba, O; Nishino, T; Kita, T; Kimura, T				Izuhara, Masayasu; Ono, Koh; Shiomi, Hiroki; Morimoto, Takeshi; Furukawa, Yutaka; Nakagawa, Yoshihisa; Shizuta, Satoshi; Tada, Tomohisa; Tazaki, Junichi; Horie, Takahiro; Kuwabara, Yasuhide; Baba, Osamu; Nishino, Tomohiro; Kita, Toru; Kimura, Takeshi		CREDO-Kyoto PCI CABG Registry Coho	High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: A report from the CREDO-Kyoto registry cohort-2	ATHEROSCLEROSIS			English	Article						High-density; Lipoprotein cholesterol; Myocardial infarction; Percutaneous coronary intervention; Statin	APOLIPOPROTEIN-A-I; HDL-CHOLESTEROL; STATIN THERAPY; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; CLINICAL-OUTCOMES; EFFLUX CAPACITY; HIGH-RISK; EVENTS; TRIAL	Objective: To determine whether low HDL-C is a risk factor for adverse cardiovascular events in patients with known CAD. Methods: We evaluated 10,391 patients who underwent PCI from January 2005 to December 2007. In total, 3838 (36.9%) patients had low HDL-C (HDL-C < 40 mg/dL in males and < 50 mg/dL in females) and 6553 (63.1%) patients had normal HDL-C based on measurements on admission. Results: The unadjusted 5-year incidence of major adverse cardiac events (MACE: composite of cardiovascular death, myocardial infarction or stroke) was significantly higher in the low HDL-C group than in the normal HDL-C group (17.6% vs. 14.0%, P < 0.0001). However, after adjusting for confounders, low HDL-C was not associated with a higher risk of MACE (adjusted hazard ratio [HR] 1.07, 95% confidence interval (CI) 0.97-1.19; P = 0.19). There was no significant interaction between the effect of low HDL-C on MACE and several subgroup factors including age, sex, clinical presentation of CAD, statins use, serum low-density lipoprotein cholesterol level, and serum triglycerides level. Conclusion: Low HDL-C, as compared with normal HDL-C, was not associated with higher 5-year risk of MACE in patients who underwent PCI. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Izuhara, Masayasu; Ono, Koh; Shiomi, Hiroki; Shizuta, Satoshi; Tada, Tomohisa; Tazaki, Junichi; Horie, Takahiro; Kuwabara, Yasuhide; Baba, Osamu; Nishino, Tomohiro; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Div Gen Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Furukawa, Yutaka; Kita, Toru] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Nakagawa, Yoshihisa] Tenri Hosp, Dept Cardiol, Tokyo, Japan	Ono, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kohono@kuhp.kyoto-u.ac.jp			Pharmaceuticals and Medical Devices Agency (PMDA) of Japan	This study was supported by the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan.	van de Woestijne AP, 2013, J AM COLL CARDIOL, V62, P1834, DOI 10.1016/j.jacc.2013.04.101; Chenevard R, 2012, CARDIOVASC THER, V30, pe51, DOI 10.1111/j.1755-5922.2010.00221.x; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; Rosenson RS, 2005, AM J MED, V118, P1067, DOI 10.1016/j.amjmed.2004.12.021; Sattler KJE, 2009, EUR HEART J, V30, P1894, DOI 10.1093/eurheartj/ehp183; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Seo SM, 2011, HEART, V97, P1943, DOI 10.1136/hrt.2011.225466; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; BURING JE, 1992, CIRCULATION, V85, P22; SHAH PK, 1992, CIRCULATION, V85, P1279; Wolfram RM, 2006, AM J CARDIOL, V98, P711, DOI 10.1016/j.amjcard.2006.04.006; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; GENEST JJ, 1992, CIRCULATION, V85, P2025; Topakian R, 2008, EUR J NEUROL, V15, P179, DOI 10.1111/j.1468-1331.2007.02026.x; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Ghazzal ZB, 2009, AM J CARDIOL, V103, P902, DOI 10.1016/j.amjcard.2008.11.053; Peng DC, 2011, BRIT J PHARMACOL, V162, P1792, DOI 10.1111/j.1476-5381.2011.01202.x; Cordero A, 2012, REV ESP CARDIOL, V65, P319, DOI [10.1016/j.recesp.2011.07.022, 10.1016/j.rec.2011.09.003]; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Tziakas DN, 2007, ATHEROSCLEROSIS, V193, P196, DOI 10.1016/j.atherosclerosis.2006.06.016; Sukhija R, 2007, AM J CARDIOL, V100, P777, DOI 10.1016/j.amjcard.2007.03.097; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Santos-Gallego CG, 2012, REV ESP CARDIOL, V65, P305, DOI [10.1016/j.recesp.2011.10.021, 10.1016/j.rec.2011.10.023]; Ridker PM, 2010, LANCET, V376, P333, DOI 10.1016/S0140-6736(10)60713-1; Yamashita S, 2010, J ATHEROSCLER THROMB, V17, P436; Shah PK, 2011, NAT REV CARDIOL, V8, P187, DOI 10.1038/nrcardio.2011.37; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Khera AV, 2013, J AM COLL CARDIOL, V62, P1909, DOI 10.1016/j.jacc.2013.07.025; CASTELLI WP, 1983, AM HEART J, V106, P1191, DOI 10.1016/0002-8703(83)90174-6; Rousset X, 2010, J PHARMACOL EXP THER, V335, P140, DOI 10.1124/jpet.110.169540; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; GENEST J, 1992, J AM COLL CARDIOL, V19, P792; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Horie T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003376; Kimura Takeshi, 2011, Cardiovasc Interv Ther, V26, P234, DOI 10.1007/s12928-011-0065-0; Nagano Makoto, 2004, J Atheroscler Thromb, V11, P110; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; ROTTIERS V, 2013, SCI TRANSL MED, V0005; Santos-Gallego CG, 2014, ENDOCRIN METAB CLIN, V43, P913, DOI 10.1016/j.ecl.2014.08.001	46	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					632	638		10.1016/j.atherosclerosis.2015.05.010		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000037		
J	Hara, T; Fukuda, D; Tanaka, K; Higashikuni, Y; Hirata, Y; Nishimoto, S; Yagi, S; Yamada, H; Soeki, T; Wakatsuki, T; Shimabukuro, M; Sata, M				Hara, Tomoya; Fukuda, Daiju; Tanaka, Kimie; Higashikuni, Yasutomi; Hirata, Yoichiro; Nishimoto, Sachiko; Yagi, Shusuke; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Sata, Masataka			Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice	ATHEROSCLEROSIS			English	Article						Macrophages; Atherosclerosis; Inflammation; Coagulation; Activated factor X; Rivaroxaban	FACTOR-XA INHIBITOR; ACUTE CORONARY SYNDROME; COAGULATION-FACTOR XA; ACS 2-TIMI 51; ACTIVATED RECEPTOR; ANTITHROMBOTIC AGENT; THROMBIN RECEPTOR; TISSUE FACTOR; MOUSE MODEL; IN-VITRO	Objective: Activated factor X (FXa) plays a key role in the coagulation cascade, whereas accumulating evidence suggests that it also contributes to the pathophysiology of chronic inflammation on the vasculature. In this study, we assessed the hypothesis that rivaroxaban (Riv), a direct FXa inhibitor, inhibits atherogenesis by reducing macrophage activation. Methods and results: Expression levels of PAR-1 and PAR-2, receptors for FXa, increased in the aorta of apolipoprotein E-deficient (ApoE(-/-)) mice compared with wild-type mice (P < 0.01, P < 0.05, respectively). Administration of Riv (5 mg/kg/day) for 20 weeks to 8-week-old ApoE(-/-) mice reduced atherosclerotic lesion progression in the aortic arch as determined by en-face Sudan IV staining compared with the non-treated group (P < 0.05) without alteration of plasma lipid levels and blood pressure. Histological analyses demonstrated that Riv significantly decreased lipid deposition, collagen loss, macrophage accumulation and matrix metallopeptidase-9 (MMP-9) expression in atherosclerotic plaques in the aortic root. Quantitative RT-PCR analyses using abdominal aorta revealed that Riv significantly reduced mRNA expression of inflammatory molecules, such as MMP-9, tumor necrosis factor-alpha (TNF-alpha). In vitro experiments using mouse peritoneal macrophages or murine macrophage cell line RAW264.7 demonstrated that FXa increased mRNA expression of inflammatory molecules (e.g., interleukin (IL)-1 beta and TNF-a), which was blocked in the presence of Riv. Conclusions: Riv attenuates atherosclerotic plaque progression and destabilization in ApoE(-/-) mice, at least in part by inhibiting pro-inflammatory activation of macrophages. These results indicate that Riv may be particularly beneficial for the management of atherosclerotic diseases, in addition to its antithrombotic activity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hara, Tomoya; Yagi, Shusuke; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Fukuda, Daiju; Shimabukuro, Michio] Univ Tokushima, Inst Hlth Biosci, Dept Cardiodiabet Med, Grad Sch, Tokushima 7708503, Japan; [Tanaka, Kimie; Shimabukuro, Michio] Univ Tokyo, Div Hlth Serv Promot, Tokyo, Japan; [Higashikuni, Yasutomi] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Hirata, Yoichiro] Tokyo Univ Hosp, Dept Pediat, Tokyo 113, Japan; [Nishimoto, Sachiko] Univ Tokushima, Inst Hlth Biosci, Dept Nutr & Metab, Grad Sch, Tokushima 7708503, Japan	Fukuda, D (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Cardiodiabet Med, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	daiju.fukuda@tokushima-u.ac.jp; masataka.sata@tokushima-u.ac.jp			JSPS Kakenhi Grants [25460369, 25860586, 25860843, 23591314, 24659392, 22390159, 25670390, 25293184]; MEXT KAKENHI Grant [21117007]; Japan Research Promotion Society for Cardiovascular Diseases; Vehicle Racing Commemorative Foundation; Bayer Yakuhin, Ltd.	This work was partially supported by JSPS Kakenhi Grants (Number 25460369 to D.F., Number 25860586 to Y. Higashikuni, Number 25860843 to Y. Hirata, Number 23591314 to M. Shimabukuro, and Number 24659392, 22390159, 25670390, 25293184 to M. Sata), MEXT KAKENHI Grant Number 21117007 (M. Sata) and Sakakibara Memorial Research Grant from The Japan Research Promotion Society for Cardiovascular Diseases (D.F.), and the Grant from The Vehicle Racing Commemorative Foundation (K.T. and M. Sata). Dr. Sata received research funding from Bayer Yakuhin, Ltd. The funders had no role in study design, data collection, and analysis, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STAT MED R, P179; Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185; ONeill TP, 1997, TOXICOL PATHOL, V25, P20; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; SCHUMACHER WA, 1994, EUR J PHARMACOL, V259, P165, DOI 10.1016/0014-2999(94)90506-1; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; RAGOSTA M, 1994, CIRCULATION, V89, P1262; Santos-Gallego CG, 2014, EUR HEART J SUPPL, V16, pA56, DOI 10.1093/eurheartj/sut013; Major CD, 2003, ARTERIOSCL THROM VAS, V23, P931, DOI 10.1161/01.ATV.0000070100.47907.26; Sparkenbaugh EM, 2014, BLOOD, V123, P1747, DOI 10.1182/blood-2013-08-523936; Gulseth MP, 2008, AM J HEALTH-SYST PH, V65, P1520, DOI 10.2146/ajhp070624; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Mega JL, 2013, AM J CARDIOL, V112, P472, DOI 10.1016/j.amjcard.2013.04.011; Ageno W, 2012, THROMB HAEMOSTASIS, V107, P1027, DOI 10.1160/TH11-11-0787; Gabazza EC, 2004, INT J HEMATOL, V79, P117, DOI 10.1532/IJH97.03165; Zhou QX, 2011, MEDIAT INFLAMM, DOI 10.1155/2011/432080; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Nystedt S, 1996, J BIOL CHEM, V271, P14910; Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Moghadasian MH, 1999, LAB INVEST, V79, P355; Turpie AGG, 2007, ARTERIOSCL THROM VAS, V27, P1238, DOI 10.1161/ATVBAHA.107.139402; Lloyd DJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE496, DOI 10.1152/ajpendo.00509.2007; Krantz MJ, 2013, J AM COLL CARDIOL, V62, P777, DOI 10.1016/j.jacc.2013.05.024; Heran C, 2000, EUR J PHARMACOL, V389, P201, DOI 10.1016/S0014-2999(99)00902-4; Roehrig S, 2005, J MED CHEM, V48, P5900, DOI 10.1021/jm050101d; Mega J L, 2009, Lancet, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Berkner KL, 2004, J THROMB HAEMOST, V2, P2118, DOI 10.1111/j.1538-7836.2004.00968.x; Tiwari RL, 2008, MED RES REV, V28, P483, DOI 10.1002/med.20118; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Ellinghaus P., 2011, J THROMB HAEMOST, V9, P1; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ross R, 1999, NEW ENGL J MED, V340, P115; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; Spronk HMH, 2014, CARDIOVASC RES, V101, P344, DOI 10.1093/cvr/cvt343	43	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	OCT	2015	242	2					639	646		10.1016/j.atherosclerosis.2015.03.023		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR7DV	WOS:000361509000038		
J	Kunisawa, K; Nakashima, N; Nagao, M; Nomura, T; Kinoshita, S; Hiramatsu, M				Kunisawa, K.; Nakashima, N.; Nagao, M.; Nomura, T.; Kinoshita, S.; Hiramatsu, M.			Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex	BEHAVIOURAL BRAIN RESEARCH			English	Article						Betaine; Homocysteine; Hcy; Memory; Matrix metalloproteinase-9; MMP-9; Frontal cortex	BRAIN-BARRIER DYSFUNCTION; FOCAL CEREBRAL-ISCHEMIA; INDUCED DELAYED AMNESIA; NF-KAPPA-B; OXIDATIVE STRESS; RAT-BRAIN; COGNITIVE IMPAIRMENT; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; INDUCED MMP-9	Betaine plays important roles that include acting as a methyl donor and converting homocysteine (Hcy) to methionine. Elevated plasma Hcy levels are known as hyperhomocysteinemia (HHcy) and contribute to impairments of learning and memory. Although it is commonly known that betaine plays an important role in Hcy metabolism, the effects of betaine on Hcy-induced memory impairment have not been investigated. Previously, we demonstrated the beneficial effects of betaine on acute stress and lipopolysaccharide-induced memory impairment. In the present study, we investigated whether betaine ameliorates Hcy-induced memory impairment and the underlying mechanisms of this putative effect. Mice were treated with Hcy (0.162 mg/kg, s.c.) twice a day for nine days, and betaine (25 mg/kg, s.c.) was administered 30 min before the Hcy injections. The memory functions were evaluated using a spontaneous alternation performance test (Y-maze) at seven days and a step-down type passive avoidance test (SD) at nine and ten days after Hcy injection. We found that betaine suppressed the memory impairment induced by repeated Hcy injections. However, the blood concentrations of Hcy were significantly increased in the Hcy-treated mice immediately after the passive avoidance test, and betaine did not prevent this increase. Furthermore, Hcy induces redox stress in part by activating matrix metalloproteinase-9 (MMP-9), which leads to BBB dysfunction. Therefore, we tested whether betaine affected MMP-9 activity. Interestingly, treatment with betaine significantly inhibited Hcy-induced MMP-9 activity in the frontal cortex but not in the hippocampus after acute Hcy injection. These results suggest that the changes in MMP-9 activity after betaine treatment might have been partially responsible for the amelioration of the memory deficits and that MMP-9 might be a candidate therapeutic target for HHcy. (C) 2015 Elsevier B.V. All rights reserved.	[Kunisawa, K.; Nakashima, N.; Nagao, M.; Nomura, T.; Kinoshita, S.; Hiramatsu, M.] Meijo Univ, Dept Chem Pharmacol, Fac Pharm, Grad Sch Pharm, Nagoya, Aichi 4688503, Japan; [Hiramatsu, M.] Meijo Univ, Lab Neuropsychopharmacol, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688503, Japan	Hiramatsu, M (reprint author), Meijo Univ, Correspondence Dept Chem Pharmacol, Fac Pharm, Tenpaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.				Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Academic Frontier Project for Private Universities	This study was supported in part by a collaboration with the Local Communities Project from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Academic Frontier Project for Private Universities, which matched the subsidy provided by MEXT, and the International Center for Green Biotechnology of Meijo University to Teruhiro Takabe. We would like to thank Dr. Toshitaka Nabeshima for fruitful comments.	Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; Tyagi N, 2009, J CELL PHYSIOL, V220, P257, DOI 10.1002/jcp.21757; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Melse-Boonstra A, 2005, AM J CLIN NUTR, V81, P1378; Fujimura M, 1999, J CEREBR BLOOD F MET, V19, P495; Boxer AL, 2005, NEUROLOGY, V64, P1431; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Eikelboom JW, 1999, ANN INTERN MED, V131, P363; Barak AJ, 1996, ALCOHOL, V13, P483, DOI 10.1016/0741-8329(96)00040-7; VANDENBERG M, 1995, NEURORADIOLOGY, V37, P403; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Go EK, 2005, J GERONTOL A-BIOL, V60, P1252; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Mon NN, 2006, CANCER RES, V66, P6778, DOI 10.1158/0008-5472.CAN-05-4159; Sunden SLF, 1997, ARCH BIOCHEM BIOPHYS, V345, P171, DOI 10.1006/abbi.1997.0246; Reis EA, 2002, METAB BRAIN DIS, V17, P211, DOI 10.1023/A:1019982223034; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Hiramatsu M, 1996, EUR J PHARMACOL, V315, P119, DOI 10.1016/S0014-2999(96)00622-X; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Obeid R, 2007, CLIN CHEM LAB MED, V45, P1590, DOI 10.1515/CCLM.2007.356; Tsai HC, 2008, AM J TROP MED HYG, V78, P20; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Hiramatsu M, 1997, PHARMACOL BIOCHEM BE, V56, P73, DOI 10.1016/S0091-3057(96)00159-1; Lee GA, 2004, NEUROSCI LETT, V356, P111, DOI 10.1016/j.neulet.2003.11.030; BORDEN LA, 1995, J NEUROCHEM, V64, P977; Martin-Aragon S, 2009, NEUROCHEM RES, V34, P373, DOI 10.1007/s11064-008-9789-3; Lehre AC, 2011, EPILEPSY RES, V95, P70, DOI 10.1016/j.eplepsyres.2011.02.014; Kalani A, 2013, MOL NEUROBIOL, V48, P157, DOI 10.1007/s12035-013-8421-y; Zhang CE, 2009, AM J PATHOL, V174, P1481, DOI 10.2353/ajpath.2009.081036; Christie LA, 2005, NEUROSCI LETT, V373, P119, DOI 10.1016/j.neulet.2004.09.072; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Ferrario A, 2004, CANCER RES, V64, P2328, DOI 10.1158/0008-5472.CAN-04-0071; Romanic AM, 1998, STROKE, V29, P1020; Go EK, 2007, BIOL PHARM BULL, V30, P2244, DOI 10.1248/bpb.30.2244; Platenik J, 2005, J NEUROCHEM, V95, P1446, DOI 10.1111/j.1471-4159.03471.x; Schwab U, 2002, AM J CLIN NUTR, V76, P961; Dal-Pizzol F, 2013, MOL NEUROBIOL, V48, P62, DOI 10.1007/s12035-013-8433-7; Steenge GR, 2003, J NUTR, V133, P1291; Zhang CE, 2008, NEUROBIOL AGING, V29, P1654, DOI 10.1016/j.neurobiolaging.2007.04.015; Lee SJ, 2012, TOXICOL APPL PHARM, V260, P89, DOI 10.1016/j.taap.2012.01.026; Chai GS, 2013, J NEUROCHEM, V124, P388, DOI 10.1111/jnc.12094; Ataie A, 2010, J MED FOOD, V13, P821, DOI 10.1089/jmf.2009.1278; Kruman II, 2000, J NEUROSCI, V20, P6920; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; Barichello T, 2006, CRIT CARE MED, V34, P886, DOI 10.1097/01.CCM.0000201880.50116/12; Lee SW, 2005, DIABETES RES CLIN PR, V69, P175, DOI 10.1016/j.diabres.2004.12.010; Kinoshita S., 2011, J PHARM SCI S, V115; Miwa M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-153; Moshal KS, 2006, AM J PHYSIOL-CELL PH, V290, pC883, DOI 10.1152/ajpcell.00359.2005; Oliveira A. C., 2004, PHARM BIOCH BEHAV, V77, P269; Sandy S., 2004, INT J BIOCHEM CELL B, V36, P870; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Takanaga Hitomi, 2001, Journal of Cerebral Blood Flow and Metabolism, V21, P1232; Zeisel SH, 2003, J NUTR, V133, P1302; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165; Zhou Y., 2012, AM J PHYSIOL-RENAL, V302, P316	59	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2015	292						36	43		10.1016/j.bbr.2015.06.004		8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR8EI	WOS:000361583500005		
J	Kitamura, Y; Hattori, S; Yoneda, S; Watanabe, S; Kanemoto, E; Sugimoto, M; Kawai, T; Machida, A; Kanzaki, H; Miyazaki, I; Asanuma, M; Sendo, T				Kitamura, Yoshihisa; Hattori, Sayo; Yoneda, Saori; Watanabe, Saori; Kanemoto, Erika; Sugimoto, Misaki; Kawai, Toshiki; Machida, Ayumi; Kanzaki, Hirotaka; Miyazaki, Ikuko; Asanuma, Masato; Sendo, Toshiaki			Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation	BEHAVIOURAL BRAIN RESEARCH			English	Article						Doxorubicin; Cyclophosphamide; Anhedonia; Anxiety; Cognitive impairment; Neurogenesis; Brain-derived neurotrophic factor; Cyclin D1	RECEIVING ADJUVANT CHEMOTHERAPY; HORMONE-TREATED RATS; CHRONIC MILD STRESS; CELL-PROLIFERATION; BREAST-CANCER; DEPRESSED-PATIENTS; MAJOR DEPRESSION; TYROSINE KINASE; BDNF RELEASE; PLATELETS	Many patients who have received chemotherapy to treat cancer experience depressive- and anxiety-like symptoms or cognitive impairment. However, despite the evidence for this, the underlying mechanisms are still not understood. This study investigated behavioral and biochemical changes upon treatment with doxorubicin and cyclophosphamide, focusing on mental and cognitive systems, as well as neurogenesis in male rats. Doxorubicin (2 mg/kg), cyclophosphamide (50 mg/kg), and the combination of doxorubicin and cyclophosphamide were injected intraperitoneally once per week for 4 weeks. In particular, the co-administration of doxorubicin and cyclophosphamide produced anhedonia-like, anxiety-like, and spatial cognitive impairments in rats. It also reduced both the number of proliferating cells in the subgranular zone of the hippocampal dentate gyrus and their survival. Serum brain-derived neurotrophic factor (BDNF) levels were decreased along with chemotherapy-induced decreases in platelet levels. However, hippocampal BDNF levels and Bdnf mRNA levels were not decreased by this treatment. On the other hand, hippocampal cyclin D1 levels were significantly decreased by chemotherapy. These results suggest that the co-administration of doxorubicin and cyclophosphamide induces psychological and cognitive impairment, in addition to negatively affecting hippocampal neurogenesis, which may be related to hippocampal cyclin D1 levels, but not hippocampal BDNF levels. (C) 2015 Elsevier B.V. All rights reserved.	[Kitamura, Yoshihisa; Hattori, Sayo; Yoneda, Saori; Watanabe, Saori; Kanemoto, Erika; Sugimoto, Misaki; Kawai, Toshiki; Machida, Ayumi; Kanzaki, Hirotaka; Sendo, Toshiaki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Pharm, Kita Ku, Okayama 7008558, Japan; [Miyazaki, Ikuko; Asanuma, Masato] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Kita Ku, Okayama 7008558, Japan	Kitamura, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Pharm, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kitamu-y@cc.okayama-u.ac.jp			Smoking Research Foundation in Japan	This work was supported by a grant from the Smoking Research Foundation in Japan (YK). The funders had no role in study design, data collection, analysis, or the decision to prepare or submit the manuscript.	Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Mustafa S, 2008, EUR J NEUROSCI, V28, P323, DOI 10.1111/j.1460-9568.2008.06325.x; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1091/0269216302pm507oa; Doi M, 2010, ACTA MED OKAYAMA, V64, P219; Tannock IF, 2004, J CLIN ONCOL, V22, P2233, DOI 10.1200/JCO.2004.08.094; Dagyte G, 2011, BEHAV BRAIN RES, V218, P121, DOI 10.1016/j.bbr.2010.11.045; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tchen N, 2003, J CLIN ONCOL, V21, P4175, DOI 10.1200/JCO.2003.01.119; Sheline YI, 1999, J NEUROSCI, V19, P5034; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Ahles TA, 2002, J CLIN ONCOL, V20, P485, DOI 10.1200/JCO.20.2.485; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Lee BH, 2009, PROG NEURO-PSYCHOPH, V33, P849, DOI 10.1016/j.pnpbp.2009.04.002; Somers JM, 2004, CAN J PSYCHIAT, V49, P373; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; Kitamura Y, 2011, BIOL PHARM BULL, V34, P77, DOI 10.1248/bpb.34.77; Watanabe K, 2010, PROG NEURO-PSYCHOPH, V34, P1450, DOI 10.1016/j.pnpbp.2010.07.036; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Pencea V, 2001, J NEUROSCI, V21, P6706; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; [Anonymous], 2014, BIOCH BEHAV, DOI DOI 10.1016/J.PBB.2014.04.003; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143; Schagen SB, 1999, CANCER, V85, P640, DOI 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G; Brezden CB, 2000, J CLIN ONCOL, V18, P2695; Matsuoka Y, 2007, BIOCHEM BIOPH RES CO, V362, P682, DOI 10.1017/j.bbrc.2007.08.022; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Deltheil T, 2009, INT J NEUROPSYCHOPH, V12, P905, DOI 10.1017/S1461145709000017; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Merzoug S, 2011, PHARMACOL BIOCHEM BE, V99, P639, DOI 10.1016/j.pbb.2011.06.015; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Falleti MG, 2005, BRAIN COGNITION, V59, P60, DOI 10.1016/j.bandc.2005.05.001; Aziriova S, 2014, PHARMACOL BIOCHEM BE, V124, P284, DOI 10.1016/j.pbb.2014.06.021; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Murray P.S., 2011, INT J PEPT, V2011, DOI DOI 10.1155/2011/654085; Stafford L., 2015, SUPPORTIVE CARE CANC; Wittmann Marc, 2006, Palliat Support Care, V4, P357, DOI 10.1017/S1478951506060469	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2015	292						184	193		10.1016/j.bbr.2015.06.007		10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR8EI	WOS:000361583500023		
J	Saitoh, A; Makino, Y; Hashimoto, T; Yamada, M; Gotoh, L; Sugiyama, A; Ohashi, M; Tsukagoshi, M; Oka, JI; Yamada, M				Saitoh, Akiyoshi; Makino, Yuya; Hashimoto, Tomio; Yamada, Misa; Gotoh, Leo; Sugiyama, Azusa; Ohashi, Masanori; Tsukagoshi, Mai; Oka, Jun-Ichiro; Yamada, Mitsuhiko			The voltage-gated sodium channel activator veratrine induces anxiogenic-like behaviors in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Innate anxiety; Anxiety-like behaviors; Riluzole; Diazepam; Anxiolytics	OPEN-LABEL TRIAL; OBSESSIVE-COMPULSIVE DISORDER; PLUS-MAZE; RECEPTOR AGONIST; ANIMAL-MODEL; RILUZOLE; ANXIETY; GLUTAMATE; SCN8A; MICE	In this study, we investigated the anxiogenic-like effects of systemically administered veratrine in rat models of anxiety. In the light/dark test, veratrine (0.6 mg/kg, s.c.) significantly and dose-dependently decreased the time rats spent in and the number of entries into a light box 30 min after administration, suggesting that veratrine increases anxiety-like behaviors. These findings were also supported by results from the elevated-plus maze test and the tail-swing behavior test. In addition, veratrine (0.6 mg/kg, s.c.) significantly increased the plasma concentration of corticosterone, an endogenous biomarker for anxiety, compared to vehicle. On the basis of these results, we conclude that veratrine induces anxiogenic-like behaviors in rats. The anxiogenic-like behaviors induced by veratrine (0.6 mg/kg, s.c.) were completely abolished by co-treatment with the typical benzodiazepine anxiolytic diazepam (1 mg/kg, s.c.), when assessed in the elevated-plus maze test. Similar results were obtained with co-treatment with riluzole (10 mg/kg, p.o.), which directly affects the glutamatergic system and has recently been suggested to have anxiolytic-like effects. In conclusion, this study provides evidence that systemically administered veratrine induces anxiogenic-like behaviors in rats. We propose the veratrine model as a novel pathological animal model to explore possible candidate drugs for anxiolytics. (C) 2015 Elsevier B.V. All rights reserved.	[Saitoh, Akiyoshi; Makino, Yuya; Hashimoto, Tomio; Yamada, Misa; Gotoh, Leo; Sugiyama, Azusa; Ohashi, Masanori; Tsukagoshi, Mai; Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Makino, Yuya; Sugiyama, Azusa; Ohashi, Masanori; Tsukagoshi, Mai; Oka, Jun-Ichiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Pharmacol Lab, Chiba 2788510, Japan	Saitoh, A (reprint author), Natl Ctr Neurol & Psychiat, Dept Neuropsychopharmacol, Natl Inst Mental Hlth, 4-1-1 Ogawahigashimachi, Kodaira, Tokyo 1878553, Japan.	asaitoh@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan [24-2]	This research was supported by research grants from Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, Japan. This manuscript was checked for English grammar and spelling by a professional scientific editing company (Exact Science Communications LLC; http://www.exactsci.com). We are entirely responsible for the scientific content of this manuscript.	McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Sanacora G, 2007, BIOL PSYCHIAT, V61, P822, DOI 10.1016/j.biopsych.2006.08.037; LUCKI I, 1989, J PHARMACOL EXP THER, V249, P155; LAHTI RA, 1975, RES COMMUN CHEM PATH, V11, P595; DRINGENBERG HC, 1995, BEHAV BRAIN RES, V68, P229, DOI 10.1016/0166-4328(94)00174-E; Waldmeier PC, 1996, N-S ARCH PHARMACOL, V354, P164; Grant P, 2007, J CHILD ADOL PSYCHOP, V17, P761, DOI 10.1089/cap.2007.0021; PELLOW S, 1985, PHYSIOL BEHAV, V35, P587, DOI 10.1016/0031-9384(85)90145-3; Lingamaneni R, 1999, NEUROSCI LETT, V276, P127, DOI 10.1016/S0304-3940(99)00810-1; Coric V, 2003, PSYCHOPHARMACOLOGY, V167, P219, DOI 10.1007/s00213-003-1396-z; Saitoh A, 2005, PSYCHOPHARMACOLOGY, V182, P327, DOI 10.1007/s00213-005-0112-6; Pittenger C, 2008, CNS DRUGS, V22, P761, DOI 10.2165/00023210-200822090-00004; Coric V, 2005, BIOL PSYCHIAT, V58, P424, DOI 10.1016/j.biopsych.2005.04.043; Sugiyama A, 2012, NEUROPHARMACOLOGY, V62, P2489, DOI 10.1016/j.neuropharm.2012.02.012; Golembiowska K, 2002, POL J PHARMACOL, V54, P625; Rodgers RJ, 2005, BEHAV PHARMACOL, V16, P405, DOI 10.1097/00008877-200509000-00013; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Takahashi K, 2011, BEHAV BRAIN RES, V216, P46, DOI 10.1016/j.bbr.2010.07.002; Cortese BM, 2005, CNS SPECTRUMS, V10, P820; SEMBA J, 1995, J NEURAL TRANSM-GEN, V100, P39, DOI 10.1007/BF01276864; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171; Dalvi A, 1996, PSYCHOPHARMACOLOGY, V128, P380, DOI 10.1007/s002130050148; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Mathew SJ, 2005, AM J PSYCHIAT, V162, P2379, DOI 10.1176/appi.ajp.162.12.2379; Hertzberg MA, 1999, BIOL PSYCHIAT, V45, P1226, DOI 10.1016/S0006-3223(99)00011-6; Ohashi M., 2014, PSYCHOPHARMACOLOGY B; Saitoh A, 2013, NEUROPHARMACOLOGY, V67, P485, DOI 10.1016/j.neuropharm.2012.11.025; Saitoh A., 2014, J NEUROSCI RES; Ukai M, 2003, METHOD FIND EXP CLIN, V25, P355, DOI 10.1358/mf.2003.25.5.769656; Wang Y, 2008, PROG NEURO-PSYCHOPH, V32, P1902, DOI 10.1016/j.pnpbp.2008.09.003; Wasserman D, 2005, AM J MED GENET B, V133B, P116, DOI 10.1002/ajmg.b.30128	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2015	292						316	322		10.1016/j.bbr.2015.06.022		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR8EI	WOS:000361583500037		
J	Yasue, M; Nakagami, A; Banno, T; Nakagaki, K; Ichinohe, N; Kawai, N				Yasue, Miyuki; Nakagami, Akiko; Banno, Taku; Nakagaki, Keiko; Ichinohe, Noritaka; Kawai, Nobuyuki			Indifference of marmosets with prenatal valproate exposure to third-party non-reciprocal interactions with otherwise avoided non-reciprocal individuals	BEHAVIOURAL BRAIN RESEARCH			English	Article						Animal model; Autistic spectrum disorder (ASD); Monkey; Third-party relationship; Social preference; Reciprocity	NONHUMAN-PRIMATES; ANIMAL-MODEL; AUTISM; GENERATION	Autism is characterized by deficits in social interaction and social recognition. Although animal models of autism have demonstrated that model animals engage less in social interaction or attend less to conspecifics than control animals, no animal model has yet replicated the deficit in recognition of complex social interaction as is seen in humans with autism. Here, we show that marmosets discriminated between human actors who reciprocated in social exchanges and those who did not; however, marmosets with foetal exposure to valproic acid (VPA marmosets) did not. In the reciprocal condition, two actors exchanged food equally, while in the non-reciprocal condition, one actor (non-reciprocator) ended up with all food and the other actor with none. After observing these exchanges, the control marmosets avoided receiving food from the non-reciprocator in the non-reciprocal condition. However, the VPA marmosets did not show differential preferences in either condition, suggesting that the VPA marmosets did not discriminate between reciprocal and non-reciprocal interactions. These results indicate that normal marmosets can evaluate social interaction between third-parties, while the VPA marmosets are unable to recognize whether an individual is being reciprocal or not. This test battery can serve as a useful tool to qualify primate models of autism. (C) 2015 Elsevier B.V. All rights reserved.	[Yasue, Miyuki; Nakagami, Akiko; Kawai, Nobuyuki] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Yasue, Miyuki; Nakagami, Akiko; Banno, Taku; Nakagaki, Keiko; Ichinohe, Noritaka; Kawai, Nobuyuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo, Japan; [Ichinohe, Noritaka] Lab Mol Anal Higher Brain Funct RIKEN BSI, Ichinohe Neural Syst Grp, Saitama, Japan	Ichinohe, N (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo, Japan.	nichino@ncnp.go.jp; kawai@is.nagoya-u.ac.jp			KAKENHI [24243068, 15K13159]; Intramural Research Grant for Neurological and Psychiatric Disorders from National Center of Neurology and Psychiatry [23-7]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Strategic Research Program for Brain Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25110740, 25117009, 26118717]	This research was supported by KAKENHI (B) 24243068, 15K13159 (to N.K), and by an Intramural Research Grant (grant number 23-7) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry, by a Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), by the Strategic Research Program for Brain Science, by a Grant-in-Aid for Scientific Research on Innovative Areas, "Foundation of Synapse Neurocircuit Pathology" (No. 25110740), "Glia-Assembly" (No.25117009), and "Seishun-no" (No.26118717) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to N.I.)	Anderson J. R., 2013, NAT COMMUN, V4; Landa RJ, 2007, ARCH GEN PSYCHIAT, V64, P853, DOI 10.1001/archpsyc.64.7.853; Kubo-Kawai N, 2007, J COMP PSYCHOL, V121, P189, DOI 10.1037/0735-7036.121.2.189; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Anderson JR, 2013, COGNITION, V127, P140, DOI 10.1016/j.cognition.2012.12.007; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Yamazaki Y, 2009, JPN PSYCHOL RES, V51, P182, DOI 10.1111/j.1468-5884.2009.00398.x; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Bambini V, 2011, BRAIN RES, V1408, P8, DOI 10.1016/j.brainres.2011.06.015; Chawarska K, 2007, J CHILD PSYCHOL PSYC, V48, P128, DOI 10.1111/j.1469-7610.2006.01685.x; Prescott MJ, 2007, ANIM WELFARE, V16, P21; Burkart J. M., 2014, NAT COMMUN, V5; Crawley Jacqueline N, 2012, Dialogues Clin Neurosci, V14, P293; Kawai N., 2014, BIOL LETT, V10; Phillips I R, 1976, Adv Anat Embryol Cell Biol, V52, P3; Yasue M., 2014, 74 ANN M JAP SOC AN	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2015	292						323	326		10.1016/j.bbr.2015.06.006		4	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR8EI	WOS:000361583500038		
J	Zhao, ZL; Sato, Y; Qin, L				Zhao, Zhenling; Sato, Yu; Qin, Ling			Response properties of neurons in the cat's putamen during auditory discrimination	BEHAVIOURAL BRAIN RESEARCH			English	Article						Striatum; Spike activity; Sound discrimination; Goal-directed behavior; Free-moving animal	CORTICAL DISCRIMINATION; TEMPORAL ASYMMETRY; PREFRONTAL CORTEX; PRIMATE PUTAMEN; OVERLYING AREAS; SINGLE NEURONS; STIMULI; STRIATUM; SOUND; TASK	The striatum integrates diverse convergent input and plays a critical role in the goal-directed behaviors. To date, the auditory functions of striatum are less studied. Recently, it was demonstrated that auditory cortico-striatal projections influence behavioral performance during a frequency discrimination task. To reveal the functions of striatal neurons in auditory discrimination, we recorded the single-unit spike activities in the putamen (dorsal striatum) of free-moving cats while performing a Go/No-go task to discriminate the sounds with different modulation rates (12.5 Hz vs. 50 Hz) or envelopes (damped vs. ramped). We found that the putamen neurons can be broadly divided into four groups according to their contributions to sound discrimination. First, 40% of neurons showed vigorous responses synchronized to the sound envelope, and could precisely discriminate different sounds. Second, 18% of neurons showed a high preference of ramped to damped sounds, but no preference for modulation rate. They could only discriminate the change of sound envelope. Third, 27% of neurons rapidly adapted to the sound stimuli, had no ability of sound discrimination. Fourth, 15% of neurons discriminated the sounds dependent on the reward-prediction. Comparing to passively listening condition, the activities of putamen neurons were significantly enhanced by the engagement of the auditory tasks, but not modulated by the cat's behavioral choice. The coexistence of multiple types of neurons suggests that the putamen is involved in the transformation from auditory representation to stimulus-reward association. (C) 2015 Elsevier B.V. All rights reserved.	[Zhao, Zhenling; Sato, Yu] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Physiol, Chuo Ku, Yamanashi 4093898, Japan; [Zhao, Zhenling] Jinan Univ, Sch Life Sci & Technol, Jinan Biomed R&D Ctr, Guangzhou 510632, Guangdong, Peoples R China; [Qin, Ling] China Med Univ, Dept Physiol, Shenyang 110001, Peoples R China	Qin, L (reprint author), China Med Univ, Dept Physiol, Shenyang 110001, Peoples R China.	qinlingling@yahoo.com			Japan Ministry of Education, Culture, Sports, Science and Technology [23700377, 08038015]; National Nature Science Foundation of China [31171057, 31471057]	We thank Professor Kazuo Kitamura for providing facilities for conducting the research, and N. Yaguchi for assistance with animal care. This study was supported by the Strategic Research Program for Brain Sciences 08038015 and Grant No.23700377 from the Japan Ministry of Education, Culture, Sports, Science and Technology (Y.S. and L.Q.), and the National Nature Science Foundation of China under Grant No. 31171057 and 31471057 (L.Q).	YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8; Hori Y, 2009, J NEUROPHYSIOL, V102, P3530, DOI 10.1152/jn.00104.2009; Lu T, 2001, J NEUROPHYSIOL, V85, P2364; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Hart G, 2014, NEUROBIOL LEARN MEM, V108, P104, DOI 10.1016/j.nlm.2013.11.003; Yamada H, 2013, J NEUROPHYSIOL, V109, P1140, DOI 10.1152/jn.00289.2012; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Akeroyd MA, 1997, J ACOUST SOC AM, V101, P430, DOI 10.1121/1.417988; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Zhang XA, 2012, BEHAV BRAIN RES, V232, P114, DOI 10.1016/j.bbr.2012.03.025; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; CLAREY JC, 1986, EXP BRAIN RES, V61, P432; BORDI F, 1992, J NEUROSCI, V12, P2493; Pasquereau B, 2007, J NEUROSCI, V27, P1176, DOI 10.1523/JNEUROSCI.3745-06.2007; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Fritz JB, 2010, NAT NEUROSCI, V13, P1011, DOI 10.1038/nn.2598; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Russ BE, 2008, CURR BIOL, V18, P1483, DOI 10.1016/j.cub.2008.08.054; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; Merchant H, 1997, J NEUROPHYSIOL, V77, P1132; TAKADA M, 1985, NEUROSCI LETT, V54, P207; Lemus L, 2009, P NATL ACAD SCI USA, V106, P9471, DOI 10.1073/pnas.0904066106; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Muranishi M, 2011, EXP BRAIN RES, V209, P235, DOI 10.1007/s00221-011-2545-y; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI [10.1016/j.jneumeth.2003.12.011, 10.1016/j.neumeth.2003.12.011]; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077; Niwa M, 2012, J NEUROSCI, V32, P9323, DOI 10.1523/JNEUROSCI.5832-11.2012; Irino T, 1996, J ACOUST SOC AM, V99, P2316, DOI 10.1121/1.415419; Dong C, 2013, J NEUROSCI, V33, P13126, DOI 10.1523/JNEUROSCI.1724-13.2013; Zhong RJ, 2014, J NEUROPHYSIOL, V111, P2124, DOI 10.1152/jn.00830.2013; Atiani S, 2014, NEURON, V82, P486, DOI 10.1016/j.neuron.2014.02.029; Tsunada J, 2011, J NEUROPHYSIOL, V105, P2634, DOI 10.1152/jn.00037.2011; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025895; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Kay R. H., 1982, PHYSL REV, V62; Kreitzer A. C., 2008, NEURON, V60; Lee Jung H, 2009, Front Integr Neurosci, V3, P16, DOI 10.3389/neuro.07.016.2009; Liu Y., 2010, BEHAV BRAIN RES, V215, P28; Ma HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052942; Mardia K. V., 2000, DIRECTIONAL STAT; Qin L, 2009, J NEUROSCI, V29, P15650, DOI 10.1523/JNEUROSCI.2442-09.2009; Reinoso-Suarez F, 1961, TOPOGRAPHISCHER HIRN; Wang J., 2013, NEUROSCIENCE, V256, P309; Xiong Q., 2015, NATURE, V521; Zhang XN, 2011, BEHAV BRAIN RES, V217, P315, DOI 10.1016/j.bbr.2010.10.034	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 1	2015	292						448	462		10.1016/j.bbr.2015.07.002		15	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CR8EI	WOS:000361583500052		
J	Goto, T; Okayama, T; Toyoda, A				Goto, Tatsuhiko; Okayama, Tsuyoshi; Toyoda, Atsushi			Strain differences in temporal changes of nesting behaviors in C57BL/6N, DBA/2N, and their F-1 hybrid mice assessed by a three-dimensional monitoring system	BEHAVIOURAL PROCESSES			English	Article						3D depth image; Behavior; Learning; Mouse; Nest building; Strain difference	BUILDING BEHAVIOR; SELECTION; PERFORMANCE; POPULATION; RESPONSES; CAMERA; RATS	Nest building is one of the innate behaviors that are widely observed throughout the animal kingdom. Previous studies have reported specific brain regions and genetic loci associated with nest building in mice. These studies mainly evaluated the nest structure, without observing the nesting process. In this study, we evaluated the effects of strain and learning on the nesting process of mice using a 3D depth camera. To determine the quality of the nest structure, a conventional scoring method, Deacon scores 1-5, was applied to the recorded depth images. The final score of the nest, latency to start nesting behavior, and latencies to reach Deacon scores 3-5, were determined using three genetically different mouse strains-C57BL/6NCrl (B6), DBA/2NCrICrlj (DBA), and B6D2F1/Crl (B6D2F1). The final score of the DBA nest was significantly lower than that of the B6D2F1 nest, and DBA mice showed significantly longer latency to start nest building than the other two strains in the first trial. By observing the time course of nest building, we confirmed that DBA mice took significantly longer to build their nests than B6 and B6D2F1 mice. Although we did not find any significant differences between DBA and B6 mice in the final assessment of the nest based on the Deacon method, overnight monitoring of the nesting behavior using a 3D depth camera could elucidate the clear differences in the amount of time spent nesting between DBA and B6 mice. In addition, the learning effect was more evident in DBA mice than it was in B6 in terms of latencies to reach Deacon score 3-5 in five repeated trials. DBA mice showed a gradual decrease in latency to build, whereas nesting behaviors of B6 mice were relatively consistent throughout the five trials. Therefore, our 3D depth image method gives higher resolution and structural information regarding the nesting process in mice. Future genetic analyses using the 3D assessment system will provide novel insights into the complex genetic basis for nesting and other behaviors in animals. (C) 2015 Elsevier B.V. All rights reserved.	[Goto, Tatsuhiko; Okayama, Tsuyoshi; Toyoda, Atsushi] Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan; [Goto, Tatsuhiko; Okayama, Tsuyoshi; Toyoda, Atsushi] Ibaraki Univ Cooperat Agr & Med Sci IUCAM, Ami, Ibaraki 3000393, Japan; [Okayama, Tsuyoshi; Toyoda, Atsushi] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo 1838509, Japan	Toyoda, A (reprint author), Ibaraki Univ, Coll Agr, Ami, Ibaraki 3000393, Japan.	atoyoda@mx.ibaraki.ac.jp			Ibaraki University Cooperation between Agriculture and Medical Science (IUCAM) (MEXT, Japan)	This research was supported in part by Ibaraki University Cooperation between Agriculture and Medical Science (IUCAM) (MEXT, Japan).	Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Okayama T, 2015, J NEUROSCI METH, V251, P151, DOI 10.1016/j.jneumeth.2015.05.019; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Koide T, 2012, EXP ANIM TOKYO, V61, P503; Matsumoto J, 2014, BEHAV BRAIN RES, V272, P16, DOI 10.1016/j.bbr.2014.06.047; Nadeau JH, 2012, MAMM GENOME, V23, P693, DOI 10.1007/s00335-012-9426-y; [Anonymous], 2013, JOVE-J VIS EXP; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Yalcin B, 2012, MAMM GENOME, V23, P719, DOI 10.1007/s00335-012-9409-z; FORDYCE DE, 1995, BRAIN RES, V672, P170, DOI 10.1016/0006-8993(94)01389-Y; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Mallon AM, 2012, MAMM GENOME, V23, P641, DOI 10.1007/s00335-012-9428-9; Peripato AC, 2002, GENETICS, V162, P1341; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Ou-Yang TH, 2011, J NEUROSCI METH, V201, P116, DOI 10.1016/j.jneumeth.2011.07.019; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-183X.2004.00076.x; ZARROW MX, 1971, HORM BEHAV, V2, P227, DOI 10.1016/0018-506X(71)90020-1; Bult A, 1996, BEHAV GENET, V26, P439, DOI 10.1007/BF02359488; Iio W, 2012, BIOCHEM BIOPH RES CO, V421, P301, DOI 10.1016/j.bbrc.2012.04.004; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; LYNCH CB, 1980, GENETICS, V96, P757; Bult A, 2000, BEHAV GENET, V30, P193, DOI 10.1023/A:1001962124005; Robinson L, 2014, J NEUROSCI METH, V234, P13, DOI 10.1016/j.jneumeth.2014.06.013; Belforte JE, 2009, NAT NEUROSCI, V13, P76, DOI DOI 10.1038/NN.2447; Etherton M. R., 2009, P NATL ACAD SCI USA, V106, P998; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Peripato A. C., 2012, FRONT GENET, P390	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-6357	1872-8308		BEHAV PROCESS	Behav. Processes	OCT	2015	119						86	92		10.1016/j.beproc.2015.07.007		7	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	CS0TF	WOS:000361774400013		
J	Masuda, Y; Takahashi, H; Hatakeyama, S				Masuda, Yasushi; Takahashi, Hidehisa; Hatakeyama, Shigetsugu			TRIM29 regulates the p63-mediated pathway in cervical cancer cells	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						TRIM29; Cell adhesion; Cervical cancer; p63; Integrin	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-PAPILLOMAVIRUS TYPES; TELANGIECTASIA GROUP-D; MEDIATOR COMPLEX; PROSTATE-CANCER; P63; TUMORIGENESIS; TRANSCRIPTION; PROTEIN; GENOME	Cell invasion and adhesion play an important role in cancer metastasis and are orchestrated by a complicated network of transcription factors including p63. Here, we show that a member of the tripartite motif protein family, TRIM29, is required for regulation of the p63-mediated pathway in cervical cancer cells. TRIM29 knockdown alters the adhesion and invasion activities of cervical cancer cells. TRIM29 knockdown and overexpression cause a significant decrease and increase of TAp63 alpha expression, respectively. TRIM29 knockdown alters the expression pattern of integrins and increases ZEB1 expression. TRIM29 is required for suppression of an increase in the adhesion activity of cells by TAp63 alpha. These findings suggest that TRIM29 regulates the p63-mediated pathway and the behavior of cervical cancer cells. (C) 2015 Elsevier B.V. All rights reserved.	[Masuda, Yasushi; Takahashi, Hidehisa; Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hatakeyama, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	hatas@med.hokudai.ac.jp		Hatakeyama, Shigetsugu/0000-0002-2150-9979	Ministry of Education, Culture, Sports, Science and Technology in Japan [24112006, 2439 0065]; Naito Foundation; Uehara Memorial Foundation	This work was supported in part by KAKENHI (24112006, 2439 0065) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and by the Naito Foundation and the Uehara Memorial Foundation (to S. Hatakeyama).	Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Maity G, 2010, MOL CELL BIOCHEM, V336, P65, DOI 10.1007/s11010-009-0256-5; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Tran MN, 2013, J BIOL CHEM, V288, P3275, DOI 10.1074/jbc.M112.408104; Kanno Y, 2014, ACTA HISTOCHEM, V116, P708, DOI 10.1016/j.acthis.2013.12.009; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Tang ZP, 2013, TUMOR BIOL, V34, P2835, DOI 10.1007/s13277-013-0843-7; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; KAPP LN, 1992, AM J HUM GENET, V51, P45; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Gallegos JR, 2008, J BIOL CHEM, V283, P66, DOI 10.1074/jbc.M704686200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kaewprag J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071611; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Wang LD, 2015, GENE DEV, V29, P171, DOI 10.1101/gad.253591.114	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	A				2296	2305		10.1016/j.bbamcr.2015.05.035		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TM	WOS:000361775100011		
J	Bozickovic, O; Hoang, T; Fenne, IS; Helland, T; Skartveit, L; Ouchida, M; Mellgren, G; Sagen, JV				Bozickovic, Olivera; Hoang, Tuyen; Fenne, Ingvild S.; Helland, Thomas; Skartveit, Linn; Ouchida, Mamoru; Mellgren, Gunnar; Sagen, Jorn V.			Cyclin C interacts with steroid receptor coactivator 2 and upregulates cell cycle genes in MCF-7 cells	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						GRIP1; TIF2; NCoA2; CycC; Mediator	BREAST-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; INTERMEDIARY FACTOR-2; NUCLEAR RECEPTORS; KINASE-ACTIVITY; PROTEIN-KINASE; EXPRESSION; CDK8; COMPLEX; MEDIATOR	Steroid receptor coactivator 2 (SRC-2) is a coactivator that regulates nuclear receptor activity. We previously reported that SRC-2 protein is degraded through the action of cAMP-dependent protein kinase A (PKA) and CAMP response element binding protein (CREB). In the study presented here, we aimed to identify proteins that interact with and thereby regulate SRC-2. We isolated cyclin C (CCNC) as an interacting partner with the SRC-2 degradation domain aa 347-758 in a yeast two-hybrid assay and confirmed direct interaction in an in vitro assay. The protein level of SRC-2 was increased with CCNC overexpression in COS-1 cells and decreased with CCNC silencing in COS-1 and MCF-7 cells. In a pulse-chase assay, we further show that silencing of CCNC resulted in a different SRC-2 degradation pattern during the first 6 h after the pulse. Finally, we provide evidence that CCNC regulates expression of cell cycle genes upregulated by SRC-2. In conclusion, our results suggest that CCNC temporarily protects SRC-2 against degradation and this event is involved in the transcriptional regulation of SRC-2 cell cycle target genes. (C) 2015 Elsevier B.V. All rights reserved.	[Bozickovic, Olivera; Hoang, Tuyen; Fenne, Ingvild S.; Helland, Thomas; Skartveit, Linn; Mellgren, Gunnar; Sagen, Jorn V.] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway; [Bozickovic, Olivera; Fenne, Ingvild S.; Helland, Thomas; Skartveit, Linn; Mellgren, Gunnar; Sagen, Jorn V.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Ouchida, Mamoru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Genet, Okayama, Japan	Sagen, JV (reprint author), Haukeland Hosp, Univ Bergen, Dept Clin Sci, Hormone Lab, N-5021 Bergen, Norway.	Olivera.Bozickovic@uib.no; Tuyen.Hoang@uib.no; fenneingvild@gmail.com; Thomas.Helland@uib.no; Linn.Skartveit@uib.no; ouchidam@md.okayama-u.acjp; Gunnar.Mellgren@uib.no; Jorn.Sagen@uib.no			University of Bergen.; Norwegian Cancer Society; Western Norway Regional Health Authority	The authors wish to thank Carol Cook for her expert technical assistance and proofreading, Dr. Lise Bj. Gundersen and Dr. Bente B. Johannson for their critical help in pulse-chase experiments, and Dr. Bert W. O'Malley (Baylor College of Medicine, USA) for his gift of expression vectors. This study was supported by the University of Bergen., Norwegian Cancer Society and Western Norway Regional Health Authority.	Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077; Hoang T, 2013, ENDOCRINOLOGY, V154, P1513, DOI 10.1210/en.2012-2049; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Wu JZ, 2012, ASIAN PAC J CANCER P, V13, P3681, DOI 10.7314/APJCP.2012.13.8.3681; Katona RL, 2007, ACTA BIOL HUNG, V58, P133, DOI 10.1556/ABiol.58.2007.1.12; Moiola C, 2012, CELL PHYSIOL BIOCHEM, V30, P596, DOI 10.1159/000341441; Thangavel C, 2013, CELL CYCLE, V12, P98, DOI 10.4161/cc.23029; Fenne IS, 2008, ENDOCRINOLOGY, V149, P4336, DOI 10.1210/en.2008-0037; Ohata N, 2006, INT J MOL MED, V18, P1153; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; Tian J, 2009, PHYSIOL GENOMICS, V40, P48, DOI 10.1152/physiolgenomics.00094.2009; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Kurebayashi J, 2000, CLIN CANCER RES, V6, P512; Miyata Y, 2010, STEM CELLS, V28, P308, DOI 10.1002/stem.270; Modder UI, 2009, J BIOL CHEM, V284, P18767, DOI 10.1074/jbc.M109.000836; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; Wang B, 2012, HEPATO-GASTROENTEROL, V59, P515, DOI 10.5754/hge11534; Hoang T, 2004, J BIOL CHEM, V279, P49120, DOI 10.1074/jbc.M409746200; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Cesi V, 2011, CELL CYCLE, V10, P4149, DOI 10.4161/cc.10.23.18346; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Makkonen KM, 2009, J MOL BIOL, V393, P261, DOI 10.1016/j.jmb.2009.08.024; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; ONATE SA, 1995, SCIENCE, V270, P1354; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Husdal A, 2006, CELL ONCOL, V28, P107; Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697; Bondi J, 2005, J CLIN PATHOL, V58, P509, DOI 10.1136/jcp.2004.020347; Brewster CD, 2011, VIROLOGY, V409, P299, DOI 10.1016/j.virol.2010.10.022; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Borud B, 2002, MOL ENDOCRINOL, V16, P757, DOI 10.1210/me.16.4.757; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Liu LX, 2003, HEPATO-GASTROENTEROL, V50, P1496; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Gold MO, 1996, NUCLEIC ACIDS RES, V24, P3771, DOI 10.1093/nar/24.19.3771; Voegel JJ, 1996, EMBO J, V15, P3667; Hoeppner S, 2005, J MOL BIOL, V350, P833, DOI 10.1016/j.jmb.2005.05.041; Fenne I.S., 2013, PLOS ONE, V8; Huang Y., 2013, PLOS ONE, V8; Luo Jian-Hua, 2011, World J Clin Oncol, V2, P120, DOI 10.5306/wjco.v2.i2.120; Thorner A.R., 2010, PLOS ONE, V5	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	A				2383	2391		10.1016/j.bbamcr.2015.05.016		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TM	WOS:000361775100018		
J	Matsuto, M; Kano, F; Murata, M				Matsuto, Mariko; Kano, Fumi; Murata, Masayuki			Reconstitution of the targeting of Rab6A to the Golgi apparatus in semi-intact HeLa cells: A role of BICD2 in stabilizing Rab6A on Golgi membranes and a concerted role of Rab6A/BICD2 interactions in Golgi-to-ER retrograde transport	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Rab6; BICD2; Semi-intact cell; Golgi-targeting assay; Retrograde transport	GTP-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; TGN TRANSPORT; BICAUDAL-D; SYNTAXIN 18; IN-VIVO; GTPASES; DYNEIN; LOCALIZATION; TRAFFICKING	Rab is a small GTP-binding protein family that regulates various pathways of vesicular transport. Although more than 60 Rab proteins are targeted to specific organelles in mammalian cells, the mechanisms underlying the specificity of Rab proteins for the respective organelles remain unknown. In this study, we reconstituted the Golgi targeting of Rab6A in streptolysin O (SLO)-permeabilized HeLa cells in a cytosol-dependent manner and investigated the biochemical requirements of targeting. Golgi-targeting assays identified Bicaudal-D (BICD)2, which is reportedly involved in the dynein-mediated transport of mRNAs during oogenesis and emblyogenesis in Drosophila, as a cytosolic factor for the Golgi targeting of Rab6A in SLO-permeabilized HeLa cells. Subsequent immunofluorescence analyses indicated decreased amounts of the GTP-bound active form of Rab6 in BICD2-knockdown cells. In addition, fluorescence recovery after photobleaching (FRAP) analyses revealed that overexpression of the C-terminal region of BICD2 decreased the exchange rate of GFP-Rab6A between the Golgi membrane and the cytosol. Collectively, these results indicated that BICD2 facilitates the binding of Rab6A to the Golgi by stabilizing its GTP-bound form. Moreover, several analyses of vesicular transport demonstrated that Rab6A and BICD2 play crucial roles in Golgi tubule fusion with the endoplasmic reticulum (ER) in brefeldin A (BFA)-treated cells, indicating that BICD2 is involved in coat protein I (COPI)-independent Golgi-to-ER retrograde vesicular transport. (C) 2015 Elsevier B.V. All rights reserved.	[Matsuto, Mariko; Kano, Fumi; Murata, Masayuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kano, Fumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Murata, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	mmurata@bio.c.u-tokyo.ac.jp			Technology Development Program for Advanced Measurement and Analysis, JST; PRESTO, Japan Science Technology Agency [102-10204]	The authors thank Ms. Kishiko Osaka, Ms. Naomi Okamoto, and Dr. Taichi Sugawara for experimental assistance. The authors are grateful to Dr. Ken Sato (The University of Tokyo, Japan) for the use of fluorescence spectrophotometer and for helpful discussions. The authors also thank Dr. Daiki Nakatsu for helpful advice and assistance with the statistical analysis. This study was supported by grants from the Technology Development Program for Advanced Measurement and Analysis, JST (to M.M.) and PRESTO, Japan Science Technology Agency (102-10204 to F.K.).	Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Tisdale EJ, 2003, J BIOL CHEM, V278, P52524, DOI 10.1074/jbc.M309343200; BERANGER F, 1994, J BIOL CHEM, V269, P13637; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837; Wanschers BFJ, 2007, EXP CELL RES, V313, P3408, DOI 10.1016/j.yexcr.2007.05.032; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Terenzio M, 2010, EMBO J, V29, P1625, DOI 10.1038/emboj.2010.78; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Iinuma T, 2009, J CELL SCI, V122, P1680, DOI 10.1242/jcs.036103; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Echard A, 2000, MOL BIOL CELL, V11, P3819; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Dienstbier M, 2009, BIOCHEM SOC T, V37, P1066, DOI 10.1042/BST0371066; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb670; Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; STENMARK H, 1994, EMBO J, V13, P575; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Adachi A, 2009, GENES CELLS, V14, P355, DOI 10.1111/j.1365-2443.2008.01274.x; SOLDATI T, 1993, MOL BIOL CELL, V4, P425; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Girod A, 1999, NAT CELL BIOL, V1, P423; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; STROUS GJ, 1991, BIOL CELL, V71, P25, DOI 10.1016/0248-4900(91)90048-R; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Cole NB, 1996, MOL BIOL CELL, V7, P631; Opdam FJM, 2000, J CELL SCI, V113, P2725; Kano F, 2000, MOL BIOL CELL, V11, P3073; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; JOHNSTON PA, 1991, NEURON, V7, P101, DOI 10.1016/0896-6273(91)90078-E; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; BERANGER F, 1994, MOL CELL BIOL, V14, P744; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048; Nagelkerken B, 2000, BIOCHEM J, V346, P593, DOI 10.1042/0264-6021:3460593; Kano F, 2011, BBA-MOL CELL RES, V1813, P784, DOI 10.1016/j.bbamcr.2011.01.023; Fuchs E, 2005, METHOD ENZYMOL, V403, P607, DOI 10.1016/S0076-6879(05)03053-3; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Morikawa RK, 2009, J BIOL CHEM, V284, P26620, DOI 10.1074/jbc.M109.038869; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; BHAKDI S, 1985, INFECT IMMUN, V47, P47; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; ANTONY C, 1992, J CELL SCI, V103, P785; Kano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044127; KHOSRAVIFAR R, 1991, P NATL ACAD SCI USA, V88, P6264, DOI 10.1073/pnas.88.14.6264; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W	78	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	A				2592	2609		10.1016/j.bbamcr.2015.05.005		18	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TM	WOS:000361775100037		
J	Kimoto, C; Moriyama, T; Tsujii, A; Igarashi, Y; Obuse, C; Miyamoto, Y; Oka, M; Yoneda, Y				Kimoto, Chihiro; Moriyama, Tetsuji; Tsujii, Akira; Igarashi, Yoshinobu; Obuse, Chikashi; Miyamoto, Yoichi; Oka, Masahiro; Yoneda, Yoshihiro			Functional characterization of importin alpha 8 as a classical nuclear localization signal receptor	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Importin alpha; KPNA; Nuclear localization signal; DDB2; Mass spectrometry; Dimer	PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; KARYOPHERIN ALPHA; RECOGNITION; KPNA7; PROTEINS; FAMILY; MEMBER; IDENTIFICATION; ISOFORMS	Importin alpha 8 has recently been identified as an importin a family member based on its primary structure and binding ability to importin beta 1 and to several karyophilic proteins. However, there has been no experimental evidence that importin alpha 8 actually functions in the nuclear transport of classical nuclear localization signal (cNLS)-containing cargo. Here, using an in vitro transport assay, we demonstrate that purified recombinant importin a8 can transport SV40T antigen cNLS-containing cargo into the nucleus of HeLa cells, in conjunction with importin beta 1. Pull-down assays, followed by mass spectrometry analysis, identified 179 putative importin alpha 8-binding proteins, only 62 of which overlap with those of importin alpha 1, the closest impordn alpha family member. Among the importin alpha 8-binding candidates, we showed that DNA damage-binding protein 2 (DDB2) was actually transported into the nucleus via the importin alpha 8/beta 1 pathway. Furthermore, we found that the other subtypes of importin alpha, which were also identified as importin alpha 8-binding candidates, indeed form heterodimers with importin alpha 8. Notably, we found that these importin alpha 8-containing heterodimers were more stable in the presence of cNLS-substrates than heterodimers containing importin alpha 1. From these findings, we propose that importin alpha 8 functions as a cNLS receptor with distinct cargo specificity, and that heterodimerization by importin alpha 8 is a novel regulatory mode of cNLS binding, in addition to the autoinhibitory regulation by the importin beta binding domain. (C) 2015 Elsevier B.V. All rights reserved.	[Kimoto, Chihiro; Moriyama, Tetsuji; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Biomol Dynam Lab, Suita, Osaka 5650871, Japan; [Kimoto, Chihiro; Moriyama, Tetsuji; Tsujii, Akira; Miyamoto, Yoichi; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr, Lab Nucl Transport Dynam, Osaka 5670085, Japan; [Igarashi, Yoshinobu] Natl Inst Biomed Innovat Hlth & Nutr, Lab Toxicogen Informat, Osaka 5670085, Japan; [Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Oka, Masahiro; Yoneda, Yoshihiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biomed Innovat, Suita, Osaka 5650871, Japan; [Miyamoto, Yoichi; Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr, Osaka 5670085, Japan	Miyamoto, Y (reprint author), Natl Inst Biomed Innovat Hlth & Nutr, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	ymiyamoto@nibiohn.go.jp; moka@nibiohn.go.jp; y-yoneda@nibiohn.go.jp			JSPS [24247036, 25116008, 26891032, 26870341]; Grant-in-Aid for Scientific Research on Innovative Areas [25116008]	We thank Hitomi Inoue for her technical contributions to this study. This work was supported in part by the JSPS Grant-in-Aid for Scientific Research (A) (No. 24247036) to Y.Y., Grant-in-Aid for Scientific Research on Innovative Areas (No. 25116008) to Y.Y. and M.O., JSPS Grant-in-Aid for Research Activity start-up (No. 26891032) to Y.M., Grant-in-Aid for Young Scientists (B) (No. 26870341) to T.M.	Alvisi G, 2015, STRUCTURE, V23, P251, DOI 10.1016/j.str.2015.01.005; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Arjomand A, 2014, FASEB J, V28, P3480, DOI 10.1096/fj.13-244913; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Miyamoto Y, 2013, BBA-MOL CELL RES, V1833, P731, DOI 10.1016/j.bbamcr.2012.11.005; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Wang X, 2012, REPROD FERT DEVELOP, V24, P382, DOI 10.1071/RD11119; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Laurila E, 2014, EXP CELL RES, V322, P159, DOI 10.1016/j.yexcr.2013.11.014; Yokoya F, 1999, MOL BIOL CELL, V10, P1119; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Sekimoto T, 2012, GENES CELLS, V17, P525, DOI 10.1111/j.1365-2443.2012.01609.x; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Hugel S, 2014, MOL CELL PROTEOMICS, V13, P1286, DOI 10.1074/mcp.M112.026856; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Miyamoto Y, 2012, BBA-GENE REGUL MECH, V1819, P616, DOI 10.1016/j.bbagrm.2012.01.015; Miyatake H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115995; Park KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038990; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Wang L, 2014, MOL REPROD DEV, V81, P1136, DOI 10.1002/mrd.22433; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	A				2676	2683		10.1016/j.bbamcr.2015.07.017		8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TM	WOS:000361775100044		
J	Okamoto, K				Okamoto, Koji			Preface - The special issue on mitophagy	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Editorial Material									Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka 5650871, Japan	Okamoto, K (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	kokamoto@fbs.osaka-u.ac.jp						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	B		SI		2755	2755		10.1016/j.bbamcr.2015.06.014		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TO	WOS:000361775300001		
J	Kanki, T; Furukawa, K; Yamashita, S				Kanki, Tomotake; Furukawa, Kentaro; Yamashita, Shun-ichi			Mitophagy in yeast: Molecular mechanisms and physiological role	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Review						Autophagy; Mitophagy; Mitochondrion; Atg32; ERMES; Yeast	VACUOLE TARGETING PATHWAY; AUTOPHAGY-RELATED PATHWAYS; DYNAMIN-RELATED GTPASE; STATIONARY-PHASE MITOPHAGY; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; MITOCHONDRIAL PROTEIN; PICHIA-PASTORIS; PEROXISOME DEGRADATION; ENDOPLASMIC-RETICULUM	Mitochondria autophagy (mitophagy) is a process that selectively degrades mitochondria via autophagy. Recently, there has been significant progress in the understanding of mitophagy in yeast. Atg32, a mitochondrial outer membrane receptor, is indispensable for mitophagy. Phosphorylation of Atg32 is an initial cue for selective mitochondrial degradation. Atg32 expression and phosphorylation regulate the induction and efficiency of mitophagy. In addition to Atg32-related processes, recent studies have revealed that mitochondrial fission and the mitochondria-endoplasmic reticulum (ER) contact site may play important roles in mitophagy. Mitochondrial fission is required to regulate mitochondrial size. Mitochondria-ER contact is mediated by the ER-mitochondria encounter structure and is important to supply lipids from the ER for autophagosome biogenesis for mitophagy. Mitophagy is physiologically important for regulating the number of mitochondria, diminishing mitochondrial production of reactive oxygen species, and extending chronological lifespan under caloric restriction. These findings suggest that mitophagy contributes to maintain mitochondrial homeostasis. However, whether mitophagy selectively degrades damaged or dysfunctional mitochondria in yeast is unknown. This article is part of a Special Issue entitled: Mitophagy. (C) 2015 Elsevier B.V. All rights reserved.	[Kanki, Tomotake; Furukawa, Kentaro; Yamashita, Shun-ichi] Niigata Univ, Grad Sch Med & Dent Sci, Lab Biosignaling, Chuo Ku, Niigata 9518510, Japan	Kanki, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Lab Biosignaling, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kanki@med.niigata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology; JSPS KAKENHI [25117714, 25560414, 26291039]; Grant for Basic Science Research Projects from The Sumitomo Foundation	This work was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology; JSPS KAKENHI (grant nos. 25117714, 25560414, and 26291039); and a Grant for Basic Science Research Projects from The Sumitomo Foundation.	Abeliovich H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3789; Harding TM, 1996, J BIOL CHEM, V271, P17621; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Cao Y, 2007, AUTOPHAGY, V3, P17; Ichimura Y, 2000, NATURE, V408, P488; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Bleazard W, 1999, NAT CELL BIOL, V1, P298; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Araki Y, 2013, J CELL BIOL, V203, P299, DOI 10.1083/jcb.201304123; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kissova I, 2007, AUTOPHAGY, V3, P329; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Lupo D, 2011, TRAFFIC, V12, P1457, DOI 10.1111/j.1600-0854.2011.01239.x; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; Guan J, 2001, MOL BIOL CELL, V12, P3821; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Teter SA, 2001, J BIOL CHEM, V276, P2083; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbre.2007.02.150; Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Zhang Y, 2007, AUTOPHAGY, V3, P337; Eiyama A, 2013, FEBS LETT, V587, P1787, DOI 10.1016/j.febslet.2013.04.030; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kaufmann A, 2014, AUTOPHAGY, V10, P1343, DOI 10.4161/auto.28980; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Wang K, 2013, AUTOPHAGY, V9, P1828, DOI 10.4161/auto.26281; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Kim J, 1999, MOL BIOL CELL, V10, P1337; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Yuan WP, 1997, J CELL SCI, V110, P1935; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Richard VR, 2013, AGING-US, V5, P234; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Barth H, 2002, FEBS LETT, V512, P173, DOI 10.1016/S0014-5793(02)02252-4; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Pfaffenwimmer T, 2014, EMBO REP, V15, P862, DOI 10.15252/embr.201438932; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Aihara M, 2014, J CELL SCI, V127, P3184, DOI 10.1242/jcs.153254; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Seet BT, 2004, CURR BIOL, V14, pR708, DOI 10.1016/j.cub.2004.08.044; Kitada T, 1998, NATURE, V392, P605; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Epple UD, 2003, J BIOL CHEM, V278, P7810, DOI 10.1074/jbc.M209309200; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Bernales S, 2007, AUTOPHAGY, V3, P285; Welter E, 2013, FEBS J, V280, P4970, DOI 10.1111/febs.12468; Boclder S., 2014, DEV CELL, V28, P450; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406; Hirota Y., 2015, AUTOPHAGY IN PRESS; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; Mochida K, 2014, FEBS LETT, V588, P3862, DOI 10.1016/j.febslet.2014.09.032; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Poole A.C., 2010, PLOS ONE, V5; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428	137	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	B		SI		2756	2765		10.1016/j.bbamcr.2015.01.005		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TO	WOS:000361775300002		
J	Koyano, F; Matsuda, N				Koyano, Fumika; Matsuda, Noriyuki			Molecular mechanisms underlying PINK1 and Parkin catalyzed ubiquitylation of substrates on damaged mitochondria	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Review						PINK1; Parkin; Activation; E3; Ubiquitin	UBIQUITIN-LIKE DOMAIN; PINK1/PARKIN-MEDIATED MITOPHAGY; DEPOLARIZED MITOCHONDRIA; MEDIATED MITOPHAGY; ACTIVATE PARKIN; LIGASE; DISEASE; PHOSPHORYLATION; TRANSLOCATION; P62/SQSTM1	PINK1 and Parkin are gene products that cause genetic recessive Parkinsonism. PINK1 is a protein kinase and Parkin is a ubiquitin ligase (E3) that links ubiquitin to a substrate. Importantly, under steady state conditions, the enzymatic activity of Parkin is completely suppressed, but is activated when mitochondria become abnormal. In 2013 and 2014, biochemical and structure-function analyses revealed a number of critical mechanistic insights. First, Parkin is a self-inhibitory E3 that suppresses its E3 activity via intramolecular interactions. Second, in response to a decrease in mitochondrial membrane potential, PINK1 phosphorylates Ser65 in both the Parkin ubiquitin-like domain and ubiquitin itself. These phosphorylation events cooperate to relieve the Parkin autoinhibition. Third, activated Parkin forms a ubiquitin-thioester bond at Cys431 to produce a reaction intermediate that catalyzes ubiquitylation of substrates on damaged mitochondria. While the molecular mechanism regulating Parkin enzymatic activity has largely eluded clarification, a complete picture is now emerging. This article is part of a Special Issue entitled: Mitophagy. (C) 2015 Elsevier B.V. All rights reserved.	[Koyano, Fumika; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan	Matsuda, N (reprint author), Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Room 202,2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	matsuda-nr@igakuken.or.jp			JST PREST [10336]; JSPS KAKENHI [23687018]; MEXT KAKENHI [24111557, 25112522]; Tomizawa Jun-ichi and Keiko Fund for Young Scientist; Takeda Science Foundation	This work was supported by JST PREST 10336, JSPS KAKENHI Grant Number 23687018, MEXT KAKENHI Grant Numbers 24111557 and 25112522, the Tomizawa Jun-ichi and Keiko Fund for Young Scientist, and by the Takeda Science Foundation (to N.M.). We thank Dr. Hideaki Shimizu of RIKEN for Parkin structural modeling.	Abeliovich Asa, 2014, Nature, V510, P44, DOI 10.1038/510044a; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Matsuda N, 2001, J CELL SCI, V114, P1949; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Kitada T, 1998, NATURE, V392, P605; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Zheng XD, 2014, EMBO J, V33, P1621, DOI 10.15252/embj.201489185; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Shimura H, 2000, NAT GENET, V25, P302; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Kazlauskaite A, 2015, FEBS J, V282, P215, DOI 10.1111/febs.13127; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Trempe Jean-François, 2013, Front Neurol, V4, P38, DOI 10.3389/fneur.2013.00038; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111	36	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	B		SI		2791	2796		10.1016/j.bbamcr.2015.02.009		6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TO	WOS:000361775300006		
J	Yoshii, SR; Mizushima, N				Yoshii, Saori R.; Mizushima, Noboru			Autophagy machinery in the context of mammalian mitophagy	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Review						Two-step model; Mitophagy; Parkin; Selective autophagy	PARKIN-MEDIATED MITOPHAGY; ENDOPLASMIC-RETICULUM; SELECTIVE AUTOPHAGY; SYNTAXIN 17; MITOCHONDRIAL TRANSLOCATION; DEPOLARIZED MITOCHONDRIA; DAMAGED MITOCHONDRIA; REGULATES MITOPHAGY; ACTIVATE PARKIN; FORMATION SITE	Autophagy is an intracellular catabolic system that degrades cytoplasmic proteins and organelles. Damaged mitochondria can be degraded by a selective type of autophagy, which is termed mitophagy. PINK1-Parkin-dependent mitophagy has been extensively studied in the mammalian system. PINK1 accumulates on damaged mitochondria to recruit Parkin, which subsequently ubiquitinates a broad range of outer mitochondrial membrane proteins. Ubiquitinated mitochondria associate with the autophagosome formation site, and are selectively incorporated into autophagosomes. During this process, damaged mitochondria first associate with the autophagosome formation site together with upstream autophagy factors, then are efficiently incorporated into autophagosomes through binding with autophagosome adaptors. This "two-step model" may be applied to other selective types of autophagy. This article is part of a Special Issue entitled: Mitophagy. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshii, Saori R.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	Mizushima, N (reprint author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009		Japan Society for the Promotion of Science (JSPS) KAKENHI [25111005]; Daiichi-Sankyo Foundation of Life Science; Research Fellowships of JSPS for Young Scientists	We would like to thank Ikuko Koyama-Honda for valuable advice. This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research on Innovative Areas [grant number 25111005] and Daiichi-Sankyo Foundation of Life Science (N.M.) and grants for Research Fellowships of JSPS for Young Scientists (S.R.Y.).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.odd.4401936; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2010, AUTOPHAGY, V6, P764; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Mercer CA, 2009, AUTOPHAGY, V5, P649; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Kitada T, 1998, NATURE, V392, P605; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Li W, 2014, J BIOL CHEM, V289, P10691, DOI 10.1074/jbc.M113.537050; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Newman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050672; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612	69	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	OCT	2015	1853	10	B		SI		2797	2801		10.1016/j.bbamcr.2015.01.013		5	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CS0TO	WOS:000361775300007		
J	Zheng, MH; Watanabe, K; Hoshino, O				Zheng, Meihong; Watanabe, Kazuo; Hoshino, Osamu			GABA diffusion across neuronal columns for efficient sensory tuning	BIOLOGICAL CYBERNETICS			English	Article						GABA diffusion; Neuronal column; Sensory tuning	CEREBELLAR GRANULE CELLS; AMBIENT GABA; STRIATE CORTEX; SOMATOSENSORY CORTEX; AUDITORY-CORTEX; BASKET CELLS; INHIBITION; RECEPTORS; RAT; CAT	Synaptic (phasic) lateral inhibition between neuronal columns mediated by GABAergic interneurons is, in general, essential for primary sensory cortices to respond selectively to elemental features. We propose here a neural network model with a nonsynaptic (tonic) lateral inhibitory mechanism. While firing, intrasynaptic GABA molecules spill over into extracellular space and accumulate in neuronal columns. Through accumulation in and diffusion across these columns, a level of ambient (extracellular) GABA changes in a neuronal activity-dependent manner. Ambient GABA molecules act on extrasynaptic receptors and provide neurons with tonic inhibitory currents. We examined whether and how the diffusion of GABA molecules across neuronal columns affects tuning performance of the network to a feature stimulus: selective responsiveness. The GABA diffusion led to reducing ambient GABA in the stimulus-relevant column while augmenting ambient GABA in stimulus-irrelevant columns, thereby improving the tuning performance. The GABA diffusion was effective especially when provided with a broader sensory input. Interestingly, this diffusion-based, nonsynaptic (tonic) lateral inhibitory scheme worked well together with the conventional, synaptic (phasic) lateral inhibitory scheme, enhancing the sensory tuning. We suggest that the nonsynaptic lateral inhibition, mediated through GABA diffusion across neuronal columns, may be beneficial for the cortex to tune to sensory features.	[Zheng, Meihong] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China; [Watanabe, Kazuo; Hoshino, Osamu] Southern Tohoku Gen Hosp, Southern Tohoku Res Inst Neurosci, Koriyama, Fukushima 9638563, Japan; [Hoshino, Osamu] Ibaraki Univ, Dept Intelligent Syst Engn, Hitachi, Ibaraki 3168511, Japan	Hoshino, O (reprint author), Southern Tohoku Gen Hosp, Southern Tohoku Res Inst Neurosci, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan.	hoshino@mx.ibaraki.ac.jp					Hoshino O, 2007, NEURAL COMPUT, V19, P3310, DOI 10.1162/neco.2007.19.12.3310; Segovia G, 2006, BRAIN RES BULL, V70, P8, DOI 10.1016/j.brainresbull.2005.11.005; Miyamoto A, 2012, NEURAL COMPUT, V24, P744, DOI 10.1162/NECO_a_00251; Miles R, 2000, SCIENCE, V287, P244, DOI 10.1126/science.287.5451.244; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753; Scimemi A, 2006, EUR J NEUROSCI, V24, P1157, DOI 10.1111/j.1460-9568.2006.04989.x; Bianchi L, 2003, NEUROCHEM RES, V28, P565, DOI 10.1023/A:1022881625378; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808; Hoshino O, 2009, NEURAL COMPUT, V21, P1683, DOI 10.1162/neco.2009.05-08-778; Krimer LS, 2001, J NEUROSCI, V21, P3788; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; Hoshino O, 2010, NEURAL COMPUT, V22, P1358, DOI 10.1162/neco.2010.02-09-969; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; EYSEL UT, 1992, PROG BRAIN RES, V90, P407; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Hoshino O, 2012, NEURAL COMPUT, V24, P2964, DOI 10.1162/NECO_a_00356; Soltesz I, 2001, NATURE, V409, P24, DOI 10.1038/35051187; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Totoki Y, 2010, COGN PROCESS, V11, P347, DOI [10.1007/s10339-010-0366-8, 10.1007/s10339.010.0366.8]; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Nusser Z, 1998, J NEUROSCI, V18, P1693; Hoshino O, 2008, NETWORK-COMP NEURAL, V19, P95, DOI 10.1080/09548980701840343; PRIETO JJ, 1994, J COMP NEUROL, V344, P349, DOI 10.1002/cne.903440304; Hoshino O, 2013, NEURAL COMPUT, V25, P1164, DOI 10.1162/NECO_a_00431; Hoshino O, 2011, NEURAL COMPUT, V23, P958, DOI 10.1162/NECO_a_00096; Xu XM, 2002, VISUAL NEUROSCI, V19, P97, DOI 10.1017/S0952523802191097; Salin PA, 1996, J NEUROPHYSIOL, V75, P1589; Tang ZQ, 2011, J NEUROSCI, V31, P6121, DOI 10.1523/JNEUROSCI.4733-10.2011; Hoshino O, 2015, NEURAL COMPUT, V27, P1223, DOI 10.1162/NECO_a_00733; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; Wei WZ, 2003, J NEUROSCI, V23, P10650; Hoshino O, 2011, NEURAL COMPUT, V23, P3205, DOI 10.1162/NECO_a_00211; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Hoshino O, 2007, NEURAL COMPUT, V19, P351, DOI 10.1162/neco.2007.19.2.351; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hoshino O, 2008, NEURAL COMPUT, V20, P3055, DOI 10.1162/neco.2008.08-07-589; Destexhe A., 1998, METHODS NEURONAL MOD, P1; Fairen A., 1984, CEREB CORTEX, V1, P201; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Sillito AM, 1984, FUNCTIONAL PROPERTIE, P91; Yost WA, 1994, FUNDAMENTALS HEARING, P228	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-1200	1432-0770		BIOL CYBERN	Biol. Cybern.	OCT	2015	109	4-5					493	503		10.1007/s00422-015-0657-3		11	Computer Science, Cybernetics; Neurosciences	Computer Science; Neurosciences & Neurology	CR6UW	WOS:000361484300006		
J	Fuji, S; Einsele, H; Savani, BN; Kapp, M				Fuji, Shigeo; Einsele, Hermann; Savani, Bipin N.; Kapp, Markus			Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Review						Nutritional support; Hematopoietic stem cell transplantation; Hyperglycemia; Long-term follow-up	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; BODY-MASS INDEX; CRITICALLY-ILL PATIENTS; NON-RELAPSE MORTALITY; SUPPLEMENTED PARENTERAL-NUTRITION; INTENSIVE INSULIN THERAPY; LONG-TERM SURVIVORS; DIABETES-MELLITUS; ENTERAL NUTRITION	various hematological diseases. However, in allogeneic HSCT, patients often suffer from severe gastrointestinal complications caused by the conditioning regimen and acute/chronic graft-versus-host disease, which requires support by multidisciplinary nutritional support teams (NST). In addition, pretransplantation nutritional status can affect the clinical outcome after allogeneic HSCT. Therefore, it is important to refer the patient to a NST when becoming aware of nutritional problems before allogeneic HSCT. It is also important to follow nutritional status over the long term, as patients often suffer from various nutritional problems, such as malnutrition and metabolic syndrome, even late after allogeneic HSCT. In summary, NST can contribute to the improvement of nutritional status and possibly prognosis at every stage before and after allogeneic HSCT. Here, we aim to give a comprehensive overview of current understanding about nutritional support in allogeneic HSCT and try to provoke a constructive discussion to stimulate further investigation. (C) 2015 American Society for Blood and Marrow Transplantation.	[Fuji, Shigeo; Einsele, Hermann; Kapp, Markus] Univ Hosp Wurzburg, Dept Internal Med 2, Div Hematol, Wurzburg, Germany; [Fuji, Shigeo] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo 1040045, Japan; [Savani, Bipin N.] Vanderbilt Univ, Med Ctr, Dept Med, Hematol & Stem Cell Transplantat Sect,Div Hematol, Nashville, TN USA; [Savani, Bipin N.] Vet Affairs Med Ctr, Nashville, TN 37212 USA	Fuji, S (reprint author), Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sfuji@ncc.go.jp					Andrews PJD, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1542; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Iestra JA, 1999, BONE MARROW TRANSPL, V23, P933, DOI 10.1038/sj.bmt.1701747; Hammer MJ, 2009, BIOL BLOOD MARROW TR, V15, P344, DOI 10.1016/j.bbmt.2008.12.488; [Anonymous], 2014, DIABETES CARE, V37, pS14, DOI DOI 10.2337/DC14-S014; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Langdana A, 2001, BONE MARROW TRANSPL, V27, P741, DOI 10.1038/sj.bmt.1702855; Inaba H, 2012, J CLIN ONCOL, V30, P3991, DOI 10.1200/JCO.2011.40.0457; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Walrath M, 2015, NUTR CLIN PRACT, V30, P305, DOI 10.1177/0884533614547084; Argiles JM, 2015, CURR OPIN PHARMACOL, V22, P100, DOI 10.1016/j.coph.2015.04.003; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Jakoby MG, 2012, JPEN-PARENTER ENTER, V36, P183, DOI 10.1177/0148607111415628; Co-Reyes E, 2012, PEDIATR BLOOD CANCER, V59, P1160, DOI 10.1002/pbc.24272; Grkovic L, 2012, LEUKEMIA, V26, P633, DOI 10.1038/leu.2011.254; Fuji S, 2007, TRANSPLANTATION, V84, P814, DOI 10.1097/01.tp.0000282790.66889.a5; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Barba P, 2012, BONE MARROW TRANSPL, V47, P1343, DOI 10.1038/bmt.2012.25; Hirsch IB, 2009, JAMA-J AM MED ASSOC, V301, P213, DOI 10.1001/jama.2008.943; Martin-Salces M, 2008, NUTRITION, V24, P769, DOI 10.1016/j.nut.2008.02.021; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Griffith ML, 2010, ENDOCR PRACT, V16, P699, DOI 10.4158/EP10027.RA; Seguy D, 2006, TRANSPLANTATION, V82, P835, DOI 10.1097/01.tp.0000229419.73428.ff; Handelsman Y, 2015, ENDOCR PRACT, V21, P1, DOI [10.4158/EP15672.GLSUPPL, 10.4158/EP15672.GL]; Le Blanc K, 2003, HAEMATOLOGICA, V88, P1044; Urbain P, 2013, BONE MARROW TRANSPL, V48, P446, DOI 10.1038/bmt.2012.158; Barba P, 2011, BIOL BLOOD MARROW TR, V17, P1653, DOI 10.1016/j.bbmt.2011.04.009; Docampo MD, 2015, BIOL BLOOD MARROW TR, V21, P1360, DOI 10.1016/j.bbmt.2015.02.016; Pidala J, 2011, BIOL BLOOD MARROW TR, V17, P239, DOI 10.1016/j.bbmt.2010.07.005; Azarnoush S, 2012, BONE MARROW TRANSPL, V47, P1191, DOI 10.1038/bmt.2011.248; Derr RL, 2008, DIABETES CARE, V31, P1972, DOI 10.2337/dc08-0574; Crowther M, 2009, BONE MARROW TRANSPL, V44, P413, DOI 10.1038/bmt.2009.41; LENSSEN P, 1990, J AM DIET ASSOC, V90, P835; Bozzetti F, 2009, CLIN NUTR, V28, P445, DOI 10.1016/j.clnu.2009.04.011; Navarro WH, 2010, BIOL BLOOD MARROW TR, V16, P1442, DOI 10.1016/j.bbmt.2010.04.009; McKenney JM, 2007, PHARMACOTHERAPY, V27, P715, DOI 10.1592/phco.27.5.715; Gebremedhin E, 2013, INFLAMMATION, V36, P177, DOI 10.1007/s10753-012-9533-7; Mirtallo J, 2004, JPEN-PARENTER ENTER, V28, pS39; Tichelli A, 2007, BLOOD, V110, P3463, DOI 10.1182/blood-2006-10-054080; Carreras E, 1998, BLOOD, V92, P3599; Isenring EA, 2013, CURR OPIN SUPPORT PA, V7, P390, DOI 10.1097/SPC.0000000000000016; Habschmidt MG, 2012, NUTR CLIN PRACT, V27, P655, DOI 10.1177/0884533612457179; Torres HOD, 2008, BONE MARROW TRANSPL, V41, P1021, DOI 10.1038/bmt.2008.27; Fuji S, 2009, AM J HEMATOL, V84, P63, DOI 10.1002/ajh.21307; Sheean P, 2006, JPEN-PARENTER ENTER, V30, P345, DOI 10.1177/0148607106030004345; Mattsson J, 2006, BONE MARROW TRANSPL, V38, P629, DOI 10.1038/sj.bmt.1705493; Weiss BM, 2013, BONE MARROW TRANSPL, V48, P1152, DOI 10.1038/bmt.2012.201; Nau KC, 2010, AM FAM PHYSICIAN, V81, P1130; Majhail NS, 2009, BONE MARROW TRANSPL, V43, P49, DOI 10.1038/bmt.2008.263; ZIEGLER TR, 1992, ANN INTERN MED, V116, P821; Griffith ML, 2011, BIOL BLOOD MARROW TR, V17, P86, DOI 10.1016/j.bbmt.2010.06.010; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Heyland DK, 2015, JPEN-PARENTER ENTER, V39, P401, DOI 10.1177/0148607114529994; Jacobsohn DA, 2002, BONE MARROW TRANSPL, V29, P231, DOI 10.1038/sj/bmt/1703352; van der Meij BS, 2013, BONE MARROW TRANSPL, V48, P474, DOI 10.1038/bmt.2012.124; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Gosmanov AR, 2013, CURR DIABETES REP, V13, P155, DOI 10.1007/s11892-012-0335-y; Grau T, 2011, CRIT CARE MED, V39, P1263, DOI 10.1097/CCM.0b013e31820eb774; Uderzo C, 2011, TRANSPLANTATION, V91, P1321, DOI 10.1097/TP.0b013e31821ab959; Urbain P, 2013, ANN HEMATOL, V92, P111, DOI 10.1007/s00277-012-1573-4; Nakao M, 2014, BONE MARROW TRANSPL, V49, P66, DOI 10.1038/bmt.2013.128; Sheean PM, 2006, BIOL BLOOD MARROW TR, V12, P656, DOI 10.1016/j.bbmt.2006.01.010; Blijlevens NM, 2005, SUPPORT CARE CANCER, V13, P790, DOI 10.1007/s00520-005-0790-y; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; Guieze R, 2014, CLIN NUTR, V33, P533, DOI 10.1016/j.clnu.2013.07.012; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495; Baker KS, 2007, BLOOD, V109, P1765; Seguy D, 2012, TRANSPLANTATION, V94, P287, DOI 10.1097/TP.0b013e3182558f60; Takatsuka H, 2001, BONE MARROW TRANSPL, V28, P769, DOI 10.1038/sj.bmt.1703226; MCDONALD GB, 1993, ANN INTERN MED, V118, P255; Dickson TMC, 2000, JPEN-PARENTER ENTER, V24, P61; Tillman EM, 2013, NUTR CLIN PRACT, V28, P30, DOI 10.1177/0884533612462900; Browning B, 2006, BONE MARROW TRANSPL, V37, P527, DOI 10.1038/sj.bmt.1705268; Fuji S, 2009, BONE MARROW TRANSPL, V44, P105, DOI 10.1038/bmt.2008.431; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Grintescu IM, 2015, CLIN NUTR, V34, P377, DOI 10.1016/j.clnu.2014.05.006; Sun YQ, 2015, BIOL BLOOD MARROW TR, V21, P1117, DOI 10.1016/j.bbmt.2015.03.018; Rovo A, 2012, SEMIN HEMATOL, V49, P25, DOI 10.1053/j.seminhematol.2011.10.001; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Baker KS, 2012, BONE MARROW TRANSPL, V47, P619, DOI 10.1038/bmt.2011.118; Cogoluenhes VC, 1998, CLIN NUTR, V17, P253; Bicakli DH, 2012, PEDIATR BLOOD CANCER, V59, P1327, DOI 10.1002/pbc.24275; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; Lenssen P, 1998, AM J CLIN NUTR, V67, P927; Aplenc R, 2014, BLOOD, V123, P3504, DOI 10.1182/blood-2013-03-490334; Bassim CW, 2014, BONE MARROW TRANSPL, V49, P1300, DOI 10.1038/bmt.2014.145; Calvo Ma Victoria, 2002, Nutrition, V18, P769, DOI 10.1016/S0899-9007(02)00828-6; DEEG HJ, 1995, BONE MARROW TRANSPL, V15, P461; Fuji S, 2014, BONE MARROW TRANSPL, V49, P1505, DOI 10.1038/bmt.2014.178; Fuji S, 2015, BONE MARROW TRANSPL, V50, P100, DOI 10.1038/bmt.2014.228; Fuji S., 2012, Food and Nutrition Sciences, V3, P417; Healy SJ, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0581-x; Heinbokel T, 2013, TRANSPLANTATION, V96, P10, DOI 10.1097/TP.0b013e3182869d2f; Lemal R, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0663-8; Lenssen P, 2009, THOMAS HEMATOPOIETIC, P1551, DOI 10.1002/9781444303537.ch101; Mesotten Dieter, 2009, Best Pract Res Clin Anaesthesiol, V23, P421; Nannya Yasuhito, 2014, Biol Blood Marrow Transplant, V20, P430, DOI 10.1016/j.bbmt.2013.12.554; Radfar M, 2015, ENDOCR RES, V40, P20, DOI 10.3109/07435800.2014.914037; Sattar N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4596; Schloerb PR, 1999, JPEN-PARENTER ENTER, V23, P117, DOI 10.1177/0148607199023003117; Takano K, 2015, BONE MARROW TRANSPL, V50, P553, DOI 10.1038/bmt.2014.315	104	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	OCT	2015	21	10					1707	1713		10.1016/j.bbmt.2015.07.003		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CS0VU	WOS:000361781100004		
J	Inamoto, Y; Flowers, MED; Wang, T; Urbano-Ispizua, A; Hemmer, MT; Cutler, CS; Couriel, DR; Alousi, AM; Antin, JH; Gale, RP; Gupta, V; Hamilton, BK; Kharfan-Dabaja, MA; Marks, DI; Ringden, OTH; Socie, G; Solh, MM; Akpek, G; Cairo, MS; Chao, NJ; Hayashi, RJ; Nishihori, T; Reshef, R; Saad, A; Shah, A; Teshima, T; Tallman, MS; Wirk, B; Spellman, SR; Arora, M; Martin, PJ				Inamoto, Yoshihiro; Flowers, Mary E. D.; Wang, Tao; Urbano-Ispizua, Alvaro; Hemmer, Michael T.; Cutler, Corey S.; Couriel, Daniel R.; Alousi, Amin M.; Antin, Joseph H.; Gale, Robert Peter; Gupta, Vikas; Hamilton, Betty K.; Kharfan-Dabaja, Mohamed A.; Marks, David I.; Ringden, Olle T. H.; Socie, Gerard; Solh, Melhem M.; Akpek, Goerguen; Cairo, Mitchell S.; Chao, Nelson J.; Hayashi, Robert J.; Nishihori, Taiga; Reshef, Ran; Saad, Ayman; Shah, Ami; Teshima, Takanori; Tallman, Martin S.; Wirk, Baldeep; Spellman, Stephen R.; Arora, Mukta; Martin, Paul J.			Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Aplastic anemia; Hematopoietic cell transplantation; Graft-versus-host disease; Immunosuppression; Cyclosporine; Tacrolimus	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; UNRELATED DONOR TRANSPLANTATION; PERIPHERAL-BLOOD; COMPARING METHOTREXATE; SIBLING DONORS; ACUTE GVHD; PHASE-III; GRAFT; PROPHYLAXIS	Combinations of cyclosporine (CSP) with methotrexate (MTX) have been widely used for immunosuppression after allogeneic transplantation for acquired aplastic anemia. We compared outcomes with tacrolimus (TAC)+MTX versus CSP+MTX after transplantation from HLA-identical siblings (SIB) or unrelated donors (URD) in a retrospective cohort of 949 patients with severe aplastic anemia. Study endpoints included hematopoietic recovery, graft failure, acute graft-versus-host disease (GVHD), chronic GVHD, and mortality. TAC+MTX was used more frequently in older patients and, in recent years, in both SIB and URD groups. In multivariate analysis, TAC+MTX was associated with a lower risk of mortality in URD recipients and with slightly earlier absolute neutrophil count recovery in SIB recipients. Other outcomes did not differ statistically between the 2 regimens. No firm conclusions were reached regarding the relative merits of TAC+MTX versus CSP+MTX after hematopoietic cell transplantation for acquired aplastic anemia, Prospective studies would be needed to determine whether the use of TAC+MTX is associated with lower risk of mortality in URD recipients with acquired aplastic anemia. (C) 2015 American Society for Blood and Marrow Transplantation.	[Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo 1040045, Japan; [Flowers, Mary E. D.; Martin, Paul J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Wang, Tao; Hemmer, Michael T.] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Wang, Tao] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA; [Urbano-Ispizua, Alvaro] Univ Barcelona, Dept Hematol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Urbano-Ispizua, Alvaro] Inst Res Josep Carreras, Barcelona, Spain; [Cutler, Corey S.; Antin, Joseph H.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Hematol Oncol, Boston, MA 02115 USA; [Couriel, Daniel R.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Alousi, Amin M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA; [Gale, Robert Peter] Univ London Imperial Coll Sci Technol & Med, Hematol Res Ctr, Dept Med, Div Expt Med, London, England; [Gupta, Vikas] Univ Hlth Network, Princess Margaret Canc Ctr, Blood & Marrow Transplant Program, Toronto, ON, Canada; [Hamilton, Betty K.] Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA; [Kharfan-Dabaja, Mohamed A.; Nishihori, Taiga] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA; [Marks, David I.] Univ Hosp Bristol NHS Trust, Pediat Bone Marrow Transplant, Bristol, Avon, England; [Ringden, Olle T. H.] Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden; [Ringden, Olle T. H.] Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden; [Socie, Gerard] Hosp St Louis, Dept Hematol, Paris, France; [Solh, Melhem M.] Florida Hosp, Med Grp, Blood & Marrow Transplant Ctr, Orlando, FL USA; [Akpek, Goerguen] Banner MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy Program, Gilbert, AZ USA; [Cairo, Mitchell S.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy & Hematol, Durham, NC 27710 USA; [Hayashi, Robert J.] Washington Univ, Dept Pediat, Sch Med St Louis, Div Pediat Hematol Oncol, St Louis, MO 63130 USA; [Reshef, Ran] Univ Penn, Med Ctr, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA; [Saad, Ayman] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA; [Shah, Ami] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Wirk, Baldeep] Seattle Canc Care Alliance, Div Bone Marrow Transplant, Seattle, WA USA; [Spellman, Stephen R.] Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program, Be Match, Minneapolis, MN USA; [Arora, Mukta] Univ Minnesota, Med Ctr, Dept Med, Div Hematol,Oncol,Transplantat, Minneapolis, MN 55455 USA	Inamoto, Y (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yinamoto@ncc.go.jp			National Cancer Institute [U24-CA076518]; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute [5U10HL069294]; Health Resources and Services Administration (HRSA/DHHS) [HHSH250201200016C]; Office of Naval Research [N00014-13-1-0039, N00014-14-1-0028]; Actinium Pharmaceuticals; Allos Therapeutics, Inc.; Amgen	The CIBMTR is supported by Public Health Service grant/cooperative agreement U24-CA076518 from the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Institute of Allergy and Infectious Diseases; a grant/cooperative agreement 5U10HL069294 from National Heart, Lung, and Blood Institute and National Cancer Institute; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); 2 grants N00014-13-1-0039 and N00014-14-1-0028 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals; Allos Therapeutics, Inc.; *Amgen; an anonymous donation to the Medical College of Wisconsin; Ariad; Be The Match Foundation; *Blue Cross and Blue Shield Association; *Celgene Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.; *Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; *Gentium SpA; Genzyme Corporation; GlaxoSmithKline; Health Research, Inc.; Roswell Park Cancer Institute; HistoGenetics; Incyte Corporation; Jeff Gordon Children's Foundation; Kiadis Pharma; The Leukemia & Lymphoma Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co., Inc.; Millennium: The Takeda Oncology Co.; *Milliman USA, Inc.; *Miltenyi Biotec; National Marrow Donor Program; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Osiris Therapeutics; Otsuka America Pharmaceutical, Inc.; Perkin Elmer, Inc.; *Remedy Informatics; *Sanofi US; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; St. Baldrick's Foundation; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; *Tarix Pharmaceuticals; *Terumo BCT; *Teva Neuroscience, Inc.; *Therakos; University of Minnesota; University of Utah; and *WellPoint The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration or any other agency of the US Government.	Nash RA, 2000, BLOOD, V96, P2062; Kumar S, 2002, BONE MARROW TRANSPL, V30, P161, DOI 10.1038/sj.bmt.1703616; Locatelli F, 2000, BLOOD, V95, P1572; Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324/haematol.2009.018267; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Hiraoka A, 2001, BONE MARROW TRANSPL, V28, P181, DOI 10.1038/sj.bmt.1703097; GLUCKMAN E, 1992, BLOOD, V79, P269; Bacigalupo A, 2012, HAEMATOL-HEMATOL J, V97, P1142, DOI 10.3324/haematol.2011.054841; Yanada M, 2004, BONE MARROW TRANSPL, V34, P331, DOI 10.1038/sj.bmt.1704596; Kojima S, 2002, BLOOD, V100, P799, DOI 10.1182/blood.V100.3.799; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Eapen M, 2011, BLOOD, V118, P2618, DOI 10.1182/blood-2011-05-354001; Ades L, 2004, BLOOD, V103, P2490, DOI 10.1182/blood-2003-07-2546; Champlin RE, 2007, BLOOD, V109, P4582, DOI 10.1182/blood-2006-10-052308; Chu R, 2011, BIOL BLOOD MARROW TR, V17, P1018, DOI 10.1016/j.bbmt.2010.10.029; STORB R, 1986, BLOOD, V68, P119; Inamoto Y, 2011, BIOL BLOOD MARROW TR, V17, P1088, DOI 10.1016/j.bbmt.2011.01.017; Schrezenmeier H, 2007, BLOOD, V110, P1397, DOI 10.1182/blood-2007-03-081596; Yagasaki H, 2009, BIOL BLOOD MARROW TR, V15, P1603, DOI 10.1016/j.bbmt.2009.08.012; CAMITTA BM, 1979, BLOOD, V53, P504; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Weisdorf D, 2008, BIOL BLOOD MARROW TR, V14, P748, DOI 10.1016/j.bbmt.2008.04.003; Inamoto Y, 2008, BIOL BLOOD MARROW TR, V14, P43, DOI 10.1016/j.bbmt.2007.06.015; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Ratanatharathorn V, 1998, BLOOD, V92, P2303	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	OCT	2015	21	10					1776	1782		10.1016/j.bbmt.2015.05.023		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CS0VU	WOS:000361781100013		
J	Khera, N; Majhail, NS; Brazauskas, R; Wang, ZW; He, NY; Aljurf, MD; Akpek, G; Atsuta, Y; Beattie, S; Bredeson, CN; Burns, LJ; Dalal, JD; Freytes, CO; Gupta, V; Inamoto, Y; Lazarus, HM; LeMaistre, CF; Steinberg, A; Szwajcer, D; Wingard, JR; Wirk, B; Wood, WA; Joffe, S; Hahn, TE; Loberiza, FR; Anasetti, C; Horowitz, MM; Lee, SJ				Khera, Nandita; Majhail, Navneet S.; Brazauskas, Ruta; Wang, Zhiwei; He, Naya; Aljurf, Mahmoud D.; Akpek, Goerguen; Atsuta, Yoshiko; Beattie, Sara; Bredeson, Christopher N.; Burns, Linda J.; Dalal, Jignesh D.; Freytes, Cesar O.; Gupta, Vikas; Inamoto, Yoshihiro; Lazarus, Hillard M.; LeMaistre, Charles F.; Steinberg, Amir; Szwajcer, David; Wingard, John R.; Wirk, Baldeep; Wood, William A.; Joffe, Steven; Hahn, Theresa E.; Loberiza, Fausto R.; Anasetti, Claudio; Horowitz, Mary M.; Lee, Stephanie J.			Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Trial participation; Hematopoietic cell transplantation	VERSUS-HOST-DISEASE; UNRELATED DONORS; MYOCARDIAL-INFARCTION; EXTERNAL VALIDITY; IMPROVED SURVIVAL; CANCER; POPULATION; GENERALIZABILITY; LEUKEMIA; REGISTRY	Controversy surrounds the question of whether clinical trial participants have better outcomes than comparable patients who are not treated on a trial. We explored this question using a recent large, randomized, multicenter study comparing peripheral blood (PB) with bone marrow transplantation from unrelated donors, conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). We compared characteristics and outcomes of study participants (n = 494) and nonparticipants (n = 1384) who appeared eligible and received similar treatment without enrolling on the BMT CTN trial at participating centers during the study time period. Data were obtained from the Center for International Blood and Marrow Transplant Research. Outcomes were compared between the 2 groups using Cox proportional hazards regression models. No significant differences in age, sex, disease distribution, race/ethnicity, HLA matching, comorbidities, and interval from diagnosis to hematopoietic cell transplantation were seen between the participants and non-participants. Nonparticipants were more likely to have lower performance status, lower risk disease, and older donors, and to receive myeloablative conditioning and antithymocyte globulin. Nonparticipants were also more likely to receive PB grafts, the intervention tested in the trial (66% versus 50%, P < .001). Overall survival, transplantation-related mortality, and incidences of acute or chronic graft-versus-host disease were comparable between the 2 groups though relapse was higher (hazard ratio, 1.22; 95% confidence interval, 1.02 to 1.46; P = .028) in nonparticipants. Despite differences in certain baseline characteristics, survival was comparable between study participants and nonparticipants. The results of the BMT CTN trial appear generalizable to the population of trial-eligible patients. (C) 2015 American Society for Blood and Marrow Transplantation.	[Khera, Nandita] Mayo Clin, Dept Hematol Oncol, Phoenix, AZ 85054 USA; [Majhail, Navneet S.] Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA; [Brazauskas, Ruta; Wang, Zhiwei; He, Naya; Horowitz, Mary M.] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Brazauskas, Ruta] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA; [Aljurf, Mahmoud D.] King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia; [Akpek, Goerguen] Banner MD Anderson Canc Ctr, Hematol Oncol Sect, Gilbert, AZ USA; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Beattie, Sara] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Bredeson, Christopher N.] Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada; [Bredeson, Christopher N.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Burns, Linda J.] Be Match, Natl Marrow Donor Program, Hlth Serv Res, Minneapolis, MN USA; [Dalal, Jignesh D.] Childrens Mercy Hosp & Clin, Bone Marrow Transplantat, Pediat Hematol Oncol, Kansas City, MO USA; [Freytes, Cesar O.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Freytes, Cesar O.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Gupta, Vikas] Univ Hlth Network, Blood & Marrow Transplant Program, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Inamoto, Yoshihiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Lazarus, Hillard M.] Univ Hosp Cleveland, Case Med Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA; [LeMaistre, Charles F.] Sarah Cannon, Hematol & Bone Marrow Transplant, Nashville, TN USA; [Steinberg, Amir] Mt Sinai Hosp, Dept Hematol Oncol, New York, NY 10029 USA; [Szwajcer, David] Univ Manitoba, Dept Hematol, CancerCare Manitoba, Winnipeg, MB, Canada; [Wingard, John R.] Univ Florida, Div Hematol & Oncol, Dept Med, Gainesville, FL USA; [Wirk, Baldeep] SUNY Stony Brook, Dept Internal Med, Stony Brook, NY 11794 USA; [Wood, William A.] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA; [Joffe, Steven] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Hahn, Theresa E.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Loberiza, Fausto R.] Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Anasetti, Claudio] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Bone Marrow Transplant Program, Tampa, FL 33612 USA; [Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Clin Transplant Res, Seattle, WA 98104 USA	Khera, N (reprint author), Mayo Clin, Coll Med, Med, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	khera.nandita@mayo.edu		Joffe, Steven/0000-0002-0667-7384	NCI [U24-CA076518]; NHLBI; National Institute of Allergy and Infectious Diseases; NHLBI [5U10HL069294]; NCI; Health Resources and Services Administration (HRSA/DHHS) [HHSH250201200016C]; Office of Naval Research [N00014-12-1-0142, N00014-13-1-0039]; Actinium Pharmaceuticals; Allos Therapeutics, Inc.; Amgen	The CIBMTR is supported by Public Health Service grant/cooperative agreement U24-CA076518 from the NCI, the NHLBI, and the National Institute of Allergy and Infectious Diseases; a grant/cooperative agreement 5U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); 2 Grants N00014-12-1-0142 and N00014-13-1-0039 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals; Allos Therapeutics, Inc.; *Amgen; anonymous donation to the Medical College of Wisconsin; Ariad; Be The Match Foundation; *Blue Cross and Blue Shield Association; *Celgene Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.; *Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; *Gentium SpA; Genzyme Corporation; GlaxoSmithKline; Health Research, Inc.; Roswell Park Cancer Institute; HistoGenetics; Incyte Corporation; Jeff Gordon Children's Foundation; Kiadis Pharma; The Leukemia & Lymphoma Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co., Inc.; Millennium: The Takeda Oncology Co.; *Milliman USA, Inc.; *Miltenyi Biotec; National Marrow Donor Program; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Osiris Therapeutics; Otsuka America Pharmaceutical, Inc.; Perkin Elmer, Inc.; *Remedy Informatics; *Sanofi US; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; St. Baldrick's Foundation; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; *Tarix Pharmaceuticals; *Terumo BCT; *Teva Neuroscience, Inc.; *Therakos; University of Minnesota; University of Utah; and *WellPoint. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration or any other agency of the US Government.	Stiller CA, 1999, BRIT J CANCER, V79, P658, DOI 10.1038/sj.bjc.6690104; Elting LS, 2006, CANCER, V106, P2452, DOI 10.1002/cncr.21907; Udell JA, 2014, JAMA-J AM MED ASSOC, V312, P841, DOI 10.1001/jama.2014.6217; Mengis C, 2003, J CLIN ONCOL, V21, P3933, DOI 10.1200/JCO.2003.03.186; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Bahit MC, 2003, AM HEART J, V145, P109, DOI 10.1067/mhj.2003.43; Gale RP, 2009, BONE MARROW TRANSPL, V43, P435, DOI 10.1038/bmt.2008.447; Peppercorn JM, 2004, LANCET, V363, P263, DOI 10.1016/S0140-6736(03)15383-4; Fossa SD, 2002, ACTA ONCOL, V41, P131; DAVIS S, 1985, CANCER, V56, P1710, DOI 10.1002/1097-0142(19851001)56:7<1710::AID-CNCR2820560741>3.0.CO;2-T; Sateren WB, 2002, J CLIN ONCOL, V20, P2109, DOI 10.1200/JCO.2002.08.056; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Finke J, 2003, J CLIN ONCOL, V21, P506, DOI 10.1200/JCO.2003.03.129; Moher D, 2001, ANN INTERN MED, V134, P657; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Eapen M, 2007, BIOL BLOOD MARROW TR, V13, P1461, DOI 10.1016/j.bbmt.2007.08.006; Unger JM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju002; van de Water W, 2014, JNCI-J NATL CANCER I, V106; Vist GE, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.MR000009.PUB4	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	OCT	2015	21	10					1815	1822		10.1016/j.bbmt.2015.06.004		8	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CS0VU	WOS:000361781100019		
J	Ogasawara, S; Kiyota, Y; Chuman, Y; Kowata, A; Yoshimura, F; Tanino, K; Kamada, R; Sakaguchi, K				Ogasawara, Sari; Kiyota, Yuhei; Chuman, Yoshiro; Kowata, Ayano; Yoshimura, Fumihiko; Tanino, Keiji; Kamada, Rui; Sakaguchi, Kazuyasu			Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Dephosphorylation; Anti-tumor; Protein phosphatase; Inhibitors; Apoptosis	PROTEIN PHOSPHATASE; WIP1; P53; BREAST; AMPLIFICATION; RADIATION; TUMORS	Protein phosphatase magnesium-dependent 1 delta (PPM1D, Wip1) is a p53 inducible serine/threonine phosphatase. PPM1D is a promising target protein in cancer therapy since overexpression, missense mutations, truncating mutations, and gene amplification of PPM1D are reported in many tumors, including breast cancer and neuroblastoma. Herein, we report that a specific inhibitor, SL-176 that can be readily synthesized in 10 steps, significantly inhibits proliferation of a breast cancer cell line overexpressing PPM1D and induces G2/M arrest and apoptosis. SL-176 decreases PPM1D enzyme activity potently and specifically in vitro. These results demonstrate that SL-176 could be a useful lead compound in the development of effective anti-cancer agents. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogasawara, Sari; Kiyota, Yuhei; Chuman, Yoshiro; Kamada, Rui; Sakaguchi, Kazuyasu] Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab,Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Kowata, Ayano; Yoshimura, Fumihiko; Tanino, Keiji] Hokkaido Univ, Fac Sci, Dept Chem, Organ Chem Lab 2, Sapporo, Hokkaido 0600810, Japan	Sakaguchi, K (reprint author), Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab,Kita Ku, North 10,West 8, Sapporo, Hokkaido 0600810, Japan.	kazuyasu@sci.hokudai.ac.jp	Yoshimura, Fumihiko/A-4116-2012		JSPS - Japan [24310152, 24570416]	This work was supported in part by Grants-in-Aid for Scientific Research (B) (No. 24310152) from JSPS - Japan (to K.S.) and Grant-in-Aid for Scientific Research (C) (No. 24570416) from JSPS - Japan (to Y.C.). We thank J.I. Janairo for providing valuable comments and suggestions.	Akbari M. R., 2014, JNCI-J NATL CANCER I, V106, P3; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/nchembio.1427, 10.1038/NCHEMBIO.1427]; Fukuda R, 2013, J BIOL CHEM, V288, P16117, DOI 10.1074/jbc.M112.442442; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Jarvinen TAH, 1999, GENE CHROMOSOME CANC, V26, P142; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Richter M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115635; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Yagi H, 2012, BIOORG MED CHEM LETT, V22, P729, DOI 10.1016/j.bmcl.2011.10.084; Goloudina AR, 2012, P NATL ACAD SCI USA, V109, pE68, DOI 10.1073/pnas.1107017108; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Kozakai Y, 2014, BIOORG MED CHEM LETT, V24, P5593, DOI 10.1016/j.bmcl.2014.10.093; Li GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060775	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	OCT 1	2015	23	19					6246	6249		10.1016/j.bmc.2015.08.042		4	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CR8XT	WOS:000361638400002		
J	Nakajima, R; Yamamoto, N; Hirayama, S; Iwai, T; Saitoh, A; Nagumo, Y; Fujii, H; Nagase, H				Nakajima, Ryo; Yamamoto, Naoshi; Hirayama, Shigeto; Iwai, Takashi; Saitoh, Akiyoshi; Nagumo, Yasuyuki; Fujii, Hideaki; Nagase, Hiroshi			Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Opioid; Propellane; KOR selectivity; Analgesic; Nalfurafine	RECEPTOR AGONIST NALFURAFINE; RATIONAL DRUG DESIGN; DECAHYDRO(IMINOETHANO)PHENANTHRENE DERIVATIVES; KAPPA-AGONIST; BINDING; TAN-821; KNT-127; TAN-67; LIGAND	We designed and synthesized pentacyclic propellane derivatives with a 6-amide side chain to afford compounds with higher MOR/KOR ratio and lower sedative effects than nalfurafine. The obtained etheno-bridged derivative with a beta-amide side chain, YNT-854, showed a higher MOR/KOR ratio than nalfurafine. YNT-854 also exhibited a higher dose ratio between the sedative effect and the analgesic effect than observed with nalfurafine, which may guide the future design of useful analgesics with a weaker sedative effect than nalfurafine. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakajima, Ryo; Nagase, Hiroshi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Yamamoto, Naoshi; Nagumo, Yasuyuki; Nagase, Hiroshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Hirayama, Shigeto; Iwai, Takashi; Fujii, Hideaki] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Saitoh, Akiyoshi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsychopharmacol, Tokyo 1878553, Japan	Nagase, H (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058571, Japan.	nagase.hiroshi.gt@u.tsukuba.ac.jp			JSPS KAKENHI [26860076, 15J03517]	This work was supported by JSPS KAKENHI 26860076, 15J03517. We also acknowledge the Institute of Instrumental Analysis of Kitasato University. School of Pharmacy for its facilities.	Nagase H, 2012, BIOORG MED CHEM LETT, V22, P5071, DOI 10.1016/j.bmcl.2012.05.122; Nemoto T, 2011, BIOORGAN MED CHEM, V19, P1205, DOI 10.1016/j.bmc.2010.12.035; Nakao K, 2009, DRUG TODAY, V45, P323, DOI 10.1358/dot.2009.45.5.1362067; Yamaotsu N, 2011, TOP CURR CHEM, V299, P277, DOI 10.1007/128_2010_84; Nagase H, 2010, BIOORG MED CHEM LETT, V20, P6302, DOI 10.1016/j.bmcl.2010.08.083; Ida Y, 2012, BIOORGAN MED CHEM, V20, P949, DOI 10.1016/j.bmc.2011.11.047; Nagase H, 2011, TOP CURR CHEM, V299, P29, DOI 10.1007/128_2010_74; Fujii H, 2004, BIOORGAN MED CHEM, V12, P4133, DOI 10.1016/j.bmc.2004.05.024; Nagase H, 2012, CHEM PHARM BULL, V60, P945; Fujii H, 2006, CURR MED CHEM, V13, P1109, DOI 10.2174/092986706776360851; Nagase H, 2009, BIOORG MED CHEM LETT, V19, P2792, DOI 10.1016/j.bmcl.2009.03.099; MILLAN MJ, 1990, TRENDS PHARMACOL SCI, V11, P70, DOI 10.1016/0165-6147(90)90321-X; Endoh T, 1999, LIFE SCI, V65, P1685, DOI 10.1016/S0024-3205(99)00417-8; Fujii H, 2012, BIOORG MED CHEM LETT, V22, P7697, DOI 10.1016/j.bmcl.2012.09.102; Nagase H, 1998, CHEM PHARM BULL, V46, P1695; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Kawai K, 2008, BIOORGAN MED CHEM, V16, P9188, DOI 10.1016/j.bmc.2008.09.011; MUCHA RF, 1985, PSYCHOPHARMACOLOGY, V86, P274, DOI 10.1007/BF00432213; Nagase H, 2001, LIFE SCI, V68, P2227, DOI 10.1016/S0024-3205(01)01010-4; Nemoto T, 2008, BIOORG MED CHEM LETT, V18, P6398, DOI 10.1016/j.bmcl.2008.10.081; SZMUSZKOVICZ J, 1982, J MED CHEM, V25, P1125, DOI 10.1021/jm00352a005; Yamaotsu N, 2010, BIOORGAN MED CHEM, V18, P4446, DOI 10.1016/j.bmc.2010.04.069; Hutchby M, 2012, ANGEW CHEM INT EDIT, V51, P548, DOI 10.1002/anie.201107117; Nagase H, 2010, BIOORG MED CHEM LETT, V20, P121, DOI 10.1016/j.bmcl.2009.11.027; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Nagase H, 1998, CHEM PHARM BULL, V46, P366; Fujii H, 2012, BIOORG MED CHEM LETT, V22, P7711, DOI 10.1016/j.bmcl.2012.09.101; Yamamoto N, 2011, BIOORG MED CHEM LETT, V21, P4104, DOI 10.1016/j.bmcl.2011.04.147; LAHTI RA, 1982, LIFE SCI, V31, P2257, DOI 10.1016/0024-3205(82)90132-1; Saitoh A, 2011, BEHAV BRAIN RES, V223, P271, DOI 10.1016/j.bbr.2011.04.041; LAHTI RA, 1985, EUR J PHARMACOL, V109, P281, DOI 10.1016/0014-2999(85)90431-5; Narita M., 2008, NEUROPSYCHOPHARMACOL, V1097, P33; Portghese P. S., 1990, J MED CHEM, V257, P676	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	OCT 1	2015	23	19					6271	6279		10.1016/j.bmc.2015.08.036		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CR8XT	WOS:000361638400005		
J	Odili, AN; Abdullahi, B; Nwankwo, AM; Asayama, K; Staessen, JA				Odili, Augustine N.; Abdullahi, Bolaji; Nwankwo, Adaku M.; Asayama, Kei; Staessen, Jan A.			Characteristics of self-measured home blood pressure in a Nigerian urban community: the NIPREGH study	BLOOD PRESSURE MONITORING			English	Article						blood pressure measurement; clinical science; home blood pressure; hypertension; office blood pressure	SUB-SAHARAN AFRICA; ARTERIAL-HYPERTENSION; REPRODUCIBILITY; METAANALYSIS; PREVALENCE; PHENOTYPE; COUNTRIES; DEVICES; QUALITY	ObjectiveWe investigated the characteristics of self-measured home blood pressure (HBP) in a randomly selected population of Nigerians living in Abuja, Nigeria.MethodsHBP was the average of 28 measurements comprising duplicate morning and evening readings obtained over a 7-day period by the participants using a semiautomated oscillometric device. Blood pressure measured five consecutive times by trained observers using mercury sphygmomanometer was averaged as the office blood pressure (OBP).ResultsAmong the 337 participants included in the analysis, 46.6% were women and their mean age (SD) 40.3 (11.3). The mean, mean+2SD and 95th percentile of HBP and OBP were 117/76, 147/96 and 145/93mmHg and 114/73, 147/97 and 142/73mmHg, respectively. The corresponding values in normotensive individuals were 113/73, 137/89 and 132/88mmHg and 108/70, 130/88 and 128/84mmHg. Morning HBPs were significantly higher than that of the evening, with a mean difference (confidence interval) of 1.8mmHg (1.1-2.5mmHg) and 1.9mmHg (1.4-2.3mmHg) for systolic and diastolic pressures, respectively (P<0.0001). There is a strong correlation between the office and home systolic (r=0.8, P<0.0001) and diastolic (r=0.7, P<0.0001) pressures. Overall, the HBP values were significantly higher than OBP, with a mean difference (confidence interval) of systolic/diastolic of 3.6mmHg (2.5-4.6mmHg)/2.3mmHg (1.4-3.1mmHg) (P<0.0001). The HBP/OBP difference was maintained in men and normotensive individuals, but in women and hypertensive participants, there was no significant difference between HBP and OBP.ConclusionOur findings have shown that self-measured blood pressure is feasible and can be used to evaluate blood pressure outside the clinic environment among Nigerians.	[Odili, Augustine N.; Staessen, Jan A.] Univ Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven Dept Cardiovasc Sci, Studies Coordinating Ctr, Leuven, Belgium; [Odili, Augustine N.] Univ Abuja, Coll Hlth Sci, Dept Internal Med, Div Cardiol, Garki, Abuja, Nigeria; [Abdullahi, Bolaji; Nwankwo, Adaku M.] Univ Abuja Teaching Hosp, Dept Med, Abuja, Nigeria; [Asayama, Kei] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Odili, AN (reprint author), Univ Abuja, Coll Hlth Sci, Dept Internal Med, Div Cardiol, PMB 117, Garki, Abuja, Nigeria.	odilimercy@yahoo.com			Doctoral School of Biomedical Sciences, University of Leuven	NIPREGH is partly supported through scholarship funding for a PhD programme of Augustine Odili at the Doctoral School of Biomedical Sciences, University of Leuven.	Adediran O, 2012, J Cardiovasc Dis Res, V3, P191, DOI 10.4103/0975-3583.98890; Parati G, 2005, BLOOD PRESS MONIT, V10, P3, DOI 10.1097/00126097-200502000-00002; Ragot S, 2000, AM J HYPERTENS, V13, P632, DOI 10.1016/S0895-7061(99)00258-7; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; WEISSER B, 1994, J HUM HYPERTENS, V8, P227; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Guerra-Riccio GM, 2004, AM J HYPERTENS, V17, P523, DOI 10.1016/j.amjhyper.2004.02.007; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; Tsunoda S, 2002, HYPERTENS RES, V25, P167, DOI 10.1291/hypres.25.167; Odili AN, 2014, BLOOD PRESS MONIT, V19, P220, DOI 10.1097/MBP.0000000000000053; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Little P, 2002, BRIT MED J, V325, P258, DOI 10.1136/bmj.325.7358.258; JAMES GD, 1988, HYPERTENSION, V11, P545; Colloca L, 2011, PSYCHOSOM MED, V73, P598, DOI 10.1097/PSY.0b013e3182294a50; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/01.mbp.0000087393.96145.b1; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Chakravarti IM, 1967, HDB METHODS APPL STA; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Ogah Okechukwu S, 2012, World J Cardiol, V4, P327, DOI 10.4330/wjc.v4.i12.327; Snecdecor GW, 1991, STAT METHODS; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71; Verdecchia P, 1999, Blood Press Monit, V4, P175, DOI 10.1097/00126097-199906000-00013; Wilson MD, 1997, BLOOD PRESS MONIT, V2, P201; World Medical Association, 2000, JAMA-J AM MED ASSOC, V284, P3043, DOI DOI 10.1001/JAMA.284.23.3043	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1359-5237	1473-5725		BLOOD PRESS MONIT	Blood Press. Monit.	OCT	2015	20	5					260	265		10.1097/MBP.0000000000000136		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR6SN	WOS:000361477800005		
J	Takahashi, H; Yoshika, M; Yokoi, T				Takahashi, Hakuo; Yoshika, Masamichi; Yokoi, Toyohiko			Validation of two automatic devices: Omron HEM-7252G-HP and Omron HEM-7251G for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010	BLOOD PRESSURE MONITORING			English	Article						blood pressure measurement; device; European Society of Hypertension International Protocol revision 2010; guideline	ADULTS; HOME	ObjectiveThe aim of this study was to validate the performance of Omron HEM-7252G-HP and Omron HEM-7251G for monitoring upper arm blood pressure (BP) in accordance with the European Society of Hypertension International Protocol revision 2010 (ESH-IP revision 2010).MethodsThree trained medical doctors validated the performance of these devices by comparing data obtained from these devices with those obtained using a standard mercury sphygmomanometer. We included 33 participants (19 men and 14 women for the experiment using HEM-7252G-HP; 16 men and 17 women for the experiment using HEM-7251G). The mean age of the participants was 5012 and 5310 years in the respective studies.ResultsThe percentages of test device-observer mercury sphygmomanometer BP differences within 5, 10, and 15mmHg were 76, 92, and 97% for systolic BP (SBP) and 83, 97, and 99% for diastolic BP (DBP), respectively, in the Omron HEM-7252G-HP and 77, 92, and 99% for SBP and 85, 94, and 98% for DBP, respectively, in the Omron HEM-7251G in the part 1 analysis; both SBP and DBP passed the part 1 and part 2 criteria.The mean differences between the device and mercury readings for SBP and DBP were as follows: HEM-7252G-HP, -1.5 +/- 5.1 and -1.2 +/- 3.9mmHg, respectively; HEM-7351G, -0.6 +/- 4.7 and -0.2 +/- 4.4mmHg, respectively.ConclusionThe Omron HEM-7252G-HP and HEM-7251G passed all the requirements of the ESH-IP 2010 revision.	[Takahashi, Hakuo; Yoshika, Masamichi; Yokoi, Toyohiko] Kansai Med Univ, Dept Clin Sci & Lab Med, Hirakata, Osaka 5731010, Japan	Takahashi, H (reprint author), Kansai Med Univ, Dept Clin Sci & Lab Med, Shin Machi 2-5-1, Hirakata, Osaka 5731010, Japan.	takahash@hirakata.kmu.ac.jp			Kansai Medical University	The study was funded by the Kansai Medical University.	O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; International Organization for Standardization, 8106022013 ISOOCE; NICE, 2011, HYP CLIN MAN PRIM HY; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Verberk Willem J, 2007, Vasc Health Risk Manag, V3, P959	8	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1359-5237	1473-5725		BLOOD PRESS MONIT	Blood Press. Monit.	OCT	2015	20	5					286	290		10.1097/MBP.0000000000000127		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CR6SN	WOS:000361477800010		
J	Egami, C; Yamashita, Y; Tada, Y; Anai, C; Mukasa, A; Yuge, K; Nagamitsu, S; Matsuishi, T				Egami, Chiyomi; Yamashita, Yushiro; Tada, Yasuhiro; Anai, Chiduru; Mukasa, Akiko; Yuge, Kotaro; Nagamitsu, Shinichiro; Matsuishi, Toyojiro			Developmental trajectories for attention and working memory in healthy Japanese school-aged children	BRAIN & DEVELOPMENT			English	Article						Attention; Working memory; Short-term memory; Developmental trajectories; Typically developing children	DEFICIT HYPERACTIVITY DISORDER; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTIONS; HUMAN BRAIN; CAPACITY; CHILDHOOD; TASK; SCHIZOPHRENIA; PERFORMANCE; BATTERY	Objective: The aim of this study was to investigate the developmental trajectories of attention, short-term memory, and working memory in school-aged children using a 10 min test battery of cognitive function. Methods: Participants comprised 144 typically developing children (TDC) aged 7-12 years and 24 healthy adults, divided according to age into seven groups (12 males and 12 females for each age group). Participants were assessed using CogHealth, which is a computer-based measure composed of five tasks. We measured attention, short-term memory, and working memory (WM) with visual stimulation. Each task was analyzed for age-related differences in reaction time and accuracy rate. Results: Attention tasks were faster in stages from the age of 7-10 years. Accuracy rate of short-term memory gradually increased from 12 years of age and suddenly increased and continued to increase at 22 years of age. Accuracy rate of working memory increased until 12 years of age. Correlations were found between the ages and reaction time, and between ages and accuracy rate of the tasks. Conclusion: These results indicate that there were rapid improvements in attention, short-term memory, and WM performance between 7 and 10 years of age followed by gradual improvement until 12 years of age. Increase in short-term memory continued until 22 years of age. In our experience CogHealth was an easy and useful measure for the evaluation of cognitive function in school-age children. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Egami, Chiyomi] Fukuoka Prefectural Univ, Dept Nursing, Fukuoka, Japan; [Yamashita, Yushiro; Yuge, Kotaro; Nagamitsu, Shinichiro; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan; [Yamashita, Yushiro; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 8300011, Japan	Yamashita, Y (reprint author), Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 8300011, Japan.	yushiro@med.kurume-u.ac.jp			Intramural Research Grant (Clinical Research for Diagnostic and Therapeutic Innovations in Developmental Disorders) for Neurological and Psychiatric Disorders of NCNP [22-6, 25-6]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591519]	This study was supported by Intramural Research Grant (22-6, 25-6; Clinical Research for Diagnostic and Therapeutic Innovations in Developmental Disorders) for Neurological and Psychiatric Disorders of NCNP and the Grant-in-Aid for Scientific Research C (23591519) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We also thank Dr. Paul Maruff for his editorial advice.	Anderson V, 2001, DEV NEUROREHABIL, V4, P119, DOI DOI 10.1080/1363849; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Mollica CM, 2004, HUM PSYCHOPHARM CLIN, V19, P445, DOI 10.1002/hup.624; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Barnett R, 2001, PSYCHOL MED, V31, P1107; Baddeley AD, 2011, NEUROPSYCHOLOGIA, V49, P1393, DOI 10.1016/j.neuropsychologia.2010.12.042; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Klimkeit EI, 2004, CHILD NEUROPSYCHOL, V10, P201, DOI 10.1080/09297040490911050; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Yamashita Y, 2011, BRAIN DEV-JPN, V33, P260, DOI 10.1016/j.braindev.2010.09.005; CASE R, 1972, J EXP CHILD PSYCHOL, V14, P287, DOI 10.1016/0022-0965(72)90051-3; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Pietrzak RH, 2006, NEUROSCI BIOBEHAV R, V30, P1225, DOI 10.1016/j.neubiorev.2006.10.002; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Li J, 2013, NEUROIMAGE, V75, P79, DOI 10.1016/j.neuroimage.2012.09.077; KEATING DP, 1978, CHILD DEV, V49, P155, DOI 10.2307/1128604; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; SALTHOUSE TA, 1992, ACTA PSYCHOL, V79, P155, DOI 10.1016/0001-6918(92)90030-H; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Brodeur DA, 2001, J ABNORM CHILD PSYCH, V29, P229, DOI 10.1023/A:1010381731658; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037//0033-295X.101.2.343; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Nelson CA, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P327; PASCUALL.J, 1970, ACTA PSYCHOL, V32, P301, DOI 10.1016/0001-6918(70)90108-3	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					840	848		10.1016/j.braindev.2015.02.003		9	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400002		
J	Hino-Fukuyo, N; Haginoya, K; Nakashima, I; Sato, DK; Takahashi, T; Misu, T; Fujihara, K; Hirose, M; Kakisaka, Y; Uematsu, M; Kobayashi, T; Kure, S				Hino-Fukuyo, Naomi; Haginoya, Kazuhiro; Nakashima, Ichiro; Sato, Douglas Kazutoshi; Takahashi, Toshiyuki; Misu, Tatsuro; Fujihara, Kazuo; Hirose, Mieko; Kakisaka, Yosuke; Uematsu, Mitsugu; Kobayashi, Tomoko; Kure, Shigeo			Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies	BRAIN & DEVELOPMENT			English	Article						Acute disseminated encephalomyelitis; Multiple sclerosis; Optic neuritis; Neuromyelitis optica; Myelin-oligodendrocyte glycoprotein	NMO SPECTRUM DISORDERS; DEMYELINATING DISEASES; AQUAPORIN-4; CRITERIA	Background: Myelin-oligodendrocyte glycoprotein and aquaporin-4. have been extensively analyzed as targets for humoral immune reactions in central nervous system (CNS) demyelinating diseases, and the results indicated a possible role of these antibodies in the pathogenesis of various demyelinating diseases. Objective: To investigate the antibody titer levels against myelin-oligodendrocyte glycoprotein and aquaporin-4 in pediatric patients with inflammatory CNS disorders, and to evaluate clinical significance to study anti-myelin-oligodendrocyte glycoprotein antibodies. Methods: Sera at onset from patients with acute disseminated encephalomyelitis (ADEM) in 7, optic neuritis (ON) in 5, pediatric MS in 4 and neuromyelitis optica in one were tested for myelin-oligodendrocyte glycoprotein and aquaporin-4 antibodies using cell-based assays with live transfected cells. The duration of the observation periods ranged from 1 to 21 years (median, 10 years). We also described clinical course of patients with positive anti-myelin-oligodendrocyte glycoprotein antibodies. Results: Among 17 patients diagnosed with inflammatory CNS demyelinating diseases nine (52%) were positive to anti-myelin-oligodendrocyte glycoprotein antibodies. Of note, all cases with positive anti-myelin-oligodendrocyte glycoprotein antibodies showed seronegativity against anti-aquaporin-4 antibodies and had a favorable prognosis. Conclusions: This preliminary report showed that anti-myelin-oligodendrocyte glycoprotein antibodies testing at onset could be a useful tool predicting clinical outcome of children with ADEM, ON, and MS. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Hino-Fukuyo, Naomi; Haginoya, Kazuhiro; Hirose, Mieko; Kakisaka, Yosuke; Uematsu, Mitsugu; Kobayashi, Tomoko; Kure, Shigeo] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan; [Nakashima, Ichiro; Sato, Douglas Kazutoshi; Takahashi, Toshiyuki; Misu, Tatsuro; Fujihara, Kazuo] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan	Hino-Fukuyo, N (reprint author), Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	naomi-h@zc4.so-net.ne.jp	Sato, Douglas/F-2508-2013	Sato, Douglas/0000-0002-7695-6020			Rostasy K, 2013, NEUROPEDIATRICS, V44, P297, DOI 10.1055/s-0033-1358602; Kitley J, 2014, JAMA NEUROL, V71, P276, DOI 10.1001/jamaneurol.2013.5857; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Sato DK, 2013, NEUROLOGY, V80, P2210, DOI 10.1212/WNL.0b013e318296ea08; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					849	852		10.1016/j.braindev.2015.02.006		4	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400003		
J	Kihara, K; Kawasaki, Y; Yagi, M; Takada, S				Kihara, Kenji; Kawasaki, Yoko; Yagi, Mariko; Takada, Satoshi			Relationship between stature and tibial length for children with moderate-to-severe cerebral palsy	BRAIN & DEVELOPMENT			English	Article						Cerebral palsy; Stature; Measurement; Tibial length; Reliability	KNEE HEIGHT; GROWTH	Objective: To derive the equation for estimating stature, based on tibial length, for children with moderate-to-severe cerebral palsy (CP) and lower limb joint contracture or scoliosis. Methods: The participants (3-12-years-old) included 50 children with moderate-to-severe CP (mean age, 8.3 +/- 2.4 years) and 38 typically developed (TD) children (mean age, 7.5 +/- 2.6 years). Thirty-four (68%) of the children with CP had a gross motor function classification system level of V. Furthermore, 40 (80%) had definite lower limb joint contracture or scoliosis. The stature and the tibial length measurements of all participants were determined. Regression equations to estimate stature, based on tibial lengths, were determined for both TD children and children with CP. Moreover, regression equations defining the relationship between tibial length and age were compared between the two groups of children, using multiple regression analysis. Results: The regression equations for estimating stature, based on tibial length, were stature = tibial length x 3.25 + 34.45 [cm], R-2 = 0.91 (TD children), and stature = tibial length x 3.42 + 31.82 [cm], R-2 = 0.81 (CP children). In children with CP, tibial lengths were significantly shorter than those in similarly aged TD children. Conclusion: The stature of children with moderate-to-severe CP can be estimated from their tibial lengths, regardless of the presence of joint contracture or scoliosis. The tibial length may be a proxy for estimating stature during the growth assessment of children with moderate-to-severe CP. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kihara, Kenji; Takada, Satoshi] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Kihara, Kenji; Kawasaki, Yoko; Yagi, Mariko] Nikoniko House Med Welf Ctr, Kita Ku, Kobe, Hyogo 6511102, Japan	Takada, S (reprint author), Kobe Univ, Grad Sch Hlth Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	satoshi@kobe-u.ac.jp					Dahlseng MO, 2012, ACTA PAEDIATR, V101, P92, DOI 10.1111/j.1651-2227.2011.02412.x; Kong CK, 1999, DEV MED CHILD NEUROL, V41, P758, DOI 10.1017/S0012162299001528; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214; Hogan SE, 1999, J AM COLL NUTR, V18, P201; Campanozzi A, 2007, BRAIN DEV-JPN, V29, P25, DOI 10.1016/j.braindev.2006.05.008; Krick J, 1996, J AM DIET ASSOC, V96, P680, DOI 10.1016/S0002-8223(96)00188-5; STALLINGS VA, 1993, DEV MED CHILD NEUROL, V35, P126; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; Oeffinger D, 2010, DEV MED CHILD NEUROL, V52, pE195, DOI 10.1111/j.1469-8749.2010.03711.x; Smith SL, 2007, J FORENSIC SCI, V52, P538, DOI 10.1111/j.1556-4029.2007.00428.x; JOHNSON RK, 1991, J AM DIET ASSOC, V91, P1283; Stevenson RD, 2006, PEDIATRICS, V118, P1010, DOI 10.1542/peds.2006-0298; Dahl M, 1996, ACTA PAEDIATR, V85, P697, DOI 10.1111/j.1651-2227.1996.tb14129.x; Karagiozoglou-Lampoudi T, 2012, ACTA PAEDIATR, V101, P649, DOI 10.1111/j.1651-2227.2012.02641.x; Kihara Kenji, 2013, No To Hattatsu, V45, P349; STEVENSON RD, 1995, ARCH PEDIAT ADOL MED, V149, P658	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					853	857		10.1016/j.braindev.2015.01.007		5	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400004		
J	Kobayashi, S; Wakusawa, K; Inui, T; Tanaka, S; Kobayashi, Y; Onuma, A; Haginoya, K				Kobayashi, Satoru; Wakusawa, Keisuke; Inui, Takehiko; Tanaka, Soichiro; Kobayashi, Yasuko; Onuma, Akira; Haginoya, Kazuhiro			The neurological outcomes of cerebellar injury in premature infants	BRAIN & DEVELOPMENT			English	Article						Cerebellar injury; Preterm infants; Magnetic resonance image; Cerebral palsy	LOW-BIRTH-WEIGHT; CEREBRAL-PALSY; PRETERM INFANTS; MOTOR FUNCTION; COMPLICATION; CHILDREN; SIZE; AGE	Aim: Cerebellar injury is a characteristic injury associated with preterm infants. However, the impact of cerebellar injury on the development of preterm infants is unclear. Method: We reviewed magnetic resonance image studies of preterm infants with cerebral palsy retrospectively and evaluated the developmental outcomes. Results: Cerebellar injury was recognized in 9 (2.4%) of 381 patients with cerebral palsy who were born preterm. The median gestational age was 26 (range 23-32) weeks and the median birth weight was 938 (range 492-1450) g. Seven of the nine patients had severe symmetric injuries to the inferior cerebellar hemispheres, resulting in a pancake-like appearance of the residual upper cerebellum. Supratentorial lesions were also recognized: periventricular leukomalacia in seven; atrophy of the basal ganglia in two; and intraventricular hemorrhage in two. Importantly, the motor dysfunction was related to the reduction in the white matter volume and severity of basal ganglia atrophy, but not to the cerebellar injury. Four of the nine patients could walk without limitations despite extensive cerebellar disruption. Only four patients could speak meaningful words during the study and only one spoke two-word sentences. Interpretation: The patients with cerebellar injury might have a communication handicap, rather than altered motor function. Prematurity-related cerebellar complications require more attention in terms of cognitive and speech function, in addition to neuromotor development. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kobayashi, Satoru; Wakusawa, Keisuke; Inui, Takehiko; Tanaka, Soichiro; Kobayashi, Yasuko; Onuma, Akira; Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Sendai, Miyagi, Japan; [Tanaka, Soichiro; Haginoya, Kazuhiro] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Kobayashi, Yasuko] Nishitaga Natl Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Onuma, Akira] Ekoh Ryoikuen, Dept Pediat, Sendai, Miyagi, Japan	Kobayashi, S (reprint author), Nagoya City West Med Ctr, Dept Pediat, Kita Ku, 1-1-1 Hirate Cho, Nagoya, Aichi 4628508, Japan.	kobasato@muf.biglobe.ne.jp					Srinivasan L, 2006, AM J NEURORADIOL, V27, P573; Messerschmidt A, 2008, EUR J PEDIATR, V167, P1141, DOI 10.1007/s00431-007-0647-0; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; Bodensteiner JB, 2005, J CHILD NEUROL, V20, P139, DOI 10.1177/08830738050200021101; Johnsen SD, 2002, J CHILD NEUROL, V17, P320, DOI 10.1177/088307380201700502; Johnsen SD, 2005, J CHILD NEUROL, V20, P60, DOI 10.1177/08830738050200011001; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Bednarek N, 2008, J CHILD NEUROL, V23, P906, DOI 10.1177/0883073808318063; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214; BAKER LL, 1988, RADIOLOGY, V168, P809; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; GillBody KM, 1997, PHYS THER, V77, P534; Messerschmidt A, 2005, AM J NEURORADIOL, V26, P1659; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Steinlin M, 2007, CEREBELLUM, V6, P237, DOI 10.1080/14734220701344507; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Suzuki J, 2002, BRAIN DEV-JPN, V24, P39, DOI 10.1016/S0387-7604(01)00395-3; MCARDLE CB, 1987, RADIOLOGY, V162, P230; Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Drummond PM, 2002, PAEDIATR PERINAT EP, V16, P172, DOI 10.1046/j.1365-3016.2002.00408.x; Barkovich AJ, 2005, PEDIAT NEUROIMAGING, P76; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816	23	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					858	863		10.1016/j.braindev.2015.01.009		6	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400005		
J	Nakazawa, M; Toda, S; Abe, S; Ikeno, M; Igarashi, A; Nakahara, E; Yamashita, S; Niijima, S; Shimizu, T; Okumura, A				Nakazawa, Mika; Toda, Soichiro; Abe, Shinpei; Ikeno, Mitsuru; Igarashi, Ayuko; Nakahara, Eri; Yamashita, Shintaro; Niijima, Shinichi; Shimizu, Toshiaki; Okumura, Akihisa			Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis	BRAIN & DEVELOPMENT			English	Article						Fosphenytoin; Benign convulsions with mild gastroenteritis; Efficacy; Safety	INFANTILE CONVULSIONS; CHILDREN; THERAPY; DRUGS	Objective: To clarify the efficacy and safety of fosphenytoin for seizures in children with benign convulsions and mild gastroenteritis. Methods: Using the mailing list of the Annual Zao Conference on Pediatric Neurology, we recruited patients who met the following criteria: (1) clinical diagnosis of benign convulsions with mild gastroenteritis and (2) treatment with intravenous fosphenytoin. Benign convulsions with mild gastroenteritis were defined as a condition of (a) seizures associated with gastroenteritis without electrolyte imbalance, hypoglycemia, or dehydration in patients (b) between 6 months and 3 years of age with (c) no preexisting neurological disorders, (d) no impaired consciousness, and (e) a body temperature less than 38.0 degrees C before and after the seizures. The efficacy of fosphenytoin was categorized as effective when cessation of seizures was achieved. Results: Data from 16 child patients were obtained (median age, 20 months). Seizures were completely controlled after the initial dose of fosphenytoin in 14 of 16 patients. The median loading dose of fosphenytoin was 22.5 mg/kg. In 10 patients, fosphenytoin was administered after other antiepileptic drugs such as diazepam and midazolam were used. Adverse effects of fosphenytoin, excessive sedation, or intravenous fluid incompatibility were not observed in any patients. Conclusion: Fosphenytoin is effective and well tolerated among children with benign convulsions with mild gastroenteritis. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Nakazawa, Mika; Abe, Shinpei; Ikeno, Mitsuru; Igarashi, Ayuko; Nakahara, Eri; Shimizu, Toshiaki; Okumura, Akihisa] Juntendo Univ, Fac Med, Dept Pediat, Tokyo 1138421, Japan; [Toda, Soichiro] Kameda Med Ctr, Dept Pediat, Kamogawa, Chiba, Japan; [Yamashita, Shintaro; Niijima, Shinichi] Juntendo Univ, Nerima Hosp, Dept Pediat, Tokyo 1138421, Japan; [Okumura, Akihisa] Aichi Med Univ, Dept Pediat, Nagakute, Aichi, Japan	Nakazawa, M (reprint author), Juntendo Univ, Fac Med, Dept Pediat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	mknakaza@juntendo.ac.jp			Ministry of Health, Labor, and Welfare [H24-Shinkou-Ippan-002]; Ministry of Education, Culture, Sports, Science, and Technology [26461551]	This work was partly supported by a Grant from the Ministry of Health, Labor, and Welfare (H24-Shinkou-Ippan-002) and a Grant from the Ministry of Education, Culture, Sports, Science, and Technology (26461551).	Matsufuji H, 2005, BRAIN DEV-JPN, V27, P554, DOI 10.1016/j.braindev.2005.01.005; Tanabe T, 2011, BRAIN DEV-JPN, V33, P120, DOI 10.1016/j.braindev.2010.02.007; Takami Yuichi, 2012, No To Hattatsu, V44, P461; Trinka E, 2009, EPILEPSIA, V50, P40, DOI 10.1111/j.1528-1167.2009.02368.x; Okumura A, 2004, BRAIN DEV-JPN, V26, P164, DOI 10.1016/S038707604(03)00121-9; Okumura A, 2004, BRAIN DEV-JPN, V26, P525, DOI 10.1016/j.braindev.2004.02.009; Verrotti A, 2014, EUR J PAEDIATR NEURO, V18, P572, DOI 10.1016/j.ejpn.2014.04.006; Uemura N, 2002, BRAIN DEV-JPN, V24, P745, DOI 10.1016/S0387-7604(02)00097-9; Bialer M, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2009.02348.x; Eriksson Kai, 2009, Expert Opin Drug Metab Toxicol, V5, P695, DOI 10.1517/17425250902997975; Li TS, 2014, SEIZURE-EUR J EPILEP, V23, P16, DOI 10.1016/j.seizure.2013.09.003; Morooka K., 1982, SHONIKA, V23, P131; Nagashima M, 2013, No To Hattatsu, V45, P62; Nakazawa M, 2015, BRAIN DEV-JPN, V37, P418, DOI 10.1016/j.braindev.2014.06.009	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					864	867		10.1016/j.braindev.2015.02.001		4	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400006		
J	Yoshitomi, S; Takahashi, Y; Ishizuka, M; Yamaguchi, T; Watanabe, A; Nasu, H; Ueda, Y; Ohtani, H; Ikeda, H; Imai, K; Shigematsu, H; Inoue, Y; Tanahashi, Y; Aiba, K; Ohta, H; Shimada, S; Yamamoto, T				Yoshitomi, Shinsaku; Takahashi, Yukitoshi; Ishizuka, Mamiko; Yamaguchi, Tokito; Watanabe, Akito; Nasu, Hirosato; Ueda, Yuki; Ohtani, Hideyuki; Ikeda, Hiroko; Imai, Katsumi; Shigematsu, Hideo; Inoue, Yushi; Tanahashi, Yoshihiro; Aiba, Kaori; Ohta, Hodaka; Shimada, Shino; Yamamoto, Toshiyuki			Three patients manifesting early infantile epileptic spasms associated with 2q24.3 microduplications	BRAIN & DEVELOPMENT			English	Article						2q24.3 microduplication; Epileptic spasms; Array comparative genomic hybridization array (aCGH); SCN1A; SCN2A; SCN3A	LINKED MENTAL-RETARDATION; SCN2A MUTATIONS; DRAVET SYNDROME; SEIZURES; DUPLICATION; ENCEPHALOPATHY; SCN3A; PHENOTYPE; CHILDREN; SPECTRUM	Background: Recent development of genetic analyses enabled us to reveal underlying genetic causes of the patients with epileptic encephalopathy in infancy. Mutations of voltage-gated sodium channel type I alpha subunit gene (SCN1A) are to be causally related with several phenotypes of epilepsy, generalized epilepsy with febrile seizure plus (GEFS), Dravet syndrome, and other infantile epileptic encephalopathies. In addition to SCN1A, contiguous genes such as SCN2A and SCN3A in 2q24.3 are also reported to have contribution to epileptic seizures. Therefore, gene abnormality involving this region is reasonable to contribute to epilepsy manifestation. Results: We encountered three patients with 2q24.3 microduplication diagnosed by Array comparative genomic hybridization array (aCGH). They developed partial seizures and epileptic spasms in their early infantile periods and showed remarkable developmental delay, although their seizures disappeared from 11 to 14 months of age. One of three patients had 2q24.3 microduplication which excludes SCNI A. Therefore, characteristics of epilepsy with 2q24.3 microduplication do not necessarily need duplication of SCNI A. This study suggested that 2q24.3 microduplication is one of the causes for early infantile epileptic spasms. Epileptic spasms associated with 2q24.3 microduplications may have better seizure outcome comparing with other etiologies. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Yoshitomi, Shinsaku; Takahashi, Yukitoshi; Ishizuka, Mamiko; Yamaguchi, Tokito; Watanabe, Akito; Nasu, Hirosato; Ueda, Yuki; Ohtani, Hideyuki; Ikeda, Hiroko; Imai, Katsumi; Shigematsu, Hideo; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Tanahashi, Yoshihiro] Ogaki Municipal Hosp, Ogaki, Japan; [Aiba, Kaori] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; [Ohta, Hodaka] Mie Prefectural Gen Med Ctr, Yokaichi, Japan; [Shimada, Shino; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan; [Shimada, Shino; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan	Yoshitomi, S (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan.				Comprehensive Research on Disability Health and Welfare; Research on Rare and Intractable Diseases; Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan; Japan Epilepsy Research Foundation;  [21591342];  [23591238];  [24591537]	We would like to express our gratitude to the patients and their families for their cooperation. This work was supported by Grants-in-aid for Scientific Research I Nos. 21591342, 23591238 and 24591537 (Y.T.); Comprehensive Research on Disability Health and Welfare; Research on Rare and Intractable Diseases (Y.T.); a Grant-in-Aid for Scientific Research from Health Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare, Japan (T.Y.) and grants from The Japan Epilepsy Research Foundation (Y.T.).	Vanoye CG, 2014, NEUROBIOL DIS, V62, P313, DOI 10.1016/j.nbd.2013.10.015; Raymond G, 2011, AM J MED GENET A, V155A, P920, DOI 10.1002/ajmg.a.33929; Herlenius E, 2007, EPILEPSIA, V48, P1138, DOI 10.1111/j.1528-1167.2007.01049.x; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Okumura A, 2011, EPILEPSIA, V52, pE66, DOI 10.1111/j.1528-1167.2011.03139.x; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Shimojima K, 2011, J HUM GENET, V56, P561, DOI 10.1038/jhg.2011.58; Higurashi N, 2013, EPILEPSY RES, V106, P191, DOI 10.1016/j.eplepsyres.2013.04.005; Writzl K, 2012, EPILEPSIA, V53, pe106, DOI 10.1111/j.1528-1167.2012.03437.x; Lim BC, 2014, J CHILD NEUROL, V29, P260, DOI 10.1177/0883073813478659; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Striano P, 2006, EPILEPSIA, V47, P218, DOI 10.1111/j.1528-1167.2006.00392.x; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Mulley JC, 2013, EPILEPSIA, V54, pe122, DOI 10.1111/epi.12323; Simonetti BG, 2012, EPILEPSIA, V53, P2128, DOI 10.1111/j.1528-1167.2012.03676.x; Vecchi M, 2011, SEIZURE-EUR J EPILEP, V20, P813, DOI 10.1016/j.seizure.2011.07.008; Liang JS, 2011, EPILEPSIA, V52, P1835, DOI 10.1111/j.1528-1167.2011.03174.x; Heron SE, 2010, EPILEPSIA, V51, P1865, DOI 10.1111/j.1528-1167.2010.02558.x; Berkovic SF, 2004, ANN NEUROL, V55, P550, DOI 10.1002/ana.20029; Gorter JA, 2010, EPILEPSIA, V51, P1791, DOI 10.1111/j.1528-1167.2010.02678.x	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					874	879		10.1016/j.braindev.2015.03.001		6	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400008		
J	Yang, HP; Kobayashi, K; Wang, S; Jiao, H; Xiao, JX; Toda, T; Wu, XR; Xiong, H				Yang, Haipo; Kobayashi, Kazuhiro; Wang, Shuo; Jiao, Hui; Xiao, Jiangxi; Toda, Tatsushi; Wu, Xiru; Xiong, Hui			Founder mutation causes classical Fukuyama congenital muscular dystrophy (FCMD) in Chinese patients	BRAIN & DEVELOPMENT			English	Article						Fukuyama congenital muscular dystrophy; FKTN; 3-kb insertion; Haplotype analysis; Founder mutation	WALKER-WARBURG-SYNDROME; RETROTRANSPOSAL INSERTION; DEFECTIVE GLYCOSYLATION; FUKUTIN; DYSTROGLYCAN; GENE; INVOLVEMENT; PHENOTYPE; DISEASE	Purpose: Fukuyama congenital muscular dystrophy (FCMD) is a congenital muscular dystrophy rarely reported outside Japan. Here, we report three patients with Fukuyama congenital muscular dystrophy (FCMD) in China who shared a similar clinical phenotype and 3-kb insertion in the FKTN 3' untranslated region. Methods: Immunofluorescence staining was undertaken on muscle biopsies from three patients using alpha dystroglycan antibody (IIH6). Genomic DNA from patients and parents was extracted from peripheral blood leukocytes. Polymerase chain reaction and DNA sequencing were employed to analyze the exons and surrounding intron sequences of the fukutin (FKTIV) gene to detect mutations. Haplotype analysis was also performed on each patient and their parents. Results: All patients had delayed mental and motor development, febrile convulsions, muscle weakness, and moderate to significant raised levels of serum creatine kinase (7000-11,160 U/L, 25-60 x normal). Brain MRI scans showed micropolygyria and extensive dysplasia in the white matter and brainstem. Electromyography revealed myopathic changes. Muscle immunofluorescence studies demonstrated reduced IIH6 staining. Genetic testing showed compound heterozygous mutations of FKTN. Cases 1 and 2 had a c.139C>T (p.Arg47*) heterozygous mutation. Case 3 had a c.346C>T (p.Gln116*) heterozygous mutation. Conclusion: All patients had a heterozygous 3-kb insertion in the FKTN 3' untranslated region. Haplotype analyses suggested that these patients had the same haplotype as Japanese patients. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Yang, Haipo; Wang, Shuo; Jiao, Hui; Wu, Xiru; Xiong, Hui] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China; [Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Xiao, Jiangxi] Peking Univ, Hosp 1, Dept Radiol, Beijing 100034, Peoples R China	Xiong, H (reprint author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.	xh_bjbj@163.com			National Natural Science Foundation of China [81271400]; National Basic Research Program of China [2012CB944602]	We are in deep mourning for Prof. Fukuyama. We will never forget him and will let him live in our heart and continue his work. The authors are grateful to all the patients and their families who have participated in this study and thank Dr. Anne Rutkowski, MD, for her comments and criticisms on the manuscript. This work was supported by grants from the National Natural Science Foundation of China (81271400), and the National Basic Research Program of China (2012CB944602).	Kobayashi K, 1998, NATURE, V394, P388; FUKUYAMA Y, 1984, BRAIN DEV-JPN, V6, P373; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Hiroi A, 2011, ACTA HISTOCHEM CYTOC, V44, P91, DOI 10.1267/ahc.10045; Hino N, 2001, BRAIN DEV-JPN, V23, P97, DOI 10.1016/S0387-7604(01)00189-9; Tachikawa M, 2012, J BIOL CHEM, V287, P8398, DOI 10.1074/jbc.M111.300905; Chang W, 2009, PRENATAL DIAG, V29, P560, DOI 10.1002/pd.2238; Kobayashi K, 1998, HUM GENET, V103, P323, DOI 10.1007/s004390050824; Yoshioka M, 2005, J CHILD NEUROL, V20, P385, DOI 10.1177/08830738050200041901; Jang DH, 2013, J CHILD NEUROL, V28, P132, DOI 10.1177/0883073812437425; Puckett RL, 2009, NEUROMUSCULAR DISORD, V19, P352, DOI 10.1016/j.nmd.2009.03.001; Xiong H, 2009, AM J MED GENET A, V149A, P2403, DOI 10.1002/ajmg.a.33057; Toda T, 1999, J MOL MED, V77, P816, DOI 10.1007/s001099900065; Jong YJ, 2000, NEUROMUSCULAR DISORD, V10, P108, DOI 10.1016/S0960-8966(99)00091-7; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Watanabe M, 2005, AM J MED GENET A, V138A, P344, DOI 10.1002/ajmg.a.30978; Cotarelo RP, 2008, CLIN GENET, V73, P139, DOI 10.1111/j.1399-0004.2007.00936.x; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Lim BC, 2010, NEUROMUSCULAR DISORD, V20, P524, DOI 10.1016/j.nmd.2010.06.005; de Bernabe DBV, 2003, J MED GENET, V40, P845; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Saito K, 2012, FUKUYAMA CONGENITAL	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					880	886		10.1016/j.braindev.2015.02.010		7	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400009		
J	Kawase, K; Nishino, I; Sugimoto, M; Togawa, T; Sugiura, T; Kouwaki, M; Kibe, T; Koyama, N; Yokochi, K				Kawase, Koya; Nishino, Ichizo; Sugimoto, Mari; Togawa, Takao; Sugiura, Tokio; Kouwaki, Masanori; Kibe, Tetsuya; Koyama, Norihisa; Yokochi, Kenji			Nemaline myopathy with KLHL40 mutation presenting as congenital totally locked-in state	BRAIN & DEVELOPMENT			English	Article						Nemaline myopathy; KEHL40; Congenital totally locked-in state; Hydrops fetalis		We report a case of nemaline myopathy with KLHL40 Mutation, presenting as congenital totally locked-in state. At birth, a male patient developed hydrops fetalis, which was diagnosed based on the generalized edema and pleural effusion and could perform no significant spontaneous movements. His eyes were open, without blinking, and the eyeballs were locked in the midposition. He could not express his intentions by vocalization or moving his trunk, extremities, facial muscles, mouth, eyelids, or eyeballs in response to ambient events or personal interactions. Electrophysiological tests and neuroimaging revealed no evidence of visual or auditory impairment that might indicate a lack of sensory perception, and no evidence of impaired consciousness or intellectual disorder(s) that might prevent him from recognizing ambient events or expressing his intentions. He subsequently died at 4 years of age. Our case highlights the fact that severe congenital neuromuscular disorders can present as congenital totally locked-in state, and that special attention should be provided to these patients. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kawase, Koya; Sugimoto, Mari; Kouwaki, Masanori; Koyama, Norihisa; Yokochi, Kenji] Toyohashi Municipal Hosp, Dept Pediat, Toyohashi, Aichi, Japan; [Kawase, Koya; Togawa, Takao; Sugiura, Tokio] Nagoya City Univ, Grad Sch Med Sci, Dept Neonatol & Pediat, Nagoya, Aichi 4678601, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1870031, Japan; [Kibe, Tetsuya; Yokochi, Kenji] Seirei Mikatahara Gen Hosp, Dept Pediat Neurol, Hamamatsu, Shizuoka, Japan	Kawase, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Neonatol & Pediat, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	kkawase@med.nagoya-cu.ac.jp					Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; HAYASHI H, 1989, J NEUROL SCI, V93, P19, DOI 10.1016/0022-510X(89)90158-5; Domsch H, 2010, INFANT BEHAV DEV, V33, P321, DOI 10.1016/j.infbeh.2010.03.008	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					887	890		10.1016/j.braindev.2015.02.002		4	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400010		
J	Abe, Y; Terashima, H; Hoshino, H; Sassa, K; Sakai, T; Ohtake, A; Kubota, M; Yamanouchi, H				Abe, Yuichi; Terashima, Hiroshi; Hoshino, Hideki; Sassa, Kaori; Sakai, Tetsuro; Ohtake, Akira; Kubota, Masaya; Yamanouchi, Hideo			Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy	BRAIN & DEVELOPMENT			English	Article						Chronic inflammatory demyelinating polyradiculoneuropathy; Peripheral nerve; Trigeminal nerve; Brachial plexus; Lumber plexus; Neurofibromatosis type 1; Hereditary motor and sensory neuropathy	CRANIAL NERVE INVOLVEMENT; POLYNEUROPATHY; HYPERTROPHY	We present characteristic magnetic resonance imaging (MRI) features in a pediatric female patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Muscle weakness developed at 8 years old and fluctuated during the clinical course over 7 years. Electrophysiological studies showed a demyelination pattern with moderately delayed nerve conduction velocity, as well as dispersion phenomenon. MRI showed marked changes in thickening of the spinal nerve roots and their peripheral nerves in the lumber and brachial plexuses, as well as in the bilateral trigeminal nerves. It is suggested that these MRI features are characteristic and strongly supportive of the diagnosis of CIDP with a prolonged clinical course. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Abe, Yuichi; Sassa, Kaori; Sakai, Tetsuro; Ohtake, Akira; Yamanouchi, Hideo] Saitama Med Univ, Dept Pediat, Saitama, Japan; [Terashima, Hiroshi; Hoshino, Hideki; Kubota, Masaya] Natl Ctr Child Hlth & Dev, Div Neurol, Tokyo, Japan	Abe, Y (reprint author), 38 Morohongo, Moroyama, Saitama 3500495, Japan.	abeyped@saitama-med.ac.jp					Aho TR, 2004, AM J NEURORADIOL, V25, P494; Cai FC, 1997, J CHILD NEUROL, V12, P13; Khadilkar SV, 2013, NEUROL INDIA, V61, P566, DOI 10.4103/0028-3886.121960; Niino M, 1999, INTERNAL MED, V38, P445, DOI 10.2169/internalmedicine.38.445; Guibord N, 1998, NEUROLOGY, V51, P1459; Yener GG, 2001, J NEUROL, V248, P193, DOI 10.1007/s004150170225; Duggins AJ, 1999, BRAIN, V122, P1383, DOI 10.1093/brain/122.7.1383; Costello F, 2002, J CHILD NEUROL, V17, P819, DOI 10.1177/08830738020170111201; De Smet K, 2013, CLIN RADIOL, V68, P317, DOI 10.1016/j.crad.2012.07.014; Van den Bergh PYK, 2010, J PERIPHER NERV SYST, V15, P1	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					894	896		10.1016/j.braindev.2015.01.006		3	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400012		
J	Kajimoto, M; Koga, M; Narumi, H; Inoue, H; Matsushige, T; Ohga, S				Kajimoto, Madoka; Koga, Michiaki; Narumi, Hiroko; Inoue, Hirofumi; Matsushige, Takeshi; Ohga, Shouichi			Successful control of radicular pain in a pediatric patient with Guillain-Barre syndrome	BRAIN & DEVELOPMENT			English	Article						Neuropathy; Pain control; Prednisolone; Children	METHYLPREDNISOLONE; CHILDREN	A 10-year-old boy was diagnosed as having the axonal form of Guillain Barre syndrome (GBS). The patient noticed progressive weakness of the lower legs on the 1st day of illness. Intravenous immunoglobulin therapy was immediately started on the 2nd day of illness. Despite the favorable recovery of muscle weakness, he complained of severe needle-like pain in the thighs and buttocks and also painful numbness over the gastrocnemius regions. Acetaminophen and hydroxyzine therapy was ineffective for the pain control. Oral prednisolone therapy (0.7 mg/kg/day) led to drastic pain-relief with favorable improvement of the weakness. Corticosteroid therapy is not typically used in the management of GBS patients. Although GBS-associated pain frequently occurs in children, only a few reports have indicated the analgesic utility of steroids in the treatment of pediatric GBS. This observation may suggest the alternative of this therapy as for the as the limited, but potentially rapid, control of GBS-associated acute radicular pain in pediatric patients. (C) 2015 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology.	[Kajimoto, Madoka; Narumi, Hiroko; Inoue, Hirofumi; Matsushige, Takeshi; Ohga, Shouichi] Yamaguchi Univ, Dept Pediat, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Koga, Michiaki] Yamaguchi Univ, Dept Neurol & Clin Neurosci, Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Kajimoto, M (reprint author), Yamaguchi Univ, Dept Pediat, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	kajimoto@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Dr. Brian Quinn (Editor-in-Chief. Japan Medical Communication) for editing the manuscript. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ruts L, 2007, J NEUROL, V254, P1318, DOI 10.1007/s00415-006-0515-2; HUGHES RAC, 1991, LANCET, V338, P1142, DOI 10.1016/0140-6736(91)91995-7; Pier DB, 2010, ACTA PAEDIATR, V99, P1589, DOI 10.1111/j.1651-2227.2010.01860.x; Wilmshurst JM, 2001, ACTA PAEDIATR, V90, P691, DOI 10.1080/080352501750258784; Nguyen DK, 1999, J PEDIATR-US, V134, P773, DOI 10.1016/S0022-3476(99)70297-0; Endo Kuniyuki, 2013, Rinsho Shinkeigaku, V53, P543; Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6; Liu J.W., 2013, COMPUT MATH METHOD M, V2013, P10; Roodbol J, 2014, J PERIPHER NERV SYST, V19, P121, DOI 10.1111/jns5.12068; Rosen Beth A, 2012, Pediatr Rev, V33, P164, DOI 10.1542/pir.33-4-164	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					897	900		10.1016/j.braindev.2015.01.004		4	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400013		
J	Kato, T; Morisada, N; Nagase, H; Nishiyama, M; Toyoshima, D; Nakagawa, T; Maruyama, A; Fu, XJ; Nozu, K; Wada, H; Takada, S; Iijima, K				Kato, Takeshi; Morisada, Naoya; Nagase, Hiroaki; Nishiyama, Masahiro; Toyoshima, Daisaku; Nakagawa, Taku; Maruyama, Azusa; Fu, Xue Jun; Nozu, Kandai; Wada, Hiroko; Takada, Satoshi; Iijima, Kazumoto			Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing	BRAIN & DEVELOPMENT			English	Article						CDKL5; Early infantile epileptic encephalopathy (EIEE); Somatic mosaicism; Next-generation sequencing; Double mutations	EPILEPTIC ENCEPHALOPATHY; CLINICAL-FEATURES; SPECTRUM	Introduction: CDKL5-related encephalopathy is an. X-linked dominantly inherited disorder that is characterized by early infantile epileptic encephalopathy or atypical Rett syndrome. We describe a 5-year-old Japanese boy with intractable epilepsy, severe developmental delay, and Rett syndrome-like features. Onset was at 2 months, when his electroencephalogram showed sporadic single poly spikes and diffuse irregular poly spikes. Methods: We conducted a genetic analysis using an Illumina (R) TruSight (TM) One sequencing panel on a next-generation sequencer. Results: We identified two epilepsy-associated single nucleotide variants in our case: CDKL5 p.Ala40Val and KCNQ2 p.Glu515Asp. CDKL5 p.Ala40Val has been previously reported to be responsible for early infantile epileptic encephalopathy. In our case, the CDKL5 heterozygous mutation showed somatic mosaicism because the boy's karyotype was 46,XY. The KCNQ2 variant p.Glu515Asp is known to cause benign familial neonatal. seizures-1, and this variant showed paternal inheritance. Conclusions: Although we believe that the somatic mosaic CDKL5 mutation is mainly responsible for the neurological phenotype in the patient, the KCNQ2 variant might have some neurological effect. Genetic analysis by next-generation sequencing is capable of identifying multiple variants in a patient. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kato, Takeshi; Morisada, Naoya; Nishiyama, Masahiro; Toyoshima, Daisaku; Nakagawa, Taku; Fu, Xue Jun; Nozu, Kandai; Iijima, Kazumoto] Kobe Univ, Dept Pediat, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Nagase, Hiroaki; Maruyama, Azusa] Hyogo Prefectural Kobe Childrens Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Wada, Hiroko] Med Welf Ctr Sakura, Sanda, Japan; [Takada, Satoshi] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6500017, Japan	Morisada, N (reprint author), Kobe Univ, Dept Pediat, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	morisada@med.kobe-u.ac.jp					Rosas-Vargas H, 2008, J MED GENET, V45, P172, DOI 10.1136/jmg.2007.053504; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Liang JS, 2011, EPILEPSIA, V52, P1835, DOI 10.1111/j.1528-1167.2011.03174.x; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Bienvenu T., 2011, MOL SYNDROMOL, V2, P137; Mei D, 2014, EPILEPSIA, V55, P1748, DOI 10.1111/epi.12803; Zhao Y, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-24	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					911	915		10.1016/j.braindev.2015.03.002		5	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400017		
J	Nakajiri, T; Kobayashi, K; Okamoto, N; Oka, M; Miya, F; Kosaki, K; Yoshinaga, H				Nakajiri, Tomoshi; Kobayashi, Katsuhiro; Okamoto, Nobuhiko; Oka, Makio; Miya, Fuyuki; Kosaki, Kenjiro; Yoshinaga, Harumi			Late-onset epileptic spasms in a female patient with a CASK mutation	BRAIN & DEVELOPMENT			English	Article						CASK; Mutation; Late-onset; Epilepsy	HYPOPLASIA; PHENOTYPE; FEATURES; ENCEPHALOPATHY	We report a female patient with late-onset epileptic spasms (ESs) of a rare form, distinct from those seen in typical West syndrome, in association with a heterozygous frameshift CASK mutation (c.1896dupC (p.C633fs*2)). She has a phenotype of microcephaly with pontine and cerebellar hypoplasia (MICPCH), and has had intractable ESs in clusters since 3 years 8 months of age with multifocal, particularly bifrontal, epileptic discharges in electroencephalogram. The available literature on patients with both ESs and CASK mutations has been reviewed, revealing that four of the five female children, including the present girl, had late-onset ESs, in contrast to the four males, who tended toward early-onset ESs. (C) 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Nakajiri, Tomoshi; Kobayashi, Katsuhiro; Oka, Makio; Yoshinaga, Harumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama 7008530, Japan; [Nakajiri, Tomoshi; Kobayashi, Katsuhiro; Oka, Makio; Yoshinaga, Harumi] Okayama Univ Hosp, Okayama 7008558, Japan; [Nakajiri, Tomoshi] Kakogawa West City Hosp, Dept Pediat, Kakogawa, Hyogo, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Miya, Fuyuki] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan	Kobayashi, K (reprint author), Okayama Univ Hosp, Dept Child Neurol, Kita Ku, Shikatacho 2 Chome 5-1, Okayama 7008558, Japan.	k_koba@md.okayama-u.ac.jp			Health and Labour Research Grants by the Ministry of Health, Labour and Welfare in Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591513]; Japan Epilepsy Research Foundation	This study was supported by Health and Labour Research Grants in 2013 and 2014 by the Ministry of Health, Labour and Welfare in Japan. K. Kobayashi was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 24591513). H. Yoshinaga was supported in part by the Japan Epilepsy Research Foundation.	Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Caumes R, 2014, EUR J PAEDIATR NEURO, V18, P475, DOI 10.1016/j.ejpn.2014.03.005; Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x; Auvin S, 2010, EPILEPSIA, V51, P1290, DOI 10.1111/j.1528-1167.2010.02534.x; Hayashi S, 2008, AM J MED GENET A, V146A, P2145, DOI 10.1002/ajmg.a.32433; Takanashi J, 2012, AM J MED GENET A, V158A, P3112, DOI 10.1002/ajmg.a.35640; Ishikawa N, 2014, NEUROPEDIATRICS, V45, P36, DOI 10.1055/s-0033-1357479; Burglen L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-18; Okamoto N, 2014, CLIN GENET IN PRESS	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	OCT	2015	37	9					919	923		10.1016/j.braindev.2015.02.007		5	Clinical Neurology	Neurosciences & Neurology	CS0VX	WOS:000361781400019		
J	Yamazaki, S; Wada, J; Kakiuchi, K				Yamazaki, Shoko; Wada, Junya; Kakiuchi, Kiyomi			Stereospecific cyclization reaction of alkenyl esters and amides of ethenetricarboxylate	CANADIAN JOURNAL OF CHEMISTRY			English	Article						stereospecificity; ethenetricarboxylate; cyclization; halogenation; ene reaction	DIELS-ALDER REACTION; ASYMMETRIC 3+2 CYCLOADDITION; INTRAMOLECULAR ENE REACTION; ACID-PROMOTED CYCLIZATION; LEWIS-ACID; ENANTIOSELECTIVE SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; (-)-ALPHA-KAINIC ACID; RADICAL CYCLIZATIONS; EFFICIENT SYNTHESIS	The stereospecificity of the cyclization reaction of (E)- and (Z)-2-alkenyl esters and amides of ethenetricarboxylate has been examined. The reaction of (E)/(Z)-2-butenyl esters with AlCl3 or FeCl3 gave trans-substituted chlorinated gamma-lactone diastereomers stereospecifically. (E)/(Z)-2-butenyl and pentenyl amides undergo an intramolecular ene reaction at room temperature gradually. At 80 degrees C, the (Z)-alkenyl amides were transformed to cis-substituted ene adducts and the (E)-amides were transformed to cis- and trans-substituted ene adduct mixtures. The reaction of (E)/(Z)-2-alkenyl amides with ZnI2 gave trans-substituted gamma-lactam diastereomers stereospecifically along with the ene adducts.	[Yamazaki, Shoko; Wada, Junya] Nara Univ Educ, Dept Chem, Nara 6308528, Japan; [Kakiuchi, Kiyomi] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan	Yamazaki, S (reprint author), Nara Univ Educ, Dept Chem, Takabatake Cho, Nara 6308528, Japan.	yamazaks@nara-edu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Nanotechnology Platform Program of MEXT	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was partly supported by the Nanotechnology Platform Program of MEXT. We thank Mr. M. Takebayashi (Kinki University Technical College) for experimental help.	SNIDER BB, 1979, J AM CHEM SOC, V101, P6023, DOI 10.1021/ja00514a026; Yamazaki S, 2005, ORG LETT, V7, P759, DOI 10.1021/ol047693z; Fukushima Y, 2014, ORG BIOMOL CHEM, V12, P3964, DOI 10.1039/c4ob00233d; Urabe F, 2013, J ORG CHEM, V78, P3847, DOI 10.1021/jo400263w; BOECKMAN RK, 1982, J AM CHEM SOC, V104, P1033, DOI 10.1021/ja00368a020; Wu HP, 2001, ORGANOMETALLICS, V20, P2183, DOI 10.1021/om010045o; Wang C, 1999, J ORG CHEM, V64, P2346, DOI 10.1021/jo9820770; Fallis AG, 1997, TETRAHEDRON, V53, P17543, DOI 10.1016/S0040-4020(97)10060-6; Hatakeyama S, 2009, PURE APPL CHEM, V81, P217, DOI 10.1351/PAC-CON-08-07-14; Balduzzi S, 2005, ORGANOMETALLICS, V24, P2617, DOI 10.1021/om050019g; MAGID RM, 1979, J ORG CHEM, V44, P359, DOI 10.1021/jo01317a011; Brazeau JF, 2012, J AM CHEM SOC, V134, P2742, DOI 10.1021/ja210388g; Yamazaki S, 2004, ORG BIOMOL CHEM, V2, P3134, DOI 10.1039/b408728c; Evans PA, 2012, J AM CHEM SOC, V134, P3635, DOI 10.1021/ja210804r; NAGASHIMA H, 1993, J ORG CHEM, V58, P464, DOI 10.1021/jo00054a034; OPPOLZER W, 1975, HELV CHIM ACTA, V58, P593, DOI 10.1002/hlca.19750580232; Yamazaki S, 2013, J ORG CHEM, V78, P8405, DOI 10.1021/jo401106m; Trost BM, 2012, ORG LETT, V14, P5632, DOI 10.1021/ol302409g; White JD, 2000, ORG LETT, V2, P3313, DOI 10.1021/ol000200f; Galliford CV, 2007, ANGEW CHEM INT EDIT, V46, P8748, DOI 10.1002/anie.200701342; Yang D, 2009, J ORG CHEM, V74, P8610, DOI 10.1021/jo9017099; Gonzalez AZ, 2011, J AM CHEM SOC, V133, P5500, DOI 10.1021/ja200084a; Cheng X, 2008, J ORG CHEM, V73, P8960, DOI 10.1021/jo8015677; LEBEL NA, 1989, J AM CHEM SOC, V111, P3363, DOI 10.1021/ja00191a038; Jang KP, 2014, J AM CHEM SOC, V136, P76, DOI 10.1021/ja410932t; Cossy J, 1997, J ORG CHEM, V62, P7106, DOI 10.1021/jo970257o; OPPOLZER W, 1979, HELV CHIM ACTA, V62, P2282, DOI 10.1002/hlca.19790620724; Yamazaki S, 2011, J ORG CHEM, V76, P6432, DOI 10.1021/jo201011n; DENMARK SE, 1987, J ORG CHEM, V52, P4031, DOI 10.1021/jo00227a017; Carlson EC, 2008, J ORG CHEM, V73, P5155, DOI 10.1021/jo800749t; Yu CM, 2005, ORG LETT, V7, P3733, DOI 10.1021/ol0513701; Galeazzi R, 1996, TETRAHEDRON-ASYMMETR, V7, P79, DOI 10.1016/0957-4166(95)00423-8; Tantillo DJ, 2001, J ORG CHEM, V66, P1938, DOI 10.1021/jo001172h; Campbell MJ, 2010, J ORG CHEM, V75, P6317, DOI 10.1021/jo1010735; Trost BM, 2013, J AM CHEM SOC, V135, P2459, DOI 10.1021/ja312351s; Peris G, 2007, J AM CHEM SOC, V129, P8710, DOI 10.1021/ja073055a; Yamazaki S, 2008, CHEM-EUR J, V14, P6026, DOI 10.1002/chem.200800195; OPPOLZER W, 1981, PURE APPL CHEM, V53, P1181, DOI 10.1351/pac198153061181; Stanley LM, 2008, CHEM REV, V108, P2887, DOI 10.1021/cr078371m; SNIDER BB, 1979, J ORG CHEM, V44, P4229, DOI 10.1021/jo01338a003; OPPOLZER W, 1982, J AM CHEM SOC, V104, P4978, DOI 10.1021/ja00382a054; Besev M, 2002, ORG LETT, V4, P3023, DOI 10.1021/ol026038t; Adrio J, 2011, CHEM COMMUN, V47, P6784, DOI 10.1039/c1cc10779h; GiessnerPrettre C, 1997, J ORG CHEM, V62, P1439, DOI 10.1021/jo9609586; Xia Q, 2001, ORG LETT, V3, P485, DOI 10.1021/ol007009q; Gartner M, 2011, CHEM-EUR J, V17, P7605, DOI 10.1002/chem.201100649; Yang D, 2003, TETRAHEDRON, V59, P10465, DOI 10.1016/j.tet.2003.06.009; Weingarten MD, 1997, J ORG CHEM, V62, P2001, DOI 10.1021/jo962184z; YOO SE, 1988, TETRAHEDRON LETT, V29, P2195, DOI 10.1016/S0040-4039(00)86709-X; Pedrosa R, 2005, J ORG CHEM, V70, P4332, DOI 10.1021/jo050360a; JUNG ME, 1991, J AM CHEM SOC, V113, P224, DOI 10.1021/ja00001a032; MARTIN T, 1995, TETRAHEDRON-ASYMMETR, V6, P1151, DOI 10.1016/0957-4166(95)00141-B; Rehbein J, 2009, J ORG CHEM, V74, P1531, DOI 10.1021/jo802303m; Trost BM, 2012, J AM CHEM SOC, V134, P4941, DOI 10.1021/ja210981a; Liu ZJ, 2011, J AM CHEM SOC, V133, P2772, DOI 10.1021/ja1057949; Jui NT, 2012, J AM CHEM SOC, V134, P11400, DOI 10.1021/ja305076b; Brown AR, 2013, J AM CHEM SOC, V135, P6747, DOI 10.1021/ja402893z; O'Hagan D, 2000, NAT PROD REP, V17, P435, DOI 10.1039/a707613d; OPPOLZER W, 1975, HELV CHIM ACTA, V58, P590, DOI 10.1002/hlca.19750580231; Lorente A, 2013, CHEM REV, V113, P4567, DOI 10.1021/cr3004778; MIKAMI K, 1992, CHEM REV, V92, P1021, DOI 10.1021/cr00013a014; Bellina F, 2006, TETRAHEDRON, V62, P7213, DOI 10.1016/j.tet.2006.05.024; CONIA JM, 1975, SYNTHESIS-STUTTGART, P1; Delaude C., 1986, ALKALOIDS, V27, P269; Ishibashi H, 2002, SYNTHESIS-STUTTGART, P695; Keay B. A., 2008, COMPREHENSIVE HETERO, VIII, P571, DOI DOI 10.1016/B978-008044992-0.00308-4; KELLY TR, 1973, TETRAHEDRON LETT, P437; Felpin FX, 2003, EUR J ORG CHEM, P3693, DOI 10.1002/ejoc.200300193; OPPOLZER W, 1978, ANGEW CHEM INT EDIT, V17, P476, DOI 10.1002/anie.197804761; Padwa A., 2003, SYNTHETIC APPL 1 3 D; STERNBACH DD, 1985, TETRAHEDRON LETT, V26, P591, DOI 10.1016/S0040-4039(00)89155-8; TROST BM, 1990, ACCOUNTS CHEM RES, V23, P34, DOI 10.1021/ar00170a004; WAKABAYASHI T, 1976, CHEM LETT, P1283, DOI 10.1246/cl.1976.1283; Yamazaki S, 2014, EUR J ORG CHEM, P7023, DOI 10.1002/ejoc.201402637	74	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	OCT	2015	93	10					1122	1131		10.1139/cjc-2015-0129		10	Chemistry, Multidisciplinary	Chemistry	CS1NG	WOS:000361832400010		
J	Harris, LN; Bajno, R; Gallagher, CP; Koizumi, I; Johnson, LK; Howland, KL; Taylor, EB; Reist, JD				Harris, Les N.; Bajno, Robert; Gallagher, Colin P.; Koizumi, Itsuro; Johnson, Lucy K.; Howland, Kimberly L.; Taylor, Eric B.; Reist, James D.			Life-history characteristics and landscape attributes as drivers of genetic variation, gene flow, and fine-scale population structure in northern Dolly Varden (Salvelinus malma malma) in Canada	CANADIAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES			English	Article							TROUT ONCORHYNCHUS-MYKISS; COASTAL CUTTHROAT TROUT; SEX-BIASED DISPERSAL; ATLANTIC SALMON; FRESH-WATER; BROOK CHARR; BULL TROUT; ENVIRONMENTAL-FACTORS; MULTILOCUS GENOTYPES; PROSOPIUM-COULTERII	The northern Dolly Varden (Salvelinus malma malma) displays variable life-history types and occupies freshwater habitats with varying levels of connectivity. Here, we assayed microsatellite DNA variation in northern Dolly Varden from the western Canadian Arctic to resolve landscape and life-history variables driving variation in genetic diversity and population structure. Overall, genetic variation was highest in anadromous populations and lowest in those isolated above waterfalls, with stream-resident forms intermediate between the two. Anadromous and isolated populations were genetically divergent from each other, while no genetic differentiation was detectable between sympatric anadromous and stream-resident forms. Population structure was stable over 25 years, hierarchically organized, and conformed to an isolation-by-distance pattern, but stream-isolated forms often deviated from these patterns. Gene flow occurred primarily among Yukon North Slope populations and between sympatric anadromous and resident forms. These results were sex-dependent to some extent, but were influenced more by reproductive status and life history. Our study provides novel insights into the life history, population demographic, and habitat variables that shape the distribution of genetic variation and population structure in Arctic fluvial habitats while providing a spatial context for management and conservation.	[Harris, Les N.; Bajno, Robert; Gallagher, Colin P.; Howland, Kimberly L.; Reist, James D.] Fisheries & Oceans Canada, Winnipeg, MB R3T 2N6, Canada; [Koizumi, Itsuro] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Johnson, Lucy K.] Int Polar Bear Conservat Ctr, Winnipeg, MB R3R 0B8, Canada; [Taylor, Eric B.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Taylor, Eric B.] Univ British Columbia, Beaty Biodivers Museum, Vancouver, BC V6T 1Z4, Canada	Harris, LN (reprint author), Fisheries & Oceans Canada, 501 Univ Crescent, Winnipeg, MB R3T 2N6, Canada.	Les.N.Harris@dfo-mpo.gc.ca			Fisheries Joint Management Committee; Gwich'in Renewable Resources Board; Fisheries and Oceans Canada (DFO) (Genomics Research Development Initiative); International Polar Year Chars and Climate Change project	Funding primarily awarded to JDR supported field collections and subsequent analyses and included multiple project awards from the Fisheries Joint Management Committee, the Gwich'in Renewable Resources Board, Fisheries and Oceans Canada (DFO) (including both regular and Genomics Research Development Initiative sources), and International Polar Year Chars and Climate Change project. Field assistance and (or) some samples were provided by R. Fudge, L. Harwood, B. Macdonald, K. Maier, N. Millar, N. Mochnacz, S. Sandstrom, S. Stephenson, as well as Inuvialuit and Gwich'in field assistants and Yukon Territorial Government staff. Logistical support was provided by Polar Continental Shelf Program (helicopter time), DFO Inuvik Area office staff, and Parks Canada. The manuscript was improved greatly following the suggestions of five anonymous reviewers. Data available from the Dryad Digital Repository: doi:10.5061/dryad.652vq.	Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Tonteri A, 2007, J FISH BIOL, V70, P381, DOI 10.1111/j.1095-8649.2007.01519.x; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; MANTEL N, 1967, CANCER RES, V27, P209; DECICCO AL, 1992, ARCTIC, V45, P120; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1006/jfbi.1999.1210; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Wilson CC, 1998, CAN J FISH AQUAT SCI, V55, P1010, DOI 10.1139/cjfas-55-4-1010; Dyke AS, 2004, DEV QUA SCI, V2, P373; Taylor EB, 2003, MOL ECOL, V12, P2609, DOI 10.1046/j.1365-294X.2003.01937.x; Harris LN, 2013, ECOL EVOL, V3, P145, DOI 10.1002/ece3.439; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; Taylor EB, 2015, CAN J FISH AQUAT SCI, V72, P1048, DOI 10.1139/cjfas-2015-0003; Oleinik AG, 2014, J ZOOL SYST EVOL RES, V52, P293, DOI 10.1111/jzs.12067; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Seymour M, 2013, ECOL EVOL, V3, P492, DOI 10.1002/ece3.476; Fleming IA, 2014, J FISH BIOL, V85, P1, DOI 10.1111/jfb.12429; Gowell CP, 2012, J EVOLUTION BIOL, V25, P2432, DOI 10.1111/jeb.12011; Gomez-Uchida D, 2009, MOL ECOL, V18, P4854, DOI 10.1111/j.1365-294X.2009.04409.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.2307/2640449; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Pritchard JK, 2000, GENETICS, V155, P945; GYLLENSTEN U, 1985, J FISH BIOL, V26, P691, DOI 10.1111/j.1095-8649.1985.tb04309.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Vaha JP, 2007, MOL ECOL, V16, P2638, DOI 10.1111/j.1365-294X.2007.03329.x; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Theriault V, 2007, BEHAV ECOL SOCIOBIOL, V62, P51, DOI 10.1007/s00265-007-0437-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Redenbach Z, 2002, EVOLUTION, V56, P1021; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Wilson GA, 2003, GENETICS, V163, P1177; Sepulveda-Villet OJ, 2012, MOL ECOL, V21, P5795, DOI 10.1111/mec.12044; Reist JD, 2006, AMBIO, V35, P381, DOI 10.1579/0044-7447(2006)35[381:AOOEOC]2.0.CO;2; Dunham J, 2008, FISHERIES, V33, P537, DOI 10.1577/1548-8446-33.11.537; Koizumi I, 2006, MOL ECOL, V15, P3175, DOI 10.1111/j.1365-294X.2006.03019.x; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Warnock WG, 2010, CONSERV GENET, V11, P1421, DOI 10.1007/s10592-009-9969-y; Taylor EB, 2001, CAN J FISH AQUAT SCI, V58, P406, DOI 10.1139/cjfas-58-2-406; Koizumi I, 2006, J FISH BIOL, V68, P1513, DOI 10.1111/j.1095-8649.2006.01038.x; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Pearse DE, 2009, J HERED, V100, P515, DOI 10.1093/jhered/esp040; Harris LN, 2010, J EVOLUTION BIOL, V23, P72, DOI 10.1111/j.1420-9101.2009.01858.x; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; HUTCHINGS JA, 1994, EVOL ECOL, V8, P256, DOI 10.1007/BF01238277; Heath DD, 2001, HEREDITY, V86, P618, DOI 10.1046/j.1365-2540.2001.00867.x; Guy TJ, 2008, CAN J FISH AQUAT SCI, V65, P1749, DOI 10.1139/F08-090; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Tamkee P, 2010, CAN J FISH AQUAT SCI, V67, P919, DOI 10.1139/F10-034; Koizumi I, 2008, POPUL ECOL, V50, P367, DOI 10.1007/s10144-008-0108-2; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127; Wofford JEB, 2005, ECOL APPL, V15, P628, DOI 10.1890/04-0095; [Anonymous], 2011, FRESHWATER BIOL, DOI DOI 10.1111/J.1365-2427.2010.02527.X; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Rousset F, 1997, GENETICS, V145, P1219; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Taylor EB, 2011, CAN J ZOOL, V89, P255, DOI 10.1139/Z10-114; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; [Anonymous], 1999, INT SOC ARCTIC CHAR; Nosil P, 2005, EVOLUTION, V59, P705; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Bond MH, 2014, ECOL EVOL, V4, P2515, DOI 10.1002/ece3.1113; Theriault V, 2007, J EVOLUTION BIOL, V20, P2266, DOI 10.1111/j.1420-9101.2007.01417.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Moore JS, 2013, CAN J FISH AQUAT SCI, V70, P1327, DOI 10.1139/cjfas-2013-0138; BABY MC, 1991, J FISH BIOL, V39, P61, DOI 10.1111/j.1095-8649.1991.tb05068.x; McCracken GR, 2013, FRESHWATER BIOL, V58, P1903, DOI 10.1111/fwb.12179; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Neville HM, 2006, LANDSCAPE ECOL, V21, P901, DOI 10.1007/s10980-005-5221-4; Whiteley AR, 2010, CONSERV GENET, V11, P1929, DOI 10.1007/s10592-010-0083-y; Moore JS, 2014, J FISH BIOL, V84, P145, DOI 10.1111/jfb.12262; Wright S, 1943, GENETICS, V28, P114; MCCART P, 1974, J FISH RES BOARD CAN, V31, P1408; Hasselman DJ, 2010, CAN J FISH AQUAT SCI, V67, P1021, DOI 10.1139/F10-031; Ostergren J, 2012, ECOL FRESHW FISH, V21, P119, DOI 10.1111/j.1600-0633.2011.00529.x; ARMSTRON.RH, 1974, J FISH RES BOARD CAN, V31, P435; Bain H.L., 1974, THESIS U CALGARY CAL; Beerli Peter, 2009, V17, P42; Behnke RJ., 1980, CHARRS SALMONID FISH, P441; Belkhir K., 2004, 5000 CNRS UMR; CAVALLIS.LL, 1967, AM J HUM GENET, V19, P233; Cook J.A., 2013, ARCTIC BIODIVERSITY, P459; COSEWIC, 2010, COSEWIC ASS STAT REP; Crane P., 2005, 80 AL FISH; Everett Rebecca J., 1997, American Fisheries Society Symposium, V19, P240; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gallagher C.P., 2012, 2011128 DFO CAN SCI; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Harris LN, 2014, ENVIRON BIOL FISH, V97, P1233, DOI 10.1007/s10641-013-0210-y; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Hendry Andrew P., 2004, P52; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kowalchuk M., 2010, 14993848 DFO; Kowalchuk M., 2010, REV TAXONOMIC STRUCT; Lindsey C.C., 1986, P639; McCart P.J., 1980, 935 FISH AQ SCI; Mochnacz N.J., 2010, 2926 FISH AQ SCI; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Oleinik AG, 2013, J ICHTHYOL, V53, P820, DOI DOI 10.1134/S003294521310007X; Quinn T.P., 2005, BEHAV ECOLOGY PACIFI; Rambaut A., 2009, FIGTREE VERSION 1 3; Reist J. D., 1989, PHYSL ECOL JPN SPEC, V1, P405; Reist J.D., 1997, American Fisheries Society Symposium, V19, P250; Rhydderch J.G., 2001, THESIS U GUELPH GULE; Sandstrom S.J., 2002, 2603 FISH AQ SCI; SHAFER ABA, 2010, EVOLUTION, V0065; Taylor EB, 2014, RIVER RES APPL, V30, P1120, DOI 10.1002/rra.2712; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641	120	1	1	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0706-652X	1205-7533		CAN J FISH AQUAT SCI	Can. J. Fish. Aquat. Sci.	OCT	2015	72	10					1477	1493		10.1139/cjfas-2015-0016		17	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CS1LZ	WOS:000361828400005		
J	Takeshima, H; Hoshijima, M; Song, LS				Takeshima, Hiroshi; Hoshijima, Masahiko; Song, Long-Sheng			Ca2+ microdomains organized by junctophilins	CELL CALCIUM			English	Review						Muscle; Calcium channel; Excitation-contraction coupling	JUNCTIONAL MEMBRANE COMPLEX; T-TUBULE MEMBRANE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; ENDOPLASMIC-RETICULUM; HANDLING DYSFUNCTION; RYANODINE RECEPTORS	Excitable cells typically possess junctional membrane complexes (JMCs) constructed by the plasma membrane and the endo/sarcoplasmic reticulum (ER/SR) for channel crosstalk. These JMCs are termed triads in skeletal muscle, dyads in cardiac muscle, peripheral couplings in smooth and developing striated muscles, and subsurface cisterns in neurons. Junctophilin subtypes contribute to the formation and maintenance of JMCs by serving as a physical bridge between the plasma membrane and ER/SR membrane in different cell types. In muscle cells, junctophilin deficiency prevents JMC formation and functional crosstalk between cell-surface Ca2+ channels and ER/SR Ca2+ release channels. Human genetic mutations in junctophilin subtypes are linked to congenital hypertrophic cardiomyopathy and neurodegenerative diseases. Furthermore, growing evidence suggests that dysregulation of junctophilins induces pathological alterations in skeletal and cardiac muscle. (C) 2015 The Authors. Published by Elsevier Ltd.	[Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Hoshijima, Masahiko] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hoshijima, Masahiko] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Song, Long-Sheng] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Takeshima, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan.	takeshim@pharm.kyoto-u.ac.jp; mhoshijima@ucsd.edu; long-sheng-song@uiowa.edu			JSPS Core-to-Core Program; Human Frontier Science Program [RGP0027/2013]; MEXT Platform for Drug Discovery, Informatics and Structural Life Science; US NIH R01 [R01 HL090905]; American Heart Association [0635056N, 0840013N]; Takeda Science Foundation	The projects of the authors were supported by the JSPS Core-to-Core Program, the Human Frontier Science Program (RGP0027/2013 to H.T. and M.H), the MEXT Platform for Drug Discovery, Informatics and Structural Life Science, the US NIH R01 (R01 HL090905 to L.S.S.) and American Heart Association grants (0635056N to L.S.S. and 0840013N to M.H.), and the Takeda Science Foundation. All 3D EM imaging was carried out at the National Center for Microscopy and Imaging Research (NCMIR) located in University of California San Diego by M.H. and NCMIR colleagues. The authors are grateful to Shawn Roach (University of Iowa) for help in figure preparation.	Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; HUXLEY AF, 1958, J PHYSIOL-LONDON, V144, P426; Garbino A, 2010, ACTA PHARMACOL SIN, V31, P1019, DOI 10.1038/aps.2010.116; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Felder E, 2002, BIOPHYS J, V82, P3144; Kakizawa S, 2008, CEREBELLUM, V7, P385, DOI 10.1007/s12311-008-0040-1; Wu HD, 2012, CARDIOVASC RES, V95, P430, DOI 10.1093/cvr/cvs195; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Zhang HB, 2013, CARDIOVASC RES, V98, P269, DOI 10.1093/cvr/cvt030; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Das T, 2013, J MOL CELL CARDIOL, V58, P5, DOI 10.1016/j.yjmcc.2012.11.009; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Woo JS, 2010, BIOCHEM J, V427, P125, DOI 10.1042/BJ20091225; Reynolds JO, 2013, CARDIOVASC RES, V100, P44, DOI 10.1093/cvr/cvt133; Moriguchi S, 2006, P NATL ACAD SCI USA, V103, P10811, DOI 10.1073/pnas.0509863103; STERN MD, 1992, BIOPHYS J, V63, P497; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Pinali C, 2013, CIRC RES, V113, P1219, DOI 10.1161/CIRCRESAHA.113.301348; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Fabiato A, 1978, Ann N Y Acad Sci, V307, P491, DOI 10.1111/j.1749-6632.1978.tb41979.x; Shen WW, 2011, BIOL CELL, V103, P365, DOI 10.1042/BC20100152; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Zhang CM, 2014, CIRCULATION, V129, P1742, DOI 10.1161/CIRCULATIONAHA.113.008452; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Guo A, 2014, P NATL ACAD SCI USA, V111, P12240, DOI 10.1073/pnas.1412729111; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Bennett HJ, 2013, BIOCHEM J, V456, P205, DOI 10.1042/BJ20130591; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; Woo JS, 2012, J BIOL CHEM, V287, P14336, DOI 10.1074/jbc.M111.304808; Wu CJ, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1155/2011/803015; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Govert F, 2013, CURR OPIN NEUROL, V26, P420, DOI 10.1097/WCO.0b013e3283632d90; Han J, 2013, SCI CHINA LIFE SCI, V56, P647, DOI 10.1007/s11427-013-4490-4; Takeshima H, 1998, BIOCHEM J, V331, P317; Komazaki S, 2003, FEBS LETT, V542, P69, DOI 10.1016/S0014-5793(03)00340-5; Beavers DL, 2013, J AM COLL CARDIOL, V62, P2010, DOI 10.1016/j.jacc.2013.06.052; Soeller C, 1999, CIRC RES, V84, P266; Chen BY, 2013, CARDIOVASC RES, V100, P54, DOI 10.1093/cvr/cvt180; Ziman AP, 2010, J MOL CELL CARDIOL, V48, P379, DOI 10.1016/j.yjmcc.2009.09.016; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Guo A, 2013, CARDIOVASC RES, V98, P204, DOI 10.1093/cvr/cvt020; Seixas AI, 2012, ANN NEUROL, V71, P245, DOI 10.1002/ana.22598; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Xie YP, 2012, HYPERTENSION, V59, P355, DOI 10.1161/HYPERTENSIONAHA.111.180968; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Uehara A, 2002, CELL CALCIUM, V31, P89, DOI 10.1054/ceca.2001.0257; Hong TT, 2014, NAT MED, V20, P624, DOI 10.1038/nm.3543; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Wagner E, 2012, CIRC RES, V111, P402, DOI 10.1161/CIRCRESAHA.112.274530; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Chen BY, 2012, FASEB J, V26, P2531, DOI 10.1096/fj.11-199505; Phimister AJ, 2007, J BIOL CHEM, V282, P8667, DOI 10.1074/jbc.M609936200; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Hong TT, 2012, HEART RHYTHM, V9, P812, DOI 10.1016/j.hrthm.2011.11.055; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Kakizawa S, 2007, EMBO J, V26, P1924, DOI 10.1038/sj.emboj.7601639; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Di Maio Alessandro, 2007, J Muscle Res Cell Motil, V28, P231, DOI 10.1007/s10974-007-9121-x; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699; Franzini-Armstrong C, 2009, APPL PHYSIOL NUTR ME, V34, P323, DOI 10.1139/H09-017; Moriguchi S., 2014, MOL NEUROBIOL; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Pla-Martin D., 2014, HUM MOL GENET; Webster Daniel R, 2002, Cardiovasc Toxicol, V2, P75, DOI 10.1385/CT:2:2:075; Wong J, 2013, BIOPHYS J, V104, pL22, DOI 10.1016/j.bpj.2013.02.059; Wu C.Y., 2014, J AM HEART ASSOC, V3, DOI DOI 10.1161/JAHA.113.000527; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361	86	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	OCT	2015	58	4			SI		349	356		10.1016/j.ceca.2015.01.007		8	Cell Biology	Cell Biology	CS1TD	WOS:000361849700004		
J	Phua, SC; Lin, YC; Inoue, T				Phua, Siew Cheng; Lin, Yu-Chun; Inoue, Takanari			An intelligent nano-antenna: Primary cilium harnesses TRP channels to decode polymodal stimuli	CELL CALCIUM			English	Review						Primary cilium; TRPC1; TRPP2; TRPP3; TRPV4; Polymodal sensitivity; Cilium-targeted Ca2+ indicators; Local Ca2+ signals	POLYCYSTIC KIDNEY-DISEASE; CELL-CYCLE PROGRESSION; CATION CHANNEL; PLASMA-MEMBRANE; FLUID-FLOW; INTRAFLAGELLAR TRANSPORT; INTRACELLULAR CALCIUM; EPITHELIAL-CELLS; CILIARY MEMBRANE; CA2+ INFLUX	The primary cilium is a solitary hair-like organelle on the cell surface that serves as an antenna sensing ever-changing environmental conditions. In this review, we will first recapitulate the molecular basis of the polymodal sensory function of the primary cilia, specifically focusing on transient receptor potential (TRP) channels that accumulate inside the organelle and conduct calcium ions (Ca2+). Each subfamily member, namely TRPP2 TRPP3, TRPC1 and TRPV4, is gated by multiple environmental factors, including chemical (receptor ligands, intracellular second messengers such as Ca2+), mechanical (fluid shear stress, hypo-osmotic swelling), or physical (temperature, voltage) stimuli. Both activity and heterodimer compositions of the TRP channels may be dynamically regulated for precise tuning to the varying dynamic ranges of the individual input stimuli. We will thus discuss the potential regulation of TRP channels by local second messengers. Despite its reported importance in embryonic patterning and tissue morphogenesis, the precise functional significance of the downstream Ca2+ signals of the TRP channels remains unknown. We will close our review by featuring recent technological advances in visualizing and analyzing signal transduction inside the primary cilia, together with current perspectives illuminating the functional significance of intraciliary Ca2+ signals. (C) 2015 Elsevier Ltd. All rights reserved.	[Phua, Siew Cheng; Lin, Yu-Chun; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Phua, Siew Cheng; Lin, Yu-Chun; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Inoue, Takanari] Japan Sci & Technol Agcy JST, Kawaguchi, Saitama 3320012, Japan	Phua, SC (reprint author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	sphua1@jhmi.edu; jctinoue@jhmi.edu			National Institute of Health (NIH) [DK102910]; Japan Science and Technology Agency [10216]; Agency for Science, Technology and Research in Singapore; National Science Council in Taiwan	We thank Allen Kim, Hideki Nakamura and Robert DeRose for helpful comments on the manuscript. This work was supported by the National Institute of Health (NIH) (DK102910 to TI, and the Japan Science and Technology Agency (10216 to TI). S.C.P. is supported by the Agency for Science, Technology and Research in Singapore. Y.C.L is supported by the National Science Council in Taiwan.	Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Seeley ES, 2009, METHOD CELL BIOL, V94, P299, DOI 10.1016/S0091-679X(08)94015-2; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Rosivall L, 2006, AM J PHYSIOL-RENAL, V291, pF1241, DOI 10.1152/ajprenal.00203.2006; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Hoey DA, 2012, J BIOMECH, V45, P17, DOI 10.1016/j.jbiomech.2011.08.008; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Yasuhiko Y, 2001, DEV GROWTH DIFFER, V43, P671; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Choi YH, 2011, P NATL ACAD SCI USA, V108, P10679, DOI 10.1073/pnas.1016214108; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Hoffmeister H, 2011, J CELL BIOL, V192, P631, DOI 10.1083/jcb.201007050; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Dai XQ, 2007, MOL PHARMACOL, V72, P1576, DOI 10.1124/mol.107.037150; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Shimizu T, 2009, PFLUG ARCH EUR J PHY, V457, P795, DOI 10.1007/s00424-008-0558-6; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Shi J, 2014, FASEB J, V28, P244, DOI 10.1096/fj.13-238022; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Luo N, 2014, P NATL ACAD SCI USA, V111, P12871, DOI 10.1073/pnas.1323292111; [Anonymous], 1997, AM J PHYSIOL-RENAL; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Masyuk AI, 2008, AM J PHYSIOL-GASTR L, V295, pG725, DOI 10.1152/ajpgi.90265.2008; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/nchembio.1252, 10.1038/NCHEMBIO.1252]; Keady BT, 2012, DEV CELL, V22, P940, DOI 10.1016/j.devcel.2012.04.009; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P851, DOI 10.1161/ATVBAHA.109.196584; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, pF495, DOI 10.1152/ajprenal.00521.2005; Higuchi T, 2014, PFLUG ARCH EUR J PHY, V466, P1933, DOI 10.1007/s00424-013-1439-1; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Luo N, 2012, HUM MOL GENET, V21, P3333, DOI 10.1093/hmg/dds163; Young YN, 2012, BIOPHYS J, V103, P629, DOI 10.1016/j.bpj.2012.07.009; Eley L, 2004, CELL BIOL INT, V28, P119, DOI 10.1016/j.cellbi.2003.11.009; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Francis SS, 2011, J CELL BIOL, V193, P219, DOI 10.1083/jcb.201009001; Earm Y.E., 2007, TRP ION CHANNEL FUNC; Gees M., 2010, COLD SPRING HARB PER, V2; Giamarchi A., 2007, TRP ION CHANNEL FUNC; Hernan E., 2011, CELL, V144, P897; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Kim H., 2014, NAT COMMUN, V5; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Marley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070857; Roger O.N., 2007, TRP ION CHANNEL FUNC; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/nmeth.2647, 10.1038/NMETH.2647]; Yeh C, 2013, DEV CELL, V26, P358, DOI 10.1016/j.devcel.2013.07.014; Zhang P, 2014, CARDIOVASC RES, V104, P138, DOI 10.1093/cvr/cvu190; Zheng J., 2013, COMPREHENSIVE PHYSL	84	2	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	OCT	2015	58	4			SI		415	422		10.1016/j.ceca.2015.03.005		8	Cell Biology	Cell Biology	CS1TD	WOS:000361849700011		
J	Okabe, M; Ito, S; Nishio, N; Tanaka, Y; Isobe, KI				Okabe, Motohito; Ito, Sachiko; Nishio, Naomi; Tanaka, Yuriko; Isobe, Ken-Ichi			Thymic Epithelial Cells Induced from Pluripotent Stem Cells by a Three-Dimensional Spheroid Culture System Regenerates Functional T Cells in Nude Mice	CELLULAR REPROGRAMMING			English	Article							COMPLETE DIGEORGE-SYNDROME; IN-VIVO; DIFFERENTIATION; MOUSE; TRANSPLANTATION; PROGENITORS; MICROENVIRONMENT; GENERATION	The thymus is mainly composed of two types of epithelial cells, medullary thymic epithelial cells and cortex thymic epithelial cells (mTECs and cTECs). The tissue structure and mechanism for T cell development are complicated, with generation of the thymus regulated by complex molecular and cellular interactions of the thymic microenvironment during embryogenesis. Since the development of organ regeneration techniques became available, complete in vitro regeneration of the thymus has been attempted. Steric induction systems are thought to be optimal for tissue regeneration, but three-dimensional (3-D) induction of TECs from induced pluripotent stem cells (iPSCs) has not yet been reported. Here, we demonstrate the induction of functional TECs from iPSCs by a 3-D spheroid culture system with recruitment of robust numbers of T cells into the peripheral blood. Purified iPSC-derived TECs showed a sufficient expression level of FoxN1 comparable to TECs, and phenotypic analysis revealed that iPSC-derived TECs were expressing K5. Moreover, transplants of cell aggregations into recipient mice were not rejected and there was normal support of T cell development. Functional analysis revealed that T cells showed immune tolerance to both donor and recipient MHCs and could reject an allogeneic third party's skin graft without tumorigenesis. Taken together, these findings raised the possibility of using iPSC-derived TECs induced by 3-D spheroid culture in future regenerative therapy for patients with immunodeficiency.	[Okabe, Motohito; Ito, Sachiko; Nishio, Naomi; Tanaka, Yuriko; Isobe, Ken-Ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan	Okabe, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan.	okabe.motohito@med.nagoya-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan	We thank M. Tanaka and I. Mizuguchi for technical support, N. Oiwa for administrative assistance, and M. A. Malek for critical review of the manuscript. This work was supported by Micro-Nano GCOE program provided by the Ministry of Education, Science, Technology, Sports and Culture, Japan.	Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Oikawa A, 2007, TRANSPLANTATION, V84, P23, DOI 10.1097/01.tp.0000268522.44775.f0; HOLUB M, 1975, NATURE, V256, P491, DOI 10.1038/256491a0; MILLER JF, 1961, LANCET, V2, P748; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; Cheng Z, 2011, J MOL CELL BIOL, V3, P91, DOI 10.1093/jmcb/mjq044; van den Brink MRM, 2004, NAT REV IMMUNOL, V4, P856, DOI 10.1038/nri1484; Sun XN, 2013, CELL STEM CELL, V13, P230, DOI 10.1016/j.stem.2013.06.014; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Inami Y, 2011, IMMUNOL CELL BIOL, V89, P314, DOI 10.1038/icb.2010.96; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; HONG R, 1979, J EXP MED, V149, P398, DOI 10.1084/jem.149.2.398; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Lai LJ, 2009, STEM CELLS, V27, P3012, DOI 10.1002/stem.238; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Parent AV, 2013, CELL STEM CELL, V13, P219, DOI 10.1016/j.stem.2013.04.004; Hidaka K, 2010, STEM CELLS DEV, V19, P1735, DOI 10.1089/scd.2009.0466; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; Markert ML, 2003, BLOOD, V102, P1121, DOI 10.1182/blood-2002-08-2545; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; Ito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076943; Matsumoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004820; Saito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028209	31	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	OCT 1	2015	17	5					368	375		10.1089/cell.2015.0006		8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CR7IU	WOS:000361523600006		
J	Matsumoto, A; Szidarovszky, F				Matsumoto, Akio; Szidarovszky, Ferenc			Nonlinear Cournot duopoly with implementation delays	CHAOS SOLITONS & FRACTALS			English	Article							MONOPOLIES	We study the effects of two delays on the local as well as on global stability of nonlinear Cournot duopoly dynamics. The two major findings are an analytical construction of the stability switching curve on which stability is lost and the numerical confirmation of the birth of aperiodic global dynamics when the stationary state is locally unstable. The delays matters and can generate various dynamics ranging from simple to complicated dynamics. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsumoto, Akio] Chuo Univ, Int Ctr Further Dev Dynam Econ Res, Dept Econ, Hachioji, Tokyo 1920393, Japan; [Szidarovszky, Ferenc] Univ Pecs, Dept Appl Math, H-7624 Pecs, Hungary	Matsumoto, A (reprint author), Chuo Univ, Int Ctr Further Dev Dynam Econ Res, Dept Econ, 742-1 Higashi Nakano, Hachioji, Tokyo 1920393, Japan.	akiom@tamacc.chuo-u.ac.jp; szidarka@gmail.com			MEXT [2013-207]; Japan Society for the Promotion is of Science [24530707, 75380238, 76380316]	The authors highly appreciate the financial supports from the MEXT Supported Program for the Strategic Research Foundation at Private Universities 2013-207, the Japan Society for the Promotion is of Science (Grant-in-Aid for Scientific Research (C) 24530707, 75380238 and 76380316). The usual disclaimers apply.	Matsumoto A, 2014, APPL MATH COMPUT, V232, P632, DOI 10.1016/j.amc.2014.01.101; Matsumoto A, 2015, COMMUN NONLINEAR SCI, V28, P151, DOI 10.1016/j.cnsns.2015.04.011; Matsumoto A, 2011, COMPUT ECON, V38, P311, DOI 10.1007/s10614-011-9295-6; Hofbauer J, 2000, P AM MATH SOC, V128, P2675, DOI 10.1090/S0002-9939-00-05564-7; SHIBATA A, 1980, MATH BIOSCI, V51, P199, DOI 10.1016/0025-5564(80)90099-1; Bischi GI, 2010, NONLINEAR OLIGOPOLIES: STABILITY AND BIFURCATIONS, P1, DOI 10.1007/978-3-642-02106-0; Cournot A, 1960, RECHERCHES PRINCIPES; Howroyd T, 1984, J MATH ECON, V13, P7; Okuguchi K., 1999, THEORY OLIGOPOLY MUL; Okuguchi K., 1976, EXPECTATIONS STABILI; Wang H., 2012, CAN APPL MATH Q, V20, P519	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	OCT	2015	79						157	165		10.1016/j.chaos.2015.05.010		9	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CR8QK	WOS:000361618600014		
J	Miyamoto, K; Nakasuka, K; Kusano, K				Miyamoto, Koji; Nakasuka, Kosuke; Kusano, Kengo			Effect of Renal Function on Anticoagulation Therapy in Asian Patients	CIRCULATION JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; THROMBOEMBOLIC EVENTS; STROKE PREVENTION; WARFARIN; TRIAL; SUBANALYSIS; RIVAROXABAN; DABIGATRAN; APIXABAN		[Miyamoto, Koji; Nakasuka, Kosuke; Kusano, Kengo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan	Kusano, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kusanokengo@hotmail.com					Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Bohm M, 2015, J AM COLL CARDIOL, V65, P2481, DOI 10.1016/j.jacc.2015.03.577; Goto S, 2014, AM HEART J, V168, P303, DOI 10.1016/j.ahj.2014.06.005; Wong KSL, 2014, STROKE, V45, P1739, DOI 10.1161/STROKEAHA.113.002968; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Roldan V, 2013, AM J CARDIOL, V111, P1159, DOI 10.1016/j.amjcard.2012.12.045; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Hori M, 2015, CIRC J, V79, P2138, DOI 10.1253/circj.CJ-15-0594; Inoue H, 2014, CIRC J, V78, P2388, DOI 10.1253/circj.CJ-14-0507; Japanese Society of Nephrology, 2012, CLIN PRACT GUID DIAG; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Miyamoto K, 2015, HEART VESSELS, DOI [10.1007/s00380-015-0725-6, DOI 10.1007/S00380-015-0725-6]; Tada H, 2014, CIRC J, V78, P2373, DOI 10.1253/circj.CJ-14-0914	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2098	2099		10.1253/circj.CJ-15-0925		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900003		
J	Kobayashi, J				Kobayashi, Junjiro			Risk of Coronary Obstruction in Transcatheter Aortic Valve Replacement	CIRCULATION JOURNAL			English	Editorial Material							CLINICAL-OUTCOMES; IMPLANTATION; REGISTRY; STENOSIS; JAPAN		Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan	Kobayashi, J (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	jkobayas@hsp.ncvc.go.jp					Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Buellesfeld L, 2013, JACC-CARDIOVASC INTE, V6, P72, DOI 10.1016/j.jcin.2012.09.007; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Maeda K, 2013, CIRC J, V77, P359, DOI 10.1253/circj.CJ-12-0650; Ribeiro HB, 2013, JACC-CARDIOVASC INTE, V6, P452, DOI 10.1016/j.jcin.2012.11.014; Ribeiro HB, 2013, J AM COLL CARDIOL, V62, P1552, DOI 10.1016/j.jacc.2013.07.040; Zamorano JL, 2014, EUR HEART J, V35, P1578, DOI 10.1093/eurheartj/eht569; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Tatsuishi W, 2015, CIRC J, V79, P2157, DOI 10.1253/circj.CJ-15-0415	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2100	2102		10.1253/circj.CJ-15-0910		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900004		
J	Kume, T; Uemura, S				Kume, Teruyoshi; Uemura, Shiro			Late Failure of First-Generation Drug-Eluting Stents in Hemodialysis Patients	CIRCULATION JOURNAL			English	Editorial Material							OPTICAL COHERENCE TOMOGRAPHY; CORONARY REVASCULARIZATION; BARE-METAL; NEOATHEROSCLEROSIS; IMPLANTATION; REGISTRY; EVENTS		[Kume, Teruyoshi; Uemura, Shiro] Kawasaki Med Univ, Cardiovasc Med, Kurashiki, Okayama 7010192, Japan	Uemura, S (reprint author), Kawasaki Med Univ, Cardiovasc Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	suemura@med.kawasaki-m.ac.jp					Kumada Y, 2014, CIRC J, V78, P986, DOI 10.1253/circj.CJ-13-1357; Bhan I, 2009, CLIN J AM SOC NEPHRO, V4, pS102, DOI 10.2215/CJN.04800709; Naidu SS, 2003, AM J CARDIOL, V92, P1160, DOI 10.1016/j.amjcard.2003.07.023; Yonetsu T, 2012, CIRC-CARDIOVASC IMAG, V5, P660, DOI 10.1161/CIRCIMAGING.112.976167; Kubo S, 2014, CIRC J, V78, P101, DOI 10.1253/circj.CJ-13-0780; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Cook S, 2012, EUR HEART J, V33, P1334, DOI 10.1093/eurheartj/ehr484; Buronova N, 2015, CIRC J, V79, P2169, DOI 10.1253/circj.CJ-15-0113; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Yonetsu T, 2012, AM J CARDIOL, V110, P933, DOI 10.1016/j.amjcard.2012.05.027	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2103	2105		10.1253/circj.CJ-15-0913		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900005		
J	Motomura, N				Motomura, Noboru			Key Approach to Expanding the Less Invasive Off-Pump Coronary Artery Bypass Grafting Procedure Worldwide	CIRCULATION JOURNAL			English	Editorial Material									Toho Univ, Sakura Med Ctr, Dept Cardiovasc Surg, Sakura, Chiba 2858741, Japan	Motomura, N (reprint author), Toho Univ, Sakura Med Ctr, Dept Cardiovasc Surg, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan.	noboru@motomura.org					Ishikawa N, 2014, CIRC J, V78, P399, DOI 10.1253/circj.CJ-13-1115; Hattler B, 2012, CIRCULATION, V125, P2827, DOI 10.1161/CIRCULATIONAHA.111.069260; Polomsky M, 2013, J THORAC CARDIOV SUR, V145, P1193, DOI 10.1016/j.jtcvs.2013.02.002; Saito A, 2011, INTERACT CARDIOV TH, V12, P575, DOI 10.1510/icvts.2010.254813; Hiraoka A, 2014, CIRC J, V78, P2876, DOI 10.1253/circj.CJ-14-0861; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Masuda M, 2015, GEN THORAC CARDIOVAS, V63, P120; Motomura N, 2010, INTERACT CARDIOVA S1, V10, pS12; Ohira S, 2015, CIRC J, V79, P2177, DOI 10.1253/circj.CJ-15-0462	9	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2106	2107		10.1253/circj.CJ-15-0940		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900006		
J	Yamamoto, K				Yamamoto, Kazuhiro			"The Third Man" in Heart Failure - Heart Failure With Reduce Ejection Fraction Evolved From Heart Failure With Preserved Ejection Fraction -	CIRCULATION JOURNAL			English	Editorial Material							DYSFUNCTION		Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Yonago, Tottori 6838503, Japan	Yamamoto, K (reprint author), Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	ykazuhiro@med.tottori-u.ac.jp					Ho JE, 2013, CIRC-HEART FAIL, V6, P279, DOI 10.1161/CIRCHEARTFAILURE.112.972828; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; Yamamoto K, 2009, CIRC J, V73, P404; Aizawa Y, 2011, CIRC J, V75, P596, DOI 10.1253/circj.CJ-10-1037; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Prasad A, 2010, CIRC-HEART FAIL, V3, P617, DOI 10.1161/CIRCHEARTFAILURE.109.867044; Dunlay SM, 2012, CIRC-HEART FAIL, V5, P720, DOI 10.1161/CIRCHEARTFAILURE.111.966366; GREENBERG B, 1995, CIRCULATION, V91, P2573; Chatterjee K, 2007, J CARD FAIL, V13, P569, DOI 10.1016/j.cardfail.2007.04.006; Henkel DM, 2008, CIRC-HEART FAIL, V1, P91, DOI 10.1161/CIRCHEARTFAILURE.107.743146; Borlaug BA, 2014, CIRC J, V78, P20, DOI 10.1253/circj.CJ-13-1103; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; Hirai M, 2015, CIRC J, V79, P129, DOI 10.1253/circj.CJ-14-0710; Ueda T, 2015, CIRC J, V79, P2209, DOI 10.1253/circj.CJ-15-0425	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2108	2109		10.1253/circj.CJ-15-0857		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900007		
J	Nakao, YM; Miyamoto, Y				Nakao, Yoko M.; Miyamoto, Yoshihiro			J Wave Is Better Left Alone?	CIRCULATION JOURNAL			English	Editorial Material							EARLY REPOLARIZATION PATTERN; DEATH; SYNCOPE; RISK		[Nakao, Yoko M.; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658565, Japan	Miyamoto, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	miyamoty@ncvc.go.jp					Rosso R, 2011, HEART RHYTHM, V8, P923, DOI 10.1016/j.hrthm.2011.01.037; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Bartczak A, 2013, PACE, V36, P456, DOI 10.1111/pace.12072; Obeyesekere MN, 2013, CIRCULATION, V127, P1620, DOI 10.1161/CIRCULATIONAHA.112.143149; Viskin S, 2012, HEART RHYTHM, V9, P566, DOI 10.1016/j.hrthm.2011.11.042; Heng SJ, 2012, J AM COLL CARDIOL, V60, P947, DOI 10.1016/j.jacc.2012.03.061; Wu SH, 2013, J AM COLL CARDIOL, V61, P645, DOI 10.1016/j.jacc.2012.11.023; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Noseworthy PA, 2011, J AM COLL CARDIOL, V57, P2284, DOI 10.1016/j.jacc.2011.04.003; Wellens HJ, 2008, NEW ENGL J MED, V358, P2063, DOI 10.1056/NEJMe0801060; Ilkhanoff L, 2014, CIRC-ARRHYTHMIA ELEC, V7, P392, DOI 10.1161/CIRCEP.113.000874; Hisamatsu T, 2013, CIRC J, V77, P1260, DOI 10.1253/circj.CJ-12-1273; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Macfarlane PW, 2015, J AM COLL CARDIOL, V66, P470, DOI 10.1016/j.jacc.2015.05.033; Chiba Y, 2015, CIRC J, V79, P2216, DOI 10.1253/circj.CJ-15-0340; Lobe S, 2015, J ELECTROCARDIOL, DOI [10.1016/j.jelectrocard.2015.07.003, DOI 10.1016/J.JELECTROCARD.2015.07.003]; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2110	2111		10.1253/circj.CJ-15-0920		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900008		
J	Suzuki, N; Kozuma, K				Suzuki, Nobuaki; Kozuma, Ken			Coronary Imaging Modalities for Forecasting the "Eruption of the Volcano"	CIRCULATION JOURNAL			English	Editorial Material							OPTICAL COHERENCE TOMOGRAPHY; HISTOLOGY INTRAVASCULAR ULTRASOUND; VULNERABLE PLAQUE; STENT		[Suzuki, Nobuaki; Kozuma, Ken] Teikyo Univ, Sch Med, Dept Med, Tokyo 1738605, Japan	Kozuma, K (reprint author), Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	PXE00364@nifty.com					Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Kubo T, 2011, INT HEART J, V52, P175; Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Brugaletta S, 2014, CIRC J, V78, P1531, DOI 10.1253/circj.CJ-14-0496; Suzuki N, 2013, INT J CARDIOL, V168, P843, DOI 10.1016/j.ijcard.2012.10.002; Suzuki N, 2011, EUROINTERVENTION, V6, P963, DOI 10.4244/EIJV6I8A167; Kawaguchi R, 2007, J AM COLL CARDIOL, V50, P1641, DOI 10.1016/j.jacc.2007.06.051; Nagoshi R, 2013, CIRC J, V77, P652, DOI 10.1253/circj.CJ-12-0610; Coletta J, 2010, ARQ BRAS CARDIOL, V94, P268, DOI 10.1590/S0066-782X2010000200020; Coletta John, 2010, Arq Bras Cardiol, V94, P250; Coletta J, 2010, ARQUIVOS BRASILEIROS, V94, P254; Koga S, 2015, CIRC J, V79, P2231, DOI 10.1253/circj.CJ-15-0393	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2112	2113		10.1253/circj.CJ-15-0887		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900009		
J	Asanuma, H; Kitakaze, M				Asanuma, Hiroshi; Kitakaze, Masafumi			Glycemic Variability Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome	CIRCULATION JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; ANGIOGRAPHIC PROGRESSION; GLUCOSE FLUCTUATION; OXIDATIVE STRESS; MONOCYTE SUBSETS; ANGINA-PECTORIS; HYPERGLYCEMIA; ELEVATION		[Asanuma, Hiroshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Clin Res & Dev, Suita, Osaka 5658565, Japan	Kitakaze, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Clin Res & Dev, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kitakaze@zf6.so-net.ne.jp					Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Zouridakis EG, 2001, EUR HEART J, V22, P1578, DOI 10.1053/euhj.2000.2588; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; WATERS D, 1993, CIRCULATION, V87, P1067; Nakachi T, 2008, CIRC J, V72, P1953, DOI 10.1253/circj.CJ-08-0185; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; ZUANETTI G, 1993, J AM COLL CARDIOL, V22, P1788; Teraguchi I, 2014, CIRC J, V78, P170, DOI 10.1253/circj.CJ-13-0723; KASKI JC, 1995, CIRCULATION, V92, P2058; Ogawa H, 2013, CIRC J, V77, P231, DOI 10.1253/circj.CJ-66-0053; FALK E, 1995, CIRCULATION, V92, P657; Gohbara M, 2015, CIRC J, V79, P1092, DOI 10.1253/circj.CJ-14-1226; Kataoka S, 2015, CIRC J, V79, P2246, DOI 10.1253/circj.CJ-15-0496; Teraguchi I, 2014, NUTR METAB CARDIOVAS, V24, P309, DOI 10.1016/j.numecd.2013.08.010	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2114	2115		10.1253/circj.CJ-15-0919		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900010		
J	Takayama, T				Takayama, Tadateru			What Is the Prognostic Morphology of Coronary Plaque in Patients With Chronic Kidney Disease?	CIRCULATION JOURNAL			English	Editorial Material							INTRAVASCULAR ULTRASOUND; CARDIOVASCULAR-DISEASE; CULPRIT LESIONS; ATHEROSCLEROSIS; CALCIFICATION; TOMOGRAPHY		[Takayama, Tadateru] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1738610, Japan	Takayama, T (reprint author), Nihon Univ, Sch Med, Dept Med, Div Cardiol,Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	takayama.tadateru@nihon-u.ac.jp					AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Nakano T, 2010, AM J KIDNEY DIS, V55, P21, DOI 10.1053/j.ajkd.2009.06.034; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L; Kono K, 2012, KIDNEY INT, V82, P344, DOI 10.1038/ki.2012.118; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Miyagi M, 2010, NEPHROL DIAL TRANSPL, V25, P175, DOI 10.1093/ndt/gfp423; Kashiyama K, 2015, INT J CARDIOVAS IMAG, V31, P935, DOI 10.1007/s10554-015-0633-y; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Mehanna E, 2013, CIRC J, V77, P2334, DOI 10.1253/circj.CJ-12-1458; Gross P, 2014, CIRC J, V78, P2339, DOI 10.1253/circj.CJ-14-0735; Matsushita K, 2015, J AM SOC NEPHROL, V26, P439, DOI 10.1681/ASN.2014020173; Shimbo Y, 2015, CIRC J, V79, P2263, DOI 10.1253/circj.CJ-15-0460	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2116	2117		10.1253/circj.CJ-15-0918		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900011		
J	Murata, H; Miyauchi, Y; Hayashi, M; Iwasaki, Y; Yodogawa, K; Ueno, A; Hayashi, H; Tsuboi, I; Uetake, S; Takahashi, K; Yamamoto, T; Maruyama, M; Akutsu, K; Yamamoto, T; Kobayashi, Y; Tanaka, K; Atarashi, H; Katoh, T; Shimizu, W				Murata, Hiroshige; Miyauchi, Yasushi; Hayashi, Meiso; Iwasaki, Yu-ki; Yodogawa, Kenji; Ueno, Akira; Hayashi, Hiroshi; Tsuboi, Ippei; Uetake, Shunsuke; Takahashi, Kenta; Yamamoto, Teppei; Maruyama, Mitsunori; Akutsu, Koichi; Yamamoto, Takeshi; Kobayashi, Yoshinori; Tanaka, Keiji; Atarashi, Hirotsugu; Katoh, Takao; Shimizu, Wataru			Clinical and Electrocardiographic Characteristics of Electrical Storms Due to Monomorphic Ventricular Tachycardia Refractory to Intravenous Amiodarone	CIRCULATION JOURNAL			English	Article						Amiodarone; Catheter ablation; Electrical storm; Purkinje potential; Ventricular tachycardia	SHORT-TERM TREATMENT; MYOCARDIAL-INFARCTION; ISCHEMIC MYOCARDIUM; HEART-FAILURE; TACHYARRHYTHMIAS; ARRHYTHMIAS; FIBRILLATION; MEXILETINE; RECURRENT; THERAPY	Background: Few reports are available on the characteristics of electrical storms of ventricular tachycardia (VT storm) refractory to intravenous (IV) amiodarone. Methods and Results: IV-amiodarone was administered to 60 patients with ventricular tachyarrhythmia between 2007 and 2012. VT storms, defined as 3 or more episodes of VT within 24 h, occurred in 30 patients (68 +/- 12 years, 7 female), with 12 having ischemic and 18 non-ischemic heart disease. We compared the clinical and electrocardiographic characteristics of the patients with VT storms suppressed by IV-amiodarone (Effective group) to those of patients not affected by the treatment (Refractory group). IV-amiodarone could not control recurrence of VT in 9 patients (30%). The Refractory group comprised 5 patients with acute myocardial infarctions. Although there was no difference in the VT cycle length, the QRS duration of both the VT and premature ventricular contractions (PVCs) followed by VT was narrower in the Refractory group than in the Effective group (140 +/- 30 vs. 178 +/- 25 ms, P<0.01; 121 +/- 14 vs. 179 +/- 22 ms, P<0.01). In the Refractory group, additional administration of IV-mexiletine and/or Purkinje potential-guided catheter ablation was effective. Conclusions: IV-amiodarone-refractory VT exhibited a relatively narrow QRS tachycardia. The narrow triggering PVCs, suggesting a Purkinje fiber origin, may be treated by additional IV-mexiletine and endocardial catheter ablation.	[Murata, Hiroshige; Miyauchi, Yasushi; Hayashi, Meiso; Iwasaki, Yu-ki; Yodogawa, Kenji; Hayashi, Hiroshi; Tsuboi, Ippei; Uetake, Shunsuke; Takahashi, Kenta; Yamamoto, Teppei; Maruyama, Mitsunori; Akutsu, Koichi; Yamamoto, Takeshi; Tanaka, Keiji; Atarashi, Hirotsugu; Katoh, Takao; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 1138603, Japan; [Murata, Hiroshige; Ueno, Akira; Hayashi, Hiroshi; Akutsu, Koichi; Yamamoto, Takeshi; Tanaka, Keiji; Shimizu, Wataru] Nippon Med Coll Hosp, Dept Intens & Cardiovasc Care Unit, Tokyo, Japan; [Murata, Hiroshige; Atarashi, Hirotsugu] Nippon Med Sch, Tama Nagayama Hosp, Dept Internal Med & Cardiol, Tokyo 1138603, Japan; [Ueno, Akira; Kobayashi, Yoshinori] Tokai Univ, Hachioji Hosp, Div Cardiol, Tokyo 151, Japan; [Uetake, Shunsuke; Yamamoto, Teppei; Maruyama, Mitsunori] Nippon Med Sch, Chiba Hokusoh Hosp, Ctr Cardiovasc, Tokyo 1138603, Japan	Murata, H (reprint author), Nippon Med Sch, Dept Cardiovasc Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	s7086@nms.ac.jp					Gao DS, 2013, J CARDIOVASC PHARM, V62, P199, DOI 10.1097/FJC.0b013e31829651fe; KLEIN RC, 1988, AM HEART J, V115, P96, DOI 10.1016/0002-8703(88)90523-6; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; NALOS PC, 1991, AM HEART J, V122, P1629, DOI 10.1016/0002-8703(91)90280-U; Hayashi M, 2014, EUROPACE, V16, P92, DOI 10.1093/europace/eut207; REDDY CP, 1984, BRIT HEART J, V51, P648; KOWEY PR, 1995, CIRCULATION, V92, P3255; MOOSS AN, 1990, AM J CARDIOL, V65, P609, DOI 10.1016/0002-9149(90)91039-9; Goldschlager N, 2007, HEART RHYTHM, V4, P1250, DOI 10.1016/j.hrthm.2007.07.020; JAMES MA, 1989, POSTGRAD MED J, V65, P519; Chinushi M, 2003, CIRC J, V67, P263; HARIMAN RJ, 1984, AM HEART J, V107, P1109, DOI 10.1016/0002-8703(84)90265-5; FRIEDMAN PL, 1973, CIRC RES, V33, P597; Vassallo P, 2007, JAMA-J AM MED ASSOC, V298, P1312, DOI 10.1001/jama.298.11.1312; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Levine JH, 1996, J AM COLL CARDIOL, V27, P67, DOI 10.1016/0735-1097(95)00427-0; KAPLINSKY E, 1981, CIRCULATION, V63, P333; MORENO FL, 1994, CIRCULATION, V90, P94; SCHEINMAN MM, 1995, CIRCULATION, V92, P3264; HELMY I, 1988, J AM COLL CARDIOL, V12, P1015; Anastasiou-Nana MI, 2000, AM J CARDIOL, V85, P1212, DOI 10.1016/S0002-9149(00)00730-X; OCHI RP, 1989, AM J CARDIOL, V64, P599, DOI 10.1016/0002-9149(89)90486-4; Inuo K, 2002, CIRC J, V66, P403, DOI 10.1253/circj.66.403; Fedida David, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS71, DOI 10.1111/j.1540-8167.2006.00386.x; Gorenek B, 2014, EUROPACE, V16, P1655, DOI 10.1093/europace/euu208; JCS Joint Working Group, 2013, CIRC J, V77, P249; Ogawa S, 2013, CIRC J, V77, P497, DOI 10.1253/circj.CJ-66-0055; Katoh T, 2007, J ARRHYTHMIA, V23, P131; Kobayashi Y, 2008, J ARRHYTHMIA, V24, P200; MARCHLINSKI FE, 1988, CIRCULATION, V78, P583; POGWIZD SM, 1987, CIRCULATION, V76, P404	31	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2130	2137		10.1253/circj.CJ-15-0213		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900013		
J	Hori, M; Fukaya, T; Kleine, E; Reilly, PA; Ezekowitz, MD; Connolly, SJ				Hori, Masatsugu; Fukaya, Taku; Kleine, Eva; Reilly, Paul A.; Ezekowitz, Michael D.; Connolly, Stuart J.		RE-LY Investigators	Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS(2) Score	CIRCULATION JOURNAL			English	Article						Asians; CHADS(2) score; Dabigatran; RE-LY; Renal function	NONVALVULAR ATRIAL-FIBRILLATION; RANDOMIZED EVALUATION; SYSTEMIC EMBOLISM; RISK-FACTORS; TRIAL; STROKE; ANTICOAGULATION; THERAPY; THROMBOEMBOLISM; PREVENTION	Background: In Asian patients in RE-LY, dabigatran etexilate (DE) was as effective as warfarin, with a significantly lower bleeding risk. We evaluated the relationship between baseline renal function or CHADS(2) score and efficacy or safety outcomes in these patients. Methods and Results: Asian patients (n=2,782) were categorized according to baseline renal function or CHADS(2) score, and efficacy and safety outcomes were analyzed for DE (110 mg and 150 mg b.i.d.) vs. warfarin. There was an increase in the rates of stroke/systemic embolism and major bleeding with worsening renal function and CHADS(2) score. For stroke/systemic embolism (primary efficacy endpoint), there was no treatment interaction for dabigatran at either 110 or 150 mg b.i.d. compared with warfarin related to patients' baseline renal function (P-interaction=0.56 for DE 110 mg and 0.62 for DE 150 mg vs. warfarin) or CHADS(2) score (P-interaction=0.68 for DE 110 mg and 0.31 for DE 150 mg vs. warfarin). For major bleeding, there was no treatment interaction by creatinine clearance category observed for either dose (P-interaction=0.60 and 0.62 for DE 110 mg and DE 150 mg, respectively). Baseline CHADS(2) score had no significant effect on bleeding event rates with DE vs. warfarin. Conclusions: Bleeding and stroke rates in Asian patients varied according to renal function and CHADS(2) score, but the relative benefits of DE over warfarin were preserved when analyzed by subcategories.	[Hori, Masatsugu] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka 5378511, Japan; [Fukaya, Taku] Nippon Boehringer Ingelheim, Clin Dev & Med Affairs, Tokyo, Japan; [Kleine, Eva] Boehringer Ingelheim GmbH & Co KG, Biometr & Data Management, Ingelheim, Germany; [Reilly, Paul A.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Ezekowitz, Michael D.] Thomas Jefferson Med Coll, Cardiovasc Res Fdn NY, Philadelphia, PA USA; [Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Connolly, Stuart J.] Hamilton Hlth Sci, Hamilton, ON, Canada	Hori, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	hori-ma@mc.pref.osaka.jp			Boehringer Ingelheim	This study was funded by Boehringer Ingelheim. Editorial and writing assistance was provided by Lakshmi Venkatraman, PhD, and Lisa Lovelidge, PhD, of PAREXEL, with funding from Boehringer Ingelheim.	Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342; Toyoda K, 2015, INT J STROKE, V10, P836, DOI 10.1111/ijs.12452; Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119; Ogawa S, 2011, CIRC J, V75, P2719, DOI 10.1253/circj.CJ-88-0026; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Inoue H, 2013, J CARDIOL, V61, P1, DOI 10.1016/j.jjcc.2012.08.012; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI [10.7326/0003-4819-155-10-201111150-00004, 10.1059/0003-4819-155-10-201111150-00004]; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Apostolakis S, 2013, EUR HEART J, V34, P3572, DOI 10.1093/eurheartj/eht328; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	20	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2138	2147		10.1253/circj.CJ-15-0594		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900014		
J	Tatsuishi, W; Nakano, K; Kubota, S; Asano, R; Kataoka, G				Tatsuishi, Wataru; Nakano, Kiyoharu; Kubota, Sayaka; Asano, Ryota; Kataoka, Go			7 Identification of Coronary Artery Orifice to Prevent Coronary Complications in Bioprosthetic and Transcatheter Aortic Valve Replacement	CIRCULATION JOURNAL			English	Article						Aortic valve replacement; Coronary circulation; Imaging; Multidetector computed tomography; Transcatheter aortic valve replacement/implantation	MULTIDETECTOR COMPUTED-TOMOGRAPHY; ANOMALIES; ANATOMY; ANGIOGRAPHY; PATHOLOGY; HEART; OSTIA; ROOT	Background: The aim of this study was to identify anatomical variations in coronary artery orifices among high-risk patients with a small aortic root undergoing bioprosthetic aortic valve replacement (BAVR) and transcatheter aortic valve replacement (TAVR) in order to prevent coronary orifice obstruction perioperatively. Methods and Results: Coronary orifice and root structure were identified in 400 patients using aortic multidetector-row computed tomography (MDCT). We measured the aortic root diameter; intercommissural distances; and distance from coronary orifice to valve annulus, commissure, and sinotubular junction. We examined positional relationships between the coronary orifice and stent post, or sewing cuff of the bioprosthetic valve and leaflet of the transcatheter aortic valve. Most left coronary artery orifices were distributed near the center of the non-left and left-right commissures; right ones were relatively distributed on the non-right commissural side. Thirty-four patients (8.5%) with BAVR ( coronary orifice near the commissure: 31, 7.8%; low takeoff: 5, 1.3%; and both: 2) and 39 (9.8%) with TAVR were at risk for coronary orifice obstruction. During BAVR, one-stitch rotation of the stent and one-stitch rotation with intra-annular implantation were used in near-commissure and low takeoff cases, respectively. During TAVR, percutaneous coronary intervention may be required in the height of the coronary orifice was <= 10 mm from the base of the ventricle aortic junction. Conclusions: Potential coronary complications during BAVR and TAVR in high-risk patients for coronary obstruction were identified using preoperative aortic MDCT. Choice of appropriate surgical technique or valve is essential.	[Tatsuishi, Wataru; Nakano, Kiyoharu; Kubota, Sayaka; Asano, Ryota; Kataoka, Go] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Med Ctr East, Tokyo 1168567, Japan	Tatsuishi, W (reprint author), Tokyo Womens Med Univ, Dept Cardiovasc Surg, Med Ctr East, Arakawa Ku, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	wataru0812_drt@ybb.ne.jp					Minakata K, 2014, CIRC J, V78, P882, DOI 10.1253/circj.CJ-13-1068; Ribeiro HB, 2014, ARQ BRAS CARDIOL, V102, P93, DOI 10.5935/abc.20130252; Muriago M, 1997, CLIN ANAT, V10, P297, DOI 10.1002/(SICI)1098-2353(1997)10:5<297::AID-CA1>3.0.CO;2-O; VLODAVER Z, 1972, SEMIN ROENTGENOL, V7, P376, DOI 10.1016/0037-198X(72)90017-X; Patel S, 2008, SEMIN ROENTGENOL, V43, P100, DOI 10.1053/j.ro.2008.01.005; Turner K, 1996, Clin Anat, V9, P376, DOI 10.1002/(SICI)1098-2353(1996)9:6<376::AID-CA3>3.0.CO;2-9; Wolloscheck T, 2001, HERZ, V26, P461, DOI 10.1007/PL00002049; Salavati A, 2011, ANN INTERN MED, V155, P278, DOI [10.7326/0003-4819-155-4-201108160-00024, 10.1059/0003-4819-155-4-201108160-00024]; Kacmaz F, 2008, CORONARY ARTERY DIS, V19, P203, DOI 10.1097/MCA.0b013e3282f528f1; Shi HS, 2004, EUR RADIOL, V14, P2172, DOI 10.1007/s00330-004-2490-2; Schmitt R, 2005, EUR RADIOL, V15, P1110, DOI 10.1007/s00330-005-2707-z; WALLER BF, 1992, CLIN CARDIOL, V15, P451; Fuku Y, 2014, CIRC J, V78, P1357, DOI 10.1253/circj.CJ-13-1220; Cademartiri F, 2008, EUR RADIOL, V18, P781, DOI 10.1007/s00330-007-0821-9; KUNZELMAN KS, 1994, J THORAC CARDIOV SUR, V107, P162; Bunce NH, 2001, EUR RADIOL, V11, P721, DOI 10.1007/s003300000680; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Berdajs D, 2002, CARDIOVASC SURG, V10, P320, DOI 10.1016/S0967-2109(02)00018-2; Montaudon M, 2007, SURG RADIOL ANAT, V29, P343, DOI 10.1007/s00276-007-0217-1; Earls James P, 2006, Tech Vasc Interv Radiol, V9, P210, DOI 10.1053/j.tvir.2007.03.007; Nguyen-Kim Thi Dan Linh, 2014, Eur Heart J, V35, P1791, DOI 10.1093/eurheartj/eht414; Nishioka N, 2012, JPN J CARDIOVASC SUR, V41, P49	22	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2157	2161		10.1253/circj.CJ-15-0415		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900016		
J	Buronova, N; Kamishima, K; Yamaguchi, J; Jujo, K; Watanabe, E; Inagaki, Y; Kishi, S; Wada, A; Hatakeyama, S; Watanabe, M; Nakao, M; Okayama, D; Arashi, H; Yamada, N; Takagi, A; Ogawa, H; Hagiwara, N				Buronova, Nozima; Kamishima, Kazuho; Yamaguchi, Junichi; Jujo, Kentaro; Watanabe, Erisa; Inagaki, Yusuke; Kishi, Shohei; Wada, Akira; Hatakeyama, Shinya; Watanabe, Masahiro; Nakao, Masashi; Okayama, Dai; Arashi, Hiroyuki; Yamada, Norihiro; Takagi, Atsushi; Ogawa, Hiroshi; Hagiwara, Nobuhisa			Effect of Hemodialysis on 7-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation	CIRCULATION JOURNAL			English	Article						Hemodialysis; Long-term outcome; Percutaneous coronary intervention; Sirolimus-eluting stent	PERCUTANEOUS CORONARY INTERVENTION; STAGE RENAL-DISEASE; POSTMARKETING SURVEILLANCE REGISTRY; CHRONIC KIDNEY-DISEASE; LONG-TERM OUTCOMES; DIABETES-MELLITUS; HEART-FAILURE; IMPACT; REVASCULARIZATION; PREDICTORS	Background: Hemodialysis (HD) patients are reported to show poor clinical outcomes after percutaneous coronary intervention (PCI) with sirolimus-eluting stent (SES) compared with non-HD patients and their long-term prognosis remains unclear. Methods and Results: We prospectively enrolled 489 consecutive patients undergoing PCI with SES and performed a retrospective analysis focusing on HD patients. Median follow-up was 7.0 years (interquartile range, 4.2-7.9) and the follow-up rate was 100%. At the 7-year follow-up, the cumulative incidences of all-cause death, target lesion revascularization (TLR) and major adverse cardiac events (MACE) were significantly higher in HD patients than in non-HD patients (HD vs. non-HD=34.7% vs. 9.6%, 42.6% vs. 10.2% and 75.3% vs. 24.4%, respectively; log-rank P<0.001). Cox-proportional hazard analysis revealed that independent predictors of all-cause death were HD (hazard ratio [HR] 2.88, 95% confidence interval [CI]: 1.39-6.00), insulin-treated diabetes mellitus (HR 2.19, 95% CI: 1.17-4.11), heart failure (HR 2.58, 95% CI: 1.25-5.32) and older age (HR 1.06/1-age, 95% CI: 1.02-1.10). Moreover, HD was an independent predictor of TLR (HR 3.63, 95% CI: 1.85-7.11) and MACE (HR 3.54, 95% CI: 2.19-5.73). Conclusions: In the present study, Japanese HD patients undergoing PCI with SES showed poorer long-term clinical outcomes than non-HD patients. HD was a strong predictor of long-term adverse events after SES implantation.	[Buronova, Nozima; Kamishima, Kazuho; Yamaguchi, Junichi; Jujo, Kentaro; Watanabe, Erisa; Inagaki, Yusuke; Kishi, Shohei; Wada, Akira; Hatakeyama, Shinya; Watanabe, Masahiro; Nakao, Masashi; Okayama, Dai; Arashi, Hiroyuki; Yamada, Norihiro; Takagi, Atsushi; Ogawa, Hiroshi; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiol, Tokyo 1628666, Japan	Yamaguchi, J (reprint author), Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	j.yamaguchi0110@gmail.com		Ogawa, Hiroshi/0000-0002-2576-2525			Aoyama T, 2008, CIRC J, V72, P56, DOI 10.1253/circj.72.56; Kumada Y, 2014, CIRC J, V78, P986, DOI 10.1253/circj.CJ-13-1357; Ota T, 2009, AM HEART J, V158, P92, DOI 10.1016/j.ahj.2009.04.013; Nakamura M, 2010, CIRC J, V74, P2592, DOI 10.1253/circj.CJ-10-0179; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Natsuaki M, 2012, AM J CARDIOL, V110, P1568, DOI 10.1016/j.amjcard.2012.07.021; Spinar J, 2007, KIDNEY BLOOD PRESS R, V30, P347, DOI 10.1159/000107797; Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029; Seo SM, 2011, HEART, V97, P1943, DOI 10.1136/hrt.2011.225466; Azar RR, 2000, AM J CARDIOL, V86, P485, DOI 10.1016/S0002-9149(00)00998-X; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Hara H, 2013, CIRC J, V77, P988, DOI 10.1253/circj.CJ-12-0570; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Nikolsky E, 2004, AM J CARDIOL, V94, P300, DOI 10.1016/j.amjcard.2004.04.023; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Smith SC, 2001, CIRCULATION, V103, P3019; Derthoo D, 2013, ACTA CARDIOL, V68, P51, DOI 10.2143/AC.68.1.2959632; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Fujimoto H, 2012, CIRC J, V76, P57, DOI 10.1253/circj.CJ-11-0738; Hase H, 2001, NEPHROL DIAL TRANSPL, V16, P2372, DOI 10.1093/ndt/16.12.2372; Jimenez-Quevedo P, 2013, EUROINTERVENTION, V9, P328, DOI 10.4244/EIJV9I3A54; Fajadet J, 2005, CIRCULATION, V111, P1040, DOI 10.1161/01.CIR.0000156334.24955.B2; Otsuka Y, 2011, EUR HEART J, V32, P829, DOI 10.1093/eurheartj/ehq480; Le Feuvre C, 2003, AM J CARDIOL, V92, P721, DOI 10.1016/S0002-9149(03)00838-5; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Fu Qiang, 2010, Cardiovasc Interv Ther, V25, P72, DOI 10.1007/s12928-010-0013-4; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Konishi A, 2014, J CARDIOL, V64, P25, DOI 10.1016/j.jjcc.2013.10.020; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071	33	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2169	+		10.1253/circj.CJ-15-0113		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900018		
J	Ohira, S; Doi, K; Numata, S; Yamazaki, S; Yamamoto, T; Fukuishi, M; Fujita, A; Yaku, H				Ohira, Suguru; Doi, Kiyoshi; Numata, Satoshi; Yamazaki, Sachiko; Yamamoto, Tsunehisa; Fukuishi, Megumi; Fujita, Akie; Yaku, Hitoshi			Does Age at Operation Influence the Short- and Long-Term Outcomes of Off-Pump Coronary Artery Bypass Grafting?	CIRCULATION JOURNAL			English	Article						Coronary artery bypass grafting; Elderly; Heart failure	INTERNAL THORACIC ARTERY; HIGH-RISK PATIENTS; ON-PUMP; ELDERLY-PATIENTS; FOLLOW-UP; CARDIOPULMONARY BYPASS; SURGERY; REVASCULARIZATION; MORTALITY; SURVIVAL	Background: To investigate the relationship between age and both short- and long-term outcomes of off-pump coronary bypass grafting (OPCAB). Methods and Results: The 780 patients undergoing OPCAB were divided into 3 groups: 262 aged <65 years (young), 329 aged 65-74 years (early elderly), and 189 aged >75 years (late elderly), and retrospectively analyzed. The follow-up rate was 94.9%, and mean follow-up period was 5.6 +/- 3.4 years. In-hospital mortality rates were similar among the groups (0.8% in young, 1.2% in early elderly, and 1.1% in late elderly; P=0.862). In logistic regression analysis, the risk factor for predicting major complications was the New York Heart Association (NYHA) classification (odds ratio: 1.555, P=0.001), and not age. The 10-year estimated rates free from cardiac death (89.6 +/- 3.2, 95.0 +/- 2.1, and 96.5 +/- 2.1%, log rank, P=0.16) and cardiac events (71.8 +/- 3.8, 66.8 +/- 4.3, and 59.9 +/- 7.7%, P=0.61) were not significantly different among the groups. In multivariate Cox models, independent risk factors predicting cardiac events were the NYHA classification (hazard ratio (HR): 1.265, P=0.009), and ejection fraction (HR: 0.986, P=0.016), but not age (young HR: 1.0, early elderly HR: 1.276; P=0.210, late elderly HR: 0.910; P=0.707). Conclusions: Both short- and long-term cardiac outcomes of OPCAB are not influenced by age at operation.	[Ohira, Suguru; Doi, Kiyoshi; Numata, Satoshi; Yamazaki, Sachiko; Yamamoto, Tsunehisa; Fukuishi, Megumi; Fujita, Akie; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto 6028566, Japan	Ohira, S (reprint author), Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	s-ohira@koto.kpu-m.ac.jp					Nardi P, 2009, ANN THORAC SURG, V87, P1401, DOI 10.1016/j.athoracsur.2009.02.062; Higami T, 2000, ANN THORAC SURG, V70, P307, DOI 10.1016/S0003-4975(00)01436-3; Teramukai S, 2002, AM J EPIDEMIOL, V156, P344, DOI 10.1093/aje/kwf069; Pawlaczyk R, 2012, ANN THORAC SURG, V94, P29, DOI 10.1016/j.athoracsur.2012.03.037; Hattler B, 2012, CIRCULATION, V125, P2827, DOI 10.1161/CIRCULATIONAHA.111.069260; Polomsky M, 2013, J THORAC CARDIOV SUR, V145, P1193, DOI 10.1016/j.jtcvs.2013.02.002; Keeling WB, 2013, J THORAC CARDIOV SUR, V146, P1442, DOI 10.1016/j.jtcvs.2012.09.035; Kinoshita T, 2012, ANN THORAC SURG, V93, P531, DOI 10.1016/j.athoracsur.2011.09.077; Galbut DL, 2012, J THORAC CARDIOV SUR, V143, P844, DOI 10.1016/j.jtcvs.2011.12.026; Minakata K, 2014, CIRC J, V78, P2225, DOI 10.1253/circj.CJ-14-0328; Dalen M, 2015, CIRCULATION, V131, P1748, DOI 10.1161/CIRCULATIONAHA.114.014335; Polomsky M, 2012, CIRC J, V76, P784, DOI 10.1253/circj.CJ-12-0111; Cooper EA, 2013, HEART LUNG CIRC, V22, P989, DOI 10.1016/j.hlc.2013.05.650; Nagpal AD, 2006, CAN J CARDIOL, V22, P849; Kim JB, 2014, J AM COLL CARDIOL, V63, P2280, DOI 10.1016/j.jacc.2014.02.584; Stamou SC, 2005, ANN THORAC SURG, V79, P552, DOI 10.1016/j.athoracsur.2004.07.075; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Saito A, 2011, INTERACT CARDIOV TH, V12, P575, DOI 10.1510/icvts.2010.254813; Nakamura Y, 2004, CIRC J, V68, P1184, DOI 10.1253/circj.68.1184; Marui A, 2012, CIRCULATION, V126, pS151, DOI 10.1161/CIRCULATIONAHA.111.083873; Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061; Grau JB, 2015, J THORAC CARDIOV SUR, V149, P1027, DOI 10.1016/j.jtcvs.2014.12.031; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Diegeler A, 2013, NEW ENGL J MED, V368, P1189, DOI 10.1056/NEJMoa1211666; Doi K, 2010, EUR J CARDIO-THORAC, V38, P568, DOI 10.1016/j.ejcts.2010.03.021; Chaudhry UAR, 2014, ANN THORAC SURG, V98, P563, DOI 10.1016/j.athoracsur.2014.05.003; Arzentiano M, 1999, CIRCULATION S2, V100, P119; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Buxton BF, 1998, CIRCULATION, V98, pII1; Japanese Associate for Coronary Artery Surgery (JACAS), 2014, ANN THORAC CARDIOVAS, V20, P332; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Masuda M, 2015, GEN THORAC CARDIOVAS, V63, P120; Omer S, 2014, J THORAC CARDIOV SUR, V148, P1307, DOI 10.1016/j.jtcvs.2013.12.039; Song Y, 2014, CIRC J, V78, P2422, DOI 10.1253/circj.CJ-14-0378; Tashiro Tadashi, 2013, Gen Thorac Cardiovasc Surg, V61, P429, DOI 10.1007/s11748-013-0240-6; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Torikai K, 2011, GEN MED, V12, P11	37	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2177	+		10.1253/circj.CJ-15-0462		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900019		
J	Kato, NP; Okada, I; Imamura, T; Kagami, Y; Endo, M; Nitta, D; Fujino, T; Muraoka, H; Minatsuki, S; Maki, H; Inaba, T; Kinoshita, O; Nawata, K; Hatano, M; Yao, A; Kyo, S; Ono, M; Jaarsma, T; Kinugawa, K				Kato, Naoko P.; Okada, Ikuko; Imamura, Teruhiko; Kagami, Yukie; Endo, Miyoko; Nitta, Daisuke; Fujino, Takeo; Muraoka, Hironori; Minatsuki, Shun; Maki, Hisataka; Inaba, Toshiro; Kinoshita, Osamu; Nawata, Kan; Hatano, Masaru; Yao, Atsushi; Kyo, Shunei; Ono, Minoru; Jaarsma, Tiny; Kinugawa, Koichiro			Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device	CIRCULATION JOURNAL			English	Article						Heart failure; Mechanical circulatory support; Patient-reported outcomes; Quality of life	INTERMACS ANNUAL-REPORT; HEART-FAILURE PATIENTS; DESTINATION THERAPY; SUPPORT; TRANSPLANTATION; PREDICTORS; IMPROVES	Background: Improving quality of life (QOL) has become an important goal in left ventricular assist device (LVAD) therapy. We aimed (1) to assess the effect of an implantable LVAD on patients' QOL, (2) to compare LVAD patients' QOL to that of patients in different stages of heart failure (HF), and (3) to identify factors associated with patients' QOL. Methods and Results: The QOL of 33 Japanese implantable LVAD patients was assessed using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and Short-form 8 (SF-8), before and at 3 and 6 months afterwards. After LVAD implantation, QOL significantly improved [MLHFQ, SF-8 physical component score (PCS), SF-8 mental component score (MCS), all P<0.05]. Implanted LVAD patients had a better QOL than extracorporeal LVAD patients (n=33, 32.1 +/- 21.9 vs. n=17, 47.6 +/- 18.2), and Stage D HF patients (n=32, 51.1 +/- 17.3), but the score was comparable to that of patients who had undergone a heart transplant (n=13). In multiple regression analyses, postoperative lower albumin concentration and right ventricular failure were independently associated with poorer PCS. Female sex and postoperative anxiety were 2 of the independent factors for poorer MCS (all P<0.05). Conclusions: Having an implantable LVAD improves patients' QOL, which is better than that of patients with an extracorporeal LVAD. Both clinical and psychological factors are influence QOL after LVAD implantation.	[Kato, Naoko P.; Okada, Ikuko; Imamura, Teruhiko; Kyo, Shunei; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Kagami, Yukie; Endo, Miyoko] Univ Tokyo, Dept Artificial Organs & Transplantat, Tokyo 1138655, Japan; [Nitta, Daisuke; Fujino, Takeo; Muraoka, Hironori; Minatsuki, Shun; Maki, Hisataka; Inaba, Toshiro; Hatano, Masaru; Yao, Atsushi] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Dept Cardiac Surg, Tokyo 1138655, Japan; [Kato, Naoko P.; Jaarsma, Tiny] Linkoping Univ, Fac Hlth Sci, Dept Social & Welf Studies, Linkoping, Sweden	Kato, NP (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	naokat-tky@umin.ac.jp			Pfizer Health Research Foundation	This work was supported in part by a domestic collaborative research grant 2013 from the Pfizer Health Research Foundation to N.P.K. and K.K.	Nishimura T, 2014, J ARTIF ORGANS, V17, P211, DOI 10.1007/s10047-014-0779-8; Shiga T, 2012, CIRC J, V76, P2785, DOI 10.1253/circj.CJ-12-0231; Rogers JG, 2010, J AM COLL CARDIOL, V55, P1826, DOI 10.1016/j.jacc.2009.12.052; Kato TS, 2013, CIRC-HEART FAIL, V6, P785, DOI 10.1161/CIRCHEARTFAILURE.111.000358; Hallas C, 2009, J CARDIOVASC NURS, V24, P31, DOI 10.1097/01.JCN.0000317472.65671.e2; Kirklin JK, 2011, J HEART LUNG TRANSPL, V30, P115, DOI 10.1016/j.healun.2010.12.001; Grady KL, 2002, AM J CRIT CARE, V11, P345; Whittingham K, 2013, PALLIATIVE MED, V27, P596, DOI 10.1177/0269216313477179; Jakovljevic DG, 2014, AM J CARDIOL, V114, P88, DOI 10.1016/j.amjcard.2014.04.008; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Wray J, 2007, CLIN TRANSPLANT, V21, P622, DOI 10.1111/j.1399-0012.2007.00698.x; Grady KL, 2014, J HEART LUNG TRANSPL, V33, P412, DOI 10.1016/j.healun.2013.10.017; Imamura T, 2013, CIRC J, V77, P96, DOI 10.1253/circj.CJ-12-0686; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Grady KL, 2003, J HEART LUNG TRANSPL, V22, P322, DOI 10.1016/S1053-2498(02)00668-X; Brouwers C, 2014, EUR J HEART FAIL, V16, P566, DOI 10.1002/ejhf.75; Casida JM, 2011, HEART LUNG, V40, P511, DOI 10.1016/j.hrtlng.2011.05.002; Imamura T, 2012, CIRC J, V76, P1895, DOI 10.1253/circj.CJ-12-0182; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Kugler C, 2011, J HEART LUNG TRANSPL, V30, P204, DOI 10.1016/j.healun.2010.08.030; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; Kato Naoko, 2014, Curr Heart Fail Rep, V11, P290, DOI 10.1007/s11897-014-0201-0; Kato N, 2011, CIRC J, V75, P1661, DOI 10.1253/circj.CJ-10-1308; Kitamura T., 1993, ARCH PSYCHIAT DIAGNO, V4, P371; Origasa H, 2002, JPN J CLIN PHARM THE, V33, p263S; Pharmaceuticals and Medical Device Agency, JSAO IFAO JOINT INT; Rector T, 1987, HEART FAILURE, V3, P198; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2186	+		10.1253/circj.CJ-15-0502		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900020		
J	Nishida, T; Sonoda, H; Oishi, Y; Tanoue, Y; Tatewaki, H; Shiokawa, Y; Tominaga, R				Nishida, Takahiro; Sonoda, Hiromichi; Oishi, Yasuhisa; Tanoue, Yoshihisa; Tatewaki, Hideki; Shiokawa, Yuichi; Tominaga, Ryuji			Long-Term Comparison of Three Types of Aortic St. Jude Medical Mechanical Prosthesis in Japanese Patients	CIRCULATION JOURNAL			English	Article						Aortic valve replacement; Valve; Warfarin	CARDIAC-VALVE PROSTHESIS; FOLLOW-UP; HEART-VALVE; ATRIAL-FIBRILLATION; CARBOMEDICS VALVE; ELDERLY-PATIENTS; EXPERIENCE; REPLACEMENT; ANTICOAGULATION; GUIDELINES	Background: The long-term results achieved with aortic St. Jude Medical (SJM) mechanical prostheses in various age groups of Japanese patients have not been previously compared or reported. Methods and Results: Since 1981, a total of 240 SJM valves were implanted in 79 patients using the Standard model, in 58 patients with the Hemodynamic Plus model, and in 103 patients with the Regent model for aortic valve replacement (AVR). Follow-up was completed for 2,397 patient-years in 97.5% of the patients, among whom the effect of age was compared, and the subjects were divided into younger (<65 years) and older (>= 65 years) groups. Hospital mortality rate was 2.5%. No structural valve deterioration was observed during the follow-up period. In addition, no significant differences were observed in long-term survival between the 3 models. In contrast, significantly better rates of freedom from all-cause death (P<0.0001), valve-related death (P=0.0018) and valve-related morbidity (P=0.0021), including bleeding events (P=0.0007),were observed in the younger group (n=157, 50.6 +/- 1.0 years old) than in the older group (n=83, 72.5 +/- 0.7 years old). Conclusions: All types of SJM valve used for single AVR achieved satisfactory early and long-term results in each age group even 25 years after surgery. When selecting this prosthesis for elderly patients, however, relatively worse performance may be expected compared with that observed in younger patients.	[Nishida, Takahiro; Sonoda, Hiromichi; Oishi, Yasuhisa; Tanoue, Yoshihisa; Tatewaki, Hideki; Shiokawa, Yuichi; Tominaga, Ryuji] Kyushu Univ, Dept Cardiovasc Surg, Grad Sch Med Sci, Fukuoka 8128582, Japan	Nishida, T (reprint author), Kyushu Univ, Dept Cardiovasc Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tnishida@heart.med.kyushu-u.ac.jp					Aoyagi S, 2007, J HEART VALVE DIS, V16, P267; Minakata K, 2014, CIRC J, V78, P882, DOI 10.1253/circj.CJ-13-1068; Emery RW, 2010, J HEART VALVE DIS, V19, P473; Van Nooten GJ, 2003, J HEART VALVE DIS, V12, P495; Nistal JF, 1996, J THORAC CARDIOV SUR, V112, P59, DOI 10.1016/S0022-5223(96)70178-2; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Sellers MB, 2011, AM HEART J, V161, P241, DOI 10.1016/j.ahj.2010.11.002; Arom KV, 1996, J HEART VALVE DIS, V5, P505; Matsuyama K, 2002, CIRC J, V66, P668, DOI 10.1253/circj.66.668; Santini F, 2002, J HEART VALVE DIS, V11, P121; Nishida T, 2014, J THORAC CARDIOV SUR, V147, P1493, DOI 10.1016/j.jtcvs.2013.05.017; Akins CW, 2008, ANN THORAC SURG, V85, P1490, DOI 10.1016/j.athoracsur.2007.12.082; Bryan AJ, 2007, J THORAC CARDIOV SUR, V133, P614, DOI 10.1016/j.jtcvs.2006.08.075; Emery RW, 2003, ANN THORAC SURG, V75, P444, DOI 10.1016/S0003-4975(02)04537-X; Kimura M, 2001, JPN CIRC J, V65, P271, DOI 10.1253/jcj.65.271; Maruyama M, 2014, CIRC J, V78, P1372, DOI 10.1253/circj.CJ-13-1463; Emery RW, 2005, ANN THORAC SURG, V79, P776, DOI 10.1016/j.athoracsur.2004.08.047; Ikonomidis JS, 2003, J THORAC CARDIOV SUR, V126, P2022, DOI 10.1016/S0022-5223(03)01372-2; BAUDET EM, 1995, J THORAC CARDIOV SUR, V109, P858, DOI 10.1016/S0022-5223(95)70309-8; Carrier M, 2006, J HEART VALVE DIS, V15, P67; Lim KHH, 2002, J THORAC CARDIOV SUR, V123, P21, DOI 10.1067/mtc.2002.119703; Bernal JM, 1998, ANN THORAC SURG, V65, P137, DOI 10.1016/S0003-4975(97)01238-1; Bodnar E, 2006, J THORAC CARDIOV SUR, V131, P1, DOI 10.1016/j.jtcvs.2005.11.013; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; MAYUMI H, 1991, ARTIF ORGANS, V15, P503; Emery RW, 2005, ANN THORAC SURG, V79, P782; Masuda M, 2014, GEN THORAC CARDIOVAS, V62, P734; Nishida T, 2014, CIRC J, V78, P2688, DOI 10.1253/circj.CJ-14-0466; Nishida Takahiro, 2015, Gen Thorac Cardiovasc Surg, V63, P78, DOI 10.1007/s11748-014-0438-2	29	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2193	2200		10.1253/circj.CJ-15-0268		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900021		
J	Hifumi, T; Kuroda, Y; Kawakita, K; Sawano, H; Tahara, Y; Hase, M; Nishioka, K; Shirai, S; Hazui, H; Arimoto, H; Kashiwase, K; Kasaoka, S; Motomura, T; Yasuga, Y; Yonemoto, N; Yokoyama, H; Nagao, K; Nonogi, H				Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya; Sawano, Hirotaka; Tahara, Yoshio; Hase, Mamoru; Nishioka, Kenji; Shirai, Shinichi; Hazui, Hiroshi; Arimoto, Hideki; Kashiwase, Kazunori; Kasaoka, Shunji; Motomura, Tomokazu; Yasuga, Yuji; Yonemoto, Naohiro; Yokoyama, Hiroyuki; Nagao, Ken; Nonogi, Hiroshi		J-PULSE-Hypo Investigators	Effect of Admission Glasgow Coma Scale Motor Score on Neurological Outcome in Out-of-Hospital Cardiac Arrest Patients Receiving Therapeutic Hypothermia	CIRCULATION JOURNAL			English	Article						Cardiac arrest; Glasgow Coma Scale; Neurological examination; Therapeutic hypothermia	RESUSCITATION; PROGNOSTICATION; ERA	Background: Because the initial (on admission) Glasgow Coma Scale (GCS) examination has not been fully evaluated in comatose survivors of cardiac arrest (CA) who receive therapeutic hypothermia (TH), the aim of the present study was to determine any association between the admission GCS motor score and neurologic outcomes in patients with out-of-hospital CA who receive TH. Methods and Results: In the J-PULSE-HYPO study registry, patients with bystander-witnessed CA were eligible for inclusion. Patients were divided into 3 groups based on GCS motor score (1, 2-3, and 4-5) to assess various effects on neurologic outcome. Univariate and multivariate analyses were performed to identify independent predictors of good neurologic outcome at 90 days. Of 452 patients, 302 were enrolled. There was a significant difference among the 3 patient groups with regard to neurologic outcome at 90 days in the univariate analysis. Multiple logistic regression analyses showed that the GCS motor score on admission, age >65 years, bystander cardiopulmonary resuscitation, the time from collapse to return of spontaneous circulation, and pupil size <4 mm were independent predictors of a good neurologic outcome at 90 days in cases of CA (GCS motor score, 4-5: odds ratio, 8.18; 95% confidence interval: 1.90-60.28; P<0.01). Conclusions: GCS motor score is an independent predictor of good neurologic outcome at 90 days in patients sustaining out-of-hospital CA who receive TH.	[Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Ctr Emergency Med, Miki, Kagawa 7610793, Japan; [Sawano, Hirotaka] Saiseikai Senri Hosp, Senri Crit Care Med Ctr, Suita, Osaka, Japan; [Tahara, Yoshio; Yokoyama, Hiroyuki] Natl Cerebral & Cardiovasc Ctr, Div Cardiovasc Care Unit, Dept Cardiovasc Med, Suita, Osaka, Japan; [Hase, Mamoru] Sapporo Med Univ, Sch Med, Dept Traumatol & Crit Care Med, Sapporo, Hokkaido, Japan; [Nishioka, Kenji] Hiroshima City Hosp, Hiroshima, Japan; [Shirai, Shinichi] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan; [Hazui, Hiroshi] Osaka Mishima Emergency & Crit Care Ctr, Emergency Med, Takatsuki, Osaka, Japan; [Arimoto, Hideki] Osaka City Gen Hosp, Emergency & Crit Care Med Ctr, Osaka, Japan; [Kashiwase, Kazunori] Osaka Police Hosp, Div Cardiovasc, Osaka, Japan; [Kasaoka, Shunji] Kumamoto Univ Hosp, Dept Emergency & Gen Med, Kumamoto, Japan; [Motomura, Tomokazu] Nippon Med Sch, Chiba Hokusoh Hosp, Shock & Trauma Ctr, Inzai, Japan; [Yasuga, Yuji] Sumitomo Hosp, Dept Cardiol, Osaka, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Psychopharmacol, Kodaira, Tokyo, Japan; [Nagao, Ken] Surugadai Nihon Univ Hosp, Dept Cardiol Cardiopulm Resuscitat & Emergency Ca, Tokyo, Japan; [Nonogi, Hiroshi] Shizuoka Prefectural Gen Hosp, Shizuoka, Japan	Hifumi, T (reprint author), Kagawa Univ Hosp, Ctr Emergency Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hifumitoru@gmail.com			Ministry of Health, Labour and Welfare of Japan [H19-Shinkin-03]	This study was supported by a research grant for Cardiovascular Disease (H19-Shinkin-03: a study related to the establishment of a prehospital system in acute myocardial infarction and stroke) from the Ministry of Health, Labour and Welfare of Japan.	Bouwes A, 2012, ANN NEUROL, V71, P206, DOI 10.1002/ana.22632; Mitani Y, 2014, CIRC J, V78, P701, DOI 10.1253/circj.CJ-13-1162; Kobayashi N, 2013, CIRC J, V77, P673, DOI 10.1253/circj.CJ-12-0846; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; CUMMINS RO, 1991, CIRCULATION, V84, P960; TEASDALE G, 1974, LANCET, V2, P81; Greer DM, 2013, RESUSCITATION, V84, P1546, DOI 10.1016/j.resuscitation.2013.07.028; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Schefold JC, 2009, RESUSCITATION, V80, P658, DOI 10.1016/j.resuscitation.2009.03.006; Shinada T, 2014, J CARDIOL, V63, P46, DOI 10.1016/j.jjcc.2013.06.013; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Holzer M, 2002, NEW ENGL J MED, V346, P549; Yokoyama H, 2011, CIRC J, V75, P1063, DOI 10.1253/circj.CJ-11-0137; Soga T, 2012, CIRC J, V76, P2579, DOI 10.1253/circj.CJ-12-0448; Okamoto Y, 2013, CIRC J, V77, P2596, DOI 10.1253/circj.CJ-12-1604; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; [Anonymous], 2013, CIRC J, V77, P2742; Bordini AL, 2010, ARQ NEURO-PSIQUIAT, V68, P930, DOI 10.1590/S0004-282X2010000600019; ECC Committee Subcommittees and Task Forces of the American Heart Association, 2005, CIRCULATION S, V112, pIV1; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Gold B, 2014, RESUSCITATION, V85, P211, DOI 10.1016/j.resuscitation.2013.10.030; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519	24	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2201	2208		10.1253/circj.CJ-15-0308		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900022		
J	Ueda, T; Kawakami, R; Nishida, T; Onoue, K; Soeda, T; Okayama, S; Takeda, Y; Watanabe, M; Kawata, H; Uemura, S; Saito, Y				Ueda, Tomoya; Kawakami, Rika; Nishida, Taku; Onoue, Kenji; Soeda, Tsunenari; Okayama, Satoshi; Takeda, Yukiji; Watanabe, Makoto; Kawata, Hiroyuki; Uemura, Shiro; Saito, Yoshihiko			Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF	CIRCULATION JOURNAL			English	Article						Cutoff value; Echocardiography; Heart failure; Left ventricular ejection fraction	SYSTOLIC FUNCTION; INSIGHTS; SPIRONOLACTONE; EPIDEMIOLOGY; PATHOGENESIS; CANDESARTAN; PREVALENCE; INHIBITORS; PROGNOSIS; MORTALITY	Background: Heart failure (HF) with preserved (HFpEF) left ventricular ejection fraction (LVEF) is a syndrome with complex pathophysiology. Little is known about changes in LVEF that occur over time in HFpEF patients. A fundamental clinical question about HFpEF is whether HFpEF is an early manifestation of HF with reduced LVEF (HFrEF). If so, which patients with HFpEF are likely to show a decline in LVEF to less than 50%? The aim of the present study was to examine longitudinal changes in LVEF in patients with HFpEF. Methods and Results: Among 279 consecutive HFpEF patients admitted as emergencies, we examined 100 who underwent echocardiography at least 1 year after discharge. EF >50% was used as the definition of HFpEF. During a mean duration from hospitalization to follow-up echocardiography of 31.5 months, 11% of patients had LVEF <= 50% (mildly reduced LVEF), known as mildly reduced (HFmrEF). The utility of LVEF during hospitalization to predict HFmrEF was assessed with receiver-operating characteristic curve analysis. A cutoff value of 55% had sensitivity of 90.9% and specificity of 97.7%. Logistic regression analysis indicated that LVEF <= 55% and ischemic etiology were strong predictors of progression from HFpEF to HFmrEF (odds ratio [OR] 435, 95% confidence interval [CI] 52.65-10,614, P<0.0001 and OR 10.9, 95% CI 2.60-74.80, P=0.0007, respectively). Conclusions: The present study suggests that HFpEF patients with LVEF <= 55% may progress to HFmrEF in the future.	[Ueda, Tomoya; Kawakami, Rika; Nishida, Taku; Onoue, Kenji; Soeda, Tsunenari; Okayama, Satoshi; Takeda, Yukiji; Watanabe, Makoto; Kawata, Hiroyuki; Uemura, Shiro] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348522, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 6348522, Japan	Kawakami, R (reprint author), Nara Med Univ, Dept Internal Med 1, 840 Shijo, Kashihara, Nara 6348522, Japan.	rkawa@naramed-u.ac.jp			Japan Heart Foundation; Naito Foundation	Research funding: Japan Heart Foundation, The Naito Foundation Subsidies or Donations: MSD Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Co, Ltd, Novartis Pharma K.K., Shionogi & Co, Ltd, Astellas Pharma Inc, AstraZeneca K.K., Ltd, Otsuka Pharmaceutical Co, Ltd, St. Jude Medical Japan Co, Ltd, Kyowa Hakko Kirin Co Ltd.	Somaratne JB, 2009, EUR J HEART FAIL, V11, P855, DOI 10.1093/eurjhf/hfp103; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Ueda T, 2015, CIRC J, V79, P1307, DOI 10.1253/circj.CJ-14-1203; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Kaku K, 2011, J AM SOC ECHOCARDIOG, V24, P541, DOI 10.1016/j.echo.2011.01.011; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.09.046; Hamaguchi S, 2012, CIRC J, V76, P1662, DOI 10.1253/circj.CJ-11-1355; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Ueda T, 2013, CIRC J, V77, P2766, DOI 10.1253/circj.CJ-13-0718; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Clarke CL, 2013, CIRC-CARDIOVASC QUAL, V6, P680, DOI 10.1161/CIRCOUTCOMES.111.000045; Dunlay SM, 2012, CIRC-HEART FAIL, V5, P720, DOI 10.1161/CIRCHEARTFAILURE.111.966366; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Kikuchi S, 2013, CIRC J, V77, P2551, DOI 10.1253/circj.CJ-13-0426; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Garcia EH, 2006, INT J CARDIOL, V108, P181, DOI 10.1016/j.ijcard.2005.04.026; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Ueda T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001174	28	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2209	+		10.1253/circj.CJ-15-0425		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900023		
J	Chiba, Y; Minoura, Y; Onishi, Y; Inokuchi, K; Ochi, A; Kawasaki, S; Onuma, Y; Munetsugu, Y; Kikuchi, M; Ito, H; Onuki, T; Adachi, T; Asano, T; Tanno, K; Kobayashi, Y				Chiba, Yuta; Minoura, Yoshino; Onishi, Yoshimi; Inokuchi, Koichiro; Ochi, Akinori; Kawasaki, Shiro; Onuma, Yoshimasa; Munetsugu, Yumi; Kikuchi, Miwa; Ito, Hiroyuki; Onuki, Tatsuya; Adachi, Taro; Asano, Taku; Tanno, Kaoru; Kobayashi, Youichi			J-Wave in Patients With Syncope	CIRCULATION JOURNAL			English	Article						Autonomic regulation; Head-up tilt test; J-wave; Syncope	NEURALLY-MEDIATED SYNCOPE; EARLY REPOLARIZATION PATTERN; VENTRICULAR-FIBRILLATION; UNEXPLAINED SYNCOPE; MANAGEMENT; IDENTIFICATION; AUGMENTATION; ARRHYTHMIAS; DIAGNOSIS; DEATH	Background: Syncope is a common occurrence. The presence of J-wave, also known as early repolarization, on electrocardiogram is often seen in the general population, but the relationship between syncope and J-wave is unclear. Methods and Results: After excluding 67 patients with structural heart disease from 326 with syncope, we classified 259 patients according to the presence or absence of J-wave (>= 1 mm) in at least 2 inferior or lateral leads. Head-up tilt test (HUT) was performed for 30 min. If no syncope or presyncope occurred, HUT was repeated after drug loading. Before tilt, 97/259 (37%) had J-wave (57 male, 47.6 +/- 22.5 years) and 162 patients had no remarkable change (89 male, 51.1 +/- 21.2 years). HUT-positive rate was higher in patients with J-wave, compared with patients without (P<0.0001). The combination of J-wave and descending/horizontal ST segment in the inferior leads was more strongly associated with positive HUT than J-wave with ascending ST segment (odds ratio, 3.23). Conclusions: Prevalence of J-wave in the inferior or lateral leads was high in patients with syncope and was associated with HUT-induced neurally mediated reflex syncope (NMRS). Furthermore, the combination of J-wave and descending/horizontal ST segment in the inferior leads could be associated with a much higher risk of NMRS.	[Chiba, Yuta; Minoura, Yoshino; Onishi, Yoshimi; Inokuchi, Koichiro; Ochi, Akinori; Kawasaki, Shiro; Onuma, Yoshimasa; Munetsugu, Yumi; Kikuchi, Miwa; Ito, Hiroyuki; Onuki, Tatsuya; Adachi, Taro; Asano, Taku; Tanno, Kaoru; Kobayashi, Youichi] Showa Univ, Div Cardiol, Dept Med, Shinagawa Ku, Tokyo 1428666, Japan	Minoura, Y (reprint author), Showa Univ, Div Cardiol, Dept Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	yoshinomm@med.showa-u.ac.jp					Mizumaki K, 2012, HEART RHYTHM, V9, P249, DOI 10.1016/j.hrthm.2011.09.055; Rosso R, 2012, HEART RHYTHM, V9, P225, DOI 10.1016/j.hrthm.2011.09.012; Mittal S, 1999, CIRCULATION, V99, P1318; Bartczak A, 2013, PACE, V36, P456, DOI 10.1111/pace.12072; Walsh JA, 2013, J AM COLL CARDIOL, V61, P863, DOI 10.1016/j.jacc.2012.11.053; Shimizu W, 2013, CIRC J, V77, P2867, DOI 10.1253/circj.CJ-13-1217; Yoshioka K, 2013, CIRC J, V77, P610, DOI 10.1253/circj.CJ-12-0932; Kikushima S, 1999, J AM COLL CARDIOL, V33, P350, DOI 10.1016/S0735-1097(98)00567-1; Rollin A, 2012, AM J CARDIOL, V110, P1302, DOI 10.1016/j.amjcard.2012.06.033; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; ALMQUIST A, 1989, NEW ENGL J MED, V320, P346, DOI 10.1056/NEJM198902093200603; Mehta M, 1999, CLIN CARDIOL, V22, P59; Kouakam C, 1996, ARCH MAL COEUR VAISS, V89, P1247; Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068; Szentadrassy N, 2005, CARDIOVASC RES, V65, P851, DOI 10.1016/j.cardiores.2004.11.022; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Maury P, 2012, EUROPACE, V14, P148, DOI 10.1093/europace/eur264; Ghosh S, 2010, HEART RHYTHM, V7, P534, DOI 10.1016/j.hrthm.2009.12.005; Yokokawa M, 2010, J CARDIOVASC ELECTR, V21, P186, DOI 10.1111/j.1540-8167.2009.01599.x; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Letsas KP, 2008, PACE, V31, P418, DOI 10.1111/j.1540-8159.2008.01010.x; International Study on Syncope of Uncertain Etiology, 2003, EUROPACE, V5, P317; Koncz I, 2013, J MOL CELL CARDIOL, V68, P20; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; SAVAGE DD, 1985, STROKE, V16, P626; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298	26	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2216	2223		10.1253/circj.CJ-15-0340		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900024		
J	Shibuya, M; Fujii, K; Hao, H; Imanaka, T; Saita, T; Fukunaga, M; Miki, K; Tamaru, H; Nishimura, M; Horimatsu, T; Naito, Y; Ishibashi-Ueda, H; Hirota, S; Masuyama, T				Shibuya, Masahiko; Fujii, Kenichi; Hao, Hiroyuki; Imanaka, Takahiro; Saita, Ten; Fukunaga, Masashi; Miki, Kojiro; Tamaru, Hiroto; Nishimura, Machiko; Horimatsu, Tetsuo; Naito, Yoshiro; Ishibashi-Ueda, Hatsue; Hirota, Seiichi; Masuyama, Tohru			Tissue Characterization of In-Stent Neointima Using Optical Coherence Tomography in the Late Phase After Bare-Metal Stent Implantation - An Ex Vivo Validation Study	CIRCULATION JOURNAL			English	Article						Atherosclerosis; Bare-metal stent; Optical coherence tomography	NATIVE CORONARY-ARTERIES; THIN-CAP FIBROATHEROMA; RESTENOSIS; ANGIOPLASTY; THROMBOSIS; PLAQUES; OCT	Background: We performed an ex vivo study to investigate optical coherence tomography (OCT) imaging for differentiating several types of neointimal tissue during the later phases after bare-metal stent (BMS) implantation as compared with histologic results. Methods and Results: OCT imaging was performed in 6 autopsy hearts for 10 BMS with implant duration >4 years. OCT qualitative neointimal tissue characterization was based on tissue structure and classified as homogeneous pattern, heterogeneous pattern with visible struts, or heterogeneous pattern with invisible struts. Corresponding histological analyses of each 2-mm cross-section of the entire BMS were performed. Of 81 cross-sections, histological analysis revealed that the homogeneous pattern of neointima on OCT (n=39) contained smooth muscle cells with collagen, indicating high neointimal maturity. The heterogeneous patterns with visible struts (n=35) contained different tissues, including a proteoglycan-rich myxomatous matrix or dense calcified plate deposition. The heterogeneous patterns with invisible struts (n=7) included neointimal lipid/necrotic core formation, accumulation of foam cells, or microcalcification scattering. Of the 66 cross-sections containing large microvessels within the neointima on histology, only 6 (9%) were visualized by OCT. Conclusions: The present study confirmed the potential use of OCT in differentiating several types of neointima after BMS implantation. The image interpretation of OCT, based on visualization of stent struts, enables identification of several types of neointimal tissues, including in-stent fibroatheroma formation, more accurately.	[Shibuya, Masahiko; Fujii, Kenichi; Imanaka, Takahiro; Saita, Ten; Fukunaga, Masashi; Miki, Kojiro; Tamaru, Hiroto; Nishimura, Machiko; Horimatsu, Tetsuo; Naito, Yoshiro; Masuyama, Tohru] Hyogo Coll Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Hao, Hiroyuki; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan	Fujii, K (reprint author), Hyogo Coll Med, Div Cardiovasc, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kfujii@hyo-med.ac.jp					Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; Fujii K, 2014, JACC-CARDIOVASC INTE, V7, P446, DOI 10.1016/j.jcin.2013.07.018; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Vorpahl M, 2010, EUR HEART J, V31, P1889, DOI 10.1093/eurheartj/ehq087; Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B; Hou JB, 2010, HEART, V96, P1187, DOI 10.1136/hrt.2010.194381; Inoue K, 2004, CARDIOVASC PATHOL, V13, P109, DOI 10.1016/s1054-8807(03)00132-7; NOBUYOSHI M, 1991, J AM COLL CARDIOL, V17, P433; Gonzalo N, 2009, HEART, V95, P1913, DOI 10.1136/hrt.2009.172072; Gonzalo N, 2009, AM HEART J, V158, P284, DOI 10.1016/j.ahj.2009.06.004; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Inoue T, 2014, CIRC J, V78, P92, DOI 10.1253/circj.CJ-13-0374; van Soest G, 2011, JACC-CARDIOVASC IMAG, V4, P810, DOI 10.1016/j.jcmg.2011.01.022; Komatsu R, 1998, CIRCULATION, V98, P224; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Qian J, 2012, CATHETER CARDIO INTE, V79, P288, DOI 10.1002/ccd.23024; Hasegawa K, 2006, CATHETER CARDIO INTE, V68, P554, DOI 10.1002/ccd.20787; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Nagoshi R, 2013, CIRC J, V77, P652, DOI 10.1253/circj.CJ-12-0610; Fujii K, 2015, JACC-CARDIOVASC IMAG, V8, P451, DOI 10.1016/j.jcmg.2014.10.015; Ormiston JA, 1997, CIRCULATION, V96, P468; CRAMERS M, 1977, ACTA ORTHOP SCAND, V48, P245; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011	26	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2224	2230		10.1253/circj.CJ-15-0585		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900025		
J	Koga, S; Ikeda, S; Miura, M; Yoshida, T; Nakata, T; Koide, Y; Kawano, H; Maemura, K				Koga, Seiji; Ikeda, Satoshi; Miura, Miyuki; Yoshida, Takeo; Nakata, Tomoo; Koide, Yuji; Kawano, Hiroaki; Maemura, Koji			iMap-Intravascular Ultrasound Radiofrequency Signal Analysis Reflects Plaque Components of Optical Coherence Tomography-Derived Thin-Cap Fibroatheroma	CIRCULATION JOURNAL			English	Article						Angina pectoris; Intracoronary imaging; Tissue characterization	ACUTE CORONARY SYNDROME; VIRTUAL HISTOLOGY; VULNERABLE PLAQUE; ATHEROSCLEROSIS; LESIONS; IVUS; CLASSIFICATION; FEASIBILITY; CARDIOLOGY; DISEASE	Background: The ability of iMap-intravascular ultrasound (IVUS) tissue characterization to detect thin-cap fibroatheroma (TCFA) identified on optical coherence tomography (OCT) has not yet been fully elucidated. Methods and Results: We evaluated 86 coronary lesions from 73 patients with stable angina pectoris using iMap-IVUS and OCT. We defined OCT-derived TCFA (OCT-TCFA) as lipid-rich plaque with a <65-mu m-thick fibrous cap. The external elastic membrane (EEM) cross-sectional area (CSA), lumen CSA, plaque plus media (P+M) CSA, plaque burden and remodeling index were measured on gray-scale IVUS. Plaque components categorized on iMap-IVUS as fibrotic, lipidic, necrotic or calcified are presented as absolute area and proportion (%) of total plaque area. OCT-TCFA (22 lesions) had significantly greater EEM CSA, P+M CSA, plaque burden and remodeling index than non-TCFA (64 lesions). Significantly larger % necrotic area, absolute lipidic and necrotic areas and smaller % fibrotic areas were found in OCT-TCFA than in non-TCFA. On multivariate analysis, absolute necrotic area was an independent predictor of OCT-TCFA. The area under the ROC curve for absolute necrotic area required to identify OCT-TCFA was 0.86. The sensitivity, specificity, positive and negative predictive values of absolute necrotic area >= 7.3 mm(2) for identifying OCT-TCFA were 77%, 88%, 68% and 92%, respectively. Conclusions: Coronary lesions with greater iMap-IVUS absolute necrotic area were closely associated with OCT-TCFA.	[Koga, Seiji; Ikeda, Satoshi; Miura, Miyuki; Yoshida, Takeo; Nakata, Tomoo; Koide, Yuji; Kawano, Hiroaki; Maemura, Koji] Nagasaki Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan	Ikeda, S (reprint author), Nagasaki Univ, Dept Cardiovasc Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sikeda@nagasaki-u.ac.jp			JSPS [24790767]	This study was partly supported by a JSPS Grant-in-Aid for Young Scientists (B) (24790767) (to S.K.).	Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; Sawada T, 2008, EUR HEART J, V29, P1136, DOI 10.1093/eurheartj/ehn132; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Garcia-Garcia HM, 2010, EUR HEART J, V31, P2456, DOI 10.1093/eurheartj/ehq280; Kubo T, 2011, INT HEART J, V52, P175; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; Kozuki A, 2013, INT J CARDIOL, V167, P1591, DOI 10.1016/j.ijcard.2012.04.102; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Van Herck J, 2009, EUROINTERVENTION, V5, P149; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; van Soest G, 2011, JACC-CARDIOVASC IMAG, V4, P810, DOI 10.1016/j.jcmg.2011.01.022; Shin ES, 2011, EUROINTERVENTION, V6, P1017, DOI 10.4244/EIJV6I8A175; ELLIS SG, 1990, CIRCULATION, V82, P1193; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P339, DOI 10.1016/j.jcmg.2008.10.017; Palmer ND, 1999, EUR HEART J, V20, P1701, DOI 10.1053/euhj.1999.1627; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Araki T, 2013, CATHETER CARDIO INTE, V81, P471, DOI 10.1002/ccd.23501; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Sathyanarayana S, 2009, EUROINTERVENTION, V5, P133; Cheng JM, 2014, EUR HEART J, V35, P639, DOI 10.1093/eurheartj/eht484; Heo JH, 2011, CATHETER CARDIOVASC, V83, pE233; Kume T., 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Lee T, 2011, JACC-CARDIOVASC INTE, V4, P483, DOI 10.1016/j.jcin.2010.12.013; Peters R J, 1994, J Am Soc Echocardiogr, V7, P616; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; Trusinskis Karlis, 2013, Cardiovasc Revasc Med, V14, P71, DOI 10.1016/j.carrev.2012.12.001; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	30	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2231	2237		10.1253/circj.CJ-15-0393		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900026		
J	Minamisawa, M; Izawa, A; Motoki, H; Kashima, Y; Hioki, H; Abe, N; Miura, T; Ebisawa, S; Miyashita, Y; Koyama, J; Ikeda, U				Minamisawa, Masatoshi; Izawa, Atsushi; Motoki, Hirohiko; Kashima, Yuichiro; Hioki, Hirofumi; Abe, Naoyuki; Miura, Takashi; Ebisawa, Soichiro; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi			Prognostic Significance of Neuroadrenergic Dysfunction for Cardiovascular Events in Patients With Acute Myocardial Infarction	CIRCULATION JOURNAL			English	Article						Acute myocardial infarction; Autonomic nervous system; Blood pressure; Cardiovascular events	AMBULATORY BLOOD-PRESSURE; SYMPATHETIC-NERVE ACTIVITY; TARGET ORGAN DAMAGE; HEART-FAILURE; ESSENTIAL-HYPERTENSION; NEURONAL FUNCTION; CIRCADIAN-RHYTHM; NON-DIPPERS; I-123 MIBG; NORMOTENSIVES	Background: The dysregulation of systemic blood pressure (BP) variation or cardiac neuroadrenergic dysfunction is associated with adverse cardiovascular events. We aimed to clarify the prognostic significance of neuroadrenergic dysfunction for cardiovascular events in patients with acute myocardial infarction (AMI). Methods and Results: We enrolled 63 AMI patients (mean age, 67 +/- 12 years) underwent ambulatory BP monitoring (ABPM) and cardiac iodine-(123) metaiodobenzylguanidine (MIBG) imaging within 4 weeks after AMI onset. We analyzed the circadian BP pattern and heart-to-mediastinum (H/M) MIBG uptake ratio. All the patients were followed for 2 years. The study endpoint was a composite of major adverse cardiovascular events, including all-cause death, MI, coronary revascularization except for the MI culprit lesion, and stroke. Patients with a non-dipper pattern (n=29) or an H/M ratio <1.96 (n=28) had a worse prognosis than those with either a dipper pattern (n=34) or an H/M ratio >= 1.96 (n=35; log-rank, P=0.013 and 0.010, respectively). Patients with both a non-dipper pattern and an H/M ratio <1.96 (n=12) had a significantly worse prognosis than did the other patients (P=0.0020). Conclusions: Dysregulation of BP variation and cardiac MIBG uptake were associated with cardiovascular events following AMI. Examining ABPM with MIBG imaging may potentially improve risk stratification in these patients.	[Minamisawa, Masatoshi; Izawa, Atsushi; Motoki, Hirohiko; Hioki, Hirofumi; Abe, Naoyuki; Miura, Takashi; Ebisawa, Soichiro; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Dept Cardiovasc Med, Sch Med, Matsumoto, Nagano 3908621, Japan; [Kashima, Yuichiro] Shinshu Univ, Dept Emergency & Crit Care Med, Sch Med, Matsumoto, Nagano 3908621, Japan	Izawa, A (reprint author), Shinshu Univ, Dept Cardiovasc Med, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	izawa611@shinshu-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Carrio I, 2010, JACC-CARDIOVASC IMAG, V3, P92, DOI 10.1016/j.jcmg.2009.07.014; Soylu A, 2009, ECHOCARDIOGR-J CARD, V26, P378, DOI 10.1111/j.1540-8175.2008.00821.x; Kato B, 2004, J NUCL MED, V45, P1074; IMAI Y, 1988, J HYPERTENS, V6, P9; Seo HS, 2006, INT J CARDIOL, V112, P171, DOI 10.1016/j.ijcard.2005.08.038; Balachandran KP, 2003, J HUM HYPERTENS, V17, P147, DOI 10.1038/sj.jjh.1001509; de la Sierra A, 2014, AM J HYPERTENS, V27, P680, DOI 10.1093/ajh/hpt175; Fukuda M, 2008, J HYPERTENS, V26, P583, DOI 10.1097/HJH.0b013e3282f2fded; Hattori N, 2000, EUR J NUCL MED, V27, P1, DOI 10.1007/s002590050505; Liu MC, 2003, NEPHROL DIAL TRANSPL, V18, P563, DOI 10.1093/ndt/18.3.563; Somsen GA, 2004, J NUCL CARDIOL, V11, P126, DOI 10.1016/j.nuclcard.2002.10.010; Omboni S, 1998, J HYPERTENS, V16, P733, DOI 10.1097/00004872-199816060-00003; Aso S, 2009, INT J CARDIOL, V131, P240, DOI 10.1016/j.ijcard.2007.10.029; Lenska-Mieciek M, 2011, NEUROL NEUROCHIR POL, V45, P335; Nakano Y, 2001, AUTON NEUROSCI-BASIC, V88, P181, DOI 10.1016/S1566-0702(01)00238-7; Soylu A, 2009, CIRC J, V73, P899; Kashima Y, 2009, J CARDIOL, V54, P76, DOI 10.1016/j.jjcc.2009.04.008; Morita Y, 2013, CIRC J, V77, P2778, DOI 10.1253/circj.CJ-13-0251; KOHARA K, 1995, HYPERTENSION, V26, P808; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/01.hjh.0000059016.82022.ca; Vasunta RL, 2012, AM J HYPERTENS, V25, P60, DOI 10.1038/ajh.2011.159; Kario K, 2009, HYPERTENS RES, V32, P428, DOI 10.1038/hr.2009.56; Kaya MG, 2010, ATHEROSCLEROSIS, V209, P278, DOI 10.1016/j.atherosclerosis.2009.09.010; Erdogan D, 2006, INT J CARDIOVAS IMAG, V22, P157, DOI 10.1007/s10554-005-9007-1; Kasama S, 2011, HEART, V97, P20, DOI 10.1136/hrt.2010.204149; Kimura S, 2014, CIRC J, V78, P159, DOI 10.1253/circj.CJ-13-0329; TSUCHIMOCHI S, 1995, J NUCL MED, V36, P969; Kurpesa M, 2002, INT J CARDIOL, V83, P133, DOI 10.1016/S0167-5273(02)00031-1; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; Izzedine H, 2006, INT J CARDIOL, V107, P343, DOI 10.1016/j.jicard.2005.03.046; Uzu T, 1999, CIRCULATION, V100, P1635; VERDECCHIA P, 1994, HYPERTENSION, V24, P793; Ijiri H, 2000, JPN CIRC J, V64, P499, DOI 10.1253/jcj.64.499; Shah AM, 2012, JACC-CARDIOVASC IMAG, V5, P1139, DOI 10.1016/j.jcmg.2012.02.019; MERLET P, 1992, J NUCL MED, V33, P471; Ebata H, 1995, Hypertens Res, V18, P125, DOI 10.1291/hypres.18.125; Higuma T, 2015, CIRC J, V79, P641, DOI 10.1253/circj.CJ-14-0904; Izawa A, 2015, CIRC J, V79, P161, DOI 10.1253/circj.CJ-14-0877; Shimada K, 2012, CIRC J, V76, P508, DOI 10.1253/circj.CJ-88-0020; Park Chan Seok, 2011, J Cardiovasc Ultrasound, V19, P183, DOI 10.4250/jcu.2011.19.4.183	42	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2238	2245		10.1253/circj.CJ-15-0265		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900027		
J	Kataoka, S; Gohbara, M; Iwahashi, N; Sakamaki, K; Nakachi, T; Akiyama, E; Maejima, N; Tsukahara, K; Hibi, K; Kosuge, M; Ebina, T; Umemura, S; Kimura, K				Kataoka, Shunsuke; Gohbara, Masaomi; Iwahashi, Noriaki; Sakamaki, Kentaro; Nakachi, Tatsuya; Akiyama, Eiichi; Maejima, Nobuhiko; Tsukahara, Kengo; Hibi, Kiyoshi; Kosuge, Masami; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome	CIRCULATION JOURNAL			English	Article						Acute coronary syndrome; Glycemic variability; Rapid progression	ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ARTERY-DISEASE; ANGIOGRAPHIC PROGRESSION; OXIDATIVE STRESS; MONOCYTE SUBSETS; ANGINA-PECTORIS; PLAQUE RUPTURE; EVENTS; HYPERGLYCEMIA	Background: Although rapid progression (RP) of coronary artery disease (CAD) has been shown to be a powerful predictor of cardiovascular events, predictors of RP are not fully understood in patients with acute coronary syndrome (ACS). Methods and Results: We prospectively investigated the clinical impact of glycemic variability (GV), as determined on continuous glucose monitoring system (CGMS), on RP of non-culprit lesions in 88 patients with ACS. RP was defined as >= 10% diameter reduction in a pre-existing stenosis >= 50%; >= 30% diameter reduction in a stenosis <50%; development of a new stenosis >= 30% in a previously normal segment; or progression of any stenosis to total occlusion. Patients were classified into 2 groups according to the presence (progressor, n=20) or absence (non-progressor, n=68) of RP. All patients were equipped with a CGMS during the stable phase, and mean amplitude of glycemic excursion (MAGE) was calculated as a marker of GV. Mean MAGE was significantly higher in progressors than in non-progressors (55 +/- 19 mg/dl vs. 37 +/- 18 mg/dl, P<0.01). On multiple logistic regression analysis, MAGE was an independent predictor of RP (odds ratio, 1.06 per 1 mg/dl; P<0.01). Conclusions: MAGE early after the onset of ACS is a predictor of RP of non-culprit lesions.	[Kataoka, Shunsuke; Gohbara, Masaomi; Iwahashi, Noriaki; Nakachi, Tatsuya; Akiyama, Eiichi; Maejima, Nobuhiko; Tsukahara, Kengo; Hibi, Kiyoshi; Kosuge, Masami; Ebina, Toshiaki; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 2320024, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2320024, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2320024, Japan	Gohbara, M (reprint author), Yokohama City Univ, Div Cardiol, Med Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	gocchi3@hotmail.com					Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; [Anonymous], 2013, DIABETES CARE S1, V36, pS67; Deedwania P, 2008, CIRCULATION, V117, P1610, DOI 10.1161/CIRCULATIONAHA.107.188629; Rioufol G, 2007, AM HEART J, V154, P330, DOI 10.1016/j.ahj.2007.04.013; Zouridakis EG, 2001, EUR HEART J, V22, P1578, DOI 10.1053/euhj.2000.2588; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Burke AP, 2001, CIRCULATION, V103, P934; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; WATERS D, 1993, CIRCULATION, V87, P1067; Goldstein JA, 2005, AM J CARDIOL, V96, P56, DOI 10.1016/j.amjcard.2005.02.044; Nakachi T, 2008, CIRC J, V72, P1953, DOI 10.1253/circj.CJ-08-0185; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Zouridakis E, 2004, CIRCULATION, V110, P1747, DOI 10.1161/01.CIR.0000142664.18739.92; Bando YK, 2014, CIRC J, V78, P576, DOI 10.1253/circj.CJ-13-1564; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Teraguchi I, 2014, CIRC J, V78, P170, DOI 10.1253/circj.CJ-13-0723; AMBROSE JA, 1985, J AM COLL CARDIOL, V6, P1233; KASKI JC, 1995, CIRCULATION, V92, P2058; Su G, 2013, DIABETES CARE, V36, P1026, DOI 10.2337/dc12-0925; LICHTLEN PR, 1992, CIRCULATION, V86, P828; SERVICE FJ, 1970, DIABETES, V19, P644; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Ogawa H, 2013, CIRC J, V77, P231, DOI 10.1253/circj.CJ-66-0053; Meynaar IA, 2012, J CRIT CARE, V27, P119, DOI 10.1016/j.jcrc.2011.11.004; Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161/01.CIR.0000025609.13806.31; Gohbara M, 2015, CIRC J, V79, P1092, DOI 10.1253/circj.CJ-14-1226; D'Archangelo Melissa J, 2008, J Diabetes Sci Technol, V2, P332; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Teraguchi I, 2014, NUTR METAB CARDIOVAS, V24, P309, DOI 10.1016/j.numecd.2013.08.010	32	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2246	+		10.1253/circj.CJ-15-0496		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900028		
J	Shimbo, Y; Suzuki, S; Ishii, H; Shibata, Y; Tatami, Y; Harata, S; Osugi, N; Ota, T; Tanaka, A; Shibata, K; Mizukoshi, T; Yasuda, Y; Maruyama, S; Murohara, T				Shimbo, Yusaku; Suzuki, Susumu; Ishii, Hideki; Shibata, Yohei; Tatami, Yosuke; Harata, Shingo; Osugi, Naohiro; Ota, Tomoyuki; Tanaka, Akihito; Shibata, Kanako; Mizukoshi, Toshihiro; Yasuda, Yoshinari; Maruyama, Shoichi; Murohara, Toyoaki			Association of Estimated Glomerular Filtration Rate and Proteinuria With Lipid-Rich Plaque in Coronary Artery Disease	CIRCULATION JOURNAL			English	Article						Coronary artery disease; Integrated backscatter intravascular ultrasound; Lipid-rich plaque; Proteinuria	CHRONIC KIDNEY-DISEASE; BACKSCATTER INTRAVASCULAR ULTRASOUND; CARDIOLOGY TASK-FORCE; COLLABORATIVE METAANALYSIS; CLINICAL CHARACTERISTICS; TISSUE CHARACTERIZATION; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; POPULATION COHORTS; STENT IMPLANTATION	Background: Estimated glomerular filtration rate (eGFR) and proteinuria are both important determinants of the risk of cardiovascular disease and mortality. The aim of the present study was to investigate the independent and combined effects of eGFR and proteinuria on tissue characterization of the coronary plaques of culprit lesions. Methods and Results: Conventional intravascular ultrasound and 3-D integrated backscatter intravascular ultrasound (IB-IVUS) were performed in 555 patients undergoing elective percutaneous coronary intervention. They were divided into 2 groups according to the absence or presence of proteinuria (dipstick result >= 1+). Patients with proteinuria had coronary plaque with significantly greater percentage lipid volume compared with those without (43.6 +/- 14.8% vs. 48.6 +/- 16.1%, P=0.005). Combined analysis was done using eGFR and absence or presence of proteinuria. Subjects with eGFR 45-59 ml/min/1.73 m(2) and proteinuria were significantly more likely to have higher percent lipid volume compared with those with eGFR >60 ml/min/1.73 m(2) without proteinuria. After multivariate adjustment for confounders, the presence of proteinuria proved to be an independent predictor for lipid-rich plaque (OR, 1.85; 95% CI: 1.12-3.06, P=0.016). Conclusions: The addition of proteinuria to eGFR level may be of value in the risk stratification of patients with coronary artery disease.	[Shimbo, Yusaku; Suzuki, Susumu; Ishii, Hideki; Shibata, Yohei; Tatami, Yosuke; Harata, Shingo; Osugi, Naohiro; Ota, Tomoyuki; Tanaka, Akihito; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Shibata, Kanako; Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept CKD Initiat Internal Med, Nagoya, Aichi 4668550, Japan; [Mizukoshi, Toshihiro; Yasuda, Yoshinari; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4668550, Japan	Suzuki, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sususu0531@yahoo.co.jp	Murohara, Toyoaki/M-4958-2014				Amano T, 2010, CIRC J, V75, P157; Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Nakano T, 2010, AM J KIDNEY DIS, V55, P21, DOI 10.1053/j.ajkd.2009.06.034; Parving HH, 2006, KIDNEY INT, V69, P2057, DOI 10.1038/sj.ki.5000377; RYAN TJ, 1993, CIRCULATION, V88, P2987; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Hayano S, 2012, AM J CARDIOL, V109, P1131, DOI 10.1016/j.amjcard.2011.11.052; Kono K, 2012, KIDNEY INT, V82, P344, DOI 10.1038/ki.2012.118; Amano T, 2007, J AM COLL CARDIOL, V49, P1149, DOI 10.1016/j.jacc.2006.12.028; Nakano T, 2013, KIDNEY INT, V84, P373, DOI 10.1038/ki.2013.111; Yokoyama H, 2007, DIABETES CARE, V30, P989, DOI 10.2337/dc06-1859; Mykkanen L, 1998, DIABETES, V47, P793, DOI 10.2337/diabetes.47.5.793; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Minakata K, 2014, CIRC J, V78, P2225, DOI 10.1253/circj.CJ-14-0328; Schiele F, 2009, AM HEART J, V157, P327, DOI 10.1016/j.ahj.2008.09.018; Rigatto C, 2009, CLIN J AM SOC NEPHRO, V4, P291, DOI 10.2215/CJN.01840408; Park SK, 2014, CIRC J, V78, P656, DOI 10.1253/circj.CJ-13-0745; White SL, 2011, AM J KIDNEY DIS, V58, P19, DOI 10.1053/j.ajkd.2010.12.026; Kawasaki M, 2002, CIRCULATION, V105, P2487, DOI 10.1061/01.CIR.0000017200.47342.10; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Lee M, 2010, STROKE, V41, P2625, DOI 10.1161/STROKEAHA.110.581215; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Shroff GR, 2012, AM HEART J, V163, P399, DOI 10.1016/j.ahj.2011.12.002; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Ishii M, 2015, CIRC J, V79, P1115, DOI 10.1253/circj.CJ-14-0789; Amano T, 2008, JACC-CARDIOVASC IMAG, V1, P39, DOI 10.1016/j.jcmg.2007.09.003; Uchida D, 2015, CLIN EXP NEPHROL, V19, P474, DOI 10.1007/s10157-014-1019-5; Redon J, 2002, HYPERTENSION, V39, P794, DOI 10.1161/hy0302.105209; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Baber U, 2012, J AM COLL CARDIOL, V5, P53; Matsushita K, 2015, J AM SOC NEPHROL, V26, P439, DOI 10.1681/ASN.2014020173; Puri R, 2015, J AM COLL CARDIOL, V65, P1273, DOI 10.1016/j.jacc.2015.01.036; Turaj W, 2001, Med Sci Monit, V7, P989	40	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2263	2270		10.1253/circj.CJ-15-0460		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900030		
J	Ishikawa, N; Watanabe, G; Tarui, T; Kiuchi, R; Ohtake, H; Tomita, S; Kawachi, K				Ishikawa, Norihiko; Watanabe, Go; Tarui, Tatsuya; Kiuchi, Ryuta; Ohtake, Hiroshi; Tomita, Shigeyuki; Kawachi, Kenji			Two-Port Robotic Cardiac Surgery (TROCS) for Atrial Septal Defect (ASD) Using Cross-Arm Technique - TROCS ASD Repair	CIRCULATION JOURNAL			English	Article						Atrial septal defect; Congenital heart disease; Surgery; Ventricular fibrillation	TRANSCATHETER CLOSURE	Background: We successfully performed totally endoscopic atrial septal defect (ASD) repair via 2 ports, and we named this procedure two-port robotic cardiac surgery (TROCS). Methods and Results: A 51-year-old woman with secundum ASD underwent robot-assisted ASD repair under ventricle fibrillation without aortic cross-clamping. Two ports were placed in the right side of the chest, and 1 port was for the robotic endoscope. Two robotic instruments were inserted through another port and crossed while preventing them from colliding. Conclusions: TROCS ASD repair using a cross-arm technique was achieved safely with good clinical results and excellent cosmetic results.	[Ishikawa, Norihiko; Watanabe, Go; Tarui, Tatsuya; Kiuchi, Ryuta; Ohtake, Hiroshi; Tomita, Shigeyuki; Kawachi, Kenji] NewHeart Watanabe Inst, Tokyo 1680065, Japan	Ishikawa, N (reprint author), NewHeart Watanabe Inst, Suginami Ku, 3-19-11 Hamadayama, Tokyo 1680065, Japan.	iskwnrhk@gmail.com					Ishikawa N, 2014, CIRC J, V78, P399, DOI 10.1253/circj.CJ-13-1115; Torracca L, 2001, ANN THORAC SURG, V72, P1354, DOI 10.1016/S0003-4975(01)02990-3; Black MD, 1998, ANN THORAC SURG, V65, P765, DOI 10.1016/S0003-4975(97)01241-1; Bohm J, 1997, EUR J CARDIO-THORAC, V12, P869, DOI 10.1016/S1010-7940(97)00270-4; Ewert P, 2000, CIRCULATION, V101, P847; Hekmat K, 1997, ANN THORAC SURG, V63, P1456, DOI 10.1016/S0003-4975(97)00096-9; Komar M, 2014, CIRC J, V78, P2415, DOI 10.1253/circj.CJ-14-0456	7	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2271	2273		10.1253/circj.CJ-15-0678		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900031		
J	Suzuki, S; Otsuka, T; Sagara, K; Semba, H; Kano, H; Matsuno, S; Takai, H; Kato, Y; Uejima, T; Oikawa, Y; Nagashima, K; Kirigaya, H; Kunihara, T; Yajima, J; Sawada, H; Aizawa, T; Yamashita, T				Suzuki, Shinya; Otsuka, Takayuki; Sagara, Koichi; Semba, Hiroaki; Kano, Hiroto; Matsuno, Shunsuke; Takai, Hideaki; Kato, Yuko; Uejima, Tokuhisa; Oikawa, Yuji; Nagashima, Kazuyuki; Kirigaya, Hajime; Kunihara, Takashi; Yajima, Junji; Sawada, Hitoshi; Aizawa, Tadanori; Yamashita, Takeshi			ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients	CIRCULATION JOURNAL			English	Article						Anticoagulation; Atrial fibrillation; Dabigatran	VON-WILLEBRAND-FACTOR; RISK	Background: The association between ABO blood type and the activated partial thromboplastin time (aPTT) under dabigatran therapy in nonvalvular atrial fibrillation (NVAF) patients is unclear. Methods and Results: Between 2011 March and 2015 May, data on ABO blood type and aPTT under dabigatran were obtained for 396 NVAF patients (baseline aPTT, 166). The prevalence of blood type O tended to increase or significantly increase according to baseline aPTT, aPTT under dabigatran, and their difference (Delta aPTT) (P=0.054, 0.001, and 0.012, respectively). Conclusions: In these NVAF patients, a high aPTT value under dabigatran therapy was associated with blood type O.	[Suzuki, Shinya; Otsuka, Takayuki; Sagara, Koichi; Semba, Hiroaki; Kano, Hiroto; Matsuno, Shunsuke; Kato, Yuko; Uejima, Tokuhisa; Oikawa, Yuji; Nagashima, Kazuyuki; Kirigaya, Hajime; Yajima, Junji; Sawada, Hitoshi; Aizawa, Tadanori; Yamashita, Takeshi] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo 1060031, Japan; [Takai, Hideaki; Kunihara, Takashi] Cardiovasc Inst, Dept Cardiovasc Surg, Tokyo 1060031, Japan	Suzuki, S (reprint author), Cardiovasc Inst, Dept Cardiol, Minato Ku, 3-2-19 Nishiazabu, Tokyo 1060031, Japan.	sinsuz-tky@umin.ac.jp			Boehringer Ingelheim; Daiichi-Sankyo	S.S. received remuneration from Boehringer Ingelheim. T.Y. received research funding from Boehringer Ingelheim and Daiichi-Sankyo, and remuneration from Boehringer Ingelheim, Daiichi-Sankyo, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Eisai and Ono Pharmaceutical.	Casari C, 2013, J THROMB HAEMOST, V11, P202, DOI 10.1111/jth.12226; Zakai NA, 2014, J THROMB HAEMOST, V12, P564, DOI 10.1111/jth.12507; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Ohira T, 2007, J THROMB HAEMOST, V5, P1455, DOI 10.1111/j.1538-7836.2007.02579.x; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Suzuki S, 2012, CIRC J, V76, P755, DOI 10.1253/circj.CJ-11-1335; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720	7	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2274	2277		10.1253/circj.CJ-15-0386		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900032		
J	Ishihara, T; Fujita, M; Iida, O; Tsujimura, T; Uematsu, M				Ishihara, Takayuki; Fujita, Masashi; Iida, Osamu; Tsujimura, Takuya; Uematsu, Masaaki			Rupture of Calcified Nodule 105 Months After Sirolimus-Eluting Stent Implantation Observed on Coronary Angioscopy and Optical Frequency Domain Imaging In Vivo	CIRCULATION JOURNAL			English	Editorial Material									[Ishihara, Takayuki; Fujita, Masashi; Iida, Osamu; Tsujimura, Takuya; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo 6608511, Japan	Ishihara, T (reprint author), Kansai Rosai Hosp, Ctr Cardiovasc, 3-1-69 Inabaso, Amagasaki, Hyogo 6608511, Japan.	t.ishihara31@gmail.com					Burke AP, 2001, CIRCULATION, V103, P934; LIBBY P, 1995, CIRCULATION, V91, P2844; DENHEIJER P, 1994, EUR HEART J, V15, P815; New SEP, 2011, CIRC J, V75, P1305, DOI 10.1253/circj.CJ-11-0395; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066; Hao H, 2014, JACC-CARDIOVASC INTE, V7, P937, DOI 10.1016/j.jcin.2013.12.212; Akazawa Y, 2014, CIRC J, V78, P1428, DOI 10.1253/circj.CJ-14-0085; Ichikawa M, 2014, CIRC J, V79, P85	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2278	2279		10.1253/circj.CJ-15-0228		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900033		
J	Iwakami, N; Noguchi, T; Ikeda, Y; Tateishi, E; Morita, Y; Kanzaki, H; Takewa, M; Anzai, T; Ogawa, H; Yasuda, S				Iwakami, Naotsugu; Noguchi, Teruo; Ikeda, Yoshihiko; Tateishi, Emi; Morita, Yoshiaki; Kanzaki, Hideaki; Takewa, Mitsuhiko; Anzai, Toshihisa; Ogawa, Hisao; Yasuda, Satoshi			Isolated Septal Branch Myocardial Infarction Due to Coronary Spasm Mimicking Non-Ischemic Late Gadolinium Enhancement Pattern on Cardiac Magnetic Resonance Imaging	CIRCULATION JOURNAL			English	Editorial Material							HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; SARCOIDOSIS; ABLATION; THERAPY; OPTIONS; ARTERY		[Iwakami, Naotsugu; Noguchi, Teruo; Tateishi, Emi; Kanzaki, Hideaki; Anzai, Toshihisa; Ogawa, Hisao; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Tateishi, Emi; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan; [Tateishi, Emi; Yasuda, Satoshi] Kumamoto Univ, Dept Adv Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Takewa, Mitsuhiko] Amagasaki Cent Hosp, Div Cardiol, Amagasaki, Hyogo, Japan	Noguchi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tnoguchi@hsp.ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967			Song JK, 2014, CIRC J, V78, P1808, DOI 10.1253/circj.CJ-14-0524; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Yoshida A, 2013, EUR J HEART FAIL, V15, P166, DOI 10.1093/eurjhf/hfs206; Kono AK, 2011, J MAGN RESON IMAGING, V34, P50, DOI 10.1002/jmri.22602; Hen Y, 2014, CIRC J, V78, P929, DOI 10.1253/circj.CJ-13-0979; Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378; Sharma S, 2009, CURR OPIN PULM MED, V15, P507, DOI 10.1097/MCP.0b013e32832ea4c7; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; van Dockum WG, 2004, J AM COLL CARDIOL, V43, P27, DOI 10.1016/j.jacc.2003.08.031; Soriano CJ, 2005, J AM COLL CARDIOL, V45, P743, DOI 10.1016/j.jacc.2004.11.037; TOPAZ O, 1992, AM HEART J, V124, P810, DOI 10.1016/0002-8703(92)90304-E; Ise T, 2014, HEART, V100, P1165, DOI 10.1136/heartjnl-2013-305187; Singh M, 2001, MAYO CLIN PROC, V76, P799; McCrohon J. A., 2003, Circulation, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; KINCH JW, 1994, NEW ENGL J MED, V330, P1211, DOI 10.1056/NEJM199404283301707	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	OCT	2015	79	10					2280	+		10.1253/circj.CJ-15-0036		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS1HR	WOS:000361814900034		
J	Tanaka, K; Saisho, Y; Manesso, E; Tanaka, M; Meguro, S; Irie, J; Sugiura, H; Kawai, T; Jinzaki, M; Cobelli, C; Itoh, H				Tanaka, Kumiko; Saisho, Yoshifumi; Manesso, Erica; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Sugiura, Hiroaki; Kawai, Toshihide; Jinzaki, Masahiro; Cobelli, Claudio; Itoh, Hiroshi		KIND-LM Study Investigators	Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial	CLINICAL DRUG INVESTIGATION			English	Article							INCRETIN-BASED DRUGS; INSULIN SENSITIVITY; RISK; THERAPY; METAANALYSIS; GLUCOSE; EFFICACY; HUMANS; SAFETY; OBESITY	Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming one of the major therapeutic options for the treatment of type 2 diabetes mellitus (T2DM). This study was conducted as an exploratory analysis to clarify the effects of liraglutide, a GLP-1RA, on beta cell function, fat distribution and pancreas volume compared with metformin in Japanese overweight/obese patients with T2DM. A subpopulation of the Keio study for Initial treatment of type 2 Diabetes with Liraglutide versus Metformin (KIND-LM) study participants (n = 20, 10 in oral metformin group and 10 in subcutaneous liraglutide group) who were enrolled at Keio University Hospital and underwent frequently sampled mixed meal tolerance test (MTT) and abdominal computed tomography (CT) at weeks 0 and 24 were included in this analysis. The patients were treated with either metformin or liraglutide throughout the 24-week study period. Changes in glycemic parameters such as glycated hemoglobulin (HbA1c), glycated albumin and 1,5-anhydroglucitol at week 24 were comparable between the groups. An oral minimal model based on MTT revealed that static-phase beta cell responsiveness (I broken vertical bar (s)) and static-phase disposition index were significantly increased at week 24 in the liraglutide group but not in the metformin group. There was no significant change in fat distribution as well as body weight at week 24 in either group. Serum amylase and lipase levels modestly but significantly increased in the liraglutide group during the study; however, there was no incidence of pancreatitis and pancreas volume was not changed in the liraglutide group. Liraglutide monotherapy for 24 weeks improved beta cell responsiveness with no change in either body weight or fat distribution. Further investigation is needed to clarify the mechanism by which liraglutide increases serum pancreatic enzymes.	[Tanaka, Kumiko; Saisho, Yoshifumi; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Kawai, Toshihide; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Manesso, Erica] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Manesso, Erica] Swiss Inst Bioinformat, Lausanne, Switzerland; [Sugiura, Hiroaki; Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Radiol, Tokyo 1608582, Japan; [Cobelli, Claudio] Univ Padua, Dept Informat Engn, Padua, Italy	Saisho, Y (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	momo2012kumi0124ko@gmail.com; ysaisho@keio.jp; erica.manesso@chem.ethz.ch; tana176k@sepia.ocn.ne.jp; shumeg1580083@yahoo.co.jp; j-irie@z8.keio.jp; hsugiura@a6.keio.jp; tkawai@keio.jp; jinzaki@rad.med.keio.ac.jp; cobelli@dei.unipd.it; hiito@z8.keio.jp			Keio University	This study was sponsored by Keio University and was supported by Keio University's general research funds. Keio University received unrestricted donations from Novo Nordisk Pharma Limited and from other pharmaceutical manufacturers. A portion of these combined donations contributed to covering the university's research-related expenses. The authors take full responsibility for the protocol design, study conduct and content of this manuscript.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Bonner-Weir S, 2014, DIABETES OBES METAB, V16, P661, DOI 10.1111/dom.12257; Parks M, 2010, NEW ENGL J MED, V362, P774, DOI 10.1056/NEJMp1001578; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Kodani N, 2013, CLIN DRUG INVEST, V33, P563, DOI 10.1007/s40261-013-0098-5; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120; Meier JJ, 2014, DIABETOLOGIA, V57, P1320, DOI 10.1007/s00125-014-3231-y; Tanaka K, 2015, ENDOCR J, V62, P399, DOI 10.1507/endocrj.EJ14-0602; Cobelli C, 2014, DIABETES, V63, P1203, DOI 10.2337/db13-1198; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Barreto SG, 2010, AM J PHYSIOL-GASTR L, V299, pG10, DOI 10.1152/ajpgi.00077.2010; Seino Y, 2008, DIABETES RES CLIN PR, V81, P161, DOI 10.1016/j.diabres.2008.03.018; Sarwar N, 2010, LANCET, V375, P2215; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Mathieu C, 2014, DIABETES OBES METAB, V16, P636, DOI 10.1111/dom.12262; Chang AM, 2003, DIABETES, V52, P1786, DOI 10.2337/diabetes.52.7.1786; Bi Y, 2013, DIABETES-METAB RES, V29, P664, DOI 10.1002/dmrr.2443; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Kahn SE, 2013, DIABETES, V62, P2178, DOI 10.2337/db13-0520; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; Faillie JL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2780; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Kim YG, 2014, DIABETES OBES METAB, V16, P900, DOI 10.1111/dom.12293; Koehler JA, 2015, DIABETES, V64, P1046; Kou Kinsei, 2014, JOP, V15, P626, DOI 10.6092/1590-8577/2858; Lando HM, 2012, ENDOCR PRACT, V18, P1; Li L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2366; Dalla Man C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1115, DOI 10.1152/ajpendo.00705.2009; Peeters PJHL, 2015, DIABETES CARE, V38, P495, DOI 10.2337/dc14-1175; Saisho Y., 2011, DIABETOL INT, V2, P146; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501	35	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	OCT	2015	35	10					675	684		10.1007/s40261-015-0331-5		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS0PH	WOS:000361763600009		
J	Morita, Y; Hata, K; Nakanishi, M; Omata, T; Morita, N; Yura, Y; Nishimura, R; Yoneda, T				Morita, Yoshihiro; Hata, Kenji; Nakanishi, Masako; Omata, Tetsuji; Morita, Nobuo; Yura, Yoshiaki; Nishimura, Riko; Yoneda, Toshiyuki			Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Differential metastasis array; Epithelialmesenchymal transition; E-cadherin; Focal adhesion kinase; Short hairpin RNA	EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION KINASE; GROWTH FACTOR-C; TUMOR-METASTASIS; CANCER METASTASIS; NECK-CANCER; HEAD; PROTEIN; MORPHOGENESIS; INDUCTION	Lymph node metastasis (LNM) is associated with poor survival in patients with oral squamous cell carcinoma (OSCC). Vascular endothelial growth factor-C (VEGF-C) is thought to be responsible for increased lymphangiogenesis and LNM. Understanding of the mechanism by which VEGF-C expression is regulated in OSCC is thus important to design logic therapeutic interventions. We showed that inoculation of the SAS human OSCC cells expressing the venus GFP (V-SAS cells) into the tongue in nude mice developed LNM. V-SAS cells in LNM were isolated by FACS and re-inoculated into the tongue. This procedure was repeated eight times, establishing V-SAS-LM8 cells. Differential metastasis PCR array between the parental V-SAS and V-SAS-LM8 was performed to identify a molecule responsible for lymphangiogenesis and LNM. Fibronectin 1 (FN1) expression was elevated in V-SAS-LM8 cells compared to V-SAS-cells. V-SAS-LM8 tongue tumor showed increased expression of FN1 and VEGF-C, and promoted lymphangiogenesis and LNM compared with V-SAS tumor. Further, phosphorylation of focal adhesion kinase (FAK), a main downstream signaling molecule of FN1, was up-regulated, and epithelial-mesenchymal transition (EMT) was promoted in V-SAS-LM8 cells. Silencing of FN1 by shRNA in V-SAS-LM8 cells decreased FAK phosphorylation, VEGF-C expression and inhibited lymphangiogenesis and LNM. EMT was also reversed. The FAK phosphorylation inhibitor PF573228 also decreased VEGF-C expression and reversed EMT in V-SAS-LM8 cells. Finally, we detected intense FN1 expression in some clinical specimens obtained from OSCC patients with LNM. These results demonstrate that elevated expression of cellular FN1 and following activation of FAK lead to increased VEGF-C expression, lymphangiogenesis and LNM and promoted EMT in SAS human OSCC cells and suggest that FN1-phosphorylated FAK signaling cascade is a potential therapeutic target in the treatment of LNM in OSCC.	[Morita, Yoshihiro; Hata, Kenji; Nakanishi, Masako; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka, Japan; [Morita, Yoshihiro; Yura, Yoshiaki] Osaka Univ, Grad Sch Dent, Oral & Maxillofacial Surg 2, Suita, Osaka, Japan; [Morita, Yoshihiro; Morita, Nobuo] Seichokai Hannan Municipal Hosp, Dept Oral & Maxillofacial Surg, Osaka, Japan; [Omata, Tetsuji; Morita, Nobuo] Kinan Hosp, Dept Oral & Maxillofacial Surg, Tanabe, Wakayama, Japan; [Morita, Nobuo] NS Med & Healthcare Serv Gen Incorporat Fdn, Dept Oral Maxillofacial Surg, Wakayama, Japan; [Yoneda, Toshiyuki] Indiana Univ, Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA	Yoneda, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka, Japan.	toshyone@iu.edu			Ministry of Education, Culture, Sports, Science and Technology, Japan [23659870, 26670806, 26293394]	This study was supported by Grants-in -Aid, No. 23659870 [TY], 26670806 [TY] and 26293394 [TY] by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-00510C; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Morita Y, 2014, OR SURG OR MED OR PA, V117, P502, DOI 10.1016/j.oooo.2013.12.410; Lyons AJ, 2001, BRIT J ORAL MAX SURG, V39, P471, DOI 10.1054/bjom.2001.0702; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Yoo JS, 2011, MOL IMAGING BIOL, V13, P471, DOI 10.1007/s11307-010-0366-1; Takeyama H, 2011, ANTICANCER RES, V31, P1395; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Margadant C, 2012, J BIOL CHEM, V287, P44684, DOI 10.1074/jbc.M112.426445; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Hu M, 2004, MOL CANCER RES, V2, P533; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; Jerhammar F, 2010, CANCER BIOL THER, V10, P1244, DOI 10.4161/cbt.10.12.13432; Steffens S, 2012, ONCOL LETT, V3, P787, DOI 10.3892/ol.2012.566; Qi W, 2007, AM J PATHOL, V171, P744, DOI 10.2353/ajpath.2007.060813; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Karpanen T, 2001, J EXP MED, V194, pF37, DOI 10.1084/jem.194.6.F37; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; CAILLEAU R, 1974, J NATL CANCER I, V53, P661; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Ritzenthaler JD, 2008, MOL BIOSYST, V4, P1160, DOI 10.1039/b800533h; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Yanase M, 2014, J ORAL PATHOL MED, V43, P514, DOI 10.1111/jop.12167; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Cabrita MA, 2011, MOL ONCOL, V5, P517, DOI 10.1016/j.molonc.2011.10.004; Park J, 2014, ONCOGENE, V33, P1649, DOI 10.1038/onc.2013.118; Joukov V, 1996, EMBO J, V15, P1751; Morita Y, 2012, INT J ONCOL, V41, P885, DOI 10.3892/ijo.2012.1529; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Takeshita A, 2014, INT J ONCOL, V44, P59, DOI 10.3892/ijo.2013.2172; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Gil Z, 2009, CANCER, V115, P5700, DOI 10.1002/cncr.24631; Harada M, 1993, JPN J ORAL MAXILLOFA, V39, P965; Horikoshi M, 1974, Nihon Koku Geka Gakkai Zasshi, V20, P100; Kamarajan P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-330; Sudo T, 2013, ANN SURG ONCOL, V20, pS324, DOI 10.1245/s10434-012-2418-z; Takahashi K, 1989, J JPN STOMATOL SOC, V38, P20; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo	55	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	OCT	2015	32	7					739	753		10.1007/s10585-015-9741-2		15	Oncology	Oncology	CR9ZF	WOS:000361715300009		
J	Matsubayashi, H; Matsui, T; Ono, H				Matsubayashi, Hiroyuki; Matsui, Toru; Ono, Hiroyuki			Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Matsubayashi, Hiroyuki; Matsui, Toru; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka, Japan	Matsubayashi, H (reprint author), Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka, Japan.						Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Kubota K, 2014, J HEPATO-BIL-PAN SCI, V21, P902, DOI 10.1002/jhbp.160	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	OCT	2015	13	10					E151	E152		10.1016/j.cgh.2015.03.020		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CR8AW	WOS:000361574500003		
J	Kato, K; Yokochi, F; Taniguchi, M; Okiyama, R; Kawasaki, T; Kimura, K; Ushiba, J				Kato, Kenji; Yokochi, Fusako; Taniguchi, Makoto; Okiyama, Ryoichi; Kawasaki, Takashi; Kimura, Katsuo; Ushiba, Junichi			Bilateral coherence between motor cortices and subthalamic nuclei in patients with Parkinson's disease	CLINICAL NEUROPHYSIOLOGY			English	Article						Coherence; Deep brain stimulation; Motor cortex; Neuronal oscillations; Parkinson's disease; Subthalamic nucleus	DEEP BRAIN-STIMULATION; STRIATAL MICROEXCITABLE ZONES; HUMAN BASAL GANGLIA; PEDUNCULOPONTINE NUCLEUS; OSCILLATORY ACTIVITY; PATHOLOGICAL SYNCHRONIZATION; TEGMENTI PEDUNCULOPONTINUS; PRIMATE NEOSTRIATUM; CEREBRAL-CORTEX; GAIT DISORDERS	Objective: It has been suggested that abnormal synchronization and oscillation of neuronal activity in the subthalamic nucleus (STN) is associated with sensorimotor dysfunction in Parkinson's disease (PD). We investigated the bilateral subcortico-cortical functional coupling in PD patients. Methods: We simultaneously recorded local field potentials from the bilateral STN using electrodes inserted for deep brain stimulation and electroencephalograms from the bilateral motor cortices (MCx) in 11 patients at rest, and analyzed their coherences and causalities. Results: Significant coherence in the sub-beta and beta frequency bands was simultaneously observed between the STN and contralateral STN (STN-cSTN), the STN and ipsilateral MCx (STN-iMCx), and the STN and contralateral MCx (STN-cMCx). In each patient, the frequency of the peak STN-cSTN coherence was similar to that of the peak STN-iMCx and STN-cMCx coherence. The causality between the STN and MCx was strongest in the one-way direction from the MCx to the ipsilateral STN. Conclusions: Abnormal oscillations in the STN in the sub-beta and beta bands were functionally coupled among bilateral STN and MCx at the eigen-frequency in individual patients with PD. Significance: Synchronized activity through cortico-subcortical transmission may have an important role in the pathophysiology of PD. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd.	[Kato, Kenji; Yokochi, Fusako; Okiyama, Ryoichi; Kimura, Katsuo] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan; [Taniguchi, Makoto; Kawasaki, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan; [Kato, Kenji; Ushiba, Junichi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Tokyo, Kanagawa 108, Japan	Yokochi, F (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	fyokochi-tmnh@umin.net					Ray NJ, 2008, EXP NEUROL, V213, P108, DOI 10.1016/j.expneurol.2008.05.008; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417; Slowinski JL, 2007, J NEUROSURG, V106, P626, DOI 10.3171/jns.2007.106.4.626; JACKSON A, 1983, NEUROSCIENCE, V10, P725, DOI 10.1016/0306-4522(83)90213-0; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P244, DOI 10.1007/BF00238154; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Kilner JM, 2000, J NEUROSCI, V20, P8838; Hirschmann J, 2011, NEUROIMAGE, V55, P1159, DOI 10.1016/j.neuroimage.2010.11.063; Liu X, 2002, CLIN NEUROPHYSIOL, V113, P1667, DOI 10.1016/S1388-2457(02)00256-0; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/aw1346; Grabli D, 2013, J NEUROSCI, V33, P11986, DOI 10.1523/JNEUROSCI.1568-13.2013; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; Reck C, 2009, CLIN NEUROPHYSIOL, V120, P1601, DOI 10.1016/j.clinph.2009.05.018; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Chen CC, 2010, EXP NEUROL, V224, P234, DOI 10.1016/j.expneurol.2010.03.015; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P233, DOI 10.1007/BF00238153; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1401; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Nambu A, 1996, J NEUROSCI, V16, P2671; Marsden JF, 2001, BRAIN, V124, P378, DOI 10.1093/brain/124.2.378; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Tabbal SD, 2008, EXP NEUROL, V211, P234, DOI 10.1016/j.expneurol.2008.01.024; Ushiyama J, 2011, J NEUROPHYSIOL, V106, P1379, DOI 10.1152/jn.00193.2011; Cassidy M, 2003, J NEUROSCI METH, V127, P95, DOI 10.1016/S0165-0270(03)00129-8; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; HAMMOND C, 1983, NEUROSCIENCE, V9, P41, DOI 10.1016/0306-4522(83)90045-3; LAVOIE B, 1994, J COMP NEUROL, V344, P210, DOI 10.1002/cne.903440204; Hirschmann J, 2013, NEUROIMAGE, V68, P203, DOI 10.1016/j.neuroimage.2012.11.036; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Kuhn AA, 2005, EXP NEUROL, V194, P212, DOI 10.1016/j.expneurol.2005.02.010; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Takada M, 1998, BRAIN RES, V791, P335, DOI 10.1016/S0006-8993(98)00198-X; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Granger C.W.J., 1969, ECONOMETRICA, V37, P424, DOI DOI 10.2307/1912791	52	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2015	126	10					1941	1950		10.1016/j.clinph.2014.12.007		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS0HR	WOS:000361739500012		
J	Sakurada, T; Kawase, T; Komatsu, T; Kansaku, K				Sakurada, Takeshi; Kawase, Toshihiro; Komatsu, Tomoaki; Kansaku, Kenji			Use of high-frequency visual stimuli above the critical flicker frequency in a SSVEP-based BMI	CLINICAL NEUROPHYSIOLOGY			English	Article						BMI; BCI; SSVEP; Critical flicker frequency; Visual fatigue	BRAIN-COMPUTER INTERFACE; TIME-DEPENDENT STIMULI; STEADY-STATE; EVOKED-POTENTIALS; ROBOTIC WHEELCHAIR; HAND ORTHOSIS; RESPONSES; FATIGUE; BCI; LUMINANCE	Objective: This study presents a new steady-state visual evoked potential (SSVEP)-based brain-machine interface (BMI) using flickering visual stimuli at frequencies greater than the critical flicker frequency (CFF). Methods: We first asked participants to fixate on a green/blue flicker (30-70 Hz), and SSVEP amplitude was evaluated. Participants were asked to indicate whether the stimulus was visibly flickering and to report their subjective level of discomfort. We then assessed visibly (41, 43, and 45 Hz) vs. invisibly (61, 63, and 65 Hz) flickering stimulus in an SSVEP-based BMI. Visual fatigue was assessed via the flicker test before and after operation of the BMI. Results: Higher frequency stimuli reduced participants' subjective discomfort. Participants successfully controlled the SSVEP-based BMI using both the visibly and invisibly flickering stimuli (93.1% and 88.0%, respectively); the flicker test revealed a decrease in CFF (i.e., visual fatigue) under the visible condition only (-5.7%, P < 0.001). Conclusions: The use of high-frequency visual stimuli above the CFF led to high classification accuracy and decreased visual fatigue in an SSVEP-based BMI. Significance: High-frequency flicker stimuli above the CFF were able to induce SSVEPs and may prove useful in the development of BMI-based assistive products. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sakurada, Takeshi; Kawase, Toshihiro; Komatsu, Tomoaki; Kansaku, Kenji] Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama 3598555, Japan; [Kansaku, Kenji] Univ Electrocommun, Brain Sci Inspired Life Support Res Ctr, Chofu, Tokyo 1828585, Japan	Kansaku, K (reprint author), Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Syst Neurosci Sect, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	kansaku-kenji@rehab.go.jp			MHLW (BMI); MEXT [23300151]; MEXT/SRPBS (BMI) of Japan	This study was supported in part by grants from MHLW (BMI), MEXT (#23300151), and MEXT/SRPBS (BMI) of Japan. We thank H. Ora for his help and Y. Nakajima for his encouragement. Conflict of interest: The authors declare no conflicts of interest.	Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Muller MM, 2000, CLIN NEUROPHYSIOL, V111, P1544, DOI 10.1016/S1388-2457(00)00371-0; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; Harding GFA, 1999, EPILEPSIA, V40, P65, DOI 10.1111/j.1528-1157.1999.tb00909.x; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Wilson JJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025026; Murata K, 1996, IND HEALTH, V34, P61, DOI 10.2486/indhealth.34.61; Fisher RS, 2005, EPILEPSIA, V46, P1426, DOI 10.1111/j.1528-1167.2005.31405.x; Emoto M, 2005, J DISP TECHNOL, V1, P328, DOI 10.1109/JDT.2005.858938; Ishida S, 1998, EPILEPSIA, V39, P1340, DOI 10.1111/j.1528-1157.1998.tb01334.x; Parra J, 2007, BRAIN, V130, P1679, DOI 10.1093/brain/awm103; Peng XM, 2005, J NEUROPHYSIOL, V93, P1620, DOI 10.1152/jn.00793.2004; Saito K, 1999, IND HEALTH, V37, P134, DOI 10.2486/indhealth.37.134; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Bakardjian H, 2010, NEUROSCI LETT, V469, P34, DOI 10.1016/j.neulet.2009.11.039; Maeda E, 2011, JPN J RADIOL, V29, P483, DOI 10.1007/s11604-011-0585-7; Pastor MA, 2003, J NEUROSCI, V23, P11621; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Muller SMT, 2010, J MED BIOL ENG, V30, P407, DOI 10.5405/jmbe.765; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Molina GG, 2010, BIOMED TECH, V55, P173, DOI 10.1515/BMT.2010.013; REGAN D, 1977, J OPT SOC AM, V67, P1475, DOI 10.1364/JOSA.67.001475; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Portin K, 1998, CEREB CORTEX, V8, P253, DOI 10.1093/cercor/8.3.253; Takano K, 2009, NEUROSCI RES, V65, pS182, DOI 10.1016/j.neures.2009.09.971; Diez PF, 2013, MED ENG PHYS, V35, P1155, DOI 10.1016/j.medengphy.2012.12.005; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; MURATA K, 1991, INT ARCH OCC ENV HEA, V63, P109, DOI 10.1007/BF00379073; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Diez PF, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-39; Gamlin P D, 1995, Exp Brain Res, V106, P169; Guger C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00169; Sakurada T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00172; KELLY DH, 1961, J OPT SOC AM, V51, P747, DOI 10.1364/JOSA.51.000747; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; Regan D., 1989, HUMAN BRAIN ELECTROP; Zhu D, 2010, COMPUT INTELL NEUROS	44	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2015	126	10					1972	1978		10.1016/j.clinph.2014.12.010		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS0HR	WOS:000361739500015		
J	Mitsuma, S; Misawa, S; Shibuya, K; Isose, S; Sekiguchi, Y; Iwai, Y; Beppu, M; Watanabe, K; Amino, H; Kuwabara, S				Mitsuma, Satsuki; Misawa, Sonoko; Shibuya, Kazumoto; Isose, Sagiri; Sekiguchi, Yukari; Iwai, Yuta; Beppu, Minako; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi			Altered axonal excitability properties and nerve edema in POEMS syndrome	CLINICAL NEUROPHYSIOLOGY			English	Article						POEMS syndrome; Axonal excitability; Nerve ultrasound; Ion channel	INFLAMMATORY DEMYELINATING POLYNEUROPATHY; NEUROPATHY; ULTRASOUND; PROFILES; DISEASES	Objective: POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome is a rare cause of demyelinating neuropathy with upregulation of vascular endothelial growth factor (VEGF). This study aimed to elucidate axonal excitability properties and their relation to VEGF levels and nerve edema in POEMS neuropathy. Methods: Axonal excitability measurement and nerve ultrasound were performed in the median nerve of 33 patients with POEMS syndrome. Serum VEGF levels were measured by ELISA. Results: Compared with normal subjects (n = 87), POEMS patients showed longer strength-duration time constant, fanning-out of threshold electrotonus curves, and greater threshold changes in a hyperpolarizing current-threshold relationship. Nerve ultrasound showed significant enlargement in POEMS patients. Serum VEGF levels and the extent of nerve edema partly correlated with nerve conduction slowing, as well as persistent sodium currents and inward rectification. Conclusions: In POEMS syndrome, patterns of changes in excitability properties could suggest increased persistent sodium currents, and impaired potassium and inward rectifying channels. The findings were not consistent with depolarization due to nerve edema and compression ischemia. Significance: In addition to demyelination, nerve edema induced by upregulated VEGF, and upregulated inflammatory cytokines could modulate profiles of POEMS neuropathy. (C) 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Mitsuma, Satsuki; Misawa, Sonoko; Shibuya, Kazumoto; Isose, Sagiri; Sekiguchi, Yukari; Iwai, Yuta; Beppu, Minako; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan	Kuwabara, S (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kuwabara-s@faculty.chiba-u.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported in part by a grant for research on intractable diseases from the Ministry of Health, Labour and Welfare of Japan (S.K.).	Nodera H, 2006, CLIN NEUROPHYSIOL, V117, P1902, DOI 10.1016/j.clinph.2006.01.018; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Nasu S, 2014, CLIN NEUROPHYSIOL, V125, P381, DOI 10.1016/j.clinph.2013.07.014; Padua L, 2012, EUR J NEUROL, V19, P47, DOI 10.1111/j.1468-1331.2011.03421.x; Sawai S, 2008, CLIN NEUROPHYSIOL, V119, P1097, DOI 10.1016/j.clinph.2008.01.022; Kerasnoudis A, 2014, CLIN NEUROPHYSIOL, V125, P635, DOI 10.1016/j.clinph.2013.08.014; Kanda T, 2013, J NEUROL NEUROSUR PS, V84, P208, DOI 10.1136/jnnp-2012-302312; BARDWICK PA, 1980, MEDICINE, V59, P311; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Cappelen-Smith C, 2000, ANN NEUROL, V48, P826, DOI 10.1002/1531-8249(200012)48:6<826::AID-ANA2>3.0.CO;2-P; Kanai K, 2012, NEUROLOGY, V79, P575, DOI 10.1212/WNL.0b013e318263c42b; Watanabe O, 1996, LANCET, V347, P702, DOI 10.1016/S0140-6736(96)91261-1; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Sung JY, 2004, MUSCLE NERVE, V29, P28, DOI 10.1002/mus.10516; Kuwabara S, 2008, NEUROLOGY, V71, P1691, DOI 10.1212/01.wnl.0000323811.42080.a4; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Koike H, 2008, J NEUROL NEUROSUR PS, V79, P1171, DOI 10.1136/jnnp.2007.135681; Nasu S, 2012, J NEUROL NEUROSUR PS, V83, P476, DOI 10.1136/jnnp-2011-301706; Dispenzieri Angela, 2014, Am J Hematol, V89, P214, DOI 10.1002/ajh.23644; Kuwabara S, 2008, COCHRANE DB SYST REV, V4	20	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2015	126	10					2014	2018		10.1016/j.clinph.2015.01.018		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS0HR	WOS:000361739500020		
J	Osaki, Y; Nodera, H; Banzrai, C; Endo, S; Takayasu, H; Mori, A; Shimatani, Y; Kaji, R				Osaki, Yusuke; Nodera, Hiroyuki; Banzrai, Chimeglkham; Endo, Sachiko; Takayasu, Hirokazu; Mori, Atsuko; Shimatani, Yoshimitsu; Kaji, Ryuji			Effects of anesthetic agents on in vivo axonal HCN current in normal mice	CLINICAL NEUROPHYSIOLOGY			English	Article						Axonal excitability; Anesthetics; HCN channel	VOLATILE ANESTHETICS; NERVE EXCITABILITY; ION CHANNELS; ISOFLURANE; HUMANS; TARGETS; MOTOR; PHARMACOKINETICS; MEDETOMIDINE; BUTORPHANOL	Objective: The objective was to study the in vivo effects of anesthetic agents on peripheral nerve excitability. Methods: Normal male mice were anesthetized by either isoflurane inhalation or a combination of mede-tomidine, midazolam, and butorphanol intraperitoneal injection ("triple agents"). Immediately after induction, the tail sensory nerve action potential was recorded and its excitability was monitored. Results: Under both anesthetic protocols, there was an interval excitability change by long hyperpolarizing currents. There was greater threshold reduction approximately 30 min post induction, in comparison to immediately post induction. Other excitability parameters were stable over time. Modeling suggested interval suppression of internodal H conductance or leak current. Conclusions: Anesthetic agents affected responses to long hyperpolarizing currents. Significance: Axonal excitability during intraoperative monitoring may be affected by anesthetic agents. Interpretation of interval excitability changes under anesthesia requires caution, especially with long hyperpolarizing currents. (C) 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Osaki, Yusuke; Nodera, Hiroyuki; Banzrai, Chimeglkham; Endo, Sachiko; Takayasu, Hirokazu; Mori, Atsuko; Shimatani, Yoshimitsu; Kaji, Ryuji] Univ Tokushima, Dept Neurol, Tokushima 770, Japan	Nodera, H (reprint author), Dept Neurol, 3-18-15 Kuramotocho, Tokushima 7708503, Japan.	hnodera@tokushima-u.ac.jp		Nodera, Hiroyuki/0000-0002-5357-5081	Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan	This work was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan.	Nodera H, 2006, CLIN NEUROPHYSIOL, V117, P1902, DOI 10.1016/j.clinph.2006.01.018; LOCKHART SH, 1991, ANESTHESIOLOGY, V74, P575, DOI 10.1097/00000542-199103000-00028; Moldovan M, 2014, J PHYSIOL-LONDON, V592, P2735, DOI 10.1113/jphysiol.2014.270827; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Koncz I, 2011, CURR MED CHEM, V18, P3662; Barth AMI, 2008, J NEUROPHYSIOL, V99, P394, DOI 10.1152/jn.00943.2007; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Moldovan M, 2013, EUR J PHARMACOL, V708, P105, DOI 10.1016/j.ejphar.2013.03.001; Kastner SBR, 2003, J VET PHARMACOL THER, V26, P271, DOI 10.1046/j.1365-2885.2003.00492.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422; Reid CA, 2012, BRIT J PHARMACOL, V165, P49, DOI 10.1111/j.1476-5381.2011.01507.x; Tomlinson SE, 2010, MUSCLE NERVE, V41, P247, DOI 10.1002/mus.21482; Farrar MA, 2013, J PHYSIOL-LONDON, V591, P273, DOI 10.1113/jphysiol.2012.240820; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; BERTHOUD MC, 1992, DRUG SAFETY, V7, P434, DOI 10.2165/00002018-199207060-00005; Fanchaouy M, 2013, CELL CALCIUM, V54, P257, DOI 10.1016/j.ceca.2013.07.001; Maurer K, 2010, BRIT J ANAESTH, V105, P648, DOI 10.1093/bja/aeq218; Kirihara Y, 2013, EXP ANIM TOKYO, V62, P173, DOI 10.1538/expanim.62.173; Freo U, 2008, ANESTH ANALG, V106, P1516, DOI [10.1213/ane.0b013e31816a64a8, 10.1213/ane.001361816a648]; YASUDA N, 1991, ANESTHESIOLOGY, V74, P489, DOI 10.1097/00000542-199103000-00017; Mowrey DD, 2013, J BIOL CHEM, V288, P35793, DOI 10.1074/jbc.M113.508333; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Kotani N, 2013, BRAIN RES BULL, V93, P69, DOI 10.1016/j.brainresbull.2012.08.001; Kiernan MC, 2005, ANN NEUROL, V57, P339, DOI 10.1002/ana.20395; Lin CSY, 2008, BRAIN, V131, P2510, DOI 10.1093/brain/awn152; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Nodera H, 2012, NEUROSCI LETT, V518, P111, DOI 10.1016/j.neulet.2012.04.065; Knych HK, 2013, J VET PHARMACOL THER, V36, P21, DOI 10.1111/j.1365-2885.2012.01385.x; Nowicki M, 2014, MUSCLE NERVE, V50, P257, DOI 10.1002/mus.24150; Osuchowski MF, 2009, MUSCLE NERVE, V40, P610, DOI 10.1002/mus.21284; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Kakinohana M, 2014, CURR PHARM DESIGN, V20, P5744; OuYang Wei, 2007, Anesthesiology, V107, P91, DOI 10.1097/01.anes.0000268390.28362.4a; Sun Yongxing, 2014, Brain Sci, V4, P311, DOI 10.3390/brainsci4020311	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2015	126	10					2033	2039		10.1016/j.clinph.2014.12.025		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CS0HR	WOS:000361739500023		
J	Gibbons, JA; Ouatas, T; Krauwinkel, W; Ohtsu, Y; van der Walt, JS; Beddo, V; de Vries, M; Mordenti, J				Gibbons, Jacqueline A.; Ouatas, Taoufik; Krauwinkel, Walter; Ohtsu, Yoshiaki; van der Walt, Jan-Stefan; Beddo, Vanessa; de Vries, Michiel; Mordenti, Joyce			Clinical Pharmacokinetic Studies of Enzalutamide	CLINICAL PHARMACOKINETICS			English	Article							PROSTATE-CANCER; CHEMOTHERAPY	Background and Objectives Oral enzalutamide (160 mg once daily) is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This article describes the pharmacokinetics of enzalutamide and its active metabolite N-desmethyl enzalutamide. Methods Results are reported from five clinical studies. Results In a dose-escalation study (n = 140), enzalutamide half-life was 5.8 days, steady state was achieved by day 28, accumulation was 8.3-fold, exposure was approximately dose proportional from 30-360 mg/day, and intersubject variability was <= 30%. In a mass balance study (n = 6), enzalutamide was primarily eliminated by hepatic metabolism. Renal excretion was an insignificant elimination pathway for enzalutamide and N-desmethyl enzalutamide. In a food-effect study (n = 60), food did not have a meaningful effect on area under the plasma concentration-time curve (AUC) of enzalutamide or N-desmethyl enzalutamide, and in an hepatic impairment study, AUC of the sum of enzalutamide plus N-desmethyl enzalutamide was similar in men with mild (n = 6) or moderate (n = 8) impairment (Child-Pugh Class A and B) versus men with normal hepatic function (n = 14). In a phase III trial, an exposure-response analysis of steady-state predose (trough) concentrations (C-trough) versus overall survival (n = 1103) showed that active treatment C-trough quartiles for 160 mg/day were uniformly beneficial relative to placebo, and no threshold of C-trough was associated with a statistically significant better response. Conclusions Enzalutamide has predictable pharmacokinetics, with low intersubject variability. Similar efficacy was observed in patients across the concentration/exposure range associated with a fixed oral dose of enzalutamide 160 mg/day.	[Gibbons, Jacqueline A.; Mordenti, Joyce] Medivation Inc, San Francisco, CA 94105 USA; [Ouatas, Taoufik; Krauwinkel, Walter; van der Walt, Jan-Stefan; de Vries, Michiel] Astellas Pharma Europe BV, Leiden, Netherlands; [Ohtsu, Yoshiaki] Astellas Pharma Inc, Osaka, Japan; [Beddo, Vanessa] ICON Clin Res, Durham, NC USA	Gibbons, JA (reprint author), Medivation Inc, 36th Floor,525 Market St, San Francisco, CA 94105 USA.	jackie.gibbons@medivation.com		Otsu, Yoshiaki/0000-0003-0494-5717	Medivation, Inc.; Astellas Pharma, Inc.	Jacqueline Gibbons and Joyce Mordenti are employees of Medivation, Inc, and Vanessa Beddo is an employee of ICON Clinical Research. Yoshiaki Ohtsu is an employee of Astellas Pharma, Inc. All other authors are employees of Astellas Pharma Europe B.V. The research described in this study was funded by Medivation, Inc. and Astellas Pharma, Inc., and individuals from these organizations were involved in the design and conduct of the study, collection of the data, and analysis and interpretation of the data. Copy editing assistance was provided by Shannon Davis of Infusion Communications and funded by Medivation, Inc. The authors take full responsibility for the content of the paper.	Bennett D, 2014, BIOANALYSIS, V6, P737, DOI [10.4155/bio.13.325, 10.4155/bio.13.324]; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; US Department of Health and Human Services, 2005, PHARM PAT IMP HEP FU; US Department of Health and Human Services, 2003, FOOD EFF BIOAV FED B; US Department of Health and Human Services, 2000, WAIV VIV BIOAV BIOEQ; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2001, BIOAN METH VAL	10	2	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	OCT	2015	54	10					1043	1055		10.1007/s40262-015-0271-5		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS0PM	WOS:000361764200005		
J	Gibbons, JA; de Vries, M; Krauwinkel, W; Ohtsu, Y; Noukens, J; van der Walt, JS; Mol, R; Mordenti, J; Ouatas, T				Gibbons, Jacqueline A.; de Vries, Michiel; Krauwinkel, Walter; Ohtsu, Yoshiaki; Noukens, Jan; van der Walt, Jan-Stefan; Mol, Roelof; Mordenti, Joyce; Ouatas, Taoufik			Pharmacokinetic Drug Interaction Studies with Enzalutamide	CLINICAL PHARMACOKINETICS			English	Article							XANTHINE-OXIDASE ACTIVITIES; COOPERSTOWN 5+1 COCKTAIL; PROSTATE-CANCER; HEALTHY-VOLUNTEERS; INTRAVENOUS MIDAZOLAM; ELDERLY-PATIENTS; OPEN-LABEL; 3A; ENZYMES; 1A2	Background and Objectives Two phase I drug interaction studies were performed with oral enzalutamide, which is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Methods A parallel-treatment design (n = 41) was used to evaluate the effects of a strong cytochrome P450 (CYP) 2C8 inhibitor (oral gemfibrozil 600 mg twice daily) or strong CYP3A4 inhibitor (oral itraconazole 200 mg once daily) on the pharmacokinetics of enzalutamide and its active metabolite N-desmethyl enzalutamide after a single dose of enzalutamide (160 mg). A single-sequence crossover design (n = 14) was used to determine the effects of enzalutamide 160 mg/day on the pharmacokinetics of a single oral dose of sensitive substrates for CYP2C8 (pioglitazone 30 mg), CYP2C9 (warfarin 10 mg), CYP2C19 (omeprazole 20 mg), or CYP3A4 (midazolam 2 mg). Results Coadministration of gemfibrozil increased the composite area under the plasma concentration-time curve from time zero to infinity (AUC(a)) of enzalutamide plus active metabolite by 2.2-fold, and coadministration of itraconazole increased the composite AUC(a) by 1.3-fold. Enzalutamide did not affect exposure to oral pioglitazone. Enzalutamide reduced the AUC(a) of oral S-warfarin, omeprazole, and midazolam by 56, 70, and 86 %, respectively; therefore, enzalutamide is a moderate inducer of CYP2C9 and CYP2C19 and a strong inducer of CYP3A4. Conclusions If a patient requires coadministration of a strong CYP2C8 inhibitor with enzalutamide, then the enzalutamide dose should be reduced to 80 mg/day. It is recommended to avoid concomitant use of enzalutamide with narrow therapeutic index drugs metabolized by CYP2C9, CYP2C19, or CYP3A4, as enzalutamide may decrease their exposure.	[Gibbons, Jacqueline A.; Mordenti, Joyce] Medivation Inc, San Francisco, CA 94105 USA; [de Vries, Michiel; Krauwinkel, Walter; van der Walt, Jan-Stefan; Mol, Roelof; Ouatas, Taoufik] Astellas Pharma Europe BV, Leiden, Netherlands; [Ohtsu, Yoshiaki] Astellas Pharma Inc, Osaka, Japan; [Noukens, Jan] Kinesis Pharma BV, Breda, Netherlands	Gibbons, JA (reprint author), Medivation Inc, 525 Market St,36th Floor, San Francisco, CA 94105 USA.	Jackie.Gibbons@medivation.com		Otsu, Yoshiaki/0000-0003-0494-5717	Medivation; Astellas	Jacqueline Gibbons and Joyce Mordenti are employees of Medivation. Jan Noukens is an employee of Kinesis. All other authors are employees of Astellas. The research described here was funded by Medivation and Astellas, and individuals from these organizations were involved in the design and conduct of the studies, collection of the data, and analysis and interpretation of the data. Copy editing assistance was provided by Shannon Davis of Infusion Communications and funded by Medivation. The authors take full responsibility for the content of the paper.	American Cancer Society, 2014, CANC FACTS FIG 2014; Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x; Jones DR, 2010, DRUG METAB REV, V42, P55, DOI 10.3109/03602530903209395; Bennett D, 2014, BIOANALYSIS, V6, P737, DOI [10.4155/bio.13.325, 10.4155/bio.13.324]; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; BARONE JA, 1993, ANTIMICROB AGENTS CH, V37, P778; [Anonymous], 2014, GEMFIBROZIL TABLETS; Seo KA, 2010, DRUG METAB DISPOS, V38, P2007, DOI 10.1124/dmd.110.035295; Yeh RF, 2006, JAIDS-J ACQ IMM DEF, V42, P52; Chainuvati S, 2003, CLIN PHARMACOL THER, V74, P437, DOI 10.1016/S0009-9236(03)00229-7; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Goh BC, 2010, CLIN PHARMACOL THER, V88, P652, DOI 10.1038/clpt.2010.158; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Shord SS, 2010, BRIT J CLIN PHARMACO, V69, P160, DOI 10.1111/j.1365-2125.2009.03559.x; Padhi D, 2008, DRUGS R&D, V9, P335, DOI 10.2165/00126839-200809050-00004; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Jaakkola T, 2006, BRIT J CLIN PHARMACO, V61, P70, DOI 10.1111/j.1365-2125.2005.02515.x; Husson N, 2014, J NUTR HEALTH AGING, V18, P87, DOI 10.1007/s12603-013-0337-8; Ma JD, 2006, ANTIMICROB AGENTS CH, V50, P1130, DOI 10.1128/AAC.50.4.1130-1135.2006; Lehr T, 2010, CLIN PHARMACOKINET, V49, P53, DOI 10.2165/11317210-000000000-00000; Krishna G, 2009, CLIN THER, V31, P286, DOI 10.1016/j.clinthera.2009.02.022; Gibbons JA, 2015, CLIN PHARMACOKINET; Haider SI, 2007, INT J CLIN PHARM TH, V45, P643; U.S. Department of Health and Human Services, 2001, GUID IND BIOAN METH; US Department of Health and Human Services. Food and Drug Administration. Guidance for Industry, 2012, GUID IND DRUG INT ST	27	2	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	OCT	2015	54	10					1057	1069		10.1007/s40262-015-0283-1		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS0PM	WOS:000361764200006		
J	Kamiya, Y; Kawada, J; Kawano, Y; Torii, Y; Kawabe, S; Iwata, N; Ito, Y				Kamiya, Yasuko; Kawada, Jun-ichi; Kawano, Yoshihiko; Torii, Yuka; Kawabe, Shinji; Iwata, Naomi; Ito, Yoshinori			Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis	CLINICAL RHEUMATOLOGY			English	Article						Biological agents; Juvenile idiopathic arthritis; micro RNAs; miR-146; miR-155	INNATE IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; CIRCULATING MICRORNAS; EXPRESSION; DISEASES; TOCILIZUMAB; EFFICACY; PLASMA; CANCER; SAFETY	MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression of targeted mRNAs, which are important in the pathogenesis of autoimmune diseases. MiRNAs may have the potential to serve as biomarkers of disease. We evaluated serum levels of selected miRNAs and their associations with disease activity in juvenile idiopathic arthritis (JIA). Sera and peripheral blood leukocytes were collected from patients with JIA (8 systemic onset, 16 polyarthritis) and healthy controls. Levels of miR-16, miR-132, miR-146a, miR-155, and miR-223 were quantified. Levels of miR-223 in sera were significantly higher in patients in the active phase of systemic onset JIA than in controls. MiRNAs of peripheral blood leukocytes did not exhibit any difference between patients with JIA and controls. In both systemic onset JIA and polyarthritis patients, levels of miR-223 and miR-16 correlated with erythrocyte sedimentation rate and matrix metalloproteinase-3, respectively. MiR-146a and miR-223 in polyarthritis showed correlations with matrix metalloproteinase-3. Expressions of miRNAs were altered in patients with JIA. Serum levels of miR-223 may be a potential disease biomarker. Investigation of miRNAs could be helpful in understanding the pathogenesis of JIA and could aid in the identification of additional disease biomarkers.	[Kamiya, Yasuko; Kawada, Jun-ichi; Kawano, Yoshihiko; Torii, Yuka; Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kawabe, Shinji; Iwata, Naomi] Aichi Childrens Hlth & Med Ctr, Dept Infect & Immunol, Obu, Aichi 4748710, Japan	Ito, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	yoshi-i@med.nagoya-u.ac.jp					Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Maeno N, 2002, ARTHRITIS RHEUM, V46, P2539, DOI 10.1002/art.10389; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Duroux-Richard I, 2012, ARTHRITIS RHEUM-US, V64, P11, DOI 10.1002/art.30651; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Chan EKL, 2013, ANN RHEUM DIS, V72, P90, DOI 10.1136/annrheumdis-2012-202203; Foell D, 2004, ARTHRITIS RHEUM, V50, P1286, DOI 10.1002/art.20125; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Lin YT, 2011, AUTOIMMUN REV, V10, P482, DOI 10.1016/j.autrev.2011.02.001; Kawano Y, 2013, J INFECT DIS, V208, P771, DOI 10.1093/infdis/jit222; Hastings ML, 2012, METHODS, V58, P144, DOI 10.1016/j.ymeth.2012.07.026; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frosch M, 2003, ARTHRITIS RHEUM, V48, P2622, DOI 10.1002/art.11177; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Luo X, 2010, ANN RHEUM DIS, V69, P30, DOI 10.1136/ard.2009.117218; Horneff G, 2009, ANN RHEUM DIS, V68, P519, DOI 10.1136/ard.2007.087593; Ferucci ED, 2005, ARTHRITIS RHEUM, V52, P239, DOI 10.1002/art.20773; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; DEBENEDETTI F, 1991, ARTHRITIS RHEUM, V34, P1158, DOI 10.1002/art.1780340912; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493	33	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	OCT	2015	34	10					1705	1712		10.1007/s10067-015-2922-1		8	Rheumatology	Rheumatology	CR9BU	WOS:000361649000007		
J	Guler, HG; Arikawa, T; Oei, T; Yalciner, AC				Guler, Hasan Gokhan; Arikawa, Taro; Oei, Takayuki; Yalciner, Ahmet Cevdet			Performance of rubble mound breakwaters under tsunami attack, a case study: Haydarpasa Port, Istanbul, Turkey	COASTAL ENGINEERING			English	Article						Rubble mound breakwaters; Tsunami attack; Solitary wave; Tsunami overflow experiments		Ports are one of the most vulnerable coastal utilities in case of marine natural hazards such as tsunamis and need to be protected against their devastating effects. Thus, studying the effects of tsunamis on protective structures such as breakwaters is critical. The Sea of Marmara is a part of an active earthquake zone that has generated tsunamis in the history. In terms of population density, coastal utilization, and economic potential, Marmara coastline seems most vulnerable to marine hazards. The availability of natural stones allows for wide use of rubble mound breakwaters as coastal protective structures in Turkey. The stability of these types of structures under the attack of storm waves has already been studied. However, their stability and performance under the effect of long waves and tsunami attacks have not yet been studied experimentally. The present study is a case study focusing on Haydarpasa Port, located at the southern entrance of Istanbul Bosphorus Strait (North coast of the Sea of Marmara). It aims to investigate the performance level of the port in case of tsunami attack. Physical model experiments were conducted in the 105-m long wave flume in the Port and Airport Research Institute (PARI), Japan, with a Froude-type length scale of 1/30. The experiments conducted to test the stability of rubble mound breakwater were twofold: (i) solitary wave experiments and (ii) tsunami overflow experiments. The heights of incoming tsunami waves were selected from results of simulations were conducted in the same region (Oyo Int. Co., 2007; Ayca, 2012; Yalciner et al., 2014; Guler et al., 2014; Aytore, 2015). First, the incoming solitary wave heights were selected as 5, 7.5, and 10 cm. Using the overflow heights obtained from solitary wave experiments, i.e., wave height at the top of crown wall when the solitary waves are overtopping the crown wall, tsunami overflow experiments were conducted ranging from an overflow height of 1.1 cm to 4.6 cm. Results of these experiments showed that Haydarpasa Breakwater, especially the crown wall of the breakwater, is not stable under a moderate tsunami attack. Therefore, an improved cross section was also tested under the same conditions, and the improvement proved successful. (C) 2015 Elsevier B.V. All rights reserved.	[Guler, Hasan Gokhan; Yalciner, Ahmet Cevdet] Middle E Tech Univ, Ocean Engn Res Ctr, Dept Civil Engn, TR-06531 Ankara, Turkey; [Arikawa, Taro; Oei, Takayuki] PARI, Yokosuka, Kanagawa, Japan	Guler, HG (reprint author), Middle E Tech Univ, Ocean Engn Res Ctr, Dept Civil Engn, TR-06531 Ankara, Turkey.	goguler@metu.edu.tr			Japan-Turkey joint Science and Technology Research Partnership for Sustainable Development (SATREPS); ASTARTE Project - FP7 program [60383]; RAPSODI project [CONCERT_Dis-021]; TUBITAK project [113M556]	Support by the Japan-Turkey joint Science and Technology Research Partnership for Sustainable Development (SATREPS) research project MarDIM (Earthquake and Tsunami Disaster Mitigation in the Marmara Region and Disaster Education in Turkey) by Japan Science and Technology Agency (JST) is acknowledged. Partial supports from ASTARTE Project funded by FP7/2007-2013 program with grant agreement No: 60383, and from RAPSODI (CONCERT_Dis-021) project funded in the framework of CONCERT-Japan call for connecting and cooperating European Research and Technology Development with Japan, and from TUBITAK 113M556 project are also acknowledged. Furthermore, detailed reviews and comments of anonymous reviewers that increased the quality of this study are appreciated.	Ahrens J.P., 1975, 51 COAST ENG RES CTR, V51; [Anonymous], 2007, GUID WAV MOD FLUM BA; Madsen PA, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004932; Altinok Y, 2011, NAT HAZARD EARTH SYS, V11, P273, DOI 10.5194/nhess-11-273-2011; Etemad-Shahidi A, 2009, APPL OCEAN RES, V31, P197, DOI 10.1016/j.apor.2009.08.003; Yalciner AC, 2002, MAR GEOL, V190, P445, DOI 10.1016/S0025-3227(02)00358-4; Arikawa T., 2012, INT C COAST ENG ICCE; Ayca A., 2012, THESIS METU ANKARA; Aytore B., 2015, THESIS METU ANKARA; Broderick L.L., 1984, THESIS GEORGE WASHIN; CIRIA CUR CETMEF, 2007, ROCK MAN US ROCK HYD, pC683; Estaban M., 2013, I CIVIL ENG P 2013; Etemad-Shahidi A., 2011, COAST ENG, V59, P38; Guler H.G., 2014, HIGH PERFORMANCE COM; Hedar PA, 1960, THESIS U GOTEBORG SW; Hudson R.Y., 1959, LAB INVESTIGATIONS R; Kato F., 2012, INT C COAST ENG ICCE; Oyo Int Co, 2007, SIM VULN AN TSUN AFF; Thompson D.M., 1976, 61 HRS CIRIA; Van der Meer J.W., 1988, THESIS DELFT U NETHE; Vidal C., 2003, ASCE COAST STRUCT 20, P189; Vidal C., 2006, COAST ENG, V53, P712; Yalciner A.C., 2014, EUR GEOSC UN EGU GEN	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3839	1872-7379		COAST ENG	Coast. Eng.	OCT	2015	104						43	53		10.1016/j.coastaleng.2015.07.007		11	Engineering, Civil; Engineering, Ocean	Engineering	CS0SW	WOS:000361773500004		
